PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dupoiron, S; Zischek, C; Ligat, L; Carbonne, J; Boulanger, A; de Bernonville, TD; Lautier, M; Rival, P; Arlat, M; Jamet, E; Lauber, E; Albenne, C				Dupoiron, Stephanie; Zischek, Claudine; Ligat, Laetitia; Carbonne, Julien; Boulanger, Alice; de Bernonville, Thomas Duge; Lautier, Martine; Rival, Pauline; Arlat, Matthieu; Jamet, Elisabeth; Lauber, Emmanuelle; Albenne, Cecile			The N-Glycan Cluster from Xanthomonas campestris pv. campestris A TOOLBOX FOR SEQUENTIAL PLANT N-GLYCAN PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PYOGENES; ENTEROCOCCUS-FAECALIS; MEDIATES GROWTH; GLYCOSYLATION; PROTEIN; PATHOGENICITY; SECRETION; ENDOS; ACETYLGLUCOSAMINE; ENDOGLYCOSIDASE	N-Glycans are widely distributed in living organisms but represent only a small fraction of the carbohydrates found in plants. This probably explains why they have not previously been considered as substrates exploited by phytopathogenic bacteria during plant infection. Xanthomonas campestris pv. campestris, the causal agent of black rot disease of Brassica plants, possesses a specific system for GlcNAc utilization expressed during host plant infection. This system encompasses a cluster of eight genes (nixE to nixL) encoding glycoside hydrolases (GHs). In this paper, we have characterized the enzymatic activities of these GHs and demonstrated their involvement in sequential degradation of a plant N-glycan using a N-glycopeptide containing two GlcNAcs, three mannoses, one fucose, and one xylose (N2M3FX) as a substrate. The removal of the alpha-1,3-mannose by the alpha-mannosidase NixK (GH92) is a prerequisite for the subsequent action of the beta-xylosidase NixI (GH3), which is involved in the cleavage of the beta-1,2-xylose, followed by the alpha-mannosidase NixJ (GH125), which removes the alpha-1,6-mannose. These data, combined to the subcellular localization of the enzymes, allowed us to propose a model of N-glycopeptide processing by X. campestris pv. campestris. This study constitutes the first evidence suggesting N-glycan degradation by a plant pathogen, a feature shared with human pathogenic bacteria. Plant N-glycans should therefore be included in the repertoire of molecules putatively metabolized by phytopathogenic bacteria during their life cycle.	[Dupoiron, Stephanie; Ligat, Laetitia; Carbonne, Julien; Rival, Pauline; Jamet, Elisabeth; Albenne, Cecile] Univ Toulouse, Lab Rech Sci Vegetales, UMR 5546, F-31326 Castanet Tolosan, France; [Dupoiron, Stephanie; Ligat, Laetitia; Carbonne, Julien; Rival, Pauline; Jamet, Elisabeth; Albenne, Cecile] CNRS, Lab Rech Sci Vegetales, UMR 5546, F-31326 Castanet Tolosan, France; [Zischek, Claudine; Boulanger, Alice; de Bernonville, Thomas Duge; Lautier, Martine; Rival, Pauline; Arlat, Matthieu; Lauber, Emmanuelle] INRA, F-31326 Castanet Tolosan, France; [Zischek, Claudine; Boulanger, Alice; de Bernonville, Thomas Duge; Lautier, Martine; Rival, Pauline; Arlat, Matthieu; Lauber, Emmanuelle] CNRS, Lab Interact Plantes Microorganismes, UMR 2594, F-31326 Castanet Tolosan, France; [Lautier, Martine; Arlat, Matthieu] Univ Toulouse, UPS, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dupoiron, S (corresponding author), Lab Interact Plantes Microorganismes, UMR 2594 441, Chemin Borde Rouge,CS52627, F-31326 Castanet Tolosan, France.	emmanuelle.lauber@toulouse.inra.fr	Lauber, Emmanuelle/ABB-3077-2021; Rival, Pauline/HGU-3018-2022; Jamet, Elisabeth/Z-2476-2019; Arlat, Matthieu/CAH-3310-2022; Boulanger, Alice/E-6279-2019	Lauber, Emmanuelle/0000-0001-5933-4476; Boulanger, Alice/0000-0001-5918-9547; ALBENNE, Cecile/0000-0001-9856-9745; Arlat, Matthieu/0000-0001-6196-4856; Duge de Bernonville, Thomas/0000-0002-2205-2886	French Agence Nationale de la Recherche [ANR-08-BLAN-0193-01]; local Federation de Recherche Agrobiosciences, Interactions et Biodiversite; Universite Paul Sabatier; Centre National de la Recherche Scientifique; Institut National de la Recherche Agronomique; French Ministry of Research and Technology	French Agence Nationale de la Recherche(French National Research Agency (ANR)); local Federation de Recherche Agrobiosciences, Interactions et Biodiversite; Universite Paul Sabatier; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique; French Ministry of Research and Technology	This work was supported by French Agence Nationale de la Recherche Grant ANR-08-BLAN-0193-01, the local Federation de Recherche Agrobiosciences, Interactions et Biodiversite, the Universite Paul Sabatier, the Centre National de la Recherche Scientifique, the Institut National de la Recherche Agronomique, and the French Ministry of Research and Technology (to A.B.).	AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; An HJ, 2010, METHODS MOL BIOL, V600, P199, DOI 10.1007/978-1-60761-454-8_14; ARLAT M, 1991, MOL PLANT MICROBE IN, V4, P593, DOI 10.1094/MPMI-4-593; Berger S, 1995, BIOCHIMIE, V77, P751, DOI 10.1016/0300-9084(96)88193-4; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boulanger A, 2014, MBIO, V5, DOI 10.1128/mBio.01527-14; Boulanger A, 2010, J BACTERIOL, V192, P1487, DOI 10.1128/JB.01418-09; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cao YL, 2014, P NATL ACAD SCI USA, V111, P12901, DOI 10.1073/pnas.1407344111; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Dejean G, 2013, NEW PHYTOL, V198, P899, DOI 10.1111/nph.12187; Faye L, 2005, VACCINE, V23, P1770, DOI 10.1016/j.vaccine.2004.11.003; Garbe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091035; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Horsch M, 1997, PHARMACOL THERAPEUT, V76, P187, DOI 10.1016/S0163-7258(97)00110-1; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jefferson R A, 1987, EMBO J, V6, P3901; Katta S, 2013, FEMS MICROBIOL LETT, V348, P19, DOI 10.1111/1574-6968.12237; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Messner P, 1997, FEMS MICROBIOL REV, V20, P25, DOI 10.1016/S0168-6445(97)00041-7; Meyer D, 2005, MOL PLANT PATHOL, V6, P327, DOI 10.1111/j.1364-3703.2005.00287.x; Miller JH., 1992, SHORT COURSE BACTERI; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118; Roberts G, 2000, J BACTERIOL, V182, P882, DOI 10.1128/JB.182.4.882-890.2000; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sambrook J., 1989, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Suits MDL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009006; Szczesny R, 2010, NEW PHYTOL, V187, P983, DOI 10.1111/j.1469-8137.2010.03312.x; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; TURNER P, 1985, MOL GEN GENET, V199, P338, DOI 10.1007/BF00330277; Wang LF, 2008, MOL PLANT MICROBE IN, V21, P555, DOI 10.1094/MPMI-21-5-0555; Yokouchi D, 2013, GLYCOCONJUGATE J, V30, P463, DOI 10.1007/s10719-012-9441-y; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	53	25	25	4	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6022	6036		10.1074/jbc.M114.624593	http://dx.doi.org/10.1074/jbc.M114.624593			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586188	Green Published, hybrid			2022-12-28	WOS:000350732500014
J	Maruyama, Y; Oiki, S; Takase, R; Mikami, B; Murata, K; Hashimoto, W				Maruyama, Yukie; Oiki, Sayoko; Takase, Ryuichi; Mikami, Bunzo; Murata, Kousaku; Hashimoto, Wataru			Metabolic Fate of Unsaturated Glucuronic/Iduronic Acids from Glycosaminoglycans MOLECULAR IDENTIFICATION AND STRUCTURE DETERMINATION OF STREPTOCOCCAL ISOMERASE AND DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCURONYL HYDROLASE; CRYSTAL-STRUCTURE; GENOME SEQUENCE; SPECIFICITY; PNEUMONIAE; DEGRADATION; PATHOGEN; BACTERIA; STRAIN; DNA	Glycosaminoglycans in mammalian extracellular matrices are degraded to their constituents, unsaturated uronic (glucuronic/iduronic) acids and amino sugars, through successive reactions of bacterial polysaccharide lyase and unsaturated glucuronyl hydrolase. Genes coding for glycosaminoglycan-acting lyase, unsaturated glucuronyl hydrolase, and the phosphotransferase system are assembled into a cluster in the genome of pathogenic bacteria, such as streptococci and clostridia. Here, we studied the streptococcal metabolic pathway of unsaturated uronic acids and the structure/function relationship of its relevant isomerase and dehydrogenase. Two proteins (gbs1892 and gbs1891) of Streptococcus agalactiae strain NEM316 were overexpressed in Escherichia coli, purified, and characterized. 4-Deoxy-L-threo-5-hexosulose-uronate (Dhu) nonenzymatically generated from unsaturated uronic acids was converted to 2-keto-3-deoxy-D-gluconate via 3-deoxy-D-glycero-2,5-hexodiulosonate through successive reactions of gbs1892 isomerase (DhuI) and gbs1891 NADH-dependent reductase/dehydrogenase (DhuD). DhuI and DhuD enzymatically corresponded to 4-deoxy-L-threo-5-hexosulose-uronate ketolisomerase (KduI) and 2-keto-3-deoxy-D-gluconate dehydrogenase (KduD), respectively, involved in pectin metabolism, although no or low sequence identity was observed between DhuI and KduI or between DhuD and KduD, respectively. Genes for DhuI and DhuD were found to be included in the streptococcal genetic cluster, whereas KduI and KduD are encoded in clostridia. Tertiary and quaternary structures of DhuI and DhuD were determined by x-ray crystallography. Distinct from KduI beta-barrels, DhuI adopts an alpha/beta/alpha-barrel structure as a basic scaffold similar to that of ribose 5-phosphateisomerase. The structure of DhuD is unable to accommodate the substrate/cofactor, suggesting that conformational changes are essential to trigger enzyme catalysis. This is the first report on the bacterial metabolism of glycosaminoglycan-derived unsaturated uronic acids by isomerase and dehydrogenase.	[Maruyama, Yukie; Oiki, Sayoko; Takase, Ryuichi; Murata, Kousaku; Hashimoto, Wataru] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Hashimoto, W (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	whasimot@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Mizutani Foundation for Glycoscience	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Mizutani Foundation for Glycoscience	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (to K. M. and W. H.); the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; and a research grant (to W. H.) from the Mizutani Foundation for Glycoscience.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; CONDEMINE G, 1991, MOL MICROBIOL, V5, P2191, DOI 10.1111/j.1365-2958.1991.tb02149.x; CONDEMINE G, 1984, J GEN MICROBIOL, V130, P2839; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Crowther RL, 2005, PROTEINS, V61, P680, DOI 10.1002/prot.20598; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Edwards Thomas E, 2011, BMC Struct Biol, V11, P39, DOI 10.1186/1472-6807-11-39; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hashimoto W, 1997, ARCH BIOCHEM BIOPHYS, V339, P17, DOI 10.1006/abbi.1996.9851; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; HUGOUVIEUXCOTTEPATTAT N, 1994, MOL MICROBIOL, V11, P67, DOI 10.1111/j.1365-2958.1994.tb00290.x; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; Jung J, 2011, APPL MICROBIOL BIOT, V90, P517, DOI 10.1007/s00253-011-3095-8; Kawada-Matsuo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nakamichi Y, 2014, J BIOL CHEM, V289, P4787, DOI 10.1074/jbc.M113.522573; Nakamichi Y, 2011, J BIOL CHEM, V286, P6262, DOI 10.1074/jbc.M110.182618; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; PREISS J, 1963, J BIOL CHEM, V238, P1577; PREISS J, 1962, J BIOL CHEM, V237, P317; Preiss J., 1966, METHOD ENZYMOL, DOI [10.1016/0076-6879(66)09121-3, DOI 10.1016/0076-6879(66)09121-3]; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Rothe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056906; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Starr CR, 2006, INFECT IMMUN, V74, P40, DOI 10.1128/IAI.74.1.40-48.2006; Stern AL, 2011, FEBS J, V278, P793, DOI 10.1111/j.1742-4658.2010.07999.x; Takase R., 2012, ANN M JAP SOC BIOSC, P110; Takase R, 2010, BBA-PROTEINS PROTEOM, V1804, P1925, DOI 10.1016/j.bbapap.2010.05.010; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang RG, 2003, J MOL BIOL, V332, P1083, DOI 10.1016/j.jmb.2003.08.009	52	16	16	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6281	6292		10.1074/jbc.M114.604546	http://dx.doi.org/10.1074/jbc.M114.604546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605731	hybrid, Green Published			2022-12-28	WOS:000350732500034
J	Yang, SP; Zhang, L; Chen, XC; Chen, YH; Dong, JX				Yang, Shuping; Zhang, Lin; Chen, Xingcheng; Chen, Yuanhong; Dong, Jixin			Oncoprotein YAP Regulates the Spindle Checkpoint Activation in a Mitotic Phosphorylation-dependent Manner through Up-regulation of BubR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; GENE-EXPRESSION; CDK1 PHOSPHORYLATION; PHOSPHATASE CDC14A; TISSUE-GROWTH; SIZE-CONTROL; ORGAN SIZE; KINASE	The transcriptional co-activator YAP (Yes-associated protein) functions as an oncogene; however, it is largely unclear how YAP exerts its oncogenic role. In this study, we further explored the functional significance of YAP and its mitotic phosphorylation in the spindle checkpoint. We found that the dynamic mitotic phosphorylation of YAP was CDC14-dependent. We also showed that YAP was required for the spindle checkpoint activation induced by spindle poisons. Mitotic phosphorylation of YAP was required for activation of the spindle checkpoint. Furthermore, enhanced expression of active YAP hyperactivated the spindle checkpoint and induced mitotic defects in a mitotic phosphorylation-dependent manner. Mechanistically, we documented that mitotic phosphorylation of YAP controlled transcription of genes associated with the spindle checkpoint. YAP constitutively associated with BubR1 (BUB1-related protein kinase), and knockdown of BubR1 relieved YAP-driven hyperactivation of the spindle checkpoint. Finally, we demonstrated that YAP promoted epithelial cell invasion via both mitotic phosphorylation and BubR1-dependent mechanisms. Together, our results reveal a novel link between YAP and the spindle checkpoint and indicate a potential mechanism underlying the oncogenic function of YAP through dysregulation of the spindle checkpoint.	[Yang, Shuping] Shandong Univ, Shandong Prov Hosp, Dept Oncol, Jinan 250021, Shandong, Peoples R China; [Yang, Shuping; Zhang, Lin; Chen, Xingcheng; Chen, Yuanhong; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	dongj@unmc.edu	Chen, Xingcheng/AAL-3210-2020		National Institutes of Health [5P30 GM106397, R01 GM109066]; Department of Defense Health Program through the Prostate Cancer Research Program [W81XWH-14-1-0150]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109066, P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Health Program through the Prostate Cancer Research Program(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P30 GM106397 and R01 GM109066 (to J. D.). This work was also supported by Grant W81XWH-14-1-0150 from the Department of Defense Health Program through the Prostate Cancer Research Program (to J. D.).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Esteban V, 2006, CELL CYCLE, V5, P2894, DOI 10.4161/cc.5.24.3566; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Florindo C, 2012, J CELL SCI, V125, P3085, DOI 10.1242/jcs.097147; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Hansen CA, 2008, CELL CYCLE, V7, P325, DOI 10.4161/cc.7.3.5354; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Ji M, 2012, BIOCHEM J, V447, P93, DOI 10.1042/BJ20120751; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lanzetti L, 2007, J BIOL CHEM, V282, P15258, DOI 10.1074/jbc.M700914200; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park HW, 2013, TRENDS PHARMACOL SCI, V34, P581, DOI 10.1016/j.tips.2013.08.006; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Shimizu T, 2008, GENETICS, V178, P957, DOI 10.1534/genetics.107.081570; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Tumurbaatar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014711; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vazquez-Novelle MD, 2010, J BIOL CHEM, V285, P40544, DOI 10.1074/jbc.M110.133009; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yamamoto Y, 2007, CANCER GENET CYTOGEN, V174, P42, DOI 10.1016/j.cancergencyto.2006.11.012; Yang SP, 2014, CELL SIGNAL, V26, P343, DOI 10.1016/j.cellsig.2013.11.012; Yang SP, 2013, CANCER RES, V73, P6722, DOI 10.1158/0008-5472.CAN-13-2049; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang L, 2012, J BIOL CHEM, V287, P34069, DOI 10.1074/jbc.M112.385518; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	59	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6191	6202		10.1074/jbc.M114.624411	http://dx.doi.org/10.1074/jbc.M114.624411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605730	hybrid, Green Published			2022-12-28	WOS:000350732500027
J	Menden, H; Welak, S; Cossette, S; Ramchandran, R; Sampath, V				Menden, Heather; Welak, Scott; Cossette, Stephanie; Ramchandran, Ramani; Sampath, Venkatesh			Lipopolysaccharide (LPS)-mediated Angiopoietin-2-dependent Autocrine Angiogenesis Is Regulated by NADPH Oxidase 2 (Nox2) in Human Pulmonary Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG INJURY; BRONCHOPULMONARY DYSPLASIA; GROWTH-FACTORS; MESSENGER-RNA; EXPRESSION; ANGIOPOIETINS; MODEL; TIE2; GENE; ACTIVATION	Sepsis-mediated endothelial Angiopoeitin-2 (Ang2) signaling may contribute to microvascular remodeling in the developing lung. The mechanisms by which bacterial cell wall components such as LPS mediate Ang2 signaling in human pulmonary microvascular endothelial cells (HPMECs) remain understudied. In HPMEC, LPS-induced Ang2, Tie2, and VEGF-A protein expression was preceded by increased superoxide formation. NADPH oxidase 2 (Nox2) inhibition, but not Nox4 or Nox1 inhibition, attenuated LPS-induced superoxide formation and Ang2, Tie2, and VEGF-A expression. Nox2 silencing, but not Nox4 or Nox1 silencing, inhibited LPS-mediated inhibitor of kappa-B kinase beta (IKK beta) and p38 phosphorylation and nuclear translocation of NF-kappa B and AP-1. In HPMECs, LPS increased the number of angiogenic tube and network formations in Matrigel by >3-fold. Conditioned media from LPS-treated cells also induced angiogenic tube and network formation in the presence of Toll-like receptor 4 blockade but not in the presence of Ang2 and VEGF blockade. Nox2 inhibition or conditioned media from Nox2-silenced cells attenuated LPS-induced tube and network formation. Ang2 and VEGF-A treatment rescued angiogenesis in Nox2-silenced cells. We propose that Nox2 regulates LPS-mediated Ang2-dependent autocrine angiogenesis in HPMECs through the IKK beta/NF-kappa B and MAPK/AP-1 pathways.	[Menden, Heather; Welak, Scott; Cossette, Stephanie; Ramchandran, Ramani; Sampath, Venkatesh] Med Coll Wisconsin, Childrens Res Inst, Dept Pediat, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Childrens Res Inst, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Sampath, V (corresponding author), Childrens Corp Ctr, Dept Pediat, Suite 410,999 N 92nd St, Wauwatosa, WI 53226 USA.	vsampath@mcw.edu			National Institutes of Health [1R03HD062693-01A1, 8KL2TR000056, HL102745]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD062693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123338, R01HL102745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03HD062693-01A1 and 8KL2TR000056 (to V. S.) and HL102745 (to S. C. and R. R.).	Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carnesecchi S, 2012, CELL MOL LIFE SCI, V69, P2373, DOI 10.1007/s00018-012-1013-6; Chen J.-X., 2006, AM J PHYSIOL-HEART C, V291, pH1563; Cifuentes-Pagano E, 2014, ANTIOXID REDOX SIGN, V20, P2741, DOI 10.1089/ars.2013.5620; Cordero L, 1997, PEDIATR INFECT DIS J, V16, P18, DOI 10.1097/00006454-199701000-00005; David S, 2011, AM J PHYSIOL-LUNG C, V300, pL851, DOI 10.1152/ajplung.00459.2010; Fakler CR, 2000, INFLAMM RES, V49, P63, DOI 10.1007/s000110050560; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Hato T, 2009, BIOCHEM BIOPH RES CO, V381, P218, DOI 10.1016/j.bbrc.2009.02.030; Hayes AJ, 1999, MICROVASC RES, V58, P224, DOI 10.1006/mvre.1999.2179; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Hewett PW, 1998, BIOCHEM BIOPH RES CO, V252, P546, DOI 10.1006/bbrc.1998.9690; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00001; Josko J, 2004, MED SCI MONITOR, V10, pRA89; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Loukili N, 2010, J BIOL CHEM, V285, P15746, DOI 10.1074/jbc.M110.103259; Medford ARL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-27; Medhora M, 2008, AM J PHYSIOL-LUNG C, V294, pL676, DOI 10.1152/ajplung.00496.2007; Menden H, 2013, AM J PHYSIOL-LUNG C, V304, pL445, DOI 10.1152/ajplung.00261.2012; Miyoshi T, 2010, IMMUNOLOGY, V131, P331, DOI 10.1111/j.1365-2567.2010.03303.x; Mofarrahi M, 2008, AM J PHYSIOL-LUNG C, V294, pL955, DOI 10.1152/ajplung.00449.2007; Oh YT, 2008, NEUROSCI LETT, V431, P155, DOI 10.1016/j.neulet.2007.11.033; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; Patel DN, 2006, BIOCHEM BIOPH RES CO, V347, P1113, DOI 10.1016/j.bbrc.2006.07.015; Peng TQ, 2004, FASEB J, V18, P293, DOI 10.1096/fj.04-2289fje; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Takac I, 2012, CURR HYPERTENS REP, V14, P70, DOI 10.1007/s11906-011-0238-3; Teng RJ, 2009, AM J PHYSIOL-LUNG C, V297, pL184, DOI 10.1152/ajplung.90455.2008; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Thomas W, 2011, PEDIATR PULM, V46, P777, DOI 10.1002/ppul.21435; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; van der Heijden M, 2010, SHOCK, V33, P263, DOI 10.1097/SHK.0b013e3181b2f978; van Meurs M, 2009, CRIT CARE, V13, DOI 10.1186/cc7153; Veronese FM, 2002, ADV DRUG DELIVER REV, V54, P587, DOI 10.1016/S0169-409X(02)00029-7; Willam C, 2000, CIRC RES, V87, P370; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; Yang J, 2010, CHIN J TRAUMATOL, V13, P308, DOI 10.3760/cma.j.issn.1008-1275.2010.05.011; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549	52	52	52	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5449	5461		10.1074/jbc.M114.600692	http://dx.doi.org/10.1074/jbc.M114.600692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568324	Green Published, hybrid			2022-12-28	WOS:000350044200018
J	Pandey, G; Makhija, E; George, N; Chakravarti, B; Godbole, MM; Ecelbarger, CM; Tiwari, S				Pandey, Gaurav; Makhija, Ekta; George, Nelson; Chakravarti, Bandana; Godbole, Madan M.; Ecelbarger, Carolyn M.; Tiwari, Swasti			Insulin Regulates Nitric Oxide Production in the Kidney Collecting Duct Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; FACTOR-I RECEPTOR; BLOOD-PRESSURE; IGF-I; NO PRODUCTION; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; RENAL-DISEASE; SYNTHASE; MICE	The kidney is an important organ for arterial blood pressure (BP) maintenance. Reduced NO generation in the kidney is associated with hypertension in insulin resistance. NO is a critical regulator of vascular tone; however, whether insulin regulates NO production in the renal inner medullary collecting duct (IMCD), the segment with the greatest enzymatic activity for NO production in kidney, is not clear. Using an NO-sensitive 4-amino-5-methylarnino-2',7'-difluorofluorescein (DAF-FM) fluorescent dye, we found that insulin increased NO production in mouse IMCD cells (mIMCD) in a time- and dose-dependent manner. A concomitant dose-dependent increase in the NO metabolite (N0x) was also observed in the medium from insulin-stimulated cells. NO production peaked in mIMCD cells at a dose of 100 nM insulin with simultaneously increased NOx levels in the medium. At this dose, insulin significantly increased p-eNOS(Ser1177) levels in mIMCD cells. Pretreatment of cells with a PI 3-kinase inhibitor or insulin receptor silencing with RNA interference abolished these effects of insulin, whereas insulin-like growth factor-1 receptor (IGF-IR) silencing had no effect. We also showed that chronic insulin infusion to normal C57BL/6J mice resulted in increased endothelial NOS (eNOS) protein levels and NO production in the inner medulla. However, insulin-infused IRK() mice, with targeted deletion of insulin receptor from tubule epithelial cells of the kidney, had similar to 50% reduced eNOS protein levels in their inner medulla along with a significant rise in BP relative to WT littermates. We have previously reported increased baseline BP and reduced urine NOx in IRK() mice. Thus, reduced insulin receptor signaling in IMCD could contribute to hypertension in the insulin-resistant state.	[Pandey, Gaurav; Makhija, Ekta; George, Nelson; Chakravarti, Bandana; Godbole, Madan M.; Tiwari, Swasti] Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, 4th Fl,PMMSY Bldg, Lucknow 226014, Uttar Pradesh, India; [Ecelbarger, Carolyn M.] Georgetown Univ, Dept Med, Div Endocrinol & Metab, Washington, DC USA	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Georgetown University	Tiwari, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, 4th Fl,PMMSY Bldg, Lucknow 226014, Uttar Pradesh, India.	tiwaris@sgpgi.ac.in			Ramalingaswami grant from the Department of Biotechnology; University Grant Commission; Research Fellowship SERB-Fast Track Grant from the Government of India; National Institutes of Health [R01 DK082507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082507] Funding Source: NIH RePORTER	Ramalingaswami grant from the Department of Biotechnology; University Grant Commission(University Grants Commission, India); Research Fellowship SERB-Fast Track Grant from the Government of India; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Ramalingaswami grant from the Department of Biotechnology (to S. T.).r Supported by a Research Fellowship from the University Grant Commission.r Supported by a Research Fellowship SERB-Fast Track Grant from the Government of India.r Supported by National Institutes of Health Grant R01 DK082507.	Abbas A, 2011, DIABETES, V60, P2169, DOI 10.2337/db11-0197; BODEN G, 1994, J CLIN ENDOCR METAB, V78, P657, DOI 10.1210/jc.78.3.657; Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270, DOI 10.1152/ajprenal.2000.279.2.F270; COHEN DM, 1994, J BIOL CHEM, V269, P25865; Cowley AW, 2003, AM J PHYSIOL-REG I, V284, pR1355, DOI 10.1152/ajpregu.00701.2002; Ecelbarger CA, 2001, J AM SOC NEPHROL, V12, P207, DOI 10.1681/ASN.V122207; Ecelbarger CA, 2000, AM J PHYSIOL-RENAL, V279, pF46, DOI 10.1152/ajprenal.2000.279.1.F46; Elkayam U, 1996, J AM COLL CARDIOL, V28, P176, DOI 10.1016/0735-1097(96)00092-7; Erdely A, 2004, DIABETOLOGIA, V47, P1672, DOI 10.1007/s00125-004-1509-1; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Frikke-Schmidt H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076060; GARVEY WT, 1986, DIABETES, V35, P258, DOI 10.2337/diabetes.35.3.258; Gatenby VK, 2013, PFLUG ARCH EUR J PHY, V465, P1065, DOI 10.1007/s00424-013-1218-z; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grote CW, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-15; Johansson GS, 2008, MOL CELL ENDOCRINOL, V296, P58, DOI 10.1016/j.mce.2008.07.012; Kalani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060177; Kaulfuss S, 2009, MOL CANCER THER, V8, P821, DOI 10.1158/1535-7163.MCT-09-0058; Kikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095451; Kojima H, 1998, NEUROREPORT, V9, P3345, DOI 10.1097/00001756-199810260-00001; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Li GL, 2005, ENDOCRINOLOGY, V146, P4690, DOI 10.1210/en.2005-0505; Li LJ, 2013, AM J PHYSIOL-RENAL, V304, pF279, DOI 10.1152/ajprenal.00161.2012; Li LJ, 2012, AM J PHYSIOL-REG I, V303, pR505, DOI 10.1152/ajpregu.00033.2012; Lin SY, 1997, CHINESE MED J-PEKING, V110, P515; MATTSON DL, 1994, AM J PHYSIOL, V266, pH1918, DOI 10.1152/ajpheart.1994.266.5.H1918; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Muniyappa R, 2012, DIABETES, V61, P2225, DOI 10.2337/db12-0654; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Repetto S, 2005, BIOCHEM BIOPH RES CO, V337, P849, DOI 10.1016/j.bbrc.2005.09.125; Rojas FA, 2003, ENDOCRINE, V21, P115, DOI 10.1385/ENDO:21:2:115; Scherrer U, 1997, CIRCULATION, V96, P4104; Schmetterer L, 1997, DIABETES, V46, P1868, DOI 10.2337/diabetes.46.11.1868; Schmidt RJ, 2000, KIDNEY INT, V58, P1261, DOI 10.1046/j.1523-1755.2000.00281.x; Schmidt RJ, 1999, AM J PHYSIOL-RENAL, V276, pF794, DOI 10.1152/ajprenal.1999.276.5.F794; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Song J, 2006, AM J PHYSIOL-RENAL, V290, pF1055, DOI 10.1152/ajprenal.00108.2005; Tan Dun-Yong, 2000, Shengli Xuebao, V52, P103; ter Maaten JC, 2000, EUR J CLIN INVEST, V30, P1090, DOI 10.1046/j.1365-2362.2000.00749.x; ter Maaten JC, 2001, J HYPERTENS, V19, P1633, DOI 10.1097/00004872-200109000-00016; Tiwari S, 2008, P NATL ACAD SCI USA, V105, P6469, DOI 10.1073/pnas.0711283105; Tiwari S, 2007, AM J PHYSIOL-RENAL, V293, pF178, DOI 10.1152/ajprenal.00447.2006; Tiwari S, 2013, J AM SOC NEPHROL, V24, P1209, DOI 10.1681/ASN.2012060628; Tiwari S, 2009, AM J NEPHROL, V30, P554, DOI 10.1159/000252776; Trujillo J, 2005, AM J PHYSIOL-RENAL, V288, pF108, DOI 10.1152/ajprenal.00077.2004; Tsuchiya A, 2014, J ENDOCRINOL, V220, P49, DOI 10.1530/JOE-13-0172; Turini P, 2007, SWISS MED WKLY, V137, P700, DOI 2007/49/smw-11950; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; VENKATESAN N, 1995, METABOLISM, V44, P75, DOI 10.1016/0026-0495(95)90292-9; Wang Y, 2004, NITRIC OXIDE-BIOL CH, V10, P25, DOI 10.1016/j.niox.2004.02.001; Wu F, 1999, AM J PHYSIOL-RENAL, V276, pF874, DOI 10.1152/ajprenal.1999.276.6.F874; ZEIDEL ML, 1987, AM J PHYSIOL, V252, pF551, DOI 10.1152/ajprenal.1987.252.3.F551; Zimpelmann J, 2003, AM J PHYSIOL-RENAL, V285, pF1160, DOI 10.1152/ajprenal.00077.2003	57	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5582	5591		10.1074/jbc.M114.592741	http://dx.doi.org/10.1074/jbc.M114.592741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25533472	Green Published, hybrid			2022-12-28	WOS:000350044200029
J	Rouget, R; Sharma, G; LeBlanc, AC				Rouget, Raphael; Sharma, Gyanesh; LeBlanc, Andrea C.			Cyclin-dependent Kinase 5 Phosphorylation of Familial Prion Protein Mutants Exacerbates Conversion into Amyloid Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; NEURONAL CDK5 ACTIVATOR; N-TERMINAL REGION; CONFORMATIONAL-CHANGE; Y145STOP VARIANT; APLYSIA CPEB; IN-VITRO; SCRAPIE; DISEASES; ISOFORM	Familial prion protein (PrP) mutants undergo conversion from soluble and protease-sensitive to insoluble and partially protease-resistant proteins. Cyclin-dependent kinase 5 (Cdk5) phosphorylation of wild type PrP (pPrP) at serine 43 induces a conversion of PrP into aggregates and fibrils. Here, we investigated whether familial PrP mutants are predisposed to Cdk5 phosphorylation and whether phosphorylation of familial PrP mutants increases conversion. PrP mutants representing three major familial PrP diseases and different PrP structural domains were studied. We developed a novel in vitro kinase reaction coupled with Thioflavin T binding to amyloid structure assay to monitor phosphorylation-dependent amyloid conversion. Although non-phosphorylated full-length wild type or PrP mutants did not convert into amyloid, Cdk5 phosphorylation rapidly converted these into Thioflavin T-positive structures following first order kinetics. Dephosphorylation partially reversed conversion. Phosphorylation-dependent conversion of PrP from alpha-helical structures into beta-sheet structures was confirmed by circular dichroism. Relative to wild type pPrP, most PrP mutants showed increased rate constants of conversion. In contrast, non-phosphorylated truncated PrP Y145X (where X represents a stop codon) and Q160X mutants converted spontaneously into Thioflavin T-positive fibrils after a lag phase of over 20 h, indicating nucleation-dependent polymerization. Phosphorylation reduced the lag phase by over 50% and thus accelerated the formation of the nucleating event. Consistently, phosphorylated Y145X and phosphorylated Q160X exacerbated conversion in a homologous seeding reaction, whereas WT pPrP could not seed WT PrP. These results demonstrate an influence of both the N terminus and the C terminus of PrP on conversion. We conclude that post-translational modifications of the flexible N terminus of PrP can cause or exacerbate PrP mutant conversion.	[Rouget, Raphael; Sharma, Gyanesh; LeBlanc, Andrea C.] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Neurol & Neurosurg, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Sharma, Gyanesh; LeBlanc, Andrea C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	Lady Davis Institute; McGill University; McGill University	LeBlanc, AC (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Ch Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	andrea.leblanc@mcgill.ca			National Institutes of Health [1R21NS06114]; Canadian Institutes of Health Research [MOP89376, MOP 102738]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21NS06114 (to A. L. B.). This work was also supported by Canadian Institutes of Health Research Operating Grants MOP89376 and MOP 102738 (to A. L. B.).	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Asada A, 2012, J CELL SCI, V125, P3421, DOI 10.1242/jcs.100503; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Blanch EW, 2004, J MOL BIOL, V343, P467, DOI 10.1016/j.jmb.2004.08.058; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Fournier JG, 2008, CELL TISSUE RES, V332, P1, DOI 10.1007/s00441-007-0565-5; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frankenfield KN, 2005, PROTEIN SCI, V14, P2154, DOI 10.1110/ps.051434005; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Giannopoulos PN, 2009, J NEUROSCI, V29, P8743, DOI 10.1523/JNEUROSCI.2294-09.2009; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Gilch S, 2003, J BIOL CHEM, V278, P18524, DOI 10.1074/jbc.M210723200; Gill AC, 2000, EMBO J, V19, P5324, DOI 10.1093/emboj/19.20.5324; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Jodoin J, 2007, J NEUROSCI, V27, P5081, DOI 10.1523/JNEUROSCI.0957-07.2007; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; Kretzschmar H, 2013, BRAIN PATHOL, V23, P321, DOI 10.1111/bpa.12045; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Ladner-Keay CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098753; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Magzoub M, 2006, BIOCHEM BIOPH RES CO, V348, P379, DOI 10.1016/j.bbrc.2006.07.065; Maji S. K., 2009, SCIENCE, V325, P328; Masujin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058013; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Negro A, 2000, BIOCHEM BIOPH RES CO, V271, P337, DOI 10.1006/bbrc.2000.2628; Nishina K, 2004, BIOCHEMISTRY-US, V43, P2613, DOI 10.1021/bi035889l; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Rahaman H, 2012, BIOCHEMISTRY-US, V51, P5521, DOI 10.1021/bi300380h; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Raveendra BL, 2013, NAT STRUCT MOL BIOL, V20, P495, DOI 10.1038/nsmb.2503; Schmitz M, 2014, NEUROBIOL AGING, V35, P1177, DOI 10.1016/j.neurobiolaging.2013.11.010; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Wang F, 2010, BIOCHEMISTRY-US, V49, P8169, DOI 10.1021/bi101146v; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang GR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-86; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Watzlawik J, 2006, J BIOL CHEM, V281, P30242, DOI 10.1074/jbc.M605141200; Yoshikawa D, 2008, J BIOL CHEM, V283, P24202, DOI 10.1074/jbc.M804212200; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105	74	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5759	5771		10.1074/jbc.M114.630699	http://dx.doi.org/10.1074/jbc.M114.630699			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572400	Green Published, hybrid			2022-12-28	WOS:000350044200043
J	Vallabhaneni, H; Zhou, F; Maul, RW; Sarkar, J; Yin, JH; Lei, M; Harrington, L; Gearhart, PJ; Liu, Y				Vallabhaneni, Haritha; Zhou, Fang; Maul, Robert W.; Sarkar, Jaya; Yin, Jinhu; Lei, Ming; Harrington, Lea; Gearhart, Patricia J.; Liu, Yie			Defective Repair of Uracil Causes Telomere Defects in Mouse Hematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID EXCHANGE; BASE EXCISION-REPAIR; SINGLE-STRANDED-DNA; REVERSE-TRANSCRIPTASE; LENGTH REGULATOR; FRAGILE SITES; POT1; TRF1; PROTEIN; DAMAGE	Calcium transients in the cell nucleus evoked by synaptic activity in hippocampal neurons function as a signaling end point in synapse-to-nucleus communication. As an important regulator of neuronal gene expression, nuclear calcium is involved in the conversion of synaptic stimuli into functional and structural changes of neurons. Here we identify two synaptic organizers, Lrrtm1 and Lrrtm2, as targets of nuclear calcium signaling. Expression of both Lrrtm1 and Lrrtm2 increased in a synaptic NMDA receptor- and nuclear calcium-dependent manner in hippocampal neurons within 2-4 h after the induction of action potential bursting. Induction of Lrrtm1 and Lrrtm2 occurred independently of the need for new protein synthesis and required calcium/calmodulin-dependent protein kinases and the nuclear calcium signaling target CREB-binding protein. Analysis of reporter gene constructs revealed a functional cAMP response element in the proximal promoter of Lrrtm2, indicating that at least Lrrtm2 is regulated by the classical nuclear Ca2+ /calmodulin-dependent protein kinase IV-CREB/CREB-binding protein pathway. These results suggest that one mechanism by which nuclear calcium signaling controls neuronal network function is by regulating the expression of Lrrtm1 and Lrrtm2.	[Vallabhaneni, Haritha; Zhou, Fang; Sarkar, Jaya; Yin, Jinhu; Liu, Yie] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Maul, Robert W.; Gearhart, Patricia J.] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Lei, Ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Harrington, Lea] Univ Montreal, Inst Res Immunol & Canc, Dept Med, Montreal, PQ H3C 3J7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Universite de Montreal	Gearhart, PJ (corresponding author), NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA.	gearhartp@mail.nih.gov; liuyie@mail.nih.gov	Maul, Robert W./Y-6818-2019; Liu, Yie/AAO-2092-2020; Gearhart, Patricia/Y-7227-2019		Intramural Research Program of the National Institutes of Health, NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000744, ZIAAG000777] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported entirely by the Intramural Research Program of the National Institutes of Health, NIA.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Bailey SM, 2004, CYTOGENET GENOME RES, V107, P14, DOI 10.1159/000079565; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; COLLINS K, 1995, EMBO J, V14, P5422, DOI 10.1002/j.1460-2075.1995.tb00226.x; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Drosopoulos WC, 2007, NUCLEIC ACIDS RES, V35, P1155, DOI 10.1093/nar/gkm002; Frescas D, 2014, J BIOL CHEM, V289, P24180, DOI 10.1074/jbc.M114.592592; Frescas D, 2014, MOL CELL BIOL, V34, P1349, DOI 10.1128/MCB.01052-13; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Hammond PW, 1997, NUCLEIC ACIDS RES, V25, P3698, DOI 10.1093/nar/25.18.3698; HARRINGTON L, 1995, J BIOL CHEM, V270, P8893, DOI 10.1074/jbc.270.15.8893; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Huard S, 2004, NUCLEIC ACIDS RES, V32, P2171, DOI 10.1093/nar/gkh546; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Liu Y, 2012, MURINE MODELS DYSFUN; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lu J, 2010, EMBO J, V29, P398, DOI 10.1038/emboj.2009.355; Lue NF, 2013, NAT STRUCT MOL BIOL, V20, P10, DOI 10.1038/nsmb.2483; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Oulton R, 2004, MOL BIOL CELL, V15, P3244, DOI 10.1091/mbc.E04-03-0178; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Rhee DB, 2010, HUM MOL GENET, V19, P879, DOI 10.1093/hmg/ddp556; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Seow WJ, 2014, CANCER RES, V74, P4090, DOI 10.1158/0008-5472.CAN-14-0459; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Skordalakes E., 2012, TERT STRUCTURE FUNCT; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Taboski MAS, 2012, CELL REP, V1, P91, DOI 10.1016/j.celrep.2011.12.004; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tzfati Y., 2012, TELOMERASE RNA STRUC; Vallabhaneni H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003639; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wan BB, 2013, CELL REP, V4, P861, DOI 10.1016/j.celrep.2013.08.017; Wang F, 2012, CELL RES, V22, P757, DOI 10.1038/cr.2011.201; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; Wang YS, 2005, CELL CYCLE, V4, P1320, DOI 10.4161/cc.4.10.2075; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026; Zheng YL, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28705	68	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5502	5511		10.1074/jbc.M114.607101	http://dx.doi.org/10.1074/jbc.M114.607101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572391	Green Published, hybrid			2022-12-28	WOS:000350044200022
J	Akhtar, P; Dorogi, M; Pawlak, K; Kovacs, L; Bota, A; Kiss, T; Garab, G; Lambrev, PH				Akhtar, Parveen; Dorogi, Marta; Pawlak, Krzysztof; Kovacs, Laszlo; Bota, Attila; Kiss, Terez; Garab, Gyozo; Lambrev, Petar H.			Pigment Interactions in Light-harvesting Complex II in Different Molecular Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL-A/B COMPLEX; PHOTOPROTECTIVE ENERGY-DISSIPATION; TIME-RESOLVED FLUORESCENCE; PHOTOSYSTEM-II; THYLAKOID MEMBRANES; HIGHER-PLANTS; CHLOROPLAST MEMBRANES; CIRCULAR-DICHROISM; EXCITATION-ENERGY; NONBILAYER LIPIDS	Extraction of plant light-harvesting complex II (LHCII) from the native thylakoid membrane or from aggregates by the use of surfactants brings about significant changes in the excitonic circular dichroism (CD) spectrum and fluorescence quantum yield. To elucidate the cause of these changes, e.g. trimer-trimer contacts or surfactant-induced structural perturbations, we compared the CD spectra and fluorescence kinetics of LHCII aggregates, artificial and native LHCII-lipid membranes, and LHCII solubilized in different detergents or trapped in polymer gel. By this means we were able to identify CD spectral changes specific to LHCII-LHCII interactions, at (-)-437 and (+)-484 nm, and changes specific to the interaction with the detergent n-dodecyl-beta-maltoside (beta-DM) or membrane lipids, at (+)-447 and (-)-494 nm. The latter change is attributed to the conformational change of the LHCII-bound carotenoid neoxanthin, by analyzing the CD spectra of neoxanthin-deficient plant thylakoid membranes. The neoxanthin-specific band at (-)-494 nm was not pronounced in LHCII in detergent-free gels or solubilized in the alpha isomer of DM but was present when LHCII was reconstituted in membranes composed of phosphatidylcholine or plant thylakoid lipids, indicating that the conformation of neoxanthin is sensitive to the molecular environment. Neither the aggregation-specific CD bands, nor the surfactant-specific bands were positively associated with the onset of fluorescence quenching, which could be triggered without invoking such spectral changes. Significant quenching was not active in reconstituted LHCII proteoliposomes, whereas a high degree of energetic connectivity, depending on the lipid: protein ratio, in these membranes allows for efficient light harvesting.	[Akhtar, Parveen; Dorogi, Marta; Pawlak, Krzysztof; Kovacs, Laszlo; Garab, Gyozo; Lambrev, Petar H.] Hungarian Acad Sci, Biol Res Ctr, H-6726 Szeged, Hungary; [Bota, Attila; Kiss, Terez] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Mat & Environm Chem, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Lambrev, PH (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Temesvari Krt 62, H-6726 Szeged, Hungary.	lambrev@brc.hu	Kovács, Laszlo/M-2619-2016; Akhtar, Parveen/AHD-5996-2022; Lambrev, Petar H./D-3071-2017; Garab, Gyozo/AAN-5132-2021	Kovács, Laszlo/0000-0002-7337-5626; Akhtar, Parveen/0000-0002-3264-7154; Lambrev, Petar H./0000-0001-5147-153X; Garab, Gyozo/0000-0002-3869-9959	Hungarian Scientific Research Fund [OTKA-PD 104530, TAMOP-4.2.2.A-11/1/KONV-2012-0060]; Hungarian National Innovation Office; A*STAR Singapore [TET_10-1-2011-0279]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Innovation Office; A*STAR Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Hungarian Scientific Research Fund Grants OTKA-PD 104530 and TAMOP-4.2.2.A-11/1/KONV-2012-0060 and Hungarian National Innovation Office and A*STAR Singapore Grant TET_10-1-2011-0279.	Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Aro EM, 2003, ANTIOXID REDOX SIGN, V5, P55, DOI 10.1089/152308603321223540; BARBER J, 1982, ANNU REV PLANT PHYS, V33, P261, DOI 10.1146/annurev.pp.33.060182.001401; Barzda V, 1996, BIOCHEMISTRY-US, V35, P8981, DOI 10.1021/bi960114g; Barzda V, 1996, BBA-BIOENERGETICS, V1273, P231, DOI 10.1016/0005-2728(95)00147-6; Belgio E, 2012, BIOPHYS J, V102, P2761, DOI 10.1016/j.bpj.2012.05.004; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Garab G, 2000, TRENDS PLANT SCI, V5, P489, DOI 10.1016/S1360-1385(00)01767-2; Garab G, 1999, AUST J PLANT PHYSIOL, V26, P649, DOI 10.1071/PP99069; Garab G, 2009, PHOTOSYNTH RES, V101, P135, DOI 10.1007/s11120-009-9424-4; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; Haferkamp S, 2010, J BIOL CHEM, V285, P17020, DOI 10.1074/jbc.M109.077750; Hobe S, 2006, J BIOL CHEM, V281, P25156, DOI 10.1074/jbc.M604828200; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; Johnson MP, 2012, PLANTA, V235, P193, DOI 10.1007/s00425-011-1502-0; Kirchhoff H, 2013, PLANT PHYSIOL, V161, P497, DOI 10.1104/pp.112.207548; Lambrev PH, 2007, BBA-BIOENERGETICS, V1767, P847, DOI 10.1016/j.bbabio.2007.01.010; Lambrev PH, 2011, BBA-BIOENERGETICS, V1807, P1022, DOI 10.1016/j.bbabio.2011.05.003; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; MULLET JE, 1980, BIOCHIM BIOPHYS ACTA, V589, P100, DOI 10.1016/0005-2728(80)90135-8; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; NUSSBERGER S, 1994, BIOCHEMISTRY-US, V33, P14775, DOI 10.1021/bi00253a016; Opacic M, 2014, J MEMBRANE BIOL, V247, P1031, DOI 10.1007/s00232-014-9712-6; Pagliano C, 2012, BBA-BIOENERGETICS, V1817, P1506, DOI 10.1016/j.bbabio.2011.11.001; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; RUBAN AV, 1995, BIOCHEMISTRY-US, V34, P2333, DOI 10.1021/bi00007a029; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Rutkauskas D, 2012, CHEM PHYS, V404, P123, DOI 10.1016/j.chemphys.2012.05.002; Simidjiev I, 2000, P NATL ACAD SCI USA, V97, P1473, DOI 10.1073/pnas.97.4.1473; Wilk L, 2013, P NATL ACAD SCI USA, V110, P5452, DOI 10.1073/pnas.1205561110; Yang CH, 2008, BBA-BIOENERGETICS, V1777, P1463, DOI 10.1016/j.bbabio.2008.08.009; Yang CH, 2006, BBA-BIOENERGETICS, V1757, P1642, DOI 10.1016/j.bbabio.2006.08.010; Zhou F, 2009, PHOTOSYNTH RES, V99, P185, DOI 10.1007/s11120-008-9388-9	45	52	52	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4877	4886		10.1074/jbc.M114.607770	http://dx.doi.org/10.1074/jbc.M114.607770			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25525277	Green Published, hybrid			2022-12-28	WOS:000350042000032
J	Bodman, JAR; Yang, Y; Logan, MR; Eitzen, G				Bodman, James A. R.; Yang, Yang; Logan, Michael R.; Eitzen, Gary			Yeast Translation Elongation Factor-1A Binds Vacuole-localized Rho1p to Facilitate Membrane Integrity through F-actin Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FACTOR 1A; GTPASE ACTIVATION; HUMAN NEUTROPHILS; FACTOR 1-ALPHA; LIVE CELLS; CYTOSKELETON; PROTEIN; FUSION; EXOCYTOSIS	Rho GTPases are molecular switches that modulate a variety of cellular processes, most notably those involving actin dynamics. We have previously shown that yeast vacuolar membrane fusion requires re-organization of actin filaments mediated by two Rho GTPases, Rho1p and Cdc42p. Cdc42p initiates actin polymerization to facilitate membrane tethering; Rho1p has a role in the late stages of vacuolar fusion, but its mode of action is unknown. Here, we identified eEF1A as a vacuolar Rho1p-inter-acting protein. eEF1A (encoded by the TEF1 and TEF2 genes in yeast) is an aminoacyl-tRNA transferase needed during protein translation. eEF1A also has a second function that is independent of translation; it binds and organizes actin filaments into ordered cable structures. Here, we report that eEF1A interacts with Rho1p via a C-terminal subdomain. This interaction occurs predominantly when both proteins are in the GDP-bound state. Therefore, eEF1A is an atypical downstream effector of Rho1p. eEF1A does not promote vacuolar fusion; however, overexpression of the Rho1p-interacting subdomain affects vacuolar morphology. Vacuoles were destabilized and prone to leakage when treated with the eEF1A inhibitor narciclasine. We propose a model whereby eEF1A binds to Rho1p-GDP on the vacuolar membrane; it is released upon Rho1p activation and then bundles actin filaments to stabilize fused vacuoles. Therefore, the Rho1p-eEF1A complex acts to spatially localize a pool of eEF1A to vacuoles where it can readily organize F-actin.	[Bodman, James A. R.; Yang, Yang; Logan, Michael R.; Eitzen, Gary] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Eitzen, G (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.	gary.eitzen@ualberta.ca			Natural Sciences and Engineering Research Council of Canada [327237]; Queen Elizabeth II Scholarship from the Province of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen Elizabeth II Scholarship from the Province of Alberta	This work was supported by Discovery Grant 327237 from the Natural Sciences and Engineering Research Council of Canada (to G. E.).; Supported by a Queen Elizabeth II Scholarship from the Province of Alberta.	Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bunai F, 2006, J BIOCHEM, V140, P393, DOI 10.1093/jb/mvj169; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; de Kreuk BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073962; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Eitzen G, 2012, METHODS MOL BIOL, V827, P369, DOI 10.1007/978-1-61779-442-1_24; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Grant BJ, 2010, BIOPHYS J, V99, pL87, DOI 10.1016/j.bpj.2010.10.020; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Isgandarova S, 2007, J BIOL CHEM, V282, P30466, DOI 10.1074/jbc.M704117200; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Jones L, 2010, J BIOL CHEM, V285, P4298, DOI 10.1074/jbc.M109.074609; Karunakaran S, 2012, J CELL SCI, V125, P1683, DOI 10.1242/jcs.091900; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Liebl D, 2009, J CELL SCI, V122, P2935, DOI 10.1242/jcs.048355; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Logan MR, 2010, BIOCHEM BIOPH RES CO, V394, P64, DOI 10.1016/j.bbrc.2010.02.102; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008; Morita K, 2008, ZOOL SCI, V25, P22, DOI 10.2108/zsj.25.22; Munshi R, 2001, GENETICS, V157, P1425; Nightingale TD, 2011, J CELL BIOL, V194, P613, DOI 10.1083/jcb.201011119; OWEN CH, 1992, J STRUCT BIOL, V109, P248, DOI 10.1016/1047-8477(92)90037-B; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Porat-Shliom N, 2013, CELL MOL LIFE SCI, V70, P2099, DOI 10.1007/s00018-012-1156-5; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; Spector I., 1983, SCIENCE, V219, P492; Stockinger W, 2006, MOL BIOL CELL, V17, P1697, DOI 10.1091/mbc.E05-12-1140; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Toulmay A, 2013, J CELL BIOL, V202, P35, DOI 10.1083/jcb.201301039; Umikawa M, 1998, ONCOGENE, V16, P2011, DOI 10.1038/sj.onc.1201724; Van Goietsenoven G, 2010, FASEB J, V24, P4575, DOI 10.1096/fj.10-162263; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131	59	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4705	4716		10.1074/jbc.M114.630764	http://dx.doi.org/10.1074/jbc.M114.630764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561732	Green Published, hybrid			2022-12-28	WOS:000350042000014
J	Ballesteros, A; Mentink-Kane, MM; Warren, J; Kaplan, GG; Dveksler, GS				Ballesteros, Angela; Mentink-Kane, Margaret M.; Warren, James; Kaplan, Gerardo G.; Dveksler, Gabriela S.			Induction and Activation of Latent Transforming Growth Factor-beta(1) Are Carried out by Two Distinct Domains of Pregnancy-specific Glycoprotein 1 (PSG1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; SWISS-MODEL; GROWTH-FACTOR-BETA-1; RECEPTOR; CELLS; MACROPHAGES; TGF-BETA-1; COMPLEX; FAMILY	Pregnancy-specific glycoproteins (PSGs) are a family of Ig-like proteins secreted by specialized placental cells. The PSG1 structure is composed of a single Ig variable region-like N-terminal domain and three Ig constant region-like domains termed A1, A2, and B2. Members of the human and murine PSG family have been shown to induce anti-inflammatory cytokines from monocytes and macrophages and to stimulate angiogenesis. We recently showed that recombinant forms of PSG1 (PSG1-Fc and PSG1-His) and PSG1 purified from the serum of pregnant women are associated with the immunoregulatory cytokine TGF-beta(1) and activated latent TGF-beta(1). Here, we sought to examine the requirement of specific PSG1 domains in the activation of latent TGF-beta(1). Plasmon surface resonance studies showed that PSG1 directly bound to the small latent complex and to the latency-associated peptide of TGF-beta(1) and that this binding was mediated through the B2 domain. Furthermore, the B2 domain alone was sufficient for activating the small latent complex. In separate experiments, we found that the PSG1-mediated induction of TGF-beta(1) secretion in macrophages was dependent on the N-terminal domain. Mutagenesis analysis revealed that four amino acids (LYHY) of the CC' loop of the N-terminal domain were required for induction of latent TGF-beta(1) secretion. Together, our results show that two distinct domains of PSG1 are involved in the regulation of TGF-beta(1) and provide a mechanistic framework for how PSGs modulate the immunoregulatory environment at the maternal-fetal interface for successful pregnancy outcome.	[Ballesteros, Angela; Kaplan, Gerardo G.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Mentink-Kane, Margaret M.; Warren, James; Dveksler, Gabriela S.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA	US Food & Drug Administration (FDA); Uniformed Services University of the Health Sciences - USA	Dveksler, GS (corresponding author), Uniformed Serv Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gabriela.dveksler@usuhs.edu		Ballesteros Morcillo, Angela/0000-0001-5796-6875; kaplan, gerardo/0000-0003-3303-7259	National Institutes of Health from NIAID [R21AI101979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101979] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Award R21AI101979 from NIAID.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Alcaraz LB, 2014, J CELL BIOL, V205, P409, DOI 10.1083/jcb.201308031; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bailly S, 1997, J BIOL CHEM, V272, P16329, DOI 10.1074/jbc.272.26.16329; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Blois SM, 2014, MUCOSAL IMMUNOL, V7, P348, DOI 10.1038/mi.2013.53; DVEKSLER GS, 1993, J VIROL, V67, P1; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE JN, 1979, BRIT J OBSTET GYNAEC, V86, P888, DOI 10.1111/j.1471-0528.1979.tb10717.x; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lisboa FA, 2011, J BIOL CHEM, V286, P7577, DOI 10.1074/jbc.M110.161810; Martinez FF, 2012, EUR J IMMUNOL, V42, P1573, DOI 10.1002/eji.201142140; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; Motran CC, 2002, J LEUKOCYTE BIOL, V72, P512; OHNO M, 1995, J CLIN INVEST, V95, P1363, DOI 10.1172/JCI117787; OSBORNE JC, 1982, BIOCHEMISTRY-US, V21, P5523, DOI 10.1021/bi00265a022; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Shanley DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057491; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; Sulkowski GN, 2011, PLACENTA, V32, P603, DOI 10.1016/j.placenta.2011.05.008; Tangeras LH, 2014, J REPROD IMMUNOL, V106, P89, DOI 10.1016/j.jri.2014.04.004; TEGLUND S, 1994, GENOMICS, V23, P669, DOI 10.1006/geno.1994.1556; Toossi Z, 1996, J IMMUNOL, V156, P3461; TOOSSI Z, 1995, INFECT IMMUN, V63, P224, DOI 10.1128/IAI.63.1.224-228.1995; Waterhouse R, 2002, J EXP MED, V195, P277, DOI 10.1084/jem.20011741; Xiong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072772; Zhou GQ, 1997, PLACENTA, V18, P491, DOI 10.1016/0143-4004(77)90002-9; Zhou GQ, 2001, BIOL REPROD, V64, P90, DOI 10.1095/biolreprod64.1.90	39	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4422	4431		10.1074/jbc.M114.597518	http://dx.doi.org/10.1074/jbc.M114.597518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548275	Green Published, hybrid			2022-12-28	WOS:000349458400049
J	Thomas, MA; Buelow, BJ; Nevins, AM; Jones, SE; Peterson, FC; Gundry, RL; Grayson, MH; Volkman, BF				Thomas, Monica A.; Buelow, Becky J.; Nevins, Amanda M.; Jones, Stephanie E.; Peterson, Francis C.; Gundry, Rebekah L.; Grayson, Mitchell H.; Volkman, Brian F.			Structure-Function Analysis of CCL28 in the Development of Post-viral Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; CC-CHEMOKINE; AIRWAY HYPERREACTIVITY; IMPROVED SENSITIVITY; VIRAL-INFECTION; DISULFIDE BOND; T-CELLS; INFLAMMATION; PROTEIN; CCR10	CCL28 is a human chemokine constitutively expressed by epithelial cells in diverse mucosal tissues and is known to attract a variety of immune cell types including T-cell subsets and eosinophils. Elevated levels of CCL28 have been found in the airways of individuals with asthma, and previous studies have indicated that CCL28 plays a vital role in the acute development of post-viral asthma. Our study builds on this, demonstrating that CCL28 is also important in the chronic post-viral asthma phenotype. In the absence of a viral infection, we also demonstrate that CCL28 is both necessary and sufficient for induction of asthma pathology. Additionally, we present the first effort aimed at elucidating the structural features of CCL28. Chemokines are defined by a conserved tertiary structure composed of a three-stranded beta-sheet and a C-terminal alpha-helix constrained by two disulfide bonds. In addition to the four disulfide bondforming cysteine residues that define the traditional chemokine fold, CCL28 possesses two additional cysteine residues that form a third disulfide bond. If all disulfide bonds are disrupted, recombinant human CCL28 is no longer able to drive mouse CD4+ T-cell chemotaxis or in vivo airway hyper-reactivity, indicating that the conserved chemokine fold is necessary for its biologic activity. Due to the intimate relationship between CCL28 and asthma pathology, it is clear that CCL28 presents a novel target for the development of alternative asthma therapeutics.	[Thomas, Monica A.; Nevins, Amanda M.; Peterson, Francis C.; Gundry, Rebekah L.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Buelow, Becky J.; Jones, Stephanie E.; Grayson, Mitchell H.] Med Coll Wisconsin, Dept Pediat, Sect Allergy & Immunol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Grayson, MH (corresponding author), Med Coll Wisconsin, Dept Pediat, Sect Allergy & Immunol, MFRC 5064,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wheeze@allergist.com; bvolkman@mcw.edu	Volkman, Brian F./ABE-7312-2020; Gundry, Rebekah/K-6080-2019; Grayson, Mitchell/AAX-3674-2020; Grayson, Mitchell H/A-3693-2008; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Grayson, Mitchell/0000-0002-4673-2122; Grayson, Mitchell H/0000-0002-4673-2122; Volkman, Brian F./0000-0002-6681-5179; Thomas, Monica/0000-0003-2513-3371; Gundry, Rebekah L./0000-0002-9263-833X	National Institutes of Health [R01 GM097381, R56 AI112519]; Children's Research Institute of the Children's Hospital of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL072483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058072, R56AI112519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Research Institute of the Children's Hospital of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM097381 (to B. F. V.) and R56 AI112519 (to B. F. V. and M. H. G.) and by the Children's Research Institute of the Children's Hospital of Wisconsin.	BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Cheung DS, 2010, ANN ALLERG ASTHMA IM, V105, P437, DOI 10.1016/j.anai.2010.09.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; English K, 2006, IMMUNOL LETT, V103, P92, DOI 10.1016/j.imlet.2005.09.011; Ezzat M H M, 2009, Indian J Dermatol, V54, P229, DOI 10.4103/0019-5154.55630; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; John AE, 2005, AM J PATHOL, V166, P345, DOI 10.1016/S0002-9440(10)62258-4; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Keizer DW, 2000, BIOCHEMISTRY-US, V39, P6053, DOI 10.1021/bi000089l; Khan SH, 2008, CLIN THER, V30, P1017, DOI 10.1016/j.clinthera.2008.06.002; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kumar A, 2009, ANN ALLERG ASTHMA IM, V103, P181, DOI 10.1016/S1081-1206(10)60178-0; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Lofgren JLS, 2006, J APPL PHYSIOL, V101, P1495, DOI 10.1152/japplphysiol.00464.2006; Love M, 2012, BIOCHEMISTRY-US, V51, P733, DOI 10.1021/bi201601k; Meng YY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110312; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Muhandiram D. R., 1999, J MAGN RESON SER B, V103, P203; National Health and Medical Research Council, 2013, AUSTR COD PRACT CAR, P1; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Rajarathnam K, 2001, J BIOL CHEM, V276, P4909, DOI 10.1074/jbc.M005085200; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Sticht H, 1999, BIOCHEMISTRY-US, V38, P5995, DOI 10.1021/bi990065i; Takekoshi T, 2012, MOL CANCER THER, V11, P2516, DOI 10.1158/1535-7163.MCT-12-0494; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200	35	15	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4528	4536		10.1074/jbc.M114.627786	http://dx.doi.org/10.1074/jbc.M114.627786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25556652	Green Published, hybrid			2022-12-28	WOS:000349458400057
J	Tufail, S; Owais, M; Kazmi, S; Balyan, R; Khalsa, JK; Faisal, SM; Sherwani, MA; Gatoo, MA; Umar, MS; Zubair, S				Tufail, Saba; Owais, Mohammad; Kazmi, Shadab; Balyan, Renu; Khalsa, Jasneet Kaur; Faisal, Syed Mohd; Sherwani, Mohd Asif; Gatoo, Manzoor Ahmad; Umar, Mohd Saad; Zubair, Swaleha			Amyloid Form of Ovalbumin Evokes Native Antigen-specific Immune Response in the Host PROSPECTIVE IMMUNO-PROPHYLACTIC POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL APLASIA; FIBRILS; PROTEIN; STABILITY; INSIGHTS; PROVIDES; PH	Amyloids are highly organized protein aggregates that arise from inappropriately folded versions of proteins or polypeptides under both physiological as well as simulated ambiences. Once thought to be irreversible assemblies, amyloids have begun to expose their more dynamic and reversible attributes depending upon the intrinsic properties of the precursor protein/peptide and experimental conditions such as temperature, pressure, structural modifications in proteins, or presence of chemicals in the reaction mixture. It has been repeatedly proposed that amyloids undergo transformation to the bioactive peptide/protein forms under specific conditions. In the present study, amyloids assembled from the model protein ovalbumin (OVA) were found to release the precursor protein in a slow and steady manner over an extended time period. Interestingly, the released OVA from amyloid depot was found to exhibit biophysical characteristics of native protein and reacted with native-OVA specific monoclonal as well as polyclonal antibodies. Moreover, antibodies generated upon immunization of OVA amyloidal aggregates or fibrils were found to recognize the native form of OVA. The study suggests that amyloids may act as depots for the native form of the protein and therefore can be exploited as vaccine candidates, where slow antigen release over extended time periods is a pre-requisite for the development of desired immune response.	[Sherwani, Mohd Asif; Umar, Mohd Saad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Balyan, Renu; Khalsa, Jasneet Kaur] Natl Inst Immunol, New Delhi 110067, India; [Gatoo, Manzoor Ahmad] Aligarh Muslim Univ, JNMC, Dept Biochem, Aligarh 202002, Uttar Pradesh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh 202002, Uttar Pradesh, India	Aligarh Muslim University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Aligarh Muslim University; Aligarh Muslim University	Owais, M (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India.	owais_lakhnawi@yahoo.com; swalehazubair@yahoo.com	Sherwani, Mohammad Asif/AAQ-2949-2021; Syed, Mohammad Faisal/AAM-7496-2020; Sherwani, Mohammad/AAR-6089-2021; Khalsa, Jasneet/AAZ-7112-2020	Sherwani, Mohammad Asif/0000-0001-5317-1557; Syed, Mohammad Faisal/0000-0002-3968-7810; Khalsa, Jasneet/0000-0003-4656-8454; Kazmi, Shadab/0000-0002-1860-0624; Mohammad, Owais/0000-0001-7377-7388; Balyan, Renu/0000-0002-9378-040X	Council of Scientific and Industrial Research (CSIR), India, Senior Research Fellowship (SRF)	Council of Scientific and Industrial Research (CSIR), India, Senior Research Fellowship (SRF)	Supported by the Council of Scientific and Industrial Research (CSIR), India, Senior Research Fellowship (SRF).	Ahmad N, 2006, BIOCHIMIE, V88, P1391, DOI 10.1016/j.biochi.2006.04.017; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Ansari Mairaj Ahmed, 2012, Int J Nanomedicine, V7, P2433, DOI 10.2147/IJN.S25875; Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022889; Atif SM, 2006, FEBS LETT, V580, P2183, DOI 10.1016/j.febslet.2006.03.015; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Binger KJ, 2008, BIOCHEMISTRY-US, V47, P10208, DOI 10.1021/bi8009339; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chauhan A, 2011, INT J NANOMED, V6, P2305, DOI 10.2147/IJN.S23195; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dwivedi V, 2009, VACCINE, V27, P473, DOI 10.1016/j.vaccine.2008.10.054; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gupta S, 2010, P NATL ACAD SCI USA, V107, P13246, DOI 10.1073/pnas.1005704107; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Kardos J, 2011, BIOCHEMISTRY-US, V50, P3211, DOI 10.1021/bi2000017; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Legge FS, 2009, J PHYS CHEM B, V113, P14006, DOI 10.1021/jp903842u; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Locatelli F, 2007, PERITON DIALYSIS INT, V27, pS303; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mankar S, 2011, NANO REV EXP, V2, DOI 10.3402/nano.v2i0.6032; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Santiago PS, 2010, LANGMUIR, V26, P9794, DOI 10.1021/la100060p; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Taboada P, 2006, J PHYS CHEM B, V110, P20733, DOI 10.1021/jp064861r; Tanaka N, 2011, J BIOL CHEM, V286, P5884, DOI 10.1074/jbc.M110.176396; Torrent J, 2006, PROTEIN PEPTIDE LETT, V13, P271, DOI 10.2174/092986606775338371; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Yamaguchi K, 2013, BIOCHEMISTRY-US, V52, P6797, DOI 10.1021/bi400698u; Yang M, 2009, BIOCHEM BIOPH RES CO, V378, P203, DOI 10.1016/j.bbrc.2008.11.037	54	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4131	4148		10.1074/jbc.M113.540989	http://dx.doi.org/10.1074/jbc.M113.540989			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25512377	Green Published, hybrid			2022-12-28	WOS:000349458400026
J	Lyu, K; Wang, GC; He, YL; Han, JF; Ye, Q; Qin, CF; Chen, R				Lyu, Ke; Wang, Guang-Chuan; He, Ya-Ling; Han, Jian-Feng; Ye, Qing; Qin, Cheng-Feng; Chen, Rong			Crystal Structures of Enterovirus 71 (EV71) Recombinant Virus Particles Provide Insights into Vaccine Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRALIZING ANTIBODIES; MATURATION CLEAVAGE; TYPE-1 POLIOVIRUS; ANTIGENIC HYBRID; IDENTIFICATION; CHIMERA; MORPHOGENESIS; SITE; MECHANISM; PROTEIN	Hand-foot-and-mouth disease (HFMD) remains a major health concern in the Asia-Pacific regions, and its major causative agents include human enterovirus 71 (EV71) and coxsackievirus A16. A desirable vaccine against HFMD would be multivalent and able to elicit protective responses against multiple HFMD causative agents. Previously, we have demonstrated that a thermostable recombinant EV71 vaccine candidate can be produced by the insertion of a foreign peptide into the BC loop of VP1 without affecting viral replication. Here we present crystal structures of two different naturally occurring empty particles, one from a clinical C4 strain EV71 and the other from its recombinant virus containing an insertion in the VP1 BC loop. Crystal structure analysis demonstrated that the inserted foreign peptide is well exposed on the particle surface without significant structural changes in the capsid. Importantly, such insertions do not seem to affect the virus uncoating process as illustrated by the conformational similarity between an uncoating intermediate of another recombinant virus and that of EV71. Especially, at least 18 residues from the N terminus of VP1 are transiently externalized. Altogether, our study provides insights into vaccine development against HFMD.	[Lyu, Ke; He, Ya-Ling; Chen, Rong] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Wang, Guang-Chuan; Han, Jian-Feng; Ye, Qing; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Wang, Guang-Chuan] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310027, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Beijing Institute of Microbiology & Epidemiology; Zhejiang University	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	qincf@bmi.ac.cn; rongchen@ips.ac.cn	Wang, Guangchuan/AAK-6197-2021; Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Wang, Guangchuan/0000-0001-5315-1599; Lyu, Ke/0000-0002-2483-2253	Chinese Academy of Sciences; Shanghai Pu-Jiang Career Development Award [09PJ1411400]; 973 Project [2010CB912403]; National Science Foundation of China [31370730, 31070144, 31270195]; Beijing Natural Science Foundation [7122129, 7112108]; Beijing Nova Program of Science and Technology [2010B041]	Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pu-Jiang Career Development Award; 973 Project(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program of Science and Technology	This work was supported by 100 Talents' Program of Chinese Academy of Sciences, Shanghai Pu-Jiang Career Development Award Grant 09PJ1411400, 973 Project Grant 2010CB912403, and National Science Foundation of China Grants 31370730 and 31070144 (R. Chen's group) and by Beijing Natural Science Foundation Grants 7122129 and 7112108, National Science Foundation of China Grant 31270195, and Beijing Nova Program of Science and Technology Grant 2010B041 (C. F. Qin's group).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANSARDI DC, 1995, J VIROL, V69, P1540, DOI 10.1128/JVI.69.3.1540-1547.1995; BASAVAPPA R, 1994, PROTEIN SCI, V3, P1651, DOI 10.1002/pro.5560031005; BLONDEL B, 1983, VIROLOGY, V126, P707, DOI 10.1016/S0042-6822(83)80027-0; BURKE KL, 1988, NATURE, V332, P81, DOI 10.1038/332081a0; Cifuente JO, 2013, J VIROL, V87, P7637, DOI 10.1128/JVI.03519-12; COLBEREGARAPIN F, 1988, P NATL ACAD SCI USA, V85, P8668, DOI 10.1073/pnas.85.22.8668; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ding JP, 2002, STRUCTURE, V10, P999, DOI 10.1016/S0969-2126(02)00793-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANS DJ, 1989, NATURE, V339, P385, DOI 10.1038/339385a0; Foo DGW, 2008, CLIN MICROBIOL INFEC, V14, P286, DOI 10.1111/j.1469-0691.2007.01904.x; FRICKS CE, 1985, J VIROL, V54, P856, DOI 10.1128/JVI.54.3.856-859.1985; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; GUTTMAN N, 1977, J VIROL, V23, P363, DOI 10.1128/JVI.23.2.363-367.1977; JACOBSON MF, 1968, J MOL BIOL, V33, P369, DOI 10.1016/0022-2836(68)90195-2; JENKINS O, 1990, J VIROL, V64, P1201, DOI 10.1128/JVI.64.3.1201-1206.1990; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LEBOUVIER GL, 1955, LANCET, V2, P1013; Lin TW, 1996, FOLD DES, V1, P179, DOI 10.1016/S1359-0278(96)00030-2; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Lyu K, 2014, J VIROL, V88, P3114, DOI 10.1128/JVI.03029-13; MARONGIU ME, 1981, J VIROL, V39, P341, DOI 10.1128/JVI.39.2.341-347.1981; MARTIN A, 1988, EMBO J, V7, P2839, DOI 10.1002/j.1460-2075.1988.tb03140.x; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; MURDIN AD, 1989, J VIROL, V63, P5251, DOI 10.1128/JVI.63.12.5251-5257.1989; MURRAY MG, 1988, P NATL ACAD SCI USA, V85, P3203, DOI 10.1073/pnas.85.9.3203; NUGENT CI, 1995, J VIROL, V69, P13, DOI 10.1128/JVI.69.1.13-22.1995; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; Roy MD, 2008, ADV MATER, V20, P1830, DOI 10.1002/adma.200702322; Shingler KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003240; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Wang GC, 2013, P NATL ACAD SCI USA, V110, P7619, DOI 10.1073/pnas.1300233110; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; YEATES TO, 1991, EMBO J, V10, P2331, DOI 10.1002/j.1460-2075.1991.tb07772.x	38	16	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3198	3208		10.1074/jbc.M114.624536	http://dx.doi.org/10.1074/jbc.M114.624536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25492868	hybrid, Green Published			2022-12-28	WOS:000349456000002
J	Dimri, M; Cho, JH; Kang, M; Dimri, GP				Dimri, Manjari; Cho, Joon-Ho; Kang, Mingu; Dimri, Goberdhan P.			PLK1 Inhibition Down-regulates Polycomb Group Protein BMI1 via Modulation of the miR-200c/141 Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cancer Biology; Cell Growth; Cellular Regulation; Cellular Senescence; Gene Regulation; microRNA (miRNA); Polycomb	CANCER STEM-CELLS; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; IN-VIVO; TUMOR-SUPPRESSOR; SELF-RENEWAL; LIFE-SPAN; KINASE 1; SENESCENCE; EXPRESSION	Background: BMI1 regulates cancer stem cell phenotype and is overexpressed in cancer cells. Results: PLK1 regulates BMI1 expression and its inhibitors suppress BMI1 expression, and induce premature senescence. Conclusion: BMI1 acts downstream of PLK1, and its expression is strongly inhibited by PLK1 inhibitor BI 2536. Significance: PLK1 inhibitors can be used to suppress growth of breast cancer cells overexpressing BMI1. The polycomb group protein BMI1 is an important regulator of cancer stem cell (CSC) phenotype and is often overexpressed in cancer cells. Its overexpression leads to increase in CSC fraction and therapy resistance in tumors. BMI1 functions via polycomb repressive complex 1 (PRC1)-mediated gene silencing and also via PRC1-independent transcriptional activities. At present, very little is known about the therapy reagents that can efficiently inhibit BMI1 expression, and the CSC phenotype. Here, we report that the polo-like kinase 1 (PLK1) regulates BMI1 expression, and that its inhibition can efficiently down-regulate BMI1 expression and PRC1 activity, and induce premature senescence in breast cancer cells. We also show that the exogenous BMI1 overexpression mitigates anti-oncogenic effects of PLK1 inhibition and overcomes senescence induction by PLK1 inhibitors. We further show that PLK1 inhibition down-regulates BMI1 by upregulating the miRNA-200c/141 cluster, which encodes miR-200c and miR-141, both of which are known to post-transcriptionally downregulate BMI1 expression. Thus, our data suggest that PLK1 inhibitors can be successfully used to inhibit growth of tumors in which PcG protein BMI1 is overexpressed or the PRC1 activity is deregulated.	[Dimri, Manjari; Cho, Joon-Ho; Kang, Mingu; Dimri, Goberdhan P.] George Washington Univ, Med Ctr, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20037 USA	George Washington University	Dimri, M (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Med, 2300 Eye St, Washington, DC 20037 USA.	gdimri@gwu.edu; mdimri@gwu.edu	Dimri, Goberdhan/AAO-4210-2021	KANG, MINGU/0000-0001-6574-6661	NCI, National Institutes of Health [R01 CA094150]; NATIONAL CANCER INSTITUTE [R01CA094150] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by R01 CA094150 from the NCI, National Institutes of Health (to G. P. D.).	Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Cholewa BD, 2013, CANCER RES, V73, P6848, DOI 10.1158/0008-5472.CAN-13-2197; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dimri G. P., 2004, SCI AGING KNOWLEDGE, V2004, ppe40; Dimri GP, 2002, CANCER RES, V62, P4736; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dimri M, 2013, CELL CYCLE, V12, P3537, DOI 10.4161/cc.26592; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; He XQ, 2012, MOL MED, V18, P1491, DOI 10.2119/molmed.2012.00304; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jin M, 2014, CANCER RES, V74, P4183, DOI 10.1158/0008-5472.CAN-14-0404; Kim HJ, 2013, J GERONTOL A-BIOL, V68, P1145, DOI 10.1093/gerona/glt017; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005	51	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3033	3044		10.1074/jbc.M114.615179	http://dx.doi.org/10.1074/jbc.M114.615179			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505268	Green Published, hybrid			2022-12-28	WOS:000349310700040
J	Prasad, M; Kaur, J; Pawlak, KJ; Bose, M; Whittal, RM; Bose, HS				Prasad, Manoj; Kaur, Jasmeet; Pawlak, Kevin J.; Bose, Mahuya; Whittal, Randy M.; Bose, Himangshu S.			Mitochondria-associated Endoplasmic Reticulum Membrane (MAM) Regulates Steroidogenic Activity via Steroidogenic Acute Regulatory Protein (StAR)-Voltage-dependent Anion Channel 2 (VDAC2) Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Mitochondrial Metabolism; Progesterone; Steroidogenesis; Voltage-dependent Anion Channel (VDAC)	LIPOID ADRENAL-HYPERPLASIA; CHOLESTEROL TRAFFICKING; GEL-ELECTROPHORESIS; STAR; ER; IMPORT; CELLS; BIOGENESIS; TRANSPORT; MECHANISM	Background: Steroidogenic acute regulatory protein (StAR) fosters cholesterol into the adrenal and gonadal mitochondria to initiate steroidogenesis. Results: Voltage-dependent anion channel 2 (VDAC2) knockdown ablated pregnenolone synthesis and StAR processing into the mitochondria. Conclusion: Interaction between StAR and VDAC2 is critical for steroidogenesis. Significance: VDAC2 is a crucial regulator for initiating steroidogenesis. Steroid hormones are essential for carbohydrate metabolism, stress management, and reproduction and are synthesized from cholesterol in mitochondria of adrenal glands and gonads/ovaries. In acute stress or hormonal stimulation, steroidogenic acute regulatory protein (StAR) transports substrate cholesterol into the mitochondria for steroidogenesis by an unknown mechanism. Here, we report for the first time that StAR interacts with voltage-dependent anion channel 2 (VDAC2) at the mitochondria-associated endoplasmic reticulum membrane (MAM) prior to its translocation to the mitochondrial matrix. In the MAM, StAR interacts with mitochondrial proteins Tom22 and VDAC2. However, Tom22 knockdown by siRNA had no effect on pregnenolone synthesis. In the absence of VDAC2, StAR was expressed but not processed into the mitochondria as a mature 30-kDa protein. VDAC2 interacted with StAR via its C-terminal 20 amino acids and N-terminal amino acids 221-229, regulating the mitochondrial processing of StAR into the mature protein. In the absence of VDAC2, StAR could not enter the mitochondria or interact with MAM-associated proteins, and therefore steroidogenesis was inhibited. Furthermore, the N terminus was not essential for StAR activity, and the N-terminal deletion mutant continued to interact with VDAC2. The endoplasmic reticulum-targeting prolactin signal sequence did not affect StAR association with the MAM and thus its mitochondrial targeting. Therefore, VDAC2 controls StAR processing and activity, and MAM is thus a central location for initiating mitochondrial steroidogenesis.	[Prasad, Manoj; Kaur, Jasmeet; Pawlak, Kevin J.; Bose, Himangshu S.] Mercer Univ, Sch Med, Savannah, GA 31404 USA; [Bose, Mahuya] Univ Florida, Florida Biologix, Ctr Excellence Hlth Regenerat Biotechnol, Alachua, FL 32615 USA; [Bose, Mahuya] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Bose, Himangshu S.] Mem Univ Med Ctr, Anderson Canc Inst, Savannah, GA 31404 USA	Mercer University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Alberta	Bose, HS (corresponding author), Mercer Univ, Sch Med, Div Biomed Sci, Dept Biochem, Hoskins Res Bldg,4700 Waters Ave, Savannah, GA 31404 USA.	bose_hs@mercer.edu	Pawlak, Kevin/HDO-6979-2022	Whittal, Randy/0000-0003-1174-8172	National Institutes of Health [HD057876]; American Heart Association; March of Dimes; Anderson Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes(March of Dimes); Anderson Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD057876 (to H. S. B.). This work was also supported initially by the American Heart Association and the March of Dimes.; Supported by the Anderson Cancer Institute.	Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bose HS, 1998, BIOCHEMISTRY-US, V37, P9768, DOI 10.1021/bi980588a; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Bose HS, 2011, J PROTEINS PROTEOM, V2, P1; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Bose M, 2008, ELECTROPHORESIS, V29, P753, DOI 10.1002/elps.200700782; Bose M, 2007, J MOL ENDOCRINOL, V39, P67, DOI 10.1677/JME-07-0051; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; CAPPONI AM, 1988, J BIOL CHEM, V263, P16113; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; HARIKRISHNA JA, 1993, DNA CELL BIOL, V12, P371, DOI 10.1089/dna.1993.12.371; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hunte C., 2003, MEMBRANE PROTEIN PUR; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lai JC, 2006, P NATL ACAD SCI USA, V103, P7494, DOI 10.1073/pnas.0602217103; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309; Marriott KSC, 2012, J PHARMACOL EXP THER, V343, P578, DOI 10.1124/jpet.112.198168; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; NICCHITTA CV, 1989, J CELL BIOL, V108, P789, DOI 10.1083/jcb.108.3.789; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Pawlak KJ, 2011, J BIOL CHEM, V286, P39130, DOI 10.1074/jbc.M111.290031; Rajapaksha M, 2013, BIOCHEMISTRY-US, V52, P7242, DOI 10.1021/bi401125v; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Schwartz MP, 1999, P NATL ACAD SCI USA, V96, P13086, DOI 10.1073/pnas.96.23.13086; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; STERN JB, 1985, ARCH BIOCHEM BIOPHYS, V237, P244, DOI 10.1016/0003-9861(85)90275-9; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wang XJ, 1998, ENDOCRINOLOGY, V139, P3903, DOI 10.1210/en.139.9.3903; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	50	91	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2604	2616		10.1074/jbc.M114.605808	http://dx.doi.org/10.1074/jbc.M114.605808			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505173	Green Published, hybrid			2022-12-28	WOS:000349310700007
J	Ranok, A; Wongsantichon, J; Robinson, RC; Suginta, W				Ranok, Araya; Wongsantichon, Jantana; Robinson, Robert C.; Suginta, Wipa			Structural and Thermodynamic Insights into Chitooligosaccharide Binding to Human Cartilage Chitinase 3-like Protein 2 (CHI3L2 or YKL-39)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biomarker; Carbohydrate-binding Protein; Crystal Structure; Glycobiology; Glycoside Hydrolase; Isothermal Titration Calorimetry (ITC); Protein Crystallization	ACIDIC MAMMALIAN CHITINASE; ARTICULAR CHONDROCYTES; HUMAN CHITOTRIOSIDASE; CATALYTIC MECHANISM; SI-CLP; OSTEOARTHRITIS; FAMILY; GENE; IDENTIFICATION; EXPRESSION	Background: Human YKL-39 is currently recognized as a biomarker for osteoarthritis. Results: Crystal structures of YKL-39 reveal that chitooligosaccharide induces local conformational changes to stabilize sugarprotein complexes and that the protein contains five binding subsites for sugars. Conclusion: YKL-39 binds to chitooligosaccharide through enthalpic reactions. Significance: Our findings suggest how YKL-39 interacts with GlcNAc moieties of the natural ligands, which may possibly activate local tissue inflammation. Four crystal structures of human YKL-39 were solved in the absence and presence of chitooligosaccharides. The structure of YKL-39 comprises a major (/)(8) triose-phosphate isomerase barrel domain and a small + insertion domain. Structural analysis demonstrates that YKL-39 interacts with chitooligosaccharides through hydrogen bonds and hydrophobic interactions. The binding of chitin fragments induces local conformational changes that facilitate tight binding. Compared with other GH-18 members, YKL-39 has the least extended chitin-binding cleft, containing five subsites for sugars, namely (-3)(-2)(-1)(+1)(+2), with Trp-360 playing a prominent role in the sugar-protein interactions at the center of the chitin-binding cleft. Evaluation of binding affinities obtained from isothermal titration calorimetry and intrinsic fluorescence spectroscopy suggests that YKL-39 binds to chitooligosaccharides with K-d values in the micromolar concentration range and that the binding energies increase with the chain length. There were no significant differences between the K-d values of chitopentaose and chitohexaose, supporting the structural evidence for the five binding subsite topology. Thermodynamic analysis indicates that binding of chitooligosaccharide to YKL-39 is mainly driven by enthalpy.	[Ranok, Araya; Suginta, Wipa] Suranaree Univ Technol, Inst Sci, Sch Biochem, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Wongsantichon, Jantana; Robinson, Robert C.] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Robinson, Robert C.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Suranaree University of Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Robinson, RC (corresponding author), Proteos, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	rrobinson@imcb.a-star.edu.sg; wipa@sut.ac.th	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903; Wongsantichon, Jantana/0000-0002-4134-2248	Office of the Higher Education Commission through CHE333 PhD-THA-SUP Scholarship [CHE500307]; Suranaree University of Technology, Thailand [SUT1-102-57-24-19]; Biomedical Research Council of the Agency for Science, Technology, and Research (A*STAR)	Office of the Higher Education Commission through CHE333 PhD-THA-SUP Scholarship; Suranaree University of Technology, Thailand; Biomedical Research Council of the Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Office of the Higher Education Commission through CHE333 PhD-THA-SUP Scholarship Grant CHE500307 and Suranaree University of Technology, Thailand, Grant SUT1-102-57-24-19.; Supported by the Biomedical Research Council of the Agency for Science, Technology, and Research (A*STAR).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Areshkov PA, 2010, CYTOL GENET+, V44, P1, DOI 10.3103/S0095452710010019; ARIAS EB, 1994, BIOL REPROD, V51, P685, DOI 10.1095/biolreprod51.4.685; Baban J, 2010, J PHYS CHEM B, V114, P6144, DOI 10.1021/jp909801x; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102; Brameld KA, 1998, J AM CHEM SOC, V120, P3571, DOI 10.1021/ja972282h; Breedveld FC, 2004, RHEUMATOLOGY, V43, pI4, DOI 10.1093/rheumatology/keh102; De Ceuninck Frederic, 2005, J Biomol Tech, V16, P256; DeLano W.L, PYMOL MOL GRAPHICS S; Doyle ML, 1997, CURR OPIN BIOTECH, V8, P31, DOI 10.1016/S0958-1669(97)80154-1; Du H, 2005, RHEUMATOL INT, V26, P35, DOI 10.1007/s00296-004-0497-2; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint J, 2004, J MOL BIOL, V337, P417, DOI 10.1016/j.jmb.2003.12.081; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gratchev A, 2008, BIOMARK INSIGHTS, V3, P39; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Kavsan V., 2008, SCHOLARLY RES EXCHAN, V2008, P1, DOI DOI 10.3814/2008/814849; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Knorr T, 2003, ANN RHEUM DIS, V62, P995, DOI 10.1136/ard.62.10.995; Kzhyshkowska J, 2006, BLOOD, V107, P3221, DOI 10.1182/blood-2005-07-2843; Lapensee L, 1997, FERTIL STERIL, V68, P702, DOI 10.1016/S0015-0282(97)00317-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Meng G, 2010, J BIOL CHEM, V285, P39898, DOI 10.1074/jbc.M110.130781; Miyatake K, 2013, BIOCHEM BIOPH RES CO, V431, P52, DOI 10.1016/j.bbrc.2012.12.094; Norberg AL, 2010, FEBS LETT, V584, P4581, DOI 10.1016/j.febslet.2010.10.017; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Ranok Araya, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P317, DOI 10.1089/mab.2013.0016; Sakata M, 2002, CLIN EXP RHEUMATOL, V20, P343; Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377; Sekine T, 2001, ANN RHEUM DIS, V60, P49, DOI 10.1136/ard.60.1.49; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Steck E, 2002, BIOCHEM BIOPH RES CO, V299, P109, DOI 10.1016/S0006-291X(02)02585-8; Stevens AL, 2008, ARTHRITIS RHEUM-US, V58, P489, DOI 10.1002/art.23120; Takano K, 1999, BIOCHEMISTRY-US, V38, P12698, DOI 10.1021/bi9910169; Tsuruha JI, 2002, J RHEUMATOL, V29, P1459; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798	52	23	29	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2617	2629		10.1074/jbc.M114.588905	http://dx.doi.org/10.1074/jbc.M114.588905			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25477513	Green Published, hybrid			2022-12-28	WOS:000349310700008
J	Schmidpeter, PAM; Schmid, FX				Schmidpeter, Philipp A. M.; Schmid, Franz X.			Prolyl Isomerization as a Molecular Memory in the Allosteric Regulation of the Signal Adapter Protein c-CrkII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Protein; Allosteric Regulation; Biophysics; Protein Folding; Src Homology 3 Domain (SH3 Domain); c-CrkII; Native State Prolyl Isomerization; Sequential Mixing Stopped Flow	TERMINAL SH3 DOMAIN; STRUCTURAL BASIS; PROLINE SWITCH; PRODUCT; C3G	Background: Signaling by chicken c-CrkII (cellular CT10 regulator of kinase) involves native state prolyl isomerization. Results: Dynamic domain interactions are coupled with trans-to-cis isomerization at Pro-238 and down-regulation of chicken c-CrkII. Conclusion: The linkage between protein folding, prolyl isomerization, and function of c-CrkII is explained by a kinetic six-species reaction mechanism. Significance: The linkage with prolyl isomerization attenuates an allosteric transition and provides a molecular memory. c-CrkII is a central signal adapter protein. A domain opening/closing reaction between its N- and C-terminal Src homology 3 domains (SH3N and SH3C, respectively) controls signal propagation from upstream tyrosine kinases to downstream targets. In chicken but not in human c-CrkII, opening/closing is coupled with cis/trans isomerization at Pro-238 in SH3C. Here, we used advanced double-mixing experiments and kinetic simulations to uncover dynamic domain interactions in c-CrkII and to elucidate how they are linked with cis/trans isomerization and how this regulates substrate binding to SH3N. Pro-238 trans cis isomerization is not a simple on/off switch but converts chicken c-CrkII from a high affinity to a low affinity form. We present a double-box model that describes c-CrkII as an allosteric system consisting of an open, high affinity R state and a closed, low affinity T state. Coupling of the T-R transition with an intrinsically slow prolyl isomerization provides c-CrkII with a kinetic memory and possibly functions as a molecular attenuator during signal transduction.	[Schmid, Franz X.] Univ Bayreuth, Biochim Lab, D-95447 Bayreuth, Germany; Univ Bayreuth, Bayreuther Zentrum Mol Biowissenschaften, D-95447 Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Schmid, FX (corresponding author), Univ Bayreuth, Biochim Lab, Univ Str 30, D-95447 Bayreuth, Germany.	fx.schmid@unibayreuth.de	Schmidpeter, Philipp/Q-5540-2019	Schmidpeter, Philipp/0000-0003-2871-9706				Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; FELLER SM, 1995, ONCOGENE, V10, P1465; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Jankowski W, 2012, NAT CHEM BIOL, V8, P590, DOI [10.1038/NCHEMBIO.954, 10.1038/nchembio.954]; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Muralidharan V, 2006, BIOCHEMISTRY-US, V45, P8874, DOI 10.1021/bi060590z; Pace C N, 1986, Methods Enzymol, V131, P266; Pace CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/pro.2449; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Schmidpeter PAM, 2014, ACS CHEM BIOL, V9, P1145, DOI 10.1021/cb500001n; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242	22	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3021	3032		10.1074/jbc.M114.617308	http://dx.doi.org/10.1074/jbc.M114.617308			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25488658	hybrid, Green Published			2022-12-28	WOS:000349310700039
J	Tay, MYF; Saw, WG; Zhaoi, YQ; Chan, KWK; Singh, D; Chong, YW; Forwood, JK; Ooi, EE; Gruber, G; Lescar, J; Luo, DH; Vasudevan, SG				Tay, Moon Y. F.; Saw, Wuan Geok; Zhao, Yongqian; Chan, Kitti W. K.; Singh, Daljit; Chong, Yuwen; Forwood, Jade K.; Ooi, Eng Eong; Grueber, Gerhard; Lescar, Julien; Luo, Dahai; Vasudevan, Subhash G.			The C-terminal 50 Amino Acid Residues of Dengue NS3 Protein Are Important for NS3-NS5 Interaction and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; TYPE-2 NONSTRUCTURAL PROTEIN-3; X-RAY-SCATTERING; VIRUS TYPE-2; CRYSTAL-STRUCTURE; IN-VITRO; STRUCTURAL-CHARACTERIZATION; COMPLEX-FORMATION; ESCHERICHIA-COLI; CATALYTIC DOMAIN	Dengue virus multifunctional proteins NS3 protease/helicase and NS5 methyltransferase/RNA-dependent RNA polymerase form part of the viral replication complex and are involved in viral RNA genome synthesis, methylation of the 5 '-cap of viral genome, and polyprotein processing among other activities. Previous studies have shown that NS5 residue Lys-330 is required for interaction between NS3 and NS5. Here, we show by competitive NS3-NS5 interaction ELISA that the NS3 peptide spanning residues 566-585 disrupts NS3-NS5 interaction but not the null-peptide bearing the N570A mutation. Small angle x-ray scattering study on NS3(172-618) helicase and covalently linked NS3(172-618)-NS5(320-341) reveals a rigid and compact formation of the latter, indicating that peptide NS5(320-341) engages in specific and discrete interaction with NS3. Significantly, NS3: Asn-570 to alanine mutation introduced into an infectious DENV2 cDNA clone did not yield detectable virus by plaque assay even though intracellular double-stranded RNA was detected by immunofluorescence. Detection of increased negative-strand RNA synthesis by real time RT-PCR for the NS3: N570A mutant suggests that NS3-NS5 interaction plays an important role in the balanced synthesis of positive-and negative-strand RNA for robust viral replication. Dengue virus infection has become a global concern, and the lack of safe vaccines or antiviral treatments urgently needs to be addressed. NS3 and NS5 are highly conserved among the four serotypes, and the protein sequence around the pinpointed amino acids from the NS3 and NS5 regions are also conserved. The identification of the functionally essential interaction between the two proteins by biochemical and reverse genetics methods paves the way for rational drug design efforts to inhibit viral RNA synthesis.	[Tay, Moon Y. F.; Zhao, Yongqian; Chan, Kitti W. K.; Singh, Daljit; Chong, Yuwen; Ooi, Eng Eong; Vasudevan, Subhash G.] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore; [Saw, Wuan Geok; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Zhao, Yongqian; Vasudevan, Subhash G.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia; [Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 138673, Singapore; [Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 138673, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Charles Sturt University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Vasudevan, SG (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.	subhash.vasudevan@duke-nus.edu.sg	Luo, Dahai/J-6022-2012	Luo, Dahai/0000-0001-7637-7275; Forwood, Jade/0000-0003-3267-9997; Tay, Moon/0000-0002-4730-6133; Vasudevan, Subhash/0000-0002-5083-3831; Ooi, Eng Eong/0000-0002-0520-1544	Duke-National University of Singapore Signature Research Program - Ministry of Health, Singapore; National Medical Research Council, Singapore [NMRC/1315/2011, NMRC/TCR/005/2008]; Ministry of Education MOE Tier 3 Grant, Singapore [MOE2012-T3-1-008]	Duke-National University of Singapore Signature Research Program - Ministry of Health, Singapore(Ministry of Health-SingaporeNational University of Singapore); National Medical Research Council, Singapore(National Medical Research Council, Singapore); Ministry of Education MOE Tier 3 Grant, Singapore(Ministry of Education, Singapore)	This work was supported by the Duke-National University of Singapore Signature Research Program (funded by the Ministry of Health, Singapore), National Medical Research Council, Singapore, Grants NMRC/1315/2011 and NMRC/TCR/005/2008, and the Ministry of Education MOE Tier 3 Grant MOE2012-T3-1-008, Singapore.	Balakrishna AM, 2010, J BIOENERG BIOMEMBR, V42, P311, DOI 10.1007/s10863-010-9298-3; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Bartholomeus A, 1999, J VIRAL HEPATITIS, V6, P261, DOI 10.1046/j.1365-2893.1999.00173.x; BARTHOLOMEUSZ AI, 1993, ARCH VIROL, V128, P111, DOI 10.1007/BF01309792; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340; CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; CHU PWG, 1985, VIROLOGY, V140, P68, DOI 10.1016/0042-6822(85)90446-5; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Davidson AD, 2014, METHODS MOL BIOL, V1138, P113, DOI 10.1007/978-1-4939-0348-1_8; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Geiss BJ, 2009, FUTURE MED CHEM, V1, P327, DOI 10.4155/FMC.09.27; Gruber A, 2011, INFECT IMMUN, V79, P2880, DOI 10.1128/IAI.01326-10; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Ho CSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053051; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Keller AA, 2013, PHARMACEUTICALS, V6, P184, DOI 10.3390/ph6020184; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Li XD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002891; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Lipson H., 1956, ACTA CRYSTALLOGR, V9, P839; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; Moreland NJ, 2012, J VIROL METHODS, V179, P97, DOI 10.1016/j.jviromet.2011.10.006; Moreland NJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000881; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Paradkar PN, 2011, BIOSCIENCE REP, V31, P221, DOI 10.1042/BSR20100078; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468; PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990; Rawlinson SM, 2006, CURR DRUG TARGETS, V7, P1623, DOI 10.2174/138945006779025383; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; Svergun D., 2013, SMALL ANGLE XRAY NEU, P65; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Svergun DI, 1998, BIOCHEMISTRY-US, V37, P17659, DOI 10.1021/bi982367a; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomassini JE, 2003, VIROLOGY, V313, P274, DOI 10.1016/S0042-6822(03)00314-3; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Wu CF, 2003, J VIROL METHODS, V114, P45, DOI 10.1016/j.jviromet.2003.09.001; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006; ZHANG LW, 1992, J VIROL, V66, P7549, DOI 10.1128/JVI.66.12.7549-7554.1992; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010; Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189	74	88	90	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2379	2394		10.1074/jbc.M114.607341	http://dx.doi.org/10.1074/jbc.M114.607341			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488659	hybrid, Green Published			2022-12-28	WOS:000348588000041
J	Yang, L; Katchman, A; Weinberg, RL; Abrams, J; Sannad, T; Wan, E; Pitt, GS; Marx, SO				Yang, Lin; Katchman, Alexander; Weinberg, Richard L.; Abrams, Jeffrey; Sannad, Tahmina; Wan, Elaine; Pitt, Geoffrey S.; Marx, Steven O.			The PDZ Motif of the alpha(1C) Subunit Is Not Required for Surface Trafficking and Adrenergic Modulation of Ca(V)1.2 Channel in the Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; C-TERMINAL DOMAIN; CALCIUM-CHANNELS; CA2+ CHANNEL; CARDIAC MYOCYTES; ANCHORING PROTEIN; HIPPOCAMPAL-NEURONS; CARBOXYL-TERMINUS; SIGNALING COMPLEX; SKELETAL-MUSCLE	Voltage-gated Ca2+ channels play a key role in initiating muscle excitation-contraction coupling, neurotransmitter release, gene expression, and hormone secretion. The association of Ca(V)1.2 with a supramolecular complex impacts trafficking, localization, turnover, and, most importantly, multifaceted regulation of its function in the heart. Several studies hint at an important role for the C terminus of the alpha(1C) subunit as a hub for multidimensional regulation of Ca(V)1.2 channel trafficking and function. Recent studies have demonstrated an important role for the four-residue PDZ binding motif at the C terminus of alpha(1C) in interacting with scaffold proteins containing PDZ domains, in the subcellular localization of Ca(V)1.2 in neurons, and in the efficient signaling to cAMP-response element-binding protein in neurons. However, the role of the alpha(1C) PDZ ligand domain in the heart is not known. To determine whether the alpha(1C) PDZ motif is critical for Ca(V)1.2 trafficking and function in cardiomyocytes, we generated transgenic mice with inducible expression of an N-terminal FLAG epitope-tagged dihydropyridine-resistant alpha(1C) with the PDZ motif deleted (Delta PDZ). These mice were crossed with alpha-myosin heavy chain reverse transcriptional transactivator transgenic mice, and the double-transgenic mice were fed doxycycline. The Delta PDZ channels expressed, trafficked to the membrane, and supported robust excitation-contraction coupling in the presence of nisoldipine, a dihydropyridine Ca2+ channel blocker, providing functional evidence that they appropriately target to dyads. The Delta PDZ Ca2+ channels were appropriately regulated by isoproterenol and forskolin. These data indicate that the alpha(1C) PDZ motif is not required for surface trafficking, localization to the dyad, or adrenergic stimulation of Ca(V)1.2 in adult cardiomyocytes.	[Yang, Lin; Katchman, Alexander; Weinberg, Richard L.; Abrams, Jeffrey; Sannad, Tahmina; Wan, Elaine; Marx, Steven O.] Columbia Univ Coll Phys & Surg, Div Cardiol, Dept Med, New York, NY 10032 USA; [Yang, Lin; Katchman, Alexander; Weinberg, Richard L.; Abrams, Jeffrey; Sannad, Tahmina; Wan, Elaine; Marx, Steven O.] Columbia Univ Coll Phys & Surg, Div Cardiol, Dept Pharmacol, New York, NY 10032 USA; [Pitt, Geoffrey S.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA	Columbia University; Columbia University; Duke University	Marx, SO (corresponding author), Columbia Univ Coll Phys & Surg, Div Cardiol, Ctr PH 3, 630 W 168th St, New York, NY 10032 USA.	sm460@columbia.edu	Pitt, Geoffrey/L-4927-2019	Weinberg, Richard/0000-0001-8563-1554; Samad, Tahmina/0000-0001-8455-0998	NHLBI/National Institutes of Health [R01HL113136, R01 HL121253, T32 HL007854]; American Heart Association; Arlene and Arnold Goldstein Family Foundation; Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007854, R01HL121253, R01HL113136] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Arlene and Arnold Goldstein Family Foundation; Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI/National Institutes of Health Grants R01HL113136, R01 HL121253, and T32 HL007854. This work was also supported by an American Heart Association Founder's Affiliate grant-in-aid and by the Arlene and Arnold Goldstein Family Foundation. Supported by a fellowship from the Sarnoff Cardiovascular Research Foundation.; Supported by a fellowship from the Sarnoff Cardiovascular Research Foundation.	Abi-Char J, 2008, AM J PHYSIOL-HEART C, V294, pH1851, DOI 10.1152/ajpheart.01045.2007; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; BEELER GW, 1970, J PHYSIOL-LONDON, V207, P191, DOI 10.1113/jphysiol.1970.sp009056; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Domes K, 2011, J BIOL CHEM, V286, P33863, DOI 10.1074/jbc.M111.252312; El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007; FABIATO A, 1979, ANNU REV PHYSIOL, V41, P473, DOI 10.1146/annurev.ph.41.030179.002353; Fu Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175307; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Ganesan AN, 2005, BIOCHEM BIOPH RES CO, V329, P749, DOI 10.1016/j.bbrc.2005.02.015; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hambleton M, 2007, AM J PHYSIOL-HEART C, V293, pH3768, DOI 10.1152/ajpheart.00486.2007; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; Hockerman GH, 1997, P NATL ACAD SCI USA, V94, P14906, DOI 10.1073/pnas.94.26.14906; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Korb D., 2013, ISRN CELL BIOL, V2013, P1; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Lin CS, 2013, J BIOL CHEM, V288, P29403, DOI 10.1074/jbc.M113.470708; Maturana AD, 2008, CARDIOVASC RES, V78, P458, DOI 10.1093/cvr/cvn052; Maximov A, 2002, J NEUROSCI, V22, P6939; Milstein ML, 2012, P NATL ACAD SCI USA, V109, pE2134, DOI 10.1073/pnas.1109370109; Mitterdorfer J, 1996, BIOCHEMISTRY-US, V35, P9400, DOI 10.1021/bi960683o; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Ou YJ, 2003, J BIOL CHEM, V278, P1915, DOI 10.1074/jbc.M209938200; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Qu YX, 2005, AM J PHYSIOL-HEART C, V288, pH2123, DOI 10.1152/ajpheart.01023.2004; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Shy D, 2014, CIRCULATION, V130, P147, DOI 10.1161/CIRCULATIONAHA.113.007852; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Valencik ML, 2001, TRANSGENIC RES, V10, P269, DOI 10.1023/A:1016601928465; Weick JP, 2003, J NEUROSCI, V23, P3446; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xu H, 2010, BIOCHEMISTRY-US, V49, P10298, DOI 10.1021/bi101018c; Yang L, 2005, J BIOL CHEM, V280, P207, DOI 10.1074/jbc.M410509200; Yang L, 2013, CIRC RES, V113, P871, DOI 10.1161/CIRCRESAHA.113.301926; Yang L, 2011, FASEB J, V25, P928, DOI 10.1096/fj.10-172353; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	59	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2166	2174		10.1074/jbc.M114.602508	http://dx.doi.org/10.1074/jbc.M114.602508			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505241	Green Published, hybrid			2022-12-28	WOS:000348588000021
J	Layne, JD; Shridas, P; Webb, NR				Layne, Joseph D.; Shridas, Preetha; Webb, Nancy R.			Ectopically Expressed Pro-group X Secretory Phospholipase A(2) Is Proteolytically Activated in Mouse Adrenal Cells by Furin-like Proprotein Convertases IMPLICATIONS FOR THE REGULATION OF ADRENAL STEROIDOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenal; Glucocorticoid; Nuclear Receptor; Phospholipase; Proprotein Convertase Subtilisin; Kexin Type 9 (PCSK9)	GROUP-V; ARACHIDONIC-ACID; RECEPTOR; PROTEIN; MACROPHAGES; INFLAMMATION; HYDROLYSIS; GLANDS; ASTHMA; PACE4	Background: GX sPLA(2) is expressed as an inactive pro-enzyme; the protease(s) responsible for pro-GX sPLA(2) processing are unknown. Results: Epitope-tagged pro-GX sPLA(2) is proteolytically activated by furin and PCSK6 in adrenal cells. Conclusion: Furin-like proprotein convertases regulate GX sPLA(2) activity. Significance: Identifying the factors involved in activating GX sPLA(2) provides novel insight into the mechanisms surrounding its regulation. Group X secretory phospholipase A(2) (GX sPLA(2)) hydrolyzes mammalian cell membranes, liberating free fatty acids and lysophospholipids. GX sPLA(2) is produced as a pro-enzyme (pro-GX sPLA(2)) that contains an N-terminal 11-amino acid propeptide ending in a dibasic motif, suggesting cleavage by a furin-like proprotein convertase (PC). Although propeptide cleavage is clearly required for enzymatic activity, the protease(s) responsible for pro-GX sPLA(2) activation have not been identified. We previously reported that GX sPLA(2) negatively regulates adrenal glucocorticoid production, likely by suppressing liver X receptor-mediated activation of steroidogenic acute regulatory protein expression. In this study, using a FLAG epitope-tagged pro-GX sPLA(2) expression construct (FLAG-pro-GX sPLA(2)), we determined that adrenocorticotropic hormone (ACTH) enhanced FLAG-pro-GX sPLA(2) processing and phospholipase activity secreted by Y1 adrenal cells. ACTH increased the expression of furin and PCSK6, but not other members of the PC family, in Y1 cells. Overexpression of furin and PCSK6 in HEK 293 cells significantly enhanced FLAG-pro-GX sPLA(2) processing, whereas siRNA-mediated knockdown of both PCs almost completely abolished FLAG-pro-GX sPLA(2) processing in Y1 cells. Expression of either furin or PCSK6 enhanced the ability of GX sPLA(2) to suppress liver X receptor reporter activity. The PC inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethyl ketone significantly suppressed FLAG-pro-GX sPLA(2) processing and sPLA(2) activity in Y1 cells, and it significantly attenuated GX sPLA(2)-dependent inhibition of steroidogenic acute regulatory protein expression and progesterone production. These findings provide strong evidence that pro-GX sPLA(2) is a substrate for furin and PCSK6 proteolytic processing and define a novel mechanism for regulating corticosteroid production in adrenal cells.	[Layne, Joseph D.] Univ Kentucky, Med Ctr, Dept Pharmacol & Nutr Sci, Div Nutr Sci,Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Shridas, Preetha; Webb, Nancy R.] Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Webb, NR (corresponding author), Dept Pharmacol & Nutr Sci, 535 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	nrwebb1@uky.edu	Webb, Nancy/AAL-7030-2021		National Institutes of Health [R01 DK082419]; T32 Training Grant [2T32DK007778-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007778, R01DK082419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK082419 (to N.R.W.) and T32 Training Grant 2T32DK007778-11 (to J.L.).	Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Cherradi N, 2001, ENDOCRINOLOGY, V142, P3302, DOI 10.1210/en.142.8.3302; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Fon WP, 2007, ENDOCRINE, V32, P155, DOI 10.1007/s12020-007-9030-1; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Hallstrand TS, 2013, AM J RESP CRIT CARE, V188, P42, DOI 10.1164/rccm.201301-0084OC; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Higashino K, 2002, J BIOL CHEM, V277, P13583, DOI 10.1074/jbc.M108752200; Jemel I, 2011, J BIOL CHEM, V286, P36509, DOI 10.1074/jbc.M111.268540; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Morioka Y, 2000, FEBS LETT, V487, P262, DOI 10.1016/S0014-5793(00)02350-4; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; PARKER KL, 1985, P NATL ACAD SCI USA, V82, P7860, DOI 10.1073/pnas.82.23.7860; Pruzanski W, 2005, BBA-MOL CELL BIOL L, V1736, P38, DOI 10.1016/j.bbalip.2005.07.005; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Saiga A, 2001, BBA-MOL CELL BIOL L, V1530, P67, DOI 10.1016/S1388-1981(00)00167-0; Shridas P, 2011, J IMMUNOL, V187, P482, DOI 10.4049/jimmunol.1003552; Shridas P, 2010, ARTERIOSCL THROM VAS, V30, P2014, DOI 10.1161/ATVBAHA.110.210237; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Tamaru S, 2013, J IMMUNOL, V191, P1021, DOI 10.4049/jimmunol.1300738; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Yokota Y, 2001, FEBS LETT, V509, P250, DOI 10.1016/S0014-5793(01)03173-8	33	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7851	7860		10.1074/jbc.M114.634667	http://dx.doi.org/10.1074/jbc.M114.634667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623068	Green Published, hybrid			2022-12-28	WOS:000351613600043
J	Schmidt, A; Dietrich, S; Steuer, A; Weltmann, KD; von Woedtke, T; Masur, K; Wende, K				Schmidt, Anke; Dietrich, Stephan; Steuer, Anna; Weltmann, Klaus-Dieter; von Woedtke, Thomas; Masur, Kai; Wende, Kristian			Non-thermal Plasma Activates Human Keratinocytes by Stimulation of Antioxidant and Phase II Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATMOSPHERIC-PRESSURE PLASMA; GROWTH-FACTOR SYNTHESIS; HEME OXYGENASE-1; OXIDATIVE STRESS; REDOX REGULATION; TRANSCRIPTIONAL REPRESSOR; HACAT KERATINOCYTES; NUCLEAR EXPORT; IN-VITRO; C-JUN	Non-thermal atmospheric pressure plasma provides a novel therapeutic opportunity to control redox-based processes, e.g. wound healing, cancer, and inflammatory diseases. By spatial and time-resolved delivery of reactive oxygen and nitrogen species, it allows stimulation or inhibition of cellular processes in biological systems. Our data show that both gene and protein expression is highly affected by non-thermal plasma. Nuclear factor erythroid-related factor 2 (NRF2) and phase II enzyme pathway components were found to act as key controllers orchestrating the cellular response in keratinocytes. Additionally, glutathione metabolism, which is a marker for NRF2-related signaling events, was affected. Among the most robustly increased genes and proteins, heme oxygenase 1, NADPH-quinone oxidoreductase 1, and growth factors were found. The roles of NRF2 targets, investigated by siRNA silencing, revealed that NRF2 acts as an important switch for sensing oxidative stress events. Moreover, the influence of non-thermal plasma on the NRF2 pathway prepares cells against exogenic noxae and increases their resilience against oxidative species. Via paracrine mechanisms, distant cells benefit from cell-cell communication. The finding that non-thermal plasma triggers hormesis-like processes in keratinocytes facilitates the understanding	[Schmidt, Anke; Dietrich, Stephan; Masur, Kai; Wende, Kristian] Ctr Innovat Competence ZIK Plasmatis, D-17489 Greifswald, Germany; [Schmidt, Anke; Steuer, Anna; Weltmann, Klaus-Dieter; von Woedtke, Thomas] Leibniz Inst Plasma Sci & Technol, D-17489 Greifswald, Germany	Leibniz Institut fur Plasmaforschung und Technologie	Schmidt, A (corresponding author), INF Greifswald, Dept Plasma Bioengn, Felix Hausdorff Str 2, D-17489 Greifswald, Germany.	anke.schmidt@inp-greifswald.de	von Woedtke, Thomas/U-3604-2018; Wende, Kristian/AAE-8810-2020	von Woedtke, Thomas/0000-0002-1097-4832; Wende, Kristian/0000-0001-5217-0683; Dietrich, Stephan/0000-0002-0753-9266	German Federal Ministry of Education and Research [03Z2DN11]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We thank L. Kuntz for distinguished technical support: For critical reading of the manuscript; we thank J. C. Schmidt. This work was realized within the framework of the multi-disciplinary research center ZIK plasmatis, which is funded by German Federal Ministry of Education and Research Grant 03Z2DN11.	Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barton A., 2014, PLASMA MED, V3, P125, DOI [10.1615/PlasmaMed.2014008540, DOI 10.1615/PLASMAMED.2014008540]; Behmoaras J, 2008, NAT GENET, V40, P553, DOI 10.1038/ng.137; Bekeschus S, 2013, PLASMA PROCESS POLYM, V10, P706, DOI 10.1002/ppap.201300008; Blackert S, 2013, J DERMATOL SCI, V70, P173, DOI 10.1016/j.jdermsci.2013.01.012; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; Brandenburg R, 2009, IEEE T PLASMA SCI, V37, P877, DOI 10.1109/TPS.2009.2019657; Bundscherer L, 2013, IMMUNOBIOLOGY, V218, P1248, DOI 10.1016/j.imbio.2013.04.015; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Christman SA, 2005, FEBS LETT, V579, P6705, DOI 10.1016/j.febslet.2005.10.066; Correa-Costa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049569; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012; Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; Emmert S, 2013, CLIN PLASMA MED, V1, P24, DOI 10.1016/j.cpme.2012.11.002; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Green GH, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1302; Grochot-Przeczek A, 2014, ANTIOXID REDOX SIGN, V20, P1677, DOI 10.1089/ars.2013.5426; Haertel B, 2012, CELL BIOL INT, V36, P1217, DOI 10.1042/CBI20120139; Haertel B, 2012, IMMUNOBIOLOGY, V217, P628, DOI 10.1016/j.imbio.2011.10.017; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Hirakawa S, 2011, J IMMUNOL, V186, P4762, DOI 10.4049/jimmunol.1000791; Hirota A, 2005, J INVEST DERMATOL, V124, P825, DOI 10.1111/j.0022-202X.2005.23670.x; Huang BW, 2013, FASEB J, V27, P3763, DOI 10.1096/fj.12-226043; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Isbary G, 2011, ARCH DERMATOL, V147, P388, DOI 10.1001/archdermatol.2011.57; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016; Jurzak M, 2013, ACTA POL PHARM, V70, P205; Kaushik AK, 2014, J PROTEOME RES, V13, P1088, DOI 10.1021/pr401106h; Kayahara M, 2005, MOL CELL BIOL, V25, P3784, DOI 10.1128/MCB.25.9.3784-3792.2005; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Kramer A, 2013, CLIN PLASMA MED, V1, P11, DOI 10.1016/j.cpme.2013.03.002; Lichtenfels R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041345; Loo AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049215; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Mann A, 2001, J INVEST DERMATOL, V117, P1382, DOI 10.1046/j.0022-202x.2001.01600.x; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Metelmann HR, 2013, CLIN PLASMA MED, V1, P30, DOI 10.1016/j.cpme.2012.12.001; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Pham RT, 2002, MAR ENVIRON RES, V54, P291, DOI 10.1016/S0141-1136(02)00179-4; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Reuter S, 2012, IEEE T PLASMA SCI, V40, P2986, DOI 10.1109/TPS.2012.2207130; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Schmidt A., 2013, PLASMA MED, V3, P15, DOI [DOI 10.1615/PLASMAMED.2014008535, 10.1615/PlasmaMed.2014008535]; Schmidt A, 2013, FREE RADICAL RES, V47, P577, DOI 10.3109/10715762.2013.804623; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sen CK, 2003, WOUND REPAIR REGEN, V11, P431, DOI 10.1046/j.1524-475X.2003.11607.x; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Soneja A, 2005, PHARMACOL REP, V57, P108; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; von Woedtke T, 2014, CONTRIB PLASM PHYS, V54, P104, DOI 10.1002/ctpp.201310068; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; von Woedtke T, 2008, PLASMA PROCESS POLYM, V5, P534, DOI 10.1002/ppap.200800013; Wagener FADTG, 2010, CURR DRUG TARGETS, V11, P1571; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Wende K., 2013, PLASMA MED, V3, P81, DOI DOI 10.1615/PLASMAMED.2014009690; Wende K, 2014, CELL BIOL INT, V38, P412, DOI 10.1002/cbin.10200; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Winter J, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/28/285401; WINTER J, 2014, J PHYS D, P46; Zhao R, 2012, ENVIRON HEALTH PERSP, V120, P583, DOI 10.1289/ehp.1104580	87	95	96	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6731	6750		10.1074/jbc.M114.603555	http://dx.doi.org/10.1074/jbc.M114.603555			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25589789	hybrid, Green Published			2022-12-28	WOS:000350991500007
J	Yamak, A; Georges, RO; Sheikh-Hassani, M; Morin, M; Komati, H; Nemer, M				Yamak, Abir; Georges, Romain O.; Sheikh-Hassani, Massomeh; Morin, Martin; Komati, Hiba; Nemer, Mona			Novel Exons in the Tbx5 Gene Locus Generate Protein Isoforms with Distinct Expression Domains and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLT-ORAM-SYNDROME; TRANSCRIPTION FACTOR; NUCLEAR-LOCALIZATION; MUTATIONS; GATA4; DIFFERENTIATION; HEART; CARDIOGENESIS; MORPHOGENESIS; NKX2-5	TBX5 is the gene mutated in Holt-Oran syndrome, an autosomal dominant disorder with complex heart and limb deformities. Its protein product is a member of the T-box family of transcription factors and an evolutionarily conserved dosage-sensitive regulator of heart and limb development. Understanding TBX5 regulation is therefore of paramount importance. Here we uncover the existence of novel exons and provide evidence that TBX5 activity may be extensively regulated through alternative splicing to produce protein isoforms with differing N- and C-terminal domains. These isoforms are also present in human heart, indicative of an evolutionarily conserved regulatory mechanism. The newly identified isoforms have different transcriptional properties and can antagonize TBX5a target gene activation. Droplet Digital PCI1 as well as immunohistochemistry with isoform-specific antibodies reveal differential as well as overlapping expression domains. In particular, we find that the predominant isoform in skeletal myoblasts is Tbx5c, and we show that it is dramatically up-regulated in differentiating myotubes and is essential for myotube formation. Mechanistically, TBX5c antagonizes TBX5a activation of pro-proliferative signals such as IGF-1, FGF-10, and BMP4. The results provide new insight into Tbx5 regulation and function that will further our understanding of its role in health and disease. The finding of new exons in the Tbx5 locus may also be relevant to mutational screening especially in the 30% of Holt-Oram syndrome patients with no mutations in the known TBX5a exons.	[Yamak, Abir; Sheikh-Hassani, Massomeh; Komati, Hiba; Nemer, Mona] Univ Ottawa, Dept Biochem Microbiol & Immunol, Lab Mol Genet & Cardiac Regenerat, Ottawa, ON K1N 6N5, Canada; [Georges, Romain O.; Morin, Martin; Nemer, Mona] Univ Montreal, Inst Rech Clin Montreal, Grad Program Mol Biol, Montreal, PQ H2W 1R7, Canada	University of Ottawa; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Nemer, M (corresponding author), Univ Ottawa, 550 Cumberland,Rm 246, Ottawa, ON K1N 6N5, Canada.	mona.nemer@uottawa.ca			Canadian Heart and Stroke Foundation; McCain Foundation	Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); McCain Foundation	This work was supported by a grant from the Canadian Heart and Stroke Foundation and the McCain Foundation.	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Borozdin W, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9396; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camarata T, 2006, J CELL BIOL, V174, P339, DOI 10.1083/jcb.200511109; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Collavoli A, 2003, J MOL CELL CARDIOL, V35, P1191, DOI 10.1016/S0022-2828(03)00231-1; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Hariri F, 2012, ANN MED, V44, P680, DOI 10.3109/07853890.2011.607468; Heinritz Wolfram, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9375; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Kulisz A, 2008, MOL CELL BIOL, V28, P1553, DOI 10.1128/MCB.00935-07; Lavallee G, 2006, EMBO J, V25, P5201, DOI 10.1038/sj.emboj.7601379; Li QY, 1997, NAT GENET, V15, P21; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Nadeau M, 2010, P NATL ACAD SCI USA, V107, P19356, DOI 10.1073/pnas.0914888107; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Rochais F, 2014, CARDIOVASC RES, V104, P432, DOI 10.1093/cvr/cvu232; Sato M, 2011, J BIOSCI BIOENG, V112, P273, DOI 10.1016/j.jbiosc.2011.05.007; Stirnimann CU, 2010, J MOL BIOL, V400, P71, DOI 10.1016/j.jmb.2010.04.052; Yamak A, 2014, P NATL ACAD SCI USA, V111, P1415, DOI 10.1073/pnas.1312993111; Yamak A, 2012, AM J PHYSIOL-HEART C, V303, pH1057, DOI 10.1152/ajpheart.00250.2012; Zaragoza MV, 2004, GENE, V330, P9, DOI 10.1016/j.gene.2004.01.017	31	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6844	6856		10.1074/jbc.M114.634451	http://dx.doi.org/10.1074/jbc.M114.634451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25623069	Green Published, hybrid			2022-12-28	WOS:000350991500020
J	Lund, J; Troeberg, L; Kjeldal, H; Olsen, OH; Nagase, H; Sorensen, ES; Stennicke, HR; Petersen, HH; Overgaard, MT				Lund, Jacob; Troeberg, Linda; Kjeldal, Henrik; Olsen, Ole H.; Nagase, Hideaki; Sorensen, Esben S.; Stennicke, Henning R.; Petersen, Helle H.; Overgaard, Michael T.			Evidence for Restricted Reactivity of ADAMDEC1 with Protein Substrates and Endogenous Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC ACTIVITIES; CRYSTAL-STRUCTURE; CANDIDATE GENES; SNAKE-VENOM; EXPRESSION; METALLOPROTEASE; DECYSIN; ARCHITECTURE; SERRALYSINS; ASTACINS	ADAMDEC1 is a proteolytically active metzincin metalloprotease displaying rare active site architecture with a zinc-binding Asp residue (Asp-362). We previously demonstrated that substitution of Asp- :362 for a His residue, thereby reconstituting the canonical metzincin zinc-binding environment with three His zinc ligands, increases the proteolytic activity. The protease also has an atypically short domain structure with an odd number of Cys residues in the metalloprotease domain. Here, we investigated how these rare structural features in the ADAMDEC1 metalloprotease domain impact the proteolytic activity, the substrate specificity, and the effect of inhibitors. We identified carboxymethylated transferrin (Cm-TO as a new ADANIDEC1 substrate and determined the primary and secondary cleavage sites, which suggests a strong preference for Leu in the P1' position. Cys2, present in humans but only partially conserved within sequenced ADAMDEC1 orthologs, was found to be unpaired, and substitution of Cys392 for a Ser increased the reactivity with alpha(2)-macroglobulin but not with casein or Cm-Tf. Substitution of Asp(362) for His resulted in a general increase in proteolytic activity and a change in substrate specificity was observed with Cm-IT. ADAMDEC1 was inhibited by the small molecule inhibitor batimastat but not by tissue inhibitor of metalloproteases (TIMP)-1, TIMP-2, or the N-terminal inhibitory domain of TIMP-3 (N-1'IMP-3). However, N-TIMP-3 displayed profound inhibitory activity against the D362H variants with a reconstituted consensus metzincin zinc-binding environment. We hypothesize that these unique features of ADAMDEC1 may have evolved to escape from inhibition by endogenous metalloprotease inhibitors.	[Lund, Jacob; Kjeldal, Henrik; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Lund, Jacob; Olsen, Ole H.; Stennicke, Henning R.; Petersen, Helle H.] Novo Nordisk AS, Dept Haemophilia Biochem, DK-2760 Malov, Denmark; [Troeberg, Linda; Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Sorensen, Esben S.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Aalborg University; Novo Nordisk; University of Oxford; Aarhus University	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Frederik Bajers Vej 7H, DK-9220 Aalborg, Denmark.	mto@bio.aau.dk	Lund, Jacob/G-9885-2013; Overgaard, Michael Toft/E-1354-2011	Lund, Jacob/0000-0001-8627-7382; Overgaard, Michael Toft/0000-0002-1423-2481; /0000-0003-0939-4651; Sorensen, Esben Skipper/0000-0002-7050-3354	National Institutes of Health, NIAMS [AR40994]; Danish Ministry of Higher Education and Science; Arthritis Research UK Career Development Fellowship Grant [19466]; Centre for Osteoarthritis Pathogenesis Grant [20205]; Obelske Family Foundation; Novo Nordisk Foundation; Carlsberg Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; Versus Arthritis [19466] Funding Source: researchfish	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Danish Ministry of Higher Education and Science; Arthritis Research UK Career Development Fellowship Grant(Versus Arthritis); Centre for Osteoarthritis Pathogenesis Grant(Versus Arthritis); Obelske Family Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Versus Arthritis(Versus Arthritis)	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant AR40994 (to H.N.).; Supported by the Danish Ministry of Higher Education and Science.; Supported by Arthritis Research UK Career Development Fellowship Grant 19466 and Centre for Osteoarthritis Pathogenesis Grant 20205.; Supported by the Obelske Family Foundation, the Novo Nordisk Foundation, and the Carlsberg Foundation.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Bates EEM, 2002, IMMUNOGENETICS, V54, P96, DOI 10.1007/s00251-002-0430-3; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Dommels YEM, 2007, GENES NUTR, V2, P209, DOI 10.1007/s12263-007-0051-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fritsche J, 2003, IMMUNOLOGY, V110, P450, DOI 10.1111/j.1365-2567.2003.01754.x; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x; Hall T, 2012, ACTA CRYSTALLOGR F, V68, P616, DOI 10.1107/S1744309112015618; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kurisu G, 2000, J INORG BIOCHEM, V82, P225, DOI 10.1016/S0162-0134(00)00136-7; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; Lucchesi W, 2008, J VIROL, V82, P7456, DOI 10.1128/JVI.00223-08; Lund J, 2013, J BIOL CHEM, V288, P21367, DOI 10.1074/jbc.M113.474536; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McClellan MJ, 2012, J VIROL, V86, P5165, DOI 10.1128/JVI.07161-11; Mueller CGF, 1997, J EXP MED, V186, P655, DOI 10.1084/jem.186.5.655; Mueller CGF, 2001, J IMMUNOL, V167, P5052, DOI 10.4049/jimmunol.167.9.5052; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; NAGASE H, 1995, METHOD ENZYMOL, V248, P449; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tranchant I, 2014, CHEM BIOL, V21, P408, DOI 10.1016/j.chembiol.2014.01.008; Troeberg L, 2002, BIOCHEMISTRY-US, V41, P15025, DOI 10.1021/bi026454l; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu JG, 2012, NEUROL RES, V34, P701, DOI 10.1179/1743132812Y.0000000067	37	6	6	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6620	6629		10.1074/jbc.M114.601724	http://dx.doi.org/10.1074/jbc.M114.601724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564618	Green Published, hybrid			2022-12-28	WOS:000350732500063
J	Sutthangkul, J; Amparyup, P; Charoensapsri, W; Senapin, S; Phiwsaiya, K; Tassanakajon, A				Sutthangkul, Jantiwan; Amparyup, Piti; Charoensapsri, Walaiporn; Senapin, Saengchan; Phiwsaiya, Kornsunee; Tassanakajon, Anchalee			Suppression of Shrimp Melanization during White Spot Syndrome Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE-ACTIVATING ENZYME; LITOPENAEUS-VANNAMEI; SYSTEM; PHENOLOXIDASE; CRUSTACEAN; CRAYFISH; IDENTIFICATION; EXPRESSION; INHIBITOR; HEMOCYTES	The melanization cascade, activated by the prophenoloxidase (proP0) system, plays a key role in the production of cytotoxic intermediates, as well as melanin products for microbial sequestration in invertebrates. Here, we show that the proPO system is an important component of the Penaeus inonodon shrimp immune defense toward a major viral pathogen, white spot syndrome virus (WSSV). Gene silencing of PmproP0(s) resulted in increased cumulative shrimp mortality after WSSV infection, whereas incubation of WSSV with an in vitro melanization reaction prior to injection into shrimp significantly increased the shrimp survival rate. The hemolymph phenoloxidase (PO) activity of WSSV-infected shrimp was extremely reduced at days 2 and 3 post-injection compared with uninftcted shrimp but was fully restored after the addition of exogenous trypsin, suggesting that WSSV probably inhibits the activity of some proteinases in the proPO cascade. Using yeast two-hybrid screening and co-immunoprecipitation assays, the viral protein WSSV453 was found to interact with the proP0-activating enzyme 2 (Pm1PAE2) of P. nionodon. Gene silencing of WSSV453 showed a significant increase of PO activity in WSSV-infected shrimp, whereas co-silencing of WSSV453 and PmPPAE2 did not, sug- gesting that silencing of WSSV453 partially restored the PO activity via PmPPAE2 in WSSV-infected shrimp. Moreover, the activation of PO activity in shrimp plasma by PmPPAE2 was significantly decreased by preincubation with recombinant WSSV453. These results suggest that the inhibition of the shrimp proPO system by WSSV partly occurs via the PmPPAE2-inhibiting activity of WSSV453.	[Sutthangkul, Jantiwan; Amparyup, Piti; Tassanakajon, Anchalee] Chulalongkorn Univ, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Bangkok 10330, Thailand; [Amparyup, Piti; Charoensapsri, Walaiporn; Senapin, Saengchan; Phiwsaiya, Kornsunee] Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol, Dev Agcy, Klongluang 12120, Pathumthani, Thailand; [Charoensapsri, Walaiporn; Senapin, Saengchan; Phiwsaiya, Kornsunee] Mahidol Univ, Ctr Excellence Shrimp Mol Biol & Biotechnol, Bangkok 10400, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, 254 Phayathai Rd, Bangkok 10330, Thailand.	anchalee.k@chula.ac.th	Senapin, Saengchan/F-1323-2011	Senapin, Saengchan/0000-0002-5599-4343; Charoensapsri, Walaiporn/0000-0002-8651-383X; Phiwsaiya, Kornsunee/0000-0003-3876-6450	Thailand Research Fund Senior Scholar [RTA5580008]; Thailand Research Fund; National Center for Genetic Engineering and Biotechnology; National Science and Technology Development Agency [RSA5580046]; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission Grant [WCU-017-FW-57]; Japan Science and Technology Agency (JST)/the Japan International Cooperation Agency (JICA); Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan Society for the Promotion of Science (JSPS) core University Program; Royal Golden Jubilee Ph.D. Program; Chulalongkorn University; 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)	Thailand Research Fund Senior Scholar; Thailand Research Fund(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology; National Science and Technology Development Agency; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission Grant; Japan Science and Technology Agency (JST)/the Japan International Cooperation Agency (JICA); Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan Society for the Promotion of Science (JSPS) core University Program; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)(Chulalongkorn University)	This work was supported by Thailand Research Fund Senior Scholar Grant RTA5580008 (to A.T.), the Thailand Research Fund and National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency Grant RSA5580046 (to P. A.), Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission Grant WCU-017-FW-57, the Japan Science and Technology Agency (JST)/the Japan International Cooperation Agency (JICA), Science and Technology Research Partnership for Sustainable Development (SATREPS), and a visiting fellowship under the Japan Society for the Promotion of Science (JSPS) core University Program.; Recipient of a student fellowship from the Royal Golden Jubilee Ph.D. Program, Joint Funding of the Thailand Research Fund and Chulalongkorn University and the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund).	Ai HS, 2009, DEV COMP IMMUNOL, V33, P59, DOI 10.1016/j.dci.2008.07.017; Ai HS, 2008, FISH SHELLFISH IMMUN, V25, P28, DOI 10.1016/j.fsi.2007.12.002; Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Amparyup P, 2008, DEV COMP IMMUNOL, V32, P1497, DOI 10.1016/j.dci.2008.06.005; Amparyup P, 2013, FISH SHELLFISH IMMUN, V34, P990, DOI 10.1016/j.fsi.2012.08.019; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2003, CELL MICROBIOL, V5, P353, DOI 10.1046/j.1462-5822.2003.00282.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Cerenius L, 2010, J INVERTEBR PATHOL, V103, P21, DOI 10.1016/j.jip.2009.09.006; Charoensapsri W, 2014, DEV COMP IMMUNOL, V47, P150, DOI 10.1016/j.dci.2014.07.010; Charoensapsri W, 2011, DEV COMP IMMUNOL, V35, P115, DOI 10.1016/j.dci.2010.09.002; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; Gao HW, 2009, MOL BIOL REP, V36, P1159, DOI 10.1007/s11033-008-9292-6; Jang IK, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-70; Jiravanichpaisal P, 2006, FISH SHELLFISH IMMUN, V20, P718, DOI 10.1016/j.fsi.2005.09.002; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Lightner, 1996, HDB SHRIMP PATHOLOGY, P304; Lin SW, 2012, J INFECTION, V64, P325, DOI 10.1016/j.jinf.2011.11.023; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu YC, 2009, FISH SHELLFISH IMMUN, V26, P345, DOI 10.1016/j.fsi.2008.08.016; Liu YJ, 2014, DEV COMP IMMUNOL, V43, P35, DOI 10.1016/j.dci.2013.10.012; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Sangsuriya P, 2014, MOL CELL PROTEOMICS, V13, P269, DOI 10.1074/mcp.M113.029199; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Stentiford GD, 2012, J INVERTEBR PATHOL, V110, P141, DOI 10.1016/j.jip.2012.03.013; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029; Yeh SP, 2009, FISH SHELLFISH IMMUN, V26, P582, DOI 10.1016/j.fsi.2008.09.010; Zeng Y, 2009, FISH SHELLFISH IMMUN, V26, P646, DOI 10.1016/j.fsi.2008.11.005; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhao PC, 2011, INSECT BIOCHEM MOLEC, V41, P645, DOI 10.1016/j.ibmb.2011.04.006	45	46	46	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6470	6481		10.1074/jbc.M114.605568	http://dx.doi.org/10.1074/jbc.M114.605568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25572398	hybrid, Green Published			2022-12-28	WOS:000350732500050
J	Lu, L; Sirish, P; Zhang, Z; Woltz, RL; Li, N; Timofeyev, V; Knowlton, AA; Zhang, XD; Yamoah, EN; Chiamvimonvat, N				Lu, Ling; Sirish, Padmini; Zhang, Zheng; Woltz, Ryan L.; Li, Ning; Timofeyev, Valeriy; Knowlton, Anne A.; Zhang, Xiao-Dong; Yamoah, Ebenezer N.; Chiamvimonvat, Nipavan			Regulation of Gene Transcription by Voltage-gated L-type Calcium Channel, Ca(v)1.3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; C-TERMINAL DOMAIN; NULL MUTANT MICE; SMALL-CONDUCTANCE; CA2+ CHANNELS; FUNCTIONAL ROLES; ATRIAL-FIBRILLATION; SK2 CHANNEL; CONGENITAL DEAFNESS	Ca(v)1.3 L-type Ca2+ channel is known to be highly expressed in neurons and neuroendocrine cells. However, we have previously demonstrated that the Ca(v)1.3 channel is also expressed in atria and pacemaking cells in the heart. The significance of the tissue-specific expression of the channel is underpinned by our previous demonstration of atrial fibrillation in a Ca(v)1.3 null mutant mouse model. Indeed, a recent study has confirmed the critical roles of Ca(v)1.3 in the human heart (Baig, S. M., Koschak, A., Lieb, A., Gebhart, M., Dafinger, C., Nuberg, G., Ali, A., Ahmad, I., Sinnegger-Brauns, M. J., Brandt, N., Engel, J., Mangoni, M. E., Farooq, M., Khan, H. U., Nuberg, P., Striessnig, J., and Bolz, H. J. (2011) Nat. Neurosci. 14, 77-84). These studies suggest that detailed knowledge of Ca(v)1.3 may have broad therapeutic ramifications in the treatment of cardiac arrhythmias. Here, we tested the hypothesis that there is a functional crosstalk between the Ca(v)1.3 channel and a small conductance Ca2+ activated K+ channel (SK2), which we have documented to be highly expressed in human and mouse atrial myocytes. Specifically, we tested the hypothesis that the C terminus of Ca(v)1.3 may translocate to the nucleus where it functions as a transcriptional factor. Here, we reported for the first time that the C terminus of Ca(v)1.3 translocates to the nucleus where it functions as a transcriptional regulator to modulate the function of Ca2+-activated K+ channels in atrial myocytes. Nuclear translocation of the C-terminal domain of Ca(v)1.3 is directly regulated by intracellular Ca2+. Utilizing a Ca(v)1.3 null mutant mouse model, we demonstrate that ablation of Ca(v)1.3 results in a decrease in the protein expression of myosin light chain 2, which interacts and increases the membrane localization of SK2 channels.	[Lu, Ling; Sirish, Padmini; Zhang, Zheng; Woltz, Ryan L.; Li, Ning; Timofeyev, Valeriy; Knowlton, Anne A.; Zhang, Xiao-Dong; Chiamvimonvat, Nipavan] Univ Calif Davis, Div Cardiovasc Med, Dept Internal Med, Davis, CA 95616 USA; [Knowlton, Anne A.; Chiamvimonvat, Nipavan] Northern Calif Hlth Care Syst, Dept Vet Affairs, Mather, CA 95655 USA; [Yamoah, Ebenezer N.] Univ Nevada, Sch Med, Dept Physiol, Reno, NV 89557 USA; [Lu, Ling] Nanjing Normal Univ, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China	University of California System; University of California Davis; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nanjing Normal University	Lu, L (corresponding author), Univ Calif Davis, Div Cardiovasc Med, Dept Internal Med, Davis, CA 95616 USA.	linglu@njnu.edu.cn; enyamoah@gmail.com; nchiamvimonvat@ucdavis.edu	Lu, Ling/AGU-8326-2022	Lu, Ling/0000-0002-2891-7326; Chiamvimonvat, Nipavan/0000-0001-9499-8817; Sirish, Padmini/0000-0002-9216-279X; woltz, ryan/0000-0002-0446-2478	National Institutes of Health [R01 HL85727, R01 HL85844, R01 HL077281, HL079071, R01 DC003826, R01 DC007592, R01 DC010386, R01 HL85844S1]; Veterans Affairs Merit Review Grant [I01 BX000576]; Howard Hughes Medical Institute; American Heart Association Western States Affiliate; American Heart Association Western States Affiliate [14BGIA18870087]; Calcium Signaling Chinese Grant [NSFC81330035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085844, R01HL085727, T32HL086350, R01HL079071, R01HL075274, R01HL077281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010386, R01DC003826, R01DC010917, R01DC007592] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association Western States Affiliate(American Heart Association); American Heart Association Western States Affiliate(American Heart Association); Calcium Signaling Chinese Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL85727 and R01 HL85844, and Veterans Affairs Merit Review Grant I01 BX000576 (to N. C.), National Institutes of Health Grants R01 HL077281 and HL079071 (to A. K.), National Institutes of Health Grants R01 DC003826, R01 DC007592, and R01 DC010386 (to E. Y.), National Institutes of Health Grant R01 HL85844S1 (to R. L. W.), a Howard Hughes Medical Institute Med-into-Grad Training Program to the University of California Davis and an American Heart Association Western States Affiliate Predoctoral Fellowship Award (to P. S.), American Heart Association Western States Affiliate Beginning Grant-in-Aid 14BGIA18870087 (to X. D. Z.), and Calcium Signaling Chinese Grant NSFC81330035 (to L. L.).	Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Chua SK, 2011, CIRC RES, V108, P971, DOI 10.1161/CIRCRESAHA.110.238386; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; Diness JG, 2010, CIRC-ARRHYTHMIA ELEC, V3, P380, DOI 10.1161/CIRCEP.110.957407; Dolmetsch R, 2003, SCI STKE, V166, ppe4, DOI DOI 10.1016/J.NEURON.2016.01.011; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; ELLINOR PT, 1993, NATURE, V363, P455, DOI 10.1038/363455a0; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gomez-Ospina N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060526; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kikuchi K, 2005, CIRCULATION, V111, P264, DOI 10.1161/01.CIR.0000153338.47507.83; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kubodera T, 2003, NEUROSCI LETT, V341, P74, DOI 10.1016/S0304-3940(03)00156-3; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; Lu L, 2009, P NATL ACAD SCI USA, V106, P18402, DOI 10.1073/pnas.0908207106; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI13310; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Rafizadeh S, 2014, P NATL ACAD SCI USA, V111, P9989, DOI 10.1073/pnas.1323541111; Rimini R, 2000, MOL BRAIN RES, V85, P218, DOI 10.1016/S0169-328X(00)00255-2; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shmukler BE, 2001, BBA-GENE STRUCT EXPR, V1518, P36, DOI 10.1016/S0167-4781(01)00166-X; Sirish P, 2012, J MOL CELL CARDIOL, V52, P264, DOI 10.1016/j.yjmcc.2011.10.012; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; Tuteja D, 2010, CIRC RES, V107, P851, DOI 10.1161/CIRCRESAHA.109.215269; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Xu YF, 2005, J PHYSIOL-LONDON, V562, P745, DOI 10.1113/jphysiol.2004.076216; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Zhang Q, 2008, CIRC RES, V102, P465, DOI 10.1161/CIRCRESAHA.107.161778; Zhang QA, 2011, J MOL CELL CARDIOL, V50, P194, DOI 10.1016/j.yjmcc.2010.10.002; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2	58	31	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4663	4676		10.1074/jbc.M114.586883	http://dx.doi.org/10.1074/jbc.M114.586883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538241	hybrid, Green Published			2022-12-28	WOS:000350042000011
J	Belman, JP; Bian, RR; Habtemichael, EN; Li, DT; Jurczak, MJ; Alcazar-Roman, A; McNally, LJ; Shulman, GI; Bogan, JS				Belman, Jonathan P.; Bian, Rachel R.; Habtemichael, Estifanos N.; Li, Don T.; Jurczak, Michael J.; Alcazar-Roman, Abel; McNally, Leah J.; Shulman, Gerald I.; Bogan, Jonathan S.			Acetylation of TUG Protein Promotes the Accumulation of GLUT4 Glucose Transporters in an Insulin-responsive Intracellular Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; REGULATED AMINOPEPTIDASE; ENERGY-EXPENDITURE; GOLGI PROTEIN; ACYL-COENZYME; TRANSLOCATION; INTERACTS; VESICLES; 3T3-L1; CELLS	Insulin causes the exocytic translocation of GLUT4 glucose transporters to stimulate glucose uptake in fat and muscle. Previous results support a model in which TUG traps GLUT4 in intracellular, insulin-responsive vesicles termed GLUT4 storage vesicles (GSVs). Insulin triggers TUG cleavage to release the GSVs; GLUT4 then recycles through endosomes during ongoing insulin exposure. The TUG C terminus binds a GSV anchoring site comprising Golgin-160 and possibly other proteins. Here, we report that the TUG C terminus is acetylated. The TUG C-terminal peptide bound the Golgin-160-associated protein, ACBD3 (acyl-CoA-binding domain-containing 3), and acetylation reduced binding of TUG to ACBD3 but not to Golgin-160. Mutation of the acetylated residues impaired insulin-responsive GLUT4 trafficking in 3T3-L1 adipocytes. ACBD3 overexpression enhanced the translocation of GSV cargos, GLUT4 and insulin-regulated aminopeptidase (IRAP), and ACBD3 was required for intracellular retention of these cargos in unstimulated cells. Sirtuin 2 (SIRT2), a NAD(+)-dependent deacetylase, bound TUG and deacetylated the TUG peptide. SIRT2 overexpression reduced TUG acetylation and redistributed GLUT4 and IRAP to the plasma membrane in 3T3-L1 adipocytes. Mutation of the acetylated residues in TUG abrogated these effects. In mice, SIRT2 deletion increased TUG acetylation and proteolytic processing. During glucose tolerance tests, glucose disposal was enhanced in SIRT2 knock-out mice, compared with wild type controls, without any effect on insulin concentrations. Together, these data support a model in which TUG acetylation modulates its interaction with Golgi matrix proteins and is regulated by SIRT2. Moreover, acetylation of TUG enhances its function to trap GSVs within unstimulated cells and enhances insulin-stimulated glucose uptake.	[Belman, Jonathan P.; Bian, Rachel R.; Habtemichael, Estifanos N.; Li, Don T.; Jurczak, Michael J.; Alcazar-Roman, Abel; McNally, Leah J.; Shulman, Gerald I.; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Belman, Jonathan P.; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Bogan, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Bogan, Jonathan S/A-1575-2010; Shulman, Gerald I./P-7176-2019; Li, Don/F-5162-2018	Bogan, Jonathan S/0000-0001-6463-8466; Shulman, Gerald I./0000-0003-1529-5668; Alcazar-Roman, Abel R./0000-0003-1668-1886; Belman, Jonathan/0000-0002-1051-6938; Jurczak, Michael/0000-0002-6335-6915; Li, Don/0000-0001-7547-4022	National Institutes of Health [P30DK45735]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK093198, R01DK092661, T32DK007058, K01DK099402, P30DK045735, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG041383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Brad Rubin, Charisse Orme, Ali Nasiri, Jie Liu, Toren Finkel, Weimin Zhong, Carolyn Machamer, Frederick Alt, Eric Verdin, Thomas Melia, and Fred Gorelick for assistance, reagents, and advice. This work used the Cell Biology Core of the Yale Diabetes Endocrinology Research Center (supported by National Institutes of Health Grant P30DK45735) as well as services provided by the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University.	Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Castorena CM, 2014, DIABETES, V63, P2297, DOI 10.2337/db13-1686; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen Y.-S., 2012, B NETWORKING COMPUTI, V1, P1, DOI DOI 10.1039/C4CS00300D; Chen Y, 2013, J NEUROSCI, V33, P3582, DOI 10.1523/JNEUROSCI.1497-12.2013; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Goodpaster BH, 2014, DIABETES, V63, P1058, DOI 10.2337/db13-1249; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Greninger AL, 2012, J VIROL, V86, P3605, DOI 10.1128/JVI.06778-11; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Hicks SW, 2005, J BIOL CHEM, V280, P28944, DOI 10.1074/jbc.M504937200; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Huang G., 2010, THESIS BOSTON U; Huang GR, 2013, MOL BIOL CELL, V24, P3115, DOI 10.1091/mbc.E12-10-0765; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Johnson ES, 2012, CURR OPIN CELL BIOL, V24, P876, DOI 10.1016/j.ceb.2012.10.002; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; Katagiri H, 2002, MOL ENDOCRINOL, V16, P1049, DOI 10.1210/me.16.5.1049; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Loffler MG, 2013, J BIOL CHEM, V288, P20135, DOI 10.1074/jbc.M113.458075; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Orme CM, 2012, J BIOL CHEM, V287, P6679, DOI 10.1074/jbc.M111.284232; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; Ramakrishnan G, 2014, J BIOL CHEM, V289, P6054, DOI 10.1074/jbc.M113.537266; Rubin BR, 2009, VITAM HORM, V80, P155, DOI 10.1016/S0083-6729(08)00607-9; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sasaki J, 2012, EMBO J, V31, P754, DOI 10.1038/emboj.2011.429; Sbodio JI, 2007, J BIOL CHEM, V282, P29874, DOI 10.1074/jbc.M705794200; Sbodio JI, 2006, J BIOL CHEM, V281, P27924, DOI 10.1074/jbc.M603276200; Sbodio JI, 2013, CELL REP, V4, P890, DOI 10.1016/j.celrep.2013.08.001; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	78	41	43	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4447	4463		10.1074/jbc.M114.603977	http://dx.doi.org/10.1074/jbc.M114.603977			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25561724	hybrid, Green Published			2022-12-28	WOS:000349458400051
J	Borrok, MJ; Wu, YL; Beyaz, N; Yu, XQ; Oganesyan, V; Dall'Acqua, WF; Tsui, P				Borrok, M. Jack; Wu, Yanli; Beyaz, Nurten; Yu, Xiang-Qing; Oganesyan, Vaheh; Dall'Acqua, William F.; Tsui, Ping			pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM HALF-LIFE; I-RELATED RECEPTOR; MONOCLONAL-ANTIBODIES; CYNOMOLGUS MONKEYS; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; MICE; COMPLEX; PHARMACOKINETICS; VARIANTS	The Fc domain of IgG has been the target of multiple mutational studies aimed at altering the pH-dependent IgG/FcRn interaction to modulate IgG pharmacokinetics. These studies have yielded antibody variants with disparate pharmacokinetic characteristics, ranging from extended in vivo half-life to those exhibiting extremely rapid clearance. To better understand pH-dependent binding parameters that govern these outcomes and limit FcRn-mediated half-life extension, we generated a panel of novel Fc variants with high affinity binding at acidic pH that vary in pH 7.4 affinities and assessed pharmacokinetic outcomes. Pharmacokinetic studies in human FcRn transgenic mice and cynomolgus monkeys showed that multiple variants with increased FcRn affinities at acidic pH exhibited extended serum half-lives relative to the parental IgG. Importantly, the results reveal an underappreciated affinity threshold of neutral pH binding that determines IgG recycling efficiency. Variants with pH 7.4 FcRn affinities below this threshold recycle efficiently and can exhibit increased serum persistence. Increasing neutral pH FcRn affinity beyond this threshold reduced serum persistence by offsetting the benefits of increased pH 6.0 binding. Ultra-high affinity binding to FcRn at both acidic and neutral pH leads to rapid serum clearance.	[Borrok, M. Jack; Wu, Yanli; Beyaz, Nurten; Oganesyan, Vaheh; Dall'Acqua, William F.; Tsui, Ping] Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Yu, Xiang-Qing] Medimmune Inc, Clin Pharmacol & Drug Metab & Pharmacokinet, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Dall'Acqua, WF (corresponding author), Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	dallacquaw@medimmune.com; tsuip@medimmune.com						Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahiyat B. I., 2014, United States Patent Publication, Patent No. [US8637641 B2, 8637641]; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; Datta-Mannan A, 2012, DRUG METAB DISPOS, V40, P1545, DOI 10.1124/dmd.112.045864; Deng R, 2010, DRUG METAB DISPOS, V38, P600, DOI 10.1124/dmd.109.031310; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Gurbaxani B, 2006, MOL IMMUNOL, V43, P1462, DOI 10.1016/j.molimm.2005.07.032; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Igawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063236; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Israel EJ, 1996, IMMUNOLOGY, V89, P573, DOI 10.1046/j.1365-2567.1996.d01-775.x; Kabat E. A., 1991, NIH PUBLICATION 91 3, V91-3442; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Medesan C, 1997, J IMMUNOL, V158, P2211; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Tedder TF, 2009, United States Patent Application Publication, Patent No. [US2009/0136516 A1, 20090136516]; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; Wu H, 2007, J MOL BIOL, V368, P652, DOI 10.1016/j.jmb.2007.02.024; Yeung YA, 2010, CANCER RES, V70, P3269, DOI 10.1158/0008-5472.CAN-09-4580; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	41	66	90	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4282	4290		10.1074/jbc.M114.603712	http://dx.doi.org/10.1074/jbc.M114.603712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538249	Green Published, hybrid			2022-12-28	WOS:000349458400038
J	Mehta, AP; Abdelwahed, SH; Mahanta, N; Fedoseyenko, D; Philmus, B; Cooper, LE; Liu, YQ; Jhulki, I; Ealick, SE; Begley, TP				Mehta, Angad P.; Abdelwahed, Sameh H.; Mahanta, Nilkamal; Fedoseyenko, Dmytro; Philmus, Benjamin; Cooper, Lisa E.; Liu, Yiquan; Jhulki, Isita; Ealick, Steven E.; Begley, Tadhg P.			Radical S-Adenosylmethionine (SAM) Enzymes in Cofactor Biosynthesis: A Treasure Trove of Complex Organic Radical Rearrangement Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MOAA-CATALYZED REACTION; MOLYBDENUM COFACTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; IN-VITRO; MENAQUINONE; RECONSTITUTION; MOLYBDOPTERIN; INTERMEDIATE; SUPERFAMILY	In this minireview, we describe the radical S-adenosylmethionine enzymes involved in the biosynthesis of thiamin, menaquinone, molybdopterin, coenzyme F-420, and heme. Our focus is on the remarkably complex organic rearrangements involved, many of which have no precedent in organic or biological chemistry.	[Mehta, Angad P.; Abdelwahed, Sameh H.; Mahanta, Nilkamal; Fedoseyenko, Dmytro; Philmus, Benjamin; Cooper, Lisa E.; Liu, Yiquan; Jhulki, Isita; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Ealick, Steven E.] Cornell Univ, Dept Chem, Ithaca, NY 14850 USA	Texas A&M University System; Texas A&M University College Station; Cornell University	Begley, TP (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	begley@chem.tamu.edu	Begley, Tadhg/B-5801-2015; MAHANTA, NILKAMAL/K-4545-2018	Jhulki, Isita/0000-0003-1554-971X; Abdelwahed, Sameh/0000-0002-3445-4065; Philmus, Benjamin/0000-0003-2085-0873	Robert A. Welch Foundation [A-0034]; National Institutes of Health [DK44083]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044083, R01DK067081, R01DK044083] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Robert A. Welch Foundation Grant A-0034 and National Institutes of Health Grant DK44083 (to T. P. B.). This is the third article in the Thematic Minireview Series on Radical SAM Enzymes.	ATKINSON JK, 1993, BIOCHEMISTRY-US, V32, P9209, DOI 10.1021/bi00086a028; Baroudi A, 2011, J ORG CHEM, V76, P1521, DOI 10.1021/jo102467j; Baroudi A, 2010, CHEM-EUR J, V16, P12316, DOI 10.1002/chem.201002303; Bietti M, 2010, TETRAHEDRON LETT, V51, P4129, DOI 10.1016/j.tetlet.2010.05.149; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Challand MR, 2010, J BIOL CHEM, V285, P5240, DOI 10.1074/jbc.M109.056606; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee A, 2010, ANGEW CHEM INT EDIT, V49, P8653, DOI 10.1002/anie.201003419; Cooper LE, 2013, BIOCHEMISTRY-US, V52, P4592, DOI 10.1021/bi400498d; Dairi T, 2012, METHOD ENZYMOL, V515, P107, DOI 10.1016/B978-0-12-394290-6.00006-9; Dairi T, 2011, NAT PROD REP, V28, P1054, DOI 10.1039/c0np00047g; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; Hover BM, 2013, J AM CHEM SOC, V135, P7019, DOI 10.1021/ja401781t; Jarrett JT, 2015, J BIOL CHEM, V290, P3972, DOI 10.1074/jbc.R114.599308; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Kuchenreuther JM, 2014, SCIENCE, V343, P424, DOI 10.1126/science.1246572; Lawhorn BG, 2004, ORG BIOMOL CHEM, V2, P2538, DOI 10.1039/b405429f; Layer G, 2005, BIOL CHEM, V386, P971, DOI 10.1515/BC.2005.113; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; Lees NS, 2009, J AM CHEM SOC, V131, P9184, DOI 10.1021/ja903978u; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Mahanta N, 2013, J AM CHEM SOC, V135, P15318, DOI 10.1021/ja408594p; Mehta AP, 2014, J AM CHEM SOC, V136, P10609, DOI 10.1021/ja502663k; Mehta AP, 2013, J AM CHEM SOC, V135, P10883, DOI 10.1021/ja4041048; Mehta AP, 2013, BIOCHEMISTRY-US, V52, P1134, DOI 10.1021/bi3016026; Nicolet Y, 2014, ANGEW CHEM INT EDIT, V53, P11840, DOI 10.1002/anie.201407320; Rieder C, 1998, EUR J BIOCHEM, V255, P24, DOI 10.1046/j.1432-1327.1998.2550024.x; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; SEEHRA JS, 1983, BIOCHEM J, V209, P709, DOI 10.1042/bj2090709; Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stich TA, 2014, ACCOUNTS CHEM RES, V47, P2235, DOI 10.1021/ar400235n; Tazuya K., 1999, BITAMIN, V73, P373; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; YAMADA K, 1982, BIOCHEM INT, V5, P771; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	42	51	51	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3980	3986		10.1074/jbc.R114.623793	http://dx.doi.org/10.1074/jbc.R114.623793			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25477515	Green Published, hybrid			2022-12-28	WOS:000349458400010
J	Balakrishna, AM; Basak, S; Manimekalai, MSS; Gruber, G				Balakrishna, Asha Manikkoth; Basak, Sandip; Manimekalai, Malathy Sony Subramanian; Grueber, Gerhard			Crystal Structure of Subunits D and F in Complex Gives Insight into Energy Transmission of the Eukaryotic V-ATPase from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; H+-ATPASE; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; EPSILON-SUBUNIT; V-1 ATPASE; F-1-ATPASE; RESOLUTION; V-1-ATPASE; MODEL	Eukaryotic V1VO-ATPases hydrolyze ATP in the V-1 domain coupled to ion pumping in V-O. A unique mode of regulation of V-ATPases is the reversible disassembly of V-1 and V-O, which reduces ATPase activity and causes silencing of ion conduction. The subunits D and F are proposed to be key in these enzymatic processes. Here, we describe the structures of two conformations of the subunit DF assembly of Saccharomyces cerevisiae (ScDF) V-ATPase at 3.1 angstrom resolution. Subunit D (ScD) consists of a long pair of alpha-helices connected by a short helix ((79)IGYQVQE(85)) as well as a beta-hairpin region, which is flanked by two flexible loops. The long pair of helices is composed of the N-terminal alpha-helix and the C-terminal helix, showing structural alterations in the two ScDF structures. The entire subunit F (ScF) consists of an N-terminal domain of four beta-strands (beta 1-beta 4) connected by four alpha-helices (alpha 1-alpha 4). alpha 1 and beta 2 are connected via the loop (26)GQITPETQEK(35), which is unique in eukaryotic V-ATPases. Adjacent to the N-terminal domain is a flexible loop, followed by a C-terminal alpha-helix (alpha 5). A perpendicular and extended conformation of helix alpha 5 was observed in the two crystal structures and in solution x-ray scattering experiments, respectively. Fitted into the nucleotide-bound A(3)B(3) structure of the related A-ATP synthase from Enterococcus hirae, the arrangements of the ScDF molecules reflect their central function in ATPase-coupled ion conduction. Furthermore, the flexibility of the terminal helices of both subunits as well as the loop (26)GQITPETQEK(35) provides information about the regulatory step of reversible V1VO disassembly.	[Balakrishna, Asha Manikkoth; Basak, Sandip; Manimekalai, Malathy Sony Subramanian; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg	Basak, sandip/B-8007-2018; Manikkoth Balakrishna, Asha/AFP-1973-2022	Basak, sandip/0000-0003-4018-8020; Manikkoth Balakrishna, Asha/0000-0001-5239-9015	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	We thank the National Synchrotron Radiation Research Center, a national user facility supported by the National Science Council of Taiwan. We thank the staff at the Synchrotron Radiation Protein Crystallography Facility (supported by the National Research Program for Genomic Medicine) at beam line 13B1 for expert help with data collection. We sincerely thank Dr. Kamariah Neelagandan for data collection at the 13B1 National Synchrotron Radiation Research Center, Taiwan. We are grateful to Prof. R. Kraut and Dr. G. Tria from the School of Biological Sciences, Nanyang Technological University, for reading the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggeler R, 1996, J BIOL CHEM, V271, P13888, DOI 10.1074/jbc.271.23.13888; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basak S, 2013, J BIOL CHEM, V288, P11930, DOI 10.1074/jbc.M113.461533; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coskun U, 2004, J BIOENERG BIOMEMBR, V36, P249, DOI 10.1023/B:JOBB.0000031976.44466.6e; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L, PYMOL MOL GRAPHICS S; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Glatter O., 1982, SMALL ANGLE XRAY SCA, P17; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Guinier A., 1955, SMALL ANGLE SCATTERI, P5; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kluge C, 2003, J BIOENERG BIOMEMBR, V35, P377, DOI 10.1023/A:1025737117382; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lolkema JS, 2003, J BIOENERG BIOMEMBR, V35, P323, DOI 10.1023/A:1025776831494; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Muench SP, 2014, J MOL BIOL, V426, P286, DOI 10.1016/j.jmb.2013.09.018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P447, DOI 10.1007/s10863-011-9379-y; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P187, DOI 10.1007/s10863-011-9342-y; Rishikesan S, 2010, BBA-BIOMEMBRANES, V1798, P1961, DOI 10.1016/j.bbamem.2010.06.012; Rishikesan S, 2009, BBA-BIOENERGETICS, V1787, P242, DOI 10.1016/j.bbabio.2009.01.010; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Shah NB, 2013, J BIOL CHEM, V288, P9383, DOI 10.1074/jbc.M113.451583; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; Suzuki T, 2014, NAT CHEM BIOL, V10, P930, DOI [10.1038/nchembio.1635, 10.1038/NCHEMBIO.1635]; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, BIOCHEMISTRY-US, V37, P17659, DOI 10.1021/bi982367a; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wilkens S, 2001, CELL BIOCHEM BIOPHYS, V34, P191, DOI 10.1385/CBB:34:2:191; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	63	34	35	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3183	3196		10.1074/jbc.M114.622688	http://dx.doi.org/10.1074/jbc.M114.622688			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505269	hybrid, Green Published			2022-12-28	WOS:000349456000001
J	Jakob, RP; Koch, JR; Burmann, BM; Schmidpeter, PAM; Hunkeler, M; Hiller, S; Schmid, FX; Maier, T				Jakob, Roman P.; Koch, Johanna R.; Burmann, Bjoern M.; Schmidpeter, Philipp A. M.; Hunkeler, Moritz; Hiller, Sebastian; Schmid, Franz X.; Maier, Timm			Dimeric Structure of the Bacterial Extracellular Foldase PrsA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL CIS/TRANS ISOMERASE; VIRULENCE FACTOR SECRETION; OUTER-MEMBRANE PROTEIN; NMR SOLUTION STRUCTURE; BACILLUS-SUBTILIS; TRIGGER FACTOR; CRYSTALLOGRAPHIC STRUCTURE; CATALYTIC MECHANISM; ENZYMATIC CATALYSIS; FUNCTIONAL-ANALYSIS	Secretion of proteins into the membrane-cell wall space is essential for cell wall biosynthesis and pathogenicity in Gram-positive bacteria. Folding and maturation of many secreted proteins depend on a single extracellular foldase, the PrsA protein. PrsA is a 30-kDa protein, lipid anchored to the outer leaflet of the cell membrane. The crystal structure of Bacillus subtilis PrsA reveals a central catalytic parvulin-type prolyl isomerase domain, which is inserted into a larger composite NC domain formed by the N- and C-terminal regions. This domain architecture resembles, despite a lack of sequence conservation, both trigger factor, a ribosome-binding bacterial chaperone, and SurA, a periplasmic chaperone in Gram-negative bacteria. Two main structural differences are observed in that the N-terminal arm of PrsA is substantially shortened relative to the trigger factor and SurA and in that PrsA is found to dimerize in a unique fashion via its NC domain. Dimerization leads to a large, bowl-shaped crevice, which might be involved in vivo in protecting substrate proteins from aggregation. NMRexperiments reveal a direct, dynamic interaction of both the parvulin and the NC domain with secretion propeptides, which have been implicated in substrate targeting to PrsA.	[Jakob, Roman P.; Burmann, Bjoern M.; Hunkeler, Moritz; Hiller, Sebastian; Maier, Timm] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Koch, Johanna R.; Schmidpeter, Philipp A. M.; Schmid, Franz X.] Univ Bayreuth, Lab Biochem, D-95440 Bayreuth, Germany; [Koch, Johanna R.; Schmidpeter, Philipp A. M.; Schmid, Franz X.] Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, D-95440 Bayreuth, Germany	University of Basel; University of Bayreuth; University of Bayreuth	Jakob, RP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	roman.jakob@unibas.ch; timm.maier@unibas.ch	Schmidpeter, Philipp/Q-5540-2019; Burmann, Björn M./AAR-7399-2020; Burmann, Björn M./AAI-7760-2021; Maier, Timm/A-8835-2016; Burmann, Björn/M-8913-2015; Hiller, Sebastian/B-3573-2008	Schmidpeter, Philipp/0000-0003-2871-9706; Burmann, Björn M./0000-0002-3135-7964; Maier, Timm/0000-0002-7459-1363; Burmann, Björn/0000-0002-3135-7964; Hiller, Sebastian/0000-0002-6709-4684; Hunkeler, Moritz/0000-0003-0246-1188; Jakob, Roman/0000-0002-6451-8656	Swiss National Science Foundation [PP00P3_152989, R'EQUIP 145023]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants PP00P3_152989 and R'EQUIP 145023.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alonzo F, 2011, MOL MICROBIOL, V80, P1530, DOI 10.1111/j.1365-2958.2011.07665.x; Alonzo F, 2010, INFECT IMMUN, V78, P4944, DOI 10.1128/IAI.00532-10; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Behrens-Kneip S, 2010, INT J MED MICROBIOL, V300, P421, DOI 10.1016/j.ijmm.2010.04.012; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; Cahoon LA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00013; Ceh-Pavia E, 2013, INT J MOL SCI, V14, P16685, DOI 10.3390/ijms140816685; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Drouault S, 2002, APPL ENVIRON MICROB, V68, P3932, DOI 10.1128/AEM.68.8.3932-3942.2002; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emelyanov VV, 2004, IUBMB LIFE, V56, P215, DOI 10.1080/15216540410001699321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; Forster BM, 2012, MOL MICROBIOL, V84, P405, DOI 10.1111/j.1365-2958.2012.08040.x; Freudl R, 2013, RES MICROBIOL, V164, P664, DOI 10.1016/j.resmic.2013.03.014; Giuseppe PO, 2011, J STRUCT BIOL, V173, P312, DOI 10.1016/j.jsb.2010.10.009; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Guo L, 2013, MOL ORAL MICROBIOL, V28, P154, DOI 10.1111/omi.12014; HARRIS GS, 1990, J BIOL CHEM, V265, P15909; Heikkinen O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-17; Hodak H, 2008, J MOL BIOL, V376, P414, DOI 10.1016/j.jmb.2007.10.088; Hottenrott S, 1997, J BIOL CHEM, V272, P15697, DOI 10.1074/jbc.272.25.15697; Hyyrylainen HL, 2010, MOL MICROBIOL, V77, P108, DOI 10.1111/j.1365-2958.2010.07188.x; JACOBS M, 1993, MOL MICROBIOL, V8, P957, DOI 10.1111/j.1365-2958.1993.tb01640.x; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Jousselin A, 2012, ANTIMICROB AGENTS CH, V56, P3629, DOI 10.1128/AAC.06264-11; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakeshita H, 2011, BIOTECHNOL LETT, V33, P1847, DOI 10.1007/s10529-011-0636-2; Kakeshita H, 2011, APPL MICROBIOL BIOT, V89, P1509, DOI 10.1007/s00253-010-2954-z; Kale A, 2011, J BIOL CHEM, V286, P21254, DOI 10.1074/jbc.M111.220442; Kather I, 2008, J MOL BIOL, V381, P1040, DOI 10.1016/j.jmb.2008.06.073; Keller R., 2004, COMPUTER AIDED RESON, V1; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P6475, DOI 10.1021/bi00479a020; Kovermann M, 2013, BIOL CHEM, V394, P965, DOI 10.1515/hsz-2013-0137; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhlewein A, 2004, PROTEIN SCI, V13, P2378, DOI 10.1110/ps.04756704; Landrieu I, 2002, J MOL BIOL, V320, P321, DOI 10.1016/S0022-2836(02)00429-1; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Leskela S, 1999, MOL MICROBIOL, V31, P1075, DOI 10.1046/j.1365-2958.1999.01247.x; Li Z, 2005, BIOCHEMISTRY-US, V44, P6180, DOI 10.1021/bi050115l; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Mayr LM, 1996, BIOCHEMISTRY-US, V35, P5550, DOI 10.1021/bi953035y; MUCKE M, 1994, BIOCHEMISTRY-US, V33, P14608; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; Mueller JW, 2011, J AM CHEM SOC, V133, P20096, DOI 10.1021/ja2086195; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; RAHFELD JU, 1994, FEBS LETT, V352, P180, DOI 10.1016/0014-5793(94)00932-5; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Schmidpeter PAM, 2011, BIOCHEMISTRY-US, V50, P4796, DOI 10.1021/bi200442q; Scholz C, 1997, J MOL BIOL, V273, P752, DOI 10.1006/jmbi.1997.1301; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tossavainen H, 2006, FEBS LETT, V580, P1822, DOI 10.1016/j.febslet.2006.02.042; Uchida T, 1999, FEBS LETT, V446, P278, DOI 10.1016/S0014-5793(99)00239-2; Vitikainen M, 2004, J BIOL CHEM, V279, P19302, DOI 10.1074/jbc.M400861200; Vitikainen M, 2001, J BACTERIOL, V183, P1881, DOI 10.1128/JB.183.6.1881-1890.2001; Weininger U, 2010, PROTEIN SCI, V19, P6, DOI 10.1002/pro.277; Williams RC, 2003, J BIOL CHEM, V278, P18056, DOI 10.1074/jbc.M301244200; Wu SC, 1998, J BACTERIOL, V180, P2830, DOI 10.1128/JB.180.11.2830-2835.1998; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	87	25	26	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3278	3292		10.1074/jbc.M114.622910	http://dx.doi.org/10.1074/jbc.M114.622910			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525259	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000349456000009
J	Monsellier, E; Redeker, V; Ruiz-Arlandis, G; Bousset, L; Melki, R				Monsellier, Elodie; Redeker, Virginie; Ruiz-Arlandis, Gemma; Bousset, Luc; Melki, Ronald			Molecular Interaction between the Chaperone Hsc70 and the N-terminal Flank of Huntingtin Exon 1 Modulates Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat Shock Protein (HSP); Huntington Disease; Mass Spectrometry (MS); Molecular Chaperone; Neurodegenerative Disease; Polyglutamine; Protein Aggregation	FIBRILLAR ALPHA-SYNUCLEIN; INTERMEDIATE CAG REPEATS; AMYLOID-LIKE FIBRILS; POLYGLUTAMINE AGGREGATION; MUTANT HUNTINGTIN; ATAXIN-3 FIBRILLOGENESIS; INTRANUCLEAR INCLUSIONS; SUBSTRATE-SPECIFICITY; DISEASE PATHOLOGY; DNAK CHAPERONE	Background: Hsc70 has an alleviating effect on the toxicity of polyglutamine (polyQ)-containing proteins in vivo. Results: Hsc70 binds specifically the N-terminal flank of huntingtin exon 1. Conclusion: Hsc70 interaction with huntingtin exon 1 N-terminal flank affects the conformation of the resulting assemblies. Significance: We identify the surface interfaces between Hsc70 and huntingtin exon 1, which allows the design of future therapeutic tools. The aggregation of polyglutamine (polyQ)-containing proteins is at the origin of nine neurodegenerative diseases. Molecular chaperones prevent the aggregation of polyQ-containing proteins. The exact mechanism by which they interact with polyQ-containing, aggregation-prone proteins and interfere with their assembly is unknown. Here we dissect the mechanism of interaction between a huntingtin exon 1 fragment of increasing polyQ lengths (HttEx1Qn), the aggregation of which is tightly associated with Huntington's disease, and molecular chaperone Hsc70. We show that Hsc70, together with its Hsp40 co-chaperones, inhibits HttEx1Qn aggregation and modifies the structural, seeding, and infectious properties of the resulting fibrils in a polyQ-independent manner. We demonstrate that Hsc70 binds the 17-residue-long N-terminal flank of HttEx1Qn, and we map Hsc70-HttEx1Qn surface interfaces at the residue level. Finally, we show that this interaction competes with homotypic interactions between the N termini of different HttEx1Qn molecules that trigger the aggregation process. Our results lay the foundations of future therapeutic strategies targeting huntingtin aggregation in Huntington disease.	[Monsellier, Elodie; Redeker, Virginie; Ruiz-Arlandis, Gemma; Bousset, Luc; Melki, Ronald] CNRS, Neurosci Paris Saclay Inst, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Monsellier, E (corresponding author), CNRS, Neurosci Paris Saclay Inst, Ave Terrasse, F-91198 Gif Sur Yvette, France.	monsellier@lebs.cnrs-gif.fr; melki@lebs.cnrs-gif.fr	Redeker, Virginie/L-8929-2018; Monsellier, Elodie/GRF-5106-2022	Redeker, Virginie/0000-0003-2694-8388; Monsellier, Elodie/0000-0001-7944-7531; bousset, luc/0000-0002-0433-4337	Agence Nationale de la Recherche [ANR-11-BSV8-021-01]; CNRS; Human Frontier Science Program; European Community [264508]; Fondation Bettencourt-Schueller	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program(Human Frontier Science Program); European Community(European Commission); Fondation Bettencourt-Schueller	This work was supported by Agence Nationale de la Recherche Grant ANR-11-BSV8-021-01, CNRS, the Human Frontier Science Program, the European Community's Seventh Framework Program FP7/2010, Marie Curie Actions Grant 264508, and a "Coup d'Elan a la Recherche Francaise" award from Fondation Bettencourt-Schueller.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Groen JL, 2010, J NEUROL NEUROSUR PS, V81, P228, DOI 10.1136/jnnp.2008.170902; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Guzhova IV, 2011, HUM MOL GENET, V20, P3953, DOI 10.1093/hmg/ddr314; Ha AHD, 2011, POSTGRAD MED, V123, P116, DOI 10.3810/pgm.2011.09.2466; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Jayaraman M, 2012, BIOCHEMISTRY-US, V51, P2706, DOI 10.1021/bi3000929; Kelley NW, 2009, J MOL BIOL, V388, P919, DOI 10.1016/j.jmb.2009.01.032; Kenney C, 2007, MOVEMENT DISORD, V22, P127, DOI 10.1002/mds.21195; Killoran A, 2013, NEUROLOGY, V80, P2022, DOI 10.1212/WNL.0b013e318294b304; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Kurouski D, 2013, FEBS LETT, V587, P1638, DOI 10.1016/j.febslet.2013.03.038; Landrum E, 2014, J BIOL CHEM, V289, P10254, DOI 10.1074/jbc.C114.552943; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Mishra R, 2012, J MOL BIOL, V415, P900, DOI 10.1016/j.jmb.2011.12.011; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Redeker V, 2012, J BIOL CHEM, V287, P32630, DOI 10.1074/jbc.M112.387530; Redeker V, 2010, FEBS J, V277, P5112, DOI 10.1111/j.1742-4658.2010.07915.x; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Robertson AL, 2008, BIOPHYS J, V95, P5922, DOI 10.1529/biophysj.108.138487; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schulte Joost, 2011, Curr Trends Neurol, V5, P65; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; Sharma D, 2005, PROTEINS, V61, P398, DOI 10.1002/prot.20602; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tagawa K, 2007, J NEUROSCI, V27, P868, DOI 10.1523/JNEUROSCI.4522-06.2007; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Trevino RS, 2012, J BIOL CHEM, V287, P29722, DOI 10.1074/jbc.M112.372474; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	70	62	65	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2560	2576		10.1074/jbc.M114.603332	http://dx.doi.org/10.1074/jbc.M114.603332			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505179	Green Published, hybrid			2022-12-28	WOS:000349310700004
J	Corbisier, J; Gales, C; Huszagh, A; Parmentier, M; Springael, JY				Corbisier, Jenny; Gales, Celine; Huszagh, Alexandre; Parmentier, Marc; Springael, Jean-Yves			Biased Signaling at Chemokine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN RECRUITMENT; FUNCTIONAL SELECTIVITY; DRUG DISCOVERY; CC-CHEMOKINES; ACTIVATION; LIGANDS; PHOSPHORYLATION; INTERNALIZATION; TRANSDUCTION	The ability of G protein-coupled receptors (GPCRs) to activate selective signaling pathways according to the conformation stabilized by bound ligands (signaling bias) is a challenging concept in the GPCR field. Signaling bias has been documented for several GPCRs, including chemokine receptors. However, most of these studies examined the global signaling bias between G protein- and arrestin-de pendent pathways, leaving unaddressed the potential bias between particular G protein subtypes. Here, we investigated the coupling selectivity of chemokine receptors CCR2, CCR5, and CCR7 in response to various ligands with G protein subtypes by using bioluminescence resonance energy transfer biosensors monitoring directly the activation of G proteins. We also compared data obtained with the G protein biosensors with those obtained with other functional readouts, such as beta-arrestin-2 recruitment, cAMP accumulation, and calcium mobilization assays. We showed that the binding of chemokines to CCR2, CCR5, and CCR7 activated the three G alpha(i) subtypes (G alpha(i1); G alpha(i2), and G alpha(i3)) and the two G alpha(o) isoforms (G alpha(oa) and G alpha(ob)) with potencies that generally correlate to their binding affinities. In addition, we showed that the binding of chemokines to CCR5 and CCR2 also activated Ga-12, but not Ga-13. For each receptor, we showed that the relative potency of various agonist chemokines was not identical in all assays, supporting the notion that signaling bias exists at chemokine receptors.	[Corbisier, Jenny; Huszagh, Alexandre; Parmentier, Marc; Springael, Jean-Yves] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium; [Parmentier, Marc] Univ Libre Bruxelles, Welbio, B-1070 Brussels, Belgium; [Gales, Celine] Univ Toulouse 3, Inst Natl Sante & Rech Med, Inst Malad Metab & Cardiovasc, F-31432 Toulouse, France	Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Springael, JY (corresponding author), Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	jyspring@ulb.ac.be	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; GALES, Celine/0000-0002-4938-1583	Fonds de la Recherche Scientifique Medicale of Belgium; Actions de Recherche Concertees; Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy [P7-14]; Belgian Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture	Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees(University of Liege); Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); Belgian Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Fonds de la Recherche Scientifique Medicale of Belgium, the Actions de Recherche Concertees, and the Interuniversity Attraction Poles Programme (P7-14), Belgian State, Belgian Science Policy.r Recipient of a a studentship from the Belgian Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture.	Barak LS, 2008, MOL PHARMACOL, V74, P585, DOI 10.1124/mol.108.048884; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Berg KA, 1998, ANN NY ACAD SCI, V861, P104, DOI 10.1111/j.1749-6632.1998.tb10180.x; Blanpain C, 1999, BLOOD, V94, P1899; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Byers MA, 2008, J IMMUNOL, V181, P4723, DOI 10.4049/jimmunol.181.7.4723; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ferain T, 2011, J PHARMACOL EXP THER, V337, P655, DOI 10.1124/jpet.111.179622; Fuxe K, 2010, J RECEPT SIG TRANSD, V30, P271, DOI 10.3109/10799893.2010.507367; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kuroumalis A, 2005, J IMMUNOL, V175, P5403, DOI 10.4049/jimmunol.175.8.5403; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mottola DM, 2002, J PHARMACOL EXP THER, V301, P1166, DOI 10.1124/jpet.301.3.1166; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Strange PG, 2008, CURR OPIN DRUG DISC, V11, P196; Tian Y, 2004, EUR J IMMUNOL, V34, P785, DOI 10.1002/eji.200324166; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	31	83	83	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9542	9554		10.1074/jbc.M114.596098	http://dx.doi.org/10.1074/jbc.M114.596098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25614627	Green Published, hybrid			2022-12-28	WOS:000352729400021
J	Marchand, B; Arsenault, D; Raymond-Fleury, A; Boisvert, FM; Boucher, MJ				Marchand, Benoit; Arsenault, Dominique; Raymond-Fleury, Alexandre; Boisvert, Francois-Michel; Boucher, Marie-Josee			Glycogen Synthase Kinase-3 (GSK3) Inhibition Induces Prosurvival Autophagic Signals in Human Pancreatic Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LYSOSOMAL BIOGENESIS; RAG GTPASES; TRANSCRIPTION; GEMCITABINE; MTORC1; SURVIVAL; BIOLOGY; GENE; TFEB	Glycogen synthase kinase-3 (GSK3) are ubiquitously expressed serine-threonine kinases involved in a plethora of functions ranging from the control of glycogen metabolism to transcriptional regulation. We recently demonstrated that GSK3 inhibition triggers JNK-cJUN-dependent apoptosis in human pancreatic cancer cells. However, the comprehensive picture of downstream GSK3-regulated pathways/functions remains elusive. Herein, counterbalancing the death signals, we show that GSK3 inhibition induces prosurvival signals through increased activity of the autophagy/lysosomal network. Our data also reveal a contribution of GSK3 in the regulation of the master transcriptional regulator of autophagy and lysosomal biogenesis, transcription factor EB (TFEB) in pancreatic cancer cells. Similarly to mammalian target of rapamycin (mTOR) inhibition, GSK3 inhibitors promote TFEB nuclear localization and leads to TFEB dephosphorylation through endogenous serine/threonine phosphatase action. However, GSK3 and mTOR inhibition impinge differently and independently on TFEB phosphorylation suggesting that TFEB is regulated by a panel of kinases and/or phosphatases. Despite their differential impact on TFEB phosphorylation, both GSK3 and mTOR inhibitors promote 14-3-3 dissociation and TFEB nuclear localization. Quantitative mass spectrometry analyses further reveal an increased association of TFEB with nuclear proteins upon GSK3 and mTOR inhibition suggesting a positive impact on TFEB transcriptional function. Finally, a predominant nuclear localization of TFEB is unveiled in fully fed pancreatic cancer cells, whereas a reduction in TFEB expression significantly impairs their capacity for growth in an anchorage-independent manner. In addition, TFEB-restricted cells are more sensitive to apoptosis upon GSK3 inhibition. Altogether, our data uncover new functions under the control of GSK3 in pancreatic cancer cells in addition to providing key insight into TFEB regulation.	[Marchand, Benoit; Arsenault, Dominique; Raymond-Fleury, Alexandre; Boucher, Marie-Josee] Univ Sherbrooke, Dept Med, Div Gastroenterol, Sherbrooke, PQ J1E 4K8, Canada; [Boisvert, Francois-Michel] Univ Sherbrooke, Dept Anat & Cell Biol, Fac Med & Sci Sante, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke; University of Sherbrooke	Boucher, MJ (corresponding author), Univ Sherbrooke, 3201 Rue Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	marie-josee.boucher@usherbrooke.ca		Boucher, Marie-Josee/0000-0002-7615-3121; Marchand, Benoit/0000-0001-9302-6688	Natural Sciences and Engineering Research Council of Canada [NSERC 341809]; Canadian Institutes of Health Research [MOP-106456]; Fonds de Recherche Sante Quebec (FRQ-S)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Sante Quebec (FRQ-S)	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Grant NSERC 341809 and Canadian Institutes of Health Research Grant MOP-106456 (to M. J. B.).; Scholars from the Fonds de Recherche Sante Quebec (FRQ-S) and members of the FRQ-S-funded Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS).	Bang D, 2013, CANCER DISCOV, V3, P690, DOI 10.1158/2159-8290.CD-12-0541; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Billadeau DD, 2007, PANCREATOLOGY, V7, P398, DOI 10.1159/000108955; Boisvert F. M., 2012, PROTEOMICS, V11; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Donohue E, 2013, J CANCER, V4, P585, DOI 10.7150/jca.7030; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Furukawa T, 1996, AM J PATHOL, V148, P1763; Garcea G, 2007, CURR CANCER DRUG TAR, V7, P209, DOI 10.2174/156800907780618266; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; Hashimoto D, 2014, EUR J CANCER, V50, P1382, DOI 10.1016/j.ejca.2014.01.011; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kitano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055289; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Papademetrio DL, 2014, TARGET ONCOL, V9, P123, DOI 10.1007/s11523-013-0278-5; Lee SJ, 2011, NAT REV NEPHROL, V7, P718, DOI 10.1038/nrneph.2011.150; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Maes H, 2013, TRENDS MOL MED, V19, P428, DOI 10.1016/j.molmed.2013.04.005; Mamaghani S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-132; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Martinez A, 2008, MED RES REV, V28, P773, DOI 10.1002/med.20119; Miyashita K, 2009, ANTI-CANCER AGENT ME, V9, P1114, DOI 10.2174/187152009789734982; Mukubou H, 2010, INT J ONCOL, V37, P821, DOI 10.3892/ijo_00000732; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pan S, 2014, J PROTEOME RES, V13, P1293, DOI 10.1021/pr4010184; Pardo R, 2010, PANCREATOLOGY, V10, P19, DOI 10.1159/000264680; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Strohecker AM, 2014, AUTOPHAGY, V10, P384, DOI 10.4161/auto.27320; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yang SH, 2011, AUTOPHAGY, V7, P912, DOI 10.4161/auto.7.8.15762; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang JS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.102; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	60	116	126	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5592	5605		10.1074/jbc.M114.616714	http://dx.doi.org/10.1074/jbc.M114.616714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561726	Green Published, hybrid			2022-12-28	WOS:000350044200030
J	Savolainen, MH; Yan, X; Myohanen, TT; Huttunen, HJ				Savolainen, Mari H.; Yan, Xu; Myohanen, Timo T.; Huttunen, Henri J.			Prolyl Oligopeptidase Enhances alpha-Synuclein Dimerization via Direct Protein-Protein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODY DEMENTIA; PARKINSONS-DISEASE; FIBRIL FORMATION; MICROSCALE THERMOPHORESIS; MEMBRANE INTERACTIONS; TAU PHOSPHORYLATION; ALZHEIMERS-DISEASE; AGGREGATION; DOPAMINE; BINDING	Prolyl oligopeptidase (PREP) accelerates the aggregation of alpha-synuclein (aSyn), a key protein involved in development of Parkinson disease and other synucleinopathies. PREP inhibitors reduce aSyn aggregation, but the mechanism has remained unknown. We have now used protein-fragment complementation assays (PCA) and microscale thermophoresis in parallel to show that PREP interacts directly with aSyn in both intact cells and in a cell-free system. Using split luciferase-based PCA, we first showed that PREP enhances the formation of soluble aSyn dimers in live Neuro-2A neuroblastoma cells. APREP inhibitor, KYP-2047, reduced aSyn dimerization in PREP-expressing cells but not in cells lacking PREP expression. aSyn dimerization was also enhanced by PREP(S554A), an enzymatically inactive PREP mutant, but this was not affected by KYP-2047. PCA and microscale thermophoresis studies showed that aSyn interacts with both PREP and PREP(S554A) with low micromolar affinity. Neither the proline-rich, C-terminal domain of aSyn nor the hydrolytic activity of PREP was required for the interaction with PREP. Our results show that PREP binds directly to aSyn to enhance its dimerization and may thus serve as a nucleation point for aSyn aggregation. Native gel analysis showed that KYP-2047 shifts PREP to a compact monomeric form with reduced ability to promote aSyn nucleation. As PREP inhibition also enhances autophagic clearance of aSyn, PREP inhibitors may reduce accumulation of aSyn inclusions via a dual mechanism and are thus a novel therapeutic candidate for synucleinopathies. Our results also suggest that PREP has other cellular functions in addition to its peptidase activity.	[Savolainen, Mari H.; Myohanen, Timo T.] Univ Helsinki, Div Pharmacol & Pharmacotherapy, FI-00014 Helsinki, Finland; [Yan, Xu; Huttunen, Henri J.] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Huttunen, HJ (corresponding author), Univ Helsinki, Ctr Neurosci, POB 56 Viikinkaari 4, FIN-00014 Helsinki, Finland.	Henri.Huttunen@helsinki.fi		Huttunen, Henri/0000-0002-9867-4438; Myohanen, Timo/0000-0002-9277-6687	Academy of Finland [218081, 263762, 267788, 2737991]; Brain and Mind doctoral program; Doctoral Program in Drug Research; University of Helsinki; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); Brain and Mind doctoral program; Doctoral Program in Drug Research; University of Helsinki; Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation	This work was supported by grants from the Academy of Finland (218081 and 263762 (to H. J. H.) and 267788 and 2737991 (to T. T. M.)), the Brain and Mind doctoral program (to X. Y.), the Doctoral Program in Drug Research (to M. S.), the University of Helsinki (to H. J. H. and T. T. M.), the Jane and Aatos Erkko Foundation (to T. T. M.), the Sigrid Juselius Foundation (to T. T. M.), and the Emil Aaltonen Foundation (to M. S.). H. J. H. is an employee and shareholder of Herantis Pharma plc.	Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; Arima K, 1998, ACTA NEUROPATHOL, V96, P439, DOI 10.1007/s004010050917; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bisaglia M, 2009, NEUROMOL MED, V11, P239, DOI 10.1007/s12017-009-8082-1; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Brandt I, 2008, PEPTIDES, V29, P1472, DOI 10.1016/j.peptides.2008.05.005; Brandt I, 2007, CLIN CHIM ACTA, V377, P50, DOI 10.1016/j.cca.2006.09.001; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Di Daniel E, 2009, MOL CELL NEUROSCI, V41, P373, DOI 10.1016/j.mcn.2009.03.003; Dokleja L, 2014, NEUROSCI LETT, V583, P37, DOI 10.1016/j.neulet.2014.09.026; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Hannula MJ, 2013, NEUROSCIENCE, V242, P140, DOI 10.1016/j.neuroscience.2013.03.049; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Jalkanen AJ, 2012, NEUROCHEM INT, V60, P301, DOI 10.1016/j.neuint.2011.12.010; Jalkanen AJ, 2011, BASIC CLIN PHARMACOL, V109, P443, DOI 10.1111/j.1742-7843.2011.00747.x; Jarho EM, 2004, J MED CHEM, V47, P5605, DOI 10.1021/jm049503w; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kaszuba K, 2012, BIOCHIMIE, V94, P1398, DOI 10.1016/j.biochi.2012.03.012; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lai Y, 2014, BIOCHEMISTRY-US, V53, P3889, DOI 10.1021/bi5002536; Lambeir AM, 2011, CNS NEUROL DISORD-DR, V10, P349, DOI 10.2174/187152711794653878; Lee D, 2002, J NEUROCHEM, V82, P1007, DOI 10.1046/j.1471-4159.2002.01024.x; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Mannisto PT, 2007, DRUG NEWS PERSPECT, V20, P293; Mantle D, 1996, CLIN CHIM ACTA, V249, P129, DOI 10.1016/0009-8981(96)06282-1; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Myohanen TT, 2012, BRIT J PHARMACOL, V166, P1097, DOI 10.1111/j.1476-5381.2012.01846.x; Myohanen TT, 2008, HISTOCHEM CELL BIOL, V130, P993, DOI 10.1007/s00418-008-0468-x; Myohanen TT, 2009, J HISTOCHEM CYTOCHEM, V57, P831, DOI 10.1369/jhc.2009.953711; Nykanen NP, 2012, J BIOL CHEM, V287, P6743, DOI 10.1074/jbc.M111.309385; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Savolainen MH, 2014, NEUROBIOL DIS, V68, P1, DOI 10.1016/j.nbd.2014.04.003; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Szeltner Z, 2013, BBA-PROTEINS PROTEOM, V1834, P98, DOI 10.1016/j.bbapap.2012.08.012; Szeltner Z, 2010, BBA-PROTEINS PROTEOM, V1804, P2162, DOI 10.1016/j.bbapap.2010.09.010; Tarrago T, 2009, FEBS LETT, V583, P3344, DOI 10.1016/j.febslet.2009.09.036; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Venalainen JI, 2006, BIOCHEM PHARMACOL, V71, P683, DOI 10.1016/j.bcp.2005.11.029; WALTER R, 1971, SCIENCE, V173, P828, DOI 10.1126/science.173.3999.827; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	56	44	45	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5117	5126		10.1074/jbc.M114.592931	http://dx.doi.org/10.1074/jbc.M114.592931			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555914	Green Published, hybrid			2022-12-28	WOS:000350042000051
J	von Stockum, S; Giorgio, V; Trevisan, E; Lippe, G; Glick, GD; Forte, MA; Da-Re, C; Checchetto, V; Mazzotta, G; Costa, R; Szabo, I; Bernardi, P				von Stockum, Sophia; Giorgio, Valentina; Trevisan, Elena; Lippe, Giovanna; Glick, Gary D.; Forte, Michael A.; Da-Re, Caterina; Checchetto, Vanessa; Mazzotta, Gabriella; Costa, Rodolfo; Szabo, Ildiko; Bernardi, Paolo			F-ATPase of Drosophila melanogaster Forms 53-Picosiemen (53-pS) Channels Responsible for Mitochondrial Ca2+-induced Ca2+ Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; C-SUBUNIT RING; CELL-DEATH; ESSENTIAL COMPONENT; UNCOUPLING CHANNEL; CASPASE ACTIVATION; MOLECULAR TARGET; CYTOCHROME-C; S2 CELLS; SYNTHASE	Mitochondria of Drosophila melanogaster undergo Ca2+-induced Ca2+ release through a putative channel (mCrC) that has several regulatory features of the permeability transition pore (PTP). The PTP is an inner membrane channel that forms from F-ATPase, possessing a conductance of 500 picosiemens (pS) in mammals and of 300 pS in yeast. In contrast to the PTP, the mCrC of Drosophila is not permeable to sucrose and appears to be selective for Ca2+ and H+. We show (i) that like the PTP, the mCrC is affected by the sense of rotation of F-ATPase, by Bz-423, and by Mg2+/ADP; (ii) that expression of human cyclophilin D in mitochondria of Drosophila S2R+ cells sensitizes the mCrC to Ca2+ but does not increase its apparent size; and (iii) that purified dimers of D. melanogaster F-ATPase reconstituted into lipid bilayers form 53-pS channels activated by Ca2+ and thiol oxidants and inhibited byMg(2+)/gamma-imino ATP. These findings indicate that the mCrC is the PTP of D. melanogaster and that the signature conductance of F-ATPase channels depends on unique structural features that may underscore specific roles in different species.	[von Stockum, Sophia; Giorgio, Valentina; Trevisan, Elena; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Da-Re, Caterina; Checchetto, Vanessa; Mazzotta, Gabriella; Costa, Rodolfo; Szabo, Ildiko] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Lippe, Giovanna] Univ Udine, Dept Food Sci, I-33100 Udine, Italy; [Glick, Gary D.] Univ Michigan, Dept Chem, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Forte, Michael A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Padua; University of Padua; University of Udine; University of Michigan System; University of Michigan; Oregon Health & Science University	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Giorgio, Valentina/O-1969-2015; checchetto, vanessa/ABI-6145-2020; Padova, Ildiko/K-5344-2016; Szabo, Ildiko/AAW-5972-2021; Bernardi, Paolo/C-3656-2008; Giorgio, Valentina/I-6110-2016	Giorgio, Valentina/0000-0002-4229-3054; checchetto, vanessa/0000-0001-8911-6146; Szabo, Ildiko/0000-0002-3637-3947; Bernardi, Paolo/0000-0001-9187-3736; MAZZOTTA, GABRIELLA MARGHERITA/0000-0001-5461-6837	AIRC [IG13392, IG11814]; PRIN Programs [20107Z8XBW, 2010CSJX4F]; National Institutes of Health-Public Health Service [1R01GM069883]; University of Padova Progetti Strategici di Ateneo Models of Mitochondrial Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); PRIN Programs; National Institutes of Health-Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); University of Padova Progetti Strategici di Ateneo Models of Mitochondrial Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by AIRC Grants IG13392 (to P. B.) and IG11814 (to I. S.), PRIN Programs 20107Z8XBW (to P. B.) and 2010CSJX4F (to I. S.), National Institutes of Health-Public Health Service Grant 1R01GM069883 (to M. F. and P. B.), and the University of Padova Progetti Strategici di Ateneo Models of Mitochondrial Diseases (to P. B.).	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; ALTSCHULD RA, 1992, AM J PHYSIOL, V262, pH1699, DOI 10.1152/ajpheart.1992.262.6.H1699; Barsukova A, 2011, EUR J NEUROSCI, V33, P831, DOI 10.1111/j.1460-9568.2010.07576.x; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BERNARDI P, 1983, EUR J BIOCHEM, V134, P377, DOI 10.1111/j.1432-1033.1983.tb07578.x; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Bradshaw PC, 2013, YEAST, V30, P471, DOI 10.1002/yea.2984; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; Chinopoulos C, 2014, FRONT ONCOL, V4, DOI [10.3389/fonc.2014.002350, 10.3389/fonc.2014.00235]; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Da-Re C, 2014, J BIOL CHEM, V289, P29235, DOI 10.1074/jbc.M114.602938; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dorstyn L, 2004, J CELL BIOL, V167, P405, DOI 10.1083/jcb.200408054; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; Jung DW, 1997, J BIOL CHEM, V272, P21104, DOI 10.1074/jbc.272.34.21104; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; Li B, 2012, BBA-BIOENERGETICS, V1817, P1628, DOI 10.1016/j.bbabio.2012.05.011; McGeoch J E, 2001, Eur J Paediatr Neurol, V5 Suppl A, P147, DOI 10.1053/ejpn.2000.0452; McGeoch JEM, 2000, BIOCHEM BIOPH RES CO, V274, P835, DOI 10.1006/bbrc.2000.3231; McGeoch JEM, 1997, BRAIN RES, V766, P188, DOI 10.1016/S0006-8993(97)00618-5; Means J, 2006, CELL DEATH DIFFER, V13, P1222, DOI 10.1038/sj.cdd.4401821; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Pemberton TJ, 2005, COMP FUNCT GENOM, V6, P277, DOI 10.1002/cfg.482; PETRONILLI V, 1989, FEBS LETT, V259, P137, DOI 10.1016/0014-5793(89)81513-3; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Rasola A, 2014, CELL CALCIUM, V56, P437, DOI 10.1016/j.ceca.2014.10.003; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Scorrano L, 1997, MOL CELL BIOCHEM, V174, P181, DOI 10.1023/A:1006887921810; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stelzer AC, 2010, BIOPOLYMERS, V93, P85, DOI 10.1002/bip.21306; SZABO I, 1992, J BIOL CHEM, V267, P2940; Szabo I, 2011, CELL DEATH DIFFER, V18, P427, DOI 10.1038/cdd.2010.112; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; von Stockum S, 2011, J BIOL CHEM, V286, P41163, DOI 10.1074/jbc.M111.268375; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Xu DB, 2009, FLY, V3, P78, DOI 10.4161/fly.3.1.7800; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	59	56	56	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4537	4544		10.1074/jbc.C114.629766	http://dx.doi.org/10.1074/jbc.C114.629766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25550160	hybrid, Green Published			2022-12-28	WOS:000350042000001
J	Walkup, WG; Washburn, L; Sweredoski, MJ; Carlisle, HJ; Graham, RL; Hess, S; Kennedy, MB				Walkup, Ward G.; Washburn, Lorraine; Sweredoski, Michael J.; Carlisle, Holly J.; Graham, Robert L.; Hess, Sonja; Kennedy, Mary B.			Phosphorylation of Synaptic GTPase-activating Protein (synGAP) by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) and Cyclin-dependent Kinase 5 (CDK5) Alters the Ratio of Its GAP Activity toward Ras and Rap GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURE; MUTATIONS; PLASTICITY; DOMAIN; STIMULATION; INHIBITION; CALPAIN; CLONING	synGAP is a neuron-specific Ras and Rap GTPase-activating protein (GAP) found in high concentrations in the postsynaptic density (PSD) fraction from the mammalian forebrain. We have previously shown that, in situ in the PSD fraction or in recombinant form in Sf9 cell membranes, synGAP is phosphorylated by Ca2+/calmodulin-dependent protein kinase II (CaMKII), another prominent component of the PSD. Here, we show that recombinant synGAP (r-synGAP), lacking 102 residues at the N terminus, can be purified in soluble form and is phosphorylated by cyclin-dependent kinase 5 (CDK5) as well as by CaMKII. Phosphorylation of r-synGAP by CaMKII increases its HRas GAP activity by 25% and its Rap1 GAP activity by 76%. Conversely, phosphorylation by CDK5 increases r-synGAP's HRas GAP activity by 98% and its Rap1 GAP activity by 20%. Thus, phosphorylation by both kinases increases synGAP activity; CaMKII shifts the relative GAP activity toward inactivation of Rap1, and CDK5 shifts the relative activity toward inactivation of HRas. GAPactivity toward Rap2 is not altered by phosphorylation by either kinase. CDK5 phosphorylates synGAP primarily at two sites, Ser-773 and Ser-802. Phosphorylation at Ser-773 inhibits r-synGAP activity, and phosphorylation at Ser-802 increases it. However, the net effect of concurrent phosphorylation of both sites, Ser-773 and Ser-802, is an increase in GAP activity. synGAP is phosphorylated at Ser-773 and Ser-802 in the PSD fraction, and its phosphorylation by CDK5 and CaMKII is differentially regulated by activation of NMDA-type glutamate receptors in cultured neurons.	[Walkup, Ward G.; Washburn, Lorraine; Carlisle, Holly J.; Kennedy, Mary B.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Graham, Robert L.; Hess, Sonja] CALTECH, Proteome Explorat Lab, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Graham, Robert L.; Hess, Sonja] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Kennedy, MB (corresponding author), CALTECH, Div Biol & Biol Engn 216 76, Pasadena, CA 91125 USA.	kennedym@its.caltech.edu		Carlisle, Holly/0000-0001-8798-9445	Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095095] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Jost Vielmetter and Michael Anaya of the Beckman Institute Protein Expression Center, Dr. Jie Zhou of the Protein/Peptide Microanalytical Laboratory, and Leslie Schenker of the Kennedy laboratory for technical assistance. The Proteome Exploration Laboratory is supported by the Gordon and Betty Moore Foundation through grant GBMF775 and the Beckman Institute.	Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chen YC, 2005, MOL CELL NEUROSCI, V28, P215, DOI 10.1016/j.mcn.2004.08.012; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Collins MO, 2009, SCIENCE, V325, P1635, DOI 10.1126/science.1180331; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Dhavan R, 2002, J NEUROSCI, V22, P7879; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fersht A, 1999, STRUCTURE MECH PROTE, P362; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; JOHN J, 1989, J BIOL CHEM, V264, P13086; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Kennedy M. B., 2013, COLD SPRING HARB PER; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; LEUPOLD CM, 1983, EUR J BIOCHEM, V135, P237, DOI 10.1111/j.1432-1033.1983.tb07643.x; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Penzes P, 2011, MOL CELL NEUROSCI, V46, P368, DOI 10.1016/j.mcn.2010.11.008; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Timm W, 2010, ANAL CHEM, V82, P3977, DOI 10.1021/ac100118u; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Yaman E, 2009, FEBS J, V276, P4607, DOI 10.1111/j.1742-4658.2009.07166.x; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	60	46	47	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4908	4927		10.1074/jbc.M114.614420	http://dx.doi.org/10.1074/jbc.M114.614420			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533468	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000350042000035
J	Wang, A; Stout, CD; Zhang, QH; Johnson, EF				Wang, An; Stout, C. David; Zhang, Qinghai; Johnson, Eric F.			Contributions of Ionic Interactions and Protein Dynamics to Cytochrome P450 2D6 (CYP2D6) Substrate and Inhibitor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PLASMA-LEVELS; HUMAN-LIVER; THIORIDAZINE; CRYSTALLOGRAPHY; PHARMACOPHORE; CONFORMATION; METABOLISM; P4502B4; MODEL	P450 2D6 contributes significantly to the metabolism of > 15% of the 200 most marketed drugs. Open and closed crystal structures of P450 2D6 thioridazine complexes were obtained using different crystallization conditions. The protonated piperidine moiety of thioridazine forms a charge-stabilized hydrogen bond with Asp-301 in the active sites of both complexes. The more open conformation exhibits a second molecule of thioridazine bound in an expanded substrate access channel antechamber with its piperidine moiety forming a charge-stabilized hydrogen bond with Glu-222. Incubation of the crystalline open thioridazine complex with alternative ligands, prinomastat, quinidine, quinine, or ajmalicine, displaced both thioridazines. Quinine and ajmalicine formed charge-stabilized hydrogen bonds with Glu-216, whereas the protonated nitrogen of quinidine is equidistant from Asp-301 and Glu-216 with protonated nitrogen H-bonded to a water molecule in the access channel. Prinomastat is not ionized. Adaptations of active site side-chain rotamers and polypeptide conformations were evident between the complexes, with the binding of ajmalicine eliciting a closure of the open structure reflecting in part the inward movement of Glu-216 to form a hydrogen bond with ajmalicine as well as sparse lattice restraints that would hinder adaptations. These results indicate that P450 2D6 exhibits sufficient elasticity within the crystal lattice to allow the passage of compounds between the active site and bulk solvent and to adopt a more closed form that adapts for binding alternative ligands with different degrees of closure. These crystals provide a means to characterize substrate and inhibitor binding to the enzyme after replacement of thioridazine with alternative compounds.	[Wang, An; Johnson, Eric F.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Stout, C. David; Zhang, Qinghai] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Johnson, EF (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,MEM 255, La Jolla, CA 92037 USA.	johnson@scripps.edu			United States Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources, Biomedical Technology Program; NIGMS of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098538, R01GM031001] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the United States Department of Energy, Office of Biological and Environmental Research and by the National Center for Research Resources, Biomedical Technology Program, and NIGMS of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; de Groot MJ, 1999, J MED CHEM, V42, P1515, DOI 10.1021/jm981118h; DeVore NM, 2012, J BIOL CHEM, V287, P26576, DOI 10.1074/jbc.M112.372813; Eap CB, 1996, CLIN PHARMACOL THER, V59, P322, DOI 10.1016/S0009-9236(96)80010-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FONNEPFISTER R, 1988, BIOCHEM PHARMACOL, V37, P3829, DOI 10.1016/0006-2952(88)90063-9; FROIMOWITZ M, 1993, J MED CHEM, V36, P2219, DOI 10.1021/jm00067a019; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Hutzler JM, 2003, CHEM RES TOXICOL, V16, P450, DOI 10.1021/tx025674x; Johnson EF, 2014, DRUG METAB DISPOS, V42, P9, DOI 10.1124/dmd.113.054627; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KROEMER HK, 1995, LIFE SCI, V56, P2285, DOI 10.1016/0024-3205(95)00223-S; Lee SC, 2013, P NATL ACAD SCI USA, V110, pE1203, DOI 10.1073/pnas.1221442110; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCDOWELL JJH, 1975, ACTA CRYSTALLOGR B, V31, P2256, DOI 10.1107/S0567740875007352; MEYER JW, 1990, EUR J CLIN PHARMACOL, V39, P613, DOI 10.1007/BF00316110; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; NIEDZWIECKI DM, 1984, J PHARMACOL EXP THER, V228, P636; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Obach RS, 2002, DRUG METAB DISPOS, V30, P831, DOI 10.1124/dmd.30.7.831; OMURA T, 1964, J BIOL CHEM, V239, P2379; OTTON SV, 1984, LIFE SCI, V34, P73, DOI 10.1016/0024-3205(84)90332-1; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Smart O. S., 2011, GRADE VERSION 1 101; STROBL GR, 1993, J MED CHEM, V36, P1136, DOI 10.1021/jm00061a004; VandenBrink BM, 2012, DRUG METAB DISPOS, V40, P47, DOI 10.1124/dmd.111.041210; VONBAHR C, 1991, CLIN PHARMACOL THER, V49, P234, DOI 10.1038/clpt.1991.22; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wang B, 2009, DRUG METAB REV, V41, P573, DOI 10.1080/03602530903118729; Wen B, 2009, CHEM-BIOL INTERACT, V181, P220, DOI 10.1016/j.cbi.2009.05.014; Wojcikowski J, 2006, DRUG METAB DISPOS, V34, P471, DOI 10.1124/dmd.105.006445; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200	42	65	66	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5092	5104		10.1074/jbc.M114.627661	http://dx.doi.org/10.1074/jbc.M114.627661			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555909	Green Published, hybrid			2022-12-28	WOS:000350042000049
J	Arechederra, M; Priego, N; Vazquez-Carballo, A; Sequera, C; Gutierrez-Uzquiza, A; Cerezo-Guisado, MI; Ortiz-Rivero, S; Roncero, C; Cuenda, A; Guerrero, C; Porras, A				Arechederra, Maria; Priego, Neibla; Vazquez-Carballo, Ana; Sequera, Celia; Gutierrez-Uzquiza, Alvaro; Isabel Cerezo-Guisado, Maria; Ortiz-Rivero, Sara; Roncero, Cesareo; Cuenda, Ana; Guerrero, Carmen; Porras, Almudena			p38 MAPK Down-regulates Fibulin 3 Expression through Methylation of Gene Regulatory Sequences ROLE IN MIGRATION AND INVASION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PROMOTER METHYLATION; CELL PROLIFERATION; DNA METHYLATION; P38-ALPHA MAPK; BREAST-CANCER; MESSENGER-RNA; GROWTH; P38-DELTA; STRESS	p38 MAPKs regulate migration and invasion. However, the mechanisms involved are only partially known. We had previously identified fibulin 3, which plays a role in migration, invasion, and tumorigenesis, as a gene regulated by p38 alpha. We have characterized in detail how p38 MAPK regulates fibulin 3 expression and its role. We describe here for the first time that p38 alpha, p38 gamma, and p38 delta down-regulate fibulin 3 expression. p38 alpha has a stronger effect, and it does so through hypermethylation of CpG sites in the regulatory sequences of the gene. This would be mediated by the DNA methylase, DNMT3A, which is down-regulated in cells lacking p38 alpha, but once re-introduced represses Fibulin 3 expression. p38 alpha through HuR stabilizes dnmt3a mRNA leading to an increase in DNMT3A protein levels. Moreover, by knocking-down fibulin 3, we have found that Fibulin 3 inhibits migration and invasion in MEFs by mechanisms involving p38 alpha/beta inhibition. Hence, p38 alpha pro-migratory/invasive effect might be, at least in part, mediated by fibulin 3 down-regulation in MEFs. In contrast, in HCT116 cells, Fibulin 3 promotes migration and invasion through a mechanism dependent on p38 alpha and/or p38 beta activation. Furthermore, Fibulin 3 promotes in vitro and in vivo tumor growth of HCT116 cells through a mechanism dependent on p38 alpha, which surprisingly acts as a potent inducer of tumor growth. At the same time, p38 alpha limits fibulin 3 expression, which might represent a negative feed-back loop.	[Roncero, Cesareo; Porras, Almudena] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, E-28040 Madrid, Spain; [Isabel Cerezo-Guisado, Maria; Cuenda, Ana] Ctr Nacl Biotecnol CSIC, Dept Inmunol & Oncol, Madrid 28049, Spain; [Ortiz-Rivero, Sara; Guerrero, Carmen] Univ Salamanca, Fac Med, Inst Invest Biomed Salamanca IBSAL, Dept Med,IBMCC,Ctr Invest Canc, Salamanca 37007, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Guerrero, C (corresponding author), Ctr Invest Canc, Campus Unamuno S-N, Salamanca 37007, Spain.	cguerrero@usal.es; maporras@ucm.es	Sequera, Celia/Y-6369-2019; Uzquiza, Alvaro Gutierrez/E-4073-2012; Arechederra, Maria/F-4373-2016; Guerrero, Carmen/F-1776-2010; Ortiz-Rivero, Sara/A-4366-2017; Porras, Almudena/N-2121-2015; Arechederra, María/L-9108-2019; Roncero, Cesáreo/H-9039-2015	Sequera, Celia/0000-0001-6409-3910; Uzquiza, Alvaro Gutierrez/0000-0002-0446-4131; Arechederra, Maria/0000-0002-4830-1924; Guerrero, Carmen/0000-0002-8747-6831; Porras, Almudena/0000-0002-6495-3308; Arechederra, María/0000-0002-4830-1924; Roncero, Cesáreo/0000-0001-7608-8553	Spanish Ministry of Economy and Competitiveness [SAF2010-20918-C02-01, SAF2103-48210-C2-02, SAF2010-20918-C02-02, SAF2103-48210-C2-01]; Council of Health and Social Welfare; Council of Education from Junta de Castilla y Leon, Spain [SA157A12-1]; European FEDER Program; Spanish Ministry of Education; Spanish Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitiveness(Spanish Government); Council of Health and Social Welfare; Council of Education from Junta de Castilla y Leon, Spain; European FEDER Program(European Commission); Spanish Ministry of Education(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2010-20918-C02-01 and SAF2103-48210-C2-02 (to A.P.), SAF2010-20918-C02-02, SAF2103-48210-C2-01 (to C.G.)) and from the Council of Health and Social Welfare and the Council of Education from Junta de Castilla y Leon (SA157A12-1, to C.G.), Spain. All funding was cosponsored by the European FEDER Program. This work was also supported by the Spanish Ministry of Education (FPU fellowship) (to M.A. and N.P.) and the Spanish Ministry of Economy and Competitiveness (to A.V.).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Behren A, 2010, ONCOGENE, V29, P1519, DOI 10.1038/onc.2009.436; Blackburn J, 2003, INVEST OPHTH VIS SCI, V44, P4613, DOI 10.1167/iovs.03-0112; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Chen XJ, 2014, CARCINOGENESIS, V35, P1707, DOI 10.1093/carcin/bgu023; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; del Reino P, 2014, CANCER RES, V74, P6150, DOI 10.1158/0008-5472.CAN-14-0870; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; Gupta J, 2014, CANCER CELL, V25, P484, DOI 10.1016/j.ccr.2014.02.019; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu B, 2012, CANCER RES, V72, P3873, DOI 10.1158/0008-5472.CAN-12-1060; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Cerezo-Guisado MI, 2011, CARCINOGENESIS, V32, P1093, DOI 10.1093/carcin/bgr079; Johansson N, 2000, J CELL SCI, V113, P227; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Kim IG, 2013, ONCOGENE, V1, P1, DOI DOI 10.1128/JVI.01181-13; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Leelahavanichkul K, 2014, MOL ONCOL, V8, P105, DOI 10.1016/j.molonc.2013.10.003; de Silanes IL, 2009, NUCLEIC ACIDS RES, V37, P2658, DOI 10.1093/nar/gkp123; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Miremadi A, 2007, HUM MOL GENET, V16, pR28, DOI 10.1093/hmg/ddm021; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Obaya AJ, 2012, CANCER LETT, V325, P132, DOI 10.1016/j.canlet.2012.06.019; Paradisi A, 2008, J BIOL CHEM, V283, P6005, DOI 10.1074/jbc.M707964200; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tong JD, 2011, NEOPLASMA, V58, P441, DOI 10.4149/neo_2011_05_441; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xu S, 2014, ONCOL REP, V31, P79, DOI 10.3892/or.2013.2799; Zuluaga S, 2007, FEBS LETT, V581, P3819, DOI 10.1016/j.febslet.2007.06.078	53	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4383	4397		10.1074/jbc.M114.582239	http://dx.doi.org/10.1074/jbc.M114.582239			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548290	Green Published, hybrid			2022-12-28	WOS:000349458400046
J	Inagaki, T; Iwasaki, S; Matsumura, Y; Kawamura, T; Tanaka, T; Abe, Y; Yamasaki, A; Tsurutani, Y; Yoshida, A; Chikaoka, Y; Nakamura, K; Magoori, K; Nakaki, R; Osborne, TF; Fukami, K; Aburatani, H; Kodama, T; Sakai, J				Inagaki, Takeshi; Iwasaki, Satoshi; Matsumura, Yoshihiro; Kawamura, Takeshi; Tanaka, Toshiya; Abe, Yohei; Yamasaki, Ayumu; Tsurutani, Yuya; Yoshida, Ayano; Chikaoka, Yoko; Nakamura, Kanako; Magoori, Kenta; Nakaki, Ryo; Osborne, Timothy F.; Fukami, Kiyoko; Aburatani, Hiroyuki; Kodama, Tatsuhiko; Sakai, Juro			The FBXL10/KDM2B Scaffolding Protein Associates with Novel Polycomb Repressive Complex-1 to Regulate Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEMETHYLASE FBXL10; H2A UBIQUITYLATION; GENE-EXPRESSION; PPAR-GAMMA; CELL-CYCLE; ADIPOCYTE DIFFERENTIATION; UBIQUITIN LIGASES; DOWN-REGULATION; PRC1 COMPLEX; CPG ISLANDS	Polycomb repressive complex 1 (PRC1) plays an essential role in the epigenetic repression of gene expression during development and cellular differentiation via multiple effector mechanisms, including ubiquitination of H2A and chromatin compaction. However, whether it regulates the stepwise progression of adipogenesis is unknown. Here, we show that FBXL10/KDM2B is an anti-adipogenic factor that is up-regulated during the early phase of 3T3-L1 preadipocyte differentiation and in adipose tissue in a diet-induced model of obesity. Interestingly, inhibition of adipogenesis does not require the JmjC demethylase domain of FBXL10, but it does require the F-box and leucine-rich repeat domains, which we show recruit a noncanonical polycomb repressive complex 1 (PRC1) containing RING1B, SKP1, PCGF1, and BCOR. Knockdown of either RING1B or SKP1 prevented FBXL10-mediated repression of 3T3-L1 preadipocyte differentiation indicating that PRC1 formation mediates the inhibitory effect of FBXL10 on adipogenesis. Using ChIP-seq, we show that FBXL10 recruits RING1B to key specific genomic loci surrounding the key cell cycle and the adipogenic genes Cdk1, Uhrf1, Pparg1, and Pparg2 to repress adipogenesis. These results suggest that FBXL10 represses adipogenesis by targeting a noncanonical PRC1 complex to repress key genes (e.g. Pparg) that control conversion of pluripotent cells into the adipogenic lineage.	[Inagaki, Takeshi; Iwasaki, Satoshi; Matsumura, Yoshihiro; Tanaka, Toshiya; Abe, Yohei; Yamasaki, Ayumu; Tsurutani, Yuya; Yoshida, Ayano; Nakamura, Kanako; Magoori, Kenta; Sakai, Juro] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Metab Med, Tokyo 1538904, Japan; [Kawamura, Takeshi; Tanaka, Toshiya; Chikaoka, Yoko; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Nakaki, Ryo; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo 1538904, Japan; [Inagaki, Takeshi; Tanaka, Toshiya; Magoori, Kenta; Aburatani, Hiroyuki; Sakai, Juro] Univ Tokyo, Translat Syst Biol & Med Initiat, Ctr Dis Biol & Integrat Med, Tokyo 1538904, Japan; [Osborne, Timothy F.] Sanford Burnham Med Res Inst, Metab Dis Program, Orlando, FL 32827 USA; [Yoshida, Ayano; Nakamura, Kanako; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, Tokyo 1920392, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Sanford Burnham Prebys Medical Discovery Institute; Tokyo University of Pharmacy & Life Sciences	Inagaki, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Div Metab Med, Tokyo 1538904, Japan.	inagaki@lsbm.org; jmsakai-tky@umin.ac.jp	Inagaki, Takeshi/J-8802-2013	Inagaki, Takeshi/0000-0003-1711-8286; Matsumura, Yoshihiro/0000-0002-3108-0440; Sakai, Juro/0000-0003-4043-1035	Ministry of Education, Culture, Sports, Science and Technology of Japan [22229009, 25291002, 25126704]; Grants-in-Aid for Scientific Research [14J05296, 26116708] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (S) 22229009 and (B) 25291002, Grant-in-aid for Scientific Research on Innovative Areas 25126704, and a grant for Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Ge R, 2011, CELL DEATH DIFFER, V18, P1184, DOI 10.1038/cdd.2010.185; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hoang Stephen A, 2011, BMC Res Notes, V4, P288, DOI 10.1186/1756-0500-4-288; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Janzer A, 2012, J BIOL CHEM, V287, P30984, DOI 10.1074/jbc.M112.341040; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; Kitagawa J, 2010, J CLIN EXP HEMATOP, V50, P99, DOI 10.3960/jslrt.50.99; Kliewer SA, 1998, CURR OPIN GENET DEV, V8, P576, DOI 10.1016/S0959-437X(98)80014-2; Konuma T, 2011, EXP HEMATOL, V39, P697, DOI 10.1016/j.exphem.2011.03.008; Koyama-Nasu R, 2007, NAT CELL BIOL, V9, P1074, DOI 10.1038/ncb1628; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ohguchi H, 2008, MOL CELL BIOL, V28, P3917, DOI 10.1128/MCB.02154-07; Okamura M, 2010, ORGANOGENESIS, V6, P24, DOI 10.4161/org.6.1.11121; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Tanaka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05412; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	59	27	30	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4163	4177		10.1074/jbc.M114.626929	http://dx.doi.org/10.1074/jbc.M114.626929			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25533466	hybrid, Green Published			2022-12-28	WOS:000349458400028
J	Elimam, H; Papillon, J; Takano, T; Cybulsky, AV				Elimam, Hanan; Papillon, Joan; Takano, Tomoko; Cybulsky, Andrey V.			Calcium-independent Phospholipase A(2)gamma Enhances Activation of the ATF6 Transcription Factor during Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Cell Signaling; Endoplasmic Reticulum (ER); Endoplasmic Reticulum Stress (ER Stress); Phospholipase A; Unfolded Protein Response (UPR)	UNFOLDED PROTEIN RESPONSE; EPITHELIAL-CELL INJURY; ER STRESS; GENETIC ABLATION; LIPID-METABOLISM; MITOCHONDRIAL; DEATH; A(2); EXPRESSION; DIFFERENTIATION	Background: Calcium-independent PLA(2) (iPLA(2)) is a membrane-bound enzyme that localizes at the endoplasmic reticulum (ER). Results: iPLA(2) amplified activation of the ATF6 pathway of the unfolded protein response, resulting in up-regulation of ER chaperones and cytoprotection. Conclusion: iPLA(2) enhances activation of ATF6. Significance: Modulating iPLA(2) activity may provide opportunities for pharmacological intervention in glomerular diseases associated with ER stress. Injury of visceral glomerular epithelial cells (GECs) causes proteinuria in many glomerular diseases. We reported previously that calcium-independent phospholipase A(2) (iPLA(2)) is cytoprotective against complement-mediated GEC injury. Because iPLA(2) is localized at the endoplasmic reticulum (ER), this study addressed whether the cytoprotective effect of iPLA(2) involves the ER stress unfolded protein response (UPR). In cultured rat GECs, overexpression of the full-length iPLA(2), but not a mutant iPLA(2) that fails to associate with the ER, augmented tunicamycin-induced activation of activating transcription factor-6 (ATF6) and induction of the ER chaperones, glucose-regulated protein 94 (GRP94) and glucose-regulated protein 78 (GRP78). Augmented responses were inhibited by the iPLA(2) inhibitor, (R)-bromoenol lactone, but not by the cyclooxygenase inhibitor, indomethacin. Tunicamycin-induced cytotoxicity was reduced in GECs expressing iPLA(2), and the cytoprotection was reversed by dominant-negative ATF6. GECs from iPLA(2) knock-out mice showed blunted ATF6 activation and chaperone up-regulation in response to tunicamycin. Unlike ATF6, the two other UPR pathways, i.e. inositol-requiring enzyme 1 and protein kinase RNA-like ER kinase pathways, were not affected by iPLA(2). Thus, in GECs, iPLA(2) amplified activation of the ATF6 pathway of the UPR, resulting in up-regulation of ER chaperones and cytoprotection. These effects were dependent on iPLA(2) catalytic activity and association with the ER but not on prostanoids. Modulating iPLA(2) activity may provide opportunities for pharmacological intervention in glomerular diseases associated with ER stress.	[Elimam, Hanan; Papillon, Joan; Takano, Tomoko; Cybulsky, Andrey V.] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A1, Canada	McGill University	Takano, T (corresponding author), McGill Univ, Div Nephrol, 3775 Univ St,Rm 236, Montreal, PQ H3A 2B4, Canada.	tomoko.takano@mcgill.ca; andrey.cybulsky@mcgill.ca	Elimam, Hanan/H-5858-2017; Cybulsky, Andrey V./AAG-8238-2020	Elimam, Hanan/0000-0003-2585-9957; Cybulsky, Andrey V./0000-0003-4348-2348	National Institutes of Health [RO1 HL118639]; Canadian Institutes of Health Research [MOP-53264, MOP-133492, MOP-125988, MOP-53335]; Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL118639. This work was also supported by Research Grants MOP-53264, MOP-133492, MOP-125988, and MOP-53335 from the Canadian Institutes of Health Research, the Kidney Foundation of Canada, and the Catherine McLaughlin Hakim Chair (to A. V. C.).	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Belmont PJ, 2010, CIRC RES, V106, P307, DOI 10.1161/CIRCRESAHA.109.203901; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Coers W, 1996, EXP NEPHROL, V4, P184; Cohen D, 2008, AM J PHYSIOL-RENAL, V294, pF469, DOI 10.1152/ajprenal.00372.2007; Cummings BS, 2004, J PHARMACOL EXP THER, V308, P921, DOI 10.1124/jpet.103.060541; Cummings BS, 2002, AM J PHYSIOL-RENAL, V283, pF492, DOI 10.1152/ajprenal.00022.2002; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cybulsky AV, 2013, KIDNEY INT, V84, P25, DOI 10.1038/ki.2012.390; Cybulsky AV, 2011, AM J PHYSIOL-RENAL, V301, pF496, DOI 10.1152/ajprenal.00728.2010; Cybulsky AV, 2002, J BIOL CHEM, V277, P41342, DOI 10.1074/jbc.M204694200; Elimam H, 2013, J BIOL CHEM, V288, P3871, DOI 10.1074/jbc.M112.396614; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Maiuolo J, 2011, P NATL ACAD SCI USA, V108, P7832, DOI 10.1073/pnas.1101379108; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Ren GH, 2010, BBA-MOL CELL RES, V1803, P468, DOI 10.1016/j.bbamcr.2010.01.020; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang Y, 2000, J BIOL CHEM, V275, P27013; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	43	13	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3009	3020		10.1074/jbc.M114.592261	http://dx.doi.org/10.1074/jbc.M114.592261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25492867	Green Published, hybrid			2022-12-28	WOS:000349310700038
J	Fisher, OS; Liu, WZ; Zhang, R; Stiegler, AL; Ghedia, S; Weber, JL; Boggon, TJ				Fisher, Oriana S.; Liu, Weizhi; Zhang, Rong; Stiegler, Amy L.; Ghedia, Sondhya; Weber, James L.; Boggon, Titus J.			Structural Basis for the Disruption of the Cerebral Cavernous Malformations 2 (CCM2) Interaction with Krev Interaction Trapped 1 (KRIT1) by Disease-associated Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Crystallography; Genetic Disease; Protein Complex; Protein-Protein Interaction; Cerebral Cavernous Malformations; PTB Domain; Point Mutation	PHOSPHOTYROSINE-BINDING DOMAIN; TRUNCATING MUTATIONS; 2-HIT MECHANISM; ENCODING KRIT1; PROTEIN; GENE; PATHOGENESIS; COMPLEX; RECOGNITION; HEART	Background: Mutations in Krev interaction trapped 1 (KRIT1) and cerebral cavernous malformations 2 (CCM2) are associated with CCM disease. Results: The CCM2-KRIT1 interaction is characterized structurally and biochemically. Conclusion: CCM2 preferentially binds the third NPX(Y/F) motif of KRIT1, and disease-associated mutations destabilize this interaction. Significance: These data may inform future studies into the biology of CCM disease. Familial cerebral cavernous malformations (CCMs) are predominantly neurovascular lesions and are associated with mutations within the KRIT1, CCM2, and PDCD10 genes. The protein products of KRIT1 and CCM2 (Krev interaction trapped 1 (KRIT1) and cerebral cavernous malformations 2 (CCM2), respectively) directly interact with each other. Disease-associated mutations in KRIT1 and CCM2 mostly result in loss of their protein products, although rare missense point mutations can also occur. From gene sequencing of patients known or suspected to have one or more CCMs, we discover a series of missense point mutations in KRIT1 and CCM2 that result in missense mutations in the CCM2 and KRIT1 proteins. To place these mutations in the context of the molecular level interactions of CCM2 and KRIT1, we map the interaction of KRIT1 and CCM2 and find that the CCM2 phosphotyrosine binding (PTB) domain displays a preference toward the third of the three KRIT1 NPX(Y/F) motifs. We determine the 2.75 co-crystal structure of the CCM2 PTB domain with a peptide corresponding to KRIT1(NPX(Y/F)3), revealing a Dab-like PTB fold for CCM2 and its interaction with KRIT1(NPX(Y/F)3). We find that several disease-associated missense mutations in CCM2 have the potential to interrupt the KRIT1-CCM2 interaction by destabilizing the CCM2 PTB domain and that a KRIT1 mutation also disrupts this interaction. We therefore provide new insights into the architecture of CCM2 and how the CCM complex is disrupted in CCM disease.	[Fisher, Oriana S.; Liu, Weizhi; Zhang, Rong; Stiegler, Amy L.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Ghedia, Sondhya] Royal N Shore Hosp, Dept Clin Genet, St Leonards, NSW 2065, Australia; [Weber, James L.] PreventionGenetics, Marshfield, WI 54449 USA	Yale University; Royal North Shore Hospital	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu		Fisher, Oriana/0000-0003-3215-0831	National Institutes of Health [NS085078]; National Institutes of Health Training Grant [GM007324]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS085078 (to T. J. B.) and National Institutes of Health Training Grant GM007324 (to O. S. F.).; Supported in part by a National Science Foundation graduate research fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crose LES, 2009, J BIOL CHEM, V284, P13301, DOI 10.1074/jbc.C900009200; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Domingues F, 2008, ARQ NEURO-PSIQUIAT, V66, P795, DOI 10.1590/S0004-282X2008000600003; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Dvir H, 2012, P NATL ACAD SCI USA, V109, P6916, DOI 10.1073/pnas.1114128109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Fisher OS, 2014, CELL MOL LIFE SCI, V71, P1881, DOI 10.1007/s00018-013-1532-9; Fisher OS, 2013, FEBS LETT, V587, P272, DOI 10.1016/j.febslet.2012.12.011; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gingras AR, 2013, J BIOL CHEM, V288, P23639, DOI 10.1074/jbc.M113.462911; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Li XF, 2012, J BIOL CHEM, V287, P22317, DOI 10.1074/jbc.M112.361295; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Liu WZ, 2013, ACTA CRYSTALLOGR F, V69, P494, DOI 10.1107/S1744309113010762; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mondejar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086286; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Shi N, 2004, J BIOL CHEM, V279, P4962, DOI 10.1074/jbc.M311030200; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Stiegler AL, 2014, J BIOL CHEM, V289, P25362, DOI 10.1074/jbc.M114.584011; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	51	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2842	2853		10.1074/jbc.M114.616433	http://dx.doi.org/10.1074/jbc.M114.616433			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525273	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000349310700025
J	Wang, HZ; Graham, I; Hastings, R; Gunewardena, S; Brinkmeier, ML; Conn, PM; Camper, SA; Kumar, TR				Wang, Huizhen; Graham, Ian; Hastings, Richard; Gunewardena, Sumedha; Brinkmeier, Michelle L.; Conn, P. Michael; Camper, Sally A.; Kumar, T. Rajendra			Gonadotrope-specific Deletion of Dicer Results in Severely Suppressed Gonadotropins and Fertility Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein; MicroRNA (miRNA); Pituitary Gland; Reproduction; Secretion	FOLLICLE-STIMULATING-HORMONE; BETA-SUBUNIT GENE; RECEPTOR KNOCKOUT MICE; PITUITARY DEVELOPMENT; TRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISMS; TARGETED DISRUPTION; SOMATIC-CELLS; EXPRESSION; ACTIVIN	Background: DICER mediates microRNA production, and its functional role in gonadotropes is not known. Results: Deletion of Dicer in gonadotropes leads to suppression of gonadotropin synthesis and secretion and results in fertility defects. Conclusion: DICER-dependent microRNAs are critical for gonadotropin homeostasis and fertility. Significance: Understanding how microRNAs regulate gonadotropin homeostasis provides a new approach to enhance or block fertility in mammals. Pituitary gonadotropins follicle-stimulating hormone and luteinizing hormone are heterodimeric glycoproteins expressed in gonadotropes. They act on gonads and promote their development and functions including steroidogenesis and gametogenesis. Although transcriptional regulation of gonadotropin subunits has been well studied, the post-transcriptional regulation of gonadotropin subunits is not well understood. To test if microRNAs regulate the hormone-specific gonadotropin subunits in vivo, we deleted Dicer in gonadotropes by a Cre-lox genetic approach. We found that many of the DICER-dependent microRNAs, predicted in silico to bind gonadotropin subunit mRNAs, were suppressed in purified gonadotropes of mutant mice. Loss of DICER-dependent microRNAs in gonadotropes resulted in profound suppression of gonadotropin- subunit proteins and, consequently, the heterodimeric hormone secretion. In addition to suppression of basal levels, interestingly, the post-gonadectomy-induced rise in pituitary gonadotropin synthesis and secretion were both abolished in mutants, indicating a defective gonadal negative feedback control. Furthermore, mutants lacking Dicer in gonadotropes displayed severely reduced fertility and were rescued with exogenous hormones confirming that the fertility defects were secondary to suppressed gonadotropins. Our studies reveal that DICER-dependent microRNAs are essential for gonadotropin homeostasis and fertility in mice. Our studies also implicate microRNAs in gonadal feedback control of gonadotropin synthesis and secretion. Thus, DICER-dependent microRNAs confer a new layer of transcriptional and post-transcriptional regulation in gonadotropes to orchestrate the hypothalamus-pituitary-gonadal axis physiology.	[Wang, Huizhen; Graham, Ian; Gunewardena, Sumedha; Kumar, T. Rajendra] Univ Kansas, Med Ctr, Dept Mol Physiol, Kansas City, KS 66160 USA; [Wang, Huizhen; Graham, Ian; Gunewardena, Sumedha; Kumar, T. Rajendra] Univ Kansas, Med Ctr, Dept Integrat Physiol, Kansas City, KS 66160 USA; [Kumar, T. Rajendra] Univ Kansas, Med Ctr, Ctr Reprod Sci, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Hastings, Richard] Univ Kansas, Med Ctr, Flow Cytometry Core Lab, Kansas City, KS 66160 USA; [Brinkmeier, Michelle L.; Camper, Sally A.] Univ Michigan, Dept Mol & Human Genet, Ann Arbor, MI 48109 USA; [Conn, P. Michael] Texas Tech Univ, Dept Internal Med, Lubbock, TX 79430 USA; [Conn, P. Michael] Texas Tech Univ, Dept Cell Biol, Lubbock, TX 79430 USA; [Conn, P. Michael] Texas Tech Univ, Dept Biochem, Lubbock, TX 79430 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Michigan System; University of Michigan; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Kumar, TR (corresponding author), Univ Kansas, Med Ctr, 3901 Rainbow Blvd,HLSIC Bldg 3073, Kansas City, KS 66160 USA.	tkumar@kumc.edu		Brinkmeier, Michelle/0000-0001-9505-4682; Camper, Sally/0000-0001-8556-3379	National Institutes of Health [HD056082, HD069751, AG029531, CA166557]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934, R01HD034283, U54HD028934, R03HD069751] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028934, R03HD056082] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA166557, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG029531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HD056082, HD069751, AG029531, and CA166557 (to T. R. K.).	Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442; Bakke M, 2001, MOL CELL ENDOCRINOL, V179, P33, DOI 10.1016/S0303-7207(01)00468-3; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bilezikjian LM, 2012, MOL CELL ENDOCRINOL, V359, P43, DOI 10.1016/j.mce.2012.01.025; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Bousfield GR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1581; CARROLL RS, 1991, ENDOCRINOLOGY, V129, P1721, DOI 10.1210/endo-129-4-1721; Charles MA, 2008, GENESIS, V46, P507, DOI 10.1002/dvg.20398; Ciccone NA, 2009, CURR OPIN ENDOCRINOL, V16, P321, DOI 10.1097/MED.0b013e32832d88fb; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Di Ieva A, 2014, NEUROSURGERY, V75, P181, DOI 10.1227/NEU.0000000000000369; Drouin J, 2006, FRONT HORM RES, V35, P74, DOI 10.1159/000094310; Flemr M, 2013, CELL, V155, P807, DOI 10.1016/j.cell.2013.10.001; Fortin J, 2014, FASEB J, V28, P3396, DOI 10.1096/fj.14-249532; Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802; Gadelha MR, 2013, J ENDOCRINOL INVEST, V36, P889, DOI 10.1007/BF03346759; Godoy J, 2011, MOL ENDOCRINOL, V25, P810, DOI 10.1210/me.2010-0352; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Gonzalez-Gonzalez E, 2008, BBA-GENE REGUL MECH, V1779, P306, DOI 10.1016/j.bbagrm.2008.01.007; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; Gregory SJ, 2004, SEMIN REPROD MED, V 22, P253, DOI 10.1055/s-2004-831901; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hannon GJ, 2006, COLD SPRING HARB SYM, V71, P551, DOI 10.1101/sqb.2006.71.064; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P1257, DOI 10.1210/me.2011-0099; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; HE L, 2004, NAT REV GENET, V5, P522; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2267, DOI 10.1210/en.142.6.2267; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk; Koopman P, 2001, EXS, V91, P25; KUMAR TR, 1992, MOL ENDOCRINOL, V6, P81, DOI 10.1210/me.6.1.81; Kumar TR, 2005, REPRODUCTION, V130, P293, DOI 10.1530/rep.1.00660; Kumar TR, 2006, MOL CELL ENDOCRINOL, V247, P103, DOI 10.1016/j.mce.2005.12.006; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Kumar TR, 2005, ENDOCRINE, V26, P227, DOI 10.1385/ENDO:26:3:227; Kumar TR, 2001, ENDOCRINOLOGY, V142, P3512, DOI 10.1210/en.142.8.3512; KUMAR TR, 1995, NEUROENDOCRINOLOGY, V61, P628, DOI 10.1159/000126889; KUMAR TR, 1993, MOL ENDOCRINOL, V7, P898, DOI 10.1210/me.7.7.898; Lau E., 2014, NAT REV GENET, V15, P642; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024883; Liu HC, 2010, J ASSIST REPROD GEN, V27, P571, DOI 10.1007/s10815-010-9456-x; Luense LJ, 2009, TRENDS ENDOCRIN MET, V20, P265, DOI 10.1016/j.tem.2009.05.001; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; McClelland K, 2012, ASIAN J ANDROL, V14, P164, DOI 10.1038/aja.2011.169; Melamed P, 2006, MOL CELL ENDOCRINOL, V252, P167, DOI 10.1016/j.mce.2006.03.024; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; O'Shaughnessy PJ, 2010, REPRODUCTION, V139, P177, DOI 10.1530/REP-09-0377; OSHAUGHNESSY PJ, 1992, J ENDOCRINOL, V135, P517, DOI 10.1677/joe.0.1350517; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Panneerdoss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041146; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Perez-Millan MI, 2013, GENESIS, V51, P785, DOI 10.1002/dvg.22425; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Salisbury TB, 2008, MOL ENDOCRINOL, V22, P1295, DOI 10.1210/me.2007-0515; Schneeberger M, 2013, MOL METAB, V2, P74, DOI 10.1016/j.molmet.2012.10.001; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Spady TJ, 2004, MOL ENDOCRINOL, V18, P925, DOI 10.1210/me.2003-0115; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang HZ, 2014, P NATL ACAD SCI USA, V111, P5735, DOI 10.1073/pnas.1321404111; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; WEISS J, 1995, ENDOCRINOLOGY, V136, P1885, DOI 10.1210/en.136.5.1885; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; West BE, 2004, ENDOCRINOLOGY, V145, P4866, DOI 10.1210/en.2004-0598; Wreford NG, 2001, ENDOCRINOLOGY, V142, P2916, DOI 10.1210/en.142.7.2916; Xie HM, 2013, MOL ENDOCRINOL, V27, P422, DOI 10.1210/me.2012-1289; Ye RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057156; Yuen T, 2009, MOL CELL ENDOCRINOL, V302, P12, DOI 10.1016/j.mce.2008.12.013; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhang LF, 2013, INT J MOL SCI, V14, P20326, DOI 10.3390/ijms141020326; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006; Zhu XY, 2005, CURR OPIN GENET DEV, V15, P332, DOI 10.1016/j.gde.2005.04.011	93	35	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2699	2714		10.1074/jbc.M114.621565	http://dx.doi.org/10.1074/jbc.M114.621565			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525274	Green Published, hybrid			2022-12-28	WOS:000349310700014
J	Bjerregaard, H; Severinsen, K; Said, S; Wiborg, O; Sinning, S				Bjerregaard, Henriette; Severinsen, Kasper; Said, Saida; Wiborg, Ove; Sinning, Steffen			A Dualistic Conformational Response to Substrate Binding in the Human Serotonin Transporter Reveals a High Affinity State for Serotonin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Membrane Protein; Monoamine Transporter; Neurotransmitter; Neurotransmitter Transport; Protein Conformation; Serotonin; Serotonin Transporter; Transport; LeuT	CYSTEINE-SCANNING MUTAGENESIS; BACTERIAL HOMOLOG; DOPAMINE TRANSPORTER; LIGAND-BINDING; MECHANISM; 5-HYDROXYTRYPTAMINE; EXPRESSION; CLONING; LEUT; INHIBITOR	Background: The serotonin transporter (SERT) mediates neuronal reuptake of serotonin and is inhibited by most antidepressants. Results: A dualistic conformational response in SERT reveals a high affinity state in response to serotonin. Conclusion: Membrane cholesterol modulates the dualistic conformational response to serotonin in SERT. Significance: The interplay between the conformational responses in SERT and cholesterol is important for understanding an important pharmaceutical target in depression. Serotonergic neurotransmission is modulated by the membrane-embedded serotonin transporter (SERT). SERT mediates the reuptake of serotonin into the presynaptic neurons. Conformational changes in SERT occur upon binding of ions and substrate and are crucial for translocation of serotonin across the membrane. Our understanding of these conformational changes is mainly based on crystal structures of a bacterial homolog in various conformations, derived homology models of eukaryotic neurotransmitter transporters, and substituted cysteine accessibility method of SERT. However, the dynamic changes that occur in the human SERT upon binding of ions, the translocation of substrate, and the role of cholesterol in this interplay are not fully elucidated. Here we show that serotonin induces a dualistic conformational response in SERT. We exploited the substituted cysteine scanning method under conditions that were sensitized to detect a more outward-facing conformation of SERT. We found a novel high affinity outward-facing conformational state of the human SERT induced by serotonin. The ionic requirements for this new conformational response to serotonin mirror the ionic requirements for translocation. Furthermore, we found that membrane cholesterol plays a role in the dualistic conformational response in SERT induced by serotonin. Our results indicate the existence of a subpopulation of SERT responding differently to serotonin binding than hitherto believed and that membrane cholesterol plays a role in this subpopulation of SERT.	[Bjerregaard, Henriette; Severinsen, Kasper; Said, Saida; Wiborg, Ove; Sinning, Steffen] Aarhus Univ, Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, DK-8240 Risskov, Denmark	Aarhus University	Sinning, S (corresponding author), Aarhus Univ, Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, Skovagervej 2, DK-8240 Risskov, Denmark.	steffen.sinning@clin.au.dk		Sinning, Steffen/0000-0001-6971-6929	Lundbeck Foundation; Lundbeck Foundation [R34-2011-3868, R126-2012-12576] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a grant from the Lundbeck Foundation.	Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Androutsellis-Theotokis A, 2001, J BIOL CHEM, V276, P45933, DOI 10.1074/jbc.M107462200; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Carlsson A, 1968, J Pharm Pharmacol, V20, P150; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; CERRITO F, 1979, EUR J PHARMACOL, V57, P427, DOI 10.1016/0014-2999(79)90506-5; Chang AS, 1996, MOL BRAIN RES, V43, P185, DOI 10.1016/S0169-328X(96)00172-6; Chang JC, 2012, J NEUROSCI, V32, P8919, DOI 10.1523/JNEUROSCI.0048-12.2012; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; GU H, 1994, J BIOL CHEM, V269, P7124; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; HUMPHREYS CJ, 1994, BIOCHEMISTRY-US, V33, P9118, DOI 10.1021/bi00197a014; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2004, EUR J NEUROSCI, V19, P1513, DOI 10.1111/j.1460-9568.2004.03202.x; LINGJAERDE O, 1969, FEBS LETT, V3, P103, DOI 10.1016/0014-5793(69)80108-0; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; MARSHALL EF, 1960, BRIT J PHARM CHEMOTH, V15, P35, DOI 10.1111/j.1476-5381.1960.tb01207.x; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; RUDNICK G, 1978, BIOCHEMISTRY-US, V17, P4739, DOI 10.1021/bi00615a021; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Severinsen K, 2008, J NEUROCHEM, V105, P1794, DOI 10.1111/j.1471-4159.2008.05285.x; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; SIWERS B, 1977, CLIN PHARMACOL THER, V21, P194; STACEY RS, 1961, BRIT J PHARM CHEMOTH, V16, P284, DOI 10.1111/j.1476-5381.1961.tb01087.x; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	52	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7747	7755		10.1074/jbc.M114.573477	http://dx.doi.org/10.1074/jbc.M114.573477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25614630	hybrid, Green Published			2022-12-28	WOS:000351613600035
J	Bolte, C; Ren, XM; Tomley, T; Ustiyan, V; Pradhan, A; Hoggatt, A; Kalin, TV; Herring, BP; Kalinichenko, VV				Bolte, Craig; Ren, Xiaomeng; Tomley, Tatiana; Ustiyan, Vladimir; Pradhan, Arun; Hoggatt, April; Kalin, Tanya V.; Herring, B. Paul; Kalinichenko, Vladimir V.			Forkhead Box F2 Regulation of Platelet-derived Growth Factor and Myocardin/Serum Response Factor Signaling Is Essential for Intestinal Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Knockout; Intestine; Myocardin; Smooth Muscle; Transcription Factor; Transgenic Mice; Forkhead Protein; Foxf2	M1 TRANSCRIPTION FACTOR; SMOOTH-MUSCLE-CELLS; MOUSE EMBRYONIC GUT; GASTROINTESTINAL-TRACT; PULMONARY VASCULATURE; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; FACTOR FOXF1; DIFFERENTIATION	Background: Transcriptional regulation of smooth muscle cells is an understudied component of intestinal development and physiology. Results: Foxf2 deletion from smooth muscle causes intestinal malformations and colon remodeling. Conclusion: Foxf2 regulation of PDGF and myocardin/SRF signaling is essential for intestinal development and homeostasis. Significance: Better understanding of transcriptional mechanisms regulating postnatal intestine development and homeostasis may provide therapeutic approaches for congenital and acquired gastrointestinal diseases. Alterations in the forkhead box F2 gene expression have been reported in numerous pathologies, and Foxf2(-/-) mice are perinatal lethal with multiple malformations; however, molecular mechanisms pertaining to Foxf2 signaling are severely lacking. In this study, Foxf2 requirements in murine smooth muscle cells were examined using a conditional knock-out approach. We generated novel Foxf2-floxed mice, which we bred to smMHC-Cre-eGFP mice to generate a mouse line with Foxf2 deleted specifically from smooth muscle. These mice exhibited growth retardation due to reduced intestinal length as well as inflammation and remodeling of the small intestine. Colons of Tg(smMHC-Cre-eGFP(+/-));Foxf2(-/-) mice had expansion of the myenteric nerve plexus and increased proliferation of smooth muscle cells leading to thickening of the longitudinal smooth muscle layer. Foxf2 deficiency in colonic smooth muscle was associated with increased expression of Foxf1, PDGFa, PDGFb, PDGF receptor , and myocardin. FOXF2 bound to promoter regions of these genes indicating direct transcriptional regulation. Foxf2 repressed Foxf1 promoter activity in co-transfection experiments. We also show that knockdown of Foxf2 in colonic smooth muscle cells in vitro and in transgenic mice increased myocardin/serum response factor signaling and increased expression of contractile proteins. Foxf2 attenuated myocardin/serum response factor signaling in smooth muscle cells through direct binding to the N-terminal region of myocardin. Our results indicate that Foxf2 signaling in smooth muscle cells is essential for intestinal development and serum response factor signaling.	[Bolte, Craig; Ren, Xiaomeng; Tomley, Tatiana; Ustiyan, Vladimir; Pradhan, Arun; Kalin, Tanya V.; Kalinichenko, Vladimir V.] Cincinnati Childrens Res Fdn, Dept Pediat, Perinatal Inst, Cincinnati, OH 45229 USA; [Hoggatt, April; Herring, B. Paul] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Indiana University System; Indiana University Bloomington	Bolte, C (corresponding author), Cincinnati Childrens Res Fdn, Dept Pediat, Perinatal Inst, 3333 Burnet Ave,MLC 7009, Cincinnati, OH 45229 USA.	Craig.Bolte@cchmc.org; Vladimir.Kalinichenko@cchmc.org	Ren, Xiaomeng/U-1751-2019		National Institutes of Health [HL84151, HL123490, CA142724, DK061130]; NATIONAL CANCER INSTITUTE [R01CA142724] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151, R01HL123490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL84151 (to V. V. K.), HL123490 (to V. V. K.), CA142724 (to T. V. K.), and DK061130 (to B. P. H.).	Aitola M, 2000, DEV DYNAM, V218, P136, DOI 10.1002/(SICI)1097-0177(200005)218:1<136::AID-DVDY12>3.0.CO;2-U; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Balli D, 2013, EMBO J, V32, P231, DOI 10.1038/emboj.2012.336; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Barbara PD, 2005, DEV DYNAM, V234, P312, DOI 10.1002/dvdy.20554; Blair PJ, 2012, NEUROGASTROENT MOTIL, V24, pe437, DOI 10.1111/j.1365-2982.2012.01975.x; Bolte C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022217; Bolte C, 2009, AM J PHYSIOL-HEART C, V296, pH967, DOI 10.1152/ajpheart.00909.2008; Cai YQ, 2013, J BIOL CHEM, V288, P22527, DOI 10.1074/jbc.M113.455089; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; ECCLESTON PA, 1993, DEV BIOL, V155, P459, DOI 10.1006/dbio.1993.1044; Flynn RS, 2009, AM J PHYSIOL-GASTR L, V297, pG1232, DOI 10.1152/ajpgi.00323.2009; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Graham MF, 1996, GASTROENTEROLOGY, V110, P344, DOI 10.1053/gast.1996.v110.pm8566579; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hazelgrove KB, 2009, AM J PHYSIOL-GASTR L, V296, pG1230, DOI 10.1152/ajpgi.90508.2008; Hellqvist M, 1996, J BIOL CHEM, V271, P4482; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Hoggatt AM, 2013, J BIOL CHEM, V288, P28477, DOI 10.1074/jbc.M113.478974; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalinichenko VV, 2001, DEV BIOL, V235, P489, DOI 10.1006/dbio.2001.0322; KEDINGER M, 1990, DIFFERENTIATION, V43, P87, DOI 10.1111/j.1432-0436.1990.tb00434.x; Kim IM, 2005, J BIOL CHEM, V280, P37908, DOI 10.1074/jbc.M506531200; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Kurahashi M, 2008, NEUROGASTROENT MOTIL, V20, P521, DOI 10.1111/j.1365-2982.2007.01055.x; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lobsiger CS, 2000, GLIA, V30, P290, DOI 10.1002/(SICI)1098-1136(200005)30:3<290::AID-GLIA8>3.0.CO;2-6; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; McKeone R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025489; Mclin VA, 2010, INT J DEV BIOL, V54, P919, DOI 10.1387/ijdb.092916vm; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Nik AM, 2013, GASTROENTEROLOGY, V144, P1001, DOI 10.1053/j.gastro.2013.01.045; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Ormestad M, 2004, DEV DYNAM, V229, P328, DOI 10.1002/dvdy.10426; Peterson RS, 1997, MECH DEVELOP, V69, P53, DOI 10.1016/S0925-4773(97)00153-6; Philip-Couderc P, 2008, CIRC RES, V102, pE20, DOI 10.1161/CIRCRESAHA.107.166744; Ramakrishna S, 2007, DEV DYNAM, V236, P1000, DOI 10.1002/dvdy.21113; Ren XM, 2014, CIRC RES, V115, P709, DOI 10.1161/CIRCRESAHA.115.304382; Ren XM, 2013, MOL CELL BIOL, V33, P371, DOI 10.1128/MCB.00934-12; Ren XM, 2010, MOL CELL BIOL, V30, P5381, DOI 10.1128/MCB.00876-10; Reneker LW, 1996, INVEST OPHTH VIS SCI, V37, P2455; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Spence JR, 2011, DEV DYNAM, V240, P501, DOI 10.1002/dvdy.22540; Stanzel RDP, 2010, AM J PHYSIOL-CELL PH, V299, pC805, DOI 10.1152/ajpcell.00086.2010; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; Torihashi S, 2009, DIFFERENTIATION, V77, P277, DOI 10.1016/j.diff.2008.10.003; Ustiyan V, 2009, DEV BIOL, V336, P266, DOI 10.1016/j.ydbio.2009.10.007; van der Heul-Nieuwenhuijsen L, 2009, PROSTATE, V69, P1538, DOI 10.1002/pros.20996; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wang IC, 2014, ONCOGENE, V33, P5391, DOI 10.1038/onc.2013.475; Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Young HM, 2005, CELL TISSUE RES, V320, P1, DOI 10.1007/s00441-004-1057-5; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	63	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7563	7575		10.1074/jbc.M114.609487	http://dx.doi.org/10.1074/jbc.M114.609487			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25631042	Green Published, hybrid			2022-12-28	WOS:000351613600021
J	Mantilla, BS; Paes, LS; Pral, EMF; Martil, DE; Thiemann, OH; Fernandez-Silva, P; Bastos, EL; Silber, AM				Mantilla, Brian S.; Paes, Lisvane S.; Pral, Elizabeth M. F.; Martil, Daiana E.; Thiemann, Otavio H.; Fernandez-Silva, Patricio; Bastos, Erick L.; Silber, Ariel M.			Role of Delta(1)-Pyrroline-5-Carboxylate Dehydrogenase Supports Mitochondrial Metabolism and Host-Cell Invasion of Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Enzyme Mechanism; Host-Pathogen Interaction; Mitochondrial Metabolism; Parasite Metabolism; Trypanosoma cruzi	GLUTAMIC-GAMMA-SEMIALDEHYDE; YEAST SACCHAROMYCES-CEREVISIAE; RAY SOLUTION SCATTERING; DELTA-1-PYRROLINE-5-CARBOXYLIC ACID; BIOCHEMICAL-CHARACTERIZATION; II HYPERPROLINEMIA; PROLINE CATABOLISM; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; MAMMALIAN STAGES	Background: The enzyme, (1)-pyrroline-5-carboxylate dehydrogenase (P5CDH), is a key enzyme involved in proline catabolism. Results: The parasite Trypanosoma cruzi up-regulates P5CDH during host infection. Conclusion:T. cruzi uses P5C to produce energy, resist metabolic stress, and invade host cells through this mitochondrion-bound enzyme. Significance: The oxidation of P5C is sufficient to supply energy and enhance the pathogenicity of T. cruzi. Proline is crucial for energizing critical events throughout the life cycle of Trypanosoma cruzi, the etiological agent of Chagas disease. The proline breakdown pathway consists of two oxidation steps, both of which produce reducing equivalents as follows: the conversion of proline to (1)-pyrroline-5-carboxylate (P5C), and the subsequent conversion of P5C to glutamate. We have identified and characterized the (1)-pyrroline-5-carboxylate dehydrogenase from T. cruzi (TcP5CDH) and report here on how this enzyme contributes to a central metabolic pathway in this parasite. Size-exclusion chromatography, two-dimensional gel electrophoresis, and small angle x-ray scattering analysis of TcP5CDH revealed an oligomeric state composed of two subunits of six protomers. TcP5CDH was found to complement a yeast strain deficient in PUT2 activity, confirming the enzyme's functional role; and the biochemical parameters (K-m, k(cat), and k(cat)/K-m) of the recombinant TcP5CDH were determined, exhibiting values comparable with those from T. cruzi lysates. In addition, TcP5CDH exhibited mitochondrial staining during the main stages of the T. cruzi life cycle. mRNA and enzymatic activity levels indicated the up-regulation (6-fold change) of TcP5CDH during the infective stages of the parasite. The participation of P5C as an energy source was also demonstrated. Overall, we propose that this enzymatic step is crucial for the viability of both replicative and infective forms of T. cruzi.	[Mantilla, Brian S.; Paes, Lisvane S.; Pral, Elizabeth M. F.; Silber, Ariel M.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508000 Sao Paulo, Brazil; [Martil, Daiana E.; Thiemann, Otavio H.] Univ Sao Paulo, Inst Fis Sao Carlos, Lab Biol Estrutural, BR-13560590 Sao Paulo, Brazil; [Bastos, Erick L.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, BR-13560590 Sao Paulo, Brazil; [Fernandez-Silva, Patricio] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50013 Zaragoza, Spain	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Zaragoza	Silber, AM (corresponding author), Inst Ciencias Biomed, Dept Parasitol, Ave Lineu Prestes 1374,Sala 24,Cidade Univ, BR-05508900 Sao Paulo, Brazil.	asilber@usp.br	Silva, Patricio Fernandez/U-2256-2017; Vieira, Lisvane Paes/AAI-6761-2020; Thiemann, Otavio H/D-9767-2012; Bastos, Erick L/F-8746-2012; Silber, Ariel/O-6951-2015	Silva, Patricio Fernandez/0000-0001-8971-7355; Vieira, Lisvane Paes/0000-0001-8589-5939; Bastos, Erick L/0000-0002-0592-9455; Suarez Mantilla, Brian/0000-0001-7839-1222; Silber, Ariel/0000-0003-4528-4732	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [13/18970-6]; Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475741/2013-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 13/18970-6 (to A. M. S.), Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant 475741/2013-7 (to A. M. S.).	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009; Avilan L., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/932549; Balana-Fouce R, 2012, MOL BIOCHEM PARASIT, V181, P85, DOI 10.1016/j.molbiopara.2011.10.007; BARRETT FM, 1975, COMP BIOCHEM PHYS B, V52, P427; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Bastos IMD, 2005, BIOCHEM J, V388, P29, DOI 10.1042/BJ20041049; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bayer-Santos E, 2013, J PROTEOME RES, V12, P883, DOI 10.1021/pr300947g; BEARNE SL, 1995, BIOCHEMISTRY-US, V34, P11515, DOI 10.1021/bi00036a026; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bookout A. L., 2003, CURRENT PROTOCOLS MO; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDRISS MC, 1986, MOL CELL BIOL, V6, P3502, DOI 10.1128/MCB.6.10.3502; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; BRENER Z, 1971, Revista do Instituto de Medicina Tropical de Sao Paulo, V13, P171; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Carranza JC, 2009, J BIOENERG BIOMEMBR, V41, P299, DOI 10.1007/s10863-009-9228-4; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Christmas PB, 2000, FEMS MICROBIOL LETT, V183, P225, DOI 10.1111/j.1574-6968.2000.tb08962.x; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cooper H. M., 2000, CURRENT PROTOCOLS MO; Covarrubias C, 2007, INT J PARASITOL, V37, P1609, DOI 10.1016/j.ijpara.2007.05.013; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; DENICOLASEOANE A, 1992, MOL BIOCHEM PARASIT, V54, P43, DOI 10.1016/0166-6851(92)90093-Y; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; ELTHON TE, 1981, PLANT PHYSIOL, V67, P780, DOI 10.1104/pp.67.4.780; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Ernster L., 1970, MEMBRANES MITOCHONDR, P175; Farrant RD, 2001, J BIOL CHEM, V276, P15107, DOI 10.1074/jbc.M010860200; Fernandes MP, 2010, J BIOENERG BIOMEMBR, V42, P69, DOI 10.1007/s10863-010-9268-9; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; FLEMING GA, 1984, METABOLISM, V33, P739, DOI 10.1016/0026-0495(84)90215-4; FORTEMCROBBIE C, 1989, BIOCHEM J, V261, P935, DOI 10.1042/bj2610935; FORTEMCROBBIE CM, 1986, J BIOL CHEM, V261, P2154; Geraghty MT, 1998, HUM MOL GENET, V7, P1411, DOI 10.1093/hmg/7.9.1411; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Haslett MR, 2004, BBA-GEN SUBJECTS, V1675, P81, DOI 10.1016/j.bbagen.2004.08.008; He F, 2011, MITOCHONDRION, V11, P397, DOI 10.1016/j.mito.2010.12.001; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOMSY JJ, 1989, J PROTOZOOL, V36, P150, DOI 10.1111/j.1550-7408.1989.tb01063.x; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; JOCKERSSCHERUBL MC, 1989, EUR J BIOCHEM, V180, P267, DOI 10.1111/j.1432-1033.1989.tb14643.x; JUAN SM, 1978, INT J BIOCHEM, V9, P395, DOI 10.1016/0020-711X(78)90052-6; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krnacova K, 2012, J MOL EVOL, V75, P119, DOI 10.1007/s00239-012-9523-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee IR, 2013, GENETICS, V194, P421, DOI 10.1534/genetics.113.150326; LEWIS ML, 1993, BIOORG MED CHEM LETT, V3, P1193, DOI 10.1016/S0960-894X(00)80313-3; Lijek RS, 2012, P NATL ACAD SCI USA, V109, P13823, DOI 10.1073/pnas.1208075109; Lisvane Silva Paes, 2011, Curr Pharm Des, V17, P2074; Lundblad V., 2003, CURRENT PROTOCOLS MO; Luo M, 2013, J MOL BIOL, V425, P3106, DOI 10.1016/j.jmb.2013.05.027; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Magdaleno Anahi, 2011, Enzyme Res, V2011, P486928, DOI 10.4061/2011/486928; Magdaleno A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004534; Marciano D, 2008, MOL BIOCHEM PARASIT, V161, P12, DOI 10.1016/j.molbiopara.2008.05.005; Marciano D, 2009, MOL BIOCHEM PARASIT, V166, P172, DOI 10.1016/j.molbiopara.2009.04.001; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; MIXSON AJ, 1988, J BIOL CHEM, V263, P10720; MONTEMARTINI M, 1993, BIOCHEM J, V292, P901, DOI 10.1042/bj2920901; Monzote L, 2010, CURR CLIN PHARMACOL, V5, P55, DOI 10.2174/157488410790410605; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; ODALY JA, 1983, INT J PARASITOL, V13, P433, DOI 10.1016/S0020-7519(83)80005-8; Paes LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069419; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Sambrook P. M., 2001, MOL CLONING LAB MANU; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider A., 2007, METHOD MOL BIOL, P379; SEMON BA, 1991, IN VITRO CELL DEV B, V27, P665, DOI 10.1007/BF02631111; Silber AM, 2006, INT J PARASITOL, V36, P157, DOI 10.1016/j.ijpara.2005.10.006; Silber AM, 2009, MOL BIOCHEM PARASIT, V168, P102, DOI 10.1016/j.molbiopara.2009.07.006; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; SILVIUS JR, 1981, J THEOR BIOL, V88, P135, DOI 10.1016/0022-5193(81)90332-5; Souza DHF, 1998, FEBS LETT, V424, P131, DOI 10.1016/S0014-5793(98)00154-9; Srivastava D, 2012, J MOL BIOL, V420, P176, DOI 10.1016/j.jmb.2012.04.010; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; STRECKER HJ, 1960, J BIOL CHEM, V235, P2045; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; SYLVESTER D, 1976, COMP BIOCHEM PHYS B, V55, P443, DOI 10.1016/0305-0491(76)90318-7; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; TSCHUDI C, 1985, P NATL ACAD SCI USA, V82, P3998, DOI 10.1073/pnas.82.12.3998; TURRENS JF, 1989, BIOCHEM J, V259, P363, DOI 10.1042/bj2590363; Van Der Heyden N, 2000, MOL BIOCHEM PARASIT, V105, P237, DOI 10.1016/S0166-6851(99)00184-X; VOGEL HJ, 1952, J AM CHEM SOC, V74, P109, DOI 10.1021/ja01121a025; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; World Health Organization, 2012, EP BURD DIS	108	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7767	7790		10.1074/jbc.M114.574525	http://dx.doi.org/10.1074/jbc.M114.574525			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623067	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000351613600037
J	Sun, GQ; Yu, X; Bao, C; Wang, L; Li, M; Gan, JH; Qu, D; Ma, JB; Chen, L				Sun, Guiqin; Yu, Xiang; Bao, Celimuge; Wang, Lei; Li, Meng; Gan, Jianhua; Qu, Di; Ma, Jinbiao; Chen, Li			Identification and Characterization of a Novel Prokaryotic Peptide N-GLYCOSIDASE FROM ELIZABETHKINGIA MENINGOSEPTICA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Crystal Structure; Enzyme; Glycoprotein; N-Linked Glycosylation; Peptide:N-Glycosidase (PNGase); PNGase F; Glycosylation; Deglycosylation; Glycoprotein; Crystal Structure	PEPTIDE-N-4-(N-ACETYL-BETA-D-GLUCOSAMINYL)ASPARAGINE AMIDASE-F; MASS-SPECTROMETRY; BINDING MODULE; PNGASE-F; GLYCANASE; CELLS; OLIGOSACCHARIDES; DEGLYCOSYLATION; DEGRADATION; MATRIX	Background: A putative peptide:N-glycosidase (PNGase), distinct from the well characterized PNGase F, was identified in Elizabethkingia meningoseptica. Results: The candidate protein possesses PNGase activity and a distinct substrate spectrum and domain structure. Conclusion: The candidate (named PNGase F-II) is a novel PNGase. Significance: Characterization of PNGase F-II may provide an alternative tool for glycobiology. Peptide:N-glycosidase (PNGase) F, the first PNGase identified in prokaryotic cells, catalyzes the removal of intact asparagine-linked oligosaccharide chains from glycoproteins and/or glycopeptides. Since its discovery in 1984, PNGase F has remained as the sole prokaryotic PNGase. Recently, a novel gene encoding a protein with a predicted PNGase domain was identified from a clinical isolate of Elizabethkingia meningoseptica. In this study, the candidate protein was expressed in vitro and was subjected to biochemical and structural analyses. The results revealed that it possesses PNGase activity and has substrate specificity different from that of PNGase F. The crystal structure of the protein was determined at 1.9 resolution. Structural comparison with PNGase F revealed a relatively larger glycan-binding groove in the catalytic domain and an additional bowl-like domain with unknown function at the N terminus of the candidate protein. These structural and functional analyses indicated that the candidate protein is a novel prokaryotic N-glycosidase. The protein has been named PNGase F-II.	[Sun, Guiqin; Bao, Celimuge; Wang, Lei; Li, Meng; Qu, Di; Chen, Li] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ & Hlth, Shanghai 200032, Peoples R China; [Yu, Xiang; Ma, Jinbiao] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Gan, Jianhua] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai 200433, Peoples R China; [Sun, Guiqin] Zhejiang Chinese Med Univ, Hangzhou 310053, Zhejiang, Peoples R China	Fudan University; Fudan University; Fudan University; Zhejiang Chinese Medical University	Ma, JB (corresponding author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China.	majb@fudan.edu.cn; lichen_bk@fudan.edu.cn		Chen, Li/0000-0002-7006-4443	Fudan University [EZF101507]; Ministry of Science and Technology of China [2012CB910502, 2011CB966304]; National Science and Technology Major Project of China [2012ZX10003008-010]	Fudan University; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project of China	This work was supported in part by Fudan University Grant EZF101507. A part of this work was performed under the National Science and Technology Major Project of China (2012ZX10003008-010). This work was also supported in part by Ministry of Science and Technology of China Grants 2012CB910502 and 2011CB966304.	Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; ALTMANN F, 1995, GLYCOCONJUGATE J, V12, P84, DOI 10.1007/BF00731873; Berger S, 1995, BIOCHIMIE, V77, P751, DOI 10.1016/0300-9084(96)88193-4; Cai Y, 2013, ANALYST, V138, P6270, DOI 10.1039/c3an01228j; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Chiba Y, 1998, J BIOL CHEM, V273, P26298, DOI 10.1074/jbc.273.41.26298; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan JQ, 1997, J BIOL CHEM, V272, P27058, DOI 10.1074/jbc.272.43.27058; KITAJIMA K, 1995, ARCH BIOCHEM BIOPHYS, V319, P393, DOI 10.1006/abbi.1995.1309; KUHN P, 1994, BIOCHEMISTRY-US, V33, P11699, DOI 10.1021/bi00205a005; KUHN P, 1995, J BIOL CHEM, V270, P29493, DOI 10.1074/jbc.270.49.29493; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORRIS GE, 1994, STRUCTURE, V2, P1049, DOI 10.1016/S0969-2126(94)00108-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; PLUMMER TH, 1987, EUR J BIOCHEM, V163, P167, DOI 10.1111/j.1432-1033.1987.tb10751.x; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; SEKO A, 1991, J BIOL CHEM, V266, P22110; SUGIYAMA K, 1983, BIOCHEM BIOPH RES CO, V112, P155, DOI 10.1016/0006-291X(83)91810-7; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V304, P326, DOI 10.1016/S0006-291X(03)00600-4; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; VANHOEK AN, 1995, BIOCHEMISTRY-US, V34, P2212, DOI 10.1021/bi00007a015; Yang BY, 1996, CARBOHYD RES, V287, P203, DOI 10.1016/0008-6215(96)00073-0; Zhang W, 2011, ANAL CHEM, V83, P4975, DOI 10.1021/ac200753e; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	31	21	23	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7452	7462		10.1074/jbc.M114.605493	http://dx.doi.org/10.1074/jbc.M114.605493			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25614628	Green Published, hybrid			2022-12-28	WOS:000351613600014
J	Genetet, S; Ripoche, P; Le Van Kim, C; Colin, Y; Lopez, C				Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude			Evidence of a Structural and Functional Ammonium Transporter RhBG center dot Anion Exchanger 1 center dot Ankyrin-G Complex in Kidney Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-G; CYTOPLASMIC DOMAIN; CARDIAC-ARRHYTHMIA; CRYSTAL-STRUCTURE; MEMBRANE BILAYER; SODIUM-CHANNEL; IN-SITU; BINDING; BAND-3; IDENTIFICATION	The renal ammonium transporter RhBG and anion exchanger 1 kAE1 colocalize in the basolateral domain of a-intercalated cells in the distal nephron. Although we have previously shown that RhBG is linked to the spectrin-based skeleton through ankyrin-G and that its NH3 transport activity is dependent on this association, there is no evidence for an interaction of kAE1 with this adaptor protein. We report here that the kAE1 cytoplasmic N terminus actually binds to ankyrin-G, both in yeast two-hybrid analysis and by coimmunoprecipitation in situ in HEK293 cells expressing recombinant kAE1. A site-directed mutagenesis study allowed the identification of three dispersed regions on kAE1 molecule linking the third and fourth repeat domains of ankyrin-G. One secondary docking site corresponds to a major interacting loop of the erythroid anion exchanger 1 (eAE1) with ankyrin-R, whereas the main binding region of kAE1 does not encompass any eAE1 determinant. Stopped flow spectrofluorometry analysis of recombinant HEK293 cells revealed that the Cl-/HCO3- exchange activity of a kAE1 protein mutated on the ankyrin-G binding site was abolished. This disruption impaired plasma membrane expression of kAE1 leading to total retention on cytoplasmic structures in polarized epithelial Madin-Darby canine kidney cell transfectants. kAE1 also directly interacts with RhBG without affecting its surface expression and NH3 transport function. This is the first description of a structural and functional RhBGIAEl center dot ankyrin-G complex at the plasma membrane of kidney epithelial cells, comparable with the well known Rh center dot eAE1.ankyrin-R complex in the red blood cell membrane. This renal complex could participate in the regulation of acid-base homeostasis.	[Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude] INSERM, U1134, F-75739 Paris, France; [Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude] Univ Paris Diderot, Sorbonne Paris Cite, UMR S1134, F-75739 Paris, France; [Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude] Inst Natl Transfus Sanguine, F-75739 Paris, France; [Genetet, Sandrine; Ripoche, Pierre; Le Van Kim, Caroline; Colin, Yves; Lopez, Claude] Lab Excellence GR Ex, F-75238 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lopez, C (corresponding author), INSERM, INTS, UMR S1134, 6 Rue Alexandre Cabanel, F-75015 Paris, France.	claude.lopez@inserm.fr	colin, yves/O-1910-2017; le van kim, caroline/O-7030-2017	colin, yves/0000-0001-5196-4254; GENETET, Sandrine/0000-0001-8497-0087; le van kim, caroline/0000-0002-3251-1310	INSERM [U1134]; Institut National de la Transfusion Sanguine; Laboratory of Excellence GR-Ex Grant [ANR-11-LABX-0051]; program Investissements d'Avenir of the French National Research Agency [ANR-11-IDEX-0005-02]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Transfusion Sanguine; Laboratory of Excellence GR-Ex Grant; program Investissements d'Avenir of the French National Research Agency(French National Research Agency (ANR))	This work was supported by institutional funding to the INSERM U1134 and Institut National de la Transfusion Sanguine. This study was supported by Laboratory of Excellence GR-Ex Grant ANR-11-LABX-0051. The labex GR-Ex is funded by the program Investissements d'Avenir of the French National Research Agency through Grant ANR-11-IDEX-0005-02.	Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bustos SP, 2011, BIOCHEM J, V433, P313, DOI 10.1042/BJ20101375; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DING Y, 1994, J BIOL CHEM, V269, P32201; Frumence E, 2013, AM J PHYSIOL-CELL PH, V305, pC654, DOI 10.1152/ajpcell.00142.2013; Grey JL, 2012, BIOCHEMISTRY-US, V51, P6838, DOI 10.1021/bi300693k; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Li JD, 2010, J BIOL CHEM, V285, P28723, DOI 10.1074/jbc.M110.147868; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Lopez C, 2005, J BIOL CHEM, V280, P8221, DOI 10.1074/jbc.M413351200; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J CELL SCI, V115, P1565; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Pang AJ, 2008, BIOCHEMISTRY-US, V47, P4510, DOI 10.1021/bi702149b; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Shirahata E, 2006, J NEUROPHYSIOL, V96, P1347, DOI 10.1152/jn.01264.2005; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sohet F, 2008, J BIOL CHEM, V283, P26557, DOI 10.1074/jbc.M803120200; SRINIVASAN Y, 1992, J BIOL CHEM, V267, P7483; Su Y, 2015, J AM SOC NEPHROL, V26, P400, DOI 10.1681/ASN.2013101063; Thevananther S, 1998, J BIOL CHEM, V273, P23952, DOI 10.1074/jbc.273.37.23952; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; WANG CC, 1995, J BIOL CHEM, V270, P17892, DOI 10.1074/jbc.270.30.17892; Williamson RC, 2008, J CELL SCI, V121, P3422, DOI 10.1242/jcs.035584; Zhang DC, 2000, BLOOD, V96, P2925; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	51	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6925	6936		10.1074/jbc.M114.610048	http://dx.doi.org/10.1074/jbc.M114.610048			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25616663	Green Published, hybrid			2022-12-28	WOS:000350991500027
J	Rosenberg, J; Dickmanns, A; Neumann, P; Gunka, K; Arens, J; Kaever, V; Stulke, J; Ficner, R; Commichau, FM				Rosenberg, Jonathan; Dickmanns, Achim; Neumann, Piotr; Gunka, Katrin; Arens, Johannes; Kaever, Volkhard; Stuelke, Joerg; Ficner, Ralf; Commichau, Fabian M.			Structural and Biochemical Analysis of the Essential Diadenylate Cyclase CdaA from Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-AMP; PROTEIN HOMOLOGY DETECTION; BACILLUS-SUBTILIS; CHECKPOINT PROTEIN; DNA INTEGRITY; IDENTIFICATION; GMP; BACTERIA; CAMP; ANTIBIOTICS	The recently identified second messenger cyclic di-AMP (c-di-AMP) is involved in several important cellular processes, such as cell wall metabolism, maintenance of DNA integrity, ion transport, transcription regulation, and allosteric regulation of enzyme function. Interestingly, c-di-AMP is essential for growth of the Gram-positive model bacterium Bacillus subtilis. Although the genome of B. subtilis encodes three c-di-AMPproducing diadenlyate cyclases that can functionally replace each other, the phylogenetically related human pathogens like Listeria nionocytogenes and Staphylococcus aureus possess only one enzyme, the diadenlyate cydase CdaA. Because CdaA is also essential for growth of these bacteria, the enzyme is a promising target for the development of novel antibiotics. Here we present the first crystal structure of the L. monocytogenes CdaA diadenylate cydase domain that is conserved in many human pathogens. Moreover, biochemical characterization of the cyclase revealed an unusual metal cofactor requirement.	[Rosenberg, Jonathan; Gunka, Katrin; Stuelke, Joerg; Commichau, Fabian M.] Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Dickmanns, Achim; Neumann, Piotr; Arens, Johannes; Ficner, Ralf] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Struct Biol, D-37077 Gottingen, Germany; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-30625 Hannover, Germany	University of Gottingen; University of Gottingen; Hannover Medical School	Commichau, FM (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37077 Gottingen, Germany.	fcommic1@gwdg.de	Stülke, Jörg/AAD-1600-2021; Kaever, Volkhard/G-3280-2013; Commichau, Fabian/A-9664-2018	Stulke, Jorg/0000-0001-5881-5390; Commichau, Fabian/0000-0003-0323-7479	Deutsche Forschungsgemeinschaft (DFG) [SFB 860]; DFG [CO 1139/1-1]; Fonds der Chemischen Industrie; Max-Buchner-Forschungsstiftung [MBFSt-Kennziffer 3381]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Max-Buchner-Forschungsstiftung	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB 860 (to R. F. and J. S.) and by grants of the DFG (CO 1139/1-1), the Fonds der Chemischen Industrie, and the Max-Buchner-Forschungsstiftung (MBFSt-Kennziffer 3381) (to F. M. C.).	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agranoff DD, 1998, MOL MICROBIOL, V28, P403, DOI 10.1046/j.1365-2958.1998.00790.x; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bassetti M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-22; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Bi WL, 1997, NUCLEIC ACIDS RES, V25, P2949, DOI 10.1093/nar/25.14.2949; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Bumann D, 2008, CURR OPIN MICROBIOL, V11, P387, DOI 10.1016/j.mib.2008.08.002; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; de Alda JAGO, 2000, J BACTERIOL, V182, P3839, DOI 10.1128/JB.182.13.3839-3842.2000; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Gao A, 2014, NAT CHEM BIOL, V10, P787, DOI [10.1038/NCHEMBIO.1607, 10.1038/nchembio.1607]; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gundlach J, 2015, J BIOL CHEM, V290, P3069, DOI 10.1074/jbc.M114.619619; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; Mehne FMP, 2014, J BIOL CHEM, V289, P21098, DOI 10.1074/jbc.M114.562066; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Merzbacher M, 2004, EUR J BIOCHEM, V271, P367, DOI 10.1046/j.1432-1033.2003.03935.x; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sambrook J., 2001, MOL CLONING LAB MANU; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song JH, 2005, MOL CELLS, V19, P365; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Tschowri N, 2014, CELL, V158, P1136, DOI 10.1016/j.cell.2014.07.022; Underwood AJ, 2014, J MICROBIOL METH, V107, P58, DOI 10.1016/j.mimet.2014.08.026; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zheng C, 2013, ENZYME MICROB TECH, V52, P319, DOI 10.1016/j.enzmictec.2013.03.007; Zheng Y, 2014, CHEM COMMUN, V50, P11234, DOI 10.1039/c4cc02916j; Zhou J, 2014, ANAL CHEM, V86, P2412, DOI 10.1021/ac403203x	70	44	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6596	6606		10.1074/jbc.M114.630418	http://dx.doi.org/10.1074/jbc.M114.630418			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605729	hybrid, Green Published			2022-12-28	WOS:000350732500061
J	Pandey, VG; Jain, S; Rana, A; Puri, N; Arudra, KC; Mopidevi, B; Kaw, M; Nasjletti, A; Kumar, A				Pandey, Varunkumar G.; Jain, Sudhir; Rana, Anita; Puri, Nitin; Arudra, Krishna C.; Mopidevi, Brahmaraju; Kaw, Meenakshi; Nasjletti, Alberto; Kumar, Ashok			Dexamethasone Promotes Hypertension by Allele-specific Regulation of the Human Angiotensinogen Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; TRANSGENIC MICE; C/EBP BETA; POLYMORPHISMS; RENIN; TRANSCRIPTION; HERITABILITY; PREECLAMPSIA; INDUCTION; SECRETION	The human angiotensinogen (hAGT) gene has polymorphisms in its 2.5-kb promoter that form two haplotype (Hap) blocks: -6A/G (-1670A/G, -1562C/T, and -1561T/C) and -217A/G (-532T/C, -793A/G, -1074T/C, and -1178G/A). Hap -6A/-217A is associated with human hypertension, whereas Hap -6G/-217G reduces cardiovascular risk. Hap -6A/-217A has increased promoter activity with enhanced transcription factor binding, including to the glucocorticoid receptor (GR). Glucocorticoid therapy frequently causes hypertension, the mechanisms for which are incompletely understood. We have engineered double transgenic (TG) mice containing the human renin gene with either Hap of the hAGT gene and examined the physiological significance of glucocorticoid-mediated allele-specific regulation of the hAGT gene. We have also studied the consequential effects on the renin angiotensin system and blood pressure. TG mice with Hap -6A and -6G were treated with and without a low dose of a GR agonist, dexamethasone (2.5 mu g/ml), for 72 h. We found greater chromatin-GR binding with increased GR agonist-induced hAGT expression in liver and renal tissues of Hap -6A mice. Additionally, dexamethasone treatment increased circulating hAGT and angiotensin II levels in Hap -6A mice, as compared with -6G mice. Importantly, GR agonist significantly increased blood pressure and redox markers in TG mice with Hap-6A of the hAGT gene. Taken together, our results show, for the first time, that glucocorticoids affect hAGT expression in a haplotype-dependent fashion with SNPs in Hap -6A favoring agonist-induced GR binding. This leads to increased expression of the hAGT, up-regulation of the renin angiotensin system, and increased blood pressure and oxidative stress in Hap -6A mice.	[Pandey, Varunkumar G.; Jain, Sudhir; Rana, Anita; Puri, Nitin; Mopidevi, Brahmaraju; Kaw, Meenakshi; Nasjletti, Alberto; Kumar, Ashok] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Arudra, Krishna C.] Univ Toledo, Coll Med, Dept Pathol, Toledo, OH 43614 USA; [Pandey, Varunkumar G.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	University of Toledo; University of Toledo; New York Medical College	Kumar, A (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Rm 351,3000 Arlington Ave,MS 1008,Hlth Sci Campus, Toledo, OH 43614 USA.	ashok.kumar2@utoledo.edu	Mopidevi, Brahmaraju/D-6003-2015	Mopidevi, Brahmaraju/0000-0003-1231-7796	National Institutes of Health [HL81752, HL105113, HL092558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081752, R01HL105113, R01HL092558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81752, HL105113, and HL092558 (to A. K.).	Aubert J, 1997, BIOCHEM J, V328, P701, DOI 10.1042/bj3280701; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; CLOUSTON WM, 1989, EMBO J, V8, P3337, DOI 10.1002/j.1460-2075.1989.tb08495.x; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; GOULD AB, 1971, CARDIOVASC RES, V5, P86, DOI 10.1093/cvr/5.1.86; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; HACKENTHAL E, 1993, J STEROID BIOCHEM, V45, P33, DOI 10.1016/0960-0760(93)90119-H; Hottenga JJ, 2005, TWIN RES HUM GENET, V8, P499, DOI 10.1375/183242705774310123; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Jain S, 2005, J MOL MED, V83, P121, DOI 10.1007/s00109-004-0621-5; Jain S, 2010, J BIOL CHEM, V285, P41172, DOI 10.1074/jbc.M110.167585; Jain S, 2008, AM J PHYSIOL-REG I, V295, pR1849, DOI 10.1152/ajpregu.90637.2008; Jenkins LD, 2008, REPROD SCI, V15, P696, DOI 10.1177/1933719108316984; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; KLETT C, 1992, ENDOCRINOLOGY, V130, P3660, DOI 10.1210/en.130.6.3660; Kupper N, 2005, HYPERTENSION, V45, P80, DOI 10.1161/01.HYP.0000149952.84391.54; MANTERO F, 1992, J STEROID BIOCHEM, V43, P409, DOI 10.1016/0960-0760(92)90077-V; Markovic D, 2005, HUM HERED, V60, P89, DOI 10.1159/000088657; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matsuno F, 1996, J BIOCHEM-TOKYO, V119, P524; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; MATTSON DL, 1991, AM J PHYSIOL, V260, pR1200, DOI 10.1152/ajpregu.1991.260.6.R1200; Moritz KM, 2002, ENDOCRINOLOGY, V143, P4455, DOI 10.1210/en.2002-220534; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Suh DS, 1997, MOL ENDOCRINOL, V11, P1822, DOI 10.1210/me.11.12.1822; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; Watkins WS, 2010, J HYPERTENS, V28, P65, DOI 10.1097/HJH.0b013e328332031a	28	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5749	5758		10.1074/jbc.M114.601922	http://dx.doi.org/10.1074/jbc.M114.601922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568318	hybrid, Green Published			2022-12-28	WOS:000350044200042
J	Yuan, SF; Wu, TH; Lee, HL; Hsieh, HY; Lin, WL; Yang, B; Chang, CK; Li, Q; Gao, J; Huang, CH; Ho, MC; Guo, RT; Liang, PH				Yuan, Shuo-Fu; Wu, Tzu-Hui; Lee, Hsiao-Lin; Hsieh, Han-Yu; Lin, Wen-Ling; Yang, Barbara; Chang, Chih-Kang; Li, Qian; Gao, Jian; Huang, Chun-Hsiang; Ho, Meng-Chiao; Guo, Rey-Ting; Liang, Po-Huang			Biochemical Characterization and Structural Analysis of a Bifunctional Cellulase/Xylanase from Clostridium thermocellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROLASE FAMILY 5; SUBSTRATE-SPECIFICITY; THERMOTOGA-MARITIMA; CRYSTAL-STRUCTURE; GLYCOSYL HYDROLASES; ENDOGLUCANASE; COMPLEX; POLYSACCHARIDES; CLASSIFICATION; CELLOTETRAOSE	We expressed an active form of CtCel5E (a bifunctional cellulase/xylanase from Clostridium thermocellum), performed biochemical characterization, and determined its apo- and ligand-bound crystal structures. From the structures, Asn-93, His-168, His-169, Asn-208, Trp-347, and Asn-349 were shown to provide hydrogen-bonding/hydrophobic interactions with both ligands. Compared with the structures of TmCel5A, a bifunctional cellulase/mannanase homolog from Thermotoga maritima, a flexible loop region in CtCel5E is the key for discriminating substrates. Moreover, site-directed mutagenesis data confirmed that His-168 is essential for xylanase activity, and His-169 is more important for xylanase activity, whereas Asn-93, Asn-208, Tyr-270, Trp-347, and Asn-349 are critical for both activities. In contrast, F267A improves enzyme activities.	[Lee, Hsiao-Lin; Lin, Wen-Ling; Chang, Chih-Kang; Ho, Meng-Chiao; Liang, Po-Huang] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Yuan, Shuo-Fu; Hsieh, Han-Yu; Yang, Barbara; Ho, Meng-Chiao; Liang, Po-Huang] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Wu, Tzu-Hui] Natl Taiwan Univ, Inst Biotechnol, Taipei 10617, Taiwan; [Li, Qian; Gao, Jian; Huang, Chun-Hsiang; Guo, Rey-Ting] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Ind Enzymes Natl Engn Lab, Tianjin 300308, Peoples R China	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Ho, MC (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan.	joeho@gate.sinica.edu.tw; guo_rt@tib.cas.cn; phliang@gate.sinica.edu.tw	Liang, Po-Huang/H-6610-2015; Ho, Meng-Chiao/H-2448-2015	Liang, Po-Huang/0000-0003-1207-5256; Ho, Meng-Chiao/0000-0002-5424-4524; Guo, Rey-Ting/0000-0003-2942-7246; Wu, Tzu-Hui/0000-0001-6926-5814; LEE, Hsiao-Lin/0000-0002-4828-3383; Yuan, Shuo-Fu/0000-0002-5530-8702	National Science Council, Taiwan [101-3113-P-008-001]; National Core Facility Program for Biotechnology, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Core Facility Program for Biotechnology, Taiwan	This work was supported by National Science Council, Taiwan, Grant 101-3113-P-008-001. Portions of this research were carried out at the National Synchrotron Radiation Research Center, a national user facility supported by the National Science Council of Taiwan. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Core Facility Program for Biotechnology, Taiwan.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Chang JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-53; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GILKES NR, 1991, EUR J BIOCHEM, V202, P367, DOI 10.1111/j.1432-1033.1991.tb16384.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Karita S, 1996, J FERMENT BIOENG, V81, P553, DOI 10.1016/0922-338X(96)81479-6; Lee HL, 2012, PROTEIN ENG DES SEL, V25, P733, DOI 10.1093/protein/gzs073; Lee HL, 2011, BIORESOURCE TECHNOL, V102, P3973, DOI 10.1016/j.biortech.2010.11.114; Lo Leggio L, 2002, FEBS LETT, V523, P103, DOI 10.1016/S0014-5793(02)02954-X; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notenboom V, 1998, BIOCHEMISTRY-US, V37, P4751, DOI 10.1021/bi9729211; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Schagerlof U, 2007, BIOMACROMOLECULES, V8, P2358, DOI 10.1021/bm0701200; Taylor EJ, 2005, J BIOL CHEM, V280, P32761, DOI 10.1074/jbc.M506580200; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Wang HM, 2009, BIOTECHNOL PROGR, V25, P1582, DOI 10.1002/btpr.274; Wu TH, 2011, BBA-PROTEINS PROTEOM, V1814, P1832, DOI 10.1016/j.bbapap.2011.07.020; YAGUE E, 1990, GENE, V89, P61, DOI 10.1016/0378-1119(90)90206-7; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhang ZQ, 2007, ANAL BIOCHEM, V371, P118, DOI 10.1016/j.ab.2007.07.003	31	47	48	1	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5739	5748		10.1074/jbc.M114.604454	http://dx.doi.org/10.1074/jbc.M114.604454			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575592	Green Published, hybrid			2022-12-28	WOS:000350044200041
J	Faust, JE; Desai, T; Verma, A; Ulengin, I; Sun, TL; Moss, TJ; Betancourt-Solis, MA; Huang, HW; Lee, T; McNew, JA				Faust, Joseph E.; Desai, Tanvi; Verma, Avani; Ulengin, Idil; Sun, Tzu-Lin; Moss, Tyler J.; Betancourt-Solis, Miguel A.; Huang, Huey W.; Lee, Tina; McNew, James A.			The Atlastin C-terminal Tail Is an Amphipathic Helix That Perturbs the Bilayer Structure during Endoplasmic Reticulum Homotypic Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER NETWORK FORMATION; MEMBRANE-FUSION; GTPASE ATLASTIN; REQUIRES; PROTEIN; RECONSTITUTION; DIMERIZATION; MECHANISMS; EXOCYTOSIS; LIPOSOMES	Fusion of tubular membranes is required to form three-way junctions found in reticular subdomains of the endoplasmic reticulum. The large GTPase Atlastin has recently been shown to drive endoplasmic reticulum membrane fusion and three-way junction formation. The mechanism of Atlastin-mediated membrane fusion is distinct from SNARE-mediated membrane fusion, and many details remain unclear. In particular, the role of the amphipathic C-terminal tail of Atlastin is still unknown. We found that a peptide corresponding to the Atlastin C-terminal tail binds to membranes as a parallel alpha helix, induces bilayer thinning, and increases acyl chain disorder. The function of the C-terminal tail is conserved in human Atlastin. Mutations in the C-terminal tail decrease fusion activity in vitro, but not GTPase activity, and impair Atlastin function in vivo. In the context of unstable lipid bilayers, the requirement for the C-terminal tail is abrogated. These data suggest that the C-terminal tail of Atlastin locally destabilizes bilayers to facilitate membrane fusion.	[Faust, Joseph E.; Desai, Tanvi; Verma, Avani; Moss, Tyler J.; Betancourt-Solis, Miguel A.; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Ulengin, Idil; Lee, Tina] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Sun, Tzu-Lin; Huang, Huey W.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Rice University; Carnegie Mellon University; Rice University	McNew, JA (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St Rice Univ,MS601, Houston, TX 77005 USA.	mcnew@rice.edu	McNew, James/AAV-4911-2020; Desai, Tanvi/AAH-7038-2021; McNew, James/ABD-8081-2020	McNew, James/0000-0001-8459-3664; Betancourt-Solis, Miguel Alberto/0000-0001-8041-4120; Desai, Tanvi/0000-0003-2571-5910; Faust, Joseph/0000-0002-2183-8529	National Institutes of Health [GM55203, GM107285, GM101377]; Robert A. Welch Foundation [C-0991]; Virginia and L. E. Simmons Family Foundation; Hamill Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101377, R01GM055203, R01GM107285] Funding Source: NIH RePORTER; Direct For Education and Human Resources [0966303] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Virginia and L. E. Simmons Family Foundation; Hamill Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	Supported by National Institutes of Health Grant GM55203 and Robert A. Welch Foundation Grant C-0991.; Supported by National Institutes of Health Grant GM107285.; Supported by National Institutes of Health Grant GM101377, by The Virginia and L. E. Simmons Family Foundation, and by The Hamill Foundation. To whom correspondence should be addressed: Dept. of Biochemistry and Cell Biology, Rice University, 6100 Main St. Rice University, MS601, Houston, TX 77005. Tel.: 713-348-3133; E-mail: mcnew@rice.edu.	Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Brugger B, 2014, ANNU REV BIOCHEM, V83, P79, DOI 10.1146/annurev-biochem-060713-035324; Byrnes LJ, 2013, EMBO J, V32, P369, DOI 10.1038/emboj.2012.353; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; English AR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013227; Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Graf ER, 2012, J NEUROSCI, V32, P16586, DOI 10.1523/JNEUROSCI.0965-12.2012; Hoff KG, 2009, CHEM BIOL, V16, P1299, DOI 10.1016/j.chembiol.2009.11.011; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Liu TY, 2012, P NATL ACAD SCI USA, V109, pE2146, DOI 10.1073/pnas.1208385109; Mcnew JA, 2008, CHEM REV, V108, P1669, DOI 10.1021/cr0782325; McNew JA, 2013, ANNU REV CELL DEV BI, V29, P529, DOI 10.1146/annurev-cellbio-101512-122328; Morin-Leisk J, 2011, J CELL BIOL, V195, P605, DOI 10.1083/jcb.201105006; Moss TJ, 2011, P NATL ACAD SCI USA, V108, P11133, DOI 10.1073/pnas.1105056108; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pendin D, 2011, P NATL ACAD SCI USA, V108, P16283, DOI 10.1073/pnas.1106421108; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Sun TL, 2013, BIOPHYS J, V104, P1923, DOI 10.1016/j.bpj.2013.03.039; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; WU Y, 1990, BIOPHYS J, V57, P797, DOI 10.1016/S0006-3495(90)82599-6	31	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4772	4783		10.1074/jbc.M114.601823	http://dx.doi.org/10.1074/jbc.M114.601823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555915	Green Published, hybrid			2022-12-28	WOS:000350042000020
J	Fedele, C; Singh, A; Zerlanko, BJ; Iozzo, RV; Languino, LR				Fedele, Carmine; Singh, Amrita; Zerlanko, Brad J.; Iozzo, Renato V.; Languino, Lucia R.			The alpha(v)beta(6) Integrin Is Transferred Intercellularly via Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-V-BETA-6 INTEGRIN; CANCER-CELLS; IN-VIVO; PROSTATE; PROMOTES; MICROVESICLES; IDENTIFICATION; PROLIFERATION; METASTASIS; SECRETION	Exosomes, cell-derived vesicles of endosomal origin, are continuously released in the extracellular environment and play a key role in intercellular crosstalk. In this study, we have investigated whether transfer of integrins through exosomes between prostate cancer (PrCa) cells occurs and whether transferred integrins promote cell adhesion and migration. Among others, we have focused on the alpha(v)beta(6) integrin, which is not detectable in normal human prostate but is highly expressed in human primary PrCa as well as murine PrCa in Pten(pc-/-) mice. After confirming the fidelity of the exosome preparations by electron microscopy, density gradient, and immunoblotting, we determined that the alpha(v)beta(6) integrin is actively packaged into exosomes isolated from PC3 and RWPE PrCa cell lines. We also demonstrate that alpha(v)beta(6) is efficiently transferred via exosomes from a donor cell to an alpha(v)beta(6)-negative recipient cell and localizes to the cell surface. De novo alpha(v)beta(6) expression in an alpha(v)beta(6)-negative recipient cell is not a result of a change in mRNA levels but is a consequence of exosome-mediated transfer of this integrin between different PrCa cells. Recipient cells incubated with exosomes containing alpha(v)beta(6) migrate on an alpha(v)beta(6) specific substrate, latency-associated peptide-TGF beta, to a greater extent than cells treated with exosomes in which alpha(v)beta(6) is stably or transiently down-regulated by shRNA or siRNA, respectively. Overall, this study shows that exosomes from PrCa cells may contribute to a horizontal propagation of integrin-associated phenotypes, which would promote cell migration, and consequently, metastasis in a paracrine fashion.	[Fedele, Carmine; Singh, Amrita; Zerlanko, Brad J.; Languino, Lucia R.] Thomas Jefferson Univ, Prostate Canc Discovery & Dev Program, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Fedele, Carmine; Singh, Amrita; Zerlanko, Brad J.; Iozzo, Renato V.; Languino, Lucia R.] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Languino, LR (corresponding author), 233 S 10th St,BLSB 506, Philadelphia, PA 19107 USA.	Lucia.Languino@jefferson.edu	Iozzo, Renato/AAS-1980-2020; Singh, Amrita/J-3106-2019	Languino, Lucia/0000-0001-9011-7031; Singh, Amrita/0000-0001-8023-0807	NCI, National Institutes of Health [P30CA056036]; NATIONAL CANCER INSTITUTE [R01CA089720, R56CA089720, P30CA056036, R01CA109874, P01CA140043] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bodil Tuma for assistance in the transmission electron microscopy analysis; and A. Sayeed, H. Lu, T. De Angelis, L. Riddell, A. N. Duffy, and R. M. De Rita (from the Languino laboratory); Jeffrey L. Benovic; K. Komolov, and X. Tifan (from the J. L. Benovic laboratory); M. J. Root; and C. Wirblich (from the M. J. Schnell laboratory) for constructive suggestions. Also, we are thankful to Y. Covarrubias and J. H. Keen for constructive suggestions and technical support in bioimaging experiments. The Sidney Kimmel Cancer Center Bioimaging and Flow Cytometry Facilities were supported by the NCI, National Institutes of Health, under Award P30CA056036. We also thank S. Violette and P. Weinreb for providing antibodies to alpha<INF>v</INF>beta<INF>6</INF>.	Agrez M, 1999, INT J CANCER, V81, P90, DOI 10.1002/(SICI)1097-0215(19990331)81:1<90::AID-IJC16>3.0.CO;2-K; AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; Atay S, 2014, P NATL ACAD SCI USA, V111, P711, DOI 10.1073/pnas.1310501111; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Bijnsdorp Irene V, 2013, J Extracell Vesicles, V2, DOI 10.3402/jev.v2i0.22097; Brocks D, 2014, CELL REP, V8, P798, DOI 10.1016/j.celrep.2014.06.053; Chen X, 2011, J LEUKOCYTE BIOL, V90, P751, DOI 10.1189/jlb.1210696; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Deng XY, 2014, CANCER TREAT REV, V40, P730, DOI 10.1016/j.ctrv.2014.04.003; Dixit RB, 1996, J BIOL CHEM, V271, P25976, DOI 10.1074/jbc.271.42.25976; Dutta A, 2014, CANCER RES, V74, P1598, DOI 10.1158/0008-5472.CAN-13-1796; Garlick DS, 2012, AM J TRANSL RES, V4, P165; Gerlinger M, 2015, EUR UROL, V67, P729, DOI 10.1016/j.eururo.2014.04.014; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Hecht JL, 2008, APPL IMMUNOHISTO M M, V16, P543, DOI 10.1097/PAI.0b013e31816bc5ee; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Lee HD, 2014, EUR J IMMUNOL, V44, P1156, DOI 10.1002/eji.201343660; Li XW, 2003, J BIOL CHEM, V278, P41646, DOI 10.1074/jbc.M306274200; Martin SK, 2012, ONCOL REP, V28, P409, DOI 10.3892/or.2012.1832; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Ports MO, 2009, CANCER RES, V69, P5007, DOI 10.1158/0008-5472.CAN-09-0354; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; Sayeed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076513; Sheppard D, 2000, MATRIX BIOL, V19, P203, DOI 10.1016/S0945-053X(00)00065-2; Shin SJ, 2013, P NATL ACAD SCI USA, V110, P19414, DOI 10.1073/pnas.1309720110; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thompson CA, 2013, J BIOL CHEM, V288, P10093, DOI 10.1074/jbc.C112.444562; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Wu XY, 2013, ENDOCR-RELAT CANCER, V20, pR155, DOI 10.1530/ERC-12-0285; Yang GY, 2008, CANCER SCI, V99, P879, DOI 10.1111/j.1349-7006.2008.00762.x	42	115	117	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4545	4551		10.1074/jbc.C114.617662	http://dx.doi.org/10.1074/jbc.C114.617662			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25568317	Green Published, hybrid			2022-12-28	WOS:000350042000002
J	Li, K; Jia, R; Li, MH; Zheng, YM; Miao, CH; Yao, YF; Ji, HL; Geng, YQ; Qiao, WT; Albritton, LM; Liang, C; Liu, SL				Li, Kun; Jia, Rui; Li, Minghua; Zheng, Yi-Min; Miao, Chunhui; Yao, Yunfang; Ji, Hong-Long; Geng, Yunqi; Qiao, Wentao; Albritton, Lorraine M.; Liang, Chen; Liu, Shan-Lu			A Sorting Signal Suppresses IFITM1 Restriction of Viral Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED TRANSMEMBRANE PROTEIN-3; N-TERMINAL REGION; INFLUENZA-A VIRUS; WEST NILE VIRUS; DENGUE VIRUS; ANTIVIRAL ACTIVITY; CYTOPLASMIC TAIL; S-PALMITOYLATION; LOW PH; INFECTION	The interferon-induced transmembrane proteins (IFITMs) broadly inhibit virus infections, particularly at the viral entry level. However, despite this shared ability to inhibit fusion, IFITMs differ in the potency and breadth of viruses restricted, an anomaly that is not fully understood. Here, we show that differences in the range of viruses restricted by IFITM1 are regulated by a C-terminal non-canonical dibasic sorting signal KRXX that suppresses restriction of some viruses by governing its intracellular distribution. Replacing the two basic residues with alanine (KR/AA) increased restriction of jaagsiekte sheep retrovirus and 10A1 amphotropic murine leukemia virus. Deconvolution microscopy revealed an altered subcellular distribution for KR/AA, with fewer molecules in LAMP1-positive lysosomes balanced by increased levels in CD63-positive multivesicular bodies, where jaagsiekte sheep retrovirus pseudovirions are colocalized. IFITM1 binds to cellular adaptor protein complex 3 (AP-3), an association that is lost when the dibasic motif is altered. Although knockdown of AP-3 itself decreases some virus entry, expression of parental IFITM1, but not its KR/AA mutant, potentiates inhibition of viral infections in AP-3 knockdown cells. By using the substituted cysteine accessibility method, we provide evidence that IFITM1 adopts more than one membrane topology co-existing in cellular membranes. Because the C-terminal dibasic sorting signal is unique to human IFITM1, our results provide novel insight into understanding the species-and virus-specific antiviral effect of IFITMs.	[Liu, Shan-Lu] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Jia, Rui; Yao, Yunfang; Geng, Yunqi; Qiao, Wentao] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Biotechnol, Tianjin 300071, Peoples R China; [Jia, Rui; Yao, Yunfang; Geng, Yunqi; Qiao, Wentao] Nankai Univ, Coll Life Sci, Key Lab Microbial Funct Genom Tianjin, Tianjin 300071, Peoples R China; [Ji, Hong-Long] Univ Texas Hlth Sci Ctr, Texas Lung Injury Inst, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Albritton, Lorraine M.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Liang, Chen] McGill AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Liang, Chen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	University of Missouri System; University of Missouri Columbia; Nankai University; Nankai University; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Tennessee System; University of Tennessee Health Science Center; Lady Davis Institute; McGill University; McGill University	Liu, SL (corresponding author), Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	liushan@missouri.edu	Liu, Shan-Lu/L-5923-2016; Li, Minghua/M-8776-2016; Li, Kun/E-5255-2017	Liu, Shan-Lu/0000-0003-1620-3817; Li, Kun/0000-0002-8582-2913; Jia, Rui/0000-0002-1797-4069; Miao, Chunhui/0000-0003-4503-2180	National Institutes of Health [AI 105584, AI 112381, AI 109464]; Canadian Institutes of Health Research [MOP-77649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112381, R56AI107095, R21AI105584, R21AI109464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 105584, AI 112381, and AI 109464 (to S. L. L.). This work was also supported by Canadian Institutes of Health Research Grant MOP-77649 (to C. L. and S. L. L.).	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Bailey CC, 2013, J BIOL CHEM, V288, P32184, DOI 10.1074/jbc.M113.514356; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Bertrand P, 2008, J VIROL, V82, P2555, DOI 10.1128/JVI.01853-07; Bogdanov M, 2010, METHODS MOL BIOL, V619, P79, DOI 10.1007/978-1-60327-412-8_5; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Cote M, 2008, J VIROL, V82, P9023, DOI 10.1128/JVI.00648-08; Cote M, 2008, J VIROL, V82, P2543, DOI 10.1128/JVI.01852-07; Cote M, 2012, J BIOL CHEM, V287, P7640, DOI 10.1074/jbc.M111.334722; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; Janaka SK, 2013, J VIROL, V87, P12805, DOI 10.1128/JVI.01847-13; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kreis TE, 1995, ANNU REV CELL DEV BI, V11, P677, DOI 10.1146/annurev.cb.11.110195.003333; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Williams DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110096; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Zhou HX, 2010, J VIROL, V84, P3542, DOI 10.1128/JVI.02570-09	46	28	28	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4248	4259		10.1074/jbc.M114.630780	http://dx.doi.org/10.1074/jbc.M114.630780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25527505	Green Published, hybrid			2022-12-28	WOS:000349458400035
J	Tan, FZ; Qian, C; Tang, K; Abd-Allah, SM; Jing, NH				Tan, Fangzhi; Qian, Cheng; Tang, Ke; Abd-Allah, Saber Mohamed; Jing, Naihe			Inhibition of Transforming Growth Factor beta (TGF-beta) Signaling can Substitute for Oct4 Protein in Reprogramming and Maintain Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; MOUSE SOMATIC-CELLS; GROUND-STATE; EXTRACELLULAR-MATRIX; PRIMITIVE ENDODERM; INDUCTION; EPIBLAST; DIFFERENTIATION; FIBROBLASTS; PATHWAY	Mouse pluripotent stem cells (PSCs), such as ES cells and induced PSCs (iPSCs), are an excellent system to investigate the molecular and cellular mechanisms involved in early embryonic development. The signaling pathways orchestrated by leukemia inhibitor factor/STAT3, Wnt/beta-catenin, and FGF/MEK/ERK play key roles in the generation of pluripotency. However, the function of TGF-beta signaling in this process remains elusive. Here we show that inhibiting TGF-beta signaling with its inhibitor SB431542 can substitute for Oct4 during reprogramming. Moreover, inhibiting TGF-beta signaling can sustain the pluripotency of iPSCs and ES cells through modulating FGF/MEK/ERK signaling. Therefore, this study reveals a novel function of TGF-beta signaling inhibition in the generation and maintenance of PSCs.	[Tan, Fangzhi; Qian, Cheng; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China; [Abd-Allah, Saber Mohamed] Beni Suef Univ, Fac Vet Med, Dept Theriogenol, Bani Suwayf 62511, Egypt	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanchang University; Egyptian Knowledge Bank (EKB); Beni Suef University	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	njing@sibcb.ac.cn			Chinese Academy of Sciences [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [91219303, 31430058]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010201, by National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500, and by National Natural Science Foundation of China Grants 91219303 and 31430058.	Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Du J, 2014, CELL SIGNAL, V26, P2107, DOI 10.1016/j.cellsig.2014.06.002; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Galvin KE, 2010, J BIOL CHEM, V285, P19747, DOI 10.1074/jbc.M109.077347; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hassani SN, 2014, STEM CELL REV REP, V10, P16, DOI 10.1007/s12015-013-9473-0; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jiao J, 2013, STEM CELLS, V31, P729, DOI 10.1002/stem.1318; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; Moustakas A, 2001, J CELL SCI, V114, P4359; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Pangas SA, 2000, TRENDS ENDOCRIN MET, V11, P309, DOI 10.1016/S1043-2760(00)00294-0; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhang T, 2013, J BIOL CHEM, V288, P6166, DOI 10.1074/jbc.M112.418376	52	31	34	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4500	4511		10.1074/jbc.M114.609016	http://dx.doi.org/10.1074/jbc.M114.609016			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548277	Green Published, hybrid			2022-12-28	WOS:000349458400055
J	Gill-Thind, JK; Dhankher, P; D'Oyley, JM; Sheppard, TD; Millar, NS				Gill-Thind, JasKiran K.; Dhankher, Persis; D'Oyley, Jarryl M.; Sheppard, Tom D.; Millar, Neil S.			Structurally Similar Allosteric Modulators of alpha 7 Nicotinic Acetylcholine Receptors Exhibit Five Distinct Pharmacological Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; TRANSMEMBRANE SITE; CHANNEL DOMAIN; AMINO-ACIDS; IN-VITRO; AGONIST; SUBUNIT; EXPRESSION; BINDING; DESENSITIZATION	Activation of nicotinic acetylcholine receptors (nAChRs) is associated with the binding of agonists such as acetylcholine to an extracellular site that is located at the interface between two adjacent receptor subunits. More recently, there has been considerable interest in compounds, such as positive and negative allosteric modulators (PAMs and NAMs), that are able to modulate nAChR function by binding to distinct allosteric sites. Here we examined a series of compounds differing only in methyl substitution of a single aromatic ring. This series of compounds includes a previously described alpha 7-selective allosteric agonist, cis-cis-4-p-tolyl-3a, 4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4MP-TQS), together with all other possible combinations of methyl substitution at a phenyl ring (18 additional compounds). Studies conducted with this series of compounds have revealed five distinct pharmacological effects on alpha 7 nAChRs. These five effects can be summarized as: 1) nondesensitizing activation (allosteric agonists), 2) potentiation associated with minimal effects on receptor desensitization (type I PAMs), 3) potentiation associated with reduced desensitization (type II PAMs), 4) noncompetitive antagonism (NAMs), and 5) compounds that have no effect on orthosteric agonist responses but block allosteric modulation (silent allosteric modulators (SAMs)). Several lines of experimental evidence are consistent with all of these compounds acting at a common, transmembrane allosteric site. Notably, all of these chemically similar compounds that have been classified as nondesensitizing allosteric agonists or as nondesensitizing (type II) PAMs are cis-cis-diastereoisomers, whereas all of the NAMs, SAMs, and type I PAMs are cis-trans-diastereoisomers. Our data illustrate the remarkable pharmacological diversity of allosteric modulators acting on nAChRs.	[Gill-Thind, JasKiran K.; Millar, Neil S.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Dhankher, Persis; D'Oyley, Jarryl M.; Sheppard, Tom D.] UCL, Dept Chem, London WC1H 0AJ, England	University of London; University College London; University of London; University College London	Millar, NS (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	n.millar@ucl.ac.uk	Sheppard, Tom D./C-2383-2008	Sheppard, Tom D./0000-0002-3455-1164	Biotechnology and Biological Sciences Research Council [BB/F017146/1]; Biotechnology and Biological Sciences Research Council; Eli Lilly; University College London Ph.D. Programme in Drug Discovery; Engineering and Physical Sciences Research Council [EP/E052789/1]; EPSRC [EP/E052789/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eli Lilly(Eli Lilly); University College London Ph.D. Programme in Drug Discovery; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F017146/1.; Supported by a Biotechnology and Biological Sciences Research Council Collaborative Award in Science and Engineering Ph.D. studentship that was co-funded by the Biotechnology and Biological Sciences Research Council and Eli Lilly.; Supported by PhD studentships associated with the University College London Ph.D. Programme in Drug Discovery.; Supported by Engineering and Physical Sciences Research Council Advanced Research Fellowship Grant EP/E052789/1.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; Arias HR, 2010, ADV PROTEIN CHEM STR, V80, P153, DOI [10.1016/S1876-1623(10)80005-7, 10.1016/B978-0-12-381264-3.00005-9]; Baker ER, 2004, MOL PHARMACOL, V65, P453, DOI 10.1124/mol.65.2.453; Becker C, 2004, [No title captured], Patent No. [2004/098600, 2004098600]; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bertrand S, 1997, NEUROREPORT, V8, P3591, DOI 10.1097/00001756-199711100-00034; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Burford NT, 2013, P NATL ACAD SCI USA, V110, P10830, DOI 10.1073/pnas.1300393110; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Cooper ST, 1997, J NEUROCHEM, V68, P2140; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dhankher P, 2014, SYNLETT, V25, P381, DOI 10.1055/s-0033-1340302; Gill JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055047; Gill JK, 2012, MOL PHARMACOL, V81, P710, DOI 10.1124/mol.111.076026; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Harkness PC, 2001, NEUROPHARMACOLOGY, V41, P79, DOI 10.1016/S0028-3908(01)00042-9; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Leonard S, 2006, BIOL PSYCHIAT, V60, P115, DOI 10.1016/j.biopsych.2006.03.054; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lynagh T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00160; Malysz J, 2009, J PHARMACOL EXP THER, V330, P257, DOI 10.1124/jpet.109.151886; Mantione E, 2012, FUTURE MED CHEM, V4, P2217, DOI [10.4155/FMC.12.172, 10.4155/fmc.12.172]; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Ng HJ, 2007, P NATL ACAD SCI USA, V104, P8059, DOI 10.1073/pnas.0701321104; Noblin DJ, 2012, ASSAY DRUG DEV TECHN, V10, P457, DOI 10.1089/adt.2011.443; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pandya AA, 2013, BIOCHEM PHARMACOL, V86, P1054, DOI 10.1016/j.bcp.2013.05.018; Papke RL, 2014, J BIOL CHEM, V289, P4515, DOI 10.1074/jbc.M113.524603; Puinean AM, 2013, J NEUROCHEM, V124, P590, DOI 10.1111/jnc.12029; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; Thakur GA, 2013, J MED CHEM, V56, P8943, DOI 10.1021/jm401267t; Thomsen MS, 2012, CURR DRUG TARGETS, V13, P707, DOI 10.2174/138945012800399035; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809	46	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3552	3562		10.1074/jbc.M114.619221	http://dx.doi.org/10.1074/jbc.M114.619221			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25516597	hybrid, Green Published			2022-12-28	WOS:000349456000029
J	Konitsiotis, AD; Jovanovic, B; Ciepla, P; Spitaler, M; Lanyon-Hogg, T; Tate, EW; Magee, AI				Konitsiotis, Antonio D.; Jovanovic, Biljana; Ciepla, Paulina; Spitaler, Martin; Lanyon-Hogg, Thomas; Tate, Edward W.; Magee, Anthony I.			Topological Analysis of Hedgehog Acyltransferase, a Multipalmitoylated Transmembrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND O-ACYLTRANSFERASES; SONIC-HEDGEHOG; SACCHAROMYCES-CEREVISIAE; LIPID MODIFICATIONS; S-ACYLTRANSFERASES; COMPLETE GENOMES; PALMITOYLATION; MEMBRANE; PREDICTION; CALNEXIN	Hedgehog proteins are secreted morphogens that play critical roles in development and disease. During maturation of the proteins through the secretory pathway, they are modified by the addition of N-terminal palmitic acid and C-terminal cholesterol moieties, both of which are critical for their correct function and localization. Hedgehog acyltransferase(HHAT) is the enzyme in the endoplasmic reticulum that palmitoylates Hedgehog proteins, is a member of a small subfamily of membrane-bound O-acyltransferase proteins that acylate secreted proteins, and is an important drug target in cancer. However, little is known about HHAT structure and mode of function. We show that HHAT is comprised of ten transmembrane domains and two reentrant loops with the critical His and Asp residues on opposite sides of the endoplasmic reticulum membrane. We further show that HHAT is palmitoylated on multiple cytosolic cysteines that maintain protein structure within the membrane. Finally, we provide evidence that mutation of the conserved His residue in the hypothesized catalytic domain results in a complete loss ofHHATpalmitoylation, providing novel insights into how the protein may function in vivo.	[Konitsiotis, Antonio D.; Jovanovic, Biljana; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Mol Med Sect, London SW7 2AZ, England; [Spitaler, Martin] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, FILM, London SW7 2AZ, England; [Ciepla, Paulina; Lanyon-Hogg, Thomas; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; [Ciepla, Paulina; Tate, Edward W.; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Inst Chem Biol, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Tate, EW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.	e.tate@imperial.ac.uk; t.magee@imperial.ac.uk	Magee, Anthony/V-8345-2019	Lanyon-Hogg, Thomas/0000-0002-7092-8096; Spitaler, Martin/0000-0002-8833-638X; Ciepla, Paulina/0000-0002-5139-9635; Tate, Edward/0000-0003-2213-5814	Pancreatic Cancer Research Fund; Cancer Research UK; NHLI Foundation; Imperial College London Institute of Chemical Biology EPSRC Centre for Doctoral Training [EP/F500416/1]; EPSRC [EP/J021199/1] Funding Source: UKRI; MRC [G0400710] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [978583] Funding Source: researchfish; Cancer Research UK [16402] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J021199/1] Funding Source: researchfish; Medical Research Council [G0400710] Funding Source: researchfish	Pancreatic Cancer Research Fund; Cancer Research UK(Cancer Research UK); NHLI Foundation; Imperial College London Institute of Chemical Biology EPSRC Centre for Doctoral Training(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Pancreatic Cancer Research Fund and Cancer Research UK grants (to A. I. M. and E. W. T.).; Supported by a Ph.D. studentship from the NHLI Foundation. Present address: Dept. of Biosciences and Nutrition, Karolinska Institutet, 14157 Huddinge, Sweden.; Supported by a Ph.D. studentship from the Imperial College London Institute of Chemical Biology EPSRC Centre for Doctoral Training (Grant EP/F500416/1).	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Heal WP, 2011, CHEM COMMUN, V47, P4081, DOI 10.1039/c0cc04710d; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; JOSEPH M, 1995, J BIOL CHEM, V270, P19439, DOI 10.1074/jbc.270.33.19439; Konitsiotis AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089899; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Law RJ, 2002, CURR BIOL, V12, pR250, DOI 10.1016/S0960-9822(02)00784-4; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pagac M, 2012, MOL MICROBIOL, V86, P1156, DOI 10.1111/mmi.12047; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rodriguez-Blanco J, 2013, ONCOGENE, V32, P2335, DOI 10.1038/onc.2012.243; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Tsirigos KD, 2012, PROTEOMICS, V12, P2282, DOI 10.1002/pmic.201100495; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037	42	44	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3293	3307		10.1074/jbc.M114.614578	http://dx.doi.org/10.1074/jbc.M114.614578			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505265	Green Published, hybrid			2022-12-28	WOS:000349456000010
J	Woeller, CF; O'Loughlin, CW; Roztocil, E; Feldon, SE; Phipps, RP				Woeller, Collynn F.; O'Loughlin, Charles W.; Roztocil, Elisa; Feldon, Steven E.; Phipps, Richard P.			Salinomycin and Other Polyether Ionophores Are a New Class of Antiscarring Agent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNALING PATHWAY; EXTRACELLULAR-MATRIX; TISSUE-REPAIR; MYOFIBROBLAST; FIBROBLASTS; INHIBITOR; EYE; CONTRACTION; EXPRESSION	Although scarring is a component of wound healing, excessive scar formation is a debilitating condition that results in pain, loss of tissue function, and even death. Many tissues, including the lungs, heart, skin, and eyes, can develop excessive scar tissue as a result of tissue injury, chronic inflammation, or autoimmune disease. Unfortunately, there are few, if any, effective treatments to prevent excess scarring, and new treatment strategies are needed. Using HEK293FT cells stably transfected with a TGF beta-dependent luciferase reporter, we performed a small molecule screen to identify novel compounds with antiscarring activity. We discovered that the polyether ionophore salinomycin potently inhibited the formation of scar-forming myofibroblasts. Salinomycin (250 nM) blocked TGF beta-dependent expression of the cardinal myofibroblast products alpha smooth muscle actin, calponin, and collagen in primary human fibroblasts without causing cell death. Salinomycin blocked phosphorylation and activation of TAK1 and p38, two proteins fundamentally involved in signaling myofibroblast and scar formation. Expression of constitutively active mitogen activated kinase kinase 6, which activates p38 MAPK, attenuated the ability of salinomycin to block myofibroblast formation, demonstrating that salinomycin targets the p38 kinase pathway to disrupt TGF beta signaling. These data identify salinomycin and other polyether ionophores as novel potential antiscarring therapeutics.	[Woeller, Collynn F.; Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; [O'Loughlin, Charles W.; Roztocil, Elisa; Feldon, Steven E.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Dept Environm Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	Richard_Phipps@urmc.rochester.edu	Woeller, Collynn/U-3877-2019	Woeller, Collynn/0000-0001-7197-5057; Feldon, Steven/0000-0003-0603-9312	National Institutes of Health [ES-023032, EY-023239, ES-001247]; Research to Prevent Blindness; Rochester/Finger Lakes Eye and Tissue Bank; NATIONAL EYE INSTITUTE [R01EY023239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, R21ES023032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Rochester/Finger Lakes Eye and Tissue Bank; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES-023032 and EY-023239, and ES-001247. This work was also supported by an unrestricted grant from the Research to Prevent Blindness and by a research grant from the Rochester/Finger Lakes Eye and Tissue Bank.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Antoszczak M, 2014, EUR J MED CHEM, V76, P435, DOI 10.1016/j.ejmech.2014.02.031; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Bourlier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031274; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fan HN, 2013, EUR REV MED PHARMACO, V17, P644; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; George SJ, 2009, J MOL CELL CARDIOL, V46, P610, DOI 10.1016/j.yjmcc.2009.02.008; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; Guo NX, 2011, J BIOL CHEM, V286, P18856, DOI 10.1074/jbc.M110.179317; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Huczynski A, 2012, CHEM BIOL DRUG DES, V79, P235, DOI 10.1111/j.1747-0285.2011.01287.x; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Knirschova R, 2007, FOLIA MICROBIOL, V52, P359, DOI 10.1007/BF02932090; Kuriyan AE, 2008, CURR OPIN OPHTHALMOL, V19, P499, DOI 10.1097/ICU.0b013e3283131557; Kuriyan AE, 2008, THYROID, V18, P911, DOI 10.1089/thy.2007.0325; Kuriyan AE, 2013, INVEST OPHTH VIS SCI, V54, P7370, DOI 10.1167/iovs.13-12741; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Li JH, 2006, AM J PATHOL, V169, P1527, DOI 10.2353/ajpath.2006.060169; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuoka H, 2002, AM J PHYSIOL-LUNG C, V283, pL103, DOI 10.1152/ajplung.00187.2001; Micallef L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S5; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Mortier L, 2005, RAPID COMMUN MASS SP, V19, P533, DOI 10.1002/rcm.1819; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Naujokat C, 2010, MOL MED REP, V3, P555, DOI 10.3892/mmr_00000296; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Schimmer AD, 2012, CL LYMPH MYELOM LEUK, V12, P330, DOI 10.1016/j.clml.2012.05.005; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Smith RS, 1997, AM J PATHOL, V151, P317; Sundaresh V, 2013, J CLIN ENDOCR METAB, V98, P3671, DOI 10.1210/jc.2013-1954; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Usuki J, 2012, J NIPPON MED SCH, V79, P46, DOI 10.1272/jnms.79.46; Wang Y, 2011, MED CHEM, V7, P106, DOI 10.2174/157340611794859307; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Yang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077300; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	54	27	27	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3563	3575		10.1074/jbc.M114.601872	http://dx.doi.org/10.1074/jbc.M114.601872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538236	Green Published, hybrid			2022-12-28	WOS:000349456000030
J	Singh, KK; Lovren, F; Pan, Y; Quan, A; Ramadan, A; Matkar, PN; Ehsan, M; Sandhu, P; Mantella, LE; Gupta, N; Teoh, H; Parotto, M; Tabuchi, A; Kuebler, WM; Al-Omran, M; Finkel, T; Verma, S				Singh, Krishna K.; Lovren, Fina; Pan, Yi; Quan, Adrian; Ramadan, Azza; Matkar, Pratiek N.; Ehsan, Mehroz; Sandhu, Paul; Mantella, Laura E.; Gupta, Nandini; Teoh, Hwee; Parotto, Matteo; Tabuchi, Arata; Kuebler, Wolfgang M.; Al-Omran, Mohammed; Finkel, Toren; Verma, Subodh			The Essential Autophagy Gene ATG7 Modulates Organ Fibrosis via Regulation of Endothelial-to-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Autophagy-related Protein 7 (ATG7); Endothelial Cell; Gene Silencing; Pulmonary Fibrosis; Endothelial-to-mesenchymal Transition	PULMONARY-FIBROSIS; SYSTEMIC-SCLEROSIS; SHEAR-STRESS; PATHOGENESIS; CONTRIBUTES; COLLAGEN; LUNG; TRANSFORMATION; FIBROBLASTS; IMPAIRMENT	Background: Endothelial-to-mesenchymal transition (EndMT) is implicated in the development of organ fibrosis. Results: Loss of the autophagy gene ATG7 promotes EndMT and up-regulates TGF signaling and the associated pro-fibrotic genes. Endothelial-specific ATG7 knock-out mice exhibited increased bleomycin-induced pulmonary fibrosis. Conclusion:ATG7 is a novel regulator of EndMT-induced organ fibrosis. Significance: Intact endothelial autophagy prevents aberrant EndMT and represents a potential target to limit organ fibrosis. Pulmonary fibrosis is a progressive disease characterized by fibroblast proliferation and excess deposition of collagen and other extracellular matrix components. Although the origin of fibroblasts is multifactorial, recent data implicate endothelial-to-mesenchymal transition as an important source of fibroblasts. We report herein that loss of the essential autophagy gene ATG7 in endothelial cells (ECs) leads to impaired autophagic flux accompanied by marked changes in EC architecture, loss of endothelial, and gain of mesenchymal markers consistent with endothelial-to-mesenchymal transition. Loss of ATG7 also up-regulates TGF signaling and key pro-fibrotic genes in vitro. In vivo, EC-specific ATG7 knock-out mice exhibit a basal reduction in endothelial-specific markers and demonstrate an increased susceptibility to bleomycin-induced pulmonary fibrosis and collagen accumulation. Our findings help define the role of endothelial autophagy as a potential therapeutic target to limit organ fibrosis, a condition for which presently there are no effective available treatments.	[Singh, Krishna K.; Lovren, Fina; Pan, Yi; Quan, Adrian; Ramadan, Azza; Ehsan, Mehroz; Sandhu, Paul; Mantella, Laura E.; Gupta, Nandini; Teoh, Hwee; Verma, Subodh] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada; [Singh, Krishna K.; Al-Omran, Mohammed] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Vasc Surg, Toronto, ON M5B 1W8, Canada; [Matkar, Pratiek N.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Teoh, Hwee] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; [Singh, Krishna K.; Lovren, Fina; Pan, Yi; Quan, Adrian; Ramadan, Azza; Ehsan, Mehroz; Sandhu, Paul; Mantella, Laura E.; Gupta, Nandini; Teoh, Hwee; Tabuchi, Arata; Kuebler, Wolfgang M.; Al-Omran, Mohammed; Verma, Subodh] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Dept Surg, Toronto, ON M5B 1W8, Canada; [Matkar, Pratiek N.; Teoh, Hwee] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Dept Med, Toronto, ON M5B 1W8, Canada; [Matkar, Pratiek N.; Teoh, Hwee] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Singh, Krishna K.; Kuebler, Wolfgang M.; Al-Omran, Mohammed; Verma, Subodh] Univ Toronto, Dept Surg, Toronto, ON M5S 2J7, Canada; [Kuebler, Wolfgang M.] Univ Toronto, Dept Physiol, Toronto, ON M5S 2J7, Canada; [Parotto, Matteo] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5S 2J7, Canada; [Kuebler, Wolfgang M.] Charite, Inst Physiol, D-10117 Berlin, Germany; [Al-Omran, Mohammed; Verma, Subodh] King Saud Univ, Li Ka Shing Collaborat Res Program, Riyadh 12372, Saudi Arabia; [Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; King Saud University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Verma, S (corresponding author), St Michaels Hosp, Div Cardiac Surg, 8th Floor,Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	vermasu@smh.ca	Pan, Yi/AAJ-2341-2021; Teoh, Hwee/F-2498-2018	Quan, Adrian/0000-0001-8008-028X; Parotto, Matteo/0000-0003-1165-4264; Teoh, Hwee/0000-0003-1036-4767; Kuebler, Wolfgang/0000-0003-4100-2961; Ramadan, Azza/0000-0001-5988-7783	Heart and Stroke Foundation of Canada [G-13-0003003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by in part by the Heart and Stroke Foundation of Canada Grant G-13-0003003 (to S. V.).	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Araya J, 2013, INTERNAL MED, V52, P2295, DOI 10.2169/internalmedicine.52.1118; Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; Bharath LP, 2014, CAN J PHYSIOL PHARM, V92, P605, DOI 10.1139/cjpp-2014-0017; Chen F, 2014, CELL PHYSIOL BIOCHEM, V33, P1058, DOI 10.1159/000358676; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; Dolhnikoff M, 1999, AM J RESP CRIT CARE, V160, P1750, DOI 10.1164/ajrccm.160.5.9812040; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Goumans MJ, 2008, TRENDS CARDIOVAS MED, V18, P293, DOI 10.1016/j.tcm.2009.01.001; Guo FX, 2014, ANN BIOMED ENG, V42, P1978, DOI 10.1007/s10439-014-1033-5; Hashimoto N, 2010, AM J RESP CELL MOL, V43, P161, DOI 10.1165/rcmb.2009-0031OC; Hayashi S, 2009, ARTERIOSCL THROM VAS, V29, P1909, DOI 10.1161/ATVBAHA.109.188516; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HERMAN EH, 1995, TOXICOLOGY, V98, P163, DOI 10.1016/0300-483X(94)02987-6; Imanishi Y, 2009, J ARTIF ORGANS, V12, P187, DOI 10.1007/s10047-009-0465-4; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Kato H, 2014, J THORAC CARDIOV SUR, V148, P245, DOI 10.1016/j.jtcvs.2013.08.046; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Kirshenbaum LA, 2012, J CARDIOVASC PHARM, V60, P109, DOI 10.1097/FJC.0b013e31825f6faa; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Klionsky DJ, 2008, AUTOPHAGY, V4, P740, DOI 10.4161/auto.6398; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; LaRocca TJ, 2012, J PHYSIOL-LONDON, V590, P3305, DOI 10.1113/jphysiol.2012.229690; Lee JG, 2006, EXP EYE RES, V83, P1309, DOI 10.1016/j.exer.2006.04.007; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2013, CARCINOGENESIS, V34, P1343, DOI 10.1093/carcin/bgt063; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Manali ED, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-33; MARKWALD RR, 1975, DEV BIOL, V42, P160, DOI 10.1016/0012-1606(75)90321-8; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nataraj D, 2010, AM J RESP CELL MOL, V43, P129, DOI 10.1165/rcmb.2010-0044ED; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P614, DOI 10.1164/arrd.1983.127.5.614; SCHRIER DJ, 1982, J IMMUNOL, V129, P2156; Singh KK, 2014, J THORAC CARDIOV SUR, V147, P1065, DOI 10.1016/j.jtcvs.2013.04.042; Singh KK, 2013, J THORAC CARDIOV SUR, V146, P949, DOI 10.1016/j.jtcvs.2012.12.064; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Sudano I, 2010, SWISS MED WKLY, V140, P139, DOI [smw-12966, 10.4414/smw.2010.13122]; Torisu T, 2013, NAT MED, V19, P1281, DOI 10.1038/nm.3288; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wei J, 2011, AUTOIMMUN REV, V10, P267, DOI 10.1016/j.autrev.2010.09.015; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	70	69	71	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2547	2559		10.1074/jbc.M114.604603	http://dx.doi.org/10.1074/jbc.M114.604603			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527499	Green Published, hybrid			2022-12-28	WOS:000349310700003
J	Tyson, GH; Halavaty, AS; Kim, H; Geissler, B; Agard, M; Satchell, KJ; Cho, W; Anderson, WF; Hauser, AR				Tyson, Gregory H.; Halavaty, Andrei S.; Kim, Hyunjin; Geissler, Brett; Agard, Mallory; Satchell, Karla J.; Cho, Wonhwa; Anderson, Wayne F.; Hauser, Alan R.			A Novel Phosphatidylinositol 4,5-Bisphosphate Binding Domain Mediates Plasma Membrane Localization of ExoU and Other Patatin-like Phospholipases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Bacterial Toxin; Crystal Structure; Phosphatidylinositol Signaling; Phospholipase; Pseudomonas aeruginosa (P; aeruginosa)	AERUGINOSA CYTOTOXIN EXOU; III SECRETION SYSTEM; BACTERIAL PROTEIN TOXINS; PSEUDOMONAS-AERUGINOSA; STRUCTURAL BASIS; STRUCTURE VALIDATION; HOST-CELLS; EMBL-EBI; IDENTIFICATION; ACTIVATION	Background: The Pseudomonas aeruginosa cytotoxin ExoU localizes to the plasma membrane in eukaryotic cells. Results: ExoU and related proteins utilize a conserved four-helical bundle to bind the lipid phosphatidylinositol 4,5-bisphosphate for localization. Conclusion: The membrane localization domain of ExoU represents a novel phosphoinositide binding domain. Significance: This is the first report of a four-helical bundle with specificity for phosphatidylinositol 4,5-bisphosphate. Bacterial toxins require localization to specific intracellular compartments following injection into host cells. In this study, we examined the membrane targeting of a broad family of bacterial proteins, the patatin-like phospholipases. The best characterized member of this family is ExoU, an effector of the Pseudomonas aeruginosa type III secretion system. Upon injection into host cells, ExoU localizes to the plasma membrane, where it uses its phospholipase A(2) activity to lyse infected cells. The targeting mechanism of ExoU is poorly characterized, but it was recently found to bind to the phospholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2), a marker for the plasma membrane of eukaryotic cells. We confirmed that the membrane localization domain (MLD) of ExoU had a direct affinity for PI(4,5)P-2, and we determined that this binding was required for ExoU localization. Previously uncharacterized ExoU homologs from Pseudomonas fluorescens and Photorhabdus asymbiotica also localized to the plasma membrane and required PI(4,5)P-2 for this localization. A conserved arginine within the MLD was critical for interaction of each protein with PI(4,5)P-2 and for localization. Furthermore, we determined the crystal structure of the full-length P. fluorescens ExoU and found that it was similar to that of P. aeruginosa ExoU. Each MLD contains a four-helical bundle, with the conserved arginine exposed at its cap to allow for interaction with the negatively charged PI(4,5)P-2. Overall, these findings provide a structural explanation for the targeting of patatin-like phospholipases to the plasma membrane and define the MLD of ExoU as a member of a new class of PI(4,5)P-2 binding domains.	[Tyson, Gregory H.; Geissler, Brett; Agard, Mallory; Satchell, Karla J.; Hauser, Alan R.] Northwestern Univ, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Hauser, Alan R.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Halavaty, Andrei S.; Anderson, Wayne F.] Northwestern Univ, Dept Biochem, Chicago, IL 60611 USA; [Halavaty, Andrei S.; Anderson, Wayne F.] Northwestern Univ, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Kim, Hyunjin; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hauser, AR (corresponding author), Northwestern Univ, Dept Microbiol & Immunol, 303 E Chicago Ave, Chicago, IL 60611 USA.	ahauser@northwestern.edu	Satchell, Karla/GSN-3100-2022	Tyson, Gregory/0000-0002-2729-5035	National Institutes of Health [AI053674, AI075191, AI099269, AI04831, AI088286, AI092825, AI051490]; American Heart Association [12PRE8660003]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075191, R01AI099269, K24AI104831, R21AI088286, R01AI053674, R01AI092825, R01AI051490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI053674, AI075191, AI099269, AI04831, and AI088286 (to A. R. H.) and AI092825 and AI051490 (to K. J. S.). This work was also supported by American Heart Association Grant 12PRE8660003 (to G. H. T.).	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Aurass P, 2009, APPL ENVIRON MICROB, V75, P4506, DOI 10.1128/AEM.00187-09; Banerji S, 2004, MICROBIOL-SGM, V150, P522, DOI 10.1099/mic.0.26957-0; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bishe B, 2012, J BIOL CHEM, V287, P27637, DOI 10.1074/jbc.M112.346569; Boucrot E, 2003, J BIOL CHEM, V278, P14196, DOI 10.1074/jbc.M207901200; Chen S, 2011, J BIOL CHEM, V286, P15067, DOI 10.1074/jbc.M111.224493; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XY, 2010, CELL SIGNAL, V22, P1097, DOI 10.1016/j.cellsig.2010.03.003; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Costa SCP, 2009, INFECT IMMUN, V77, P1022, DOI 10.1128/IAI.01064-08; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Del Campo CM, 2014, STRUCTURE, V22, P397, DOI 10.1016/j.str.2013.12.018; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Geissler B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00075; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Halavaty AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049388; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kamitani S, 2010, J BIOL CHEM, V285, P25467, DOI 10.1074/jbc.M110.102285; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kim H, 2013, J LIPID RES, V54, P3531, DOI 10.1194/jlr.D041376; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lang C, 2011, EUR J CELL BIOL, V90, P903, DOI 10.1016/j.ejcb.2010.12.003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Berre L, 2006, PROSTAG OTH LIPID M, V81, P113, DOI 10.1016/j.prostaglandins.2006.08.004; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Li LY, 2014, TRENDS BIOCHEM SCI, V39, P130, DOI 10.1016/j.tibs.2014.01.002; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabin SDP, 2006, INFECT IMMUN, V74, P2552, DOI 10.1128/IAI.74.5.2552-2561.2006; Rabin SDP, 2005, INFECT IMMUN, V73, P573, DOI 10.1128/IAI.73.1.573-582.2005; Rabin SDP, 2003, INFECT IMMUN, V71, P4144, DOI 10.1128/IAI.71.7.4144-4150.2003; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Salomon D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3973; Satchell KJF, 2009, TOXINS, V1, P123, DOI 10.3390/toxins1020123; Sato H, 2005, J BACTERIOL, V187, P1192, DOI 10.1128/JB.187.3.1192-1195.2005; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103127; Schorr M, 2001, CURR BIOL, V11, P1421, DOI 10.1016/S0960-9822(01)00449-3; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Tyson GH, 2013, INFECT IMMUN, V81, P2873, DOI 10.1128/IAI.00414-13; VanRheenen SM, 2006, INFECT IMMUN, V74, P3597, DOI 10.1128/IAI.02060-05; Varivarn K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-92; Varnai P, 2008, METHODS, V46, P167, DOI 10.1016/j.ymeth.2008.09.019; Veesenmeyer JL, 2010, INFECT IMMUN, V78, P3346, DOI 10.1128/IAI.00223-10; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wiradjaja F, 2007, J BIOL CHEM, V282, P16295, DOI 10.1074/jbc.M701038200; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]; Zhang Y, 2007, CELL MICROBIOL, V9, P2192, DOI 10.1111/j.1462-5822.2007.00949.x; Zhu WH, 2013, CELL MICROBIOL, V15, P1783, DOI 10.1111/cmi.12157	81	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2919	2937		10.1074/jbc.M114.611251	http://dx.doi.org/10.1074/jbc.M114.611251			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505182	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000349310700031
J	Morrow, GP; MacMillan, L; Lamarre, SG; Young, SK; MacFarlane, AJ; Brosnan, ME; Brosnan, JT				Morrow, Gregory P.; MacMillan, Luke; Lamarre, Simon G.; Young, Sara K.; MacFarlane, Amanda J.; Brosnan, Margaret E.; Brosnan, John T.			In Vivo Kinetics of Formate Metabolism in Folate-deficient and Folate-replete Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; HOMOCYSTEINE REMETHYLATION; NEURAL-TUBE; SERINE; LIVER; ASSAY; MICE; HUMANS; TRANSSULFURATION; NUTRITION	It is now established that the mitochondrial production of formate is a major process in the endogenous generation of folate-linked one-carbon groups. We have developed an in vivo approach involving the constant infusion of [C-13] formate until isotopic steady state is attained to measure the rate of endogenous formate production in rats fed on either a folate-replete or folate-deficient diet. Formate was produced at a rate of 76 mu mol.h(-1).100 g of body weight(-1) in the folate-replete rats, and this was decreased by 44% in folate-deficient rats. This decreased formate production was confirmed in isolated rat liver mitochondria where formate production from serine, the principal precursor of one-carbon groups, was decreased by 85%, although formate production from sarcosine and dimethylglycine (choline metabolites) was significantly increased. We attribute this unexpected result to the demonstrated production of formaldehyde by sarcosine dehydrogenase and dimethylglycine dehydrogenase from their respective substrates in the absence of tetrahydrofolate and subsequent formation of formate by formaldehyde dehydrogenase. Comparison of formate production with the ingestion of dietary formate precursors (serine, glycine, tryptophan, histidine, methionine, and choline) showed that similar to 75% of these precursors were converted to formate, indicating that formate is a significant, although under-appreciated end product of choline and amino acid oxidation. Ingestion of a high protein diet did not result in increased production of formate, suggesting a regulation of the conversion of these precursors at the mitochondrial level to formate.	[Morrow, Gregory P.; MacMillan, Luke; Young, Sara K.; Brosnan, Margaret E.; Brosnan, John T.] Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada; [Lamarre, Simon G.] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada; [MacFarlane, Amanda J.] Hlth Canada, Nutr Res Div, Ottawa, ON K1A 0K9, Canada	Memorial University Newfoundland; University of Moncton; Health Canada	Brosnan, JT (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada.	jbrosnan@mun.ca	Lamarre, Simon/A-5674-2008	Lamarre, Simon/0000-0001-7038-4626	Canadian Institutes of Health Research; Research Development Corporation; School of Graduate Studies, Memorial University of Newfoundland; Research Development Corp.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Development Corporation; School of Graduate Studies, Memorial University of Newfoundland; Research Development Corp.	This work was supported, in whole or in part, by grants from the Canadian Institutes of Health Research and the Research Development Corporation (to J. T. B. and M. E. B.). We also acknowledge support by graduate fellowships from the School of Graduate Studies, Memorial University of Newfoundland (to G. P. M. and to L. M.), and Canadian Institutes of Health Research and Research Development Corp. (to L. M.).	ANNISON EF, 1962, BIOCHEM J, V84, P552, DOI 10.1042/bj0840552; BARLOWE C K, 1988, Biofactors, V1, P171; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BILLS ND, 1992, BLOOD, V79, P2273; BROSNAN JT, 1983, AM J PHYSIOL, V244, pE151, DOI 10.1152/ajpendo.1983.244.2.E151; Damian P, 1996, TOXICOL APPL PHARM, V139, P22, DOI 10.1006/taap.1996.0139; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; FERRELL CL, 1986, J NUTR, V116, P2525, DOI 10.1093/jn/116.12.2525; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; GRADY S, 1986, J ANAL TOXICOL, V10, P1; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; HORNE DW, 1988, CLIN CHEM, V34, P2357; Kalhan SC, 2011, J BIOL CHEM, V286, P5266, DOI 10.1074/jbc.M110.185991; KREBS HA, 1976, BIOCHEM J, V158, P341, DOI 10.1042/bj1580341; Lamarre SG, 2014, AMINO ACIDS, V46, P1885, DOI 10.1007/s00726-014-1738-7; Lamarre SG, 2013, CLIN CHEM LAB MED, V51, P571, DOI 10.1515/cclm-2012-0552; Lamarre SG, 2012, AM J PHYSIOL-ENDOC M, V302, pE61, DOI 10.1152/ajpendo.00345.2011; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Narisawa A, 2012, HUM MOL GENET, V21, P1496, DOI 10.1093/hmg/ddr585; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Qian DL, 1996, BIOCHEM J, V313, P479, DOI 10.1042/bj3130479; RAFECAS I, 1994, BRIT J NUTR, V72, P199, DOI 10.1079/BJN19940024; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SONNE JC, 1948, J BIOL CHEM, V173, P69; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; WAYDHAS C, 1978, EUR J BIOCHEM, V89, P143, DOI 10.1111/j.1432-1033.1978.tb20906.x; Wolfe R. R., 1992, RADIOACTIVE AND STAB, P258; WOLFE RR, 1982, J APPL PHYSIOL, V52, P458, DOI 10.1152/jappl.1982.52.2.458	31	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2244	2250		10.1074/jbc.M114.600718	http://dx.doi.org/10.1074/jbc.M114.600718			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480787	hybrid, Green Published			2022-12-28	WOS:000348588000028
J	Qiao, YB; Wang, R; Yang, XF; Tang, K; Jing, NH				Qiao, Yunbo; Wang, Ran; Yang, Xianfa; Tang, Ke; Jing, Naihe			Dual Roles of Histone H3 Lysine 9 Acetylation in Human Embryonic Stem Cell Pluripotency and Neural Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Background: H3K9Ac is an epigenetic mark representing transcriptionally active chromatin. Results: Inhibition of HDAC activity promotes pluripotency maintenance at the initiation of hESC differentiation and inhibits neural differentiation during neural commitment stage. Conclusion: H3K9Ac plays dual roles in hESC pluripotency maintenance and neural differentiation through regulating different targets. Significance: This work provides insight into the epigenetic mechanisms underlying neural differentiation of hESCs associated with histone acetylation patterns.	[Qiao, Yunbo; Wang, Ran; Yang, Xianfa; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Yang, Xianfa] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Tang, Ke] Nanchang Univ, Inst Life Sci, Nanchang 330031, Jiangxi, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University; Nanchang University	Jing, NH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	njing@sibcb.ac.cn		Yang, Xianfa/0000-0002-6843-8055	"Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01010201]; National Key Basic Research and Development Program of China [2014CB964804, 2015CB964500]; National Natural Science Foundation of China [91219303, 31430058]	"Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the "Strategic Priority Research Program" of the Chinese Academy of Sciences Grant XDA01010201, National Key Basic Research and Development Program of China Grants 2014CB964804 and 2015CB964500, and National Natural Science Foundation of China Grants 91219303 and 31430058.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Balasubramaniyan V, 2006, NEUROSCIENCE, V143, P939, DOI 10.1016/j.neuroscience.2006.08.082; Balmer NV, 2012, HUM MOL GENET, V21, P4104, DOI 10.1093/hmg/dds239; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Fang F, 2014, STEM CELLS, V32, P1805, DOI 10.1002/stem.1705; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Golebiewska A, 2009, STEM CELLS, V27, P1298, DOI 10.1002/stem.59; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hansen JC, 2006, ACS CHEM BIOL, V1, P69, DOI 10.1021/cb6000894; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Qiao YB, 2012, CELL RES, V22, P1546, DOI 10.1038/cr.2012.122; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Serra M, 2012, TRENDS BIOTECHNOL, V30, P350, DOI 10.1016/j.tibtech.2012.03.003; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tulpule Asmin, 2009, V482, P35, DOI 10.1007/978-1-59745-060-7_3; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200	54	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2508	2520		10.1074/jbc.M114.603761	http://dx.doi.org/10.1074/jbc.M114.603761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VC7PX	25519907	Green Published, hybrid			2022-12-28	WOS:000434590200001
J	Krska, D; Ravulapalli, R; Fieldhouse, RJ; Lugo, MR; Merrill, AR				Krska, Daniel; Ravulapalli, Ravikiran; Fieldhouse, Robert J.; Lugo, Miguel R.; Merrill, A. Rod			C3larvin Toxin, an ADP-ribosyltransferase from Paenibacillus larvae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AERUGINOSA EXOTOXIN-A; PSEUDOMONAS-AERUGINOSA; CLOSTRIDIUM-LIMOSUM; RIBOSYLATING TOXINS; BACILLUS-CEREUS; INHIBITORS; EXOENZYME; COMPLEX; MIMICRY; NAD(+)	C3larvin toxin was identified by a bioinformatic strategy as a putative mono-ADP-ribosyltransferase and a possible virulence factor from Paenibacillus larvae, which is the causative agent of American Foulbrood in honey bees. C3larvin targets RhoA as a substrate for its transferase reaction, and kinetics for both the NAD(+) (K-m = 34 +/- 12 mu M) and RhoA (K-m = 17 +/- 3 mu M) substrates were characterized for this enzyme from the mono-ADP-ribosyltransferase C3 toxin subgroup. C3larvin is toxic to yeast when expressed in the cytoplasm, and catalytic variants of the enzyme lost the ability to kill the yeast host, indicating that the toxin exerts its lethality through its enzyme activity. A small molecule inhibitor of C3larvin enzymatic activity was discovered called M3 (K-i = 11 +/- 2 mu M), and to our knowledge, is the first inhibitor of transferase activity of the C3 toxin family. C3larvin was crystallized, and its crystal structure (apoenzyme) was solved to 2.3 angstrom resolution. C3larvin was also shown to have a different mechanism of cell entry from other C3 toxins.	[Krska, Daniel; Ravulapalli, Ravikiran; Lugo, Miguel R.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Fieldhouse, Robert J.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Fieldhouse, Robert J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Guelph; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014		Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported by the Canadian Institutes of Health Research (to A. R. M.). The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong S, 2002, J ENZYM INHIB MED CH, V17, P235, DOI 10.1080/1475636021000010914; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Bohmer J, 1996, BIOCHEMISTRY-US, V35, P282, DOI 10.1021/bi951784+; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Fieldhouse RJ, 2012, J BIOL CHEM, V287, P21176, DOI 10.1074/jbc.M111.337311; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Funfhaus A, 2013, ENVIRON MICROBIOL, V15, P2951, DOI 10.1111/1462-2920.12229; Genersch E., 2010, PAENIBACILLUS LARVAE, V103, pS10; Goblirsch MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069831; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; Rieg S, 2010, EMERG INFECT DIS, V16, P487, DOI 10.3201/eid1603.091457; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Swann SL, 2011, J MED CHEM, V54, P1223, DOI 10.1021/jm1013677; Tautzenberger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085695; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; Visschedyk D, 2012, J BIOL CHEM, V287, P41089, DOI 10.1074/jbc.M112.412809; Vogelsgesang M, 2006, BIOCHEMISTRY-US, V45, P1017, DOI 10.1021/bi052253g; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Wilde C, 2003, BIOCHEMISTRY-US, V42, P9694, DOI 10.1021/bi034583b; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Yates SP, 2005, ANAL BIOCHEM, V340, P41, DOI 10.1016/j.ab.2005.01.051	36	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1639	1653		10.1074/jbc.M114.589846	http://dx.doi.org/10.1074/jbc.M114.589846			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477523	hybrid, Green Published			2022-12-28	WOS:000348056400031
J	Moonens, K; Van den Broeck, I; De Kerpel, M; Deboeck, F; Raymaekers, H; Remaut, H; De Greve, H				Moonens, Kristof; Van den Broeck, Imke; De Kerpel, Maia; Deboeck, Francine; Raymaekers, Hanne; Remaut, Han; De Greve, Henri			Structural and Functional Insight into the Carbohydrate Receptor Binding of F4 Fimbriae-producing Enterotoxigenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; ADHESIN VARIANTS; MAJOR SUBUNIT; K88 FIMBRIAE; PSA FIMBRIAE; IDENTIFICATION; FIMH; ANTIGEN; BIOSYNTHESIS	Enterotoxigenic Escherichia coli (ETEC) strains are important causes of intestinal disease in humans and lead to severe production losses in animal farming. A range of fimbrial adhesins in ETEC strains determines host and tissue tropism. ETEC strains expressing F4 fimbriae are associated with neonatal and post-weaning diarrhea in piglets. Three naturally occurring variants of F4 fimbriae (F4(ab), F4(ac), and F4(ad)) exist that differ in the primary sequence of their major adhesive subunit FaeG, and each features a related yet distinct receptor binding profile. Here the x-ray structure of FaeGad bound to lactose provides the first structural insight into the receptor specificity and mode of binding by the poly-adhesive F4 fimbriae. A small D'-D''-alpha 1-alpha 2 subdomain grafted on the immunoglobulin-like core of FaeG hosts the carbohydrate binding site. Two short amino acid stretches Phe(150)-Glu(152) and Val(166)-Glu(170) of FaeG(ad) bind the terminal galactose in the lactosyl unit and provide affinity and specificity to the interaction. A hemagglutination-based assay with E. coli expressing mutant F4(ad) fimbriae confirmed the elucidated co-complex structure. Interestingly, the crucial D'-alpha 1 loop that borders the FaeG(ad) binding site adopts a different conformation in the two other FaeG variants and hints at a heterogeneous binding pocket among the FaeG serotypes.	[Moonens, Kristof; Van den Broeck, Imke; De Kerpel, Maia; Raymaekers, Hanne; Remaut, Han; De Greve, Henri] VIB Struct Biol Res Ctr, Struct & Mol Microbiol, B-1050 Brussels, Belgium; [Moonens, Kristof; Van den Broeck, Imke; De Kerpel, Maia; Raymaekers, Hanne; Remaut, Han; De Greve, Henri] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Deboeck, Francine] Vrije Univ Brussel, Viral Genet Lab, B-1050 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel	De Greve, H (corresponding author), Vrije Univ Brussel, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium.	hdegreve@vub.ac.be		Remaut, Han/0000-0002-9775-4102	Hercules Foundation [UABR/09/005]	Hercules Foundation	We are grateful to the beamline staff of the Proxima1 beamline (Soleil, France) for support with data collection and processing. This work was supported by Equipment Grant UABR/09/005 from the Hercules Foundation.	AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; BAKKER D, 1991, MOL MICROBIOL, V5, P875, DOI 10.1111/j.1365-2958.1991.tb00761.x; BAKKER D, 1992, J BACTERIOL, V174, P6350, DOI 10.1128/JB.174.20.6350-6358.1992; BAKKER D, 1992, MOL MICROBIOL, V6, P247, DOI 10.1111/j.1365-2958.1992.tb02006.x; Bao R, 2013, P NATL ACAD SCI USA, V110, P1065, DOI 10.1073/pnas.1212431110; BIJLSMA IGW, 1982, INFECT IMMUN, V37, P891, DOI 10.1128/IAI.37.3.891-894.1982; Billey LO, 1998, VET MICROBIOL, V59, P203, DOI 10.1016/S0378-1135(97)00193-4; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Busch A, 2012, PHILOS T R SOC B, V367, P1112, DOI 10.1098/rstb.2011.0206; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; Coddens A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023309; De Greve H, 2007, CURR OPIN STRUC BIOL, V17, P506, DOI 10.1016/j.sbi.2007.06.011; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Erickson AK, 1997, ADV EXP MED BIOL, V412, P167; ERICKSON AK, 1992, INFECT IMMUN, V60, P983, DOI 10.1128/IAI.60.3.983-988.1992; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Francis DH, 1999, ADV EXP MED BIOL, V473, P147; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Galvan EM, 2007, INFECT IMMUN, V75, P1272, DOI 10.1128/IAI.01153-06; GIBBONS RA, 1975, J GEN MICROBIOL, V86, P228, DOI 10.1099/00221287-86-2-228; Grange PA, 1996, INFECT IMMUN, V64, P606, DOI 10.1128/IAI.64.2.606-610.1996; Grange PA, 1999, INFECT IMMUN, V67, P165, DOI 10.1128/IAI.67.1.165-172.1999; Grange PA, 1998, INFECT IMMUN, V66, P1613, DOI 10.1128/IAI.66.4.1613-1621.1998; Grange PA, 2002, INFECT IMMUN, V70, P2336, DOI 10.1128/IAI.70.5.2336-2343.2002; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Jones G. W., 1977, MICROBIAL INTERACTIO, P141; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Larsson A, 2003, BIOORGAN MED CHEM, V11, P2255, DOI 10.1016/S0968-0896(03)00114-7; LAUX DC, 1986, INFECT IMMUN, V52, P18, DOI 10.1128/IAI.52.1.18-25.1986; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Meng Q, 1998, J ANIM SCI, V76, P551; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; Moonens K, 2012, MOL MICROBIOL, V86, P82, DOI 10.1111/j.1365-2958.2012.08174.x; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nagy B, 1999, VET RES, V30, P259; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; ORSKOV I, 1964, ACTA PATHOL MIC SC, V62, P439, DOI 10.1111/apm.1964.62.3.439; OUDEGA B, 1989, MOL MICROBIOL, V3, P645, DOI 10.1111/j.1365-2958.1989.tb00212.x; PAYNE D, 1993, INFECT IMMUN, V61, P3673, DOI 10.1128/IAI.61.9.3673-3677.1993; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; SELLWOOD R, 1980, BIOCHIM BIOPHYS ACTA, V632, P326, DOI 10.1016/0304-4165(80)90090-2; Sujatha MS, 2007, J MOL STRUC-THEOCHEM, V814, P11, DOI 10.1016/j.theochem.2007.02.032; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; VALENT QA, 1995, MOL MICROBIOL, V16, P1243, DOI 10.1111/j.1365-2958.1995.tb02346.x; Van Molle I, 2007, J MOL BIOL, V368, P791, DOI 10.1016/j.jmb.2007.02.051; Van Molle I, 2009, J MOL BIOL, V394, P957, DOI 10.1016/j.jmb.2009.09.059; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; WILLEMSEN PTJ, 1992, MICROB PATHOGENESIS, V12, P367, DOI 10.1016/0882-4010(92)90099-A; Zhang WP, 2009, INFECT IMMUN, V77, P699, DOI 10.1128/IAI.01165-08	59	22	22	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8409	8419		10.1074/jbc.M114.618595	http://dx.doi.org/10.1074/jbc.M114.618595			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25631050	Green Published, hybrid			2022-12-28	WOS:000351662600034
J	Sahay, S; Ghosh, D; Dwivedi, S; Anoop, A; Mohite, GM; Kombrabail, M; Krishnamoorthy, G; Maji, SK				Sahay, Shruti; Ghosh, Dhiman; Dwivedi, Saumya; Anoop, Arunagiri; Mohite, Ganesh Maruti; Kombrabail, Mamata; Krishnamoorthy, Guruswamy; Maji, Samir K.			Familial Parkinson Disease-associated Mutations Alter the Site-specific Microenvironment and Dynamics of alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Amyloid; Fluorescence Anisotropy; Parkinson Disease; Protein Aggregation; Protein Misfolding	TIME-RESOLVED FLUORESCENCE; PHOTOINDUCED CROSS-LINKING; AMYLOID FIBRIL FORMATION; FREE-ENERGY LANDSCAPES; IN-VITRO; TRYPTOPHAN FLUORESCENCE; E46K MUTATION; LEWY BODIES; WILD-TYPE; NEURON DEATH	Background: Aggregation of -Syn is associated with PD pathogenesis. Results: Despite being natively unfolded, a site-specific structure exists in -Syn that is significantly altered by familial PD-associated E46K, A53T, and A30P mutations. Conclusion: Altered site-specific structure of the PD-associated mutants may attribute to their different aggregation propensity. Significance: This study contributes to understanding the relationship between structure and aggregation of -Syn. Human -synuclein (-Syn) is a natively unstructured protein whose aggregation into amyloid fibrils is associated with Parkinson disease (PD) pathogenesis. Mutations of -Syn, E46K, A53T, and A30P, have been linked to the familial form of PD. In vitro aggregation studies suggest that increased propensity to form non-fibrillar oligomers is the shared property of these familial PD-associated mutants. However, the structural basis of the altered aggregation propensities of these PD-associated mutants is not yet clear. To understand this, we studied the site-specific structural dynamics of wild type (WT) -Syn and its three PD mutants (A53T, E46K, and A30P). Tryptophan (Trp) was substituted at the N terminus, central hydrophobic region, and C terminus of all -Syns. Using various biophysical techniques including time-resolved fluorescence studies, we show that irrespective of similar secondary structure and early oligomerization propensities, familial PD-associated mutations alter the site-specific microenvironment, solvent exposure, and conformational flexibility of the protein. Our results further show that the common structural feature of the three PD-associated mutants is more compact and rigid sites at their N and C termini compared with WT -Syn that may facilitate the formation of a partially folded intermediate that eventually leads to their increased oligomerization propensities.	[Sahay, Shruti; Ghosh, Dhiman; Dwivedi, Saumya; Anoop, Arunagiri; Mohite, Ganesh Maruti; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Kombrabail, Mamata; Krishnamoorthy, Guruswamy] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR)	Krishnamoorthy, G (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	gk@tifr.res.in; samirmaji@iitb.ac.in	Maji, Samir K. K./B-9640-2019; Arunagiri, Anoop/P-2528-2018	Maji, Samir K. K./0000-0002-9110-1565; Arunagiri, Anoop/0000-0001-9839-1860	Department of Biotechnology, Government of India [BT/PR14344Med/30/501/2010, BT/PR13359/BRB/10/752/2009]; Council of Scientific and Industrial Research, Government of India; Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Government of India	This work was supported in part by Department of Biotechnology, Government of India Grants BT/PR14344Med/30/501/2010 and BT/PR13359/BRB/10/752/2009.; Supported by a Shyama Prasad Mukherjee fellowship from the Council of Scientific and Industrial Research, Government of India.; Recipient of a J.C. Bose fellowship of the Government of India.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anoop A, 2014, J BIOL CHEM, V289, P16884, DOI 10.1074/jbc.M114.548354; Ariesandi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053487; Baba M, 1998, AM J PATHOL, V152, P879; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bevington P. R, 1969, DATA REDUCTION ERROR; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Coskuner O, 2013, ACS CHEM NEUROSCI, V4, P1101, DOI 10.1021/cn400041j; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fujioka S, 2014, PARKINSONISM RELAT D, V20, P1129, DOI [10.1016/S1353-8020(13)70010-5, 10.1016/j.parkreldis.2014.07.014]; Garzon-Rodriguez W, 2000, J BIOL CHEM, V275, P22645, DOI 10.1074/jbc.M000756200; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jha A, 2009, J MOL BIOL, V393, P735, DOI 10.1016/j.jmb.2009.08.053; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Krishnamoorthy G, 2012, CURR SCI INDIA, V102, P266; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lakshmikanth GS, 2001, NAT STRUCT BIOL, V8, P799, DOI 10.1038/nsb0901-799; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Lee SJ, 2008, ACTA NEUROBIOL EXP, V68, P509; Li HT, 2006, PROTEIN PEPTIDE LETT, V13, P385, DOI 10.2174/092986606775974384; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maji SK, 2005, BIOCHEMISTRY-US, V44, P13365, DOI 10.1021/bi0508284; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Ono K, 2012, NEUROBIOL AGING, V33, P2172, DOI 10.1016/j.neurobiolaging.2011.10.015; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sahay S, 2014, BIOCHEMISTRY-US, V53, P807, DOI 10.1021/bi401543z; Sambrook J., 2001, MOL CLONING LAB MANU; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Singh TS, 2012, BIOCHEMISTRY-US, V51, P9260, DOI 10.1021/bi301110u; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wise-Scira O, 2013, ACS CHEM NEUROSCI, V4, P486, DOI 10.1021/cn300198q; Wise-Scira O, 2013, ACS CHEM NEUROSCI, V4, P498, DOI 10.1021/cn3002027; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhang L, 2008, BRAIN RES, V1244, P40, DOI 10.1016/j.brainres.2008.08.067; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	76	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7804	7822		10.1074/jbc.M114.598607	http://dx.doi.org/10.1074/jbc.M114.598607			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635052	Green Published, hybrid			2022-12-28	WOS:000351613600039
J	Ziegler, K; Tumova, S; Kerimi, A; Williamson, G				Ziegler, Kerstin; Tumova, Sarka; Kerimi, Asimina; Williamson, Gary			Cellular Asymmetric Catalysis by UDP-glucuronosyltransferase 1A8 Shows Functional Localization to the Basolateral Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Polarity; Fatty Acid; Flavonoid; Intestinal Metabolism; Membrane Enzyme; Polyunsaturated Fatty Acid (PUFA); Uridine 5'-Diphosphoglucuronosyltransferase (UDP-glucuronosyltransferase); Xenobiotic	TANDEM MASS-SPECTROMETRY; ACTIVATED RECEPTORS ALPHA; FATTY-ACIDS; RAT-LIVER; ENDOPLASMIC-RETICULUM; HYDROXYCINNAMIC ACIDS; MICROSOMAL ENZYMES; EXPRESSION LEVELS; SIGNAL SEQUENCE; SMALL-INTESTINE	Background: Conjugating enzymes such as UDP-glucuronosyltransferases (UGTs) determine small molecule bioavailability. Results: UGT1A8 is induced by certain fatty acids and functionally localizes in the basolateral plasmalemma in HT29-MTX goblet cells. Conclusion: The conjugation pattern is asymmetric, suggesting association of UGT1A8 with membrane transporters. Significance: The enzyme localization allows the cell to carry out conjugation without the small molecule entering into the interior of the cell. UDP-glucuronosyltransferases (UGTs) are highly expressed in liver, intestine and kidney, and catalyze the glucuronic acid conjugation of both endogenous compounds and xenobiotics. Using recombinant human UGT isoforms, we show that glucuronic acid conjugation of the model substrate, (-)-epicatechin, is catalyzed mainly by UGT1A8 and UGT1A9. In HepG2 cells, pretreatment with polyunsaturated fatty acids increased substrate glucuronidation. In the intestinal Caco-2/HT29-MTX co-culture model, overall relative glucuronidation rates were much higher than in HepG2 cells, and (-)-epicatechin was much more readily conjugated when applied to the basolateral side of the cell monolayer. Under these conditions, 95% of the conjugated product was effluxed back to the site of application, and none of the other phase 2-derived metabolites followed this distribution pattern. HT29-MTX cells contained >1000-fold higher levels of UGT1A8 mRNA than Caco-2 or HepG2 cells. Gene expression of UGT1A8 increased after treatment of cells with docosahexaenoic acid, as did UGT1A protein levels. Immunofluorescence staining and Western blotting showed the presence of UGT1A in the basal and lateral parts of the plasma membrane of HT29-MTX cells. These results suggest that some of the UGT1A8 enzyme is not residing in the endoplasmic reticulum but spans the plasma membrane, resulting in increased accessibility to compounds outside the cell. This facilitates more efficient conjugation of substrate and is additionally coupled with rapid efflux by functionally associated basolateral transporters. This novel molecular strategy allows the cell to carry out conjugation without the xenobiotic entering into the interior of the cell.	[Ziegler, Kerstin; Tumova, Sarka; Kerimi, Asimina; Williamson, Gary] Univ Leeds, Fac Math & Phys Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Williamson, G (corresponding author), Univ Leeds, Fac Math & Phys Sci, Leeds LS2 9JT, W Yorkshire, England.	g.williamson@leeds.ac.uk	Tumova, Sarka/AAD-6353-2019; Williamson, Gary/AAE-9665-2019	Tumova, Sarka/0000-0003-2044-4998; Williamson, Gary/0000-0002-5624-6267; Ziegler, Kerstin/0000-0001-8146-8905	Nestle Research Center, Lausanne (Switzerland); European Research Council [322467]	Nestle Research Center, Lausanne (Switzerland); European Research Council(European Research Council (ERC)European Commission)	Recipient of a Ph.D. studentship from The Nestle Research Center, Lausanne (Switzerland).; Supported by European Research Council Advanced Grant POLYTRUE? 322467.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Actis-Goretta L, 2012, FREE RADICAL BIO MED, V53, P787, DOI 10.1016/j.freeradbiomed.2012.05.023; ANTOINE B, 1983, BIOCHEM PHARMACOL, V32, P2629, DOI 10.1016/0006-2952(83)90037-0; ANTOINE B, 1984, XENOBIOTICA, V14, P575, DOI 10.3109/00498258409151451; Auger C, 2008, J NUTR, V138, P1535; Barbier O, 2003, J BIOL CHEM, V278, P13975, DOI 10.1074/jbc.M300749200; Barre L, 2005, FEBS J, V272, P1063, DOI 10.1111/j.1742-4658.2005.04548.x; Campbell BJ, 2001, GLYCOBIOLOGY, V11, P385, DOI 10.1093/glycob/11.5.385; Cheng ZQ, 1999, DRUG METAB DISPOS, V27, P1165; CHOWDHURY JR, 1985, P NATL ACAD SCI USA, V82, P2990, DOI 10.1073/pnas.82.9.2990; Clarke KA, 2014, J CHROMATOGR B, V972, P29, DOI 10.1016/j.jchromb.2014.09.035; Court MH, 2012, XENOBIOTICA, V42, P266, DOI 10.3109/00498254.2011.618954; Croix JA, 2011, EXP BIOL MED, V236, P1402, DOI 10.1258/ebm.2011.011186; DANNENBERG AJ, 1993, BIOCHIM BIOPHYS ACTA, V1210, P8, DOI 10.1016/0005-2760(93)90042-8; DANNENBERG AJ, 1992, BIOCHEM PHARMACOL, V44, P335, DOI 10.1016/0006-2952(92)90017-D; DANNENBERG AJ, 1992, J NUTR, V122, P1607, DOI 10.1093/jn/122.8.1607; Fallon JK, 2013, J PROTEOME RES, V12, P4402, DOI 10.1021/pr4004213; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORSTNER J, 1991, EXP MOL PATHOL, V54, P129, DOI 10.1016/0014-4800(91)90026-T; Gill KL, 2012, DRUG METAB DISPOS, V40, P825, DOI 10.1124/dmd.111.043984; Grosse L, 2013, BASIC CLIN PHARMACOL, V113, P92, DOI 10.1111/bcpt.12071; Hanioka N, 2012, CHEMOSPHERE, V89, P526, DOI 10.1016/j.chemosphere.2012.05.039; Harbourt DE, 2012, ANAL CHEM, V84, P98, DOI 10.1021/ac201704a; HAUSER SC, 1984, J BIOL CHEM, V259, P4527; Huang YH, 2002, PHARMACOGENETICS, V12, P287, DOI 10.1097/00008571-200206000-00004; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; Jenkinson Carl, 2013, Front Endocrinol (Lausanne), V4, P80, DOI 10.3389/fendo.2013.00080; Jimenez R, 2012, J AGR FOOD CHEM, V60, P8823, DOI 10.1021/jf205370q; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kato J, 2003, J HEALTH SCI, V49, P105, DOI 10.1248/jhs.49.105; Kato Y, 2008, DRUG METAB DISPOS, V36, P51, DOI 10.1124/dmd.107.018184; Kimura R, 2013, J LIPID RES, V54, P3258, DOI 10.1194/jlr.M034942; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Leung HY, 2007, TOXICOLOGY, V242, P153, DOI 10.1016/j.tox.2007.09.027; Levesque B, 1999, PHARMACOGENETICS, V9, P207; MAGDALOU J, 1982, ENZYME, V28, P41, DOI 10.1159/000459083; Malfatti MA, 2005, MUTAT RES-FUND MOL M, V570, P205, DOI 10.1016/j.mrfmmm.2004.11.007; Meech R, 2012, PHARMACOL THERAPEUT, V134, P200, DOI 10.1016/j.pharmthera.2012.01.009; Mojarrabi B, 1998, BIOCHEM BIOPH RES CO, V247, P704, DOI 10.1006/bbrc.1998.8843; Ng SP, 2005, J PHARM PHARM SCI, V8, P1; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Okamura K, 2006, BIOCHEM BIOPH RES CO, V345, P1649, DOI 10.1016/j.bbrc.2006.05.089; Ouzzine M, 1999, FEBS LETT, V454, P187, DOI 10.1016/S0014-5793(99)00797-8; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; Rouleau M, 2013, BIOCHEM J, V450, P107, DOI 10.1042/BJ20121594; Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019; Sato Y, 2014, DRUG METAB DISPOS, V42, P885, DOI 10.1124/dmd.113.056291; Shibuya A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02903; Singh R, 2011, J AGR FOOD CHEM, V59, P7452, DOI 10.1021/jf1041454; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; Stalmach A, 2010, MOL NUTR FOOD RES, V54, P323, DOI 10.1002/mnfr.200900194; Strassburg CP, 1999, GASTROENTEROLOGY, V116, P149, DOI 10.1016/S0016-5085(99)70239-8; Strassburg CP, 2000, J BIOL CHEM, V275, P36164, DOI 10.1074/jbc.M002180200; Thibaudeau J, 2006, CANCER RES, V66, P125, DOI 10.1158/0008-5472.CAN-05-2857; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Tsoutsikos P, 2004, BIOCHEM PHARMACOL, V67, P191, DOI 10.1016/j.bcp.2003.08.025; Vaidyanathan JB, 2002, DRUG METAB DISPOS, V30, P897, DOI 10.1124/dmd.30.8.897; VESSEY DA, 1971, J BIOL CHEM, V246, P4649; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057045; Wong CC, 2011, MOL NUTR FOOD RES, V55, P979, DOI 10.1002/mnfr.201000652; Wong CC, 2010, J NUTR BIOCHEM, V21, P1060, DOI 10.1016/j.jnutbio.2009.09.001; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Xu L, 2006, DRUG METAB DISPOS, V34, P1406, DOI 10.1124/dmd.106.009399; ZAKIM D, 1973, EUR J BIOCHEM, V38, P59, DOI 10.1111/j.1432-1033.1973.tb03033.x; ZAKIM D, 1970, J BIOL CHEM, V245, P4953; ZALESKI J, 1982, CAN J BIOCHEM CELL B, V60, P972, DOI 10.1139/o82-125	68	7	7	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7622	7633		10.1074/jbc.M114.634428	http://dx.doi.org/10.1074/jbc.M114.634428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25586184	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000351613600025
J	Torr, EE; Ngam, CR; Bernau, K; Tomasini-Johansson, B; Acton, B; Sandbo, N				Torr, Elizabeth E.; Ngam, Caitlyn R.; Bernau, Ksenija; Tomasini-Johansson, Bianca; Acton, Benjamin; Sandbo, Nathan			Myofibroblasts Exhibit Enhanced Fibronectin Assembly That Is Intrinsic to Their Contractile Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; SMOOTH MUSCLE ACTIN; STRESS FIBER FORMATION; EXTRACELLULAR-MATRIX; GRANULATION-TISSUE; PULMONARY-FIBROSIS; STREPTOCOCCUS-PYOGENES; MURINE MODEL; TGF-BETA; DIFFERENTIATION	Myofibroblasts have increased expression of contractile proteins and display augmented contractility. It is not known if the augmented contractile gene expression characterizing the myofibroblast phenotype impacts its intrinsic ability to assemble fibronectin (FN) and extracellular matrix. In this study we investigated whether myofibroblasts displayed increased rates of EN fibril assembly when compared with their undifferentiated counterparts. Freshly plated myofibroblasts assemble exogenous FN (488-FN) into a fibrillar matrix more rapidly than fibroblasts that have not undergone myofibroblast differentiation. The augmented rate of FN matrix formation by myofibroblasts was dependent on intact Rho/Rho kinase (ROCK) and myosin signals inasmuch as treatment with Y27632 or blebbistatin attenuated 488-EN assembly. Inhibiting contractile gene expression by pharmacologic disruption of the transcription factors megakaryoblastic leukemia-1 (MKL1)/serum response factor (SRE) during myofibroblast differentiation resulted in decreased contractile force generation and attenuated 488-EN incorporation although not FN expression. Furthermore, disruption of the MKL1/SRF target gene, smooth muscle alpha-actin (alpha-SMA) via siRNA knockdown resulted in attenuation of 488-EN assembly. In conclusion, this study demonstrates a linkage between increased contractile gene expression, most importantly a-SMA, and the intrinsic capacity of myofibroblasts to assemble exogenous EN into fibrillar extracellular matrix.	[Torr, Elizabeth E.; Ngam, Caitlyn R.; Bernau, Ksenija; Acton, Benjamin; Sandbo, Nathan] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53792 USA; [Tomasini-Johansson, Bianca] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sandbo, N (corresponding author), Univ Wisconsin, Dept Med, Div Allergy Pulm & Crit Care Med, H4-620,600 Highland Ave, Madison, WI 53792 USA.	nsandbo@medicine.wisc.edu			National Institutes of Health (NCI) [5K08HL093367, P30 CA014520]; University of Wisconsin; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093367] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Wisconsin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5K08HL093367 (to N. S.) and P30 CA014520 (NCI; to the University of Wisconsin Comprehensive Cancer Center). This work was also supported by University of Wisconsin Development Funding (to N. S.).	Altrock E., 2014, J HEPATOL, DOI [10.1016/j.j-hep.2014.06.010, DOI 10.1016/J.J-HEP.2014.06.010]; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Cho J, 2006, J THROMB HAEMOST, V4, P943, DOI 10.1111/j.1538-7836.2006.01862.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Haak AJ, 2014, J PHARMACOL EXP THER, V349, P480, DOI 10.1124/jpet.114.213520; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Holtz ML, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-18; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; KUHN C, 1991, AM J PATHOL, V138, P1257; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Pankov Roumen, 2009, V522, P261, DOI 10.1007/978-1-59745-413-1_18; Pereira M, 2002, J CELL SCI, V115, P609; PETERS DMP, 1987, J CELL BIOL, V104, P121, DOI 10.1083/jcb.104.1.121; Phan SH, 1996, KIDNEY INT, V49, pS46; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Sandbo N, 2005, MOL PHARMACOL, V67, P789, DOI 10.1124/mol.104.006874; Sandbo N, 2013, J BIOL CHEM, V288, P15466, DOI 10.1074/jbc.M113.464461; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimizu Y, 2001, AM J RESP CRIT CARE, V163, P210, DOI 10.1164/ajrccm.163.1.2001089; SINGER II, 1984, J CELL BIOL, V98, P2091, DOI 10.1083/jcb.98.6.2091; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2012, MATRIX BIOL, V31, P360, DOI 10.1016/j.matbio.2012.07.003; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	49	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6951	6961		10.1074/jbc.M114.606186	http://dx.doi.org/10.1074/jbc.M114.606186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627685	Green Published, hybrid			2022-12-28	WOS:000350991500029
J	Haldar, S; Dru, C; Choudhury, D; Mishra, R; Fernandez, A; Biondi, S; Liu, ZQ; Shimada, K; Arditi, M; Bhowmick, NA				Haldar, Subhash; Dru, Christopher; Choudhury, Diptiman; Mishra, Rajeev; Fernandez, Ana; Biondi, Shea; Liu, Zhenqiu; Shimada, Kenichi; Arditi, Moshe; Bhowmick, Neil A.			Inflammation and Pyroptosis Mediate Muscle Expansion in an Interleukin-1 beta (IL-1 beta)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; HEMORRHAGIC CYSTITIS; NLRP3 INFLAMMASOME; BLADDER INFLAMMATION; MITOCHONDRIAL-DNA; OXIDATIVE STRESS; CELL-DEATH; OGG1 GENE; METHYLATION; ACROLEIN	Muscle inflammation is often associated with its expansion. Bladder smooth muscle inflammation-induced cell death is accompanied by hyperplasia and hypertrophy as the primary cause for poor bladder function. In mice, DNA damage initiated by chemotherapeutic drug cydophosphamide activated caspase 1 through the formation of the NINP3 complex resulting in detrusor hyperplasia. A cyclophosphamide metabolite, acrolein, caused global DNA methylation and accumulation of DNA damage in a mouse model of bladder inflammation and in cultured bladder muscle cells. In correlation, global DNA methylation and NLRP:3 expression was up-regulated in human chronic bladder inflammatory tissues. The epigenetic silencing of DNA damage repair gene, Oggl, could be reversed by the use of demethylating agents. In mice, demethylating agents reversed cydophosphamide-induced bladder inflammation and detrusor expansion. The transgenic knock-out olOgg1 in as few as 10% of the detrusor cells tripled the proliferation of the remaining wild type counterparts in an in vitro co-culture titration experiment. Antagonizing IL-1 beta with Anakinra, a rheumatoid arthritis therapeutic, prevented detrusor proliferation in conditioned media experiments as well as in a mouse model of bladder inflammation. Radiation treatment validated the role of DNA damage in the NLRP3-associated caspase 1-mediated IL-1 beta secretory phenotype. A protein array analysis identified IGF1 to be downstream of IL-1 beta signaling. IL-1 beta-induced detrusor proliferation and hypertrophy could be reversed with the use of Anakinra as well as an IGT1 neutralizing antibody. IL-1 beta antagonists in current clinical practice can exploit the revealed mechanism for DNA damage-mediated muscular expansion.	[Haldar, Subhash; Dru, Christopher; Choudhury, Diptiman; Mishra, Rajeev; Fernandez, Ana; Biondi, Shea; Liu, Zhenqiu; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Choudhury, Diptiman; Fernandez, Ana; Biondi, Shea; Bhowmick, Neil A.] Greater Los Angeles Vet Adm, Los Angeles, CA USA; [Shimada, Kenichi; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, Dept Med, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	bhowmickn@cshs.org	Bhowmick, Neil/AAA-7302-2019; Mishra, Rajeev/AEX-2208-2022; Mishra, Rajeev/T-4216-2017	Bhowmick, Neil/0000-0001-8747-5989; Mishra, Rajeev/0000-0002-7411-4022; Haldar, Subhash/0000-0002-1230-1770	National Institutes of Health [R01CA108646]; NATIONAL CANCER INSTITUTE [R01CA108646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA108646 (NCI).	AHLUWALIA A, 1994, BRIT J PHARMACOL, V111, P1017, DOI 10.1111/j.1476-5381.1994.tb14845.x; Ando M, 2014, BREAST CANCER RES TR, V145, P401, DOI 10.1007/s10549-014-2947-1; Auge C, 2013, EUR J PHARMACOL, V707, P32, DOI 10.1016/j.ejphar.2013.03.008; Banerjee J, 2014, ONCOGENE, V33, P4924, DOI 10.1038/onc.2013.431; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bechis SK, 2014, J UROLOGY, V192, P16, DOI 10.1016/j.juro.2014.01.114; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Boudes M, 2011, NEUROUROL URODYNAM, V30, P1659, DOI 10.1002/nau.21180; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Burgio G, 2010, BBA-GENE REGUL MECH, V1799, P671, DOI 10.1016/j.bbagrm.2010.05.007; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chen HJC, 2011, MOL NUTR FOOD RES, V55, P1391, DOI 10.1002/mnfr.201100185; Christmas TJ, 1996, BRIT J UROL, V78, P862, DOI 10.1046/j.1464-410X.1996.02599.x; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; COX PJ, 1979, BIOCHEM PHARMACOL, V28, P2045, DOI 10.1016/0006-2952(79)90222-3; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; DEVRIES CR, 1990, J UROLOGY, V143, P1; EFROS M, 1990, J UROLOGY, V144, P1231, DOI 10.1016/S0022-5347(17)39702-1; FRIEDMAN J, 1977, NUCLEIC ACIDS RES, V4, P3483, DOI 10.1093/nar/4.10.3483; Geisler CH, 2014, BLOOD, V123, P3255, DOI 10.1182/blood-2014-01-547737; Hartman KG, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt366; HASELBERGER MB, 1995, ANN PHARMACOTHER, V29, P918, DOI 10.1177/106002809502900914; He X, 2014, CELL PROLIFERAT, V47, P161, DOI 10.1111/cpr.12091; Hu RQ, 2008, RHEUMATOL INT, V28, P1161, DOI 10.1007/s00296-008-0581-0; Junttila Ilkka, 2013, Duodecim, V129, P705; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; LEVINE LA, 1993, J UROLOGY, V149, P719, DOI 10.1016/S0022-5347(17)36192-X; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Li XH, 2012, MOL CANCER RES, V10, P494, DOI 10.1158/1541-7786.MCR-11-0506; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Martinez-Ferrer M, 2008, AM J PATHOL, V172, P59, DOI 10.2353/ajpath.2008.070529; Martinez-Ferrer M, 2010, AM J PATHOL, V176, P98, DOI 10.2353/ajpath.2010.090283; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Maryanovich M, 2013, TRENDS CELL BIOL, V23, P129, DOI 10.1016/j.tcb.2012.09.007; Miao CG, 2013, CELL SIGNAL, V25, P875, DOI 10.1016/j.cellsig.2012.12.017; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; O'Toole TE, 2009, TOXICOL APPL PHARM, V236, P194, DOI 10.1016/j.taap.2009.01.024; Obtulowicz T, 2010, MUTAGENESIS, V25, P463, DOI 10.1093/mutage/geq028; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Smit SG, 2010, NAT REV UROL, V7, P206, DOI 10.1038/nrurol.2010.23; Starkman JS, 2008, J UROLOGY, V179, P2440, DOI 10.1016/j.juro.2008.01.082; Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388; Terado M, 2005, ENDOCRINE, V26, P55, DOI 10.1385/ENDO:26:1:055; Tian YJ, 2014, BRIT J NUTR, V111, P1594, DOI 10.1017/S0007114513004054; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Wang HT, 2013, CARCINOGENESIS, V34, P220, DOI 10.1093/carcin/bgs323; Wu M, 2011, INFECT IMMUN, V79, P75, DOI 10.1128/IAI.00815-10	54	36	39	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6574	6583		10.1074/jbc.M114.617886	http://dx.doi.org/10.1074/jbc.M114.617886			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25596528	Green Published, hybrid			2022-12-28	WOS:000350732500059
J	Liu, ZH; Li, FD; Zhang, BB; Li, S; Wu, JH; Shi, YY				Liu, Zhonghua; Li, Fudong; Zhang, Beibei; Li, Sai; Wu, Jihui; Shi, Yunyu			Structural Basis of Plant Homeodomain Finger 6 (PHF6) Recognition by the Retinoblastoma Binding Protein 4 (RBBP4) Component of the Nucleosome Remodeling and Deacetylase (NuRD) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORJESON-FORSSMAN-LEHMANN; HISTONE DEACETYLASE; MI-2/NURD COMPLEX; MUTATIONS; RECRUITMENT; INSIGHTS; FEATURES; FEMALES; FOG-1	The NuRD complex is a conserved transcriptional coregulator that contains both chromatin-remodeling and histone deacetylase activities. Mutations of PHF6 are found in patients with Biirjeson-Forssman-Lehmann syndrome, T-cell acute lymphoblastic leukemia, or acute myeloid leukemia. Recently, PHF6 was identified to interact with the NuRD complex, and this interaction is mediated by the RBBP4 component. However, little is known about the molecular basis for the interaction. Here, we present the crystal structure of the complex of the NuRD subunit RBBP4 bound to the 1HF6 peptide (residues 162-170). The PHF6 peptide binds to the top surface of the RBBP4 beta-propeller. A pair of positively charged residues of the PHF6 peptide insert into the negatively charged pocket of RBBP4, which is critical for the interaction between PHF6 and RBBP4. Corresponding PHF6 mutants impair this interaction in vitro and in vivo. Structural comparison shows that the PHF6binding pocket overlaps with LOGI and histone H3 on RBBP4/ Nur155, but it is distinct from the pocket recognizing histone H4, Su(z)12, and MTAL We further show that the middle disordered region (residues 145-207, containing the RBBP4-binding motif) is sufficient for the transcriptional repression mediated by Pl4F6 on the GAL4 reporter, and knockdown of.RBBP4 diminished the PHI6-mediated repression. Our RBBP4-PHI6 complex structure provides insights into the molecular basis of PHF6-NuRD complex interaction and implicates a role for PHF6 in chromatin structure modulation and gene regulation.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759	National Basic Research Program of China 973 Program [2011CB966302, 2012CB917201, 2011CB911104]; Chinese National Natural Science Foundation [31170693, 31330018]; Chinese Academy of Sciences [KJZD-EW-L05]; Strategic Priority Research Program [XDB08010101, XDB08030302]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Priority Research Program(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China 973 Program Grants 2011CB966302, 2012CB917201, and 2011CB911104; Chinese National Natural Science Foundation Grants 31170693 and 31330018; and Chinese Academy of Sciences Grant KJZD-EW-L05 and Strategic Priority Research Program Grants XDB08010101 and XDB08030302.	Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BORJESON M, 1962, ACTA MED SCAND, V171, P13; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Brackertz M, 2002, J BIOL CHEM, V277, P40958, DOI 10.1074/jbc.M207467200; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Conomos D, 2014, NAT STRUCT MOL BIOL, V21, P760, DOI 10.1038/nsmb.2877; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Kosho T, 2014, AM J MED GENET C, V166, P241, DOI 10.1002/ajmg.c.31415; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Liu ZH, 2014, J BIOL CHEM, V289, P10069, DOI 10.1074/jbc.M113.535351; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Pavlopoulos E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006373; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Todd MAM, 2012, J PROTEOME RES, V11, P4326, DOI 10.1021/pr3004369; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Turner G, 2004, CLIN GENET, V65, P226, DOI 10.1111/j.0009-9163.2004.00215.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Visootsak J, 2004, J PEDIATR-US, V145, P819, DOI 10.1016/j.jpeds.2004.07.041; Voss AK, 2007, GENE EXPR PATTERNS, V7, P858, DOI 10.1016/j.modgep.2007.06.007; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zweier C, 2014, AM J MED GENET C, V166, P290, DOI 10.1002/ajmg.c.31408	37	26	29	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6630	6638		10.1074/jbc.M114.610196	http://dx.doi.org/10.1074/jbc.M114.610196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25601084	Green Published, hybrid			2022-12-28	WOS:000350732500064
J	Petrosyan, A; Ali, MF; Cheng, PW				Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan			Keratin 1 Plays a Critical Role in Golgi Localization of Core 2 N-Acetylglucosaminyltransferase M via Interaction with Its Cytoplasmic Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-SPANNING DOMAIN; NONMUSCLE MYOSIN IIA; ENDOPLASMIC-RETICULUM; INTERMEDIATE-FILAMENTS; MUCIN BIOSYNTHESIS; MOLECULAR-CLONING; BREFELDIN-A; IN-VITRO; GLYCOSYLTRANSFERASES; PROTEIN	Core 2 N-acetylglucosaminyltransferase 2/M (C2GnT-M) synthesizes all three beta 6GlcNAc branch structures found in secreted mucins. Loss of C2GnT-M leads to development of colitis and colon cancer. Recently we have shown that C2GnT-M targets the Golgi at the Giantin site and is recycled by binding to non-muscle myosin IIA, a motor protein, via the cytoplasmic tail (CT). But how this enzyme is retained in the Golgi is not known. Proteomics analysis identifies keratin type II cytoskeletal 1 (KRT1) as a protein pulled down with anti-c-Myc antibody or C2GnT-M CT from the lysate of Panc1 cells expressing bC2GnT-M tagged with c-Myc. Yeast two-hybrid analysis shows that the rod domain of KRT1 interacts directly with the WKR6 motif in the C2GnT-M CT. Knockdown of KRT1 does not affect Golgi morphology but increases the interaction of C2GnT-M with non-muscle myosin IIA and its transportation to the endoplasmic reticulum, ubiquitination, and degradation. During Golgi recovery after brefeldin A treatment, C2GnT-M forms a complex with Giantin before KRT1, demonstrating CT-mediated sequential events of Golgi targeting and retention of C2GnT-M. In HeLa cells transiently expressing C2GnT-M-GFP, knockdown of KRT1 does not affect Golgi morphology but leaves C2GnT-M outside of the Golgi, resulting in the formation of sialyl-T antigen. Interaction of C2GnT-M and KRT1 was also detected in the goblet cells of human colon epithelial tissue and primary culture of colonic epithelial cells. The results indicate that glycosylation and thus the function of glycoconjugates can be regulated by a protein that helps retain a glycosyltransferase in the Golgi.	[Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan] VA Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE 68105 USA; [Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan] Univ Nebraska, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Cheng, Pi-Wan] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center	Cheng, PW (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	pcheng@unmc.edu	Petrosyan, Armen/T-7071-2018	Petrosyan, Armen/0000-0003-3895-3993	Office of Research and Development, Department of Veterans Affairs [VA 1I1BX000985]; National Institutes of Health [R21 HL097238]; State of Nebraska [LB506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA022979] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000985] Funding Source: NIH RePORTER	Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the Office of Research and Development, Department of Veterans Affairs (VA 1I1BX000985), the National Institutes of Health Grant R21 HL097238, and the State of Nebraska (LB506).	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; BURGESS TL, 1991, CELL MOTIL CYTOSKEL, V20, P289, DOI 10.1002/cm.970200405; BURKE J, 1994, J BIOL CHEM, V269, P12049; Cheng PW, 2011, ADV EXP MED BIOL, V705, P465, DOI 10.1007/978-1-4419-7877-6_25; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Choi KH, 2004, AM J RESP CELL MOL, V30, P710, DOI 10.1165/rcmb.2003-0202OC; Chu PG, 2000, MODERN PATHOL, V13, P962, DOI 10.1038/modpathol.3880175; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Dabelsteen E, 1996, J PATHOL, V179, P358; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; Eklund Erik A, 2006, NeuroRx, V3, P254; El-Battari A, 2006, METHOD ENZYMOL, V416, P102, DOI 10.1016/S0076-6879(06)16007-3; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; England K, 2002, CELL SIGNAL, V14, P529, DOI 10.1016/S0898-6568(01)00277-7; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HENDRICKS LC, 1992, P NATL ACAD SCI USA, V89, P7242, DOI 10.1073/pnas.89.15.7242; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; Jiang S, 2005, MOL BIOL CELL, V16, P2586, DOI 10.1091/mbc.e04-10-0861; JOHNSON LD, 1985, P NATL ACAD SCI USA, V82, P1896, DOI 10.1073/pnas.82.7.1896; KARTASOVA T, 1993, J CELL BIOL, V120, P1251, DOI 10.1083/jcb.120.5.1251; Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514; Kumar R, 1996, BLOOD, V88, P3872, DOI 10.1182/blood.V88.10.3872.bloodjournal88103872; Kumemura H, 2004, CELL MOTIL CYTOSKEL, V57, P37, DOI 10.1002/cm.10152; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; May JA, 1998, PLATELETS, V9, P227, DOI 10.1080/09537109876744; Nakamura M, 1998, J BIOL CHEM, V273, P26779, DOI 10.1074/jbc.273.41.26779; Nilsson T, 1996, J CELL SCI, V109, P1975; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Osman N, 1996, J BIOL CHEM, V271, P33105, DOI 10.1074/jbc.271.51.33105; Pellett PA, 2013, ELIFE, V2, DOI 10.7554/eLife.01296; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Petrosyan A, 2014, MOL CANCER RES, V12, P1704, DOI 10.1158/1541-7786.MCR-14-0291-T; Petrosyan A, 2014, CELL STRESS CHAPERON, V19, P241, DOI 10.1007/s12192-013-0450-y; Petrosyan A, 2013, GLYCOBIOLOGY, V23, P690, DOI 10.1093/glycob/cwt009; Petrosyan A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.C112.403006; Petrosyan A, 2012, INT J BIOCHEM CELL B, V44, P1153, DOI 10.1016/j.biocel.2012.04.004; Quintero CA, 2008, BIOCHEM J, V412, P19, DOI 10.1042/BJ20071725; Quintero CA, 2010, J BIOL CHEM, V285, P30340, DOI 10.1074/jbc.M110.128868; Rhee SW, 2005, TRAFFIC, V6, P978, DOI 10.1111/j.1600-0854.2005.00333.x; ROPP PA, 1991, J BIOL CHEM, V266, P23863; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; St Hill C. A., 2011, PLOS ONE, V6; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Styers ML, 2005, TRAFFIC, V6, P359, DOI 10.1111/j.1600-0854.2005.00286.x; Tal O, 2005, CLIN EXP DERMATOL, V30, P64, DOI 10.1111/j.1365-2230.2004.01661.x; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Toivola DM, 2008, AM J PATHOL, V172, P882, DOI 10.2353/ajpath.2008.070830; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; TURNER JR, 1989, J CELL BIOL, V109, P2081, DOI 10.1083/jcb.109.5.2081; Varki A., 2009, ESSENTIALS GLYCOBIOL; Virtanen M, 2003, J INVEST DERMATOL, V121, P1013, DOI 10.1046/j.1523-1747.2003.12534.x; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wassler MJ, 2001, J CELL SCI, V114, P2291; Weber KL, 2002, J CELL SCI, V115, P1373; Whitehouse C, 1997, J CELL BIOL, V137, P1229, DOI 10.1083/jcb.137.6.1229; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; YANG JM, 1994, J INVEST DERMATOL, V102, P17, DOI 10.1111/1523-1747.ep12371725; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Zerfaoui M, 2002, GLYCOBIOLOGY, V12, P15, DOI 10.1093/glycob/12.1.15	73	19	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6256	6269		10.1074/jbc.M114.618702	http://dx.doi.org/10.1074/jbc.M114.618702			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605727	hybrid, Green Published			2022-12-28	WOS:000350732500032
J	Padmanabhan, J; Brown, KR; Padilla, A; Shelanski, ML				Padmanabhan, Jaya; Brown, Kristy R.; Padilla, Amelia; Shelanski, Michael L.			Functional Role of RNA Polymerase II and P70 S6 Kinase in KCl Withdrawal-induced Cerebellar Granule Neuron Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; PROGRAMMED CELL-DEATH; DNA-DAMAGING AGENTS; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; NERVOUS-SYSTEM; MESSENGER-RNAS; HISTONE H3; IN-VITRO; P-TEFB	KCl withdrawal-induced apoptosis in cerebellar granule neurons is associated with aberrant cell cycle activation, and treatment with cyclin-dependent kinase (Cdk) inhibitors protects cells from undergoing apoptosis. Because the Cdk inhibitor flavopiridol is known to inhibit RNA polymerase II (Pol II)-dependent transcription elongation by inhibiting the positive transcription elongation factor b (P-TEFb, a complex of CDK9 and cyclin T), we examined whether inhibition of RNA Pol II protects neurons from apoptosis. Treatment of neurons with 5, 6-dichloro-1-beta-D-ribobenzimidazole (DRB), an RNA Pol II-dependent transcription elongation inhibitor, and flavopiridol inhibited phosphorylation and activation of Pol II and protected neurons from undergoing apoptosis. In addition to Pol II, neurons subjected to KCl withdrawal showed increased phosphorylation and activation of p70 S6 kinase, which was inhibited by both DRB and flavopiridol. Immunostaining analysis of the neurons deprived of KCl showed increased nuclear levels of phospho-p70 S6 kinase, and neurons protected with DRB and flavopiridol showed accumulation of the kinase into large spliceosome assembly factor-positive speckle domains within the nuclei. The formation of these foci corresponded with cell survival, and removal of the inhibitors resulted in dispersal of the speckles into smaller foci with subsequent apoptosis induction. Because p70 S6 kinase is known to induce translation of mRNAs containing a 5'-terminal oligopyrimidine tract, our data suggest that transcription and translation of this subset of mRNAs may contribute to KCl withdrawal-induced apoptosis in neurons.	[Padmanabhan, Jaya; Padilla, Amelia] Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL 33613 USA; [Brown, Kristy R.; Shelanski, Michael L.] Columbia Univ, Coll Phys & Surg, Taub Ctr Alzheimers Dis, Dept Pathol & Cell Biol, New York, NY 10032 USA	State University System of Florida; University of South Florida; Columbia University	Padmanabhan, J (corresponding author), Univ S Florida, USF Hlth Byrd Alzheimers Inst, Dept Mol Med, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	jpadmana@health.usf.edu	Padmanabhan, Jaya/A-4226-2012	Padmanabhan, Jaya/0000-0003-2019-5135	NINDS/National Institutes of Health Javits Neuroscience Award [NS-15076]; NIA/National Institutes of Health R21 Award [1R21AG031429-01A2]; Alzheimer's Association Investigator Initiated Research Grant [IIRG-08-90842]; Byrd Institute Small Grants Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031429] Funding Source: NIH RePORTER	NINDS/National Institutes of Health Javits Neuroscience Award; NIA/National Institutes of Health R21 Award; Alzheimer's Association Investigator Initiated Research Grant; Byrd Institute Small Grants Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Javits Neuroscience Award NS-15076 (to M. L. S.) and by NIA/National Institutes of Health R21 Award 1R21AG031429-01A2 (to J. P.).This work was also supported by Alzheimer's Association Investigator Initiated Research Grant IIRG-08-90842 (to J. P.) and by the Byrd Institute Small Grants Program (to J. P.).	Alvira D, 2007, NEUROSCIENCE, V146, P350, DOI 10.1016/j.neuroscience.2007.01.042; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; BALLOU LM, 1988, P NATL ACAD SCI USA, V85, P7154, DOI 10.1073/pnas.85.19.7154; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; BARRATT MJ, 1994, P NATL ACAD SCI USA, V91, P4781, DOI 10.1073/pnas.91.11.4781; Barth-Baus D, 2002, NUCLEIC ACIDS RES, V30, P1919, DOI 10.1093/nar/30.9.1919; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Blagosklonny MV, 2004, CELL CYCLE, V3, P1537, DOI 10.4161/cc.3.12.1278; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x; Carlson BA, 1996, CANCER RES, V56, P2973; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Cmarko D, 1999, MOL BIOL CELL, V10, P211, DOI 10.1091/mbc.10.1.211; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; DREYER EB, 1995, NEUROREPORT, V6, P942, DOI 10.1097/00001756-199504190-00029; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Dumont F J, 1996, Life Sci, V58, P373; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; GALLI C, 1995, J NEUROSCI, V15, P1172; GALLO V, 1987, J NEUROSCI, V7, P2203; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hubert T, 2014, J NEUROSCI, V34, P758, DOI 10.1523/JNEUROSCI.2886-13.2014; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Kim SJ, 1997, BIOCHEM BIOPH RES CO, V234, P681, DOI 10.1006/bbrc.1997.6699; Kole AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.220; Konishi Y, 2003, J NEUROSCI, V23, P1649; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Kwon HK, 2002, ARCH PHARM RES, V25, P685, DOI 10.1007/BF02976945; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Miller TM, 1996, J NEUROSCI, V16, P7487; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Padmanabhan J, 2007, DEV NEUROBIOL, V67, P818, DOI 10.1002/dneu.20394; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Park DS, 1998, J NEUROSCI, V18, P830; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P8975; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rogalinska M, 2010, J CELL BIOCHEM, V109, P217, DOI 10.1002/jcb.22400; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; Schwab MS, 1999, MOL CELL BIOL, V19, P2485; Schwartz BE, 2003, MOL CELL BIOL, V23, P6876, DOI 10.1128/MCB.23.19.6876-6886.2003; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Stefanis L, 1999, J NEUROSCI, V19, P6235; Tang Z, 2013, J BIOL CHEM, V288, P15556, DOI 10.1074/jbc.M112.435123; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; VILLA P, 1994, J NEUROCHEM, V62, P1468; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; Yang K, 2013, BRAIN STRUCT FUNCT, V218, P669, DOI 10.1007/s00429-012-0420-7; Zhou XW, 2008, FEBS LETT, V582, P159, DOI 10.1016/j.febslet.2007.11.078	72	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5267	5279		10.1074/jbc.M114.575225	http://dx.doi.org/10.1074/jbc.M114.575225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568312	Green Published, hybrid			2022-12-28	WOS:000350044200004
J	Habeck, M; Haviv, H; Katz, A; Kapri-Pardes, E; Ayciriex, S; Shevchenko, A; Ogawa, H; Toyoshima, C; Karlish, SJD				Habeck, Michael; Haviv, Haim; Katz, Adriana; Kapri-Pardes, Einat; Ayciriex, Sophie; Shevchenko, Andrej; Ogawa, Haruo; Toyoshima, Chikashi; Karlish, Steven J. D.			Stimulation, Inhibition, or Stabilization of Na,K-ATPase Caused by Specific Lipid Interactions at Distinct Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; MOLECULAR ACTIVITY; K+-ATPASE; PROTEIN INTERACTIONS; MEMBRANE-PROTEINS; NA+,K+-ATPASE; CHOLESTEROL; BINDING; KIDNEY	The activity of membrane proteins such as Na,K-ATPase depends strongly on the surrounding lipid environment. Interactions can be annular, depending on the physical properties of the membrane, or specific with lipids bound in pockets between transmembrane domains. This paper describes three specific lipid-protein interactions using purified recombinant Na, K-ATPase. (a) Thermal stability of the Na, K-ATPase depends crucially on a specific interaction with 18:0/18:1 phosphatidylserine (1-stearoyl-2-oleoyl-sn-glycero-3-phospho-L-serine; SOPS) and cholesterol, which strongly amplifies stabilization. We show here that cholesterol associates with SOPS, FXYD1, and the alpha subunit between trans-membrane segments alpha TM8 and -10 to stabilize the protein. (b) Polyunsaturated neutral lipids stimulate Na, K-ATPase turnover by >60%. A screen of the lipid specificity showed that 18:0/20:4 and 18:0/22:6 phosphatidyle-thanolamine (PE) are the optimal phospholipids for this effect. (c) Saturated phosphatidylcholine and sphingomyelin, but not saturated phosphatidylserine or PE, inhibit Na,K-ATPase activity by 70-80%. This effect depends strongly on the presence of cholesterol. Analysis of the Na,K-ATPase activity and E-1-E-2 conformational transitions reveals the kinetic mechanisms of these effects. Both stimulatory and inhibitory lipids poise the conformational equilibrium toward E-2, but their detailed mechanisms of action are different. PE accelerates the rate of E-1 -> E2P but does not affect E-2(2K) ATP -> E(1)3NaATP, whereas sphingomyelin inhibits the rate of E-2(2K) ATP -> E(1)3NaATP, with very little effect on E-1 -> E2P. We discuss these lipid effects in relation to recent crystal structures of Na,K-ATPase and propose that there are three separate sites for the specific lipid interactions, with potential physiological roles to regulate activity and stability of the pump.	[Habeck, Michael; Haviv, Haim; Katz, Adriana; Kapri-Pardes, Einat; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Ayciriex, Sophie; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Ogawa, Haruo; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Weizmann Institute of Science; Max Planck Society; University of Tokyo	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il	Ayciriex, Sophie/C-1804-2017; Toyoshima, Chikashi/R-4153-2019	Ayciriex, Sophie/0000-0003-4813-5900; Habeck, Michael/0000-0002-4586-0499; Toyoshima, Chikashi/0000-0001-9640-0778	Minerva Foundation	Minerva Foundation	Supported by the Minerva Foundation.	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Apell HJ, 2004, BIOELECTROCHEMISTRY, V63, P149, DOI 10.1016/j.bioelechem.2003.09.021; Barrera NP, 2013, TRENDS CELL BIOL, V23, P1, DOI 10.1016/j.tcb.2012.08.007; Belogus T, 2009, J BIOL CHEM, V284, P31038, DOI 10.1074/jbc.M109.050054; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BUHLER R, 1991, J MEMBRANE BIOL, V121, P141, DOI 10.1007/BF01870529; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Cirri E, 2011, BIOCHEMISTRY-US, V50, P3736, DOI 10.1021/bi2001714; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; Else PL, 2003, ANN NY ACAD SCI, V986, P525, DOI 10.1111/j.1749-6632.2003.tb07240.x; Esmann M, 2006, CHEM PHYS LIPIDS, V141, P94, DOI 10.1016/j.chemphyslip.2006.02.018; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Forbush B 3rd, 1991, Soc Gen Physiol Ser, V46, P210; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Haviv H, 2013, J BIOL CHEM, V288, P10073, DOI 10.1074/jbc.M112.446997; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Jorgensen P L, 1988, Prog Clin Biol Res, V268A, P19; JORGENSEN PL, 1986, BIOCHEMISTRY-US, V25, P2889; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liu LJ, 2011, BIOCHEMISTRY-US, V50, P8664, DOI 10.1021/bi2009008; Lupfert C, 2001, BIOPHYS J, V81, P2069, DOI 10.1016/S0006-3495(01)75856-0; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nealon JR, 2008, J EXP BIOL, V211, P3195, DOI 10.1242/jeb.019968; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Post RL, 1996, AM J PHYSIOL-CELL PH, V271, pC1415, DOI 10.1152/ajpcell.1996.271.5.C1415; POST RL, 1972, J BIOL CHEM, V247, P6530; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Sonntag Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1307; STARLING AP, 1995, BIOCHEM J, V310, P875, DOI 10.1042/bj3100875; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Turner N, 2003, ANN NY ACAD SCI, V986, P606, DOI 10.1111/j.1749-6632.2003.tb07260.x; Turner N, 2006, PHYSIOL BIOCHEM ZOOL, V79, P522, DOI 10.1086/502815; WHEELER KP, 1970, J PHYSIOL-LONDON, V207, P303, DOI 10.1113/jphysiol.1970.sp009063; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; YABUUCHI H, 1968, J LIPID RES, V9, P65; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004	69	46	51	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4829	4842		10.1074/jbc.M114.611384	http://dx.doi.org/10.1074/jbc.M114.611384			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533463	hybrid, Green Published			2022-12-28	WOS:000350042000028
J	Ravi, A; Kaushik, S; Ravichandran, A; Pan, CQ; Low, BC				Ravi, Archna; Kaushik, Shelly; Ravichandran, Aarthi; Pan, Catherine Qiurong; Low, Boon Chuan			Epidermal Growth Factor Activates the Rho GTPase-activating Protein (GAP) Deleted in Liver Cancer 1 via Focal Adhesion Kinase and Protein Phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-MIGRATION; DLC1; BINDING; DOMAIN; GENE; RAS; PHOSPHORYLATION; TUMORIGENESIS; CYTOSKELETON	Deleted in Liver Cancer 1 (DLC1) is a RHO GTPase-activating protein (GAP) that negatively regulates RHO. Through its GAP activity, it modulates the actin cytoskeleton network and focal adhesion dynamics, ultimately leading to suppression of cell invasion and metastasis. Despite its presence in various structural and signaling components, little is known about how the activity of DLC1 is regulated at focal adhesions. Here we show that EGF stimulation activates the GAP activity of DLC1 through a concerted mechanism involving DLC1 phosphorylation by MEK/ERK and its subsequent dephosphorylation by protein phosphatase 2A (PP2A) and inhibition of focal adhesion kinase by MEK/ERK to allow the binding between DLC1 and PP2A. Phosphoproteomics and mutation studies revealed that threonine 301 and serine 308 on DLC1, known previously to be mutated in certain cancers, are required for DLC1-PP2A interaction and the subsequent activation of DLC1 upon their dephosphorylation. The intricate interplay of this "MEK/ERK-focal adhesion kinase-DLC1-PP2A" quartet provides a novel checkpoint in the spatiotemporal control of cell spreading and cell motility.	[Ravi, Archna; Kaushik, Shelly; Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117543, Singapore; [Ravi, Archna; Kaushik, Shelly; Ravichandran, Aarthi; Pan, Catherine Qiurong; Low, Boon Chuan] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	National University of Singapore; National University of Singapore	Low, BC (corresponding author), Natl Univ Singapore, Mechanobiol Inst, 5A Engn Dr, Singapore 117411, Singapore.	dbslowbc@nus.edu.sg	Low, Boon Chuan/AAU-7685-2021; Ravi, Archna/P-4801-2018; Kaushik, Shelly/O-4307-2019; Low, Boon Chuan/H-8049-2012	Low, Boon Chuan/0000-0003-0756-096X; Ravi, Archna/0000-0002-4336-5320; Low, Boon Chuan/0000-0003-0756-096X; Kaushik, Shelly/0000-0002-8967-3265	Mechanobiology Institute (Singapore); Ministry of Education (Singapore) Academic Research Fund [T208A3121]	Mechanobiology Institute (Singapore); Ministry of Education (Singapore) Academic Research Fund(Ministry of Education, Singapore)	This work was supported by grants from The Mechanobiology Institute (Singapore) and by Ministry of Education (Singapore) Academic Research Fund T208A3121 (to B. C. L.). This work was also supported by a graduate fellowship (to A. R.).	Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cao X, 2012, P NATL ACAD SCI USA, V109, P1455, DOI 10.1073/pnas.1114368109; Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; Du XL, 2012, CANCER RES, V72, P4405, DOI 10.1158/0008-5472.CAN-12-0777; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Kaushik S, 2014, CYTOSKELETON, V71, P677, DOI 10.1002/cm.21201; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Kim TY, 2008, J BIOL CHEM, V283, P32762, DOI 10.1074/jbc.M800617200; Ko FCF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2604; Ko FCF, 2010, GASTROENTEROLOGY, V139, P1397, DOI 10.1053/j.gastro.2010.06.051; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; SHIMA H, 1994, P NATL ACAD SCI USA, V91, P9267, DOI 10.1073/pnas.91.20.9267; Takeuchi T, 2009, BIOORGAN MED CHEM, V17, P8113, DOI 10.1016/j.bmc.2009.09.050; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zhang T, 2009, CANCER LETT, V283, P59, DOI 10.1016/j.canlet.2009.03.025; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013; Zhong D, 2009, J CELL SCI, V122, P414, DOI 10.1242/jcs.027482; Zhou X, 2008, INT J ONCOL, V32, P1285	44	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4149	4162		10.1074/jbc.M114.616839	http://dx.doi.org/10.1074/jbc.M114.616839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25525271	Green Published, hybrid			2022-12-28	WOS:000349458400027
J	Kawasaki, K; Ushioda, R; Ito, S; Ikeda, K; Masago, Y; Nagata, K				Kawasaki, Kunito; Ushioda, Ryo; Ito, Shinya; Ikeda, Kazuo; Masago, Yusaku; Nagata, Kazuhiro			Deletion of the Collagen-specific Molecular Chaperone Hsp47 Causes Endoplasmic Reticulum Stress-mediated Apoptosis of Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CARBOXYL-TERMINAL PROPEPTIDE; A-COUPLED LIPOSOMES; I COLLAGEN; TRANSMEMBRANE PROTEIN; OSTEOGENESIS IMPERFECTA; INTESTINAL FIBROSIS; LIVER FIBROSIS; UP-REGULATION; PROCOLLAGEN	Chronic liver injury, often caused by alcoholism and viral hepatitis, causes liver fibrosis via the induction of collagen production. In liver fibrosis, hepatic stellate cells (HSCs) are activated and transform into myofibroblasts, which actively produce and secrete collagen into the extracellular matrix. Hsp47 (heat shock protein 47) is a collagen-specific molecular chaperone that is essential for the maturation and secretion of collagen. Here, we used the Cre-LoxP system to disrupt the Hsp47 gene in isolated HSCs from Hsp47 floxed mice. Immature type I procollagen accumulated and partially aggregated in Hsp47-KO HSCs. This accumulation was augmented when autophagy was inhibited, which induced expression of the endoplasmic reticulum (ER) stress-inducible proteins BiP (immunoglobulin heavy chain-binding protein) and Grp94 (94-kDa glucose-regulated protein). The inhibition of autophagy in Hsp47-KO HSCs also induced CHOP (CCAAT/enhancer-binding protein homologous protein), which is an ER stress-induced transcription factor responsible for apoptosis. These data suggest that apoptosis is induced through ER stress by procollagen accumulation in Hsp47-KO HSCs when autophagy is inhibited. Thus, Hsp47 could be a promising therapeutic target in liver fibrosis.	[Kawasaki, Kunito; Ushioda, Ryo; Ito, Shinya; Masago, Yusaku; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan; [Kawasaki, Kunito; Ito, Shinya; Masago, Yusaku] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan; [Ikeda, Kazuo] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Abeno Ku, Osaka 5458585, Japan; [Nagata, Kazuhiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kyoto Sangyo University; Kyoto University; Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Ushioda, R (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	ryo3ussy3@cc.kyoto-su.ac.jp; nagata@cc.kyoto-su.ac.jp		Masago, Yusaku/0000-0002-0173-9179; Ushioda, Ryo/0000-0003-2775-8746	Japan Society for the Promotion of Science [24227009, 24121725, 26111521, 25840079];  [11J05697]; Grants-in-Aid for Scientific Research [15H01545] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (S) 24227009 from the Japan Society for the Promotion of Science (to K. N.), Grants-in-Aid for Scientific Research on Innovative Areas 24121725 and 26111521 and for Scientific Research for Young Scientists (B) 25840079 from the Japan Society for the Promotion of Science (to R. U.), and Grant-in-Aid for Japan Society for the Promotion of Science Fellows 11J05697 (to S. I.).	CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; FERREIRA LR, 1994, J CELL BIOCHEM, V56, P518, DOI 10.1002/jcb.240560412; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Honzawa Y, 2014, GUT, V63, P1902, DOI 10.1136/gutjnl-2013-305632; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kinoshita K, 2007, GUT, V56, P396, DOI 10.1136/gut.2005.085704; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kitamura H, 2011, BIOCHEM BIOPH RES CO, V404, P599, DOI 10.1016/j.bbrc.2010.12.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; LAMANDE SR, 1993, BIOCHEM J, V293, P387, DOI 10.1042/bj2930387; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Masago Y, 2012, J CELL SCI, V125, P1118, DOI 10.1242/jcs.089748; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Mehtani S, 1998, J BIOL CHEM, V273, P13236, DOI 10.1074/jbc.273.21.13236; MORI K, 1993, CELL, V74, P743; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; Naitoh M, 2001, BIOCHEM BIOPH RES CO, V280, P1316, DOI 10.1006/bbrc.2001.4257; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; Radaeva S, 2007, AM J PHYSIOL-GASTR L, V293, pG809, DOI 10.1152/ajpgi.00212.2007; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Sunamoto M, 1998, LAB INVEST, V78, P967; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Thoen LFR, 2011, J HEPATOL, V55, P1353, DOI 10.1016/j.jhep.2011.07.010; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wake K, 1980, Int Rev Cytol, V66, P303; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637	50	58	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3639	3646		10.1074/jbc.M114.592139	http://dx.doi.org/10.1074/jbc.M114.592139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525267	Green Published, hybrid			2022-12-28	WOS:000349456000036
J	Zhang, JL; Yuan, CF; Wu, JG; Elsayed, Z; Fu, Z				Zhang, Jinglei; Yuan, Chengfu; Wu, Jianguo; Elsayed, Zeinab; Fu, Zheng			Polo-like Kinase 1-mediated Phosphorylation of Forkhead Box Protein M1b Antagonizes Its SUMOylation and Facilitates Its Mitotic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; SUMO-1 MODIFICATION; TRANSCRIPTION FACTOR; CELL-CYCLE; IN-VIVO; FOXM1; BINDING; DOMAIN; PROGRESSION; REQUIRES	Transcription factor Forkhead box protein M1b (FoxM1b) plays an important role during mitotic entry and progression. Our previous studies identified polo-like kinase 1 (PLK1) as a major regulator of FoxM1b. During G(2)/M transition, PLK1 directly interacts with and phosphorylates FoxM1b, resulting in full activation of the transactivation capacity of FoxM1b. Such a vital regulatory mechanism is essential for timely mitotic entry and progression. However, the molecular mechanism by which PLK1-mediated phosphorylation enhances the transcriptional activity of FoxM1b remains to be determined. We demonstrate that FoxM1b can be SUMOylated in vitro and in vivo, preferentially by SUMO-1. SUMOylation of FoxM1b was found to occur at multiple sites, leading to suppression of FoxM1b transcriptional activity. Such a posttranslational modification of FoxM1b was antagonized by PLK1-mediated phosphorylation. By immunofluorescence staining and subcellular fractionation, we demonstrate that SUMO conjugation promotes cytosolic translocation of FoxM1b. Moreover, SUMO modification of FoxM1b facilitates the ubiquitin-mediated proteasomal degradation of FoxM1b. PLK1-mediated phosphorylation of FoxM1b abrogates the inhibitory effect on FoxM1b by SUMO modification, thereby promoting its nuclear translocation and preventing its proteolytic degradation in the cytoplasm. Such an antagonistic regulatory mechanism is essential for the mitotic function of FoxM1b, ensuring timely mitotic entry and progression. Taken together, our studies have revealed a working mechanism by which PLK1 positively regulates the activity and level of FoxM1b, which would greatly facilitate therapeutic interventions that focus on targeting the PLK1-mediated and/or FoxM1-mediated signaling network.	[Zhang, Jinglei; Yuan, Chengfu; Wu, Jianguo; Elsayed, Zeinab; Fu, Zheng] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Inst Mol Genet,Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University	Fu, Z (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, 401 Coll St, Richmond, VA 23298 USA.	zfu@vcu.edu	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	NCI Cancer Center/National Institutes of Health [P30CA016059]; Department of Defense Prostate Cancer Research Program [PC094435]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER	NCI Cancer Center/National Institutes of Health; Department of Defense Prostate Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI Cancer Center/National Institutes of Health Support Grant P30CA016059 (to the Virginia Commonwealth University Massey Cancer Center). This work was also supported by Department of Defense Prostate Cancer Research Program Grant PC094435 (to Z. F.).	Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Everett RD, 1999, J CELL SCI, V112, P4581; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Wang CM, 2014, INT J MOL SCI, V15, P10233, DOI 10.3390/ijms150610233; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wierstra I, 2007, BIOL CHEM, V388, P805, DOI 10.1515/BC.2007.094; Wierstra I, 2007, BIOCHEM BIOPH RES CO, V352, P61, DOI 10.1016/j.bbrc.2006.10.151; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Yuan CF, 2012, MOL CELL BIOCHEM, V359, P333, DOI 10.1007/s11010-011-1027-7; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006	38	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3708	3719		10.1074/jbc.M114.634386	http://dx.doi.org/10.1074/jbc.M114.634386			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533473	Green Published, hybrid			2022-12-28	WOS:000349456000042
J	Campeotto, I; Zhang, Y; Mladenov, MG; Freemont, PS; Grundling, A				Campeotto, Ivan; Zhang, Yong; Mladenov, Miroslav G.; Freemont, Paul S.; Grundling, Angelika			Complex Structure and Biochemical Characterization of the Staphylococcus aureus Cyclic Diadenylate Monophosphate (c-di-AMP)-binding Protein PstA, the Founding Member of a New Signal Transduction Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Bioinformatics; Crystal Structure; Nucleotide; Staphylococcus aureus (S; aureus); Complex	C-DI-AMP; CRYSTAL-STRUCTURES; GMP-AMP; SEQUENCE; BINDING; 2ND-MESSENGER; MECHANISM; REVEALS; CYANOBACTERIA; CONSERVATION	Background: PstA is a cyclic di-AMP receptor and PII-like signal transduction protein. Results: Apo-PstA and complex crystal structures reveal a novel cyclic di-AMP-binding mode and induced conformational changes. Conclusion: PstA has a similar fold but distinct signal transduction properties from classic PII proteins, which function in nitrogen metabolism. Significance: Identification of common features allows for rational prediction of cyclic di-AMP-binding sites. Signaling nucleotides are integral parts of signal transduction systems allowing bacteria to cope with and rapidly respond to changes in the environment. The Staphylococcus aureus PII-like signal transduction protein PstA was recently identified as a cyclic diadenylate monophosphate (c-di-AMP)-binding protein. Here, we present the crystal structures of the apo- and c-di-AMP-bound PstA protein, which is trimeric in solution as well as in the crystals. The structures combined with detailed bioinformatics analysis revealed that the protein belongs to a new family of proteins with a similar core fold but with distinct features to classical PII proteins, which usually function in nitrogen metabolism pathways in bacteria. The complex structure revealed three identical c-di-AMP-binding sites per trimer with each binding site at a monomer-monomer interface. Although distinctly different from other cyclic-di-nucleotide-binding sites, as the half-binding sites are not symmetrical, the complex structure also highlighted common features for c-di-AMP-binding sites. A comparison between the apo and complex structures revealed a series of conformational changes that result in the ordering of two anti-parallel -strands that protrude from each monomer and allowed us to propose a mechanism on how the PstA protein functions as a signaling transduction protein.	[Campeotto, Ivan; Zhang, Yong; Mladenov, Miroslav G.; Grundling, Angelika] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, London SW7 2AZ, England; [Campeotto, Ivan; Zhang, Yong; Mladenov, Miroslav G.; Grundling, Angelika] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Struct Biol, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Struct Biol, South Kensington Campus,Sir Ernst Chain Bldg, London SW7 2AZ, England.	p.freemont@imperial.ac.uk; a.grundling@imperial.ac.uk	ZHANG, YONG/H-1959-2011; ZHANG, YONG/J-3689-2019	ZHANG, YONG/0000-0003-2968-0081; ZHANG, YONG/0000-0003-2968-0081; Campeotto, Ivan/0000-0002-0814-619X; Grundling, Angelika/0000-0002-6235-8687	European Research Council [260371]; Wellcome Trust [100289]; EMBO Long Term Fellowship [ALTF 721-2013]; MRC [MR/J006874/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Research Council Grant 260371, Wellcome Trust Grant 100289 (to A. G.), and the EMBO Long Term Fellowship ALTF 721-2013 (to Y. Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Helfmann S, 2010, J MOL BIOL, V402, P165, DOI 10.1016/j.jmb.2010.07.020; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lu D, 2009, P NATL ACAD SCI USA, V106, P1584, DOI 10.1073/pnas.0809020106; Maier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026327; Nichols CE, 2006, ACTA CRYSTALLOGR F, V62, P494, DOI 10.1107/S1744309106015430; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Read RJ, 2013, ACTA CRYSTALLOGR D, V69, P176, DOI 10.1107/S0907444912045374; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sakai H, 2005, J STRUCT BIOL, V149, P99, DOI 10.1016/j.jsb.2004.08.007; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2003, ACTA CRYSTALLOGR D, V59, P2183, DOI 10.1107/S0907444903019589; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zheng C, 2013, ENZYME MICROB TECH, V52, P319, DOI 10.1016/j.enzmictec.2013.03.007	46	42	44	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2888	2901		10.1074/jbc.M114.621789	http://dx.doi.org/10.1074/jbc.M114.621789			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505271	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000349310700029
J	Deng, SS; Wu, LY; Wang, YC; Cao, PR; Xu, L; Li, QR; Liu, M; Zhang, L; Jiang, YJ; Yang, XY; Sun, SN; Tan, MJ; Qian, M; Zang, Y; Feng, LY; Li, J				Deng, Si-Si; Wu, Le-Yu; Wang, Ya-Chao; Cao, Peng-Rong; Xu, Lei; Li, Qian-Ru; Liu, Meng; Zhang, Lun; Jiang, Yue-Jing; Yang, Xiao-Yu; Sun, Sheng-Nan; Tan, Min-jia; Qian, Min; Zang, Yi; Feng, Linyin; Li, Jia			Protein Kinase A Rescues Microtubule Affinity-regulating Kinase 2-induced Microtubule Instability and Neurite Disruption by Phosphorylating Serine 409	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Microtubule; Microtubule-associated Protein (MAP); Neurite Outgrowth; Protein Kinase A (PKA); Tau Protein (Tau); MARK2	UBIQUITIN-ASSOCIATED DOMAINS; TAU-PHOSPHORYLATION; ALZHEIMERS-DISEASE; NEURONAL POLARITY; MARK/PAR-1; FAMILY; OUTGROWTH; TOXICITY; DIFFERENTIATION; ESTABLISHMENT	Background: MARK2 and PKA are both involved in the regulation of microtubule stability. Results: PKA significantly inhibits MARK2 by phosphorylating serine 409 and rescues MARK2-induced microtubule instability and neurite disruption. Conclusion: PKA functions as an upstream inhibitor of MARK2 by directly interacting and phosphorylating it. Significance: The results identify a novel interaction between PKA and MARK2, providing new insight into the signal networks of both. Microtubule affinity-regulating kinase 2 (MARK2)/PAR-1b and protein kinase A (PKA) are both involved in the regulation of microtubule stability and neurite outgrowth, but whether a direct cross-talk exists between them remains unclear. Here, we found the disruption of microtubule and neurite outgrowth induced by MARK2 overexpression was blocked by active PKA. The interaction between PKA and MARK2 was confirmed by coimmunoprecipitation and immunocytochemistry both in vitro and in vivo. PKA was found to inhibit MARK2 kinase activity by phosphorylating a novel site, serine 409. PKA could not reverse the microtubule disruption effect induced by a serine 409 to alanine (Ala) mutant of MARK2 (MARK2 S409A). In contrast, mutation of MARK2 serine 409 to glutamic acid (Glu) (MARK2 S409E) did not affect microtubule stability and neurite outgrowth. We propose that PKA functions as an upstream inhibitor of MARK2 in regulating microtubule stability and neurite outgrowth by directly interacting and phosphorylating MARK2.	[Deng, Si-Si; Cao, Peng-Rong; Xu, Lei; Li, Qian-Ru; Liu, Meng; Zhang, Lun; Jiang, Yue-Jing; Zang, Yi; Li, Jia] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Wu, Le-Yu; Yang, Xiao-Yu; Feng, Linyin] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Dept Neuropharmacol, Shanghai 201203, Peoples R China; [Sun, Sheng-Nan; Tan, Min-jia] Chinese Acad Sci, Shanghai Inst Mat Med, Chem Prote Ctr, Shanghai 201203, Peoples R China; [Sun, Sheng-Nan; Tan, Min-jia] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Wang, Ya-Chao; Qian, Min; Li, Jia] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China Normal University	Zang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Natl Ctr Drug Screening, 189 Guo Shoujing Rd, Shanghai 201203, Peoples R China.	yzang@simm.ac.cn; lyfeng@simm.ac.cn; jli@simm.ac.cn	Ya-chao, Wang/AAB-8162-2020; YANG, Xiaoyu/AFF-7937-2022; Zang, Yi/C-5683-2014; Li, Jia/F-9116-2011; li, jia/GVT-7587-2022; Tan, Minjia/C-4491-2014	YANG, Xiaoyu/0000-0003-2508-4805; Zang, Yi/0000-0001-9835-922X; Tan, Minjia/0000-0002-6784-9653; Wang, Ya-chao/0000-0003-3709-5368	National Science Fund for Distinguished Young Scholars [81125023]; Program of Shanghai Subject Chief Scientist Grant [13XD1404300]; National Natural Science Foundation of China [81173033, 81123004]; Open Project Program of State Key Laboratory of Natural Medicines; China Pharmaceutical University [SKLN-MKF201407]; Chinese Academy of Science "strategic leader in science and technology projects" [XDA01040303, XDA01040304]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Program of Shanghai Subject Chief Scientist Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project Program of State Key Laboratory of Natural Medicines; China Pharmaceutical University; Chinese Academy of Science "strategic leader in science and technology projects"	This work was supported by National Science Fund for Distinguished Young Scholars Grant 81125023, Program of Shanghai Subject Chief Scientist Grant 13XD1404300, National Natural Science Foundation of China Grants 81173033 and 81123004, the Open Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University Grant SKLN-MKF201407, and Chinese Academy of Science "strategic leader in science and technology projects" Grants XDA01040303 and XDA01040304.	Aglah C, 2008, NEUROPHARMACOLOGY, V55, P8, DOI 10.1016/j.neuropharm.2008.04.005; Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Birukova AA, 2004, AM J PHYSIOL-LUNG C, V287, pL86, DOI 10.1152/ajplung.00441.2003; Carlyle BC, 2014, P NATL ACAD SCI USA, V111, P5036, DOI 10.1073/pnas.1322360111; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Chen YM, 2012, J NEUROSCI, V32, P11390, DOI 10.1523/JNEUROSCI.0757-12.2012; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Dehmelt L, 2005, GENOME BIOL, V6; Diegelmann S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-76; Drewes G, 2004, TRENDS BIOCHEM SCI, V29, P548, DOI 10.1016/j.tibs.2004.08.001; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Gu GJ, 2013, J ALZHEIMERS DIS, V33, P699, DOI 10.3233/JAD-2012-121357; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hayashi Kenji, 2011, Bioarchitecture, V1, P261; Hayashi K, 2012, CELL STRUCT FUNCT, V37, P21; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Hurov J, 2007, CELL CYCLE, V6, P1966, DOI 10.4161/cc.6.16.4576; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Lin J, 2009, J IMMUNOL, V183, P1215, DOI 10.4049/jimmunol.0803887; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Sapir T, 2008, J NEUROSCI, V28, P5710, DOI 10.1523/JNEUROSCI.0911-08.2008; Sapir T, 2008, J NEUROSCI, V28, P13008, DOI 10.1523/JNEUROSCI.2363-08.2008; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Wu PR, 2011, CELL DEATH DIFFER, V18, P1507, DOI 10.1038/cdd.2011.2; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yoshimura Y, 2010, MOL CELL BIOL, V30, P2206, DOI 10.1128/MCB.01181-09; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhang YW, 2009, NEURON, V64, P328, DOI 10.1016/j.neuron.2009.08.036; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	48	7	7	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3149	3160		10.1074/jbc.M114.629873	http://dx.doi.org/10.1074/jbc.M114.629873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512381	hybrid, Green Published			2022-12-28	WOS:000349310700049
J	Koo, CX; Kobiyama, K; Shen, YJ; LeBert, N; Ahmad, S; Khatoo, M; Aoshi, T; Gasser, S; Ishii, KJ				Koo, Christine Xing'er; Kobiyama, Kouji; Shen, Yu J.; LeBert, Nina; Ahmad, Shandar; Khatoo, Muznah; Aoshi, Taiki; Gasser, Stephan; Ishii, Ken J.			RNA Polymerase III Regulates Cytosolic RNA:DNA Hybrids and Intracellular MicroRNA Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; DNA Damage; Innate Immunity; MicroRNA (miRNA); RNA Polymerase III; RNA Transport; RNA:DNA Hybrid; RNase H; Antibody S9.6	DNA-DAMAGE RESPONSE; GENOME INSTABILITY; ELONGATION COMPLEX; RNA/DNA HYBRIDS; HUMAN-CELLS; R-LOOPS; TRANSCRIPTION; TERMINATION; SUBCOMPLEX; STABILITY	Background: RNA:DNA hybrids exist in the nucleus and mitochondria but not in the cytosol, except in viral infection. Results: RNA:DNA hybrids exist in the cytosol of various human cells and are mediated by RNA polymerase III (Pol III), which regulates the microRNA machinery. Conclusion: Cytosolic RNA:DNA hybrids are regulated by Pol III. Significance: Previous unknown cytosolic RNA:DNA hybrids may have physiological relevance to miRNA machinery and RNA transport. RNA:DNA hybrids form in the nuclei and mitochondria of cells as transcription-induced R-loops or G-quadruplexes, but exist only in the cytosol of virus-infected cells. Little is known about the existence of RNA:DNA hybrids in the cytosol of virus-free cells, in particular cancer or transformed cells. Here, we show that cytosolic RNA:DNA hybrids are present in various human cell lines, including transformed cells. Inhibition of RNA polymerase III (Pol III), but not DNA polymerase, abrogated cytosolic RNA:DNA hybrids. Cytosolic RNA:DNA hybrids bind to several components of the microRNA (miRNA) machinery-related proteins, including AGO2 and DDX17. Furthermore, we identified miRNAs that are specifically regulated by Pol III, providing a potential link between RNA:DNA hybrids and the miRNA machinery. One of the target genes, exportin-1, is shown to regulate cytosolic RNA:DNA hybrids. Taken together, we reveal previously unknown mechanism by which Pol III regulates the presence of cytosolic RNA:DNA hybrids and miRNA biogenesis in various human cells.	[Koo, Christine Xing'er; Shen, Yu J.; LeBert, Nina; Khatoo, Muznah; Gasser, Stephan] Natl Univ Singapore, Immunol Programme, Ctr Life Sci, Singapore 117456, Singapore; [Koo, Christine Xing'er; Shen, Yu J.; LeBert, Nina; Khatoo, Muznah; Gasser, Stephan] Natl Univ Singapore, Dept Microbiol, Ctr Life Sci, Singapore 117456, Singapore; [Koo, Christine Xing'er; Shen, Yu J.; Gasser, Stephan] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Koo, Christine Xing'er; Kobiyama, Kouji; Aoshi, Taiki; Ishii, Ken J.] Natl Inst Biomed Innovat NIBIO, Lab Adjuvant Innovat, Osaka 5670085, Japan; [Ahmad, Shandar] Natl Inst Biomed Innovat NIBIO, Lab Bioinformat, Osaka 5670085, Japan; [Kobiyama, Kouji; Aoshi, Taiki; Ishii, Ken J.] Osaka Univ, Lab Vaccine Sci, World Premier Int Immunol Frontier Res Ctr iFREC, Suita, Osaka 5650871, Japan	National University of Singapore; National University of Singapore; National University of Singapore; Osaka University	Gasser, S (corresponding author), Natl Univ Singapore, Immunol Programme, Ctr Life Sci, Singapore 117456, Singapore.	stephan_gasser@nuhs.edu.sg; kenishii@biken.osaka-u.ac.jp	Ishii, Ken J/B-1685-2012; Shen, Yujia/L-2407-2018	Ishii, Ken J/0000-0002-6728-3872; Le Bert, Nina/0000-0003-0502-2527; Gasser, Stephan/0000-0002-5616-0914	Health and Labour Sciences Research Grant Adjuvant Database Project from the Japanese Ministry of Health, Labour and Welfare; National Research Foundation Grant HUJ-CREATE-Cellular and Molecular Mechanisms of Inflammation	Health and Labour Sciences Research Grant Adjuvant Database Project from the Japanese Ministry of Health, Labour and Welfare; National Research Foundation Grant HUJ-CREATE-Cellular and Molecular Mechanisms of Inflammation	This work was supported by the Health and Labour Sciences Research Grant Adjuvant Database Project from the Japanese Ministry of Health, Labour and Welfare and by the National Research Foundation Grant HUJ-CREATE-Cellular and Molecular Mechanisms of Inflammation (to S. G.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200; Bussing I, 2010, EMBO J, V29, P1830, DOI 10.1038/emboj.2010.82; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Chan YA, 2014, TRENDS GENET, V30, P245, DOI 10.1016/j.tig.2014.03.005; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Dragan AI, 2010, BIOPHYS J, V99, P3010, DOI 10.1016/j.bpj.2010.09.012; FRANK P, 1994, NUCLEIC ACIDS RES, V22, P5247, DOI 10.1093/nar/22.24.5247; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gao M, 2014, CELL RES, V24, P532, DOI 10.1038/cr.2014.36; Gjidoda A, 2013, BBA-GENE REGUL MECH, V1829, P385, DOI 10.1016/j.bbagrm.2012.09.011; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Haugland R. P., 2005, MOL PROBES HDB GUIDE; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; JAEHNING JA, 1977, J BIOL CHEM, V252, P8753; Jounai N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00168; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Nakama M, 2012, GENES CELLS, V17, P218, DOI 10.1111/j.1365-2443.2012.01583.x; PEDRALINOY G, 1979, BIOCHEM BIOPH RES CO, V88, P1194, DOI 10.1016/0006-291X(79)91106-9; Pothof J, 2009, CELL CYCLE, V8, P3462, DOI 10.4161/cc.8.21.9835; Rigby RE, 2014, EMBO J, V33, P542, DOI 10.1002/embj.201386117; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5889; Shaw NN, 2008, BIOCHIMIE, V90, P1026, DOI 10.1016/j.biochi.2008.04.011; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; TAKANO T, 1974, COLD SPRING HARB SYM, V39, P1009, DOI 10.1101/SQB.1974.039.01.116; Theofilopoulos AN, 2011, J INTERF CYTOK RES, V31, P867, DOI 10.1089/jir.2011.0092; Valentine R, 2010, J GEN VIROL, V91, P2221, DOI 10.1099/vir.0.021998-0; Vanaja SK, 2014, P NATL ACAD SCI USA, V111, P7765, DOI 10.1073/pnas.1400075111; Veras L, 2009, J MOL BIOL, V387, P523, DOI 10.1016/j.jmb.2009.02.008; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wang YM, 2013, CELL CYCLE, V12, P32, DOI 10.4161/cc.23051; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x	53	28	28	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7463	7473		10.1074/jbc.M115.636365	http://dx.doi.org/10.1074/jbc.M115.636365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623070	hybrid, Green Published			2022-12-28	WOS:000351613600015
J	Smith, AD; Wilks, A				Smith, Aaron D.; Wilks, Angela			Differential Contributions of the Outer Membrane Receptors PhuR and HasR to Heme Acquisition in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Receptor; Heme; Iron Metabolism; Mass Spectrometry (MS); Membrane Transport	GRAM-NEGATIVE BACTERIA; BINDING PROTEIN PHUS; SERRATIA-MARCESCENS; UPTAKE SYSTEM; SHIGELLA-DYSENTERIAE; STAPHYLOCOCCUS-AUREUS; TRAFFICKING PROTEIN; HEMOGLOBIN RECEPTOR; CRYSTAL-STRUCTURE; OXYGENASE HEMO	Background:Pseudomonas aeruginosa utilizes extracellular heme as a source of iron on infection of the host. Results: Both PhuR and HasR are required for efficient utilization of heme by P. aeruginosa. Conclusion: Non-redundant outer membrane receptors allow for heme acquisition across a range of physiological conditions. Significance: PhuR and HasR have complimentary roles in heme acquisition and utilization. Pseudomonas aeruginosa PAO1 encodes two outer membrane receptors, PhuR (Pseudomonasheme uptake) and HasR (heme assimilation system). The HasR and PhuR receptors have distinct heme coordinating ligands and substrate specificities. HasR is encoded in an operon with a secreted hemophore, HasAp. In contrast the non-hemophore-dependent PhuR is encoded within an operon along with proteins required for heme translocation into the cytoplasm. Herein we report on the contributions of the HasR and PhuR receptors to heme uptake and utilization. Employing bacterial genetics and isotopic [C-13]heme labeling studies we have shown both PhuR and HasR are required for optimal heme utilization. However, the unique His-Tyr-ligated PhuR plays a major role in the acquisition of heme. In contrast the HasR receptor plays a primary role in the sensing of extracellular heme and a supplementary role in heme uptake. We propose PhuR and HasR represent non-redundant heme receptors, capable of accessing heme across a wide range of physiological conditions on colonization of the host.	[Smith, Aaron D.; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu	Smith, Aaron/AAS-5716-2021	Smith, Aaron/0000-0001-8864-1934	National Institutes of Health [AI 102883]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 102883 (to A. W.).	Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Barkovits K, 2008, FEMS MICROBIOL LETT, V280, P160, DOI 10.1111/j.1574-6968.2007.01058.x; Benevides-Matos N, 2010, MICROBIOL-SGM, V156, P1749, DOI 10.1099/mic.0.034405-0; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; Bracken CS, 1999, J BACTERIOL, V181, P6063, DOI 10.1128/JB.181.19.6063-6072.1999; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Cobessi D, 2010, PROTEINS, V78, P286, DOI 10.1002/prot.22539; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Cornelis P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00075; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Eakanunkul S, 2005, BIOCHEMISTRY-US, V44, P13179, DOI 10.1021/bi050422r; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; HENDERSON DP, 1994, J BACTERIOL, V176, P3269, DOI 10.1128/jb.176.11.3269-3277.1994; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jepkorir G, 2010, J AM CHEM SOC, V132, P9857, DOI 10.1021/ja103498z; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Letoffe S, 1996, EMBO J, V15, P5804, DOI 10.1002/j.1460-2075.1996.tb00967.x; Letoffe S, 2004, J BACTERIOL, V186, P4067, DOI 10.1128/JB.186.13.4067-4074.2004; Marvig RL, 2014, MBIO, V5, DOI 10.1128/mBio.00966-14; Mokry DZ, 2014, BBA-GEN SUBJECTS, V1840, P3058, DOI 10.1016/j.bbagen.2014.06.009; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; O'Neill MJ, 2013, ACS CHEM BIOL, V8, P1794, DOI 10.1021/cb400165b; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; Rossi MS, 2001, INFECT IMMUN, V69, P6707, DOI 10.1128/IAI.69.11.6707-6717.2001; Schrodinger L, 2012, PYMOL MOL GRAPHICS S; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wilks A, 2011, HANDB PORPHYR SCI, V15, P357; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f	51	43	43	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7756	7766		10.1074/jbc.M114.633495	http://dx.doi.org/10.1074/jbc.M114.633495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25616666	Green Published, hybrid			2022-12-28	WOS:000351613600036
J	Pituch, KC; Moyano, AL; Lopez-Rosas, A; Marottoli, FM; Li, GN; Hu, CQ; van Breemen, R; Mansson, JE; Givogri, MI				Pituch, Katarzyna C.; Moyano, Ana L.; Lopez-Rosas, Aurora; Marottoli, Felecia M.; Li, Guannan; Hu, Chenqi; van Breemen, Richard; Mansson, Jan E.; Givogri, Maria I.			Dysfunction of Platelet-derived Growth Factor Receptor a (PDGFR alpha) Represses the Production of Oligodendrocytes from Arylsulfatase A-deficient Multipotential Neural Precursor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD OLIGODENDROCYTES; METACHROMATIC LEUKODYSTROPHY; PROGENITOR CELLS; MYELIN MEMBRANE; SONIC HEDGEHOG; LIPID RAFTS; INTRACELLULAR TRAFFICKING; MULTIVESICULAR ENDOSOMES; RETICULOCYTE MATURATION	The membrane-bound receptor for platelet-derived growth factor A (PDGFR alpha) is crucial for controlling the production of oligodendrocytes (OLs) for myelination, but regulation of its activity during OL differentiation is largely unknown. We have examined the effect of increased sulfated content of galactosylceramides (sulfatides) on the regulation of PDGTR alpha in multipotential neural precursors (NPs) that are deficient in arylsulfatase A (ASA) activity. This enzyme is responsible for the lysosomal hydrolysis of sulfatides. We show that sulfatide accumulation significantly impacts the formation of OLs via deregulation of PDGFR alpha function. PDGFR alpha is less associated with detergent-resistant membranes in ASA-deficient cells and showed a significant decrease in AKT phosphorylation Rescue experiments with ASA showed a normalization of the ratio of long versus short sulfatides, restored PDGTRa levels, corrected its localization to detergent-resistant membranes, increased AKT phosphorylation, and normalized the production of OLs in ASA-deficient NPs. Moreover, our studies identified a novel mechanism that regulates the secretion of PDGFR alpha in NPs, in glial cells, and in the brain cortex via exosomal shedding. Our study provides a first step in understanding the role of sulfatides in regulating PDGFR alpha levels in OLs and its impact in myelination.	[Pituch, Katarzyna C.; Moyano, Ana L.; Lopez-Rosas, Aurora; Marottoli, Felecia M.; Givogri, Maria I.] Univ Illinois, Dept Anat & Cell Biol, Coll Med, Chicago, IL 60612 USA; [Li, Guannan; Hu, Chenqi; van Breemen, Richard] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA; [Mansson, Jan E.] Univ Gothenburg, Sahlgren Acad, Dept Clin Chem, SE-41345 Gothenburg, Sweden	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Gothenburg	Givogri, MI (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Coll Med, 808 S Wood St,M-C 512, Chicago, IL 60612 USA.	mgivogri@uic.edu	van Breemen, Richard/AAO-2875-2020; Li, Guannan/J-4474-2019	Li, Guannan/0000-0002-9533-7524; van Breemen, Richard/0000-0003-2016-0063; Moyano, Ana Lis/0000-0002-1089-8542	National Institutes of Health Ruth L. Kirschstein National Research Service Award [F31]; National Multiple Sclerosis Society [PP1516, RG 4439-A-2]; Department of Defense [W81XWH-11-1-0198]	National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Department of Defense(United States Department of Defense)	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award F31 (to K. P. C.). This work was also supported by National Multiple Sclerosis Society Grants PP1516 and RG 4439-A-2 and by Department of Defense Contract W81XWH-11-1-0198 (to M. I. G.).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; [Anonymous], 2006, NOVART FDN SYMP; [Anonymous], 2006, NOVART FDN SYMP; [Anonymous], 2006, NOVART FDN SYMP; [Anonymous], 2006, NOVART FDN SYMP; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Bansal R, 1999, J NEUROSCI, V19, P7913; BANSAL R, 1989, P NATL ACAD SCI USA, V86, P6181, DOI 10.1073/pnas.86.16.6181; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; Baron W, 2003, CURR BIOL, V13, P151, DOI 10.1016/S0960-9822(02)01437-9; Baron W, 2002, EMBO J, V21, P1957, DOI 10.1093/emboj/21.8.1957; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bhat NR, 1996, J NEUROCHEM, V66, P1986; Blanc L, 2010, CURR OPIN HEMATOL, V17, P177, DOI 10.1097/MOH.0b013e328337b4e3; Blomqvist M, 2002, GLYCOCONJUGATE J, V19, P403, DOI 10.1023/B:GLYC.0000004012.14438.e6; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bodennec J, 2000, METHOD ENZYMOL, V312, P101; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Bosio A, 1998, J NEUROCHEM, V70, P308; BURKART T, 1981, DEV BIOL, V83, P42, DOI 10.1016/S0012-1606(81)80006-1; Butt AM, 1997, MOL CELL NEUROSCI, V8, P311, DOI 10.1006/mcne.1996.0590; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Carayon K, 2011, J BIOL CHEM, V286, P34426, DOI 10.1074/jbc.M111.257444; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Chojnacki A, 2011, J NEUROSCI, V31, P9503, DOI 10.1523/JNEUROSCI.1531-11.2011; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; COLLARINI EJ, 1991, J CELL SCI, P117; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Laurentiis Angela, 2007, Open Biochem J, V1, P12, DOI 10.2174/1874091X00701010012; Decker L, 2004, BIOCHEM SOC T, V32, P426, DOI 10.1042/BST0320426; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Du H, 2005, AM J HUM GENET, V77, P1061, DOI 10.1086/498652; DYER CA, 1988, J NEUROSCI, V8, P4307; Flores AI, 2000, J NEUROSCI, V20, P7622; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gieselmann V, 2003, ACTA PAEDIATR, V92, P74, DOI 10.1080/08035320310000528; Givogri MI, 2008, DEV NEUROSCI-BASEL, V30, P340, DOI 10.1159/000150127; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Givogri MI, 2001, J NEUROSCI RES, V66, P679, DOI 10.1002/jnr.10031; Givogri MI, 2006, J NEUROSCI, V26, P3109, DOI 10.1523/JNEUROSCI.4366-05.2006; Gonnord P, 2012, SEMIN CELL DEV BIOL, V23, P154, DOI 10.1016/j.semcdb.2011.11.002; Gonzalez-Gaitan M, 2008, DEV CELL, V15, P172, DOI 10.1016/j.devcel.2008.07.001; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Haghighi S, 2012, ACTA NEUROL SCAND, V125, P64, DOI 10.1111/j.1600-0404.2011.01554.x; Hall A, 1996, DEVELOPMENT, V122, P4085; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Hirahara Y, 2004, GLIA, V45, P269, DOI 10.1002/glia.10327; HIRAIWA N, 1990, CANCER RES, V50, P2917; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; LOUIS JC, 1992, GLIA, V6, P30, DOI 10.1002/glia.440060105; Luca T, 2005, MOL THER, V12, P669, DOI 10.1016/j.ymthe.2005.06.438; Marsching C, 2011, ANAL BIOANAL CHEM, V401, P53, DOI 10.1007/s00216-011-4802-0; Marsh M, 2008, SCIENCE, V319, P1191, DOI 10.1126/science.1155750; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1991, ANN NY ACAD SCI, V638, P378, DOI 10.1111/j.1749-6632.1991.tb49048.x; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Morichika H, 1996, CANCER, V78, P43, DOI 10.1002/(SICI)1097-0142(19960701)78:1<43::AID-CNCR8>3.3.CO;2-2; Moyano AL, 2013, J NEUROCHEM, V127, P600, DOI 10.1111/jnc.12341; Moyano AL, 2014, ANAL BIOCHEM, V467, P31, DOI 10.1016/j.ab.2014.08.033; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Reis-Sobreiro M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.15; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; SAKAKIBARA N, 1991, CANCER LETT, V57, P187, DOI 10.1016/0304-3835(91)90155-B; SANDHOFF K, 1994, FEBS LETT, V346, P103, DOI 10.1016/0014-5793(94)00282-7; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Takahashi T, 2012, J BIOCHEM, V152, P373, DOI 10.1093/jb/mvs080; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; THOMPSON TE, 1985, ANNU REV BIOPHYS BIO, V14, P361, DOI 10.1146/annurev.biophys.14.1.361; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Verweij Frederik J, 2012, Commun Integr Biol, V5, P88; Vidal M, 1997, J CELL SCI, V110, P1867; WARF BC, 1991, J NEUROSCI, V11, P2477; White AB, 2011, J NEUROSCI RES, V89, P352, DOI 10.1002/jnr.22564; White AB, 2009, J NEUROSCI, V29, P6068, DOI 10.1523/JNEUROSCI.5597-08.2009; Yaghootfam A, 2005, EUR J NEUROSCI, V21, P711, DOI 10.1111/j.1460-9568.2005.03891.x	102	29	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7040	7053		10.1074/jbc.M115.636498	http://dx.doi.org/10.1074/jbc.M115.636498			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605750	Green Published, hybrid			2022-12-28	WOS:000350991500037
J	Chen, XD; Khajeh, JA; Ju, JH; Gupta, YK; Stanley, CB; Do, C; Heller, WT; Aggarwal, AK; Callaway, DJE; Bu, ZM				Chen, Xiaodong; Khajeh, Jahan Ali; Ju, Jeong Ho; Gupta, Yogesh K.; Stanley, Christopher B.; Do, Changwoo; Heller, William T.; Aggarwal, Aneel K.; Callaway, David J. E.; Bu, Zimei			Phosphatidylinositol 4,5-Bisphosphate Clusters the Cell Adhesion Molecule CD44 and Assembles a Specific CD44-Ezrin Heterocomplex, as Revealed by Small Angle Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; TRANSMEMBRANE CONDUCTANCE REGULATOR; SCAFFOLDING PROTEIN NHERF1; BREAST-CANCER CELLS; N-TERMINAL DOMAIN; ERM PROTEINS; BIOLOGICAL MACROMOLECULES; PROSPECTIVE IDENTIFICATION; SEDIMENTATION EQUILIBRIUM; CYTOPLASMIC DOMAIN	The cell adhesion molecule CD44 regulates diverse cellular functions, including cell-cell and cell-matrix interaction, cell motility, migration, differentiation, and growth. In cells, CD44 co-localizes with the membrane-cytoskeleton adapter protein Ezrin that links the CD44 assembled receptor signaling complexes to the cytoskeletal actin network, which organizes the spatial and temporal localization of signaling events. Here we report that the cytoplasmic tail of CD44 (CD44ct) is largely disordered. Upon binding to the signaling lipid phosphatidylinositol 4,5-bisphosphate (PI12), CD44ct clusters into aggregates. Further, contrary to the generally accepted model, CD44ct does not bind directly to the FERM domain of Ezrin or to the fulllength Ezrin but only forms a complex with FERM or with the full-length Ezrin in the presence of PIP2. Using contrast variation small angle neutron scattering, we show that PIP2 mediates the assembly of a specific heterotetramer complex of CD44ct with Ezrin. This study reveals the role of PIP2 in clustering CD44 and in assembling multimeric CD44-Ezrin complexes. We hypothesize that polyvalent electrostatic interactions are responsible for the assembly of CD44 clusters and the multimeric PIP2-('D44-Ezrin complexes.	[Chen, Xiaodong; Khajeh, Jahan Ali; Ju, Jeong Ho; Callaway, David J. E.; Bu, Zimei] CUNY, Dept Chem & Biochem, New York, NY 10031 USA; [Chen, Xiaodong] Jiangxi Univ Tradit Chinese Med, Sch Pharm, Nanchang 330004, Jiangxi, Peoples R China; [Gupta, Yogesh K.; Aggarwal, Aneel K.] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA; [Stanley, Christopher B.; Do, Changwoo; Heller, William T.] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA	City University of New York (CUNY) System; Jiangxi University of Traditional Chinese Medicine; Icahn School of Medicine at Mount Sinai; United States Department of Energy (DOE); Oak Ridge National Laboratory	Bu, ZM (corresponding author), CUNY, Dept Chem, 160 Convent Ave, New York, NY 10031 USA.	zbu@ccny.cuny.edu	chen, xia/GYR-3948-2022; Do, Changwoo/ABG-6709-2020; Gupta, Yogesh K/B-6949-2009; Heller, William/ABE-1104-2020; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; Gupta, Yogesh/AFH-5204-2022; Do, Changwoo/A-9670-2011; Stanley, Christopher/AAC-2732-2022	Do, Changwoo/0000-0001-8358-8417; Gupta, Yogesh K/0000-0001-6372-5007; Heller, William/0000-0001-6456-2975; Gupta, Yogesh/0000-0001-6372-5007; Do, Changwoo/0000-0001-8358-8417; Stanley, Christopher/0000-0002-4226-7710	National Institutes of Health [R01HL086496]; National Center for Research Resources [2G12 RR003060]; Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086496] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL086496 (to Z. B.) and 2G12 RR003060 from the National Center for Research Resources (to City College of New York). This work was also supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy and the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Momany A, 2014, J CELL SCI, V127, P5164, DOI 10.1242/jcs.147744; Allaire M, 2011, J SYNCHROTRON RADIAT, V18, P41, DOI 10.1107/S0909049510036022; Babina IS, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3614; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bu ZM, 2011, ADV PROTEIN CHEM STR, V83, P163, DOI 10.1016/B978-0-12-381262-9.00005-7; Bu ZM, 1999, BIOPHYS J, V77, P1064, DOI 10.1016/S0006-3495(99)76956-0; Bu ZM, 1998, J APPL CRYSTALLOGR, V31, P533, DOI 10.1107/S0021889897015422; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Farago B, 2010, BIOPHYS J, V99, P3473, DOI 10.1016/j.bpj.2010.09.058; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glatter O., 1982, SMALL ANGLE XRAY SCA; Grover JR, 2015, J VIROL, V89, P454, DOI 10.1128/JVI.02178-14; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ho DL, 2004, J BIOL CHEM, V279, P39146, DOI 10.1074/jbc.M404565200; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Jayasundar JJ, 2012, J BIOL CHEM, V287, P37119, DOI 10.1074/jbc.M112.380972; Khajeh JA, 2014, J MOL BIOL, V426, P2755, DOI 10.1016/j.jmb.2014.05.011; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; NEAME SJ, 1995, J CELL SCI, V108, P3127; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Roch F, 2010, J CELL SCI, V123, P2057, DOI 10.1242/jcs.064550; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; STUHRMANN HB, 1974, J APPL CRYSTALLOGR, V7, P173, DOI 10.1107/S0021889874009071; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WIGNALL GD, 1987, J APPL CRYSTALLOGR, V20, P28, DOI 10.1107/S0021889887087181; Wobus M, 2002, APPL IMMUNOHISTO M M, V10, P34, DOI 10.1097/00022744-200203000-00006; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Yang L, 2013, J SYNCHROTRON RADIAT, V20, P211, DOI 10.1107/S0909049512048984; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhao JK, 2010, J APPL CRYSTALLOGR, V43, P1068, DOI 10.1107/S002188981002217X; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	74	23	23	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6639	6652		10.1074/jbc.M114.589523	http://dx.doi.org/10.1074/jbc.M114.589523			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25572402	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000350732500065
J	Corrigan, RM; Bowman, L; Willis, AR; Kaever, V; Grundling, A				Corrigan, Rebecca M.; Bowman, Lisa; Willis, Alexandra R.; Kaever, Volkhard; Gruendling, Angelika			Cross-talk between Two Nucleotide-signaling Pathways in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-AMP; BETA-LACTAM RESISTANCE; BACILLUS-SUBTILIS; STRINGENT RESPONSE; STREPTOCOCCUS-PNEUMONIAE; ALLELIC REPLACEMENT; LACTOCOCCUS-LACTIS; STRESS RESISTANCE; ESCHERICHIA-COLI; ESSENTIAL GENES	Nucleotide-signaling pathways are found in all kingdoms of life and are utilized to coordinate a rapid response to external stimuli. The stringent response alarmones guanosine tetra-(ppGpp) and pentaphosphate (pppGpp) control a global response allowing cells to adapt to starvation conditions such as amino acid depletion. One more recently discovered signaling nucleotide is the secondary messenger cyclic diadenosine monophosphate (c-di-AMP). Here, we demonstrate that this signaling nucleotide is essential for the growth of Staphylococcus aureus, and its increased production during late growth phases indicates that c-di-AMP controls processes that are important for the survival of cells in stationary phase. By examining the transcriptional profile of cells with high levels of c-diAMP, we reveal a significant overlap with a stringent response transcription signature. Examination of the intracellular nucleotide levels under stress conditions provides further evidence that high levels of c-di-AMP lead to an activation of the stringent response through a RelA/SpoT homologue (RSH) enzyme-dependent increase in the (p) ppGpp levels. This activation is shown to be indirect as c-di-AMP does not interact directly with the RSH protein. Our data extend this interconnection further by showing that the S. aureus c-di-AMP phosphodiesterase enzyme GdpP is inhibited in a dose-dependent manner by ppGpp, which itself is not a substrate for this enzyme. Altogether, these findings add a new layer of complexity to our understanding of nucleotide signaling in bacteria as they highlight intricate interconnections between different nucleotide-signaling networks.	[Corrigan, Rebecca M.; Bowman, Lisa; Willis, Alexandra R.; Gruendling, Angelika] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, London SW7 2AZ, England; [Corrigan, Rebecca M.; Bowman, Lisa; Willis, Alexandra R.; Gruendling, Angelika] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Bacteriol & Infect, MRC, London SW7 2AZ, England; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-306625 Hannover, Germany	Imperial College London; Imperial College London; Hannover Medical School	Grundling, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Flowers Bldg,RM 3-21, London SW7 2AZ, England.	a.grundling@imperial.ac.uk	Corrigan, Rebecca M/H-7249-2019; Kaever, Volkhard/G-3280-2013	Corrigan, Rebecca M/0000-0002-6031-1148; Grundling, Angelika/0000-0002-6235-8687	European Research Council [260371]; Wellcome Trust [100289]; Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship; Medical Research Council [MR/J006874/1, MR/J006874/1B] Funding Source: researchfish; MRC [MR/J006874/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Research Council Grant 260371 and Wellcome Trust Grant 100289 (to A. G.).; Supported by a Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship.	An SQ, 2013, EMBO J, V32, P2430, DOI 10.1038/emboj.2013.165; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; CASHEL M, 1969, J BIOL CHEM, V244, P3133; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; FIIL NP, 1972, J MOL BIOL, V71, P769; Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gao W, 2013, J INFECT DIS, V207, P929, DOI 10.1093/infdis/jis772; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Geiger T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003016; Geiger T, 2010, INFECT IMMUN, V78, P1873, DOI 10.1128/IAI.01439-09; Gentry D, 2000, J BACTERIOL, V182, P4995, DOI 10.1128/JB.182.17.4995-4997.2000; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jenvert RMK, 2005, FEBS J, V272, P685, DOI 10.1111/j.1742-4658.2004.04502.x; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lemos JAC, 2004, INFECT IMMUN, V72, P1431, DOI 10.1128/IAI.72.3.1431-1440.2004; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Lu D, 2009, P NATL ACAD SCI USA, V106, P1584, DOI 10.1073/pnas.0809020106; Lund E., 1972, FEBS, V28, P316; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Miller HK, 2012, J BACTERIOL, V194, P4342, DOI 10.1128/JB.00484-12; Mwangi MM, 2013, MICROB DRUG RESIST, V19, P153, DOI 10.1089/mdr.2013.0053; Nagarajan V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-351; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; OCHI K, 1981, J BIOL CHEM, V256, P6866; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Song JH, 2005, MOL CELLS, V19, P365; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	62	78	80	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5826	5839		10.1074/jbc.M114.598300	http://dx.doi.org/10.1074/jbc.M114.598300			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575594	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000350044200048
J	Haldar, S; Tripathi, A; Qian, J; Beserra, A; Suda, S; McElwee, M; Turner, J; Hopfer, U; Singh, N				Haldar, Swati; Tripathi, Ajai; Qian, Juan; Beserra, Amber; Suda, Srinivas; McElwee, Matthew; Turner, Jerrold; Hopfer, Ulrich; Singh, Neena			Prion Protein Promotes Kidney Iron Uptake via Its Ferrireductase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE PATHOGENESIS; VESICULAR TRANSPORT; PROXIMAL TUBULE; HUMAN URINE; METABOLISM; CELLS; LOCALIZATION; TRANSFERRIN; BRAIN; DEFERIPRONE	Brain iron-dyshomeostasis is an important cause of neurotoxicity in prion disorders, a group of neurodegenerative conditions associated with the conversion of prion protein (PrPC) from its normal conformation to an aggregated, PrP-scrapie (PrPSc) isoform. Alteration of iron homeostasis is believed to result from impaired function of PrPC in neuronal iron uptake via its ferrireductase activity. However, unequivocal evidence supporting the ferrireductase activity of PrPC is lacking. Kidney provides a relevant model for this evaluation because PrPC is expressed in the kidney, and similar to 370 in of iron are reabsorbed daily from the glomerular filtrate by kidney proximal tubule cells (PT), requiring ferrireductase activity. Here, we report that PrPC promotes the uptake of transferrin (Tf) and non-if-bound iron (NTBI) by the kidney in vivo and mainly NTBI by PT cells in vitro. Thus, uptake of Fe-59 administered by gastric gavage, intravenously, or intraperitoneally was significantly lower in PrP-knock-out (PrP-/-) kidney relative to PrP+/+ controls. Selective in vivo radiolabeling of plasma NTBI with Fe-59 revealed similar results. Expression of exogenous PrPC in immortalized PT cells showed localization on the plasma membrane and intracellular vesicles and increased transepithelial transport of Fe-59-NTBI and to a smaller extent Fe-59-Tf from the apical to the basolateral domain. Notably, the ferrireductase-deficient mutant of PrP (PrP Delta(51-89)) lacked this activity. Furthermore, excess NTBI and hemin caused aggregation of PrPC to a detergent-insoluble form, limiting iron uptake. Together, these observations suggest that PrPC promotes retrieval of iron from the glomerular filtrate via its ferrireductase activity and modulates kidney iron metabolism.	[Haldar, Swati; Tripathi, Ajai; Qian, Juan; Beserra, Amber; Suda, Srinivas; McElwee, Matthew; Singh, Neena] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Hopfer, Ulrich] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Turner, Jerrold] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University of Chicago	Singh, N (corresponding author), Case Western Reserve Univ, Dept Pathol, 2103 Cornell Rd, Cleveland, OH 44106 USA.	neena.singh@case.edu	Tripathi, Ajai/I-1983-2019; Haldar, Swati/AAH-5388-2021; Turner, Jerrold/H-1502-2019	Tripathi, Ajai/0000-0002-5070-2567; Suda, Srinivas/0000-0003-0860-0169; Haldar, Swati/0000-0002-1566-1907; McElwee, Matthew/0000-0003-1659-6112	National Institutes of Health [DK 088390, NS 076139, NS NS077438]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077438, R21NS076139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 088390, NS 076139 (NINDS), and NS NS077438 (to N. S.).	Abbaspour N, 2014, J RES MED SCI, V19, P164; Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; [Anonymous], 2010, PLOS ONE, V19, P5; Ashe KH, 2013, PRION, V7, P55, DOI 10.4161/pri.23061; Aydinok Y, 2007, HAEMATOLOGICA, V92, P1599, DOI 10.3324/haematol.11414; Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 1991, Curr Top Microbiol Immunol, V172, P93; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Christoforidis A, 2007, J PEDIAT HEMATOL ONC, V29, P598, DOI 10.1097/MPH.0b013e318142b51e; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Dagdanova A, 2010, J BIOL CHEM, V285, P30489, DOI 10.1074/jbc.M110.161794; Ddorizz G., 2015, J CELL BIOL, V135, P39; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Gu YP, 2003, J NEUROCHEM, V84, P10, DOI 10.1046/j.1471-4159.2003.01255.x; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; hierse D., 2015, PLOS ONE, V6; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Lee KS, 2007, J BIOL CHEM, V282, P36525, DOI 10.1074/jbc.M705620200; Linder MC, 2006, BIOL RES, V39, P143, DOI 10.4067/S0716-97602006000100016; Martines AMF, 2013, NAT REV NEPHROL, V9, P385, DOI 10.1038/nrneph.2013.98; Mckie AT, 2008, BIOCHEM SOC T, V36, P1239, DOI 10.1042/BST0361239; Mishra RS, 2004, J NEUROSCI, V24, P11280, DOI 10.1523/JNEUROSCI.2864-04.2004; Mishra RS, 2002, J BIOL CHEM, V277, P24554, DOI 10.1074/jbc.M200213200; Moriya M, 2006, AM J PHYSIOL-GASTR L, V290, pG301, DOI 10.1152/ajpgi.00029.2005; Moulouel B, 2013, KIDNEY INT, V84, P756, DOI 10.1038/ki.2013.142; Narang HK, 2005, EXP BIOL MED, V230, P343, DOI 10.1177/153537020523000508; Nestel FP, 2000, BLOOD, V96, P1836, DOI 10.1182/blood.V96.5.1836.h8001836_1836_1843; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Parkin E.T., 2004, J BIOL CHEM, V279, P1170; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SEARS DA, 1966, BLOOD-J HEMATOL, V28, P708, DOI 10.1182/blood.V28.5.708.708; Singh A, 2013, J ALZHEIMERS DIS, V35, P541, DOI 10.3233/JAD-130218; Singh A, 2012, NEUROBIOL DIS, V45, P930, DOI 10.1016/j.nbd.2011.12.012; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Singh N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004335; Singh N, 2014, ANTIOXID REDOX SIGN, V20, P1324, DOI 10.1089/ars.2012.4931; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Wang EI, 2000, TRAFFIC, V1, P480, DOI 10.1034/j.1600-0854.2000.010606.x; Wareing M, 2000, J PHYSIOL-LONDON, V524, P581, DOI 10.1111/j.1469-7793.2000.00581.x; Woost PG, 2007, IN VITRO CELL DEV-AN, V43, P352, DOI 10.1007/s11626-007-9061-1; Zhang DL, 2007, J AM SOC NEPHROL, V18, P401, DOI 10.1681/ASN.2006080908; Zhang X, 2013, FREE RADICAL BIO MED, V63, P243, DOI 10.1016/j.freeradbiomed.2013.05.004; Zhao HX, 2006, VIRUS RES, V115, P43, DOI 10.1016/j.virusres.2005.07.004	51	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5512	5522		10.1074/jbc.M114.607507	http://dx.doi.org/10.1074/jbc.M114.607507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572394	Green Published, hybrid			2022-12-28	WOS:000350044200023
J	Lurick, A; Kuhlee, A; Brocker, C; Kummel, D; Raunser, S; Ungermann, C				Luerick, Anna; Kuhlee, Anne; Broecker, Cornelia; Kuemmel, Daniel; Raunser, Stefan; Ungermann, Christian			The H-abc Domain of the SNARE Vam3 Interacts with the HOPS Tethering Complex to Facilitate Vacuole Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL PEPTIDE; RAB INTERACTIONS; STRUCTURAL BASIS; YEAST VACUOLE; PROTEIN VPS33; MEMBRANE; DOCKING; PHOSPHOINOSITIDES; RECRUITMENT; ENDOSOME	Membrane fusion at vacuoles requires a consecutive action of the HOPS tethering complex, which is recruited by the Rab GTPase Ypt7, and vacuolar SNAREs to drive membrane fusion. It is assumed that the Sec1/Munc18-like Vps33 within the HOPS complex is largely responsible for SNARE chaperoning. Here, we present direct evidence for HOPS binding to SNAREs and the H-abc domain of the Vam3 SNARE protein, which may explain its function during fusion. We show that HOPS interacts strongly with the Vam3 H-abc domain, assembled Q-SNAREs, and the R-SNARE Ykt6, but not the Q-SNARE Vti1 or the Vam3 SNARE domain. Electron microscopy combined with Nanogold labeling reveals that the binding sites for vacuolar SNAREs and the H-abc domain are located in the large head of the HOPS complex, where Vps16 and Vps33 have been identified before. Competition experiments suggest that HOPS bound to the H-abc domain can still interact with assembled Q-SNAREs, whereas Q-SNARE binding prevents recognition of the H-abc domain. In agreement, membranes carrying Vam(3)Delta H-abc fuse poorly unless an excess of HOPS is provided. These data suggest that the H-abc domain of Vam3 facilitates the assembly of the HOPS/SNARE machinery at fusion sites and thus supports efficient membrane fusion.	[Luerick, Anna; Broecker, Cornelia; Ungermann, Christian] Univ Osnabruck, Dept Biol Chem, Biochem Sect, D-49076 Osnabruck, Germany; [Kuemmel, Daniel] Univ Osnabruck, Dept Biol Chem, D-49076 Osnabruck, Germany; [Kuhlee, Anne; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany	University Osnabruck; University Osnabruck; Max Planck Society	Ungermann, C (corresponding author), Dept Biol Chem, Biochem Sect, Barbarastr 13, D-49076 Osnabruck, Germany.	cu@uos.de	Raunser, Stefan/AHE-1573-2022	Raunser, Stefan/0000-0001-9373-3016	Deutsche Forschungsgemeinschaft [UN111/5-3, KU2531/2-1]; Hans-Muhlenhoff foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans-Muhlenhoff foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants UN111/5-3 (to C. U. and S.R.) and KU2531/2-1 (to D. K.) and by funds from the Hans-Muhlenhoff foundation (to C. U.).	Baker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067409; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Collins RN, 2003, MOL CELL, V12, P1064, DOI 10.1016/S1097-2765(03)00445-3; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Kummel D, 2014, CURR OPIN CELL BIOL, V29, P61, DOI 10.1016/j.ceb.2014.04.007; Laage R, 2001, MOL BIOL CELL, V12, P3375, DOI 10.1091/mbc.12.11.3375; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97	34	24	25	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5405	5413		10.1074/jbc.M114.631465	http://dx.doi.org/10.1074/jbc.M114.631465			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25564619	Green Published, hybrid			2022-12-28	WOS:000350044200014
J	Campbell, GR; Bruckman, RS; Chu, YL; Spector, SA				Campbell, Grant R.; Bruckman, Rachel S.; Chu, Yen-Lin; Spector, Stephen A.			Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUBEROYLANILIDE HYDROXAMIC ACID; VERSUS-HOST-DISEASE; CELL-DEATH; T-CELLS; HDAC INHIBITORS; EXPRESSION; INFECTION; SAHA; GUIDELINES	Histone deacetylase inhibitors (HDACi) are being evaluated in a "shock-and-kill" therapeutic approach to reverse human immunodeficiency virus type-1 (HIV) latency from CD4(+) T cells. Using this approach, HDACi have induced HIV RNA synthesis in latently infected cells from some patients. The hope is that the increase in viral production will lead to killing of the infected cell either by the virus itself or by the patient's immune system, a "sterilizing cure." Although administered within the context of combination antiretroviral therapy, the infection of bystander cells remains a concern. In this study, we investigated the effect of HDACi (belinostat, givinostat, panobinostat, romidepsin, and vorinostat) on the productive infection of macrophages. We demonstrate that the HDACi tested do not alter the initial susceptibility of macrophages to HIV infection. However, we demonstrate that HDACi decrease HIV release from macrophages in a dose-dependent manner (belinostat < givinostat < vorinostat < panobinostat < romidepsin) via degradation of intracellular HIV through the canonical autophagy pathway. This mechanism involves unc-51-like autophagy-activating kinase 1 (ULK1) and the inhibition of the mammalian target of rapamycin and requires the formation of autophagosomes and their maturation into autolysosomes in the absence of increased cell death. These data provide further evidence in support of a role for autophagy in the control of HIV infection and suggest that careful consideration of off-target effects will be essential if HDACi are to be a component of a multipronged approach to eliminate latently infected cells.	[Campbell, Grant R.; Bruckman, Rachel S.; Chu, Yen-Lin; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Campbell, GR (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gcampbell@ucsd.edu; saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	National Institutes of Health from NINDS [R01 NS084912]; National Institutes of Health from the NIAID [AI084573]; International Maternal Pediatric Adolescent AIDS Clinical Trials Network and California HIV/AIDS Research Program [ID12-SD-255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI084573, UM1AI068632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084912] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Maternal Pediatric Adolescent AIDS Clinical Trials Network and California HIV/AIDS Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS084912 from NINDS, AI084573 from the NIAID. This work was also supported by the International Maternal Pediatric Adolescent AIDS Clinical Trials Network and California HIV/AIDS Research Program ID12-SD-255. This work was presented in part at the 21st Conference on Retroviruses and Opportunistic Infections, March 3-6, 2014, Boston, MA.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bose P, 2014, PHARMACOL THERAPEUT, V143, P323, DOI 10.1016/j.pharmthera.2014.04.004; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Campbell GR, 2011, AIDS RES HUM RETROV, V27, P647, DOI [10.1089/aid.2010.0192, 10.1089/AID.2010.0192]; Campbell GR, 2013, CURR OPIN MICROBIOL, V16, P349, DOI 10.1016/j.mib.2013.05.006; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003017; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Cao Q, 2008, INT J BIOCHEM CELL B, V40, P272, DOI 10.1016/j.biocel.2007.07.020; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; DeAngelo DJ, 2013, LEUKEMIA, V27, P1628, DOI 10.1038/leu.2013.38; Donia M, 2010, BRIT J CLIN PHARMACO, V70, P784, DOI 10.1111/j.1365-2125.2010.03735.x; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Frankfurt OS, 2001, J IMMUNOL METHODS, V253, P133, DOI 10.1016/S0022-1759(01)00387-8; Fujiwara Y, 2009, CANCER SCI, V100, P1728, DOI 10.1111/j.1349-7006.2009.01237.x; Furlan A, 2011, MOL MED, V17, P353, DOI 10.2119/molmed.2011.00020; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gammoh N, 2012, P NATL ACAD SCI USA, V109, P6561, DOI 10.1073/pnas.1204429109; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Johnson J, 2008, TRANSPL P, V40, P459, DOI 10.1016/j.transproceed.2008.01.039; Jorajuria S, 2004, ANTIMICROB AGENTS CH, V48, P1889, DOI 10.1128/AAC.48.5.1889-1891.2004; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Leng C, 2006, EXP HEMATOL, V34, P776, DOI 10.1016/j.exphem.2006.02.014; Lucas JL, 2009, CELL IMMUNOL, V257, P97, DOI 10.1016/j.cellimm.2009.03.004; Lucera MB, 2014, J VIROL, V88, P10803, DOI 10.1128/JVI.00320-14; McManamy Mary E. Manson, 2014, Antiviral Chemistry & Chemotherapy, V23, P145, DOI 10.3851/IMP2551; Nardacci R, 2014, AUTOPHAGY, V10, P1167, DOI 10.4161/auto.28678; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popovic M., 1988, RETROVIRUSES HUMAN A, P21; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P993, DOI 10.4161/hv.23800; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030815; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Shulak L, 2014, J VIROL, V88, P2927, DOI 10.1128/JVI.03406-13; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Steele NL, 2011, CANCER CHEMOTH PHARM, V67, P1273, DOI 10.1007/s00280-010-1419-5; Wang DP, 2012, BIOL BLOOD MARROW TR, V18, P1182, DOI 10.1016/j.bbmt.2012.06.002; Wang LQ, 2009, IMMUNOL CELL BIOL, V87, P195, DOI 10.1038/icb.2008.106; Watanabe T, 2010, BRIT J CANCER, V103, P1580, DOI 10.1038/sj.bjc.6605954; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Wu S, 2013, J BIOL CHEM, V288, P35500, DOI 10.1074/jbc.M113.479865; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	57	52	53	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5028	5040		10.1074/jbc.M114.605428	http://dx.doi.org/10.1074/jbc.M114.605428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540204	Green Published, hybrid			2022-12-28	WOS:000350042000044
J	Qin, Y; Ke, JY; Gu, X; Fang, JP; Wang, WC; Cong, QF; Li, J; Tan, JZ; Brunzelle, JS; Zhang, CH; Jiang, Y; Melcher, K; Li, JP; Xu, HE; Ding, K				Qin, Yi; Ke, Jiyuan; Gu, Xin; Fang, Jianping; Wang, Wucheng; Cong, Qifei; Li, Jie; Tan, Jinzhi; Brunzelle, Joseph S.; Zhang, Chenghai; Jiang, Yi; Melcher, Karsten; Li, Jin-ping; Xu, H. Eric; Ding, Kan			Structural and Functional Study of D-Glucuronyl C5-epimerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-IDURONIC ACID; CAPSULAR POLYSACCHARIDE; HEPARIN/HEPARAN SULFATE; BIOSYNTHESIS; ENZYME; C-5-EPIMERASE; 2-O-SULFOTRANSFERASE; SPECIFICITY; DISRUPTION; EPIMERASE	Heparan sulfate (HS) is a glycosaminoglycan present on the cell surface and in the extracellular matrix, which interacts with diverse signal molecules and is essential for many physiological processes including embryonic development, cell growth, inflammation, and blood coagulation. D-Glucuronyl C5-epimerase (Glce) is a crucial enzyme in HS synthesis, converting D-glucuronic acid to L-iduronic acid to increase HS flexibility. This modification of HS is important for protein ligand recognition. We have determined the crystal structures of Glce in apo-form (unliganded) and in complex with heparin hexasaccharide (product of Glce following O-sulfation), both in a stable dimer conformation. A Glce dimer contains two catalytic sites, each at a positively charged cleft in C-terminal alpha-helical domains binding one negatively charged hexasaccharide. Based on the structural and mutagenesis studies, three tyrosine residues, Tyr(468), Tyr(528), and Tyr(546), in the active site were found to be crucial for the enzymatic activity. The complex structure also reveals the mechanism of product inhibition (i.e. 2-O- and 6-O-sulfation of HS keeps the C5 carbon of L-iduronic acid away from the active-site tyrosine residues). Our structural and functional data advance understanding of the key modification in HS biosynthesis.	[Qin, Yi; Fang, Jianping; Wang, Wucheng; Cong, Qifei; Li, Jie; Ding, Kan] Chinese Acad Sci, Shanghai Inst Mat Med, Glycochemistry & Glycobiol Lab, Shanghai 201203, Peoples R China; [Qin, Yi; Tan, Jinzhi; Zhang, Chenghai; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Ke, Jiyuan; Gu, Xin; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Ctr Struct Biol & Drug Discovery, Grand Rapids, MI 49503 USA; [Fang, Jianping; Li, Jin-ping] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Brunzelle, Joseph S.] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; Uppsala University; Northwestern University	Ke, JY (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	Jiyuan.Ke@vai.org; Eric.Xu@vai.org; dingkan@simm.ac.cn	Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020	Melcher, Karsten/0000-0002-9125-4027; Ding, Kan/0000-0002-8140-9259; Xu, H. Eric/0000-0002-6829-8144; Cong, Qifei/0000-0002-4446-7222	National Natural Science Foundation of China (NSFC) [31230022]; National Science Fund for Distinguished Young Scholars [81125025]; New Drug Creation and Manufacturing Program [2012ZX09301001-003]; Swedish Research Council; Swedish Cancer Foundation; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); New Drug Creation and Manufacturing Program; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant	This work was supported by National Natural Science Foundation of China (NSFC) Grant 31230022, National Science Fund for Distinguished Young Scholars Grant 81125025, New Drug Creation and Manufacturing Program Grant 2012ZX09301001-003, the Swedish Research Council and Swedish Cancer Foundation (to J. P. L.), the Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CAMPBELL P, 1983, ANAL BIOCHEM, V131, P146, DOI 10.1016/0003-2697(83)90146-X; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Dejima K, 2013, J BIOL CHEM, V288, P34384, DOI 10.1074/jbc.M113.499269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Grigorieva EV, 2011, BRIT J CANCER, V105, P74, DOI 10.1038/bjc.2011.170; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hagner-McWhirter A, 2004, J BIOL CHEM, V279, P14631, DOI 10.1074/jbc.M313760200; Hagner-McWhirter A, 2000, GLYCOBIOLOGY, V10, P159, DOI 10.1093/glycob/10.2.159; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; Jerga A, 2006, BIOCHEMISTRY-US, V45, P9138, DOI 10.1021/bi060748f; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke JY, 2013, GENE DEV, V27, P2305, DOI 10.1101/gad.228544.113; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Li J, 2014, BIOCHEM J, V459, P405, DOI 10.1042/BJ20131360; Li JP, 2010, PROG MOL BIOL TRANSL, V93, P59, DOI 10.1016/S1877-1173(10)93004-4; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Prudnikova TY, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-27; Raedts J, 2013, J BIOL CHEM, V288, P24332, DOI 10.1074/jbc.M113.476440; Reijmers RM, 2011, BLOOD, V117, P6162, DOI 10.1182/blood-2010-12-325522; Reijmers RM, 2010, J IMMUNOL, V184, P3656, DOI 10.4049/jimmunol.0902200; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478	37	28	32	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4620	4630		10.1074/jbc.M114.602201	http://dx.doi.org/10.1074/jbc.M114.602201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25568314	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000350042000008
J	Sun, XH; Zakharian, E				Sun, Xiaohui; Zakharian, Eleonora			Regulation of the Temperature-dependent Activation of Transient Receptor Potential Vanilloid 1 (TRPV1) by Phospholipids in Planar Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; ION-CHANNEL; TRPM8 CHANNELS; NOXIOUS HEAT; MEMBRANE; PHOSPHOINOSITIDES; NEURONS; RAT	TRPV1 (transient receptor potential vanilloid 1) proteins are heat-activated nonselective cation channels. TRPV1 channels are polymodal in their function and exhibit multifaceted regulation with various molecular compounds. In this regard, phosphoinositides, particularly phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 4-phosphate, are important channel regulators. However, their effects on TRPV1 channel activity have not been conclusively determined. To characterize temperature-induced activation of TRPV1 in the presence of different phospholipids, we purified the TRPV1 protein from HEK-293 cells and incorporated it into planar lipid bilayers. In the presence of 2.5 mu M phosphatidylinositol 4,5-bisphosphate, TRPV1 channels demonstrated rapid activation at 33-39 degrees C and achieved full channel opening at 42 degrees C. At this temperature range, TRPV1 heat activation exhibited steep temperature dependence (temperature coefficient (Q(10)) of 18), and the channel openings were accompanied by large changes in entropy and enthalpy, suggesting a substantial conformation change. At a similar temperature range, another phosphoinositide, phosphatidylinositol 4-phosphate, also potentiated heat activation of TRPV1, but with much lower efficiency. Negatively charged phosphatidylglycerol could also induce heat activation of TRPV1 channels, although with a small-conductance state. Our data demonstrate that phospholipids, specifically phosphoinositides, are important regulators of TRPV1 and are required for heat-induced channel activity.	[Sun, Xiaohui; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA	University of Illinois System; University of Illinois Peoria	Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	zakharel@uic.edu	Sun, Xiaohui/G-5146-2013	Sun, Xiaohui/0000-0003-0294-6855	National Institutes of Health [R01GM098052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM098052 (to E. Z.).	Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Raisinghani M, 2005, J PHYSIOL-LONDON, V567, P771, DOI 10.1113/jphysiol.2005.087874; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Vlachova V, 2001, J PHYSIOL-LONDON, V533, P717, DOI 10.1111/j.1469-7793.2001.t01-1-00717.x; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	19	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4741	4747		10.1074/jbc.M114.611459	http://dx.doi.org/10.1074/jbc.M114.611459			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561742	Green Published, hybrid			2022-12-28	WOS:000350042000017
J	Tutunea-Fatan, E; Caetano, FA; Gros, R; Ferguson, SSG				Tutunea-Fatan, Elena; Caetano, Fabiana A.; Gros, Robert; Ferguson, Stephen S. G.			GRK2 Targeted Knock-down Results in Spontaneous Hypertension, and Altered Vascular GPCR Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR KINASE 2; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; BLOOD-PRESSURE; BETA-ARRESTIN; EXPRESSION; MICE; OVEREXPRESSION; PROLIFERATION; INHIBITION	Hypertension, elevated arterial pressure, occurs as the consequence of increased peripheral resistance. G protein-coupled receptors (GPCRs) contribute to the regulation of vasodilator and vasoconstrictor responses, and their activity is regulated by a family of GPCR kinases (GRKs). GRK2 expression is increased in hypertension and this facilitates the development of the hypertensive state by increasing the desensitization of GPCRs important for vasodilation. We demonstrate here, that genetic knockdown of GRK2 using a small hairpin (sh) RNA results in altered vascular reactivity and the development of hypertension between 8-12 weeks of age in shGRK2 mice due to enhanced G alpha(q/11) signaling. Vascular smooth muscle cells (VSMCs) cultured from shGRK2 knockdown mice show increases in GPCR-mediated G alpha(s) and G alpha(q/11) signaling, as the consequence of reduced GRK2-mediated desensitization. In addition, agonists and biased agonists exhibited age-dependent alterations in ERK1/2 and Akt signaling, as well as cell proliferation and migration responses in shGRK2 knockdown VSMCs when cultured from mice that are either 3 months or 6 months of age. Changes in angiotensin II-stimulated ERK1/2 phosphorylation are observed in VSMCs derived from 6-week-old shGRK2 mice prior to the development of the hypertensive phenotype. Thus, our findings indicate that the balance between mechanisms regulating vascular tone are shifted to favor vasoconstriction in the absence of GRK2 expression and that this leads to the age-dependent development of hypertension, as a consequence of global alterations in GPCR signaling. Consequently, therapeutic strategies that target GRK2 activity, not expression, may be more effective for the treatment of hypertension.	[Tutunea-Fatan, Elena; Caetano, Fabiana A.; Gros, Robert; Ferguson, Stephen S. G.] Univ Western Ontario, Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5K8, Canada; [Gros, Robert] Univ Western Ontario, Robarts Res Inst, Vasc Biol Grp, London, ON N6A 5K8, Canada; [Gros, Robert] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; [Tutunea-Fatan, Elena; Gros, Robert; Ferguson, Stephen S. G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Gros, R (corresponding author), Univ Western Ontario, Robarts Res Inst, 100 Perth Dr, London, ON N6A 5K8, Canada.	rgros@robarts.ca; ferguson@robarts.ca	Gros, Robert/AAV-2237-2020; Gros, Robert/A-3010-2009	Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011	Canadian Institutes of Health Research [MOP 111093, MOP 82756]; Canadian Institutes of Health Research Strategic Training Program in Vascular Research; New Investigator Award from the Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Strategic Training Program in Vascular Research(Canadian Institutes of Health Research (CIHR)); New Investigator Award from the Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This study was supported by grants from the Canadian Institutes of Health Research MOP 111093 (to S. S. G. F.) and MOP 82756 (to R. G.).; Supported in part through funding provided by Canadian Institutes of Health Research Strategic Training Program in Vascular Research.; Supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. To whom correspondence may be addressed: Robarts Research Institute, University of Western Ontario, 100 Perth Dr., London, Ontario N6A 5K8, Canada. Tel.: 519-663-5777, Ext. 24429; Fax: 519-931-5252; E-mail: rgros@robarts.ca.; Recipient of a Tier I Canada Research Chair and Career Investigator Award from the Heart and Stroke Foundation of Ontario. To whom correspondence may be addressed: Robarts Research Institute, University of Western Ontario, 100 Perth Dr., London, Ontario N6A 5K8, Canada. Tel.: 519-931-5706; Fax: 519-931-5252; E-mail: ferguson@robarts.ca.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Avendano MS, 2014, HYPERTENSION, V63, P369, DOI 10.1161/HYPERTENSIONAHA.113.01991; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brinks HL, 2010, BBA-MOL BASIS DIS, V1802, P1268, DOI 10.1016/j.bbadis.2010.01.005; Carotenuto A, 2013, EUR J MED CHEM, V69, P384, DOI 10.1016/j.ejmech.2013.08.039; Cohn HI, 2009, HYPERTENSION, V54, P71, DOI 10.1161/HYPERTENSIONAHA.108.125955; Cohn HI, 2008, AM J PHYSIOL-HEART C, V295, pH1695, DOI 10.1152/ajpheart.00564.2008; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081, DOI 10.1152/ajpcell.1998.275.4.C1081; Eckhart AD, 2002, MOL PHARMACOL, V61, P749, DOI 10.1124/mol.61.4.749; Feldman RD, 1998, TRENDS CARDIOVAS MED, V8, P297, DOI 10.1016/S1050-1738(98)00022-X; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Ferguson SSG, 2014, CAN J CARDIOL, V30, pS3, DOI 10.1016/j.cjca.2014.01.017; Gros R, 2003, ENDOCRINOLOGY, V144, P2242, DOI 10.1210/en.2003-0007; Gros R, 2002, AM J PHYSIOL-HEART C, V282, pH380, DOI 10.1152/ajpheart.2002.282.1.H380; Gros R, 1999, CLIN PHARMACOL THER, V65, P545, DOI 10.1016/S0009-9236(99)70074-3; Gros R, 2000, HYPERTENSION, V35, P38, DOI 10.1161/01.HYP.35.1.38; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Gros R, 2006, CIRC RES, V99, P845, DOI 10.1161/01.RES.0000245189.21703.c0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harris DM, 2007, AM J PHYSIOL-HEART C, V293, pH3072, DOI 10.1152/ajpheart.00880.2007; Izzo R, 2008, CTS-CLIN TRANSL SCI, V1, P215, DOI 10.1111/j.1752-8062.2008.00050.x; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Lafarga V, 2012, CELL ADHES MIGR, V6, P495, DOI 10.4161/cam.21585; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Luttrell LM, 2011, METHODS MOL BIOL, V756, P3, DOI 10.1007/978-1-61779-160-4_1; Metaye T, 2008, J ENDOCRINOL, V198, P101, DOI 10.1677/JOE-07-0562; Mii S, 1996, AM J PHYSIOL-HEART C, V270, pH142, DOI 10.1152/ajpheart.1996.270.1.H142; Morris GE, 2010, CARDIOVASC RES, V85, P424, DOI 10.1093/cvr/cvp310; Napolitano R, 2012, AM J HYPERTENS, V25, P366, DOI 10.1038/ajh.2011.211; Peppel K, 2000, CIRCULATION, V102, P793, DOI 10.1161/01.CIR.102.7.793; Ribeiro FM, 2010, J NEUROSCI, V30, P316, DOI 10.1523/JNEUROSCI.4974-09.2010; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Touyz RM, 2002, J HYPERTENS, V20, P1127, DOI 10.1097/00004872-200206000-00024; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wei ZY, 2012, J CELL PHYSIOL, V227, P2371, DOI 10.1002/jcp.22972; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Zhang J, 1997, RECEPTOR CHANNEL, V5, P193; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	41	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5141	5155		10.1074/jbc.M114.615658	http://dx.doi.org/10.1074/jbc.M114.615658			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561731	Green Published, hybrid			2022-12-28	WOS:000350042000053
J	Lu, XX; Zhang, TL; Xu, Z; Liu, SS; Zhao, B; Lan, WX; Wang, CX; Ding, JP; Cao, CY				Lu, Xiuxiu; Zhang, Tianlong; Xu, Zeng; Liu, Shanshan; Zhao, Bin; Lan, Wenxian; Wang, Chunxi; Ding, Jianping; Cao, Chunyang			Crystal Structure of DNA Cytidine Deaminase ABOBEC3G Catalytic Deamination Domain Suggests a Binding Mode of Full-length Enzyme to Single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL; CBF-BETA; HIV-1 VIRIONS; APOBEC3G; VIF; RESTRICTION; HYPERMUTATION; EVOLUTION; DETERMINANTS; SPECIFICITY	APOBEC3G (A3G) is a DNA cytidine deaminase (CD) that demonstrates antiviral activity against human immunodeficiency virus 1 (HIV-1) and other pathogenic virus. It has an inactive N-terminal CD1 virus infectivity factor (Vif) protein binding domain (A3G-CD1) and an actively catalytic C-terminal CD2 deamination domain (A3G-CD2). Although many studies on the structure of A3G-CD2 and enzymatic properties of full-length A3G have been reported, the mechanism of how A3G interacts with HIV-1 single-stranded DNA (ssDNA) is still not well characterized. Here, we reported a crystal structure of a novel A3G-CD2 head-to-tail dimer (in which the N terminus of the monomer H (head) interacts with the C terminus of monomer T (tail)), where a continuous DNA binding groove was observed. By constructing the A3G-CD1 structural model, we found that its overall fold was almost identical to that of A3G-CD2. We mutated the residues located in or along the groove in monomer H and the residues in A3G-CD1 that correspond to those seated in or along the groove in monomer T. Then, by performing enzymatic assays, we confirmed the reported key elements and the residues in A3G necessary to the catalytic deamination. Moreover, we identified more than 10 residues in A3G essential to DNA binding and deamination reaction. Therefore, this dimer structure may represent a structural model of full-length A3G, which indicates a possible binding mode of A3G to HIV-1 ssDNA.	[Lu, Xiuxiu; Xu, Zeng; Liu, Shanshan; Zhao, Bin; Lan, Wenxian; Wang, Chunxi; Cao, Chunyang] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Zhang, Tianlong; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cao, CY (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	ccao@mail.sioc.ac.cn		ding, jian ping/0000-0001-7029-7346	Ministry of Science and Technology of China [2011CB966300]; National Natural Science Foundation of China [21472229, 20902103, 21272261]; Science and Technology Commission of Shanghai Municipality [15ZR1449300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grant 2011CB966300; National Natural Science Foundation of China Grants 21472229, 20902103, and 21272261; and Science and Technology Commission of Shanghai Municipality Grant 15ZR1449300.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MN, 2007, SURFACTANT SCI SER, V133, P1; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mitra M, 2014, NUCLEIC ACIDS RES, V42, P1095, DOI 10.1093/nar/gkt945; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718	57	42	42	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4010	4021		10.1074/jbc.M114.624262	http://dx.doi.org/10.1074/jbc.M114.624262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25542899	hybrid, Green Published			2022-12-28	WOS:000349458400014
J	Sun, LP; Huang, Y; Wei, Q; Tong, XM; Cai, R; Nalepa, G; Ye, X				Sun, Liping; Huang, Yan; Wei, Qian; Tong, Xiaomei; Cai, Rong; Nalepa, Grzegorz; Ye, Xin			Cyclin E-CDK2 Protein Phosphorylates Plant Homeodomain Finger Protein 8 (PHF8) and Regulates Its Function in the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; HISTONE DEMETHYLASE PHF8; RIBOSOMAL-RNA SYNTHESIS; S-PHASE PROGRESSION; DEPENDENT KINASE 2; GENE-TRANSCRIPTION; E/CDK2 SUBSTRATE; RECRUITMENT; TRANSITION; BINDING	Cyclin E-CDK2 is a key regulator in G1/S transition. Previously, we identified a number of CDK2-interacting proteins, including PHF8 (plant homeodomain finger protein 8). In this report, we confirmed that PHF8 is a novel cyclin E-CDK2 substrate. By taking the approach of mass spectrometry, we identified that PHF8 Ser-844 is phosphorylated by cyclin E-CDK2. Immunoblotting analysis indicated that WT PHF8 demethylates histone H3K9me2 more efficiently than the cyclin E-CDK2 phosphorylation-deficient PHF8-S844A mutant. Furthermore, flow cytometry analysis showed that WT PHF8 promotes S phase progression more robustly than PHF8-S844A. Real-time PCR results demonstrated that PHF8 increases transcription of cyclin E, E2F3, and E2F7 to significantly higher levels compared with PHF8-S844A. Further analysis by ChIP assay indicated that PHF8binds to the cyclin E promoter stronger than PHF8-S844A and reduces the H3K9me2 level at the cyclin E promoter more efficiently than PHF8-S844A. In addition, we found that cyclin E-CDK2-mediated phosphorylation of PHF8 Ser-844 promotes PHF8-dependent rRNA transcription in luciferase reporter assays and real-time PCR. Taken together, these results indicate that cyclin E-CDK2 phosphorylates PHF8 to stimulate its demethylase activity to promote rRNA transcription and cell cycle progression.	[Sun, Liping; Huang, Yan; Wei, Qian; Tong, Xiaomei; Cai, Rong; Ye, Xin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Sun, Liping; Huang, Yan; Wei, Qian; Cai, Rong] Univ Chinese Acad Sci, Beijing 100101, Peoples R China; [Nalepa, Grzegorz] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Nalepa, Grzegorz] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Div Pediat Hematol Oncol, Indianapolis, IN 46202 USA; [Nalepa, Grzegorz] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ye, X (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn		Lab, Nalepa/0000-0002-7560-1906; Nalepa, Grzegorz/0000-0002-5779-9103	National Natural Science Foundation of China [81272272]; Ministry of Science and Technology of China [2013ZX10004611, 2012CB519003, 2011CB504705]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068371] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Natural Science Foundation of China Grant 81272272 and by Ministry of Science and Technology of China Grants 2013ZX10004611, 2012CB519003, and 2011CB504705.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cooley A, 2010, CELL CYCLE, V9, P4900, DOI 10.4161/cc.9.24.14158; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2011, EPIGENETICS-US, V6, P4, DOI 10.4161/epi.6.1.13297; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Krishnan S, 2011, CHEMBIOCHEM, V12, P254, DOI 10.1002/cbic.201000545; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Li JH, 2011, J BIOL CHEM, V286, P39776, DOI 10.1074/jbc.M111.226464; Lim HJ, 2013, MOL CELL BIOL, V33, P4166, DOI 10.1128/MCB.00689-13; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wei Q, 2013, J BIOL CHEM, V288, P19715, DOI 10.1074/jbc.M112.449652; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Westendorp B, 2012, NUCLEIC ACIDS RES, V40, P3511, DOI 10.1093/nar/gkr1203; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhu ZQ, 2010, CELL RES, V20, P794, DOI 10.1038/cr.2010.75	35	18	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4075	4085		10.1074/jbc.M114.602532	http://dx.doi.org/10.1074/jbc.M114.602532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548279	Green Published, hybrid			2022-12-28	WOS:000349458400019
J	Tian, YF; Gawlak, G; Shah, AS; Higginbotham, K; Tian, XY; Kawasaki, Y; Akiyama, T; Sacks, DB; Birukova, AA				Tian, Yufeng; Gawlak, Grzegorz; Shah, Alok S.; Higginbotham, Katherine; Tian, Xinyong; Kawasaki, Yoshihiro; Akiyama, Tetsu; Sacks, David B.; Birukova, Anna A.			Hepatocyte Growth Factor-induced Asef-IQGAP1 Complex Controls Cytoskeletal Remodeling and Endothelial Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDIZED PHOSPHOLIPIDS; ACTIN-FILAMENTS; SCATTER FACTOR; BETA-CATENIN; RHO GTPASES; C-MET; IQGAP1; RAC; CDC42; PERMEABILITY	Hepatocyte growth factor (HGF) attenuates agonist-induced endothelial cell (EC) permeability and increases pulmonary endothelial barrier function via Rac-dependent enhancement of the peripheral actin cytoskeleton. However, the precise mechanisms of HGF effects on the peripheral cytoskeleton are not well understood. This study evaluated a role for Rac/Cdc42-specific guanine nucleotide exchange factor Asef and the multifunctional Rac effector, IQGAP1, in the mechanism of HGF-induced EC barrier enhancement. HGF induced Asef and IQGAP1 co-localization at the cell cortical area and stimulated formation of an Asef-IQGAP1 functional protein complex. siRNA-induced knockdown of Asef or IQGAP1 attenuated HGF-induced EC barrier enhancement. Asef knockdown attenuated HGF-induced Rac activation and Rac association with IQGAP1, and it abolished both IQGAP1 accumulation at the cell cortical layer and IQGAP1 interaction with actin cytoskeletal regulators cortactin and Arp3. Asef activation state was essential for Asef interaction with IQGAP1 and protein complex accumulation at the cell periphery. In addition to the previously reported role of the IQGAP1 RasGAP-related domain in the Rac-dependent IQGAP1 activation and interaction with its targets, we show that the IQGAP1 C-terminal domain is essential for HGF-induced IQGAP1/Asef interaction and Asef-Rac-dependent activation leading to IQGAP1 interaction with Arp3 and cortactin as a positive feedback mechanism of IQGAP1 activation. These results demonstrate a novel feedback mechanism of HGF-induced endothelial barrier enhancement via Asef/IQGAP1 interactions, which regulate the level of HGF-induced Rac activation and promote cortical cytoskeletal remodeling via IQGAP1Arp3/cortactin interactions.	[Tian, Yufeng; Gawlak, Grzegorz; Shah, Alok S.; Higginbotham, Katherine; Tian, Xinyong; Birukova, Anna A.] Univ Chicago, Dept Med, Sect Pulm & Crit Med, Chicago, IL 60637 USA; [Kawasaki, Yoshihiro; Akiyama, Tetsu] Univ Tokyo, Lab Mol & Genet Informat, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan; [Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	University of Chicago; University of Tokyo; National Institutes of Health (NIH) - USA	Birukova, AA (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave,MC-6026, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu		Sacks, David/0000-0003-3100-0735	National Institutes of Health from NHLBI [HL89257, HL107920]; Intramural Research Program of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089257, R56HL107920, R01HL107920] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health Grants HL89257 and HL107920 from NHLBI and by the Intramural Research Program of the National Institutes of Health.	Aoki M, 2000, J Atheroscler Thromb, V7, P71; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Broman MT, 2006, CIRC RES, V98, P73, DOI 10.1161/01.RES.0000198387.44395.e9; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kawasaki Y, 2009, J BIOL CHEM, V284, P22436, DOI 10.1074/jbc.M109.020768; Kouklis P, 2004, CIRC RES, V94, P159, DOI 10.1161/01.RES.0000110418.38500.31; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rosen EM, 1995, ADV CANCER RES, V67, P257, DOI 10.1016/S0065-230X(08)60715-0; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14; Tomita N, 2000, J Atheroscler Thromb, V7, P1; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Waheed F, 2013, MOL BIOL CELL, V24, P1068, DOI 10.1091/mbc.E12-09-0661; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Zhang LL, 2000, J NEUROSCI RES, V59, P489, DOI 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	54	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4097	4109		10.1074/jbc.M114.620377	http://dx.doi.org/10.1074/jbc.M114.620377			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25492863	hybrid, Green Published			2022-12-28	WOS:000349458400021
J	Gourlay, K; Hu, JG; Arantes, V; Penttila, M; Saddler, JN				Gourlay, Keith; Hu, Jinguang; Arantes, Valdeir; Penttila, Merja; Saddler, Jack N.			The Use of Carbohydrate Binding Modules (CBMs) to Monitor Changes in Fragmentation and Cellulose Fiber Surface Morphology during Cellulase- and Swollenin-induced Deconstruction of Lignocellulosic Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulase; Cellulose; Enzyme; Fungi; Microbiology; Amorphogenesis; Cellulose Binding Modules; Fiber Dislocations; Swollenin; Fragmentation; Carbohydrate Binding Modules (CBMs); Confocal Microscopy	ENZYMATIC-HYDROLYSIS; PULP FIBERS; AMORPHOGENESIS STEP; CRYSTAL-STRUCTURE; PROTEIN; DISLOCATIONS; ACCESSIBILITY; DISRUPTION; INSIGHTS; EXPANSIN	Background: Fiber fragmentation is thought to occur at dislocations, which are potential targets for the non-hydrolytic protein, Swollenin. Results: Changes in cellulose morphology within dislocations were assessed using fluorescent CBMs; Swollenin appeared to promote fragmentation at these sites. Conclusion: Swollenin targets and disrupts cellulose at fiber dislocations. Significance: Fragmentation is a key step in cellulose deconstruction and is enhanced by the actions of Swollenin. Although the actions of many of the hydrolytic enzymes involved in cellulose hydrolysis are relatively well understood, the contributions that amorphogenesis-inducing proteins might contribute to cellulose deconstruction are still relatively undefined. Earlier work has shown that disruptive proteins, such as the non-hydrolytic non-oxidative protein Swollenin, can open up and disaggregate the less-ordered regions of lignocellulosic substrates. Within the cellulosic fraction, relatively disordered, amorphous regions known as dislocations are known to occur along the length of the fibers. It was postulated that Swollenin might act synergistically with hydrolytic enzymes to initiate biomass deconstruction within these dislocation regions. Carbohydrate binding modules (CBMs) that preferentially bind to cellulosic substructures were fluorescently labeled. They were imaged, using confocal microscopy, to assess the distribution of crystalline and amorphous cellulose at the fiber surface, as well as to track changes in surface morphology over the course of enzymatic hydrolysis and fiber fragmentation. Swollenin was shown to promote targeted disruption of the cellulosic structure at fiber dislocations.	[Gourlay, Keith; Hu, Jinguang; Arantes, Valdeir; Saddler, Jack N.] Univ British Columbia, Fac Forestry, Dept Wood Sci, Forest Prod Biotechnol Bioenergy Grp, Vancouver, BC V6T 1Z4, Canada; [Penttila, Merja] VTT Tech Res Ctr Finland, FI-02044 Espoo, Vtt, Finland	University of British Columbia; VTT Technical Research Center Finland	Saddler, JN (corresponding author), Univ British Columbia, Fac Forestry, Dept Wood Sci, Forest Prod Biotechnol Bioenergy Grp, 2424 Main Mall, Vancouver, BC V6T 1Z4, Canada.	jack.saddler@ubc.ca	Penttilä, Merja E/A-4710-2013; Arantes, Valdeir/A-3442-2015	Arantes, Valdeir/0000-0001-9565-1006; Hu, Jinguang/0000-0001-8033-7102; Penttila, Merja/0000-0002-6929-1032	Natural Sciences and Engineering Council [16]; fungi of Canada (NSERC); Bioconversion Network	Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); fungi of Canada (NSERC); Bioconversion Network	This work was supported by the Natural Sciences and Engineering Council (16)), and fungi of Canada (NSERC) and the Bioconversion Network.	Ander P, 2008, BIORESOURCES, V3, P477; Arantes V, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-87; Arantes V, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-3; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Baley C, 2004, J MATER SCI, V39, P331, DOI 10.1023/B:JMSC.0000007768.63055.ae; BEREZIN I V, 1977, Biokhimiya, V42, P1631; Berlin A, 2006, BIOTECHNOL BIOENG, V93, P880, DOI 10.1002/bit.20783; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Clarke K, 2011, BIOMASS BIOENERG, V35, P3943, DOI 10.1016/j.biombioe.2011.06.007; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Del Rio LF, 2012, BIORESOURCE TECHNOL, V107, P235, DOI 10.1016/j.biortech.2011.12.057; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Du RY, 2013, RSC ADV, V3, P1871, DOI 10.1039/c2ra21781c; Eder M, 2008, HOLZFORSCHUNG, V62, P77, DOI 10.1515/HF.2008.011; Filonova L, 2007, BIOMACROMOLECULES, V8, P91, DOI 10.1021/bm060632z; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Gao SH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-24; Gourlay K, 2013, BIORESOURCE TECHNOL, V142, P498, DOI 10.1016/j.biortech.2013.05.053; Gourlay K, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-51; HALLIWELL G, 1970, BIOCHEM J, V116, P35, DOI 10.1042/bj1160035; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hidayat BJ, 2012, CELLULOSE, V19, P1481, DOI 10.1007/s10570-012-9740-2; Hilden L, 2003, BIOTECHNOL LETT, V25, P553, DOI 10.1023/A:1022846304826; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Hu JG, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-36; Huang WD, 2011, ENERG ENVIRON SCI, V4, P784, DOI 10.1039/c0ee00069h; Jager G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-33; Kang K, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-42; Karlsson J, 2001, EUR J BIOCHEM, V268, P6498, DOI 10.1046/j.0014-2956.2001.02605.x; Kawakubo T, 2010, BIOTECHNOL BIOENG, V105, P499, DOI 10.1002/bit.22550; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Lee HJ, 2010, MOL CELLS, V29, P379, DOI 10.1007/s10059-010-0033-z; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nyholm K, 2001, NORD PULP PAP RES J, V16, P376, DOI 10.3183/npprj-2001-16-04-p376-384; ONG E, 1993, BIOTECHNOL BIOENG, V42, P401, DOI 10.1002/bit.260420402; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Quiroz-Castaneda RE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-8; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050; Thygesen LG, 2007, J MATER SCI, V42, P558, DOI 10.1007/s10853-006-1113-5; Thygesen LG, 2011, J IND MICROBIOL BIOT, V38, P975, DOI 10.1007/s10295-010-0870-y; Tozzi EJ, 2014, AICHE J, V60, P1582, DOI 10.1002/aic.14374; Tu MB, 2007, BIOTECHNOL PROGR, V23, P1130, DOI 10.1021/bp070129d; WALKER LP, 1992, BIOTECHNOL BIOENG, V40, P1019, DOI 10.1002/bit.260400905	49	35	35	0	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2938	2945		10.1074/jbc.M114.627604	http://dx.doi.org/10.1074/jbc.M114.627604			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527502	Green Published, hybrid			2022-12-28	WOS:000349310700032
J	Villalba, MI; Canul-Tec, JC; Luna-Martinez, OD; Sanchez-Alcala, R; Olamendi-Portugal, T; Rudino-Pinera, E; Rojas, S; Sanchez-Lopez, R; Fernandez-Velasco, DA; Becerril, B				Villalba, Miryam I.; Canul-Tec, Juan C.; Luna-Martinez, Oscar D.; Sanchez-Alcala, Rosalba; Olamendi-Portugal, Timoteo; Rudino-Pinera, Enrique; Rojas, Sonia; Sanchez-Lopez, Rosana; Fernandez-Velasco, Daniel A.; Becerril, Baltazar			Site-directed Mutagenesis Reveals Regions Implicated in the Stability and Fiber Formation of Human lambda 3r Light Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Antibody; Fibril; Mutagenesis in Vitro; Thermodynamics	PRIMARY AL AMYLOIDOSIS; PROTEIN; SEQUENCE; AGGREGATION; KAPPA; PREDICTION; MUTATIONS; SYSTEM	Background: 6a and 3r are the most implicated germ lines in light chain amyloidosis. Results: Mutagenesis at N-terminal, loop 40-60, and CDR3 regions affected 3r fibrillogenesis. Conclusion: Changes at residues 7, 48, and 91 increased fibril formation while changes at residues 8 and 40 reverted fibrillogenesis. Significance: Characterization of light chain germ lines helps to identify key regions implicated in amyloidosis. Light chain amyloidosis (AL) is a disease that affects vital organs by the fibrillar aggregation of monoclonal light chains. 3r germ line is significantly implicated in this disease. In this work, we contrasted the thermodynamic stability and aggregation propensity of 3mJL2 (nonamyloidogenic) and 3rJL2 (amyloidogenic) 3 germ lines. Because of an inherent limitation (extremely low expression), Cys at position 34 of the 3r germ line was replaced by Tyr reaching a good expression yield. A second substitution (W91A) was introduced in 3r to obtain a better template to incorporate additional mutations. Although the single mutant (C34Y) was not fibrillogenic, the second mutation located at CDR3 (W91A) induced fibrillogenesis. We propose, for the first time, that CDR3 (position 91) affects the stability and fiber formation of human 3r light chains. Using the double mutant (3rJL2/YA) as template, other variants were constructed to evaluate the importance of those substitutions into the stability and aggregation propensity of 3 light chains. A change in position 7 (P7D) boosted 3rJL2/YA fibrillogenic properties. Modification of position 48 (I48M) partially reverted 3rJL2/YA fibril aggregation. Finally, changes at positions 8 (P8S) or 40 (P40S) completely reverted fibril formation. These results confirm the influential roles of N-terminal region (positions 7 and 8) and the loop 40-60 (positions 40 and 48) on AL. X-ray crystallography revealed that the three-dimensional topology of the single and double 3r mutants was not significantly altered. This mutagenic approach helped to identify key regions implicated in 3 AL.	[Villalba, Miryam I.; Canul-Tec, Juan C.; Luna-Martinez, Oscar D.; Sanchez-Alcala, Rosalba; Olamendi-Portugal, Timoteo; Rudino-Pinera, Enrique; Rojas, Sonia; Becerril, Baltazar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Med, Mexico City 04510, DF, Mexico; [Villalba, Miryam I.; Canul-Tec, Juan C.; Luna-Martinez, Oscar D.; Sanchez-Alcala, Rosalba; Olamendi-Portugal, Timoteo; Rudino-Pinera, Enrique; Rojas, Sonia; Becerril, Baltazar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Bioproc, Mexico City 04510, DF, Mexico; [Sanchez-Lopez, Rosana] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Biol Plants, Mexico City 04510, DF, Mexico; [Fernandez-Velasco, Daniel A.] Univ Nacl Autonoma Mexico, Fac Med, Lab Phys Chem & Prot Engn, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Fernandez-Velasco, DA (corresponding author), Ave Univ 3000 Colonia UNAM, Mexico City 04510, DF, Mexico.	fdaniel@unam.mx		Rudino-Pinera, Enrique/0000-0001-8170-6379; SANCHEZ-LOPEZ, ROSANA/0000-0002-1628-7240; Canul Tec, Juan Carlos/0000-0003-0513-545X	National Institutes of Health [GM-0080]; U.S. Department of Energy [DE-AC02-98CH10886]; Consejo Nacional de Ciencia y Tecnologia [185179, 177224]; CONACyT [102370]; Programa de Apoyos a Proyectos de Investigacion y de Innovacion Tecnologica [IN204611]; PAPIIT [IN217510, UNAM]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyos a Proyectos de Investigacion y de Innovacion Tecnologica; PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-0080 (to X6A Beamline). This work was also supported in part by U.S. Department of Energy Contract DE-AC02-98CH10886 to the National Synchrotron Light Source at Brookhaven National Laboratory.; Recipient of Scholarship 185179 from the Consejo Nacional de Ciencia y Tecnologia.; Recipient of Scholarship 177224 from the Consejo Nacional de Ciencia y Tecnologia.; Supported by CONACyT Project 102370 and Programa de Apoyos a Proyectos de Investigacion y de Innovacion Tecnologica IN204611.; Supported by PAPIIT IN217510, UNAM.	Abe M, 1998, CLIN EXP IMMUNOL, V111, P457; Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dealwis C, 2004, CURR DRUG TARGETS, V5, P159, DOI 10.2174/1389450043490550; Yauner LD, 2008, PROTEINS, V72, P684, DOI 10.1002/prot.21934; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farner NL, 1999, J IMMUNOL, V162, P2137; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Hernandez-Santoyo A, 2010, J MOL BIOL, V396, P280, DOI 10.1016/j.jmb.2009.11.038; Huang DB, 1996, ACTA CRYSTALLOGR D, V52, P1058, DOI 10.1107/S090744499600813X; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LOPEZDECASTRO JA, 1978, BIOCHEMISTRY-US, V17, P1718, DOI 10.1021/bi00602a021; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merlini G, 2006, BLOOD, V108, P2520, DOI 10.1182/blood-2006-03-001164; Milardi D, 1997, BIOPHYS CHEM, V69, P43, DOI 10.1016/S0301-4622(97)00071-9; Muller AMS, 2006, ONCOLOGIST, V11, P824, DOI 10.1634/theoncologist.11-7-824; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nowak M, 2004, PROTEINS, V55, P11, DOI 10.1002/prot.10606; Obici L, 2005, BBA-PROTEINS PROTEOM, V1753, P11, DOI 10.1016/j.bbapap.2005.08.014; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V245, P713, DOI 10.1006/bbrc.1998.8515; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Poshusta TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005169; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; Randles EG, 2009, J MOL BIOL, V389, P199, DOI 10.1016/j.jmb.2009.04.010; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Stevens F J, 1995, Methods Mol Biol, V51, P51; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall J, 1999, METHOD ENZYMOL, V309, P204; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Williams SC, 1996, J MOL BIOL, V264, P220, DOI 10.1006/jmbi.1996.0636	55	11	11	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2577	2592		10.1074/jbc.M114.629550	http://dx.doi.org/10.1074/jbc.M114.629550			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505244	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000349310700005
J	Arribas-Gonzalez, E; de Juan-Sanz, J; Aragon, C; Lopez-Corcuera, B				Arribas-Gonzalez, Esther; de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz			Molecular Basis of the Dominant Negative Effect of a Glycine Transporter 2 Mutation Associated with Hyperekplexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; NEUROTRANSMITTER TRANSPORTERS; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; SLC6 TRANSPORTERS; STARTLE DISEASE; GLYT2; DYSFUNCTION; TRAFFICKING; MECHANISMS	Hyperekplexia or startle disease is a rare clinical syndrome characterized by an exaggerated startle in response to trivial tactile or acoustic stimuli. This neurological disorder can have serious consequences in neonates, provoking brain damage and/or sudden death due to apnea episodes and cardiorespiratory failure. Hyperekplexia is caused by defective inhibitory glycinergic neurotransmission. Mutations in the human SLC6A5 gene encoding the neuronal GlyT2 glycine transporter are responsible for the presynaptic form of the disease. GlyT2 mediates synaptic glycine recycling, which constitutes the main source of releasable transmitter at glycinergic synapses. Although the majority of GlyT2 mutations detected so far are recessive, a dominant negative mutant that affects GlyT2 trafficking does exist. In this study, we explore the properties and structural alterations of the S512R mutation in GlyT2. We analyze its dominant negative effect that retains wild-type GlyT2 in the endoplasmic reticulum (ER), preventing surface expression. We show that the presence of an arginine rather than serine 512 provoked transporter misfolding, enhanced association to the ER-chaperone calnexin, altered association with the coat-protein complex II component Sec24D, and thereby impeded ER exit. The S512R mutant formed oligomers with wild-type GlyT2 causing its retention in the ER. Overexpression of calnexin rescued wild-type GlyT2 from the dominant negative effect of the mutant, increasing the amount of transporter that reached the plasma membrane and dampening the interaction between the wild-type and mutant GlyT2. The ability of chemical chaperones to overcome the dominant negative effect of the disease mutation on the wild-type transporter was demonstrated in heterologous cells and primary neurons.	[Arribas-Gonzalez, Esther; de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, Dept Biol Mol, CSIC, E-28049 Madrid, Spain; [Arribas-Gonzalez, Esther; de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain; [Arribas-Gonzalez, Esther; de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, IdiPAZ Hosp Univ La Paz, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario La Paz	Lopez-Corcuera, B (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	blopez@cbm.csic.es	Corcuera, Beatriz López/D-5188-2009; Aragon, Carmen/K-9783-2014; de Juan-Sanz, Jaime/L-7990-2017	Corcuera, Beatriz López/0000-0002-0383-4241; Aragon, Carmen/0000-0001-8287-9386; de Juan-Sanz, Jaime/0000-0002-1212-5623; Arribas Gonzalez, Esther/0000-0001-6579-3396	Spanish "Ministerio de Economia y Competitividad" [SAF2011-28674]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Fundacion Ramon Areces	Spanish "Ministerio de Economia y Competitividad"; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Fundacion Ramon Areces	This work was supported by Spanish "Ministerio de Economia y Competitividad" Grant SAF2011-28674, by the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), and by an institutional grant from the "Fundacion Ramon Areces."	Apostolides PF, 2013, J NEUROSCI, V33, P4768, DOI 10.1523/JNEUROSCI.5555-12.2013; Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Arribas-Gonzalez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063230; Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; Conn PM, 2009, TRENDS PHARMACOL SCI, V30, P228, DOI 10.1016/j.tips.2009.02.002; de Juan-Sanz J, 2013, J NEUROSCI, V33, P14269, DOI 10.1523/JNEUROSCI.1532-13.2013; de Juan-Sanz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058863; de Juan-Sanz J, 2011, TRAFFIC, V12, P1850, DOI 10.1111/j.1600-0854.2011.01278.x; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Fujiwara M, 2013, J PHARMACOL SCI, V122, P71, DOI 10.1254/jphs.12194FP; Geerlings A, 2002, J NEUROCHEM, V82, P58, DOI 10.1046/j.1471-4159.2002.00930.x; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gimenez C, 2012, J BIOL CHEM, V287, P28986, DOI 10.1074/jbc.M111.319244; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Harvey RJ, 2013, NAT REV DRUG DISCOV, V12, P866, DOI 10.1038/nrd3893; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Leidenheimer NJ, 2014, PHARMACOL RES, V83, P10, DOI 10.1016/j.phrs.2014.01.005; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; LIU QR, 1993, J BIOL CHEM, V268, P22802; LOPEZCORCUERA B, 1991, J BIOL CHEM, V266, P24809; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Perez-Siles G, 2012, BIOCHEM J, V442, P323, DOI 10.1042/BJ20110247; Pettit RS, 2012, ANN PHARMACOTHER, V46, P1065, DOI 10.1345/aph.1R076; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x	50	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2150	2165		10.1074/jbc.M114.587055	http://dx.doi.org/10.1074/jbc.M114.587055			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480793	Green Published, hybrid			2022-12-28	WOS:000348588000020
J	Kim, D; Dai, J; Fai, LY; Yao, H; Son, YO; Wang, L; Pratheeshkumar, P; Kondo, K; Shi, XL; Zhang, Z				Kim, Donghern; Dai, Jin; Fai, Leonard Yenwong; Yao, Hua; Son, Young-Ok; Wang, Lei; Pratheeshkumar, Poyil; Kondo, Kazuya; Shi, Xianglin; Zhang, Zhuo			Constitutive Activation of Epidermal Growth Factor Receptor Promotes Tumorigenesis of Cr(VI)-transformed Cells through Decreased Reactive Oxygen Species and Apoptosis Resistance Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HEXAVALENT CHROMIUM; SIGNALING PATHWAY; EGFR MUTATIONS; CANCER-CELLS; TUMOR-CELLS; DNA-DAMAGE; PHOSPHORYLATION; TRANSFORMATION; MECHANISMS	Hexavalent chromium (Cr(VI)) compounds are well-established lung carcinogens. Epidermal growth factor receptor (EGFR) is a tyrosine kinase transmembrane receptor that regulates cell survival, tumor invasion, and angiogenesis. Our results show that chronic exposure of human bronchial epithelial (BEAS-2B) cells to Cr(VI) is able to cause malignant cell transformation. These transformed cells exhibit apoptosis resistance with reduced poly ADP-ribose polymerase cleavage (C-PARP) and Bax expression and enhanced expressions of Bcl-2 and Bcl-xL. These transformed cells also exhibit reduced capacity of reactive oxygen species (ROS) generation along with elevated expression of antioxidant manganese superoxide dismutase 2 (SOD2). The expression of this antioxidant was also elevated in lung tumor tissue from a worker exposed to Cr(VI) for 19 years. EGFR was activated in Cr(VI)-transformed BEAS-2B cells, lung tissue from animals exposed to Cr(VI) particles, and human lung tumor tissue. Further study indicates that constitutive activation of EGFR in Cr(VI)-transformed cells was due to increased binding to its ligand amphiregulin (AREG). Inhibition of EGFR or AREG increased Bax expression and reduced Bcl-2 expression, resulting in reduced apoptosis resistance. Furthermore, inhibition of AREG or EGFR restored capacity of ROS generation and decreased SOD2 expression. PI3K/AKT was activated, which depended on EGFR in Cr(VI)-transformed BEAS-2B cells. Inhibition of PI3K/AKT increased ROS generation and reduced SOD2 expression, resulting in reduced apoptosis resistance with commitment increase in Bax expression and reduction of Bcl-2 expression. Xenograft mouse tumor study further demonstrates the essential role of EGFR in tumorigenesis of Cr(VI)-transformed cells. In summary, the present study suggests that ligand-dependent constitutive activation of EGFR causes reduced ROS generation and increased antioxidant expression, leading to development of apoptosis resistance, contributing to Cr(VI)-induced tumorigenesis.	[Kim, Donghern; Dai, Jin; Fai, Leonard Yenwong; Zhang, Zhuo] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Son, Young-Ok; Wang, Lei; Pratheeshkumar, Poyil; Shi, Xianglin] Univ Kentucky, Ctr Res Environm Dis, Lexington, KY 40536 USA; [Yao, Hua] Zhejiang Univ, Affiliated Hosp 1, Dept Stomatol, Hangzhou 310003, Zhejiang, Peoples R China; [Kondo, Kazuya] Univ Tokushima, Inst Hlth Biosci, Dept Oncol Med Serv, Grad Sch, Tokushima 7708509, Japan	University of Kentucky; University of Kentucky; Zhejiang University; Tokushima University	Zhang, Z (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	zhuo.zhang@uky.edu	Kondo, Kazuya/J-9163-2012; Son, Youngok/AAB-1380-2021; Shi, Xianglin/B-8588-2012; Zhang, Zhuo/B-8601-2012; Son, Young-Ok/P-3675-2015	Son, Youngok/0000-0003-0154-4061	National Institutes of Health/NIEHS [R01ES018883]; National Institutes of Health/NCI [R03CA171604]; NATIONAL CANCER INSTITUTE [P30CA177558, R03CA171604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021771, R01ES018883] Funding Source: NIH RePORTER	National Institutes of Health/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by National Institutes of Health/NIEHS R01ES018883 and National Institutes of Health/NCI R03CA171604 (to Z. Z.).	[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V49, P1; Beaver L. M., 2010, ENV HLTH PERSPEC, V117, P1898; Chen CH, 2006, MOL PHARMACOL, V69, P1347, DOI 10.1124/mol.105.017558; Chen F, 2001, MOL CELL BIOCHEM, V222, P183, DOI 10.1023/A:1017970330982; Chiarugi P, 2007, ANTIOXID REDOX SIGN, V9, P1, DOI 10.1089/ars.2007.9.1; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hill R, 2008, DNA REPAIR, V7, P239, DOI 10.1016/j.dnarep.2007.10.001; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; Ivanova D, 2013, ADV CLIN EXP MED, V22, P899; Kagan V., 1990, MEMBRANE LIPID OXIDA, V3, P192; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; LANGARD S, 1990, AM J IND MED, V17, P189, DOI 10.1002/ajim.4700170205; Lee DH, 2009, J CELL BIOCHEM, V106, P1113, DOI 10.1002/jcb.22098; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Marinov M, 2009, CLIN CANCER RES, V15, P1277, DOI 10.1158/1078-0432.CCR-08-2166; Medan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037045; Mesquita FS, 2010, BIOL REPROD, V82, P341, DOI 10.1095/biolreprod.108.075887; Orcutt KP, 2011, CANCER RES, V71, P3932, DOI 10.1158/0008-5472.CAN-10-3425; Paletta-Silva R, 2013, INT J MOL SCI, V14, P3683, DOI 10.3390/ijms14023683; Pellerin C, 2000, ENVIRON HEALTH PERSP, V108, pA402, DOI 10.2307/3434980; Peus D, 2000, PHOTOCHEM PHOTOBIOL, V72, P135, DOI 10.1562/0031-8655(2000)072<0135:UIEGFR>2.0.CO;2; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rodrigues CFD, 2009, MUTAT RES-FUND MOL M, V670, P42, DOI 10.1016/j.mrfmmm.2009.07.004; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Scagliotti GV, 2004, CLIN CANCER RES, V10, p4227S, DOI 10.1158/1078-0432.CCR-040007; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; SHI XL, 1989, BIOCHEM BIOPH RES CO, V163, P627, DOI 10.1016/0006-291X(89)92183-9; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Wang BJ, 2010, TOXICOL LETT, V198, P216, DOI 10.1016/j.toxlet.2010.06.024; Wang X, 2011, TOXICOL SCI, V123, P399, DOI 10.1093/toxsci/kfr180; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wyllie AH, 1999, BRIT J CANCER, V80, P34; Yao H, 2008, J ENVIRON PATHOL TOX, V27, P77, DOI 10.1615/JEnvironPatholToxicolOncol.v27.i2.10; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye JP, 1999, J BIOL CHEM, V274, P34974, DOI 10.1074/jbc.274.49.34974; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zhou CL, 2006, INT J ONCOL, V29, P269; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	51	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2213	2224		10.1074/jbc.M114.619783	http://dx.doi.org/10.1074/jbc.M114.619783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477514	Green Published, hybrid			2022-12-28	WOS:000348588000025
J	Bufe, B; Schumann, T; Kappl, R; Bogeski, I; Kummerow, C; Podgorska, M; Smola, S; Hoth, M; Zufall, F				Bufe, Bernd; Schumann, Timo; Kappl, Reinhard; Bogeski, Ivan; Kummerow, Carsten; Podgorska, Marta; Smola, Sigrun; Hoth, Markus; Zufall, Frank			Recognition of Bacterial Signal Peptides by Mammalian Formyl Peptide Receptors A NEW MECHANISM FOR SENSING PATHOGENS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Imaging; Chemical Biology; G-protein-coupled Receptor (GPCR); Innate Immunity; Molecular Pharmacology; Pathogen-associated Molecular Pattern (PAMP); Pattern Recognition Receptor (PRR); Vomeronasal Organ (VNO)	VOMERONASAL SENSORY NEURONS; GENERAL SECRETORY PATHWAY; STAPHYLOCOCCUS-AUREUS; HUMAN NEUTROPHILS; HOST-DEFENSE; LISTERIA-MONOCYTOGENES; PROTEIN SECRETION; INFLAMMATION; IDENTIFICATION; RESPONSES	Background: The function of formyl peptide receptors (FPRs) is incompletely understood. Results: We report the identification of bacterial signal peptides as potent activators of mammalian FPRs and innate immune responses and define critical features underlying FPR peptide recognition. Conclusion: These findings identify a molecular signature for FPR activation. Significance: Our results define a novel mechanism for sensing bacteria. Formyl peptide receptors (FPRs) are G-protein-coupled receptors that function as chemoattractant receptors in innate immune responses. Here we perform systematic structure-function analyses of FPRs from six mammalian species using structurally diverse FPR peptide agonists and identify a common set of conserved agonist properties with typical features of pathogen-associated molecular patterns. Guided by these results, we discover that bacterial signal peptides, normally used to translocate proteins across cytoplasmic membranes, are a vast family of natural FPR agonists. N-terminally formylated signal peptide fragments with variable sequence and length activate human and mouse FPR1 and FPR2 at low nanomolar concentrations, thus establishing FPR1 and FPR2 as sensitive and broad signal peptide receptors. The vomeronasal receptor mFpr-rs1 and its sequence orthologue hFPR3 also react to signal peptides but are much more narrowly tuned in signal peptide recognition. Furthermore, all signal peptides examined here function as potent activators of the innate immune system. They elicit robust, FPR-dependent calcium mobilization in human and mouse leukocytes and trigger a range of classical innate defense mechanisms, such as the production of reactive oxygen species, metalloprotease release, and chemotaxis. Thus, bacterial signal peptides constitute a novel class of immune activators that are likely to contribute to mammalian immune defense against bacteria. This evolutionarily conserved detection mechanism combines structural promiscuity with high specificity and enables discrimination between bacterial and eukaryotic signal sequences. With at least 175,542 predicted sequences, bacterial signal peptides represent the largest and structurally most heterogeneous class of G-protein-coupled receptor agonists currently known for the innate immune system.	[Bufe, Bernd; Schumann, Timo; Zufall, Frank] Univ Saarland, Sch Med, Dept Physiol, D-66421 Homburg, Germany; [Kappl, Reinhard; Bogeski, Ivan; Kummerow, Carsten; Hoth, Markus] Univ Saarland, Sch Med, Dept Biophys, D-66421 Homburg, Germany; [Podgorska, Marta; Smola, Sigrun] Univ Saarland, Sch Med, Dept Virol, D-66421 Homburg, Germany	Saarland University; Saarland University; Saarland University	Bufe, B (corresponding author), Univ Saarland, Sch Med, Dept Physiol, Kirrbergerstr Bldg 58, D-66424 Homburg, Germany.	bernd.bufe@uks.eu	Bogeski, Ivan/ABA-2141-2021; Zufall, Frank/AAE-5290-2021; Bufe, Bernd/N-6685-2018	Bogeski, Ivan/0000-0001-9879-7174; Zufall, Frank/0000-0002-4383-8618; Hoth, Markus/0000-0001-7080-4643; Bufe, Bernd/0000-0003-1610-0658; Kappl, Reinhard/0000-0003-0223-6642; Kummerow, Carsten/0000-0001-5667-2293	Deutsche Forschungsgemeinschaft [INST 256/271-1 FUGG, Sonderforschungsbereich 894/A1, Sonderforschungsbereich 894/A17, Sonderforschungsbereich 1027/A2, Sonderforschungsbereich 1027/C4, Schwerpunktprogramm 1392]; University of Saarland	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Saarland	This work was supported by Deutsche Forschungsgemeinschaft Grants INST 256/271-1 FUGG (to F. Z. and B. B), Sonderforschungsbereich 894/A1 (to M. H.) and A17 (to F. Z.), Sonderforschungsbereich 1027/A2 and C4 (to M. H. and I. B.), and Schwerpunktprogramm 1392 (to F. Z.). This work was also supported by the University of Saarland through HOMFORexcellent Grants 2011 (to B. B.) and 2013 (to I. B.) and a graduate scholarship (GradUS) (to T. S.).	Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Bae GH, 2012, EXP MOL MED, V44, P130, DOI 10.3858/emm.2012.44.2.008; Baek SH, 1996, J BIOL CHEM, V271, P8170, DOI 10.1074/jbc.271.14.8170; Benelli D, 2009, RES MICROBIOL, V160, P493, DOI 10.1016/j.resmic.2009.06.003; Bogeski I, 2011, CELL CALCIUM, V50, P407, DOI 10.1016/j.ceca.2011.07.006; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bufe B, 2012, J BIOL CHEM, V287, P33644, DOI 10.1074/jbc.M112.375774; Chamero P, 2012, TRENDS NEUROSCI, V35, P597, DOI 10.1016/j.tins.2012.04.011; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEMMERICH B, 1988, J LEUKOCYTE BIOL, V43, P125, DOI 10.1002/jlb.43.2.125; Kretschmer D, 2012, J INNATE IMMUN, V4, P201, DOI 10.1159/000332142; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; LACY M, 1995, J NEUROIMMUNOL, V61, P71, DOI 10.1016/0165-5728(95)00075-D; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Le YY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0003.2001; Leinders-Zufall T, 2014, J NEUROSCI, V34, P5121, DOI 10.1523/JNEUROSCI.0186-14.2014; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Li YS, 2013, J MOL MED, V91, P781, DOI 10.1007/s00109-013-1005-5; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mollica Adriano, 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P20; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Panaro MA, 2006, IMMUNOPHARM IMMUNOT, V28, P103, DOI 10.1080/08923970600625975; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Ravipaty S, 2010, MOL CELL PROTEOMICS, V9, P1898, DOI 10.1074/mcp.M900494-MCP200; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rienstra CM, 2002, P NATL ACAD SCI USA, V99, P10260, DOI 10.1073/pnas.152346599; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Ruiz-Gomez G, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900344w; Sagan L, 1967, J Theor Biol, V14, P255; Schepetkin IA, 2013, BIOCHEM PHARMACOL, V85, P404, DOI 10.1016/j.bcp.2012.11.015; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schwartz K, 2014, INFECT IMMUN, V82, P3837, DOI 10.1128/IAI.02111-14; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Shao GH, 2011, AM J RESP CELL MOL, V44, P264, DOI 10.1165/rcmb.2010-0246RC; SHAWAR SM, 1995, BIOCHEM BIOPH RES CO, V211, P812, DOI 10.1006/bbrc.1995.1884; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078	57	68	69	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7369	7387		10.1074/jbc.M114.626747	http://dx.doi.org/10.1074/jbc.M114.626747			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605714	hybrid, Green Published			2022-12-28	WOS:000351613600007
J	Liu, MX; Allegood, J; Zhu, XW; Seo, J; Gebre, AK; Boudyguina, E; Cheng, DM; Chuang, CC; Shelness, GS; Spiegel, S; Parks, JS				Liu, Mingxia; Allegood, Jeremy; Zhu, Xuewei; Seo, Jeongmin; Gebre, Abraham K.; Boudyguina, Elena; Cheng, Dongmei; Chuang, Chia-Chi; Shelness, Gregory S.; Spiegel, Sarah; Parks, John S.			Uncleaved ApoM Signal Peptide Is Required for Formation of Large ApoM/Sphingosine 1-Phosphate (S1P)-enriched HDL Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ceramide; Cholesterol; Liver; Sphingolipid; Sphingosine 1-Phosphate (S1P); Apolipoprotein M; Fumonisin B1; High Density Lipoproteins; Myriocin	HIGH-DENSITY-LIPOPROTEIN; PRE-BETA-HDL; PLASMA-MEMBRANE MICROSOLUBILIZATION; REVERSE CHOLESTEROL TRANSPORT; APOLIPOPROTEIN-M; CELLULAR CHOLESTEROL; NASCENT HDL; SPHINGOSINE-1-PHOSPHATE; SECRETION; EFFLUX	Background: ApoM overexpression generates larger nascent and plasma HDLs. Results: ApoM(Q22A) overexpression generates smaller nascent and plasma HDL and enhances apoM and S1P secretion as compared with apoM(WT). Conclusion: ApoM secretion regulates hepatocyte S1P secretion, and its uncleaved signal peptide delays apoM secretion, promoting larger nascent and plasma HDL particle formation. Significance: ApoM signal peptide is required for large apoM/S1P-enriched HDL formation. Apolipoprotein M (apoM), a plasma sphingosine 1-phosphate (S1P) carrier, associates with plasma HDL via its uncleaved signal peptide. Hepatocyte-specific apoM overexpression in mice stimulates formation of both larger nascent HDL in hepatocytes and larger mature apoM/S1P-enriched HDL particles in plasma by enhancing hepatic S1P synthesis and secretion. Mutagenesis of apoM glutamine 22 to alanine (apoM(Q22A)) introduces a functional signal peptidase cleavage site. Expression of apoM(Q22A) in ABCA1-expressing HEK293 cells resulted in the formation of smaller nascent HDL particles compared with wild type apoM (apoM(WT)). When apoM(Q22A) was expressed in vivo, using recombinant adenoviruses, smaller plasma HDL particles and decreased plasma S1P and apoM were observed relative to expression of apoM(WT). Hepatocytes isolated from both apoM(WT)- and apoM(Q22A)-expressing mice displayed an equivalent increase in cellular levels of S1P, relative to LacZ controls; however, relative to apoM(WT), apoM(Q22A) hepatocytes displayed more rapid apoM and S1P secretion but minimal apoM(Q22A) bound to nascent lipoproteins. Pharmacologic inhibition of ceramide synthesis increased cellular sphingosine and S1P but not medium S1P in both apoM(WT) and apoM(Q22A) hepatocytes. We conclude that apoM secretion is rate-limiting for hepatocyte S1P secretion and that its uncleaved signal peptide delays apoM trafficking out of the cell, promoting formation of larger nascent apoM- and S1P-enriched HDL particles that are probably precursors of larger apoM/S1P-enriched plasma HDL.	[Liu, Mingxia; Zhu, Xuewei; Seo, Jeongmin; Gebre, Abraham K.; Boudyguina, Elena; Cheng, Dongmei; Chuang, Chia-Chi; Shelness, Gregory S.; Parks, John S.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Shelness, Gregory S.; Parks, John S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Allegood, Jeremy; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Wake Forest University; Wake Forest University; Virginia Commonwealth University	Parks, JS (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jparks@wakehealth.edu		Key, Chia-Chi/0000-0003-0669-2936	National Institutes of Health [P01HL49373, R01HL119962, R37GM043880]; American Heart Association [12PRE12040309]; RJR-Leon Golberg postdoctoral fellowship; National Institutes of Health, NCI, Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [R01CA061774, P30CA016059, P30CA012197] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, R01HL119962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880, R01GM043880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); RJR-Leon Golberg postdoctoral fellowship; National Institutes of Health, NCI, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL49373 (to J. S. P. and G. S. S.), R01HL119962 (to J. S. P.), and R37GM043880 (to S. S.). This work was also supported by American Heart Association Predoctoral Fellowship 12PRE12040309 and an RJR-Leon Golberg postdoctoral fellowship (to M. L.). The Lipidomics Core Facility in the Virginia Commonwealth University Biochemistry and Molecular Biology Department is supported in part by funding to the Massey Cancer Center from National Institutes of Health, NCI, Cancer Center Support Grant P30 CA016059.	Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Ahnstrom J, 2010, PROTEIN PEPTIDE LETT, V17, P1285, DOI 10.2174/092986610792231410; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bi X, 2013, ARTERIOSCL THROM VAS, V33, P2288, DOI 10.1161/ATVBAHA.112.301110; Boadu E, 2008, CURR OPIN LIPIDOL, V19, P270, DOI 10.1097/MOL.0b013e3282feea99; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Chisholm JW, 2002, J LIPID RES, V43, P36; Christoffersen C, 2008, J BIOL CHEM, V283, P18765, DOI 10.1074/jbc.M800695200; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Elsoe S, 2012, ATHEROSCLEROSIS, V221, P91, DOI 10.1016/j.atherosclerosis.2011.11.031; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Gallagher JW, 2004, J LIPID RES, V45, P1826, DOI 10.1194/jlr.M400188-JLR200; Gillotte KL, 1998, J LIPID RES, V39, P1918; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Karuna R, 2011, ATHEROSCLEROSIS, V219, P855, DOI 10.1016/j.atherosclerosis.2011.08.049; Kontush A, 2010, CURR OPIN LIPIDOL, V21, P312, DOI 10.1097/MOL.0b013e32833bcdc1; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Liu MX, 2014, J BIOL CHEM, V289, P2801, DOI 10.1074/jbc.M113.499913; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mulya A, 2008, J LIPID RES, V49, P2390, DOI 10.1194/jlr.M800241-JLR200; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Mulya A, 2010, J LIPID RES, V51, P514, DOI 10.1194/jlr.M002162; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Sorenson RC, 1999, ARTERIOSCL THROM VAS, V19, P2214, DOI 10.1161/01.ATV.19.9.2214; Sutter I, 2014, J LIPID RES, V55, P1730, DOI 10.1194/jlr.M050021; VerHague MA, 2013, ARTERIOSCL THROM VAS, V33, P2501, DOI 10.1161/ATVBAHA.113.301948; WANG E, 1991, J BIOL CHEM, V266, P14486; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286	38	21	27	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7861	7870		10.1074/jbc.M114.631101	http://dx.doi.org/10.1074/jbc.M114.631101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25627684	Green Published, hybrid			2022-12-28	WOS:000351613600044
J	Cao, XY; Cronan, JE				Cao, Xinyun; Cronan, John E.			The Streptomyces coelicolor Lipoate-protein Ligase Is a Circularly Permuted Version of the Escherichia coli Enzyme Composed of Discrete Interacting Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; LIPOIC ACID; THERMOPLASMA-ACIDOPHILUM; POSTTRANSLATIONAL MODIFICATION; MULTIENZYME COMPLEX; FLUOROPHORE LIGASE; CRYSTAL-STRUCTURE; SWINGING ARMS; LPLA; IDENTIFICATION	Lipoate-protein ligases are used to scavenge lipoic acid from the environment and attach the coenzyme to its cognate proteins, which are generally the E2 components of the 2-oxoacid dehydrogenases. The enzymes use ATP to activate lipoate to its adenylate, lipoyl-AMP, which remains tightly bound in the active site. This mixed anhydride is attacked by the epsilon-amino group of a specific lysine present on a highly conserved acceptor protein domain, resulting in the amide-linked coenzyme. The Streptomyces coelicolor genome encodes only a single putative lipoate ligase. However, this protein had only low sequence identity (<25%) to the lipoate ligases of demonstrated activity and appears to be a circularly permuted version of the known lipoate ligase proteins in that the canonical C-terminal domain seems to have been transposed to the N terminus We tested the activity of this protein both by in vivo complementation of an Escherichia coli ligase-deficient strain and by in vitro assays. Moreover, when the domains were rearranged into a protein that mimicked the arrangement found in the canonical lipoate ligases, the enzyme retained complementation activity. Finally, when the two domains were separated into two proteins, both domain-containing proteins were required for complementation and catalysis of the overall ligase reaction in vitro. However, only the large domain-containing protein was required for transfer of lipoate from the lipoyl-AMP intermediate to the acceptor proteins, whereas both domain-containing proteins were required to form lipoyl-AM	[Cao, Xinyun; Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health from NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650 from NIAID.	ALI ST, 1990, MOL MICROBIOL, V4, P943, DOI 10.1111/j.1365-2958.1990.tb00667.x; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baruah H, 2008, ANGEW CHEM INT EDIT, V47, P7018, DOI 10.1002/anie.200802088; BERG A, 1994, EUR J BIOCHEM, V221, P87, DOI 10.1111/j.1432-1033.1994.tb18717.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Christensen QH, 2011, J BIOL CHEM, V286, P31447, DOI 10.1074/jbc.M111.273607; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Cohen JD, 2012, CHEMBIOCHEM, V13, P888, DOI 10.1002/cbic.201100764; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Cronan JE., 2014, ECOSAL PLUS, V6, P1, DOI [10.1128/ecosalplus.ESP-0001-2012, DOI 10.1128/ECOSALPLUS.ESP-0001-2012]; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Fujino T, 2001, J BIOL CHEM, V276, P35961, DOI 10.1074/jbc.M106651200; Fujiwara K, 2001, J BIOL CHEM, V276, P28819, DOI 10.1074/jbc.M101748200; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Fujiwara K, 2010, J BIOL CHEM, V285, P9971, DOI 10.1074/jbc.M109.078717; Gueguen V, 1999, J BIOL CHEM, V274, P26344, DOI 10.1074/jbc.274.37.26344; GUEST JR, 1985, J MOL BIOL, V185, P743, DOI 10.1016/0022-2836(85)90059-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HERBERT AA, 1968, J GEN MICROBIOL, V53, P363, DOI 10.1099/00221287-53-3-363; Hermes FAM, 2009, J BACTERIOL, V191, P6796, DOI 10.1128/JB.00798-09; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; Liu DS, 2014, P NATL ACAD SCI USA, V111, pE4551, DOI 10.1073/pnas.1404736111; Martin N, 2011, MOL MICROBIOL, V80, P335, DOI 10.1111/j.1365-2958.2011.07597.x; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posner MG, 2013, BIOCHEM J, V449, P415, DOI 10.1042/BJ20121150; Posner MG, 2009, FEBS J, V276, P4012, DOI 10.1111/j.1742-4658.2009.07110.x; Reche P, 1999, EMBO J, V18, P2673, DOI 10.1093/emboj/18.10.2673; REED LJ, 1958, J BIOL CHEM, V232, P143; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Vessey DA, 2003, J BIOCHEM MOL TOXIC, V17, P1, DOI 10.1002/jbt.10056; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	44	10	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7280	7290		10.1074/jbc.M114.626879	http://dx.doi.org/10.1074/jbc.M114.626879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631049	hybrid, Green Published			2022-12-28	WOS:000350991500056
J	Richards, EJ; Zhang, G; Li, ZP; Permuth-Wey, J; Challa, S; Li, YJ; Kong, W; Dan, S; Bui, MM; Coppola, D; Mao, WM; Sellers, TA; Cheng, JQ				Richards, Edward J.; Zhang, Gu; Li, Zhu-Peng; Permuth-Wey, Jennifer; Challa, Sridevi; Li, Yajuan; Kong, William; Dan, Su; Bui, Marilyn M.; Coppola, Domenico; Mao, Wei-Min; Sellers, Thomas A.; Cheng, Jin Q.			Long Non-coding RNAs (LncRNA) Regulated by Transforming Growth Factor (TGF) beta LncRNA-HIT-MEDIATED TGF beta-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY EPITHELIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; METASTASIS; CHROMATIN; CONSERVATION; CELLS; CONTRIBUTES; PROMOTES	Long noncoding RNAs (lncRNAs) are emerging as key regulators in various biological processes. Epithelial-to-mesenchymal transition (EMT) is a developmental process hijacked by tumor cells to depart from the primary tumor site, invade surrounding tissue, and establish distant metastases. Transforming growth factor beta(TGF beta) signaling has been shown to be a major inducer of EMT and to facilitate breast cancer metastasis. However, the role of lncRNAs in this process remains largely unknown. Here we report a genome-wide lncRNA profile in mouse mammary epithelial NMuMG cells upon TGF beta induction of EMT. Among 10,802 lncRNAs profiled, over 600 were up-regulated and down-regulated during the EMT, respectively. Furthermore, we identify that lncRNA-HIT (HOXA transcript induced by TGF beta mediates TGF beta function, i.e. depletion of lncRNA-HIT inhibits TGF beta-induced migration, invasion, and EMT in NMuMG. LncRNA-HIT is also significantly elevated in the highly metastatic 4T1 cells. Knockdown of lncRNA-HIT in 4T1 results in decrease of cell migration, invasion, tumor growth, and metastasis. E-cadherin was identified as a major target of lncRNA-HIT. Moreover, lncRNA-HIT is conserved in humans and elevated expression associates with more invasive human primary breast carcinoma. Collectively, these data suggest that a subset of lncRNAs such as lncRNA-HIT play a significant role in regulation of EMT and breast cancer invasion and metastasis, and could be potential therapeutic targets in breast cancers.	[Richards, Edward J.; Challa, Sridevi; Li, Yajuan; Kong, William; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Permuth-Wey, Jennifer; Sellers, Thomas A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Bui, Marilyn M.; Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol Anat, Tampa, FL 33612 USA; [Zhang, Gu; Li, Zhu-Peng; Dan, Su; Mao, Wei-Min] Zhejiang Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China; [Zhang, Gu; Li, Zhu-Peng; Dan, Su; Mao, Wei-Min] Zhejiang Canc Res Inst, Hangzhou 310022, Zhejiang, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Cheng, JQ (corresponding author), 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org			National Institutes of Health [CA137041, CA160455, CA114343-03S1]; National Natural Science Foundation of China [81172081]; NATIONAL CANCER INSTITUTE [R25CA174664, R01CA114343, P30CA076292, R01CA160455, R01CA137041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA137041, CA160455 (to J. Q. C.), and CA114343-03S1 (to T. A. S.) and the National Natural Science Foundation of China, Grant 81172081 (to W. M. M.).	Allred DC, 1998, MODERN PATHOL, V11, P155; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chau YM, 2002, J CLIN ENDOCR METAB, V87, P2674, DOI 10.1210/jc.87.6.2674; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Quagliata L, 2014, HEPATOLOGY, V59, P911, DOI 10.1002/hep.26740; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xie W, 2002, CANCER RES, V62, P497; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	29	124	133	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6857	6867		10.1074/jbc.M114.610915	http://dx.doi.org/10.1074/jbc.M114.610915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605728	hybrid, Green Published			2022-12-28	WOS:000350991500021
J	Sanchez-Casalongue, ME; Lee, J; Diamond, A; Shuldiner, S; Moir, RD; Willis, IM				Sanchez-Casalongue, Manuel E.; Lee, Jaehoon; Diamond, Aviva; Shuldiner, Scott; Moir, Robyn D.; Willis, Ian M.			Differential Phosphorylation of a Regulatory Subunit of Protein Kinase CK2 by Target of Rapamycin Complex 1 Signaling and the Cdc-like Kinase Kns1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; BETA-SUBUNIT; CRYSTAL-STRUCTURE; GLOBAL ANALYSIS; TRANSCRIPTION; YEAST; ACTIVATION; CELL	Transcriptional regulation of ribosome and tRNA synthesis plays a central role in determining protein synthetic capacity and is tightly controlled in response to nutrient availability and cellular stress. In Saccharomyces cerevisiae, the regulation of ribosome and tRNA synthesis was recently shown to involve the Cdc-like kinase Kns1 and the GSK-3 kinase Mck1. In this study, we explored additional roles for these conserved kinases in processes connected to the target of rapamycin complex 1 (TORC1). We conducted a synthetic chemical-genetic screen in a kns1 Delta mck1 Delta strain and identified many novel rapamycin-hypersensitive genes. Gene ontology analysis showed enrichment for TORC1-regulated processes (vesicle-mediated transport, autophagy, and regulation of cell size) and identified new connections to protein complexes including the protein kinase CK2. CK2 is considered to be a constitutively active kinase and in budding yeast, the holoenzyme comprises two regulatory subunits, Ckb1 and Ckb2, and two catalytic subunits, Cka1 and Cka2. We show that Ckb1 is differentially phosphorylated in vivo and that Kns1 mediates this phosphorylation when nutrients are limiting and under all tested stress conditions. We determined that the phosphorylation of Ckb1 does not detectably affect the stability of the CK2 holoenzyme but correlates with the reduced occupancy of Ckb1 on tRNA genes after rapamycin treatment. Thus, the differential occupancy of tRNA genes by CK2 is likely to modulate its activation of RNA polymerase III transcription. Our data suggest that TORC1, via its effector kinase Kns1, may regulate the association of CK2 with some of its substrates by phosphorylating Ckb1.	[Sanchez-Casalongue, Manuel E.; Lee, Jaehoon; Diamond, Aviva; Shuldiner, Scott; Moir, Robyn D.; Willis, Ian M.] Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Sanchez-Casalongue, Manuel E.; Lee, Jaehoon; Diamond, Aviva; Shuldiner, Scott; Moir, Robyn D.; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Willis, IM (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ian.willis@einstein.yu.edu		Willis, Ian/0000-0001-6599-2395	National Institutes of Health [RO1 GM085177]; Albert Einstein College of Medicine; Medical Scientist Training Program from National Institutes of Health, NIGMS [T32-GM007288]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, R01GM085177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; Medical Scientist Training Program from National Institutes of Health, NIGMS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM085177 (to I. M. W.) and the Albert Einstein College of Medicine.; Supported by the Medical Scientist Training Program Grant T32-GM007288 from the National Institutes of Health, NIGMS.	Acker J, 2013, BBA-GENE REGUL MECH, V1829, P283, DOI 10.1016/j.bbagrm.2012.10.002; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Bibby AC, 2005, INT J BIOL SCI, V1, P67; BIDWAI AP, 1994, ARCH BIOCHEM BIOPHYS, V309, P348, DOI 10.1006/abbi.1994.1123; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BOLDYREFF B, 1994, J BIOL CHEM, V269, P4827; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Campbell KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018408; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cho BR, 2014, MOL MICROBIOL, V93, P306, DOI 10.1111/mmi.12660; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Faresse NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003028; Farley AR, 2011, J PROTEOME RES, V10, P1481, DOI 10.1021/pr100877m; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghavidel A, 2001, CELL, V106, P575, DOI 10.1016/S0092-8674(01)00473-1; Ghavidel A, 1997, GENE DEV, V11, P2780, DOI 10.1101/gad.11.21.2780; Gjidoda A, 2013, BBA-GENE REGUL MECH, V1829, P385, DOI 10.1016/j.bbagrm.2012.09.011; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Graczyk D, 2011, P NATL ACAD SCI USA, V108, P4926, DOI 10.1073/pnas.1010010108; Graham KC, 2000, J BIOL CHEM, V275, P5003, DOI 10.1074/jbc.275.7.5003; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; Hockman DJ, 1996, MOL CELL BIOL, V16, P892; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnston IM, 2002, MOL CELL BIOL, V22, P3757, DOI 10.1128/MCB.22.11.3757-3768.2002; Kim HS, 2014, CELL REP, V6, P892, DOI 10.1016/j.celrep.2014.01.029; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee J, 2012, MOL CELL, V45, P836, DOI 10.1016/j.molcel.2012.01.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Moir RD, 2012, J BIOL CHEM, V287, P30833, DOI 10.1074/jbc.M112.378828; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Sanchez-Casalongue M., 2014, THESIS A EINSTEIN CO; Silva AC, 2012, J BIOL CHEM, V287, P1709, DOI 10.1074/jbc.M111.316489; Soragni E, 2008, J BIOL CHEM, V283, P26568, DOI 10.1074/jbc.M803769200; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Tripodi F, 2011, MOL CELL BIOCHEM, V356, P269, DOI 10.1007/s11010-011-0958-3; Umekawa M., 2012, INT J CELL BIOL, V2012, DOI [DOI 10.1155/2012/142634, 10.1155/ 2012/142634]; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Young BP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-354; Zhang CJ, 2002, ONCOGENE, V21, P3754, DOI 10.1038/sj.onc.1205467	62	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7221	7233		10.1074/jbc.M114.626523	http://dx.doi.org/10.1074/jbc.M114.626523			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631054	Green Published, hybrid			2022-12-28	WOS:000350991500051
J	Lee, YD; Yoon, SH; Park, CK; Lee, J; Lee, ZH; Kim, HH				Lee, Yong Deok; Yoon, Soo-Hyun; Park, Cheol Kyu; Lee, Jiyeon; Lee, Zang Hee; Kim, Hong-Hee			Caveolin-1 Regulates Osteoclastogenesis and Bone Metabolism in a Sex-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ESTROGEN-RECEPTOR-ALPHA; LIPID RAFTS; ENDOTHELIAL-CELLS; FAS LIGAND; IN-VITRO; ER-ALPHA; ACTIVATION; DIFFERENTIATION; OSTEOBLASTS	Lipid raft microdomains have important roles in various cellular responses. Caveolae are a specialized type of lipid rafts that are stabilized by oligomers of caveolin proteins. Here, we show that caveolin-1 (Cav-1) plays a crucial role in the regulation of osteoclastogenesis. We found that caveolin-1 was dramatically up-regulated by receptor activator of nuclear.factor kappa B ligand (RANKI,), the osteoclast differentiation factor. Knockdown of Cav- I reduced osteodastogenesis and induction of NFATcl, the master transcription factor for osteoclastogenesis, by RANKL. Consistent with the in vitro results, injection of caveolin-1 siRNA onto mice calvariae showed reduction in RANK!,induced bone resorption and osteoclast formation. Moreover, Cav-1(-/-) female mice had higher bone volume and lower osteodast number compared with wild type mice. However, Cav-1(-/-) male mice had both osteoclast and osteoblast numbers higher than wild type mice with no difference in bone volume. The sex dependence in the effect of Cav- I deficiency was partly attributed to decreased receptor activator of nuclear factor kappa B and increased cFms expression in osteoclast precursors of female and male mice, respectively. Taken together, these data demonstrate that Cav-1 has a complicated but critical role for osteodastogenesis.	[Kim, Hong-Hee] Seoul Natl Univ, Dept Cell & Dev Biol, BK21 Program, Seoul 110749, South Korea; Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, HH (corresponding author), Seoul Natl Univ, Dept Cell & Dev Biol, BK21 Program, 28 Yeongon Dong, Seoul 110749, South Korea.	hhbkim@snu.ac.kr			Korean MSIP/KRF via Science Research Center [2014001895]; Korean Ministry of Health and Welfare [A111787]	Korean MSIP/KRF via Science Research Center; Korean Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korean MSIP/KRF via Science Research Center Grant 2014001895 and by Korean Ministry of Health and Welfare Grant A111787.	Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Buitrago C, 2010, J STEROID BIOCHEM, V121, P169, DOI 10.1016/j.jsbmb.2010.03.002; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; CHOW J, 1992, J CLIN INVEST, V89, P74, DOI 10.1172/JCI115588; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fielding CJ, 1997, P NATL ACAD SCI USA, V94, P3753, DOI 10.1073/pnas.94.8.3753; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Frank PG, 2007, CURR PHARM DESIGN, V13, P1761, DOI 10.2174/138161207780831202; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hada N, 2012, BONE, V50, P226, DOI 10.1016/j.bone.2011.10.028; Jiao H, 2013, J IMMUNOL, V191, P6191, DOI 10.4049/jimmunol.1300873; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Kwiatek AM, 2006, MOL PHARMACOL, V70, P1174, DOI 10.1124/mol.105.021741; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Mirza MK, 2010, AM J PATHOL, V176, P2344, DOI 10.2353/ajpath.2010.091088; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Qu Q, 1998, BONE, V22, P201, DOI 10.1016/S8756-3282(97)00276-7; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Saintier D, 2006, J STEROID BIOCHEM, V99, P165, DOI 10.1016/j.jsbmb.2006.01.009; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tomassian T, 2011, J IMMUNOL, V187, P2993, DOI 10.4049/jimmunol.1101447; TRAVIS J, 1993, SCIENCE, V262, P1208, DOI 10.1126/science.8235646	41	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6522	6530		10.1074/jbc.M114.598581	http://dx.doi.org/10.1074/jbc.M114.598581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25561739	Green Published, hybrid			2022-12-28	WOS:000350732500055
J	Deming, PB; Campbell, SL; Stone, JB; Rivard, RL; Mercier, AL; Howe, AK				Deming, Paula B.; Campbell, Shirley L.; Stone, Jamie B.; Rivard, Robert L.; Mercier, Alison L.; Howe, Alan K.			Anchoring of Protein Kinase A by ERM (Ezrin-Radixin-Moesin) Proteins Is Required for Proper Netrin Signaling through DCC (Deleted in Colorectal Cancer)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE GUIDANCE; ADENOSINE A2B RECEPTOR; FOCAL ADHESION KINASE; CELL-MIGRATION; AXON OUTGROWTH; CYCLIC-AMP; NEUROBLASTOMA-CELLS; FILOPODIA FORMATION; ENA/VASP PROTEINS; PLASMA-MEMBRANE	Netrin-1, acting through its principal receptor DCC (deleted in colorectal cancer), serves as an axon guidance cue during neural development and also contributes to vascular morphogenesis, epithelial migration, and the pathogenesis of some tumors. Several lines of evidence suggest that netrin-DCC signaling can regulate and be regulated by the cAMP-dependent protein kinase, PKA, although the molecular details of this relationship are poorly understood. Specificity in PKA signaling is often achieved through differential subcellular localization of the enzyme by interaction with protein kinase A anchoring proteins (AKAPs). Here, we show that AKAP function is required for DCC-mediated activation of PKA and phosphorylation of cytoskeletal regulatory proteins of the Mena/VASP (vasodilator-stimulated phosphoprotein) family. Moreover, we show that DCC and PKA physically interact and that this association is mediated by the ezrin-radixin-moesin (ERM) family of plasma membrane-actin cytoskeleton cross-linking proteins. Silencing of ERM protein expression inhibits DCC-PKA interaction, DCC-mediated PKA activation, and phosphorylation of Mena/VASP proteins as well as growth cone morphology and neurite outgrowth. Finally, although expression of wild-type radixin partially rescued growth cone morphology and tropism toward netrin in ERM-knockdown cells, expression of an AKAP-deficient mutant of radixin did not fully rescue growth cone morphology and switched netrin tropism from attraction to repulsion. These data support a model in which ERM-mediated anchoring of PKA activity to DCC is required for proper netrin/DCC-mediated signaling.	[Deming, Paula B.] Univ Vermont, Coll Med, Dept Med Lab & Radiat Sci, Burlington, VT 05405 USA; [Campbell, Shirley L.; Stone, Jamie B.; Rivard, Robert L.; Mercier, Alison L.; Howe, Alan K.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Deming, Paula B.; Campbell, Shirley L.; Howe, Alan K.] Univ Vermont, Coll Med, Ctr Canc, Burlington, VT 05405 USA; [Campbell, Shirley L.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	University of Vermont; University of Vermont; University of Vermont; Universite de Montreal	Howe, AK (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, 149 Beaumont Ave,HSRF Room 322, Burlington, VT 05405 USA.	Alan.Howe@uvm.edu		Deming, Paula/0000-0003-3278-1705	National Institutes of Health [R01GM074204, R01GM097495]; National Institutes of Health (COBRE (Centers of Biomedical Research Excellence)) [P20RR016435]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074204, R01GM097495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (COBRE (Centers of Biomedical Research Excellence)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074204 and R01GM097495 (to A. K. H.) and P20RR016435 (to R. Parsons and A. K. H., COBRE (Centers of Biomedical Research Excellence) Project 1).	Abrahamsen H, 2003, J BIOL CHEM, V278, P17170, DOI 10.1074/jbc.M211426200; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; BIRGBAUER E, 1991, J NEUROSCI RES, V30, P232; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; Chedotal A, 2007, PROG EXP TUMOR RES, V39, P78, DOI 10.1159/000100048; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Delloye-Bourgeois C, 2009, J EXP MED, V206, P833, DOI 10.1084/jem.20082299; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Evans GJO, 2003, BIOCHEM SOC T, V31, P824, DOI 10.1042/bst0310824; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; Finci LI, 2014, NEURON, V83, P839, DOI 10.1016/j.neuron.2014.07.010; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; GonzalezAgosti C, 1996, CELL MOTIL CYTOSKEL, V34, P122, DOI 10.1002/(SICI)1097-0169(1996)34:2<122::AID-CM4>3.0.CO;2-D; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Gronholm M, 2003, J BIOL CHEM, V278, P41167, DOI 10.1074/jbc.M306149200; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; GUPTA M, 1985, DEV BRAIN RES, V19, P21, DOI 10.1016/0165-3806(85)90227-5; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hochbaum D, 2011, J BIOL CHEM, V286, P859, DOI 10.1074/jbc.M110.163816; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Howe AK, 2002, J BIOL CHEM, V277, P38121, DOI 10.1074/jbc.M205379200; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Martin M, 2006, EUR J CELL BIOL, V85, P769, DOI 10.1016/j.ejcb.2006.02.013; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Mehlen P, 2005, CELL MOL LIFE SCI, V62, P2599, DOI 10.1007/s00018-005-5191-3; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Moore SW, 2006, J NEUROSCI, V26, P2419, DOI 10.1523/JNEUROSCI.5419-05.2006; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Nicol X, 2011, P NATL ACAD SCI USA, V108, P13776, DOI 10.1073/pnas.1100247108; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; PARK D, 1992, MOL CELL BIOL, V12, P5816, DOI 10.1128/MCB.12.12.5816; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Petrie RJ, 2009, BIOL CELL, V101, P77, DOI 10.1042/BC20070108; Poongodi GL, 2002, J BIOL CHEM, V277, P28200, DOI 10.1074/jbc.M202731200; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ramesh V, 2004, NAT REV NEUROSCI, V5, P462, DOI 10.1038/nrn1407; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Rivard RL, 2009, CELL MOTIL CYTOSKEL, V66, P693, DOI 10.1002/cm.20399; ROSSINO P, 1991, CELL REGUL, V2, P1021, DOI 10.1091/mbc.2.12.1021; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Semenova I, 2009, TRAFFIC, V10, P153, DOI 10.1111/j.1600-0854.2008.00852.x; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Yang F, 1999, ANAL BIOCHEM, V266, P167, DOI 10.1006/abio.1998.2885; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335	86	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5783	5796		10.1074/jbc.M114.628644	http://dx.doi.org/10.1074/jbc.M114.628644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575591	Green Published, hybrid			2022-12-28	WOS:000350044200045
J	Salem, D; Subang, R; Okazaki, Y; Laplante, P; Levine, JS; Kuwana, M; Rauch, J				Salem, David; Subang, Rebecca; Okazaki, Yuka; Laplante, Patrick; Levine, Jerrold S.; Kuwana, Masataka; Rauch, Joyce			beta(2)-Glycoprotein I-specific T Cells Are Associated with Epitope Spread to Lupus-related Autoantibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIPHOSPHOLIPID SYNDROME; BINDING; BETA-2-GLYCOPROTEIN-I; ANTIBODIES; ATHEROSCLEROSIS; ANTICARDIOLIPIN; ERYTHEMATOSUS; CLEARANCE; RECEPTOR; ONSET	Systemic lupus erythematosus (SLE) is a prototypic model for B cell epitope spread in autoimmunity. Autoantibodies to numerous and molecularly distinct self-antigens emerge in a sequential manner over several years, leading to disease manifestations. Among the earliest autoantibodies to appear are those targeting the apoptotic cell-binding protein beta(2)-glycoprotein I (beta(2)GPI). Notably, mice immunized with beta(2)GPI and LPS display a remarkably similar pattern of autoantibody emergence to that seen in human SLL. Here, we used this model to investigate whether epitope spread to SLE-related autoantibodies is associated with a unique or limited AAWI-specific T cell response. We ask whether MHC class II haplotype and its associated T cell epitope restriction impact epitope spread to SLE-related autoantibodies. We found that beta(2)GPI/LPS-immunized mice produced similar SLE-related autoantibody profiles regardless of their beta(2)GPI T cell epitope specificity or MHC class II haplotype. Although beta(2)GPI T cell epitope specificity was clearly determined by MHC class II haplotype, a number of different beta(2)GP IT cell epitopes were associated with epitope spread to SLE-related autoantibodies. Notably, one beta(2)GPI T cell epitope (peptide 23, NTGFYLNGADSAKCT) was also recognized by T cells from an HLA-DRB1*0403(+) autoimmune patient. These data suggest that the generation of a beta(2)GPI-reacfive T cell response is associated with epitope spread to SLE-related autoantibodies, independent of epitope specificity or MHC class II restriction. On the basis of these findings, we propose that factors enabling a beta(2)GPI-reactive T cell response may predispose individuals to the development of SLE-related autoantibodies independent of their MHC class II haplotype.	[Salem, David; Subang, Rebecca; Laplante, Patrick; Rauch, Joyce] McGill Univ, Ctr Hlth, Res Inst, Div Rheumatol,Dept Med, Montreal, PQ H3G 1A4, Canada; [Okazaki, Yuka; Kuwana, Masataka] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo 1608582, Japan; [Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; [Levine, Jerrold S.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Nephrol Sect, Chicago, IL 60612 USA	McGill University; Keio University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rauch, J (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	joyce.rauch@mcgill.ca			Canadian Institutes of Health Research (CIHR)/Institute of Musculoskeletal Health and Arthritis (IMHA)/Arthritis Society [MOP-42391]; CIHR [MOP-67101, MOP-97916]; CIHR/IMHA [MUS-67101]; Japanese Ministry of Health, Labor and Welfare; Arthritis Society/Canadian Arthritis Network; Research Institute of the McGill University Health Centre; Section of Nephrology, University of Illinois at Chicago	Canadian Institutes of Health Research (CIHR)/Institute of Musculoskeletal Health and Arthritis (IMHA)/Arthritis Society(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); CIHR/IMHA(Canadian Institutes of Health Research (CIHR)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Arthritis Society/Canadian Arthritis Network; Research Institute of the McGill University Health Centre; Section of Nephrology, University of Illinois at Chicago	This was supported in part by Canadian Institutes of Health Research (CIHR)/Institute of Musculoskeletal Health and Arthritis (IMHA)/Arthritis Society Grant MOP-42391, CIHR Grants MOP-67101 and MOP-97916, and CIHR/IMHA (Fall 2008 Priority Announcement) Grant MUS-67101 (to J. R.); and a research grant on intractable diseases from the Japanese Ministry of Health, Labor and Welfare (to M. K.).; Supported by postdoctoral fellowships from The Arthritis Society/Canadian Arthritis Network and the Research Institute of the McGill University Health Centre. Present address: Centre Hospitaller de l'Universite de Montreal Research Center, 900 St-Denis, Montreal, Quebec H2X 0A9, Canada.; Supported by institutional funds from Dr. Jose A. Arruda and the Section of Nephrology, University of Illinois at Chicago.	Arai T, 2001, BLOOD, V98, P1889, DOI 10.1182/blood.V98.6.1889; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Behar SM, 1999, J IMMUNOL, V162, P161; Blank M, 1998, J IMMUNOL, V161, P5303; Buttari B, 2011, BLOOD, V117, P6152, DOI 10.1182/blood-2010-12-325514; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Conti F, 2014, ARTERIOSCL THROM VAS, V34, P661, DOI 10.1161/ATVBAHA.113.302680; Galeazzi M, 2000, LUPUS, V9, P47, DOI 10.1177/096120330000900109; George J, 2000, CIRCULATION, V102, P1822; Hattori N, 2000, ARTHRITIS RHEUM-US, V43, P65, DOI 10.1002/1529-0131(200001)43:1<65::AID-ANR9>3.0.CO;2-I; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Ito H, 2000, HUM IMMUNOL, V61, P366, DOI 10.1016/S0198-8859(99)00184-6; Kaburaki J, 1996, INTERNAL MED, V35, P105, DOI 10.2169/internalmedicine.35.105; Levine JS, 2014, LUPUS, V23, P752, DOI 10.1177/0961203314525676; Levine JS, 2006, J IMMUNOL, V177, P6504, DOI 10.4049/jimmunol.177.9.6504; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; MCRAE BL, 1992, J NEUROIMMUNOL, V38, P229, DOI 10.1016/0165-5728(92)90016-E; Price BE, 1996, J IMMUNOL, V157, P2201; Qian Y, 2004, J IMMUNOL, V172, P625, DOI 10.4049/jimmunol.172.1.625; Reed JH, 2009, ARTHRITIS RHEUM-US, V60, P860, DOI 10.1002/art.24361; Tolomeo T, 2009, AUTOIMMUNITY, V42, P292, DOI 10.1080/08916930902828254; Visvanathan S, 1999, J IMMUNOL, V162, P6919	24	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5543	5554		10.1074/jbc.M114.619817	http://dx.doi.org/10.1074/jbc.M114.619817			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25555913	Green Published, hybrid			2022-12-28	WOS:000350044200026
J	Kunze, M; Malkani, N; Maurer-Stroh, S; Wiesinger, C; Schmid, JA; Berger, J				Kunze, Markus; Malkani, Naila; Maurer-Stroh, Sebastian; Wiesinger, Christoph; Schmid, Johannes A.; Berger, Johannes			Mechanistic Insights into PTS2-mediated Peroxisomal Protein Import THE CO-RECEPTOR PEX5L DRASTICALLY INCREASES THE INTERACTION STRENGTH BETWEEN THE CARGO PROTEIN AND THE RECEPTOR PEX7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL TYPE-2; RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; SACCHAROMYCES-CEREVISIAE; RECEPTOR PEX5P; YARROWIA-LIPOLYTICA; IN-VIVO; MEMBRANE; THIOLASE; YEAST; REQUIREMENTS	The destination of peroxisomal matrix proteins is encoded by short peptide sequences, which have been characterized as peroxisomal targeting signals (PTS) residing either at the C terminus (PTS1) or close to the N terminus (PTS2). PTS2-carrying proteins interact with their cognate receptor protein PEX7 that mediates their transport to peroxisomes by a concerted action with a co-receptor protein, which in mammals is the PTS1 receptor PEX5L. Using a modified version of the mammalian two-hybrid assay, we demonstrate that the interaction strength between cargo and PEX7 is drastically increased in the presence of the co-receptor PEX5L. In addition, cargo binding is a prerequisite for the interaction between PEX7 and PEX5L and ectopic overexpression of PTS2-carrying cargo protein drastically increases the formation of PEX7-PEX5L complexes in this assay. Consistently, we find that the peroxisomal transfer of PEX7 depends on cargo binding and that ectopic overexpression of cargo protein stimulates this process. Thus, the sequential formation of a highly stable trimeric complex involving cargo protein, PEX7 and PEX5L stabilizes cargo binding and is a prerequisite for PTS2-mediated peroxisomal import.	[Kunze, Markus; Wiesinger, Christoph; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; [Malkani, Naila; Schmid, Johannes A.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; [Maurer-Stroh, Sebastian] ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore; [Maurer-Stroh, Sebastian] Nanyang Technol Univ, Sch Biol Sci, Singapore 117597, Singapore	Medical University of Vienna; Medical University of Vienna; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kunze, M (corresponding author), Med Univ Vienna, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	markus.kunze@meduniwien.ac.at	Maurer-Stroh, Sebastian/Q-9476-2019; Schmid, Johannes A./C-7659-2009; Malkani, Naila/AAA-9224-2022; Berger, Johannes/A-9122-2014	Maurer-Stroh, Sebastian/0000-0003-0813-9640; Schmid, Johannes A./0000-0002-6586-3507; Malkani, Naila/0000-0001-6454-1525; Berger, Johannes/0000-0003-0182-2658; Wiesinger, Christoph/0000-0003-1257-4522	European Union [LSHG-C/2004-512018]; Austrian Science Fund (FWF) [P15510-B14, P21950-B20]; Austrian Science Fund (FWF) [P 21950] Funding Source: researchfish	European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the European Union Project "Peroxisomes" LSHG-C/2004-512018 and Austrian Science Fund (FWF) Projects P15510-B14 and P21950-B20.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; Ghys K, 2002, BIOCHEM J, V365, P41, DOI 10.1042/BJ20011432; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grunau S, 2009, TRAFFIC, V10, P451, DOI [10.1111/j.1600-0854.2009.00876.x, 10.1111/j.1600-0854.2008.00876.x]; Islinger M, 2009, TRAFFIC, V10, P1711, DOI 10.1111/j.1600-0854.2009.00966.x; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kunze M, 2011, J BIOL CHEM, V286, P45048, DOI 10.1074/jbc.M111.301853; Lee JR, 2006, PLANT J, V47, P457, DOI 10.1111/j.1365-313X.2006.02797.x; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pan DQ, 2013, NAT STRUCT MOL BIOL, V20, P987, DOI 10.1038/nsmb.2618; Petriv OI, 2004, J MOL BIOL, V341, P119, DOI 10.1016/j.jmb.2004.05.064; Purdue PE, 1998, J CELL BIOL, V143, P1859; Reumann S, 2004, PLANT PHYSIOL, V135, P783, DOI 10.1104/pp.103.035584; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Sughra K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012683; Titorenko VI, 1998, J CELL BIOL, V142, P403, DOI 10.1083/jcb.142.2.403; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422	38	26	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4928	4940		10.1074/jbc.M114.601575	http://dx.doi.org/10.1074/jbc.M114.601575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538232	Green Published, hybrid			2022-12-28	WOS:000350042000036
J	Bauerle, MR; Schwalm, EL; Booker, SJ				Bauerle, Matthew R.; Schwalm, Erica L.; Booker, Squire J.			Mechanistic Diversity of Radical S-Adenosylmethionine (SAM)-dependent Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CONFERS ANTIBIOTIC-RESISTANCE; CATECHOL O-METHYLTRANSFERASE; 23S RIBOSOMAL-RNA; SAM ENZYMES; CATALYTIC MECHANISM; ESCHERICHIA-COLI; CYTOSINE METHYLTRANSFERASE; BIOSYNTHESIS; CFR; IDENTIFICATION	Radical S-adenosylmethionine (SAM) enzymes use the oxidizing power of a 5'-deoxyadenosyl 5'-radical to initiate an amazing array of transformations, usually through the abstraction of a target substrate hydrogen atom. A common reaction of radical SAM(RS) enzymes is the methylation of unactivated carbon or phosphorous atoms found in numerous primary and secondary metabolites, as well as in proteins, sugars, lipids, and RNA. However, neither the chemical mechanisms by which these unactivated atoms obtain methyl groups nor the actual methyl donors are conserved. In fact, RS methylases have been grouped into three classes based on protein architecture, cofactor requirement, and predicted mechanism of catalysis. Class A methylases use two cysteine residues to methylate sp(2)-hybridized carbon centers. Class B methylases require a cobalamin cofactor to methylate both sp(2)-hybridized and sp(3)-hybridized carbon centers as well as phosphinate phosphorous atoms. Class C methylases share significant sequence homology with the RS enzyme, HemN, and may bind two SAM molecules simultaneously to methylate sp(2)-hybridized carbon centers. Lastly, we describe a new class of recently discovered RS methylases. These Class D methylases, unlike Class A, B, and C enzymes, which use SAM as the source of the donated methyl carbon, are proposed to methylate sp(2)-hybridized carbon centers using methylenetetrahydrofolate as the source of the appended methyl carbon.	[Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	squire@psu.edu			National Institutes of Health [GM101957, GM103268]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103268, R01GM101957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM101957 and GM103268 (to S. J. B.). This is the fifth article in the Thematic Minireview series Radical SAM Enzymes.	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Allen KD, 2014, J BACTERIOL, V196, P3315, DOI 10.1128/JB.01903-14; Allen KD, 2014, ARCH BIOCHEM BIOPHYS, V543, P67, DOI 10.1016/j.abb.2013.12.004; Benitez-Paez A, 2012, RNA, V18, P1783, DOI 10.1261/rna.033266.112; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Booker Squire J, 2010, F1000 Biol Rep, V2, P52, DOI 10.3410/B2-52; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; CANTONI GL, 1953, J BIOL CHEM, V204, P403; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chan KKJ, 2013, CHEMBIOCHEM, V14, P675, DOI 10.1002/cbic.201200762; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHEN L, 1993, J AM CHEM SOC, V115, P5318, DOI 10.1021/ja00065a063; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Fujimori DG, 2013, CURR OPIN CHEM BIOL, V17, P597, DOI 10.1016/j.cbpa.2013.05.032; GABBARA S, 1995, BIOCHEMISTRY-US, V34, P8914, DOI 10.1021/bi00027a044; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Hiratsuka T, 2014, ANGEW CHEM INT EDIT, V53, P5423, DOI 10.1002/anie.201402623; Huang W, 2012, J AM CHEM SOC, V134, P8831, DOI 10.1021/ja211098r; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; HURLEY LH, 1983, J ANTIBIOT, V36, P383, DOI 10.7164/antibiotics.36.383; Hutcheson RU, 2012, METALLOMICS, V4, P1149, DOI 10.1039/c2mt20136d; Igarashi Y, 2003, J ANTIBIOT, V56, P107, DOI 10.7164/antibiotics.56.107; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; KUZUYAMA T, 1992, J ANTIBIOT, V45, P1812, DOI 10.7164/antibiotics.45.1812; Lanz ND, 2012, BBA-PROTEINS PROTEOM, V1824, P1196, DOI 10.1016/j.bbapap.2012.07.009; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Lin HN, 2011, BIOORG CHEM, V39, P161, DOI 10.1016/j.bioorg.2011.06.001; Markham G. D., 2010, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0000662.pub2, DOI 10.1002/9780470015902.A0000662.PUB2]; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; McCusker KP, 2012, J AM CHEM SOC, V134, P18074, DOI 10.1021/ja307855d; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i; Silakov A, 2014, J AM CHEM SOC, V136, P8221, DOI 10.1021/ja410560p; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; TAKUSAGAWA F, 1998, COMPREHENSIVE BIOL C, P1; Tan S, 2006, AMINO ACIDS, V30, P195, DOI 10.1007/s00726-005-0254-1; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Tichenor MS, 2004, J AM CHEM SOC, V126, P8396, DOI 10.1021/ja0472735; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Watanabe H, 2006, TETRAHEDRON LETT, V47, P1399, DOI 10.1016/j.tetlet.2005.12.091; Watanabe H, 2006, J ANTIBIOT, V59, P607, DOI 10.1038/ja.2006.82; Werner WJ, 2011, BIOCHEMISTRY-US, V50, P8986, DOI 10.1021/bi201220r; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; WU JC, 1987, J BIOL CHEM, V262, P4778; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c; ZHOU P, 1989, J AM CHEM SOC, V111, P7274, DOI 10.1021/ja00200a065	64	150	151	2	94	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3995	4002		10.1074/jbc.R114.607044	http://dx.doi.org/10.1074/jbc.R114.607044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25477520	hybrid, Green Published			2022-12-28	WOS:000349458400012
J	Volonte, D; Zou, HF; Bartholomew, JN; Liu, ZM; Morel, PA; Galbiati, F				Volonte, Daniela; Zou, Huafei; Bartholomew, Janine N.; Liu, Zhongmin; Morel, Penelope A.; Galbiati, Ferruccio			Oxidative Stress-induced Inhibition of Sirt1 by Caveolin-1 Promotes p53-dependent Premature Senescence and Stimulates the Secretion of Interleukin 6 (IL-6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SENESCENCE; REPLICATIVE SENESCENCE; HUMAN FIBROBLASTS; IN-VIVO; TRANSFORMING GROWTH-FACTOR-BETA-1; SCAFFOLDING DOMAIN; GENE-EXPRESSION; AGING PRIMATES; HUMAN-CELLS; DNA-DAMAGE	Oxidative stress can induce premature cellular senescence. Senescent cells secrete various growth factors and cytokines, such as IL-6, that can signal to the tumor microenvironment and promote cancer cell growth. Sirtuin 1 (Sirt1) is a class III histone deacetylase that regulates a variety of physiological processes, including senescence. We found that caveolin-1, a structural protein component of caveolar membranes, is a direct binding partner of Sirt1, as shown by the binding of the scaffolding domain of caveolin-1 (amino acids 82-101) to the caveolin-binding domain of Sirt1 (amino acids 310-317). Our data show that oxidative stress promotes the sequestration of Sirt1 into caveolar membranes and the interaction of Sirt1 with caveolin-1, which lead to inhibition of Sirt1 activity. Reactive oxygen species stimulation promotes acetylation of p53 and premature senescence in wild-type but not caveolin-1 null mouse embryonic fibroblasts (MEFs). Either down-regulation of Sirt1 expression or re-expression of caveolin-1 in caveolin-1 null MEFs restores reactive oxygen species-induced acetylation of p53 and premature senescence. In addition, overexpression of caveolin-1 induces stress induced premature senescence in p53 wildtype but not p53 knockout MEFs. Phosphorylation of caveolin-1 on tyrosine 14 promotes the sequestration of Sirt1 into caveolar membranes and activates p53/senescence signaling. We also identified IL-6 as a caveolin-1-specific cytokine that is secreted by senescent fibroblasts following the caveolin-1-mediated inhibition of Sirt1. The caveolin-1-mediated secretion of IL-6 by senescent fibroblasts stimulates the growth of cancer cells. Therefore, by inhibiting Sirt1, caveolin-1 links free radicals to the activation of the p53/senescence pathway and the protumorigenic properties of IL-6.	[Volonte, Daniela; Zou, Huafei; Bartholomew, Janine N.; Liu, Zhongmin; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Morel, Penelope A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), 200 Lothrop St, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Galbiati, Ferruccio/AAF-3527-2020; Morel, Penelope Anne/AAI-6239-2020	Morel, Penelope Anne/0000-0002-1743-3676	NIA/National Institutes of Health [R01-AG030636]; NHLBI/National Institutes of Health [R56-HL124747]; American Heart Association [13GRNT16560012, 12SDG8800012]; University of Pittsburgh Cancer Institute (UPCI) Specialized Program of Research Excellence (SPORE) in Lung Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL124747, R01HL124747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030636] Funding Source: NIH RePORTER	NIA/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); University of Pittsburgh Cancer Institute (UPCI) Specialized Program of Research Excellence (SPORE) in Lung Cancer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIA/National Institutes of Health Grant R01-AG030636 and NHLBI/National Institutes of Health Grant R56-HL124747. This work was also supported by American Heart Association Grant 13GRNT16560012 and the University of Pittsburgh Cancer Institute (UPCI) Specialized Program of Research Excellence (SPORE) in Lung Cancer (to F. G.) and by American Heart Association Grant 12SDG8800012 (to D. V.).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Dean JP, 2008, BRIT J CANCER, V98, P245, DOI 10.1038/sj.bjc.6604087; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Ewald JA, 2013, PROSTATE, V73, P337, DOI 10.1002/pros.22571; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Jagannadham MV, 2002, BIOCHEM BIOPH RES CO, V298, P203, DOI 10.1016/S0006-291X(02)02426-9; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lansdorp PM, 2000, MECH AGEING DEV, V118, P23, DOI 10.1016/S0047-6374(00)00151-2; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; MILLIS AJT, 1992, EXP CELL RES, V201, P373, DOI 10.1016/0014-4827(92)90286-H; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Wynford-Thomas D, 1999, J PATHOL, V187, P100; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	54	73	77	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4202	4214		10.1074/jbc.M114.598268	http://dx.doi.org/10.1074/jbc.M114.598268			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25512378	hybrid, Green Published			2022-12-28	WOS:000349458400031
J	Shahi, P; Slorach, EM; Wang, CY; Chou, J; Lu, A; Ruderisch, A; Werb, Z				Shahi, Payam; Slorach, Euan M.; Wang, Chih-Yang; Chou, Jonathan; Lu, Angela; Ruderisch, Aline; Werb, Zena			The Transcriptional Repressor ZNF503/Zeppo2 Promotes Mammary Epithelial Cell Proliferation and Enhances Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; E-CADHERIN; ADHERENS JUNCTIONS; RAC1 ACTIVATION; FAMILY; EXPRESSION; CANCER; GENE; PROTEINS; SITES	The NET (nocA, Nlz, elB, TLP-1) subfamily of zinc finger proteins is an important mediator during developmental processes. The evolutionary conserved zinc finger protein ZNF503/Zeppo2 (zinc finger elbow-related proline domain protein 2, Zpo2) plays critical roles during embryogenesis. We found that Zpo2 is expressed in adult tissue and examined its function. We found that ZPO2 is a nuclearly targeted transcriptional repressor that is expressed in mammary epithelial cells. Elevated Zpo2 levels increase mammary epithelial cell proliferation. Zpo2 promotes cellular invasion through down-regulation of E-cadherin and regulates the invasive phenotype in a RAC1-dependent manner. We detect elevated Zpo2 expression during breast cancer progression in a MMTV-PyMT transgenic mouse model. Tumor transplant experiments indicated that overexpression of Zpo2 in MMTV-PyMT mammary tumor cell lines enhances lung metastasis. Our findings suggest that Zpo2 plays a significant role in mammary gland homeostasis and that deregulation of Zpo2 may promote breast cancer development.	[Shahi, Payam; Slorach, Euan M.; Chou, Jonathan; Lu, Angela; Ruderisch, Aline; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Wang, Chih-Yang] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 70101, Taiwan	University of California System; University of California San Francisco; National Cheng Kung University	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, Box 0452,513 Parnassus Ave, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu	Wang, Chihyang/ADO-2306-2022	Wang, Chihyang/0000-0002-4137-5074; Lu, Angela/0000-0003-2128-1369	NCI/National Institutes of Health [R01 CA129523, R01 CA057621]; National Research Service Award [T32 CA108462]; NATIONAL CANCER INSTITUTE [T32CA108462, R01CA129523, R01CA057621] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by NCI/National Institutes of Health Grants R01 CA129523 and R01 CA057621 and National Research Service Award T32 CA108462.	Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; [Anonymous], 2007, MOL CELL BIOL, V27, P678; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; CROSS JC, 1995, DEVELOPMENT, V121, P2513; Dorfman R, 2002, DEVELOPMENT, V129, P3585; Hage B, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-23; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Hoyle J, 2004, DEV DYNAM, V229, P835, DOI 10.1002/dvdy.20001; Kitt KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017841; Ko HA, 2013, NEUROSCI LETT, V548, P44, DOI 10.1016/j.neulet.2013.05.020; Lee HH, 2010, J CELL SCI, V123, P3368, DOI 10.1242/jcs.071555; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakagawa M, 2001, J CELL SCI, V114, P1829; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Reynisdottir I, 2013, CANCER MED-US, V2, P437, DOI 10.1002/cam4.88; Runko AP, 2004, J BIOL CHEM, V279, P11917, DOI 10.1074/jbc.M310076200; Sircoulomb F, 2011, EMBO MOL MED, V3, P153, DOI 10.1002/emmm.201100121; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Sundberg LJ, 2003, J BIOL CHEM, V278, P29783, DOI 10.1074/jbc.M303771200; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072053; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	27	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3803	3813		10.1074/jbc.M114.611202	http://dx.doi.org/10.1074/jbc.M114.611202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538248	Green Published, hybrid			2022-12-28	WOS:000349456000051
J	Asuthkar, S; Demirkhanyan, L; Sun, XH; Elustondo, PA; Krishnan, V; Baskaran, P; Velpula, KK; Thyagarajan, B; Pavlov, EV; Zakharian, E				Asuthkar, Swapna; Demirkhanyan, Lusine; Sun, Xiaohui; Elustondo, Pia A.; Krishnan, Vivek; Baskaran, Padmamalini; Velpula, Kiran Kumar; Thyagarajan, Baskaran; Pavlov, Evgeny V.; Zakharian, Eleonora			The TRPM8 Protein Is a Testosterone Receptor II. FUNCTIONAL EVIDENCE FOR AN IONOTROPIC EFFECT OF TESTOSTERONE ON TRPM8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen; Androgen Receptor; Calcium Channel; Ion Channel; Testosterone; Transient Receptor Potential Channels (TRP Channels); Cold and Menthol Receptor TRPM8	PROSTATE-CANCER; ANDROGEN RECEPTOR; STEROID-HORMONES; EPITHELIAL-CELLS; NONGENOMIC ACTIONS; SKELETAL-MUSCLE; T-CELLS; CHANNELS; COLD; ACTIVATION	Background: TRPM8 channels are highly expressed in prostate tissues, where the role of this cold receptor is not well understood. Results: Testosterone activates TRPM8 in various cellular systems and in the planar lipid bilayers. Conclusion: TRPM8 is an ionotropic testosterone receptor. Significance: TRPM8 channels may be implicated in various physiological processes regulated by androgens. Testosterone is a key steroid hormone in the development of male reproductive tissues and the regulation of the central nervous system. The rapid signaling mechanism induced by testosterone affects numerous behavioral traits, including sexual drive, aggressiveness, and fear conditioning. However, the currently identified testosterone receptor(s) is not believed to underlie the fast signaling, suggesting an orphan pathway. Here we report that an ion channel from the transient receptor potential family, TRPM8, commonly known as the cold and menthol receptor is the major component of testosterone-induced rapid actions. Using cultured and primary cell lines along with the purified TRPM8 protein, we demonstrate that testosterone directly activates TRPM8 channel at low picomolar range. Specifically, testosterone induced TRPM8 responses in primary human prostate cells, PC3 prostate cancer cells, dorsal root ganglion neurons, and hippocampal neurons. Picomolar concentrations of testosterone resulted in full openings of the purified TRPM8 channel in planar lipid bilayers. Furthermore, acute applications of testosterone on human skin elicited a cooling sensation. Our data conclusively demonstrate that testosterone is an endogenous and highly potent agonist of TRPM8, suggesting a role of TRPM8 channels well beyond their well established function in somatosensory neurons. This discovery may further imply TRPM8 channel function in testosterone-dependent behavioral traits.	[Asuthkar, Swapna; Demirkhanyan, Lusine; Sun, Xiaohui; Velpula, Kiran Kumar; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Elustondo, Pia A.; Pavlov, Evgeny V.] Dalhousie Univ, Halifax, NS B3H 4R2, Canada; [Krishnan, Vivek; Baskaran, Padmamalini; Thyagarajan, Baskaran] Univ Wyoming, Sch Pharm, Coll Hlth Sci, Laramie, WY 82071 USA; [Pavlov, Evgeny V.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA	University of Illinois System; University of Illinois Peoria; Dalhousie University; University of Wyoming; New York University	Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	zakharel@uic.edu	Sun, Xiaohui/G-5146-2013	Sun, Xiaohui/0000-0003-0294-6855; Baskaran, Padmamalini/0000-0001-8851-1486	National Institutes of Health [R01GM098052]; Heart and Stroke Foundation of Canada [G-13-00030008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM098052 (to E. Z.). This work was also supported by Grant G-13-00030008 from the Heart and Stroke Foundation of Canada (to E. P.).	Almeida MC, 2012, J NEUROSCI, V32, P2086, DOI 10.1523/JNEUROSCI.5606-11.2012; Asuthkar S, 2015, J BIOL CHEM, V290, P2659, DOI 10.1074/jbc.M114.610824; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Benten WPM, 1997, FEBS LETT, V407, P211, DOI 10.1016/S0014-5793(97)00346-3; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bruck N, 2005, CELL SIGNAL, V17, P1229, DOI 10.1016/j.cellsig.2004.12.006; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Estrada M, 2000, AM J PHYSIOL-ENDOC M, V279, pE132, DOI 10.1152/ajpendo.2000.279.1.E132; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Jones RD, 2003, BRIT J PHARMACOL, V138, P733, DOI 10.1038/sj.bjp.0705141; KOENIG H, 1989, CIRC RES, V64, P415, DOI 10.1161/01.RES.64.3.415; LIEBERHERR M, 1994, J BIOL CHEM, V269, P7217; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Lyng FM, 2000, BIOL REPROD, V63, P736, DOI 10.1095/biolreprod63.3.736; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MICHEL G, 1980, ENDOCRINOLOGY, V107, P2088, DOI 10.1210/endo-107-6-2088; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Revelli A, 1998, ENDOCR REV, V19, P3, DOI 10.1210/er.19.1.3; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	37	71	73	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2670	2688		10.1074/jbc.M114.610873	http://dx.doi.org/10.1074/jbc.M114.610873			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25480785	Green Published, hybrid			2022-12-28	WOS:000349310700012
J	Goupil, E; Fillion, D; Clement, S; Luo, XY; Devost, D; Sleno, R; Petrin, D; Saragovi, HU; Thorin, E; Laporte, SA; Hebert, TE				Goupil, Eugenie; Fillion, Dany; Clement, Stephanie; Luo, Xiaoyan; Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Saragovi, H. Uri; Thorin, Eric; Laporte, Stephane A.; Hebert, Terence E.			Angiotensin II Type I and Prostaglandin F2 alpha Receptors Cooperatively Modulate Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Angiotensin II; G Protein; G Protein-coupled Receptor (GPCR); Prostaglandin; Dimerization	PROTEIN-COUPLED RECEPTORS; A GPCR DIMERS; BETA(2)-ADRENERGIC RECEPTOR; CROSS-TALK; PHARMACOLOGICAL CHARACTERIZATION; ERK1/2 ACTIVATION; OXYTOCIN RECEPTOR; OPIOID RECEPTORS; DRUG DISCOVERY; BLOOD-PRESSURE	Background: Evidence suggests that FP modulates AT1R physiological responses. Results: In heterologous and native systems, both receptors allosterically modulated each other's function. Conclusion: This is likely via the agency of an AT1R/FP heterodimer. Significance: This may have implications in hypertension management. The angiotensin II type I (AT1R) and the prostaglandin F2 (PGF2) F prostanoid (FP) receptors are both potent regulators of blood pressure. Physiological interplay between AT1R and FP has been described. Abdominal aortic ring contraction experiments revealed that PGF2-dependent activation of FP potentiated angiotensin II-induced contraction, whereas FP antagonists had the opposite effect. Similarly, PGF2-mediated vasoconstriction was symmetrically regulated by co-treatment with AT1R agonist and antagonist. The underlying canonical G(q) signaling via production of inositol phosphates mediated by each receptor was also regulated by antagonists for the other receptor. However, binding to their respective agonists, regulation of receptor-mediated MAPK activation and vascular smooth muscle cell growth were differentially or asymmetrically regulated depending on how each of the two receptors were occupied by either agonist or antagonist. Physical interactions between these receptors have never been reported, and here we show that AT1R and FP form heterodimeric complexes in both HEK 293 and vascular smooth muscle cells. These findings imply that formation of the AT1R/FP dimer creates a novel allosteric signaling unit that shows symmetrical and asymmetrical signaling behavior, depending on the outcome measured. AT1R/FP dimers may thus be important in the regulation of blood pressure.	[Goupil, Eugenie; Fillion, Dany; Clement, Stephanie; Devost, Dominic; Sleno, Rory; Petrin, Darlaine; Saragovi, H. Uri; Laporte, Stephane A.; Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H3A 2B2, Canada; [Laporte, Stephane A.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0CT, Canada; [Saragovi, H. Uri] Montreal Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Luo, Xiaoyan; Thorin, Eric] Inst Cardiol Montreal, Ctr Rech, Montreal, PQ H1T 1C8, Canada	McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Universite de Montreal; Institut de Cardiologie de Montreal	Laporte, SA (corresponding author), McGill Univ, Dept Med, 3640 Univ St,Ste W315, Montreal, PQ H3A 2B2, Canada.	stephane.laporte@mcgill.ca; terence.hebert@mcgill.ca	Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021; Thorin, Eric/K-3978-2013	Laporte, Stephane/0000-0002-0633-543X; Thorin, Eric/0000-0001-5827-8935; Goupil, Eugenie/0000-0001-5554-8717	Canadian Institutes of Health Research Team Grant in GPCR Allosteric Regulation (TiGAR) [CTP 79848]; Canadian Institutes of Health Research [MOP-36379, MOP-74603]	Canadian Institutes of Health Research Team Grant in GPCR Allosteric Regulation (TiGAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by in part Canadian Institutes of Health Research Team Grant in GPCR Allosteric Regulation (TiGAR) CTP 79848 (to T. E. H. and S. A. L., co-investigators) and Canadian Institutes of Health Research Grants MOP-36379 (to T. E. H.) and MOP-74603 (to S. A. L.).	Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Berk BC, 1999, J AM SOC NEPHROL, V10, pS62; BERK BC, 1993, J CELL PHYSIOL, V154, P368, DOI 10.1002/jcp.1041540221; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Bourguet CB, 2011, J MED CHEM, V54, P6085, DOI 10.1021/jm200608k; Bouvier M, 2014, J PHYSIOL-LONDON, V592, P2439, DOI 10.1113/jphysiol.2014.272252; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Critchley HOD, 2006, ENDOCRINOLOGY, V147, P744, DOI 10.1210/en.2005-1153; de Gasparo M, 2000, PHARMACOL REV, V52, P415; DORN GW, 1992, J BIOL CHEM, V267, P24897; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Fujino H, 2000, MOL PHARMACOL, V57, P353; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Goupil E, 2013, METHOD CELL BIOL, V117, P165, DOI 10.1016/B978-0-12-408143-7.00009-8; Goupil E, 2013, BRIT J PHARMACOL, V168, P1101, DOI 10.1111/bph.12040; Goupil E, 2012, MOL ENDOCRINOL, V26, P1189, DOI 10.1210/me.2011-1245; Goupil E, 2010, J BIOL CHEM, V285, P25624, DOI 10.1074/jbc.M110.115196; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; Griffin BW, 1998, J PHARMACOL EXP THER, V286, P411; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Herrera M, 2013, HYPERTENSION, V61, P253, DOI 10.1161/HYPERTENSIONAHA.112.203679; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Lambert NA, 2014, J PHYSIOL-LONDON, V592, P2443, DOI 10.1113/jphysiol.2014.272997; Laporte SA, 1996, MOL PHARMACOL, V49, P89; Lavoie C, 2003, CAN J PHYSIOL PHARM, V81, P186, DOI 10.1139/Y02-167; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; LEE PY, 1988, INVEST OPHTH VIS SCI, V29, P1474; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Makino S, 2007, SEMIN REPROD MED, V25, P60, DOI 10.1055/s-2006-956776; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Renna NF, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/808353; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Servant G, 1997, J BIOL CHEM, V272, P8653, DOI 10.1074/jbc.272.13.8653; Siddiquee K, 2013, BRIT J PHARMACOL, V168, P1104, DOI 10.1111/j.1476-5381.2012.02192.x; Speth RC, 2001, METH MOLEC MED, V51, P275, DOI 10.1385/1-59259-087-X:275; Thorin E, 1998, BRIT J PHARMACOL, V125, P1188, DOI 10.1038/sj.bjp.0702199; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Wrzal PK, 2012, CELL SIGNAL, V24, P342, DOI 10.1016/j.cellsig.2011.09.020; Wrzal PK, 2012, CELL SIGNAL, V24, P333, DOI 10.1016/j.cellsig.2011.09.019; Yu Y, 2009, P NATL ACAD SCI USA, V106, P7985, DOI 10.1073/pnas.0811834106; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	56	38	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3137	3148		10.1074/jbc.M114.631119	http://dx.doi.org/10.1074/jbc.M114.631119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512374	Green Published, hybrid			2022-12-28	WOS:000349310700048
J	Perez-Canamas, M; Hernandez, C				Perez-Canamas, Miryam; Hernandez, Carmen			Key Importance of Small RNA Binding for the Activity of a Glycine-Tryptophan (GW) Motif-containing Viral Suppressor of RNA Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; Host-Pathogen Interaction; Nucleolus; Plant Virus; RNA Virus; GW; WG Motifs; Pelargonium Line Pattern Virus; Coat Protein; sRNA Binding; Viral Suppressor of RNA Silencing	SMALL INTERFERING RNA; LINE-PATTERN-VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; LONG-DISTANCE MOVEMENT; NECROTIC-MOSAIC-VIRUS; CITRUS-TRISTEZA-VIRUS; DICER-LIKE PROTEINS; COAT PROTEIN; ANTIVIRAL DEFENSE; 2B PROTEIN	Background: GW/WG motif-containing viral suppressors of RNA silencing (VSRs) have been proposed to act through interaction with Argonaute (AGO) proteins. Results: The activity of a GW motif-containing VSR was found to rely on small RNA binding capability rather than on AGO interaction. Conclusion: Overlapping signals in VSRs may lead to misinterpretation of relevant molecular traits. Significance: Knowing primary target(s) of VSRs is critical for better understanding of the host-virus arms race. Viruses express viral suppressors of RNA silencing (VSRs) to counteract RNA silencing-based host defenses. Although virtually all stages of the antiviral silencing pathway can be inhibited by VSRs, small RNAs (sRNAs) and Argonaute (AGO) proteins seem to be the most frequent targets. Recently, GW/WG motifs of some VSRs have been proposed to dictate their suppressor function by mediating interaction with AGO(s). Here we have studied the VSR encoded by Pelargonium line pattern virus (family Tombusviridae). The results show that p37, the viral coat protein, blocks RNA silencing. Site-directed mutagenesis of some p37 sequence traits, including a conserved GW motif, allowed generation of suppressor-competent and -incompetent molecules and uncoupling of the VSR and particle assembly capacities. The engineered mutants were used to assess the importance of p37 functions for viral infection and the relative contribution of diverse molecular interactions to suppressor activity. Two main conclusions can be drawn: (i) the silencing suppression and encapsidation functions of p37 are both required for systemic Pelargonium line pattern virus infection, and (ii) the suppressor activity of p37 relies on the ability to bind sRNAs rather than on interaction with AGOs. The data also caution against potential misinterpretations of results due to overlap of sequence signals related to distinct protein properties. This is well illustrated by mutation of the GW motif in p37 that concurrently affects nucleolar localization, efficient interaction with AGO1, and sRNA binding capability. These concomitant effects could have been overlooked in other GW motif-containing suppressors, as we exemplify with the orthologous p38 of turnip crinkle virus.	[Perez-Canamas, Miryam; Hernandez, Carmen] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Perez-Canamas, M (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, Ciudad Politecn Innovac,Ed 8E,Camino Vera S-N, E-46022 Valencia, Spain.	cahernan@ibmcp.upv.es	Hernandez, C./R-2047-2018	Hernandez, C./0000-0003-1192-6223; Perez-Canamas, Miryam/0000-0002-0767-277X	Ministerio de Economia y Competitividad (MINECO, Spain) [BFU2012-36095]	Ministerio de Economia y Competitividad (MINECO, Spain)	This work was supported by Grant BFU2012-36095 from the Ministerio de Economia y Competitividad (MINECO, Spain) ( to C. H.).	Alonso M, 2005, EUR J PLANT PATHOL, V112, P95, DOI 10.1007/s10658-005-0803-1; Alvarado V, 2009, SEMIN CELL DEV BIOL, V20, P1032, DOI 10.1016/j.semcdb.2009.06.001; Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Bragg JN, 2004, MOL PLANT PATHOL, V5, P465, DOI [10.1111/j.1364-3703.2004.00246.x, 10.1111/J.1364-3703.2004.00246.X]; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Cao MX, 2010, J VIROL, V84, P7793, DOI 10.1128/JVI.02643-09; Castano A, 2007, ACTA VIROL, V51, P271; Castano A, 2005, ARCH VIROL, V150, P949, DOI 10.1007/s00705-004-0464-y; Castano A, 2009, VIROLOGY, V386, P417, DOI 10.1016/j.virol.2009.01.017; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; Chiba S, 2013, MOL PLANT MICROBE IN, V26, P168, DOI 10.1094/MPMI-06-12-0142-R; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Csorba T, 2010, PLANT J, V62, P463, DOI 10.1111/j.1365-313X.2010.04163.x; Cuellar WJ, 2008, J GEN VIROL, V89, P573, DOI 10.1099/vir.0.83471-0; DALMAY T, 1992, MOL PLANT MICROBE IN, V5, P379, DOI 10.1094/MPMI-5-379; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Duan CG, 2012, PLANT CELL, V24, P259, DOI 10.1105/tpc.111.092718; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Giner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000996; Gonzalez I, 2012, RNA, V18, P771, DOI 10.1261/rna.031260.111; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Haas G, 2008, EMBO J, V27, P2102, DOI 10.1038/emboj.2008.129; HACKER DL, 1992, VIROLOGY, V186, P1, DOI 10.1016/0042-6822(92)90055-T; Hamera S, 2012, PLANT J, V69, P104, DOI 10.1111/j.1365-313X.2011.04774.x; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Ivars P, 2004, EUR J PLANT PATHOL, V110, P275, DOI 10.1023/B:EJPP.0000019798.87567.22; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kim SH, 2007, P NATL ACAD SCI USA, V104, P11115, DOI 10.1073/pnas.0704632104; Kinard GR, 2002, ACTA HORTIC, P17, DOI 10.17660/ActaHortic.2002.568.1; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lucy AP, 2000, EMBO J, V19, P1672, DOI 10.1093/emboj/19.7.1672; Mangwende T, 2009, VIROLOGY, V384, P38, DOI 10.1016/j.virol.2008.10.034; Marques NT, 2012, EUR J PLANT PATHOL, V133, P229, DOI 10.1007/s10658-011-9877-0; Martinez-Turino S, 2009, J GEN VIROL, V90, P519, DOI 10.1099/vir.0.006098-0; Martinez-Turino S, 2011, VIROLOGY, V413, P310, DOI 10.1016/j.virol.2011.03.001; Meng CY, 2006, J GEN VIROL, V87, P451, DOI 10.1099/vir.0.81578-0; Merai Z, 2005, J VIROL, V79, P7217, DOI 10.1128/JVI.79.11.7217-7226.2005; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Molnar A, 1997, J GEN VIROL, V78, P1235, DOI 10.1099/0022-1317-78-6-1235; Pickford AS, 2003, CELL MOL LIFE SCI, V60, P871, DOI 10.1007/s00018-003-2245-2; Powers JG, 2008, VIROLOGY, V381, P277, DOI 10.1016/j.virol.2008.09.004; Powers JG, 2008, MOL PLANT MICROBE IN, V21, P879, DOI 10.1094/MPMI-21-7-0879; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Reade R, 2003, VIRUS RES, V91, P171, DOI 10.1016/S0168-1702(02)00251-4; Rochon D., 2012, 9 INT COMM TAX VIR, P1111; Rubino L, 1997, J GEN VIROL, V78, P1219, DOI 10.1099/0022-1317-78-6-1219; Ruiz-Ruiz S, 2013, MOL PLANT MICROBE IN, V26, P306, DOI 10.1094/MPMI-08-12-0201-R; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Senshu H, 2009, J GEN VIROL, V90, P1014, DOI 10.1099/vir.0.008243-0; SIT TL, 1995, VIROLOGY, V206, P38, DOI 10.1016/S0042-6822(95)80017-4; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776; Thomas CL, 2003, VIROLOGY, V306, P33, DOI 10.1016/S0042-6822(02)00018-1; VAEWHONGS AA, 1995, VIROLOGY, V212, P607, DOI 10.1006/viro.1995.1518; Valli A, 2008, J VIROL, V82, P974, DOI 10.1128/JVI.01664-07; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Vogler H, 2007, J VIROL, V81, P10379, DOI 10.1128/JVI.00727-07; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang YZ, 2004, J GEN VIROL, V85, P3135, DOI 10.1099/vir.0.80250-0; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Xu AX, 2013, MOL PLANT PATHOL, V14, P803, DOI 10.1111/mpp.12051; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	94	37	38	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3106	3120		10.1074/jbc.M114.593707	http://dx.doi.org/10.1074/jbc.M114.593707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505185	Green Published, hybrid			2022-12-28	WOS:000349310700046
J	Lu, ZP; Chen, Y; Aponte, AM; Battaglia, V; Gucek, M; Sack, MN				Lu, Zhongping; Chen, Yong; Aponte, Angel M.; Battaglia, Valentina; Gucek, Marjan; Sack, Michael N.			Prolonged Fasting Identifies Heat Shock Protein 10 as a Sirtuin 3 Substrate ELUCIDATING A NEW MECHANISM LINKING MITOCHONDRIAL PROTEIN ACETYLATION TO FATTY ACID OXIDATION ENZYME FOLDING AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA DEHYDROGENASE; MUSCLE INSULIN-RESISTANCE; ACID OXIDATION; SKELETAL-MUSCLE; LYSINE ACETYLATION; UREA CYCLE; DEACETYLATION; DEGRADATION; HSP60; METABOLISM	Although Sirtuin 3 (SIRT3), a mitochondrially enriched deacetylase and activator of fat oxidation, is down-regulated in response to high fat feeding, the rate of fatty acid oxidation and mitochondrial protein acetylation are invariably enhanced in this dietary milieu. These paradoxical data implicate that additional acetylation modification-dependent levels of regulation may be operational under nutrient excess conditions. Because the heat shock protein (Hsp) Hsp10-Hsp60 chaperone complex mediates folding of the fatty acid oxidation enzyme mediumchain acyl-CoA dehydrogenase, we tested whether acetylation-dependent mitochondrial protein folding contributes to this regulatory discrepancy. We demonstrate that Hsp10 is a functional SIRT3 substrate and that, in response to prolonged fasting, SIRT3 levels modulate mitochondrial protein folding. Acetyl mutagenesis of Hsp10 lysine 56 alters Hsp10-Hsp60 binding, conformation, and protein folding. Consistent with Hsp10-Hsp60 regulation of fatty acid oxidation enzyme integrity, medium-chain acyl-CoA dehydrogenase activity and fat oxidation are elevated by Hsp10 acetylation. These data identify acetyl modification of Hsp10 as a nutrient-sensing regulatory node controlling mitochondrial protein folding and metabolic function.	[Lu, Zhongping; Sack, Michael N.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Chen, Yong; Aponte, Angel M.; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA; [Lu, Zhongping; Battaglia, Valentina] George Washington Univ, Dept Biochem & Mol Med, Washington, DC 20052 USA; [Lu, Zhongping; Battaglia, Valentina] Vet Affairs Med Ctr, Washington, DC 20422 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lu, ZP (corresponding author), George Washington Univ, Vet Affairs Med Ctr, Washington, DC 20052 USA.	luz@gwu.edu	chen, yong/E-2432-2011	chen, yong/0000-0003-1528-3456	NHLBI/National Institutes of Health Intramural Research Program [HL006047-01]; NHLBI/National Institutes of Health K22 Award [K22HL109236]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, K22HL109236, ZICHL005903, ZIAHL006047] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI/National Institutes of Health K22 Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI/National Institutes of Health Intramural Research Program HL006047-01 and by NHLBI/National Institutes of Health K22 Award K22HL109236.	Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Bie AS, 2011, CELL STRESS CHAPERON, V16, P633, DOI 10.1007/s12192-011-0275-5; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Corydon TJ, 2005, MOL GENET METAB, V85, P260, DOI 10.1016/j.ymgme.2005.04.003; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Ghosh P, 2003, J BIOL CHEM, V278, P14543, DOI 10.1074/jbc.M212543200; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Lu ZP, 2011, EMBO REP, V12, P840, DOI 10.1038/embor.2011.121; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Sack MN, 2009, J MOL CELL CARDIOL, V46, P842, DOI 10.1016/j.yjmcc.2009.02.001; SAIJO T, 1994, J BIOL CHEM, V269, P4401; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073457; ter Veld F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006449; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Webster BR, 2014, BBA-MOL CELL BIOL L, V1841, P525, DOI 10.1016/j.bbalip.2014.02.001; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	44	40	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2466	2476		10.1074/jbc.M114.606228	http://dx.doi.org/10.1074/jbc.M114.606228			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505263	Green Published, hybrid			2022-12-28	WOS:000348588000048
J	Porcari, R; Proukakis, C; Waudby, CA; Bolognesi, B; Mangione, PP; Paton, JFS; Mullin, S; Cabrita, LD; Penco, A; Relini, A; Verona, G; Vendruscolo, M; Stoppini, M; Tartaglia, GG; Camilloni, C; Christodoulou, J; Schapira, AHV; Bellotti, V				Porcari, Riccardo; Proukakis, Christos; Waudby, Christopher A.; Bolognesi, Benedetta; Mangione, P. Pattizia; Paton, Jack F. S.; Mullin, Stephen; Cabrita, Lisa D.; Penco, Amanda; Relini, Annalisa; Verona, Guglielmo; Vendruscolo, Michele; Stoppini, Monica; Gaetano Tartaglia, Gian; Camilloni, Carlo; Christodoulou, John; Schapira, Anthony H. V.; Bellotti, Vittorio			The H50Q Mutation Induces a 10-fold Decrease in the Solubility of alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; SECONDARY STRUCTURE; AGGREGATION RATES; AMYLOID FIBRILS; GLOBULAR-PROTEINS; LEWY BODIES; IN-VITRO; NMR; PREDICTION	The conversion of alpha-synuclein from its intrinsically disordered monomeric state into the fibrillar cross-beta aggregates characteristically present in Lewy bodies is largely unknown. The investigation of alpha-synuclein variants causative of familial forms of Parkinson disease can provide unique insights into the conditions that promote or inhibit aggregate formation. It has been shown recently that a newly identified pathogenic mutation of alpha-synuclein, H50Q, aggregates faster than the wild-type. We investigate here its aggregation propensity by using a sequence-based prediction algorithm, NMRchemical shift analysis of secondary structure populations in the monomeric state, and determination of thermodynamic stability of the fibrils. Our data show that the H50Q mutation induces only a small increment in polyproline II structure around the site of the mutation and a slight increase in the overall aggregation propensity. We also find, however, that the H50Q mutation strongly stabilizes alpha-synuclein fibrils by 5.0 +/- 1.0 kJ mol(-1), thus increasing the supersaturation of monomeric alpha-synuclein within the cell, and strongly favors its aggregation process. We further show that wild-type alpha-synuclein can decelerate the aggregation kinetics of the H50Q variant in a dose-dependent manner when coaggregating with it. These last findings suggest that the precise balance of alpha-synuclein synthesized from the wild-type and mutant alleles may influence the natural history and heterogeneous clinical phenotype of Parkinson disease.	[Porcari, Riccardo; Mangione, P. Pattizia; Verona, Guglielmo; Bellotti, Vittorio] UCL, Wolfson Drug Discovery Unit, Ctr Amyloidosis & Acute Phase Prot, Div Med, London NW3 2PF, England; [Proukakis, Christos; Schapira, Anthony H. V.] UCL, Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England; [Bolognesi, Benedetta; Gaetano Tartaglia, Gian] Ctr Genom Regulat, Barcelona 08003, Spain; [Bolognesi, Benedetta; Gaetano Tartaglia, Gian] Univ Pompeu Fabra, Barcelona 08003, Spain; [Mangione, P. Pattizia; Verona, Guglielmo; Stoppini, Monica; Bellotti, Vittorio] Univ Pavia, Inst Biochem, Dept Mol Med, I-27100 Pavia, Italy; [Waudby, Christopher A.; Paton, Jack F. S.; Mullin, Stephen; Cabrita, Lisa D.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Vendruscolo, Michele; Camilloni, Carlo] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Penco, Amanda; Relini, Annalisa] Univ Genoa, Dept Phys, I-16146 Genoa, Italy	University of London; University College London; University of London; University College London; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Pavia; University of London; University College London; University of Cambridge; University of Genoa	Christodoulou, J (corresponding author), UCL, Dept Struct & Mol Biol, Mortimer St, London WC1E 6BT, England.	j.christodoulou@ucl.ac.uk; v.bellotti@ucl.ac.uk	Schapira, Anthony H V/A-1245-2010; Camilloni, Carlo/A-4395-2009; bolognesi, benedetta/J-6961-2014; proukakis, christos/ABE-3447-2020; Vendruscolo, Michele/F-5901-2012; Mullin, Stephen/V-6313-2019; Verona, Guglielmo/AAH-9802-2019; Relini, Annalisa/AHC-3105-2022; Waudby, Christopher/AAT-1736-2021; Tartaglia, Gian Gaetano/K-1229-2014	Schapira, Anthony H V/0000-0002-3018-3966; Camilloni, Carlo/0000-0002-9923-8590; bolognesi, benedetta/0000-0002-6632-947X; proukakis, christos/0000-0001-6423-6539; Vendruscolo, Michele/0000-0002-3616-1610; Mullin, Stephen/0000-0002-1936-394X; Verona, Guglielmo/0000-0001-8100-3876; Waudby, Christopher/0000-0001-7810-3753; Cabrita, Lisa/0000-0003-2963-8078; Paton, Julian/0000-0001-7410-2913; Mangione, Palma/0000-0003-0260-1400; Christodoulou, John/0000-0002-6710-3843; Tartaglia, Gian Gaetano/0000-0001-7524-6310; RELINI, ANNALISA/0000-0002-4040-9279	United Kingdom Medical Research Council [MR/K000187/1]; Italian Ministry of University and Research [FIRB RBFR109EOS]; Cariplo Foundation [2011-2096]; Istituto Nazionale di Biostrutture e Biosistemi; Spanish Ministry of Economy and Competitiveness [SAF2011-26211]; European Research Council; Marie Curie Action; Wellcome Trust/MRC Joint Call in Neurodegeneration Award [WT089698]; Wellcome Trust Investigator Award [097806/Z/11/Z]; University College London Amyloidosis Research Fund; University College London Wolfson Drug Discovery Unit Funds; University College London Hospital National Institute for Health Research Biomedical Research Centre; UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme; MRC [MR/K000187/1, MC_U117533887] Funding Source: UKRI; Medical Research Council [MR/K000187/1, MC_U117533887] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10237] Funding Source: researchfish; Parkinson&quot;s UK [G-1104] Funding Source: researchfish; The Francis Crick Institute [10029] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Cariplo Foundation(Fondazione Cariplo); Istituto Nazionale di Biostrutture e Biosistemi; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Marie Curie Action(European Commission); Wellcome Trust/MRC Joint Call in Neurodegeneration Award(Wellcome TrustUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator Award(Wellcome Trust); University College London Amyloidosis Research Fund; University College London Wolfson Drug Discovery Unit Funds; University College London Hospital National Institute for Health Research Biomedical Research Centre; UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); The Francis Crick Institute	This work was supported by United Kingdom Medical Research Council Grant MR/K000187/1 and Italian Ministry of University and Research Project FIRB RBFR109EOS (to V. B.); the Cariplo Foundation Project 2011-2096 (to M. S.); Istituto Nazionale di Biostrutture e Biosistemi (to V. B. and M. S.); Spanish Ministry of Economy and Competitiveness Grant SAF2011-26211 and European Research Council Starting Grant (to G. G. T.); Marie Curie Action (to B. B.); Wellcome Trust/MRC Joint Call in Neurodegeneration Award WT089698 (to A. H. V. S.); the Wellcome Trust Investigator Award (097806/Z/11/Z to J. C. and J. F. S. P. studentship); the University College London Amyloidosis Research Fund; the University College London Wolfson Drug Discovery Unit Funds and the University College London Hospital National Institute for Health Research Biomedical Research Centre. Core support for the Wolfson Drug Discovery Unit is provided by the UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme.	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Camilloni C, 2013, J PHYS CHEM B, V117, P10737, DOI 10.1021/jp405614j; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Chi YC, 2014, J BIOL CHEM, V289, P15474, DOI 10.1074/jbc.M113.544049; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Croke RL, 2011, PROTEIN SCI, V20, P256, DOI 10.1002/pro.556; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Kang LJ, 2011, J AM CHEM SOC, V133, P13465, DOI 10.1021/ja203979j; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kobayashi H, 2003, BRAIN, V126, P32, DOI 10.1093/brain/awg010; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lemkau LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049750; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Rutherford NJ, 2014, J NEUROCHEM, V131, P859, DOI 10.1111/jnc.12806; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Tartaglia GG, 2007, STRUCTURE, V15, P139, DOI 10.1016/j.str.2006.12.007; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Voutsinas GE, 2010, HUM MUTAT, V31, P685, DOI 10.1002/humu.21248; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waudby CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072286; Waudby CA, 2012, J AM CHEM SOC, V134, P11312, DOI 10.1021/ja304912c; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349; Zanzoni A, 2013, NUCLEIC ACIDS RES, V41, P9987, DOI 10.1093/nar/gkt794; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	62	49	49	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2395	2404		10.1074/jbc.M114.610527	http://dx.doi.org/10.1074/jbc.M114.610527			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505181	Green Published, hybrid			2022-12-28	WOS:000348588000042
J	Sun, XJ; Dang, FB; Zhang, DY; Yuan, Y; Zhang, C; Wu, YT; Wang, YG; Liu, Y				Sun, Xiujie; Dang, Fabin; Zhang, Deyi; Yuan, Yuan; Zhang, Cui; Wu, Yuting; Wang, Yiguo; Liu, Yi			Glucagon-CREB/CRTC2 Signaling Cascade Regulates Hepatic BMAL1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB COACTIVATOR TORC2; REV-ERB-ALPHA; CIRCADIAN CLOCK; MODULATES GLUCONEOGENESIS; PERIPHERAL-TISSUES; GENE-EXPRESSION; MAMMALIAN CLOCK; KEY REGULATOR; LIVER; TRANSCRIPTION	Energy metabolism follows a diurnal pattern responding to the cycles of light and food exposures. Although food availability is a potent synchronizer of peripheral circadian clock in mammals, the underlying mechanism remains elusive. Here, we found that the temporal signals of fasting and refeeding hormones regulate the transcription of Bmal1, a key transcription activator of molecular clock, in the liver. During fasting, glucagon, a major fasting hormone, activates CREB/CRTC2 transcriptional complex that is recruited to Bmal1 promoter to induce its expression. Furthermore, we showed that CRTC2 is required for basal transcriptional regulation of Bmal1 by experiments using either adenovirus-mediated CRTC2 RNAi knockdown or primary Crtc2 null hepatocytes. On the other hand, insulin suppresses fasting-induced Bmal1 expression by inhibiting CRTC2 activity after refeeding. Taken together, our results indicate CRTC2 as a key component of the circadian oscillator that integrates the mammalian clock and energy metabolism.	[Sun, Xiujie; Dang, Fabin; Zhang, Deyi; Yuan, Yuan; Zhang, Cui; Wu, Yuting; Liu, Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Sun, Xiujie; Dang, Fabin; Zhang, Deyi; Yuan, Yuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Yiguo] Tsinghua Univ, Minist Educ, Key Lab Bioinformat, Tsinghua Peking Ctr Life Sci,Sch Life Sci, Beijing 700084, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Liu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	liuyi@sibs.ac.cn	Sun, Xiujie/L-1244-2017	Sun, Xiujie/0000-0003-3814-7406; Zhang, Deyi/0000-0002-1581-2357	National Basic Research 973 (NBR973) Program [2014CB910500]; National Natural Science Foundation of China [81390351, 31222028]; NBR973 [2012CB524900]; Chinese Academy of Sciences [KSCX2-EW-R-09, 2010OHTP08]; Shanghai Pujiang Program [10PJ1411200]	National Basic Research 973 (NBR973) Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NBR973(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by grants from the National Basic Research 973 (NBR973) Program (2014CB910500), National Natural Science Foundation of China (81390351 and 31222028), NBR973 (2012CB524900), the Chinese Academy of Sciences (KSCX2-EW-R-09 and 2010OHTP08), and Shanghai Pujiang Program (10PJ1411200).	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froy O, 2009, MECH AGEING DEV, V130, P154, DOI 10.1016/j.mad.2008.10.006; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kawamoto T, 2006, J BIOCHEM, V140, P401, DOI 10.1093/jb/mvj165; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Oike H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023709; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoon YS, 2010, P NATL ACAD SCI USA, V107, P17704, DOI 10.1073/pnas.1012665107	35	47	52	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2189	2197		10.1074/jbc.M114.612358	http://dx.doi.org/10.1074/jbc.M114.612358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480789	Green Published, hybrid			2022-12-28	WOS:000348588000023
J	San Roman, AK; Aronson, BE; Krasinski, SD; Shivdasani, RA; Verzi, MP				San Roman, Adrianna K.; Aronson, Boaz E.; Krasinski, Stephen D.; Shivdasani, Ramesh A.; Verzi, Michael P.			Transcription Factors GATA4 and HNF4A Control Distinct Aspects of Intestinal Homeostasis in Conjunction with Transcription Factor CDX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEIN; GENE-EXPRESSION; INSULIN GENE; MOUSE COLON; ADULT; DIFFERENTIATION; EPITHELIUM; MAINTENANCE; PROMOTER; MICE	Distinct groups of transcription factors (TFs) assemble at tissue- specific cis-regulatory sites, implying that different TF combinations may control different genes and cellular functions. Within such combinations, TFs that specify or maintain a lineage and are therefore considered master regulators may play a key role. Gene enhancers often attract these tissue-restricted TFs, as well as TFs that are expressed more broadly. However, the contributions of the individual TFs to combinatorial regulatory activity have not been examined critically in many cases in vivo. We address this question using a genetic approach in mice to inactivate the intestine-specifying and intestine-restricted factor CDX2 alone or in combination with its more broadly expressed partner factors, GATA4 and HNF4A. Compared with single mutants, each combination produced significantly greater defects and rapid lethality through distinct anomalies. Intestines lacking Gata4 and Cdx2 were deficient in crypt cell replication, whereas combined loss of Hnf4a and Cdx2 specifically impaired viability and maturation of villus enterocytes. Integrated analysis of TF binding and of transcripts affected in Hnf4a; Cdx2 compound-mutant intestines indicated that this TF pair controls genes required to construct the apical brush border and absorb nutrients, including dietary lipids. This study thus defines combinatorial TF activities, their specific requirements during tissue homeostasis, and modules of transcriptional targets in intestinal epithelial cells in vivo.	[San Roman, Adrianna K.; Shivdasani, Ramesh A.; Verzi, Michael P.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [San Roman, Adrianna K.; Shivdasani, Ramesh A.; Verzi, Michael P.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [San Roman, Adrianna K.] Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA 02115 USA; [Aronson, Boaz E.; Krasinski, Stephen D.] Boston Childrens Hosp, Div Pediat Gastroenterol & Nutr, Dept Med, Boston, MA 02115 USA; [Aronson, Boaz E.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Verzi, Michael P.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu; verzi@biology.rutgers.edu	San Roman, Adrianna K/K-7245-2019	San Roman, Adrianna K/0000-0003-4511-3052	National Institutes of Health [R01DK08229, R01DK061382, F31CA180784, K01DK088868]; National Science Foundation; Human Genetics Institute of New Jersey; Nutricia Research Foundation; European Society for Pediatric Research; KWF Kankerbestrijding; Prins Bernhard Cultuurfonds; Specialized Program of Research Excellence in Gastrointestinal Cancer Award from the NCI, National Institutes of Health [P50CA127003]; NATIONAL CANCER INSTITUTE [P50CA127003, F31CA180784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK088868, R01DK061382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Genetics Institute of New Jersey; Nutricia Research Foundation(Danone Nutricia); European Society for Pediatric Research; KWF Kankerbestrijding(KWF Kankerbestrijding); Prins Bernhard Cultuurfonds; Specialized Program of Research Excellence in Gastrointestinal Cancer Award from the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK08229 (to R. A. S.) and R01DK061382 (to S. D. K.) and Fellowships F31CA180784 (to A. K. S. R.) and K01DK088868 (to M. P. V.). This work was also supported by a National Science Foundation graduate research fellowship (to A. K. S. R.); the Human Genetics Institute of New Jersey (to M. P. V.); the Nutricia Research Foundation, the European Society for Pediatric Research, KWF Kankerbestrijding, and Prins Bernhard Cultuurfonds (to B. E. A.); and Specialized Program of Research Excellence in Gastrointestinal Cancer Award P50CA127003 from the NCI, National Institutes of Health.	Aronson BE, 2014, BBA-GENE REGUL MECH, V1839, P1273, DOI 10.1016/j.bbagrm.2014.05.018; Babeu JP, 2009, AM J PHYSIOL-GASTR L, V297, pG124, DOI 10.1152/ajpgi.90690.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Beuling E, 2012, MOL CELL BIOL, V32, P3392, DOI 10.1128/MCB.00070-12; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gregory PA, 2004, MOL PHARMACOL, V65, P953, DOI 10.1124/mol.65.4.953; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JAMES R, 1991, J BIOL CHEM, V266, P3246; JAMES R, 1994, J BIOL CHEM, V269, P15229; Jin TR, 1996, MOL CELL BIOL, V16, P19; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitchelmore C, 2000, BIOCHEM J, V346, P529, DOI 10.1042/0264-6021:3460529; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Roberts LR, 2009, TXB GASTROENTEROLOGY, V2, P2386; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sodhi CP, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-19; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Sturley SL, 2012, J LIPID RES, V53, P1800, DOI 10.1194/jlr.R028290; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Wering HM, 2004, AM J PHYSIOL-GASTR L, V287, pG899, DOI 10.1152/ajpgi.00150.2004; Verzi MP, 2013, MOL CELL BIOL, V33, P281, DOI 10.1128/MCB.01185-12; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	45	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1850	1860		10.1074/jbc.M114.620211	http://dx.doi.org/10.1074/jbc.M114.620211			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25488664	hybrid, Green Published			2022-12-28	WOS:000348056400049
J	Liu, YY; Ayers, S; Milanesi, A; Teng, XC; Rabi, S; Akiba, Y; Brent, GA				Liu, Yan-Yun; Ayers, Stephen; Milanesi, Anna; Teng, Xiaochun; Rabi, Sina; Akiba, Ysutada; Brent, Gregory A.			Thyroid Hormone Receptor Sumoylation Is Required for Preadipocyte Differentiation and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Cell Proliferation; Peroxisome Proliferator-activated Receptor (PPAR); Sumoylation; Wnt Signaling; 3T3L1; Human Primary Preadipocytes; NCoR; Perilipin1; TR	PPAR-GAMMA; IN-VIVO; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; LIPID DROPLETS; SUMO CHAINS; NUCLEAR RECEPTOR; PERILIPIN-GENE; STEM-CELLS; ALPHA-GENE	Background: Thyroid hormone receptor (TR) sumoylation is essential for thyroid hormone regulation of gene expression. Results: TR sumoylation mutants impair differentiation though down-regulation of C/EBPs, constitutive interaction with NCoR, interference with PPAR signaling, and disruption of the Wnt canonical signaling pathway important for preadipocyte proliferation. Conclusion: TR sumoylation site mutations impair preadipocyte proliferation and differentiation. Significance: TR sumoylation is required for adipogenesis. Thyroid hormone and thyroid hormone receptor (TR) play an essential role in metabolic regulation. However, the role of TR in adipogenesis has not been established. We reported previously that TR sumoylation is essential for TR-mediated gene regulation and that mutation of either of the two sites in TR or any of the three sites in TR reduces TR sumoylation. Here, we transfected TR sumoylation site mutants into human primary preadiocytes and the mouse 3T3L1 preadipocyte cell line to determine the role of TR sumoylation in adipogenesis. Reduced sumoylation of TR or TR resulted in fewer and smaller lipid droplets and reduced proliferation of preadipocytes. TR sumoylation mutations, compared with wild-type TR, results in reduced C/EBP expression and reduced PPAR(2) mRNA and protein levels. TR sumoylation mutants recruited NCoR and disrupted PPAR-mediated perilipin1 (Plin1) gene expression, associated with impaired lipid droplet formation. Expression of NCoRID, a mutant NCoR lacking the TR interaction domain, partially rescued the delayed adipogenesis and restored Plin1 gene expression and adipogenesis. TR sumoylation site mutants impaired Wnt/-catenin signaling pathways and the proliferation of primary human preadipocytes. Expression of the TR K146Q sumoylation site mutant down-regulated the essential genes required for canonical Wnt signal-mediated proliferation, including Wnt ligands, Fzds, -catenin, LEF1, and CCND1. Additionally, the TR K146Q mutant enhanced the canonical Wnt signaling inhibitor Dickkopf-related protein 1 (DKK1). Our data demonstrate that TR sumoylation is required for activation of the Wnt canonical signaling pathway during preadipocyte proliferation and enhances the PPAR signaling that promotes differentiation.	[Liu, Yan-Yun; Milanesi, Anna; Rabi, Sina; Akiba, Ysutada; Brent, Gregory A.] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Los Angeles, CA 90073 USA; [Liu, Yan-Yun; Milanesi, Anna; Rabi, Sina; Akiba, Ysutada; Brent, Gregory A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90073 USA; [Liu, Yan-Yun; Milanesi, Anna; Rabi, Sina; Akiba, Ysutada; Brent, Gregory A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; [Ayers, Stephen] Methodist Hosp, Res Inst, Genom Med Program, Houston, TX 77030 USA; [Teng, Xiaochun] China Med Univ, Inst Endocrinol, Shenyang 110001, Peoples R China	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; The Methodist Hospital System; The Methodist Hospital - Houston; China Medical University	Liu, YY (corresponding author), VA Greater Los Angeles Healthcare Syst, Bldg 114,Rm 230,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	yyl@ucla.edu; gbrent@ucla.edu		Liu, Yan-Yun/0000-0003-1946-2275	National Institutes of Health [R01DK098576]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098576, K08DK097295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by National Institutes of Health Grant R01DK098576 (to G. A. B.).	Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Albert JS, 2014, NEW ENGL J MED, V370, P2307, DOI 10.1056/NEJMoa1315496; Araki O, 2009, MOL ENDOCRINOL, V23, P308, DOI 10.1210/me.2008-0311; Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Bucan V, 2012, GENES CELLS, V17, P559, DOI 10.1111/j.1365-2443.2012.01613.x; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Fozzatti L, 2013, P NATL ACAD SCI USA, V110, P7850, DOI 10.1073/pnas.1222334110; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Hadjihannas MV, 2012, EMBO REP, V13, P347, DOI 10.1038/embor.2012.12; Hodgson MC, 2008, MOL CANCER THER, V7, P3187, DOI 10.1158/1535-7163.MCT-08-0461; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Langlois D, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-169; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Listenberger L. L., 2007, CURR PROTOC CELL BIO, V24; Liu YY, 2007, ENDOCRINOLOGY, V148, P1206, DOI 10.1210/en.2006-0836; Liu YY, 2012, J BIOL CHEM, V287, P36499, DOI 10.1074/jbc.M112.344317; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; Lu CX, 2010, J MOL ENDOCRINOL, V44, P143, DOI 10.1677/JME-09-0107; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Menendez-Hurtado A, 2000, ENDOCRINOLOGY, V141, P4164, DOI 10.1210/en.141.11.4164; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Pinho S, 2007, DIFFERENTIATION, V75, P957, DOI 10.1111/j.1432-0436.2007.00185.x; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Seo JB, 2004, J BIOL CHEM, V279, P22108, DOI 10.1074/jbc.M400238200; Shimizu M, 2004, MOL CELL BIOL, V24, P1313, DOI 10.1128/MCB.24.3.1313-1323.2004; Silva JE, 2008, THYROID, V18, P157, DOI 10.1089/thy.2007.0252; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Windecker H, 2008, J MOL BIOL, V376, P221, DOI 10.1016/j.jmb.2007.12.008; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Yin DT, 2013, ENDOCR-RELAT CANCER, V20, P507, DOI 10.1530/ERC-13-0053; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06	67	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7402	7415		10.1074/jbc.M114.600312	http://dx.doi.org/10.1074/jbc.M114.600312			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25572392	hybrid, Green Published			2022-12-28	WOS:000351613600009
J	Dutta, K; Varshney, AK; Franklin, MC; Goger, M; Wang, XB; Fries, BC				Dutta, Kaushik; Varshney, Avanish K.; Franklin, Matthew C.; Goger, Michael; Wang, Xiaobo; Fries, Bettina C.			Mechanisms Mediating Enhanced Neutralization Efficacy of Staphylococcal Enterotoxin B by Combinations of Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; POLARIZATION TRANSFER; FUSION PROTEIN; IN-VITRO; SUPERANTIGEN; TOXIN; SUBUNIT; COMPLEX; MOLECULES; TOXICITY	Staphylococcal enterotoxin B (SEB) is a superantigen that cross-links the major histocompatibility complex class II and specific V-beta chains of the T-cell receptor, thus forming a ternary complex. Developing neutralizing mAb to disrupt the ternary complex and abrogate the resulting toxicity is a major therapeutic challenge because SEB is effective at very low concentrations. We show that combining two SEB-specific mAbs enhances their efficacy, even though one of the two mAbs by itself has no effect on neutralization. Crystallography was employed for fine-mapping conformational epitopes in binary and ternary complexes between SEB and Fab fragments. NMR spectroscopy was used to validate and identify subtle allosteric changes induced by mAbs binding to SEB. The mapping of epitopes established that a combination of different mAbs can enhance efficacy of mAb-mediated protection from SEB induced lethal shock by two different mechanisms: one mAb mixture promoted clearance of the toxin both in vitro and in vivo by FcR-mediated cross-linking and clearance, whereas the other mAb mixture induced subtle allosteric conformational changes in SEB that perturbed formation of the SEB.T-cell receptor.major histocompatibility complex class II trimer. Finally structural information accurately predicted mAb binding to other superantigens that share conformational epitopes with SEB. Fine mapping of conformational epitopes is a powerful tool to establish the mechanism and optimize the action of synergistic mAb combinations.	[Dutta, Kaushik; Franklin, Matthew C.; Goger, Michael] New York Struct Biol Ctr, New York, NY 10027 USA; [Varshney, Avanish K.; Fries, Bettina C.] SUNY Stony Brook, Dept Med & Mol Genet & Microbiol, Stony Brook, NY 11790 USA; [Varshney, Avanish K.; Wang, Xiaobo; Fries, Bettina C.] Albert Einstein Coll Med, Dept Med Microbiol & Immunol, Bronx, NY 10461 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yeshiva University; Albert Einstein College of Medicine	Dutta, K (corresponding author), New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA.	dutta@nysbc.org; Bettina.Fries@stonybrookmedicine.edu			National Institutes of Health [U54 AI057158, P41GM066354]; Department of Defense [W911NF0710053]; New York Division of Science, Technology and Innovation, Office of Research Infrastructure Programs/National Institutes of Health facility improvement [CO6RR015495]; Keck Foundation; New York State Assembly; U.S. Department of Defense; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R21AI114259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM066354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); New York Division of Science, Technology and Innovation, Office of Research Infrastructure Programs/National Institutes of Health facility improvement; Keck Foundation(W.M. Keck Foundation); New York State Assembly; U.S. Department of Defense(United States Department of Defense); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057158 (to B. C. F. and Prof. W. Ian Lipkin (Principal Investigator), Columbia University). This work was also supported by U.S. Department of Defense Grant W911NF0710053 (to the New York Structural Biology Center), a grant from New York Division of Science, Technology and Innovation, Office of Research Infrastructure Programs/National Institutes of Health facility improvement Grant CO6RR015495. The 900-MHz NMR spectrometers were purchased with funds from National Institutes of Health Grant P41GM066354, the Keck Foundation, New York State Assembly, and the U.S. Department of Defense. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Allende D., 2010, ANTIMICROB AGENTS CH, V54, P239; Andersen LM, 2012, J BIOL CHEM, V287, P8994, DOI 10.1074/jbc.M111.312330; Bakker ABH, 2008, VACCINE, V26, P5922, DOI 10.1016/j.vaccine.2008.08.050; BOUCHER P, 1994, INFECT IMMUN, V62, P449, DOI 10.1128/IAI.62.2.449-456.1994; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043845; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Davies John Q, 2005, Methods Mol Biol, V290, P91; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demarest SJ, 2010, MABS-AUSTIN, V2, P190, DOI 10.4161/mabs.2.2.11220; Drozdowski Brian, 2010, J Immune Based Ther Vaccines, V8, P9, DOI 10.1186/1476-8518-8-9; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; HAMAD ARA, 1994, J EXP MED, V180, P615, DOI 10.1084/jem.180.2.615; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karauzum H, 2012, J BIOL CHEM, V287, P25203, DOI 10.1074/jbc.M112.364075; Kerschbaumer RJ, 2004, J BIOL CHEM, V279, P40445, DOI 10.1074/jbc.M405966200; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; Larkin EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013253; Lehnert NM, 2001, BIOCHEMISTRY-US, V40, P4222, DOI 10.1021/bi002172e; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Lomonte B, 2009, TOXICON, V54, P1012, DOI 10.1016/j.toxicon.2009.03.015; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meddeb-Mouelhi F, 2003, TOXICON, V42, P785, DOI 10.1016/j.toxicon.2003.10.021; Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603; MOLLICK JA, 1993, J CLIN INVEST, V92, P710, DOI 10.1172/JCI116641; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; O'Hara JM, 2013, J IMMUNOL METHODS, V395, P71, DOI 10.1016/j.jim.2013.06.004; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Pinchuk IV, 2010, TOXINS, V2, P2177, DOI 10.3390/toxins2082177; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; Riek R, 1999, P NATL ACAD SCI USA, V96, P4918, DOI 10.1073/pnas.96.9.4918; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Smith MJ, 2009, INFECT IMMUN, V77, P2730, DOI 10.1128/IAI.00005-09; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Tilahun ME, 2010, INFECT IMMUN, V78, P2801, DOI 10.1128/IAI.01121-09; Ulrich RG, 1997, TXB MILITARY MED 1, P621; Varshney A. K., 2009, APPL ENVIRON MICROB, P6839; Varshney AK, 2014, MBIO, V5, DOI 10.1128/mBio.01007-14; Varshney AK, 2014, J INFECT DIS, V210, P973, DOI 10.1093/infdis/jiu198; Varshney AK, 2011, J BIOL CHEM, V286, P9737, DOI 10.1074/jbc.M110.212407; Xia T, 2014, MABS-AUSTIN, V6, P119, DOI 10.4161/mabs.27106; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13	52	26	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6715	6730		10.1074/jbc.M114.630715	http://dx.doi.org/10.1074/jbc.M114.630715			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25572397	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000350991500006
J	Obrochta, KM; Krois, CR; Campos, B; Napoli, JL				Obrochta, Kristin M.; Krois, Charles R.; Campos, Benito; Napoli, Joseph L.			Insulin Regulates Retinol Dehydrogenase Expression and All-trans-retinoic Acid Biosynthesis through FoxO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCOSE-UPTAKE; SHORT-CHAIN DEHYDROGENASE/REDUCTASE; VITAMIN-A; IN-VIVO; INTRAPORTAL GLUCOSE; ACTIVATED RECEPTOR; RESPONSE ELEMENT; BINDING-PROTEIN	All-trans-retinoic acid (atRA), an autacoid derived from retinol (vitamin A), regulates energy balance and reduces adiposity. We show that energy status regulates atRA biosynthesis at the rate-limiting step, catalyzed by retinol dehydrogenases (RDH). Six h after re-feeding, Rdh1 expression decreased 80-90% in liver and brown adipose tissue and Rdh10 expression was decreased 45 63% in liver, pancreas, and kidney, all relative to mice fasted 16 h. atRA in the liver was decreased 44% 3 h after reduced Rdh expression. Oral gavage with glucose or injection with insulin decreased Rdh1 and Rdh10 mRNA 50% or greater in mouse liver. Removing serum from the medium of the human hepatoma cell line HepG2 increased Rdh10 and Rdh16 (human Rdh1 ortholog) mRNA expression 2-3-fold by 4 h, by increasing transcription and stabilizing mRNA. Insulin decreased Rdh10 and Rdh16 mRNA in HepG2 cells incubated in serum-free medium by inhibiting transcription and destabilizing mRNA. Insulin action required PI3K and Akt, which suppress FoxO1. Serum removal increased atRA biosynthesis 4-fold from retinol in HepG2 cells, whereas dominant-negative FoxO1 prevented the increase. Thus, energy status via insulin and FoxO1 regulate Rdh expression and atRA biosynthesis. These results reveal mechanisms for regulating atRA biosynthesis and the opposing effects of atRA and insulin on gluconeogenesis, and also suggest an interaction between atRA and insulin signaling related diseases, such as type II diabetes and cancer.	[Obrochta, Kristin M.; Krois, Charles R.; Campos, Benito; Napoli, Joseph L.] Univ Calif Berkeley, Grad Program Metab Biol, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Grad Program Metab Biol, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	jna@berkeley.edu			National Institutes of Health [DK090522, AA017927]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061918, R01DK090522, R01DK036870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK090522 and AA017927 (to J. L. N.).	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; BERGMAN RN, 1982, DIABETES, V31, P27, DOI 10.2337/diabetes.31.1.27; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Campos B, 2012, INT J CANCER, V131, P1963, DOI 10.1002/ijc.27446; Chakravarti N, 2007, CLIN CANCER RES, V13, P4817, DOI 10.1158/1078-0432.CCR-06-3026; CHERTOW BS, 1987, J CLIN INVEST, V79, P163, DOI 10.1172/JCI112778; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; ENG J, 1992, J BIOL CHEM, V267, P7402; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Frey SK, 2011, NUTRIENTS, V3, P27, DOI 10.3390/nu3010027; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; ISHIDA T, 1983, J CLIN INVEST, V72, P590, DOI 10.1172/JCI111007; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2011, MOL CELL BIOL, V31, P3277, DOI 10.1128/MCB.05516-11; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kido Y, 2001, J CLIN ENDOCR METAB, V86, P972, DOI 10.1210/jc.86.3.972; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; MATSUURA T, 1993, ARCH BIOCHEM BIOPHYS, V301, P221, DOI 10.1006/abbi.1993.1137; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Mercader J, 2010, OBESITY, V18, P655, DOI 10.1038/oby.2009.330; Mira-y-Lopez R, 2000, J CELL PHYSIOL, V185, P302, DOI 10.1002/1097-4652(200011)185:2<302::AID-JCP15>3.0.CO;2-#; Mithieux G, 1996, DIABETES, V45, P891, DOI 10.2337/diabetes.45.7.891; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; MYERS SR, 1991, J CLIN INVEST, V88, P158, DOI 10.1172/JCI115273; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Noy N, 2013, ADIPOCYTE, V2, P184, DOI 10.4161/adip.23489; Ohlsson L, 2014, REGUL PEPTIDES, V189, P40, DOI 10.1016/j.regpep.2014.02.001; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Pierzchalski K, 2013, FASEB J, V27, P1904, DOI 10.1096/fj.12-219410; Pino-Lagos K, 2010, BIOFACTORS, V36, P430, DOI 10.1002/biof.117; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ross AC, 2007, VITAM HORM, V75, P197, DOI 10.1016/S0083-6729(06)75008-7; Ross AC, 2011, PHYSIOL GENOMICS, V43, P57, DOI 10.1152/physiolgenomics.00182.2010; Rossi E, 2007, CANCER BIOL THER, V6, P238, DOI 10.4161/cbt.6.2.3625; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Scott DK, 1996, J BIOL CHEM, V271, P6260, DOI 10.1074/jbc.271.11.6260; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shin DJ, 2002, MOL CELL ENDOCRINOL, V195, P39, DOI 10.1016/S0303-7207(02)00215-0; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; Tanabe K, 2008, CANCER SCI, V99, P267, DOI 10.1111/j.1349-7006.2007.00684.x; TOBE K, 1992, J BIOL CHEM, V267, P21089; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WOLF G, 1958, Prog Nucl Energy 6 Biol Sci, V2, P457; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Yamamoto Y, 2000, FASEB J, V14, P2119, DOI 10.1096/fj.00-0061com; Zarrinpar A, 2012, ALIMENT PHARM THER, V36, P909, DOI 10.1111/apt.12084; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhao S, 2012, BIOCHEM CELL BIOL, V90, P142, DOI [10.1139/O11-079, 10.1139/o11-079]; Zizola CF, 2010, MOL CELL BIOL, V30, P3412, DOI 10.1128/MCB.00014-10	77	30	33	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7259	7268		10.1074/jbc.M114.609313	http://dx.doi.org/10.1074/jbc.M114.609313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627686	Green Published, hybrid			2022-12-28	WOS:000350991500054
J	Pircher, H; von Grafenstein, S; Diener, T; Metzger, C; Albertini, E; Taferner, A; Unterluggauer, H; Kramer, C; Liedl, KR; Janesn-Durr, P				Pircher, Haymo; von Grafenstein, Susanne; Diener, Thomas; Metzger, Christina; Albertini, Eva; Taferner, Andrea; Unterluggauer, Hermann; Kramer, Christian; Liedl, Klaus R.; Janesn-Duerr, Pidder			Identification of FAH Domain-containing Protein 1 (FAHD1) as Oxaloacetate Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FUMARYLACETOACETATE HYDROLASE; CRYSTAL-STRUCTURE; MECHANISM; PURIFICATION; ENZYMES	Fumarylacetoacetate hydrolase (FAH) domain-containing proteins occur in both prokaryotes and eukaryotes, where they carry out diverse enzymatic reactions, probably related to structural differences in their respective FAH domains; however, the precise relationship between structure of the FAH domain and the associated enzyme function remains elusive. In mammals, three FAH domain-containing proteins, FAHD1, FAHD2A, and FAHD2B, are known; however, their enzymatic function, if any, remains to be demonstrated. In bacteria, oxaloacetate is subject to enzymatic decarboxylation; however, oxaloacetate decarboxylases (ODx) were so far not identified in eukaryotes. Based on molecular modeling and subsequent biochemical investigations, we identified FAHD1 as a eukaryotic ODx enzyme. The results presented here indicate that dedicated oxaloacetate decarboxylases exist in eukaryotes.	[Pircher, Haymo; Diener, Thomas; Metzger, Christina; Albertini, Eva; Taferner, Andrea; Unterluggauer, Hermann; Janesn-Duerr, Pidder] Univ Innsbruck, Inst Biomed Aging Res, A-6020 Innsbruck, Austria; [Pircher, Haymo; von Grafenstein, Susanne; Diener, Thomas; Metzger, Christina; Albertini, Eva; Taferner, Andrea; Unterluggauer, Hermann; Kramer, Christian; Liedl, Klaus R.; Janesn-Duerr, Pidder] Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [von Grafenstein, Susanne; Kramer, Christian; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; University of Innsbruck	Janesn-Durr, P (corresponding author), Univ Innsbruck, Inst Biomed Aging Res, Rennweg 10, A-6020 Innsbruck, Austria.	pidder.jansen-duerr@uibk.ac.at	Liedl, Klaus/ABB-4725-2021; Jansen-Dürr, Pidder/ABG-2466-2020; Albertini, Emidio/F-7393-2014; Liedl, Klaus R/F-3099-2015	Liedl, Klaus/0000-0002-0985-2299; Jansen-Dürr, Pidder/0000-0001-7771-3429; Liedl, Klaus R/0000-0002-0985-2299	Austrian Science Funds (FWF) [NFN 593]; European Union	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); European Union(European Commission)	This work was supported by a grant from the Austrian Science Funds (FWF; NFN 593) (to P. J.-D.) and by the European Union through the FP6 Integrated Project MiMAGE (to P. J.-D.).	BALLARD FJ, 1970, BIOCHEM J, V119, P735, DOI 10.1042/bj1190735; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; CORWIN LM, 1959, J BIOL CHEM, V234, P1338; DEAN B, 1973, BIOCHEM J, V135, P667, DOI 10.1042/bj1350667; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HSIANG HH, 1972, BIOCHEMISTRY-US, V11, P2098, DOI 10.1021/bi00761a016; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Klaffl S, 2010, J BACTERIOL, V192, P2604, DOI 10.1128/JB.01678-09; Lietzan AD, 2014, ARCH BIOCHEM BIOPHYS, V544, P75, DOI 10.1016/j.abb.2013.10.014; Manjasetty BA, 2004, BIOL CHEM, V385, P935, DOI 10.1515/BC.2004.122; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; PARVIN R, 1980, ANAL BIOCHEM, V104, P296, DOI 10.1016/0003-2697(80)90078-0; PHANEUF D, 1991, AM J HUM GENET, V48, P525; Pircher H, 2011, J BIOL CHEM, V286, P36500, DOI 10.1074/jbc.M111.264770; Pollard JR, 1998, EUR J BIOCHEM, V251, P98, DOI 10.1046/j.1432-1327.1998.2510098.x; Ran TT, 2013, BIOCHEM J, V449, P51, DOI 10.1042/BJ20120913; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tame JRH, 2002, BIOCHEMISTRY-US, V41, P2982, DOI 10.1021/bi015717t; Timm DE, 1999, STRUCTURE, V7, P1023, DOI 10.1016/S0969-2126(99)80170-1; WOJTCZAK AB, 1974, BIOCHIM BIOPHYS ACTA, V347, P168, DOI 10.1016/0005-2728(74)90042-5; Wolfenden R, 2011, J AM CHEM SOC, V133, P5683, DOI 10.1021/ja111457h; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	23	24	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6755	6762		10.1074/jbc.M114.609305	http://dx.doi.org/10.1074/jbc.M114.609305			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25575590	hybrid, Green Published			2022-12-28	WOS:000350991500012
J	Zhang, Y; Geng, LY; Talmon, G; Wang, J				Zhang, Yang; Geng, Liying; Talmon, Geoffrey; Wang, Jing			MicroRNA-520g Confers Drug Resistance by Regulating p21 Expression in Colorectal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN RESISTANCE; INDUCED APOPTOSIS; P53; 5-FLUOROURACIL; INHIBITION; MECHANISMS; GROWTH; CHEMOTHERAPY; RESTORATION; PACLITAXEL	Development of drug resistance is one of the major causes of colorectal cancer recurrence, yet mechanistic understanding and therapeutic options remain limited. Here, we show that expression of microRNA (miR)-520g is correlated with drug resistance of colon cancer cells. Ectopic expression of miR-520g conferred resistance to 5-fluorouracil (5-FU)-or oxaliplatin-induced apoptosis in vitro and reduced the effectiveness of 5-FU in the inhibition of tumor growth in a mouse xenograft model in vivo. Further studies indicated that miR-520g mediated drug resistance through down-regulation of p21 expression. Moreover, p53 suppressed miR-520g expression, and deletion of p53 up-regulated miR-520g expression. Inhibition of miR-520g in p53(-/-) cells increased their sensitivity to 5-FU treatment. Importantly, studies of patient samples indicated that expression of miR-520g correlated with chemoresistance in colorectal cancer. These findings indicate that the p53/miR-520g/p21 signaling axis plays an important role in the response of colorectal cancer to chemotherapy. A major implication of our studies is that inhibition of miR-520g or restoration of p21 expression may have considerable therapeutic potential to overcome drug resistance in colorectal cancer patients, especially in those with mutant p53.	[Zhang, Yang; Geng, Liying; Wang, Jing] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yang; Wang, Jing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Wang, Jing] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Wang, Jing] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Talmon, Geoffrey] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu	Zhang, Yang/H-3299-2018	Zhang, Yang/0000-0003-2315-9009	National Institutes of Health from NCI [R01CA140988-01]; Nebraska Department of Health and Human Services [LB506 (2014-40)]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA140988, R01CA058755, P30CA013148] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA140988-01 from NCI. This work was also supported by Nebraska Department of Health and Human Services Grant LB506 (2014-40; to J. W.).	Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; Aneja R, 2007, CANCER RES, V67, P3862, DOI 10.1158/0008-5472.CAN-06-4282; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; BOYD DD, 1988, CANCER RES, V48, P2469; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chakraborty S, 2014, FEBS LETT, V588, P549, DOI 10.1016/j.febslet.2013.11.040; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrandiz N, 2010, CANCER LETT, V292, P133, DOI 10.1016/j.canlet.2009.11.017; Galmarini CM, 2006, INT J CANCER, V119, P60, DOI 10.1002/ijc.21770; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Geng L, 2014, ONCOGENE, V33, P5332, DOI 10.1038/onc.2013.478; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Grassilli E, 2013, CLIN CANCER RES, V19, P3820, DOI 10.1158/1078-0432.CCR-12-3289; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Kang KH, 1999, EXP CELL RES, V253, P403, DOI 10.1006/excr.1999.4644; Kim CW, 2013, INT J ONCOL, V43, P1495, DOI 10.3892/ijo.2013.2070; Kim SH, 2009, AM J CLIN ONCOL-CANC, V32, P38, DOI 10.1097/COC.0b013e31817be58e; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krell J, 2013, EPIGENOMICS-UK, V5, P417, DOI [10.2217/EPI.13.41, 10.2217/epi.13.41]; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang F, 2009, SWISS MED WKLY, V139, P724, DOI smw-12754; Lim HK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/413575; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Metzinger DS, 2006, CANCER LETT, V236, P302, DOI 10.1016/j.canlet.2005.05.016; MIYASHITA T, 1995, CELL, V80, P293; MOERTEL CG, 1978, NEW ENGL J MED, V299, P1049, DOI 10.1056/NEJM197811092991906; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Rougier P, 1998, LANCET, V352, P1407, DOI 10.1016/S0140-6736(98)03085-2; SLICHENMYER WJ, 1993, CANCER RES, V53, P4164; Stoklosa T, 2004, CELL CYCLE, V3, P1463, DOI 10.4161/cc.3.11.1229; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Yang JY, 2013, ONCOL RES, V21, P43, DOI 10.3727/096504013X13793555706722; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	47	86	89	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6215	6225		10.1074/jbc.M114.620252	http://dx.doi.org/10.1074/jbc.M114.620252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25616665	Green Published, hybrid			2022-12-28	WOS:000350732500029
J	Tokhtaeva, E; Capri, J; Marcus, EA; Whitelegge, JP; Khuzakhmetova, V; Bukharaeva, E; Deiss-Yehiely, N; Dada, LA; Sachs, G; Fernandez-Salas, E; Vagin, O				Tokhtaeva, Elmira; Capri, Joe; Marcus, Elizabeth A.; Whitelegge, Julian P.; Khuzakhmetova, Venera; Bukharaeva, Ellya; Deiss-Yehiely, Nimrod; Dada, Laura A.; Sachs, George; Fernandez-Salas, Ester; Vagin, Olga			Septin Dynamics Are Essential for Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOKED QUANTAL RELEASE; MICROTUBULE ORGANIZATION; NEUROTRANSMITTER RELEASE; ENDOPLASMIC-RETICULUM; BARRIER FUNCTION; ALPHA-SNAP; COMPLEX; FORCHLORFENURON; DISRUPTION; BINDING	Septins are a family of 14 cytoskeletal proteins that dynamically form hetero-oligomers and organize membrane microdomains for protein complexes. The previously reported interactions with SNARE proteins suggested the involvement of septins in exocytosis. However, the contradictory results of up-or down-regulation of septin-5 in various cells and mouse models or septin-4 in mice suggested either an inhibitory or a stimulatory role for these septins in exocytosis. The involvement of the ubiquitously expressed septin-2 or general septin polymerization in exocytosis has not been explored to date. Here, by nano-LC with tandem MS and immunoblot analyses of the septin-2 interactome in mouse brain, we identified not only SNARE proteins but also Munc-18-1 (stabilizes assembled SNARE complexes), N-ethylmaleimide-sensitive factor (NSF) (disassembles SNARE complexes after each membrane fusion event), and the chaperones Hsc70 and synucleins (maintain functional conformation of SNARE proteins after complex disassembly). Importantly, alpha-soluble NSF attachment protein (SNAP), the adaptor protein that mediates NSF binding to the SNARE complex, did not interact with septin-2, indicating that septins undergo reorganization during each exocytosis cycle. Partial depletion of septin-2 by siRNA or impairment of septin dynamics by forchlorfenuron inhibited constitutive and stimulated exocytosis of secreted and transmembrane proteins in various cell types. Forchlorfenuron impaired the interaction between SNAP-25 and its chaperone Hsc70, decreasing SNAP-25 levels in cultured neuroendocrine cells, and inhibited both spontaneous and stimulated acetylcholine secretion in mouse motor neurons. The results demonstrate a stimulatory role of septin-2 and the dynamic reorganization of septin oligomers in exocytosis.	[Sachs, George] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Marcus, Elizabeth A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Tokhtaeva, Elmira; Marcus, Elizabeth A.; Sachs, George; Vagin, Olga] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Capri, Joe; Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Semel Inst, Neuropsychiat Inst, Los Angeles, CA 90024 USA; [Khuzakhmetova, Venera; Bukharaeva, Ellya] Russian Acad Sci, Kazan Sci Ctr, Kazan Inst Biochem & Biophys, Kazan 420111, Russia; [Bukharaeva, Ellya] Kazan Fed Univ, Kazan 420008, Russia; [Deiss-Yehiely, Nimrod; Dada, Laura A.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Fernandez-Salas, Ester] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; Kazan Federal University; Northwestern University; Feinberg School of Medicine; University of Michigan System; University of Michigan	Vagin, O (corresponding author), Univ Calif Los Angeles, Dept Physiol & Med, VAGLAHS West LA, 11301 Wilshire Blvd,Bldg 113,Rm 324, Los Angeles, CA 90073 USA.	olgav@ucla.edu			National Institutes of Health from the NHLBI [R01HL113350]; National Institutes of Health from the NIDDK [UL1TR000124, K08DK100661-01, P30DK063491]; UCLA Children's Discovery and Innovation Institute; Program of Competitive Growth of Kazan Federal University; Russian Foundation for Basic Research [15-04-02983a]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100661, P30DK063491, P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from the NIDDK; UCLA Children's Discovery and Innovation Institute; Program of Competitive Growth of Kazan Federal University(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL113350 from the NHLBI (to L. A. D. and O. V.), UL1TR000124 (to the UCLA Clinical and Translational Science Institute and E. A. M.), and K08DK100661-01 (to E. A. M.) and P30DK063491 from the NIDDK (to J. P. W) This work was also supported by the UCLA Children's Discovery and Innovation Institute (to E. A. M.), the Program of Competitive Growth of Kazan Federal University (to E. B. and V. K.), and Russian Foundation for Basic Research Grant 15-04-02983a (to E. B. and V. K.).	Ageta-Ishihara N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3532; Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Angelis D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096390; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Bowen JR, 2011, J CELL BIOL, V194, P187, DOI 10.1083/jcb.201102076; BRIGANT JL, 1982, J PHYSIOL-LONDON, V333, P619, DOI 10.1113/jphysiol.1982.sp014472; Bukcharaeva EA, 1999, J PHYSIOL-LONDON, V517, P879, DOI 10.1111/j.1469-7793.1999.0879s.x; Bukharaeva EA, 2007, J NEUROCHEM, V100, P939, DOI 10.1111/j.1471-4159.2006.04282.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Carmosino M, 2000, PFLUG ARCH EUR J PHY, V440, P871, DOI 10.1007/s004240000363; Chailler P, 2005, J CELL PHYSIOL, V202, P263, DOI 10.1002/jcp.20124; Cipriano DJ, 2013, J BIOL CHEM, V288, P23436, DOI 10.1074/jbc.M113.476705; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Done SC, 2002, J BIOL CHEM, V277, P17108, DOI 10.1074/jbc.M201326200; Gerlach RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078912; Ghossoub R, 2013, J CELL SCI, V126, P2583, DOI 10.1242/jcs.111377; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heasley LR, 2014, EUKARYOT CELL, V13, P1411, DOI 10.1128/EC.00191-14; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Ito H, 2009, J NEUROCHEM, V108, P867, DOI 10.1111/j.1471-4159.2008.05849.x; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kinoshita A, 2000, J COMP NEUROL, V428, P223, DOI 10.1002/1096-9861(20001211)428:2<223::AID-CNE3>3.0.CO;2-M; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Mandel-Gutfreund Y, 2011, BIOL CHEM, V392, P783, DOI 10.1515/BC.2011.089; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mostowy S, 2009, J BIOL CHEM, V284, P11613, DOI 10.1074/jbc.M900231200; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Nakahira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013799; Naydenov NG, 2012, J BIOL CHEM, V287, P5928, DOI 10.1074/jbc.M111.278358; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Padilla-Benavides T, 2010, MOL BIOL CELL, V21, P2217, DOI 10.1091/mbc.E10-01-0081; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Saarikangas J, 2011, EMBO REP, V12, P1118, DOI 10.1038/embor.2011.193; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Sidhaye VK, 2011, AM J RESP CELL MOL, V45, P120, DOI 10.1165/rcmb.2010-0235OC; Smith SM, 2012, CELL CALCIUM, V52, P226, DOI 10.1016/j.ceca.2012.06.001; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2010, CYTOSKELETON, V67, P339, DOI 10.1002/cm.20448; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tokhtaeva E, 2012, J BIOL CHEM, V287, P26115, DOI 10.1074/jbc.M112.370734; Tokhtaeva E, 2012, J CELL SCI, V125, P1605, DOI 10.1242/jcs.100149; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Tsang CW, 2008, MOL CELL BIOL, V28, P7012, DOI 10.1128/MCB.00035-08; Tsang CW, 2011, BIOL CHEM, V392, P739, DOI 10.1515/BC.2011.077; Vagin O, 2014, J CELL SCI, V127, P3294, DOI 10.1242/jcs.146324; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Vega IE, 2003, NEUROREPORT, V14, P31, DOI 10.1097/00001756-200301200-00006; Wasik AA, 2012, MOL BIOL CELL, V23, P3370, DOI 10.1091/mbc.E11-12-1010; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003	69	52	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5280	5297		10.1074/jbc.M114.616201	http://dx.doi.org/10.1074/jbc.M114.616201			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575596	Green Published, hybrid			2022-12-28	WOS:000350044200005
J	Willenborg, J; Huber, C; Koczula, A; Lange, B; Eisenreich, W; Valentin-Weigand, P; Goethe, R				Willenborg, Joerg; Huber, Claudia; Koczula, Anna; Lange, Birgit; Eisenreich, Wolfgang; Valentin-Weigand, Peter; Goethe, Ralph			Characterization of the Pivotal Carbon Metabolism of Streptococcus suis Serotype 2 under ex Vivo and Chemically Defined in Vitro Conditions by Isotopologue Profiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-MENINGITIS; FLUID BARRIER; VIRULENCE; PATHOGENESIS; SERINE; ACID; EPIDEMIOLOGY; TRANSDUCTION; PNEUMONIAE; RESISTANCE	Streptococcus suis is a neglected zoonotic pathogen that has to adapt to the nutritional requirements in the different host niches encountered during infection and establishment of invasive diseases. To dissect the central metabolic activity of S. suis under different conditions of nutrient availability, we performed labeling experiments starting from [C-13]glucose specimens and analyzed the resulting isotopologue patterns in amino acids of S. suis grown under in vitro and ex vivo conditions. In combination with classical growth experiments, we found that S. suis is auxotrophic for Arg, Gln/Glu, His, Leu, and Trp in chemically defined medium. De novo biosynthesis was shown for Ala, Asp, Ser, and Thr at high rates and for Gly, Lys, Phe, Tyr, and Val at moderate or low rates, respectively. Glucose degradation occurred mainly by glycolysis and to a minor extent by the pentose phosphate pathway. Furthermore, the exclusive formation of oxaloacetate by phosphoenolpyruvate (PEP) carboxylation became evident from the patterns in de novo synthesized amino acids. Labeling experiments with S. suis grown ex vivo in blood or cerebrospinal fluid reflected the metabolic adaptation to these host niches with different nutrient availability; however, similar key metabolic activities were identified under these conditions. This points at the robustness of the core metabolic pathways in S. suis during the infection process. The crucial role of PEP carboxylation for growth of S. suis in the host was supported by experiments with a PEP carboxylase-deficient mutant strain in blood and cerebrospinal fluid.	[Willenborg, Joerg; Koczula, Anna; Valentin-Weigand, Peter; Goethe, Ralph] Univ Vet Med Hannover, Inst Microbiol, D-30173 Hannover, Germany; [Huber, Claudia; Lange, Birgit; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany	University of Veterinary Medicine Hannover, Foundation; Technical University of Munich	Willenborg, J (corresponding author), Univ Vet Med Hannover, Inst Microbiol, Bischofsholer Damm 15, D-30173 Hannover, Germany.	joerg.willenborg@tiho-hannover.de	Lange, Birgit/X-6514-2019; Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279	Deutsche Forschungsgemeinschaft [GO-983-3/1, EI-384/5-1, SPP1316]; Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony	This work was supported by Grants GO-983-3/1 and EI-384/5-1 from the Deutsche Forschungsgemeinschaft within the Priority Programme SPP1316 and by the Niedersachsen-Research Network on Neuroinfectiology of the Ministry of Science and Culture of Lower Saxony.	Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; BLAKLEY RL, 1955, BIOCHEM J, V61, P315, DOI 10.1042/bj0610315; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Fittipaldi N, 2007, VACCINE, V25, P3524, DOI 10.1016/j.vaccine.2007.01.084; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fuchs TM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00023; Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x; Garrigues C, 1997, J BACTERIOL, V179, P5282, DOI 10.1128/jb.179.17.5282-5287.1997; Gillmaier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052378; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; Hartel T, 2012, J BIOL CHEM, V287, P4260, DOI 10.1074/jbc.M111.304311; HICKMAN R, 1986, EUR SURG RES, V18, P283, DOI 10.1159/000128537; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Hui ACF, 2005, CLIN NEUROL NEUROSUR, V107, P366, DOI 10.1016/j.clineuro.2004.10.006; Kaiser GM, 2007, LAB ANIM-UK, V41, P80, DOI 10.1258/002367707779399509; Koczula A, 2014, J MICROBIOL METH, V107, P80, DOI 10.1016/j.mimet.2014.09.007; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; MONTGOMERY GW, 1980, HORM METAB RES, V12, P304, DOI 10.1055/s-2007-996276; Neijssel O.M., 1997, SOC APPL BACTERIOL S, V26, P125; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Okwumabua O, 2001, CLIN DIAGN LAB IMMUN, V8, P251, DOI 10.1128/CDLI.8.2.251-257.2001; Pan XZ, 2009, J BACTERIOL, V191, P2601, DOI 10.1128/JB.01309-08; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; POOLMAN B, 1993, FEMS MICROBIOL REV, V12, P125, DOI 10.1111/j.1574-6976.1993.tb00015.x; Rosenling T, 2009, J PROTEOME RES, V8, P5511, DOI 10.1021/pr9005876; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; SCHIRCH V, 1985, J BACTERIOL, V163, P1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silva LMG, 2006, VET MICROBIOL, V115, P117, DOI 10.1016/j.vetmic.2005.12.013; SMITH HE, 1995, MICROBIOL-UK, V141, P181, DOI 10.1099/00221287-141-1-181; Sperandio B, 2007, J BACTERIOL, V189, P7032, DOI 10.1128/JB.00703-07; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Tang JKH, 2012, J R SOC INTERFACE, V9, P2767, DOI 10.1098/rsif.2012.0396; Tenenbaum T, 2005, FEMS IMMUNOL MED MIC, V44, P25, DOI 10.1016/j.femsim.2004.12.006; Tenenbaum T, 2009, CELL MICROBIOL, V11, P323, DOI 10.1111/j.1462-5822.2008.01255.x; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P143; Varela NP, 2013, ANIM HEALTH RES REV, V14, P68, DOI 10.1017/S1466252313000029; Huong VTL, 2014, EMERG INFECT DIS, V20, P1105, DOI 10.3201/eid2007.131594; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Willenborg J, 2011, MICROBIOL-SGM, V157, P1823, DOI 10.1099/mic.0.046417-0; Willenborg J, 2014, MOL MICROBIOL, V92, P61, DOI 10.1111/mmi.12537; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	55	11	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5840	5854		10.1074/jbc.M114.619163	http://dx.doi.org/10.1074/jbc.M114.619163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575595	Green Published, hybrid			2022-12-28	WOS:000350044200049
J	Adhikari, S; Chetram, MA; Woodrick, J; Mitra, PS; Manthena, PV; Khatkar, P; Dakshanamurthy, S; Dixon, M; Karmahapatra, SK; Nuthalapati, NK; Gupta, S; Narasimhan, G; Mazumder, R; Loffredo, CA; Uren, A; Roy, R				Adhikari, Sanjay; Chetram, Mahandranauth A.; Woodrick, Jordan; Mitra, Partha S.; Manthena, Praveen V.; Khatkar, Pooja; Dakshanamurthy, Sivanesan; Dixon, Monica; Karmahapatra, Soumendra K.; Nuthalapati, Nikhil K.; Gupta, Suhani; Narasimhan, Ganga; Mazumder, Raja; Loffredo, Christopher A.; Ueren, Aykut; Roy, Rabindra			Germ Line Variants of Human N-Methylpurine DNA Glycosylase Show Impaired DNA Repair Activity and Facilitate 1,N-6-Ethenoadenine-induced Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; 3-METHYLADENINE-DNA GLYCOSYLASE; ESCHERICHIA-COLI; HUMAN-POPULATION; CANCER RISK; HUMAN-CELLS; DAMAGE; MOUSE; SUBSTRATE; POLYMORPHISMS	Human N-methylpurine DNA glycosylase (hMPG) initiates base excision repair of a number of structurally diverse purine bases including 1,N-6-ethenoadenine, hypoxanthine, and alkylation adducts in DNA. Genetic studies discovered at least eight validated non-synonymous single nucleotide polymorphisms (nsSNPs) of the hMPG gene in human populations that result in specific single amino acid substitutions. In this study, we tested the functional consequences of these nsSNPs of hMPG. Our results showed that two specific arginine residues, Arg-141 and Arg-120, are important for the activity of hMPG as the germ line variants R120C and R141Q had reduced enzymatic activity in vitro as well as in mammalian cells. Expression of these two variants in mammalian cells lacking endogenous MPG also showed an increase in mutations and sensitivity to an alkylating agent compared with the WT hMPG. Real time binding experiments by surface plasmon resonance spectroscopy suggested that these variants have substantial reduction in the equilibrium dissociation constant of binding( K-D) of hMPG toward 1,N-6-ethenoadenine- containing oligonucleotide (epsilon A-DNA). Pre-steady-state kinetic studies showed that the substitutions at arginine residues affected the turnover of the enzyme significantly under multiple turnover condition. Surface plasmon resonance spectroscopy further showed that both variants had significantly decreased nonspecific (undamaged) DNA binding. Molecular modeling suggested that R141Q substitution may have resulted in a direct loss of the salt bridge between epsilon A-DNA and hMPG, whereas R120C substitution redistributed, at a distance, the interactions among residues in the catalytic pocket. Together our results suggest that individuals carrying R120C and R141Q MPG variants may be at risk for genomic instability and associated diseases as a consequence.	[Adhikari, Sanjay; Chetram, Mahandranauth A.; Woodrick, Jordan; Mitra, Partha S.; Manthena, Praveen V.; Khatkar, Pooja; Dakshanamurthy, Sivanesan; Dixon, Monica; Karmahapatra, Soumendra K.; Nuthalapati, Nikhil K.; Gupta, Suhani; Narasimhan, Ganga; Loffredo, Christopher A.; Ueren, Aykut; Roy, Rabindra] Georgetown Univ, Mol Oncol Program, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC 20057 USA; [Adhikari, Sanjay] Houston Methodist Hosp Res Inst, Canc Res Program, Houston, TX 77030 USA; [Mazumder, Raja] George Washington Univ, Dept Biochem & Mol Med, Washington, DC 20037 USA	Georgetown University; The Methodist Hospital System; The Methodist Hospital - Houston; George Washington University	Roy, R (corresponding author), Georgetown Univ, Mol Oncol Program, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC 20057 USA.	rr228@georgetown.edu	Khatkar, Pooja/GVT-3706-2022; Dakshanamurthy, Sivanesan/CAF-4258-2022	Dakshanamurthy, Sivanesan/0000-0003-3681-4121; khatkar, pooja/0000-0003-3842-5146; Mazumder, Raja/0000-0001-8823-9945	National Institutes of Health [P30CA51008]; NATIONAL CANCER INSTITUTE [R01CA113447, P30CA051008, T32CA009686, R01CA108641, R01CA092306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Veronica Rodriguez for technical help in surface plasmon resonance experiments performed at the Biacore Molecular Interaction Shared Resource of the Lombardi Comprehensive Cancer Center. The Biacore Molecular Interaction Shared Resource of the Lombardi Comprehensive Cancer Center is supported by National Institutes of Health Grant P30CA51008.	Adhikari S, 2008, ANTI-CANCER AGENT ME, V8, P351, DOI 10.2174/187152008784220366; Adhikari S, 2008, PROTEIN EXPRES PURIF, V58, P257, DOI 10.1016/j.pep.2007.12.001; Adhikari S, 2008, DNA REPAIR, V7, P31, DOI 10.1016/j.dnarep.2007.07.012; Adhikari S, 2007, J BIOL CHEM, V282, P30078, DOI 10.1074/jbc.M704051200; Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; Adhikari Sanjay, 2009, DNA Repair (Amst), V8, P1201, DOI 10.1016/j.dnarep.2009.06.005; Barbin A, 2000, MUTAT RES-REV MUTAT, V462, P55, DOI 10.1016/S1383-5742(00)00014-4; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Choudhury S, 2008, MOL CELL BIOCHEM, V313, P19, DOI 10.1007/s11010-008-9737-1; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; Dey S, 2012, DNA REPAIR, V11, P570, DOI 10.1016/j.dnarep.2012.03.005; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; Galick HA, 2013, P NATL ACAD SCI USA, V110, P14314, DOI 10.1073/pnas.1306752110; Godschalk R, 2002, CARCINOGENESIS, V23, P2081, DOI 10.1093/carcin/23.12.2081; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hanson RN, 2003, J MED CHEM, V46, P2865, DOI 10.1021/jm0205806; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Leitner-Dagan Y, 2012, JNCI-J NATL CANCER I, V104, P1765, DOI 10.1093/jnci/djs445; Levine RL, 2000, CANCER RES, V60, P4098; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Meira LB, 2009, P NATL ACAD SCI USA, V106, P888, DOI 10.1073/pnas.0807030106; Miao F, 2000, J BIOL CHEM, V275, P28433, DOI 10.1074/jbc.M001064200; Nair J, 2006, ANTIOXID REDOX SIGN, V8, P1003, DOI 10.1089/ars.2006.8.1003; Nyaga SG, 1997, BIOCHEMISTRY-US, V36, P4080, DOI 10.1021/bi962218x; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Paik J, 2005, CANCER RES, V65, P10472, DOI 10.1158/0008-5472.CAN-05-1495; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; ROY R, 1994, BIOCHEMISTRY-US, V33, P15131, DOI 10.1021/bi00254a024; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Roy R, 1996, CARCINOGENESIS, V17, P2177, DOI 10.1093/carcin/17.10.2177; Sambrook J., 2001, MOL CLONING LAB MANU; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Speina E, 2003, CANCER RES, V63, P4351; Tolentino JH, 2008, NUCLEIC ACIDS RES, V36, P1300, DOI 10.1093/nar/gkm1157; von Hippel PH, 2007, ANNU REV BIOPH BIOM, V36, P79, DOI 10.1146/annurev.biophys.34.040204.144521; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	43	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4966	4980		10.1074/jbc.M114.627000	http://dx.doi.org/10.1074/jbc.M114.627000			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538240	hybrid, Green Published			2022-12-28	WOS:000350042000039
J	Blancas-Mejia, LM; Hammernik, J; Marin-Argany, M; Ramirez-Alvarado, M				Blancas-Mejia, Luis M.; Hammernik, Jared; Marin-Argany, Marta; Ramirez-Alvarado, Marina			Differential Effects on Light Chain Amyloid Formation Depend on Mutations and Type of Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; DIMER INTERFACE; CONFORMATIONAL STABILITY; STRUCTURAL FEATURES; PROTEIN STABILITY; AL AMYLOIDOSIS; IMMUNOGLOBULIN; AGGREGATION; SULFATE; AMYLOIDOGENICITY	Amyloid light chain (AL) amyloidosis is a protein misfolding disease where immunoglobulin light chains sample partially folded states that lead to misfolding and amyloid formation, resulting in organ dysfunction and death. In vivo, amyloid deposits are found in the extracellular space and involve a variety of accessory molecules, such as glycosaminoglycans, one of the main components of the extracellular matrix. Glycosaminoglycans are a group of negatively charged heteropolysaccharides composed of repeating disaccharide units. In this study, we investigated the effect of glycosaminoglycans on the kinetics of amyloid fibril formation of three AL cardiac amyloidosis light chains. These proteins have similar thermodynamic stability but exhibit different kinetics of fibril formation. We also studied single restorative and reciprocal mutants and wild type germ line control protein. We found that the type of glycosaminoglycan has a different effect on the kinetics of fibril formation, and this effect seems to be associated with the natural propensity of each AL protein to form fibrils. Heparan sulfate accelerated AL-12, AL-09, kappa I Y87H, and AL-103 H92D fibril formation; delayed fibril formation for AL-103; and did not promote any fibril formation for AL-12 R65S, AL-103 delP95aIns, or kappa I O18/O8. Chondroitin sulfate A, on the other hand, showed a strong fibril formation inhibition for all proteins. We propose that heparan sulfate facilitates the formation of transient amyloidogenic conformations of AL light chains, thereby promoting amyloid formation, whereas chondroitin sulfate A kinetically traps partially unfolded intermediates, and further fibril elongation into fibrils is inhibited, resulting in formation/accumulation of oligomeric/protofibrillar aggregates.	[Blancas-Mejia, Luis M.; Marin-Argany, Marta; Ramirez-Alvarado, Marina] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ramirez-Alvarado, Marina] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Hammernik, Jared] Univ Illinois, Sch Mol & Cellular Biol, Urbana, IL 61801 USA	Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu		Ramirez-Alvarado, Marina/0000-0003-2325-6773; Argany, Meysam/0000-0001-6577-4443	National Institutes of Health [R01 GM 071514]; Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 071514. This work was also supported by the Mayo Foundation.	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Aguilera JJ, 2014, BIOCHIMIE, V104, P70, DOI 10.1016/j.biochi.2014.05.007; ALBINSSON B, 1992, J PHYS CHEM-US, V96, P6204, DOI 10.1021/j100194a023; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Dubrey SW, 1998, QJM-MON J ASSOC PHYS, V91, P141, DOI 10.1093/qjmed/91.2.141; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Fauerbach JA, 2012, BIOPHYS J, V102, P1127, DOI 10.1016/j.bpj.2012.01.051; Guerrero-Munoz MJ, 2014, BIOCHEM PHARMACOL, V88, P468, DOI 10.1016/j.bcp.2013.12.023; Hernandez-Santoyo A, 2010, J MOL BIOL, V396, P280, DOI 10.1016/j.jmb.2009.11.038; Hu DM, 2008, BIOCHEMISTRY-US, V47, P8665, DOI 10.1021/bi800806d; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Jiang XL, 1997, BIOCHEMISTRY-US, V36, P13187, DOI 10.1021/bi970408h; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kumar SK, 2011, AM J HEMATOL, V86, P251, DOI 10.1002/ajh.21948; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Martin DJ, 2011, BIOPHYS CHEM, V158, P81, DOI 10.1016/j.bpc.2011.05.011; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Merlini G, 2006, BLOOD, V108, P2520, DOI 10.1182/blood-2006-03-001164; NELSON SR, 1991, BIOCHEM J, V275, P67, DOI 10.1042/bj2750067; OHISHI H, 1990, CLIN CHEM, V36, P88; Peterson FC, 2010, STRUCTURE, V18, P563, DOI 10.1016/j.str.2010.02.012; Pokkuluri PR, 2002, PROTEIN SCI, V11, P1687, DOI 10.1110/ps.4920102; Poshusta TL, 2013, INT J MOL SCI, V14, P22604, DOI 10.3390/ijms141122604; Randles EG, 2009, J MOL BIOL, V389, P199, DOI 10.1016/j.jmb.2009.04.010; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; SCHORMANN N, 1995, P NATL ACAD SCI USA, V92, P9490, DOI 10.1073/pnas.92.21.9490; Seyrek E, 2010, ADV COLLOID INTERFAC, V158, P119, DOI 10.1016/j.cis.2010.03.001; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Sreerama N, 1999, BIOCHEMISTRY-US, V38, P10814, DOI 10.1021/bi990516z; Stevens FJ, 2000, CELL MOL LIFE SCI, V57, P441, DOI 10.1007/PL00000706; Trinkaus-Randall V, 2005, AM J PATHOL, V166, P197, DOI 10.1016/S0002-9440(10)62244-4; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8	50	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4953	4965		10.1074/jbc.M114.615401	http://dx.doi.org/10.1074/jbc.M114.615401			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538238	Green Published, hybrid			2022-12-28	WOS:000350042000038
J	Shalygin, A; Skopin, A; Kalinina, V; Zimina, O; Glushankova, L; Mozhayeva, GN; Kaznacheyeva, E				Shalygin, Alexey; Skopin, Anton; Kalinina, Vera; Zimina, Olga; Glushankova, Lyuba; Mozhayeva, Galina N.; Kaznacheyeva, Elena			STIM1 and STIM2 Proteins Differently Regulate Endogenous Store-operated Channels in HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA A431 CELLS; CALCIUM SENSORS STIM1; CA2+ ENTRY; PLASMA-MEMBRANE; FUNCTIONAL-PROPERTIES; TRPC CHANNELS; I-CRAC; ORAI1; ACTIVATION; INFLUX	The endoplasmic reticulum calcium sensors stromal interaction molecules 1 and 2 (STIM1 and STIM2) are key modulators of store-operated calcium entry. Both these sensors play a major role in physiological functions in normal tissue and in pathology, but available data on native STIM2-regulated plasma membrane channels are scarce. Only a few studies have recorded STIM2-induced CRAC (calcium release-activated calcium) currents. On the other hand, many cell types display store-operated currents different from CRAC. The STIM1 protein regulates not only CRAC but also transient receptor potential canonical (TRPC) channels, but it has remained unclear whether STIM2 is capable of regulating store-operated non-CRAC channels. Here we present for the first time experimental evidence for the existence of endogenous non-CRAC STIM2-regulated channels. As shown in single-channel patch clamp experiments on HEK293 cells, selective activation of native STIM2 proteins or STIM2 overexpression results in store-operated activation of I-min channels, whereas STIM1 activation blocks this process. Changes in the ratio between active STIM2 and STIM1 proteins can switch the regulation of I-min channels between store-operated and store-independent modes. We have previously characterized electrophysiological properties of different Ca2+ influx channels coexisting in HEK293 cells. The results of this study show that STIM1 and STIM2 differ in the ability to activate these store-operated channels; I-min channels are regulated by STIM2, TRPC3-containing I-NS channels are induced by STIM1, and TRPC1-composed I-max channels are activated by both STIM1 and STIM2. These new data about cross-talk between STIM1 and STIM2 and their different roles in store-operated channel activation are indicative of an additional level in the regulation of store-operated calcium entry pathways.	[Shalygin, Alexey; Skopin, Anton; Kalinina, Vera; Zimina, Olga; Glushankova, Lyuba; Mozhayeva, Galina N.; Kaznacheyeva, Elena] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Shalygin, A (corresponding author), Russian Acad Sci, Inst Cytol, 4 Tikhoretsky Ave, St Petersburg 194064, Russia.	a_shalygin@mail.ru; evkazn@incras.ru	Shalygin, Alexey V/Q-1361-2017; Kalinina, Vera/V-2408-2018; Glushankova, Lyubov/AAE-9361-2021; Kaznacheyeva, Elena V/I-7260-2017; Skopin, Anton Y/G-5457-2017	Shalygin, Alexey V/0000-0002-9896-1832; Kalinina, Vera/0000-0003-2053-5101; Glushankova, Lyubov/0000-0002-9995-1214; Kaznacheyeva, Elena V/0000-0003-1273-1188; Skopin, Anton/0000-0002-9693-0098	Russian Scientific Foundation [14-14-00720]; Russian Academy of Sciences; Scientific School Support Program [SS-1721.2014.4]; Dynasty Foundation; Russian Foundation for Basic Research; Russian Science Foundation [14-14-00720] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Academy of Sciences(Russian Academy of Sciences); Scientific School Support Program; Dynasty Foundation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Scientific Foundation, Project 14-14-00720 (to E. K. and A. S.); the program "Molecular and Cellular Biology" of the Russian Academy of Sciences (to G. N. M. and L. G.); the Scientific School Support Program, Project SS-1721.2014.4 (to G. N. M.); the Dynasty Foundation; and the Russian Foundation for Basic Research.	Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Antigny F, 2013, J CELL SCI, V126, P2525, DOI 10.1242/jcs.122911; Aytes A, 2012, MOL CARCINOGEN, V51, P746, DOI 10.1002/mc.20843; Bandyopadhyay BC, 2011, J LEUKOCYTE BIOL, V89, P57, DOI 10.1189/jlb.0610381; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Bojarski L, 2009, BBA-MOL CELL RES, V1793, P1050, DOI 10.1016/j.bbamcr.2008.11.008; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; Cheng KT, 2012, P NATL ACAD SCI USA, V109, P14544, DOI 10.1073/pnas.1207354109; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Darbellay B, 2010, J BIOL CHEM, V285, P22437, DOI 10.1074/jbc.M110.118984; Ercan E, 2009, TRAFFIC, V10, P1802, DOI 10.1111/j.1600-0854.2009.00995.x; Gruszczynska-Biegala J, 2013, J NEUROCHEM, V126, P727, DOI 10.1111/jnc.12320; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Gusev K, 2003, J GEN PHYSIOL, V122, P81, DOI 10.1085/jgp.200308815; Hooper JS, 2013, BRAIN RES, V1503, P7, DOI 10.1016/j.brainres.2013.02.002; Horinouchi T, 2012, BIOCHEM BIOPH RES CO, V428, P252, DOI 10.1016/j.bbrc.2012.10.034; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2009, BIOCHEM J, V420, P267, DOI 10.1042/BJ20082179; Kar P, 2012, P NATL ACAD SCI USA, V109, P6969, DOI 10.1073/pnas.1201204109; Kaznacheyeva E, 2000, J BIOL CHEM, V275, P4561, DOI 10.1074/jbc.275.7.4561; Kaznacheyeva E, 2001, P NATL ACAD SCI USA, V98, P148, DOI 10.1073/pnas.98.1.148; Kaznacheyeva E, 2007, J BIOL CHEM, V282, P23655, DOI 10.1074/jbc.M608378200; Kiselyov KI, 1999, PFLUG ARCH EUR J PHY, V437, P305, DOI 10.1007/s004240050784; Kiselyov KI, 1997, FEBS LETT, V407, P309, DOI 10.1016/S0014-5793(97)00366-9; Lee KP, 2014, J BIOL CHEM, V289, P6372, DOI 10.1074/jbc.M113.546556; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Ma HT, 2008, J IMMUNOL, V180, P2233, DOI 10.4049/jimmunol.180.4.2233; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Rao JN, 2012, AM J PHYSIOL-CELL PH, V303, pC308, DOI 10.1152/ajpcell.00120.2012; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ryazantseva M, 2013, BIOCHIMIE, V95, P1506, DOI 10.1016/j.biochi.2013.04.009; Saul S, 2014, EUR J PHARMACOL, V739, P49, DOI 10.1016/j.ejphar.2013.10.071; Schuhmann MK, 2010, J IMMUNOL, V184, P1536, DOI 10.4049/jimmunol.0902161; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Shalygin A, 2010, CELL CALCIUM, V48, P209, DOI 10.1016/j.ceca.2010.09.002; Skopin A, 2013, BIOCHIMIE, V95, P347, DOI 10.1016/j.biochi.2012.10.004; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Stanisz H, 2014, PIGM CELL MELANOMA R, V27, P442, DOI 10.1111/pcmr.12222; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Thiel M, 2013, J PHYSIOL-LONDON, V591, P1433, DOI 10.1113/jphysiol.2012.245399; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Weidinger C, 2013, EMBO MOL MED, V5, P1311, DOI 10.1002/emmm.201302989; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2; Zubov AI, 1999, J BIOL CHEM, V274, P25983, DOI 10.1074/jbc.274.37.25983	67	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4717	4727		10.1074/jbc.M114.601856	http://dx.doi.org/10.1074/jbc.M114.601856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533457	Green Published, hybrid			2022-12-28	WOS:000350042000015
J	Li, YT; Schmidt-Edelkraut, U; Poetz, F; Oliva, I; Mandl, C; Holzl-Wenig, G; Schonig, K; Bartsch, D; Ciccolini, F				Li, Yuting; Schmidt-Edelkraut, Udo; Poetz, Fabian; Oliva, Ilaria; Mandl, Claudia; Hoelzl-Wenig, Gabriele; Schoenig, Kai; Bartsch, Dusan; Ciccolini, Francesca			gamma-Aminobutyric A Receptor (GABA(A)R) Regulates Aquaporin 4 Expression in the Subependymal Zone RELEVANCE TO NEURAL PRECURSORS AND WATER EXCHANGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; BRAIN; AQP4; PHOSPHORYLATION; ASTROCYTES; ACTIVATION; MIGRATION; DIFFERENTIATION; PROLIFERATION; TRAFFICKING	Activation of gamma-aminobutyric A receptors (GABA(A)Rs) in the subependymal zone (SEZ) induces hyperpolarization and osmotic swelling in precursors, thereby promoting surface expression of the epidermal growth factor receptor (EGFR) and cell cycle entry. However, the mechanisms underlying the GABAergic modulation of cell swelling are unclear. Here, we show that GABA(A)Rs colocalize with the water channel aquaporin (AQP) 4 in prominin-1 immunopositive (P+) precursors in the postnatal SEZ, which include neural stem cells. GABA(A)R signaling promotes AQP4 expression by decreasing serine phosphorylation associated with the water channel. The modulation of AQP4 expression by GABA(A)R signaling is key to its effect on cell swelling and EGFR expression. In addition, GABA(A)R function also affects the ability of neural precursors to swell in response to an osmotic challenge in vitro and in vivo. Thus, the regulation of AQP4 by GABA(A)Rs is involved in controlling activation of neural stem cells and water exchange dynamics in the SEZ.	[Ciccolini, Francesca] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany; [Schoenig, Kai; Bartsch, Dusan] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Ciccolini, F (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Ciccolini@nbio.uni-heidelberg.de		Ciccolini, Francesca/0000-0002-7276-7361; Poetz, Fabian/0000-0002-5278-8931	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Aprea J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/816049; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Carmosino M, 2007, BIOL CELL, V99, P25, DOI 10.1042/BC200600068; Carrillo-Garcia C, 2010, MOL CELL NEUROSCI, V44, P318, DOI 10.1016/j.mcn.2010.04.003; Cavazzin C, 2006, GLIA, V53, P167, DOI 10.1002/glia.20256; Cesetti T, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00003; Cesetti T, 2011, STEM CELLS, V29, P307, DOI 10.1002/stem.573; Cesetti T, 2009, STEM CELLS, V27, P1443, DOI 10.1002/stem.74; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Johnstone SR, 2012, CIRC RES, V111, P201, DOI 10.1161/CIRCRESAHA.112.272302; Kadohira I, 2008, BIOCHEM BIOPH RES CO, V377, P463, DOI 10.1016/j.bbrc.2008.09.155; Khatri P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03803; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Mccoy ES, 2010, NEUROSCIENCE, V168, P971, DOI 10.1016/j.neuroscience.2009.09.020; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nase G, 2008, GLIA, V56, P895, DOI 10.1002/glia.20664; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nguyen L, 2003, J NEUROSCI, V23, P3278; Nicchia GP, 2008, GLIA, V56, P869, DOI 10.1002/glia.20661; Obernier K, 2011, STEM CELLS, V29, P1415, DOI 10.1002/stem.682; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Vicini S, 2008, J PHYSIOL-LONDON, V586, P3737, DOI 10.1113/jphysiol.2008.159046; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001	43	7	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4343	4355		10.1074/jbc.M114.618686	http://dx.doi.org/10.1074/jbc.M114.618686			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540202	Green Published, hybrid			2022-12-28	WOS:000349458400043
J	Tsuji, R; Koizumi, H; Aoki, D; Watanabe, Y; Sugihara, Y; Matsushita, Y; Fukushima, K; Fujiwara, D				Tsuji, Ryohei; Koizumi, Hideki; Aoki, Dan; Watanabe, Yuta; Sugihara, Yoshihiko; Matsushita, Yasuyuki; Fukushima, Kazuhiko; Fujiwara, Daisuke			Lignin-rich Enzyme Lignin (LREL), a Cellulase-treated Lignin-Carbohydrate Derived from Plants, Activates Myeloid Dendritic Cells via Toll-like Receptor 4 (TLR4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYCINNAMIC ACIDS; GENE-EXPRESSION; BARLEY; EXTRACT; COMPLEX; INDUCTION; ANTITUMOR; SYRINGYL; PROTEIN; WHEAT	Lignin-carbohydrates, one of the major cell wall components, are believed to be the structures that form chemical linkage between lignin and cell wall polysaccharides. Due to the molecular complexity of lignin-containing substances, their isolation and the assignment of their biological activities have so far remained a difficult task. Here, we extracted two lignin-containing carbohydrates, lignin-rich enzyme lignin (LREL) and pure enzyme lignin (PEL), from barley husk and demonstrated that they act as immune stimulators of dendritic cells (DCs), which are particularly important in linking innate and adaptive immunity. Thioacidolysis, acid hydrolysis, and mild alkali hydrolysis of both LREL and PEL revealed that their immunostimulatory activities depended on the lignin structure and/or content, neutral sugar content (especially the characteristic distribution of galactose and mannose), and presence of an ester bond. Furthermore, we showed that the immunostimulatory potency of the lignin-carbohydrate depended on its molecular weight and degree of polymerization. We also demonstrated that the LREL-induced activation of DCs was mediated via TLR4. Thus, LREL-induced increases in the expression levels of several cell surface marker proteins, production of inflammatory cytokines IL-12p40 and TNF-alpha, and activation and nuclear translocation of transcription factors, as was observed in the WT DCs, were completely abrogated in DCs derived from the TLR4(-/-) mice but not in DCs derived from the TLR2(-/-), TLR7(-/-), and TLR9(-/-) mice. We further demonstrated that LRELs isolated from other plant tissues also activated DCs. These immunostimulatory activities of lignin-carbohydrates, extracted from edible plant tissues, could have potential relevance in anti-infectious immunity and vaccine adjuvants.	[Tsuji, Ryohei; Koizumi, Hideki; Watanabe, Yuta; Sugihara, Yoshihiko; Fujiwara, Daisuke] Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Aoki, Dan; Matsushita, Yasuyuki; Fukushima, Kazuhiko] Nagoya Univ, Div Biol Mat Sci, Dept Biosphere Resources Sci, Grad Sch Bioagr Sci,Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Tsuji, R (corresponding author), Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Ryohei_Tsuji@kirin.co.jp	Matsushita, Yasuyuki/I-6924-2014; Aoki, Dan/I-6926-2014; Matsushita, Yasuyuki/AFN-3168-2022	Matsushita, Yasuyuki/0000-0003-1357-3927; Aoki, Dan/0000-0003-3696-4103				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; BACIC A, 1981, AUST J PLANT PHYSIOL, V8, P475, DOI 10.1071/PP9810475; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Bjorkman A., 1957, Svensk Papperstidning, V60, P243; Bjorkman A., 1956, SVEN PAPPERSTIDN, V59, P477, DOI DOI 10.1016/J.CHROMA.2003.08.046; Campbell MM, 1996, PLANT PHYSIOL, V110, P3, DOI 10.1104/pp.110.1.3; Choi EM, 2005, J MED FOOD, V8, P446, DOI 10.1089/jmf.2005.8.446; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; FINCHER GB, 1975, J I BREWING, V81, P116, DOI 10.1002/j.2050-0416.1975.tb03672.x; Fu SL, 2006, BIOCHEM BIOPH RES CO, V339, P137, DOI 10.1016/j.bbrc.2005.11.005; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Helm R. F., 1999, LIGNIN HIST BIOL MAT, P161; Hernanz D, 2001, J AGR FOOD CHEM, V49, P4884, DOI 10.1021/jf010530u; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; IIYAMA K, 1990, PHYTOCHEMISTRY, V29, P733, DOI 10.1016/0031-9422(90)80009-6; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawano M, 2010, IN VIVO, V24, P543; Kawano M, 2010, ANTICANCER RES, V30, P2567; Kelly G S, 1999, Altern Med Rev, V4, P96; Kishimoto T, 2010, J AGR FOOD CHEM, V58, P895, DOI 10.1021/jf9035172; Kushida T, 2011, ANTICANCER RES, V31, P1241; Leung MYK, 2004, GLYCOBIOLOGY, V14, P501, DOI 10.1093/glycob/cwh050; LUNDQUIST K, 1992, METHODS LIGNIN CHEM, P65; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; Okamoto M, 2004, CLIN DIAGN LAB IMMUN, V11, P483, DOI 10.1128/CDLI.11.3.483-495.2004; Olkku J, 2005, J AM SOC BREW CHEM, V63, P17, DOI 10.1094/ASBCJ-63-0017; Oscarsson M, 1996, J CEREAL SCI, V24, P161, DOI 10.1006/jcrs.1996.0049; Pitkanen L, 2008, J AGR FOOD CHEM, V56, P5069, DOI 10.1021/jf800315q; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Reale S, 2004, MASS SPECTROM REV, V23, P87, DOI 10.1002/mas.10072; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rolando C., 1992, METHODS LIGNIN CHEM, P334, DOI DOI 10.1007/978-3-642-74065-7_23; Russell JB, 2009, FEMS MICROBIOL ECOL, V67, P183, DOI 10.1111/j.1574-6941.2008.00633.x; Saito K, 2012, PLANT J, V69, P542, DOI 10.1111/j.1365-313X.2011.04811.x; Sakagami H, 2005, PHYTOCHEMISTRY, V66, P2108, DOI 10.1016/j.phytochem.2005.05.013; SAKAGAMI H, 1989, ANTICANCER RES, V9, P1593; Sakagami H., 2012, COMPENDIUM ESSAYS AL, DOI [10.5772/30449, DOI 10.5772/30449]; Sakagami H, 2010, PHARMACOL THERAPEUT, V128, P91, DOI 10.1016/j.pharmthera.2010.05.004; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; Sun RC, 2002, IND CROP PROD, V15, P179, DOI 10.1016/S0926-6690(01)00112-1; Sun RC, 2001, J AGR FOOD CHEM, V49, P5122, DOI 10.1021/jf010500r; Sun RC, 1998, J AGR FOOD CHEM, V46, P718, DOI 10.1021/jf9705532; SUZUKI H, 1990, AGR BIOL CHEM TOKYO, V54, P479, DOI 10.1080/00021369.1990.10869950; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vailhe MAB, 2000, J AGR FOOD CHEM, V48, P618, DOI 10.1021/jf9906329; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Yue FX, 2012, J AGR FOOD CHEM, V60, P922, DOI 10.1021/jf204481x; Zhong B, 2006, VIROLOGY, V352, P14, DOI 10.1016/j.virol.2006.04.029	55	12	15	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4410	4421		10.1074/jbc.M114.593673	http://dx.doi.org/10.1074/jbc.M114.593673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548274	Green Published, hybrid			2022-12-28	WOS:000349458400048
J	Aissaoui, H; Prevost, C; Boucharaba, A; Sanhadji, K; Bordet, JC; Negrier, C; Boukerche, H				Aissaoui, Hanaa; Prevost, Celia; Boucharaba, Ahmed; Sanhadji, Kamel; Bordet, Jean-Claude; Negrier, Claude; Boukerche, Habib			MDA-9/Syntenin Is Essential for Factor VIIa-induced Signaling, Migration, and Metastasis in Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED FACTOR-X; TISSUE FACTOR; SRC KINASE; COAGULATION; EXPRESSION; RECEPTORS; PROMOTES; PAXILLIN; MOTILITY; BINDING	Melanoma differentiation associated gene-9 (MDA-9), also known as syntenin, is a novel gene that positively regulates cancer cell motility, invasion, and metastasis through distinct biochemical and signaling pathways, but how MDA-9/syntenin is regulated in response to signals with the extracellular environment and promotes tumor progression is unclear. We now demonstrate that MDA-9/syntenin is dramatically up-regulated by a combination of rFVIIa and factor F(X) in malignant melanoma. Induction of MDA-9/syntenin in melanoma was found to occur in a thrombin-independent signaling pathway and involves the PAR-1/c-Src/Rho GTPases Rac1 and Cdc42/c-Jun N-terminal kinase axis resulting in the activation of paxillin, NF-kappa B, and matrix metalloproteinase-2 (MMP-2). MDA-9/syntenin physically interacts with c-Src through its PDZ binding motif following stimulation of melanoma cells with rFVIIa and FX. We also document that induction of this signaling pathway is required for TF.FVIIa.Xa-induced cell migration, invasion, and metastasis by melanoma cells. The present finding uncovers a novel role of MDA-9/syntenin as an important TF.FVIIa.Xa/PAR-1-regulated gene that initiates a signaling circuit essential for cell motility and invasion of metastatic melanoma. In these contexts, targeting TF.FVIIa.Xa and its relevant downstream targets such as MDA-9/syntenin, may represent a novel therapeutic strategy to control the evolution of neoplastic cells.	[Aissaoui, Hanaa; Prevost, Celia; Bordet, Jean-Claude; Negrier, Claude; Boukerche, Habib] Univ Lyon 1, INSERM, EA 4174, Oncohematol Unit, F-69372 Lyon, France; [Boucharaba, Ahmed] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Sanhadji, Kamel] Edouart Herriot Hosp, Transplantat & Clin Immunol Dept, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; CHU Lyon	Boukerche, H (corresponding author), INSERM, 7 Rue Guillaume Paradin, F-69372 Lyon 08, France.	habib.boukerche@univ-lyon1.fr		Negrier, Claude/0000-0003-3569-0366; Chamouard, Valerie/0000-0002-4443-1609	Ligue Nationale Contre le Cancer (Comites du rhone and Ardeche); French Association pour la Recherche sur le Cancer, ARC	Ligue Nationale Contre le Cancer (Comites du rhone and Ardeche); French Association pour la Recherche sur le Cancer, ARC(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from the Ligue Nationale Contre le Cancer (Comites du rhone and Ardeche) (to H. B.) and the French Association pour la Recherche sur le Cancer, ARC (to H. B.).	Abouzahr-Rifai S, 2008, J BIOL CHEM, V283, P31665, DOI 10.1074/jbc.M800078200; ALTIERI DC, 1988, J BIOL CHEM, V263, P7007; Amarzguioui M, 2006, CLIN CANCER RES, V12, P4055, DOI 10.1158/1078-0432.CCR-05-2482; BACH RR, 1988, CRC CR REV BIOCH MOL, V23, P339, DOI 10.3109/10409238809082548; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BLADBJERG EM, 1995, SCAND J CLIN LAB INV, V55, P267, DOI 10.3109/00365519509089623; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2010, ONCOGENE, V29, P3054, DOI 10.1038/onc.2010.65; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; BROMBERG ME, 1995, P NATL ACAD SCI USA, V92, P8205, DOI 10.1073/pnas.92.18.8205; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Conn EM, 2008, J BIOL CHEM, V283, P26518, DOI 10.1074/jbc.M803337200; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Das SK, 2012, FRONT BIOSCI-LANDMRK, V17, P1, DOI 10.2741/3911; Dasgupta S, 2013, CLIN CANCER RES, V19, P4621, DOI 10.1158/1078-0432.CCR-13-0585; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Depasquale I, 2008, HISTOPATHOLOGY, V52, P500, DOI 10.1111/j.1365-2559.2008.02978.x; Durrant JD, 2010, J MOL RECOGNIT, V23, P173, DOI 10.1002/jmr.989; Ettelaie C, 2007, ATHEROSCLEROSIS, V194, P88, DOI 10.1016/j.atherosclerosis.2006.10.010; Falanga A, 2013, J THROMB HAEMOST, V11, P223, DOI 10.1111/jth.12075; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Gangemi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029989; GNONI GV, 1985, BIOCHEM BIOPH RES CO, V128, P525, DOI 10.1016/0006-291X(85)90078-6; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Hahn N, 2012, J CANCER RES CLIN, V138, P695, DOI 10.1007/s00432-011-1139-1; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jiang X, 2004, J THROMB HAEMOST, V2, P93, DOI 10.1111/j.1538-7836.2004.00545.x; Jung ID, 2002, FEBS LETT, V532, P351, DOI 10.1016/S0014-5793(02)03698-0; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Koizume S, 2006, CANCER RES, V66, P9453, DOI 10.1158/0008-5472.CAN-06-1803; Lin JJ, 1998, GENE, V207, P105, DOI 10.1016/S0378-1119(97)00562-3; McEachron TA, 2010, BLOOD, V116, P5037, DOI 10.1182/blood-2010-06-293126; MUELLER BM, 1992, P NATL ACAD SCI USA, V89, P11832, DOI 10.1073/pnas.89.24.11832; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Pendurthi UR, 1997, P NATL ACAD SCI USA, V94, P12598, DOI 10.1073/pnas.94.23.12598; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Plantier JL, 2010, J THROMB HAEMOST, V8, P286, DOI 10.1111/j.1538-7836.2009.03675.x; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; RICKLES FR, 1995, THROMB HAEMOSTASIS, V74, P391; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Sarkar D, 2008, CANCER RES, V68, P3087, DOI 10.1158/0008-5472.CAN-07-6210; Shi XL, 2004, MOL CANCER RES, V2, P395; Silini A, 2010, CLIN EXP METASTAS, V27, P43, DOI 10.1007/s10585-009-9301-8; Velasco-Velazquez MA, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-8; Villares GJ, 2009, CANCER RES, V69, P6730, DOI 10.1158/0008-5472.CAN-09-0300; WILDGOOSE P, 1990, P NATL ACAD SCI USA, V87, P7290, DOI 10.1073/pnas.87.18.7290; Yamauchi J, 2002, FEBS LETT, V527, P284, DOI 10.1016/S0014-5793(02)03231-3; ZACHARSKI LR, 1992, SEMIN THROMB HEMOST, V18, P104, DOI 10.1055/s-2007-1002415; ZACHARSKI LR, 1991, THROMB HAEMOSTASIS, V65, P545	53	7	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3333	3348		10.1074/jbc.M114.606913	http://dx.doi.org/10.1074/jbc.M114.606913			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505176	Green Published, hybrid			2022-12-28	WOS:000349456000012
J	Park, H; Huang, X; Lu, CM; Cairo, MS; Zhou, XZ				Park, Haein; Huang, Xin; Lu, Changming; Cairo, Mitchell S.; Zhou, Xianzheng			MicroRNA-146a and MicroRNA-146b Regulate Human Dendritic Cell Apoptosis and Cytokine Production by Targeting TRAF6 and IRAK1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cytokine; Dendritic Cell; Differentiation; MicroRNA (miRNA); NF-kappa B (NF-B); TNF Receptor-associated Factor (TRAF); IL-1 Receptor-associated Kinases (IRAK); miR-146	NF-KAPPA-B; T-CELL; IMMUNE-RESPONSE; ACTIVATION; EXPRESSION; MATURATION; MIR-146A; CANCER; MICE; INTERLEUKIN-12	Background: MicroRNA (miR)-146a and miR-146b (miR-146a/b) expression is induced upon human monocyte differentiation into dendritic cells (DCs). Results: miR-146a/b negatively regulates DC apoptosis and cytokine production. Conclusion: The miR-146a/b-TRAF6/IRAK1-NF-B axis is responsible for DC apoptosis. Significance: Our data reveal a novel negative feedback regulation in DCs and may have implications in the pathogenesis and treatment of autoimmune diseases. We have previously reported 27 differentially expressed microRNAs (miRNAs) during human monocyte differentiation into immature dendritic cells (imDCs) and mature DCs (mDCs). However, their roles in DC differentiation and function remain largely elusive. Here, we report that microRNA (miR)-146a and miR-146b modulate DC apoptosis and cytokine production. Expression of miR-146a and miR-146b was significantly increased upon monocyte differentiation into imDCs and mDCs. Silencing of miR-146a and/or miR-146b in imDCs and mDCs significantly prevented DC apoptosis, whereas overexpressing miR-146a and/or miR-146b increased DC apoptosis. miR-146a and miR-146b expression in imDCs and mDCs was inversely correlated with TRAF6 and IRAK1 expression. Furthermore, siRNA silencing of TRAF6 and/or IRAK1 in imDCs and mDCs enhanced DC apoptosis. By contrast, lentivirus overexpression of TRAF6 and/or IRAK1 promoted DC survival. Moreover, silencing of miR-146a and miR-146b expression had little effect on DC maturation but enhanced IL-12p70, IL-6, and TNF- production as well as IFN- production by IL-12p70-mediated activation of natural killer cells, whereas miR-146a and miR-146b overexpression in mDCs reduced cytokine production. Silencing of miR-146a and miR-146b in DCs also down-regulated NF-B inhibitor IB and increased Bcl-2 expression. Our results identify a new negative feedback mechanism involving the miR-146a/b-TRAF6/IRAK1-NF-B axis in promoting DC apoptosis.	[Park, Haein; Huang, Xin; Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Pediat, Div Hematol Oncol & Stem Cell Transplantat, Valhalla, NY 10595 USA; [Park, Haein; Huang, Xin; Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Cairo, Mitchell S.; Zhou, Xianzheng] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Cairo, Mitchell S.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Cairo, Mitchell S.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Lu, Changming] Univ Alabama Birmingham, Sch Dent, Inst Oral Hlth, Birmingham, AL 35233 USA	New York Medical College; New York Medical College; New York Medical College; New York Medical College; New York Medical College; University of Alabama System; University of Alabama Birmingham	Zhou, XZ (corresponding author), New York Med Coll, 40 Sunshine Cottage Rd,Vosburgh Pavil,Rm 320, Valhalla, NY 10595 USA.	xianzheng_zhou@nymc.edu			National Institutes of Health [AI092220]; Pediatric Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI092220 (to X. Z.). This work was also supported by the Pediatric Cancer Research Foundation (to M. S. C.).	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baseler WA, 2012, AM J PHYSIOL-CELL PH, V303, pC1244, DOI 10.1152/ajpcell.00137.2012; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Chen M, 2010, IMMUNOL REV, V236, P11, DOI 10.1111/j.1600-065X.2010.00916.x; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hong JA, 2004, J IMMUNOL, V172, P5870, DOI 10.4049/jimmunol.172.10.5870; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huang X, 2008, MOL THER, V16, P580, DOI 10.1038/sj.mt.6300404; Jiang H, 2009, EXP HEMATOL, V37, P1201, DOI 10.1016/j.exphem.2009.07.010; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Karrich JJ, 2013, BLOOD, V122, P3001, DOI 10.1182/blood-2012-12-475087; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim HJ, 2010, VACCINE, V28, P2877, DOI 10.1016/j.vaccine.2010.01.061; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Lanzavecchia A, 2004, NAT IMMUNOL, V5, P1201, DOI 10.1038/ni1204-1201; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van de Laar L, 2010, J IMMUNOL, V185, P7252, DOI 10.4049/jimmunol.1000672; vanKooten C, 1997, CURR OPIN IMMUNOL, V9, P330, DOI 10.1016/S0952-7915(97)80078-7; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zhou XZ, 2003, HUM GENE THER, V14, P1089, DOI 10.1089/104303403322124800	45	171	190	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2831	2841		10.1074/jbc.M114.591420	http://dx.doi.org/10.1074/jbc.M114.591420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505246	hybrid, Green Published			2022-12-28	WOS:000349310700024
J	Gheinani, AH; Burkhard, FC; Rehrauer, H; Fournier, CA; Monastyrskaya, K				Gheinani, Ali Hashenni; Burkhard, Fiona C.; Rehrauer, Hubert; Fournier, Catharine Aquino; Monastyrskaya, Katia			MicroRNA MiR-199a-5p Regulates Smooth Muscle Cell Proliferation and Morphology by Targeting WNT2 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER PAIN SYNDROME; DOWN-REGULATION; MYOGENIC DIFFERENTIATION; STEM-CELLS; EXPRESSION; MYOCARDIN; FIBROSIS; DISEASE; CANCER; PATHOGENESIS	MicroRNA miR-199a-5p impairs tight junction formation, leading to increased urothelial permeability in bladder pain syndrome. Now, using transcriptome analysis in urothelial TEU-2 cells, we implicate it in the regulation of cell cycle, cytoskeleton remodeling, TGF, and WNT signaling pathways. MiR-199a-5p is highly expressed in the smooth muscle layer of the bladder, and we altered its levels in bladder smooth muscle cells (SMCs) to validate the pathway analysis. Inhibition of miR-199a-5p with antimiR increased SMC proliferation, reduced cell size, and upregulated miR-199a-5p targets, including WNT2. Overexpression of WNT2 protein or treating SMCs with recombinant WNT2 closely mimicked the miR-199a-5p inhibition, whereas down-regulation of WNT2 in antimiR-expressing SMCs with shRNA restored cell phenotype and proliferation rates. Overexpression of miR-199a-5p in the bladder SMCs significantly increased cell size and up-regulated SM22, SM a-actin, and SM myosin heavy chain mRNA and protein levels. These changes as well as increased expression of ACTG2, TGFB111, and CDKN1A were mediated by up-regulation of the smooth muscle-specific transcriptional activator myocardin at mRNA and protein levels. Myocardin-related transcription factor A downstream targets Id3 and MYL9 were also induced. Up-regulation of myocardin was accompanied by down-regulation of WNT-dependent inhibitory Kruppel-like transcription factor 4 in miR-199a-5p-overexpressing cells. In contrast, Kruppel-like transcription factor 4 was induced in antimiR-expressing cells following the activation of WNT2 signaling, leading to repression of myocardin-dependent genes. MiR-199a-5p plays a critical role in the processes in the smooth muscle and may behave as a key modulator of smooth muscle hypertrophy, which is relevant for organ remodeling.	[Gheinani, Ali Hashenni; Monastyrskaya, Katia] Univ Bern, Dept Clin Res, Urol Res Lab, CH-3010 Bern, Switzerland; [Burkhard, Fiona C.] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland; [Rehrauer, Hubert; Fournier, Catharine Aquino] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Monastyrskaya, K (corresponding author), Univ Bern, Dept Clin Res, Urol Res Lab, Murtenstr 35, CH-3010 Bern, Switzerland.	monastyk@dkf.unibe.ch	Gheinani, Ali Hashemi/L-2929-2019; Hashemi Gheinani, Ali/I-5148-2013; Burkhard, Fiona/AAE-4524-2020	Hashemi Gheinani, Ali/0000-0002-9625-6259; Aquino, Catharine/0000-0002-3600-9862; Monastyrskaya, Katia/0000-0003-2042-1139; Burkhard, Fiona/0000-0002-8271-014X	Swiss National Science Foundation [320030_135783]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 320030_135783 (to K. M.).	Adam RM, 2006, NEPHRON EXP NEPHROL, V102, pE1, DOI 10.1159/000088310; Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Applebaum M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0053-9; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bowen T, 2013, J PATHOL, V229, P274, DOI 10.1002/path.4119; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chacko S, 2004, SCAND J UROL NEPHROL, V38, P26, DOI 10.1080/03008880410015147; Chan YC, 2012, J BIOL CHEM, V287, P41032, DOI 10.1074/jbc.M112.413294; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Ekman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082308; Freire VS, 2011, BJU INT, V108, pE126, DOI 10.1111/j.1464-410X.2010.09934.x; Freire VS, 2010, AM J PATHOL, V176, P288, DOI 10.2353/ajpath.2010.090552; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gheinani AH, 2013, CELL MOL LIFE SCI, V70, P3773, DOI 10.1007/s00018-013-1275-7; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; Hsu CY, 2014, J PATHOL, V232, P330, DOI 10.1002/path.4295; Hu YB, 2014, DIGEST DIS SCI, V59, P2163, DOI 10.1007/s10620-014-3136-0; Hypolite JA, 2006, J UROLOGY, V175, P777, DOI 10.1016/S0022-5347(05)00138-2; Imamura M, 2013, J CELL PHYSIOL, V228, P1819, DOI 10.1002/jcp.24333; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Kropp BP, 1999, J UROLOGY, V162, P1779, DOI 10.1016/S0022-5347(05)68237-7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lu TY, 2013, J MOL CELL CARDIOL, V63, P146, DOI 10.1016/j.yjmcc.2013.07.019; Luo XG, 2014, CANCER LETT, V344, P129, DOI 10.1016/j.canlet.2013.10.026; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Mohamed JS, 2013, J BIOL CHEM, V288, P24560, DOI 10.1074/jbc.M112.434423; Monastyrskaya K, 2013, AM J PATHOL, V182, P431, DOI 10.1016/j.ajpath.2012.10.020; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Myers JB, 2009, J UROLOGY, V181, P1926, DOI 10.1016/j.juro.2008.11.077; Onizuka T, 2012, J MOL CELL CARDIOL, V52, P650, DOI 10.1016/j.yjmcc.2011.11.010; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rickard A, 2008, IN VITRO CELL DEV-AN, V44, P261, DOI 10.1007/s11626-008-9116-y; Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Sasaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075010; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Slobodov G, 2004, J UROLOGY, V171, P1554, DOI 10.1097/01.ju.0000118938.09119.a5; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; UEKI N, 1987, P NATL ACAD SCI USA, V84, P9049, DOI 10.1073/pnas.84.24.9049; Wang H, 2007, J BIOL CHEM, V282, P782, DOI 10.1074/jbc.M606610200; Wilmott JS, 2011, PATHOLOGY, V43, P657, DOI 10.1097/PAT.0b013e32834a7358; Wu ZY, 2014, GENET MOL RES, V13, P2727, DOI 10.4238/2014.April.14.2; Yang J, 2013, AM J PHYSIOL-LUNG C, V305, pL312, DOI 10.1152/ajplung.00054.2013; Zhang S, 2012, AM J PATHOL, V181, P937, DOI 10.1016/j.ajpath.2012.05.035; Zhang XM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-15; Zheng XL, 2014, ARCH BIOCHEM BIOPHYS, V543, P48, DOI 10.1016/j.abb.2013.12.015	59	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7067	7086		10.1074/jbc.M114.618694	http://dx.doi.org/10.1074/jbc.M114.618694			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25596533	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000350991500039
J	Gupte, TM; Haque, F; Gangadharan, B; Sunitha, MS; Mukherjee, S; Anandhan, S; Rani, DS; Mukundan, N; Jambekar, A; Thangaraj, K; Sowdhamini, R; Sommese, RF; Nag, S; Spudich, JA; Mercer, JA				Gupte, Tejas M.; Haque, Farah; Gangadharan, Binnu; Sunitha, Margaret S.; Mukherjee, Souhrid; Anandhan, Swetha; Rani, Deepa Selvi; Mukundan, Namita; Jambekar, Amruta; Thangaraj, Kumarasanny; Sowdhamini, Ramanathan; Sommese, Ruth F.; Nag, Suman; Spudich, James A.; Mercer, John A.			Mechanistic Heterogeneity in Contractile Properties of alpha-Tropomyosin (TPM1) Mutants Associated with Inherited Cardiomyopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL DILATED CARDIOMYOPATHY; THIN FILAMENT MUTATIONS; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC TROPONIN; FORCE GENERATION; STRUCTURAL BASIS; BINDING-SITES; CA2+ BINDING; MUSCLE; MYOSIN	The most frequent known causes of primary cardiomyopathies are mutations in the genes encoding sarcomeric proteins. Among those are 30 single-residue mutations in TPM1, the gene encoding a-tropomyosin. We examined seven mutant tropomyosins, E62Q, D84N, I172T, L185R, S215L, D230N, and M281T, that were chosen based on their clinical severity and locations along the molecule. The goal of our study was to determine how the biochemical characteristics of each of these mutant proteins are altered, which in turn could provide a structural rationale for treatment of the cardiomyopathies they produce. Measurements of Ca2+ sensitivity of human beta-cardiac myosin ATPase activity are consistent with the hypothesis that hypertrophic cardiomyopathies are hypersensitive to Ca2+ activation, and dilated cardiomyopathies are hyposensitive. We also report correlations between ATPase activity at maximum Ca2+ concentrations and conformational changes in TnC measured using a fluorescent probe, which provide evidence that different substitutions perturb the structure of the regulatory complex in different ways. Moreover, we observed changes in protein stability and protein-protein interactions in these mutants. Our results suggest multiple mechanistic pathways to hypertrophic and dilated cardiomyopathies. Finally, we examined a computationally designed mutant, E181K, that is hypersensitive, confirming predictions derived from in silico structural analysis.	[Gupte, Tejas M.; Haque, Farah; Gangadharan, Binnu; Sunitha, Margaret S.; Mukherjee, Souhrid; Anandhan, Swetha; Jambekar, Amruta; Spudich, James A.; Mercer, John A.] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India; [Haque, Farah; Sunitha, Margaret S.; Mukundan, Namita; Jambekar, Amruta; Sowdhamini, Ramanathan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Gangadharan, Binnu] Manipal Univ, Manipal 576104, Karnataka, India; [Rani, Deepa Selvi; Thangaraj, Kumarasanny] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India; [Sommese, Ruth F.; Nag, Suman; Spudich, James A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Mercer, John A.] McLaughlin Res Inst, Great Falls, MT 59405 USA	Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Manipal Academy of Higher Education (MAHE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Stanford University; McLaughlin Research Institute for Biomedical Sciences, Inc.	Mercer, JA (corresponding author), InStem NCBS TIFR, GKVK Post, Bellary Rd, Bangalore 560065, Karnataka, India.	jam@instem.res.in	Jambekar, Amruta/J-5939-2019; Haque, Farah/ABA-3956-2020	Jambekar, Amruta/0000-0002-0781-6104; Haque, Farah/0000-0002-5492-3164; Gupte, Tejas/0000-0001-7422-016X; GANGADHARAN, BINNU/0000-0002-5126-1089; Mercer, John/0000-0003-0307-4438; Anandhan, Swetha/0000-0001-9187-7921; Thangaraj, Kumarasamy/0000-0002-0075-0106; , Margaret Sunitha S/0000-0002-2751-9254	National Institutes of Health [GM33289, HL117138]; inStem (Department of Biotechnology, Government of India); Shanta Wadhwani Centre for Cardiac and Neural Research; Human Frontiers Science Program [RGP0054/2009-C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); inStem (Department of Biotechnology, Government of India); Shanta Wadhwani Centre for Cardiac and Neural Research; Human Frontiers Science Program(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33289 and HL117138 (to J. A. S.). This work was also supported by intramural grants from inStem (Department of Biotechnology, Government of India), the Shanta Wadhwani Centre for Cardiac and Neural Research, and program Grant RGP0054/2009-C from the Human Frontiers Science Program (to R. S. and J. A. S.).	Alves ML, 2010, J MOL CELL CARDIOL, V48, P834, DOI 10.1016/j.yjmcc.2010.01.003; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; Barua B, 2011, P NATL ACAD SCI USA, V108, P10150, DOI 10.1073/pnas.1101221108; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bing W, 2000, J MOL CELL CARDIOL, V32, P1489, DOI 10.1006/jmcc.2000.1182; Borovikov YS, 2009, BIOCHEM BIOPH RES CO, V381, P403, DOI 10.1016/j.bbrc.2009.02.054; Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200; COME PC, 1977, CIRCULATION, V55, P901, DOI 10.1161/01.CIR.55.6.901; Correa F, 2007, BIOPHYS J, V92, P2463, DOI 10.1529/biophysj.106.098541; Coulton AT, 2008, BIOCHEMISTRY-US, V47, P388, DOI 10.1021/bi701144g; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Desai R, 2015, J BIOL CHEM, V290, P1915, DOI 10.1074/jbc.M114.609743; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Golitsina N, 1997, BIOCHEMISTRY-US, V36, P4637, DOI 10.1021/bi962970y; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Greenfield NJ, 2002, BIOPHYS J, V83, P2754, DOI 10.1016/S0006-3495(02)75285-5; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Hitchcock-DeGregori SE, 2010, J STRUCT BIOL, V170, P319, DOI 10.1016/j.jsb.2009.12.013; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; Hodges RS, 2009, J MOL BIOL, V392, P747, DOI 10.1016/j.jmb.2009.07.039; Janco M, 2012, BIOCHEMISTRY-US, V51, P9880, DOI 10.1021/bi301323n; Jarraya M, 2012, NEUROMUSCULAR DISORD, V22, pS137, DOI 10.1016/j.nmd.2012.06.347; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Jongbloed RJ, 2003, J AM COLL CARDIOL, V41, P981, DOI 10.1016/S0735-1097(02)03005-X; Kalyva A, 2012, BIOCHEMISTRY-US, V51, P6388, DOI 10.1021/bi300340r; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kraft T, 2005, P NATL ACAD SCI USA, V102, P13861, DOI 10.1073/pnas.0504026102; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Li XC, 2012, BIOCHEM BIOPH RES CO, V424, P493, DOI 10.1016/j.bbrc.2012.06.141; Makhoul M, 2011, PEDIATR CARDIOL, V32, P215, DOI 10.1007/s00246-010-9843-1; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; MARON BJ, 1984, AM J CARDIOL, V53, P1087, DOI 10.1016/0002-9149(84)90643-X; Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Michele DE, 1999, NAT MED, V5, P1413; Michele DE, 2002, PHYSIOL GENOMICS, V9, P103, DOI 10.1152/physiolgenomics.00099.2001; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Murphy CT, 2001, NAT CELL BIOL, V3, P311, DOI 10.1038/35060110; Nallari P, 2010, ENVIRON MOL MUTAGEN, V51, P722; Ochala J, 2012, HUM MOL GENET, V21, P4473, DOI 10.1093/hmg/dds289; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Rao VS, 2011, J BIOL CHEM, V286, P24135, DOI 10.1074/jbc.M110.167957; Redwood C, 2013, J MUSCLE RES CELL M, V34, P285, DOI 10.1007/s10974-013-9358-5; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; Rieck DC, 2013, ARCH BIOCHEM BIOPHYS, V537, P198, DOI 10.1016/j.abb.2013.07.013; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Sanoudou D, 2005, PHYSIOL GENOMICS, V21, P131, DOI 10.1152/physiolgenomics.00259.2004; Sheehan KA, 2011, J MOL CELL CARDIOL, V50, P442, DOI 10.1016/j.yjmcc.2010.10.032; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; Smith L, 2009, BIOPHYS J, V96, P3692, DOI 10.1016/j.bpj.2009.02.018; Sommese RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083403; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Margaret SM, 2012, BIOINFORM BIOL INSIG, V6, P203, DOI 10.4137/BBI.S9798; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; van de Meerakker JBA, 2013, BBA-MOL CELL RES, V1833, P833, DOI 10.1016/j.bbamcr.2012.11.003; Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF; Van Driest SL, 2002, AM J CARDIOL, V90, P1123, DOI 10.1016/S0002-9149(02)02780-7; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yar S, 2013, J BIOL CHEM, V288, P16235, DOI 10.1074/jbc.M113.458695; Zhou ZQ, 2012, J BIOL CHEM, V287, P7661, DOI 10.1074/jbc.M111.281600	70	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7003	7015		10.1074/jbc.M114.596676	http://dx.doi.org/10.1074/jbc.M114.596676			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25548289	Green Published, hybrid			2022-12-28	WOS:000350991500034
J	de la Parra, C; Borrero-Garcia, LD; Cruz-Collazo, A; Schneider, RJ; Dharmawardhane, S				de la Parra, Columba; Borrero-Garcia, Luis D.; Cruz-Collazo, Ailed; Schneider, Robert J.; Dharmawardhane, Suranganie			Equol, an Isoflavone Metabolite, Regulates Cancer Cell Viability and Protein Synthesis Initiation via c-Myc and eIF4G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; INTERNAL RIBOSOME ENTRY; OVARIECTOMIZED ATHYMIC MICE; INFLAMMATORY BREAST-CANCER; IN-VITRO; TRANSLATIONAL CONTROL; GENE-EXPRESSION; MESSENGER-RNAS; TUMOR-CELLS; GROWTH-FACTOR	Epidemiological studies implicate dietary soy isoflavones as breast cancer preventives, especially due to their anti-estrogenic properties. However, soy isoflavones may also have a role in promoting breast cancer, which has yet to be clarified. We previously reported that equol, a metabolite of the soy isoflavone daidzein, may advance breast cancer potential via up-regulation of the eukaryotic initiation factor 4GI (eIF4GI). In estrogen receptor negative (ER-) metastatic breast cancer cells, equol induced elevated levels of eIF4G, which were associated with increased cell viability and the selective translation of mRNAs that use non-canonical means of initiation, including internal ribosome entry site (IRES), ribosome shunting, and eIF4G enhancers. These mRNAs typically code for oncogenic, survival, and cell stress molecules. Among those mRNAs translationally increased by equol was the oncogene and eIF4G enhancer, c-Myc. Here we report that siRNA-mediated knockdown of c-Myc abrogates the increase in cancer cell viability and mammosphere formation by equol, and results in a significant down-regulation of eIF4GI (the major eIF4G isoform), as well as reduces levels of some, but not all, proteins encoded by mRNAs that are translationally stimulated by equol treatment. Knockdown of eIF4GI also markedly reduces an equol-mediated increase in IRES-dependent mRNA translation and the expression of specific oncogenic proteins. However, eIF4GI knockdown did not reciprocally affect c-Myc levels or cell viability. This study therefore implicates c-Myc as a potential regulator of the cancer-promoting effects of equol via up-regulation of eIF4GI and selective initiation of translation on mRNAs that utilize non-canonical initiation, including certain oncogenes.	[de la Parra, Columba; Borrero-Garcia, Luis D.; Cruz-Collazo, Ailed; Dharmawardhane, Suranganie] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [de la Parra, Columba; Schneider, Robert J.] NYU, Sch Med, Dept Microbiol & Radiat Oncol, Inst Canc, New York, NY 10016 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; New York University	Dharmawardhane, S (corresponding author), POB 365067, San Juan, PR 00936 USA.	su.d@upr.edu		Borrero-Garcia, Luis D/0000-0002-5256-7581; Schneider, Robert/0000-0001-5807-5564	United States Army/BCRP Grant [W81XWH-11-1-0199]; National Institutes of Health/NIGMS Grant [SC3GM084824]; National Institutes of Health/NIMHHD Grants [G12RR035051, R25GM061838]; Breast Cancer Research Foundation; Avon Foundation; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, SC3GM084824] Funding Source: NIH RePORTER	United States Army/BCRP Grant; National Institutes of Health/NIGMS Grant; National Institutes of Health/NIMHHD Grants; Breast Cancer Research Foundation; Avon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by United States Army/BCRP Grant W81XWH-11-1-0199 (to C. D.), National Institutes of Health/NIGMS Grant SC3GM084824 (to S. D.), National Institutes of Health/NIMHHD Grants G12RR035051 and R25GM061838 (to L. D. B.) to UPR MSC, and the Breast Cancer Research Foundation and Avon Foundation (to R. J. S.).	Avdulov S, 2015, CANCER RES, V75, P687, DOI 10.1158/0008-5472.CAN-14-2571; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Bauer C, 2002, INT J CANCER, V98, P181, DOI 10.1002/ijc.10180; Bolca S, 2007, J NUTR, V137, P2242, DOI 10.1093/jn/137.10.2242; Bosviel R, 2012, BRIT J NUTR, V108, P1187, DOI 10.1017/S000711451100657X; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Carreau C, 2009, MOL NUTR FOOD RES, V53, P652, DOI 10.1002/mnfr.200800061; Charalambous C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-238; Choi EJ, 2008, MOL MED REP, V1, P239; Choi EJ, 2009, CHEM-BIOL INTERACT, V177, P7, DOI 10.1016/j.cbi.2008.09.031; Cuesta R, 2009, PROG MOL BIOL TRANSL, V90, P255, DOI 10.1016/S1877-1173(09)90007-2; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Davison Z, 2011, NEOPLASIA, V13, P504, DOI 10.1593/neo.101590; de la Parra C, 2012, J BIOL CHEM, V287, P41640, DOI 10.1074/jbc.M112.393470; Douglas CC, 2013, ANTI-CANCER AGENT ME, V13, P1178, DOI 10.2174/18715206113139990320; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Frenzel Anna, 2010, Genes Cancer, V1, P660, DOI 10.1177/1947601910377488; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Haron H, 2011, INT J FOOD SCI NUTR, V62, P642, DOI 10.3109/09637486.2011.570742; Hilakivi-Clarke L, 2010, J NUTR, V140, p2326S, DOI 10.3945/jn.110.124230; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Ju YH, 2006, CARCINOGENESIS, V27, P856, DOI 10.1093/carcin/bgi320; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Lamartiniere CA, 2002, TOXICOL SCI, V65, P228, DOI 10.1093/toxsci/65.2.228; Lee T, 2012, FUTURE MED CHEM, V4, P19, DOI [10.4155/FMC.11.150, 10.4155/fmc.11.150]; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Liu HQ, 2010, J NUTR BIOCHEM, V21, P390, DOI 10.1016/j.jnutbio.2009.01.016; Liu XP, 2012, LIFE SCI, V91, P415, DOI 10.1016/j.lfs.2012.08.022; Magee PJ, 2006, NUTR CANCER, V54, P232, DOI 10.1207/s15327914nc5402_10; Magee PJ, 2004, CANCER LETT, V208, P35, DOI 10.1016/j.canlet.2003.11.012; Magklara A, 2000, BREAST CANCER RES TR, V59, P263, DOI 10.1023/A:1006304518750; Martinez-Montemayor MM, 2010, CLIN EXP METASTAS, V27, P465, DOI 10.1007/s10585-010-9336-x; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Montalvo-Ortiz BL, 2012, J BIOL CHEM, V287, P13228, DOI 10.1074/jbc.M111.334524; Moumen M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-132; Muthyala RS, 2004, BIOORGAN MED CHEM, V12, P1559, DOI 10.1016/j.bmc.2003.11.035; Nair R, 2014, ONCOGENE, V33, P3992, DOI 10.1038/onc.2013.368; Okabe Y, 2011, J SCI FOOD AGR, V91, P658, DOI 10.1002/jsfa.4228; Onoda A, 2011, FOOD CHEM TOXICOL, V49, P2279, DOI 10.1016/j.fct.2011.06.027; Park J, 2005, IMMUNOLOGY, V116, P71, DOI 10.1111/j.1365-2567.2005.02199.x; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P760, DOI 10.2741/3956; Poola I, 2000, J STEROID BIOCHEM, V72, P249, DOI 10.1016/S0960-0760(00)00033-9; Ramirez-Valle F., 2008, J CELL BIOL, V181, P293; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Silvera D, 2009, CELL CYCLE, V8, P3091, DOI 10.4161/cc.8.19.9637; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Taghizadeh B, 2015, BREAST CANCER-TOKYO, V22, P382, DOI 10.1007/s12282-013-0492-0; Tonetti DA, 2007, NUTR CANCER, V58, P222, DOI 10.1080/01635580701328545; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; WELSHONS WV, 1987, BREAST CANCER RES TR, V10, P169, DOI 10.1007/BF01810580; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2; Wolf E, 2015, TRENDS CELL BIOL, V25, P241, DOI 10.1016/j.tcb.2014.10.006; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Yi TF, 2014, ONCOTARGET, V5, P6028, DOI 10.18632/oncotarget.2112; Yi TF, 2013, J BIOL CHEM, V288, P18732, DOI 10.1074/jbc.M113.471466; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498	71	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6047	6057		10.1074/jbc.M114.617415	http://dx.doi.org/10.1074/jbc.M114.617415			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593313	hybrid, Green Published			2022-12-28	WOS:000350732500016
J	Neidel, S; de Motes, CM; Mansur, DS; Strnadova, P; Smith, GL; Graham, SC				Neidel, Sarah; de Motes, Carlos Maluquer; Mansur, Daniel S.; Strnadova, Pavla; Smith, Geoffrey L.; Graham, Stephen C.			Vaccinia Virus Protein A49 Is an Unexpected Member of the B-cell Lymphoma (Bcl)-2 Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BCL-2 FAMILY; BETA-TRCP; SEQUENCE SIMILARITY; N1L PROTEIN; ACTIVATION; VIRULENCE; COMPLEX; INHIBITOR; KINASE	Vaccinia virus (VACV) encodes several proteins that inhibit activation of the proinflammatory transcription factor nuclear factor kappa B (NF-kappa B). VACV protein A49 prevents translocation of NF-kappa B to the nucleus by sequestering cellular beta-TrCP, a protein required for the degradation of the inhibitor of kappa B. A49 does not share overall sequence similarity with any protein of known structure or function. We solved the crystal structure of A49 from VACV Western Reserve to 1.8 angstrom resolution and showed, surprisingly, that A49 has the same three-dimensional fold as Bcl-2 family proteins despite lacking identifiable sequence similarity. Whereas Bcl-2 family members characteristically modulate cellular apoptosis, A49 lacks a surface groove suitable for binding BH3 peptides and does not bind proapoptotic Bcl-2 family proteins Bax or Bak. The N-terminal 17 residues of A49 do not adopt a single well ordered conformation, consistent with their proposed role in binding beta-TrCP. Whereas pairs of A49 molecules interact symmetrically via a large hydrophobic surface in crystallo, A49 does not dimerize in solution or in cells, and we propose that this hydrophobic interaction surface may mediate binding to a yet undefined cellular partner. A49 represents the eleventh VACV Bcl-2 family protein and, despite these proteins sharing very low sequence identity, structure-based phylogenetic analysis shows that all poxvirus Bcl-2 proteins are structurally more similar to each other than they are to any cellular or herpesvirus Bcl-2 proteins. This is consistent with duplication and diversification of a single BCL2 family gene acquired by an ancestral poxvirus.	[Neidel, Sarah; de Motes, Carlos Maluquer; Strnadova, Pavla; Smith, Geoffrey L.; Graham, Stephen C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Mansur, Daniel S.] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, BR-88040900 Florianopolis, SC, Brazil	University of Cambridge; Universidade Federal de Santa Catarina (UFSC)	Graham, SC (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	scg34@cam.ac.uk	Mansur, Daniel/AAQ-8062-2020; de Motes, Carlos Maluquer/AAF-8092-2021	de Motes, Carlos Maluquer/0000-0003-4712-4601; Smith, Geoffrey L/0000-0002-3730-9955; Mansur, Daniel/0000-0001-6773-9334; Graham, Stephen/0000-0003-4547-4034	Wellcome Trust Principal Research Fellowship [090315]; Sir Henry Dale Fellowship - Wellcome Trust [098406/Z/12/Z]; Sir Henry Dale Fellowship - Royal Society [098406/Z/12/Z]; United Kingdom Medical Research Council [G1000099]; MRC [G1000099] Funding Source: UKRI; Medical Research Council [G1000099] Funding Source: researchfish	Wellcome Trust Principal Research Fellowship(Wellcome Trust); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Principal Research Fellowship 090315 (to G. L. S.), Sir Henry Dale Fellowship 098406/Z/12/Z, jointly funded by the Wellcome Trust and the Royal Society (to S. C. G.), and United Kingdom Medical Research Council Grant G1000099 (to David Stuart).	Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; de Motes CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002430; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; Ember SWJ, 2012, J GEN VIROL, V93, P2098, DOI 10.1099/vir.0.045070-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Fedosyuk S, 2014, J BIOL CHEM, V289, P3749, DOI 10.1074/jbc.M113.512756; Ferguson BJ, 2013, J GEN VIROL, V94, P2070, DOI 10.1099/vir.0.054114-0; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; Gerlic M, 2013, P NATL ACAD SCI USA, V110, P7808, DOI 10.1073/pnas.1215995110; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gonzalez JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-59; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Holyoak T, 2003, ACTA CRYSTALLOGR D, V59, P2356, DOI 10.1107/S0907444903021784; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; KOTWAL GJ, 1988, VIROLOGY, V167, P524, DOI 10.1016/S0042-6822(88)90115-8; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.436; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Lama D, 2010, BIOCHEMISTRY-US, V49, P2574, DOI 10.1021/bi100029k; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mansur DS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003183; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moss B, 2007, FIELDS VIROLOGY; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PICKUP DJ, 1984, P NATL ACAD SCI-BIOL, V81, P6817, DOI 10.1073/pnas.81.21.6817; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; Ravantti J, 2013, J STRUCT BIOL, V183, P47, DOI 10.1016/j.jsb.2013.05.007; ROSSMANN MG, 1976, J MOL BIOL, V105, P75, DOI 10.1016/0022-2836(76)90195-9; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; SMITH GL, 1991, J GEN VIROL, V72, P1349, DOI 10.1099/0022-1317-72-6-1349; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stack J, 2013, J BIOL CHEM, V288, P33642, DOI 10.1074/jbc.M113.485490; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Buuren N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004326; Veyer DL, 2014, J GEN VIROL, V95, P2757, DOI 10.1099/vir.0.068833-0; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walsh SR, 2011, EXPERT REV VACCINES, V10, P1221, DOI [10.1586/ERV.11.79, 10.1586/erv.11.79]; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Wang Y, 2013, J BIOL CHEM, V288, P35840, DOI 10.1074/jbc.M113.503680; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	84	34	35	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5991	6002		10.1074/jbc.M114.624650	http://dx.doi.org/10.1074/jbc.M114.624650			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605733	Green Published, hybrid			2022-12-28	WOS:000350732500005
J	Grosjean, K; Mongrand, S; Beney, L; Simon-Plas, F; Gerbeau-Pissot, P				Grosjean, Kevin; Mongrand, Sebastien; Beney, Laurent; Simon-Plas, Francoise; Gerbeau-Pissot, Patricia			Differential Effect of Plant Lipids on Membrane Organization SPECIFICITIES OF PHYTOSPHINGOLIPIDS AND PHYTOSTEROLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIANT UNILAMELLAR VESICLES; RESONANCE ENERGY-TRANSFER; LATERAL PHASE-SEPARATION; CHAIN BASE COMPOSITION; PROGRAMMED CELL-DEATH; LIQUID-ORDERED PHASES; PLASMA-MEMBRANE; MODEL MEMBRANES; COLD-ACCLIMATION; PHOSPHOLIPID-MEMBRANES	The high diversity of the plant lipid mixture raises the question of their respective involvement in the definition of membrane organization. This is particularly the case for plant plasma membrane, which is enriched in specific lipids, such as free and conjugated forms of phytosterols and typical phytosphingolipids, such as glycosylinositolphosphoceramides. This question was here addressed extensively by characterizing the order level of membrane from vesicles prepared using various plant lipid mixtures and labeled with an environment-sensitive probe. Fluorescence spectroscopy experiments showed that among major phytosterols, campesterol exhibits a stronger ability than beta-sitosterol and stigmasterol to order model membranes. Multispectral confocal microscopy, allowing spatial analysis of membrane organization, demonstrated accordingly the strong ability of campesterol to promote ordered domain formation and to organize their spatial distribution at the membrane surface. Conjugated sterol forms, alone and in synergy with free sterols, exhibit a striking ability to order membrane. Plant sphingolipids, particularly glycosylinositolphosphoceramides, enhanced the sterol-induced ordering effect, emphasizing the formation and increasing the size of sterol-dependent ordered domains. Altogether, our results support a differential involvement of free and conjugated phytosterols in the formation of ordered domains and suggest that the diversity of plant lipids, allowing various local combinations of lipid species, could be a major contributor to membrane organization in particular through the formation of sphingolipid-sterol interacting domains.	[Grosjean, Kevin; Gerbeau-Pissot, Patricia] Univ Bourgogne, CNRS, ERL 6300, Agroecol UMR1347, 17 Rue Sully,BP 86510, F-21065 Dijon, France; [Mongrand, Sebastien] CNRS, UMR 5200, LBM, F-33000 Villenave Dornon, France; [Mongrand, Sebastien] Univ Bordeaux, UMR 5200, LBM, F-33000 Villenave Dornon, France; [Beney, Laurent] AgroSup Dijon, Lab Proc Alimentaires & Microbiol, F-21000 Dijon, France; [Simon-Plas, Francoise] INRA, CNRS, Agroecol UMR1347, ERL 6300, F-21065 Dijon, France	Centre National de la Recherche Scientifique (CNRS); Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Gerbeau-Pissot, P (corresponding author), Univ Bourgogne, CNRS, ERL 6300, Agroecol UMR1347, 17 Rue Sully,BP 86510, F-21065 Dijon, France.	pgerbeau@dijon.inra.fr		Laurent, Beney/0000-0002-2757-2506	French Agence Nationale de la Recherche, program blanc, ANR "PANACEA" [NT09_517917]	French Agence Nationale de la Recherche, program blanc, ANR "PANACEA"(French National Research Agency (ANR))	This work was supported by the French Agence Nationale de la Recherche, program blanc, ANR "PANACEA" NT09_517917 (contracts to S. M. and F. S. P.) and platform Metabolome-Lipidome-Fluxome of Bordeaux (contribution toward lipid analysis equipment).	Aguilar LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040254; Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Almeida PF, 2011, BIOPHYS J, V100, P420, DOI 10.1016/j.bpj.2010.12.3694; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Ariola FS, 2009, BIOPHYS J, V96, P2696, DOI 10.1016/j.bpj.2008.12.3922; Arnqvist L, 2008, PLANTA, V227, P309, DOI 10.1007/s00425-007-0618-8; Bagatolli LA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00457; BARENHOLZ Y, 1980, BIOCHIM BIOPHYS ACTA, V604, P129, DOI 10.1016/0005-2736(80)90572-6; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V506, P265, DOI 10.1016/0005-2736(78)90397-8; Berglund AH, 2002, BBA-BIOMEMBRANES, V1564, P466, DOI 10.1016/S0005-2736(02)00498-4; Bonneau L, 2010, BBA-BIOMEMBRANES, V1798, P2150, DOI 10.1016/j.bbamem.2010.07.026; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BRUCKDORFER KR, 1968, EUR J BIOCHEM, V4, P512, DOI 10.1111/j.1432-1033.1968.tb00242.x; Bure C, 2014, ANAL BIOANAL CHEM, V406, P995, DOI 10.1007/s00216-013-7130-8; Bure C, 2011, RAPID COMMUN MASS SP, V25, P3131, DOI 10.1002/rcm.5206; Cacas JL, 2013, PHYTOCHEMISTRY, V96, P191, DOI 10.1016/j.phytochem.2013.08.002; Cacas JL, 2012, PROG LIPID RES, V51, P272, DOI 10.1016/j.plipres.2012.04.001; CARTER HE, 1958, J BIOL CHEM, V233, P1309; CARTER HE, 1969, J LIPID RES, V10, P363; Clarke JA, 2006, BIOPHYS J, V90, P2383, DOI 10.1529/biophysj.104.056499; de Joannis J, 2011, J AM CHEM SOC, V133, P3625, DOI 10.1021/ja110425s; DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V255, P311, DOI 10.1016/0005-2736(72)90030-2; DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V255, P321, DOI 10.1016/0005-2736(72)90031-4; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; DIMITROV DS, 1988, BIOELECTROCH BIOENER, V19, P323, DOI 10.1016/0302-4598(88)80013-8; Dinic J, 2013, BBA-BIOMEMBRANES, V1828, P1102, DOI 10.1016/j.bbamem.2012.12.004; Dinic J, 2011, BBA-BIOMEMBRANES, V1808, P298, DOI 10.1016/j.bbamem.2010.10.002; EDWARDS PA, 1972, FEBS LETT, V20, P97, DOI 10.1016/0014-5793(72)80026-7; Frazier ML, 2007, BIOPHYS J, V92, P2422, DOI 10.1529/biophysj.106.100107; FUJINO Y, 1985, AGR BIOL CHEM TOKYO, V49, P2753, DOI 10.1080/00021369.1985.10867139; Furl F., 2007, PLANT SIGNAL BEHAV, V2, P508; Gandhavadi M, 2002, BIOPHYS J, V82, P1469, DOI 10.1016/S0006-3495(02)75501-X; GEBHARDT C, 1977, Z NATURFORSCH C, V32, P581; Gerbeau-Pissot P, 2014, PLANT PHYSIOL, V164, P273, DOI 10.1104/pp.113.225755; GRANT CWM, 1974, BIOCHIM BIOPHYS ACTA, V363, P151, DOI 10.1016/0005-2736(74)90055-8; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; GUO DA, 1995, LIPIDS, V30, P203, DOI 10.1007/BF02537823; Halling KK, 2004, BBA-BIOMEMBRANES, V1664, P161, DOI 10.1016/j.bbamem.2004.05.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Heinz E., 1996, PLANT GLYCOLIPIDS ST, V3, P211; Henriksen J, 2006, BIOPHYS J, V90, P1639, DOI 10.1529/biophysj.105.067652; HSIEH TCY, 1981, J BIOL CHEM, V256, P7747; HSIEH TCY, 1978, BIOCHEMISTRY-US, V17, P3575, DOI 10.1021/bi00610a024; Islam MN, 2012, METABOLOMICS, V8, P598, DOI 10.1007/s11306-011-0352-x; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jimenez-Rojo N, 2014, BBA-BIOMEMBRANES, V1838, P456, DOI 10.1016/j.bbamem.2013.10.010; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; KAUL K, 1975, PLANT PHYSIOL, V55, P120, DOI 10.1104/pp.55.1.120; Kim K, 2013, P NATL ACAD SCI USA, V110, pE3054, DOI 10.1073/pnas.1303304110; Kovganko NV, 1999, CHEM NAT COMPD+, V35, P479, DOI 10.1007/BF02323277; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lefebvre B, 2007, PLANT PHYSIOL, V144, P402, DOI 10.1104/pp.106.094102; LENTZ BR, 1976, BIOCHEMISTRY-US, V15, P4529, DOI 10.1021/bi00665a030; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu P, 2009, PLANT J, V60, P303, DOI 10.1111/j.1365-313X.2009.03955.x; Lonnfors M, 2011, BIOPHYS J, V100, P2633, DOI 10.1016/j.bpj.2011.03.066; Lopez-Perez L, 2009, PHYTOCHEMISTRY, V70, P492, DOI 10.1016/j.phytochem.2009.01.014; LYNCH DV, 1987, PLANT PHYSIOL, V83, P761, DOI 10.1104/pp.83.4.761; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mannock DA, 2010, CHEM PHYS LIPIDS, V163, P403, DOI 10.1016/j.chemphyslip.2010.03.011; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; Marsh D, 2010, BBA-BIOMEMBRANES, V1798, P688, DOI 10.1016/j.bbamem.2009.12.027; MASSERINI M, 1988, BIOCHEMISTRY-US, V27, P7973, DOI 10.1021/bi00420a057; MASSERINI M, 1986, BIOCHEMISTRY-US, V25, P1043, DOI 10.1021/bi00353a014; MASSERINI M, 1989, BIOCHEMISTRY-US, V28, P5029, DOI 10.1021/bi00438a019; Menger FM, 1998, ACCOUNTS CHEM RES, V31, P789, DOI 10.1021/ar970103v; Millard AC, 2004, BIOPHYS J, V86, P1169, DOI 10.1016/S0006-3495(04)74191-0; Minami A, 2010, PLANT SIGNAL BEHAV, V5, P1115, DOI [10.4161/psb.5.9.12478, 10.4161/psb.5.9. 12478]; Minami A, 2009, PLANT CELL PHYSIOL, V50, P341, DOI 10.1093/pcp/pcn202; Mombelli E, 2003, BIOPHYS J, V84, P1507, DOI 10.1016/S0006-3495(03)74963-7; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; MUDD JB, 1980, PLANT PHYSIOL, V65, P78, DOI 10.1104/pp.65.1.78; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Ouimet J, 2004, LANGMUIR, V20, P7474, DOI 10.1021/la0491293; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Owen DM, 2010, MICROSC RES TECHNIQ, V73, P618, DOI 10.1002/jemt.20801; PALTA JP, 1993, PLANT PHYSIOL, V103, P793, DOI 10.1104/pp.103.3.793; Pandit SA, 2004, BIOPHYS J, V87, P1092, DOI 10.1529/biophysj.104.041939; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; PASCHER I, 1976, BIOCHIM BIOPHYS ACTA, V455, P433, DOI 10.1016/0005-2736(76)90316-3; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; PHILLIPS MC, 1970, CHEM PHYS LIPIDS, V4, P409, DOI 10.1016/0009-3084(70)90039-3; Pinto SN, 2013, BBA-BIOMEMBRANES, V1828, P2099, DOI 10.1016/j.bbamem.2013.05.011; Quartacci MF, 2002, J EXP BOT, V53, P2159, DOI 10.1093/jxb/erf076; Quinn PJ, 2010, PROG LIPID RES, V49, P390, DOI 10.1016/j.plipres.2010.05.002; Quinn PJ, 2009, BBA-BIOMEMBRANES, V1788, P33, DOI 10.1016/j.bbamem.2008.08.005; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; RANADIVE GN, 1987, BIOCHEMISTRY-US, V26, P2426, DOI 10.1021/bi00383a005; REINL H, 1992, BIOPHYS J, V61, P1025, DOI 10.1016/S0006-3495(92)81910-0; Roche Y, 2008, FASEB J, V22, P3980, DOI 10.1096/fj.08-111070; Roche Y, 2010, BBA-BIOMEMBRANES, V1798, P1601, DOI 10.1016/j.bbamem.2010.03.024; RUJANAVECH C, 1986, J BIOL CHEM, V261, P7204; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Schaller H, 2004, PLANT PHYSIOL BIOCH, V42, P465, DOI 10.1016/j.plaphy.2004.05.012; Scherfeld D, 2003, BIOPHYS J, V85, P3758, DOI 10.1016/S0006-3495(03)74791-2; SCHMIDT CF, 1977, BIOCHEMISTRY-US, V16, P2649, DOI 10.1021/bi00631a011; Schrick K, 2012, LIPIDS, V47, P185, DOI 10.1007/s11745-011-3602-9; SCHULER I, 1991, P NATL ACAD SCI USA, V88, P6926, DOI 10.1073/pnas.88.16.6926; SCHULER I, 1990, BIOCHIM BIOPHYS ACTA, V1028, P82, DOI 10.1016/0005-2736(90)90268-S; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; SHIMSHICK EJ, 1973, BIOCHEMISTRY-US, V12, P2351, DOI 10.1021/bi00736a026; Sonnino S, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00153; Spassieva SD, 2002, PLANT J, V32, P561, DOI 10.1046/j.1365-313X.2002.01444.x; Sperling P, 2005, PLANT PHYSIOL BIOCH, V43, P1031, DOI 10.1016/j.plaphy.2005.10.004; Stevens MM, 2010, SOFT MATTER, V6, P5882, DOI 10.1039/c0sm00373e; STILLWELL W, 1990, METHOD ENZYMOL, V189, P373; SUBBARAO NK, 1991, BIOCHIM BIOPHYS ACTA, V1063, P147, DOI 10.1016/0005-2736(91)90364-E; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; UEMURA M, 1994, PLANT PHYSIOL, V104, P479, DOI 10.1104/pp.104.2.479; Uline MJ, 2013, FARADAY DISCUSS, V161, P177, DOI 10.1039/c2fd20091k; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V291, P577, DOI 10.1016/0005-2736(73)90509-9; Wang KR, 2012, PLANT PHYSIOL, V158, P1789, DOI 10.1104/pp.111.189217; Wang WM, 2008, PLANT CELL, V20, P3163, DOI 10.1105/tpc.108.060053; WEBB MS, 1995, BBA-BIOMEMBRANES, V1239, P226, DOI 10.1016/0005-2736(95)00147-U; Wesolowska O, 2009, ACTA BIOCHIM POL, V56, P33; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; Wojciechowski Z. A., 1991, BIOCH PHYTOSTEROL CO	126	69	70	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5810	5825		10.1074/jbc.M114.598805	http://dx.doi.org/10.1074/jbc.M114.598805			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575593	Green Published, hybrid			2022-12-28	WOS:000350044200047
J	Makowska-Grzyska, M; Kim, Y; Maltseva, N; Osipiuk, J; Gu, MY; Zhang, MJ; Mandapati, K; Gollapalli, DR; Gorla, SK; Hedstrom, L; Joachimiak, A				Makowska-Grzyska, Magdalena; Kim, Youngchang; Maltseva, Natalia; Osipiuk, Jerzy; Gu, Minyi; Zhang, Minjia; Mandapati, Kavitha; Gollapalli, Deviprasad R.; Gorla, Suresh Kumar; Hedstrom, Lizbeth; Joachimiak, Andrzej			A Novel Cofactor-binding Mode in Bacterial IMP Dehydrogenases Explains Inhibitor Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; NICOTINAMIDE ADENINE-DINUCLEOTIDE; 5'-MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN; COMPLEX; INTEGRATION; MECHANISM; SUBSTRATE	The steadily rising frequency of emerging diseases and antibiotic resistance creates an urgent need for new drugs and targets. Inosine 5'-monophosphate dehydrogenase (IMP dehydrogenase or IMPDH) is a promising target for the development of new antimicrobial agents. IMPDH catalyzes the oxidation of IMP to XMP with the concomitant reduction of NAD(+), which is the pivotal step in the biosynthesis of guanine nucleotides. Potent inhibitors of bacterial IMPDHs have been identified that bind in a structurally distinct pocket that is absent in eukaryotic IMPDHs. The physiological role of this pocket was not understood. Here, we report the structures of complexes with different classes of inhibitors of Bacillus anthracis, Campylobacter jejuni, and Clostridium perfringens IMPDHs. These structures in combination with inhibition studies provide important insights into the interactions that modulate selectivity and potency. We also present two structures of the Vibrio cholerae IMPDH in complex with IMP/NAD(+) and XMP/NAD(+). In both structures, the cofactor assumes a dramatically different conformation than reported previously for eukaryotic IMPDHs and other dehydrogenases, with the major change observed for the position of the NAD(+) adenosine moiety. More importantly, this new NAD(+)-binding site involves the same pocket that is utilized by the inhibitors. Thus, the bacterial IMPDH-specific NAD(+) binding mode helps to rationalize the conformation adopted by several classes of prokaryotic IMPDH inhibitors. These findings offer a potential strategy for further ligand optimization.	[Makowska-Grzyska, Magdalena; Kim, Youngchang; Maltseva, Natalia; Osipiuk, Jerzy; Gu, Minyi; Joachimiak, Andrzej] Univ Chicago, Ctr Struct Genom Infect Dis, Chicago, IL 60637 USA; [Makowska-Grzyska, Magdalena; Kim, Youngchang; Maltseva, Natalia; Osipiuk, Jerzy; Gu, Minyi; Joachimiak, Andrzej] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Kim, Youngchang; Osipiuk, Jerzy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Zhang, Minjia; Mandapati, Kavitha; Gollapalli, Deviprasad R.; Gorla, Suresh Kumar; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Brandeis University; Brandeis University	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biol & Chem, 415 South St, Waltham, MA 02454 USA.	hedstrom@brandeis.edu; andrzejj@anl.gov		Kim, Youngchang/0000-0002-1610-4889; Joachimiak, Andrzej/0000-0003-2535-6209	United States Department of Energy, Office of Biological and Environmental Research under National Institutes of Health [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093459] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research under National Institutes of Health(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The use of Structural Biology Center beamlines was supported by the United States Department of Energy, Office of Biological and Environmental Research under National Institutes of Health Contract DE-AC02-06CH11357, Argonne, a United States Department of Energy Office of Science Laboratory, is operated under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBINI A, 1984, CHEM REV, V84, P43, DOI 10.1021/cr00059a004; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bell CE, 1997, PROTEIN SCI, V6, P2084; BROWN GB, 1964, BIOCHEMISTRY-US, V3, P880, DOI 10.1021/bi00895a002; Chen LQ, 2010, J MED CHEM, V53, P4768, DOI 10.1021/jm100424m; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felczak K, 2011, BIOORGAN MED CHEM, V19, P1594, DOI 10.1016/j.bmc.2011.01.042; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Giangreco I, 2013, J MED CHEM, V56, P6175, DOI 10.1021/jm400644z; Gollapalli DR, 2010, CHEM BIOL, V17, P1084, DOI 10.1016/j.chembiol.2010.07.014; Gorla SK, 2013, J MED CHEM, V56, P4028, DOI 10.1021/jm400241j; Gorla SK, 2012, J MED CHEM, V55, P7759, DOI 10.1021/jm3007917; Hedstrom L, 2011, CURR MED CHEM, V18, P1909, DOI 10.2174/092986711795590129; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Johnson CR, 2013, BIOORG MED CHEM LETT, V23, P1004, DOI 10.1016/j.bmcl.2012.12.037; Kerr KM, 2000, BIOCHEMISTRY-US, V39, P9804, DOI 10.1021/bi0005409; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; Kirubakaran S, 2012, BIOORG MED CHEM LETT, V22, P1985, DOI 10.1016/j.bmcl.2012.01.029; Kuppuraj G, 2011, J PHYS CHEM B, V115, P7932, DOI 10.1021/jp1118663; MacPherson IS, 2010, J AM CHEM SOC, V132, P1230, DOI 10.1021/ja909947a; Makowska-Grzyska M, 2012, BIOCHEMISTRY-US, V51, P6148, DOI 10.1021/bi300511w; Mandapati K, 2014, ACS MED CHEM LETT, V5, P846, DOI 10.1021/ml500203p; Maurya SK, 2009, J MED CHEM, V52, P4623, DOI 10.1021/jm900410u; Michael G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nimmesgern E, 1999, PROTEIN EXPRES PURIF, V17, P282, DOI 10.1006/prep.1999.1136; Pankiewicz KW, 2003, ACS SYM SER, V839, P1; Patton GC, 2011, NAT CHEM BIOL, V7, P950, DOI [10.1038/NCHEMBIO.693, 10.1038/nchembio.693]; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Prosise GL, 2003, J MOL BIOL, V326, P517, DOI 10.1016/S0022-2836(02)01383-9; Rao VA, 2013, ACTA CRYSTALLOGR F, V69, P243, DOI 10.1107/S1744309113002352; Riera TV, 2011, BIOCHEMISTRY-US, V50, P8508, DOI 10.1021/bi200785s; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Sharling L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000794; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Trzhtsinskaya B.V., 1991, SULFUR REP, V10, P389, DOI DOI 10.1080/01961779108048760; Umejiego NN, 2008, CHEM BIOL, V15, P70, DOI 10.1016/j.chembiol.2007.12.010; Usha V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033886; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; World Health Organization, 2013, GLOB TUB REP 2013, P45; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang RG, 1999, CURR MED CHEM, V6, P537	53	30	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5893	5911		10.1074/jbc.M114.619767	http://dx.doi.org/10.1074/jbc.M114.619767			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572472	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000350044200053
J	Palchetti, S; Starace, D; De Cesaris, P; Filippini, A; Ziparo, E; Riccioli, A				Palchetti, Sara; Starace, Donatella; De Cesaris, Paola; Filippini, Antonio; Ziparo, Elio; Riccioli, Anna			Transfected Poly(I:C) Activates Different dsRNA Receptors, Leading to Apoptosis or Immunoadjuvant Response in Androgen-independent Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ACID/CATIONIC LIPOSOME COMPLEX; NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; VIRUS INFECTION; UP-REGULATION; RECOGNITION; BETA; KINASE	Despite the effectiveness of surgery or radiation therapy for the treatment of early-stage prostate cancer (PCa), there is currently no effective strategy for late-stage disease. New therapeutic targets are emerging; in particular, dsRNA receptors Toll-like receptor 3 (TLR3) and cytosolic helicases expressed by cancer cells, once activated, exert a pro-apoptotic effect in different tumors. We previously demonstrated that the synthetic analog of dsRNA poly(I:C) induces apoptosis in the androgen-dependent PCa cell line LNCaP in a TLR3-dependent fashion, whereas only a weak apoptotic effect is observed in the more aggressive and androgen-independent PCa cells PC3 and DU145. In this paper, we characterize the receptors and the signaling pathways involved in the remarkable apoptosis induced by poly(I:C) transfected by Lipofectamine (in-poly(I:C)) compared with the 12-fold higher free poly(I:C) concentration in PC3 and DU145 cells. By using genetic inhibition of different poly(I:C) receptors, we demonstrate the crucial role of TLR3 and Src in in-poly(I:C)-induced apoptosis. Therefore, we show that the increased in-poly(I:C) apoptotic efficacy is due to a higher binding of endosomal TLR3. On the other hand, we show that in-poly(I:C) binding to cytosolic receptors MDA5 and RIG-I triggers IRF3-mediated signaling, leading uniquely to the up-regulation of IFN-beta, which likely in turn induces increased TLR3, MDA5, and RIG-I proteins. In summary, in-poly(I:C) activates two distinct antitumor pathways in PC3 and DU145 cells:one mediated by the TLR3/Src/STAT1 axis, leading to apoptosis, and the other one mediated by MDA5/RIG-I/IRF3, leading to immunoadjuvant IFN-beta expression.	[Palchetti, Sara; Starace, Donatella; Filippini, Antonio; Ziparo, Elio; Riccioli, Anna] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Med Embryol, Ist Pasteur Fdn Cenci Bolognetti, I-00161 Rome, Italy; [De Cesaris, Paola] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; University of L'Aquila	Starace, D (corresponding author), Univ Roma La Sapienza, DAHFMO Unit Histol & Med Embryol, Via Antonio Scarpa 16, I-00161 Rome, Italy.	donatella.starace@uniroma1.it; anna.riccioli@uniroma1.it	Palchetti, Sara/AAF-6645-2020	Palchetti, Sara/0000-0001-9582-953X; filippini, antonio/0000-0001-8453-287X; Ziparo, Elio/0000-0002-8776-3515; DE CESARIS, Paola/0000-0002-3802-9103	Italian Ministry of University and Research (MIUR) [prot.2010MCLPLB]; Fondazione Roma; Ricerca Scientifica Ateneo "Sapienza"	Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione Roma(Fondazione RomaEuropean Commission); Ricerca Scientifica Ateneo "Sapienza"	This work was supported by the Italian Ministry of University and Research (MIUR) Grant prot.2010MCLPLB, a grant from Fondazione Roma (to E. Z.), and Ricerca Scientifica Ateneo "Sapienza" 2014 (to E. Z.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alonso-Curbelo D, 2010, AUTOPHAGY, V6, P148, DOI 10.4161/auto.6.1.10464; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Chattopadhyay S, 2013, J VIROL, V87, P16, DOI 10.1128/JVI.01853-12; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Cheng YS, 2010, CANCER BIOL THER, V10, P1219, DOI 10.4161/cbt.10.12.13450; Chin AI, 2010, CANCER RES, V70, P2595, DOI 10.1158/0008-5472.CAN-09-1162; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; Dempoya J, 2012, J VIROL, V86, P12760, DOI 10.1128/JVI.01881-12; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Faraji AH, 2009, BIOORGAN MED CHEM, V17, P2950, DOI 10.1016/j.bmc.2009.02.043; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujii K, 2010, J PROTEOMICS, V73, P1196, DOI 10.1016/j.jprot.2010.02.009; Galli R, 2013, P NATL ACAD SCI USA, V110, P9812, DOI 10.1073/pnas.1304610110; Gambara G., 2014, J CELL MOL MED; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Gil J, 1999, MOL CELL BIOL, V19, P4653; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Harashima N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-217; Hertzog PJ, 2013, CYTOKINE GROWTH F R, V24, P217, DOI 10.1016/j.cytogfr.2013.04.002; Hirabayashi K, 1999, CANCER RES, V59, P4325; Hsieh MY, 2014, J BIOL CHEM, V289, P9208, DOI 10.1074/jbc.M113.508663; Inao T, 2012, BREAST CANCER RES TR, V134, P89, DOI 10.1007/s10549-011-1930-3; Into T, 2005, CELL MICROBIOL, V7, P1305, DOI 10.1111/j.1462-5822.2005.00558.x; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsushima-Miyagi T, 2012, CLIN CANCER RES, V18, P6271, DOI 10.1158/1078-0432.CCR-12-1595; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myskiw C, 2011, VIROLOGY, V413, P183, DOI 10.1016/j.virol.2011.01.034; Palchetti S, 2013, RSC ADV, V3, P24597, DOI 10.1039/c3ra44093a; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Paone A, 2010, NEOPLASIA, V12, P539, DOI 10.1593/neo.92106; Peng S, 2009, CANCER SCI, V100, P529, DOI 10.1111/j.1349-7006.2008.01062.x; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Qu J, 2013, INT IMMUNOPHARMACOL, V17, P814, DOI 10.1016/j.intimp.2013.08.013; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Uno T, 2005, MOL CANCER THER, V4, P799, DOI 10.1158/1535-7163.MCT-04-0317; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P1557, DOI 10.4161/onci.22428; Van DN, 2012, FASEB J, V26, P3188, DOI 10.1096/fj.11-202333; Vince JE, 2010, EMBO J, V29, P1627, DOI 10.1038/emboj.2010.79; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yount JS, 2007, J VIROL, V81, P7316, DOI 10.1128/JVI.00545-07; Zhou Y, 2013, INNATE IMMUN-LONDON, V19, P184, DOI 10.1177/1753425912459975	59	72	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5470	5483		10.1074/jbc.M114.601625	http://dx.doi.org/10.1074/jbc.M114.601625			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568326	Green Published, hybrid			2022-12-28	WOS:000350044200020
J	Ma, WJ; Ma, HQ; Fogerty, FJ; Mosher, DF				Ma, Wenjiang; Ma, Hanqing; Fogerty, Frances J.; Mosher, Deane F.			Bivalent Ligation of the Collagen-binding Modules of Fibronectin by SFS, a Non-anchored Bacterial Protein of Streptococcus equi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL UPSTREAM DOMAIN; LANCEFIELD GROUP-C; COOPERATIVE BINDING; STRUCTURAL-ANALYSIS; GENOME SEQUENCE; I COLLAGEN; SITES; PYOGENES; CLEAVAGE; IDENTIFICATION	SFS is a non-anchored protein of Streptococcus equi subspecies equi that causes upper respiratory infection in horses. SFS has been shown to bind to fibronectin (FN) and block interaction of FN with type I collagen. We have characterized interactions of a recombinant 60-mer polypeptide, R1R2, with FN. R1R2 contains two copies of collagen-like 19-residue repeats. Experiments utilizing various FN fragments and epitope-mapped anti-FN monoclonal antibodies located the binding site to 8-9FNI modules of the gelatin-binding domain. Fluorescence polarization and competitive enzyme-linked assays demonstrated that R1R2 binds preferentially to compact dimeric FN rather than monomeric constructs containing 8-9FNI or a large dimeric FN construct that is constitutively in an extended conformation. In contrast to bacterial peptides that bind 2-5FNI in addition to 8-9FNI, R1R2 did not cause conformational extension of FN as assessed by a conformationally sensitive antibody. Equilibrium and stopped-flow binding assays and size exclusion chromatography were compatible with a two-step binding reaction in which each of the repeats of R1R2 interacts with one of the subunits of dimeric FN, resulting in a stable complex with a slow k(off). In addition to not binding to type I collagen, the R1R2.FN complex incorporated less efficiently into extracellular matrix than free FN. Thus, R1R2 binds to FN utilizing features of compact soluble FN and in doing so interferes with the organization of the extracellular matrix. Asimilar bivalent binding strategy may underlie the collagen-FN interaction.	[Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	dfmosher@wisc.edu			National Institutes of Health [P01 HL088594, R01 HL021644]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594, R01HL021644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL088594. Reagents and ideas for these studies were developed with National Institutes of Health Grant R01 HL021644.	An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; BARNHAM M, 1987, EPIDEMIOL INFECT, V98, P183, DOI 10.1017/S0950268800061896; Beres SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003026; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; da Piedade I, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00683-13; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; FURCHT LT, 1980, J HISTOCHEM CYTOCHEM, V28, P1319, DOI 10.1177/28.12.7014712; Goodrich J. A., 2007, BINDING KINETICS MOL, P166; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Harris G, 2014, J BIOL CHEM, V289, P22490, DOI 10.1074/jbc.M114.578419; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Karlstrom A, 2006, VET MICROBIOL, V114, P72, DOI 10.1016/j.vetmic.2005.10.036; Lannergard J, 2005, INFECT IMMUN, V73, P7243, DOI 10.1128/IAI.73.11.7243-7251.2005; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; Lindmark H, 1996, INFECT IMMUN, V64, P3993, DOI 10.1128/IAI.64.10.3993-3999.1996; Ma Z, 2011, J BACTERIOL, V193, P5583, DOI 10.1128/JB.05700-11; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MENZEL J, 1983, COLLAGEN REL RES, V3, P217; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1979, J CLIN INVEST, V64, P781, DOI 10.1172/JCI109524; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Sevilla CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077316; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Timoney JF, 2008, EQUINE VET J, V40, P637, DOI 10.2746/042516408X322120; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2012, MATRIX BIOL, V31, P360, DOI 10.1016/j.matbio.2012.07.003; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; UGAROVA T, 1995, THROMB HAEMOSTASIS, V74, P253; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200	55	8	8	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4866	4876		10.1074/jbc.M114.612259	http://dx.doi.org/10.1074/jbc.M114.612259			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25525266	hybrid, Green Published			2022-12-28	WOS:000350042000031
J	Sommerfeld, A; Reinehr, R; Haussinger, D				Sommerfeld, Annika; Reinehr, Roland; Haeussinger, Dieter			Free Fatty Acids Shift Insulin-induced Hepatocyte Proliferation towards CD95-dependent Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HEPATIC STELLATE CELLS; LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; MEDIATED PHOSPHORYLATION; AUTOPHAGIC PROTEOLYSIS; SIGNAL-TRANSDUCTION; NADPH OXIDASE; CD95 LIGAND; ACTIVATION	Insulin is known to induce hepatocyte swelling, which triggers via integrins and c-Src kinase an activation of the epidermal growth factor receptor (EGFR) and subsequent cell proliferation (1). Free fatty acids (FFAs) are known to induce lipoapoptosis in liver cells in a c-Jun-NH2-terminal kinase (JNK)-dependent, but death receptor-independent way (2). As non-alcoholic steatohepatitis (NASH) is associated with hyperinsulinemia and increased FFA-blood levels, the interplay between insulin and FFA was studied with regard to hepatocyte proliferation and apoptosis in isolated rat and mouse hepatocytes. Saturated long chain FFAs induced apoptosis and JNK activation in primary rat hepatocytes, but did not activate the CD95 (Fas, APO-1) system, whereas insulin triggered EGFR activation and hepatocyte proliferation. Coadministration of insulin and FFAs, however, abolished hepatocyte proliferation and triggered CD95-dependent apoptosis due to a JNK-dependent association of the activated EGFR with CD95, subsequent CD95 tyrosine phosphorylation and formation of the death-inducing signaling complex (DISC). JNK inhibition restored the proliferative insulin effect in presence of FFAs and prevented EGFR/CD95 association, CD95 tyrosine phosphorylation and DISC formation. Likewise, in presence of FFAs insulin increased apoptosis in hepatocytes from wild type but not from Alb-Cre-FAS(fl/fl) mice, which lack functional CD95. It is concluded that FFAs can shift insulin-induced hepatocyte proliferation toward hepatocyte apoptosis by triggering a JNK signal, which allows activated EGFR to associate with CD95 and to trigger CD95-dependent apoptosis. Such phenomena may contribute to the pathogenesis of NASH.	[Sommerfeld, Annika; Reinehr, Roland; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016		Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (Dusseldorf) "Communication and System Relevance in Liver Injury and Regeneration"	Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (Dusseldorf) "Communication and System Relevance in Liver Injury and Regeneration"	This work was supported by Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (Dusseldorf) "Communication and System Relevance in Liver Injury and Regeneration."	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Akbar DH, 2006, MED SCI MONITOR, V12, pRA23; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Eberle A, 2005, HEPATOLOGY, V41, P315, DOI 10.1002/hep.20564; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Haussinger D, 2011, CELL PHYSIOL BIOCHEM, V28, P1089, DOI 10.1159/000335845; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; HAUSSINGER D, 1992, TRENDS PHARMACOL SCI, V13, P371, DOI 10.1016/0165-6147(92)90114-L; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Kordes C, 2014, J CLIN INVEST, V124, P5503, DOI 10.1172/JCI74119; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; MEIJER AJ, 1975, J BIOL CHEM, V250, P7728; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nystrom FH, 1999, CELL SIGNAL, V11, P563, DOI 10.1016/S0898-6568(99)00025-X; Pereira S, 2014, AM J PHYSIOL-ENDOC M, V307, pE34, DOI 10.1152/ajpendo.00436.2013; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Reinehr R, 2004, J BIOL CHEM, V279, P10364, DOI 10.1074/jbc.M311997200; Reinehr R, 2008, GASTROENTEROLOGY, V134, P1494, DOI 10.1053/j.gastro.2008.02.021; Reinehr R, 2012, ARCH BIOCHEM BIOPHYS, V518, P2, DOI 10.1016/j.abb.2011.12.004; Reinehr R, 2010, J BIOL CHEM, V285, P25904, DOI 10.1074/jbc.M110.125781; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Schliess F, 2001, BIOL CHEM, V382, P1063, DOI 10.1515/BC.2001.133; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Sommerfeld A, 2009, J BIOL CHEM, V284, P22173, DOI 10.1074/jbc.M109.005355; Susca M, 2001, DIGEST LIVER DIS, V33, P768, DOI 10.1016/S1590-8658(01)80694-0; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Volkmann X, 2007, HEPATOLOGY, V46, P1498, DOI 10.1002/hep.21846; vom Dahl S, 2003, J BIOL CHEM, V278, P27088, DOI 10.1074/jbc.M210699200; Wang Y, 2008, J NUTR, V138, P1866, DOI 10.1093/jn/138.10.1866; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Zafrani ES, 2004, VIRCHOWS ARCH, V444, P3, DOI 10.1007/s00428-003-0943-7	57	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4398	4409		10.1074/jbc.M114.617035	http://dx.doi.org/10.1074/jbc.M114.617035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548285	Green Published, hybrid			2022-12-28	WOS:000349458400047
J	Steeland, S; Puimege, L; Vandenbroucke, RE; Van Hauwermeiren, F; Haustraete, J; Devoogdt, N; Hulpiau, P; Leroux-Roels, G; Laukens, D; Meuleman, P; De Vos, M; Libert, C				Steeland, Sophie; Puimege, Leen; Vandenbroucke, Roosmarijn E.; Van Hauwermeiren, Filip; Haustraete, Jurgen; Devoogdt, Nick; Hulpiau, Paco; Leroux-Roels, Geert; Laukens, Debby; Meuleman, Philip; De Vos, Martine; Libert, Claude			Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; ANTI-TNF THERAPY; FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; LYMPHOTOXIN-ALPHA; MURINE MODEL; CRYSTAL-STRUCTURE; ADVERSE EVENTS; IN-VIVO; AGENTS	The cytokine TNF is a well known drug target for several inflammatory diseases such as Crohn disease. Despite the great success of TNF blockers, therapy could be improved because of high costs and side effects. Selective inhibition of TNF receptor (TNFR) 1 signaling holds the potential to greatly reduce the pro-inflammatory activity of TNF, thereby preserving the advantageous immunomodulatory signals mediated by TNFR2. We generated a selective human TNFR1 inhibitor based on Nano-body (Nb) technology. Two anti-human TNFR1 Nbs were linked with an anti-albumin Nb to generate Nb Alb-70-96 named "TNF Receptor-One Silencer" (TROS). TROS selectively binds and inhibits TNF/TNFR1 and lymphotoxin-alpha/TNFR1 signaling with good affinity and IC50 values, both of which are in the nano-molar range. Surface plasmon resonance analysis reveals that TROS competes with TNF for binding to human TNFR1. In HEK293T cells, TROS strongly reduces TNF-induced gene expression, like IL8 and TNF, in a dose-dependent manner; and in ex vivo cultured colon biopsies of CD patients, TROS inhibits inflammation. Finally, in liver chimeric humanized mice, TROS antagonizes inflammation in a model of acute TNF-induced liver inflammation, reflected in reduced human IL8 expression in liver and reduced IL6 levels in serum. These results demonstrate the considerable potential of TROS and justify the evaluation of TROS in relevant disease animal models of both acute and chronic inflammation and eventually in patients.	[Steeland, Sophie; Puimege, Leen; Vandenbroucke, Roosmarijn E.; Van Hauwermeiren, Filip; Hulpiau, Paco; Libert, Claude] Univ Ghent VIB, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Steeland, Sophie; Puimege, Leen; Vandenbroucke, Roosmarijn E.; Van Hauwermeiren, Filip; Hulpiau, Paco; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Haustraete, Jurgen] Univ Ghent VIB, Inflammat Res Ctr, Prot Serv Facil, B-9052 Ghent, Zwijnaarde, Belgium; [Devoogdt, Nick] Vrije Univ Brussel, Vivo Cellular & Mol Imaging Lab, B-1000 Brussels, Belgium; [Devoogdt, Nick] Vrije Univ Brussel, Cellular & Mol Immunol Lab, B-1000 Brussels, Belgium; [Leroux-Roels, Geert; Meuleman, Philip] Ghent Univ Hosp, Ctr Vaccinol, Dept Clin Chem, B-9000 Ghent, Belgium; [Laukens, Debby; De Vos, Martine] Ghent Univ Hosp, Ctr Vaccinol, Dept Gastroenterol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Libert, C (corresponding author), Univ Ghent VIB, Inflammat Res Ctr, Dept Biomed Mol Biol, Technol Pk 927, B-9052 Ghent, Zwijnaarde, Belgium.	Claude.Libert@irc.VIB-UGent.be	Steeland, Sophie/Q-6061-2017; Vandenbroucke, Roosmarijn E/B-9419-2009; Hulpiau, Paco/C-3215-2009; Vandenbroucke, Roosmarijn/AAC-2757-2019; Devoogdt, Nick/H-5156-2013; Meuleman, Philip/H-2899-2013	Steeland, Sophie/0000-0002-8989-130X; Vandenbroucke, Roosmarijn E/0000-0002-8327-620X; Hulpiau, Paco/0000-0002-6692-2150; Devoogdt, Nick/0000-0001-9220-4833; Meuleman, Philip/0000-0001-6821-234X; Laukens, Debby/0000-0002-1984-5850	Agency for Innovation by Science and Technology in Flanders; Research Council of Ghent University; Research Foundation Flanders (FWO Vlaanderen); Interuniversity Attraction Poles Program of the Belgian Science Policy [IAP-VI-18, IAP-VII-47]	Agency for Innovation by Science and Technology in Flanders; Research Council of Ghent University(Ghent University); Research Foundation Flanders (FWO Vlaanderen)(FWO); Interuniversity Attraction Poles Program of the Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Agency for Innovation by Science and Technology in Flanders, the Research Council of Ghent University, the Research Foundation Flanders (FWO Vlaanderen), and Interuniversity Attraction Poles Program of the Belgian Science Policy Grants IAP-VI-18 and IAP-VII-47.	Ablynx, 2007, WO Patent, Patent No. [2008/028977 A2, 2008028977]; Ablynx, 2013, FAV IMM PROF ALX0171; Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2014, ARTHRITIS RHEUMATOL, V66, P2657, DOI 10.1002/art.38753; Aikawa NE, 2010, CLIN REV ALLERG IMMU, V38, P82, DOI 10.1007/s12016-009-8140-3; Almoallim Hani, 2012, Open Rheumatol J, V6, P315, DOI 10.2174/1874312901206010315; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atzeni F, 2013, AUTOIMMUN REV, V12, P703, DOI 10.1016/j.autrev.2012.10.021; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Ben-Horin S, 2011, ALIMENT PHARM THER, V33, P987, DOI 10.1111/j.1365-2036.2011.04612.x; Ben-Horin S, 2014, NAT REV GASTRO HEPAT, V11, P243, DOI 10.1038/nrgastro.2013.253; Bluml S, 2010, ARTHRITIS RHEUM-US, V62, P1608, DOI 10.1002/art.27399; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Calmon-Hamaty F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3376; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Chuang VTG, 2009, DRUG METAB PHARMACOK, V24, P358, DOI 10.2133/dmpk.24.358; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Cleynen I, 2012, NAT REV GASTRO HEPAT, V9, P496, DOI 10.1038/nrgastro.2012.125; Cohen M, 2012, REV NEUROL-FRANCE, V168, P33, DOI 10.1016/j.neurol.2011.06.005; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Deffar K, 2009, AFR J BIOTECHNOL, V8, P2645; Deng GM, 2010, J IMMUNOL, V184, P7154, DOI 10.4049/jimmunol.0902514; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; DIXON FJ, 1953, P SOC EXP BIOL MED, V83, P287; Emery P, 2012, RHEUMATOLOGY, V51, pV22, DOI 10.1093/rheumatology/kes115; Esters N, 2002, AM J GASTROENTEROL, V97, P1458; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.3.CO;2-1; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fellermann K, 2013, DIGEST DIS, V31, P374, DOI 10.1159/000354703; Fischer R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027621; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Heyninck K, 2003, BIOCHEM PHARMACOL, V66, P1409, DOI 10.1016/S0006-2952(03)00491-X; Housley WJ, 2011, J IMMUNOL, V186, P6779, DOI 10.4049/jimmunol.1003868; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Ishikawa D, 2013, MUCOSAL IMMUNOL, V6, P267, DOI 10.1038/mi.2012.67; Kagi D, 1999, J IMMUNOL, V162, P4598; Kary S, 2006, ANN RHEUM DIS, V65, P405, DOI 10.1136/ard.2005.037424; Katikireddi VS, 2010, INT J RHEUM DIS, V13, P12, DOI 10.1111/j.1756-185X.2009.01457.x; Kim SY, 2010, NAT REV RHEUMATOL, V6, P165, DOI 10.1038/nrrheum.2009.279; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; Liu MY, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-68; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; McCann FE, 2014, ARTHRITIS RHEUMATOL, V66, P2728, DOI 10.1002/art.38755; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; MILATOVICH A, 1991, SOMAT CELL MOLEC GEN, V17, P519, DOI 10.1007/BF01233176; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Neregard P, 2014, SCAND J RHEUMATOL, V43, P85, DOI 10.3109/03009742.2013.834964; Nielsen OH, 2000, AM J GASTROENTEROL, V95, P359; Panaccione Remo, 2010, Therap Adv Gastroenterol, V3, P179, DOI 10.1177/1756283X09357579; Panes J, 2007, GUT, V56, P1184, DOI 10.1136/gut.2007.121830; Reinisch W, 2010, CURR DRUG TARGETS, V11, P152, DOI 10.2174/138945010790309894; Ricciardelli I, 2008, IMMUNOLOGY, V125, P178, DOI 10.1111/j.1365-2567.2008.02839.x; Rosenblum H, 2011, AUTOIMMUN REV, V10, P563, DOI 10.1016/j.autrev.2011.04.010; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schabert VF, 2013, J MANAGE CARE PHARM, V19, P621, DOI 10.18553/jmcp.2013.19.8.621; Schoonooghe Steve, 2012, Methods Mol Biol, V907, P325, DOI 10.1007/978-1-61779-974-7_19; Siontorou CG, 2013, INT J NANOMED, V8, P4215, DOI 10.2147/IJN.S39428; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Tada Y, 2001, CLIN IMMUNOL, V99, P325, DOI 10.1006/clim.2001.5027; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeire S, 2003, GASTROENTEROLOGY, V125, P32, DOI 10.1016/S0016-5085(03)00701-7; Verweij CL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2724; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wunder A, 2003, J IMMUNOL, V170, P4793, DOI 10.4049/jimmunol.170.9.4793; Yarur AJ, 2014, WORLD J GASTROENTERO, V20, P3475, DOI 10.3748/wjg.v20.i13.3475	82	52	56	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4022	4037		10.1074/jbc.M114.617787	http://dx.doi.org/10.1074/jbc.M114.617787			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538244	Green Published, hybrid			2022-12-28	WOS:000349458400015
J	Guo, C; Li, YL; Gow, CH; Wong, M; Zha, JK; Yan, CX; Liu, HQ; Wang, YJ; Burris, TP; Zhang, JS				Guo, Chun; Li, Yali; Gow, Chien-Hung; Wong, Madeline; Zha, Jikun; Yan, Chunxia; Liu, Hongqi; Wang, Yongjun; Burris, Thomas P.; Zhang, Jinsong			The Optimal Corepressor Function of Nuclear Receptor Corepressor (NCoR) for Peroxisome Proliferator-activated Receptor gamma Requires G Protein Pathway Suppressor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; LIGAND-BINDING DOMAIN; PPAR-GAMMA; TRANSCRIPTIONAL REPRESSION; ADIPOCYTE DIFFERENTIATION; GENE-TRANSCRIPTION; CRYSTAL-STRUCTURE; ADIPOSE-TISSUE; CO-REPRESSOR; SUBUNIT GPS2	Repression of peroxisome proliferator-activated receptor gamma (PPAR gamma)-dependent transcription by the nuclear receptor corepressor (NCoR) is important for homeostatic expression of PPAR gamma target genes in vivo. The current model states that NCoR-mediated repression requires its direct interaction with PPAR gamma in the repressive conformation. Previous studies, however, have shown that DNA-bound PPAR gamma is incompatible with a direct, high-affinity association with NCoR because of the inherent ability of PPAR gamma to adopt the active conformation. Here we show that NCoR acquires the ability to repress active PPAR gamma-mediated transcription via G protein pathway suppressor 2 (GPS2), a component of the NCoR corepressor complex. Unlike NCoR, GPS2 can recognize and bind the active state of PPAR gamma. In GPS2-deficient mouse embryonic fibroblast cells, loss of GPS2 markedly reduces the corepressor function of NCoR for PPAR gamma, leading to constitutive activation of PPAR gamma target genes and spontaneous adipogenesis of the cells. GPS2, however, is dispensable for repression mediated by unliganded thyroid hormone receptor gamma or aPPAR gamma mutant unable to adopt the active conformation. This study shows that GPS2, although dispensable for the intrinsic repression function of NCoR, can mediate a novel corepressor repression pathway that allows NCoR to directly repress active PPAR gamma-mediated transcription, which is important for the optimal corepressor function of NCoR for PPAR gamma. Interestingly, GPS2-dependent repression specifically targets PPAR gamma but not PPAR alpha or PPAR delta. Therefore, GPS2 may serve as a unique target to manipulate PPAR gamma signaling in diseases.	[Guo, Chun; Wong, Madeline; Zha, Jikun; Wang, Yongjun; Burris, Thomas P.; Zhang, Jinsong] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Guo, Chun; Li, Yali; Gow, Chien-Hung; Yan, Chunxia; Zhang, Jinsong] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc Biol, Cincinnati, OH 45267 USA; [Gow, Chien-Hung] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City 220, Taiwan; [Yan, Chunxia] Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710049, Shaanxi, Peoples R China; [Liu, Hongqi] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Biol, Infect & Immun Res Grp, Kunming 650018, Yunnan, Peoples R China	Saint Louis University; University System of Ohio; University of Cincinnati; Far Eastern Memorial Hospital; Xi'an Jiaotong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College	Zhang, JS (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	jinsongzhang@slu.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449; Zhang, Jinsong/0000-0002-8798-7316	National Institutes of Health [R21CA178513, R01MH093429]; Saint Louis University; University of Cincinnati Cancer Center; Chinese Scholarship Council; Institute of Medical Biology, Chinese Academy of Medical Science [IMB-201]; NATIONAL CANCER INSTITUTE [R21CA178513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; University of Cincinnati Cancer Center; Chinese Scholarship Council(China Scholarship Council); Institute of Medical Biology, Chinese Academy of Medical Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R21CA178513 (to J. Z.) and R01MH093429 (to T. P. B.). This work was also supported by a start-up fund from Saint Louis University (to J. Z.), by a University of Cincinnati Cancer Center Pilot grant (to J. Z.), by the Chinese Scholarship Council (to C. Y.), and by Institute of Medical Biology, Chinese Academy of Medical Science Grant IMB-201 (to H. L.).	Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Fozzatti L, 2011, P NATL ACAD SCI USA, V108, P17462, DOI 10.1073/pnas.1107474108; Gizard F, 2002, J BIOL CHEM, V277, P39144, DOI 10.1074/jbc.M205786200; Gizard F, 2001, J BIOL CHEM, V276, P33881, DOI 10.1074/jbc.M100113200; Glass CK, 2000, GENE DEV, V14, P121; Gow CH, 2014, NUCLEIC ACIDS RES, V42, P137, DOI 10.1093/nar/gkt855; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo C, 2012, J BIOL CHEM, V287, P12111, DOI 10.1074/jbc.M111.327023; Guo C, 2009, MOL CELL BIOL, V29, P2644, DOI 10.1128/MCB.00073-09; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li P, 2013, DIABETES RES CLIN PR, V102, P35, DOI 10.1016/j.diabres.2013.08.009; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Oger F, 2014, J BIOL CHEM, V289, P708, DOI 10.1074/jbc.M113.526996; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Shechter I, 2003, J LIPID RES, V44, P2169, DOI 10.1194/jlr.M300285-JLR200; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200; Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 1999, MOL CELL BIOL, V19, P6448; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zheng RD, 2013, PEDIATR RES, V73, P263, DOI 10.1038/pr.2012.190	76	15	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3666	3679		10.1074/jbc.M114.598797	http://dx.doi.org/10.1074/jbc.M114.598797			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25519902	hybrid, Green Published			2022-12-28	WOS:000349456000039
J	Mehmedbasic, A; Christensen, SK; Nilsson, J; Rutschi, U; Gustafsen, C; Poulsen, ASA; Rasmussen, RW; Fjorback, AN; Larson, G; Andersen, OM				Mehmedbasic, Arnela; Christensen, Sofie K.; Nilsson, Jonas; Ruetschi, Ulla; Gustafsen, Camilla; Poulsen, Annemarie Svane Aavild; Rasmussen, Rikke W.; Fjorback, Anja N.; Larson, Goran; Andersen, Olav M.			SorLA Complement-type Repeat Domains Protect the Amyloid Precursor Protein against Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; SORTILIN-RELATED RECEPTOR; APOLIPOPROTEIN-E RECEPTOR; CELL-SURFACE; ALZHEIMERS-DISEASE; BETA-SECRETASE; LDL RECEPTOR; LR11/SORLA EXPRESSION; MOSAIC RECEPTOR; O-GLYCOSYLATION	SorLA is a neuronal sorting receptor that is genetically associated with Alzheimer disease. SorLA interacts directly with the amyloid precursor protein (APP) and affects the processing of the precursor, leading to a decreased generation of the amyloid-beta peptide. The SorLA complement-type repeat (CR) domains associate in vitro with APP, but the precise molecular determinants of SorLA.APP complex formation and the mechanisms responsible for the effect of binding on APP processing have not yet been elucidated. Here, we have generated protein expression constructs for SorLA devoid of the 11 CR-domains and for two SorLA mutants harboring substitutions of the fingerprint residues in the central CR-domains. We generated SH-SY5Y cell lines that stably express these SorLA variants to study the binding and processing of APP using co-immunoprecipitation and Western blotting/ELISAs, respectively. We found that the SorLA CR-cluster is essential for interaction with APP and that deletion of the CR-cluster abolishes the protection against APP processing. Mutation of identified fingerprint residues in the SorLA CR-domains leads to changes in the O-linked glycosylation of APP when expressed in SH-SY5Y cells. Our results provide novel information on the mechanisms behind the influence of SorLA activity on APP metabolism by controlling post-translational glycosylation in the Golgi, suggesting new strategies against amyloidogenesis in Alzheimer disease.	[Mehmedbasic, Arnela; Christensen, Sofie K.; Gustafsen, Camilla; Poulsen, Annemarie Svane Aavild; Rasmussen, Rikke W.; Fjorback, Anja N.; Andersen, Olav M.] Aarhus Univ, Dept Biomed, Danish Res Inst Translat Neurosci Nord EMBL Partn, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus C, Denmark; [Nilsson, Jonas; Ruetschi, Ulla; Larson, Goran] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden	Aarhus University; Lundbeckfonden; University of Gothenburg	Andersen, OM (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3,Bldg 1170, DK-8000 Aarhus C, Denmark.	o.andersen@biomed.au.dk	Larson, Göran/AAF-3404-2019; Andersen, Olav/N-2777-2017	Nilsson, Jonas/0000-0001-5263-2454; Gustafsen, Camilla/0000-0002-3349-4639; Andersen, Olav/0000-0003-4226-3354; Christensen, Sofie Kjellerup/0000-0003-2375-254X	Lundbeck Foundation; Novo Nordisk Foundation; Augustinus Foundation; Danish Alzheimer Research Foundation; Aase and Einar Danielsen Foundation; Hartman Foundation; Horslev Foundation; Lundbeck Foundation [R62-2010-5361] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1015311] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Augustinus Foundation; Danish Alzheimer Research Foundation; Aase and Einar Danielsen Foundation; Hartman Foundation; Horslev Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Augustinus Foundation, the Danish Alzheimer Research Foundation, the Aase and Einar Danielsen Foundation, the Hartman Foundation, and the Horslev Foundation.	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Andersen OM, 2001, BIOCHEMISTRY-US, V40, P15408, DOI 10.1021/bi0110692; Beglov D, 2009, PROTEINS, V77, P940, DOI 10.1002/prot.22519; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Bhalla A, 2012, NEUROBIOL DIS, V47, P126, DOI 10.1016/j.nbd.2012.03.030; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bohm C, 2006, J BIOL CHEM, V281, P14547, DOI 10.1074/jbc.M601660200; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Georgopoulou N, 2001, BIOCHEM SOC SYMP, V67, P23; GRAEBERT KS, 1995, EUR J CELL BIOL, V66, P39; Gustafsen C, 2013, J NEUROSCI, V33, P64, DOI 10.1523/JNEUROSCI.2371-12.2013; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Guttman M, 2010, BIOCHEMISTRY-US, V49, P1207, DOI 10.1021/bi9017208; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Halim A, 2011, P NATL ACAD SCI USA, V108, P11848, DOI 10.1073/pnas.1102664108; Hampe W, 2000, J CELL SCI, V113, P4475; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hermans-Borgmeyer I, 1998, MECH DEVELOP, V70, P65, DOI 10.1016/S0925-4773(97)00177-9; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Huang S, 2010, J LIPID RES, V51, P297, DOI 10.1194/jlr.M000422; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Knauer MF, 1996, BRAIN RES, V740, P6, DOI 10.1016/S0006-8993(96)00711-1; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lane RF, 2013, J NEUROSCI, V33, P7099, DOI 10.1523/JNEUROSCI.5270-12.2013; Lane RF, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-62; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; McFarlane I, 1999, NEUROSCIENCE, V90, P15, DOI 10.1016/S0306-4522(98)00361-3; Morwald S, 1997, ARTERIOSCL THROM VAS, V17, P996, DOI 10.1161/01.ATV.17.5.996; Motoi Y, 1999, BRAIN RES, V833, P209, DOI 10.1016/S0006-8993(99)01542-5; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PAHLSSON P, 1992, BIOCHEM BIOPH RES CO, V189, P1667, DOI 10.1016/0006-291X(92)90269-Q; Perdivara I, 2009, J PROTEOME RES, V8, P631, DOI 10.1021/pr800758g; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Reitz C, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.13; Reitz C, 2011, ANN NEUROL, V69, P47, DOI 10.1002/ana.22308; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Ullrich S, 2010, J BIOL CHEM, V285, P20664, DOI 10.1074/jbc.M109.055608; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Willnow TE, 2013, J CELL SCI, V126, P2751, DOI 10.1242/jcs.125393; Xue Y, 2011, J BIOL CHEM, V286, P29748, DOI 10.1074/jbc.M111.219659; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010	75	26	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3359	3376		10.1074/jbc.M114.619940	http://dx.doi.org/10.1074/jbc.M114.619940			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525276	hybrid, Green Published			2022-12-28	WOS:000349456000014
J	Meng, SM; Cao, J; He, QY; Xiong, LS; Chang, E; Radovick, S; Wondisford, FE; He, L				Meng, Shumei; Cao, Jia; He, Qiyi; Xiong, Lishou; Chang, Evan; Radovick, Sally; Wondisford, Fredric E.; He, Ling			Metformin Activates AMP-activated Protein Kinase by Promoting Formation of the alpha beta gamma Heterotrimeric Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; HEPATIC GLUCONEOGENESIS; GLUCOSE-PRODUCTION; GENE-EXPRESSION; PHOSPHORYLATION; MECHANISM; LKB1; INHIBITION; BINDING	Metformin is the most widely prescribed oral anti-diabetic agent. Recently, we have shown that low metformin concentrations found in the portal vein suppress glucose production in hepatocytes through activation of AMPK. Moreover, low concentrations of metformin were found to activate AMPK by increasing the phosphorylation of AMPK alpha at Thr-172. However, the mechanism underlying the increase in AMPK alpha phosphorylation at Thr-172 and activation by metformin remains unknown. In the current study, we find that low concentrations of metformin promote the formation of the AMPK alpha beta gamma complex, resulting in an increase in net phosphorylation of the AMPK alpha catalytic subunit at Thr-172 by augmenting phosphorylation by LKB1 and antagonizing dephosphorylation by PP2C.	[Meng, Shumei; Cao, Jia; He, Qiyi; Xiong, Lishou; Chang, Evan; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA; [Meng, Shumei; Cao, Jia; He, Qiyi; Xiong, Lishou; Chang, Evan; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Metab, Baltimore, MD 21287 USA; [Meng, Shumei; Cao, Jia; He, Qiyi; Xiong, Lishou; Chang, Evan; Wondisford, Fredric E.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Med, Div Metab, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Endocrinol, Baltimore, MD 21287 USA; [Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	He, L (corresponding author), Div Metab, 600 N Wolfe St, Baltimore, MD 21287 USA.	heling@jhmi.edu		Cao, Jia/0000-0002-9508-1397	NIDDK, National Institutes of Health [R00DK085142, R01DK63349]; JHU-UMD Diabetes Research Center [P60DK079637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085142, P30DK079637, P60DK079637, R01DK063349] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JHU-UMD Diabetes Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants from the NIDDK, National Institutes of Health: R00DK085142 (to L. H.), R01DK63349 (to F. E. W.), and the JHU-UMD Diabetes Research Center, P60DK079637.	Aatsinki SM, 2014, BRIT J PHARMACOL, V171, P2351, DOI 10.1111/bph.12585; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1994, EUR J BIOCHEM, V223, P351, DOI 10.1111/j.1432-1033.1994.tb19001.x; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; He L, 2014, J ENDOCRINOL, V221, P363, DOI 10.1530/JOE-14-0084; He L, 2013, MOL ENDOCRINOL, V27, P1322, DOI 10.1210/me.2012-1413; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Heishi M, 2008, J TOXICOL SCI, V33, P339, DOI 10.2131/jts.33.339; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Wondisford AR, 2014, J BIOL CHEM, V289, P4326, DOI 10.1074/jbc.M113.540500; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	38	83	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3793	3802		10.1074/jbc.M114.604421	http://dx.doi.org/10.1074/jbc.M114.604421			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538235	hybrid, Green Published			2022-12-28	WOS:000349456000050
J	Kumar, V; Weng, YC; Geldenhuys, WJ; Wang, D; Han, XQ; Messing, RO; Chou, WH				Kumar, Varun; Weng, Yi-Chinn; Geldenhuys, Werner J.; Wang, Dan; Han, Xiqian; Messing, Robert O.; Chou, Wen-Hai			Generation and Characterization of ATP Analog-specific Protein Kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL GENETIC SCREEN; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; INHIBITOR SELECTIVITY; PEPTIDE INHIBITOR; STRUCTURAL BASIS; ACTIVATION; SUBSTRATE; EPSILON; PKC	To better study the role of PKC delta in normal function and disease, we developed an ATP analog-specific (AS) PKC delta that is sensitive to specific kinase inhibitors and can be used to identify PKC delta substrates. ASPKC delta showed nearly 200 times higher affinity (K-m) and 150 times higher efficiency (k(cat)/K-m) than wild type (WT) PKC delta toward N-6-(benzyl)-ATP. AS PKC delta was uniquely inhibited by 1-(tert-butyl)-3-(1-naphthyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (1NA-PP1) and 1-(tert-butyl)-3-(2-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (2MB-PP1) but not by other 4-amino-5-(4-methylphenyl)-7-(t-butyl) pyrazolo[3,4-d] pyrimidine (PP1) analogs tested, whereas WT PKC delta was insensitive to all PP1 analogs. To understand the mechanisms for specificity and affinity of these analogs, we created in silico WT and AS PKC delta homology models based on the crystal structure of PKC delta. N6-(Benzyl)-ATP and ATP showed similar positioning within the purine binding pocket of AS PKC delta, whereas N6-(benzyl)-ATP was displaced from the pocket of WT PKC delta and was unable to interact with the glycine-rich loop that is required for phosphoryl transfer. The adenine rings of 1NA-PP1 and 2MB-PP1 matched the adenine ring of ATP when docked in AS PKC delta, and this interaction prevented the potential interaction of ATP with Lys-378, Glu-428, Leu-430, and Phe-633 residues. 1NA-PP1 failed to effectively dock within WT PKC delta. Other PP1 analogs failed to interact with either AS PKC delta or WT PKC delta. These results provide a structural basis for the ability of AS PKC delta to efficiently and specifically utilize N-6-(benzyl)-ATP as a phosphate donor and for its selective inhibition by 1NA-PP1 and 2MB-PP1. Such homology modeling could prove useful in designing molecules to target PKC delta and other kinases to understand their function in cell signaling and to identify unique substrates.	[Kumar, Varun; Weng, Yi-Chinn; Han, Xiqian; Chou, Wen-Hai] Kent State Univ, Dept Biol Sci, Sch Biomed Sci, Kent, OH 44242 USA; [Geldenhuys, Werner J.] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH 44272 USA; [Wang, Dan; Messing, Robert O.; Chou, Wen-Hai] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA 94608 USA; [Wang, Dan; Messing, Robert O.; Chou, Wen-Hai] Univ Calif San Francisco, Res Ctr, Dept Neurol, Emeryville, CA 94608 USA; [Messing, Robert O.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Northeast Ohio Medical University (NEOMED); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin	Chou, WH (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	wchou2@kent.edu	Messing, Robert/D-3642-2015; Chou, Wen-Hai/H-1970-2016	Messing, Robert/0000-0002-5345-4431; Chou, Wen-Hai/0000-0002-7899-1129; Kumar, Varun/0000-0001-6867-494X	National Institutes of Health [R21 NS057195, R01 AA018316]; Kent State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kent State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS057195 (to W. H. C.) and R01 AA018316 (to R. O. M.). This work was also supported by a grant from the Kent State University start-up fund (to W. H. C.).	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Allen JJ, 2005, J AM CHEM SOC, V127, P5288, DOI 10.1021/ja050727t; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Choi DS, 2008, J NEUROSCI, V28, P11890, DOI 10.1523/JNEUROSCI.3156-08.2008; Chou WH, 2010, J NEUROSCI, V30, P13955, DOI 10.1523/JNEUROSCI.0270-10.2010; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; DECHATELET LR, 1976, BLOOD, V47, P545; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hindley AD, 2004, FEBS LETT, V556, P26, DOI 10.1016/S0014-5793(03)01352-8; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Larochelle S, 2006, NAT STRUCT MOL BIOL, V13, P55, DOI 10.1038/nsmb1028; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Niswender CM, 2002, J BIOL CHEM, V277, P28916, DOI 10.1074/jbc.M203327200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pongracz J, 1999, J BIOL CHEM, V274, P37329, DOI 10.1074/jbc.274.52.37329; Qi ZH, 2007, J BIOL CHEM, V282, P33052, DOI 10.1074/jbc.M707233200; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; Tanramluk D, 2009, CHEM BIOL DRUG DES, V74, P16, DOI 10.1111/j.1747-0285.2009.00832.x; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Witucki LA, 2002, CHEM BIOL, V9, P25, DOI 10.1016/S1074-5521(02)00091-1; Wu DF, 2012, J CLIN INVEST, V122, P1306, DOI 10.1172/JCI61934; Zhang C, 2013, ACS CHEM BIOL, V8, P1931, DOI 10.1021/cb400376p; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	52	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1936	1951		10.1074/jbc.M114.598698	http://dx.doi.org/10.1074/jbc.M114.598698			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505183	Green Published, hybrid			2022-12-28	WOS:000348588000004
J	Duan, XL; Liu, NN; Yang, YT; Li, HH; Li, M; Dou, SX; Xi, XG				Duan, Xiao-Lei; Liu, Na-Nv; Yang, Yan-Tao; Li, Hai-Hong; Li, Ming; Dou, Shuo-Xing; Xi, Xu-Guang			G-quadruplexes Significantly Stimulate Pif1 Helicase-catalyzed Duplex DNA Unwinding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; DNA Replication; G-quadruplex; Genomic Instability; Kinetics; Replication Origin	ESCHERICHIA-COLI RECQ; SINGLE-STRANDED-DNA; HUMAN TUMOR-CELLS; GENOME-WIDE; SACCHAROMYCES-CEREVISIAE; SMALL-MOLECULE; REGULATORY ELEMENTS; REPLICATION ORIGINS; BINDING PROTEIN; GENE-EXPRESSION	Background: G-quadruplexes (G4s) play a variety of roles in DNA transactions. Results: Pif1-catalyzed duplex DNA unwinding was greatly stimulated by G4s in several aspects, including the unwinding rate and amplitude and the chemical-mechanical coupling efficiency. Conclusion: G4s significantly activate helicase Pif1-catalyzed duplex DNA unwinding through a mechanism of G4-induced dimerization. Significance: The G4-activating effect may be implicated in the rescue of stalled replication forks, activating of replication origins, and lagging strand maturation. The evolutionarily conserved G-quadruplexes (G4s) are faithfully inherited and serve a variety of cellular functions such as telomere maintenance, gene regulation, DNA replication initiation, and epigenetic regulation. Different from the Watson-Crick base-pairing found in duplex DNA, G4s are formed via Hoogsteen base pairing and are very stable and compact DNA structures. Failure of untangling them in the cell impedes DNA-based transactions and leads to genome instability. Cells have evolved highly specific helicases to resolve G4 structures. We used a recombinant nuclear form of Saccharomyces cerevisiae Pif1 to characterize Pif1-mediated DNA unwinding with a substrate mimicking an ongoing lagging strand synthesis stalled by G4s, which resembles a replication origin and a G4-structured flap in Okazaki fragment maturation. We find that the presence of G4 may greatly stimulate the Pif1 helicase to unwind duplex DNA. Further studies reveal that this stimulation results from G4-enhanced Pif1 dimerization, which is required for duplex DNA unwinding. This finding provides new insights into the properties and functions of G4s. We discuss the observed activation phenomenon in relation to the possible regulatory role of G4s in the rapid rescue of the stalled lagging strand synthesis by helping the replicator recognize and activate the replication origin as well as by quickly removing the G4-structured flap during Okazaki fragment maturation.	[Duan, Xiao-Lei; Liu, Na-Nv; Yang, Yan-Tao; Li, Hai-Hong; Xi, Xu-Guang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Li, Ming; Dou, Shuo-Xing] Chinese Acad Sci, CAS Key Lab Soft Matter Phys, Int Associated Lab CNRS Inst Phys, Beijing 100190, Peoples R China; [Xi, Xu-Guang] Ecole Normale Super, Lab Biol & Pharmacol Appl, CNRS, F-94235 Cachan, France	Northwest A&F University - China; Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Dou, SX (corresponding author), Chinese Acad Sci, CAS Key Lab Soft Matter Phys, Beijing 100190, Peoples R China.	sxdou@iphy.ac.cn; xxi01@ens-cachan.fr	Xi, Xu Guang/AAK-4511-2020	Dou, Shuo-Xing/0000-0002-7201-2081	National Natural Science Foundation of China [31370798, 11304252, 31301632]; Ministry of Education of China [985, 211]; CNRS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the National Natural Science Foundation of China Grants 31370798, 11304252, and 31301632 and Projects 985 and 211 from the Ministry of Education of China. The research was partially financed by a grant from CNRS and conducted within the context of the "LIA helicase-mediated G-quadruplex DNA unwinding and genome stability."	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Basu A, 2012, NAT STRUCT MOL BIOL, V19, P538, DOI 10.1038/nsmb.2278; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bjornson KP, 1996, BIOCHEMISTRY-US, V35, P2268, DOI 10.1021/bi9522763; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budhathoki JB, 2014, NUCLEIC ACIDS RES, V42, P11528, DOI 10.1093/nar/gku856; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Du Z, 2009, NUCLEIC ACIDS RES, V37, P6784, DOI 10.1093/nar/gkp710; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Fischer CJ, 2007, BIOCHEMISTRY-US, V46, P12416, DOI 10.1021/bi700930n; George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671; Nguyen GH, 2014, P NATL ACAD SCI USA, V111, P9905, DOI 10.1073/pnas.1404807111; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Izbicka E, 1999, CANCER RES, V59, P639; Konig SLB, 2013, NUCLEIC ACIDS RES, V41, P7453, DOI 10.1093/nar/gkt476; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Neidle S, 2008, BIOCHIMIE, V90, P1184, DOI 10.1016/j.biochi.2008.03.003; Oei SL, 2004, GENOMICS, V83, P873, DOI 10.1016/j.ygeno.2003.11.001; Okoh MP, 2006, BIOCHEMISTRY-US, V45, P14764, DOI 10.1021/bi060960j; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136; Pike JE, 2010, J BIOL CHEM, V285, P41712, DOI 10.1074/jbc.M110.146894; Rajendran A, 2014, ANGEW CHEM INT EDIT, V53, P4107, DOI 10.1002/anie.201308903; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Salvati E, 2010, ONCOGENE, V29, P6280, DOI 10.1038/onc.2010.344; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Tarsounas M, 2013, J MOL BIOL, V425, P4782, DOI 10.1016/j.jmb.2013.09.026; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Whitehouse I, 2013, CURR OPIN GENET DEV, V23, P140, DOI 10.1016/j.gde.2012.12.007; Xu YN, 2012, NUCLEIC ACIDS RES, V40, P9802, DOI 10.1093/nar/gks728; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190; Zhou YJ, 2007, J PHYS CHEM B, V111, P13600, DOI 10.1021/jp073708+	60	39	44	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7722	7735		10.1074/jbc.M114.628008	http://dx.doi.org/10.1074/jbc.M114.628008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25627683	Green Published, hybrid			2022-12-28	WOS:000351613600033
J	Mukhopadhyay, S; Saqcena, M; Chatterjee, A; Garcia, A; Frias, MA; Foster, DA				Mukhopadhyay, Suman; Saqcena, Mahesh; Chatterjee, Amrita; Garcia, Avalon; Frias, Maria A.; Foster, David A.			Reciprocal Regulation of AMP-activated Protein Kinase and Phospholipase D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; PHOSPHATIDIC-ACID; MAMMALIAN TARGET; COMPLEX 1; MTOR; LKB1; PHOSPHORYLATION; NUTRIENT; PATHWAY; SIGNALS	AMP-activated protein kinase (AMPK), a critical sensor of energy sufficiency, acts as central metabolic switch in cell metabolism. Once activated by low energy status, AMPK phosphorylates key regulatory substrates and turns off anabolic biosynthetic pathways. In contrast, the mammalian/mechanistic target of rapamycin (mTOR) is active when there are sufficient nutrients for anabolic reactions. A critical factor regulating mTOR is phosphatidic acid (PA), a central metabolite of membrane lipid biosynthesis and the product of the phospholipase D (PLD)-catalyzed hydrolysis of phosphatidylcholine. PLD is a downstream target of the GTPase Rheb, which is turned off in response to AMPK via the tuberous sclerosis complex. Although many studies have linked AMPK with mTOR, very little is known about the connection between AMPK and PLD. In this report, we provide evidence for reciprocal regulation of PLD by AMPK and regulation of AMPK by PLD and PA. Suppression of AMPK activity led to an increase in PLD activity, and conversely, activation of AMPK suppressed PLD activity. Suppression of PLD activity resulted in elevated AMPK activity. Exogenously supplied PA abolished the inhibitory effects of elevated AMPK activity on mTOR signaling. In contrast, exogenously supplied PA could not overcome the effect AMPK activation if either mTOR or Raptor was suppressed, indicating that the inhibitory effects of PLD and PA on AMPK activity are mediated by mTOR. These data suggest a reciprocal feedback mechanism involving AMPK and the PLD/mTOR signaling node in cancer cells with therapeutic implications.	[Mukhopadhyay, Suman; Saqcena, Mahesh; Chatterjee, Amrita; Garcia, Avalon; Frias, Maria A.; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Mukhopadhyay, Suman/N-3556-2017; Saqcena, Mahesh/U-5973-2017	Mukhopadhyay, Suman/0000-0002-4658-1942; Saqcena, Mahesh/0000-0002-2210-3444; Frias, Maria A/0000-0001-7753-6290	National Institutes of Health from NCI [R01-CA046677, R01-CA179542]; National Institutes of Health Research Centers in Minority Institutions Award from the National Center for Research Resources [RR-03039]; NATIONAL CANCER INSTITUTE [R01CA179542, R01CA046677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S03RR003039] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Research Centers in Minority Institutions Award from the National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA046677 and R01-CA179542 from NCI and by National Institutes of Health Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources (to the Department of Biological Sciences, Hunter College of the City University of New York).	Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Blagosklonny MV, 2011, AGING-US, V3, P1130, DOI 10.18632/aging.100422; Blaskovich MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078632; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Habib SL, 2010, EUR J CANCER, V46, P2806, DOI 10.1016/j.ejca.2010.06.117; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jang YH, 2014, CELL DEATH DIFFER, V21, P533, DOI 10.1038/cdd.2013.174; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009600; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Rehman G, 2014, ARCH PHARM, V347, P457, DOI 10.1002/ardp.201300402; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shackelford David B, 2013, J Carcinog, V12, P16, DOI 10.4103/1477-3163.116323; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Shirwany NA, 2014, FRONT BIOSCI-LANDMRK, V19, P447, DOI 10.2741/4218; SONG JG, 1993, BIOCHEM J, V294, P711, DOI 10.1042/bj2940711; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Toschi A, 2008, ONCOGENE, V27, P2746, DOI 10.1038/sj.onc.1210927; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yellen P, 2013, CANCER LETT, V333, P239, DOI 10.1016/j.canlet.2013.01.041; Yellen P, 2011, CELL CYCLE, V10, P3948, DOI 10.4161/cc.10.22.18124; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	55	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6986	6993		10.1074/jbc.M114.622571	http://dx.doi.org/10.1074/jbc.M114.622571			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25632961	Green Published, hybrid			2022-12-28	WOS:000350991500032
J	Pasula, R; Azad, AK; Gardner, JC; Schlesinger, LS; McCormack, FX				Pasula, Rajamouli; Azad, Abul K.; Gardner, Jason C.; Schlesinger, Larry S.; McCormack, Francis X.			Keratinocyte Growth Factor Administration Attenuates Murine Pulmonary Mycobacterium tuberculosis Infection through Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF)-dependent Macrophage Activation and Phagolysosome Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG INJURY; GM-CSF; II CELLS; EPITHELIAL-CELLS; TRANSGENIC MICE; SP-A; EXPRESSION; RATS; INSTILLATION; LIPOGENESIS	Augmentation of innate immune defenses is an appealing adjunctive strategy for treatment of pulmonary Mycobacterium tuberculosis infections, especially those caused by drug-resistant strains. The effect of intranasal administration of keratinocyte growth factor (KGF), an epithelial mitogen and differentiation factor, on M. tuberculosis infection in mice was tested in prophylaxis, treatment, and rescue scenarios. Infection of C57131.6 mice with M. tuberculosis resulted in inoculum size-dependent weight loss and mortality. A single dose of KCF given 1 day prior to infection with 105 M. tuberculosis bacilli prevented weight loss and enhanced pulmonary mycobacterial clearance (compared with saline-pretreated mice) for up to 28 days. Similar effects were seen when KGF was delivered intranasally every third day for 15 days, but weight loss and bacillary growth resumed when KGT was withdrawn. For mice with a well established M. tuberculosis infection, KGF given every 3 days beginning on day 15 postinoculation was associated with reversal of weight loss and an increase in M. tuberculosis clearance. In in vitro co-culture experiments, M. tuberculosis-infected macrophages exposed to conditioned medium from KGF-treated alveolar type II cell (MLE-15) monolayers exhibited enhanced GM-CST-dependent killing through mechanisms that included promotion of phagolysosome fusion and induction of nitric oxide, Alveolar macrophages from KGF-treated mice also exhibited enhanced GM-CS F.-dependent phagolysosomal fusion. These results provide evidence that administration of KGF promotes M. tuberculosis clearance through GM-CSF-dependent mechanisms and enhances host defense against M. tuberculosis infection.	[Pasula, Rajamouli; Gardner, Jason C.; McCormack, Francis X.] Univ Cincinnati, Div Pulm Crit Care & Sleep Med, Dept Med, Cincinnati, OH 45267 USA; [Azad, Abul K.; Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University	McCormack, FX (corresponding author), Univ Cincinnati, Div Pulm Crit Care & Sleep Med, Dept Med, OH MSB 6165,231 Albert Sabin Way,POB 670564, Cincinnati, OH 45267 USA.	frank.mccormack@uc.edu	McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464; Gardner, Jason/0000-0002-5924-9201	National Institutes of Health, NCATS [8UL1TR000077-04]; NIH [T32 HL007752-21]; Veterans Affairs Merit Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007752] Funding Source: NIH RePORTER	National Institutes of Health, NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NCATS, Grant 8UL1TR000077-04 and by funding from NIH Grant T32 HL007752-21. This work was also supported by a Veterans Affairs Merit Award (to F. X. M.). Preliminary results from this work have been reported in poster form at the 2011 American Thoracic Society Meeting. Drs. McCormack and Pasula have applied for a patent entitled "Growth Factors for Treatment of Mycobacterial Infection" (PCT/US2013/038206).	Barasch A, 2009, BIOL-TARGETS THER, V3, P111; Blijlevens N, 2007, ANN ONCOL, V18, P817, DOI 10.1093/annonc/mdl332; Chang YS, 2006, AM J RESP CELL MOL, V35, P268, DOI 10.1165/rcmb.2006-0037OC; Charafeddine L, 1999, AM J PHYSIOL-LUNG C, V276, pL105, DOI 10.1152/ajplung.1999.276.1.L105; Deterding RR, 1997, P ASSOC AM PHYSICIAN, V109, P254; Erdag G, 2004, MOL THER, V10, P76, DOI 10.1016/j.ymthe.2004.04.013; Fehrenbach H, 2000, HISTOCHEM CELL BIOL, V114, P49; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Francisco-Cruz A, 2013, CLIN EXP IMMUNOL, V171, P283, DOI 10.1111/cei.12015; Francisco-Cruz A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0774-6; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Gross TJ, 2014, J IMMUNOL, V192, P2326, DOI 10.4049/jimmunol.1301758; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Higgins DM, 2008, J IMMUNOL, V180, P4892, DOI 10.4049/jimmunol.180.7.4892; IKEDA K, 1994, AM J PHYSIOL, V267, pL309, DOI 10.1152/ajplung.1994.267.3.L309; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Mason RJ, 2002, CHEST, V121, p77S, DOI 10.1378/chest.121.3_suppl.77S; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Nambiar JK, 2010, EUR J IMMUNOL, V40, P153, DOI 10.1002/eji.200939665; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; Pasula R, 1997, AM J RESP CELL MOL, V17, P209, DOI 10.1165/ajrcmb.17.2.2469; Pasula R, 2009, J IMMUNOL, V182, P7102, DOI 10.4049/jimmunol.0803642; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Ryan AA, 2007, J IMMUNOL, V179, P8418, DOI 10.4049/jimmunol.179.12.8418; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; Shyamsundar M, 2014, AM J RESP CRIT CARE, V189, P1520, DOI 10.1164/rccm.201310-1892OC; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Sturrock A, 2012, AM J PHYSIOL-LUNG C, V302, pL343, DOI 10.1152/ajplung.00276.2011; Sundaramurthy V, 2007, MICROBES INFECT, V9, P1671, DOI 10.1016/j.micinf.2007.09.007; Szeliga J, 2008, TUBERCULOSIS, V88, P7, DOI 10.1016/j.tube.2007.08.009; Valdivia-Arenas Ma, 2007, Drug Discov Today Dis Mech, V4, P73, DOI 10.1016/j.ddmec.2007.10.003; Viget NB, 2000, AM J PHYSIOL-LUNG C, V279, pL1199, DOI 10.1152/ajplung.2000.279.6.L1199; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wu HX, 2011, J BIOL CHEM, V286, P14932, DOI 10.1074/jbc.M110.182170; Xu XS, 1998, AM J RESP CELL MOL, V18, P168, DOI 10.1165/ajrcmb.18.2.2824; Yano T, 1996, AM J RESP CELL MOL, V15, P433, DOI 10.1165/ajrcmb.15.4.8879176; Yano T, 2000, AM J PHYSIOL-LUNG C, V279, pL1146, DOI 10.1152/ajplung.2000.279.6.L1146; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	41	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7151	7159		10.1074/jbc.M114.591891	http://dx.doi.org/10.1074/jbc.M114.591891			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605711	hybrid, Green Published			2022-12-28	WOS:000350991500045
J	Vaughan, AT; Chan, CHT; Klein, C; Glennie, MJ; Beers, SA; Cragg, MS				Vaughan, Andrew T.; Chan, Claude H. T.; Klein, Christian; Glennie, Martin J.; Beers, Stephen A.; Cragg, Mark S.			Activatory and Inhibitory Fc gamma Receptors Augment Rituximab-mediated Internalization of CD20 Independent of Signaling via the Cytoplasmic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LIPID RAFTS; B-CELLS; MEMBRANE RAFTS; MONOCLONAL-ANTIBODIES; SURFACE EXPRESSION; CALCIUM FLUX; IN-VIVO; RIIA; ASSOCIATION	Type I anti-CD20 mAb such as rituximab and ofatumumab engage with the inhibitory Fc gamma R, Fc gamma RIIb on the surface of B cells, resulting in immunoreceptor tyrosine-based inhibitory motif (ITIM) phosphorylation. Internalization of the CD20 center dot mAb center dot Fc gamma RIIb complex follows, the rate of which correlates with Fc gamma RIIb expression. In contrast, although type II anti-CD20 mAb such as tositumomab and obinutuzumab also interact with and activate Fc gamma RIIb, this interaction fails to augment the rate of CD20 center dot mAb internalization, raising the question of whether ITIM phosphorylation plays any role in this process. We have assessed the molecular requirements for the internalization process and demonstrate that in contrast to internalization of IgG immune complexes, Fc gamma RIIb-augmented internalization of rituximab-ligated CD20 occurs independently of the Fc gamma RIIb ITIM, indicating that signaling downstream of Fc gamma RIIb is not required. In transfected cells, activatory Fc gamma RI, Fc gamma RIIa, and Fc gamma RIIIa augmented internalization of rituximab-ligated CD20 in a similar manner. However, Fc gamma RIIa mediated a slower rate of internalization than cells expressing equivalent levels of the highly homologous Fc gamma RIIb. The difference was maintained in cells expressing Fc gamma RIIa and Fc gamma RIIb lacking cytoplasmic domains and in which the transmembrane domains had been exchanged. This difference may be due to increased degradation of Fc gamma RIIa, which traffics to lysosomes independently of rituximab. We conclude that the cytoplasmic domain of Fc gamma R is not required for promoting internalization of rituximab-ligated CD20. Instead, we propose that Fc gamma R provides a structural role in augmenting endocytosis that differs from that employed during the endocytosis of immune complexes.	[Vaughan, Andrew T.; Chan, Claude H. T.; Glennie, Martin J.; Beers, Stephen A.; Cragg, Mark S.] Univ Southampton, Fac Med, Gen Hosp, Antibody & Vaccine Grp,Canc Sci Unit, Southampton SO16 6YD, Hants, England; [Klein, Christian] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Zurich, CH-8952 Schlieren, Switzerland	University of Southampton; Roche Holding	Cragg, MS (corresponding author), Univ Southampton, Fac Med, Gen Hosp, Antibody & Vaccine Grp,Canc Sci Unit, Southampton SO16 6YD, Hants, England.	msc@soton.ac.uk	Cragg, Mark S/E-5965-2010; Klein, Christian/G-1336-2010	Cragg, Mark S/0000-0003-2077-089X; Klein, Christian/0000-0001-7594-7280; chan, claude/0000-0003-0530-9480; Vaughan, Andrew/0000-0001-6076-3649; Beers, Stephen/0000-0002-3765-3342	Leukaemia and Lymphoma Research Grants [09009, 12050]; Roche; BioInvent International	Leukaemia and Lymphoma Research Grants; Roche(Roche Holding); BioInvent International	This work was supported by Leukaemia and Lymphoma Research Grants 09009, 12050, and a research grant from Roche. C. K. is a paid employee of Roche. M. J. G. acts as a consultant to a number of biotech companies to write general antibody expert reports and receives institutional payments and royalties from antibody patents and licenses. M. S. C. serves as a consultant for and received grant funding from BioInvent International and has previously served as an ad hoc consultant for Roche. The remaining authors declare no competing financial interests.	Aman MJ, 2001, J BIOL CHEM, V276, P46371, DOI 10.1074/jbc.M104069200; Beers SA, 2008, BLOOD, V112, P4170, DOI 10.1182/blood-2008-04-149161; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bournazos S, 2009, J IMMUNOL, V182, P8026, DOI 10.4049/jimmunol.0900107; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BUDDE P, 1994, J BIOL CHEM, V269, P30636; Chan HTC, 2003, CANCER RES, V63, P5480; Cragg MS, 2004, BLOOD, V103, P2738, DOI 10.1182/blood-2003-06-2031; Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761; Gamberale R, 2005, LEUKEMIA RES, V29, P1277, DOI 10.1016/j.leukres.2005.04.008; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; GLENNIE MJ, 1987, J IMMUNOL, V139, P2367; GREENMAN J, 1991, MOL IMMUNOL, V28, P1243, DOI 10.1016/0161-5890(91)90011-8; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Ivanov A, 2009, J CLIN INVEST, V119, P2143, DOI 10.1172/JCI37884; Kim MK, 2003, BLOOD, V101, P4479, DOI 10.1182/blood.V101.11.4479; Kono H, 2005, HUM MOL GENET, V14, P2881, DOI 10.1093/hmg/ddi320; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lee CS, 2015, BRIT J HAEMATOL, V168, P145, DOI 10.1111/bjh.13071; Li HD, 2004, J BIOL CHEM, V279, P19893, DOI 10.1074/jbc.M400525200; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Lim SH, 2011, BLOOD, V118, P2530, DOI 10.1182/blood-2011-01-330357; MIETTINEN HM, 1992, J CELL BIOL, V116, P875, DOI 10.1083/jcb.116.4.875; O'Reilly MK, 2011, J IMMUNOL, V186, P1554, DOI 10.4049/jimmunol.1003005; Polyak MJ, 1998, J IMMUNOL, V161, P3242; Qian L, 2012, BLOOD, V120, P581, DOI 10.1182/blood-2011-08-377242; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rosman Z, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-88; Su KH, 2007, J IMMUNOL, V178, P3272, DOI 10.4049/jimmunol.178.5.3272; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202; vanVugt MJ, 1996, BLOOD, V87, P3593, DOI 10.1182/blood.V87.9.3593.bloodjournal8793593; Vaughan AT, 2014, BLOOD, V123, P669, DOI 10.1182/blood-2013-04-490821; Walshe CA, 2008, J BIOL CHEM, V283, P16971, DOI 10.1074/jbc.M708459200; Zhang CY, 2010, J BIOL CHEM, V285, P34250, DOI 10.1074/jbc.M110.143834	35	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5424	5437		10.1074/jbc.M114.593806	http://dx.doi.org/10.1074/jbc.M114.593806			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568316	Green Published, hybrid			2022-12-28	WOS:000350044200016
J	Banerjee, R				Banerjee, Ruma			Introduction to the Thematic Minireview Series on Radical S-Adenosylmethionine (SAM) Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								In the early days, radical enzyme reactions that use S-adenosylmethionine (SAM) coordinated to an Fe-S cluster, which Perry Frey described as a "poor man's coenzyme B12," were believed to be relatively rare chemical curiosities. Today, bioinformatics analyses have revealed the wide prevalence and sheer numbers of radical SAM enzymes, conferring superfamily status. In this thematic minireview series, the JBC presents six articles on radical SAM enzymes that accomplish wide-ranging chemical transformations. We learn that despite the diversity of the reactions catalyzed, family members share some common structural and mechanistic themes. Still in its infancy, continued explorations promise to be fertile grounds for discoveries that will undoubtedly further broaden our understanding of the catalytic repertoire and deepen our understanding of the chemical strategies used by radical SAM enzymes.	[Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58984, R01 HL058984] Funding Source: Medline; NIDDK NIH HHS [DK45776, R01 DK045776] Funding Source: Medline; NIGMS NIH HHS [R01 GM112455, GM112455] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; Byer AS, 2015, J BIOL CHEM, V290, P3987, DOI 10.1074/jbc.R114.578161; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Jarrett JT, 2015, J BIOL CHEM, V290, P3972, DOI 10.1074/jbc.R114.599308; Mehta AP, 2015, J BIOL CHEM, V290, P3980, DOI 10.1074/jbc.R114.623793; Yang LL, 2015, J BIOL CHEM, V290, P4003, DOI 10.1074/jbc.R114.573675	6	4	5	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3962	3963		10.1074/jbc.R114.630251	http://dx.doi.org/10.1074/jbc.R114.630251			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25477525	hybrid, Green Published			2022-12-28	WOS:000349458400007
J	Marcano-Velazquez, JG; Batey, RT				Marcano-Velazquez, Joan G.; Batey, Robert T.			Structure-guided Mutational Analysis of Gene Regulation by the Bacillus subtilis pbuE Adenine-responsive Riboswitch in a Cellular Context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; PURINE RIBOSWITCH; S-ADENOSYLMETHIONINE; IN-VITRO; RNA; APTAMER; TRANSCRIPTION; KINETICS; EXPRESSION; STABILITY	Riboswitches are a broadly distributed form of RNA-based gene regulation in Bacteria and, more rarely, Archaea and Eukarya. Most often found in the 5'-leader sequence of bacterial mRNAs, they are generally composed of two functional domains: a receptor (aptamer) domain that binds an effector molecule and a regulatory domain (or expression platform) that instructs the expression machinery. One of the most studied riboswitches is the Bacillus subtilis adenine-responsive pbuE riboswitch, which regulates gene expression at the transcriptional level, up-regulating expression in response to increased intracellular effector concentrations. In this work, we analyzed sequence and structural elements that contribute to efficient ligand-dependent regulatory activity in a co-transcriptional and cellular context. Unexpectedly, we found that the P1 helix, which acts as the antitermination element of the switch in this RNA, supported ligand-dependent activation of a reporter gene over a broad spectrum of lengths from 3 to 10 bp. This same trend was also observed using a minimal in vitro single-turnover transcription assay, revealing that this behavior is intrinsic to the RNA sequence. We also found that the sequences at the distal tip of the terminator not directly involved in alternative secondary structure formation are highly important for efficient regulation. These data strongly support a model in which the switch is highly localized to the P1 helix adjacent to the ligand-binding pocket that likely presents a local kinetic block to invasion of the aptamer by the terminator.	[Marcano-Velazquez, Joan G.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 596, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625	National Institutes of Health [GM073850, T32 GM065103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073850, T32GM065103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073850 (to R. T. B.) and Biophysics Training Grant T32 GM065103 (to J. G. M.-V.).	Artsimovitch I, 2009, METHODS, V47, P37, DOI 10.1016/j.ymeth.2008.10.006; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blose JM, 2009, J AM CHEM SOC, V131, P8474, DOI 10.1021/ja900065e; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; Ceres P, 2013, NUCLEIC ACIDS RES, V41, P10449, DOI 10.1093/nar/gkt787; Ceres P, 2013, ACS SYNTH BIOL, V2, P463, DOI 10.1021/sb4000096; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Edwards Andrea L., 2009, V535, P135, DOI 10.1007/978-1-59745-557-2_9; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; Garst AD, 2012, J MOL BIOL, V423, P17, DOI 10.1016/j.jmb.2012.06.038; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Lemay JF, 2007, RNA, V13, P339, DOI 10.1261/rna.142007; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; Mahen EM, 2005, MOL CELL, V19, P27, DOI 10.1016/j.molcel.2005.05.025; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Nagel JHA, 2006, NUCLEIC ACIDS RES, V34, P3568, DOI 10.1093/nar/gkl445; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Nozinovic S, 2014, RNA BIOL, V11, P655, DOI 10.4161/rna.29439; Porter EB, 2014, BBA-GENE REGUL MECH, V1839, P919, DOI 10.1016/j.bbagrm.2014.02.014; Sambrook J., 2001, MOL CLONING LAB MANU; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Strulson CA, 2014, RNA, V20, P331, DOI 10.1261/rna.042747.113; Strulson CA, 2013, BIOCHEMISTRY-US, V52, P8187, DOI 10.1021/bi400816s; Tomsic J, 2008, J BACTERIOL, V190, P823, DOI 10.1128/JB.01034-07; Trausch JJ, 2011, STRUCTURE, V19, P1413, DOI 10.1016/j.str.2011.06.019; Tyrrell J, 2013, BIOCHEMISTRY-US, V52, P8777, DOI 10.1021/bi401207q; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Zakataeva NP, 2007, RES MICROBIOL, V158, P659, DOI 10.1016/j.resmic.2007.08.003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	18	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4464	4475		10.1074/jbc.M114.613497	http://dx.doi.org/10.1074/jbc.M114.613497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25550163	Green Published, hybrid			2022-12-28	WOS:000349458400052
J	Matsuo, K; Akakabe, Y; Kitamura, Y; Shimoda, Y; Ono, K; Ueyama, T; Matoba, S; Yamada, H; Hatakeyama, K; Asada, Y; Emoto, N; Ikeda, K				Matsuo, Kiyonari; Akakabe, Yoshiki; Kitamura, Youhei; Shimoda, Yoshiaki; Ono, Kazunori; Ueyama, Tomomi; Matoba, Satoaki; Yamada, Hiroyuki; Hatakeyama, Kinta; Asada, Yujiro; Emoto, Noriaki; Ikeda, Koji			Loss of Apoptosis Regulator through Modulating IAP Expression (ARIA) Protects Blood Vessels from Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR AVASIMIBE; MACROPHAGES; MICE; INFLAMMATION; DISEASE; LESIONS; CELLS	Atherosclerosis is the primary cause for cardiovascular disease. Here we identified a novel mechanism underlying atherosclerosis, which is provided by ARIA (apoptosis regulator through modulating IAP expression), the transmembrane protein that we recently identified. ARIA is expressed in macrophages present in human atherosclerotic plaque as well as in mouse peritoneal macrophages. When challenged with acetylated LDL, peritoneal macrophages isolated from ARIA-deficient mice showed substantially reduced foam cell formation, whereas the uptake did not differ from that in wild-type macrophages. Mechanistically, loss of ARIA enhanced PI3K/Akt signaling and consequently reduced the expression of acyl coenzyme A: cholesterol acyltransferase-1 (ACAT-1), an enzyme that esterifies cholesterol and promotes its storage, in macrophages. Inhibition of PI3K abolished the reduction in ACAT-1 expression and foam cell formation in ARIA-deficient macrophages. In contrast, overexpression of ARIA reduced Akt activity and enhanced foam cell formation in RAW264.7 macrophages, which was abrogated by treatment with ACAT inhibitor. Of note, genetic deletion of ARIA significantly reduced the atherosclerosis in ApoE-deficient mice. Oil red-O-positive lipid-rich lesion was reduced, which was accompanied by an increase of collagen fiber and decrease of necrotic core lesion in atherosclerotic plaque in ARIA/ApoE double-deficient mice. Analysis of bone marrow chimeric mice revealed that loss of ARIA in bone marrow cells was sufficient to reduce the atherosclerogenesis in ApoE-deficient mice. Together, we identified a unique role of ARIA in the pathogenesis of atherosclerosis at least partly by modulating macrophage foam cell formation. Our results indicate that ARIA could serve as a novel pharmacotherapeutic target for the treatment of atherosclerotic diseases.	[Matsuo, Kiyonari; Akakabe, Yoshiki; Kitamura, Youhei; Shimoda, Yoshiaki; Ono, Kazunori; Ueyama, Tomomi; Matoba, Satoaki; Yamada, Hiroyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiol, Kamigyo Ku, Kyoto 6028566, Japan; [Emoto, Noriaki; Ikeda, Koji] Kobe Pharmaceut Univ, Dept Clin Pharm, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Hatakeyama, Kinta; Asada, Yujiro] Miyazaki Univ, Dept Pathol, Fac Med, Miyazaki 8891692, Japan	Kyoto Prefectural University of Medicine; Kobe Pharmaceutical University; University of Miyazaki	Ikeda, K (corresponding author), Kobe Pharmaceut Univ, Dept Clin Pharm, Higashinada Ku, 4-19-1 Motoyama Kitamachi, Kobe, Hyogo 6588558, Japan.	ikedak-circ@umin.ac.jp		ikeda, Koji/0000-0002-9972-7255; Emoto, Noriaki/0000-0001-6673-2616	Takeda Science Foundation;  [C:KAKENHI-23591107];  [KAKENHI-23659423];  [KAKENHI-26670406]	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; 	This work was supported by Grant-in-aid for Scientific Research C:KAKENHI-23591107 and Grants-in-aid for Challenging Exploratory Research KAKENHI-23659423 and -26670406, as well as a research grant from Takeda Science Foundation.	Akakabe Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3389; Bocan TMA, 2000, ARTERIOSCL THROM VAS, V20, P70, DOI 10.1161/01.ATV.20.1.70; Daugherty A, 2002, CIRC RES, V90, P1039, DOI 10.1161/01.RES.0000021397.28936.F9; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Farese RV, 2006, ARTERIOSCL THROM VAS, V26, P1684, DOI 10.1161/01.ATV.0000227511.35456.90; Faxon DP, 2004, CIRCULATION, V109, P2595, DOI 10.1161/01.CIR.0000128517.52533.DB; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Ikeda K, 2009, P NATL ACAD SCI USA, V106, P8227, DOI 10.1073/pnas.0806780106; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; Kharbanda RK, 2005, CIRCULATION, V111, P804, DOI 10.1161/01.CIR.0000155236.25081.9B; Kitamura Y, 2014, J BIOL CHEM, V289, P2788, DOI 10.1074/jbc.M113.508143; Koide M, 2011, P NATL ACAD SCI USA, V108, P9472, DOI 10.1073/pnas.1101296108; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Perrey S, 2001, ATHEROSCLEROSIS, V155, P359, DOI 10.1016/S0021-9150(00)00599-2; Rodriguez A, 1999, ARTERIOSCL THROM VAS, V19, P2199, DOI 10.1161/01.ATV.19.9.2199; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Shimoda Y, 2014, BIOCHEM BIOPH RES CO, V446, P1243, DOI 10.1016/j.bbrc.2014.03.098; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Yuan Y, 2012, PROTEIN CELL, V3, P173, DOI 10.1007/s13238-012-2025-6	27	5	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3784	3792		10.1074/jbc.M114.605287	http://dx.doi.org/10.1074/jbc.M114.605287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533470	Green Published, hybrid			2022-12-28	WOS:000349456000049
J	Sridharan, V; Park, H; Ryu, H; Azuma, Y				Sridharan, Vinidhra; Park, Hyewon; Ryu, Hyunju; Azuma, Yoshiaki			SUMOylation Regulates Polo-like Kinase 1-interacting Checkpoint Helicase (PICH) during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-DNA GLYCOSYLASE; TOPOISOMERASE-II; SUMO-1 MODIFICATION; CHROMOSOME SEGREGATION; MITOTIC CHROMOSOMES; UBIQUITIN; CONJUGATION; PROTEINS; BINDING; MOTIF	Mitotic SUMOylation has an essential role in faithful chromosome segregation in eukaryotes, although its molecular consequences are not yet fully understood. In Xenopus egg extract assays, we showed that poly(ADP-ribose) polymerase 1 (PARP1) is modified by SUMO2/3 at mitotic centromeres and that its enzymatic activity could be regulated by SUMOylation. To determine the molecular consequence of mitotic SUMOylation, we analyzed SUMOylated PARP1-specific binding proteins. We identified Polo-like kinase 1-interacting checkpoint helicase (PICH) as an interaction partner of SUMOylated PARP1 in Xenopus egg extract. Interestingly, PICH also bound to SUMOylated topoisomerase II alpha (TopoII alpha), a major centromeric small ubiquitin-like modifier (SUMO) substrate. Purified recombinant human PICH interacted with SUMOylated substrates, indicating that PICH directly interacts with SUMO, and this interaction is conserved among species. Further analysis of mitotic chromosomes revealed that PICH localized to the centromere independent of mitotic SUMOylation. Additionally, we found that PICH is modified by SUMO2/3 on mitotic chromosomes and in vitro. PICH SUMOylation is highly dependent on protein inhibitor of activated STAT, PIASy, consistent with other mitotic chromosomal SUMO substrates. Finally, the SUMOylation of PICH significantly reduced its DNA binding capability, indicating that SUMOylation might regulate its DNA-dependent ATPase activity. Collectively, our findings suggest a novel SUMO-mediated regulation of the function of PICH at mitotic centromeres.	[Sridharan, Vinidhra; Park, Hyewon; Ryu, Hyunju; Azuma, Yoshiaki] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Azuma, Y (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave,Haworth Hall Rm 3037, Lawrence, KS 66045 USA.	azumay@ku.edu			National Institutes of Health through the NIGMS [GM80278]; University of Kansas; University of Kansas [2301743]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080278] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Kansas; University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM80278 through the NIGMS (to Y. A.) and is currently supported by bridge funding from the University of Kansas and in part by a general research fund (Grant 2301743) from the University of Kansas.	Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Biebricher A, 2013, MOL CELL, V51, P691, DOI 10.1016/j.molcel.2013.07.016; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cubenas-Potts C, 2013, MOL BIOL CELL, V24, P3483, DOI 10.1091/mbc.E13-05-0230; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Kaulich M, 2012, CHROMOSOMA, V121, P395, DOI 10.1007/s00412-012-0370-0; Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kornbluth Sally, 2006, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1111s29; Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950; Leng M, 2008, CELL CYCLE, V7, P1480, DOI 10.4161/cc.7.10.5951; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Porter ACG, 2004, CHROMOSOME RES, V12, P569, DOI 10.1023/B:CHRO.0000036608.91085.d1; Ryu H, 2010, J CELL BIOL, V191, P783, DOI 10.1083/jcb.201004033; Ryu H, 2010, J BIOL CHEM, V285, P32576, DOI 10.1074/jbc.M110.153817; Ryu H, 2010, J BIOL CHEM, V285, P14415, DOI 10.1074/jbc.M109.074583; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Watts FZ, 2007, CHROMOSOMA, V116, P15, DOI 10.1007/s00412-006-0079-z; Ying SM, 2011, INT J HEMATOL, V93, P440, DOI 10.1007/s12185-011-0818-7	39	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3269	3276		10.1074/jbc.C114.601906	http://dx.doi.org/10.1074/jbc.C114.601906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25564610	hybrid, Green Published			2022-12-28	WOS:000349456000007
J	Cong, WN; Chadwick, W; Wang, R; Daimon, CM; Cai, H; Amma, J; Wood, WH; Becker, KG; Martin, B; Maudsley, S				Cong, Wei-Na; Chadwick, Wayne; Wang, Rui; Daimon, Caitlin M.; Cai, Huan; Amma, Jennifer; Wood, William H., III; Becker, Kevin G.; Martin, Bronwen; Maudsley, Stuart			Amitriptyline Improves Motor Function via Enhanced Neurotrophin Signaling and Mitochondrial Functions in the Murine N171-82Q Huntington Disease Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Brain-derived Neurotrophic Factor (BDNF); Huntington Disease; Mitochondria; Neurodegenerative Disease; Amitriptyline; Motor Function; mHTT	STRIATAL PROJECTION NEURONS; TRKB RECEPTOR; MOUSE MODEL; MUTANT HUNTINGTIN; UNCOUPLING PROTEIN-2; THERAPEUTIC TARGET; TRANSGENIC MOUSE; SLOWS DISEASE; HUMAN BRAIN; IN-VIVO	Background: Etiology of Huntington disease (HD) is related to the overproduction of mutant huntingtin (mHTT) protein. Results: Amitriptyline improved motor symptoms via decreasing mHTT protein expression, improving neurotrophin signaling, and enhancing mitochondrial functions in HD mice. Conclusion: Amitriptyline demonstrated beneficial effects in HD mice. Significance: Amitriptyline has therapeutic potential in treating HD. Huntington disease (HD) is a neurodegenerative disorder characterized by progressive motor impairment and cognitive alterations. Hereditary HD is primarily caused by the expansion of a CAG trinucleotide repeat in the huntingtin (Htt) gene, which results in the production of mutant huntingtin protein (mHTT) with an expanded amino-terminal polyglutamine (poly(Q)) stretch. Besides pathological mHTT aggregation, reduced brain-derived neurotrophic factor (BDNF) levels, impaired neurotrophin signaling, and compromised mitochondrial functions also contribute to the deleterious progressive etiology of HD. As a well tolerated Food and Drug Administration-approved antidepressant, amitriptyline (AMI) has shown efficacy in treating neurodegenerative murine models via potentiation of BDNF levels and amelioration of alterations in neurotrophin signaling pathways. In this study, we observed profound improvements in the motor coordination of AMI-treated N171-82Q HD model mice. The beneficial effects of AMI treatment were associated with its ability to reduce mHTT aggregation, potentiation of the BDNF-TrkB signaling system, and support of mitochondrial integrity and functionality. Our study not only provides preclinical evidence for the therapeutic potency of AMI in treating HD, but it also represents an important example of the usefulness of additional pharmacogenomic profiling of pre-existing drugs for novel therapeutic effects with often intractable pathological scenarios.	[Cong, Wei-Na; Wang, Rui; Daimon, Caitlin M.; Cai, Huan; Amma, Jennifer; Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Chadwick, Wayne; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Wood, William H., III; Becker, Kevin G.] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; [Maudsley, Stuart] Univ Antwerp, Inst Born Bunge, Dept Mol Genet VIB, Neurogenet Lab, B-2000 Antwerp, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Flanders Institute for Biotechnology (VIB); University of Antwerp	Martin, B (corresponding author), NIA, Metab Unit, NIH, 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	bronwenmartin@gmail.com; stuart.maudsley@molgen.vib-ua.be	Wang, Rui/I-5643-2019; Maudsley, Stuart/Q-4782-2019; Cai, Huan/B-6578-2016; Maudsley, Stuart/AAV-9929-2021	Wang, Rui/0000-0001-7015-0272; Cai, Huan/0000-0001-7731-8891; Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	National Institutes of Health Intramural Research Program of the NIA; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIA.	Aidt F. H., 2013, PLOS CURR; Andreassen OA, 2001, NEUROBIOL DIS, V8, P479, DOI 10.1006/nbdi.2001.0406; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; Baydyuk M, 2013, J NEUROSCI, V33, P3363, DOI 10.1523/JNEUROSCI.3687-12.2013; Baydyuk M, 2011, P NATL ACAD SCI USA, V108, P1669, DOI 10.1073/pnas.1004744108; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Besusso D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3031; Bhoopathi P, 2011, CANCER RES, V71, P4908, DOI 10.1158/0008-5472.CAN-10-3395; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Chadwick W., 2011, J SIGNAL TRANSDUCTIO, V2011; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062665; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Cong WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047240; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; Deierborg T, 2008, J CEREBR BLOOD F MET, V28, P1186, DOI 10.1038/jcbfm.2008.8; DEPINTO V, 1992, J BIOENERG BIOMEMBR, V24, P21, DOI 10.1007/BF00769526; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Duan WZ, 2004, ANN NEUROL, V55, P590, DOI 10.1002/ana.20075; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Fjorback AW, 2011, FEBS J, V278, P493, DOI 10.1111/j.1742-4658.2010.07970.x; Franklin K. B., 2008, MOUSE BRAIN STEREOTA, P34; Gesty-Palmer D, 2013, MOL ENDOCRINOL, V27, P296, DOI 10.1210/me.2012-1091; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Gines S, 2006, EUR J NEUROSCI, V23, P649, DOI 10.1111/j.1460-9568.2006.04590.x; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Hoffner G, 2002, BIOCHIMIE, V84, P273, DOI 10.1016/S0300-9084(02)01398-6; Iannaccone Martina, 2013, Recent Pat CNS Drug Discov, V8, P161; Ishii T, 2013, BBA-BIOENERGETICS, V1827, P588, DOI 10.1016/j.bbabio.2012.10.016; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krzyszton-Russjan J, 2013, J BIOENERG BIOMEMBR, V45, P71, DOI 10.1007/s10863-012-9479-3; Lee BH, 2010, J CLIN PSYCHOPHARM, V30, P623, DOI 10.1097/JCP.0b013e3181f13f0b; Lee HY, 2012, CELL MOL NEUROBIOL, V32, P577, DOI 10.1007/s10571-012-9802-x; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; Estrada-Sanchez AM, 2010, NEUROCHEM RES, V35, P1156, DOI 10.1007/s11064-010-0168-5; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2012, J BIOL CHEM, V287, P31766, DOI 10.1074/jbc.M112.387316; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Masuda N, 2008, NEUROBIOL DIS, V30, P293, DOI 10.1016/j.nbd.2008.01.014; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Moltzen EK, 2006, CURR TOP MED CHEM, V6, P1801, DOI 10.2174/156802606778249810; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Peng Q, 2008, EXP NEUROL, V210, P154, DOI 10.1016/j.expneurol.2007.10.015; Perez-Navarro E, 2000, J NEUROCHEM, V75, P2190, DOI 10.1046/j.1471-4159.2000.0752190.x; Plotkin JL, 2014, NEURON, V83, P178, DOI 10.1016/j.neuron.2014.05.032; Read RD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003253; Rosenstock TR, 2010, CURR DRUG TARGETS, V11, P1218; Russell L, 2000, CELL STRUCT FUNCT, V25, P103, DOI 10.1247/csf.25.103; Ryu Hoon, 2005, Expert Opin Emerg Drugs, V10, P345, DOI 10.1517/14728214.10.2.345; Scribner KB, 2008, AM J PHYSIOL-ENDOC M, V295, pE1126, DOI 10.1152/ajpendo.90487.2008; Shin YK, 2012, J GERONTOL A-BIOL, V67, P336, DOI 10.1093/gerona/glr192; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Villani G, 2000, FREE RADICAL BIO MED, V29, P202, DOI 10.1016/S0891-5849(00)00303-8; Wang HY, 2007, EUR J NEUROSCI, V26, P633, DOI 10.1111/j.1460-9568.2007.05663.x; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Xu HY, 2003, NEUROPSYCHOPHARMACOL, V28, P53, DOI 10.1038/sj.npp.1300009; Yuste JE, 2012, NEUROPHARMACOLOGY, V63, P1258, DOI 10.1016/j.neuropharm.2012.07.031; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	87	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2728	2743		10.1074/jbc.M114.588608	http://dx.doi.org/10.1074/jbc.M114.588608			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505248	Green Published, hybrid			2022-12-28	WOS:000349310700016
J	Culp, DJ; Robinson, B; Cash, MN; Bhattacharyya, I; Stewart, C; Cuadra-Saenz, G				Culp, David J.; Robinson, Bently; Cash, Melanie N.; Bhattacharyya, Indraneel; Stewart, Carol; Cuadra-Saenz, Giancarlo			Salivary Mucin 19 Glycoproteins INNATE IMMUNE FUNCTIONS IN STREPTOCOCCUS MUTANS-INDUCED CARIES IN MICE AND EVIDENCE FOR EXPRESSION IN HUMAN SALIVA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Animal Model; Glycobiology; Infectious Disease; Innate Immunity; Microbiome; Mucin; Streptococcus	ORAL MICROBIAL COMMUNITIES; ACQUIRED ENAMEL PELLICLE; WHOLE SALIVA; O-GLYCOSYLATION; CROHNS-DISEASE; DENTAL-CARIES; MUC5B; MOUSE; EXPRESSION; GLAND	Background: We investigated murine salivary Muc19, in vivo and in vitro, to protect against dental infections. Results: Muc19 attenuates dental infections by Streptococcus mutans and promotes its aggregation. Evidence for human salivary MUC19 is presented. Conclusion: Murine Muc19 helps limit colonization via clearance of S. mutans. Significance: A role for Muc19 in clearance expands upon acknowledged innate immune functions of salivary gel-forming mucins. Saliva functions in innate immunity of the oral cavity, protecting against demineralization of teeth (i.e. dental caries), a highly prevalent infectious disease associated with Streptococcus mutans, a pathogen also linked to endocarditis and atheromatous plaques. Gel-forming mucins are a major constituent of saliva. Because Muc19 is the dominant salivary gel-forming mucin in mice, we studied Muc19(-/-) mice for changes in innate immune functions of saliva in interactions with S. mutans. When challenged with S. mutans and a cariogenic diet, total smooth and sulcal surface lesions are more than 2- and 1.6-fold higher in Muc19(-/-) mice compared with wild type, whereas the severity of lesions are up to 6- and 10-fold higher, respectively. Furthermore, the oral microbiota of Muc19(-/-) mice display higher levels of indigenous streptococci. Results emphasize the importance of a single salivary constituent in the innate immune functions of saliva. In vitro studies of S. mutans and Muc19 interactions (i.e. adherence, aggregation, and biofilm formation) demonstrate Muc19 poorly aggregates S. mutans. Nonetheless, aggregation is enhanced upon adding Muc19 to saliva from Muc19(-/-) mice, indicating Muc19 assists in bacterial clearance through formation of heterotypic complexes with salivary constituents that bind S. mutans, thus representing a novel innate immune function for salivary gel-forming mucins. In humans, expression of salivary MUC19 is unclear. We find MUC19 transcripts in salivary glands of seven subjects and demonstrate MUC19 glycoproteins in glandular mucous cells and saliva. Similarities and differences between mice and humans in the expression and functions of salivary gel-forming mucins are discussed.	[Culp, David J.; Robinson, Bently; Cash, Melanie N.; Cuadra-Saenz, Giancarlo] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Bhattacharyya, Indraneel; Stewart, Carol] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Culp, DJ (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, 1395 Ctr Dr,POB 100424, Gainesville, FL 32610 USA.	dculp@dental.ufl.edu	Bhattacharyya, Indraneel/U-7752-2019; Cash, Melanie/AAT-3751-2020		National Institutes of Health [DE16362, DE014730]; NIDCR [DE020147]; University of Florida Research Opportunity Fund Award [83064];  [T90DE021990]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016362, R21DE020147, R01DE014730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Florida Research Opportunity Fund Award; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE16362, DE014730, and DE020147 from NIDCR and Grant T90DE021990 (to G. C.). This work was also supported by University of Florida Research Opportunity Fund Award 83064 (to D. J. C.).	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; Almiron M, 2013, CURR MICROBIOL, V67, P395, DOI 10.1007/s00284-013-0367-9; Alos L, 2005, AM J SURG PATHOL, V29, P806, DOI 10.1097/01.pas.0000155856.84553.c9; Amerongen AV, 2004, CARIES RES, V38, P247, DOI 10.1159/000077762; AMERONGEN AVN, 1987, CARIES RES, V21, P297; AMERONGEN AVN, 1989, J BIOL BUCCALE, V17, P85; [Anonymous], ORAL HLTH AM REPORT; Aviles-Reyes A, 2014, MOL ORAL MICROBIOL, V29, P11, DOI 10.1111/mom.12041; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; Banderas-Tarabay JA, 2002, ARCH MED RES, V33, P499, DOI 10.1016/S0188-4409(02)00395-8; BARLETTA RG, 1988, INFECT IMMUN, V56, P322, DOI 10.1128/IAI.56.2.322-330.1988; BARLETTA RG, 1989, INFECT IMMUN, V57, P992, DOI 10.1128/IAI.57.3.992-995.1989; BISGAARD M, 1986, ACTA PATH MICRO IM B, V94, P1; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; BOLSCHER J, 1995, BIOCHEM J, V309, P801, DOI 10.1042/bj3090801; Boro S, 2010, CURR MICROBIOL, V61, P357, DOI 10.1007/s00284-010-9619-0; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; BRADSHAW DJ, 1994, MICROBIOL-UK, V140, P3407, DOI 10.1099/13500872-140-12-3407; Brandtzaeg P., 2013, J ORAL MICROBIOL, DOI [10.3402/jom.v6.26102, DOI 10.3402/JOM.V6.26102]; Carlen A, 1996, ARCH ORAL BIOL, V41, P1133, DOI 10.1016/S0003-9969(96)00094-5; Castro I, 2013, AUTOIMMUN REV, V12, P567, DOI 10.1016/j.autrev.2012.10.018; Chen T., 2010, DATABASE, V2010; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chi AC, 2010, AM FAM PHYSICIAN, V82, P1381; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; CLARK WB, 1978, INFECT IMMUN, V19, P846, DOI 10.1128/IAI.19.3.846-853.1978; Clavel T, 2013, ARCH MICROBIOL, V195, P43, DOI 10.1007/s00203-012-0846-6; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornejo OE, 2013, MOL BIOL EVOL, V30, P881, DOI 10.1093/molbev/mss278; Culp DJ, 2011, BBA-MOL BASIS DIS, V1812, P1567, DOI 10.1016/j.bbadis.2011.09.006; Culp DJ, 2005, CARIES RES, V39, P448, DOI 10.1159/000088179; Culp DJ, 2004, PHYSIOL GENOMICS, V19, P303, DOI 10.1152/physiolgenomics.00161.2004; Das B, 2013, J BIOL CHEM, V288, P14742, DOI 10.1074/jbc.M113.468645; Das B, 2010, J HISTOCHEM CYTOCHEM, V58, P141, DOI 10.1369/jhc.2009.954891; Das B, 2009, J HISTOCHEM CYTOCHEM, V57, P383, DOI 10.1369/jhc.2008.952853; DENNY PA, 1982, HISTOCHEM J, V14, P403, DOI 10.1007/BF01011852; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Denny PC, 1996, GLYCOBIOLOGY, V6, P43, DOI 10.1093/glycob/6.1.43; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dijkema T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-91; EMILSON CG, 1976, J CLIN MICROBIOL, V4, P95; Flowers SA, 2013, MOL CELL PROTEOMICS, V12, P921, DOI 10.1074/mcp.M113.028878; GERKEN TA, 1992, BIOCHEMISTRY-US, V31, P639, DOI 10.1021/bi00118a002; Glantz PO, 1997, COLLOID SURFACE A, V123, P657, DOI 10.1016/S0927-7757(96)03817-4; Gozalo AS, 2010, J AM ASSOC LAB ANIM, V49, P480; Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559; Hand AR, 1999, ARCH ORAL BIOL, V44, pS3, DOI 10.1016/S0003-9969(99)00042-4; Handra-Luca A, 2005, AM J SURG PATHOL, V29, P881, DOI 10.1097/01.pas.0000159103.95360.e8; Haukioja A, 2008, ORAL MICROBIOL IMMUN, V23, P336, DOI 10.1111/j.1399-302X.2008.00435.x; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; Issa SMA, 2011, ELECTROPHORESIS, V32, P3554, DOI 10.1002/elps.201100374; JAY GD, 1990, ANAL BIOCHEM, V185, P324, DOI 10.1016/0003-2697(90)90302-P; JOHNSSON M, 1993, CRIT REV ORAL BIOL M, V4, P371, DOI 10.1177/10454411930040031601; Karn RC, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030275; Kawashima H, 2012, BIOL PHARM BULL, V35, P1637, DOI 10.1248/bpb.b12-00412; Kerschner JE, 2013, INT J PEDIATR OTORHI, V77, P1, DOI 10.1016/j.ijporl.2012.11.038; KEYES PAUL H., 1958, JOUR DENTAL RES, V37, P1088, DOI 10.1177/00220345580370060901; KISHIMOTO E, 1989, INFECT IMMUN, V57, P3702, DOI 10.1128/IAI.57.12.3702-3707.1989; Koo H, 2006, CARIES RES, V40, P20, DOI 10.1159/000088901; KOPEC LK, 1995, CARIES RES, V29, P507, DOI 10.1159/000262122; Kouznetsova I, 2010, CELL PHYSIOL BIOCHEM, V26, P375, DOI 10.1159/000320561; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; Kumar V, 2013, INFLAMM BOWEL DIS, V19, P1254, DOI 10.1097/MIB.0b013e318281f454; Larson R.H., 1981, SPL SUPP MICROBIOL A, P195; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lee YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067919; Lemos JA, 2010, METHODS MOL BIOL, V666, P87, DOI 10.1007/978-1-60761-820-1_7; Li J, 2003, ORAL MICROBIOL IMMUN, V18, P183, DOI 10.1034/j.1399-302X.2003.00065.x; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; LIGTENBERG AJM, 1990, ANTON LEEUW INT J G, V57, P97, DOI 10.1007/BF00403161; Ligtenberg AJM, 2000, ANTON LEEUW INT J G, V77, P21, DOI 10.1023/A:1002054810170; LIGTENBERG AJM, 1992, INFECT IMMUN, V60, P3878, DOI 10.1128/IAI.60.9.3878-3884.1992; Liu B, 2000, BIOCHEM J, V345, P557, DOI 10.1042/0264-6021:3450557; Loomes KM, 1999, EUR J BIOCHEM, V266, P105, DOI 10.1046/j.1432-1327.1999.00824.x; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Mothey D, 2014, FEMS MICROBIOL LETT, V350, P161, DOI 10.1111/1574-6968.12336; Moye ZD, 2014, APPL ENVIRON MICROB, V80, P972, DOI 10.1128/AEM.03579-13; MURRAY PA, 1992, INFECT IMMUN, V60, P31, DOI 10.1128/IAI.60.1.31-38.1992; Nakajima K, 2003, J HISTOCHEM CYTOCHEM, V51, P1689, DOI 10.1177/002215540305101213; Nakano K, 2010, J PHARMACOL SCI, V113, P120, DOI 10.1254/jphs.09R24FM; Nielsen PA, 1997, GLYCOBIOLOGY, V7, P413, DOI 10.1093/glycob/7.3.413; Offner G D, 2000, Adv Dent Res, V14, P69; Ozcan S, 2013, J PROTEOME RES, V12, P1090, DOI 10.1021/pr3008013; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pinkstaff C A, 1980, Int Rev Cytol, V63, P141, DOI 10.1016/S0074-7696(08)61759-3; PRAKOBPHOL A, 1993, CRIT REV ORAL BIOL M, V4, P325, DOI 10.1177/10454411930040031001; Prakobphol A, 2005, BIOCHEMISTRY-US, V44, P2216, DOI 10.1021/bi0480180; Radaelli E, 2010, J AM ASSOC LAB ANIM, V49, P69; Rayment SA, 2000, J DENT RES, V79, P1765; Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; ROSAN B, 1982, INFECT IMMUN, V38, P1056, DOI 10.1128/IAI.38.3.1056-1059.1982; ROTHER P, 1963, ACTA HISTOCHEM, V15, P325; Rousseau K, 2008, BIOCHEM J, V413, P545, DOI 10.1042/BJ20080260; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Siqueira WL, 2012, J DENT RES, V91, P1110, DOI 10.1177/0022034512462578; SLOMIANY A, 1978, J BIOL CHEM, V253, P7301; SLOMIANY BL, 1993, INT J BIOCHEM, V25, P935, DOI 10.1016/0020-711X(93)90250-I; Smith AMV, 2000, ARCH ORAL BIOL, V45, P277, DOI 10.1016/S0003-9969(99)00141-7; Sonesson M, 2008, ARCH ORAL BIOL, V53, P523, DOI 10.1016/j.archoralbio.2008.01.002; SUNDH B, 1993, ORAL SURG ORAL MED O, V76, P564, DOI 10.1016/0030-4220(93)90063-A; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; TABAK LA, 1985, ARCH ORAL BIOL, V30, P423, DOI 10.1016/0003-9969(85)90070-6; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Tanzer JM, 2006, J DENT RES, V85, P369, DOI 10.1177/154405910608500417; Thomsson KA, 2002, GLYCOBIOLOGY, V12, P1, DOI 10.1093/glycob/12.1.1; Thornton DJ, 1999, GLYCOBIOLOGY, V9, P293, DOI 10.1093/glycob/9.3.293; THORNTON DJ, 1995, ANAL BIOCHEM, V227, P162, DOI 10.1006/abio.1995.1266; Troxler RF, 1997, GLYCOBIOLOGY, V7, P965, DOI 10.1093/glycob/7.7.965; Umeno J, 2011, INFLAMM BOWEL DIS, V17, P2407, DOI 10.1002/ibd.21651; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; VANDERHOEVEN JS, 1990, ANTON LEEUW INT J G, V57, P165, DOI 10.1007/BF00403951; Veerman ECI, 2003, GLYCOBIOLOGY, V13, P363, DOI 10.1093/glycob/cwg037; Watson GE, 1997, ARCH ORAL BIOL, V42, P161, DOI 10.1016/S0003-9969(96)00100-8; Wen ZT, 2001, PLASMID, V45, P31, DOI 10.1006/plas.2000.1498; Wickstrom C, 2008, ORAL MICROBIOL IMMUN, V23, P177, DOI 10.1111/j.1399-302X.2007.00407.x; Wickstrom C, 2000, BIOCHEM J, V351, P421, DOI 10.1042/0264-6021:3510421; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Zhu LX, 2011, AM J RESP CELL MOL, V45, P348, DOI 10.1165/rcmb.2010-0312OC; Zimmerman JN, 2013, INT J MOL SCI, V14, P920, DOI 10.3390/ijms14010920	126	36	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2993	3008		10.1074/jbc.M114.597906	http://dx.doi.org/10.1074/jbc.M114.597906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512380	Green Published, hybrid			2022-12-28	WOS:000349310700037
J	Zhang, X; Meekins, DA; An, CJ; Zolkiewski, M; Battaile, KP; Kanost, MR; Lovell, S; Michel, K				Zhang, Xin; Meekins, David A.; An, Chunju; Zolkiewski, Michal; Battaile, Kevin P.; Kanost, Michael R.; Lovell, Scott; Michel, Kristin			Structural and Inhibitory Effects of Hinge Loop Mutagenesis in Serpin-2 from the Malaria Vector Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Host-Pathogen Interaction; Insect Immunity; Malaria; Serpin; Structural Biology	SERINE PROTEINASE HOMOLOGS; MANDUCA-SEXTA; FACTOR-XA; PROPHENOLOXIDASE ACTIVATION; MACROMOLECULAR STRUCTURES; ALLOSTERIC MECHANISM; ANTITHROMBIN-HEPARIN; IMMUNE-RESPONSES; SPACE-GROUP; INSECT	Background: Serpin-2 (SRPN2) is a key regulator of mosquito immunity and contains an inserted hinge region linked to activation in other serpins. Results: Structure/function analyses of hinge mutations refute a hypothesized activation mechanism in SRPN2. Conclusion: SRPN2 hinge insertion provides a thermodynamically stable conformation without restricting inhibitory capability. Significance: To effectively utilize SRPN2 for vector control, its mode of action must be understood. Serpin-2 (SRPN2) is a key negative regulator of the melanization response in the malaria vector Anopheles gambiae. SRPN2 irreversibly inhibits clip domain serine proteinase 9 (CLIPB9), which functions in a serine proteinase cascade culminating in the activation of prophenoloxidase and melanization. Silencing of SRPN2 in A. gambiae results in spontaneous melanization and decreased life span and is therefore a promising target for vector control. The previously determined structure of SRPN2 revealed a partial insertion of the hinge region of the reactive center loop (RCL) into sheet A. This partial hinge insertion participates in heparin-linked activation in other serpins, notably antithrombin III. SRPN2 does not contain a heparin binding site, and any possible mechanistic function of the hinge insertion was previously unknown. To investigate the function of the SRPN2 hinge insertion, we developed three SRPN2 variants in which the hinge regions are either constitutively expelled or inserted and analyzed their structure, thermostability, and inhibitory activity. We determined that constitutive hinge expulsion resulted in a 2.7-fold increase in the rate of CLIPB9(Xa) inhibition, which is significantly lower than previous observations of allosteric serpin activation. Furthermore, we determined that stable insertion of the hinge region did not appreciably decrease the accessibility of the RCL to CLIPB9. Together, these results indicate that the partial hinge insertion in SRPN2 does not participate in the allosteric activation observed in other serpins and instead represents a molecular trade-off between RCL accessibility and efficient formation of an inhibitory complex with the cognate proteinase.	[Zhang, Xin; Meekins, David A.; An, Chunju; Michel, Kristin] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [An, Chunju] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China; [Zolkiewski, Michal; Kanost, Michael R.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, Adv Photon Source Argonne Natl Lab, Ind Macromolecular Crystallog Assoc Collaborat Ac, Argonne, IL 60439 USA; [Lovell, Scott] Univ Kansas, Prot Struct Lab, Del Shankel Struct Biol Ctr, Lawrence, KS 66407 USA	Kansas State University; China Agricultural University; Kansas State University; Hauptman Woodward Medical Research Institute; University of Kansas	Michel, K (corresponding author), Kansas State Univ, Div Biol, 267 Chalmers Hall, Manhattan, KS 66506 USA.	kmichel@ksu.edu		Kanost, Michael/0000-0002-6827-0061; Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [R01AI095842, 5P20RR017708-10, 8P20GM103420-10]; Industrial Macromolecular Crystallography Association through Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Industrial Macromolecular Crystallography Association through Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI095842 (to K. M.). Use of the University of Kansas Protein Structure Laboratory was supported by National Institutes of Health Grants 5P20RR017708-10 and 8P20GM103420-10. Use of the Industrial Macromolecular Crystallography Association Collaborative Access Team beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; An CJ, 2011, PROTEINS, V79, P1999, DOI 10.1002/prot.23002; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dementiev A, 2013, J BIOL CHEM, V288, P33611, DOI 10.1074/jbc.M113.510727; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dunstone MA, 2011, METHOD ENZYMOL, V501, P63, DOI 10.1016/B978-0-12-385950-1.00005-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Felfoldi G, 2011, J IMMUNOL, V186, P4828, DOI 10.4049/jimmunol.1003246; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gulley MM, 2013, J INSECT PHYSIOL, V59, P138, DOI 10.1016/j.jinsphys.2012.08.015; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Jiang H, 1995, INSECT BIOCHEM MOLEC, V25, P1093, DOI 10.1016/0965-1748(95)00042-9; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Karunamoorthi K, 2014, INT J PREVENTIVE MED, V5, P529; Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76; Koella JC, 2009, ADV PARASIT, V68, P315, DOI 10.1016/S0065-308X(08)00612-X; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langdown J, 2004, J BIOL CHEM, V279, P47288, DOI 10.1074/jbc.M408961200; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park SH, 2011, J BIOL CHEM, V286, P1567, DOI 10.1074/jbc.M110.144006; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623; RATCLIFFE NA, 1984, SCIENCE, V226, P557, DOI 10.1126/science.226.4674.557; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Silva APB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-450; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Walderveen MC, 2010, J BIOCHEM, V148, P255, DOI 10.1093/jb/mvq060; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang JM, 2005, ACTA CRYSTALLOGR D, V61, P67, DOI 10.1107/S0907444904026721; Weiss DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-171; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1	75	6	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2946	2956		10.1074/jbc.M114.625665	http://dx.doi.org/10.1074/jbc.M114.625665			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525260	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000349310700033
J	Qu, Y; Chakrabarty, R; Iran, HT; Kwon, EJG; Kwon, M; Nguyen, TD; Ro, DK				Qu, Yang; Chakrabarty, Romit; Iran, Hue T.; Kwon, Eun-Joo G.; Kwon, Moonhyuk; Nguyen, Trinh-Don; Ro, Dae-Kyun			A Lettuce (Lactuca sativa) Homolog of Human Nogo-B Receptor Interacts with cis-Prenyltransferase and Is Necessary for Natural Rubber Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHATE SYNTHASE; GERANYL DIPHOSPHATE; DOLICHOL SYNTHESIS; OIL BODIES; PROTEIN LOCALIZATION; ALTERNATIVE SOURCES; CRYSTAL-STRUCTURE; BUDDING YEAST; KEY ENZYME; EXPRESSION	Natural rubber (cis-1,4-polyisoprene) is an indispensable biopolymer used to manufacture diverse consumer products. Although a major source of natural rubber is the rubber tree (Hevea brasiliensis), lettuce (Lactuca sativa) is also known to synthesize natural rubber. Here, we report that an unusual cisprenyltransferase- like 2 (CPTL2) that lacks the conserved motifs of conventional cis-prenyltransferase is required for natural rubber biosynthesis in lettuce. CPTL2, identified from the lettuce rubber particle proteome, displays homology to a human NogoB receptor and is predominantly expressed in latex. Multiple transgenic lettuces expressing CPTL2-RNAi constructs showed that a decrease of CPTL2 transcripts (3-15% CPTL2 expression relative to controls) coincided with the reduction of natural rubber as low as 5%. We also identified a conventional cis-prenyltransferase 3 (CPT3), exclusively expressed in latex. In subcellular localization studies using fluorescent proteins, cytosolic CPT3 was relocalized to endoplasmic reticulum by co-occurrence of CPTL2 in tobacco and yeast at the log phase. Furthermore, yeast two-hybrid data showed that CPTL2 and CPT3 interact. Yeast microsomes containing CPTL2/CPT3 showed enhanced synthesis of short cis-polyisoprenes, but natural rubber could not be synthesized in vitro. Intriguingly, a homologous pair CPTL1/CPT1, which displays ubiquitous expressions in lettuce, showed a potent dolichol biosynthetic activity in vitro. Taken together, our data suggest that CPTL2 is a scaffolding protein that tethers CPT3 on endoplasmic reticulum and is necessary for natural rubber biosynthesis in planta, but yeast-expressed CPTL2 and CPT3 alone could not synthesize high molecular weight natural rubber in vitro.	[Qu, Yang; Chakrabarty, Romit; Iran, Hue T.; Kwon, Eun-Joo G.; Kwon, Moonhyuk; Nguyen, Trinh-Don; Ro, Dae-Kyun] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Ro, DK (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	daekyun.ro@ucalgary.ca	Ro, Dae-Kyun/G-9289-2012	Ro, Dae-Kyun/0000-0003-1288-5347; Qu, Yang/0000-0002-0847-7212; Nguyen, Trinh-Don/0000-0002-2759-5791	Alberta Ingenuity New Faculty Award from Alberta Innovates Technology Future; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair; Next-Generation BioGreen 21 Program SSAC Grant from the Korean Rural Development Administration [PJ009549032014]	Alberta Ingenuity New Faculty Award from Alberta Innovates Technology Future; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Next-Generation BioGreen 21 Program SSAC Grant from the Korean Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by funds from the Alberta Ingenuity New Faculty Award from Alberta Innovates Technology Future, the Natural Sciences and Engineering Research Council of Canada, and the Canada Research Chair (to D. K. R.).; Supported by Next-Generation BioGreen 21 Program SSAC Grant PJ009549032014 from the Korean Rural Development Administration.	Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; Asawatreratanakul K, 2003, EUR J BIOCHEM, V270, P4671, DOI 10.1046/j.1432-1033.2003.03863.x; Burke C, 2002, J BIOL CHEM, V277, P3141, DOI 10.1074/jbc.M105900200; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Bushman BS, 2006, PHYTOCHEMISTRY, V67, P2590, DOI 10.1016/j.phytochem.2006.09.012; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; Cornish K, 2001, NAT PROD REP, V18, P182, DOI 10.1039/a902191d; Fehrenbacher KL, 2002, MOL BIOL CELL, V13, P854, DOI 10.1091/mbc.01-04-0184; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Golemis E. A., 2008, CURR PROTOC MOL BIOL; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kato JI, 1999, J BACTERIOL, V181, P2733, DOI 10.1128/JB.181.9.2733-2738.1999; Kera K, 2012, FEBS J, V279, P3813, DOI 10.1111/j.1742-4658.2012.08742.x; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Sasaki D, 2011, J BIOL CHEM, V286, P3729, DOI 10.1074/jbc.M110.147991; Sato M, 2001, GENES CELLS, V6, P495, DOI 10.1046/j.1365-2443.2001.00438.x; Sato M, 1999, MOL CELL BIOL, V19, P471; Schmidt T, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-11; SEILER GJ, 1991, ECON BOT, V45, P4, DOI 10.1007/BF02860045; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; SWANSON CL, 1979, J APPL POLYM SCI, V23, P743, DOI 10.1002/app.1979.070230309; Takahashi S, 2006, CHEM REC, V6, P194, DOI 10.1002/tcr.20083; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Teng KH, 2012, BIOORG CHEM, V43, P51, DOI 10.1016/j.bioorg.2011.09.004; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; TZEN JTC, 1992, J BIOL CHEM, V267, P15626; van Beilen JB, 2007, CRIT REV BIOTECHNOL, V27, P217, DOI 10.1080/07388550701775927; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Zhang HR, 2008, PLANT CELL, V20, P1879, DOI 10.1105/tpc.108.061150; Zulak KG, 2009, MOL CELL PROTEOMICS, V8, P86, DOI 10.1074/mcp.M800211-MCP200	46	54	56	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1898	1914		10.1074/jbc.M114.616920	http://dx.doi.org/10.1074/jbc.M114.616920			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477521	Green Published, hybrid			2022-12-28	WOS:000348588000001
J	Rodriguez, E; Nan, R; Li, KY; Gor, J; Perkins, SJ				Rodriguez, Elizabeth; Nan, Ruodan; Li, Keying; Gor, Jayesh; Perkins, Stephen J.			A Revised Mechanism for the Activation of Complement C3 to C3b A MOLECULAR EXPLANATION OF A DISEASE-ASSOCIATED POLYMORPHISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRON-SCATTERING; FACTOR-H; X-RAY; SEDIMENTATION-VELOCITY; CRYSTAL-STRUCTURE; COMPONENT C3; REVEALS; ULTRACENTRIFUGATION; FRAGMENTS; PROTEINS	The solution structure of complement C3b is crucial for the understanding of complement activation and regulation. C3b is generated by the removal of C3a from C3. Hydrolysis of the C3 thioester produces C3u, an analog of C3b. C3b cleavage results in C3c and C3d (thioester-containing domain; TED). To resolve functional questions in relation to C3b and C3u, analytical ultracentrifugation and x-ray and neutron scattering studies were used with C3, C3b, C3u, C3c, and C3d, using the wild-type allotype with Arg(102). In 50 mM NaCl buffer, atomistic scattering modeling showed that both C3b and C3u adopted a compact structure, similar to the C3b crystal structure in which its TED and macroglobulin 1 (MG1) domains were connected through the Arg(102)-Glu(1032) salt bridge. In physiological 137 mM NaCl, scattering modeling showed that C3b and C3u were both extended in structure, with the TED and MG1 domains now separated by up to 6 nm. The importance of the Arg(102)-Glu(1032) salt bridge was determined using surface plasmon resonance to monitor the binding of wild-type C3d(E1032) and mutant C3d(A1032) to immobilized C3c. The mutant did not bind, whereas the wild-type form did. The high conformational variability of TED in C3b in physiological buffer showed that C3b is more reactive than previously thought. Because the Arg(102)-Glu(1032) salt bridge is essential for the C3b-Factor H complex during the regulatory control of C3b, the known clinical associations of the major C3S (Arg(102)) and disease-linked C3F (Gly(102)) allotypes of C3b were experimentally explained for the first time.	[Rodriguez, Elizabeth; Nan, Ruodan; Li, Keying; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England	University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Div Biosci, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk			Centre for Molecular Structures and Dynamics of the Science and Technology Facilities Council; Engineering and Physical Sciences Research Council; CCP-SAS, a joint Engineering and Physical Sciences Research Council [EP/K039121/1]; National Science Foundation [CHE-1265821]; EPSRC [EP/K039121/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K039121/1] Funding Source: researchfish	Centre for Molecular Structures and Dynamics of the Science and Technology Facilities Council; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CCP-SAS, a joint Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Centre for Molecular Structures and Dynamics of the Science and Technology Facilities Council and the Engineering and Physical Sciences Research Council. Support for this work was also provided in part by the CCP-SAS project, a joint Engineering and Physical Sciences Research Council (EP/K039121/1) and National Science Foundation (CHE-1265821) grant. The work described here won an award for Best Oral Presentation at the XXVth International Complement Workshop in Rio de Janeiro, September 14 - 18, 2014.	Aleshin AE, 2012, J BIOL CHEM, V287, P19642, DOI 10.1074/jbc.M112.361121; ARVILOMMI H, 1975, J IMMUNOL METHODS, V8, P345, DOI 10.1016/0022-1759(75)90056-3; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Delanghe JR, 2014, PATHOLOGY, V46, P1, DOI 10.1097/PAT.0000000000000042; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Glatter O., 1982, SMALL ANGLE XRAY SCA, P17; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; HARDY RC, 1949, J RES NAT BUR STAND, V42, P573, DOI 10.6028/jres.042.049; HASE S, 1985, J BIOCHEM-TOKYO, V98, P863, DOI 10.1093/oxfordjournals.jbchem.a135366; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Heurich M, 2011, P NATL ACAD SCI USA, V108, P8761, DOI 10.1073/pnas.1019338108; HIRANI S, 1986, BIOCHEM J, V233, P613, DOI 10.1042/bj2330613; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Law S.K.A., 1995, COMPLEMENT; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; Li KY, 2010, BIOCHEM J, V431, P63, DOI 10.1042/BJ20100759; LINDNER P, 1992, PHYSICA B, V180, P967, DOI 10.1016/0921-4526(92)90524-V; Marrero A, 2012, ANGEW CHEM INT EDIT, V51, P3340, DOI 10.1002/anie.201108015; Nan R, 2008, J MOL BIOL, V384, P1341, DOI 10.1016/j.jmb.2008.10.030; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; PERKINS SJ, 1990, BIOCHEMISTRY-US, V29, P1175, DOI 10.1021/bi00457a012; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2011, METHODS, V54, P181, DOI 10.1016/j.ymeth.2011.01.004; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Winters MS, 2005, J IMMUNOL, V174, P3469, DOI 10.4049/jimmunol.174.6.3469; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	49	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2334	2350		10.1074/jbc.M114.605691	http://dx.doi.org/10.1074/jbc.M114.605691			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488663	Green Published, hybrid			2022-12-28	WOS:000348588000038
J	Li, J; Diaz, J; Wang, X; Tsang, SH; You, JX				Li, Jing; Diaz, Jason; Wang, Xin; Tsang, Sabrina H.; You, Jianxin			Phosphorylation of Merkel Cell Polyomavirus Large Tumor Antigen at Serine 816 by ATM Kinase Induces Apoptosis in Host Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; RETINOBLASTOMA FAMILY; SUPPRESSOR PROTEINS; CYCLE CHECKPOINT; VIRUS T; CARCINOMA; SIMIAN-VIRUS-40; REPLICATION	Merkel cell carcinoma is a highly aggressive form of skin cancer. Merkel cell polyomavirus (MCV) infection and DNA integration into the host genome correlate with 80% of all Merkel cell carcinoma cases. Integration of the MCV genome frequently results in mutations in the large tumor antigen (LT), leading to expression of a truncated LT that retains pRB binding but with a deletion of the C-terminal domain. Studies from our laboratory and others have shown that the MCV LT C-terminal helicase domain contains growth-inhibiting properties. Additionally, we have shown that host DNA damage response factors are recruited to viral replication centers. In this study, we identified a novel MCV LT phosphorylation site at Ser-816 in the C-terminal domain. We demonstrate that activation of the ATM pathway stimulated MCV LT phosphorylation at Ser-816, whereas inhibition of ATM kinase activity prevented LT phosphorylation at this site. In vitro phosphorylation experiments confirmed that ATM kinase is responsible for phosphorylating MCV LT at Ser-816. Finally, we show that ATM kinase-mediated MCV LT Ser-816 phosphorylation may contribute to the anti-tumorigenic properties of the MCV LT C-terminal domain.	[Li, Jing] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Diaz, Jason; Tsang, Sabrina H.; You, Jianxin] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Xin] Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44295 USA	The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Cleveland Clinic Foundation	You, JX (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, 201C Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu			National Institutes of Health [R01CA148768, R01CA142723, 3R01CA142723-05S1]; NATIONAL CANCER INSTITUTE [R01CA187718, T32CA115299, R01CA148768, R01CA142723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA148768, R01CA142723, and 3R01CA142723-05S1.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Agelli M, 2003, J AM ACAD DERMATOL, V49, P832, DOI 10.1016/S0190-9622(03)02108-X; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Bichakjian CK, 2007, CANCER-AM CANCER SOC, V110, P1, DOI 10.1002/cncr.22765; Bollag B, 2000, VIROLOGY, V274, P165, DOI 10.1006/viro.2000.0451; Borchert S, 2014, J VIROL, V88, P3144, DOI 10.1128/JVI.02916-13; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Carter JJ, 2013, P NATL ACAD SCI USA, V110, P12744, DOI 10.1073/pnas.1303526110; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cheng JW, 2013, J VIROL, V87, P6118, DOI 10.1128/JVI.00385-13; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; D'Amours D, 2001, J CELL SCI, V114, P3771; Demetriou SK, 2012, INT J CANCER, V131, P1818, DOI 10.1002/ijc.27440; Diaz J, 2014, CANCERS, V6, P1464, DOI 10.3390/cancers6031464; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022468; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Fradet-Turcotte A, 2007, J VIROL, V81, P9162, DOI 10.1128/JVI.00384-07; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gjoerup O, 2010, ADV CANCER RES, V106, P1, DOI 10.1016/S0065-230X(10)06001-X; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harris KF, 1996, J VIROL, V70, P2378, DOI 10.1128/JVI.70.4.2378-2386.1996; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Katunuma N, 2001, ADV ENZYME REGUL, V41, P237, DOI 10.1016/S0065-2571(00)00018-2; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; Li J, 2013, J VIROL, V87, P9173, DOI 10.1128/JVI.01216-13; Li Peng, 2004, Cell, VS116, pS57, DOI 10.1016/S0092-8674(04)00031-5; McVey D, 1996, J VIROL, V70, P3887, DOI 10.1128/JVI.70.6.3887-3893.1996; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Salvesen GS, 2002, CELL DEATH DIFFER, V9, P3, DOI 10.1038/sj.cdd.4400963; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Schrama D, 2012, CURR OPIN ONCOL, V24, P141, DOI 10.1097/CCO.0b013e32834fc9fe; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Shimazu T, 2006, ONCOGENE, V25, P7391, DOI 10.1038/sj.onc.1209731; Shivakumar CV, 1996, ONCOGENE, V13, P323; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Tsang SH, 2014, J VIROL, V88, P3285, DOI 10.1128/JVI.03656-13; Wang X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003021; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	54	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1874	1884		10.1074/jbc.M114.594895	http://dx.doi.org/10.1074/jbc.M114.594895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25480786	Green Published, hybrid			2022-12-28	WOS:000348056400051
J	Davies, HA; Madine, J; Middleton, DA				Davies, Hannah A.; Madine, Jillian; Middleton, David A.			Comparisons with Amyloid-beta Reveal an Aspartate Residue That Stabilizes Fibrils of the Aortic Amyloid Peptide Medin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Amyloid-beta (AB); Homology Modeling; Protein Misfolding; Protein Structure; Site-directed Mutagenesis; Dipolar Assisted Rotational Resonance; Rotational Echo Double Resonance; Salt Bridge; Solid-state NMR	PROTEIN SECONDARY STRUCTURE; SOLID-STATE NMR; CIRCULAR-DICHROISM SPECTRA; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; POLYPEPTIDE MEDIN; STRUCTURAL BASIS; ROTATING SOLIDS; OLIGOMERS; AGGREGATION	Background: Aggregates of the 50-aa protein medin are the main constituent of aortic medial amyloid. Results: Medin aggregation involves an aspartate residue analogous to Asp(23) of the Alzheimer A peptide. Conclusion: There are striking similarities in the aggregation properties of medin and A. Significance: Mechanistic insights will assist future investigations of medin in the most common form of human amyloid. Aortic medial amyloid (AMA) is the most common localized human amyloid, occurring in virtually all of the Caucasian population over the age of 50. The main protein component of AMA, medin, readily assembles into amyloid-like fibrils in vitro. Despite the prevalence of AMA, little is known about the self-assembly mechanism of medin or the molecular architecture of the fibrils. The amino acid sequence of medin is strikingly similar to the sequence of the Alzheimer disease (AD) amyloid- (A) polypeptides around the structural turn region of A, where mutations associated with familial, early onset AD, have been identified. Asp(25) and Lys(30) of medin align with residues Asp(23) and Lys(28) of A, which are known to form a stabilizing salt bridge in some fibril morphologies. Here we show that substituting Asp(25) of medin with asparagine (D25N) impedes assembly into fibrils and stabilizes non-cytotoxic oligomers. Wild-type medin, by contrast, aggregates into -sheet-rich amyloid-like fibrils within 50 h. A structural analysis of wild-type fibrils by solid-state NMR suggests a molecular repeat unit comprising at least two extended -strands, separated by a turn stabilized by a Asp(25)-Lys(30) salt bridge. We propose that Asp(25) drives the assembly of medin by stabilizing the fibrillar conformation of the peptide and is thus reminiscent of the influence of Asp(23) on the aggregation of A. Pharmacological comparisons of wild-type medin and D25N will help to ascertain the pathological significance of this poorly understood protein.	[Davies, Hannah A.; Madine, Jillian] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Middleton, David A.] Univ Lancaster, Dept Chem, Lancaster LA1 4YB, England	University of Liverpool; Lancaster University	Middleton, DA (corresponding author), Univ Lancaster, Dept Chem, Lancaster LA1 4YB, England.	d.middleton@lancaster.ac.uk	Madine, Jillian/AAM-6232-2021	Madine, Jillian/0000-0001-9963-5871; Davies, Hannah A/0000-0003-3025-8531; Middleton, David/0000-0002-3227-7632	British Heart Foundation [FS/09/033/ 27742, FS/12/61/29877]; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council; University of Warwick through Birmingham Science City Advanced Materials - Advantage West Midlands; European Regional Development Fund; EPSRC [EP/F017901/1] Funding Source: UKRI; British Heart Foundation [FS/09/033/27742] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/F017901/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Warwick through Birmingham Science City Advanced Materials - Advantage West Midlands; European Regional Development Fund(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by British Heart Foundation Grants FS/09/033/ 27742 and FS/12/61/29877. The UK 850 MHz Solid-State NMR Facility is funded by the Engineering and Physical Sciences Research Council, the Biotechnology and Biological Sciences Research Council, and the University of Warwick, including funding through Birmingham Science City Advanced Materials Projects 1 and 2 supported by Advantage West Midlands and the European Regional Development Fund.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Belitzky A, 2011, PHYS CHEM CHEM PHYS, V13, P13809, DOI 10.1039/c1cp20832b; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Berhanu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041479; Bram Yaron, 2014, Sci Rep, V4, P4267, DOI 10.1038/srep04267; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Cruz L, 2012, J PHYS CHEM B, V116, P6311, DOI 10.1021/jp301619v; Davies HA, 2014, PROTEIN EXPRES PURIF, V98, P32, DOI 10.1016/j.pep.2014.02.009; Davies HA, 2012, J PEPT SCI, V18, P65, DOI 10.1002/psc.1418; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fawzi NL, 2008, J AM CHEM SOC, V130, P6145, DOI 10.1021/ja710366c; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gu L, 2013, J NEUROCHEM, V126, P305, DOI 10.1111/jnc.12202; Gu L, 2013, J BIOL CHEM, V288, P18673, DOI 10.1074/jbc.M113.457739; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Haupt C, 2012, ANGEW CHEM INT EDIT, V51, P1576, DOI 10.1002/anie.201105638; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Izuo N, 2013, BIOCHEM BIOPH RES CO, V438, P1, DOI 10.1016/j.bbrc.2013.05.106; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Larsson A, 2007, BIOCHEM BIOPH RES CO, V361, P822, DOI 10.1016/j.bbrc.2007.06.187; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Levy E, 2006, J ALZHEIMERS DIS, V9, P329; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Madine J, 2010, EUR BIOPHYS J BIOPHY, V39, P1281, DOI 10.1007/s00249-010-0581-3; Madine J, 2009, BIOCHEMISTRY-US, V48, P3089, DOI 10.1021/bi802164e; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Patke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064974; Peng S, 2007, LAB INVEST, V87, P1195, DOI 10.1038/labinvest.3700679; Peng SW, 2005, AMYLOID, V12, P96, DOI 10.1080/13506120500107006; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Reches M, 2004, AMYLOID, V11, P81, DOI 10.1080/13506120412331272287; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tagliavini F., 1999, ALZHEIMERS REP, V2, pS28; Takahashi T, 2012, CHEM COMMUN, V48, P1568, DOI 10.1039/c1cc14552e; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tu LH, 2013, BIOCHEMISTRY-US, V52, P333, DOI 10.1021/bi3014278; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102	57	8	8	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7791	7803		10.1074/jbc.M114.602177	http://dx.doi.org/10.1074/jbc.M114.602177			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25614623	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000351613600038
J	Saliba, M; Ramalanjaona, N; Gulberti, S; Bertin-Jung, I; Thomas, A; Dahbi, S; Lopin-Bon, C; Jacquinet, JC; Breton, C; Ouzzine, M; Fournel-Gigleux, S				Saliba, Mineem; Ramalanjaona, Nick; Gulberti, Sandrine; Bertin-Jung, Isabelle; Thomas, Aline; Dahbi, Samir; Lopin-Bon, Chrystel; Jacquinet, Jean-Claude; Breton, Christelle; Ouzzine, Mohamed; Fournel-Gigleux, Sylvie			Probing the Acceptor Active Site Organization of the Human Recombinant beta 1,4-Galactosyltransferase 7 and Design of Xyloside-based Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Enzyme Kinetics; Glycosaminoglycan; Glycosyltransferase; Proteoglycan Synthesis; Site-directed Mutagenesis	EHLERS-DANLOS-SYNDROME; GALACTOSYLTRANSFERASE-I BETA-4GALT-7; PROTEIN LINKAGE REGION; HEPARAN-SULFATE BIOSYNTHESIS; BETA-D-XYLOSIDES; CHONDROITIN SULFATE; PROTEOGLYCAN BIOSYNTHESIS; TUMOR ATTENUATION; MOLECULAR-CLONING; PROGEROID FORM	Background: Glycosyltransferase inhibitors have important applications in therapeutics and as chemical biology tools. Results: The human 1,4-galactosyltransferase 7 enzyme active site was mapped by modeling, mutagenesis, and in vitro/in cellulo assays, and novel inhibitors were synthesized. Conclusion: An efficient inhibitor of 1,4-galactosyltransferase 7 and glycosaminoglycan synthesis was obtained. Significance: This inhibitory molecule can be exploited to investigate glycosaminoglycan biology and modulate glycosaminoglycan synthesis in therapeutics. Among glycosaminoglycan (GAG) biosynthetic enzymes, the human 1,4-galactosyltransferase 7 (h4GalT7) is characterized by its unique capacity to take over xyloside derivatives linked to a hydrophobic aglycone as substrates and/or inhibitors. This glycosyltransferase is thus a prime target for the development of regulators of GAG synthesis in therapeutics. Here, we report the structure-guided design of h4GalT7 inhibitors. By combining molecular modeling, in vitro mutagenesis, and kinetic measurements, and in cellulo analysis of GAG anabolism and decorin glycosylation, we mapped the organization of the acceptor binding pocket, in complex with 4-methylumbelliferone-xylopyranoside as prototype substrate. We show that its organization is governed, on one side, by three tyrosine residues, Tyr(194), Tyr(196), and Tyr(199), which create a hydrophobic environment and provide stacking interactions with both xylopyranoside and aglycone rings. On the opposite side, a hydrogen-bond network is established between the charged amino acids Asp(228), Asp(229), and Arg(226), and the hydroxyl groups of xylose. We identified two key structural features, i.e. the strategic position of Tyr(194) forming stacking interactions with the aglycone, and the hydrogen bond between the His(195) nitrogen backbone and the carbonyl group of the coumarinyl molecule to develop a tight binder of h4GalT7. This led to the synthesis of 4-deoxy-4-fluoroxylose linked to 4-methylumbelliferone that inhibited h4GalT7 activity in vitro with a K-i 10 times lower than the K-m value and efficiently impaired GAG synthesis in a cell assay. This study provides a valuable probe for the investigation of GAG biology and opens avenues toward the development of bioactive compounds to correct GAG synthesis disorders implicated in different types of malignancies.	[Saliba, Mineem; Ramalanjaona, Nick; Gulberti, Sandrine; Bertin-Jung, Isabelle; Ouzzine, Mohamed; Fournel-Gigleux, Sylvie] Univ Lorraine, CNRS, Fac Med, UMR 7365,Biopole, F-54505 Vandoeuvre Les Nancy, France; [Thomas, Aline; Breton, Christelle] Univ Grenoble Alpes, CERMAV, F-38041 Grenoble 9, France; [Dahbi, Samir; Lopin-Bon, Chrystel; Jacquinet, Jean-Claude] Univ Orleans, Inst Chim Organ & Analyt, Pole Chim, UMR 7311,CNRS, F-45067 Orleans 02, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Fournel-Gigleux, S (corresponding author), Univ Lorraine, CNRS, Fac Med, UMR 7365,Biopole, CS 50184, F-54505 Vandoeuvre Les Nancy, France.	sylvie.fournel-gigleux@univ-lorraine.fr	Ouzzine, Mohamed/G-4368-2013	lopin-bon, chrystel/0000-0002-5146-2905; GULBERTI, Sandrine/0000-0002-9378-4697; OUZZINE, Mohamed/0000-0003-0058-4950	Agence Nationale pour la Recherche (ANR) Meca-GT [ANR-13-BSV8-0011-01]; ANR GAG-Sorting Grant [ANR-13-JS07-0004-01]; Labex SynOrg Grant [ANR-11-LABX-0029]; International Associated Laboratory CNRS-Universite de Lorraine-University of Dundee; SFGEN; Region Lorraine-FEDER (Glyco-Fluo) grant; Region Lorraine; MSEDgenetique association	Agence Nationale pour la Recherche (ANR) Meca-GT(French National Research Agency (ANR)); ANR GAG-Sorting Grant(French National Research Agency (ANR)); Labex SynOrg Grant; International Associated Laboratory CNRS-Universite de Lorraine-University of Dundee; SFGEN; Region Lorraine-FEDER (Glyco-Fluo) grant(Region Grand-Est); Region Lorraine(Region Grand-Est); MSEDgenetique association	This work was supported by Agence Nationale pour la Recherche (ANR) Meca-GT Grant ANR-13-BSV8-0011-01, ANR GAG-Sorting Grant ANR-13-JS07-0004-01, Labex SynOrg Grant ANR-11-LABX-0029, International Associated Laboratory CNRS-Universite de Lorraine-University of Dundee, SFGEN), Region Lorraine-FEDER (Glyco-Fluo) grant, grants from the Region Lorraine (to N. R. and S. F. G.), and the AMSEDgenetique association.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bui C, 2010, FEBS LETT, V584, P3962, DOI 10.1016/j.febslet.2010.08.001; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clark SJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00412; Daligault F, 2009, BIOCHEM J, V418, P605, DOI 10.1042/BJ20081093; Eneyskaya EV, 2005, ORG BIOMOL CHEM, V3, P146, DOI 10.1039/b409583a; ESKO JD, 1987, J BIOL CHEM, V262, P12189; FOURNELGIGLEUX S, 1989, FEBS LETT, V243, P119, DOI 10.1016/0014-5793(89)80111-5; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Furukawa K, 2002, BBA-GEN SUBJECTS, V1573, P377, DOI 10.1016/S0304-4165(02)00406-3; Garud DR, 2008, J BIOL CHEM, V283, P28881, DOI 10.1074/jbc.M805939200; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; Gotte M, 2005, BIOCHEM GENET, V43, P65, DOI 10.1007/s10528-005-1068-2; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Halper J, 2014, ADV EXP MED BIOL, V802, P49, DOI 10.1007/978-94-007-7893-1_4; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Kadomatsu K, 2014, ARCH BIOCHEM BIOPHYS, V558, P36, DOI 10.1016/j.abb.2014.06.009; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; KOLSET SO, 1990, BIOCHEM J, V265, P637, DOI 10.1042/bj2650637; LAZARENO S, 1993, BRIT J PHARMACOL, V109, P1110, DOI 10.1111/j.1476-5381.1993.tb13737.x; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Malfait F, 2013, AM J HUM GENET, V92, P935, DOI 10.1016/j.ajhg.2013.04.016; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; Mani K, 1998, CANCER RES, V58, P1099; Martin NB, 1996, SEMIN THROMB HEMOST, V22, P247, DOI 10.1055/s-2007-999015; Muto J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025480; Nguyen TKN, 2013, ACS CHEM BIOL, V8, P939, DOI 10.1021/cb400132r; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Rahuel-Clermont S, 2010, BIOCHEM J, V432, P303, DOI 10.1042/BJ20100921; Ramakrishnan B, 2010, J BIOL CHEM, V285, P15619, DOI 10.1074/jbc.M109.099564; Raman K, 2011, BIOCHEM BIOPH RES CO, V404, P86, DOI 10.1016/j.bbrc.2010.11.069; Repasky Matthew P, 2007, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0812s18; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Siegbahn A, 2014, CHEM SCI, V5, P3501, DOI 10.1039/c4sc01244e; Siegbahn A, 2011, BIOORGAN MED CHEM, V19, P4114, DOI 10.1016/j.bmc.2011.05.007; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Talhaoui I, 2010, J BIOL CHEM, V285, P37342, DOI 10.1074/jbc.M110.151951; Tsutsui Y, 2013, J BIOL CHEM, V288, P31963, DOI 10.1074/jbc.M113.509984; Tsuzuki Y, 2010, BIOORG MED CHEM LETT, V20, P7269, DOI 10.1016/j.bmcl.2010.10.085; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Vassal-Stermann E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047933; Wang PP, 2014, PROTEIN PEPTIDE LETT, V21, P1048, DOI 10.2174/0929866521666140626095145; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200	51	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7658	7670		10.1074/jbc.M114.628123	http://dx.doi.org/10.1074/jbc.M114.628123			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25568325	Green Published, hybrid			2022-12-28	WOS:000351613600028
J	Ahmad, F; Shen, WX; Vandeput, F; Szabo-Fresnais, N; Krall, J; Degerman, E; Goetz, F; Klussmann, E; Movsesian, M; Manganiello, V				Ahmad, Faiyaz; Shen, Weixing; Vandeput, Fabrice; Szabo-Fresnais, Nicolas; Krall, Judith; Degerman, Eva; Goetz, Frank; Klussmann, Enno; Movsesian, Matthew; Manganiello, Vincent			Regulation of Sarcoplasmic Reticulum Ca2+ ATPase 2 (SERCA2) Activity by Phosphodiesterase 3A (PDE3A) in Human Myocardium PHOSPHORYLATION-DEPENDENT INTERACTION OF PDE3A1 WITH SERCA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTES; CALCIUM-ATPASE; 3B PDE3B; PROTEIN; HEART; PHOSPHOLAMBAN; INSULIN; ISOFORMS; CONTRACTILITY; ACTIVATION	Cyclic nucleotide phosphodiesterase 3A (PDE3) regulates cAMP-mediated signaling in the heart, and PDE3 inhibitors augment contractility in patients with heart failure. Studies in mice showed that PDE3A, not PDE3B, is the subfamily responsible for these inotropic effects and that murine PDE3A1 associates with sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2), phospholamban (PLB), and AKAP18 in a multiprotein signalosome in human sarcoplasmic reticulum (SR). Immunohistochemical staining demonstrated that PDE3A co-localizes in Z-bands of human cardiac myocytes with desmin, SERCA2, PLB, and AKAP18. In human SR fractions, cAMPincreased PLB phosphorylation and SERCA2 activity; this was potentiated by PDE3 inhibition but not by PDE4 inhibition. During gel filtration chromatography of solubilized SR membranes, PDE3 activity was recovered in distinct high molecular weight (HMW) and low molecular weight (LMW) peaks. HMW peaks contained PDE3A1 and PDE3A2, whereas LMW peaks contained PDE3A1, PDE3A2, and PDE3A3. Western blotting showed that endogenous HMW PDE3A1 was the principal PKA-phosphorylated isoform. Phosphorylation of endogenous PDE3A by rPKAc increased cAMP-hydrolytic activity, correlated with shift of PDE3A from LMW to HMW peaks, and increased co-immunoprecipitation of SERCA2, cav3, PKAregulatory subunit (PKARII), PP2A, and AKAP18 with PDE3A. In experiments with recombinant proteins, phosphorylation of recombinant human PDE3A isoforms by recombinant PKA catalytic subunit increased co-immunoprecipitation with rSERCA2 and rat rAKAP18 (recombinant AKAP18). Deletion of the recombinant human PDE3A1/PDE3A2 N terminus blocked interactions with recombinant SERCA2. Serine-to-alanine substitutions identified Ser-292/Ser-293, a site unique to human PDE3A1, as the principal site regulating its interaction with SERCA2. These results indicate that phosphorylation of human PDE3A1 at a PKA site in its unique N-terminal extension promotes its incorporation into SERCA2/AKAP18 signalosomes, where it regulates a discrete cAMP pool that controls contractility by modulating phosphorylation-dependent protein-protein interactions, PLB phosphorylation, and SERCA2 activity.	[Ahmad, Faiyaz; Shen, Weixing; Manganiello, Vincent] NHLBI, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA; [Vandeput, Fabrice; Szabo-Fresnais, Nicolas; Krall, Judith; Movsesian, Matthew] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Vandeput, Fabrice; Szabo-Fresnais, Nicolas; Krall, Judith; Movsesian, Matthew] Univ Utah, Salt Lake City, UT USA; [Degerman, Eva] Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden; [Klussmann, Enno] Max Delbrueck Ctr Mol Med Berlin Buch MDC, D-13125 Berlin, Germany; [Klussmann, Enno] German Ctr Cardiovasc Res, DZHK, D-13347 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Lund University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research	Ahmad, F (corresponding author), NHLBI, Cardiovasc Pulm Branch, NIH, Bldg 10,Rm 5N311,9000 Rockville Pike, Bethesda, MD 20892 USA.	Ahmadf@nhlbi.nih.gov	Szabo, Nicolas/AAG-1067-2019; Khan, Faiyaz Ahmad/AAW-7944-2021		National Institutes of Health NHLBI Intramural program; Foundation Leducq Grant [06CVD02 cAMP]; American Heart Association; Swedish Research Council [3362]; Deutsche Forschungsgemeinschaft [KL1415-4/2]; Else Kroner-Fresenius-Stiftung [2013_A145]; German-Israeli Foundation [I-1210-286.13/2012]; United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL002540] Funding Source: NIH RePORTER	National Institutes of Health NHLBI Intramural program; Foundation Leducq Grant; American Heart Association(American Heart Association); Swedish Research Council(Swedish Research CouncilEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Intramural program. This work was also supported by medical research funds from the United States Department of Veterans Affairs and Foundation Leducq Grant 06CVD02 cAMP and an American Heart Association grant-in-aid (to M. M.); by Swedish Research Council Project 3362 (to E.D.); and by Deutsche Forschungsgemeinschaft Grant KL1415-4/2, the Else Kroner-Fresenius-Stiftung (2013_A145), and the German-Israeli Foundation (I-1210-286.13/2012) (to E. K. and F. G.).	Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; Ahmad F, 2009, BIOCHEM J, V424, P399, DOI 10.1042/BJ20090842; [Anonymous], 2011, BASIC RES CARDIOL, V106, P249; Babick AP, 2004, AM J PHYSIOL-CELL PH, V287, pC1202, DOI 10.1152/ajpcell.00155.2004; Beca S, 2013, CIRC RES, V112, P289, DOI 10.1161/CIRCRESAHA.111.300003; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Kawase Y, 2008, NAT CLIN PRACT CARD, V5, P554, DOI 10.1038/ncpcardio1301; KIRCHGESSER M, 1990, J CLIN CHEM CLIN BIO, V28, P407; Kuschel M, 1999, AM J PHYSIOL-HEART C, V276, pH1625, DOI 10.1152/ajpheart.1999.276.5.H1625; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MANGANIELLO V, 1973, J BIOL CHEM, V248, P7164; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Mishra S, 2005, HEART VESSELS, V20, P23, DOI 10.1007/s00380-004-0792-6; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Movsesian MA, 2003, J CARD FAIL, V9, P475, DOI 10.1016/S1071-9164(03)00135-0; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Onuma H, 2002, DIABETES, V51, P3362, DOI 10.2337/diabetes.51.12.3362; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Perino A, 2011, MOL CELL, V42, P84, DOI 10.1016/j.molcel.2011.01.030; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; Sande JB, 2002, CARDIOVASC RES, V53, P382, DOI 10.1016/S0008-6363(01)00489-8; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P846, DOI 10.1016/j.yjmcc.2008.09.003; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Singh A, 2011, MOL PHARMACOL, V79, P533, DOI 10.1124/mol.110.065425; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110; Wechsler J, 2002, J BIOL CHEM, V277, P38072, DOI 10.1074/jbc.M203647200; Weninger S, 2014, CELL SIGNAL, V26, P2573, DOI 10.1016/j.cellsig.2014.07.027; Wilson LS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217026; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x	39	59	61	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6763	6776		10.1074/jbc.M115.638585	http://dx.doi.org/10.1074/jbc.M115.638585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25593322	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000350991500013
J	Baker, B; Geng, S; Chen, KQ; Diao, N; Yuan, RX; Xu, XG; Dougherty, S; Stephenson, C; Xiong, HB; Chu, HW; Li, LW				Baker, Bianca; Geng, Shuo; Chen, Keqiang; Diao, Na; Yuan, Ruoxi; Xu, Xiguang; Dougherty, Sean; Stephenson, Caroline; Xiong, Huabao; Chu, Hong Wei; Li, Liwu			Alteration of Lysosome Fusion and Low-grade Inflammation Mediated by Super-low-dose Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN GENE; NEGATIVE REGULATION; KAPPA-B; AUTOPHAGY; TOLLIP; SUSCEPTIBILITY; MACROPHAGES; LIPOPOLYSACCHARIDE; INDUCTION; VPS34	Subclinical super-low-dose endotoxin I,PS is a risk factor for the establishment of low-grade inflammation during the pathogenesis and progression of chronic diseases. However, the underlying mechanisms are not well understood. At the cellular level, a disruption of lysosome fusion with endosomes or autophagosomes may contribute to the potentiation of low-grade inflammation. In this study, we identified that subclinical super-low-dose endotoxin LPS can potently inhibit the process of endosome acidification and lysosome fusion with endosomes or autophagosomes in primary macrophages. Super-low-dose LPS induced the inhibitory phosphorylation of VPS34, thus leading to the disruption of endosome-lysosome fusion. This effect may depend upon the clearance and relocation of Tollip in macrophages by super-low-dose LPS. Consistent with this notion, Tollip-deficient macrophages had constitutively elevated levels of VPS34 inhibitory phosphorylation and constitutive disruption of endosome-lysosome fusion. By employing a skin excision wound-healing model, we observed that Tollip-deficient mice had significantly elevated levels of cell stress and reduced wound repair. This study reveals a novel mechanism responsible for the modulation of endosome-lysosome fusion and low-grade inflammation in innate macrophages.	[Baker, Bianca; Geng, Shuo; Chen, Keqiang; Diao, Na; Yuan, Ruoxi; Xu, Xiguang; Dougherty, Sean; Stephenson, Caroline; Li, Liwu] Virginia Polytech Inst & State Univ, Lab Inflammat Biol, Dept Biol Sci, Blacksburg, VA 24061 USA; [Xiong, Huabao] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Chu, Hong Wei] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	Virginia Polytechnic Institute & State University; Icahn School of Medicine at Mount Sinai; National Jewish Health	Li, LW (corresponding author), Virginia Tech, Dept Biol, Life Sci 1 Bldg,Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu	Geng, Shuo/J-3735-2013	Li, Liwu/0000-0001-8870-5299; Xu, Xiguang/0000-0001-6862-7545; Stephenson, Caroline/0000-0001-5615-4920; Yuan, Ruoxi/0000-0002-8719-341X	National Institutes of Health [R01HL115835, AI106287]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL115835 and AI106287 (to H. W. C. and L. L.).	Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Cannizzo ES, 2012, CELL REP, V2, P136, DOI 10.1016/j.celrep.2012.06.005; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Chang S., 2011, J MED SCI, V31, P191; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Maitra U, 2009, MOL CELL BIOL, V29, P5989, DOI 10.1128/MCB.00541-09; Mao K, 2011, CIRC RES, V108, P787, DOI 10.1161/RES.0b013e3182194c29; Mayer ML, 2013, J IMMUNOL, V190, P1227, DOI 10.4049/jimmunol.1201404; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Miura K, 2011, INFECT IMMUN, V79, P4947, DOI 10.1128/IAI.05640-11; Montoya-Buelna M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/459169; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Noda T, 2010, SEMIN CELL DEV BIOL, V21, P671, DOI 10.1016/j.semcdb.2010.04.002; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Puri R, 2012, HUM MOL GENET, V21, P175, DOI 10.1093/hmg/ddr452; Schimming TT, 2007, BMC DERMATOL, V7, DOI 10.1186/1471-5945-7-3; Shah JA, 2012, J IMMUNOL, V189, P1737, DOI 10.4049/jimmunol.1103541; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song ZJ, 2011, CRIT CARE, V15, DOI 10.1186/cc9413; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Wang JH, 2005, J IMMUNOL, V174, P6113, DOI 10.4049/jimmunol.174.10.6113; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yang QA, 2010, APOPTOSIS, V15, P1410, DOI 10.1007/s10495-010-0475-y; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	45	36	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6670	6678		10.1074/jbc.M114.611442	http://dx.doi.org/10.1074/jbc.M114.611442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586187	Green Published, hybrid			2022-12-28	WOS:000350732500067
J	Naito, A; Yamamoto, H; Kagawa, Y; Naito, Y; Okuzaki, D; Otani, K; Iwamoto, Y; Maeda, S; Kikuta, J; Nishikawa, K; Uemura, M; Nishimura, J; Hata, T; Takemasa, I; Mizushima, T; Ishii, H; Doki, Y; Mori, M; Ishii, M				Naito, Atsushi; Yamamoto, Hirofumi; Kagawa, Yoshinori; Naito, Yoko; Okuzaki, Daisuke; Otani, Keisuke; Iwamoto, Yoriko; Maeda, Sakae; Kikuta, Junichi; Nishikawa, Keizo; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki; Ishii, Masaru			RFPL4A Increases the G(1) Population and Decreases Sensitivity to Chemotherapy in Human Colorectal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; INITIATING CELLS; CYCLE PROGRESSION; P53; 5-FLUOROURACIL; CARCINOMA; EFFICIENT; THERAPY; PROTEIN; GROWTH	Cell cycle-arrested cancer cells are resistant to conventional chemotherapy that acts on the mitotic phases of the cell cycle, although the molecular mechanisms involved in halting cell cycle progression remain unclear. Here, we demonstrated that RFPL4A, an uncharacterized ubiquitin ligase, induced G(1) retention and thus conferred decreased sensitivity to chemotherapy in the human colorectal cancer cell line, HCT116. Long term time lapse observations in HCT116 cells bearing a "fluorescence ubiquitin-based cell cycle indicator" identified a characteristic population that is viable but remains in the G(1) phase for an extended period of time (up to 56 h). Microarray analyses showed that expression of RFPL4A was significantly up-regulated in these G(1)-arrested cells, not only in HCT116 cells but also in other cancer cell lines, and overexpression of RFPL4A increased the G(1) population and decreased sensitivity to chemotherapy. However, knockdown of RFPL4A expression caused the cells to resume mitosis and induced their susceptibility to anti-cancer drugs in vitro and in vivo. These results indicate that RFPL4A is a novel factor that increases the G(1) population and decreases sensitivity to chemotherapy and thus may be a promising therapeutic target for refractory tumor conditions.	[Naito, Atsushi; Kagawa, Yoshinori; Naito, Yoko; Otani, Keisuke; Iwamoto, Yoriko; Maeda, Sakae; Kikuta, Junichi; Nishikawa, Keizo; Ishii, Masaru] Osaka Univ, Grad Sch Med, Dept Immunol & Cell Biol, Suita, Osaka 5650871, Japan; [Naito, Atsushi; Yamamoto, Hirofumi; Kagawa, Yoshinori; Maeda, Sakae; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Ishii, Hideshi] Osaka Univ, Grad Sch Med, Dept Canc Profiling Discovery, Suita, Osaka 5650871, Japan; [Kagawa, Yoshinori; Naito, Yoko; Maeda, Sakae; Kikuta, Junichi; Nishikawa, Keizo; Ishii, Masaru] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Okuzaki, Daisuke] Osaka Univ, DNA Chip Dev Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Nishikawa, Keizo; Ishii, Masaru] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Mori, M (corresponding author), Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med & Frontier Biosci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	mmori@gesrug.med.osaka-u.ac.jp; mishii@icb.med.osaka-u.ac.jp	Kikuta, Junichi/HHS-8875-2022; Nishimura, Junichi/K-8390-2015; Ishii, Hideshi/AAV-5317-2020; Okuzaki, Daisuke/AAN-5641-2020; Otani, Keisuke/B-5705-2017	Nishimura, Junichi/0000-0001-8220-3423; Okuzaki, Daisuke/0000-0002-4552-783X; Otani, Keisuke/0000-0002-8275-0651	Ministry of Education, Science, Sports and Culture of Japan [22113007, 25253070]; International Human Frontier Science Program [RGY0077/2011]; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [22113007] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Human Frontier Science Program(Human Frontier Science Program); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grant-in-aid for Scientific Research on Innovative Areas 22113007 and by Grant-in-aid for Scientific Research (A) 25253070 from the Ministry of Education, Science, Sports and Culture of Japan; by International Human Frontier Science Program Grants RGY0077/2011; and by grants from the Takeda Science Foundation and Uehara Memorial Foundation.	Bonnefont J, 2008, AM J HUM GENET, V83, P208, DOI 10.1016/j.ajhg.2008.07.007; Bras-Goncalves RA, 2001, GASTROENTEROLOGY, V120, P874, DOI 10.1053/gast.2001.22440; Bras-Goncalves RA, 2000, BRIT J CANCER, V82, P913, DOI 10.1054/bjoc.1999.1019; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Iwahashi S, 2013, SURG TODAY, V43, P654, DOI 10.1007/s00595-012-0437-9; Kagawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083629; Kaminska B, 2013, ADV EXP MED BIOL, V986, P171, DOI 10.1007/978-94-007-4719-7_9; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Rajkovic A, 2002, MECH DEVELOP, V112, P173, DOI 10.1016/S0925-4773(01)00635-9; Roccio M, 2013, DEVELOPMENT, V140, P459, DOI 10.1242/dev.086215; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salcido CD, 2010, BRIT J CANCER, V102, P1636, DOI 10.1038/sj.bjc.6605668; Satow R, 2010, J BIOL CHEM, V285, P26289, DOI 10.1074/jbc.M109.090597; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shimada H, 2014, SURG TODAY, V44, P1957, DOI 10.1007/s00595-013-0787-y; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sohn KJ, 2004, JNCI-J NATL CANCER I, V96, P134, DOI 10.1093/jnci/djh015; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Takeishi S, 2014, BRIT J CANCER, V111, P1054, DOI 10.1038/bjc.2014.259; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wada H, 2007, ONCOL REP, V18, P801; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	35	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6326	6337		10.1074/jbc.M114.614859	http://dx.doi.org/10.1074/jbc.M114.614859			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605732	hybrid, Green Published			2022-12-28	WOS:000350732500038
J	Hansson, ML; Albert, S; Somermeyer, LG; Peco, R; Mejia-Ramirez, E; Montserrat, N; Belmonte, JCI				Hansson, Magnus L.; Albert, Silvia; Gonzalez Somermeyer, Louisa; Peco, Ruben; Mejia-Ramirez, Eva; Montserrat, Nuria; Izpisua Belmonte, Juan Carlos			Efficient Delivery and Functional Expression of Transfected Modified mRNA in Human Embryonic Stem Cell-derived Retinal Pigmented Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED DIFFERENTIATION; INNATE IMMUNITY; MITF; ACTIVATION; RPE; TRANSPLANTATION; RECOGNITION; TFE3; FATE	Gene- and cell-based therapies are promising strategies for the treatment of degenerative retinal diseases such as age-related macular degeneration, Stargardt disease, and retinitis pigmentosa. Cellular engineering before transplantation may allow the delivery of cellular factors that can promote functional improvements, such as increased engraftment or survival of transplanted cells. A current challenge in traditional DNA-based vector transfection is to find a delivery system that is both safe and efficient, but using mRNA as an alternative to DNA can circumvent these major roadblocks. In this study, we show that both unmodified and modified mRNA can be delivered to retinal pigmented epithelial (RPE) cells with a high efficiency compared with conventional plasmid delivery systems. On the other hand, administration of unmodified mRNA induced a strong innate immune response that was almost absent when using modified mRNA. Importantly, transfection of mRNA encoding a key regulator of RPE gene expression, microphthalmia-associated transcription factor (MITE), confirmed the functionality of the delivered mRNA. Immunostaining showed that transfection with either type of mRNA led to the expression of roughly equal levels of MITE, primarily localized in the nucleus. Despite these findings, quantitative RT-PCR analyses showed that the activation of the expression of MITE target genes was higher following toransfection with modified mRNA compared with unmodified mRNA. Our findings, therefore, show that modified mRNA transfection can be applied to human embryonic stem cell-derived RPE cells and that the method is safe, efficient, and functional.	[Hansson, Magnus L.; Albert, Silvia; Gonzalez Somermeyer, Louisa; Peco, Ruben; Mejia-Ramirez, Eva; Montserrat, Nuria] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Gonzalez Somermeyer, Louisa] Univ Barcelona, E-08007 Barcelona, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; University of Barcelona; Salk Institute	Hansson, ML (corresponding author), Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	magnus.l.hansson@ki.se; belmonte@salk.edu	Albert, Silvia/P-8231-2015; Montserrat, Nuria/F-3136-2016	Albert, Silvia/0000-0002-6921-0351; Montserrat, Nuria/0000-0002-1603-1755; Mejia-Ramirez, EVA/0000-0003-1251-5223; Gonzalez Somermeyer, Louisa/0000-0001-9139-5383	PLE-MINECO [PLE2009-0164]; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442] Funding Source: NIH RePORTER	PLE-MINECO; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by PLE-MINECO Grant PLE2009-0164, by the Moxie Foundation, by Leona M. and Harry B. Helmsley Charitable Trust Grant 2012-PG-MED002, and by the G. Harold and Leila Y. Mathers Charitable Foundation. To whom correspondence may be addressed: 10010 N. Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-453-4100; E-mail: belmonte@salk.edu.	Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson BR, 2011, NUCLEIC ACIDS RES, V39, P9329, DOI 10.1093/nar/gkr586; ARONSON JF, 1983, IN VITRO CELL DEV B, V19, P642; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Capowski EE, 2014, HUM MOL GENET, V23, P6332, DOI 10.1093/hmg/ddu351; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Chen HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036864; Falkner-Radler CI, 2011, BRIT J OPHTHALMOL, V95, P370, DOI 10.1136/bjo.2009.176305; Housset M, 2013, J NEUROSCI, V33, P9890, DOI 10.1523/JNEUROSCI.1099-13.2013; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Liu Y., 2010, INVEST OPHTH VIS SCI, V51, P3172; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Lu SY, 2010, HISTOCHEM CELL BIOL, V133, P651, DOI 10.1007/s00418-010-0703-0; Lui KO, 2013, CELL RES, V23, P1172, DOI 10.1038/cr.2013.112; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Maruotti J, 2012, PIGM CELL MELANOMA R, V25, P641, DOI 10.1111/j.1755-148X.2012.01033.x; Masuda T, 2014, J BIOL CHEM, V289, P12908, DOI 10.1074/jbc.M114.556738; Mays LE, 2013, J CLIN INVEST, V123, P1216, DOI 10.1172/JCI65351; Melville H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-53; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Puras G, 2014, J CONTROL RELEASE, V174, P27, DOI 10.1016/j.jconrel.2013.11.004; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Sunshine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037543; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Tucker BA, 2014, HUM MOL GENET, V23, pR9, DOI 10.1093/hmg/ddu124; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Vercauteren D, 2011, BIOMATERIALS, V32, P3072, DOI 10.1016/j.biomaterials.2010.12.045; Wang YH, 2013, MOL THER, V21, P358, DOI 10.1038/mt.2012.250; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682; Zhang KJ, 2014, PROTEIN CELL, V5, P48, DOI 10.1007/s13238-013-0011-2	48	18	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5661	5672		10.1074/jbc.M114.618835	http://dx.doi.org/10.1074/jbc.M114.618835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25555917	Green Published, hybrid			2022-12-28	WOS:000350044200035
J	Silva, JP; Vetterlein, O; Jose, J; Peters, S; Kirby, H				Silva, John-Paul; Vetterlein, Olivia; Jose, Joby; Peters, Shirley; Kirby, Hishani			The S228P Mutation Prevents in Vivo and in Vitro IgG4 Fab-arm Exchange as Demonstrated using a Combination of Novel Quantitative Immunoassays and Physiological Matrix Preparation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING ASSAYS; IMMUNOGLOBULIN G4; INTERACTION STRENGTH; DISULFIDE BOND; ANTIBODIES; HETEROGENEITY; VALIDATION; MOLECULES; DYNAMICS; ISOTYPE	Human immunoglobulin G isotype 4 (IgG4) antibodies (Abs) are potential candidates for immunotherapy when reduced effector functions are desirable. IgG4 Abs are dynamic molecules able to undergo a process known as Fab arm exchange (FAE). This results in functionally monovalent, bispecific antibodies (bsAbs) with unknown specificity and hence, potentially, reduced therapeutic efficacy. IgG4 FAE is suggested to be an important biological mechanism that provides the basis for the anti-inflammatory activity attributed to IgG4 Abs. To date, the mechanism of FAE is not entirely understood and studies measuring FAE in ex vivo matrices have been hampered by the presence and abundance of endogenous IgG4 wild-type (WT) Abs. Using representative humanized WT IgG4 monoclonal Abs, namely, anti-IL-6 and anti-TNF, and a core-hinge stabilized serine 228 to proline (S228P) anti-IL-6 IgG4 mutant, it is demonstrated for the first time how anti-IgG4 affinity chromatography can be used to prepare physiologically relevant matrices for assessing and quantifying FAE. A novel method for quantifying FAE using a single MSD immunoassay is also reported and confirms previous findings that, dependent on the redox conditions, the S228P mutation can prevent IgG4 FAE to undetectable levels both in vitro and in vivo. Together, the findings and novel methodologies will allow researchers to monitor and quantify FAE of their own IgG4 molecules in physiologically relevant matrices.	[Silva, John-Paul; Vetterlein, Olivia; Jose, Joby; Kirby, Hishani] UCB Pharma, Dept Bioanalyt Sci, Nonclin Dev, Slough SL1 3WE, Berks, England; [Peters, Shirley] UCB Pharma, Dept Antibody Technol & Biol, Slough SL1 3WE, Berks, England	UCB Pharma SA; UCB Pharma SA	Silva, JP (corresponding author), UCB Pharma, Dept Bioanalyt Sci, 208 Bath Rd, Slough SL1 3WE, Berks, England.	john.silva@UCB.com						Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; Bloom JW, 1997, PROTEIN SCI, V6, P407; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Burton DR, 2007, SCIENCE, V317, P1507, DOI 10.1126/science.1148905; Deng L, 2004, BIOTECHNOL APPL BIOC, V40, P261; DeSilva B, 2003, PHARM RES-DORDR, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Divatia M, 2012, YONSEI MED J, V53, P15, DOI 10.3349/ymj.2012.53.1.15; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; Kabat EA, 1991, SEQUENCES PROTEINS I; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Labrijn AF, 2008, CURR OPIN IMMUNOL, V20, P479, DOI 10.1016/j.coi.2008.05.010; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lewis KB, 2009, MOL IMMUNOL, V46, P3488, DOI 10.1016/j.molimm.2009.07.009; MARGNI RA, 1988, ANNU REV IMMUNOL, V6, P535, DOI 10.1146/annurev.iy.06.040188.002535; MILES J, 1994, ANN CLIN BIOCHEM, V31, P245, DOI 10.1177/000456329403100305; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Peters SJ, 2012, J BIOL CHEM, V287, P24525, DOI 10.1074/jbc.M112.369744; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rispens T, 2014, J BIOL CHEM, V289, P6098, DOI 10.1074/jbc.M113.541813; Rispens T, 2012, MULT SCLER J, V18, P899, DOI 10.1177/1352458511431073; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rispens T, 2010, MOL IMMUNOL, V47, P1592, DOI 10.1016/j.molimm.2010.02.021; Rose RJ, 2011, STRUCTURE, V19, P1274, DOI 10.1016/j.str.2011.06.016; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Shapiro RI, 2011, J PHARMACEUT BIOMED, V55, P168, DOI 10.1016/j.jpba.2011.01.006; Stubenrauch K, 2010, DRUG METAB DISPOS, V38, P84, DOI 10.1124/dmd.109.029751; Unt E, 2008, SCAND J MED SCI SPOR, V18, P360, DOI 10.1111/j.1600-0838.2007.00674.x; Viswanathan CT, 2007, PHARM RES, V24, P1962, DOI 10.1007/s11095-007-9291-7; Wilkinson IC, 2013, MABS-AUSTIN, V5, P406, DOI 10.4161/mabs.23941	35	39	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5462	5469		10.1074/jbc.M114.600973	http://dx.doi.org/10.1074/jbc.M114.600973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568323	hybrid, Green Published			2022-12-28	WOS:000350044200019
J	Takuma, H; Ushio, N; Minoji, M; Kazayama, A; Shigi, N; Hirata, A; Tomikawa, C; Ochi, A; Hori, H				Takuma, Hiroyuki; Ushio, Natsumi; Minoji, Masayuki; Kazayama, Ai; Shigi, Naoki; Hirata, Akira; Tomikawa, Chie; Ochi, Anna; Hori, Hiroyuki			Substrate tRNA Recognition Mechanism of Eubacterial tRNA (m(1)A58) Methyltransferase (TrmI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID METHYLASES; PHENYLALANINE TRANSFER-RNA; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; M(7)G46 METHYLTRANSFERASE; EXTREME THERMOPHILE; IN-VITRO; PURIFICATION; COMPLEX	TrmI generates N-1-methyladenosine at position 58 (m(1)A58) in tRNA. The Thermus thermophilus tRNA(Phe) transcript was methylated efficiently by T. thermophilus TrmI, whereas the yeast tRNA(Phe) transcript was poorly methylated. Fourteen chimeric tRNA transcripts derived from these two tRNAs revealed that TrmI recognized the combination of aminoacyl stem, variable region, and T-loop. This was confirmed by 10 deletion tRNA variants: TrmI methylated transcripts containing the aminoacyl stem, variable region, and T-arm. The requirement for the T-stem itself was confirmed by disrupting the T-stem. Disrupting the interaction between T- and D-arms accelerated the methylation, suggesting that this disruption is included in part of the reaction. Experiments with 17 point mutant transcripts elucidated the positive sequence determinants C56, purine 57, A58, and U60. Replacing A58 with inosine and 2-aminopurine completely abrogated methylation, demonstrating that the 6-amino group in A58 is recognized by TrmI. T. thermophilus tRNA(GGU)(GGU)(Thr)(Thr) contains C60 instead of U60. The tRNA(GGU)(Thr) transcript was poorly methylated by TrmI, and replacing C60 with U increased the methylation, consistent with the point mutation experiments. A gel shift assay revealed that tRNA(GGU)(Thr) had a low affinity for TrmI than tRNA(Phe). Furthermore, analysis of tRNA(GGU)(Thr) purified from the trmI gene disruptant strain revealed that the other modifications in tRNA accelerated the formation of m1A58 by TrmI. Moreover, nucleoside analysis of tRNA(GGU)(Thr) from the wild-type strain indicated that less than 50% of tRNA(GGU)(Thr) contained m(1)A58. Thus, the results from the in vitro experiments were confirmed by the in vivo methylation patterns.	[Takuma, Hiroyuki; Ushio, Natsumi; Minoji, Masayuki; Kazayama, Ai; Hirata, Akira; Tomikawa, Chie; Ochi, Anna; Hori, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan; [Shigi, Naoki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Koto Ku, Tokyo 1350064, Japan	Ehime University; National Institute of Advanced Industrial Science & Technology (AIST)	Hori, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Shigi, Naoki/L-7135-2018; Hori, Hiroyuki/AAB-3911-2021	Shigi, Naoki/0000-0003-4452-8264; 	Japan Society for the Promotion Science [23350081]	Japan Society for the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Science Research 23350081 (to H. H.) from the Japan Society for the Promotion Science.	Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Anderson J, 2000, P NATL ACAD SCI USA, V97, P5173, DOI 10.1073/pnas.090102597; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Awai T, 2011, J BIOL CHEM, V286, P35236, DOI 10.1074/jbc.M111.253641; Awai T, 2009, J BIOL CHEM, V284, P20467, DOI 10.1074/jbc.M109.020024; Barraud P, 2008, J MOL BIOL, V377, P535, DOI 10.1016/j.jmb.2008.01.041; Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112; Constantinesco F, 1999, NUCLEIC ACIDS RES, V27, P1308, DOI 10.1093/nar/27.5.1308; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; Droogmans L, 2003, NUCLEIC ACIDS RES, V31, P2148, DOI 10.1093/nar/gkg314; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; GLICK JM, 1977, J BIOL CHEM, V252, P4790; GRAWUNDER U, 1992, NUCLEIC ACIDS RES, V20, P137, DOI 10.1093/nar/20.1.137; GROSJEAN H, 1995, NUCLEIC ACIDS RES, V23, P4312, DOI 10.1093/nar/23.21.4312; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; GU XG, 1991, BIOCHEMISTRY-US, V30, P2999, DOI 10.1021/bi00226a003; Guelorget A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-48; Guelorget A, 2010, NUCLEIC ACIDS RES, V38, P6206, DOI 10.1093/nar/gkq381; Gupta A, 2001, J MOL BIOL, V312, P381, DOI 10.1006/jmbi.2001.4935; Hamdane D, 2014, NUCLEIC ACIDS RES, V42, P11697, DOI 10.1093/nar/gku820; Hori H, 1998, J BIOL CHEM, V273, P25721, DOI 10.1074/jbc.273.40.25721; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; HORIE N, 1985, BIOCHEMISTRY-US, V24, P5711, DOI 10.1021/bi00342a004; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Hoseki J, 2003, BIOCHEMISTRY-US, V42, P14469, DOI 10.1021/bi034776z; Ishida K, 2011, NUCLEIC ACIDS RES, V39, P2304, DOI 10.1093/nar/gkq1180; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kazayama A, 2015, J BIOCHEM, V157, P411, DOI 10.1093/jb/mvu089; Kempenaers M, 2010, NUCLEIC ACIDS RES, V38, P6533, DOI 10.1093/nar/gkq451; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; KLAGSBRUN M, 1973, J BIOL CHEM, V248, P2606; KRAUS J, 1978, BIOCHEM J, V169, P247, DOI 10.1042/bj1690247; Kuratani Mitsuo, 2014, Journal of Structural and Functional Genomics, V15, P173, DOI 10.1007/s10969-014-9183-0; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Matsumoto K, 2007, FEBS LETT, V581, P1599, DOI 10.1016/j.febslet.2007.03.023; MCFARLANE ES, 1972, BIOCHEM J, V129, P513, DOI 10.1042/bj1290513; MUTZEL R, 1986, EUR J BIOCHEM, V160, P101, DOI 10.1111/j.1432-1033.1986.tb09945.x; Ochi A, 2013, J BIOL CHEM, V288, P25562, DOI 10.1074/jbc.M113.485128; Okamoto H, 2004, J BIOL CHEM, V279, P49151, DOI 10.1074/jbc.M408209200; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Renda MJ, 2001, J VIROL, V75, P9671, DOI 10.1128/JVI.75.20.9671-9678.2001; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Roovers M, 2004, NUCLEIC ACIDS RES, V32, P465, DOI 10.1093/nar/gkh191; Roovers M, 2008, NUCLEIC ACIDS RES, V36, P3252, DOI 10.1093/nar/gkn169; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; Takano Y, 2006, MOL MICROBIOL, V60, P81, DOI 10.1111/j.1365-2958.2006.05080.x; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; Tomikawa C, 2010, NUCLEIC ACIDS RES, V38, P942, DOI 10.1093/nar/gkp1059; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; WATANABE K, 1976, BIOCHEM BIOPH RES CO, V72, P1137, DOI 10.1016/S0006-291X(76)80250-1; WIERZBICKA H, 1975, NUCLEIC ACIDS RES, V2, P101, DOI 10.1093/nar/2.1.101; WONG RSL, 1971, J BACTERIOL, V108, P446, DOI 10.1128/JB.108.1.446-450.1971; Yamagami R, 2012, J BIOL CHEM, V287, P42480, DOI 10.1074/jbc.M112.390112; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182	59	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5912	5925		10.1074/jbc.M114.606038	http://dx.doi.org/10.1074/jbc.M114.606038			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25593312	Green Published, hybrid			2022-12-28	WOS:000350044200054
J	Wendell, SG; Golin-Bisello, F; Wenzel, S; Sobol, RW; Holguin, F; Freeman, BA				Wendell, Stacy Gelhaus; Golin-Bisello, Franca; Wenzel, Sally; Sobol, Robert W.; Holguin, Fernando; Freeman, Bruce A.			15-Hydroxyprostaglandin Dehydrogenase Generation of Electrophilic Lipid Signaling Mediators from Hydroxy Omega-3 Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; DOCOSAHEXAENOIC ACID; LINOLEIC-ACID; IN-VIVO; FATTY; PROTEIN; INHIBITION; SUPPRESSOR; EXPRESSION; ADDUCTION	15-Hydroxyprostaglandin dehydrogenase (15PGDH) is the primary enzyme catalyzing the conversion of hydroxylated arachidonic acid species to their corresponding oxidized metabolites. The oxidation of hydroxylated fatty acids, such as the conversion of prostaglandin (PG) E-2 to 15-ketoPGE(2), by 15PGDH is viewed to inactivate signaling responses. In contrast, the typically electrophilic products can also induce anti-inflammatory and anti-proliferative responses. This study determined that hydroxylated docosahexaenoic acid metabolites (HDoHEs) are substrates for 15PGDH. Examination of 15PGDH substrate specificity was conducted in cell culture (A549 and primary human airway epithelia and alveolar macrophages) using chemical inhibition and shRNA knockdown of 15PGDH. Substrate specificity is broad and relies on the carbon position of the acyl chain hydroxyl group. 14-HDoHE was determined to be the optimal DHA substrate for 15PGDH, resulting in the formation of its electrophilic metabolite, 14-oxoDHA. Consistent with this, 14-HDoHE was detected in bronchoalveolar lavage cells of mild to moderate asthmatics, and the exogenous addition of 14-oxoDHA to primary alveolar macrophages inhibited LPS-induced proinflammatory cytokine mRNA expression. These data reveal that 15PGDH-derived DHA metabolites are biologically active and can contribute to the salutary signaling actions of Omega-3 fatty acids.	[Wendell, Stacy Gelhaus; Golin-Bisello, Franca; Sobol, Robert W.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wenzel, Sally; Holguin, Fernando] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA 15261 USA; [Wenzel, Sally; Holguin, Fernando] Univ Pittsburgh, Pittsburgh, PA 15261 USA; [Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wendell, SG (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, 200 Lothrop St,Biomed Sci Tower E1340, Pittsburgh, PA 15261 USA.	gstacy@pitt.edu; freerad@pitt.edu	Gelhaus, Stacy/AAF-2570-2019; Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563; Wenzel, Sally/0000-0002-4242-0164	National Institutes of Health Cancer Center Support Grant [CA047904]; NATIONAL CANCER INSTITUTE [R01CA148629, P30CA047904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058115, R01HL058115, R01HL064937, P01HL103455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R43ES021116, R44ES021116, R21ES019498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM099213, R43GM087798, R44GM087798] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Meghan Delmastro-Greenwood for critical review of the manuscript. Support for the UPCI Lentiviral Facility was provided by National Institutes of Health Cancer Center Support Grant CA047904.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Bilal S, 2011, BBA-MOL BASIS DIS, V1812, P1164, DOI 10.1016/j.bbadis.2011.05.002; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; Bull AW, 1996, LIFE SCI, V58, P2355, DOI 10.1016/0024-3205(96)00236-6; Charles RL, 2014, P NATL ACAD SCI USA, V111, P8167, DOI 10.1073/pnas.1402965111; Chiang N, 2003, BRIT J PHARMACOL, V139, P89, DOI 10.1038/sj.bjp.0705220; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Clish CB, 2000, J BIOL CHEM, V275, P25372, DOI 10.1074/jbc.M002863200; COHEN AB, 1971, J CLIN INVEST, V50, P1390, DOI 10.1172/JCI106622; Davies John Q, 2005, Methods Mol Biol, V290, P105; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; HEMPEL SL, 1994, J CLIN INVEST, V93, P391, DOI 10.1172/JCI116971; Hughes D, 2008, CANCER PREV RES, V1, P241, DOI 10.1158/1940-6207.CAPR-08-0055; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Liu XJ, 2011, CHEM RES TOXICOL, V24, P2227, DOI 10.1021/tx200336f; Liu ZX, 2008, CARCINOGENESIS, V29, P1219, DOI 10.1093/carcin/bgm297; Lu D, 2014, ONCOGENE, V33, P1101, DOI 10.1038/onc.2013.69; Lu DD, 2013, J BIOL CHEM, V288, P19484, DOI 10.1074/jbc.M113.453886; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Na HK, 2011, BIOCHEM PHARMACOL, V82, P1352, DOI 10.1016/j.bcp.2011.08.005; O'Flaherty JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045480; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; PACEASCIAK C, 1975, J BIOL CHEM, V250, P2795; Patel P, 2009, J PHARMACOL EXP THER, V329, P335, DOI 10.1124/jpet.108.143453; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Snyder NW, 2015, CHEM-BIOL INTERACT, V234, P144, DOI 10.1016/j.cbi.2014.10.029; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Tang JB, 2010, MOL CANCER RES, V8, P67, DOI 10.1158/1541-7786.MCR-09-0411; Trudeau J, 2006, J ALLERGY CLIN IMMUN, V117, P1446, DOI 10.1016/j.jaci.2006.01.049; VANROLLINS M, 1984, J BIOL CHEM, V259, P5776; VANROLLINS M, 1984, J LIPID RES, V25, P507; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Wei C, 2009, MOL PHARMACOL, V76, P516, DOI 10.1124/mol.109.057489; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Zhang JF, 2010, CIRC RES, V107, P540, DOI 10.1161/CIRCRESAHA.110.218404	43	18	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5868	5880		10.1074/jbc.M114.635151	http://dx.doi.org/10.1074/jbc.M114.635151			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25586183	hybrid, Green Published			2022-12-28	WOS:000350044200051
J	Zhao, HL; Bauzon, F; Bi, EG; Yu, JJ; Fu, H; Lu, ZL; Cui, JH; Jeon, HJ; Zang, XX; Ye, BH; Zhu, L				Zhao, Hongling; Bauzon, Frederick; Bi, Enguang; Yu, J. Jessica; Fu, Hao; Lu, Zhonglei; Cui, Jinhua; Jeon, Hyungjun; Zang, Xingxing; Ye, B. Hilda; Zhu, Liang			Substituting Threonine 187 with Alanine in p27Kip1 Prevents Pituitary Tumorigenesis by Two-Hit Loss of Rb1 and Enhances Humoral Immunity in Old Age	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; GERMINAL CENTER FORMATION; STEM-CELL QUIESCENCE; T-CELLS; P27 DEGRADATION; MICE LACKING; P27(KIP1); PHOSPHORYLATION; CENTERS; SCFSKP2	p27Kip1 (p27) is an inhibitor of cyclin-dependent kinases. Inhibiting p27 protein degradation is an actively developing cancer therapy strategy. One focus has been to identify small molecule inhibitors to block recruitment of Thr-187-phosphorylated p27 (p27T187p) to SCFSkp2/Cks1 ubiquitin ligase. Since phosphorylation of Thr-187 is required for this recruitment, p27T187A knockin (KI) mice were generated to determine the effects of systemically blocking interaction between p27 and Skp2/Cks1 on tumor susceptibility and other proliferation related mouse physiology. Rb1(+/-) mice develop pituitary tumors with full penetrance and the tumors are invariably Rb1(-/-), modeling tumorigenesis by two-hit loss of RB1 in humans. Immunization induced humoral immunity depends on rapid B cell proliferation and clonal selection in germinal centers (GCs) and declines with age in mice and humans. Here, we show that p27T187A KI prevented pituitary tumorigenesis in Rb1(+/-) mice and corrected decline in humoral immunity in older mice following immunization with sheep red blood cells (SRBC). These findings reveal physiological contexts that depend on p27 ubiquitination by SCFSkp2-Cks1 ubiquitin ligase and therefore help forecast clinical potentials of Skp2/Cks1-p27T187p interaction inhibitors. We further show that GC B cells and T cells use different mechanisms to regulate their p27 protein levels, and propose a T helper cell exhaustion model resembling that of stem cell exhaustion to understand decline in T cell-dependent humoral immunity in older age.	[Zhao, Hongling; Bauzon, Frederick; Fu, Hao; Lu, Zhonglei; Cui, Jinhua; Zhu, Liang] Albert Einstein Comprehens Canc Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Zhao, Hongling; Bauzon, Frederick; Bi, Enguang; Yu, J. Jessica; Fu, Hao; Lu, Zhonglei; Cui, Jinhua; Jeon, Hyungjun; Zang, Xingxing; Ye, B. Hilda; Zhu, Liang] Albert Einstein Comprehens Canc Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Liver Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Yeshiva University; Yeshiva University; Albert Einstein College of Medicine	Zhu, L (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave,Room U-521, Bronx, NY 10461 USA.	liang.zhu@einstein.yu.edu		Lu, Zhonglei/0000-0002-8915-4828; Zang, Xingxing/0000-0001-5380-1942	NIH [R01CA127901, R01CA131421, R01 CA85573]; Department of Defense PCRP Postdoctoral Fellowship [PC121837]; Irma T. Hirschl Career Scientist Award; NATIONAL CANCER INSTITUTE [R01CA085573, R01CA175495, P30CA013330, R01CA131421, R01CA127901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061153, P30DK041296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense PCRP Postdoctoral Fellowship(United States Department of Defense); Irma T. Hirschl Career Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants R01CA127901 and R01CA131421 (to L. Z.), and R01 CA85573 (to B. H. Y.). This work was also supported by a Department of Defense PCRP Postdoctoral Fellowship (PC121837) (to H. Z.), and the Irma T. Hirschl Career Scientist Award (to B. H. Y. and L. Z.).	Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Eaton SM, 2004, J EXP MED, V200, P1613, DOI 10.1084/jem.20041395; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Linterman MA, 2014, IMMUNOL CELL BIOL, V92, P72, DOI 10.1038/icb.2013.77; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Looney RJ, 2001, J CLIN IMMUNOL, V21, P30, DOI 10.1023/A:1006736931381; Lu ZL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4463; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Mountz JD, 2011, DISCOV MED, V11, P76; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ooi LC, 2013, CANCER SCI, V104, P1461, DOI 10.1111/cas.12246; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; Sanz-Gonzalez SM, 2006, J CELL BIOCHEM, V97, P735, DOI 10.1002/jcb.20680; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; Ungermannova D, 2013, J BIOMOL SCREEN, V18, P910, DOI 10.1177/1087057113485789; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Victora G. D., 2014, CELL, V159; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Yang XH, 1996, J EXP MED, V183, P959, DOI 10.1084/jem.183.3.959; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021; Zhu L, 2015, ONCOGENE, V34, P4547, DOI 10.1038/onc.2014.399	43	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5797	5809		10.1074/jbc.M114.625350	http://dx.doi.org/10.1074/jbc.M114.625350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25583987	Green Published, hybrid			2022-12-28	WOS:000350044200046
J	Gordon, ON; Luis, PB; Sintim, HO; Schneider, C				Gordon, Odaine N.; Luis, Paula B.; Sintim, Herman O.; Schneider, Claus			Unraveling Curcumin Degradation AUTOXIDATION PROCEEDS THROUGH SPIROEPOXIDE AND VINYLETHER INTERMEDIATES EN ROUTE TO THE MAIN BICYCLOPENTADIONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA TOPOISOMERASE-II; KAPPA-B KINASE; ANTIOXIDANT MECHANISM; BIOLOGICAL-ACTIVITIES; DIETARY CURCUMIN; HEME OXYGENASE-1; FATTY-ACIDS; METABOLITES; PRODUCTS; CANCER	Curcumin is a dietary anti-inflammatory and chemopreventive agent consisting of two methoxyphenol rings connected by a conjugated heptadienedione chain. Curcumin is unstable at physiological pH and rapidly degrades in an autoxidation reaction to a major bicyclopentadione product in which the 7-carbon chain has undergone oxygenation and double cyclization. Early degradation products (but not the final bicyclopentadione) mediate topoisomerase poisoning and possibly many other activities of curcumin, but it is not known how many and what autoxidation products are formed, nor their mechanism of formation. Here, using [C-14(2)] curcumin as a tracer, seven novel autoxidation products, including two reaction intermediates, were isolated and identified using one-and two-dimensional NMR and mass spectrometry. The unusual spiroepoxide and vinylether reaction intermediates are precursors to the final bicyclopentadione product. A mechanism for the autoxidation of curcumin is proposed that accounts for the addition and exchange of oxygen that have been determined using O-18(2) and (H2O)-O-18. Several of the by-products are formed from an endoperoxide intermediate via reactions that are well precedented in lipid peroxidation. The electrophilic spiroepoxide intermediate formed a stable adduct with N-acetylcysteine, suggesting that oxidative transformation is required for biological effects mediated by covalent adduction to protein thiols. The spontaneous autoxidation distinguishes curcumin among natural polyphenolic compounds of therapeutic interest; the formation of chemically diverse reactive and electrophilic products provides a novel paradigm for understanding the polypharmacological effects of curcumin.	[Gordon, Odaine N.; Luis, Paula B.; Schneider, Claus] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Gordon, Odaine N.; Luis, Paula B.; Schneider, Claus] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Sch Med, Nashville, TN 37232 USA; [Sintim, Herman O.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Vanderbilt University; Vanderbilt University; University System of Maryland; University of Maryland College Park	Schneider, C (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, 23rd Ave S Pierce, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu	Sintim, Herman O./B-4475-2009	Sintim, Herman O./0000-0002-2280-9359	National Institutes of Health [CA159382, AT006896, GM076592]; NIGMS [2T32GM07628]; NCCAM [F31AT007287]; Camille Dreyfus Foundation; Vanderbilt Institute in Chemical Biology [P30DK058404]; Vanderbilt Digestive Diseases Research Center; NCI SPORE in GI Cancer Pilot Award [5P50CA095103]; NATIONAL CANCER INSTITUTE [P50CA095103, R03CA159382] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [F31AT007287] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592, T32GM007628, R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Camille Dreyfus Foundation; Vanderbilt Institute in Chemical Biology; Vanderbilt Digestive Diseases Research Center; NCI SPORE in GI Cancer Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA159382, AT006896, and GM076592 (to C. S.) and NIGMS Training Grant 2T32GM07628 and NCCAM Predoctoral Fellowship Award F31AT007287 (to O. N. G.). This work was also supported by the Camille Dreyfus Foundation (to H. O. S.), Pilot Award P30DK058404 from the Vanderbilt Institute in Chemical Biology, the Vanderbilt Digestive Diseases Research Center, and the NCI SPORE in GI Cancer Pilot Award 5P50CA095103.	Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Ballatore C, 2011, J MED CHEM, V54, P6969, DOI 10.1021/jm200980u; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dhillon N, 2009, CLIN CANCER RES, V15, P7108, DOI 10.1158/1078-0432.CCR-09-2362; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; FORRESTER IT, 1988, BIOCHEM BIOPH RES CO, V157, P992, DOI 10.1016/S0006-291X(88)80972-0; Foti MC, 2007, J PHARM PHARMACOL, V59, P1673, DOI 10.1211/jpp.59.12.0010; Funk JL, 2010, J AGR FOOD CHEM, V58, P842, DOI 10.1021/jf9027206; Funk JL, 2006, J NAT PROD, V69, P351, DOI 10.1021/np050327j; Galano A, 2009, CHEM PHYS, V363, P13, DOI 10.1016/j.chemphys.2009.07.003; GIERER J, 1977, ACTA CHEM SCAND B, V31, P561, DOI 10.3891/acta.chem.scand.31b-0561; Gimenez-Bastida JA, 2012, MOL NUTR FOOD RES, V56, P784, DOI 10.1002/mnfr.201100677; Gordon ON, 2013, J LABELLED COMPD RAD, V56, P696, DOI 10.1002/jlcr.3102; Gordon ON, 2012, TRENDS MOL MED, V18, P361, DOI 10.1016/j.molmed.2012.04.011; Griesser M, 2011, J BIOL CHEM, V286, P1114, DOI 10.1074/jbc.M110.178806; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HUANG MT, 1994, CANCER RES, V54, P5841; Ireson C, 2001, CANCER RES, V61, P1058; Jahn U, 2008, ANGEW CHEM INT EDIT, V47, P5894, DOI 10.1002/anie.200705122; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Jiao Y, 2009, BLOOD, V113, P462, DOI 10.1182/blood-2008-05-155952; Jovanovic SV, 1999, J AM CHEM SOC, V121, P9677, DOI 10.1021/ja991446m; Karhu M., 1981, J CHEM SOC PERK T, V1, P303; Ketron AC, 2013, BIOCHEMISTRY-US, V52, P221, DOI 10.1021/bi3014455; KORNBLUM N, 1951, J AM CHEM SOC, V73, P880, DOI 10.1021/ja01146a542; Lambert JD, 2007, MOL PHARMACEUT, V4, P819, DOI 10.1021/mp700075m; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Litwinienko G, 2004, J ORG CHEM, V69, P5888, DOI 10.1021/jo049254j; Litwinienko G, 2007, ACCOUNTS CHEM RES, V40, P222, DOI 10.1021/ar0682029; Lopez-Lazaro M, 2007, J NAT PROD, V70, P1884, DOI 10.1021/np070332i; Martin-Cordero C, 2003, J ENZYM INHIB MED CH, V18, P505, DOI 10.1080/14756360310001613085; Masuda T, 1999, J AGR FOOD CHEM, V47, P71, DOI 10.1021/jf9805348; Masuda T, 2001, J AGR FOOD CHEM, V49, P2539, DOI 10.1021/jf001442x; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; PABON HJJ, 1964, RECL TRAV CHIM PAY B, V83, P379; Pereira MA, 1996, CARCINOGENESIS, V17, P1305, DOI 10.1093/carcin/17.6.1305; PORTER NA, 1984, TETRAHEDRON LETT, V25, P807, DOI 10.1016/S0040-4039(01)80032-0; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Priyadarsini KI, 2003, FREE RADICAL BIO MED, V35, P475, DOI 10.1016/S0891-5849(03)00325-3; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 1998, J MOL CATAL B-ENZYM, V4, P219, DOI 10.1016/S1381-1177(98)00002-2; Shen L, 2012, TRENDS MOL MED, V18, P138, DOI 10.1016/j.molmed.2012.01.004; Szewczuk LM, 2005, J NAT PROD, V68, P36, DOI 10.1021/np049702i; Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200; TAUROG A, 1992, ANAL BIOCHEM, V205, P271, DOI 10.1016/0003-2697(92)90434-9; Toth G, 2000, MAGN RESON CHEM, V38, P51, DOI 10.1002/(SICI)1097-458X(200001)38:1<51::AID-MRC593>3.3.CO;2-U; VEDERAS JC, 1980, J AM CHEM SOC, V102, P374, DOI 10.1021/ja00521a063; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Wu JC, 2011, MOL NUTR FOOD RES, V55, P1646, DOI 10.1002/mnfr.201100454; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z	57	108	111	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4817	4828		10.1074/jbc.M114.618785	http://dx.doi.org/10.1074/jbc.M114.618785			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564617	hybrid, Green Published			2022-12-28	WOS:000350042000027
J	Sankhala, RS; Koksal, AC; Ho, L; Nitschke, F; Minassian, BA; Cingolani, G				Sankhala, Rajeshwer S.; Koksal, Adem C.; Ho, Lan; Nitschke, Felix; Minassian, Berge A.; Cingolani, Gino			Dimeric Quaternary Structure of Human Laforin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; PROGRESSIVE MYOCLONUS EPILEPSY; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; BINDING DOMAIN; EPM2A GENE; PROTEIN; MUTATIONS; GLYCOGEN; PHOSPHORYLATION	The phosphatase laforin removes phosphate groups from glycogen during biosynthetic activity. Loss-of-function mutations in the gene encoding laforin is the predominant cause of Lafora disease, a fatal form of progressive myoclonic epilepsy. Here, we used hybrid structural methods to determine the molecular architecture of human laforin. We found that laforin adopts a dimeric quaternary structure, topologically similar to the prototypical dual specificity phosphatase VH1. The interface between the laforin carbohydrate-binding module and the dual specificity phosphatase domain generates an intimate substrate-binding crevice that allows for recognition and dephosphorylation of phosphomonoesters of glucose. We identify novel molecular determinants in the laforin active site that help decipher the mechanism of glucan phosphatase activity.	[Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Koksal, Adem C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Nitschke, Felix; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Univ Toronto, Inst Med Sci, Dept Pediat, Toronto, ON M5S 1A8, Canada	Jefferson University; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu	Nitschke, Felix/AAN-1155-2021	Nitschke, Felix/0000-0002-1118-2693; Koksal, Adem/0000-0002-3163-7421	NCI [P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017987] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the staff at the National Synchrotron Light Source beamlines X6A, X29, and X9 for assistance in data collection. Research in this publication includes work carried out at the Sydney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility, which is supported in part by NCI Grant P30 CA56036.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AFONINE PV, 2013, COMPUT CRYSTALLOGR N, V0004; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; DePaoli-Roach AA, 2015, J BIOL CHEM, V290, P841, DOI 10.1074/jbc.M114.607796; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Dukhande VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gayarre J, 2014, BRAIN, V137, P806, DOI 10.1093/brain/awt353; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Hejazi M, 2010, PLANT PHYSIOL, V152, P711, DOI 10.1104/pp.109.149914; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; Koksal AC, 2011, J BIOL CHEM, V286, P14373, DOI 10.1074/jbc.M111.226357; Koksal AC, 2009, J BIOL CHEM, V284, P10129, DOI 10.1074/jbc.M808362200; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Lokareddy RK, 2013, BIOCHEMISTRY-US, V52, P938, DOI 10.1021/bi301476m; Meekins DA, 2014, P NATL ACAD SCI USA, V111, P7272, DOI 10.1073/pnas.1400757111; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2002, ADV NEUROL, V89, P199; Minassian BA, 2001, ANN NEUROL, V49, P271, DOI 10.1002/1531-8249(20010201)49:2<271::AID-ANA52>3.3.CO;2-4; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez-Martin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069523; Sankhala RS, 2014, BIOCHEMISTRY-US, V53, P862, DOI 10.1021/bi401240x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiao JY, 2011, P NATL ACAD SCI USA, V108, P11860, DOI 10.1073/pnas.1109290108	49	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4552	4559		10.1074/jbc.M114.627406	http://dx.doi.org/10.1074/jbc.M114.627406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538239	hybrid, Green Published			2022-12-28	WOS:000350042000003
J	Zamurs, LK; Idoate, MA; Hanssen, E; Gomez-Ibanez, A; Pastor, P; Lamande, SR				Zamurs, Laura K.; Idoate, Miguel A.; Hanssen, Eric; Gomez-Ibanez, Asier; Pastor, Pau; Lamande, Shireen R.			Aberrant Mitochondria in a Bethlem Myopathy Patient with a Homozygous Amino Acid Substitution That Destabilizes the Collagen VI alpha 2(VI) Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; MICROFIBRIL FORMATION; GLYCINE MUTATIONS; DOMINANT; MUSCLE; DOMAIN; CELLS; GENE; CONTRACTURES; DEGRADATION	Bethlem myopathy and Ullrich congenital muscular dystrophy (UCMD) sit at opposite ends of a clinical spectrum caused by mutations in the extracellular matrix protein collagen VI. Bethlem myopathy is relatively mild, and patients remain ambulant in adulthood while many UCMD patients lose ambulation by their teenage years and require respiratory interventions. Dominant and recessive mutations are found across the entire clinical spectrum; however, recessive Bethlem myopathy is rare, and our understanding of the molecular pathology is limited. We studied a patient with Bethlem myopathy. Electron microscopy of his muscle biopsy revealed abnormal mitochondria. We identified a homozygous COL6A2 p. D871N amino acid substitution in the C-terminal C2 A-domain. Mutant alpha 2(VI) chains are unable to associate with alpha 1(VI) and alpha 3(VI) and are degraded by the proteasomal pathway. Some collagen VI is assembled, albeit more slowly than normal, and is secreted. These molecules contain the minor alpha 2(VI) C2a splice form that has an alternative C terminus that does include the mutation. Collagen VI tetramers containing the alpha 2(VI) C2a chain do not assemble efficiently into microfibrils and there is a severe collagen VI deficiency in the extracellular matrix. We expressed wildtype and mutant alpha 2(VI) C2 domains in mammalian cells and showed that while wild-type C2 domains are efficiently secreted, the mutant p.D871N domain is retained in the cell. These studies shed new light on the protein domains important for intracellular and extracellular collagen VI assembly and emphasize the importance of molecular investigations for families with collagen VI disorders to ensure accurate diagnosis and genetic counseling.	[Zamurs, Laura K.; Lamande, Shireen R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Idoate, Miguel A.] Univ Navarra, Sch Med, Univ Navarra Clin, Dept Pathol, Pamplona 31008, Spain; [Gomez-Ibanez, Asier] Univ Navarra, Sch Med, Univ Navarra Clin, Dept Neurol, Pamplona 31008, Spain; [Hanssen, Eric] Univ Melbourne, Electron Microscopy Unit, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Lamande, Shireen R.] Univ Melbourne, Dept Paediat, Parkville, Vic 3010, Australia; [Pastor, Pau] Univ Navarra, Ctr Appl Med Res, Div Neurosci, Neurogenet Lab, Pamplona 31008, Spain; [Pastor, Pau] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28220, Spain	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Navarra; University of Navarra; University of Melbourne; University of Melbourne; University of Navarra; CIBERNED; Instituto de Salud Carlos III	Lamande, SR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	shireen.lamande@mcri.edu.au	Pastor, Pau/C-9834-2009; Hanssen, Eric/A-7217-2013; Idoate, Miguel-Ángel/D-8502-2019	Pastor, Pau/0000-0002-7493-8777; Hanssen, Eric/0000-0002-4064-1844; Idoate, Miguel-Ángel/0000-0002-1596-1192; Lamande, Shireen/0000-0003-2938-2711	National Health & Medical Research Council of Australia [491252, 436903]; Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program	This work was supported in part by Project Grant 491252 and Research Fellowship 436903 (to S. R. L.) from the National Health & Medical Research Council of Australia, the Murdoch Childrens Research Institute, and the Victorian Government's Operational Infrastructure Support Program.	Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; Brockington M, 2004, PRENATAL DIAG, V24, P440, DOI 10.1002/pd.902; Butterfield RJ, 2013, HUM MUTAT, V34, P1558, DOI 10.1002/humu.22429; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Foley AR, 2009, NEUROMUSCULAR DISORD, V19, P813, DOI 10.1016/j.nmd.2009.09.010; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gualandi F, 2009, NEUROLOGY, V73, P1883, DOI 10.1212/WNL.0b013e3181c3fd2a; Higuchi I, 2001, ANN NEUROL, V50, P261, DOI 10.1002/ana.1120; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jimenez-Mallebrera C, 2006, NEUROMUSCULAR DISORD, V16, P571, DOI 10.1016/j.nmd.2006.07.015; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Lamande SR, 2002, J BIOL CHEM, V277, P1949, DOI 10.1074/jbc.M109932200; Lamande SR, 1999, J BIOL CHEM, V274, P21817, DOI 10.1074/jbc.274.31.21817; MALANDRINI A, 1995, J NEUROL SCI, V132, P195, DOI 10.1016/0022-510X(95)00156-V; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355; Pace RA, 2008, ANN NEUROL, V64, P294, DOI 10.1002/ana.21439; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; STOKES DG, 1991, J BIOL CHEM, V266, P8626; Timpl R, 1994, EXTRACELLULAR MATRIX, P207, DOI 10.1016/B978-0-12-775170-2.50012-3; Tooley LD, 2010, J BIOL CHEM, V285, P33567, DOI 10.1074/jbc.M110.152520; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wilson R, 2002, J BIOL CHEM, V277, P12516, DOI 10.1074/jbc.M112044200; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; ZANUSSI S, 1992, J BIOL CHEM, V267, P24082; Zhang RZ, 2010, J BIOL CHEM, V285, P10005, DOI 10.1074/jbc.M109.093666	38	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4272	4281		10.1074/jbc.M114.632208	http://dx.doi.org/10.1074/jbc.M114.632208			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25533456	hybrid, Green Published			2022-12-28	WOS:000349458400037
J	Cotter, K; Capecci, J; Sennoune, S; Huss, M; Maier, M; Martinez-Zaguilan, R; Forgac, M				Cotter, Kristina; Capecci, Joseph; Sennoune, Souad; Huss, Markus; Maier, Martin; Martinez-Zaguilan, Raul; Forgac, Michael			Activity of Plasma Membrane V-ATPases Is Critical for the Invasion of MDA-MB231 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; AMINO-TERMINAL DOMAIN; CATHEPSIN-B; A3 ISOFORM; SUBUNIT ISOFORMS; PROTON PUMPS; METASTASIS; BINDING; PH; INHIBITION	The vacuolar (H+)-ATPases (V-ATPases) are a family of ATP-driven proton pumps that couple ATP hydrolysis with translocation of protons across membranes. Previous studies have implicated V-ATPases in cancer cell invasion. It has been proposed that V-ATPases participate in invasion by localizing to the plasma membrane and causing acidification of the extracellular space. To test this hypothesis, we utilized two separate approaches to specifically inhibit plasma membrane V-ATPases. First, we stably transfected highly invasive MDA-MB231 cells with a V5-tagged construct of the membrane-embedded c subunit of the V-ATPase, allowing for extracellular expression of the V5 epitope. We evaluated the effect of addition of a monoclonal antibody directed against the V5 epitope on both V-ATPase-mediated proton translocation across the plasma-membrane and invasion using an in vitro Matrigel assay. The addition of anti-V5 antibody resulted in acidification of the cytosol and a decrease in V-ATPase-dependent proton flux across the plasma membrane in transfected but not control (untransfected) cells. These results demonstrate that the anti-V5 antibody inhibits activity of plasma membrane V-ATPases in transfected cells. Addition of the anti-V5 antibody also inhibited in vitro invasion of transfected (but not untransfected) cells. Second, we utilized a biotin-conjugated form of the specific V-ATPase inhibitor bafilomycin. When bound to streptavidin, this compound cannot cross the plasma membrane. Addition of this compound to MDA-MB231 cells also inhibited in vitro invasion. These studies suggest that plasma membrane V-ATPases play an important role in invasion of breast cancer cells.	[Cotter, Kristina; Capecci, Joseph; Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Cotter, Kristina; Capecci, Joseph; Forgac, Michael] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Sennoune, Souad; Martinez-Zaguilan, Raul] Texas Tech Univ, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Huss, Markus] Univ Osnabruck, Div Anim Physiol, Dept Biol Chem, D-49069 Osnabruck, Germany; [Maier, Martin] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany	Tufts University; Tufts University; Texas Tech University System; Texas Tech University; University Osnabruck; Eberhard Karls University of Tubingen	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34478 (to M. F.).; Supported in part by a Sackler Families Collaborative Cancer Biology Award from Tufts University.	Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cai M., 2014, PLOS ONE, V9, DOI [10.1371/annotation/ca9f2d5b-93ab-4d7c-b577-cd045b343e53, DOI 10.1371/ANNOTATION/CA9F2D5B-93AB-4D7C-B577-CD045B343E53]; Capecci J, 2013, J BIOL CHEM, V288, P32731, DOI 10.1074/jbc.M113.503771; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; FENG Y, 1992, J BIOL CHEM, V267, P5817; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gondi CS, 2013, EXPERT OPIN THER TAR, V17, P281, DOI 10.1517/14728222.2013.740461; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hendrix A, 2013, INT J CANCER, V133, P843, DOI 10.1002/ijc.28079; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Liberman R, 2013, J BIOL CHEM, V288, P22798, DOI 10.1074/jbc.M113.460295; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Nalla AK, 2010, CANCER GENE THER, V17, P599, DOI 10.1038/cgt.2010.16; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Partridge J, 2009, JOVE-J VIS EXP, P1475; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Robey IF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/485196; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	55	72	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3680	3692		10.1074/jbc.M114.611210	http://dx.doi.org/10.1074/jbc.M114.611210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505184	Green Published, hybrid			2022-12-28	WOS:000349456000040
J	Pallan, PS; Nagy, LD; Lei, L; Gonzalez, E; Kramlinger, VM; Azumaya, CM; Wawrzak, Z; Waterman, MR; Guengerich, FP; Egli, M				Pallan, Pradeep S.; Nagy, Leslie D.; Lei, Li; Gonzalez, Eric; Kramlinger, Valerie M.; Azumaya, Caleigh M.; Wawrzak, Zdzislaw; Waterman, Michael R.; Guengerich, F. Peter; Egli, Martin			Structural and Kinetic Basis of Steroid 17 alpha,20-Lyase Activity in Teleost Fish Cytochrome P450 17A1 and Its Absence in Cytochrome P450 17A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU PROTEOLYSIS; 17,20-LYASE ACTIVITY; ORTERONEL TAK-700; ANDROGEN SYNTHESIS; LYASE ACTIVITY; HUMAN P450C17; OXIDATION; EXPRESSION; INHIBITOR; PHOSPHORYLATION	Cytochrome P450 (P450) 17A enzymes play a critical role in the oxidation of the steroids progesterone (Prog) and pregnenolone (Preg) to glucocorticoids and androgens. In mammals, a single enzyme, P450 17A1, catalyzes both 17 alpha-hydroxylation and a subsequent 17 alpha,20-lyase reaction with both Prog and Preg. Teleost fish contain two 17A P450s; zebrafish P450 17A1 catalyzes both 17 alpha-hydroxylation and lyase reactions with Prog and Preg, and P450 17A2 is more efficient in pregnenolone 17 alpha-hydroxylation but does not catalyze the lyase reaction, even in the presence of cytochrome b(5). P450 17A2 binds all substrates and products, although more loosely than P450 17A1. Pulse-chase and kinetic spectral experiments and modeling established that the two-step P450 17A1 Prog oxidation is more distributive than the Preg reaction, i.e. 17 alpha-OHproduct dissociates more prior to the lyase step. The drug orteronel selectively blocked the lyase reaction of P450 17A1 but only in the case of Prog. X-ray crystal structures of zebrafish P450 17A1 and 17A2 were obtained with the ligand abiraterone and with Prog for P450 17A2. Comparison of the two fish P450 17A-abiraterone structures with human P450 17A1 (DeVore, N. M., and Scott, E. E. (2013) Nature 482, 116-119) showed only a few differences near the active site, despite only similar to 50% identity among the three proteins. The P450 17A2 structure differed in four residues near the heme periphery. These residues may allow the proposed alternative ferric peroxide mechanism for the lyase reaction, or residues removed from the active site may allow conformations that lead to the lyase activity.	[Pallan, Pradeep S.; Nagy, Leslie D.; Lei, Li; Gonzalez, Eric; Kramlinger, Valerie M.; Azumaya, Caleigh M.; Waterman, Michael R.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Argonne Natl Lab, Adv Photon Source, Sect 21, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	Vanderbilt University; United States Department of Energy (DOE); Argonne National Laboratory	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu; martin.egli@vanderbilt.edu			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459, R01GM103937] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Millennium Pharmaceuticals for orteronel, J. A. Oates for use of the radio-TLC imaging scanner, and K. Trisler for assistance in preparation of the manuscript. Vanderbilt University is a member institution of the Life Sciences Collaborative Access Team (LSCAT) at Sector 21 of the Advanced Photon Source (APS), Argonne, IL. Use of the APS at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; AKHTAR M, 1994, J CHEM SOC PERK T 1, P263, DOI 10.1039/p19940000263; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; Brock BJ, 1999, BIOCHEMISTRY-US, V38, P1598, DOI 10.1021/bi9821059; Chen CF, 2010, FISH PHYSIOL BIOCHEM, V36, P1001, DOI 10.1007/s10695-009-9378-7; Chowdhury G, 2012, BIOCHEMISTRY-US, V51, P9995, DOI 10.1021/bi301092c; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Gregory M, 2013, ANGEW CHEM INT EDIT, V52, P5342, DOI 10.1002/anie.201300760; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2015, CYTOCHROME P450 STRU, V4th; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2011, ARCH BIOCHEM BIOPHYS, V507, P126, DOI 10.1016/j.abb.2010.08.017; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hanson KL, 2010, DRUG METAB DISPOS, V38, P963, DOI 10.1124/dmd.110.032391; Hara T, 2013, J STEROID BIOCHEM, V134, P80, DOI 10.1016/j.jsbmb.2012.10.020; He X, 2005, J BIOL CHEM, V280, P22697, DOI 10.1074/jbc.M502632200; HIGUCHI A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P240, DOI 10.1016/0005-2760(91)90064-O; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Johnson Kenneth A., 2003, P1; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kagawa Norio, 1995, P419; Kaku T, 2011, BIOORGAN MED CHEM, V19, P6383, DOI 10.1016/j.bmc.2011.08.066; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; KUHNVELTEN WN, 1991, J BIOL CHEM, V266, P6291; LEEROBICHAUD P, 1995, BIOCHEMISTRY-US, V34, P14104, DOI 10.1021/bi00043a015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 1998, ENDOCR RES, V24, P817, DOI 10.3109/07435809809032692; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHARDSON TH, 1995, ARCH BIOCHEM BIOPHYS, V323, P87, DOI 10.1006/abbi.1995.0013; SANDHU P, 1993, ARCH BIOCHEM BIOPHYS, V306, P443, DOI 10.1006/abbi.1993.1536; SHIMADA T, 1986, J BIOL CHEM, V261, P909; Shimshoni JA, 2012, J BIOL CHEM, V287, P42223, DOI 10.1074/jbc.M112.404475; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soucy P, 2000, EUR J BIOCHEM, V267, P3243, DOI 10.1046/j.1432-1327.2000.01349.x; Strittmatter P, 1978, Methods Enzymol, V52, P97; SWINNEY DC, 1994, BIOCHEMISTRY-US, V33, P2185, DOI 10.1021/bi00174a027; TAGASHIRA H, 1995, BIOCHEMISTRY-US, V34, P10939, DOI 10.1021/bi00034a028; Tee MK, 2008, ENDOCRINOLOGY, V149, P2667, DOI 10.1210/en.2007-1527; Tee MK, 2013, J BIOL CHEM, V288, P23903, DOI 10.1074/jbc.M113.460048; Walsh C., 1979, ENZYMATIC REACTION M, P33; Wang YJ, 2004, GEN COMP ENDOCR, V135, P241, DOI 10.1016/j.ygcen.2003.09.015; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yamaoka M, 2013, J STEROID BIOCHEM, V138, P298, DOI 10.1016/j.jsbmb.2013.07.002; Yamaoka M, 2012, J STEROID BIOCHEM, V129, P115, DOI 10.1016/j.jsbmb.2012.01.001; YAMAZAKI T, 1992, BIOCHIM BIOPHYS ACTA, V1134, P143, DOI 10.1016/0167-4889(92)90037-C; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; YAMAZAKI T, 1992, BIOCHIM BIOPHYS ACTA, V1125, P335; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487; Zhu JG, 2012, ARCH BIOCHEM BIOPHYS, V523, P30, DOI 10.1016/j.abb.2012.01.013	77	45	46	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3248	3268		10.1074/jbc.M114.627265	http://dx.doi.org/10.1074/jbc.M114.627265			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533464	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000349456000006
J	Wang, XZ; Maynard, JA				Wang, Xianzhe; Maynard, Jennifer A.			The Bordetella Adenylate Cyclase Repeat-in-Toxin (RTX) Domain Is Immunodominant and Elicits Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACELLULAR PERTUSSIS VACCINES; ESCHERICHIA-COLI; RESPIRATORY-INFECTION; MONOCLONAL-ANTIBODIES; PROTECTIVE ACTIVITY; HUMAN NEUTROPHILS; PHAGE DISPLAY; TARGET-CELLS; CYAA TOXIN; HIGH-LEVEL	The adenylate cyclase toxin (ACT) is a multifunctional virulence factor secreted by Bordetella species. Upon interaction of its C-terminal hemolysin moiety with the cell surface receptor alpha(M)beta(2) integrin, the N-terminal cyclase domain translocates into the host cell cytosol where it rapidly generates supraphysiological cAMP concentrations, which inhibit host cell anti-bacterial activities. Although ACT has been shown to induce protective immunity in mice, it is not included in any current acellular pertussis vaccines due to protein stability issues and a poor understanding of its role as a protective antigen. Here, we aimed to determine whether any single domain could recapitulate the antibody responses induced by the holo-toxin and to characterize the dominant neutralizing antibody response. We first immunized mice with ACT and screened antibody phage display libraries for binding to purified ACT. The vast majority of unique antibodies identified bound the C-terminal repeat-in-toxin (RTX) domain. Representative antibodies binding two nonoverlapping, neutralizing epitopes in the RTX domain prevented ACT association with J774A.1 macrophages and soluble alpha(M)beta(2) integrin, suggesting that these antibodies inhibit the ACT-receptor interaction. Sera from mice immunized with the RTX domain showed similar neutralizing activity as ACT-immunized mice, indicating that this domain induced an antibody response similar to that induced by ACT. These data demonstrate that RTX can elicit neutralizing antibodies and suggest it may present an alternative to ACT.	[Wang, Xianzhe] Univ Texas Austin, Dept Biochem, Austin, TX 78712 USA; [Maynard, Jennifer A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Maynard, JA (corresponding author), Univ Texas Austin, 200 E Dean Keeton,MC0400, Austin, TX 78712 USA.	maynard@che.utexas.edu			National Institutes of Health [GM095638]; Welch Foundation [F-1767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095638 (to J. A. M.). This work was also supported by Welch Foundation Grant F-1767.	Angkawidjaja C, 2007, FEBS LETT, V581, P5060, DOI 10.1016/j.febslet.2007.09.048; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BENZ R, 1994, J BIOL CHEM, V269, P27231; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; BETSOU F, 1995, INFECT IMMUN, V63, P3309, DOI 10.1128/IAI.63.9.3309-3315.1995; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; Blenner MA, 2010, J MOL BIOL, V400, P244, DOI 10.1016/j.jmb.2010.04.056; BREZIN C, 1987, FEMS MICROBIOL LETT, V42, P75, DOI 10.1016/0378-1097(87)90501-5; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Chenal-Francisque V, 2009, RES MICROBIOL, V160, P330, DOI 10.1016/j.resmic.2009.03.006; Cherry JD, 2010, CLIN VACCINE IMMUNOL, V17, P741, DOI 10.1128/CVI.00469-09; Cheung GYC, 2006, INFECT IMMUN, V74, P6797, DOI 10.1128/IAI.01104-06; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Eby JC, 2013, INFECT IMMUN, V81, P1390, DOI 10.1128/IAI.00110-13; Eby JC, 2012, INFECT IMMUN, V80, P850, DOI 10.1128/IAI.05979-11; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; FARFEL Z, 1990, J MED MICROBIOL, V32, P173, DOI 10.1099/00222615-32-3-173; Gallay J, 2004, EUR J BIOCHEM, V271, P821, DOI 10.1111/j.1432-1033.2004.03987.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; Goldstein D, 1990, CLIN METHODS HIST PH; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GOYARD S, 1989, BIOCHEMISTRY-US, V28, P1964, DOI 10.1021/bi00431a002; Gray MC, 2004, MOL MICROBIOL, V53, P1709, DOI 10.1111/j.1365-2958.2004.04227.x; Gray MC, 2001, J BACTERIOL, V183, P5904, DOI 10.1128/JB.183.20.5904-5910.2001; GUEIRARD P, 1993, INFECT IMMUN, V61, P4072, DOI 10.1128/IAI.61.10.4072-4078.1993; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; GUISO N, 1989, MICROB PATHOGENESIS, V7, P373, DOI 10.1016/0882-4010(89)90040-5; GUISO N, 1991, MICROB PATHOGENESIS, V11, P423, DOI 10.1016/0882-4010(91)90038-C; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; Hayhurst A, 2003, J IMMUNOL METHODS, V276, P185, DOI 10.1016/S0022-1759(03)00100-5; Henderson MW, 2012, INFECT IMMUN, V80, P2061, DOI 10.1128/IAI.00148-12; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hormozi K, 1999, FEMS IMMUNOL MED MIC, V23, P273, DOI 10.1016/S0928-8244(98)00146-1; Karimova G., 2007, CSH PROTOC, V2007; Karst JC, 2014, J BIOL CHEM, V289, P30702, DOI 10.1074/jbc.M114.580852; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; KHELEF N, 1993, INFECT IMMUN, V61, P486, DOI 10.1128/IAI.61.2.486-490.1993; KHELEF N, 1992, MICROB PATHOGENESIS, V12, P227, DOI 10.1016/0882-4010(92)90057-U; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Lee SJ, 1999, INFECT IMMUN, V67, P2090, DOI 10.1128/IAI.67.5.2090-2095.1999; Lim A, 2014, MICROBES INFECT, V16, P51, DOI 10.1016/j.micinf.2013.10.002; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; MONNERON A, 1988, BIOCHEMISTRY-US, V27, P536, DOI 10.1021/bi00402a005; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pojanapotha P, 2011, PROTEIN EXPRES PURIF, V75, P127, DOI 10.1016/j.pep.2010.07.012; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; Powthongchin B, 2008, ARCH MICROBIOL, V189, P169, DOI 10.1007/s00203-007-0302-1; RAPTIS A, 1989, INFECT IMMUN, V57, P1725, DOI 10.1128/IAI.57.6.1725-1730.1989; ROGEL A, 1988, J BIOL CHEM, V263, P13310; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; Saggy I, 2012, PROTEIN ENG DES SEL, V25, P539, DOI 10.1093/protein/gzs060; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sutherland JN, 2011, CLIN VACCINE IMMUNOL, V18, P954, DOI 10.1128/CVI.00561-10; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Watanabe M, 2006, CLIN VACCINE IMMUNOL, V13, P341, DOI 10.1128/CVI.13.3.341-348.2006; Weingart CL, 2000, INFECT IMMUN, V68, P1735, DOI 10.1128/IAI.68.3.1735-1739.2000; Weingart CL, 2000, INFECT IMMUN, V68, P7152, DOI 10.1128/IAI.68.12.7152-7155.2000; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilkins MR, 1999, METH MOL B, V112, P531; Witt MA, 2013, CLIN INFECT DIS, V56, P1248, DOI 10.1093/cid/cit046; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287	78	23	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3576	3591		10.1074/jbc.M114.585281	http://dx.doi.org/10.1074/jbc.M114.585281			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505186	Green Published, hybrid			2022-12-28	WOS:000349456000031
J	Zacherl, S; La Venuta, G; Muller, HM; Wegehingel, S; Dimou, E; Sehr, P; Lewis, JD; Erfle, H; Pepperkok, R; Nickel, W				Zacherl, Sonja; La Venuta, Giuseppe; Mueller, Hans-Michael; Wegehingel, Sabine; Dimou, Eleni; Sehr, Peter; Lewis, Joe D.; Erfle, Holger; Pepperkok, Rainer; Nickel, Walter			A Direct Role for ATP1A1 in Unconventional Secretion of Fibroblast Growth Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; PROTEIN SECRETION; QUALITY-CONTROL; CELL-SURFACE; TEC FAMILY; EXPORT; TRANSLOCATION; TRANSPORT; FGF-2	Previous studies proposed a role for the Na/K-ATPase in unconventional secretion of fibroblast growth factor 2 (FGF2). This conclusion was based upon pharmacological inhibition of FGF2 secretion in the presence of ouabain. However, neither independent experimental evidence nor a potential mechanism was provided. Based upon an unbiased RNAi screen, we now report the identification of ATP1A1, the alpha 1-chain of the Na/K-ATPase, as a factor required for efficient secretion of FGF2. As opposed to ATP1A1, down-regulation of the beta 1- and beta 3-chains (ATP1B1 and ATP1B3) of the Na/K-ATPase did not affect FGF2 secretion, suggesting that they are dispensable for this process. These findings indicate that it is not the membrane potential-generating function of the Na/K-ATPase complex but rather a so far unidentified role of potentially unassembled alpha 1-chains that is critical for unconventional secretion of FGF2. Consistently, in the absence of beta-chains, we found a direct interaction between the cytoplasmic domain of ATP1A1 and FGF2 with submicromolar affinity. Based upon these observations, we propose that ATP1A1 is a recruitment factor for FGF2 at the inner leaflet of plasma membranes that may control phosphatidylinositol 4,5-bisphosphate-dependent membrane translocation as part of the unconventional secretory pathway of FGF2.	[Zacherl, Sonja; La Venuta, Giuseppe; Mueller, Hans-Michael; Wegehingel, Sabine; Dimou, Eleni; Nickel, Walter] Heidelberg Univ, Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Sehr, Peter; Lewis, Joe D.; Pepperkok, Rainer] EMBL, D-69117 Heidelberg, Germany; [Erfle, Holger] Heidelberg Univ, BioQuant, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Nickel, W (corresponding author), Heidelberg Univ, Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de		Muller, Hans-Michael/0000-0002-2384-7285; Lewis, Joe/0000-0002-9926-1328; Sehr, Peter/0000-0002-4348-5066; Dimou, Eleni/0000-0003-4885-135X	Deutsche Forschungsgemeinschaft (DFG) [SFB 638, SFB/TRR 83, GRK1188]; Federal Ministry for Education and Research of Germany; Boehringer Ingelheim Fonds; DFG cluster of excellence CellNetworks	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry for Education and Research of Germany; Boehringer Ingelheim Fonds(Boehringer Ingelheim); DFG cluster of excellence CellNetworks	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB 638, SFB/TRR 83, and GRK1188; the AID-NET program of the Federal Ministry for Education and Research of Germany (to W. N.); the Boehringer Ingelheim Fonds (to S. Z.); and the DFG cluster of excellence CellNetworks.	Aftab O, 2014, APOPTOSIS, V19, P1411, DOI 10.1007/s10495-014-1009-9; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schaeffer EM, 2000, CURR OPIN IMMUNOL, V12, P282, DOI 10.1016/S0952-7915(00)00088-1; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Taouji S, 2009, CURR GENOMICS, V10, P93, DOI 10.2174/138920209787847041; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103	40	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3654	3665		10.1074/jbc.M114.590067	http://dx.doi.org/10.1074/jbc.M114.590067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533462	Green Published, hybrid			2022-12-28	WOS:000349456000038
J	Doi, Y; Takaya, N				Doi, Yuki; Takaya, Naoki			A Novel A3 Group Aconitase Tolerates Oxidation and Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI ACONITASE; MUTATIONAL ANALYSIS; IRON; PEROXYNITRITE; INACTIVATION; DEHYDRATASE; SUPEROXIDE; PROPIONATE; BACTERIAL; CLUSTERS	Achromobacter denitrificans YD35 is an NO2--tolerant bacterium that expresses the aconitase genes acnA3, acnA4, and acnB, of which acnA3 is essential for growth tolerance against 100 mM NO2-. Atmospheric oxygen inactivated AcnA3 at a rate of 1.6 x 10(-3) min(-1), which was 2.7- and 37-fold lower compared with AcnA4 and AcnB, respectively. Stoichiometric titration showed that the [4Fe-4S](2+) cluster of AcnA3 was more stable against oxidative inactivation by ferricyanide than that of AcnA4. Aconitase activity of AcnA3 persisted against high NO2- levels that generate reactive nitrogen species with an inactivation rate constant of k = 7.8 x 10(-3) min(-1), which was 1.6- and 7.8-fold lower than those for AcnA4 and AcnB, respectively. When exposed to NO2-, the acnA3 mutant (AcnA3Tn) accumulated higher levels of cellular citrate compared with the other aconitase mutants, indicating that AcnA3 is a major producer of cellular aconitase activity. The extreme resistance of AcnA3 against oxidation and reactive nitrogen species apparently contributes to bacterial NO2- tolerance. AcnA3Tn accumulated less cellular NADH and ATP compared with YD35 under our culture conditions. The accumulation of more NO by AcnA3Tn suggested that NADH-dependent enzymes detoxify NO for survival in a high NO2- milieu. This novel aconitase is distributed in Alcaligenaceae bacteria, including pathogens and denitrifiers, and it appears to contribute to a novel NO2- tolerance mechanism in this strain.	[Doi, Yuki; Takaya, Naoki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	takaya.naoki.ge@u.tsukuba.ac.jp			Ministry of Education, Science, Culture and Sports of Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Culture and Sports of Japan.	Baothman OAS, 2013, MICROBIOL-SGM, V159, P1209, DOI 10.1099/mic.0.067934-0; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Blank L, 2002, MICROBIOL-SGM, V148, P133, DOI 10.1099/00221287-148-1-133; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Claes WA, 2002, J BACTERIOL, V184, P2728, DOI 10.1128/JB.184.10.2728-2739.2002; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; Doi Y, 2014, APPL ENVIRON MICROB, V80, P1910, DOI 10.1128/AEM.03316-13; Doi Y, 2009, APPL ENVIRON MICROB, V75, P5186, DOI 10.1128/AEM.00604-09; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GRUER MJ, 1994, MICROBIOL-SGM, V140, P2531, DOI 10.1099/00221287-140-10-2531; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Horswill AR, 1999, J BACTERIOL, V181, P5615, DOI 10.1128/JB.181.18.5615-5623.1999; Hughes MN, 1999, BBA-BIOENERGETICS, V1411, P263, DOI 10.1016/S0005-2728(99)00019-5; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Keyer K, 1997, J BIOL CHEM, V272, P27652, DOI 10.1074/jbc.272.44.27652; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin JT, 1998, ADV MICROB PHYSIOL, V39, P1; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Tang Y, 2005, MOL MICROBIOL, V56, P1149, DOI 10.1111/j.1365-2958.2005.04610.x; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Yabuuchi E, 1998, MICROBIOL IMMUNOL, V42, P429, DOI 10.1111/j.1348-0421.1998.tb02306.x; ZHENG L, 1992, J BIOL CHEM, V267, P7895; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	39	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1412	1421		10.1074/jbc.M114.614164	http://dx.doi.org/10.1074/jbc.M114.614164			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477516	hybrid, Green Published			2022-12-28	WOS:000348056400011
J	Fujinaga, K; Luo, ZP; Schaufele, F; Peterlin, BM				Fujinaga, Koh; Luo, Zeping; Schaufele, Fred; Peterlin, B. Matija			Visualization of Positive Transcription Elongation Factor b (P-TEFb) Activation in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SMALL NUCLEAR RIBONUCLEOPROTEIN; EMBRYONIC STEM-CELLS; C-TERMINAL DOMAIN; 7SK SNRNA; HIV TRANSCRIPTION; PRIMORDIAL DWARFISM; GENE-EXPRESSION; CYCLIN T1; HEXIM1	Regulation of transcription elongation by positive transcription elongation factor b (P-TEFb) plays a central role in determining the state of cell activation, proliferation, and differentiation. In cells, P-TEFb exists in active and inactive forms. Its release from the inactive 7SK small nuclear ribonucleoprotein complex is a critical step for P-TEFb to activate transcription elongation. However, no good method exists to analyze this P-TEFb equilibrium in living cells. Only inaccurate and labor-intensive cell-free biochemical assays are currently available. In this study, we present the first experimental system to monitor P-TEFb activation in living cells. We created a bimolecular fluorescence complementation assay to detect interactions between P-TEFb and its substrate, the C-terminal domain of RNA polymerase II. When cells were treated with suberoylanilide hydroxamic acid, which releases P-TEFb from the 7SK small nuclear ribonucleoprotein, they turned green. Other known P-TEFb-releasing agents, including histone deacetylase inhibitors, bromodomain and extraterminal bromodomain inhibitors, and protein kinase C agonists, also scored positive in this assay. Finally, we identified 5'-azacytidine as a new P-TEFb-releasing agent. This release of P-TEFb correlated directly with activation of human HIV and HEXIM1 transcription. Thus, our visualization of P-TEFb activation by fluorescent complementation assay could be used to find new P-TEFb-releasing agents, compare different classes of agents, and assess their efficacy singly and/or in combination.	[Fujinaga, Koh; Luo, Zeping; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Fujinaga, Koh; Luo, Zeping; Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Fujinaga, Koh; Luo, Zeping; Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; [Schaufele, Fred] Univ Calif San Francisco, Diabet & Endocrinol Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med Microbiol & Immunol, Rm U432,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu			National Institutes of Health CARE Center [U19 AI096113]; HARC Center [P50 GM082250, AI1049104]; American Foundation of AIDS Research Grant [108241-51-RGRL]; California HIV/AIDS Research Program [ID13-SF-558]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health CARE Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HARC Center; American Foundation of AIDS Research Grant; California HIV/AIDS Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health CARE Center Grant U19 AI096113 and HARC Center Grants P50 GM082250 and AI1049104 (to B. M. P.). This work was also supported by American Foundation of AIDS Research Grant 108241-51-RGRL and California HIV/AIDS Research Program Grant ID13-SF-558 (to K. F.).	Alazami AM, 2012, HUM MUTAT, V33, P1429, DOI 10.1002/humu.22175; Aune GJ, 2008, CLIN CANCER RES, V14, P6449, DOI 10.1158/1078-0432.CCR-08-0730; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Biewenga P, 2008, GYNECOL ONCOL, V108, P520, DOI 10.1016/j.ygyno.2007.11.024; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Castelo-Branco G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r98; Cheng YL, 2012, LAB INVEST, V92, P1013, DOI 10.1038/labinvest.2012.59; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Dai Q, 2014, CELL REP, V7, P735, DOI 10.1016/j.celrep.2014.03.053; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fernandez G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-266; Fujinaga K, 2002, J VIROL, V76, P10873, DOI 10.1128/JVI.76.21.10873-10881.2002; Fujinaga K, 2014, J BIOL CHEM, V289, P21181, DOI 10.1074/jbc.M114.557751; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Hsin JP, 2014, MOL CELL BIOL, V34, P2488, DOI 10.1128/MCB.00181-14; Hu Chang-Deng, 2006, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2103s29; Izeddin I, 2014, ELIFE, V3, DOI 10.7554/eLife.02230; Jeeninga RE, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-37; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Liu PY, 2014, J BIOL CHEM, V289, P9918, DOI 10.1074/jbc.M113.539015; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Napolitano G, 2002, J CELL PHYSIOL, V192, P209, DOI 10.1002/jcp.10130; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Okamura D, 2012, GENE DEV, V26, P2477, DOI 10.1101/gad.202242.112; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Peterlin BM, 2010, CELL CYCLE, V9, P2933, DOI 10.4161/cc.9.15.12698; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Ramakrishnan Rajesh, 2012, Biology (Basel), V1, P94, DOI 10.3390/biology1010094; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	50	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1829	1836		10.1074/jbc.M114.605816	http://dx.doi.org/10.1074/jbc.M114.605816			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25492871	Green Published, hybrid			2022-12-28	WOS:000348056400047
J	Staquicini, FI; Qian, MD; Salameh, A; Dobroff, AS; Edwards, JK; Cimino, DF; Moeller, BJ; Kelly, P; Nunez, MI; Tang, XM; Liu, DD; Lee, JJ; Hong, WK; Ferrara, F; Bradbury, ARM; Lobb, RR; Edelman, MJ; Sidman, RL; Wistuba, II; Arap, W; Pasqualini, R				Staquicini, Fernanda I.; Qian, Ming D.; Salameh, Ahmad; Dobroff, Andrey S.; Edwards, Julianna K.; Cimino, Daniel F.; Moeller, Benjamin J.; Kelly, Patrick; Nunez, Maria I.; Tang, Ximing; Liu, Diane D.; Lee, J. Jack; Hong, Waun Ki; Ferrara, Fortunato; Bradbury, Andrew R. M.; Lobb, Roy R.; Edelman, Martin J.; Sidman, Richard L.; Wistuba, Ignacio I.; Arap, Wadih; Pasqualini, Renata			Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; DNA Damage; DNA Damage Response; DNA Repair; Monoclonal Antibody; Receptor Tyrosine Kinase; Ionizing Radiation	GROWTH-FACTOR RECEPTOR; DNA-DAMAGE RESPONSE; SIGNALING NETWORKS; ATM; EXPRESSION; PHOSPHORYLATION; PATHOGENESIS; CHECKPOINTS; PATHWAY; FAMILY	Background: EphA5 is a functional target in lung cancer, the most common cause of tumor-related death in mankind. Results: EphA5 regulates cell cycle checkpoints and DNA damage repair induced by ionizing radiation. Conclusion: EphA5 is a novel regulator of DNA damage repair with clinical implications. Significance: EphA5 may serve as a novel biomarker of radioresistance and a candidate target for therapeutic intervention in human lung cancer. Lung cancer is often refractory to radiotherapy, but molecular mechanisms of tumor resistance remain poorly defined. Here we show that the receptor tyrosine kinase EphA5 is specifically overexpressed in lung cancer and is involved in regulating cellular responses to genotoxic insult. In the absence of EphA5, lung cancer cells displayed a defective G(1)/S cell cycle checkpoint, were unable to resolve DNA damage, and became radiosensitive. Upon irradiation, EphA5 was transported into the nucleus where it interacted with activated ATM (ataxia-telangiectasia mutated) at sites of DNA repair. Finally, we demonstrate that a new monoclonal antibody against human EphA5 sensitized lung cancer cells and human lung cancer xenografts to radiotherapy and significantly prolonged survival, thus suggesting the likelihood of translational applications.	[Staquicini, Fernanda I.; Dobroff, Andrey S.; Cimino, Daniel F.; Ferrara, Fortunato; Arap, Wadih; Pasqualini, Renata] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Staquicini, Fernanda I.; Dobroff, Andrey S.; Cimino, Daniel F.; Ferrara, Fortunato; Pasqualini, Renata] Univ New Mexico, Sch Med, Dept Internal Med, Div Mol Med, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Dept Internal Med, Div Hematol Med Oncol, Albuquerque, NM 87131 USA; [Qian, Ming D.; Salameh, Ahmad; Edwards, Julianna K.; Moeller, Benjamin J.; Kelly, Patrick] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Moeller, Benjamin J.; Kelly, Patrick] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Nunez, Maria I.; Tang, Ximing; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Liu, Diane D.; Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Biostat, Houston, TX 77030 USA; [Hong, Waun Ki] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Bradbury, Andrew R. M.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Lobb, Roy R.; Edelman, Martin J.] Arrowhead Res Corp, Alvos Therapeut, Pasadena, CA 91101 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Sidman, Richard L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Los Alamos National Laboratory; University System of Maryland; University of Maryland Baltimore; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Arap, W (corresponding author), Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA.	warap@salud.unm.edu; rpasqual@salud.unm.edu	Dobroff, Andrey/A-9814-2016; Lee, Jack/P-7331-2019; Edelman, Martin/HGA-7272-2022; Ferrara, Fortunato/AAD-5947-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019	Dobroff, Andrey/0000-0003-2162-9951; Lee, Jack/0000-0002-4584-929X; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Edelman, Martin/0000-0002-3752-0726; Bradbury, Andrew/0000-0002-5567-8172; Bronk, Julianna/0000-0003-3459-1833; Ferrara, Fortunato/0000-0002-4615-035X	National Institutes of Health; National Cancer Institute; Department of Defense; Specialized Program of Research Excellence in Lung Cancer; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA103830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Specialized Program of Research Excellence in Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants (to R. P. and W. A.). This work was also supported by funds from the National Cancer Institute (to R. P., W. A., and I. I. W.), the Department of Defense (to R. P., W. A., I. I. W., and W. K. H.), and the Specialized Program of Research Excellence in Lung Cancer (to I. I. W.). The University of Texas M. D. Anderson Cancer Center and some of its researchers at the time (W. A. and R. P.) had equity positions in Alvos Therapeutics (Arrowhead Research Corporation, Pasadena, CA), which was subjected to certain restrictions under university policy; the University manages and monitors the terms of these arrangements in accordance with its conflict-of-interest policy. F. I. S., W. A., and R. P. are coinventors of issued patents filed by Alvos Therapeutics that cover the mAb 11C12 and are entitled to royalties that could result from commercial success of the drug.	Ambrose M, 2013, BLOOD, V121, P4036, DOI 10.1182/blood-2012-09-456897; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; Chatterjee N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a019836; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrara F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049535; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Giaginis C, 2010, PATHOL ONCOL RES, V16, P267, DOI 10.1007/s12253-009-9221-6; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoppin J, 2011, J PHARMACOL EXP THER, V337, P350, DOI 10.1124/jpet.110.172916; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5472.CAN-05-2748; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pasqualini R, 2000, CANCER RES, V60, P722; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Rengan R, 2011, CLIN CANCER RES, V17, P4192, DOI 10.1158/1078-0432.CCR-10-2760; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; TAYLOR V, 1994, NEUROSCIENCE, V63, P163, DOI 10.1016/0306-4522(94)90014-0; von Stechow L, 2013, ARCH TOXICOL, V87, P1635, DOI 10.1007/s00204-013-1106-5; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhou RP, 1997, CELL TISSUE RES, V290, P251, DOI 10.1007/s004410050929	40	34	36	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7345	7359		10.1074/jbc.M114.630525	http://dx.doi.org/10.1074/jbc.M114.630525			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623065	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000351613600003
J	Catalan, E; Jaime-Sanchez, P; Aguilo, N; Simon, MM; Froelich, CJ; Pardo, J				Catalan, Elena; Jaime-Sanchez, Paula; Aguilo, Nacho; Simon, Markus M.; Froelich, Christopher J.; Pardo, Julian			Mouse Cytotoxic T Cell-derived Granzyme B Activates the Mitochondrial Cell Death Pathway in a Bim-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CASPASE ACTIVATION; MEDIATED APOPTOSIS; PROTEIN BIM; ER STRESS; BAX; REQUIRES; DIVERGENT; CLEAVAGE; COMPLEX	Cytotoxic T cells (Tc) use perforin and granzyme B (gzmB) to kill virus-infected cells and cancer cells. Recent evidence suggests that human gzmB primarily induces apoptosis via the intrinsic mitochondrial pathway by either cleaving Bid or activating Bim leading to the activation of Bak/Bax and subsequent generation of active caspase-3. In contrast, mouse gzmB is thought to predominantly induce apoptosis by directly processing pro-caspase-3. However, in certain mouse cell types gzmB-mediated apoptosis mainly occurs via the mitochondrial pathway. To investigate whether Bim is involved under the latter conditions, we have now employed ex vivo virus-immune mouse Tc that selectively kill by using perforin and gzmB (gzmB(+)Tc) as effector cells and wild type as well as Bim- or Bak/Bax-deficient spontaneously (3T9) or virus-(SV40) transformed mouse embryonic fibroblast cells as targets. We show that gzmB(+)Tc-mediated apoptosis (phosphatidylserine translocation, mitochondrial depolarization, cytochrome c release, and caspase-3 activation) was severely reduced in 3T9 cells lacking either Bim or both Bak and Bax. This outcome was related to the ability of c cells to induce the degradation of Mcl-1 and Bcl-X-L, the anti-apoptotic counterparts of Bim. In contrast, gzmB(+)Tc-mediated apoptosis was not affected in SV40-transformed mouse embryonic fibroblast cells lacking Bak/Bax. The data provide evidence that Bim participates in mouse gzmB+Tc-mediated apoptosis of certain targets by activating the mitochondrial pathway and suggest that the mode of cell death depends on the target cell. Our results suggest that the various molecular events leading to transformation and/or immortalization of cells have an impact on their relative resistance to the multiple gzmB(+)Tc-induced death pathways.	[Catalan, Elena; Jaime-Sanchez, Paula; Pardo, Julian] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Catalan, Elena; Jaime-Sanchez, Paula; Pardo, Julian] Univ Zaragoza, Biomed Res Ctr Aragon, IIS Aragon, E-50009 Zaragoza, Spain; [Aguilo, Nacho; Pardo, Julian] Univ Zaragoza, Dept Microbiol Med Prevent & Salud Publ, E-50009 Zaragoza, Spain; [Simon, Markus M.] Max Planck Inst Immunbiol & Epigenet, Metschnikoff Lab, D-79108 Freiburg, Germany; [Froelich, Christopher J.] Univ Chicago, NorthShore Univ Hlth Syst Res Inst, Evanston, IL 60201 USA; [Pardo, Julian] Univ Zaragoza, Nanosci Inst Aragon, Zaragoza 50015, Spain; [Pardo, Julian] Aragon I D Fdn, Zaragoza 50015, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; Max Planck Society; NorthShore University Health System; University of Chicago; University of Zaragoza	Pardo, J (corresponding author), Biomed Res Ctr Aragon, Edificio CIBA,Avda San Juan Bosco 13, Zaragoza 50009, Spain.	pardojim@unizar.es	Pardo, Julián/K-6764-2014; AGUILO, NACHO/K-2750-2014; AGUILO, NACHO/GPK-7678-2022	Pardo, Julián/0000-0003-0154-0730; AGUILO, NACHO/0000-0001-7897-9173; AGUILO, NACHO/0000-0001-7897-9173	Spanish Ministry of Science and Innovation and Economy and Competitiveness [SAF2008-02139, SAF2011-25390]	Spanish Ministry of Science and Innovation and Economy and Competitiveness	This work was supported in part by Grants SAF2008-02139 and SAF2011-25390 from the Spanish Ministry of Science and Innovation and Economy and Competitiveness.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Ashton-Rickardt PG, 2005, CRIT REV IMMUNOL, V25, P161, DOI 10.1615/CritRevImmunol.v25.i3.10; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Bleackley RC, 2005, BIOCHEM CELL BIOL, V83, P747, DOI 10.1139/O05-146; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Casciola-Rosen L, 2007, J BIOL CHEM, V282, P4545, DOI 10.1074/jbc.M606564200; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Hutcheson J, 2005, J EXP MED, V201, P1949, DOI 10.1084/jem.20041484; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Pardo J, 2002, EUR J IMMUNOL, V32, P1980, DOI 10.1002/1521-4141(200207)32:7<1980::AID-IMMU1980>3.0.CO;2-Z; Pardo J, 2009, MICROBES INFECT, V11, P452, DOI 10.1016/j.micinf.2009.02.004; Pinkoski MJ, 2001, J BIOL CHEM, V276, P12060, DOI 10.1074/jbc.M009038200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Trapani JA, 2008, IMMUNITY, V29, P665, DOI 10.1016/j.immuni.2008.10.002; Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	41	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6868	6877		10.1074/jbc.M114.631564	http://dx.doi.org/10.1074/jbc.M114.631564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605735	Green Published, hybrid			2022-12-28	WOS:000350991500022
J	Dijksterhuis, JP; Baljinnyam, B; Stanger, K; Sercan, HO; Ji, Y; Andres, O; Rubin, JS; Hannoush, RN; Schulte, G				Dijksterhuis, Jacomijn P.; Baljinnyam, Bolormaa; Stanger, Karen; Sercan, Hakki O.; Ji, Yun; Andres, Osler; Rubin, Jeffrey S.; Hannoush, Rami N.; Schulte, Gunnar			Systematic Mapping of WNT-FZD Protein Interactions Reveals Functional Selectivity by Distinct WNT-FZD Pairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN; INTERNATIONAL UNION; FRIZZLED 6; MICROGLIA; RECEPTORS; MEMBRANE; PATHWAY; PHOSPHORYLATION; ACTIVATION; SURVIVAL	The seven-transmembrane-spanning receptors of the FZD1-10 class are bound and activated by the WNT family of lipoglycoproteins, thereby inducing a complex network of signaling pathways. However, the specificity of the interaction between mammalian WNT and FZD proteins and the subsequent signaling cascade downstream of the different WNT-FZD pairs have not been systematically addressed to date. In this study, we determined the binding affinities of various WNTs for different members of the FZD family by using bio-layer interferometry and characterized their functional selectivity in a cell system. Using purified WNTs, we show that different FZD cysteine-rich domains prefer to bind to distinct WNTs with fast on-rates and slow off-rates. In a 32D cell-based system engineered to overexpress FZD(2), FZD(4), or FZD(5), we found that WNT-3A (but not WNT-4, -5A, or -9B) activated the WNT-beta-catenin pathway through FZD(2/4/5) as measured by phosphorylation of LRP6 and beta-catenin stabilization. Surprisingly, different WNT-FZD pairs showed differential effects on phosphorylation of DVL2 and DVL3, revealing a previously unappreciated DVL isoform selectivity by different WNT-FZD pairs in 32D cells. In summary, we present extensive mapping of WNT-FZD cysteine-rich domain interactions complemented by analysis of WNT-FZD pair functionality in a unique cell system expressing individual FZD isoforms. Differential WNT-FZD binding and selective functional readouts suggest that endogenous WNT ligands evolved with an intrinsic natural bias toward different downstream signaling pathways, a phenomenon that could be of great importance in the design of FZD-targeting drugs.	[Dijksterhuis, Jacomijn P.; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, S-17177 Stockholm, Sweden; [Dijksterhuis, Jacomijn P.; Sercan, Hakki O.; Ji, Yun; Andres, Osler; Rubin, Jeffrey S.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stanger, Karen; Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Schulte, Gunnar] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roche Holding; Genentech; Masaryk University Brno	Hannoush, RN (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	hannoush.rami@gene.com; gunnar.schulte@ki.se		Schulte, Gunnar/0000-0002-2700-7013; Dijksterhuis, Jacomijn/0000-0002-9214-6255	National Institutes of Health NCI Intramural Research Program; Karolinska Institutet; Swedish Research Council [K2008-68P-20810-01-4, K2008-68X-20805-01-4, K2011-67X-20805-05-3]; Swedish Cancer Society [CAN 2008/539, 2011/690]; KI-NIH Joint PhD Program; Signhild Engkvist Foundations; KI-MU Project [CZ.1.07/2.3.00/20.0180]; Czech Research Council [GACR 13-32990S]	National Institutes of Health NCI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); KI-NIH Joint PhD Program; Signhild Engkvist Foundations; KI-MU Project; Czech Research Council	The work was supported, in whole or in part, by the National Institutes of Health NCI Intramural Research Program. The work also was also supported by the Karolinska Institutet; Swedish Research Council Grants K2008-68P-20810-01-4, K2008-68X-20805-01-4, and K2011-67X-20805-05-3; Swedish Cancer Society Grants CAN 2008/539 and 2011/690; The KI-NIH Joint PhD Program; the Signhild Engkvist Foundations; KI-MU Project Grant CZ.1.07/2.3.00/20.0180; and Czech Research Council (GACR 13-32990S).	Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Gattinoni L, 2010, CLIN CANCER RES, V16, P4695, DOI 10.1158/1078-0432.CCR-10-0356; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Halleskog C, 2013, J NEUROCHEM, V125, P803, DOI 10.1111/jnc.12250; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Halleskog C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-111; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Kilander MBC, 2014, CELL SIGNAL, V26, P1943, DOI 10.1016/j.cellsig.2014.05.012; Kilander MBC, 2011, CELL SIGNAL, V23, P550, DOI 10.1016/j.cellsig.2010.11.004; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Naz G, 2012, BRIT J DERMATOL, V166, P1088, DOI 10.1111/j.1365-2133.2011.10800.x; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2	50	93	97	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6789	6798		10.1074/jbc.M114.612648	http://dx.doi.org/10.1074/jbc.M114.612648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605717	Green Published, hybrid			2022-12-28	WOS:000350991500015
J	Schwarzer, C; Fu, Z; Morita, T; Whitt, AG; Neely, AM; Li, C; Machen, TE				Schwarzer, Christian; Fu, Zhu; Morita, Takeshi; Whitt, Aaron G.; Neely, Aaron M.; Li, Chi; Machen, Terry E.			Paraoxonase 2 Serves a Proapopotic Function in Mouse and Human Cells in Response to the Pseudomonas aeruginosa Quorum-sensing Molecule N-(3-Oxododecanoyl)-homoserine Lactone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; N-3-OXODODECANOYL HOMOSERINE LACTONE; GENE-EXPRESSION; INDUCED APOPTOSIS; EPITHELIAL-CELLS; ER STRESS; SIGNAL; INACTIVATION; LEUKEMIA; THAPSIGARGIN	Pseudomonas aeruginosa use quorum-sensing molecules, including N-(3-oxododecanoyl)-homoserine lactone (C12), for intercellular communication. C12 activated apoptosis in mouse embryo fibroblasts (MEF) from both wild type (WT) and Bax/Bak double knock-out mice (WT MET and DKO MET that were responsive to C12, DKOR MEI): nuclei fragmented; mitochondrial membrane potential (Delta psi(mito)) depolarized; Ca2+ was released from the endoplasmic reticulum (ER), increasing cytosolic [Ca2+] (Ca-cyto); and caspase 3/7 was activated. DKOR MEF had been isolated from a nondonal pool of DKO MEE that were non-responsive to C12 (DKONR MEF). RNA seq analysis, quantitative PCR, and Western blots showed that WT and DKOR MEF both expressed genes associated with cancer, including paraoxonase 2 (PON2), whereas DKONR MEF expressed little PON2. Adenovirus-mediated expression of human PON2 in DKONR MEF rendered them responsive to C12: Delta psi(mito) depolarized, Ca-cyto increased, and caspase 3/7 activated. Human embryonic kidney 293T (HEK293T) cells expressed low levels of endogenous PON2, and these cells were also less responsive to C12. Overexpression of PON2, but not PON2-H114Q (no lactonase activity) in HEK293T cells caused them to become sensitive to C12. Because [C12] may reach high levels in biofilms in lungs of cystic fibrosis (CF) patients, PON2 lactonase activity may control Delta psi(mito), Ca2+ release from the ER, and apoptosis in CF airway epithelia. Coupled with previous data, these results also indicate that PON2 uses its lactonase activity to prevent Bax- and Bak-dependent apoptosis in response to common proapoptotic drugs like doxorubicin and staurosporine, but activates Bax- and Bak-independent apoptosis in response to C12.	[Schwarzer, Christian; Fu, Zhu; Morita, Takeshi; Machen, Terry E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Whitt, Aaron G.; Neely, Aaron M.; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Med, Louisville, KY 40202 USA; [Whitt, Aaron G.; Neely, Aaron M.; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Pharmacol, Louisville, KY 40202 USA; [Whitt, Aaron G.; Neely, Aaron M.; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Toxicol, Louisville, KY 40202 USA	University of California System; University of California Berkeley; University of Louisville; University of Louisville; University of Louisville	Machen, TE (corresponding author), Univ Calif Berkeley, 231 LSA, Berkeley, CA 94720 USA.	tmachen@berkeley.edu		Morita, Takeshi/0000-0002-8570-6744	National Institutes of Health [PN2-EY-018241, R01AM10141, K01CA106599, P20RR018733, R01 CA175003]; Cystic Fibrosis Research, Inc.; University of Louisville; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM010141] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA175003, K01CA106599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Research, Inc.; University of Louisville; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants PN2-EY-018241, R01AM10141, K01CA106599, P20RR018733, and R01 CA175003, Cystic Fibrosis Research, Inc. (New Horizons), and a Research Initiation Grant from the University of Louisville.	Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bar-Rogovsky H, 2013, J BIOL CHEM, V288, P23914, DOI 10.1074/jbc.M112.427922; Barathi Subramanian, 2010, J Ocul Biol Dis Infor, V3, P64, DOI 10.1007/s12177-011-9057-7; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Chambers CE, 2005, FEMS MICROBIOL LETT, V244, P297, DOI 10.1016/j.femsle.2005.01.055; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; CHRISTENSEN SB, 1993, FEBS LETT, V335, P345, DOI 10.1016/0014-5793(93)80416-R; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Devarajan A, 2014, ADV EXP MED BIOL, V824, P33, DOI 10.1007/978-3-319-07320-0_5; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Frank O, 2006, LEUKEMIA, V20, P1400, DOI 10.1038/sj.leu.2404270; Griffin PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042241; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Jacobi CA, 2009, INT J MED MICROBIOL, V299, P509, DOI 10.1016/j.ijmm.2009.03.005; Kirisits MJ, 2006, CELL MICROBIOL, V8, P1841, DOI 10.1111/j.1462-5822.2006.00817.x; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Li L, 2004, ONCOGENE, V23, P4894, DOI 10.1038/sj.onc.1207612; Li Y, 2002, J CANCER RES CLIN, V128, P369, DOI 10.1007/s00432-002-0347-0; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Pise-Masison CA, 2002, CANCER RES, V62, P3562; Ribarska Teodora, 2010, Cancer Genomics & Proteomics, V7, P51; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Rumbaugh KP, 2000, MICROBES INFECT, V2, P1721, DOI 10.1016/S1286-4579(00)01327-7; Schwarzer C, 2008, J BIOL CHEM, V283, P27144, DOI 10.1074/jbc.M709693200; Schwarzer C, 2014, CELL MICROBIOL, V16, P1094, DOI 10.1111/cmi.12263; Schwarzer C, 2014, AM J PHYSIOL-CELL PH, V306, pC844, DOI 10.1152/ajpcell.00002.2014; Schwarzer C, 2012, CELL MICROBIOL, V14, P698, DOI 10.1111/j.1462-5822.2012.01753.x; Schwarzer C, 2010, J BIOL CHEM, V285, P34850, DOI 10.1074/jbc.M110.167668; Schweikert EM, 2012, CELL DEATH DIFFER, V19, P1549, DOI 10.1038/cdd.2012.35; Schweikert EM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/352857; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Staudinger BJ, 2014, AM J RESP CRIT CARE, V189, P812, DOI 10.1164/rccm.201312-2142OC; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valentine CD, 2014, CELL MICROBIOL, V16, P1, DOI 10.1111/cmi.12176; Valentine CD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003576; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Williams SC, 2004, J BACTERIOL, V186, P2281, DOI 10.1128/JB.186.8.2281-2287.2004; Witte I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.91; Witte I, 2012, J LIPIDS, V2012, DOI 10.1155/2012/342806	53	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7247	7258		10.1074/jbc.M114.620039	http://dx.doi.org/10.1074/jbc.M114.620039			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627690	Green Published, hybrid			2022-12-28	WOS:000350991500053
J	Mir, SUR; George, NM; Zahoor, L; Harms, R; Guinn, Z; Sarvetnick, NE				Mir, Shakeel U. R.; George, Nicholas M.; Zahoor, Lubna; Harms, Robert; Guinn, Zachary; Sarvetnick, Nora E.			Inhibition of Autophagic Turnover in beta-Cells by Fatty Acids and Glucose Leads to Apoptotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ISLET AMYLOID POLYPEPTIDE; INSULIN-RESISTANCE; DISEASE; TYPE-2; SYSTEM; MICE; HYPERGLYCEMIA; ACCUMULATION; DEGRADATION	Autophagy, a cellular recycling process responsible for turnover of cytoplasmic contents, is critical for maintenance of health. Defects in this process have been linked to diabetes. Diabetes-associated glucotoxicity/lipotoxicity contribute to impaired beta-cell function and have been implicated as contributing factors to this disease. We tested the hypothesis that these two conditions affect beta-cell function by modulating autophagy. We report that exposure of beta-cell lines and human pancreatic islets to high levels of glucose and lipids blocks autophagic flux and leads to apoptotic cell death. EM analysis showed accumulation of autophagy intermediates (autophagosomes), with abundant engulfed cargo in palmitic acid (PA)-or glucose-treated cells, indicating suppressed autophagic turnover. EM studies also showed accumulation of damaged mitochondria, endoplasmic reticulum distention, and vacuolar changes in PA-treated cells. Pulse-chase experiments indicated decreased protein turnover in beta-cells treated with PA/glucose. Expression of mTORC1, an inhibitor of autophagy, was elevated in beta-cells treated with PA/glucose. mTORC1 inhibition, by treatment with rapamycin, reversed changes in autophagic flux, and cell death induced by glucose/PA. Our results indicate that nutrient toxicity-induced cell death occurs via impaired autophagy and is mediated by activation of mTORC1 in beta-cells, contributing to beta-cell failure in the presence of metabolic stress.	[Mir, Shakeel U. R.; George, Nicholas M.; Zahoor, Lubna; Harms, Robert; Guinn, Zachary; Sarvetnick, Nora E.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE 68198 USA; [Mir, Shakeel U. R.; George, Nicholas M.; Zahoor, Lubna; Harms, Robert; Guinn, Zachary; Sarvetnick, Nora E.] Univ Nebraska Med Ctr, Holland Regenerat Med Program, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sarvetnick, NE (corresponding author), Univ Nebraska Med Ctr, Dept Surg, Holland Regenerat Med Project, Omaha, NE 68198 USA.	noras@unmc.edu			National Institutes of Health [1UO1AI102012-01, DK091991]; Kieckhefer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI102012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kieckhefer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1UO1AI102012-01 (to N. E. S.). This work was also supported by generous funding from the Kieckhefer Foundation (to N. E. S.).; Supported by National Institutes of Health Postdoctoral Fellowship DK091991.	Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Bartolome A, 2014, DIABETES, V63, P2996, DOI 10.2337/db13-0970; Bartolome A, 2012, AUTOPHAGY, V8, P1757, DOI 10.4161/auto.21994; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Elghazi L, 2010, DIABETES, V59, P2390, DOI 10.2337/db09-0851; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kim J, 2014, J CLIN INVEST, V124, P3311, DOI 10.1172/JCI69625; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koyanagi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023238; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mir SUR, 2012, INT J CANCER, V131, pE1, DOI 10.1002/ijc.26432; Mir SUR, 2012, J BIOL CHEM, V287, P14494, DOI 10.1074/jbc.M111.324921; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shibata M, 2010, BIOCHEM BIOPH RES CO, V393, P274, DOI 10.1016/j.bbrc.2010.01.121; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	56	86	89	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6071	6085		10.1074/jbc.M114.605345	http://dx.doi.org/10.1074/jbc.M114.605345			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25548282	Green Published, hybrid			2022-12-28	WOS:000350732500018
J	Scarlett, K; Pattabiraman, V; Barnett, P; Liu, D; Anderson, LM				Scarlett, Kisha; Pattabiraman, Vaishnavi; Barnett, Petrina; Liu, Dong; Anderson, Leonard M.			The Proangiogenic Effect of Iroquois Homeobox Transcription Factor Irx3 in Human Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENES; ANGIOGENESIS; NOTCH; EXPRESSION; MORPHOGENESIS; ACTIVATION; MIGRATION; APOPTOSIS; HEART; ROLES	Angiogenesis is a dynamic process required for embryonic development. However, postnatal vascular growth is characteristic of multiple disease states. Despite insights into the multistep process in which adhesion molecules, extracellular matrix proteins, growth factors, and their receptors work in concert to form new vessels from the preexisting vasculature, there remains a lack of insight of the nuclear transcriptional mechanisms that occur within endothelial cells (ECs) in response to VEGF. Iroquois homeobox gene 3 (Irx3) is a transcription factor of the Iroquois family of homeobox genes. Irx homeodomain transcription factors are involved in the patterning and development of several tissues. Irx3 is known for its role during embryogenesis in multiple organisms. However, the expression and function of Irx3 in human postnatal vasculature remains to be investigated. Here we show that Irx3 is expressed in human microvascular endothelial cells, and expression is elevated by VEGF stimulation. Genetic Irx3 gain and loss of function studies in human microvascular endothelial cells resulted in the modulation of EC migration during wound healing, chemotaxis and invasion, and tubulogenesis. Additionally, we observed increased delta-like ligand 4 (Dll4) expression, which suggests an increase in EC tip cell population. Finally, siRNA screening studies revealed that transient knockdown of Hey1, a downstream Notch signaling mediator, resulted in increased Irx3 expression in response to VEGF treatment. Strategies to pharmacologically regulate Irx3 function in adult endothelial cells may provide new therapies for angiogenesis.	[Scarlett, Kisha; Pattabiraman, Vaishnavi; Liu, Dong; Anderson, Leonard M.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Liu, Dong; Anderson, Leonard M.] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Barnett, Petrina] Clark Atlanta Univ, Canc Ctr Therapeut Dev, Atlanta, GA 30314 USA	Morehouse School of Medicine; Morehouse School of Medicine; Clark Atlanta University	Anderson, LM (corresponding author), Morehouse Sch Med, Cardiovasc Res Inst, 720 Westview Dr SW, Atlanta, GA 30310 USA.	landerson@msm.edu	Pattabiraman, Vaishnavi/K-1924-2019		National Institutes of Health [K01 HL084760-01, 5R25 HL003676, 5G12 MD007602]; National Science Foundation from Georgia Tech/Emory Center for the Engineering of Living Tissues Grant [EEC-9731643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003676, K01HL084760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation from Georgia Tech/Emory Center for the Engineering of Living Tissues Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 HL084760-01 (to L. M. A.), 5R25 HL003676 (to G. H. G.), and 5G12 MD007602 (to V. M. R.). This work was also supported by the National Science Foundation from Georgia Tech/Emory Center for the Engineering of Living Tissues Grant EEC-9731643 (to L. M. A.).	Al-Kadi OS, 2008, IEEE T BIO-MED ENG, V55, P1822, DOI 10.1109/TBME.2008.919735; Benedito R, 2013, EXP CELL RES, V319, P1281, DOI 10.1016/j.yexcr.2013.01.010; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Bonnard C, 2012, NAT GENET, V44, P709, DOI 10.1038/ng.2259; Cardona Sandra M, 2013, Methods Mol Biol, V1013, P1, DOI 10.1007/978-1-62703-426-5_1; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chen W, 2008, J BIOL CHEM, V283, P16293, DOI 10.1074/jbc.M801803200; Cheng Z, 2011, HUM GENET, V130, P657, DOI 10.1007/s00439-011-0996-7; Christoffels VM, 2000, DEV BIOL, V224, P263, DOI 10.1006/dbio.2000.9801; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Doi T, 2011, J PEDIATR SURG, V46, P62, DOI 10.1016/j.jpedsurg.2010.09.059; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Folkman J, 1983, Symp Fundam Cancer Res, V36, P201; Gaborit N, 2012, DEVELOPMENT, V139, P4007, DOI 10.1242/dev.081703; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Gorski DH, 2000, CIRC RES, V87, P865, DOI 10.1161/01.RES.87.10.865; Hamik A, 2006, ARTERIOSCLER THROMB, V26, P1926; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Herbert SP, 2012, CURR BIOL, V22, P1789, DOI 10.1016/j.cub.2012.07.037; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Holderfield MT, 2006, BIOCHEM BIOPH RES CO, V346, P637, DOI 10.1016/j.bbrc.2006.05.177; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kachgal S, 2012, CELL ADHES MIGR, V6, P457, DOI 10.4161/cam.22164; Kang T, 2013, J BIOL CHEM, V288, P34394, DOI 10.1074/jbc.M113.514372; Kieran M. W., 2012, COLD SPRING HARB PER, V12, P1; Kim KH, 2012, CIRC RES, V110, P1513, DOI 10.1161/CIRCRESAHA.112.265041; Lecaudey V, 2005, J COMP NEUROL, V492, P289, DOI 10.1002/cne.20765; Li DY, 2014, DEV CELL, V29, P233, DOI 10.1016/j.devcel.2014.03.001; Liu D, 2006, CIRC RES, V98, P480, DOI 10.1161/01.RES.0000205764.85931.4b; Myrthue A, 2008, CLIN CANCER RES, V14, P3562, DOI 10.1158/1078-0432.CCR-07-4649; Padua MB, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.117002; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Robertshaw E, 2013, P NATL ACAD SCI USA, V110, pE3919, DOI 10.1073/pnas.1304311110; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Shah G, 2008, J SURG RES, V149, P171, DOI 10.1016/j.jss.2008.03.016; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Sotillos S, 2006, MECH DEVELOP, V123, P241, DOI 10.1016/j.mod.2005.12.002; Thomas JL, 2013, CELL MOL LIFE SCI, V70, P1779, DOI 10.1007/s00018-013-1312-6; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tung JJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006601; van Tuyl M, 2006, AM J PHYSIOL-LUNG C, V290, pL777, DOI 10.1152/ajplung.00293.2005; Wei YH, 2013, P NATL ACAD SCI USA, V110, pE3910, DOI 10.1073/pnas.1309276110; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	52	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6303	6315		10.1074/jbc.M114.601146	http://dx.doi.org/10.1074/jbc.M114.601146			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25512384	hybrid, Green Published			2022-12-28	WOS:000350732500036
J	Huang, CX; Wang, JJ; Ma, JH; Jin, CJ; Yu, Q; Zhang, SX				Huang, Chuangxin; Wang, Joshua J.; Ma, Jacey H.; Jin, Chenjin; Yu, Qiang; Zhang, Sarah X.			Activation of the UPR Protects against Cigarette Smoke-induced RPE Apoptosis through Up-Regulation of Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED-OXIDATIVE STRESS; MACULAR DEGENERATION; INDUCIBLE PROTEIN; EPITHELIAL-CELLS; DNA-DAMAGE; EXPRESSION; CHOP; DEFICIENCY; PROLIFERATION	Recent studies have revealed a role of endoplasmic reticulum (ER) stress-induced unfolded protein response (UPR) in the regulation of RPE cell activity and survival. Herein, we examined the mechanisms by which the UPR modulates apoptotic signaling in human RPE cells challenged with cigarette smoking extract (CSE). Our results show that CSE exposure induced a dose-and time-dependent increase in ER stress markers, enhanced reactive oxygen species (ROS), mitochondrial fragmentation, and apoptosis of RPE cells. These changes were prevented by the anti-oxidant NAC or chemical chaperone TMAO, suggesting a close interaction between oxidative and ER stress in CSE-induced apoptosis. To decipher the role of the UPR, overexpression or down-regulation of XBP1 and CHOP genes was manipulated by adenovirus or siRNA. Overexpressing XBP1 protected against CSE-induced apoptosis by reducing CHOP, p-p38, and caspase-3 activation. In contrast, XBP1 knockdown sensitized the cells to CSE-induced apoptosis, which is likely through a CHOP-independent pathway. Surprisingly, knockdown of CHOP reduced p-eIF2 alpha and Nrf2 resulting in a marked increase in caspase-3 activation and apoptosis. Furthermore, Nrf2 inhibition increased ER stress and exacerbated cell apoptosis, while Nrf2 overexpression reduced CHOP and protected RPE cells. Our data suggest that although CHOP may function as a pro-apoptotic gene during ER stress, it is also required for Nrf2 up-regulation and RPE cell survival. In addition, enhancing Nrf2 and XBP1 activity may help reduce oxidative and ER stress and protect RPE cells from cigarette smoke-induced damage.	[Huang, Chuangxin; Wang, Joshua J.; Ma, Jacey H.; Zhang, Sarah X.] SUNY Buffalo, Sch Med & Biomed Sci, Ross Eye Inst, Dept Ophthalmol, Buffalo, NY 14215 USA; [Huang, Chuangxin; Wang, Joshua J.; Ma, Jacey H.; Zhang, Sarah X.] SUNY Buffalo, SUNY Eye Inst, Buffalo, NY 14215 USA; [Huang, Chuangxin; Ma, Jacey H.; Jin, Chenjin; Yu, Qiang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, Sarah X.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14215 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Sun Yat Sen University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhang, SX (corresponding author), SUNY Buffalo, Ross Eye Inst, Dept Ophthalmol, 3435 Main St, Buffalo, NY 14214 USA.	xzhang38@buffalo.edu			National Institutes of Health/NEI [EY019949, EY025061]; American Diabetes Association; American Health Assistance Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY025061, R01EY019949] Funding Source: NIH RePORTER	National Institutes of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Diabetes Association(American Diabetes Association); American Health Assistance Foundation(BrightFocus Foundation); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in part, by National Institutes of Health/NEI Grants EY019949, EY025061, by grants from American Diabetes Association and American Health Assistance Foundation, and by an Unrestricted Grant to the Dept. of Ophthalmology, SUNY-Buffalo, from Research to Prevent Blindness (all to S. X. Z.).	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Ariyama Y, 2008, METABOLISM, V57, P1625, DOI 10.1016/j.metabol.2008.06.019; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Chang YS, 2007, INVEST OPHTH VIS SCI, V48, P2792, DOI 10.1167/iovs.06-1146; Chen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040801; Chen C, 2014, ANTIOXID REDOX SIGN, V20, P2091, DOI 10.1089/ars.2013.5240; Chen C, 2013, MOL VIS, V19, P39; Chen HW, 2009, ENVIRON MOL MUTAGEN, V50, P96, DOI 10.1002/em.20441; Chen HW, 2004, CHEM-BIOL INTERACT, V150, P233, DOI 10.1016/j.cbi.2004.09.014; Cheng SE, 2009, FREE RADICAL BIO MED, V46, P948, DOI 10.1016/j.freeradbiomed.2009.01.006; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Dou GR, 2012, FREE RADICAL BIO MED, V53, P1111, DOI 10.1016/j.freeradbiomed.2012.06.042; Edirisinghe I, 2010, ANTIOXID REDOX SIGN, V12, P1355, DOI 10.1089/ars.2009.2874; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Esposito V, 2013, AM J PHYSIOL-RENAL, V304, pF440, DOI 10.1152/ajprenal.00487.2011; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Friedman AD, 1996, CANCER RES, V56, P3250; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Geraghty P, 2011, INT J CHRONIC OBSTR, V6, P309, DOI 10.2147/COPD.S19599; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kenche H, 2013, FASEB J, V27, P965, DOI 10.1096/fj.12-216234; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kim YJ, 2011, BASIC CLIN PHARMACOL, V109, P17, DOI 10.1111/j.1742-7843.2011.00673.x; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Kunchithapautham K, 2014, J BIOL CHEM, V289, P14534, DOI 10.1074/jbc.M114.564674; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Losonczy G, 2011, ACTA OPHTHALMOL, V89, P255, DOI 10.1111/j.1755-3768.2009.01687.x; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Nashine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063205; Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, pH130, DOI 10.1152/ajpheart.00599.2006; Pieramici D J, 1998, Curr Opin Ophthalmol, V9, P38, DOI 10.1097/00055735-199806000-00007; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Souied EH, 2005, MOL VIS, V11, P1135; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Tamakoshi A, 1997, BRIT J OPHTHALMOL, V81, P901, DOI 10.1136/bjo.81.10.901; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang L, 2014, FREE RADICAL BIO MED, V70, P155, DOI 10.1016/j.freeradbiomed.2014.01.015; Wilson GA, 2001, NEW ZEAL MED J, V114, P471; Wu WX, 2011, AM J PHYSIOL-LUNG C, V300, pL821, DOI 10.1152/ajplung.00267.2010; Xu L, 2011, VIRCHOWS ARCH, V459, P415, DOI 10.1007/s00428-011-1141-7; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang W, 2012, NEOPLASMA, V59, P216, DOI 10.4149/neo_2012_028; Yoon JS, 2013, J ENDOCRINOL, V216, P145, DOI 10.1530/JOE-12-0257; Zeng DX, 2011, J CELL BIOCHEM, V112, P2082, DOI 10.1002/jcb.23131; Zhong YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038616; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	60	51	55	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5367	5380		10.1074/jbc.M114.603738	http://dx.doi.org/10.1074/jbc.M114.603738			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568320	Green Published, hybrid			2022-12-28	WOS:000350044200011
J	Scott, S; Lynch, JW; Keramidas, A				Scott, Suzanne; Lynch, Joseph W.; Keramidas, Angelo			Correlating Structural and Energetic Changes in Glycine Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; SINGLE-CHANNEL; HYPEREKPLEXIA MUTATIONS; TRANSMEMBRANE DOMAIN; CYS-LOOP; ACETYLCHOLINE-RECEPTORS; CHLORIDE CONDUCTANCE; AGONIST-BINDING; OPEN STATE	Pentameric ligand-gated ion channels (pLGICs) mediate fast chemoelectrical transduction in the nervous system. The mechanism by which the energy of ligand binding leads to currentconducting receptors is poorly understood and may vary among family members. We addressed these questions by correlating the structural and energetic mechanisms by which a naturally occurring M1 domain mutation (alpha 1(Q-26'E)) enhances receptor activation in homo- and heteromeric glycine receptors. We systematically altered the charge of spatially clustered residues at positions 19' and 24', in the M2 and M2-M3 linker domains, respectively, which are known to be critical to efficient receptor activation, on a background of alpha 1(Q-26'E)]:" Changes in the durations of single receptor activations (clusters) and conductance were used to determine interaction coupling energies, which we correlated with conformational displacements as measured in pLGIC crystal structures. Presence of the alpha 1(Q-26'E) - enhanced cluster durations and reduced channel conductance in homoand heteromeric receptors. Strong coupling between alpha 1(-26') and alpha 1(19') across the subunit interface suggests an important role in receptor activation. A lack of coupling between alpha 1(-26') and alpha 1(24') implies that 24' mutations disrupt activation via other interactions. A similar lack of energetic coupling between al-26' and reciprocal mutations in the beta subunit suggests that this subunit remains relatively static during receptor activation. However, the channel effects of alpha 1(Q-26'E) on alpha 1 beta receptors suggests at least one alpha 1-alpha 1 interface per pentamer. The coupling-energy change between alpha 1(-26') and a1l9' correlates with a local structural rearrangement essential for pLGIC activation, implying it comprises a key energetic pathway in activating glycine receptors and other pLGICs.	[Scott, Suzanne; Lynch, Joseph W.; Keramidas, Angelo] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Keramidas, A (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	a.keramidas@uq.edu.au	Scott, Suzanne/AAY-4374-2020; Keramidas, Angelo/I-1704-2013	Keramidas, Angelo/0000-0003-2846-052X; Scott, Suzanne/0000-0002-5830-8943	National Health and Medical Research Council of Australia; Australian Research Council [DP 1030101702]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia and Australian Research Council Grant DP 1030101702.	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bode A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-2; Bode A, 2013, J BIOL CHEM, V288, P33745, DOI 10.1074/jbc.M113.509240; Bode A, 2013, J BIOL CHEM, V288, P33760, DOI 10.1074/jbc.M113.513804; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; Dreissen YEM, 2012, EPILEPSIA, V53, P3, DOI 10.1111/j.1528-1167.2012.03709.x; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Grosman C, 2000, J GEN PHYSIOL, V115, P621, DOI 10.1085/jgp.115.5.621; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; JACKSON MB, 1984, P NATL ACAD SCI-BIOL, V81, P3901, DOI 10.1073/pnas.81.12.3901; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Legendre P, 1997, J NEUROPHYSIOL, V77, P2400, DOI 10.1152/jn.1997.77.5.2400; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mohammadi B, 2003, EUR BIOPHYS J BIOPHY, V32, P529, DOI 10.1007/s00249-003-0286-y; Moorhouse AJ, 1999, MOL PHARMACOL, V55, P386, DOI 10.1124/mol.55.2.386; Purohit P, 2014, BIOPHYS J, V107, P88, DOI 10.1016/j.bpj.2014.04.057; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Sivilotti LG, 2010, J PHYSIOL-LONDON, V588, P45, DOI 10.1113/jphysiol.2009.178525; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yang Z, 2012, BIOCHEMISTRY-US, V51, P5229, DOI 10.1021/bi300063m	51	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5621	5634		10.1074/jbc.M114.616573	http://dx.doi.org/10.1074/jbc.M114.616573			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572390	Green Published, hybrid			2022-12-28	WOS:000350044200032
J	Kelley, RA; Al-Ubaidi, MR; Naash, MI				Kelley, Ryan A.; Al-Ubaidi, Muayyad R.; Naash, Muna I.			Retbindin Is an Extracellular Riboflavin-binding Protein Found at the Photoreceptor/Retinal Pigment Epithelium Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHINE-OXIDASE CATALYZES; FATTY ACYL DERIVATIVES; LIPID-PEROXIDATION; HUMAN RETINA; INTERPHOTORECEPTOR MATRIX; PHOTOCHEMICAL DEGRADATION; PERIPHERIN/RDS CAUSES; OXYGEN-CONSUMPTION; TRANSGENIC MICE; COENZYME-A	Retbindin is a novel retina-specific protein of unknown function. In this study, we have used various approaches to evaluate protein expression, localization, biochemical properties, and function. We find that retbindin is secreted by the rod photoreceptors into the inter-photoreceptor matrix where it is maintained via electrostatic forces. Retbindin is predominantly localized at the interface between photoreceptors and retinal pigment epithelium microvilli, a region critical for retinal function and homeostasis. Interestingly, although it is associated with photoreceptor outer segments, retbindin's expression is not dependent on their presence. In vitro, retbindin is capable of binding riboflavin, thus implicating the protein as a metabolite carrier between the retina and the retinal pigment epithelium. Altogether, our data show that retbindin is a novel photoreceptor-specific protein with a unique localization and function. We hypothesize that retbindin is an excellent candidate for binding retinal flavins and possibly participating in their transport from the extracellular space to the photoreceptors. Further investigations are warranted to determine the exact function of retbindin in retinal homeostasis and disease.	[Kelley, Ryan A.; Al-Ubaidi, Muayyad R.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	Muna-Naash@ouhsc.edu			National Institutes of Health from NEI [R01EY10609, R01EY018137, P30EY021725]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [P30EY021725, R01EY018656, R01EY018137, R01EY010609] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY10609 (to M. I. N.), R01EY018137 (to M. R. A.), and P30EY021725 from NEI. This work was also supported by the Foundation Fighting Blindness (to M. I. N. and M. R. A.).	ALDER VA, 1990, INVEST OPHTH VIS SCI, V31, P1029; BATEY DW, 1991, INVEST OPHTH VIS SCI, V32, P1981; BATEY DW, 1992, EXP EYE RES, V54, P605, DOI 10.1016/0014-4835(92)90139-J; BECVAR J, 1982, J BIOL CHEM, V257, P5607; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; CAIRNS WL, 1971, J AM CHEM SOC, V93, P2772; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chakraborty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098939; CRANE FL, 1956, J BIOL CHEM, V218, P701; CRANE FL, 1956, J BIOL CHEM, V218, P717; DELAPAZ M, 1992, INVEST OPHTH VIS SCI, V33, P3497; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; DONOSO LA, 1990, CURR EYE RES, V9, P343, DOI 10.3109/02713689008999622; Doonan S, 1996, Methods Mol Biol, V59, P1; ECKHERT CD, 1993, EXPERIENTIA, V49, P1084, DOI 10.1007/BF01929917; FEENEY L, 1973, DEV BIOL, V32, P115, DOI 10.1016/0012-1606(73)90224-8; FONG SL, 1984, J BIOL CHEM, V259, P6534; Fox NE, 1998, FREE RADICAL BIO MED, V24, P900, DOI 10.1016/S0891-5849(97)00369-9; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; FRIDOVICH I, 1958, J BIOL CHEM, V231, P899; FUTTERMAN S, 1959, J BIOL CHEM, V234, P723; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gille C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-64; GOLDSMITH G A, 1975, P221; HAMAZUME Y, 1987, J BIOCHEM-TOKYO, V101, P217, DOI 10.1093/oxfordjournals.jbchem.a121894; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Huvaere K, 2010, J PHYS CHEM B, V114, P5583, DOI 10.1021/jp9121744; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kopitz J, 2004, BIOCHIMIE, V86, P825, DOI 10.1016/j.biochi.2004.09.029; Kruse HD, 1940, PUBLIC HEALTH REP, V55, P157, DOI 10.2307/4583161; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Morre DJ, 2003, FREE RADICAL RES, V37, P795, DOI 10.1080/1071576031000083107; Njie-Mbye YF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00366; OSTER G, 1962, EXPERIENTIA, V18, P249, DOI 10.1007/BF02148213; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; ROHLICH P, 1970, EXP EYE RES, V10, P80, DOI 10.1016/S0014-4835(70)80013-6; Said HM, 2005, J PHYSIOL-LONDON, V566, P369, DOI 10.1113/jphysiol.2005.085811; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Taibi G, 2001, J ENZYM INHIB, V16, P275, DOI 10.1080/14756360109162376; Taibi G, 2007, J ENZYM INHIB MED CH, V22, P471, DOI 10.1080/14756360701408739; Thompson CL, 2003, INVEST OPHTH VIS SCI, V44, P4515, DOI 10.1167/iovs.03-0303; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tomitsuka E, 2003, J BIOCHEM, V134, P191, DOI 10.1093/jb/mvg144; TREADWELL GE, 1968, J CHROMATOGR, V35, P376, DOI 10.1016/S0021-9673(01)82399-2; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Wistow G, 2002, MOL VIS, V8, P196	54	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5041	5052		10.1074/jbc.M114.624189	http://dx.doi.org/10.1074/jbc.M114.624189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25542898	Green Published, hybrid			2022-12-28	WOS:000350042000045
J	Ghosh, S; Adhikary, A; Chakraborty, S; Bhattacharjee, P; Mazumder, M; Putatunda, S; Gorain, M; Chakraborty, A; Kundu, GC; Das, T; Sen, PC				Ghosh, Swatilekha; Adhikary, Arghya; Chakraborty, Supriya; Bhattacharjee, Pushpak; Mazumder, Minakshi; Putatunda, Salil; Gorain, Mahadeo; Chakraborty, Arijit; Kundu, Gopal C.; Das, Tanya; Sen, Parimal C.			Cross-talk between Endoplasmic Reticulum (ER) Stress and the MEK/ERK Pathway Potentiates Apoptosis in Human Triple Negative Breast Carcinoma Cells ROLE OF A DIHYDROPYRIMIDONE, NIFETEPIMINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TFII-I; CANCER; GRP78; EXPRESSION; IDENTIFICATION; INVOLVEMENT; INDUCTION; PATTERNS; MELANOMA	Triple negative breast cancers (TNBC) are among the most aggressive and therapy-resistant breast tumors and currently possess almost no molecular targets for therapeutic options in this horizon. In the present study we discerned the molecular mechanisms of potential interaction between the endoplasmic reticulum (ER) stress response and the MEK/ERK pathway in inducing apoptosis in TNBC cells. Here we observed that induction of ER stress alone was not sufficient to trigger significant apoptosis but simultaneous inhibition of the MEK/ERK pathway enhanced ER stress-induced apoptosis via a caspase-dependent mechanism. Our study also demonstrated nifetepimine, a dihydropyrimidone derivative as a potent anti-cancer agent in TNBC cells. Nifetepimine down-regulated the MEK/ERK pathway in MDAMB-231 and MDAMB-468 cells and resulted in blockage of ER stress-mediated GRP78 up-regulation. Detailed mechanistic studies also revealed that nifetepimine by down-regulating pERK expression also declined the promoter binding activity of TFII-I to the GRP78 promoter and in turn regulated GRP78 transcription. Studies further extended to in vivo Swiss albino and SCID mice models also revalidated the anti-carcinogenic property of nifetepimine. Thus our findings cumulatively suggest that nifetepimine couples two distinct signaling pathways to induce the apoptotic death cascade in TNBC cells and raises the possibility for the use of nifetepimine as a potent anticancer agent with strong immune-restoring properties for therapeutic intervention for this group of cancer bearers.	[Ghosh, Swatilekha; Adhikary, Arghya; Chakraborty, Supriya; Bhattacharjee, Pushpak; Mazumder, Minakshi; Das, Tanya; Sen, Parimal C.] Calcutta Improvement Trust Scheme VII M, Bose Inst, Div Mol Med, Kolkata 700054, India; [Putatunda, Salil; Chakraborty, Arijit] Maulana Azad Coll, Dept Chem, Kolkata 700013, India; [Gorain, Mahadeo; Kundu, Gopal C.] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Das, T (corresponding author), Calcutta Improvement Trust Scheme VII M, Bose Inst, Div Mol Med, P-1-12, Kolkata 700054, India.	tanya@jcbose.ac.in; parimal@jcbose.ac.in	Putatunda, Salil/O-1172-2017; Kundu, Gopal C./ABA-9897-2020; Chakraborty, Supriya/GNP-4762-2022; Bhattacharjee, Pushpak/AFV-4590-2022; Chakraborty, Supriya/U-4306-2018	Putatunda, Salil/0000-0002-0244-3329; Chakraborty, Supriya/0000-0002-6517-0217; Chakraborty, Supriya/0000-0002-0800-5792	Department of Science and Technology; Council of Scientific and Industrial Research; Department of Atomic Energy; University Grants Commission, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Atomic Energy(Department of Atomic Energy (DAE)); University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by the grants from Department of Science and Technology, Council of Scientific and Industrial Research, Department of Atomic Energy, and the University Grants Commission, Government of India.	Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chaabane C, 2006, BIOCHEM BIOPH RES CO, V345, P1377, DOI 10.1016/j.bbrc.2006.05.054; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; De Laurentiis M, 2010, CANCER TREAT REV, V36, pS80, DOI 10.1016/S0305-7372(10)70025-6; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Ghosh S, 2012, J BIOL CHEM, V287, P32881, DOI 10.1074/jbc.M112.357889; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hersey P, 2006, INT REV CYTOL, V251, P131, DOI 10.1016/S0074-7696(06)51004-6; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kim DW, 2000, MOL CELL BIOL, V20, P1140, DOI 10.1128/MCB.20.4.1140-1148.2000; Kim DW, 2001, MOL CELL BIOL, V21, P3387, DOI 10.1128/MCB.21.10.3387-3397.2000; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mhaidat N., 2011, INT J BIOL BIOMED EN, V5, P41; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Novina CD, 1998, J BIOL CHEM, V273, P33443, DOI 10.1074/jbc.273.50.33443; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Reed John C., 1999, Current Opinion in Oncology, V11, P68, DOI 10.1097/00001622-199901000-00014; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Roy AL, 2006, ACS CHEM BIOL, V1, P619, DOI 10.1021/cb6004323; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	42	23	24	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3936	3949		10.1074/jbc.M114.594028	http://dx.doi.org/10.1074/jbc.M114.594028			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25527500	Green Published, hybrid			2022-12-28	WOS:000349458400005
J	Wang, DL; Coco, MW; Rose, RB				Wang, Dongli; Coco, Matthew W.; Rose, Robert B.			Interactions with the Bifunctional Interface of the Transcriptional Coactivator DCoH1 Are Kinetically Regulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE; PHENYLALANINE-HYDROXYLASE; PTERIN-4A-CARBINOLAMINE DEHYDRATASE; 4A-CARBINOLAMINE DEHYDRATASE; 3-DIMENSIONAL STRUCTURE; DIMERIZATION COFACTOR; STRUCTURAL BASIS; PCBD1 CAUSE; PROTEIN; GENE	Pterin-4a-carbinolamine dehydratase (PCD) is a highly conserved enzyme that evolved a second, unrelated function in mammals, as a transcriptional coactivator. As a coactivator, PCD is known as DCoH or dimerization cofactor of the transcription factor HNF-1. These two activities are associated with a change in oligomeric state: from two dimers interacting as an enzyme in the cytoplasm to a dimer interacting with a dimer of HNF-1 in the nucleus. The same interface of DCoH forms both complexes. To determine how DCoH partitions between its two functions, we studied the folding and stability of the DCoH homotetramer. We show that the DCoH1 homotetramer is kinetically trapped, meaning once it forms it will not dissociate to interact with HNF-1. In contrast, DCoH2, a paralog of DCoH1, unfolds within hours. A simple mutation in the interface of DCoH2 from Ser-51 to Thr, as found in DCoH1, increases the kinetic stability by 9 orders of magnitude, to tau(1/2) similar to 2 million years. This suggests that the DCoH1 similar to HNF-1 complex must co-fold to interact. We conclude that simple mutations can dramatically affect the dissociation kinetics of a complex. Residue 51 represents a "kinetic hot spot" instead of a "thermodynamic hot spot." Kinetic regulation allows PCD to adopt two distinct functions. Mutations in DCoH1 associated with diabetes affect both functions of DCoH1, perhaps by disrupting the balance between the two DCoH complexes.	[Wang, Dongli; Coco, Matthew W.; Rose, Robert B.] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Rose, RB (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, 128 Polk Hall, Raleigh, NC 27695 USA.	bob_rose@ncsu.edu		Rose, Robert/0000-0001-9496-6671	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY SW, 1993, ADV EXP MED BIOL, V338, P47; Bayle JH, 2002, J BIOL CHEM, V277, P28884, DOI 10.1074/jbc.M201983200; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P11891, DOI 10.1073/pnas.89.24.11891; CITRON BA, 1993, AM J HUM GENET, V53, P768; CURTIUS HC, 1990, BIOCHEM BIOPH RES CO, V172, P1060, DOI 10.1016/0006-291X(90)91554-6; DAVIS MD, 1992, FEBS LETT, V302, P73, DOI 10.1016/0014-5793(92)80288-R; Depaepe V, 2000, MOL BRAIN RES, V75, P76, DOI 10.1016/S0169-328X(99)00297-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDRIZZI JA, 1995, SCIENCE, V268, P556, DOI 10.1126/science.7725101; Ferre S, 2014, J AM SOC NEPHROL, V25, P574, DOI 10.1681/ASN.2013040337; FICNER R, 1995, EMBO J, V14, P2034, DOI 10.1002/j.1460-2075.1995.tb07195.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HAUER CR, 1993, J BIOL CHEM, V268, P4828; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; KAUFMAN S, 1958, J BIOL CHEM, V230, P931; Kaufman S, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P103; Kelch BA, 2007, J MOL BIOL, V370, P784, DOI 10.1016/j.jmb.2007.04.078; Lim S, 2002, J BIOL CHEM, V277, P25040, DOI 10.1074/jbc.M203257200; Longo N, 2009, J INHERIT METAB DIS, V32, P333, DOI 10.1007/s10545-009-1067-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Mukaiyama A, 2009, INT J MOL SCI, V10, P1369, DOI 10.3390/ijms10031369; Naponelli V, 2008, PLANT PHYSIOL, V146, P1515, DOI 10.1104/pp.107.114090; REBRIN I, 1995, BIOCHEMISTRY-US, V34, P5801, DOI 10.1021/bi00017a011; Resibois A, 1999, HISTOCHEM CELL BIOL, V111, P381, DOI 10.1007/s004180050371; Rho H, 2010, BIOCHEMISTRY-US, V49, P10187, DOI 10.1021/bi1015056; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rose RB, 2004, BIOCHEMISTRY-US, V43, P7345, DOI 10.1021/bi049620t; Rose RB, 2000, NAT STRUCT BIOL, V7, P744; Salimi NL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000689; Simaite D, 2014, DIABETES, V63, P3557, DOI 10.2337/db13-1784; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Song J, 1999, J BACTERIOL, V181, P2789, DOI 10.1128/JB.181.9.2789-2796.1999; Strandmann EPV, 1998, INT J DEV BIOL, V42, P53; Tejero J, 2013, IUBMB LIFE, V65, P358, DOI 10.1002/iub.1136; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Thony B, 1998, AM J HUM GENET, V62, P1302, DOI 10.1086/301887; Truhlar SME, 2004, PROTEIN SCI, V13, P381, DOI 10.1110/ps.03336804; Walters J, 2009, METHOD ENZYMOL, V455, P1, DOI 10.1016/S0076-6879(08)04201-8; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Wang Q, 2006, MOL BIOCHEM PARASIT, V146, P109, DOI 10.1016/j.molbiopara.2005.11.002; Watschinger K, 2013, IUBMB LIFE, V65, P366, DOI 10.1002/iub.1143; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; ZHAO GS, 1994, P NATL ACAD SCI USA, V91, P1366, DOI 10.1073/pnas.91.4.1366	51	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4319	4329		10.1074/jbc.M114.616870	http://dx.doi.org/10.1074/jbc.M114.616870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538247	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000349458400041
J	Driesbaugh, KH; Buzza, MS; Martin, EW; Conway, GD; Kao, JPY; Antalis, TM				Driesbaugh, Kathryn H.; Buzza, Marguerite S.; Martin, Erik W.; Conway, Gregory D.; Kao, Joseph P. Y.; Antalis, Toni M.			Proteolytic Activation of the Protease-activated Receptor (PAR)-2 by the Glycosylphosphatidylinositol-anchored Serine Protease Testisin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TESTICULAR GERM-CELLS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; LIPID RAFTS; FLUORESCENT INDICATORS; SIGNAL-TRANSDUCTION; THROMBIN RECEPTOR; FACTOR VIIA; IN-VITRO; PROTEINASE	Protease-activated receptors (PARs) are a family of seven-transmembrane, G-protein-coupled receptors that are activated by multiple serine proteases through specific N-terminal proteolytic cleavage and the unmasking of a tethered ligand. The majority of PAR-activating proteases described to date are soluble proteases that are active during injury, coagulation, and inflammation. Less investigation, however, has focused on the potential for membrane-anchored serine proteases to regulate PAR activation. Testisin is a unique trypsin-like serine protease that is tethered to the extracellular membrane of cells through a glycophosphatidylinositol (GPI) anchor. Here, we show that the N-terminal domain of PAR-2 is a substrate for testisin and that proteolytic cleavage of PAR-2 by recombinant testisin activates downstream signaling pathways, including intracellular Ca2+ mobilization and ERK1/2 phosphorylation. When testisin and PAR-2 are co-expressed in HeLa cells, GPI-anchored testisin specifically releases the PAR-2 tethered ligand. Conversely, knockdown of endogenous testisin in NCI/ADR-Res ovarian tumor cells reduces PAR-2 N-terminal proteolytic cleavage. The cleavage of PAR-2 by testisin induces activation of the intracellular serum-response element and NF kappa B signaling pathways and the induction of IL-8 and IL-6 cytokine gene expression. Furthermore, the activation of PAR-2 by testisin results in the loss and internalization of PAR-2 from the cell surface. This study reveals a new biological substrate for testisin and is the first demonstration of the activation of a PAR by a serine protease GPI-linked to the cell surface.	[Driesbaugh, Kathryn H.; Buzza, Marguerite S.; Martin, Erik W.; Conway, Gregory D.; Kao, Joseph P. Y.; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Driesbaugh, Kathryn H.; Buzza, Marguerite S.; Martin, Erik W.; Conway, Gregory D.; Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Kao, Joseph P. Y.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Antalis, TM (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 West Baltimore St, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu		Kao, Joseph/0000-0002-8875-2180; Martin, Erik/0000-0003-3979-2378	National Institutes of Health [HL084387, HL118390, DK081376, T32 HL07698]; American Heart Association [10PRE3640012]; Women's Board of the American Heart Association Greater Washington Region; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084387, T32HL007954, T32HL007698, R01HL118390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Women's Board of the American Heart Association Greater Washington Region; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084387 (to T. M. A.), HL118390 (to T. M. A.), DK081376 (to T. M. A.), and T32 HL07698 (to K. H. D.). This work was also supported by American Heart Association Predoctoral Fellowship 10PRE3640012 (to K. H. D.) and the Women's Board of the American Heart Association Greater Washington Region.	Adams MN, 2012, N-S ARCH PHARMACOL, V385, P861, DOI 10.1007/s00210-012-0783-6; Adams MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028018; Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Awasthi V, 2007, ARTERIOSCL THROM VAS, V27, P1447, DOI 10.1161/ATVBAHA.107.143438; Bocheva G, 2009, J INVEST DERMATOL, V129, P1816, DOI 10.1038/jid.2008.449; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Del Rosso M, 2002, CLIN EXP METASTAS, V19, P193, DOI 10.1023/A:1015531321445; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hooper JD, 1999, CANCER RES, V59, P3199; Hooper JD, 2000, BBA-GENE STRUCT EXPR, V1492, P63, DOI 10.1016/S0167-4781(00)00071-3; Inoue M, 1999, BIOCHEM BIOPH RES CO, V266, P564, DOI 10.1006/bbrc.1999.1870; Jahan I, 2007, ANN ONCOL, V18, P1506, DOI 10.1093/annonc/mdm190; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Kao JPY, 2010, METHOD CELL BIOL, V99, P113, DOI [10.1016/S0091-679X(10)99005-5, 10.1016/B978-0-12-374841-6.00005-0]; Kaufmann R, 2011, J CANCER RES CLIN, V137, P965, DOI 10.1007/s00432-010-0961-1; Kawano N, 2010, BIOL REPROD, V83, P359, DOI 10.1095/biolreprod.109.083089; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Liu CY, 2013, ARCH BIOCHEM BIOPHYS, V535, P234, DOI 10.1016/j.abb.2013.02.013; Ludeman MJ, 2004, J BIOL CHEM, V279, P18592, DOI 10.1074/jbc.M310836200; MINTA A, 1989, J BIOL CHEM, V264, P8171; Miyata H, 2012, CYTOSKELETON, V69, P207, DOI 10.1002/cm.21012; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Osuga Yutaka, 2012, Front Biosci (Schol Ed), V4, P1201; Pendurthi UR, 2008, THROMB RES, V122, pS14, DOI 10.1016/S0049-3848(08)70012-4; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Russo A, 2009, MOL INTERV, V9, P87, DOI 10.1124/mi.9.2.8; Sales K. U., 2014, ONCOGENE, DOI [10.1038/pmc/2013.563, DOI 10.1038/PMC/2013.563]; Scarman AL, 2001, EUR J BIOCHEM, V268, P1250, DOI 10.1046/j.1432-1327.2001.01986.x; Schaffner F, 2009, ARTERIOSCL THROM VAS, V29, P1999, DOI 10.1161/ATVBAHA.108.177428; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Shigemasa K, 2000, J SOC GYNECOL INVEST, V7, P358, DOI 10.1016/S1071-5576(00)00086-1; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Sorensen BB, 2003, BLOOD, V102, P1708, DOI 10.1182/blood-2003-01-0157; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Tang T, 2005, CANCER RES, V65, P868; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Versteeg HH, 2004, ONCOGENE, V23, P410, DOI 10.1038/sj.onc.1207066; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weidinger S, 2003, HUM REPROD, V18, P2519, DOI 10.1093/humrep/deg476; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x; Yeom SY, 2010, FEBS LETT, V584, P1469, DOI 10.1016/j.febslet.2010.02.072; Yoshida N, 2007, INT J MOL MED, V19, P335; YU JX, 1994, J BIOL CHEM, V269, P18843	61	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3529	3541		10.1074/jbc.M114.628560	http://dx.doi.org/10.1074/jbc.M114.628560			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25519908	Green Published, hybrid			2022-12-28	WOS:000349456000027
J	Kalderon, B; Kogan, G; Bubis, E; Pines, O				Kalderon, Bella; Kogan, Gleb; Bubis, Ettel; Pines, Ophry			Cytosolic Hsp60 Can Modulate Proteasome Activity in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN PROTEIN HSP60; HEAT-SHOCK PROTEINS; BAX; EXPRESSION; SURVIVAL; CELLS; TUMOR; LOCALIZATION; CANCER; HEAT-SHOCK-PROTEIN-60	Hsp60, an essential oligomeric molecular mitochondrial chaperone, has been subject to rigorous basic and clinical research. With yeast as a model system, we provide evidence for the ability of cytosolic yHsp60 to inhibit the yeast proteasome. (i) Following biological turnover of murine Bax (a proteasome substrate), we show that co-expression of cytosolic yHsp60 stabilizes Bax, enhances its association with mitochondria, and enhances its killing capacity. (ii) Expression of yHsp60 in the yeast cytosol (yHsp60c) inhibits degradation of a cytosolic protein Delta MTS-Aco1 tagged with the degron SL17 (a ubiquitin-proteasome substrate). (iii) Conditions under which Hsp60 accumulates in the cytosol (elevated Hsp60c or growth at 37 degrees C) correlate with reduced 20 S peptidase activity in proteasomes purified from cell extracts. (iv) Elevated yHsp60 in the cytosol correlate with accumulation of polyubiquitinated proteins. (v) According to 20 S proteasome pulldown experiments, Hsp60 is physically associated with proteasomes in extracts of cells expressing Hsp60c or grown at 37 degrees C. Even mutant Hsp60 proteins, lacking chaperone activity, were still capable of proteasome inhibition. The results support the hypothesis that localization of Hsp60 to the cytosol may modulate proteasome activity according to cell need.	[Kalderon, Bella; Kogan, Gleb; Bubis, Ettel; Pines, Ophry] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Microbiol Mol Genet, IL-91120 Jerusalem, Israel; [Pines, Ophry] Natl Univ Singapore, CREATE NUS HUJ Program, Singapore 138602, Singapore	Hebrew University of Jerusalem; National University of Singapore	Pines, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Microbiol Mol Genet, IL-91120 Jerusalem, Israel.	ophryp@ekmd.huji.ac.il	pines, ophry/C-4086-2011	pines, ophry/0000-0001-7126-2575	Israel Science Foundation (ISF); Morasha program of the ISF; USA-Israel Binational Science Foundation (BSF); CREATE project of the National Research Foundation of Singapore	Israel Science Foundation (ISF)(Israel Science Foundation); Morasha program of the ISF; USA-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); CREATE project of the National Research Foundation of Singapore(National Research Foundation, Singapore)	This work was supported by grants from the Israel Science Foundation (ISF), The Morasha program of the ISF and The USA-Israel Binational Science Foundation (BSF), and the CREATE project of the National Research Foundation of Singapore.	Ang K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001290; Arlow T, 2013, P NATL ACAD SCI USA, V110, P246, DOI 10.1073/pnas.1215510110; Ben-Menachem R, 2011, J MOL BIOL, V409, P113, DOI 10.1016/j.jmb.2011.03.045; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Castagna A, 2004, PROTEOMICS, V4, P3246, DOI 10.1002/pmic.200400835; Castle PE, 2005, CANCER LETT, V229, P245, DOI 10.1016/j.canlet.2005.06.045; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chen D, 2010, CURR PROTEIN PEPT SC, V11, P459, DOI 10.2174/138920310791824057; Chun JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009422; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Cornford PA, 2000, CANCER RES, V60, P7099; DJABALLAH H, 1993, BIOCHEM J, V292, P857, DOI 10.1042/bj2920857; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; Faried A, 2004, EUR J CANCER, V40, P2804, DOI 10.1016/j.ejca.2004.08.013; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gupta S, 2002, CIRCULATION, V106, P2727, DOI 10.1161/01.CIR.0000038112.64503.6E; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Hayoun D, 2012, FEBS J, V279, P2083, DOI 10.1111/j.1742-4658.2012.08594.x; Hsu PL, 1998, CANCER RES, V58, P5507; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jurgensmeier JM, 1997, MOL BIOL CELL, V8, P325; Kalderon Bella, 2014, Front Mol Biosci, V1, P23, DOI 10.3389/fmolb.2014.00023; Karniely S, 2006, EXP CELL RES, V312, P3835, DOI 10.1016/j.yexcr.2006.08.021; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Piselli P, 2000, ANTICANCER RES, V20, P825; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schneider J, 1999, ANTICANCER RES, V19, P2141; Shamaei-Tousi A, 2007, CELL STRESS CHAPERON, V12, P384, DOI 10.1379/CSC-300.1; Shlevin L, 2007, TRAFFIC, V8, P169, DOI 10.1111/j.1600-0854.2006.00518.x; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Tsai YP, 2009, CARCINOGENESIS, V30, P1049, DOI 10.1093/carcin/bgp087; WEISS C, 1995, J BIOL CHEM, V270, P13956, DOI 10.1074/jbc.270.23.13956; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zha HB, 1996, MOL CELL BIOL, V16, P6494	47	18	18	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3542	3551		10.1074/jbc.M114.626622	http://dx.doi.org/10.1074/jbc.M114.626622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525272	hybrid, Green Published			2022-12-28	WOS:000349456000028
J	McCabe, JM; Leahy, DJ				McCabe, Jacqueline M.; Leahy, Daniel J.			Smoothened Goes Molecular: New Pieces in the Hedgehog Signaling Puzzle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STRUCTURAL INSIGHTS; ACQUIRED-RESISTANCE; PATHWAY INHIBITOR; MEMBRANE-PROTEIN; BINDING-SITE; DALLY-LIKE; ACTIVATION; RECEPTOR; MUTATIONS; MODULATION	A general aim of studies of signal transduction is to identify mediators of specific signals, order them into pathways, and understand the nature of interactions between individual components and how these interactions alter pathway behavior. Despite years of intensive study and its central importance to animal development and human health, our understanding of the Hedgehog (Hh) signaling pathway remains riddled with gaps, question marks, assumptions, and poorly understood connections. In particular, understanding how interactions between Hh and Patched (Ptc), a 12-pass integral membrane protein, lead to modulation of the function of Smoothened (Smo), a 7-pass integral membrane protein, has defied standard biochemical characterization. Recent structural and biochemical characterizations of Smoothened domains have begun to unlock this riddle, however, and lay the groundwork for improved cancer therapies.	[McCabe, Jacqueline M.; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St,716 Hunterian Bldg, Baltimore, MD 21205 USA.	dleahy@jhmi.edu			National Institutes of Health [R01 HD055545]; National Science Foundation [NSF DGE-1232825]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD055545 (to D. J. L.).; Supported by Graduate Research Fellowship Program NSF DGE-1232825 from the National Science Foundation.	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Bazan JF, 2009, CELL, V138, P1055, DOI 10.1016/j.cell.2009.09.006; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Bender MH, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-2819; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Brinkhuizen T, 2014, J AM ACAD DERMATOL, V71, P1005, DOI 10.1016/j.jaad.2014.08.001; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Carbe CJ, 2014, AM J PHYSIOL-HEART C, V307, pH66, DOI 10.1152/ajpheart.00166.2014; Carroll CE, 2012, DEVELOPMENT, V139, P612, DOI 10.1242/dev.075614; Chang ALS, 2012, ARCH DERMATOL, V148, P1324, DOI 10.1001/archdermatol.2012.2354; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gradilla AC, 2013, CURR OPIN GENET DEV, V23, P363, DOI 10.1016/j.gde.2013.04.011; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim MS, 2011, P NATL ACAD SCI USA, V108, P13112, DOI 10.1073/pnas.1109877108; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Myers BR, 2013, DEV CELL, V26, P346, DOI 10.1016/j.devcel.2013.07.015; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Nedelcu D, 2013, NAT CHEM BIOL, V9, P557, DOI [10.1038/NCHEMBIO.1290, 10.1038/nchembio.1290]; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Philipp M, 2009, CURR BIOL, V19, pR125, DOI 10.1016/j.cub.2008.12.010; Polizio AH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002396; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Rana R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3965; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Ryan KE, 2012, J BIOL CHEM, V287, P17905, DOI 10.1074/jbc.R112.356006; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Therond PP, 2012, CURR OPIN CELL BIOL, V24, P173, DOI 10.1016/j.ceb.2012.02.001; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang Y, 2012, CHEM BIOL, V19, P972, DOI 10.1016/j.chembiol.2012.06.012; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	88	18	19	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3500	3507		10.1074/jbc.R114.617936	http://dx.doi.org/10.1074/jbc.R114.617936			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25519909	Green Published, hybrid			2022-12-28	WOS:000349456000024
J	Nilsen, NJ; Vladimer, GI; Stenvik, J; Orning, MPA; Zeid-Kilani, MV; Bugge, M; Bergstroem, B; Conlon, J; Husebye, H; Hise, AG; Fitzgerald, KA; Espevik, T; Lien, E				Nilsen, Nadra J.; Vladimer, Gregory I.; Stenvik, Jorgen; Orning, M. Pontus A.; Zeid-Kilani, Maria V.; Bugge, Marit; Bergstroem, Bjarte; Conlon, Joseph; Husebye, Harald; Hise, Amy G.; Fitzgerald, Katherine A.; Espevik, Terje; Lien, Egil			A Role for the Adaptor Proteins TRAM and TRIF in Toll-like Receptor 2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LIPOPOLYSACCHARIDE-INDUCIBLE GENES; DOMAIN-CONTAINING ADAPTER; CUTTING EDGE; IFN-BETA; TRANSCRIPTION FACTORS; REGULATORY FACTOR-3; INTERFERON RESPONSE; LIPOTEICHOIC ACID; RNA HELICASE	Toll-like receptors (TLRs) are involved in sensing invading microbes by host innate immunity. TLR2 recognizes bacterial lipoproteins/lipopeptides, and lipopolysaccharide activates TLR4. TLR2 and TLR4 signal via the Toll/interleukin-1 receptor adaptors MyD88 and MAL, leading to NF-kappa B activation. TLR4 also utilizes the adaptors TRAM and TRIF, resulting in activation of interferon regulatory factor (IRF) 3. Here, we report a new role for TRAM and TRIF in TLR2 regulation and signaling. Interestingly, we observed that TLR2-mediated induction of the chemokine Ccl5 was impaired in TRAM or TRIF deficient macrophages. Inhibition of endocytosis reduced Ccl5 release, and the data also suggested that TRAM and TLR2 co-localize in early endosomes, supporting the hypothesis that signaling may occur from an intracellular compartment. Ccl5 release following lipoprotein challenge additionally involved the kinase Tbk-1 and Irf3, as well as MyD88 and Irf1. Induction of Interferon-beta and Ccl4 by lipoproteins was also partially impaired in cells lacking TRIF cells. Our results show a novel function of TRAM and TRIF in TLR2-mediated signal transduction, and the findings broaden our understanding of how Toll/interleukin-1 receptor adaptor proteins may participate in signaling downstream from TLR2.	[Nilsen, Nadra J.; Stenvik, Jorgen; Orning, M. Pontus A.; Zeid-Kilani, Maria V.; Bugge, Marit; Bergstroem, Bjarte; Husebye, Harald; Fitzgerald, Katherine A.; Espevik, Terje; Lien, Egil] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway; [Nilsen, Nadra J.; Espevik, Terje] Norwegian Univ Sci & Technol, KG Jebsen Ctr Myeloma Res, N-7489 Trondheim, Norway; [Vladimer, Gregory I.; Orning, M. Pontus A.; Conlon, Joseph; Fitzgerald, Katherine A.; Lien, Egil] Univ Massachusetts, Sch Med, Program Innate Immun, Dept Med,Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Hise, Amy G.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Hise, Amy G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester; Case Western Reserve University; Case Western Reserve University	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Program Innate Immun, Dept Med,Div Infect Dis & Immunol, 364 Plantat St,Lazare Res Bldg 311, Worcester, MA 01605 USA.	Egil.Lien@umassmed.edu	Vladimer, Gregory/X-4547-2018; Nilsen, Nadra/G-5592-2017; Fitzgerald, Katherine/ABE-6317-2020; Bergstrøm, Bjarte/H-8159-2016	Vladimer, Gregory/0000-0003-4205-7585; Nilsen, Nadra/0000-0003-0407-1060; Bergstrøm, Bjarte/0000-0002-5042-6697; Orning, Pontus/0000-0002-6177-6916; Fitzgerald, Kate/0000-0003-3175-609X; Husebye, Harald/0000-0002-8828-1059	National Institutes of Health [R01 AI57538, AI095213]; Research Council of Norway; Norwegian Cancer Society; Commission of the European Communities [QLK2-2000-00336]; Cancer Fund from St. Olavs Hospital, Trondheim, Norway; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095213] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Commission of the European Communities(European Commission); Cancer Fund from St. Olavs Hospital, Trondheim, Norway; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI57538 (to E. L.) and AI095213 (to G. I. V.). This work was also supported by the Research Council of Norway, the Norwegian Cancer Society, Commission of the European Communities Grant QLK2-2000-00336 (RTD Program "Quality of Life and Management of Living Resources" and "Hospath"), and by the Cancer Fund from St. Olavs Hospital, Trondheim, Norway.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heine H, 1999, J IMMUNOL, V162, P6971; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hirschfield GM, 2003, J IMMUNOL, V171, P6046, DOI 10.4049/jimmunol.171.11.6046; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lin RT, 1999, MOL CELL BIOL, V19, P959; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Petnicki-Ocwieja T, 2013, INFECT IMMUN, V81, P402, DOI 10.1128/IAI.00890-12; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Schjetne KW, 2003, J IMMUNOL, V171, P32, DOI 10.4049/jimmunol.171.1.32; Schmitz F, 2007, EUR J IMMUNOL, V37, P315, DOI 10.1002/eji.200636767; Solis M, 2007, EUR J IMMUNOL, V37, P528, DOI 10.1002/eji.200636090; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	50	73	76	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3209	3222		10.1074/jbc.M114.593426	http://dx.doi.org/10.1074/jbc.M114.593426			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505250	Green Published, hybrid			2022-12-28	WOS:000349456000003
J	Fishel, ML; Wu, X; Devlin, CM; Logsdon, DP; Jiang, YL; Luo, MH; He, Y; Yu, ZS; Tong, Y; Lipking, KP; Maitra, A; Rajeshkumar, NV; Scandura, G; Kelley, MR; Ivan, M				Fishel, Melissa L.; Wu, Xue; Devlin, Cecilia M.; Logsdon, Derek P.; Jiang, Yanlin; Luo, Meihua; He, Ying; Yu, Zhangsheng; Tong, Yan; Lipking, Kelsey P.; Maitra, Anirban; Rajeshkumar, N. V.; Scandura, Glenda; Kelley, Mark R.; Ivan, Mircea			Apurinic/Apyrimidinic Endonuclease/Redox Factor-1 (APE1/Ref-1) Redox Function Negatively Regulates NRF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hypoxia; Nuclear Factor 2 (Erythroid-derived 2-like Factor) (NFE2L2) (Nrf2); Reactive Oxygen Species (ROS); Redox Signaling; Transcription Factor; APE1; Ref-1; HMOX1; Pancreatic Adenocarcinoma	SIGNALING PROTEIN APE1/REF-1; PANCREATIC-CANCER CELLS; OXYGENASE-1 HO-1 INHIBITORS; HEME OXYGENASE-1; DNA-REPAIR; TUMOR-GROWTH; TRANSCRIPTION FACTORS; GENE-EXPRESSION; RESISTANCE; INDUCTION	Background: The redox activity of Ref-1 activates the binding of several transcription factors important in cancer. Results: Repression of Ref-1 potently activates NRF2 resulting in up-regulation of target gene expression. Conclusion: Activation of NRF2 is a potential mechanism of resistance to therapies based on Ref-1 inhibition. Significance: Dual blockade of Ref-1 and NRF2 or the specific downstream target, HMOX-1, represents a strategy for overcoming resistance. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) (henceforth referred to as Ref-1) is a multifunctional protein that in addition to its base excision DNA repair activity exerts redox control of multiple transcription factors, including nuclear factor -light chain enhancer of activated B cells (NF-B), STAT3, activator protein-1 (AP-1), hypoxia-inducible factor-1 (HIF-1), and tumor protein 53 (p53). In recent years, Ref-1 has emerged as a promising therapeutic target in cancer, particularly in pancreatic ductal carcinoma. Although a significant amount of research has centered on Ref-1, no wide-ranging approach had been performed on the effects of Ref-1 inhibition and transcription factor activity perturbation. Starting with a broader approach, we identified a previously unsuspected effect on the nuclear factor erythroid-related factor 2 (NRF2), a critical regulator of cellular defenses against oxidative stress. Based on genetic and small molecule inhibitor-based methodologies, we demonstrated that repression of Ref-1 potently activates NRF2 and its downstream targets in a dose-dependent fashion, and that the redox, rather than the DNA repair function of Ref-1 is critical for this effect. Intriguingly, our results also indicate that this pathway does not involve reactive oxygen species. The link between Ref-1 and NRF2 appears to be present in all cells tested in vitro, noncancerous and cancerous, including patient-derived tumor samples. In particular, we focused on understanding the implications of the novel interaction between these two pathways in primary pancreatic ductal adenocarcinoma tumor cells and provide the first evidence that this mechanism has implications for overcoming the resistance against experimental drugs targeting Ref-1 activity, with clear translational implications.	[Fishel, Melissa L.; Jiang, Yanlin; Luo, Meihua; He, Ying; Kelley, Mark R.] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Fishel, Melissa L.; Logsdon, Derek P.; Luo, Meihua; Kelley, Mark R.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Wu, Xue; Ivan, Mircea] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Devlin, Cecilia M.; Scandura, Glenda; Ivan, Mircea] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Yu, Zhangsheng; Tong, Yan] Indiana Univ, Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Lipking, Kelsey P.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Maitra, Anirban; Rajeshkumar, N. V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Maitra, Anirban; Rajeshkumar, N. V.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Johns Hopkins University; Johns Hopkins University	Fishel, ML (corresponding author), 1044 W Walnut St,Rm 4-321, Indianapolis, IN 46202 USA.	mfishel@iu.edu; mivan@iu.edu	Fishel, Melissa L./AAH-6608-2020; Wu, Xue/AAJ-9340-2020; Ivan, Mircea/A-8109-2012	Fishel, Melissa L./0000-0002-9436-6382; Wu, Xue/0000-0002-0511-9436; Kelley, Mark/0000-0002-6120-9532; Ivan, Mircea/0000-0003-3424-6642	National Institutes of Health [NCI CA167291, NCI 1R01 CA155332-01, CA121168, CA121168S1, CA167291]; Riley Children's Foundation; Indiana University Simon Cancer Center Indiana Translational Research Acceleration Collaboration (IUSCC ITRAC); Stand Up to Cancer Dream Team Translational Research Grant [SU2C-AACR]; Program of the Entertainment Industry Foundation Grant [SU2C-AACR-DT0509]; NATIONAL CANCER INSTITUTE [R01CA167291, R01CA155332, R01CA121168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; Indiana University Simon Cancer Center Indiana Translational Research Acceleration Collaboration (IUSCC ITRAC); Stand Up to Cancer Dream Team Translational Research Grant; Program of the Entertainment Industry Foundation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants NCI CA167291 (to M. L. F.), NCI 1R01 CA155332-01 (to M. I.), CA121168, CA121168S1, and CA167291, and a grant from the Riley Children's Foundation (to M. R. K.), a grant from the Indiana University Simon Cancer Center Indiana Translational Research Acceleration Collaboration (IUSCC ITRAC) basic science pilot funding mechanism (to M. I. and M. L. F.), Stand Up to Cancer Dream Team Translational Research Grant SU2C-AACR and Program of the Entertainment Industry Foundation Grant SU2C-AACR-DT0509 (to N. V. R.).	Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Cardoso AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047462; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Enomoto N, 2002, BIOCHEM BIOPH RES CO, V297, P346, DOI 10.1016/S0006-291X(02)02186-1; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fishel M. L., 2013, DNA BASE EXCISION RE; Fishel ML, 2008, DNA REPAIR, V7, P177, DOI 10.1016/j.dnarep.2007.09.008; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fishel ML, 2013, DNA REPAIR AND CANCER: FROM BENCH TO CLINIC, P233; Fishel ML, 2011, MOL CANCER THER, V10, P1698, DOI 10.1158/1535-7163.MCT-11-0107; Fishel ML, 2010, EXP HEMATOL, V38, P1178, DOI 10.1016/j.exphem.2010.08.011; Higgins LG, 2011, CHEM-BIOL INTERACT, V192, P37, DOI 10.1016/j.cbi.2010.09.025; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; Jiang YL, 2010, CANCER INVEST, V28, P885, DOI 10.3109/07357907.2010.512816; Jiwaji M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050521; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Luo MH, 2012, BIOCHEMISTRY-US, V51, P695, DOI 10.1021/bi201034z; Meng D, 2010, TOXICOL APPL PHARM, V244, P291, DOI 10.1016/j.taap.2010.01.004; Nuhn P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-37; Nyland RL, 2010, J MED CHEM, V53, P1200, DOI 10.1021/jm9014857; Pittala V, 2013, CURR MED CHEM, V20, P3711, DOI 10.2174/0929867311320300003; Rensing H, 2001, CRIT CARE MED, V29, P1962, DOI 10.1097/00003246-200110000-00019; Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186; Salerno L, 2013, BIOORGAN MED CHEM, V21, P5145, DOI 10.1016/j.bmc.2013.06.040; Sengupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068467; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Tibullo D, 2013, CURR PHARM DESIGN, V19, P2765, DOI 10.2174/1381612811319150012; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Wang D, 2004, MOL CANCER THER, V3, P679; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7778; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang J, 2013, BIOCHEMISTRY-US, V52, P2955, DOI 10.1021/bi400179m; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113	42	51	51	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3057	3068		10.1074/jbc.M114.621995	http://dx.doi.org/10.1074/jbc.M114.621995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25492865	Green Published, hybrid			2022-12-28	WOS:000349310700042
J	Kara, I; Poggi, M; Bonardo, B; Govers, R; Landrier, JF; Tian, S; Leibiger, I; Day, R; Creemers, JWM; Peiretti, F				Kara, Imene; Poggi, Marjorie; Bonardo, Bernadette; Govers, Roland; Landrier, Jean-Francois; Tian, Sun; Leibiger, Ingo; Day, Robert; Creemers, John W. M.; Peiretti, Franck			The Paired Basic Amino Acid-cleaving Enzyme 4 (PACE4) Is Involved in the Maturation of Insulin Receptor Isoform B AN OPPORTUNITY TO REDUCE THE SPECIFIC INSULIN RECEPTOR-DEPENDENT EFFECTS OF INSULIN-LIKE GROWTH FACTOR 2 (IGF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Furin; Insulin; Insulin Receptor; Insulin-like Growth Factor (IGF); Metabolic Signaling; Mitogenic Signaling; Proprotein Convertase	HAMSTER OVARY CELLS; PROPROTEIN CONVERTASES; CANCER-CELLS; FUNCTIONAL-PROPERTIES; LIGAND-BINDING; CLEAVAGE SITE; FURIN; PRORECEPTOR; ACTIVATION; INHIBITOR	Background: The insulin receptor exists as two isoforms: IRA and IRB. Results: IRA and IRB are similarly matured by furin, but when furin activity is reduced, IRB is matured by PACE4. Conclusion: Proprotein convertase inhibition can selectively reduce IRA maturation and its signaling. Significance: This can be considered as a new opportunity to target IRA signaling in cancer. Gaining the full activity of the insulin receptor (IR) requires the proteolytic cleavage of its proform by intra-Golgi furin-like activity. In mammalian cells, IR is expressed as two isoforms (IRB and IRA) that are responsible for insulin action. However, only IRA transmits the growth-promoting and mitogenic effects of insulin-like growth factor 2. Here we demonstrate that the two IR isoforms are similarly cleaved by furin, but when this furin-dependent maturation is inefficient, IR proforms move to the cell surface where the proprotein convertase PACE4 selectively supports IRB maturation. Therefore, in situations of impaired furin activity, the proteolytic maturation of IRB is greater than that of IRA, and accordingly, the amount of phosphorylated IRB is also greater than that of IRA. We highlight the ability of a particular proprotein convertase inhibitor to effectively reduce the maturation of IRA and its associated mitogenic signaling without altering the signals emanating from IRB. In conclusion, the selective PACE4-dependent maturation of IRB occurs when furin activity is reduced; accordingly, the pharmacological inhibition of furin reduces IRA maturation and its mitogenic potential without altering the insulin effects.	[Kara, Imene; Poggi, Marjorie; Bonardo, Bernadette; Govers, Roland; Landrier, Jean-Francois; Peiretti, Franck] Aix Marseille Univ, Fac Med, INSERM 1062, INRA 1260, F-13385 Marseille 05, France; [Tian, Sun] Nuolan Net 1098, Amsterdam, Netherlands; [Leibiger, Ingo] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; [Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Dept Chirur Urol, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada; [Creemers, John W. M.] Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, Ctr Human Genet, B-3000 Leuven, Belgium	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Karolinska Institutet; University of Sherbrooke; KU Leuven	Peiretti, F (corresponding author), Aix Marseille Univ, Fac Med, INSERM 1062, INRA 1260, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.	franck.peiretti@univ-amu.fr	Govers, Roland/O-5782-2016; Landrier, Jean-Francois/AAH-2757-2019; Peiretti, Franck/GLV-3378-2022; poggi, marjorie/ABG-6438-2021; peiretti, franck/L-2718-2017	Govers, Roland/0000-0003-1359-5333; Landrier, Jean-Francois/0000-0002-8690-8014; Peiretti, Franck/0000-0001-7198-0534; poggi, marjorie/0000-0001-6331-9682; peiretti, franck/0000-0001-7198-0534; Tian, Sun/0000-0002-0133-4454	INSERM; INRA; Aix-Marseille Universite; Ministere de la Recherche et de l'Enseignement Superieur; Prostate Cancer Canada [D2013-8, 2012-951, TAG2014-02]; Canadian Cancer Society Research Institute [701590]; Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; Aix-Marseille Universite; Ministere de la Recherche et de l'Enseignement Superieur; Prostate Cancer Canada; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen(FWO)	This work was supported by INSERM, INRA, and Aix-Marseille Universite.; Recipient of a grant from the Ministere de la Recherche et de l'Enseignement Superieur.; Supported by Prostate Cancer Canada Grants D2013-8, 2012-951, and TAG2014-02 and Canadian Cancer Society Research Institute Grant 701590.; Supported by Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen.	Auzan C, 1997, MOL CELL ENDOCRINOL, V128, P129, DOI 10.1016/S0303-7207(97)04024-0; Basak A, 2010, CURR MED CHEM, V17, P2214, DOI 10.2174/092986710791331040; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Becker GL, 2011, BIOORG MED CHEM LETT, V21, P4695, DOI 10.1016/j.bmcl.2011.06.091; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Bernot D, 2011, J CELL SCI, V124, P1224, DOI 10.1242/jcs.079889; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; DARDEVET D, 1991, AM J PHYSIOL, V261, pE562, DOI 10.1152/ajpendo.1991.261.5.E562; Dufour EK, 2005, PROTEIN SCI, V14, P303, DOI 10.1110/ps.04843305; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Govers Roland, 2008, V440, P129, DOI 10.1007/978-1-59745-178-9_10; HEDO JA, 1983, J BIOL CHEM, V258, P20; Hubbard SR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008946; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; KOBAYASHI M, 1988, DIABETES, V37, P653, DOI 10.2337/diabetes.37.5.653; Lalou C, 2013, CURR MED CHEM, V20, P583; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Levesque C, 2012, J MED CHEM, V55, P10501, DOI 10.1021/jm3011178; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; PASHMFOROUSH M, 1994, J BIOL CHEM, V269, P32639; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; ROBERTSON BJ, 1993, J BIOL CHEM, V268, P24274; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; SALZMAN A, 1984, BIOCHEMISTRY-US, V23, P6555, DOI 10.1021/bi00321a043; SASAOKA T, 1989, DIABETOLOGIA, V32, P371, DOI 10.1007/BF00277261; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Sucic JF, 1999, BIOCHEM J, V339, P639, DOI 10.1042/0264-6021:3390639; Tian S, 2009, BIOCHEM INSIGHTS, V2, P9, DOI 10.4137/BCI.S2049; Tian S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00261; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vidal N, 2012, BIOCHIMIE, V94, P2569, DOI 10.1016/j.biochi.2012.07.006; VOGT B, 1991, BIOCHEM BIOPH RES CO, V177, P1013, DOI 10.1016/0006-291X(91)90639-O; YAMAGUCHI Y, 1991, ENDOCRINOLOGY, V129, P2058, DOI 10.1210/endo-129-4-2058; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; YOSHIMASA Y, 1988, SCIENCE, V240, P784, DOI 10.1126/science.3283938; YOSHIMASA Y, 1990, J BIOL CHEM, V265, P17230	51	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2812	2821		10.1074/jbc.M114.592543	http://dx.doi.org/10.1074/jbc.M114.592543			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527501	Green Published, hybrid			2022-12-28	WOS:000349310700022
J	Shao, C; Ahmad, N; Hodges, K; Kuang, SH; Ratliff, T; Liu, XQ				Shao, Chen; Ahmad, Nihal; Hodges, Kurt; Kuang, Shihuan; Ratliff, Tim; Liu, Xiaoqi			Inhibition of Polo-like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INTERMITTENT ANDROGEN SUPPRESSION; ANTIDIABETIC DRUG; BREAST-CANCER; CLINICAL-EXPERIENCE; MAMMALIAN TARGET; CELL METABOLISM; BI 2536; GROWTH; PHOSPHORYLATION	The widely used anti-diabetic drug metformin has been shown to exert strong antineoplastic actions in numerous tumor types, including prostate cancer (PCa). In this study, we show that BI2536, a specific Plk1 inhibitor, acted synergistically with metformin in inhibiting PCa cell proliferation. Furthermore, we also provide evidence that Plk1 inhibition makes PCa cells carrying WT p53 much more sensitive to low-dose metformin treatment. Mechanistically, we found that co-treatment with BI2536 and metformin induced p53-dependent apoptosis and further activated the p53/Redd-1 pathway. Moreover, we also show that BI2536 treatment inhibited metformin-induced glycolysis and glutamine anaplerosis, both of which are survival responses of cells against mitochondrial poisons. Finally, we confirmed the cell-based observations using both cultured cell-derived and patient-derived xenograft studies. Collectively, our findings support another promising therapeutic strategy by combining two well tolerated drugs against PCa proliferation and the progression of androgen-dependent PCa to the castration-resistant stage.	[Shao, Chen; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Ratliff, Tim; Liu, Xiaoqi] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA; [Hodges, Kurt] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University Bloomington	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887; Kuang, Shihuan/0000-0001-9180-3180	National Institutes of Health [R01CA157429, R01AR059130, P30 CA023168]; National Science Foundation [MCB-1049693]; American Cancer Society [RSG-13-073]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA192894, R01CA157429, P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA157429 (to X. L.) and R01AR059130 (to N. A.). This work was also supported by National Science Foundation Grant MCB-1049693 and American Cancer Society Grant RSG-13-073 (to X. L.) and by the China Scholarship Council (to C. S.). Xenograft data were acquired by a Purdue Center for Cancer Research facility supported by National Institutes of Health Grant P30 CA023168.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bruchovsky N, 2000, MOL UROL, V4, P191; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi YW, 2014, CANCER LETT, V346, P300, DOI 10.1016/j.canlet.2014.01.015; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; Deeraksa A, 2013, ONCOGENE, V32, P2973, DOI 10.1038/onc.2012.309; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fendt SM, 2013, CANCER RES, V73, P4429, DOI 10.1158/0008-5472.CAN-13-0080; Gleave M, 1998, PROSTATE CANCER P D, V1, P289, DOI 10.1038/sj.pcan.4500260; Goldenberg SL, 1999, MOL UROL, V3, P287; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; Hou XZ, 2013, PROSTATE, V73, P1352, DOI 10.1002/pros.22683; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Liu AY, 2004, PROSTATE, V60, P98, DOI 10.1002/pros.20031; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu XS, 2011, J BIOL CHEM, V286, P35795, DOI 10.1074/jbc.C111.269050; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; McInnes C, 2011, DRUG DISCOV TODAY, V16, P619, DOI 10.1016/j.drudis.2011.05.002; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Segal ED, 2011, BIOCHEM BIOPH RES CO, V414, P694, DOI 10.1016/j.bbrc.2011.09.134; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sikka A, 2012, CELL CYCLE, V11, P1374, DOI 10.4161/cc.19798; Sogame Y, 2009, BIOPHARM DRUG DISPOS, V30, P476, DOI 10.1002/bdd.684; Spratt DE, 2013, EUR UROL, V63, P709, DOI 10.1016/j.eururo.2012.12.004; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	48	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2024	2033		10.1074/jbc.M114.596817	http://dx.doi.org/10.1074/jbc.M114.596817			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505174	Green Published, hybrid			2022-12-28	WOS:000348588000010
J	Lin, WC; Zhang, ZQ; Xu, ZC; Wang, B; Li, XQ; Cao, H; Wang, YQ; Zheng, SJJ				Lin, Wencheng; Zhang, Zhiqiang; Xu, Zhichao; Wang, Bin; Li, Xiaoqi; Cao, Hong; Wang, Yongqiang; Zheng, Shijun J.			The Association of Receptor of Activated Protein Kinase C 1(RACK1) with Infectious Bursal Disease Virus Viral Protein VP5 and Voltage-dependent Anion Channel 2 (VDAC2) Inhibits Apoptosis and Enhances Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAFFOLDING PROTEIN; SIGNALING PATHWAY; RACK1 INTERACTS; NONSTRUCTURAL PROTEIN; CELL APOPTOSIS; HOST-CELLS; LIFE-CYCLE; IN-VITRO; CLONING; GENOME	Infectious bursal disease (IBD) is an acute, highly contagious, and immunosuppressive avian disease caused by IBD virus (IBDV). Our previous report indicates that IBDV VP5 induces apoptosis via interaction with voltage-dependent anion channel 2 (VDAC2). However, the underlying molecular mechanism is still unclear. We report here that receptor of activated protein kinase C 1 (RACK1) interacts with both VDAC2 and VP5 and that they could form a complex. We found that overexpression of RACK1 inhibited IBDV-induced apoptosis in DF-1 cells and that knockdown of RACK1 by small interfering RNA induced apoptosis associated with activation of caspases 9 and 3 and suppressed IBDV growth. These results indicate that RACK1 plays an antiapoptotic role during IBDV infection via interaction with VDAC2 and VP5, suggesting that VP5 sequesters RACK1 and VDAC2 in the apoptosis-inducing process.	[Lin, Wencheng; Zhang, Zhiqiang; Xu, Zhichao; Wang, Bin; Li, Xiaoqi; Cao, Hong; Wang, Yongqiang; Zheng, Shijun J.] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Lin, Wencheng; Zhang, Zhiqiang; Xu, Zhichao; Wang, Bin; Li, Xiaoqi; Cao, Hong; Wang, Yongqiang; Zheng, Shijun J.] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100193, Peoples R China; [Lin, Wencheng; Zhang, Zhiqiang; Xu, Zhichao; Wang, Bin; Li, Xiaoqi; Cao, Hong; Wang, Yongqiang; Zheng, Shijun J.] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Wang, YQ (corresponding author), China Agr Univ, Coll Vet Med, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	vetwyq@cau.edu.cn; sjzheng@cau.edu.cn			National Natural Science Foundation of China [31272543, 31430085]; Earmarked Fund for Modern Agro-industry Technology Research System [NYCYTX-41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System	This work was supported by National Natural Science Foundation of China Grants 31272543 and 31430085 and by Earmarked Fund for Modern Agro-industry Technology Research System Grant NYCYTX-41.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; AZAD AA, 1985, VIROLOGY, V143, P35, DOI 10.1016/0042-6822(85)90094-7; Baumann M, 2000, EUR J BIOCHEM, V267, P3891, DOI 10.1046/j.1432-1327.2000.01430.x; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Brandon NJ, 1999, J NEUROSCI, V19, P9228; Brandon NJ, 2002, J NEUROSCI, V22, P6353; Busnadiego I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046768; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Cesar MD, 2004, ARCH BIOCHEM BIOPHYS, V422, P191, DOI 10.1016/j.abb.2003.12.030; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Choi DS, 2003, MOL PHARMACOL, V64, P1541, DOI 10.1124/mol.64.6.1541; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Daniels CC, 2008, VIROLOGY, V375, P550, DOI 10.1016/j.virol.2008.01.034; Delgui LR, 2013, J VIROL, V87, P8993, DOI 10.1128/JVI.03152-12; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Escaffre O, 2013, J VIROL, V87, P2767, DOI 10.1128/JVI.02360-12; Hafirassou ML, 2013, J HEPATOL, V58, pS470, DOI 10.1016/S0168-8278(13)61157-5; Haro T, 2004, J IMMUNOL, V173, P1151, DOI 10.4049/jimmunol.173.2.1151; Inayat-Hussain SH, 2009, TOXICOL LETT, V191, P118, DOI 10.1016/j.toxlet.2009.08.012; Isacson CK, 2007, AM J PHYSIOL-CELL PH, V292, pC1459, DOI 10.1152/ajpcell.00322.2006; KIBENGE FSB, 1991, VIROLOGY, V184, P437, DOI 10.1016/0042-6822(91)90865-9; Kubota T, 2002, J VIROL, V76, P12676, DOI 10.1128/JVI.76.24.12676-12682.2002; Li ZH, 2013, J VIROL, V87, P1221, DOI 10.1128/JVI.02421-12; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Liu MH, 2004, VIROLOGY, V330, P62, DOI 10.1016/j.virol.2004.09.009; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; MAHARDIKA GNK, 1995, ARCH VIROL, V140, P765, DOI 10.1007/BF01309964; Mamidipudi V, 2009, ONCOGENE, V28, P4421, DOI 10.1038/onc.2009.293; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Mourtacla-Maarabouni M, 2005, J LEUKOCYTE BIOL, V78, P503, DOI 10.1189/jlb.0205070; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Mundt E, 1997, J VIROL, V71, P5647, DOI 10.1128/JVI.71.7.5647-5651.1997; Ozaki T, 2003, ONCOGENE, V22, P3231, DOI 10.1038/sj.onc.1206382; Pan JH, 2009, VIROLOGY, V395, P87, DOI 10.1016/j.virol.2009.09.004; Pitcovski J, 2003, VACCINE, V21, P4736, DOI 10.1016/S0264-410X(03)00525-5; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rigas AC, 2003, J BIOL CHEM, V278, P46087, DOI 10.1074/jbc.M306219200; Rodriguez-Lecompte JC, 2005, COMP IMMUNOL MICROB, V28, P321, DOI 10.1016/j.cimid.2005.08.004; Ron D, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-53; Sang NL, 2001, J BIOL CHEM, V276, P27026, DOI 10.1074/jbc.M010346200; Sharma JM, 2000, DEV COMP IMMUNOL, V24, P223, DOI 10.1016/S0145-305X(99)00074-9; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Stricker RLO, 2010, J VIROL, V84, P10592, DOI 10.1128/JVI.02506-09; Tham KM, 1996, AVIAN DIS, V40, P109, DOI 10.2307/1592379; van den Berg TP, 2000, REV SCI TECH OIE, V19, P527; VASCONCELOS AC, 1994, J GEN VIROL, V75, P1803, DOI 10.1099/0022-1317-75-7-1803; Volta V, 2013, CELL MOL LIFE SCI, V70, P1439, DOI 10.1007/s00018-012-1215-y; Wang F, 2011, J BIOL CHEM, V286, P9097, DOI 10.1074/jbc.M110.165605; Wei L, 2011, VIROLOGY, V420, P156, DOI 10.1016/j.virol.2011.08.027; Wei L, 2011, VIROLOGY, V417, P211, DOI 10.1016/j.virol.2011.03.003; Wu YY, 2010, CELL SIGNAL, V22, P1495, DOI 10.1016/j.cellsig.2010.05.018; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yao K, 2001, VIROLOGY, V285, P50, DOI 10.1006/viro.2001.0947; Yuqi Liu, 2009, BMC Med Genet, V10, P114, DOI 10.1186/1471-2350-10-114; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006	59	35	37	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8500	8510		10.1074/jbc.M114.585687	http://dx.doi.org/10.1074/jbc.M114.585687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25583988	Green Published, hybrid			2022-12-28	WOS:000351662600041
J	Low, LH; Chow, YL; Li, YJ; Goh, CP; Putz, U; Silke, J; Ouchi, T; Howitt, J; Tan, SS				Low, Ley-Hian; Chow, Yuh-Lit; Li, Yijia; Goh, Choo-Peng; Putz, Ulrich; Silke, John; Ouchi, Toru; Howitt, Jason; Tan, Seong-Seng			Nedd4 Family Interacting Protein 1 (Ndfip1) Is Required for Ubiquitination and Nuclear Trafficking of BRCA1-associated ATM Activator 1 (BRAT1) during the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL SURVIVAL; PTEN; LIGASES; KINASE	During injury, cells are vulnerable to apoptosis from a variety of stress conditions including DNA damage causing double-stranded breaks. Without repair, these breaks lead to aberrations in DNA replication and transcription, leading to apoptosis. A major response to DNA damage is provided by the protein kinase ATM (ataxia telangiectasia mutated) that is capable of commanding a plethora of signaling networks for DNA repair, cell cycle arrest, and even apoptosis. A key element in the DNA damage response is the mobilization of activating proteins into the cell nucleus to repair damaged DNA. BRAT1 is one of these proteins, and it functions as an activator of ATM by maintaining its phosphorylated status while also keeping other phosphatases at bay. However, it is unknown how BRAT1 is trafficked into the cell nucleus to maintain ATM phosphorylation. Here we demonstrate that Ndfip1-mediated ubiquitination of BRAT1 leads to BRAT1 trafficking into the cell nucleus. Without Ndfip1, BRAT1 failed to translocate to the nucleus. Under genotoxic stress, cells showed increased expression of both Ndfip1 and phosphorylated ATM. Following brain injury, neurons show increased expression of Ndlip1 and nuclear translocation of BRATE These results point to Ndfip1 as a sensor protein during cell injury and Ndfip1 up-regulation as a cue for BRAT1 ubiquitination by Nedd4 E3 ligases, followed by nuclear translocation of BRAT1.	[Low, Ley-Hian; Chow, Yuh-Lit; Li, Yijia; Goh, Choo-Peng; Putz, Ulrich; Howitt, Jason; Tan, Seong-Seng] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Silke, John] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3010, Australia; [Ouchi, Toru] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Roswell Park Cancer Institute	Howitt, J (corresponding author), Univ Melbourne, Brain Dev & Regenerat Lab, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	jhowitt@florey.edu.au; stan@florey.edu.au	Silke, John/B-7622-2008	Silke, John/0000-0002-7611-5774; Howitt, Jason/0000-0001-9922-7931	National Health and Medical Research Council; Victorian Government through the Operational Infrastructure Scheme; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government through the Operational Infrastructure Scheme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council and the Victorian Government through the Operational Infrastructure Scheme.	Aglipay JA, 2006, J BIOL CHEM, V281, P9710, DOI 10.1074/jbc.M510332200; [Anonymous], TRENDS PHARM SCI, V31, P596; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Goh CP, 2014, EXP NEUROL, V252, P37, DOI 10.1016/j.expneurol.2013.11.017; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Howitt J, 2012, J CELL BIOL, V196, P29, DOI 10.1083/jcb.201105009; Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106; Kuo LJ, 2008, IN VIVO, V22, P305; Lackovic J, 2012, EXP NEUROL, V235, P326, DOI 10.1016/j.expneurol.2012.02.014; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li YJ, 2014, TRAFFIC, V15, P749, DOI 10.1111/tra.12175; MIZUMOTO K, 1994, MOL PHARMACOL, V46, P890; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Ouchi Mutsuko, 2010, Genes Cancer, V1, P1211, DOI 10.1177/1947601911404222; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Saitsu H, 2014, J HUM GENET, V59, P687, DOI 10.1038/jhg.2014.91; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; So Eui Young, 2014, BMC Cancer, V14, P548, DOI 10.1186/1471-2407-14-548; So EY, 2011, EXP THER MED, V2, P443, DOI 10.3892/etm.2011.232; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002	27	15	19	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7141	7150		10.1074/jbc.M114.613687	http://dx.doi.org/10.1074/jbc.M114.613687			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631046	Green Published, hybrid			2022-12-28	WOS:000350991500044
J	Yi, F; Ling, TY; Lu, T; Wang, XL; Li, JC; Claycomb, WC; Shen, WK; Lee, HC				Yi, Fu; Ling, Tian-You; Lu, Tong; Wang, Xiao-Li; Li, Jingchao; Claycomb, William C.; Shen, Win-Kuang; Lee, Hon-Chi			Down-regulation of the Small Conductance Calcium-activated Potassium Channels in Diabetic Mouse Atria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; CARDIOVASCULAR-DISEASE; VENTRICULAR MYOCYTES; FUNCTIONAL ROLES; FIBRILLATION; EXPRESSION; MELLITUS; SK2; ENDOTHELIUM; INHIBITION	The small conductance Ca2+-activated K+ (SK) channels have recently been found to be expressed in the heart, and genomewide association studies have shown that they are implicated in atrial fibrillation. Diabetes mellitus is an independent risk factor of atrial fibrillation, but the ionic mechanism underlying this relationship remains unclear. We hypothesized that SK channel function is abnormal in diabetes mellitus, leading to altered cardiac electrophysiology. We found that in streptozotocin-induced diabetic mice, the expression of SK2 and SK3 isoforms was down-regulated by 85 and 92%, respectively, whereas that of SK1 was not changed. SK currents from isolated diabetic mouse atrial myocytes were significantly reduced compared with controls. The resting potentials of isolated atrial preparations were similar between control and diabetic mice, but action potential durations were significantly prolonged in the diabetic atria. Exposure to apamin significantly prolonged action potential durations in control but not in diabetic atria. Production of reactive oxygen species was significantly increased in diabetic atria and in high glucose-cultured HL-1 cells, whereas exposure of HL-1 cells in normal glucose culture to H2O2 reduced the expression of SK2 and SK3. Tyrosine nitration in SK2 and SK3 was significantly increased by high glucose culture, leading to accelerated channel turnover. Treatment with Tiron prevented these changes. Our results suggest that increased oxidative stress in diabetes results in SK channel-associated electrical remodeling in diabetic atria and may promote arrhythmogenesis.	[Yi, Fu; Ling, Tian-You; Lu, Tong; Wang, Xiao-Li; Li, Jingchao; Lee, Hon-Chi] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Yi, Fu] Fourth Mil Med Univ, Dept Cardiovasc Dis, Xing Hosp, Xian 710032, Peoples R China; [Ling, Tian-You] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Ruijin Hosp, Shanghai 200025, Peoples R China; [Li, Jingchao] Zhengzhou Univ, Dept Emergency Med, Henan Prov Peoples Hosp, Affiliated Hosp, Zhengzhou 450003, Henan, Peoples R China; [Claycomb, William C.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Shen, Win-Kuang] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Phoenix, AZ 85255 USA	Mayo Clinic; Air Force Military Medical University; Shanghai Jiao Tong University; Zhengzhou University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Mayo Clinic; Mayo Clinic Phoenix	Lee, HC (corresponding author), Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA.	Lee.honchi@mayo.edu	yi, fu/HGE-6093-2022; Lu, Tong/A-7745-2009	Lu, Tong/0000-0002-2393-7643	National Institutes of Health [HL-080118, HL-074180]; Xijing Hospital, Fourth Military Medical University, Xi'an, China; Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China; National Natural Science Foundation of the Peoples' Republic of China [81000686, 81470479, 81400248]; American Diabetes Association [1-12-BS-119]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL074180, R01HL080118, R01HL074180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xijing Hospital, Fourth Military Medical University, Xi'an, China; Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China; National Natural Science Foundation of the Peoples' Republic of China(National Natural Science Foundation of China (NSFC)); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-080118 and HL-074180 (to H.-C. L.). This work was also supported by the Xijing Hospital, Fourth Military Medical University, Xi'an, China; the Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China; National Natural Science Foundation of the Peoples' Republic of China Grants 81000686 and 81470479 (to F. Y.) and 81400248 (to T.-Y. L.); and American Diabetes Association Grant 1-12-BS-119 (to T. L.).	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Burnham MP, 2002, BRIT J PHARMACOL, V135, P1133, DOI 10.1038/sj.bjp.0704551; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chang PC, 2013, HEART RHYTHM, V10, P1516, DOI 10.1016/j.hrthm.2013.07.003; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crow JP, 1996, METHOD ENZYMOL, V269, P185; D'hoedt D, 2004, J BIOL CHEM, V279, P12088, DOI 10.1074/jbc.C300382200; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Jongnarangsin K, 2012, J CARDIOVASC ELECTR, V23, P9, DOI 10.1111/j.1540-8167.2011.02137.x; Kannel WB, 2008, MED CLIN N AM, V92, P17, DOI 10.1016/j.mcna.2007.09.002; Kourliouros A, 2009, AM HEART J, V157, P243, DOI 10.1016/j.ahj.2008.10.009; Lang D, 2000, ARTERIOSCL THROM VAS, V20, P422, DOI 10.1161/01.ATV.20.2.422; Lee HC, 1996, J PHARMACOL EXP THER, V278, P597; Lee HC, 1999, J PHYSIOL-LONDON, V519, P153, DOI 10.1111/j.1469-7793.1999.0153o.x; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Lu T, 2006, CIRC RES, V99, P607, DOI 10.1161/01.RES.0000243147.41792.93; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Movahed MR, 2005, INT J CARDIOL, V105, P315, DOI 10.1016/j.ijcard.2005.02.050; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Resnick HE, 2002, ANNU REV MED, V53, P245, DOI 10.1146/annurev.med.53.082901.103904; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Turko IV, 2002, PHARMACOL REV, V54, P619, DOI 10.1124/pr.54.4.619; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; VanWagoner DR, 1997, CIRC RES, V80, P772; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361; Zhang Q, 2008, CIRC RES, V102, P465, DOI 10.1161/CIRCRESAHA.107.161778; Zhou W, 2005, AM J PHYSIOL-HEART C, V288, pH2210, DOI 10.1152/ajpheart.00704.2004	34	34	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7016	7026		10.1074/jbc.M114.607952	http://dx.doi.org/10.1074/jbc.M114.607952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605734	Green Published, hybrid			2022-12-28	WOS:000350991500035
J	Hortschansky, P; Ando, E; Tuppatsch, K; Arikawa, H; Kobayashi, T; Kato, M; Haas, H; Brakhage, AA				Hortschansky, Peter; Ando, Eriko; Tuppatsch, Katja; Arikawa, Hisashi; Kobayashi, Tetsuo; Kato, Masashi; Haas, Hubertus; Brakhage, Axel A.			Deciphering the Combinatorial DNA-binding Code of the CCAAT-binding Complex and the Iron-regulatory Basic Region Leucine Zipper (bZIP) Transcription Factor HapX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIDULANS; CRYSTAL-STRUCTURE; NF-Y; EXPRESSION; MECHANISM; FOS; HOMEOSTASIS; VIRULENCE; SUBUNIT; AMYLASE	The heterotrimeric CCAAT-binding complex (CBC) is evolutionarily conserved in eukaryotic organisms, including fungi, plants, and mammals. The CBC consists of three subunits, which are named in the filamentous fungus Aspergillus nidulans HapB, HapC, and HapE. HapX, a fourth CBC subunit, was identified exclusively in fungi, except for Saccharomyces cerevisiae and the closely related Saccharomycotina species. The CBC-HapX complex acts as the master regulator of iron homeostasis. HapX belongs to the class of basic region leucine zipper transcription factors. We demonstrated that the CBC and HapX bind cooperatively to bipartite DNA motifs with a general HapX/CBC/DNA 2: 1: 1 stoichiometry in a class of genes that are repressed by HapX-CBC in A. nidulans during iron limitation. This combinatorial binding mode requires protein-protein interaction between the N-terminal domain of HapE and the N-terminal CBC binding domain of HapX as well as sequence-specific DNA binding of both the CBC and HapX. Initial binding of the CBC to CCAAT boxes is mandatory for DNA recognition of HapX. HapX specifically targets the minimal motif 5'-GAT-3 3', which is located at a distance of 11-12 bp downstream of the respective CCAAT box. Single nucleotide substitutions at the 5'- and 3'-end of the GAT motif as well as different spacing between the CBC and HapX DNA-binding sites revealed a remarkable promiscuous DNA-recognition mode of HapX. This flexible DNA-binding code may have evolved as a mechanism for fine-tuning the transcriptional activity of CBC-HapX at distinct target promoters.	[Hortschansky, Peter; Tuppatsch, Katja; Brakhage, Axel A.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Ando, Eriko; Arikawa, Hisashi; Kobayashi, Tetsuo] Nagoya Univ, Dept Biol Mech & Funct, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kato, Masashi] Meijo Univ, Fac Agr, Nagoya, Aichi 4688502, Japan; [Haas, Hubertus] Med Univ Innsbruck, Bioctr, Div Mol Biol, A-6020 Innsbruck, Austria; [Brakhage, Axel A.] Univ Jena, Inst Microbiol, Dept Microbiol & Mol Biol, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Nagoya University; Meijo University; Medical University of Innsbruck; Friedrich Schiller University of Jena	Brakhage, AA (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, Beutenbergstr 11a, D-07745 Jena, Germany.	axel.brakhage@hki-jena.de	Kato, Masashi/AAG-3755-2021; Kobayashi, Tetsuo/I-6901-2014	Kato, Masashi/0000-0002-8951-3640; Kobayashi, Tetsuo/0000-0002-4008-454X	Joint D-A-CH Program; Novel Molecular Mechanisms of Iron Sensing and Homeostasis in Filamentous Fungi; Deutsche Forschungsgemeinschaft [BR 1130/14-1, HO 2596/1-1]; Austrian Science Foundation [I1346-B22]; JSPS KAKENHI [25450116]; NISR	Joint D-A-CH Program; Novel Molecular Mechanisms of Iron Sensing and Homeostasis in Filamentous Fungi; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Foundation(Austrian Science Fund (FWF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NISR	This work was supported in part by the Joint D-A-CH Program, "Novel Molecular Mechanisms of Iron Sensing and Homeostasis in Filamentous Fungi," Deutsche Forschungsgemeinschaft Grant BR 1130/14-1 (to A. A. B.) and Deutsche Forschungsgemeinschaft Grant HO 2596/1-1 (to P. H.), Austrian Science Foundation Grant I1346-B22 (to H. H.), and JSPS KAKENHI Grant 25450116 and NISR research grants (to M. K.).	Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brakhage AA, 1999, FUNGAL GENET BIOL, V27, P243, DOI 10.1006/fgbi.1999.1136; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Gordan R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r125; Gsaller F, 2014, EMBO J, V33, P2261, DOI 10.15252/embj.201489468; Gsaller F, 2012, METALLOMICS, V4, P1262, DOI 10.1039/c2mt20179h; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2014, NAT PROD REP, V31, P1266, DOI 10.1039/c4np00071d; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Huber EM, 2012, STRUCTURE, V20, P1757, DOI 10.1016/j.str.2012.07.012; Jung WH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001209; Kato M, 1997, MOL GEN GENET, V254, P119, DOI 10.1007/s004380050399; Kato M, 2002, FEBS LETT, V512, P227, DOI 10.1016/S0014-5793(02)02266-4; Kato N, 2002, CURR GENET, V42, P43, DOI 10.1007/s00294-002-0325-8; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Marui J, 2002, FUNGAL GENET BIOL, V35, P157, DOI 10.1006/fgbi.2001.1321; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Ogata K., 2003, CURR OPIN STRUC BIOL, V13, P40; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Tanaka A, 2002, BBA-GENE STRUCT EXPR, V1576, P176, DOI 10.1016/S0167-4781(02)00286-5; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; VANGORCOM RFM, 1986, GENE, V48, P211, DOI 10.1016/0378-1119(86)90079-X; Weidner G, 2001, ARCH MICROBIOL, V175, P122, DOI 10.1007/s002030000246	40	27	28	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6058	6070		10.1074/jbc.M114.628677	http://dx.doi.org/10.1074/jbc.M114.628677			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589790	Green Published, hybrid			2022-12-28	WOS:000350732500017
J	Koliwer, J; Park, M; Bauch, C; von Zastrow, M; Kreienkamp, HJ				Koliwer, Judith; Park, Minjong; Bauch, Carola; von Zastrow, Mark; Kreienkamp, Hans-Juergen			The Golgi-associated PDZ Domain Protein PIST/GOPC Stabilizes the beta 1-Adrenergic Receptor in Intracellular Compartments after Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PLASMA-MEMBRANE EXPRESSION; BETA(1)-ADRENERGIC RECEPTOR; TRAFFICKING; MECHANISM; DEGRADATION; SPECIFICITY; ENDOCYTOSIS; INTERACTS; SEQUENCE	Many G-protein-coupled receptors carry C-terminal ligand motifs for PSD-95/discs large/ZO-1 (PDZ) domains; via interaction with PDZ domain-containing scaffold proteins, this allows for integration of receptors into signaling complexes. However, the presence of PDZ domain proteins attached to intracellular membranes suggests that PDZ-type interactions may also contribute to subcellular sorting of receptors. The protein interacting specifically with Tc10 (PIST; also known as GOPC) is a trans-Golgi-associated protein that interacts through its single PDZ domain with a variety of cell surface receptors. Here we show that PIST controls trafficking of the interacting beta 1-adrenergic receptor both in the anterograde, biosynthetic pathway and during postendocytic recycling. Overexpression and knockdown experiments show that PIST leads to retention of the receptor in the trans-Golgi network (TGN), to the effect that overexpressed PIST reduces activation of the MAPK pathway by beta 1-adrenergic receptor (beta 1AR) agonists. Receptors can be released from retention in the TGN by coexpression of the plasma membrane-associated scaffold PSD-95, which allows for transport of receptors to the plasma membrane. Stimulation of beta 1 receptors and activation of the cAMP pathway lead to relocation of PIST from the TGN to an endosome-like compartment. Here PIST colocalizes with SNX1 and the internalized beta 1AR and protects endocytosed receptors from lysosomal degradation. In agreement, beta 1AR levels are decreased in hippocampi of PIST-deficient mice. Our data suggest that PIST contributes to the fine-tuning of beta 1AR sorting both during biosynthetic and postendocytic trafficking.	[Koliwer, Judith; Bauch, Carola; Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Park, Minjong; von Zastrow, Mark] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94158 USA; [Park, Minjong; von Zastrow, Mark] Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreienkamp, HJ (corresponding author), Univ Krankenhaus Hamburg Eppendorf, Inst Humangenet, Martinistr 52, D-20246 Hamburg, Germany.	Kreienkamp@uke.de		Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	National Institute on Drug Abuse, National Institutes of Health [R37DA010711]; Deutsche Forschungsgemeinschaft [GRK1459]; National Institute on Drug Abuse [T32MH889920]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R37DA010711, R01DA010711, R01DA012864] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute on Drug Abuse, National Institutes of Health Grant R37DA010711 (to M. v Z.). This work was also supported by the Deutsche Forschungsgemeinschaft (GRK1459; to H.-J.K.).; Supported by National Institute on Drug Abuse Grant T32MH889920.	BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Bauch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088529; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chen AN, 2012, J COMP NEUROL, V520, P889, DOI 10.1002/cne.22774; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Cheng S, 2010, J NEUROCHEM, V112, P588, DOI 10.1111/j.1471-4159.2009.06454.x; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Franch HA, 2001, J BIOL CHEM, V276, P19126, DOI 10.1074/jbc.M101777200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Nakagawa T, 2013, J MEMBRANE BIOL, V246, P571, DOI 10.1007/s00232-013-9571-6; ROSA P, 1992, J BIOL CHEM, V267, P12227; Roth A, 1997, DNA CELL BIOL, V16, P111, DOI 10.1089/dna.1997.16.111; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Turvy D N, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1807s36; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Xu ZG, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-80; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Zhang JQ, 2008, FEBS LETT, V582, P4117, DOI 10.1016/j.febslet.2008.10.054	30	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6120	6129		10.1074/jbc.M114.605725	http://dx.doi.org/10.1074/jbc.M114.605725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25614626	hybrid, Green Published			2022-12-28	WOS:000350732500021
J	Tittel, J; Welz, T; Czogalla, A; Dietrich, S; Samol-Wolf, A; Schulte, M; Schwille, P; Weidemann, T; Kerkhoff, E				Tittel, Janine; Welz, Tobias; Czogalla, Aleksander; Dietrich, Susanne; Samol-Wolf, Annette; Schulte, Markos; Schwille, Petra; Weidemann, Thomas; Kerkhoff, Eugen			Membrane Targeting of the Spir.Formin Actin Nucleator Complex Requires a Sequential Handshake of Polar Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; FYVE DOMAIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CELLULAR MEMBRANES; VESICLE TRANSPORT; CRYSTAL-STRUCTURE; KINASE FUNCTION; C-LOBE; PROTEIN	Spir and formin (FMN)-type actin nucleators initiate actin polymerization at vesicular membranes necessary for long range vesicular transport processes. Here we studied in detail the membrane binding properties and protein/protein interactions that govern the assembly of the membrane-associated SpirFMN complex. Using biomimetic membrane models we show that binding of the C-terminal Spir-2 FYVE-type zinc finger involves both the presence of negatively charged lipids and hydrophobic contributions from the turret loop that intrudes the lipid bilayer. In solution, we uncovered a yet unknown intramolecular interaction between the Spir-2 FYVE-type domain and the N-terminal kinase non-catalytic C-lobe domain (KIND) that could not be detected in the membrane-bound state. Interestingly, we found that the intramolecular Spir-2 FYVE/KIND and the trans-regulatory Fmn-2-FSI/Spir-2-KIND interactions are competitive. We therefore characterized co-expressed Spir-2 and Fmn-2 fluorescent protein fusions in living cells by fluorescence cross-correlation spectroscopy. The data corroborate a model according to which Spir-2 exists in two different states, a cytosolic monomeric conformation and a membrane-bound state in which the KIND domain is released and accessible for subsequent Fmn-2 recruitment. This sequence of interactions mechanistically couples membrane binding of Spir to the recruitment of FMN, a pivotal step for initiating actin nucleation at vesicular membranes.	[Tittel, Janine; Schwille, Petra; Weidemann, Thomas] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Tittel, Janine; Schwille, Petra; Weidemann, Thomas] Tech Univ TU Dresden, Biotechnol Ctr BIOTEC, Biophys Res Grp, D-01307 Dresden, Germany; [Czogalla, Aleksander] Tech Univ TU Dresden, Paul Langerhans Inst, D-01307 Dresden, Germany; [Welz, Tobias; Dietrich, Susanne; Samol-Wolf, Annette; Schulte, Markos; Kerkhoff, Eugen] Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, D-93053 Regensburg, Germany; [Czogalla, Aleksander] German Ctr Diabet Res, D-85764 Neuherberg, Germany	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden; University of Regensburg	Kerkhoff, E (corresponding author), Univ Hosp Regensburg, Dept Neurol, Mol Cell Biol Lab, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	eugen.kerkhoff@klinik.uni-regensburg.de	Czogalla, Aleksander/M-8504-2019; Weidemann, Thomas/I-9798-2017; Schwille, Petra/A-4983-2010; Czogalla, Aleksander/A-9752-2014	Weidemann, Thomas/0000-0002-6694-1087; Czogalla, Aleksander/0000-0003-3035-059X	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [SPP 1464]; Bavarian Genorne Research Network (BayGene)	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); Bavarian Genorne Research Network (BayGene)	The work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft (DFG), priority program SPP 1464) (to P. S. and E. K.) and the Bavarian Genorne Research Network (BayGene) (to E. K.).	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bacia K, 2012, CHEMPHYSCHEM, V13, P1221, DOI 10.1002/cphc.201100801; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Busse RA, 2013, AUTOPHAGY, V9, P770, DOI 10.4161/auto.23978; Ciccarelli FD, 2003, TRENDS BIOCHEM SCI, V28, P349, DOI 10.1016/S0968-0004(03)00116-6; Czogalla A, 2014, BBA-MOL CELL BIOL L, V1841, P1049, DOI 10.1016/j.bbalip.2013.12.012; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dietrich S, 2013, BIOL CHEM, V394, P1649, DOI 10.1515/hsz-2013-0176; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gil JE, 2012, J BIOL CHEM, V287, P41268, DOI 10.1074/jbc.M112.419127; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hofer CT, 2010, METHODS MOL BIOL, V606, P69, DOI 10.1007/978-1-60761-447-0_6; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Huang J, 2007, J CELL BIOL, V179, P539, DOI 10.1083/jcb.200702036; Kapusta P., 2010, APPL NOTE; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Kolondra A, 2010, BBA-BIOMEMBRANES, V1798, P2084, DOI 10.1016/j.bbamem.2010.07.024; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Montis C, 2014, SOFT MATTER, V10, P39, DOI 10.1039/c3sm52254g; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Muller P, 2014, BIOINFORMATICS, V30, P2532, DOI 10.1093/bioinformatics/btu328; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pleiser S, 2014, EUR J CELL BIOL, V93, P225, DOI 10.1016/j.ejcb.2013.11.001; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2013, DEVELOPMENT, V140, P4417, DOI 10.1242/dev.097337; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Weidemann T, 2013, METHOD ENZYMOL, V518, P43, DOI 10.1016/B978-0-12-388422-0.00003-0; Weidemann T, 2011, BIOPHYS J, V101, P2360, DOI 10.1016/j.bpj.2011.10.014; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wolny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021538; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782	55	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6428	6444		10.1074/jbc.M114.602672	http://dx.doi.org/10.1074/jbc.M114.602672			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564607	hybrid, Green Published			2022-12-28	WOS:000350732500047
J	Yang, F; Hu, Y; Liu, HX; Wan, YJY				Yang, Fan; Hu, Ying; Liu, Hui-Xin; Wan, Yu-Jui Yvonne			MiR-22-silenced Cyclin A Expression in Colon and Liver Cancer Cells Is Regulated by Bile Acid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID-X-RECEPTOR; HUMAN HEPATOCELLULAR-CARCINOMA; NUCLEAR RECEPTOR; LIPID HOMEOSTASIS; VITAMIN-D; BINDING; MICE; MICRORNA-22; PROLIFERATION; ALPHA	Because of the significant tumor-suppressive role of microRNA-22 (miR-22), the current study was designed to understand the regulation of miR-22 and to identify additional downstream miR-22 targets in liver and colon cells. The data showed that miR-22 was transcriptionally regulated by bile acid receptor farnesoid X receptor (FAR) through direct binding to an invert repeat 1 motif located at -1012 to -1025 bp upstream from miR-22. Among the studied primary and secondary bile acids, chenodeoxycholic acid, which has the highest binding affinity to FXR, induced miR-22 level in both Huh7 liver and HCT116 colon cells in a dose- and time-dependent manner. In addition, cyclin A2 (CCNA2) was identified as a miR-22 novel target in liver and colon cancer cells. The sequence of miR-22, which is conserved in mice, rats, humans, and other mammalians, aligns with the sequence of 3'-UTR of CCNA2. Chenodeoxycholic acid treatment and miR-22 mimics reduced CCNA2 protein and increased the number of Cio/G-, Huh7 and HCT116 cells. In FXR KO mice, reduction of miR-22 was accompanied by elevated hepatic and ileal CCNA2 protein, as well as an increased number of hepatic and colonic Ki-67-positive cells. In humans, the expression levels of miR-22 and CCNA2 are inversely correlated in liver and colon cancers. Taken together, our data showed that bile acid-activated FXR stimulates miR-22-silenced CCNA2, a novel pathway for FXR to exert its protective effect in the gastrointestinal tract.	[Yang, Fan; Hu, Ying; Liu, Hui-Xin; Wan, Yu-Jui Yvonne] Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Yang, Fan; Wan, Yu-Jui Yvonne] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai 201203, Peoples R China	University of California System; University of California Davis; Shanghai University of Traditional Chinese Medicine	Wan, YJY (corresponding author), Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	yjywan@ucdavis.edu	Zhu, Ren-Yuan/V-8966-2019; Yang, Fan/GYU-4249-2022	Zhu, Ren-Yuan/0000-0003-3091-7461; Liu, Hui-Xin/0000-0002-8981-9981	National Institutes of Health [DK092100, CA53596]; NATIONAL CANCER INSTITUTE [R01CA053596, R29CA053596, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK092100 and CA53596 (to Y.-J.Y.W.).	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; He YQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-575; Hu Y, 2013, BIOCHEM PHARMACOL, V85, P1007, DOI 10.1016/j.bcp.2013.01.023; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Karpen SJ, 1999, HEPATOLOGY, V30, P1107, DOI 10.1002/hep.510300439; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; Li J, 2011, MOL CELL BIOCHEM, V357, P31, DOI 10.1007/s11010-011-0872-8; Li J, 2011, MOL PHARMACOL, V80, P191, DOI 10.1124/mol.110.068247; Ling B, 2012, J CANCER RES CLIN, V138, P1355, DOI 10.1007/s00432-012-1194-2; Liu NA, 2012, MOL ENDOCRINOL, V26, P775, DOI 10.1210/me.2011-1383; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Milovic V, 2002, EUR J CLIN INVEST, V32, P29, DOI 10.1046/j.0014-2972.2001.00938.x; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Sharma R, 2010, BIOORGAN MED CHEM, V18, P6886, DOI 10.1016/j.bmc.2010.07.030; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Su HY, 2012, AM J PHYSIOL-GASTR L, V303, pG1245, DOI 10.1152/ajpgi.00439.2011; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Vallim TQD, 2013, CIRC RES, V112, P1602, DOI 10.1161/CIRCRESAHA.112.300648; Wan YJY, 2000, J BIOL CHEM, V275, P28285; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yamakuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020291; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050013; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895	35	53	56	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6507	6515		10.1074/jbc.M114.620369	http://dx.doi.org/10.1074/jbc.M114.620369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25596928	Green Published, hybrid			2022-12-28	WOS:000350732500053
J	Moon, MJ; Lee, YN; Park, S; Reyes-Alcaraz, A; Hwang, JI; Millar, RP; Choe, H; Seong, JY				Moon, Mi Jin; Lee, Yoo-Na; Park, Sumi; Reyes-Alcaraz, Arfaxad; Hwang, Jong-Ik; Millar, Robert Peter; Choe, Han; Seong, Jae Young			Ligand Binding Pocket Formed by Evolutionarily Conserved Residues in the Glucagon-like Peptide-1 (GLP-1) Receptor Core Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; PROTEIN-COUPLED RECEPTOR; HORMONE GNRH RECEPTORS; MOLECULAR EVOLUTION; EXTRACELLULAR LOOP-3; CRYSTAL-STRUCTURE; MID-REGION; AGONIST; SELECTIVITY; CELL	Glucagon-like peptide-1 (GLP-1) plays a pivotal role in glucose homeostasis through its receptor GLP1R. Due to its multiple beneficial effects, GLP-1 has gained great attention for treatment of type 2 diabetes and obesity. However, little is known about the molecular mechanism underlying the interaction of GLP-1 with the heptahelical core domain of GLP1R conferring high affinity ligand binding and ligand-induced receptor activation. Here, using chimeric and point-mutated GLP1R, we determined that the evolutionarily conserved amino acid residue Are flanked by hydrophobic Leu(379) and Phe(381) in extracellular loop 3 (ECL3) may have an interaction with Asp(9) and Gly(4) of the GLP-1 peptide. The molecular modeling study showed that Ile(196) at transmembrane helix 2, Met(233) at ECL1 and Asn(302) at ECL2 of GLP1R have contacts with His' and Thr(7) of GLP-1 This study may shed light on the mechanism underlying high affinity interaction between the ligand and the binding pocket that is formed by these conserved residues in the GLP1R core domain.	[Moon, Mi Jin; Lee, Yoo-Na; Park, Sumi; Reyes-Alcaraz, Arfaxad; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul 136705, South Korea; [Millar, Robert Peter] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0028 Pretoria, South Africa; [Millar, Robert Peter] Med Res Council Receptor Biol Unit, ZA-7925 Cape Town, South Africa; [Millar, Robert Peter] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Millar, Robert Peter] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH164TJ, Midlothian, Scotland; [Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul 138736, South Korea; [Choe, Han] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul 138736, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Pretoria; University of Cape Town; University of Edinburgh; University of Ulsan; University of Ulsan	Choe, H (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, Seoul 138736, South Korea.	hchoe@ulsan.ac.kr; jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; choe, han/0000-0003-4604-647X; Hwang, Jong-Ik/0000-0002-0729-1782; Millar, Robert P/0000-0003-3606-2708	National Research Foundation of Korea [2013R1A1A2010481]; Korea-South Africa Collaboration Program of the National Research Foundation of South Africa [2012K1A3A1A09033014]; Korea University	National Research Foundation of Korea(National Research Foundation of Korea); Korea-South Africa Collaboration Program of the National Research Foundation of South Africa; Korea University	This work was supported by grants from Basic Science Research Program (2013R1A1A2010481) of the National Research Foundation of Korea and Korea-South Africa Collaboration Program (2012K1A3A1A09033014) of the National Research Foundation of South Africa.; Supported by a research fellowship grant from Korea University.	Acharjee S, 2004, J BIOL CHEM, V279, P54445, DOI 10.1074/jbc.M408909200; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Alana I, 2007, PROTEINS, V68, P92, DOI 10.1002/prot.21372; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; Cho HJ, 2007, GEN COMP ENDOCR, V153, P98, DOI 10.1016/j.ygcen.2006.12.013; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; DaCambra MP, 2000, BIOCHEMISTRY-US, V39, P8888, DOI 10.1021/bi000497p; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Harmar AJ, 2001, GENOME BIOL, V2; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hwang JI, 2014, J MOL ENDOCRINOL, V52, pT15, DOI 10.1530/JME-13-0137; Hwang JI, 2013, MOL BIOL EVOL, V30, P1119, DOI 10.1093/molbev/mst031; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kirkpatrick A, 2012, P NATL ACAD SCI USA, V109, P19988, DOI [10.1073/pnas.1218051109, 10.1073/pnas.12180511091]; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li JH, 2005, MOL PHARMACOL, V67, P1099, DOI 10.1124/mol.104.004887; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Moon Mi Jin, 2012, Front Endocrinol (Lausanne), V3, P141, DOI 10.3389/fendo.2012.00141; Moon MJ, 2012, J BIOL CHEM, V287, P3873, DOI 10.1074/jbc.M111.276808; Moon MJ, 2011, MOL CELLS, V32, P389, DOI 10.1007/s10059-011-0157-9; Moon MJ, 2010, MOL CELLS, V30, P149, DOI 10.1007/s10059-010-0100-5; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Oh DY, 2006, INT REV CYTOL, V252, P163, DOI 10.1016/S0074-7696(06)52003-0; Park CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065420; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Venneti KC, 2011, FEBS LETT, V585, P346, DOI 10.1016/j.febslet.2010.12.011; Wang CB, 2004, MOL ENDOCRINOL, V18, P105, DOI 10.1210/me.2003-0101; Wang YJ, 2012, ENDOCRINOLOGY, V153, P5247, DOI 10.1210/en.2012-1586; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	62	23	23	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5696	5706		10.1074/jbc.M114.612606	http://dx.doi.org/10.1074/jbc.M114.612606			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561730	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000350044200038
J	Prasad, H; Rao, R				Prasad, Hari; Rao, Rajini			The Na+/H+ Exchanger NHE6 Modulates Endosomal pH to Control Processing of Amyloid Precursor Protein in a Cell Culture Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SECRETASE CLEAVAGE; A-BETA; MENTAL-RETARDATION; GENE-EXPRESSION; INTRACELLULAR TRAFFICKING; SODIUM/PROTON EXCHANGER; BAFILOMYCIN A1; RETINOIC ACID; APP; ENDOCYTOSIS	Early intervention may be key to safe and effective therapies in patients with Alzheimer disease. Endosomal dysfunction is an early step in neurodegeneration. Endosomes are a major site of production of A beta peptide from the processing of amyloid precursor protein (APP) by clipping enzymes (beta- and gamma-secretases). The beta-secretase enzyme BACE1 requires acidic lumen pH for optimum function, and acid pH promotes A beta aggregation. The Na+/H+ exchanger NHE6 provides a leak pathway for protons, limiting luminal acidification by proton pumps. Like APP, NHE6 expression was induced upon differentiation of SH-SY5Y neuroblastoma cells and localized to an endosomal compartment. Therefore, we investigated whether NHE6 expression altered APP localization and processing in a stably transfected cell culture model of human APP expression. We show that co-expression with NHE6 or treatment with the Na+/H+ ionophore monensin shifted APP away from the trans-Golgi network into early and recycling endosomes in HEK293 cells. NHE6 alkalinized the endosomal lumen, similar to monensin, and significantly attenuated APP processing and A beta secretion. In contrast, A beta production was elevated upon NHE6 knockdown. We show that NHE6 transcript and protein levels are lowered in Alzheimer brains relative to control. These findings, taken together with emerging genetic evidence linking endosomal Na+/H+ exchangers with Alzheimer disease, suggest that proton leak pathways may regulate A beta generation and contribute to disease etiology.	[Prasad, Hari; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao@jhmi.edu			National Institutes of Health [DK054214, GM62142]; International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054214 and GM62142 (to R. R.).; A Fulbright Fellow supported by the International Fulbright Science and Technology Award.	Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; Caglayan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007747; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Christianson AL, 1999, J MED GENET, V36, P759, DOI 10.1136/jmg.36.10.759; Coelho Lucio, 2010, International Journal of Software Science and Computational Intelligence, V2, P60, DOI 10.4018/jssci.2010100105; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Deane EC, 2013, J NEUROSCI, V33, P595, DOI 10.1523/JNEUROSCI.2583-12.2013; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dunckley T, 2006, NEUROBIOL AGING, V27, P1359, DOI 10.1016/j.neurobiolaging.2005.08.013; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Frost B, 2015, TRENDS CELL BIOL, V25, P46, DOI 10.1016/j.tcb.2014.07.005; Funk K. E., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/752894; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Itoh N, 2009, NEURODEGENER DIS, V6, P230, DOI 10.1159/000236902; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kim MKH, 2011, ONCOGENE, V30, P832, DOI 10.1038/onc.2010.452; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Kohn KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099269; Kojetin DJ, 2003, FEBS LETT, V554, P231, DOI 10.1016/S0014-5793(03)01167-0; Kondapalli KC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00172; Kondapalli KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3510; KONIG G, 1990, FEBS LETT, V269, P305, DOI 10.1016/0014-5793(90)81181-M; LAHIRI DK, 1994, CELL MOL NEUROBIOL, V14, P297, DOI 10.1007/BF02088713; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Lou XH, 2011, AM J PHYSIOL-CELL PH, V301, pC1431, DOI 10.1152/ajpcell.00154.2011; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; Martinelli-Boneschi F, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.008; Meda SA, 2012, NEUROIMAGE, V60, P1608, DOI 10.1016/j.neuroimage.2011.12.076; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Muro S, 2006, AM J PHYSIOL-LUNG C, V290, pL809, DOI 10.1152/ajplung.00311.2005; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Naumova OY, 2012, DEV PSYCHOPATHOL, V24, P1427, DOI 10.1017/S0954579412000818; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Nyasae LK, 2014, TRAFFIC, V15, P1344, DOI 10.1111/tra.12229; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Olubiyi OO, 2012, J PHYS CHEM B, V116, P3280, DOI 10.1021/jp2076337; Ouyang Q, 2013, NEURON, V80, P97, DOI 10.1016/j.neuron.2013.07.043; Perez-Palma E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095413; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; SchraderFischer G, 1996, BRAIN RES, V716, P91, DOI 10.1016/0006-8993(96)00002-9; Schwede M, 2014, MOL PSYCHIATR, V19, P277, DOI 10.1038/mp.2013.28; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Stromme P, 2011, BRAIN, V134, P3369, DOI 10.1093/brain/awr250; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Urmoneit B, 1998, J MOL NEUROSCI, V11, P141, DOI 10.1385/JMN:11:2:141; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wang ZL, 2012, CURR ALZHEIMER RES, V9, P217, DOI 10.2174/156720512799361691; Wegiel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035414; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; WOLOZIN B, 1992, J NEUROSCI RES, V33, P163, DOI 10.1002/jnr.490330121; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	75	39	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5311	5327		10.1074/jbc.M114.602219	http://dx.doi.org/10.1074/jbc.M114.602219			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561733	hybrid, Green Published			2022-12-28	WOS:000350044200007
J	Lamkin, E; Cheng, G; Calabro, A; Hascall, VC; Joo, EJ; Li, LY; Linhardt, RJ; Lauer, ME				Lamkin, Elliott; Cheng, Georgiana; Calabro, Anthony; Hascall, Vincent C.; Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.; Lauer, Mark E.			Heavy Chain Transfer by Tumor Necrosis Factor-stimulated Gene 6 to the Bikunin Proteoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ALPHA-TRYPSIN INHIBITOR; HYALURONAN COMPLEX; TSG-6; CD44; GLYCOSAMINOGLYCAN; ADHESION; BIND	We present data that hyaluronan (HA) polysaccharides, about 14-86 monosaccharides in length, are capable of accepting only a single heavy chain (HC) from inter-alpha-inhibitor via transfer by tumor necrosis factor-stimulated gene 6 (TSG-6) and that this transfer is irreversible. We propose that either the sulfate groups (or the sulfation pattern) at the reducing end of the chondroitin sulfate (CS) chain of bikunin, or the core protein itself, enables the bikunin proteoglycan (PG) to accept more than a single HC and permits TSG-6 to transfer these HCs from its relatively small CS chain to HA. To test these hypotheses, we investigated HC transfer to the intact CS chain of the bikunin PG, and to the free chain of bikunin. We observed that both the free CS chain and the intact bikunin PG were only able to accept a single HC from inter-alpha-inhibitor via transfer by TSG-6 and that HCs could be swapped from the bikunin PG and its free CS chain to HA. Furthermore, a significant portion of the bikunin PG was unable to accept a single heavy chain. We discuss explanations for these observations, including the intracellular assembly of inter-alpha-inhibitor. In summary, these data demonstrate that the sulfation of the CS chain of bikunin and/or its core protein promote HC transfer by TSG-6 to its relatively short CS chain, although they are insufficient to enable the CS chain of bikunin to accept more than one HC in the absence of other cofactors.	[Lamkin, Elliott; Calabro, Anthony; Hascall, Vincent C.; Lauer, Mark E.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Cheng, Georgiana] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Troy, NY 12180 USA; [Joo, Eun Ji; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, Troy, NY 12180 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Lauer, ME (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	lauerm1@ccf.org			NHLBI/National Institutes of Health [HL107147, HL62244, HL113325, HL103453, HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113325, P01HL103453, P01HL081064, P01HL107147, R01HL062244] Funding Source: NIH RePORTER	NHLBI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI/National Institutes of Health Awards HL107147, HL62244, HL113325, HL103453, and HL081064.	Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Fries E, 2003, ACTA BIOCHIM POL, V50, P735; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lord MS, 2013, J BIOL CHEM, V288, P22930, DOI 10.1074/jbc.M112.404186; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Wedes SH, 2011, J PEDIATR-US, V159, P248, DOI 10.1016/j.jpeds.2011.01.029; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	17	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5156	5166		10.1074/jbc.M114.636258	http://dx.doi.org/10.1074/jbc.M114.636258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561734	hybrid, Green Published			2022-12-28	WOS:000350042000054
J	Norden, R; Halim, A; Nystrom, K; Bennett, EP; Mandel, U; Olofsson, S; Nilsson, J; Larson, G				Norden, Rickard; Halim, Adnan; Nystrom, Kristina; Bennett, Eric P.; Mandel, Ulla; Olofsson, Sigvard; Nilsson, Jonas; Larson, Goran			O-Linked Glycosylation of the Mucin Domain of the Herpes Simplex Virus Type 1-specific Glycoprotein gC-1 Is Temporally Regulated in a Seed-and-spread Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; FUCOSYL-TRANSFERASE GENES; CELL-INDUCED DIFFERENCES; GALNAC-TRANSFERASE; T-CELLS; SUBSTRATE SPECIFICITIES; MONOCLONAL-ANTIBODIES; INFECTED CELLS; 3 MEMBERS; HOST	The herpes simplex virus type 1 (HSV-1) glycoprotein gC-1, participating in viral receptor interactions and immunity interference, harbors a mucin-like domain with multiple clustered O-linked glycans. Using HSV-1-infected diploid human fibroblasts, an authentic target for HSV-1 infection, and a protein immunoaffinity procedure, we enriched fully glycosylated gC-1 and a series of its biosynthetic intermediates. This fraction was subjected to trypsin digestion and a LC-MS/MS glycoproteomics approach. In parallel, we characterized the expression patterns of the 20 isoforms of human GalNAc transferases responsible for initiation of O-linked glycosylation. The gC-1 O-glycosylation was regulated in an orderly manner initiated by synchronous addition of one GalNAc unit each to Thr-87 and Thr-91 and one GalNAc unit to either Thr-99 or Thr-101, forming a core glycopeptide for subsequent additions of in all 11 GalNAc residues to selected Ser and Thr residues of the Thr-76-Lys-107 stretch of the mucin domain. The expression patterns of GalNAc transferases in the infected cells suggested that initial additions of GalNAc were carried out by initiating Gal-NActransferases, in particular GalNAc-T2, whereas subsequent GalNAc additions were carried out by followup transferases, in particular GalNAc-T10. Essentially all of the susceptible Ser or Thr residues had to acquire their GalNAc units before any elongation to longer O-linked glycans of the gC-1-associated GalNAc units was permitted. Because the GalNAc occupancy pattern is of relevance for receptor binding of gC-1, the data provide a model to delineate biosynthetic steps of O-linked gly-cosylation of the gC-1 mucin domain in HSV-1-infected target cells.	[Norden, Rickard; Nystrom, Kristina; Olofsson, Sigvard] Univ Gothenburg, Inst Biomed, Dept Infect Dis, SE-41345 Gothenburg, Sweden; [Halim, Adnan; Bennett, Eric P.; Mandel, Ulla] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Halim, Adnan; Bennett, Eric P.; Mandel, Ulla] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Odontol, DK-2200 Copenhagen, Denmark; [Halim, Adnan; Nilsson, Jonas] Univ Gothenburg, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden	University of Gothenburg; University of Copenhagen; University of Copenhagen; University of Gothenburg	Larson, G (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Bruna Straket 16, SE-41345 Gothenburg, Sweden.	goran.larson@clinchem.gu.se	Bennett, Eric/AAG-6120-2020; Nordén, Rickard/AAQ-8843-2020; Larson, Göran/AAF-3404-2019; Nyström, Kristina/N-3125-2014	Bennett, Eric/0000-0002-4976-0647; Halim, Adnan/0000-0003-1629-187X; Mandel, Ulla/0000-0001-7012-9836; Nilsson, Jonas/0000-0001-5263-2454; Norden, Rickard/0000-0002-3866-7228	Swedish Research Council [8266, 15283]; Swedish Governmental Grants; Danish Research Councils; Danish National Research Foundation [DNRF 107]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Grants; Danish Research Councils(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by grants from the Swedish Research Council (8266 and 15283), Swedish Governmental Grants to the Sahlgrenska University Hospital, and by the Danish Research Councils and the Danish National Research Foundation (DNRF 107).	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Antoine TE, 2013, REV MED VIROL, V23, P194, DOI 10.1002/rmv.1740; Aubert M, 2009, J VIROL, V83, P6171, DOI 10.1128/JVI.02163-08; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BERGSTROM T, 1992, MOL CELL PROBE, V6, P41, DOI 10.1016/0890-8508(92)90070-E; Biller M, 2000, GLYCOBIOLOGY, V10, P1259, DOI 10.1093/glycob/10.12.1259; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Clo E, 2012, J VIROL, V86, P6268, DOI 10.1128/JVI.00392-12; D'Arrigo I, 2013, GLYCOCONJUGATE J, V30, P633, DOI 10.1007/s10719-012-9465-3; DALLOLIO F, 1985, J VIROL, V56, P127, DOI 10.1128/JVI.56.1.127-134.1985; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Ekbad M, 2007, VIROLOGY, V367, P244, DOI 10.1016/j.virol.2007.05.040; Friedman HM, 1996, J VIROL, V70, P4253, DOI 10.1128/JVI.70.7.4253-4260.1996; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Kennedy PGE, 2013, J NEUROVIROL, V19, P346, DOI 10.1007/s13365-013-0178-6; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; LUNDSTROM M, 1987, VIROLOGY, V161, P395, DOI 10.1016/0042-6822(87)90132-2; LUNDSTROM M, 1987, VIROLOGY, V161, P385, DOI 10.1016/0042-6822(87)90131-0; LYCKE E, 1991, J GEN VIROL, V72, P1131, DOI 10.1099/0022-1317-72-5-1131; Machiels B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002387; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Mardberg K, 2004, GLYCOBIOLOGY, V14, P571, DOI 10.1093/glycob/cwh075; MARSDEN HS, 1976, J GEN VIROL, V31, P347, DOI 10.1099/0022-1317-31-3-347; Namvar L, 2005, J CLIN MICROBIOL, V43, P2058, DOI 10.1128/JCM.43.5.2058-2064.2005; Norden R, 2013, APMIS, V121, P280, DOI 10.1111/j.1600-0463.2012.02967.x; Norden R, 2013, GLYCOBIOLOGY, V23, P310, DOI 10.1093/glycob/cws160; Norden R, 2009, GLYCOBIOLOGY, V19, P776, DOI 10.1093/glycob/cwp050; Nystrom K, 2004, J VIROL METHODS, V118, P83, DOI 10.1016/j.jviromet.2004.01.019; Nystrom K, 2007, GLYCOBIOLOGY, V17, P355, DOI 10.1093/glycob/cwl083; Nystrom K, 2009, GLYCOBIOLOGY, V19, P847, DOI 10.1093/glycob/cwp057; OLOFSSON S, 1983, J GEN VIROL, V64, P2735, DOI 10.1099/0022-1317-64-12-2735; OLOFSSON S, 1992, APMIS, V100, P84; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Puttur FK, 2010, J IMMUNOL, V185, P477, DOI 10.4049/jimmunol.0904106; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SJOBLOM I, 1992, APMIS, V100, P229; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503	51	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5078	5091		10.1074/jbc.M114.616409	http://dx.doi.org/10.1074/jbc.M114.616409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25548287	hybrid, Green Published			2022-12-28	WOS:000350042000048
J	Jonas, KC; Fanelli, F; Huhtaniemi, IT; Hanyaloglu, AC				Jonas, Kim C.; Fanelli, Francesca; Huhtaniemi, Ilpo T.; Hanyaloglu, Aylin C.			Single Molecule Analysis of Functionally Asymmetric G Protein-coupled Receptor (GPCR) Oligomers Reveals Diverse Spatial and Structural Assemblies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE RECEPTORS; FOLLICLE-STIMULATING-HORMONE; PHOTOACTIVATED LOCALIZATION MICROSCOPY; BETA(2) ADRENERGIC-RECEPTOR; RESONANCE ENERGY-TRANSFER; CRYSTAL-STRUCTURE; BETA-2-ADRENERGIC RECEPTOR; LH RECEPTOR; CELLS; HOMODIMERIZATION	Formation of G protein-coupled receptors (GPCRs) into dimers and higher order oligomers represents a key mechanism in pleiotropic signaling, yet how individual protomers function within oligomers remains poorly understood. We present a super-resolution imaging approach, resolving single GPCR molecules to similar to 8 nm resolution in functional asymmetric dimers and oligomers using dual-color photoactivatable dyes and localization microscopy (PD-PALM). PD-PALM of two functionally defined mutant luteinizing hormone receptors (LHRs), a ligand-binding deficient receptor (LHRB-) and a signaling-deficient (LHRS-) receptor, which only function via intermolecular cooperation, favored oligomeric over dimeric formation. PD-PALM imaging of trimers and tetramers revealed specific spatial organizations of individual protomers in complexes where the ratiometric composition of LHRB- to LHRS- modulated ligand-induced signal sensitivity. Structural modeling of asymmetric LHR oligomers strongly aligned with PD-PALM-imaged spatial arrangements, identifying multiple possible helix interfaces mediating inter-protomer associations. Our findings reveal that diverse spatial and structural assemblies mediating GPCR oligomerization may acutely fine-tune the cellular signaling profile.	[Jonas, Kim C.; Huhtaniemi, Ilpo T.; Hanyaloglu, Aylin C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, London W12 0NN, England; [Fanelli, Francesca] Univ Modena & Reggio Emilia, Dept Life Sci, Computat Struct Biol Lab, I-41100 Modena, Italy; [Huhtaniemi, Ilpo T.] Univ Turku, Dept Physiol, Inst Biomed, FIN-20520 Turku, Finland	Imperial College London; Universita di Modena e Reggio Emilia; University of Turku	Huhtaniemi, IT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod & Dev Biol, Du Cane Rd, London W12 0NN, England.	ilpo.huhtaniemi@imperial.ac.uk; a.hanyaloglu@imperial.ac.uk	Fanelli, Francesca/O-8807-2014	Fanelli, Francesca/0000-0002-7620-6895; /0000-0003-4206-737X; Jonas, Kim/0000-0003-1891-2617	Biotechnology and Biological Sciences Research Council [BB/1008004/1]; Wellcome Trust [082101/Z/07/Z]; Society for Endocrinology Early Career Grant; BBSRC [BB/I008004/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008004/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Society for Endocrinology Early Career Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/1008004/1, Wellcome Trust Program Grant 082101/Z/07/Z, and a Society for Endocrinology Early Career Grant.	Angelova K, 2011, CELL MOL LIFE SCI, V68, P1227, DOI 10.1007/s00018-010-0519-z; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Belov VN, 2010, ANGEW CHEM INT EDIT, V49, P3520, DOI 10.1002/anie.201000150; Breen SM, 2013, MOL ENDOCRINOL, V27, P1483, DOI 10.1210/me.2013-1130; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Casciari D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-340; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; DEHEJIA A, 1982, J BIOL CHEM, V257, P13781; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; GETIS A, 1987, ECOLOGY, V68, P473, DOI 10.2307/1938452; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; GUDERMANN T, 1992, J BIOL CHEM, V267, P4479; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; HUHTANIEMI IT, 1981, ENDOCRINOLOGY, V108, P1931, DOI 10.1210/endo-108-5-1931; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Ji Q, 2004, INT J CANCER, V112, P803, DOI 10.1002/ijc.20478; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Jonas KC, 2013, METHOD CELL BIOL, V117, P433, DOI 10.1016/B978-0-12-408143-7.00023-2; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kocan M, 2011, METHODS MOL BIOL, V746, P357, DOI 10.1007/978-1-61779-126-0_20; Lee C, 2002, METHODS, V27, P318, DOI 10.1016/S1046-2023(02)00089-0; Lee CW, 2002, J BIOL CHEM, V277, P15795, DOI 10.1074/jbc.M111818200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LUBORSKY JL, 1984, ENDOCRINOLOGY, V115, P2217, DOI 10.1210/endo-115-6-2217; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Osuga Y, 1997, J BIOL CHEM, V272, P25006, DOI 10.1074/jbc.272.40.25006; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pascal G, 2005, MOL PHARMACOL, V68, P905, DOI 10.1124/mol.105.013847; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rivero-Muller A, 2013, PROG MOL BIOL TRANSL, V117, P163, DOI 10.1016/B978-0-12-386931-9.00007-6; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; ROBERTS CJ, 1995, LANGMUIR, V11, P1822, DOI 10.1021/la00005a063; Rossy J, 2014, HISTOCHEM CELL BIOL, V141, P605, DOI 10.1007/s00418-014-1208-z; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Song GJ, 2007, P NATL ACAD SCI USA, V104, P18303, DOI 10.1073/pnas.0702857104; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Wolf-Ringwall AL, 2011, J BIOL CHEM, V286, P29818, DOI 10.1074/jbc.M111.250969; Zoenen M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1991	59	88	91	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3875	3892		10.1074/jbc.M114.622498	http://dx.doi.org/10.1074/jbc.M114.622498			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25516594	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000349458400001
J	Kanazawa, I; Canaff, L; Rafeh, JA; Angrula, A; Li, JJ; Riddle, RC; Boraschi-Diaz, I; Komarova, SV; Clemens, TL; Murshed, M; Hendy, GN				Kanazawa, Ippei; Canaff, Lucie; Rafeh, Jad Abi; Angrula, Aarti; Li, Jingjing; Riddle, Ryan C.; Boraschi-Diaz, Iris; Komarova, Svetlana V.; Clemens, Thomas L.; Murshed, Monzur; Hendy, Geoffrey N.			Osteoblast Menin Regulates Bone Mass in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; MESENCHYMAL STEM-CELLS; TGF-BETA; MICE DEVELOP; GENE; TYPE-1; EXPRESSION; RECEPTOR; GROWTH; DIFFERENTIATION	Menin, the product of the multiple endocrine neoplasia type 1 (Men1) tumor suppressor gene, mediates the cell proliferation and differentiation actions of transforming growth factor-beta (TGF-beta) ligand family members. In vitro, menin modulates osteoblastogenesis and osteoblast differentiation promoted and sustained by bone morphogenetic protein-2 (BMP-2) and TGF-beta, respectively. To examine the in vivo function of menin in bone, we conditionally inactivated Men1 in mature osteoblasts by crossing osteocalcin (OC)-Cre mice with floxed Men1 (Men1(f/f)) mice to generate mice lacking menin in differentiating osteoblasts (OC-Cre; Men1(f/f) mice). These mice displayed significant reduction in bone mineral density, trabecular bone volume, and cortical bone thickness compared with control littermates. Osteoblast and osteoclast number as well as mineral apposition rate were significantly reduced, whereas osteocyte number was increased. Primary calvarial osteoblasts proliferated more quickly but had deficient mineral apposition and alkaline phosphatase activity. Although the mRNA expression of osteoblast marker and cyclin-dependent kinase inhibitor genes were all reduced, that of cyclin-dependent kinase, osteocyte marker, and pro-apoptotic genes were increased in isolated Men1 knock-out osteoblasts compared with controls. In contrast to the knock-out mice, transgenic mice overexpressing a human menin cDNA in osteoblasts driven by the 2.3-kb Col1a1 promoter, showed a gain of bone mass relative to control littermates. Osteoblast number and mineral apposition rate were significantly increased in the Col1a1-Menin-Tg mice. Therefore, osteoblast menin plays a key role in bone development, remodeling, and maintenance.	[Murshed, Monzur] McGill Univ, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, Canada; [Rafeh, Jad Abi; Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Dept Physiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Royal Victoria Hosp, Dept Human Genet, Montreal, PQ H3A 1A1, Canada; [Li, Jingjing; Boraschi-Diaz, Iris; Komarova, Svetlana V.; Murshed, Monzur] McGill Univ, Royal Victoria Hosp, Dept Dent, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada; [Riddle, Ryan C.; Clemens, Thomas L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21201 USA	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Hendy, GN (corresponding author), Royal Victoria Hosp, Calcium Res Lab, Rm H4-67,687 Pine Ave West, Montreal, PQ H3A 1A1, Canada.	geoffrey.hendy@mcgill.ca	Kanazawa, Ippei/F-8609-2010	Abi-Rafeh, Jad/0000-0002-7483-1515	Department of Medicine, McGill University [5767]; McGill University Health Centre-Research Institute [5758]; Canadian Institutes of Health Research [MOP-9315, 123310, 776403]; Fonds de la Recherche en Sante Quebec; Canadian Bureau for International Education; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Network for Oral and Bone Health Research (RSBO) Summer Student Scholarship; McGill University Faculty of Dentistry	Department of Medicine, McGill University; McGill University Health Centre-Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Bureau for International Education; Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Network for Oral and Bone Health Research (RSBO) Summer Student Scholarship; McGill University Faculty of Dentistry	This work was supported in part by the Department of Medicine, McGill University Grant 5767 and McGill University Health Centre-Research Institute Grant 5758 (to G. N. H.) and Canadian Institutes of Health Research Grants MOP-9315 (to G. N. H.), 123310 (to M. M.), and 776403 (to S. V. K.).; Recipient of fellowships from Fonds de la Recherche en Sante Quebec, Canadian Bureau for International Education, Uehara Memorial Foundation, and Kanae Foundation for the Promotion of Medical Science. Present address: Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Shimane 693-8501, Japan.; Recipient of a Network for Oral and Bone Health Research (RSBO) Summer Student Scholarship.; Supported by the McGill University Faculty of Dentistry.	Aziz A, 2009, DEV BIOL, V332, P116, DOI 10.1016/j.ydbio.2009.05.555; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, MECH DEVELOP, V120, P549, DOI 10.1016/S0925-4773(03)00039-X; Bertolino P, 2003, CANCER RES, V63, P4836; Biondi CA, 2004, MOL CELL BIOL, V24, P3125, DOI 10.1128/MCB.24.8.3125-3131.2004; Boraschi-Diaz I, 2016, CYTOTECHNOLOGY, V68, P105, DOI 10.1007/s10616-014-9759-3; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canaff L, 2012, J CLIN ENDOCR METAB, V97, pE282, DOI 10.1210/jc.2011-0241; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Engleka KA, 2007, DEV BIOL, V311, P524, DOI 10.1016/j.ydbio.2007.08.057; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Hendy GN, 2009, ADV EXP MED BIOL, V668, P37; Kaji H, 1999, CANCER RES, V59, P5097; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Lemos MC, 2009, J ENDOCRINOL, V203, P133, DOI 10.1677/JOE-09-0124; Libutti SK, 2003, CANCER RES, V63, P8022; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Marulanda J, 2013, BONE, V57, P499, DOI 10.1016/j.bone.2013.08.021; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x; Rafiei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-605; Richard C, 2010, J BONE MINER RES, V25, P1627, DOI 10.1002/jbmr.58; Riddle RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063323; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Sowa H, 2003, J BIOL CHEM, V278, P21058, DOI 10.1074/jbc.M302044200; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	41	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3910	3924		10.1074/jbc.M114.629899	http://dx.doi.org/10.1074/jbc.M114.629899			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538250	hybrid, Green Published			2022-12-28	WOS:000349458400003
J	Maier, LK; Stachler, AE; Saunders, SJ; Backofen, R; Marchfelder, A				Maier, Lisa-Katharina; Stachler, Aris-Edda; Saunders, Sita J.; Backofen, Rolf; Marchfelder, Anita			An Active Immune Defense with a Minimal CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) RNA and without the Cas6 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUIDED SURVEILLANCE COMPLEX; HALOFERAX-VOLCANII; TARGET RECOGNITION; ANTIVIRAL DEFENSE; ADAPTIVE IMMUNITY; CRYSTAL-STRUCTURE; SEED SEQUENCE; SYSTEM; PROKARYOTES; DNA	The prokaryotic immune system CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) is a defense system that protects prokaryotes against foreign DNA. The short CRISPR RNAs (crRNAs) are central components of this immune system. In CRISPR-Cas systems type I and III, crRNAs are generated by the endonuclease Cas6. We developed a Cas6b-independent crRNA maturation pathway for the Haloferax type I-B system in vivo that expresses a functional crRNA, which we termed independently generated crRNA (icrRNA). The icrRNA is effective in triggering degradation of an invader plasmid carrying the matching protospacer sequence. The Cas6b-independent maturation of the icrRNA allowed mutation of the repeat sequence without interfering with signals important for Cas6b processing. We generated 23 variants of the icrRNA and analyzed them for activity in the interference reaction. icrRNAs with deletions or mutations of the 3' handle are still active in triggering an interference reaction. The complete 3' handle could be removed without loss of activity. However, manipulations of the 5' handle mostly led to loss of interference activity. Furthermore, we could show that in the presence of an icrRNA a strain without Cas6b (Delta cas6b) is still active in interference..	[Maier, Lisa-Katharina; Stachler, Aris-Edda; Marchfelder, Anita] Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany; [Saunders, Sita J.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, D-79110 Freiburg, Germany; [Backofen, Rolf] Univ Freiburg, Cluster Excellence, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Ulm University; University of Freiburg; University of Freiburg	Marchfelder, A (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de		Marchfelder, Anita/0000-0002-1382-1794; Saunders, Sita/0000-0002-2243-5422; Backofen, Rolf/0000-0001-8231-3323	German Research Council (Deutsche Forschungsgemeinschaft), through the research group FOR 1680 [DFG MA1538/17-1, BA2168/5-1]	German Research Council (Deutsche Forschungsgemeinschaft), through the research group FOR 1680(German Research Foundation (DFG))	This work was supported by the German Research Council (Deutsche Forschungsgemeinschaft), through the research group FOR 1680 "Unravelling the prokaryotic immune system" (grant DFG MA1538/17-1 and BA2168/5-1).	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Almendros C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050797; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bikard D., 2013, 1000PRIME, DOI 10.12703/P5-47; Brendel J, 2014, J BIOL CHEM, V289, P7164, DOI 10.1074/jbc.M113.508184; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2013, CRISPR CAS SYSTEMS, P115; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Dupuis M, 2013, CRISPR CAS SYSTEMS R, P171; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Fischer S, 2010, J BIOL CHEM, V285, P34429, DOI 10.1074/jbc.M110.118950; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Holzle A, 2012, BIOCHIMIE, V94, P940, DOI 10.1016/j.biochi.2011.12.002; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Maier LK, 2013, RNA BIOL, V10, P865, DOI 10.4161/rna.24282; Maier LK, 2013, BIOCHEM SOC T, V41, P374, DOI 10.1042/BST20120263; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marchfelder A, 2012, EXTREMOPHILES, V16, P685, DOI 10.1007/s00792-012-0469-5; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Stoll B., 2013, BIOLOGY; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	56	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4192	4201		10.1074/jbc.M114.617506	http://dx.doi.org/10.1074/jbc.M114.617506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25512373	Green Published, hybrid			2022-12-28	WOS:000349458400030
J	Wang, MY; Zhong, ZM; Zhong, YB; Zhang, W; Wang, H				Wang, Mingyong; Zhong, Zhaomin; Zhong, Yingbin; Zhang, Wei; Wang, Han			The Zebrafish Period2 Protein Positively Regulates the Circadian Clock through Mediation of Retinoic Acid Receptor (RAR)-related Orphan Receptor alpha (Ror alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR ANALYSIS; PINEAL-GLAND; MOUSE CLOCK; GENE; MUTATION; PHOSPHORYLATION; EXPRESSION; TRANSCRIPTION; COMPONENT; RHYTHMS	We report the characterization of a null mutant for zebrafish circadian clock gene period2 (per2) generated by transcription activator-like effector nuclease and a positive role of PER2 in vertebrate circadian regulation. Locomotor experiments showed that per2 mutant zebrafish display reduced activities under light-dark and 2-h phase delay under constant darkness, and quantitative real time PCR analyses showed up-regulation of cry1aa, cry1ba, cry1bb, and aanat2 but down-regulation of per1b, per3, and bmal1b in per2 mutant zebrafish, suggesting that Per2 is essential for the zebrafish circadian clock. Luciferase reporter assays demonstrated that Per2 represses aanat2 expression through E-box and enhances bmal1b expression through the Ror/Rev-erb response element, implicating that Per2 plays dual roles in the zebrafish circadian clock. Cell transfection and co-immunoprecipitation assays revealed that Per2 enhances bmal1b expression through binding to orphan nuclear receptor Ror alpha. The enhancing effect of mouse PER2 on Bmal1 transcription is also mediated by ROR alpha even though it binds to REV-ERB alpha. Moreover, zebrafish Per2 also appears to have tissue-specific regulatory roles in numerous peripheral organs. These findings help define the essential functions of Per2 in the zebrafish circadian clock and in particular provide strong evidence for a positive role of PER2 in the vertebrate circadian system.	Soochow Univ, Ctr Circadian Clocks, Coll Med, Suzhou 215123, Jiangsu, Peoples R China; Soochow Univ, Sch Biol & Basic Med Sci, Coll Med, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Wang, H (corresponding author), Soochow Univ, Ctr Circadian Clocks, SIP, 199 Renai, Suzhou 215123, Jiangsu, Peoples R China.	han.wang88@gmail.com	Wang, Han/A-9774-2008	Wang, Han/0000-0003-2420-3147; Wang, Mingyong/0000-0002-5705-8145	National Basic Research Program of China (973 Program) [2012CB947600]; National Natural Science Foundation of China [31030062, 81070455]; National High Technology Research and Development Program of China (863 Program) [2011AA100402-2]; Jiangsu Distinguished Professorship Program [SR13400111]; Natural Science Foundation of Jiangsu Province [BK2012052]; Priority Academic Program Development of Jiangsu Higher Education Institutions [YX13400214]; High-Level Innovative Team of Jiangsu Province; Soochow University [Q4134918]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Jiangsu Distinguished Professorship Program; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; High-Level Innovative Team of Jiangsu Province; Soochow University	This work was supported by National Basic Research Program of China (973 Program) Grant 2012CB947600, National Natural Science Foundation of China Grants 31030062 and 81070455, National High Technology Research and Development Program of China (863 Program) Grant 2011AA100402-2, Jiangsu Distinguished Professorship Program Grant SR13400111, Natural Science Foundation of Jiangsu Province Grant BK2012052, Priority Academic Program Development of Jiangsu Higher Education Institutions Grant YX13400214, the High-Level Innovative Team of Jiangsu Province, and Soochow University Startup Fund Grant Q4134918.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akashi M, 2014, CELL REP, V7, P1056, DOI 10.1016/j.celrep.2014.03.072; Appelbaum L, 2006, J MOL ENDOCRINOL, V36, P337, DOI 10.1677/jme.1.01893; Ben-Moshe Z, 2014, NUCLEIC ACIDS RES, V42, P3750, DOI 10.1093/nar/gkt1359; Ben-Shlomo R, 2002, CELL BIOCHEM BIOPHYS, V37, P141, DOI 10.1385/CBB:37:2:141; Blau J, 2001, SEMIN CELL DEV BIOL, V12, P287, DOI 10.1006/scdb.2001.0256; Brager AJ, 2013, BEHAV BRAIN RES, V243, P255, DOI 10.1016/j.bbr.2013.01.014; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Flores MV, 2007, GENE EXPR PATTERNS, V7, P535, DOI 10.1016/j.modgep.2007.02.001; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; GARDNER GF, 1980, GENETICS, V96, P877; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, EMBO J, V11, P1; Huang J., 2015, J NEUROSCI IN PRESS; Huang P, 2014, METHODS, V69, P67, DOI 10.1016/j.ymeth.2014.02.010; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ishikawa T, 2002, GENES CELLS, V7, P1073, DOI 10.1046/j.1365-2443.2002.00579.x; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Liu C., 2015, SCI REP IN PRESS; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Storz SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054189; Subramanian P., 2003, Indian Journal of Experimental Biology, V41, P797; Tamai TK, 2012, J BIOL RHYTHM, V27, P226, DOI 10.1177/0748730412440861; Tan Y, 2008, J NEUROGENET, V22, P149, DOI 10.1080/01677060802049738; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Uz T, 2001, J PINEAL RES, V30, P166, DOI 10.1034/j.1600-079X.2001.300305.x; Vanselow K, 2007, COLD SPRING HARB SYM, V72, P167, DOI 10.1101/sqb.2007.72.036; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wang H, 2009, GENETICA, V136, P149, DOI 10.1007/s10709-008-9328-9; Wang J, 2014, ZEBRAFISH, V11, P115, DOI 10.1089/zeb.2013.0929; Wang Ming-Yong, 2012, Yichuan, V34, P1133, DOI 10.3724/SP.J.1005.2012.01133; Weger M, 2013, DEV BIOL, V380, P259, DOI 10.1016/j.ydbio.2013.04.035; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P11; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Ziv L, 2006, CHRONOBIOL INT, V23, P101, DOI 10.1080/07420520500464551; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	80	28	31	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4367	4382		10.1074/jbc.M114.605022	http://dx.doi.org/10.1074/jbc.M114.605022			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25544291	hybrid, Green Published			2022-12-28	WOS:000349458400045
J	Chan, ACK; Blair, KM; Liu, YJ; Frirdich, E; Gaynor, EC; Tanner, ME; Salama, NR; Murphy, MEP				Chan, Anson C. K.; Blair, Kris M.; Liu, Yanjie; Frirdich, Emilisa; Gaynor, Erin C.; Tanner, Martin E.; Salama, Nina R.; Murphy, Michael E. P.			Helical Shape of Helicobacter pylori Requires an Atypical Glutamine as a Zinc Ligand in the Carboxypeptidase Csd4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SHAPE; PEPTIDOGLYCAN; SEQUENCE; CONSERVATION; HYDROLASES; MECHANISM	Peptidoglycan modifying carboxypeptidases (CPs) are important determinants of bacterial cell shape. Here, we report crystal structures of Csd4, a three-domain protein from the human gastric pathogen Helicobacter pylori. The catalytic zinc in Csd4 is coordinated by a rare His-Glu-Gln configuration that is conserved among most Csd4 homologs, which form a distinct subfamily of CPs. Substitution of the glutamine to histidine, the residue found in prototypical zinc carboxypeptidases, resulted in decreased enzyme activity and inhibition by phosphate. Expression of the histidine variant at the native locus in a H. pylori csd4 deletion strain did not restore the wild-type helical morphology. Biochemical assays show that Csd4 can cleave a tripeptide peptidoglycan substrate analog to release m-DAP. Structures of Csd4 with this substrate analog or product bound at the active site reveal determinants of peptidoglycan specificity and the mechanism to cleave an isopeptide bond to release m-DAP. Our data suggest that Csd4 is the archetype of a new CP subfamily with a domain scheme that differs from this large family of peptide-cleaving enzymes.	[Chan, Anson C. K.; Frirdich, Emilisa; Gaynor, Erin C.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Blair, Kris M.; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Blair, Kris M.; Salama, Nina R.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Liu, Yanjie; Tanner, Martin E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of British Columbia	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michael.murphy@ubc.ca	Murphy, Michael/R-6805-2017; Salama, Nina Reda/AAG-2437-2019	Murphy, Michael/0000-0003-2589-0014; Salama, Nina Reda/0000-0003-2762-1424; Chan, Anson/0000-0001-6625-8942; Blair, Kris/0000-0002-2887-5592	National Institutes of Health [RO1A1094839, T32CA009657]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research [MOP-68981]; National Science Foundation [DGE-1256082]; NATIONAL CANCER INSTITUTE [T32CA009657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1A1094839 and T32CA009657. This work was also supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants (to M. E. P. M. and M. E. T.) and Canadian Institutes of Health Research Operating Grant MOP-68981 (to E. G.). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (to K. B.) under Grant DGE-1256082. Support for infrastructure for structural biology was provided by the Canadian Foundation for Innovation (to M. E. P. M.). The research described in this paper was performed using Beamlines 08B1-1 and 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Abdullah MR, 2014, MOL MICROBIOL, V93, P1183, DOI 10.1111/mmi.12729; Agnihotri G, 2011, J MED CHEM, V54, P1490, DOI 10.1021/jm101535e; Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frey P. A., 2007, ENZYMATIC REACTION M; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; GARNIER M, 1985, EUR J BIOCHEM, V148, P539, DOI 10.1111/j.1432-1033.1985.tb08873.x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hor L, 2013, BIOCHIMIE, V95, P1949, DOI 10.1016/j.biochi.2013.06.026; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Hoyland CN, 2014, STRUCTURE, V22, P949, DOI 10.1016/j.str.2014.04.015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HS, 2014, ACTA CRYSTALLOGR D, V70, P2800, DOI 10.1107/S1399004714018732; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Maqbool A, 2012, BIOCHEM J, V448, P329, DOI 10.1042/BJ20121164; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pinto-Santini DM, 2009, J BACTERIOL, V191, P7343, DOI 10.1128/JB.00946-09; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ridderstrom M, 1998, J BIOL CHEM, V273, P21623, DOI 10.1074/jbc.273.34.21623; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sousa SF, 2009, DALTON T, P7946, DOI 10.1039/b904404c; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Terry K, 2005, INFECT IMMUN, V73, P803, DOI 10.1128/IAI.73.2.803-811.2005; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wyckoff TJ, 2012, TRENDS MICROBIOL, V20, P540, DOI 10.1016/j.tim.2012.08.003; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	43	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3622	3638		10.1074/jbc.M114.624734	http://dx.doi.org/10.1074/jbc.M114.624734			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505267	hybrid, Green Published			2022-12-28	WOS:000349456000035
J	Aerts, L; Craessaerts, K; De Strooper, B; Morais, VA				Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.			PINK1 Kinase Catalytic Activity Is Regulated by Phosphorylation on Serines 228 and 402	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Neurodegenerative Disease; Parkinson Disease; Posttranslational Modification (PTM); Protein Phosphorylation; PTEN-induced Putative Kinase 1 (PINK1); Serine; Threonine Protein Kinase	COMPLEX I ACTIVITY; LOSS-OF-FUNCTION; PARKIN RECRUITMENT; PINK1-DEPENDENT PHOSPHORYLATION; MITOCHONDRIAL MORPHOLOGY; RECESSIVE PARKINSONISM; DAMAGED MITOCHONDRIA; OXIDATIVE STRESS; ACTIVATE PARKIN; PROTEASE PARL	Background: PINK1 mutations affect mitochondrial homeostasis and cause Parkinson disease. Results: PINK1 is phosphorylated on the outer mitochondrial membrane. We show here that phosphorylation of serines 228 and 402 increases the capacity of PINK1 to phosphorylate its substrates Parkin and Ubiquitin. Conclusion: PINK1 phosphorylation regulates its kinase activity. Significance: Understanding PINK1 regulation is pivotal to unravel its mitochondrial function. Mutations in the PINK1 gene cause early-onset recessive Parkinson disease. PINK1 is a mitochondrially targeted kinase that regulates multiple aspects of mitochondrial biology, from oxidative phosphorylation to mitochondrial clearance. PINK1 itself is also phosphorylated, and this might be linked to the regulation of its multiple activities. Here we systematically analyze four previously identified phosphorylation sites in PINK1 for their role in autophosphorylation, substrate phosphorylation, and mitophagy. Our data indicate that two of these sites, Ser-228 and Ser-402, are autophosphorylated on truncated PINK1 but not on full-length PINK1, suggesting that the N terminus has an inhibitory effect on phosphorylation. We furthermore establish that phosphorylation of these PINK1 residues regulates the phosphorylation of the substrates Parkin and Ubiquitin. Especially Ser-402 phosphorylation appears to be important for PINK1 function because it is involved in Parkin recruitment and the induction of mitophagy. Finally, we identify Thr-313 as a residue that is critical for PINK1 catalytic activity, but, in contrast to previous reports, we find no evidence that this activity is regulated by phosphorylation. These data clarify the regulation of PINK1 through multisite phosphorylation.	[Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Flemish Inst Biotechnol VIB, Ctr Biol Dis, B-3000 Leuven, Belgium; [Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Disorders, B-3000 Leuven, Belgium; [Aerts, Liesbeth; Craessaerts, Katleen; De Strooper, Bart; Morais, Vanessa A.] Univ Leuven, Univ Hosp Leuven, B-3000 Leuven, Belgium; [De Strooper, Bart] UCL, Inst Neurol, London WC1N 3BG, England	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; University of London; University College London	Morais, VA (corresponding author), Flemish Inst Biotechnol VIB, Ctr Biol Dis, Herestr 49,Box 602, B-3000 Leuven, Belgium.	Vanessa.Morais@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; Aerts, Liesbeth/J-7946-2015	Morais, Vanessa/0000-0002-0830-0548; Aerts, Liesbeth/0000-0002-7981-8176	Flemish agency for Innovation by Science and Technology (IWT); Fund for Scientific Research Flanders (FWO); Research Fund KU Leuven; Hercules Foundation; Federal Office for Scientific Affairs [IAP P7/16]; Methusalem grant of the Flemish government; Flemish Institute for Biotechnology; IWT; Janssen Pharmaceutica; Envivo; Remynd NV	Flemish agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); Research Fund KU Leuven(KU Leuven); Hercules Foundation; Federal Office for Scientific Affairs; Methusalem grant of the Flemish government; Flemish Institute for Biotechnology; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Envivo; Remynd NV	This work was supported by the Flemish agency for Innovation by Science and Technology (IWT), by the Fund for Scientific Research Flanders (FWO), by Research Fund KU Leuven, by the Hercules Foundation, by Federal Office for Scientific Affairs Grant IAP P7/16, by a Methusalem grant of the Flemish government, and by the Flemish Institute for Biotechnology. B. D. S. is a paid consultant for the Alzheimer disease research programs at Janssen Pharmaceutica, Envivo, and Remynd NV.; Supported by an IWT doctoral grant.	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Luo Q, 2014, EXP THER MED, V8, P286, DOI 10.3892/etm.2014.1702; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Matenia D, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00037; Matenia D, 2012, J BIOL CHEM, V287, P8174, DOI 10.1074/jbc.M111.262287; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nishi H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00270; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pogson JH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004815; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	48	76	78	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2798	2811		10.1074/jbc.M114.620906	http://dx.doi.org/10.1074/jbc.M114.620906			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527497	Green Published, hybrid			2022-12-28	WOS:000349310700021
J	Mlih, M; Host, L; Martin, S; Niederhoffer, N; Monassier, L; Terrand, J; Messaddeq, N; Radke, M; Gotthardt, M; Bruban, V; Kober, F; Bernard, M; Canet-Soulas, E; Abt-Jijon, F; Boucher, P; Matz, RL				Mlih, Mohamed; Host, Lionel; Martin, Sophie; Niederhoffer, Nathalie; Monassier, Laurent; Terrand, Jerome; Messaddeq, Nadia; Radke, Michael; Gotthardt, Michael; Bruban, Veronique; Kober, Frank; Bernard, Monique; Canet-Soulas, Emmanuelle; Abt-Jijon, Francisco; Boucher, Philippe; Matz, Rachel L.			The Src Homology and Collagen A (ShcA) Adaptor Protein Is Required for the Spatial Organization of the Costamere/Z-disk Network during Heart Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; SMOOTH-MUSCLE; CARDIAC-HYPERTROPHY; NEBULETTE MUTATIONS; MOUSE HEART; TITIN; MICE; ERBB2; CAVEOLIN-1; DISEASE	Src homology and collagen A (ShcA) is an adaptor protein that binds to tyrosine kinase receptors. Its germ line deletion is embryonic lethal with abnormal cardiovascular system formation, and its role in cardiovascular development is unknown. To investigate its functional role in cardiovascular development in mice, ShcA was deleted in cardiomyocytes and vascular smooth muscle cells by crossing ShcA flox mice with SM22a-Cre transgenic mice. Conditional mutant mice developed signs of severe dilated cardiomyopathy, myocardial infarctions, and premature death. No evidence of a vascular contribution to the phenotype was observed. Histological analysis of the heart revealed aberrant sarcomeric Z-disk and M-band structures, and misalignments of T-tubules with Z-disks. We find that not only the ErbB3/Neuregulin signaling pathway but also the baroreceptor reflex response, which have been functionally associated, are altered in the mutant mice. We further demonstrate that ShcA interacts with Caveolin-1 and the costameric protein plasma membrane Ca2+/calmodulin-dependent ATPase (PMCA), and that its deletion leads to abnormal dystrophin signaling. Collectively, these results demonstrate that ShcA interacts with crucial proteins and pathways that link Z-disk and costamere.	[Mlih, Mohamed; Host, Lionel; Martin, Sophie; Terrand, Jerome; Bruban, Veronique; Abt-Jijon, Francisco; Boucher, Philippe; Matz, Rachel L.] Univ Strasbourg, CNRS, UMR 7213, F-67401 Illkirch Graffenstaden, France; [Niederhoffer, Nathalie; Monassier, Laurent] Univ Strasbourg, Lab Neurobiol, F-67000 Strasbourg, France; [Niederhoffer, Nathalie; Monassier, Laurent] Univ Strasbourg, Cardiovasc Pharmacol Dept, EA 7296, F-67000 Strasbourg, France; [Messaddeq, Nadia] Univ Strasbourg, CNRS, IGBMC, INSERM,U964,UMR 7104, F-67401 Illkirch Graffenstaden, France; [Radke, Michael; Gotthardt, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Radke, Michael; Gotthardt, Michael] German Ctr Cardiovasc Res, DZHK, D-13347 Berlin, Germany; [Kober, Frank; Bernard, Monique] Univ Aix Marseille, CNRS, UMR 7339, CRMBM, F-13385 Marseille, France; [Canet-Soulas, Emmanuelle] CNRS, INSERM, U630, CREATIS,LRMN,UMR 5220, F-69621 Villeurbanne, France; [Canet-Soulas, Emmanuelle] Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Boucher, P (corresponding author), Univ Strasbourg, CNRS, UMR 7213, F-67401 Illkirch Graffenstaden, France.	philippe.boucher@unistra.fr; rachel.matz-westphal@unistra.fr	Niederhoffer, Nathalie/AAF-1343-2020; Mlih, Mohamed/O-4834-2019; Carmen, Team3/Y-7384-2019; Kober, Frank/L-8737-2013; martin, sophie/AAP-3498-2021; Gotthardt, Michael/ABE-8274-2021; Bernard, Monique/Q-7254-2017	Mlih, Mohamed/0000-0003-3491-9616; Carmen, Team3/0000-0002-3614-0924; Kober, Frank/0000-0002-7869-3615; Gotthardt, Michael/0000-0003-1788-3172; Bernard, Monique/0000-0002-3179-8698; Terrand, jerome/0000-0002-8169-7713; Martin, Sophie/0000-0002-2907-7445; Radke, Michael/0000-0003-0112-9917; Lab, Carmen/0000-0002-5935-3236; MATZ, Rachel/0000-0001-5832-7063; Boucher, Philippe/0000-0002-3928-9812	Fondation de France; Fondation pour la Recherche Medicale (FRM); Agence Nationale de la Recherche [ANR-06-Physio-032-01, ANR-09-BLAN-0121-01]	Fondation de France(Fondation de France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Fondation de France, Fondation pour la Recherche Medicale (FRM), and Agence Nationale de la Recherche Grants ANR-06-Physio-032-01 and ANR-09-BLAN-0121-01.	Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Camprecios G, 2011, J CELL PHYSIOL, V226, P450, DOI 10.1002/jcp.22354; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Das M, 2014, BBA-BIOMEMBRANES, V1838, P579, DOI 10.1016/j.bbamem.2013.07.017; Epstein ND, 2003, CELL, V112, P147, DOI 10.1016/S0092-8674(03)00037-0; Erickson SL, 1997, DEVELOPMENT, V124, P4999; GARDIN JM, 1995, CIRC RES, V76, P907, DOI 10.1161/01.RES.76.5.907; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Gautel M, 1996, J CELL SCI, V109, P2747; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Jacquier A, 2011, NMR BIOMED, V24, P1047, DOI 10.1002/nbm.1645; Jakobsen CJ, 2006, EUR J CARDIO-THORAC, V29, P978, DOI 10.1016/j.ejcts.2006.02.014; Jiang Zhenggang, 2010, Curr Heart Fail Rep, V7, P42, DOI 10.1007/s11897-010-0003-y; KAUFMAN MH, 1981, J ANAT, V133, P235; Kober F, 2005, MAGNET RESON MED, V53, P601, DOI 10.1002/mrm.20373; Lai KMV, 2000, GENE DEV, V14, P1132; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Maiellaro-Rafferty K, 2013, J MOL CELL CARDIOL, V60, P151, DOI 10.1016/j.yjmcc.2013.04.021; Malhowski AJ, 2011, HUM MOL GENET, V20, P1290, DOI 10.1093/hmg/ddq570; MANNING WJ, 1994, AM J PHYSIOL, V266, pH1672, DOI 10.1152/ajpheart.1994.266.4.H1672; Matz RL, 2000, BRIT J PHARMACOL, V131, P303, DOI 10.1038/sj.bjp.0703568; MONCMAN CL, 1995, CELL MOTIL CYTOSKEL, V32, P205, DOI 10.1002/cm.970320305; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pellegrini M, 2007, CELL DEATH DIFFER, V14, P338, DOI 10.1038/sj.cdd.4401997; Purevjav E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/j.jacc.2010.05.045; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Sawyer DB, 2011, J MOL CELL CARDIOL, V51, P501, DOI 10.1016/j.yjmcc.2011.06.016; SEBESTYEN MG, 1995, J CELL SCI, V108, P3029; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Sharma P, 2010, J CELL SCI, V123, P3061, DOI 10.1242/jcs.066712; Shen ZX, 2012, BIOCHEM BIOPH RES CO, V422, P639, DOI 10.1016/j.bbrc.2012.05.041; Stevenson LE, 1999, CELL GROWTH DIFFER, V10, P61; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Vanderlaan RD, 2011, CIRC RES, V108, P184, DOI 10.1161/CIRCRESAHA.110.233924; Vasti Cecilia, 2012, ISRN Cardiol, V2012, P745185, DOI 10.5402/2012/745185; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769; Woldt E, 2011, J BIOL CHEM, V286, P16775, DOI 10.1074/jbc.M110.212878; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693; Yajnik V, 1998, METH MOL B, V84, P223; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	60	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2419	2430		10.1074/jbc.M114.597377	http://dx.doi.org/10.1074/jbc.M114.597377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488665	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000348588000044
J	Cheruvara, H; Allen-Baume, VL; Kad, NM; Mason, JM				Cheruvara, Harish; Allen-Baume, Victoria L.; Kad, Neil M.; Mason, Jody M.			Intracellular Screening of a Peptide Library to Derive a Potent Peptide Inhibitor of alpha-Synuclein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alpha-synuclein (-Synuclein); Amyloid; Parkinson Disease; Protein Misfolding; Protein-Protein Interaction; Library Screening; Protein-Fragment Complementation Assay	PROTEIN AGGREGATION; PARKINSONS-DISEASE; CELL-DEATH; IN-VITRO; TOXICITY; NEUROTOXICITY; PREDICTION; FRAGMENT; DETERMINANTS; SELECTION	Background: Deposition of -synuclein into Lewy bodies is considered the primary event in Parkinson disease. Results: A peptide selected via PCA library screening functions by inhibiting fibril formation. Conclusion: A semirational design combined with intracellular PCA is an effective methodology to develop -synuclein aggregation antagonists. Significance: The technique can be applied to a number of diseases from Parkinson to Alzheimer. Aggregation of -synuclein (-syn) into toxic fibrils is a pathogenic hallmark of Parkinson disease (PD). Studies have focused largely on residues 71-82, yet most early-onset mutations are located between residues 46 and 53. A semirationally designed 209,952-member library based entirely on this region was constructed, containing all wild-type residues and changes associated with early-onset PD. Intracellular cell survival screening and growth competition isolated a 10-residue peptide antagonist that potently inhibits -syn aggregation and associated toxicity at a 1:1 stoichiometry. This was verified using continuous growth measurements and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cytotoxicity studies. Atomic force microscopy and circular dichroism on the same samples showed a random-coil structure and no oligomers. A new region of -syn for inhibitor targeting has been highlighted, together with the approach of using a semirational design and intracellular screening. The peptides can then be used as candidates for modification in drugs capable of slowing or even preventing the onset of PD.	[Cheruvara, Harish; Allen-Baume, Victoria L.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Kad, Neil M.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Mason, Jody M.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Essex; University of Kent; University of Bath	Mason, JM (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	j.mason@bath.ac.uk	Mason, Jody/W-8204-2019	Mason, Jody/0000-0002-4118-1958; Kad, Neil/0000-0002-3491-8595	Parkinson's UK Ph.D. Studentship [H-1001]; Cancer Research UK Career Establishment Award [A11738]; Parkinson&quot;s UK [H-1001] Funding Source: researchfish	Parkinson's UK Ph.D. Studentship; Cancer Research UK Career Establishment Award; Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by Parkinson's UK Ph.D. Studentship H-1001 (to H. C., N. M. K., and J. M. M.) and by Cancer Research UK Career Establishment Award A11738 (to J. M. M.).	Acerra N, 2014, PROTEIN SCI, V23, P1262, DOI 10.1002/pro.2509; Acerra N, 2013, PROTEIN ENG DES SEL, V26, P463, DOI 10.1093/protein/gzt021; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; Emadi S, 2004, BIOCHEMISTRY-US, V43, P2871, DOI 10.1021/bi036281f; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hughes E, 2000, J BIOL CHEM, V275, P25109, DOI 10.1074/jbc.M003554200; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Madine J, 2005, BIOCHEM SOC T, V33, P1113, DOI 10.1042/BST0331113; Madine J, 2008, J AM CHEM SOC, V130, P7873, DOI 10.1021/ja075356q; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; Rutherford NJ, 2014, J NEUROCHEM, V131, P859, DOI 10.1111/jnc.12806; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042	33	32	35	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7426	7435		10.1074/jbc.M114.620484	http://dx.doi.org/10.1074/jbc.M114.620484			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25616660	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000351613600011
J	Kim, Y; Lee, SE; Park, J; Kim, M; Lee, B; Hwang, D; Chang, S				Kim, Yoonju; Lee, Sang-Eun; Park, Joohyun; Kim, Minhyung; Lee, Boyoon; Hwang, Daehee; Chang, Sunghoe			ADP-ribosylation Factor 6 (ARF6) Bidirectionally Regulates Dendritic Spine Formation Depending on Neuronal Maturation and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation Factor (ARF); Dendritic Spine; Phospholipase D; Ras-related C3 Botulinum Toxin Substrate 1 (Rac1); Synaptic Plasticity; ARF6; Rac1; Neuronal Activity	CULTURED HIPPOCAMPAL-NEURONS; NUCLEOTIDE EXCHANGE FACTORS; SYNAPTIC PLASTICITY; PLASMA-MEMBRANE; CEREBRAL-CORTEX; GTPASE; RAC; ACTIVATION; STABILITY; FILOPODIA	Background: Conflicting results regarding the role of ARF6 in dendritic spine development have not been answered. Results: ARF6-mediated Rac1 or RhoA activation via PLD pathway either positively or negatively regulates spine formation. Conclusion: The key factor underlying conversion of the ARF6 effect during development is neuronal activity. Significance: Activity dependence of ARF6-mediated spine formation may play a role in structural plasticity of mature neurons. Recent studies have reported conflicting results regarding the role of ARF6 in dendritic spine development, but no clear answer for the controversy has been suggested. We found that ADP-ribosylation factor 6 (ARF6) either positively or negatively regulates dendritic spine formation depending on neuronal maturation and activity. ARF6 activation increased the spine formation in developing neurons, whereas it decreased spine density in mature neurons. Genome-wide microarray analysis revealed that ARF6 activation in each stage leads to opposite patterns of expression of a subset of genes that are involved in neuronal morphology. ARF6-mediated Rac1 activation via the phospholipase D pathway is the coincident factor in both stages, but the antagonistic RhoA pathway becomes involved in the mature stage. Furthermore, blocking neuronal activity in developing neurons using tetrodotoxin or enhancing the activity in mature neurons using picrotoxin or chemical long term potentiation reversed the effect of ARF6 on each stage. Thus, activity-dependent dynamic changes in ARF6-mediated spine structures may play a role in structural plasticity of mature neurons.	[Kim, Yoonju; Lee, Sang-Eun; Park, Joohyun; Chang, Sunghoe] Seoul Natl Univ, Dept Physiol & Biomed Sci, Coll Med, Seoul 110799, South Korea; [Kim, Yoonju; Park, Joohyun; Chang, Sunghoe] Seoul Natl Univ, Neurosci Res Inst, Coll Med, Med Res Ctr, Seoul 110799, South Korea; [Kim, Yoonju; Lee, Sang-Eun; Park, Joohyun; Chang, Sunghoe] Seoul Natl Univ, Biomembrane Plast Res Ctr, Coll Med, Seoul 110799, South Korea; [Lee, Boyoon; Chang, Sunghoe] Seoul Natl Univ, Interdisciplinary Program Neurosci, Coll Med, Seoul 110799, South Korea; [Kim, Minhyung; Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Kyungbook, South Korea; [Kim, Minhyung; Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, Kyungbook, South Korea; [Hwang, Daehee] Daegu Gyeongbuk Inst Sci & Technol, Inst Basic Sci, Ctr Syst Biol Plant Senescence & Life Hist, Daegu 711873, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Institute for Basic Science - Korea (IBS)	Chang, S (corresponding author), Seoul Natl Univ, Dept Physiol, Coll Med, 309 Biomed Sci Bldg,28 Yeongeon Dong, Seoul 110799, South Korea.	sunghoe@snu.ac.kr		Lee, Sang-Eun/0000-0001-7371-8556; Kim, Yoonju/0000-0003-2657-2923; chang, sunghoe/0000-0002-3446-7288	Biomembrane Plasticity Research Center [20100029395]; Ministry of Science, the Information and Communications Technology, and Future Planning (MSIP); Korea Health Technology Research and Development Project - Ministry of Health and Welfare [A092058]; MSIP [NRF-2013R1A1A2059850]	Biomembrane Plasticity Research Center; Ministry of Science, the Information and Communications Technology, and Future Planning (MSIP); Korea Health Technology Research and Development Project - Ministry of Health and Welfare; MSIP	This work was supported by Biomembrane Plasticity Research Center Grant 20100029395 (to S.C.) from the Ministry of Science, the Information and Communications Technology, and Future Planning (MSIP); Korea Health Technology Research and Development Project Grant A092058 (to S.C.) funded by the Ministry of Health and Welfare; and Research Fellow Grant NRF-2013R1A1A2059850 (to Y.K.) funded by the MSIP.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bongmba OYN, 2011, BRAIN RES, V1399, P79, DOI 10.1016/j.brainres.2011.05.020; Bowman AW, 1997, APPL SMOOTHING TECHN; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Choi HJ, 2012, MOL NEUROBIOL, V45, P507, DOI 10.1007/s12035-012-8268-7; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Danglot L, 2012, J NEUROSCI, V32, P9007, DOI 10.1523/JNEUROSCI.3084-11.2012; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Funakoshi Y, 2011, J CELL PHYSIOL, V226, P888, DOI 10.1002/jcp.22482; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hayashi K, 2007, DEV NEUROBIOL, V67, P655, DOI 10.1002/dneu.20363; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hernandez-Deviez DJ, 2002, NAT NEUROSCI, V5, P623, DOI 10.1038/nn865; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hongu Tsunaki, 2014, Advances in Biological Regulation, V54, P59, DOI 10.1016/j.jbior.2013.09.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Kim Y, 2013, J BIOL CHEM, V288, P29453, DOI 10.1074/jbc.M113.468801; Kusano K, 1999, MOL CELL BIOCHEM, V190, P133, DOI 10.1023/A:1006962210692; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Miyazaki H, 2005, FEBS LETT, V579, P6834, DOI 10.1016/j.febslet.2005.11.022; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	51	25	25	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7323	7335		10.1074/jbc.M114.634527	http://dx.doi.org/10.1074/jbc.M114.634527			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605715	Green Published, hybrid			2022-12-28	WOS:000351613600001
J	Tsvetanova, NG; Irannejad, R; von Zastrow, M				Tsvetanova, Nikoleta G.; Irannejad, Roshanak; von Zastrow, Mark			G Protein-coupled Receptor (GPCR) Signaling via Heterotrimeric G Proteins from Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BETA-ADRENERGIC-RECEPTOR; RETROMER COMPLEX; SORTING COMPLEX; ARRESTIN; BETA-ARRESTIN2; TRANSPORT; MEMBRANE; DOMAIN; CAMP; DEPHOSPHORYLATION	Some G protein-coupled receptors (GPCRs), in addition to activating heterotrimeric G proteins in the plasma membrane, appear to elicit a "second wave" of G protein activation after ligand-induced internalization. We briefly summarize evidence supporting this view and then discuss what is presently known about the functional significance of GPCR-G protein activation in endosomes. Endosomal activation can shape the cellular response temporally by prolonging its overall duration, and may shape the response spatially by moving the location of intracellular second messenger production relative to effectors.	[Tsvetanova, Nikoleta G.; Irannejad, Roshanak; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), MC 2140,600 16th St, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health [R01DA010711, R01DA012867, K99HL122508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012864, P01DA010154, R01DA012867, R01DA010711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01DA010711 and R01DA012867 (to M. v. Z.) and a National Institutes of Health Pathway to Independence Award K99HL122508 (to R. I.). This is the second article in the Thematic Minireview series "Cell Biology of G Protein Signaling."	[Anonymous], NAT COMMUN, V5, P4556; Audet N, 2012, J NEUROSCI, V32, P4827, DOI 10.1523/JNEUROSCI.3734-11.2012; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cancino J, 2014, DEV CELL, V30, P280, DOI 10.1016/j.devcel.2014.06.018; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferguson S S, 1998, Adv Pharmacol, V42, P420; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Koumandou VL, 2011, J CELL SCI, V124, P1496, DOI 10.1242/jcs.081596; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Lohse MJ, 2013, NATURE, V495, P457, DOI 10.1038/nature12086; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Posner BI, 2014, METHOD ENZYMOL, V535, P293, DOI 10.1016/B978-0-12-397925-4.00017-1; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vilardaga JP, 2012, TRENDS PHARMACOL SCI, V33, P423, DOI 10.1016/j.tips.2012.05.004; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Vistein R, 2013, P NATL ACAD SCI USA, V110, P15289, DOI 10.1073/pnas.1306340110; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; VONZASTROW M, 1993, J BIOL CHEM, V268, P763; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	60	96	98	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6689	6696		10.1074/jbc.R114.617951	http://dx.doi.org/10.1074/jbc.R114.617951			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605726	Green Published, hybrid			2022-12-28	WOS:000350991500003
J	Shinsky, SA; Monteith, KE; Viggiano, S; Cosgrove, MS				Shinsky, Stephen A.; Monteith, Kelsey E.; Viggiano, Susan; Cosgrove, Michael S.			Biochemical Reconstitution and Phylogenetic Comparison of Human SET1 Family Core Complexes Involved in Histone Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3K4 METHYLTRANSFERASE ACTIVITY; MULTIPLE LYSINE METHYLATION; MOLECULAR REGULATION; STRUCTURAL BASIS; 11Q23 TRANSLOCATIONS; TRITHORAX FAMILY; BINDING PROTEIN; DOMAIN; MLL1; GENE	Mixed lineage leukemia protein-1 (MLL1) is a member of the SET1 family of histone H3 lysine 4 (H3K4) methyltransferases that are required for metazoan development. MLL1 is the best characterized human SET1 family member, which includes MLL1-4 and SETd1A/B. MLL1 assembles with WDR5, RBBP5, ASH2L, DPY-30 (WRAD) to form the MLL1 core complex, which is required for H3K4 dimethylation and transcriptional activation. Because all SET1 family proteins interact with WRAD in vivo, it is hypothesized they are regulated by similar mechanisms. However, recent evidence suggests differences among family members that may reflect unique regulatory inputs in the cell. Missing is an understanding of the intrinsic enzymatic activities of different SET1 family complexes under standard conditions. In this investigation, we reconstituted each human SET1 family core complex and compared subunit assembly and enzymatic activities. We found that in the absence of WRAD, all but one SET domain catalyzes at least weak H3K4 monomethylation. In the presence of WRAD, all SET1 family members showed stimulated monomethyltransferase activity but differed in their di- and trimethylation activities. We found that these differences are correlated with evolutionary lineage, suggesting these enzyme complexes have evolved to accomplish unique tasks within metazoan genomes. To understand the structural basis for these differences, we employed a "phylogenetic scanning mutagenesis" assay and identified a cluster of amino acid substitutions that confer a WRAD-dependent gain-of-function dimethylation activity on complexes assembled with the MLL3 or Drosophila trithorax proteins. These results form the basis for understanding how WRAD differentially regulates SET1 family complexes in vivo.	[Shinsky, Stephen A.; Monteith, Kelsey E.; Viggiano, Susan; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 East Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu		Shinsky, Stephen/0000-0001-5437-1729	National Institutes of Health [1R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA140522 (to M. S. C.).	Banka S, 2013, CLIN GENET, V83, P467, DOI 10.1111/j.1399-0004.2012.01955.x; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hubert A, 2013, EPIGENETICS-US, V8, P79, DOI 10.4161/epi.23211; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2014, J BIOL CHEM, V289, P868, DOI 10.1074/jbc.M113.501064; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shinsky SA, 2014, J MOL BIOL, V426, P2283, DOI 10.1016/j.jmb.2014.03.011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Thornton JL, 2014, GENE DEV, V28, P115, DOI 10.1101/gad.232215.113; Tie F, 2014, DEVELOPMENT, V141, P1129, DOI 10.1242/dev.102392; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; van Dijk K, 2005, PLANT CELL, V17, P2439, DOI 10.1105/tpc.105.034165; van Nuland R, 2013, MOL CELL BIOL, V33, P2067, DOI 10.1128/MCB.01742-12; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yang YW, 2014, ELIFE, V3, DOI 10.7554/eLife.02046; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	68	63	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6361	6375		10.1074/jbc.M114.627646	http://dx.doi.org/10.1074/jbc.M114.627646			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25561738	Green Published, hybrid			2022-12-28	WOS:000350732500041
J	Ueyama, T; Sakuma, M; Ninoyu, Y; Hamada, T; Dupuy, C; Geiszt, M; Leto, TL; Saito, N				Ueyama, Takehiko; Sakuma, Megumi; Ninoyu, Yuzuru; Hamada, Takeshi; Dupuy, Corinne; Geiszt, Miklos; Leto, Thomas L.; Saito, Naoaki			The Extracellular A-loop of Dual Oxidases Affects the Specificity of Reactive Oxygen Species Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; NADPH OXIDASE; CONGENITAL HYPOTHYROIDISM; HOST-DEFENSE; CLONING; GENE; EVOLUTION; FAMILY; ACTIVATION; EXPRESSION	NADPH oxidase (Nox) family proteins produce superoxide (W) directly by transferring an electron to molecular oxygen. Dual oxidases (Duoxes) also produce an W intermediate, although the final species secreted by mature Duoxes is H2O2, suggesting that intramolecular O-2(center dot)-, dismutation or other mechanisms contribute to H2O2 release. We explored the structural determinants affecting reactive oxygen species formation by Duox enzymes. Duox2 showed O-2(center dot)-, leakage when mismatched with Duox activator 1 (DuoxA1). Duox2 released O-2(center dot)- even in correctly matched combinations, including Duox2 + DuoxA2 and Duox2 + N-terminally tagged DuoxA2 regardless of the type or number of tags. Conversely, Duox1 did not release O-2(center dot)-, in any combination. Chimeric Duox2 possessing the A-loop of Duoxl showed no W. leakage; chimeric Duoxl possessing the A-loop of Duox2 released W. Moreover, Duox2 proteins possessing the A-loops of Noxl or Nox5 co-expressed with DuoxA2 showed enhanced W release, and D uox1 proteins possessing the A-loops of Noxl or Nox5 co-expressed with DuoxAl acquired W leakage. Although we identified Duoxl A-loop residues His(1071), His(1072), and Gly(1074)) important for reducing O-2(center dot)- release, mutations of these residues to those of Duox2 failed to convert Duoxl to an O-2(center dot)--releasing enzyme. Using immunoprecipitation and endoglycosidase H sensitivity assays, we found that the A-loop of Duoxes binds to DuoxA N termini, creating more stable, mature Duox-DuoxA complexes. In conclusion, the A-loops of both Duoxes support H2O2 production through interaction with corresponding activators, but complex formation between the Duoxl A-loop and DuoxAl results in tighter control of H2O2 release by the enzyme complex.	[Ueyama, Takehiko; Sakuma, Megumi; Ninoyu, Yuzuru; Hamada, Takeshi; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Lab Mol Pharmacol, Kobe, Hyogo 6578501, Japan; [Dupuy, Corinne] Univ Paris 11, CNRS, Inst Gustave Roussy, Lab Stabilite Genet & Oncogenese,UMR8200, F-94805 Villejuif, France; [Geiszt, Miklos] Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary; [Geiszt, Miklos] Semmelweis Univ, Lendulet Peroxidase Enzyme Res Grp, H-1444 Budapest, Hungary; [Geiszt, Miklos] Hungarian Acad Sci, H-1444 Budapest, Hungary; [Leto, Thomas L.] NIAID, Mol Def Sect, Lab Host Def, NIH, Rockville, MD 20852 USA	Kobe University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ueyama, T (corresponding author), Kobe Univ, Biosignal Res Ctr, Lab Mol Pharmacol, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	tueyama@kobe-u.ac.jp; naosaito@kobe-u.ac.jp		Ninoyu, Yuzuru/0000-0002-9407-4697	Intramural Research Program of the NIAID, National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Hungarian Academy of Sciences; Uehara Memorial Foundation; Hyogo Science and Technology Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Uehara Memorial Foundation(Uehara Memorial Foundation); Hyogo Science and Technology Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the NIAID, National Institutes of Health. This work was also supported in part by a grant-in-aid for Scientific Research (C) of the Ministry of Education, Culture, Sports, Science and Technology, Japan, by a grant "Japan-Hungary Research Cooperative Program" from the Japan Society for the Promotion of Science and the Hungarian Academy of Sciences, by the Uehara Memorial Foundation, and by the Hyogo Science and Technology Association.	Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; De Deken X, 2014, ANTIOXID REDOX SIGN, V20, P2776, DOI 10.1089/ars.2013.5602; Donko A, 2010, FREE RADICAL BIO MED, V49, P2040, DOI 10.1016/j.freeradbiomed.2010.09.027; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Grasberger H, 2013, GASTROENTEROLOGY, V145, P1045, DOI 10.1053/j.gastro.2013.07.011; Grasberger H, 2012, MOL ENDOCRINOL, V26, P481, DOI 10.1210/me.2011-1320; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hoste C, 2012, EXP CELL RES, V318, P2353, DOI 10.1016/j.yexcr.2012.07.007; Hulur I, 2011, J CLIN ENDOCR METAB, V96, pE841, DOI 10.1210/jc.2010-2321; Johnson KR, 2007, MOL ENDOCRINOL, V21, P1593, DOI 10.1210/me.2007-0085; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Maruo Y, 2008, J CLIN ENDOCR METAB, V93, P4261, DOI 10.1210/jc.2008-0856; Matsushima S, 2014, TRENDS CARDIOVAS MED, V24, P202, DOI 10.1016/j.tcm.2014.03.003; Meitzler JL, 2011, ARCH BIOCHEM BIOPHYS, V512, P197, DOI 10.1016/j.abb.2011.05.021; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Moreno JC, 2001, GENOMICS, V75, P70, DOI 10.1006/geno.2001.6586; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nauseef WM, 2014, BBA-GEN SUBJECTS, V1840, P757, DOI 10.1016/j.bbagen.2013.04.040; Pick E, 2014, METHODS MOL BIOL, V1124, P339, DOI 10.1007/978-1-62703-845-4_22; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Ueyama T, 2013, J IMMUNOL, V191, P2560, DOI 10.4049/jimmunol.1300209; van der Vliet A, 2011, BBA-GEN SUBJECTS, V1810, P1035, DOI 10.1016/j.bbagen.2011.03.004; Zamproni I, 2008, J CLIN ENDOCR METAB, V93, P605, DOI 10.1210/jc.2007-2020	33	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6495	6506		10.1074/jbc.M114.592717	http://dx.doi.org/10.1074/jbc.M114.592717			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586178	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000350732500052
J	Mori, T; Yang, DF; Matsui, T; Hashimoto, M; Morita, H; Fujii, I; Abe, I				Mori, Takahiro; Yang, Dengfeng; Matsui, Takashi; Hashimoto, Makoto; Morita, Hiroyuki; Fujii, Isao; Abe, Ikuro			Structural Basis for the Formation of Acylalkylpyrones from Two beta-Ketoacyl Units by the Fungal Type III Polyketide Synthase CsyB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHALCONE SYNTHASE; MOLECULAR-BASIS; BIOSYNTHESIS; SPECIFICITY	The acylalkylpyrone synthase CsyB from Aspergillus oryzae catalyzes the one-pot formation of the 3-acyl-4-hydroxy-6-alkyl-alpha-pyrone scaffold from acetoacetyl-CoA, fatty acyl-CoA, and malonyl-CoA. This is the first type III polyketide synthase that performs not only the polyketide chain elongation but also the condensation of two beta-ketoacyl units. The crystal structures of wild-type CsyB and its I375F and I375W mutants were solved at 1.7-, 2.3-, and 2.0-angstrom resolutions, respectively. The crystal structures revealed a unique active site architecture featuring a hitherto unidentified novel pocket for accommodation of the acetoacetyl-CoA starter in addition to the conventional elongation/cyclization pocket with the Cys-His-Asn catalytic triad and the long hydrophobic tunnel for binding the fatty acyl chain. The structures also indicated the presence of a putative nucleophilic water molecule activated by the hydrogen bond networks with His-377 and Cys-155 at the active site center. Furthermore, an in vitro enzyme reaction confirmed that the O-18 atom of the (H2O)-O-18 molecule is enzymatically incorporated into the final product. These observations suggested that the enzyme reaction is initiated by the loading of acetoacetyl-CoA onto Cys-155, and subsequent thioester bond cleavage by the nucleophilic water generates the beta-keto acid intermediate, which is placed within the novel pocket. The second beta-ketoacyl unit is then produced by polyketide chain elongation of fatty acyl-CoA with one molecule of malonyl-CoA, and the condensation with the beta-keto acid generates the final products. Indeed, steric modulation of the novel pocket by the structure-based I375F and I375W mutations resulted in altered specificities for the chain lengths of the substrates.	[Mori, Takahiro; Yang, Dengfeng; Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Matsui, Takashi; Morita, Hiroyuki] Toyama Univ, Inst Nat Med, Dept Med Resources, Toyama 9300194, Japan; [Hashimoto, Makoto; Fujii, Isao] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan	University of Tokyo; University of Toyama; Iwate Medical University	Morita, H (corresponding author), Toyama Univ, Inst Nat Med, Dept Med Resources, 2630 Sugitani, Toyama 9300194, Japan.	hmorita@inm.u-toyama.ac.jp; ifujii@iwate-med.ac.jp; abei@mol.f.u-tokyo.ac.jp	Abe, Ikuro/E-4449-2010	Abe, Ikuro/0000-0002-3640-888X; Matsui, Takashi/0000-0002-4496-2389; Hashimoto, Makoto/0000-0002-8716-4985	Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26282210, 25108722] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. M., H. M., and I. A.).	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erol O, 2010, CHEMBIOCHEM, V11, P1253, DOI 10.1002/cbic.201000085; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; GILBERT IH, 1995, BIOORG MED CHEM LETT, V5, P1587, DOI 10.1016/0960-894X(95)00276-Y; Goyal A, 2008, J STRUCT BIOL, V162, P411, DOI 10.1016/j.jsb.2008.02.009; Hashimoto M, 2014, NAT PROD REP, V31, P1306, DOI 10.1039/c4np00096j; Hashimoto M, 2014, J BIOL CHEM, V289, P19976, DOI 10.1074/jbc.M114.569095; Hashimoto M, 2013, BIOORG MED CHEM LETT, V23, P5637, DOI 10.1016/j.bmcl.2013.08.036; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Katsuyama Y, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P147; Mori T, 2013, J BIOL CHEM, V288, P28845, DOI 10.1074/jbc.M113.493155; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2011, P NATL ACAD SCI USA, V108, P13504, DOI 10.1073/pnas.1107782108; Morita H, 2010, P NATL ACAD SCI USA, V107, P19778, DOI 10.1073/pnas.1011499107; Morita H, 2010, P NATL ACAD SCI USA, V107, P669, DOI 10.1073/pnas.0909982107; Oguro S, 2004, BIOCHEM BIOPH RES CO, V325, P561, DOI 10.1016/j.bbrc.2004.10.057; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; Seshime Y, 2010, BIOORGAN MED CHEM, V18, P4542, DOI 10.1016/j.bmc.2010.04.058; Sucipto H, 2013, CHEMBIOCHEM, V14, P1581, DOI 10.1002/cbic.201300289; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang DF, 2014, ACTA CRYSTALLOGR F, V70, P730, DOI 10.1107/S2053230X14008516	30	14	16	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5214	5225		10.1074/jbc.M114.626416	http://dx.doi.org/10.1074/jbc.M114.626416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564614	Green Published, hybrid			2022-12-28	WOS:000350042000059
J	Bayle, K; Akoka, S; Remaud, GS; Robins, RJ				Bayle, Kevin; Akoka, Serge; Remaud, Gerald S.; Robins, Richard J.			Nonstatistical C-13 Distribution during Carbon Transfer from Glucose to Ethanol during Fermentation Is Determined by the Catabolic Pathway Exploited	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-ABUNDANCE; H-2 NMR; MECHANISM; DEHYDROGENASE; ALDOLASE; 6-PHOSPHOGLUCONATE; DECARBOXYLATION; QUANTIFICATION; FRACTIONATION; SPECTROMETRY	During the anaerobic fermentation of glucose to ethanol, the three micro-organisms Saccharomyces cerevisiae, Zymomonas mobilis, and Leuconostoc mesenteroides exploit, respectively, the Embden-Meyerhof-Parnas, the Entner-Doudoroff, and the reductive pentose phosphate pathways. Thus, the atoms incorporated into ethanol do not have the same affiliation to the atomic positions in glucose. The isotopic fractionation occurring in each pathway at both the methylene and methyl positions of ethanol has been investigated by isotopic quantitative C-13 NMR spectrometry with the aim of observing whether an isotope redistribution characteristic of the enzymes active in each pathway can be measured. First, it is found that each pathway has a unique isotope redistribution signature. Second, for the methylene group, a significant apparent kinetic isotope effect is only found in the reductive pentose phosphate pathway. Third, the apparent kinetic isotope effects related to the methyl group are more pronounced than for the methylene group. These findings can (i) be related to known kinetic isotope effects of some of the enzymes concerned and (ii) give indicators as to which steps in the pathways are likely to be influencing the final isotopic composition in the ethanol.	[Bayle, Kevin; Akoka, Serge; Remaud, Gerald S.; Robins, Richard J.] Univ Nantes, CNRS, Elucidat Biosynth Isotop Spectrometry Grp, CEISAM,UMR 6230, F-44322 Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite	Robins, RJ (corresponding author), Univ Nantes, CNRS, Elucidat Biosynth Isotop Spectrometry Grp, CEISAM,UMR 6230, 2 Rue Houssiniere,BP 92208, F-44322 Nantes, France.	richard.robins@univ-nantes.fr	Akoka, Serge/T-7918-2019	Bayle, Kevin/0000-0002-1883-042X; Robins, Richard/0000-0002-5325-8983	French Research Ministry; ISOTO-POL project through French National Research Agency [ANR-11-CESA-009]	French Research Ministry(Ministry of Research, France); ISOTO-POL project through French National Research Agency(French National Research Agency (ANR))	This work was supported in part by funds from the French Research Ministry (to K. B.) and by funding from the ISOTO-POL project through French National Research Agency Project ANR-11-CESA-009.	ABELSON PH, 1961, P NATL ACAD SCI USA, V47, P623, DOI 10.1073/pnas.47.5.623; Alhambra C, 1999, J AM CHEM SOC, V121, P2253, DOI 10.1021/ja9831655; ANDERSON SR, 1994, BIOCHEMISTRY-US, V33, P10545, DOI 10.1021/bi00200a041; Bayle K, 2014, ANAL CHIM ACTA, V846, P1, DOI 10.1016/j.aca.2014.07.018; Caytan E, 2007, ANAL CHEM, V79, P8266, DOI 10.1021/ac070826k; Caytan E, 2007, TALANTA, V71, P1016, DOI 10.1016/j.talanta.2006.05.075; Chaintreau A, 2013, ANAL CHIM ACTA, V788, P108, DOI 10.1016/j.aca.2013.06.004; Cleland WW, 2006, ISOTOPE EFFECTS CHEM, P915; Cui Q, 2002, J AM CHEM SOC, V124, P3093, DOI 10.1021/ja0118439; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; GAJEWSKI JJ, 1987, J AM CHEM SOC, V109, P1170, DOI 10.1021/ja00238a029; Gilbert A, 2012, P NATL ACAD SCI USA, V109, P18204, DOI 10.1073/pnas.1211149109; Gilbert A, 2012, NAT PROD REP, V29, P476, DOI 10.1039/c2np00089j; Gilbert A, 2011, PLANT CELL ENVIRON, V34, P1104, DOI 10.1111/j.1365-3040.2011.02308.x; Gilbert A, 2009, ANAL CHEM, V81, P8978, DOI 10.1021/ac901441g; Gleixner G, 1997, J BIOL CHEM, V272, P5382, DOI 10.1074/jbc.272.9.5382; Hanau S, 2010, J BIOL CHEM, V285, P21366, DOI 10.1074/jbc.M110.105601; Hwang CC, 1998, BIOCHEMISTRY-US, V37, P12596, DOI 10.1021/bi980611s; Melander L., 1980, REACTION RATES ISOTO; Melander L., 1982, REACTION RATES ISOTO, P283; MELOCHE HP, 1964, J BIOL CHEM, V239, P3505; MELZER E, 1988, BIOCHEM J, V252, P913, DOI 10.1042/bj2520913; MELZER E, 1987, J BIOL CHEM, V262, P8159; MORRIS AJ, 1994, BIOCHEMISTRY-US, V33, P12291, DOI 10.1021/bi00206a036; Robins RJ, 2008, J BIOL CHEM, V283, P9704, DOI 10.1074/jbc.M710272200; Roger O, 2004, J BIOL CHEM, V279, P24923, DOI 10.1074/jbc.M401232200; ROSSMANN A, 1991, PLANT PHYSIOL, V96, P609, DOI 10.1104/pp.96.2.609; SCHARSCHMIDT M, 1984, BIOCHEMISTRY-US, V23, P5471, DOI 10.1021/bi00318a015; Silvestre V, 2009, J PHARMACEUT BIOMED, V50, P336, DOI 10.1016/j.jpba.2009.04.030; Tcherkez G, 2005, FUNCT PLANT BIOL, V32, P277, DOI 10.1071/FP04211; Tenailleau E, 2004, ANAL CHEM, V76, P3818, DOI 10.1021/ac0496998; Tenailleau E, 2005, INSTRUM SCI TECHNOL, V33, P391, DOI 10.1081/CI-200063700; Tenailleau E, 2007, J MAGN RESON, V185, P50, DOI 10.1016/j.jmr.2006.11.007; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Tittmann K, 2014, BIOORG CHEM, V57, P263, DOI 10.1016/j.bioorg.2014.09.001; Zhang BL, 2002, J PHYS CHEM B, V106, P2983, DOI 10.1021/jp013522p; Zhang J, 2013, COMPUT THEOR CHEM, V1025, P1, DOI 10.1016/j.comptc.2013.09.026	38	25	26	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4118	4128		10.1074/jbc.M114.621441	http://dx.doi.org/10.1074/jbc.M114.621441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538251	hybrid, Green Published			2022-12-28	WOS:000349458400023
J	Rosseels, J; Van den Brande, J; Violet, M; Jacobs, D; Grognet, P; Lopez, J; Huvent, I; Caldara, M; Swinnen, E; Papegaey, A; Caillierez, R; Buee-Scherrer, V; Engelborghs, S; Lippens, G; Colin, M; Buee, L; Galas, MC; Vanmechelen, E; Winderickx, J				Rosseels, Joelle; Van den Brande, Jeff; Violet, Marie; Jacobs, Dirk; Grognet, Pierre; Lopez, Juan; Huvent, Isabelle; Caldara, Marina; Swinnen, Erwin; Papegaey, Anthony; Caillierez, Raphaelle; Buee-Scherrer, Valerie; Engelborghs, Sebastiaan; Lippens, Guy; Colin, Morvane; Buee, Luc; Galas, Marie-Christine; Vanmechelen, Eugeen; Winderickx, Joris			Tau Monoclonal Antibody Generation Based on Humanized Yeast Models IMPACT ON TAU OLIGOMERIZATION AND DIAGNOSTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; DEPENDENT AXONAL-TRANSPORT; CEREBROSPINAL-FLUID LEVELS; HUMAN PROTEIN-TAU; ALZHEIMERS-DISEASE; TRANSGENIC MOUSE; IN-VITRO; PHOSPHORYLATION; AGGREGATION; IDENTIFICATION	A link between Tau phosphorylation and aggregation has been shown in different models for Alzheimer disease, including yeast. We used human Tau purified from yeast models to generate new monoclonal antibodies, of which three were further characterized. The first antibody, ADx201, binds the Tau proline-rich region independently of the phosphorylation status, whereas the second, ADx215, detects an epitope formed by the Tau N terminus when Tau is not phosphorylated at Tyr(18). For the third antibody, ADx210, the binding site could not be deter-mined because its epitope is probably conformational. All three antibodies stained tangle-like structures in different brain sections of THY-Tau22 transgenic mice and Alzheimer patients, and ADx201 and ADx210 also detected neuritic plaques in the cortex of the patient brains. In hippocampal homogenates from THY-Tau22 mice and cortex homogenates obtained from Alzheimer patients, ADx215 consistently stained specific low order Tau oligomers in diseased brain, which in size correspond to Tau dimers. ADx201 and ADx210 additionally reacted to higher order Tau oligomers and presumed prefibrillar structures in the patient samples. Our data further suggest that formation of the low order Tau oligomers marks an early disease stage that is initiated by Tau phosphorylation at N-terminal sites. Formation of higher order oligomers appears to require additional phosphorylation in the C terminus of Tau. When used to assess Tau levels in human cerebrospinal fluid, the antibodies permitted us to discriminate patients with Alzheimer disease or other dementia like vascular dementia, indicative that these antibodies hold promising diagnostic potential.	[Rosseels, Joelle; Van den Brande, Jeff; Caldara, Marina; Swinnen, Erwin; Winderickx, Joris] Katholieke Univ Leuven, B-3001 Heverlee, Belgium; [Van den Brande, Jeff; Jacobs, Dirk; Vanmechelen, Eugeen] ADx NeuroSci NV, Technol Pk Zwijnaarde 4, B-9052 Ghent, Belgium; [Van den Brande, Jeff; Grognet, Pierre] Fujirebio Europe, B-9052 Ghent, Belgium; [Violet, Marie; Papegaey, Anthony; Caillierez, Raphaelle; Buee-Scherrer, Valerie; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] JPArc Alzheimer & Tauopathies, UMR1172, INSERM, F-59045 Lille, France; [Violet, Marie; Papegaey, Anthony; Caillierez, Raphaelle; Buee-Scherrer, Valerie; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] Univ Lille, Fac Med, F-59045 Lille, France; [Violet, Marie; Papegaey, Anthony; Caillierez, Raphaelle; Buee-Scherrer, Valerie; Colin, Morvane; Buee, Luc; Galas, Marie-Christine] Ctr Hosp Reg Univ Lille, Memory Clin, F-59037 Lille, France; [Lopez, Juan; Huvent, Isabelle; Lippens, Guy] Univ Lille Nord France, F-59000 Lille, France; [Lopez, Juan; Huvent, Isabelle; Lippens, Guy] CNRS, Struct & Funct Glycobiol UMR8576, F-59650 Villeneuve Dascq, France; [Engelborghs, Sebastiaan] Univ Antwerp, Inst Born Bunge, Reference Ctr Biol Markers Dementia BIODEM, B-2610 Antwerp, Belgium; [Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol, B-2660 Antwerp, Belgium; [Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Memory Clin, B-2660 Antwerp, Belgium	KU Leuven; H.U. Group Holdings Inc; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Antwerp	Vanmechelen, E (corresponding author), ADx NeuroSci NV, Technol Pk Zwijnaarde 4, B-9052 Ghent, Belgium.	Eugeen.vanmechelen@adxneurosciences.com; joris.winderickx@bio.kuleuven.be	Galas, Marie-Christine/AAL-9812-2020; BUEE, Luc/B-3126-2010; Vanmechelen, Eugeen/AAA-8005-2019	BUEE, Luc/0000-0002-6261-4230; swinnen, erwin/0000-0002-6311-7260; Huvent, Isabelle/0000-0002-7241-0290; lopez, juan/0000-0002-5390-6610; Buee-Scherrer, Valerie/0000-0002-6107-1289; Colin, Morvane/0000-0003-0611-4167; Lippens, Guy/0000-0002-8236-0901; Galas, Marie-Christine/0000-0002-3766-7103; Vanmechelen, Eugeen/0000-0002-9466-5366	Research Foundation Flanders (FWO-Vlaanderen); KU Leuven Research Fund (KU Leuven-BOF); KU Leuven Research Fund (KU Leuven-IOF); KU Leuven RD; Agency for Innovation by Science and Technology (IWT); IWT Ph.D. fellowship; FWO-Vlaanderen postdoctoral fellowships; LabEx DISTALZ (Excellent Laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease); CNRS Large Scale Facility NMR THC [Fr3050]; INSERM; CNRS; University of Lille 2; Lille Metropole Communaute Urbaine (LMCU); Region Nord/Pas-de-Calais; FEDER; University of Antwerp Research Fund; Alzheimer Research Foundation (SAO-FRA); central Biobank facility of the Institute Born-Bunge/University Antwerp; Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program; Flemish Government	Research Foundation Flanders (FWO-Vlaanderen)(FWO); KU Leuven Research Fund (KU Leuven-BOF)(KU Leuven); KU Leuven Research Fund (KU Leuven-IOF); KU Leuven RD(KU Leuven); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IWT Ph.D. fellowship; FWO-Vlaanderen postdoctoral fellowships; LabEx DISTALZ (Excellent Laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease); CNRS Large Scale Facility NMR THC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 2; Lille Metropole Communaute Urbaine (LMCU); Region Nord/Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); FEDER(European Commission); University of Antwerp Research Fund; Alzheimer Research Foundation (SAO-FRA); central Biobank facility of the Institute Born-Bunge/University Antwerp(General Electric); Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program; Flemish Government(European Commission)	This work was supported by grants from the Research Foundation Flanders (FWO-Vlaanderen) (to J. W. and S. E.), KU Leuven Research Fund (KU Leuven-BOF; KU Leuven-IOF), KU Leuven R&D (to J. W.), and the Agency for Innovation by Science and Technology (IWT) (to J. W., E. V., and S. E.). This work was also supported by an IWT Ph.D. fellowship (to J. V. d. B.) and FWO-Vlaanderen postdoctoral fellowships (to M. C. and E. S.). This work was also supported through the LabEx DISTALZ (Excellent Laboratory-Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease), the CNRS Large Scale Facility NMR THC Fr3050, INSERM, CNRS, University of Lille 2, Lille Metropole Communaute Urbaine (LMCU), Region Nord/Pas-de-Calais, FEDER, the University of Antwerp Research Fund, the Alzheimer Research Foundation (SAO-FRA), the central Biobank facility of the Institute Born-Bunge/University Antwerp, the Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program, and the Flemish Government initiated Methusalem excellence grant. J. W. and E. V. are both co-founders of ADx NeuroSciences and co-inventors on the patent entitled Antibodies to Phosphorylated Tau Aggregates (WO2013007839 (A1)).	Amniai L, 2011, BIOCHEM BIOPH RES CO, V412, P743, DOI 10.1016/j.bbrc.2011.08.046; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buerger K, 2005, NEUROLOGY, V65, P1502, DOI 10.1212/01.wnl.0000183284.92920.f2; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Buttner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013700; Caillierez R, 2013, MOL THER, V21, P1358, DOI 10.1038/mt.2013.66; Castillo-Carranza DL, 2014, J ALZHEIMERS DIS, V40, pS97, DOI 10.3233/JAD-132477; Cowan CM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00114; D'Angelo F, 2013, DIS MODEL MECH, V6, P206, DOI 10.1242/dmm.010108; De Vos Ann, 2011, Int J Alzheimers Dis, V2011, P428970, DOI 10.4061/2011/428970; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Galvan M, 2001, J ALZHEIMERS DIS, V3, P417, DOI 10.3233/JAD-2001-3409; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P2252, DOI 10.1021/bi0272510; Gendreau KL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00160; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Haroutunian V, 2007, NEUROBIOL AGING, V28, P1, DOI 10.1016/j.neurobiolaging.2005.11.001; Hertze J, 2010, J ALZHEIMERS DIS, V21, P1119, DOI 10.3233/JAD-2010-100207; Iqbal K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00112; Irwin DJ, 2012, ARCH NEUROL-CHICAGO, V69, P1018, DOI 10.1001/archneurol.2012.26; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kanaan NM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.006; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Le Bastard N, 2013, J ALZHEIMERS DIS, V33, P117, DOI 10.3233/JAD-2012-121246; Lin YT, 2007, J NEUROCHEM, V103, P802, DOI 10.1111/j.1471-4159.2007.04792.x; Lippens G, 2004, CHEMBIOCHEM, V5, P73, DOI 10.1002/cbic.200300763; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Paton D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067364; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSNER H, 1994, NEUROREPORT, V5, P1164; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Sjogren M, 2001, DEMENT GERIATR COGN, V12, P257, DOI 10.1159/000051268; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Vandebroek T, 2005, BIOCHEMISTRY-US, V44, P11466, DOI 10.1021/bi0506775; Vandebroek T, 2006, J BIOL CHEM, V281, P25388, DOI 10.1074/jbc.M602792200; Vanhelmont T, 2010, FEMS YEAST RES, V10, P992, DOI 10.1111/j.1567-1364.2010.00662.x; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Ward SM, 2013, J ALZHEIMERS DIS, V37, P593, DOI 10.3233/JAD-131235; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Winderickx J, 2008, BBA-MOL CELL RES, V1783, P1381, DOI 10.1016/j.bbamcr.2008.01.020; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046	66	16	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4059	4074		10.1074/jbc.M114.627919	http://dx.doi.org/10.1074/jbc.M114.627919			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540200	hybrid, Green Published			2022-12-28	WOS:000349458400018
J	Ganai, RA; Osterman, P; Johansson, E				Ganai, Rais A.; Osterman, Pia; Johansson, Erik			Yeast DNA Polymerase epsilon Catalytic Core and Holoenzyme Have Comparable Catalytic Rates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC REPLICATION FORK; OKAZAKI FRAGMENT MATURATION; STATE KINETIC-ANALYSIS; SACCHAROMYCES-CEREVISIAE; HIGH-FIDELITY; S-PHASE; NUCLEOTIDE INCORPORATION; EXONUCLEASE ACTIVITY; ACTIVE-SITE; DELTA	The holoenzyme of yeast DNA polymerase epsilon (Pol epsilon) consists of four subunits: Pol2, Dpb2, Dpb3, and Dpb4. A protease-sensitive site results in an N-terminal proteolytic fragment of Pol2, called Pol2(core), that consists of the catalytic core of Pol epsilon and retains both polymerase and exonuclease activities. Pre-steady-state kinetics showed that the exonuclease rates on single-stranded, double-stranded, and mismatched DNA were comparable between Pol epsilon and Pol2(core). Single-turnover pre-steady- state kinetics also showed that the k(pol) of Pol epsilon and Pol2(core) were comparable when preloading the polymerase onto the primer-template before adding Mg2+ epsilon and dTTP. However, a global fit of the data over six sequential nucleotide incorporations revealed that the overall polymerization rate and processivity were higher for Pol epsilon than for Pol2(core). The largest difference between Pol epsilon and Pol2(core) was observed when challenged for the formation of a ternary complex and incorporation of the first nucleotide. Pol epsilon needed less than 1 s to incorporate a nucleotide, but several seconds passed before Pol2(core) incorporated detectable levels of the first nucleotide. We conclude that the accessory subunits and the C terminus of Pol2 do not influence the catalytic rate of Pol epsilon but facilitate the loading and incorporation of the first nucleotide by Pol epsilon.	[Ganai, Rais A.; Osterman, Pia; Johansson, Erik] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	Umea University	Johansson, E (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	erik.johansson@medchem.umu.se		Johansson, Erik/0000-0002-8526-6224; Osterman, Pia/0000-0001-9360-0782	Swedish Research Council; Swedish Cancer Society; Kempe Foundations; Knut and Alice Wallenberg Foundation; Insamlingstiftelsen at the medical faculty of Umea Universitet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Kempe Foundations; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Insamlingstiftelsen at the medical faculty of Umea Universitet	This work was supported in part by grants from the Swedish Research Council, the Swedish Cancer Society, the Kempe Foundations, the Knut and Alice Wallenberg Foundation, and Insamlingstiftelsen at the medical faculty of Umea Universitet.	Aksenova A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001209; Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Aria V, 2013, J BIOL CHEM, V288, P12742, DOI 10.1074/jbc.M112.398073; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; Brown JA, 2009, BIOCHEMISTRY-US, V48, P7502, DOI 10.1021/bi9005336; BUDD ME, 1989, J BIOL CHEM, V264, P6557; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Cho WH, 2013, P NATL ACAD SCI USA, V110, P2523, DOI 10.1073/pnas.1222494110; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Dieckman LM, 2010, BIOCHEMISTRY-US, V49, P7344, DOI 10.1021/bi100556m; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Feng WY, 2003, MOL BIOL CELL, V14, P3427, DOI 10.1091/mbc.E03-02-0088; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; Georgescu RE, 2014, NAT STRUCT MOL BIOL, V21, P664, DOI 10.1038/nsmb.2851; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goksenin AY, 2012, J BIOL CHEM, V287, P42675, DOI 10.1074/jbc.M112.422733; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; Hogg M, 2006, NUCLEIC ACIDS RES, V34, P2528, DOI 10.1093/nar/gkl300; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Hogg M, 2010, BIOCHEMISTRY-US, V49, P2317, DOI 10.1021/bi901488d; Jaszczur M, 2008, GENETICS, V178, P633, DOI 10.1534/genetics.107.082818; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; JOYCE CM, 1992, J BIOL CHEM, V267, P24485; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kane DP, 2014, CANCER RES, V74, P1895, DOI 10.1158/0008-5472.CAN-13-2892; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pursell ZF, 2007, NUCLEIC ACIDS RES, V35, P3076, DOI 10.1093/nar/gkm132; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Sabouri N, 2009, J BIOL CHEM, V284, P31555, DOI 10.1074/jbc.M109.043927; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Shcherbakova PV, 2003, J BIOL CHEM, V278, P43770, DOI 10.1074/jbc.M306893200; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Tsubotao T, 2006, J BIOL CHEM, V281, P32898, DOI 10.1074/jbc.M606637200; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zahurancik WJ, 2014, NUCLEIC ACIDS RES, V42, P13853, DOI 10.1093/nar/gku1184; Zahurancik WJ, 2013, BIOCHEMISTRY-US, V52, P7041, DOI 10.1021/bi400803v	59	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3825	3835		10.1074/jbc.M114.615278	http://dx.doi.org/10.1074/jbc.M114.615278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538242	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000349456000053
J	Pierdomenico, AM; Recchiuti, A; Simiele, F; Codagnone, M; Mari, VC; Davi, G; Romano, M				Pierdomenico, Anna Maria; Recchiuti, Antonio; Simiele, Felice; Codagnone, Marilina; Mari, Veronica Cecilia; Davi, Giovanni; Romano, Mario			MicroRNA-181b Regulates ALX/FPR2 Receptor Expression and Proresolution Signaling in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE INFLAMMATORY RESPONSES; DOWN-REGULATION; ANNEXIN A1; LIPOXIN; RESOLUTION; ASPIRIN; MEDIATORS; FIBROSIS; GENE; A(4)	Regulatory mechanisms of ALX/FPR2, the lipoxin A(4) receptor, expression have considerable relevance in inflammation resolution. Because microRNAs (miRs) are emerging as key players in inflammation resolution, here we examined microRNA-mediated regulation of ALX/FPR2 (lipoxin A4 receptor/formyl peptide receptor 2) expression. By matching data from bioinformatic algorithms, we found 27 miRs predicted to bind the 3'-UTR of ALX/FPR2. Among these, we selected miR-181b because of its link with inflammation. Using a luciferase reporter system, we assessed miR-181b binding to ALX/FPR2 3'-UTR. Consistent with this, miR-181b overexpression in human macrophages significantly down-regulated ALX/FPR2 protein levels (-25%), whereas miR-181b knockdown gave a significant increase in ALX/FPR2 (+60%). miR-181b levels decreased during monocyte to macrophage differentiation (-50%), whereas ALX/FPR2 expression increased significantly (+60%). miR-181b overexpression blunted lipoxin A(4) (0.1-10 nM)-and resolvin D1 (0.01-10 nM)-stimulated phagocytic activity of macrophages. These results unravel novel regulatory mechanisms of ALX/FPR2 expression and ligand-evoked macrophages proresolution responses mediated by miR-181b, thus uncovering novel components of the endogenous inflammation resolution circuits.	[Pierdomenico, Anna Maria; Davi, Giovanni] Univ G DAnnunzio, Dept Med & Aging Sci, I-66013 Chieti, Italy; [Recchiuti, Antonio; Simiele, Felice; Codagnone, Marilina; Mari, Veronica Cecilia; Romano, Mario] Univ G DAnnunzio, Dept Med Oral & Technol Sci, I-66013 Chieti, Italy; [Pierdomenico, Anna Maria; Recchiuti, Antonio; Simiele, Felice; Codagnone, Marilina; Mari, Veronica Cecilia; Davi, Giovanni; Romano, Mario] Univ G dAnnunzio, Ctr Excellence Aging, I-66013 Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Romano, M (corresponding author), Univ G DAnnunzio, Ctr Excellence Aging, Via Luigi Polacchi 11-13, I-66013 Chieti, Italy.	mromano@unich.it	Romano, Mario/I-7986-2012; Recchiuti, Antonio/K-7670-2016	Romano, Mario/0000-0001-8512-1458; Recchiuti, Antonio/0000-0002-1409-5261; Pierdomenico, Anna Maria/0000-0002-1788-6106	Italian Cystic Fibrosis Foundation [17/2012, 19/2013]; Italian Ministry of the University and Research	Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Italian Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part Italian Cystic Fibrosis Foundation Grants FFC#17/2012 and FFC#19/2013 and Italian Ministry of the University and Research Grant PRIN 2010-2011 (to M. R.).	Alessandri AL, 2013, PHARMACOL THERAPEUT, V139, P189, DOI 10.1016/j.pharmthera.2013.04.006; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; Brennan EP, 2013, J AM SOC NEPHROL, V24, P627, DOI 10.1681/ASN.2012060550; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Devchand PR, 2003, FASEB J, V17, P652, DOI 10.1096/fj.02-0770com; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kosicka A, 2013, FASEB J, V27, P368, DOI 10.1096/fj.12-213728; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YH, 2011, BIOCELL, V35, pB43; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016956; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Peng ZF, 2013, J NEUROSCI RES, V91, P1349, DOI 10.1002/jnr.23255; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Recchiuti A, 2014, FASEB J, V28, P3090, DOI 10.1096/fj.13-248393; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ringholz FC, 2014, EUR RESPIR J, V44, P394, DOI 10.1183/09031936.00106013; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; Romano M, 2007, THESCIENTIFICWORLDJO, V7, P1393, DOI 10.1100/tsw.2007.186; Romano M, 2010, THESCIENTIFICWORLDJO, V10, P1048, DOI 10.1100/tsw.2010.113; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SERHAN CN, 1984, BIOCHEM BIOPH RES CO, V118, P943, DOI 10.1016/0006-291X(84)91486-4; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shi ZM, 2013, RNA, V19, P552, DOI 10.1261/rna.035972.112; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Song J, 2013, BIOCHEM BIOPH RES CO, V431, P210, DOI 10.1016/j.bbrc.2012.12.133; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Visone R, 2012, ONCOTARGET, V3, P195; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025; Wu SH, 2013, BRIT J DERMATOL, V168, P172, DOI 10.1111/j.1365-2133.2012.11177.x	54	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3592	3600		10.1074/jbc.M114.592352	http://dx.doi.org/10.1074/jbc.M114.592352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505240	Green Published, hybrid			2022-12-28	WOS:000349456000032
J	Diaz-Martinez, LA; Tian, W; Li, B; Warrington, R; Jia, LY; Brautigam, CA; Luo, XL; Yu, HT				Diaz-Martinez, Laura A.; Tian, Wei; Li, Bing; Warrington, Ross; Jia, Luying; Brautigam, Chad A.; Luo, Xuelian; Yu, Hongtao			The Cdc20-binding Phe Box of the Spindle Checkpoint Protein BubR1 Maintains the Mitotic Checkpoint Complex During Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; ASSEMBLY CHECKPOINT; SUBSTRATE RECRUITMENT; DEGRON RECOGNITION; AAA-ATPASE; APC/C; CDC20; MAD2; P31(COMET); BINDING	The spindle checkpoint ensures accurate chromosome segregation by monitoring kinetochore-microtubule attachment. Unattached or tensionless kinetochores activate the checkpoint and enhance the production of the mitotic checkpoint complex (MCC) consisting of BubR1, Bub3, Mad2, and Cdc20. MCC is a critical checkpoint inhibitor of the anaphase-promoting complex/cyclosome, a ubiquitin ligase required for anaphase onset. The N-terminal region of BubR1 binds to both Cdc20 and Mad2, thus nucleating MCC formation. The middle region of human BubR1 (BubR1M) also interacts with Cdc20, but the nature and function of this interaction are not understood. Here we identify two critical motifs within BubR1M that contribute to Cdc20 binding and anaphase-promoting complex/cyclosome inhibition: a destruction box (D box) and a phenylalanine-containing motif termed the Phe box. ABubR1 mutant lacking these motifs is defective in MCC maintenance in mitotic human cells but is capable of supporting spindle-checkpoint function. Thus, the BubR1M-Cdc20 interaction indirectly contributes to MCC homeostasis. Its apparent dispensability in the spindle checkpoint might be due to functional duality or redundant, competing mechanisms.	[Diaz-Martinez, Laura A.; Tian, Wei; Li, Bing; Warrington, Ross; Jia, Luying; Luo, Xuelian; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Brautigam, Chad A.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Warrington, Ross; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Luo, XL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	xuelian.luo@utsouthwestern.edu; hongtao.yu@utsouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338; Yu, Hongtao/0000-0002-8861-049X; Diaz-Martinez, Laura/0000-0002-7226-7068; tian, wei/0000-0003-3207-375X	National Institutes of Health [GM085004]; Welch Foundation [1-1441]; Cancer Prevention and Research Institute of Texas [RP120717-P2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM085004 (to X. L.). This work was also supported by Welch Foundation Grant 1-1441 (to H. Y.) and Cancer Prevention and Research Institute of Texas Grant RP120717-P2 (to H. Y.).	Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2011, EMBO J, V30, P1818, DOI 10.1038/emboj.2011.90; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Diaz-Martinez LA, 2014, EMBO J, V33, P1960, DOI 10.15252/embj.201487826; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Eytan E, 2014, P NATL ACAD SCI USA, V111, P12019, DOI 10.1073/pnas.1412901111; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Han JS, 2014, P NATL ACAD SCI USA, V111, pE4185, DOI 10.1073/pnas.1416277111; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Heinrich S, 2013, NAT CELL BIOL, V15, P1328, DOI 10.1038/ncb2864; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Izawa D., 2014, NATURE, DOI [10.1038/nature13911, DOI 10.1038/NATURE13911]; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Kang JS, 2008, MOL CELL, V32, P394, DOI 10.1016/j.molcel.2008.09.017; Kim S, 2011, SEMIN CELL DEV BIOL, V22, P551, DOI 10.1016/j.semcdb.2011.03.008; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Luo XL, 2012, CURR BIOL, V22, pR128, DOI 10.1016/j.cub.2012.01.018; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Qi W, 2007, J BIOL CHEM, V282, P3672, DOI 10.1074/jbc.M609376200; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009	57	43	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2431	2443		10.1074/jbc.M114.616490	http://dx.doi.org/10.1074/jbc.M114.616490			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505175	Green Published, hybrid			2022-12-28	WOS:000348588000045
J	Xu, JG; Huang, CF; Yang, ZF; Jin, MM; Fu, PH; Zhang, N; Luo, J; Li, DL; Liu, MY; Zhou, Y; Zhu, YQ				Xu, Jin-Gen; Huang, Chunfeng; Yang, Zhengfeng; Jin, Mengmeng; Fu, Panhan; Zhang, Ni; Luo, Jian; Li, Dali; Liu, Mingyao; Zhou, Yan; Zhu, Yongqun			Crystal Structure of LGR4-Rspo1 Complex INSIGHTS INTO THE DIVERGENT MECHANISMS OF LIGAND RECOGNITION BY LEUCINE-RICH REPEAT G-PROTEIN-COUPLED RECEPTORS (LGRs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; R-SPONDIN RECOGNITION; WNT/BETA-CATENIN; NEGATIVE COOPERATIVITY; EXTRACELLULAR REGION; R-SPONDIN-4 RSPO4; ORPHAN RECEPTORS; WNT RECEPTORS; RELAXIN; ECTODOMAIN	Leucine-rich repeat G-protein-coupled receptors (LGRs) are a unique class of G-protein-coupled receptors characterized by a large extracellular domain to recognize ligands and regulate many important developmental processes. Among the three groups of LGRs, group B members (LGR4-6) recognize R-spondin family proteins (Rspo1-4) to stimulate Wnt signaling. In this study, we successfully utilized the "hybrid leucine-rich repeat technique," which fused LGR4 with the hagfish VLR protein, to obtain two recombinant human LGR4 proteins, LGR4(15) and LGR4(9). We determined the crystal structures of ligand-free LGR415 and the LGR4(9)-Rspo1 complex. LGR4 exhibits a twisted horseshoe-like structure. Rspo1 adopts a flat and beta-fold architecture and is bound in the concave surface of LGR4 in the complex through electrostatic and hydrophobic interactions. All the Rspo1-binding residues are conserved in LGR4-6, suggesting that LGR4-6 bind R-spondins through an identical surface. Structural analysis of our LGR4-Rspo1 complex with the previously determined LGR4 and LGR5 structures revealed that the concave surface of LGR4 is the sole binding site for R-spondins, suggesting a one-site binding model of LGR4-6 in ligand recognition. The molecular mechanism of LGR4-6 is distinct from the two-step mechanism of group A receptors LGR1-3 and the multiple-interface binding model of group C receptors LGR7-8, suggesting LGRs utilize the divergent mechanisms for ligand recognition. Our structures, together with previous reports, provide a comprehensive understanding of the ligand recognition by LGRs.	[Xu, Jin-Gen; Huang, Chunfeng; Jin, Mengmeng; Fu, Panhan; Zhang, Ni; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Jin-Gen; Huang, Chunfeng; Jin, Mengmeng; Fu, Panhan; Zhang, Ni; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Zhengfeng; Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Yang, Zhengfeng; Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	Zhejiang University; Zhejiang University; East China Normal University; East China Normal University	Zhou, Y (corresponding author), Zhejiang Univ, Inst Life Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zhouyanlsi@zju.edu.cn; zhuyonggun@zju.edu.cn	Yang, Zhengfeng/AAA-7014-2020; Luo, Jian/H-3362-2016	Liu, Mingyao/0000-0001-7339-5048; Luo, Jian/0000-0003-3583-0154; Xu, Jingen/0000-0002-2053-6369	China's Fundamental Research Funds for the Central Universities; NSFC [31370722, 81322024]; Natural Science Foundation of Zhejiang Province [LR13C05001]; Zhejiang University K. P. Chao's High Technology Development Foundation [J20130639]	China's Fundamental Research Funds for the Central Universities; NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang University K. P. Chao's High Technology Development Foundation	This work was supported by China's Fundamental Research Funds for the Central Universities, Research Grants 31370722 and 81322024 from the NSFC, Grant LR13C05001 from Natural Science Foundation of Zhejiang Province, and Grant J20130639 from Zhejiang University K. P. Chao's High Technology Development Foundation (to Y. Zhu).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bergmann C, 2006, AM J HUM GENET, V79, P1105, DOI 10.1086/509789; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Diepenhorst NA, 2014, J BIOL CHEM, V289, P34938, DOI 10.1074/jbc.M114.600882; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horvat RD, 2001, MOL ENDOCRINOL, V15, P534, DOI 10.1210/me.15.4.534; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Hsu SYT, 2003, MOL CELL ENDOCRINOL, V202, P165, DOI 10.1016/S0303-7207(03)00078-9; Jiang XL, 2014, J BIOL CHEM, V289, P14273, DOI 10.1074/jbc.M114.549592; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jin YR, 2012, INT J BIOCHEM CELL B, V44, P2278, DOI 10.1016/j.biocel.2012.09.006; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Laskowski AR, 1993, J APPL CRYSTALLOGR, V26, P283; LIMBIRD LE, 1975, BIOCHEM BIOPH RES CO, V64, P1160, DOI 10.1016/0006-291X(75)90815-3; Luo Ching-Wei, 2006, Chang Gung Med J, V29, P2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peng WC, 2013, CELL REP, V3, P1885, DOI 10.1016/j.celrep.2013.06.009; RAZ E, 1991, GENETICS, V129, P191; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Scott DJ, 2007, MOL ENDOCRINOL, V21, P1699, DOI 10.1210/me.2007-0097; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Svendsen AM, 2009, ANN NY ACAD SCI, V1160, P54, DOI 10.1111/j.1749-6632.2009.03835.x; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Xu K, 2013, STRUCTURE, V21, P1683, DOI 10.1016/j.str.2013.07.001; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	56	16	17	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2455	2465		10.1074/jbc.M114.599134	http://dx.doi.org/10.1074/jbc.M114.599134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480784	Green Published, hybrid			2022-12-28	WOS:000348588000047
J	Okuda, M; Niwa, T; Taguchi, H				Okuda, Momoko; Niwa, Tatsuya; Taguchi, Hideki			Single-molecule Analyses of the Dynamics of Heat Shock Protein 104 (Hsp104) and Protein Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases Associated with Diverse Cellular Activities (AAA); Chaperone; Fluorescence Correlation Spectroscopy (FCS); Protein Aggregation; Single-molecule Biophysics; Hsp104; Total Internal Reflection Fluorescence (TIRF) Microscopy	AAA PLUS DISAGGREGASE; CHAPERONE SYSTEM; ESCHERICHIA-COLI; LIGHT-SCATTERING; CENTRAL PORE; M-DOMAINS; CLPB; MECHANISM; HSP70; BINDING	Background: The process of disaggregation by heat shock protein 104 (Hsp104) and heat shock protein 70/40 (Hsp70/40) has not been elucidated. Results: We developed several methods to investigate the dynamics of Hsp104 at single-molecule levels. Conclusion: Statistical analyses revealed that Hsp70/40 affected the dynamics of Hsp104. Significance: Single-molecule approaches are a unique way to unravel the functional mechanisms of disaggregases. Hsp104 solubilizes protein aggregates in cooperation with Hsp70/40. Although the framework of the disaggregase function has been elucidated, the actual process of aggregate solubilization by Hsp104-Hsp70/40 remains poorly understood. Here we developed several methods to investigate the functions of Hsp104 and Hsp70/40 from Saccharomyces cerevisiae, at single-molecule levels. The single-molecule methods, which provide the size distribution of the aggregates, revealed that Hsp70/40 prevented the formation of large aggregates from small aggregates and that the solubilization of the small aggregates required both Hsp104 and Hsp70/40. We directly visualized the individual association-dissociation dynamics of Hsp104 on immobilized aggregates and found that the lifetimes of the Hsp104-aggregate complex are divided into two groups: short (approximate to 4 s) and long (approximate to 30 s). Hsp70/40 stimulated the association of Hsp104 with aggregates and increased the duration of this association. The single-molecule data provide novel insights into the functional mechanism of the Hsp104 disaggregation machine.	[Okuda, Momoko; Niwa, Tatsuya; Taguchi, Hideki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Taguchi, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B-56,4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	taguchi@bio.titech.ac.jp	Taguchi, Hideki/B-6946-2009; taguchi, hideki/AAM-2663-2021	Taguchi, Hideki/0000-0002-6612-9339; taguchi, hideki/0000-0002-6612-9339; Niwa, Tatsuya/0000-0002-1330-8974	Japan Society for the Promotion of Science (JSPS) [19058002, 24113705, 26116002]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research 19058002, 24113705 and 26116002 (to H. T.) from Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660; Endo T, 1996, J BIOL CHEM, V271, P4161; Georgalis Y, 1998, P NATL ACAD SCI USA, V95, P6118, DOI 10.1073/pnas.95.11.6118; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Inou Y, 2004, J BIOL CHEM, V279, P52319, DOI 10.1074/jbc.M408159200; Kawai-Noma S, 2006, GENES CELLS, V11, P1085, DOI 10.1111/j.1365-2443.2006.01004.x; Kawai-Noma S, 2010, J CELL BIOL, V190, P223, DOI 10.1083/jcb.201002149; Kubo Y, 1999, J MOL BIOL, V286, P447, DOI 10.1006/jmbi.1998.2465; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Panyukov Y, 2007, BIOPHYS CHEM, V127, P9, DOI 10.1016/j.bpc.2006.11.006; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Saito K, 2003, FEBS LETT, V541, P126, DOI 10.1016/S0014-5793(03)00324-7; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Yokota H, 2009, CHEM LETT, V38, P308, DOI 10.1246/cl.2009.308; Zhou ZP, 2011, J BIOCHEM, V149, P609, DOI 10.1093/jb/mvr010; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	42	10	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7833	7840		10.1074/jbc.M114.620427	http://dx.doi.org/10.1074/jbc.M114.620427			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635051	hybrid, Green Published			2022-12-28	WOS:000351613600041
J	Fukuchi, M; Nakashima, F; Tabuchi, A; Shimotori, M; Tatsumi, S; Okuno, H; Bito, H; Tsuda, M				Fukuchi, Mamoru; Nakashima, Fukumi; Tabuchi, Akiko; Shimotori, Masataka; Tatsumi, Saori; Okuno, Hiroyuki; Bito, Haruhiko; Tsuda, Masaaki			Class I Histone Deacetylase-mediated Repression of the Proximal Promoter of the Activity-regulated Cytoskeleton-associated Protein Gene Regulates Its Response to Brain-derived Neurotrophic Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; RAT CORTICAL-NEURONS; ARC MESSENGER-RNA; DENTATE GYRUS; TRANSCRIPTION FACTORS; SYNAPTIC PLASTICITY; GROWTH-FACTOR; ARC/ARG3.1; EXPRESSION	We examined the transcriptional regulation of the activity-regulated cytoskeleton-associated protein gene (Arc), focusing on BDNF-induced Arc expression in cultured rat cortical cells. Although the synaptic activity-responsive element (SARE), located -7 kbp upstream of the Arc transcription start site, responded to NMDA, BDNF, or FGF2, the proximal region of the promoter (Arc/-1679) was activated by BDNF or FGF2, but not by NMDA, suggesting the presence of at least two distinct Arc promoter regions, distal and proximal, that respond to extracellular stimuli. Specificity protein 4 (SP4) and early growth response 1 (EGR1) controlled Arc/-1679 transcriptional activity via the region encompassing -169 to -37 of the Arc promoter. We found that trichostatin A(TSA), a histone deacetylase (HDAC) inhibitor, significantly enhanced the inductive effects of BDNF or FGF2, but not those of NMDA on Arc expression. Inhibitors of class I/IIb HDACs, SAHA, and class I HDACs, MS-275, but not of class II HDACs, MC1568, enhanced BDNF-induced Arc expression. The enhancing effect of TSA was mediated by the region from -1027 to -1000 bp, to which serum response factor (SRF) and HDAC1 bound. The binding of HDAC1 to this region was reduced by TSA. Thus, Arc expression was suppressed by class I HDAC-mediated mechanisms via chromatin modification of the proximal promoter whereas the inhibition of HDAC allowed Arc expression to be markedly enhanced in response to BDNF or FGF2. These results contribute to our understanding of the physiological role of Arc expression in neuronal functions such as memory consolidation.	[Fukuchi, Mamoru; Nakashima, Fukumi; Tabuchi, Akiko; Shimotori, Masataka; Tatsumi, Saori; Tsuda, Masaaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, Toyama 9300194, Japan; [Okuno, Hiroyuki; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Toyama; University of Tokyo	Tsuda, M (corresponding author), Toyama Univ, Fac Pharmaceut Sci, Dept Biol Chem, 2630 Sugitani, Toyama 9300194, Japan.	tsuda@pha.u-toyama.ac.jp	Bito, Haruhiko/A-8635-2008	Fukuchi, Mamoru/0000-0002-6807-8707; Bito, Haruhiko/0000-0001-6315-9594; OKUNO, HIROYUKI/0000-0001-6237-6503	Ministry of Education, Science, Sports and Culture, Japan [20390023]; Mitsubishi Foundation	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation	This study was supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan (Project Number: 20390023, to M. T.) and the Mitsubishi Foundation (to M. T.).	Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; Fukuchi M, 2004, J BIOL CHEM, V279, P47856, DOI 10.1074/jbc.M409090200; Fukuchi M, 2010, BRAIN RES, V1366, P18, DOI 10.1016/j.brainres.2010.10.034; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Hara D, 2009, BIOCHEM BIOPH RES CO, V384, P506, DOI 10.1016/j.bbrc.2009.05.007; Hu E., 2003, IDENTIFICATION NOVEL; Ishimaru N, 2007, J NEUROCHEM, V100, P520, DOI 10.1111/j.1471-4159.2006.04216.x; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Koppel I, 2013, NEUROPHARMACOLOGY, V75, P106, DOI 10.1016/j.neuropharm.2013.07.015; Levkovitz Y, 2001, J NEUROSCI, V21, P45, DOI 10.1523/JNEUROSCI.21-01-00045.2001; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Ramos B, 2007, P NATL ACAD SCI USA, V104, P9882, DOI 10.1073/pnas.0701946104; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Timmusk T, 1999, J BIOL CHEM, V274, P1078; Veyrac A, 2014, PROG MOL BIOL TRANSL, V122, P89, DOI 10.1016/B978-0-12-420170-5.00004-0; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yasuda M, 2007, J NEUROCHEM, V103, P626, DOI 10.1111/j.1471-4159.2007.04851.x; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621	43	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6825	6836		10.1074/jbc.M114.617258	http://dx.doi.org/10.1074/jbc.M114.617258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25623071	hybrid, Green Published			2022-12-28	WOS:000350991500018
J	Lee, D; Kraus, A; Prins, D; Groenendyk, J; Aubry, I; Liu, WX; Li, HD; Julien, O; Touret, N; Sykes, BD; Tremblay, ML; Michalak, M				Lee, Dukgyu; Kraus, Allison; Prins, Daniel; Groenendyk, Jody; Aubry, Isabelle; Liu, Wen-Xin; Li, Hao-Dong; Julien, Olivier; Touret, Nicolas; Sykes, Brian D.; Tremblay, Michel L.; Michalak, Marek			UBC9-dependent Association between Calnexin and Protein Tyrosine Phosphatase 1B (PTP1B) at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; QUALITY-CONTROL; SARCOPLASMIC-RETICULUM; KEY COMPONENT; HEAT-SHOCK; SUMO; PHOSPHORYLATION; SUMOYLATION; SITES; CALRETICULIN	Calnexin is a type I integral endoplasmic reticulum (ER) membrane protein, molecular chaperone, and a component of the translocon. We discovered a novel interaction between the calnexin cytoplasmic domain and UBC9, a SUMOylation E2 ligase, which modified the calnexin cytoplasmic domain by the addition of SUMO. We demonstrated that calnexin interaction with the SUMOylation machinery modulates an interaction with protein tyrosine phosphatase 1B (PTP1B), an ER-associated protein tyrosine phosphatase involved in the negative regulation of insulin and leptin signaling. We showed that calnexin and PTP1B form UBC9-dependent complexes, revealing a previously unrecognized contribution of calnexin to the retention of PTP1B at the ER membrane. This work shows that the SUMOylation machinery links two ER proteins from divergent pathways to potentially affect cellular protein quality control and energy metabolism.	[Lee, Dukgyu; Kraus, Allison; Prins, Daniel; Groenendyk, Jody; Liu, Wen-Xin; Li, Hao-Dong; Julien, Olivier; Touret, Nicolas; Sykes, Brian D.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Aubry, Isabelle; Tremblay, Michel L.; Michalak, Marek] McGill Univ, Dept Biochem, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	University of Alberta; McGill University	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S7, Canada.	marek.michalak@ualberta.ca	Julien, Olivier/N-9198-2019; Julien, Olivier/A-1594-2013	Julien, Olivier/0000-0001-7068-7299; 	Canadian Institutes of Health Research (CIHR) [MOP15291, MOP62887, MOP37769, MOP93659]; Canadian Foundation for Innovation [CFI-17625]; Natural Sciences and Engineering Research Council (NSERC) Discovery Research grants; Alberta Innovates-Health Solutions (AI-HS); Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council (NSERC) Discovery Research grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates-Health Solutions (AI-HS); Multiple Sclerosis Society of Canada	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (to M. M. MOP15291; to M. L. T. MOP62887; to B. D. S. MOP37769; to N. T. MOP93659), from the Canadian Foundation for Innovation (CFI-17625) and the Natural Sciences and Engineering Research Council (NSERC) Discovery Research grants (to N. T.). A. K. was supported by a fellowship from Alberta Innovates-Health Solutions (AI-HS) and from the Multiple Sclerosis Society of Canada.	Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALA SE, 1993, J BIOL CHEM, V268, P2969; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Chevet E, 2010, SEMIN CELL DEV BIOL, V21, P486, DOI 10.1016/j.semcdb.2009.12.005; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Felberbaum R, 2012, MOL CELL BIOL, V32, P64, DOI 10.1128/MCB.05878-11; Feldhammer M, 2013, CRIT REV BIOCHEM MOL, V48, P430, DOI 10.3109/10409238.2013.819830; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Ho SC, 1999, MOL IMMUNOL, V36, P1, DOI 10.1016/S0161-5890(99)00018-8; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61; Lakkaraju AKK, 2013, MOL CELL, V51, P386, DOI 10.1016/j.molcel.2013.07.009; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Li HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021678; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Popov D, 2012, BIOCHEM BIOPH RES CO, V422, P535, DOI 10.1016/j.bbrc.2012.05.048; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Saitoh T, 2002, MOL PHARMACOL, V62, P847, DOI 10.1124/mol.62.4.847; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SCHUE V, 1994, BIOCHEM BIOPH RES CO, V203, P22, DOI 10.1006/bbrc.1994.2143; St-Pierre J, 2012, CELL METAB, V15, P292, DOI 10.1016/j.cmet.2012.02.004; Stuible M, 2010, J BIOL CHEM, V285, P23899, DOI 10.1074/jbc.M110.115295; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; Wong HN, 1998, J BIOL CHEM, V273, P17227, DOI 10.1074/jbc.273.27.17227; Yang SH, 2006, E SCHERING RES FDN W, V57, P193; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Yunus AA, 2005, METHOD ENZYMOL, V398, P74, DOI 10.1016/S0076-6879(05)98008-7	60	12	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5725	5738		10.1074/jbc.M114.635474	http://dx.doi.org/10.1074/jbc.M114.635474			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25586181	Green Published, hybrid			2022-12-28	WOS:000350044200040
J	Yuan, C; Smith, WL				Yuan, Chong; Smith, William L.			A Cyclooxygenase-2-dependent Prostaglandin E-2 Biosynthetic System in the Golgi Apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPEROXIDE-H SYNTHASE-1; CYTOSOLIC PHOSPHOLIPASE A(2)ALPHA; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; PROTEIN-DEGRADATION; SEQUENCE HOMODIMER; MESSENGER-RNA; CANCER-CELLS; BINDING	Cydooxygenases (COXs) catalyze the committed step in prostaglandin (PG) biosynthesis. COX-1 is constitutively expressed and stable, whereas COX-2 is inducible and short lived. COX-2 is degraded via endoplasmic reticulum (ER)-associated degradation (ERAD) following post-translational glycosylation of Asn-594, COX-1 and COX-2 are found in abundance on the luminal surfaces of the ER and inner membrane of the nuclear envelope. Using confocal immtinocytofluorescence, we detected both COX-2 and microsomal PGE synthase-1 (mPGES-1) but not COX-1 in the Golgi apparatus. Inhibition of trafficking between the ER and Golgi retarded COX-2 ERAD. COX-2 has a C-terminal STEL sequence, which is an inefficient ER retention signal. Substituting this sequence with KDEL, a robust ER retention signal, concentrated COX-2 in the ER where it was stable and slowly glycosylated on Asn-594. Native COX-2 and a recombinant COX-2 having a Golgi targeting signal but not native COX-1 exhibited efficient catalytic coupling to mPGES-1 We conclude that N-glycosylation of Asn-594 of COX-2 occurs in the ER, leading to anterograde movement of COX-2 to the Golgi where the Asn-594-linked glycan is trimmed prior to retrograde COX-2 transport to the ER for ERAD. Having an inefficient ER retention signal leads to sluggish Golgi to ER transit of COX-2. This permits significant Golgi residence time during which COX-2 can function catalytically. Cytosolic phospholipase Ca2+, which mobilizes arachidonic acid for PG synthesis, preferentially translocates to the Golgi in response to physiologic Ca2+ mobilization. We propose that cytosolic phospholipase COX-2, and mPGES-1 in the Golgi comprise a dedicated system for COX-2-dependent PGE(2) biosynthesis.	[Yuan, Chong; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@med.umich.edu			National Institutes of Health [GM68848, CA130810, HL117798]; NATIONAL CANCER INSTITUTE [P50CA130810, P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM68848, CA130810, and HL117798. William L. Smith has served on the scientific advisory board of Cayman Chemical Company, products from which were used in this study.	Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; Blum R, 1999, J CELL SCI, V112, P537; Chen SF, 2013, J BIOL CHEM, V288, P33462, DOI 10.1074/jbc.M113.521799; Chen Y, 2013, GLYCOBIOLOGY, V23, P904, DOI 10.1093/glycob/cwt027; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; DVORAK AM, 1992, J HISTOCHEM CYTOCHEM, V40, P759, DOI 10.1177/40.6.1316915; Elsabrouty R, 2013, MOL BIOL CELL, V24, P3300, DOI 10.1091/mbc.E13-03-0157; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Haddad A, 2012, J BIOL CHEM, V287, P17214, DOI 10.1074/jbc.M111.304220; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; Hou Z, 2011, CARCINOGENESIS, V32, P695, DOI 10.1093/carcin/bgr027; Jarving R, 2004, J BIOL CHEM, V279, P13624, DOI 10.1074/jbc.M313258200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kawasaki N, 2008, BLOOD, V111, P1972, DOI 10.1182/blood-2007-06-097022; Kojima F, 2004, ARTHRITIS RES THER, V6, pR355, DOI 10.1186/ar1195; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Liao WL, 2011, J BIOL CHEM, V286, P35499, DOI 10.1074/jbc.M111.263582; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Majed BH, 2012, PHARMACOL REV, V64, P540, DOI 10.1124/pr.111.004770; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Narumiya S, 2011, FASEB J, V25, P813, DOI 10.1096/fj.11-0302ufm; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Otto JC, 1996, J BIOL CHEM, V271, P9906, DOI 10.1074/jbc.271.17.9906; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; REDDY ST, 1994, J BIOL CHEM, V269, P15473; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Shitashige M, 1998, BBA-LIPID LIPID MET, V1389, P57, DOI 10.1016/S0005-2760(97)00129-X; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; SMITH WL, 1986, ANNU REV PHYSIOL, V48, P251; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Theesfeld CL, 2013, J BIOL CHEM, V288, P8519, DOI 10.1074/jbc.M112.404517; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664; Ushioda R, 2013, MOL BIOL CELL, V24, P3155, DOI 10.1091/mbc.E13-03-0138; Varvas K, 2009, INSECT BIOCHEM MOLEC, V39, P851, DOI 10.1016/j.ibmb.2009.10.002; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2009, J BIOL CHEM, V284, P30742, DOI 10.1074/jbc.M109.052415; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zhang H, 2013, J AM CHEM SOC, V135, P11663, DOI 10.1021/ja4056905; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	70	32	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5606	5620		10.1074/jbc.M114.632463	http://dx.doi.org/10.1074/jbc.M114.632463			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25548276	Green Published, hybrid			2022-12-28	WOS:000350044200031
J	Wei, Z; Behrman, B; Wu, WH; Chen, BS				Wei, Zhe; Behrman, Blake; Wu, Wei-Hua; Chen, Bo-Shiun			Subunit-specific Regulation of N-Methyl-D-aspartate (NMDA) Receptor Trafficking by SAP102 Protein Splice Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGUK SCAFFOLDING PROTEINS; DENDRITIC SPINE MORPHOLOGY; GUANYLATE KINASE DOMAINS; INTRAMOLECULAR INTERACTION; SYNAPTIC PLASTICITY; HIPPOCAMPAL SYNAPSES; SURFACE EXPRESSION; IN-VIVO; PSD-95; NEURONS	Synapse-associated protein 102 (SAP102) is a scaffolding protein abundantly expressed early in development that mediates glutamate receptor trafficking during synaptogenesis. Mutations in human SAP102 have been reported to cause intellectual disability, which is consistent with its important role during early postnatal development. SAP102 contains PDZ, SH3, and guanylate kinase (GK)-like domains, which mediate specific protein-protein interactions. SAP102 binds directly to N-methyl-D-aspartate receptors (NMDARs), anchors receptors at synapses, and facilitates transduction of NMDAR signals. Proper localization of SAP102 at the postsynaptic density is essential to these functions. However, how SAP102 is targeted to synapses is unclear. In the current study we find that synaptic localization of SAP102 is regulated by alternative splicing. The SAP102 splice variant that possesses a C-terminal insert (I2) between the SH3 and GK domains is highly enriched at dendritic spines. We also show that there is an intramolecular interaction between the SH3 and GK domains in SAP102 but that the I2 splicing does not influence SH3-GK interaction. Previously, we have shown that SAP102 expression promotes spine lengthening. We now find that the spine lengthening effect is independent of the C-terminal alternative splicing of SAP102. In addition, expression of I2-containing SAP102 isoforms is regulated developmentally. Knockdown of endogenous I2-containing SAP102 isoforms differentially affect NMDAR surface expression in a subunit-specific manner. These data shed new light on the role of SAP102 in the regulation of NMDAR trafficking.	[Chen, Bo-Shiun] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Chen, Bo-Shiun] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Chen, BS (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, CA3008,1120 15th St, Augusta, GA 30912 USA.	bochen@gru.edu		Behrman, David/0000-0003-1801-3662	National Institutes of Health (NINDS) [R00NS057266]; National Institutes of Health (NCI) [1K22CA122453]; NATIONAL CANCER INSTITUTE [K22CA122453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS057266] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Career Transition Awards R00NS057266 (NINDS; to B.-S. C.) and 1K22CA122453 (NCI; W.-H. W.).	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Chen BS, 2012, CELL REP, V2, P1120, DOI 10.1016/j.celrep.2012.09.024; Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Murata Y, 2013, J NEUROSCI, V33, P5040, DOI 10.1523/JNEUROSCI.2896-12.2013; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Philips AK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-49; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zanni G, 2010, NEUROGENETICS, V11, P251, DOI 10.1007/s10048-009-0224-y; Zheng CY, 2010, J NEUROSCI, V30, P4757, DOI 10.1523/JNEUROSCI.6108-09.2010; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	57	11	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5105	5116		10.1074/jbc.M114.599969	http://dx.doi.org/10.1074/jbc.M114.599969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555912	Green Published, hybrid			2022-12-28	WOS:000350042000050
J	Zhang, W; Zhang, XX; Gonzalez-Cobos, JC; Stolwijk, JA; Matrougui, K; Trebak, M				Zhang, Wei; Zhang, Xuexin; Gonzalez-Cobos, Jose C.; Stolwijk, Judith A.; Matrougui, Khalid; Trebak, Mohamed			Leukotriene-C-4 Synthase, a Critical Enzyme in the Activation of Store-independent Orai1/Orai3 Channels, Is Required for Neointimal Hyperplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL PROLIFERATION; OPERATED CALCIUM-ENTRY; SMOOTH-MUSCLE; C-4 SYNTHASE; CYSTEINYL-LEUKOTRIENES; PROMOTER POLYMORPHISM; CRAC CURRENTS; I-CRAC; STIM1; ORAI1	Leukotriene-C-4 synthase (LTC4S) generates LTC4 from arachidonic acid metabolism. LTC4 is a proinflammatory factor that acts on plasma membrane cysteinyl leukotriene receptors. Recently, however, we showed that LTC4 was also a cytosolic second messenger that activated store-independent LTC4-regulated Ca2+ (LRC) channels encoded by Orai1/Orai3 heteromultimers in vascular smooth muscle cells (VSMCs). We showed that Orai3 and LRC currents were up-regulated in medial and neointimal VSMCs after vascular injury and that Orai3 knockdown inhibited LRC currents and neointimal hyperplasia. However, the role of LTC4S in neointima formation remains unknown. Here we show that LTC4S knockdown inhibited LRC currents in VSMCs. We performed in vivo experiments where rat left carotid arteries were injured using balloon angioplasty to cause neointimal hyperplasia. Neointima formation was associated with up-regulation of LTC4S protein expression in VSMCs. Inhibition of LTC4S expression in injured carotids by lentiviral particles encoding shRNA inhibited neointima formation and inward and outward vessel remodeling. LRC current activation did not cause nuclear factor for activated T cells (NFAT) nuclear translocation in VSMCs. Surprisingly, knockdown of either LTC4S or Orai3 yielded more robust and sustained Akt1 and Akt2 phosphorylation on Ser-473/Ser-474 upon serum stimulation. LTC4S and Orai3 knockdown inhibited VSMC migration in vitro with no effect on proliferation. Akt activity was suppressed in neointimal and medial VSMCs from injured vessels at 2 weeks postinjury but was restored when the up-regulation of either LTC4S or Orai3 was prevented by shRNA. We conclude that LTC4S and Orai3 altered Akt signaling to promote VSMC migration and neointima formation.	[Zhang, Wei; Zhang, Xuexin; Gonzalez-Cobos, Jose C.; Stolwijk, Judith A.; Trebak, Mohamed] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12203 USA; [Zhang, Wei; Gonzalez-Cobos, Jose C.; Trebak, Mohamed] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Matrougui, Khalid] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute; Albany Medical College; Eastern Virginia Medical School	Trebak, M (corresponding author), SUNY Albany, Coll Nanoscale Sci & Engn, 257 Fuller Rd, Albany, NY 12203 USA.	mtrebak@albany.edu		ZHANG zhang xue xin, XUEXIN/0000-0001-8276-3885	National Institutes of Health [R01HL097111, R01HL123364, R01HL095566]; American Heart Association [14GRNT18880008]; Applied Biophysics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL095566, R01HL123364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Applied Biophysics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL097111 and R01HL123364 (to M. T.) and R01HL095566 (to K. M.). This work was also supported by American Heart Association Grant 14GRNT18880008 (to M. T.).; Partially supported by a fellowship from Applied Biophysics Inc.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Ago H, 2013, J BIOCHEM, V153, P421, DOI 10.1093/jb/mvt007; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Austen KF, 2008, NAT IMMUNOL, V9, P113, DOI 10.1038/ni0208-113; Berna-Erro A, 2012, BBA-MOL CELL RES, V1823, P1242, DOI 10.1016/j.bbamcr.2012.05.023; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Bevan S, 2008, STROKE, V39, P1109, DOI 10.1161/STROKEAHA.107.491969; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Cowburn AS, 1998, J CLIN INVEST, V101, P834, DOI 10.1172/JCI620; Di Gennaro A, 2010, P NATL ACAD SCI USA, V107, P21093, DOI 10.1073/pnas.1015166107; Freiberg JJ, 2008, ARTERIOSCL THROM VAS, V28, P990, DOI 10.1161/ATVBAHA.107.158873; Freiberg JJ, 2009, J MOL CELL CARDIOL, V46, P579, DOI 10.1016/j.yjmcc.2009.01.002; Gonzalez-Cobos JC, 2013, CIRC RES, V112, P1013, DOI 10.1161/CIRCRESAHA.111.300220; Guo RW, 2012, CARDIOVASC RES, V93, P360, DOI 10.1093/cvr/cvr307; Guo RW, 2009, CARDIOVASC RES, V81, P660, DOI 10.1093/cvr/cvn338; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Iovannisci DM, 2007, ARTERIOSCL THROM VAS, V27, P394, DOI 10.1161/01.ATV.0000252680.72734.10; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jonas M, 2005, CIRC RES, V97, P725, DOI 10.1161/01.RES.0000183730.52908.C6; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; Malik N, 1998, CIRCULATION, V98, P1657, DOI 10.1161/01.CIR.98.16.1657; Mancarella S, 2013, FASEB J, V27, P893, DOI 10.1096/fj.12-215293; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Motiani RK, 2013, CHANNELS, V7, P392, DOI 10.4161/chan.24960; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Motiani RK, 2013, FASEB J, V27, P63, DOI 10.1096/fj.12-213801; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Niegowski D, 2014, J BIOL CHEM, V289, P5199, DOI 10.1074/jbc.M113.534628; Osher E, 2006, MOL CELL ENDOCRINOL, V252, P201, DOI 10.1016/j.mce.2006.03.038; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Ruhle B, 2013, CURR TOP MEMBR, V71, P209, DOI 10.1016/B978-0-12-407870-3.00009-3; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; Shigematsu K, 2000, ARTERIOSCL THROM VAS, V20, P2373, DOI 10.1161/01.ATV.20.11.2373; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Spinelli AM, 2012, PFLUG ARCH EUR J PHY, V464, P481, DOI 10.1007/s00424-012-1160-5; Stabile E, 2003, CIRC RES, V93, P1059, DOI 10.1161/01.RES.0000105086.31909.1B; Taccone-Gallucci M, 2008, NEW ENGL J MED, V358, P746, DOI 10.1056/NEJMc073333; Thompson JL, 2013, CHANNELS, V7, P364, DOI 10.4161/chan.26156; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675; Warfel NA, 2011, J BIOL CHEM, V286, P19777, DOI 10.1074/jbc.M111.237081; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Yun SJ, 2014, BBA-MOL BASIS DIS, V1842, P2184, DOI 10.1016/j.bbadis.2014.08.014; Zhang W., 2012, T TRP CHANNELS DRUG, P101; Zhang W, 2014, JOVE-J VIS EXP, DOI 10.3791/52045; Zhang W, 2011, CIRC RES, V109, P534, DOI 10.1161/CIRCRESAHA.111.246777; Zhang XX, 2014, J GEN PHYSIOL, V143, P345, DOI 10.1085/jgp.201311084; Zhang XX, 2013, MOL CELL BIOL, V33, P3715, DOI 10.1128/MCB.00554-13	54	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5015	5027		10.1074/jbc.M114.625822	http://dx.doi.org/10.1074/jbc.M114.625822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540197	Green Published, hybrid			2022-12-28	WOS:000350042000043
J	Lee, JY; Lee, J; Yue, H; Lee, TH				Lee, Ju Yeon; Lee, Jaehyoun; Yue, Hongjun; Lee, Tae-Hee			Dynamics of Nucleosome Assembly and Effects of DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE CHAPERONE NAP1; CPG METHYLATION; IN-VITRO; CHROMATIN; PROTEIN-1; STABILITY; RECONSTITUTION; DEACETYLASE; COMPLEXES; PATTERNS	The nucleosome is the fundamental packing unit of the eukaryotic genome, and CpG methylation is an epigenetic modification associated with gene repression and silencing. We investigated nucleosome assembly mediated by histone chaperone Nap1 and the effects of CpG methylation based on three-color single molecule FRET measurements, which enabled direct monitoring of histone binding in the context of DNA wrapping. According to our observation, (H3-H4)(2) tetramer incorporation must precede H2A-H2B dimer binding, which is independent of DNA termini wrapping. Upon CpG methylation, (H3-H4) 2 tetramer incorporation and DNA termini wrapping are facilitated, whereas proper incorporation of H2A-H2B dimers is inhibited. We suggest that these changes are due to rigidified DNA and increased random binding of histones to DNA. According to the results, CpG methylation expedites nucleosome assembly in the presence of abundant DNA and histones, which may help facilitate gene packaging in chromatin. The results also indicate that the slowest steps in nucleosome assembly are DNA termini wrapping and tetramer positioning, both of which are affected heavily by changes in the physical properties of DNA.	[Lee, Tae-Hee] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, TH (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	txl18@psu.edu	Lee, Tae-Hee/A-1266-2010	Seiler, Jae Hyoun/0000-0002-6351-3546	National Institutes of Health [GM097286]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097286 (to T. H. L.).	Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Andrews AJ, 2011, METHOD ENZYMOL, P265, DOI 10.1016/B978-0-12-381268-1.00011-2; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Anselmi C, 2000, BIOPHYS J, V79, P601, DOI 10.1016/S0006-3495(00)76319-3; Azegami N, 2013, BIOCHEMISTRY-US, V52, P5155, DOI 10.1021/bi4005655; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Collings CK, 2013, NUCLEIC ACIDS RES, V41, P2918, DOI 10.1093/nar/gks893; D'Arcy S, 2013, MOL CELL, V51, P662, DOI 10.1016/j.molcel.2013.07.015; Davey C, 1997, J MOL BIOL, V267, P276, DOI 10.1006/jmbi.1997.0899; Davey CS, 2004, NUCLEIC ACIDS RES, V32, P4322, DOI 10.1093/nar/gkh749; Derreumaux S, 2001, NUCLEIC ACIDS RES, V29, P2314, DOI 10.1093/nar/29.11.2314; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Geahigan KB, 2000, BIOCHEMISTRY-US, V39, P4939, DOI 10.1021/bi9917636; Godde JS, 1996, J BIOL CHEM, V271, P24325, DOI 10.1074/jbc.271.40.24325; HOGAN ME, 1987, NATURE, V328, P554, DOI 10.1038/328554a0; Horsey I, 2000, CHEM COMMUN, P1043, DOI 10.1039/b002540m; Ito T, 1996, MOL CELL BIOL, V16, P3112; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Klein CB, 1997, MUTAT RES-REV MUTAT, V386, P163, DOI 10.1016/S1383-5742(96)00052-X; KORNBERG RD, 1981, SCI AM, V244, P48, DOI 10.1038/scientificamerican0281-52; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Lee JY, 2012, BBA-PROTEINS PROTEOM, V1824, P974, DOI 10.1016/j.bbapap.2012.05.006; Lee JY, 2012, J AM CHEM SOC, V134, P173, DOI 10.1021/ja210273w; Lee JY, 2011, J BIOL CHEM, V286, P11099, DOI 10.1074/jbc.M110.192047; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McQuibban GA, 1998, J BIOL CHEM, V273, P6582, DOI 10.1074/jbc.273.11.6582; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nathan D, 2002, J MOL BIOL, V316, P7, DOI 10.1006/jmbi.2001.5247; Pennings Sari, 2005, Briefings in Functional Genomics & Proteomics, V3, P351, DOI 10.1093/bfgp/3.4.351; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Rocha W, 2008, FEBS LETT, V582, P1938, DOI 10.1016/j.febslet.2008.03.006; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; Wang YH, 1996, J BIOL CHEM, V271, P22937, DOI 10.1074/jbc.271.38.22937; Watrob HM, 2003, J AM CHEM SOC, V125, P7336, DOI 10.1021/ja034564p; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; WILHELM FX, 1978, NUCLEIC ACIDS RES, V5, P505, DOI 10.1093/nar/5.2.505	55	31	32	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4291	4303		10.1074/jbc.M114.619213	http://dx.doi.org/10.1074/jbc.M114.619213			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25550164	Green Published, hybrid			2022-12-28	WOS:000349458400039
J	Yang, LL; Li, L				Yang, Linlin; Li, Lei			Spore Photoproduct Lyase: The Known, the Controversial, and the Unknown	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RADICAL SAM ENZYME; DNA-REPAIR ENZYME; BACILLUS-SUBTILIS SPORES; H-ATOM ABSTRACTION; S-ADENOSYLMETHIONINE; RIBONUCLEOTIDE REDUCTASE; CATALYTIC MECHANISM; ESCHERICHIA-COLI; PROTEIN SUPERFAMILY; DAMAGE RECOGNITION	Spore photoproduct lyase (SPL) repairs 5-thyminyl-5,6-dihydrothymine, a thymine dimer that is also called the spore photoproduct (SP), in germinating endospores. SPL is a radical S-adenosylmethionine (SAM) enzyme, utilizing the 5' -deoxyadenosyl radical generated by SAM reductive cleavage reaction to revert SP to two thymine residues. Here we review the current progress in SPL mechanistic studies. Protein radicals are known to be involved in SPL catalysis; however, how these radicals are quenched to close the catalytic cycle is under debate.	[Yang, Linlin; Li, Lei] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Li, Lei] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Li, L (corresponding author), Indiana Univ Purdue Univ, Dept Chem & Chem Biol, 402 N Blackford St, Indianapolis, IN 46202 USA.	lilei@iupui.edu		Li, Lei/0000-0001-7022-7313	National Institutes of Health [R00ES017177]; IUPUI Startup Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IUPUI Startup Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00ES017177 (to L. L.). This work was also supported by the IUPUI Startup Fund. This is the sixth article in the Thematic Minireview series Radical SAM Enzymes.	Benjdia A, 2012, CURR OPIN STRUC BIOL, V22, P711, DOI 10.1016/j.sbi.2012.10.002; Benjdia A, 2012, NUCLEIC ACIDS RES, V40, P9308, DOI 10.1093/nar/gks603; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; BOLLINGER JM, 1991, SCIENCE, V253, P292, DOI 10.1126/science.1650033; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Buis JM, 2006, J BIOL CHEM, V281, P25994, DOI 10.1074/jbc.M603931200; CADET J, 1990, BIOORGANIC PHOTOCHEM, V1, P1; Chandor A, 2006, J BIOL CHEM, V281, P26922, DOI 10.1074/jbc.M602297200; Chandor-Proust A, 2008, J BIOL CHEM, V283, P36361, DOI 10.1074/jbc.M806503200; Chandra T, 2009, J AM CHEM SOC, V131, P2420, DOI 10.1021/ja807375c; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Cheek J, 2002, J AM CHEM SOC, V124, P2860, DOI 10.1021/ja017784g; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Croteau DL, 2008, DNA REPAIR, V7, P392, DOI 10.1016/j.dnarep.2007.11.013; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Desnous C, 2010, CHEM REV, V110, P1213, DOI 10.1021/cr0781972; DONNELLAN JE, 1968, BIOPHYS J, V8, P17, DOI 10.1016/S0006-3495(68)86471-9; Dowling DP, 2014, NAT CHEM BIOL, V10, P106, DOI 10.1038/nchembio.1426; Fajardo-Cavazos P, 2005, CURR MICROBIOL, V51, P331, DOI 10.1007/s00284-005-0052-8; FAJARDOCAVAZOS P, 1993, J BACTERIOL, V175, P1735, DOI 10.1128/JB.175.6.1735-1744.1993; Forouhar F, 2013, NAT CHEM BIOL, V9, P333, DOI [10.1038/NCHEMBIO.1229, 10.1038/nchembio.1229]; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Friedel MG, 2006, CHEM-EUR J, V12, P6081, DOI 10.1002/chem.200600169; Friedel MG, 2006, CHEM COMMUN, P445, DOI 10.1039/b514103f; Fugate CJ, 2012, J AM CHEM SOC, V134, P9042, DOI 10.1021/ja3012963; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P15949, DOI 10.1073/pnas.1312228110; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; Heil K, 2011, CHEM-EUR J, V17, P9651, DOI 10.1002/chem.201100177; Henshaw TF, 2000, J AM CHEM SOC, V122, P8331, DOI 10.1021/ja002012q; Hover BM, 2013, J AM CHEM SOC, V135, P7019, DOI 10.1021/ja401781t; Jian YJ, 2013, J ORG CHEM, V78, P3021, DOI 10.1021/jo400013n; Kamat SS, 2013, NATURE, V497, P132, DOI 10.1038/nature12061; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; KIM SJ, 1995, J ORG CHEM, V60, P6256, DOI 10.1021/jo00125a006; Kneuttinger AC, 2014, PHOTOCHEM PHOTOBIOL, V90, P1, DOI 10.1111/php.12197; Kneuttinger AC, 2013, CHEM COMMUN, V49, P722, DOI 10.1039/c2cc37735g; Kuchenreuther JM, 2013, SCIENCE, V342, P472, DOI 10.1126/science.1241859; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lee KS, 2008, P NATL ACAD SCI USA, V105, P2806, DOI 10.1073/pnas.0708244105; Li L, 2012, BBA-PROTEINS PROTEOM, V1824, P1264, DOI 10.1016/j.bbapap.2011.11.008; Lieder KW, 1998, BIOCHEMISTRY-US, V37, P2578, DOI 10.1021/bi972417w; Lin GJ, 2011, CHEM-EUR J, V17, P9658, DOI 10.1002/chem.201101821; Lin GJ, 2010, ANGEW CHEM INT EDIT, V49, P9926, DOI 10.1002/anie.201005228; Lloyd R. S., 2005, DNA DAMAGE RECOGNITI, P21; Mantel C, 2008, J AM CHEM SOC, V130, P16978, DOI 10.1021/ja805032r; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; Marsh ENG, 2004, BIOORG CHEM, V32, P326, DOI 10.1016/j.bioorg.2004.06.001; McCarty RM, 2013, BIOCHEMISTRY-US, V52, P188, DOI 10.1021/bi301156w; McCusker KP, 2012, J AM CHEM SOC, V134, P18074, DOI 10.1021/ja307855d; Mehl RA, 1999, ORG LETT, V1, P1065, DOI 10.1021/ol9908676; Mehta AP, 2013, J AM CHEM SOC, V135, P10883, DOI 10.1021/ja4041048; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Moeller R, 2007, INT MICROBIOL, V10, P39, DOI 10.2436/20.1501.01.6; MOHR SC, 1991, P NATL ACAD SCI USA, V88, P77, DOI 10.1073/pnas.88.1.77; MUNAKATA N, 1972, J BACTERIOL, V11, P192, DOI 10.1128/JB.111.1.192-198.1972; MUNAKATA N, 1977, MOL GEN GENET, V156, P49, DOI 10.1007/BF00272251; MUNAKATA N, 1974, MOL GEN GENET, V130, P239, DOI 10.1007/BF00268802; MUNAKATA N, 1969, MOL GEN GENET, V104, P258, DOI 10.1007/BF02539290; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL, 2005, MUTAT RES-FUND MOL M, V571, P249, DOI 10.1016/j.mrfmmm.2004.10.012; NICHOLSON WL, 1990, J BACTERIOL, V172, P6900, DOI 10.1128/jb.172.12.6900-6906.1990; NICHOLSON WL, 1991, P NATL ACAD SCI USA, V88, P8288, DOI 10.1073/pnas.88.19.8288; Padovani D, 2001, BIOCHEMISTRY-US, V40, P6713, DOI 10.1021/bi002936q; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Rebeil R, 2001, P NATL ACAD SCI USA, V98, P9038, DOI 10.1073/pnas.161278998; Rebeil R, 1998, J BACTERIOL, V180, P4879, DOI 10.1128/JB.180.18.4879-4885.1998; Ruszczycky MW, 2013, P NATL ACAD SCI USA, V110, P2088, DOI 10.1073/pnas.1209446110; Ruszczycky MW, 2011, J AM CHEM SOC, V133, P7292, DOI 10.1021/ja201212f; SETLOW B, 1991, J BACTERIOL, V173, P1642, DOI 10.1128/jb.173.5.1642-1653.1991; SETLOW B, 1993, APPL ENVIRON MICROB, V59, P640, DOI 10.1128/AEM.59.2.640-643.1993; SETLOW B, 1988, APPL ENVIRON MICROB, V54, P1275, DOI 10.1128/AEM.54.5.1275-1276.1988; Setlow P, 2001, ENVIRON MOL MUTAGEN, V38, P97, DOI 10.1002/em.1058; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; SETLOW P, 1988, ANNU REV MICROBIOL, V42, P319, DOI 10.1146/annurev.mi.42.100188.001535; Silver SC, 2010, J BIOL INORG CHEM, V15, P943, DOI 10.1007/s00775-010-0656-8; Singh I, 2014, ACTA CRYSTALLOGR D, V70, P752, DOI 10.1107/S1399004713032987; Slieman TA, 2000, J BACTERIOL, V182, P6412, DOI 10.1128/JB.182.22.6412-6417.2000; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Szu PH, 2009, J AM CHEM SOC, V131, P14030, DOI 10.1021/ja903354k; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Van Houten B, 2005, MUTAT RES-FUND MOL M, V577, P92, DOI 10.1016/j.mrfmmm.2005.03.013; VANWANG TC, 1977, PHOTOCHEM PHOTOBIOL, V25, P123; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Yang LL, 2013, BIOCHEMISTRY-US, V52, P3041, DOI 10.1021/bi3016247; Yang LL, 2012, BIOCHEMISTRY-US, V51, P7173, DOI 10.1021/bi3010945; Yang LL, 2011, J AM CHEM SOC, V133, P10434, DOI 10.1021/ja110196d; Yokoyama K, 2007, J AM CHEM SOC, V129, P15147, DOI 10.1021/ja072481t; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	93	27	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4003	4009		10.1074/jbc.R114.573675	http://dx.doi.org/10.1074/jbc.R114.573675			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25477522	Green Published, hybrid			2022-12-28	WOS:000349458400013
J	Teitelman, G; Kedees, M				Teitelman, Gladys; Kedees, Mamdouh			Mouse Insulin Cells Expressing an Inducible RIPCre Transgene Are Functionally Impaired	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELLS; MICE; GLUCOSE; MASS; PROLIFERATION; PROGENITORS; SECRETION; EXENDIN-4; RECEPTOR; AGONIST	We used cre-lox technology to test whether the inducible expression of Cre minimize the deleterious effect of the enzyme on beta cell function. We studied mice in which Cre is linked to a modified estrogen receptor (ER), and its expression is controlled by the rat insulin promoter (RIP). Following the injection of tamoxifen (TM), CreER-migrates to the nucleus and promotes the appearance of a reporter protein, enhanced yellow fluorescent protein (EYFP), in cells. Immunocytochemical analysis indicated that 46.6 +/- 2.1% insulin cells of adult RIPCreER-EYFP expressed EYFP. RIPCreER-EYFP (+TM) mice were normoglycemic throughout the study, and their glucose tolerance test results were similar to control CD-1 mice. However, an extended exposure to reagents that stimulate insulin synthesis was detrimental to the survival of IN+EYFP+ cells. The administration of an inhibitor of the enzyme dipeptidyl-peptidase (DPP4i), which prevents the cleavage of glucagon-like peptide (GLP-1), to adult RIPCreER-EYFP mice lead to a decrease in the percentage of IN+EYFP+ to 17.5 +/- 1.73 and a significant increase in apoptotic cells in islets. Similarly, a 2-week administration of the GLP-1 analog exendin 4 (ex-4) induced an almost complete ablation of IN+ expressing a different reporter protein and a significant decrease in the beta cell mass and rate of beta cell proliferation. Since normal beta cells do not die when induced to increase insulin synthesis, our observations indicate that insulin cells expressing an inducible RIPCre transgene are functionally deficient. Studies employing these mice should carefully consider the pitfalls of the Cre-Lox technique.	[Teitelman, Gladys; Kedees, Mamdouh] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Teitelman, G (corresponding author), SUNY Hlth Sci Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	gteitelman@downstate.edu		Teitelman, Gladys/0000-0003-0687-3032				Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Beall C, 2010, BIOCHEM J, V429, P323, DOI 10.1042/BJ20100231; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Ellenbroek JH, 2013, DIABETOLOGIA, V56, P1980, DOI 10.1007/s00125-013-2957-2; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; GOKE R, 1993, J BIOL CHEM, V268, P19650; Grigoryan M, 2012, ENDOCRINOLOGY, V153, P3076, DOI 10.1210/en.2012-1120; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Hellerstrom C, 1985, DIABETIC PANCREAS, P53; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holst JJ, 2005, DIABETOLOGIA, V48, P612, DOI 10.1007/s00125-005-1705-7; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Liu H, 2010, ENDOCRINOLOGY, V151, P520, DOI 10.1210/en.2009-0992; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Tang TY, 2013, CELL METAB, V18, P883, DOI 10.1016/j.cmet.2013.10.012; Weinberg N, 2007, FORBES, V179, P56; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yang KT, 2014, DIABETOLOGIA, V57, P352, DOI 10.1007/s00125-013-3085-8; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026; Zeng N, 2013, AGING CELL, V12, P1000, DOI 10.1111/acel.12132	30	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3647	3653		10.1074/jbc.M114.615484	http://dx.doi.org/10.1074/jbc.M114.615484			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533471	hybrid, Green Published			2022-12-28	WOS:000349456000037
J	Iejima, D; Itabashi, T; Kawamura, Y; Noda, T; Yuasa, S; Fukuda, K; Oka, C; Iwata, T				Iejima, Daisuke; Itabashi, Takeshi; Kawamura, Yuich; Noda, Toru; Yuasa, Shinsuke; Fukuda, Keiichi; Oka, Chio; Iwata, Takeshi			HTRA1 (High Temperature Requirement A Serine Peptidase 1) Gene Is Transcriptionally Regulated by Insertion/Deletion Nucleotides Located at the 3 ' End of the ARMS2 (Age-related Maculopathy Susceptibility 2) Gene in Patients with Age-related Macular Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Photoreceptor; Retina; Retinal Degeneration; Transcription Regulation; ARMS2; EMSA; HTRA1; Age-related Macular Degeneration	POLYPOIDAL CHOROIDAL VASCULOPATHY; PROTEASE; EXPRESSION; DIFFERENTIATION; OVEREXPRESSION; POLYMORPHISM; VARIANT	Background: The biological function of insertion/deletion sequences associated with AMD has not been fully characterized. Results: The HTRA1 regulatory region contains an insertion/deletion sequence that is significantly up-regulated in retinal neuronal cell lines. Conclusion:HTRA1 expression is enhanced by a mutation in the insertion/deletion in the HTRA1 regulatory region. Significance: This is the characterization of the HTRA1 regulatory elements and the effect of insertion/deletion sequences associated with AMD. Dry age-related macular degeneration (AMD) accounts for over 85% of AMD cases in the United States, whereas Japanese AMD patients predominantly progress to wet AMD or polypoidal choroidal vasculopathy. Recent genome-wide association studies have revealed a strong association between AMD and an insertion/deletion sequence between the ARMS2 (age-related maculopathy susceptibility 2) and HTRA1 (high temperature requirement A serine peptidase 1) genes. Transcription regulator activity was localized in mouse retinas using heterozygous HtrA1 knock-out mice in which HtrA1 exon 1 was replaced with -galactosidase cDNA, thereby resulting in dominant expression of the photoreceptors. The insertion/deletion sequence significantly induced HTRA1 transcription regulator activity in photoreceptor cell lines but not in retinal pigmented epithelium or other cell types. A deletion construct of the HTRA1 regulatory region indicated that potential transcriptional suppressors and activators surround the insertion/deletion sequence. Ten double-stranded DNA probes for this region were designed, three of which interacted with nuclear extracts from 661W cells in EMSA. Liquid chromatography-mass spectrometry (LC-MS/MS) of these EMSA bands subsequently identified a protein that bound the insertion/deletion sequence, LYRIC (lysine-rich CEACAM1 co-isolated) protein. In addition, induced pluripotent stem cells from wet AMD patients carrying the insertion/deletion sequence showed significant up-regulation of the HTRA1 transcript compared with controls. These data suggest that the insertion/deletion sequence alters the suppressor and activator cis-elements of HTRA1 and triggers sustained up-regulation of HTRA1. These results are consistent with a transgenic mouse model that ubiquitously overexpresses HtrA1 and exhibits characteristics similar to those of wet AMD patients.	[Iejima, Daisuke; Itabashi, Takeshi; Kawamura, Yuich; Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo 1528902, Japan; [Noda, Toru] Natl Hosp Org Tokyo Med Ctr, Div Ophthalmol, Tokyo 1528902, Japan; [Yuasa, Shinsuke; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan; [Oka, Chio] Nara Inst Sci & Technol, Div Gene Funct Anim, Nara 6300101, Japan	Keio University; Nara Institute of Science & Technology	Iwata, T (corresponding author), Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo 1528902, Japan.	takeshi_iwata@kankakuki.go.jp	Fukuda, Keiichi/L-3777-2013	Itabashi, Takeshi/0000-0002-2222-3446; Yuasa, Shinsuke/0000-0001-5593-7552	Japanese Ministry of Health, Labor, and Welfare [10103254]; National Hospital Organization of Japan [09005752]; Japan Society for the Promotion of Science [23890258]	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); National Hospital Organization of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japanese Ministry of Health, Labor, and Welfare Grant 10103254 and National Hospital Organization of Japan Grant 09005752 (to T. I.). This work was also supported by Japan Society for the Promotion of Science Grant 23890258 (to D. I.).	Ash SC, 2008, BIOCHEM BIOPH RES CO, V371, P333, DOI 10.1016/j.bbrc.2008.04.084; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Domigan CK, 2014, CELL, V159, P473, DOI 10.1016/j.cell.2014.10.008; Ferrer-Vaquer A, 2008, DEV DYNAM, V237, P1893, DOI 10.1002/dvdy.21597; Foucaud-Scheunemann C, 2003, FEMS MICROBIOL LETT, V224, P53, DOI 10.1016/S0378-1097(03)00419-1; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Huang Y, 2014, ONCOL LETT, V8, P493, DOI 10.3892/ol.2014.2231; Jiang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046058; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Minegishi Y, 2013, HUM MOL GENET, V22, P3559, DOI 10.1093/hmg/ddt210; Nakayama M, 2014, INVEST OPHTH VIS SCI, V55, P6514, DOI 10.1167/iovs.14-14453; Noch E, 2011, CANCER BIOL THER, V11, P32, DOI 10.4161/cbt.11.1.13835; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okamoto H, 2006, MOL VIS, V12, P156; Robertson CL, 2014, CANCER RES, V74, P6184, DOI 10.1158/0008-5472.CAN-14-1357; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Supanji, 2013, EXP EYE RES, V112, P79, DOI 10.1016/j.exer.2013.04.013; Tu ZD, 2011, J NEUROIMMUNOL, V230, P183, DOI 10.1016/j.jneuroim.2010.07.022; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wu XH, 2014, FEBS LETT, V588, P143, DOI 10.1016/j.febslet.2013.11.022; Xu YQ, 2014, J CELL BIOCHEM, V115, P1112, DOI 10.1002/jcb.24751; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990; Zhu F, 2010, HEPATOB PANCREAT DIS, V9, P508	40	16	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2784	2797		10.1074/jbc.M114.593384	http://dx.doi.org/10.1074/jbc.M114.593384			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25519903	Green Published, hybrid			2022-12-28	WOS:000349310700020
J	Boban, M; Ljungdahl, PO; Foisner, R				Boban, Mirta; Ljungdahl, Per O.; Foisner, Roland			Atypical Ubiquitylation in Yeast Targets Lysine-less Asi2 for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; PEROXISOMAL IMPORT RECEPTOR; NUCLEAR-MEMBRANE PROTEIN; COMPLEX CLASS-I; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; UBIQUITIN LIGASE; MAT-ALPHA-2 REPRESSOR; DOWN-REGULATION	Proteins are typically targeted for proteasomal degradation by the attachment of a polyubiquitin chain to epsilon-amino groups of lysine residues. Non-lysine ubiquitylation of proteasomal substrates has been considered an atypical and rare event limited to complex eukaryotes. Here we report that a fully functional lysine-less mutant of an inner nuclear membrane protein in yeast, Asi2, is polyubiquitylated and targeted for proteasomal degradation. Efficient degradation of lysine-free Asi2 requires E3-ligase Doa10 and E2 enzymes Ubc6 and Ubc7, components of the endoplasmic reticulum-associated degradation pathway. Together, our data suggest that non-lysine ubiquitylation may be more prevalent than currently considered.	[Boban, Mirta; Foisner, Roland] Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, A-1030 Vienna, Austria; [Ljungdahl, Per O.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-S-10691 Stockholm, Sweden	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Stockholm University	Foisner, R (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	roland.foisner@meduniwien.ac.at	Foisner, Roland/AAD-1833-2019; Ljungdahl, Per O/M-5258-2013	Ljungdahl, Per O/0000-0002-6625-3540; Foisner, Roland/0000-0003-4734-4647	Swedish Research Council [2011-5925]; Austrian Science Fund [FWF P23805-B20]; EMBO Long-Term Fellowship; Austrian Science Fund (FWF) [P 23805] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Swedish Research Council Grant 2011-5925 (to P. O. L.), Austrian Science Fund Grant FWF P23805-B20 (to R. F.), and an EMBO Long-Term Fellowship (to M. B.).	Andreasson C, 2004, YEAST, V21, P193, DOI 10.1002/yea.1052; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Boban M, 2014, J CELL SCI, V127, P3603, DOI 10.1242/jcs.153163; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Ciechanover A, 2007, ANN NY ACAD SCI, V1116, P1, DOI 10.1196/annals.1402.078; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Domingues C, 2012, CELL DEATH DIFFER, V19, P470, DOI 10.1038/cdd.2011.116; Forsberg H, 2001, GENETICS, V158, P973; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; Herr RA, 2009, TRAFFIC, V10, P1301, DOI 10.1111/j.1600-0854.2009.00946.x; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; McBratney S, 2002, GENETICS, V162, P567; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; SIKORSKI RS, 1989, GENETICS, V122, P19; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wang XL, 2005, J VIROL, V79, P4099, DOI 10.1128/JVI.79.7.4099-4108.2005; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821; Zargari A, 2007, J BIOL CHEM, V282, P594, DOI 10.1074/jbc.M609201200	44	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2489	2495		10.1074/jbc.M114.600593	http://dx.doi.org/10.1074/jbc.M114.600593			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25492870	Green Published, hybrid			2022-12-28	WOS:000348588000050
J	Jang, W; Kim, Y; Cui, S; Jo, J; Lee, BC; Lee, Y; Kwon, KS; Park, CS; Kim, C				Jang, Wijeong; Kim, Young; Cui, Shanyu; Jo, Juyeon; Lee, Byoung-Cheol; Lee, Yeonwoo; Kwon, Ki-Sun; Park, Chul-Seung; Kim, Changsoo			The Anoctamin Family Channel Subdued Mediates Thermal Nociception in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SENSOR; ION-CHANNEL; PAINLESS; RECEPTOR	Calcium-permeable and thermosensitive transient receptor potential (TRP) channels mediate the nociceptive transduction of noxious temperature in Drosophila nociceptors. However, the underlying molecular mechanisms are not completely understood. Here we find that Subdued, a calcium-activated chloride channel of the Drosophila anoctamin family, functions in conjunction with the thermo-TRPs in thermal nociception. Genetic analysis with deletion and the RNAi-mediated reduction of subdued show that subdued is required for thermal nociception in nociceptors. Further genetic analysis of subdued mutant and thermo-TRP mutants show that they interact functionally in thermal nociception. We find that Subdued expressed in heterologous cells mediates a strong chloride conductance in the presence of both heat and calcium ions. Therefore, our analysis suggests that Subdued channels may amplify the nociceptive neuronal firing that is initiated by thermo-TRP channels in response to thermal stimuli.	[Jang, Wijeong; Kim, Young; Jo, Juyeon; Kim, Changsoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Yongbong Dong 500757, Gwangju Si, South Korea; [Cui, Shanyu; Lee, Byoung-Cheol; Lee, Yeonwoo; Park, Chul-Seung] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Cui, Shanyu; Park, Chul-Seung] Gwangju Inst Sci & Technol, Natl Leading Res Lab Ion Channel, Kwangju 500712, South Korea; [Lee, Byoung-Cheol; Lee, Yeonwoo; Park, Chul-Seung] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Kim, Young; Kwon, Ki-Sun] Korea Res Inst Biosci & BioTechnol, Aging Res Ctr, Taejon, South Korea	Chonnam National University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Park, CS (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea.	cspark@gist.ac.kr; changgk@chonnam.ac.kr		Park, Chul-Seung/0000-0003-0209-1412; Jo, Juyeon/0000-0001-8939-1623	National Leading Research Laboratories [2012R1A2A2A01014574]; Biomedical Technology Development Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2011-0030133]; National Research Foundation - Ministry of Education, Science, and Technology of Korea [2011-0028665, 2011-0001154]	National Leading Research Laboratories; Biomedical Technology Development Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; National Research Foundation - Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Leading Research Laboratories Grant 2012R1A2A2A01014574 and by Biomedical Technology Development Program Grant 2011-0030133 through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (to C. K.) and by grants to the National Leading Research Laboratories (2011-0028665) and the Cell Dynamics Research Center (2011-0001154) from the National Research Foundation funded by the Ministry of Education, Science, and Technology of Korea (to C. S. P.).	Babcock DT, 2011, CURR BIOL, V21, P1525, DOI 10.1016/j.cub.2011.08.020; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004716; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Schnakenberg SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001192; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wong XM, 2013, ELIFE, V2, DOI 10.7554/eLife.00862; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; YANG MY, 1995, NEURON, V15, P45; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	21	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2521	2528		10.1074/jbc.M114.592758	http://dx.doi.org/10.1074/jbc.M114.592758			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505177	Green Published, hybrid			2022-12-28	WOS:000348588000052
J	Corbin, J				Corbin, Jackie			The Unexpected Evolution of Basic Science Studies about Cyclic Nucleotide Action into a Treatment for Erectile Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASES; MONOPHOSPHATE-BINDING-PROTEINS; SELECTIVE PDE5 INHIBITOR; LUNG CGMP-BINDING; SMOOTH-MUSCLE; GUANOSINE 3,5-MONOPHOSPHATE; SODIUM NITROPRUSSIDE; REGULATORY SUBUNIT; ADENOSINE; ACTIVATION	In these Reflections, I describe my perceived role in discoveries made in the cyclic nucleotide field that culminated in the advent of PDE5 inhibitors that treat erectile dysfunction, such as Viagra, Levitra, and Cialis. The discoveries emphasize the critical role of basic science, which often evolves in unpredictable and circuitous paths, in improving human health.	Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Corbin, J (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	jackie.corbin@vanderbilt.edu						ASHMAN DF, 1963, BIOCHEM BIOPH RES CO, V11, P330, DOI 10.1016/0006-291X(63)90566-7; BROSTROM CO, 1971, P NATL ACAD SCI USA, V68, P2444, DOI 10.1073/pnas.68.10.2444; CARR DW, 1991, J BIOL CHEM, V266, P14188; Corbin J. D., 1968, THESIS VANDERBILT U; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; CORBIN JD, 1975, J BIOL CHEM, V250, P218; CORBIN JD, 1983, J BIOL CHEM, V258, P1391; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; CORBIN JD, 1970, J BIOL CHEM, V245, P4849; CORBIN JD, 1977, J BIOL CHEM, V252, P3854; Daugan A, 2003, J MED CHEM, V46, P4525, DOI 10.1021/jm030056e; Daugan A, 2003, J MED CHEM, V46, P4533, DOI 10.1021/jm0300577; DETEJADA IS, 1989, NEW ENGL J MED, V320, P1025, DOI 10.1056/NEJM198904203201601; DRUMMOND G, 1961, J BIOL CHEM, V236, P1126; Francis S.H., 2013, ENCYCL BIOL CHEM 2 E, V50, P574, DOI [10.1016/B978-0-12-378630-2.00344-3, DOI 10.1016/B978-0-12-378630-2.00344-3]; FRANCIS SH, 1980, J BIOL CHEM, V255, P620; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; FRIEDMAN DL, 1963, BIOCHEMISTRY-US, V2, P669, DOI 10.1021/bi00904a009; GILL GN, 1976, P NATL ACAD SCI USA, V73, P3918, DOI 10.1073/pnas.73.11.3918; HARDMAN JG, 1969, J BIOL CHEM, V244, P6363; IGNARRO LJ, 1990, BIOCHEM BIOPH RES CO, V170, P843, DOI 10.1016/0006-291X(90)92168-Y; JIANG H, 1992, J BIOL CHEM, V267, P1015; JOHNSON RM, 1985, MOL PHARMACOL, V27, P333; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P239; KUO JF, 1970, J BIOL CHEM, V245, P2493; LINCOLN TM, 1977, P NATL ACAD SCI USA, V74, P3239, DOI 10.1073/pnas.74.8.3239; LINCOLN TM, 1976, P NATL ACAD SCI USA, V73, P2559, DOI 10.1073/pnas.73.8.2559; LINCOLN TM, 1977, J BIOL CHEM, V252, P4269; LOTEN EG, 1970, BIOCHEM J, V120, P187, DOI 10.1042/bj1200187; MCALLISTERLUCAS LM, 1993, J BIOL CHEM, V268, P22863; Murray K.J., 1993, DRUG NEWS PERSPECT, V6, P150; NDUBUKA C, 1993, J BIOL CHEM, V268, P7621; ROBISON GA, 1968, ANNU REV BIOCHEM, V37, P149, DOI 10.1146/annurev.bi.37.070168.001053; RODBELL M, 1964, J BIOL CHEM, V239, P375; SCHULTZ KD, 1977, NATURE, V265, P750, DOI 10.1038/265750a0; SODERLING TR, 1970, J BIOL CHEM, V245, P6317; SUGDEN PH, 1976, BIOCHEM J, V159, P423, DOI 10.1042/bj1590423; TAKAI Y, 1976, J BIOL CHEM, V251, P1481; THOMAS MK, 1990, J BIOL CHEM, V265, P14971; THOMAS MK, 1990, J BIOL CHEM, V265, P14964; WAGNER G, 1982, CLIN ENDOCRINOL META, V11, P717, DOI 10.1016/S0300-595X(82)80009-1; WALSH DA, 1968, J BIOL CHEM, V243, P3763; ZUBAY G, 1970, P NATL ACAD SCI USA, V66, P104, DOI 10.1073/pnas.66.1.104	44	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1374	1388		10.1074/jbc.X114.632174	http://dx.doi.org/10.1074/jbc.X114.632174			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25505249	Green Published, hybrid			2022-12-28	WOS:000348056400007
J	Fei, YR; Shimizu, E; McBurney, MW; Partridge, NC				Fei, Yurong; Shimizu, Emi; McBurney, Michael W.; Partridge, Nicola C.			Sirtuin 1 Is a Negative Regulator of Parathyroid Hormone Stimulation of Matrix Metalloproteinase 13 Expression in Osteoblastic Cells ROLE OF SIRTUIN 1 IN THE ACTION OF PTH ON OSTEOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; RAT COLLAGENASE-3 PROMOTER; ACTIVATOR PROTEIN-1; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; C-JUN; RESVERATROL; DIFFERENTIATION; RECEPTOR; GROWTH	Parathyroid hormone (PTH) is the only current anabolic treatment for osteoporosis in the United States. PTH stimulates expression of matrix metalloproteinase 13 (MMP13) in bone. Sirtuin 1 (SIRT1), an NAD-dependent deacetylase, participates in a variety of human diseases. Here we identify a role for SIRT1 in the action of PTH in osteoblasts. We observed increased Mmp13 mRNA expression and protein levels in bone from Sirt1 knock-out mice compared with wild type mice. PTH-induced Mmp13 expression was significantly blocked by the SIRT1 activator, resveratrol, in osteoblastic UMR 106-01 cells. In contrast, the SIRT1 inhibitor, EX527, significantly enhanced PTH-induced Mmp13 expression. Two h of PTH treatment augmented SIRT1 association with c-Jun, a component of the transcription factor complex, activator protein 1 (AP-1), and promoted SIRT1 association with the AP-1 site of the Mmp13 promoter. This binding was further increased by resveratrol, implicating SIRT1 as a feedback inhibitor regulating Mmp13 transcription. The AP-1 site of the Mmp13 promoter is required for PTH stimulation of Mmp13 transcriptional activity. When the AP-1 site was mutated, EX527 was unable to increase PTH-stimulated Mmp13 promoter activity, indicating a role for the AP-1 site in SIRT1 inhibition. We further showed that SIRT1 deacetylates c-Jun and that the cAMP pathway participates in this deacetylation process. These data indicate that SIRT1 is a negative regulator of MMP13 expression, SIRT1 activation inhibits PTH stimulation of Mmp13 expression, and this regulation is mediated by SIRT1 association with c-Jun at the AP-1 site of the Mmp13 promoter.	[Fei, Yurong; Shimizu, Emi; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [McBurney, Michael W.] Ottawa Hlth Res Ctr Inst, Ottawa, ON K1H 8L6, Canada	New York University; University of Ottawa; Ottawa Hospital Research Institute	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 E 24th St,902A, New York, NY 10010 USA.	ncp234@nyu.edu		Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [5R01DK047420-20]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01DK047420-20 (to N. C. P.).	Andereya S, 2006, RHEUMATOL INT, V26, P432, DOI 10.1007/s00296-005-0006-2; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; BERNDT TJ, 1981, ENDOCRINOLOGY, V108, P2005, DOI 10.1210/endo-108-5-2005; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Elmali N, 2005, INFLAMM RES, V54, P158, DOI 10.1007/s00011-004-1341-6; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Khan A, 2000, CAN MED ASSOC J, V163, P184; Knight CM, 2011, DIABETES, V60, P2691, DOI 10.2337/db10-0987; Lee HS, 2013, ARTHRITIS RHEUM-US, V65, P1776, DOI 10.1002/art.37963; Lee M, 2010, J BIOL CHEM, V285, P38014, DOI 10.1074/jbc.M110.142141; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mizutani K, 2000, J NUTR SCI VITAMINOL, V46, P78, DOI 10.3177/jnsv.46.78; Niederer F, 2011, ANN RHEUM DIS, V70, P1866, DOI 10.1136/ard.2010.148957; OMURA TH, 1994, J BIOL CHEM, V269, P24994; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03022; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Shakibaei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035712; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Uchida M, 2001, J BONE MINER METAB, V19, P207, DOI 10.1007/s007740170022; Walling HW, 1998, J CELL PHYSIOL, V177, P563, DOI 10.1002/(SICI)1097-4652(199812)177:4<563::AID-JCP7>3.0.CO;2-B; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yang JH, 2010, ENDOCRINE, V37, P365, DOI 10.1007/s12020-010-9314-8; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zainabadi K., 2009, THESIS MIT; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	59	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8373	8382		10.1074/jbc.M114.602763	http://dx.doi.org/10.1074/jbc.M114.602763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25631045	Green Published, hybrid			2022-12-28	WOS:000351662600031
J	Schmidt, T; Suk, JE; Ye, F; Situ, AJ; Mazumder, P; Ginsberg, MH; Ulmer, TS				Schmidt, Thomas; Suk, Jae-Eun; Ye, Feng; Situ, Alan J.; Mazumder, Parichita; Ginsberg, Mark H.; Ulmer, Tobias S.			Annular Anionic Lipids Stabilize the Integrin alpha IIb beta 3 Transmembrane Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; PHOSPHOLIPID-BILAYER NANODISCS; MOLECULAR-DYNAMICS SIMULATIONS; MEMBRANE-PROTEIN; PLASMA-MEMBRANE; LIGAND-BINDING; WATER; MODULATION; ACTIVATION; RECEPTOR	Cationic membrane-proximal amino acids determine the topology of membrane proteins by interacting with anionic lipids that are restricted to the intracellular membrane leaflet. This mechanism implies that anionic lipids interfere with electrostatic interactions of membrane proteins. The integrin alpha IIb beta 3 transmembrane (TM) complex is stabilized by a membraneproximal alpha IIb(Arg(995))-alpha 3(Asp(723)) interaction; here, we examine the influence of anionic lipids on this complex. Anionic lipids compete for alpha IIb(Arg(995)) contacts with beta 3(Asp(723)) but paradoxically do not diminish the contribution of alpha IIb(Arg(995))-beta 3(Asp(723)) to TM complex stability. Overall, anionic lipids in annular positions stabilize the similar to IIb similar to 3 TM complex by up to 0.50 +/- 0.02 kcal/mol relative to zwitterionic lipids in a headgroup structure-dependent manner. Comparatively, integrin receptor activation requires TM complex destabilization of 1.5 +/- 0.2 kcal/mol, revealing a sizeable influence of lipid composition onTMcomplex stability. Weimplicate changes in lipid headgroup accessibility to small molecules (physical membrane characteristics) and specific but dynamic protein-lipid contacts in thisTMhelix-helix stabilization. Thus, anionic lipids in ubiquitous annular positions can benefit the stability of membrane proteins while leaving membrane-proximal electrostatic interactions intact.	[Schmidt, Thomas; Suk, Jae-Eun; Situ, Alan J.; Mazumder, Parichita; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Schmidt, Thomas; Suk, Jae-Eun; Situ, Alan J.; Mazumder, Parichita; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Southern California; University of Southern California; University of California System; University of California San Diego	Ulmer, TS (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.	tulmer@usc.edu		Mazumder, Parichita/0000-0001-7578-7854	National Institutes of Health [HL31950, HL078784, HL117807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, P01HL078784, R01HL117807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL31950, HL078784, and HL117807 (to M. H. G.).	Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; Brini M, 2010, J BIOL CHEM, V285, P30779, DOI 10.1074/jbc.M110.140475; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; CONFORTI G, 1990, J BIOL CHEM, V265, P4011; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; GarciaGuerra R, 1996, PLATELETS, V7, P195, DOI 10.3109/09537109609023579; Gumbart J, 2005, CURR OPIN STRUC BIOL, V15, P423, DOI 10.1016/j.sbi.2005.07.007; HENRY GD, 1995, J BIOMOL NMR, V6, P59, DOI 10.1007/BF00417492; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalli AC, 2011, STRUCTURE, V19, P1477, DOI 10.1016/j.str.2011.07.014; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Koldso H, 2012, J PHYS CHEM LETT, V3, P3498, DOI 10.1021/jz301570w; KOUNS WC, 1992, J BIOL CHEM, V267, P18844; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5873, DOI 10.1021/bi047439e; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Situ AJ, 2014, J MOL BIOL, V426, P3670, DOI 10.1016/j.jmb.2014.08.020; SMYTH SS, 1992, J BIOL CHEM, V267, P15568; Suk JE, 2012, J AM CHEM SOC, V134, P9030, DOI 10.1021/ja304247f; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; Triba MN, 2005, BIOPHYS J, V88, P1887, DOI 10.1529/biophysj.104.055061; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Ulmer TS, 2010, CELL ADHES MIGR, V4, P243, DOI 10.4161/cam.4.2.10592; Ulmer TS, 2004, J MAGN RESON, V166, P190, DOI 10.1016/j.jmr.2003.10.012; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhang YL, 1998, ANAL BIOCHEM, V261, P139, DOI 10.1006/abio.1998.2738; Zhao W, 2007, BIOPHYS J, V92, P1114, DOI 10.1529/biophysj.106.086272; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	58	21	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8283	8293		10.1074/jbc.M114.623504	http://dx.doi.org/10.1074/jbc.M114.623504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25632962	hybrid, Green Published			2022-12-28	WOS:000351662600024
J	Kobayashi, S; Fukuhara, A; Otsuki, M; Suganami, T; Ogawa, Y; Morii, E; Shimomura, I				Kobayashi, Sachiko; Fukuhara, Atsunori; Otsuki, Michio; Suganami, Takayoshi; Ogawa, Yoshihiro; Morii, Eiichi; Shimomura, Iichiro			Fat/Vessel-derived Secretory Protein (Favine)/CCDC3 Is Involved in Lipid Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Adipose Tissue; Lipogenesis; Liver; Obesity; Coiled-coil Domain Containing 3 Gene; Favine Gene; Hepatic Steatosis	ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE; INSULIN-RESISTANCE; INDUCED OBESITY; ADIPOGENESIS; LIPOGENESIS; ADIPOCYTES; BETA; FAT; DIFFERENTIATION	Background: Coiled-coil domain-containing 3 (Ccdc3) mRNA is highly expressed in adipose tissue and vessels, but its function remains unknown. Results: CCDC3 overexpression promoted adipogenesis of 3T3-L1 adipocytes, whereas CCDC3 deficiency reduced adiposity and inhibited age-related hepatic steatosis in mice. Conclusion: CCDC3 positively regulates lipid accumulation. Significance: CCDC3 is a possible therapeutic target to age-related obesity and diseases. We previously identified a novel gene encoding Favine/CCDC3 (NCBI protein entry NP_083080), a possible secretory factor, the mRNA of which is highly expressed in adipose tissue and the aorta. The Favine mRNA levels are increased in the course of differentiation of rat primary adipocytes and are more elevated in the adipose tissue of genetically obese and diet-induced obese mice than in lean mice. However, its biological function has not yet been elucidated until now. Here, we tested the hypothesis that Favine is involved in lipid metabolism in adipocytes. We found that overexpression of Favine promoted 3T3-L1 adipocyte differentiation. To further investigate the function of Favine in vivo, we generated Favine knock-out (KO) mice. Favine KO mice exhibited a lean phenotype as they aged. The weights of white adipose tissue and liver were less, and adipocyte size was smaller in Favine KO mice compared with wild-type littermates (WT). Expression levels of lipogenic genes, such as fatty-acid synthase (FAS), acetyl-CoA carboxylase (ACC1), and diacylglycerol O-acyltransferase-2 (Dgat2), were decreased in adipose tissue of Favine KO mice. In 1-year-old mice, Favine deficiency decreased the number of inflammatory cells in white adipose tissue and diminished hepatic steatosis. In vitro, deficiency of Favine attenuated differentiation of primary adipocytes. Taken together, these data demonstrate that Favine has adipogenic and lipogenic effects on adipocytes.	[Kobayashi, Sachiko; Fukuhara, Atsunori; Otsuki, Michio; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan; [Suganami, Takayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Organ Network & Metab, Bunkyo Ku, Tokyo, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, Tokyo, Japan	Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Fukuhara, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka, Japan.	fukuhara@endmet.med.osaka-u.ac.jp	SUGANAMI, Takayoshi/A-9475-2016; Fukuhara, Atsunori/A-9601-2018	Fukuhara, Atsunori/0000-0002-6289-3778; Ogawa, Yoshihiro/0000-0002-0834-2836	Japan Society for the Promotion of Science [215490, 25860767, 24390238]; Japan Foundation for Applied Enzymology; Japan Health Foundation; Grants-in-Aid for Scientific Research [25860767] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; Japan Health Foundation(Japan Health Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for JSPS Fellows 215490, Grant-in-aid for Young Scientists 25860767, and Grants-in-aid for Scientific Research 24390238 from the Japan Society for the Promotion of Science and a grant from Japan Foundation for Applied Enzymology and from the Japan Health Foundation.	Azad AK, 2014, CELL SIGNAL, V26, P2793, DOI 10.1016/j.cellsig.2014.08.025; BJORNTORP P, 1978, J LIPID RES, V19, P316; Boren J, 2013, J INTERN MED, V274, P25, DOI 10.1111/joim.12071; Eberlein A, 2010, COMP BIOCHEM PHYS B, V156, P19, DOI 10.1016/j.cbpb.2010.01.013; Filhoulaud G, 2013, TRENDS ENDOCRIN MET, V24, P257, DOI 10.1016/j.tem.2013.01.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kobayashi S, 2010, BIOCHEM BIOPH RES CO, V392, P29, DOI 10.1016/j.bbrc.2009.12.142; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RICHARDSON RL, 1989, J ANIM SCI, V67, P2171; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tan JTM, 2008, AM J PHYSIOL-CELL PH, V295, pC740, DOI 10.1152/ajpcell.00333.2007; Tan JTM, 2013, AM J PHYSIOL-ENDOC M, V304, pE1291, DOI 10.1152/ajpendo.00654.2012; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Ugi S, 2014, OBESITY, V22, P1070, DOI 10.1002/oby.20645; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zamboni M, 2014, MECH AGEING DEV, V136, P129, DOI 10.1016/j.mad.2013.11.008	32	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7443	7451		10.1074/jbc.M114.592493	http://dx.doi.org/10.1074/jbc.M114.592493			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605713	hybrid, Green Published			2022-12-28	WOS:000351613600013
J	Zhao, H; Chiaro, CR; Zhang, LM; Smith, PB; Chan, CY; Pedley, AM; Pugh, RJ; French, JB; Patterson, AD; Benkovic, SJ				Zhao, Hong; Chiaro, Christopher R.; Zhang, Limin; Smith, Philip B.; Chan, Chung Yu; Pedley, Anthony M.; Pugh, Raymond J.; French, Jarrod B.; Patterson, Andrew D.; Benkovic, Stephen J.			Quantitative Analysis of Purine Nucleotides Indicates That Purinosomes Increase de Novo Purine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLOSUCCINATE SYNTHETASE; MASS-SPECTROMETRY; CELL-GROWTH; ENZYME; COMPLEX; DNA; COMPARTMENTATION; PURIFICATION; VARIANTS; MODEL	Enzymes in the de novo purine biosynthesis pathway are recruited to form a dynamic metabolic complex referred to as the purinosome. Previous studies have demonstrated that purinosome assembly responds to purine levels in culture medium. Purine-depleted medium or 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT) treatment stimulates the purinosome assembly in HeLa cells. Here, several metabolomic technologies were applied to quantify the static cellular levels of purine nucleotides and measure the de novo biosynthesis rate of IMP, AMP, and GMP. Direct comparison of purinosome-rich cells (cultured in purine-depleted medium) and normal cells showed a 3-fold increase in IMP concentration in purinosomerich cells and similar levels of AMP, GMP, and ratios of AMP/GMP and ATP/ADP for both. In addition, a higher level of IMP was also observed in HeLa cells treated with DMAT. Furthermore, increases in the de novo IMP/AMP/GMP biosynthetic flux rate under purine-depleted condition were observed. The synthetic enzymes, adenylosuccinate synthase (ADSS) and inosine monophosphate dehydrogenase (IMPDH), downstream of IMP were also shown to be part of the purinosome. Collectively, these results provide further evidence that purinosome assembly is directly related to activated de novo purine biosynthesis, consistent with the functionality of the purinosome.	[Zhao, Hong; Pedley, Anthony M.; Pugh, Raymond J.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Chiaro, Christopher R.; Zhang, Limin; Smith, Philip B.; Patterson, Andrew D.] Penn State Univ, Metabol Facil, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Chan, Chung Yu] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA; [Zhang, Limin] Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China; [French, Jarrod B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [French, Jarrod B.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Patterson, AD (corresponding author), Penn State Univ, Metabol Facil, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.	adp117@psu.edu; sjb1@psu.edu	limin, zhang/O-8208-2016; Patterson, Andrew/G-3852-2012; French, Jarrod/K-6669-2014; Patterson, Andrew/ABF-1575-2020	limin, zhang/0000-0001-5689-948X; Patterson, Andrew/0000-0003-2073-0070; French, Jarrod/0000-0002-6762-1309; Patterson, Andrew/0000-0003-2073-0070; Pedley, Anthony/0000-0003-1034-5072	National Institutes of Health [GM024129, ES022186]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024129, R37GM024129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024129 (to S. J. B.) and ES022186 (to A. D. P).	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Cordell RL, 2008, J CHROMATOGR B, V871, P115, DOI 10.1016/j.jchromb.2008.07.005; Danielsson APH, 2010, ANAL BIOCHEM, V404, P30, DOI 10.1016/j.ab.2010.04.013; DELUCA M, 1983, ARCH BIOCHEM BIOPHYS, V226, P285, DOI 10.1016/0003-9861(83)90295-3; Deng YJ, 2012, J BIOL CHEM, V287, P36201, DOI 10.1074/jbc.M112.407056; Dettmer K, 2011, ANAL BIOANAL CHEM, V399, P1127, DOI 10.1007/s00216-010-4425-x; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; Labesse G, 2013, STRUCTURE, V21, P975, DOI 10.1016/j.str.2013.03.011; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; MATHEWS CK, 1993, J BACTERIOL, V175, P6377, DOI 10.1128/jb.175.20.6377-6381.1993; Muddana HS, 2010, J AM CHEM SOC, V132, P2110, DOI 10.1021/ja908773a; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; ROWE PB, 1968, J BIOL CHEM, V243, P6373; ROWE PB, 1978, J BIOL CHEM, V253, P7711; Sengupta S, 2014, ACS NANO, V8, P2410, DOI 10.1021/nn405963x; Sengupta S, 2013, J AM CHEM SOC, V135, P1406, DOI 10.1021/ja3091615; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; SRERE PA, 1973, P NATL ACAD SCI USA, V70, P2534, DOI 10.1073/pnas.70.9.2534; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Sun HY, 2005, MOL CELL BIOCHEM, V269, P85, DOI 10.1007/s11010-005-2539-9; Thomas EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051096; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANDERWE.MB, 1974, J BIOL CHEM, V249, P7282; Wang W, 2009, J BIOL CHEM, V284, P3521, DOI 10.1074/jbc.M806707200; WHITTAM R, 1960, J PHYSIOL-LONDON, V154, P614, DOI 10.1113/jphysiol.1960.sp006601; WOMBACHER H, 1983, MOL CELL BIOCHEM, V56, P155; Yamaoka T, 1997, J BIOL CHEM, V272, P17719, DOI 10.1074/jbc.272.28.17719; Yamaoka T, 2001, J BIOL CHEM, V276, P21285, DOI 10.1074/jbc.M011103200; Zamzami MA, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-24	35	65	65	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6705	6713		10.1074/jbc.M114.628701	http://dx.doi.org/10.1074/jbc.M114.628701			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605736	Green Published, hybrid			2022-12-28	WOS:000350991500005
J	Gournas, C; Evangelidis, T; Athanasopoulos, A; Mikros, E; Sophianopoulou, V				Gournas, Christos; Evangelidis, Thomas; Athanasopoulos, Alexandros; Mikros, Emmanuel; Sophianopoulou, Vicky			The Aspergillus nidulans Proline Permease as a Model for Understanding the Factors Determining Substrate Binding and Specificity of Fungal Amino Acid Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; UTILIZATION GENE-CLUSTER; MUTATIONAL ANALYSIS; METABOLITE REPRESSION; PROTEIN STRUCTURES; YEAST; MECHANISM; EXPRESSION; PREDICTION; RESIDUES	Amino acid uptake in fungi is mediated by general and specialized members of the yeast amino acid transporter (YAT) family, a branch of the amino acid polyamine organocation (APC) transporter superfamily. PrnB, a highly specific L-proline transporter, only weakly recognizes other Put4p substrates, its Saccharomyces cerevisiae orthologue. Taking advantage of the high sequence similarity between the two transporters, we combined molecular modeling, induced fit docking, genetic, and biochemical approaches to investigate the molecular basis of this difference and identify residues governing substrate binding and specificity. We demonstrate that L-proline is recognized by PrnB via interactions with residues within TMS1 (Gly(56), Thr(57)), TMS3(Glu(138)), and TMS6(Phe(248)), which are evolutionary conserved in YATs, whereas specificity is achieved by subtle amino acid substitutions in variable residues. Put4p-mimicking substitutions in TMS3 (S130C), TMS6 (F252L, S253G), TMS8 (W351F), and TMS10 (T414S) broadened the specificity of PrnB, enabling it to recognize more efficiently L-alanine, L-azetidine-2-carboxylic acid, and glycine without significantly affecting the apparent K-m for L-proline. S253G and W351F could transport L-alanine, whereas T414S, despite displaying reduced proline uptake, could transport L-alanine and glycine, a phenotype suppressed by the S130C mutation. A combination of all five Put4p-ressembling substitutions resulted in a functional allele that could also transport L-alanine and glycine, displaying a specificity profile impressively similar to that of Put4p. Our results support a model where residues in these positions determine specificity by interacting with the substrates, acting as gating elements, altering the flexibility of the substrate binding core, or affecting conformational changes of the transport cycle.	[Gournas, Christos; Athanasopoulos, Alexandros; Sophianopoulou, Vicky] NCSR Demokritos, Microbial Mol Genet Lab, Inst Biosci & Applicat, Athens 15310, Greece; [Evangelidis, Thomas; Mikros, Emmanuel] Univ Athens, Sch Pharm, GR-15771 Athens, Greece	National Centre of Scientific Research "Demokritos"; National & Kapodistrian University of Athens	Sophianopoulou, V (corresponding author), NCSR Demokritos, Microbial Mol Genet Lab, Inst Biosci & Applicat, Athens 15310, Greece.	vicky@bio.demokritos.gr	Mikros, Emmanuel/E-4223-2017; Gournas, Christos/ABD-6186-2021; Gournas, Christos/ADL-6622-2022	Mikros, Emmanuel/0000-0002-5984-5169; Gournas, Christos/0000-0003-4755-8602; Athanasopoulos, Alexandros/0000-0001-5551-4613	European Commission [262348]	European Commission(European CommissionEuropean Commission Joint Research Centre)	We are grateful to Prof. Claudio Scazzocchio and Dr. Sotiris Amillis for useful discussions and for critically reading the manuscript and Dr. Efstratios Stratikos for critically reading the manuscript. We also acknowledge financial support from the European Commission under the Seventh Framework Program by means of the grant agreement for the Integrated Infrastructure Initiative No. 262348 European Soft Matter Infrastructure (ESMI).	Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; Andre B, 1995, YEAST, V11, P1575, DOI 10.1002/yea.320111605; ANDRE B, 1993, MOL GEN GENET, V237, P17; Andreasson C, 2004, YEAST, V21, P193, DOI 10.1002/yea.1052; Apostolaki A, 2012, MOL MICROBIOL, V84, P530, DOI 10.1111/j.1365-2958.2012.08042.x; Apostolaki A, 2009, EUKARYOT CELL, V8, P339, DOI 10.1128/EC.00270-08; Athanasopoulos A, 2013, FUNGAL GENET BIOL, V53, P84, DOI 10.1016/j.fgb.2013.01.002; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; Cubero B, 2000, J BACTERIOL, V182, P233, DOI 10.1128/JB.182.1.233-235.2000; Dieterle MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010703; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Garcia I, 2004, EUKARYOT CELL, V3, P144, DOI 10.1128/EC.3.1.144-156.2004; Ghaddar K, 2014, J BIOL CHEM, V289, P7232, DOI 10.1074/jbc.M113.525915; Gomez D, 2003, MOL MICROBIOL, V50, P277, DOI 10.1046/j.1365-2958.2003.03682.x; Gonzalez R, 1997, EMBO J, V16, P2937, DOI 10.1093/emboj/16.10.2937; Gournas C, 2010, MOL MICROBIOL, V75, P246, DOI 10.1111/j.1365-2958.2009.06997.x; HORAK J, 1982, BIOCHIM BIOPHYS ACTA, V691, P144, DOI 10.1016/0005-2736(82)90223-1; Hutchings H, 1999, MOL MICROBIOL, V32, P557, DOI 10.1046/j.1365-2958.1999.01371.x; Jeschke G, 2013, EUR BIOPHYS J BIOPHY, V42, P181, DOI 10.1007/s00249-012-0802-z; Kafasla P, 2007, FUNGAL GENET BIOL, V44, P615, DOI 10.1016/j.fgb.2007.01.011; Kanda N, 2013, BIOCHEMISTRY-US, V52, P4296, DOI 10.1021/bi4004638; Karena E, 2011, J BIOL CHEM, V286, P39595, DOI 10.1074/jbc.M111.299164; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; KINGHORN JR, 1975, J GEN MICROBIOL, V86, P174, DOI 10.1099/00221287-86-1-174; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krypotou E, 2014, MOL MICROBIOL, V93, P129, DOI 10.1111/mmi.12646; Krypotou E, 2012, J BIOL CHEM, V287, P36792, DOI 10.1074/jbc.M112.400382; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Moretti MB, 1998, CELL MOL BIOL, V44, P585; Nasuno R, 2013, P NATL ACAD SCI USA, V110, P11821, DOI 10.1073/pnas.1300558110; Nomura M, 2003, J BIOCHEM, V133, P67, DOI 10.1093/jb/mvg003; Ogawa-Mitsuhashi K, 2009, YEAST, V26, P587, DOI 10.1002/yea.1708; Omura F, 2005, BIOSCI BIOTECH BIOCH, V69, P1162, DOI 10.1271/bbb.69.1162; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2013, J BIOL CHEM, V288, P36827, DOI 10.1074/jbc.M113.523340; Papakostas K, 2012, J BIOL CHEM, V287, P15684, DOI 10.1074/jbc.M112.355818; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roumelioti K, 2010, FUNGAL GENET BIOL, V47, P254, DOI 10.1016/j.fgb.2009.12.004; Sanguinetti M, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140070; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SOPHIANOPOULOU V, 1995, FEMS MICROBIOL REV, V16, P53, DOI 10.1016/0168-6445(94)00091-C; SOPHIANOPOULOU V, 1989, MOL MICROBIOL, V3, P705, DOI 10.1111/j.1365-2958.1989.tb00219.x; SOPHIANOPOULOU V, 1993, MOL GEN GENET, V236, P209, DOI 10.1007/BF00277114; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tavoularis S, 2001, FUNGAL GENET BIOL, V33, P115, DOI 10.1006/fgbi.2001.1280; Tavoularis SN, 2003, MOL MEMBR BIOL, V20, P285, DOI 10.1080/0968768031000106339; Tazebay UH, 1997, MOL MICROBIOL, V24, P105, DOI 10.1046/j.1365-2958.1997.3201689.x; TAZEBAY UH, 1995, FEMS MICROBIOL LETT, V132, P27; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Trip H, 2004, APPL ENVIRON MICROB, V70, P4775, DOI 10.1128/AEM.70.8.4775-4783.2004; Usami Y, 2014, BBA-BIOMEMBRANES, V1838, P1719, DOI 10.1016/j.bbamem.2014.03.018; Van Belle D, 2001, CURR OPIN CELL BIOL, V13, P389, DOI 10.1016/S0955-0674(00)00226-X; Vangelatos I, 2010, EUKARYOT CELL, V9, P1441, DOI 10.1128/EC.00087-10; Vangelatos I, 2009, MOL MEMBR BIOL, V26, P356, DOI 10.1080/09687680903170546; Vastermark A, 2014, PROTEINS, V82, P2797, DOI 10.1002/prot.24643; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yadav AK, 2011, J BIOL CHEM, V286, P19714, DOI 10.1074/jbc.M111.240648; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	79	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6141	6155		10.1074/jbc.M114.612069	http://dx.doi.org/10.1074/jbc.M114.612069			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25572393	Green Published, hybrid			2022-12-28	WOS:000350732500023
J	Gros, C; Fleury, L; Nahoum, V; Faux, C; Valente, S; Labella, D; Cantagrel, F; Rilova, E; Bouhlel, MA; David-Cordonnier, MH; Dufau, I; Ausseil, F; Mai, A; Mourey, L; Lacroix, L; Arimondo, PB				Gros, Christina; Fleury, Laurence; Nahoum, Virginie; Faux, Celine; Valente, Sergio; Labella, Donatella; Cantagrel, Frederic; Rilova, Elodie; Bouhlel, Mohamed Amine; David-Cordonnier, Marie-Helene; Dufau, Isabelle; Ausseil, Frederic; Mai, Antonello; Mourey, Lionel; Lacroix, Laurent; Arimondo, Paola B.			New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC THERAPY; CANCER; METHYLATION; BINDING; FUTURE; DNMT1	Among the epigenetic marks, DNA methylation is one of the most studied. It is highly deregulated in numerous diseases, including cancer. Indeed, it has been shown that hypermethylation of tumor suppressor genes promoters is a common feature of cancer cells. Because DNA methylation is reversible, the DNA methyltransferases (DNMTs), responsible for this epigenetic mark, are considered promising therapeutic targets. Several molecules have been identified as DNMT inhibitors and, among the non-nucleoside inhibitors, 4-aminoquinoline-based inhibitors, such as SGI-1027 and its analogs, showed potent inhibitory activity. Here we characterized the in vitro mechanism of action of SGI-1027 and two analogs. Enzymatic competition studies with the DNA substrate and the methyl donor cofactor, S-adenosyl-L-methionine (AdoMet), displayed AdoMet non-competitive and DNA competitive behavior. In addition, deviations from the Michaelis-Menten model in DNA competition experiments suggested an interaction with DNA. Thus their ability to interact with DNA was established; although SGI-1027 was a weak DNA ligand, analog 5, the most potent inhibitor, strongly interacted with DNA. Finally, as 5 interacted with DNMT only when the DNA duplex was present, we hypothesize that this class of chemical compounds inhibit DNMTs by interacting with the DNA substrate.	[Gros, Christina; Fleury, Laurence; Faux, Celine; Cantagrel, Frederic; Rilova, Elodie; Dufau, Isabelle; Ausseil, Frederic; Arimondo, Paola B.] ETaC, CRDPF, Unite Serv & Rech, CNRS Pierre Fabre 3388, F-31035 Toulouse 01, France; [Nahoum, Virginie; Mourey, Lionel] CNRS, Inst Pharmacol & Biol Struct IPBS, F-31077 Toulouse, France; [Nahoum, Virginie; Mourey, Lionel] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Valente, Sergio; Labella, Donatella; Mai, Antonello] Univ Roma La Sapienza, Dept Chem & Technol Drug, I-00185 Rome, Italy; [Bouhlel, Mohamed Amine; David-Cordonnier, Marie-Helene] IRCL, INSERM, JPARC Jean Pierre Aubert Res Ctr, UMR837,Team 4, F-59045 Lille, France; [Mai, Antonello] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, I-00185 Rome, Italy; [Lacroix, Laurent] CNRS, LBME, UMR5099, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Sapienza University Rome; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Fondazione Cenci Bolognetti; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Arimondo, PB (corresponding author), CNRS Pierre Fabre 3388 ETaC, CRDPF, Unite Serv & Rech, 3 Ave H Curien, F-31035 Toulouse 01, France.	paola.arimondo@etac.cnrs.fr	DAVID-CORDONNIER, Marie-Helene/P-9909-2019; Lacroix, Laurent/C-7024-2009; Mourey, Lionel/B-5662-2009; Mai, Antonello/AAC-2144-2019; David-Cordonnier, Marie-Helene/M-3725-2018; Valente, Sergio/K-2198-2016; Arimondo, Paola B/R-9095-2017	DAVID-CORDONNIER, Marie-Helene/0000-0001-9831-5577; Lacroix, Laurent/0000-0002-6382-9057; Mourey, Lionel/0000-0002-8259-1259; David-Cordonnier, Marie-Helene/0000-0001-9831-5577; Valente, Sergio/0000-0002-2241-607X; Arimondo, Paola B/0000-0001-5175-4396; Nahoum, Virginie/0000-0003-3125-6618; cantagrel, frederic/0000-0002-5354-0540; Jacob (Gros), Christina/0000-0001-8869-9028; Mai, Antonello/0000-0001-9176-2382	CNRS (Action Thematique et Incitative sur Programme); Region Midi Pyrenees (Equipe d'Excellence); Region Midi Pyrenees (FEDER CNRS/Region Midi Pyrenees); Fondation pour la Recherche Medicale [FDT20130928249]; Ligue Nationale contre le Cancer Comite du Nord; FIRB [RBFR10ZJQT]; IIT-Sapienza Project; FP7 Project [BLUEPRINT/282510]; Sapienza Ateneo Project; Institut pour la Recherche sur le Cancer de Lille	CNRS (Action Thematique et Incitative sur Programme); Region Midi Pyrenees (Equipe d'Excellence)(Region Occitanie); Region Midi Pyrenees (FEDER CNRS/Region Midi Pyrenees)(Region Occitanie); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Nationale contre le Cancer Comite du Nord; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); IIT-Sapienza Project; FP7 Project; Sapienza Ateneo Project; Institut pour la Recherche sur le Cancer de Lille	This work was supported by the CNRS (Action Thematique et Incitative sur Programme to P. B. A.) and Region Midi Pyrenees (Equipe d'Excellence and FEDER CNRS/Region Midi Pyrenees; to P. B. A.), by Grant FDT20130928249 from the Fondation pour la Recherche Medicale (to C. G.), by Ligue Nationale contre le Cancer Comite du Nord (to M.-H. D. C.), by FIRB RBFR10ZJQT, IIT-Sapienza Project and FP7 Project BLUEPRINT/282510 (to A. M.), by Sapienza Ateneo Project 2012 (by S. V.), and a post-doctoral fellowship from Institut pour la Recherche sur le Cancer de Lille (to M. A. B.).	Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Copeland RA, 1998, BIOCHEM PHARMACOL, V55, P1785, DOI 10.1016/S0006-2952(97)00663-1; Copeland RA, 2003, ANAL BIOCHEM, V320, P1, DOI 10.1016/S0003-2697(03)00346-4; Dervan PB, 1999, CURR OPIN CHEM BIOL, V3, P688, DOI 10.1016/S1367-5931(99)00027-7; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fagan RL, 2013, J BIOL CHEM, V288, P23858, DOI 10.1074/jbc.M113.480517; Fahy J, 2012, EXPERT OPIN THER PAT, V22, P1427, DOI 10.1517/13543776.2012.729579; FOX KR, 1990, BIOCHEM J, V269, P217, DOI 10.1042/bj2690217; Gamage SA, 2013, BIOORGAN MED CHEM, V21, P3147, DOI 10.1016/j.bmc.2013.03.033; Gros C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt753; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Lacroix L, 2000, ARCH BIOCHEM BIOPHYS, V381, P153, DOI 10.1006/abbi.2000.1934; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Lemster T, 2009, EUR J MED CHEM, V44, P3235, DOI 10.1016/j.ejmech.2009.03.026; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Racane L, 2013, EUR J MED CHEM, V63, P882, DOI 10.1016/j.ejmech.2013.02.026; Rilova E, 2014, CHEMMEDCHEM, V9, P590, DOI 10.1002/cmdc.201300420; Singh V, 2013, CURR CANCER DRUG TAR, V13, P379, DOI 10.2174/15680096113139990077; Song LX, 2012, ANN HEMATOL, V91, P1879, DOI 10.1007/s00277-012-1550-y; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Valente S, 2014, J MED CHEM, V57, P701, DOI 10.1021/jm4012627; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Yoo J, 2012, CURR COMPUT-AID DRUG, V8, P317, DOI 10.2174/157340912803519606	26	41	42	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6293	6302		10.1074/jbc.M114.594671	http://dx.doi.org/10.1074/jbc.M114.594671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25525263	Green Published, hybrid			2022-12-28	WOS:000350732500035
J	Kaps, S; Kettner, K; Migotti, R; Kanashova, T; Krause, U; Rodel, G; Dittmar, G; Kriegel, TM				Kaps, Sonja; Kettner, Karina; Migotti, Rebekka; Kanashova, Tamara; Krause, Udo; Roedel, Gerhard; Dittmar, Gunnar; Kriegel, Thomas M.			Protein Kinase Ymr291w/Tda1 Is Essential for Glucose Signaling in Saccharomyces cerevisiae on the Level of Hexokinase Isoenzyme ScHxk2 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO PHOSPHORYLATION; KLUYVEROMYCES-LACTIS; YEAST-HEXOKINASE; AUTOPHOSPHORYLATION-INACTIVATION; POSTTRANSLATIONAL MODIFICATIONS; GENE; PURIFICATION; PATHWAY; COMPLEX; CELLS	The enzyme ScHxk2 of Saccharomyces cerevisiae is a dual-function hexokinase that besides its catalytic role in glycolysis is involved in the transcriptional regulation of glucose-repressible genes. Relief from glucose repression is accompanied by the phosphorylation of the nuclear fraction of ScHxk2 at serine 15 and the translocation of the phosphoenzyme into the cytosol. Different studies suggest different serine/threonine protein kinases, Ymr291w/Tda1 or Snf1, to accomplish ScHxk2-S15 phosphorylation. The current paper provides evidence that Ymr291w/Tda1 is essential for that modification, whereas protein kinases Ydr477w/Snf1, Ynl307c/Mck1, Yfr014c/Cmk1, and Ykl126w/Ypk1, which are co-purified during Ymr291w/Tda1 tandem affinity purification, as well as protein kinase PKA and PKB homolog Sch9 are dispensable. Taking into account the detection of a significantly higher amount of the Ymr291w/Tda1 protein in cells grown in low-glucose media as compared with a high-glucose environment, Ymr291w/Tda1 is likely to contribute to glucose signaling in S. cerevisiae on the level of ScHxk2-S15 phosphorylation in a situation of limited external glucose availability. The evolutionary conservation of amino acid residue serine 15 in yeast hexokinases and its phosphorylation is illustrated by the finding that YMR291W/TDA1 of S. cerevisiae and the homologous KLLA0A09713 gene of Kluyveromyces lactis allow for cross-complementation of the respective protein kinase single-gene deletion strains.	[Kaps, Sonja; Kettner, Karina; Kriegel, Thomas M.] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Physiol Chem, D-01307 Dresden, Germany; [Migotti, Rebekka; Kanashova, Tamara; Dittmar, Gunnar] Max Delbruck Ctr Mol Med, Mass Spectrometry Platform, D-13125 Berlin, Germany; [Krause, Udo; Roedel, Gerhard] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany	Technische Universitat Dresden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Technische Universitat Dresden	Kettner, K (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Physiol Chem, D-01307 Dresden, Germany.	Karina.Kettner@tu-dresden.de	Roedel, Gerhard/AFQ-8997-2022; Roedel, Gerhard/AAH-3762-2022; Dittmar, Gunnar/C-6333-2019; Krause, Udo/N-8167-2014; Dittmar, Gunnar/B-6383-2016	Dittmar, Gunnar/0000-0003-3647-8623; Krause, Udo/0000-0001-9493-4522; Dittmar, Gunnar/0000-0003-3647-8623				Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Bar D, 2003, J BIOL CHEM, V278, P39280, DOI 10.1074/jbc.M305706200; Behlke J, 1998, BIOCHEMISTRY-US, V37, P11989, DOI 10.1021/bi980914m; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; BREUNIG KD, 1987, MOL CELL BIOL, V7, P4400, DOI 10.1128/MCB.7.12.4400; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Farriol-Mathis N, 2004, PROTEOMICS, V4, P1537, DOI 10.1002/pmic.200300764; Fernandez-Garcia P, 2012, J BIOL CHEM, V287, P42151, DOI 10.1074/jbc.M112.401679; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Golbik R, 2001, BIOCHEMISTRY-US, V40, P1083, DOI 10.1021/bi001745k; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Granot D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00044; Heidrich K, 1997, BIOCHEMISTRY-US, V36, P1960, DOI 10.1021/bi9623643; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kettner K, 2013, BIOCHEM BIOPH RES CO, V435, P313, DOI 10.1016/j.bbrc.2013.03.121; Kettner K, 2012, FEBS LETT, V586, P455, DOI 10.1016/j.febslet.2012.01.030; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KRIEGEL TM, 1994, BIOCHEMISTRY-US, V33, P148, DOI 10.1021/bi00167a019; Kuettner EB, 2010, J BIOL CHEM, V285, P41019, DOI 10.1074/jbc.M110.185850; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; LAZARUS NR, 1966, BIOCHEMISTRY-US, V5, P4003, DOI 10.1021/bi00876a035; MAITRA PK, 1970, J BIOL CHEM, V245, P2423; Mates N, 2014, MOL CELL PROTEOMICS, V13, P860, DOI 10.1074/mcp.M113.032714; Moreno F, 2002, FEMS MICROBIOL REV, V26, P83, DOI 10.1111/j.1574-6976.2002.tb00600.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oliveira AP, 2012, FEMS YEAST RES, V12, P104, DOI 10.1111/j.1567-1364.2011.00765.x; Pelaez R, 2012, J BIOL CHEM, V287, P3518, DOI 10.1074/jbc.M111.317230; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Randez-Gil F, 1998, MOL CELL BIOL, V18, P2940, DOI 10.1128/MCB.18.5.2940; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHULZ WA, 1993, BIOL CHEM H-S, V374, P313, DOI 10.1515/bchm3.1993.374.1-6.313; Sherman F, 1986, LAB COURSE MANUAL ME; SHERO JH, 1991, GENE DEV, V5, P549, DOI 10.1101/gad.5.4.549; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; VOJTEK AB, 1990, EUR J BIOCHEM, V190, P371, DOI 10.1111/j.1432-1033.1990.tb15585.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2	61	13	13	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6243	6255		10.1074/jbc.M114.595074	http://dx.doi.org/10.1074/jbc.M114.595074			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593311	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000350732500031
J	Frederiksen, RF; Yoshimura, Y; Storgaard, BG; Paspaliari, DK; Petersen, BO; Chen, K; Larsen, T; Duus, JO; Ingmer, H; Bovin, NV; Westerlind, U; Blixt, O; Palcic, MM; Leisner, JJ				Frederiksen, Rikki F.; Yoshimura, Yayoi; Storgaard, Birgit G.; Paspaliari, Dafni K.; Petersen, Bent O.; Chen, Kowa; Larsen, Tanja; Duus, Jens O.; Ingmer, Hanne; Bovin, Nicolai V.; Westerlind, Ulrika; Blixt, Ola; Palcic, Monica M.; Leisner, Jorgen J.			A Diverse Range of Bacterial and Eukaryotic Chitinases Hydrolyzes the LacNAc (Gal beta 1-4GlcNAc) and LacdiNAc (GalNAc beta 1-4GlcNAc) Motifs Found on Vertebrate and Insect Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENTLY LABELED OLIGOSACCHARIDES; SALMONELLA-ENTERICA; PLANT CHITINASES; REPEATING UNIT; CHITOTRIOSIDASE; PROTEINS; TRANSMISSION; EXPRESSION; EVOLUTION; INFECTION	There is emerging evidence that chitinases have additional functions beyond degrading environmental chitin, such as involvement in innate and acquired immune responses, tissue remodeling, fibrosis, and serving as virulence factors of bacterial pathogens. We have recently shown that both the human chitotriosidase and a chitinase from Salmonella enterica serovar Typhimurium hydrolyze LacNAc from Gal beta 1-4GlcNAc beta-tetramethylrhodamine (LacNAc-TMR (Gal beta 1-4GlcNAc beta (CH2)(8)-CONH(CH2)(2)NHCO-TMR)), a fluorescently labeled model substrate for glycans found in mammals. In this study we have examined the binding affinities of the Salmonella chitinase by carbohydrate microarray screening and found that it binds to a range of compounds, including five that contain LacNAc structures. We have further examined the hydrolytic specificity of this enzyme and chitinases from Sodalis glossinidius and Polysphondylium pallidum, which are phylogenetically related to the Salmonella chitinase, as well as unrelated chitinases from Listeria monocytogenes using the fluorescently labeled substrate analogs LacdiNAc-TMR (GalNAc beta 1-4GlcNAc beta-TMR), LacNAc-TMR, and LacNAc beta 1-6LacNAc beta-TMR. We found that all chitinases examined hydrolyzed LacdiNAc from the TMR aglycone to various degrees, whereas they were less active toward LacNAc-TMR conjugates. LacdiNAc is found in the mammalian glycome and is a common motif in invertebrate glycans. This substrate specificity was evident for chitinases of different phylogenetic origins. Three of the chitinases also hydrolyzed the beta 1-6 bond in LacNAc beta 1-6LacNAc beta-TMR, an activity that is of potential importance in relation to mammalian glycans. The enzymatic affinities for these mammalian-like structures suggest additional functional roles of chitinases beyond chitin hydrolysis.	[Frederiksen, Rikki F.; Storgaard, Birgit G.; Paspaliari, Dafni K.; Larsen, Tanja; Ingmer, Hanne; Leisner, Jorgen J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1870 Frederiksberg C, Denmark; [Yoshimura, Yayoi; Storgaard, Birgit G.; Petersen, Bent O.; Duus, Jens O.; Palcic, Monica M.] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Chen, Kowa] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, DK-2200 Kbh N, Denmark; [Bovin, Nicolai V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Westerlind, Ulrika] Gesell Forderung Analyt Wissensch eV, ISAS Leibnitz Inst Analyt Sci, D-44227 Dortmund, Germany; [Blixt, Ola] Univ Copenhagen, Dept Chem, DK-1871 Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Copenhagen	Leisner, JJ (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Gronnegaardsvej 10, DK-1870 Frederiksberg C, Denmark.	jjl@sund.ku.dk	Bovin, Nicolai/P-2948-2017; Duus, Jens Øllgaard/N-4279-2013; Leisner, Jørgen/L-7835-2018	Bovin, Nicolai/0000-0001-8669-4477; Duus, Jens Øllgaard/0000-0003-3625-1250; Blixt, Ola/0000-0003-4143-6276; Larsen, Tanja/0000-0002-1920-6274; Ingmer, Hanne/0000-0002-8350-5631; Frederiksen, Rikki Franklin/0000-0003-2835-1008	EU-FP7, EuroGlycoArrays [215536]; EU-FP7 Glyco-BioM [259869]; Russian Science Foundation [14-14-00579] Funding Source: Russian Science Foundation	EU-FP7, EuroGlycoArrays; EU-FP7 Glyco-BioM; Russian Science Foundation(Russian Science Foundation (RSF))	All NMR spectra were recorded on the Bruker Avance 800 spectrometer of the Danish Instrument Center for NMR Spectroscopy of Biological Macromolecules. Glycans for microarray were kindly provided by Dr. Carlo Unverzagt (Bayreuth) and supported by EU-FP7, EuroGlycoArrays (215536), and EU-FP7 Glyco-BioM (259869).	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Chaudhuri S, 2013, MBIO, V4, DOI 10.1128/mBio.00617-12; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Di Rosa M, 2006, EUR J NEUROSCI, V23, P2648, DOI 10.1111/j.1460-9568.2006.04780.x; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Goy R, 2013, EUR J INORG CHEM, V2013, P4466, DOI 10.1002/ejic.201300537; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Holt PS, 2007, APPL ENVIRON MICROB, V73, P6030, DOI 10.1128/AEM.00803-07; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Karlsson M, 2009, J MOL MICROB BIOTECH, V16, P208, DOI 10.1159/000151220; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; KOPANIC RJ, 1994, J FOOD PROTECT, V57, P125, DOI 10.4315/0362-028X-57.2.125; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Larsen T, 2014, FEBS LETT, V588, P746, DOI 10.1016/j.febslet.2013.12.035; Larsen T, 2011, GLYCOBIOLOGY, V21, P426, DOI 10.1093/glycob/cwq174; Le XC, 1997, J CHROMATOGR A, V781, P515, DOI 10.1016/S0021-9673(97)00607-9; Lee CG, 2012, J IMMUNOL, V189, P2635, DOI 10.4049/jimmunol.1201115; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Leisner JJ, 2008, APPL ENVIRON MICROB, V74, P3823, DOI 10.1128/AEM.02701-07; Leisner JJ, 2009, J APPL MICROBIOL, V107, P2080, DOI 10.1111/j.1365-2672.2009.04420.x; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moore BC, 2003, APPL ENVIRON MICROB, V69, P4556, DOI 10.1128/AEM.69.8.4556-4560.2003; Murata T, 2005, BIOCHEM BIOPH RES CO, V336, P514, DOI 10.1016/j.bbrc.2005.08.123; North SJ, 2006, GLYCOCONJUGATE J, V23, P345, DOI 10.1007/s10719-006-6693-4; Olsen AR, 2000, J FOOD PROTECT, V63, P958, DOI 10.4315/0362-028X-63.7.958; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Severov VV, 2007, RUSS J BIOORG CHEM+, V33, P122, DOI 10.1134/S1068162007010141; Shih NR, 1997, PLANT SCI, V130, P145, DOI 10.1016/S0168-9452(97)00229-X; Shilova N, 2012, GLYCOCONJUGATE J, V29, P87, DOI 10.1007/s10719-011-9368-8; Shoda S, 2006, CELLULOSE, V13, P477, DOI 10.1007/s10570-006-9066-z; Taira T., 2010, Journal of Applied Glycoscience, V57, P167, DOI 10.5458/jag.57.167; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yu TA, 2011, GLYCOBIOLOGY, V21, P206, DOI 10.1093/glycob/cwq151; ZHANG YN, 1995, ANAL BIOCHEM, V227, P368, DOI 10.1006/abio.1995.1293	42	18	18	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5354	5366		10.1074/jbc.M114.607291	http://dx.doi.org/10.1074/jbc.M114.607291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561735	Green Published, hybrid			2022-12-28	WOS:000350044200010
J	Macdonald, SS; Blaukopf, M; Withers, SG				Macdonald, Spencer S.; Blaukopf, Markus; Withers, Stephen G.			N-Acetylglucosaminidases from CAZy Family GH3 Are Really Glycoside Phosphorylases, Thereby Explaining Their Use of Histidine as an Acid/Base Catalyst in Place of Glutamic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; BETA-LACTAMASE INDUCTION; ESCHERICHIA-COLI; KINETIC-ANALYSIS; HYDROLASE NAGZ; IDENTIFICATION; GLUCOSIDASE; MECHANISMS; NUCLEOPHILE; ENZYMES	CAZy glycoside hydrolase family GH3 consists primarily of stereochemistry-retaining beta-glucosidases but also contains a subfamily of beta-N-acetylglucosaminidases. Enzymes from this subfamily were recently shown to use a histidine residue within a His-Asp dyad contained in a signature sequence as their catalytic acid/base residue. Reasons for their use of His rather than the Glu or Asp found in other glycosidases were not apparent. Through studies on a representative member, the Nag3 beta-N-acetylglucosaminidase from Cellulomonas fimi, we now show that these enzymes act preferentially as glycoside phosphorylases. Their need to accommodate an anionic nucleophile within the enzyme active site explains why histidine is used as an acid/base catalyst in place of the anionic glutamate seen in other GH3 family members. Kinetic and mechanistic studies reveal that these enzymes also employ a double-displacement mechanism involving a covalent glycosyl-enzyme intermediate, which was directly detected by mass spectrometry. Phosphate has no effect on the rates of formation of the glycosyl-enzyme intermediate, but it accelerates turnover of the N-acetylgluco-saminyl-enzyme intermediate similar to 3-fold, while accelerating turnover of the glucosyl-enzyme intermediate several hundredfold. These represent the first reported examples of retaining beta-glycoside phosphorylases, and the first instance of free beta-GlcNAc-1-phosphate in a biological context.	[Withers, Stephen G.] Univ British Columbia, Dept Chem, Ctr High Throughput Biol, Vancouver, BC V6T 1Z1, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, Ctr High Throughput Biol, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca		Macdonald, Spencer/0000-0001-9879-5507	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research; Canada Foundation for Innovation; B. C. Knowledge Development Fund; Schrodinger Fellowship from the Austrian Science Fund; Canada Research Chair	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); B. C. Knowledge Development Fund; Schrodinger Fellowship from the Austrian Science Fund(Austrian Science Fund (FWF)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes for Health Research, the Canada Foundation for Innovation, and the B. C. Knowledge Development Fund.; Recipient of a Schrodinger Fellowship from the Austrian Science Fund.; Supported by a Tier 1 Canada Research Chair. To whom correspondence should be addressed. Tel.: 604-822-3402; Fax: 604-822-8869; E-mail: withers@chem.ubc.ca.	Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Balcewich MD, 2009, PROTEIN SCI, V18, P1541, DOI 10.1002/pro.137; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Busca P, 1998, TETRAHEDRON LETT, V39, P8101, DOI 10.1016/S0040-4039(98)01838-3; Chan PHW, 2009, BIOCHEMISTRY-US, V48, P11220, DOI 10.1021/bi901606n; Chir J, 2002, BIOCHEM J, V365, P857, DOI 10.1042/BJ20020186; Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; IWASAKI H, 1989, J BACTERIOL, V171, P424, DOI 10.1128/jb.171.1.424-429.1989; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Mark BL, 2011, FUTURE MICROBIOL, V6, P1415, DOI [10.2217/FMB.11.128, 10.2217/fmb.11.128]; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Stubbs KA, 2013, CHEMBIOCHEM, V14, P1973, DOI 10.1002/cbic.201300395; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Vocadlo DJ, 2000, METH MOL B, V146, P203, DOI 10.1385/1-59259-045-4:203; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P1554; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; VOET JG, 1970, J BIOL CHEM, V245, P1020; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; WANG QP, 1995, J AM CHEM SOC, V117, P10137, DOI 10.1021/ja00145a035; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5	33	33	35	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4887	4895		10.1074/jbc.M114.621110	http://dx.doi.org/10.1074/jbc.M114.621110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533455	hybrid, Green Published			2022-12-28	WOS:000350042000033
J	Sarveswaran, S; Chakraborty, D; Chitale, D; Sears, R; Ghosh, J				Sarveswaran, Sivalokanathan; Chakraborty, Debrup; Chitale, Dhananjay; Sears, Rosalie; Ghosh, Jagadananda			Inhibition of 5-Lipoxygenase Selectively Triggers Disruption of c-Myc Signaling in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOTRIENE BIOSYNTHESIS INHIBITOR; ARACHIDONATE 5-LIPOXYGENASE; INFLAMMATORY DISEASES; GROWTH; PROTEIN; METASTASIS; EXPRESSION; APOPTOSIS; PROLIFERATION; TARGET	Myc is up-regulated in almost all cancer types and is the subject of intense investigation because of its pleiotropic effects controlling a broad spectrum of cell functions. However, despite its recognition as a stand-alone molecular target, development of suitable strategies to block its function is hindered because of its nonenzymatic nature. We reported earlier that arachidonate 5-lipoxygenase (5-Lox) plays an important role in the survival and growth of prostate cancer cells, although details of the underlying mechanisms have yet to be characterized. By whole genome gene expression array, we observed that inhibition of 5-Lox severely down-regulates the expression of c-Myc oncogene in prostate cancer cells. Moreover, inhibition of 5-Lox dramatically decreases the protein level, nuclear accumulation, DNA binding, and transcriptional activities of c-Myc. Both the 5-Lox inhibition-induced down-regulation of c-Myc and induction of apoptosis are mitigated when the cells are treated with 5-oxoeicosatetraenoic acid, a metabolite of 5-Lox, confirming a role of 5-Lox in these processes. c-Myc is a transforming oncogene widely expressed in prostate cancer cells and maintains their transformed phenotype. Interestingly, MK591, a specific 5-Lox inhibitor, strongly affects the viability of Myc-overactivated prostate cancer cells and completely blocks their invasive and soft agar colony-forming abilities, but it spares nontransformed cells where expression of 5-Lox is undetectable. These findings indicate that the oncogenic function of c-Myc in prostate cancer cells is regulated by 5-Lox activity, revealing a novel mechanism of 5-Lox action and suggesting that the oncogenic function of c-Myc can be suppressed by suitable inhibitors of 5-Lox.	[Sarveswaran, Sivalokanathan; Chakraborty, Debrup; Ghosh, Jagadananda] Henry Ford Hlth Syst, Dept Urol, Detroit, MI 48202 USA; [Chitale, Dhananjay] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI 48202 USA; [Chitale, Dhananjay; Ghosh, Jagadananda] Henry Ford Hlth Syst, Josephine Ford Canc Ctr, Detroit, MI 48202 USA; [Sears, Rosalie] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Oregon Health & Science University	Ghosh, J (corresponding author), Henry Ford Hlth Syst, Dept Urol, Vattikuti Urol Inst, 1 Ford Pl,2D, Detroit, MI 48202 USA.	jghosh1@hfhs.org		Chitale, Dhananjay/0000-0002-4421-6431	National Institutes of Health from NCI [RO1 CA152334]; Department of Defense Prostate Cancer Research Program [W81-XWH-05-1-0022]; Henry Ford Health System Internal Research Grant [A10203]; NATIONAL CANCER INSTITUTE [R01CA152334] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research Program(United States Department of Defense); Henry Ford Health System Internal Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA152334 from NCI. This work was also supported by Department of Defense Prostate Cancer Research Program W81-XWH-05-1-0022 and the Henry Ford Health System Internal Research Grant A10203 (to J. G.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Anderson KM, 1998, PROSTATE, V37, P161, DOI 10.1002/(SICI)1097-0045(19981101)37:3<161::AID-PROS5>3.0.CO;2-D; BRIDEAU C, 1992, CAN J PHYSIOL PHARM, V70, P799, DOI 10.1139/y92-107; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Evan G, 2012, SCIENCE, V335, P293, DOI 10.1126/science.1217819; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fleshner Neil, 2004, Journal of Urology, V171, pS19, DOI 10.1097/01.ju.0000107838.33623.19; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; Ghosh J, 1997, BIOCHEM BIOPH RES CO, V235, P418, DOI 10.1006/bbrc.1997.6799; Ghosh J, 1999, ADV EXP MED BIOL, V469, P577; Ghosh J., 2008, CURR ENZYME INHIB, V4, P18, DOI DOI 10.2174/157340808783502540; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; Iversen PL, 2003, CLIN CANCER RES, V9, P2510; Jenkins RB, 1997, CANCER RES, V57, P524; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; KIMURA S, 1995, CANCER RES, V55, P1379; Kolonel LN, 1999, JNCI-J NATL CANCER I, V91, P414, DOI 10.1093/jnci/91.5.414; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Matsuyama M, 2004, INT J ONCOL, V24, P821; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moretti RM, 2004, INT J CANCER, V112, P87, DOI 10.1002/ijc.20387; NAG A, 1989, PROSTATE, V15, P115, DOI 10.1002/pros.2990150205; Nie D, 2007, FRONT BIOSCI, V12, P1574, DOI 10.2741/2170; Ochoa JJ, 2004, CARCINOGENESIS, V25, P1185, DOI 10.1093/carcin/bgh116; Pham H, 2006, PROSTAG LEUKOTR ESS, V74, P271, DOI 10.1016/j.plefa.2006.01.004; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; PRASIT P, 1993, J LIPID MEDIATOR, V6, P239; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Radmark O, 2009, J LIPID RES, V50, pS40, DOI 10.1194/jlr.R800062-JLR200; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rohan JNP, 2009, ENDOCRINOLOGY, V150, P2046, DOI 10.1210/en.2008-1395; Sampson AP, 2009, CURR OPIN INVEST DR, V10, P1163; Sarveswaran S, 2013, CANCER LETT, V336, P185, DOI 10.1016/j.canlet.2013.04.027; Sarveswaran S, 2011, BBA-MOL CELL RES, V1813, P2108, DOI 10.1016/j.bbamcr.2011.07.015; Sarveswaran S, 2010, CANCER LETT, V291, P167, DOI 10.1016/j.canlet.2009.10.008; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; WANG Y, 1995, J NATL CANCER I, V87, P1456, DOI 10.1093/jnci/87.19.1456; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Yang PY, 2003, PROSTATE, V55, P281, DOI 10.1002/pros.10243; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102	66	35	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4994	5006		10.1074/jbc.M114.599035	http://dx.doi.org/10.1074/jbc.M114.599035			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540201	Green Published, hybrid			2022-12-28	WOS:000350042000041
J	Ratti, F; Ramond, F; Moncollin, V; Simonet, T; Milan, G; Mejat, A; Thomas, JL; Streichenberger, N; Gilquin, B; Matthias, P; Khochbin, S; Sandri, M; Schaeffer, L				Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Milan, Giulia; Mejat, Alexandre; Thomas, Jean-Luc; Streichenberger, Nathalie; Gilquin, Benoit; Matthias, Patrick; Khochbin, Saadi; Sandri, Marco; Schaeffer, Laurent			Histone Deacetylase 6 Is a FoxO Transcription Factor-dependent Effector in Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASES; MOUSE MODEL; HDAC6; ACETYLATION; EXPRESSION; DISEASE; STRESS; IDENTIFICATION; POLYUBIQUITIN; DEGRADATION	Skeletal muscle atrophy is a severe condition of muscle mass loss. Muscle atrophy is caused by a down-regulation of protein synthesis and by an increase of protein breakdown due to the ubiquitin-proteasome system and autophagy activation. Upregulation of specific genes, such as the muscle-specific E3 ubiquitin ligase MAFbx, by FoxO transcription factors is essential to initiate muscle protein ubiquitination and degradation during atrophy. HDAC6 is a particular HDAC, which is functionally related to the ubiquitin proteasome system via its ubiquitin binding domain. We show that HDAC6 is up-regulated during muscle atrophy. HDAC6 activation is dependent on the transcription factor FoxO3a, and the inactivation of HDAC6 in mice protects against muscle wasting. HDAC6 is able to interact with MAFbx, a key ubiquitin ligase involved in muscle atrophy. Our findings demonstrate the implication of HDAC6 in skeletal muscle wasting and identify HDAC6 as a new downstream target of FoxO3a in stress response. This work provides new insights in skeletal muscle atrophy development and opens interesting perspectives on HDAC6 as a valuable marker of muscle atrophy and a potential target for pharmacological treatments.	[Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Schaeffer, Laurent] Ecole Normale Super Lyon, F-69364 Lyon 07, France; [Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Schaeffer, Laurent] CNRS, UMR 5239, F-69364 Lyon 07, France; [Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Schaeffer, Laurent] Univ Lyon, Equipe Differenciat Neuromusculaire, F-69364 Lyon 07, France; [Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Streichenberger, Nathalie; Schaeffer, Laurent] Univ Lyon 1, F-38706 La Tronche, France; [Ratti, Francesca; Ramond, Francis; Moncollin, Vincent; Simonet, Thomas; Mejat, Alexandre; Thomas, Jean-Luc; Streichenberger, Nathalie; Schaeffer, Laurent] Hosp Civils Lyon, F-38706 La Tronche, France; [Gilquin, Benoit; Khochbin, Saadi] INSERM, U309, Inst Albert Bonniot, F-38706 La Tronche, France; [Matthias, Patrick] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Milan, Giulia; Sandri, Marco] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Milan, Giulia; Sandri, Marco] Dulbecco Telethon Inst, Venetian Inst Mol Med, I-35129 Padua, Italy	Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Friedrich Miescher Institute for Biomedical Research; University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine	Schaeffer, L (corresponding author), ENS Lyon, CNRS, UMR 5239, 46 Allee Italie, F-69364 Lyon 07, France.	Laurent.Schaeffer@ens-lyon.fr	Khochbin, Saadi/M-8090-2013; Ratti, Francesca/AAB-2116-2019; MONCOLLIN, Vincent/R-1941-2017; Ramond, Francis/GVS-2149-2022; GILQUIN, Benoit/A-6234-2014	Khochbin, Saadi/0000-0002-0455-0857; MONCOLLIN, Vincent/0000-0002-4163-0231; schaeffer, laurent/0000-0001-6600-503X; GILQUIN, benoit/0000-0001-8138-7021	Association Francaise contre les Myopathies (AFM); Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Institut National du Cancer (INCA)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France)	This work was supported by the Association Francaise contre les Myopathies (AFM), the Centre National de la Recherche Scientifique (CNRS), the Ministere de l'Education Nationale, de la Recherche et de la Technologie, and the Institut National du Cancer (INCA).	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; Gal J, 2013, J BIOL CHEM, V288, P15035, DOI 10.1074/jbc.M112.431957; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inui A, 2002, CA-CANCER J CLIN, V52, P72, DOI 10.3322/canjclin.52.2.72; Kanno K, 2012, ONCOL REP, V28, P867, DOI 10.3892/or.2012.1898; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim JW, 2007, DIFFERENTIATION, V75, P147, DOI 10.1111/j.1432-0436.2006.00118.x; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Penet MF, 2011, CANCER RES, V71, P6948, DOI 10.1158/0008-5472.CAN-11-1095; Piccirillo R, 2012, EMBO J, V31, P3334, DOI 10.1038/emboj.2012.178; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2012, NAT CELL BIOL, V14, P786, DOI 10.1038/ncb2550; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Taes I, 2013, HUM MOL GENET, V22, P1783, DOI 10.1093/hmg/ddt028; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Zuo QQ, 2012, ONCOL REP, V27, P819, DOI 10.3892/or.2011.1553	37	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4215	4224		10.1074/jbc.M114.600916	http://dx.doi.org/10.1074/jbc.M114.600916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25516595	Green Published, hybrid			2022-12-28	WOS:000349458400032
J	Hassan, C; Chabrol, E; Jahn, L; Kester, MGD; de Ru, AH; Drijfhout, JW; Rossjohn, J; Falkenburg, JHF; Heemskerk, MHM; Gras, S; van Veelen, PA				Hassan, Chopie; Chabrol, Eric; Jahn, Lorenz; Kester, Michel G. D.; de Ru, Arnoud H.; Drijfhout, Jan W.; Rossjohn, Jamie; Falkenburg, J. H. Frederik; Heemskerk, Mirjam H. M.; Gras, Stephanie; van Veelen, Peter A.			Naturally Processed Non-canonical HLA-A*02:01 Presented Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; Immunology; Mass Spectrometry (MS); Peptide Conformation; Peptides; HLA-A*02:01; Human Leukocyte Antigen Class I; T-cell Immunity; Peptidomics	MHC CLASS-I; COMPLEX CLASS-I; CELL-RECEPTOR RECOGNITION; AMINO-ACIDS; LONG; SPECIFICITY; SELECTION; IMPACT; LENGTH; TCR	Background: The impact of long epitopes on T-cell immunity remains unclear. Results: We identified and characterized 15-mer epitopes restricted to HLA-A*02:01. Conclusion: HLA-A*02:01, in addition to the HLA-B family, can bind long epitopes that represent new antigenic targets for CD8(+) T-cells. Significance: The characterization of 15-mer epitopes restricted to HLA-A*02:01 expands our knowledge of the HLA-ligandome. Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acids (aa) in length. Although an increasing number of examples with lengthy (>11 aa) peptides, presented mostly by HLA-B alleles, have been reported. Here we characterize HLA-A*02:01 restricted, in addition to the HLA-B*0702 and HLA-B*4402 restricted, lengthy peptides (>11 aa) arising from the B-cell ligandome. We analyzed a number of 15-mer peptides presented by HLA-A*02:01, and confirmed pHLA-I formation by HLA folding and thermal stability assays. Surprisingly the binding affinity and stability of the 15-mer epitopes in complex with HLA-A*02:01 were comparable with the values observed for canonical length (8 to 11 aa) HLA-A*02:01-restricted peptides. We solved the structures of two 15-mer epitopes in complex with HLA-A*02:01, within which the peptides adopted distinct super-bulged conformations. Moreover, we demonstrate that T-cells can recognize the 15-mer peptides in the context of HLA-A*02:01, indicating that these 15-mer peptides represent immunogenic ligands. Collectively, our data expand our understanding of longer epitopes in the context of HLA-I, highlighting that they are not limited to the HLA-B family, but can bind the ubiquitous HLA-A*02:01 molecule, and play an important role in T-cell immunity.	[Hassan, Chopie; de Ru, Arnoud H.; Drijfhout, Jan W.; van Veelen, Peter A.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Jahn, Lorenz; Kester, Michel G. D.; Falkenburg, J. H. Frederik; Heemskerk, Mirjam H. M.] Leiden Univ, Med Ctr, Dept Hematol, NL-2333 ZA Leiden, Netherlands; [Chabrol, Eric; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Rossjohn, Jamie; Gras, Stephanie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Monash University; Monash University; Cardiff University	Gras, S (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	stephanie.gras@monash.edu; p.a.van_veelen@lumc.nl	Drijfhout, Jan Wouter/ABA-6318-2021; Rossjohn, Jamie/F-9032-2013; Heemskerk, Mirjam H.M./ABI-2336-2020; hassan, cesare/H-2844-2012	Drijfhout, Jan Wouter/0000-0003-4808-5296; Rossjohn, Jamie/0000-0002-2020-7522; Heemskerk, Mirjam H.M./0000-0001-6320-9133; hassan, cesare/0000-0001-7167-1459; van Veelen, Peter/0000-0002-7898-9408; gras, stephanie/0000-0001-7416-038X; Jahn, Lorenz/0000-0002-9880-7026	Landsteiner Foundation for Blood Transfusion Research [LSBR0713]; Australian Research Council; National Health and Medical Research Council of Australia; National Health and Medical Research Council of Australia (NHMRC) Australia Fellowship; Australian Research Council [FT120100416]	Landsteiner Foundation for Blood Transfusion Research; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (NHMRC) Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by Landsteiner Foundation for Blood Transfusion Research Grant LSBR0713 and the Australian Research Council and the National Health and Medical Research Council of Australia.; Supported by a National Health and Medical Research Council of Australia (NHMRC) Australia Fellowship.; Supported by Australian Research Council Future Fellowship FT120100416.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bade-Doding C, 2011, HAEMATOL-HEMATOL J, V96, P110, DOI 10.3324/haematol.2010.030924; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell MJ, 2009, MOL IMMUNOL, V46, P1911, DOI 10.1016/j.molimm.2008.12.003; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Bourdetsky D, 2014, P NATL ACAD SCI USA, V111, pE1591, DOI 10.1073/pnas.1321902111; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Delano W.L, 2002, PYMOL USERS MANUAL; Ebert LM, 2009, CANCER RES, V69, P1046, DOI 10.1158/0008-5472.CAN-08-2926; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Hassan C, 2013, MOL CELL PROTEOMICS, V12, P1829, DOI 10.1074/mcp.M112.024810; Hombrink P, 2013, J IMMUNOL, V190, P3869, DOI 10.4049/jimmunol.1202351; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Liu YC, 2012, J BIOL CHEM, V287, P12267, DOI 10.1074/jbc.M112.344689; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Probst-Kepper M, 2001, J EXP MED, V193, P1189, DOI 10.1084/jem.193.10.1189; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rist MJ, 2013, J IMMUNOL, V191, P561, DOI 10.4049/jimmunol.1300292; Scull KE, 2012, MOL IMMUNOL, V51, P136, DOI 10.1016/j.molimm.2012.02.117; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; Tan TLR, 1997, J IMMUNOL METHODS, V205, P201, DOI 10.1016/S0022-1759(97)00086-0; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Wynn KK, 2008, BLOOD, V111, P4283, DOI 10.1182/blood-2007-11-122622; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	35	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2593	2603		10.1074/jbc.M114.607028	http://dx.doi.org/10.1074/jbc.M114.607028			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505266	Green Published, hybrid			2022-12-28	WOS:000349310700006
J	Kiefer, K; Carreras-Sureda, A; Garcia-Lopez, R; Rubio-Moscardo, F; Casas, J; Fabrias, G; Vicente, R				Kiefer, Kerstin; Carreras-Sureda, Amado; Garcia-Lopez, Roberto; Rubio-Moscardo, Fanny; Casas, Josefina; Fabrias, Gemma; Vicente, Ruben			Coordinated Regulation of the Orosomucoid-like Gene Family Expression Controls de Novo Ceramide Synthesis in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ceramide; Enzyme Inhibitor; Macrophage; Serine Palmitoyltransferase; Sphingolipid	GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; PROTEINS MEDIATE; ORMDL3; HOMEOSTASIS; RISK; ORM2	Background: Knockdown of orosomucoid-like (ORMDL) proteins releases serine palmitoyltransferase (SPT) activity. Results: Significant changes in SPT activity were detected when all three ORMDLs were overexpressed. Sphingolipids do not modify SPT-ORMDL interaction but rearrange ORMDLs. Macrophages suppress ORMDLs to induce de novo ceramide synthesis. Conclusion: Coordinated ORMDL expression regulation strongly influences SPT activity. Significance: SPT-ORMDL complex presents transcriptional and post-translational regulation. The orosomucoid-like (ORMDL) protein family is involved in the regulation of de novo sphingolipid synthesis, calcium homeostasis, and unfolded protein response. Single nucleotide polymorphisms (SNPs) that increase ORMDL3 expression have been associated with various immune/inflammatory diseases, although the pathophysiological mechanisms underlying this association are poorly understood. ORMDL proteins are claimed to be inhibitors of the serine palmitoyltransferase (SPT). However, it is not clear whether individual ORMDL expression levels have an impact on ceramide synthesis. The present study addressed the interaction with and regulation of SPT activity by ORMDLs to clarify their pathophysiological relevance. We have measured ceramide production in HEK293 cells incubated with palmitate as a direct substrate for SPT reaction. Our results showed that a coordinated overexpression of the three isoforms inhibits the enzyme completely, whereas individual ORMDLs are not as effective. Immunoprecipitation and fluorescence resonance energy transfer (FRET) studies showed that mammalian ORMDLs form oligomeric complexes that change conformation depending on cellular sphingolipid levels. Finally, using macrophages as a model, we demonstrate that mammalian cells modify ORMDL genes expression levels coordinately to regulate the de novo ceramide synthesis pathway. In conclusion, we have shown a physiological modulation of SPT activity by general ORMDL expression level regulation. Moreover, because single ORMDL3 protein alteration produces an incomplete inhibition of SPT activity, this work argues against the idea that ORMDL3 pathophysiology could be explained by a simple on/off mechanism on SPT activity.	[Kiefer, Kerstin; Carreras-Sureda, Amado; Garcia-Lopez, Roberto; Rubio-Moscardo, Fanny; Vicente, Ruben] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona 08003, Spain; [Casas, Josefina; Fabrias, Gemma] Inst Adv Chem Catalonia IQAC, Dept Biomed Chem, Res Unit Bioact Mol RUBAM, Barcelona 08034, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC)	Vicente, R (corresponding author), Univ Pompeu Fabra, Dr Aiguader 88, Barcelona 08003, Spain.	ruben.vicente@upf.edu	Rubio-Moscardó, Francisca/L-6247-2014; Casas, Josefina/L-7934-2014; García, Rubén Vicente/L-1097-2014	Rubio-Moscardó, Francisca/0000-0002-3609-9992; García, Rubén Vicente/0000-0003-0401-4808; Carreras Sureda, Amado/0000-0002-9032-5639; Fabrias, Gemma/0000-0001-7162-3772	Spanish Ministry of Economy and Competitiveness [SAF2010-16725, SAF2011-22444]; Fondo de Investigacion Sanitaria Red HERACLES [RD12/0042/0014]; Fondos Europeos de Desarrollo Regional; Generalitat de Catalunya [SGR2014]; Fundacio la Marato de TV3 [20134030]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo de Investigacion Sanitaria Red HERACLES(Instituto de Salud Carlos III); Fondos Europeos de Desarrollo Regional; Generalitat de Catalunya(Generalitat de Catalunya); Fundacio la Marato de TV3	This work was supported by Spanish Ministry of Economy and Competitiveness Grants SAF2010-16725 and SAF2011-22444, Fondo de Investigacion Sanitaria Red HERACLES Grant RD12/0042/0014, Fondos Europeos de Desarrollo Regional, Generalitat de Catalunya Grant SGR2014, and Fundacio la Marato de TV3 Grant 20134030.	Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Canals D, 2009, BIOORGAN MED CHEM, V17, P235, DOI 10.1016/j.bmc.2008.11.026; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carreras-Sureda A, 2013, HUM MOL GENET, V22, P519, DOI 10.1093/hmg/dds450; Chang ZQ, 2011, PROSTAG OTH LIPID M, V94, P44, DOI 10.1016/j.prostaglandins.2010.12.003; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Kurreeman FAS, 2012, AM J HUM GENET, V90, P524, DOI 10.1016/j.ajhg.2012.01.010; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Yu H, 2013, J LIPID RES, V54, P189, DOI 10.1194/jlr.M031427	24	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2822	2830		10.1074/jbc.M114.595116	http://dx.doi.org/10.1074/jbc.M114.595116			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25519910	Green Published, hybrid			2022-12-28	WOS:000349310700023
J	Yuan, L; Chen, ZB; Song, SS; Wang, S; Tian, CY; Xing, GC; Chen, XJ; Xiao, ZX; He, FC; Zhang, LQ				Yuan, Lin; Chen, Zhongbin; Song, Shanshan; Wang, Shan; Tian, Chunyan; Xing, Guichun; Chen, Xiaojuan; Xiao, Zhi-Xiong; He, Fuchu; Zhang, Lingqiang			p53 Degradation by a Coronavirus Papain-like Protease Suppresses Type I Interferon Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Innate Immunity; Interferon; Mouse Double Minute 2 Homolog (MDM2); p53; Virus; PLP2; Coronavirus	UBIQUITIN LIGASE SMURF1; RING-FINGER DOMAIN; IFN-ALPHA/BETA; SARS; ACTIVATION; INFECTION; DEUBIQUITINASE; REPLICATION; VIRUS; GENES	Background: The molecular mechanism of coronavirus PLPs suppressing the innate immune response remains unclear. Results: PLP2 induces the degradation of p53 through stabilizing MDM2, and IRF7 is a novel target gene of p53. Conclusion: PLP2 inhibits the p53-mediated production of type I IFN and apoptosis to ensure viral growth. Significance: We identify the mechanism with which coronavirus induces the low dosage IFN production. Infection by human coronaviruses is usually characterized by rampant viral replication and severe immunopathology in host cells. Recently, the coronavirus papain-like proteases (PLPs) have been identified as suppressors of the innate immune response. However, the molecular mechanism of this inhibition remains unclear. Here, we provide evidence that PLP2, a catalytic domain of the nonstructural protein 3 of human coronavirus NL63 (HCoV-NL63), deubiquitinates and stabilizes the cellular oncoprotein MDM2 and induces the proteasomal degradation of p53. Meanwhile, we identify IRF7 (interferon regulatory factor 7) as a bona fide target gene of p53 to mediate the p53-directed production of type I interferon and the innate immune response. By promoting p53 degradation, PLP2 inhibits the p53-mediated antiviral response and apoptosis to ensure viral growth in infected cells. Thus, our study reveals that coronavirus engages PLPs to escape from the innate antiviral response of the host by inhibiting p53-IRF7-IFN signaling.	[Yuan, Lin; Song, Shanshan; Wang, Shan; Tian, Chunyan; Xing, Guichun; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Prote, Beijing 100850, Peoples R China; [Yuan, Lin; Zhang, Lingqiang] Dalian Med Univ, Inst Canc Stem Cell, Dalian 116044, Liaoning Provin, Peoples R China; [Chen, Zhongbin; Chen, Xiaojuan] Beijing Inst Radiat Med, Dept Electromagnet & Laser Biol, Div Infect & Immun, Beijing 100850, Peoples R China; [Xiao, Zhi-Xiong] Sichuan Univ, Sch Life Sci, Chengdu 610065, Sichuan Provinc, Peoples R China	Academy of Military Medical Sciences - China; Dalian Medical University; Academy of Military Medical Sciences - China; Sichuan University	Zhang, LQ (corresponding author), Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn		YUAN, LIN/0000-0001-5449-3435	National Basic Research Programs [2012CB910702, 2011CB910802, 2013CB910803]; National Natural Science Foundation [81201271, 31125010, 81221004]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by National Basic Research Programs 2012CB910702, 2011CB910802, and 2013CB910803 and National Natural Science Foundation Projects 81201271, 31125010, and 81221004.	Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Chaudhuri R, 2011, J MOL BIOL, V414, P272, DOI 10.1016/j.jmb.2011.09.030; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Chen ZB, 2007, J VIROL, V81, P6007, DOI 10.1128/JVI.02747-06; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Munoz-Fontela C, 2005, ONCOGENE, V24, P3059, DOI 10.1038/sj.onc.1208477; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Nguyen ML, 2007, J VIROL, V81, P12985, DOI 10.1128/JVI.01485-07; Nicholson B, 2008, PROTEIN SCI, V17, P1035, DOI 10.1110/ps.083450408; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/JVI.00031-06; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Rivas C, 2010, VIRUSES-BASEL, V2, P298, DOI 10.3390/v2010298; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Zheng BJ, 2004, J INTERF CYTOK RES, V24, P388, DOI 10.1089/1079990041535610; Zheng DH, 2008, CELL RES, V18, P1105, DOI 10.1038/cr.2008.294	33	75	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3172	3182		10.1074/jbc.M114.619890	http://dx.doi.org/10.1074/jbc.M114.619890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505178	Green Published, hybrid			2022-12-28	WOS:000349310700051
J	Sun, C; Yu, D; Ye, WD; Liu, C; Gu, SP; Sinsheimer, NR; Song, ZC; Li, XH; Chen, C; Song, YN; Wang, SS; Schrader, L; Chen, YP				Sun, Cheng; Yu, Diankun; Ye, Wenduo; Liu, Chao; Gu, Shuping; Sinsheimer, Nathan R.; Song, Zhongchen; Li, Xihai; Chen, Chun; Song, Yingnan; Wang, Shusheng; Schrader, Laura; Chen, YiPing			The Short Stature Homeobox 2 (Shox2)-bone Morphogenetic Protein (BMP) Pathway Regulates Dorsal Mesenchymal Protrusion Development and Its Temporary Function as a Pacemaker during Cardiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINOATRIAL NODE; ATRIOVENTRICULAR SEPTATION; CARDIAC DEVELOPMENT; DEVELOPING HEART; CHANNEL HCN4; MOUSE HEART; EXPRESSION; MICE; CELLS; SHOX2	The atrioventricular (AV) junction plays a critical role in chamber septation and transmission of cardiac conduction pulses. It consists of structures that develop from embryonic dorsal mesenchymal protrusion (DMP) and the embryonic AV canal. Despite extensive studies on AV junction development, the genetic regulation of DMP development remains poorly understood. In this study we present evidence that Shox2 is expressed in the developing DMP. Intriguingly, this Shox2-expressing domain possesses a pacemaker-specific genetic profile including Hcn4 and Tbx3. This genetic profile leads to nodal-like electrophysiological properties, which is gradually silenced as the AV node becomes matured. Phenotypic analyses of Shox2(-/-) mice revealed a hypoplastic and defectively differentiated DMP, likely attributed to increased apoptosis, accompanied by dramatically reduced expression of Bmp4 and Hcn4, ectopic activation of Cx40, and an aberrant pattern of action potentials. Interestingly, conditional deletion of Bmp4 or inhibition of BMP signaling by overexpression of Noggin using a Shox2-Cre allele led to a similar DMP hypoplasia and down-regulation of Hcn4, whereas activation of a transgenic Bmp4 allele in Shox2(-/-) background attenuated DMP defects. Moreover, the lack of Hcn4 expression in the DMP of mice carrying Smad4 conditional deletion and direct binding of pSmad1/5/8 to the Hcn4 regulatory region further confirm the Shox2-BMP genetic cascade in the regulation of DMP development. Our results reveal that Shox2 regulates DMP fate and development by controlling BMP signaling through the Smad-dependent pathway to drive tissue growth and to induce Hcn4 expression and suggest a temporal pacemaking function for the DMP during early cardiogenesis.	[Sun, Cheng; Yu, Diankun; Ye, Wenduo; Liu, Chao; Gu, Shuping; Sinsheimer, Nathan R.; Song, Zhongchen; Li, Xihai; Chen, Chun; Song, Yingnan; Wang, Shusheng; Schrader, Laura; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Tulane University	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, 6823 St Charles Ave, New Orleans, LA 70118 USA.	ychen@tulane.edu	Chen, Chun/AAR-8041-2020; Schrader, Laura/ABH-4854-2020; Yu, Diankun/AFO-0203-2022	Schrader, Laura/0000-0003-3355-1194; Chen, Chun/0000-0002-6957-0103; Yu, Diankun/0000-0002-1390-7985	National Institutes of Health [R01 DE17792]; American Heart Association [13PRE13750003]; Fujian Normal University of China; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fujian Normal University of China; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE17792 (to Y. C.).; Supported by an American Heart Association Predoctoral Fellowship 13PRE13750003.; Supported by a fellowship from Fujian Normal University of China.	Aanhaanen WTJ, 2010, CIRC RES, V107, P728, DOI 10.1161/CIRCRESAHA.110.222992; ARGUELLO C, 1986, J MOL CELL CARDIOL, V18, P499, DOI 10.1016/S0022-2828(86)80915-4; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Binder G, 2011, HORM RES PAEDIAT, V75, P81, DOI 10.1159/000324105; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Briggs LE, 2013, CIRC RES, V112, P1420, DOI 10.1161/CIRCRESAHA.112.300821; Chen BY, 2009, J MOL CELL CARDIOL, V47, P706, DOI 10.1016/j.yjmcc.2009.07.007; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Espinoza-Lewis RA, 2011, DEV BIOL, V356, P359, DOI 10.1016/j.ydbio.2011.05.663; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Frank DU, 2012, P NATL ACAD SCI USA, V109, pE154, DOI 10.1073/pnas.1115165109; Hahurij ND, 2008, CIRCULATION, V117, P2850, DOI 10.1161/CIRCULATIONAHA.107.756288; Hall J. E., 2011, GUYTON HALL TXB MED; HANCOX JC, 1993, AM J PHYSIOL, V265, pH755, DOI 10.1152/ajpheart.1993.265.2.H755; He FL, 2014, DEV BIOL, V391, P170, DOI 10.1016/j.ydbio.2014.04.013; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kulessa H, 2002, GENESIS, V32, P66, DOI 10.1002/gene.10032; Kuratomi S, 2007, BIOCHEM BIOPH RES CO, V353, P67, DOI 10.1016/j.bbrc.2006.11.119; Kuratomi S, 2009, CARDIOVASC RES, V83, P682, DOI 10.1093/cvr/cvp171; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lin HX, 2009, CELL PHYSIOL BIOCHEM, V23, P317, DOI 10.1159/000218178; Liu HB, 2011, J BIOL CHEM, V286, P17029, DOI 10.1074/jbc.M111.234252; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Mahtab EAF, 2009, DEV DYNAM, V238, P183, DOI 10.1002/dvdy.21819; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; Massague J, 2000, GENE DEV, V14, P627; McGuire MA, 1996, CIRCULATION, V94, P571, DOI 10.1161/01.CIR.94.3.571; Munshi NV, 2012, CIRC RES, V110, P1525, DOI 10.1161/CIRCRESAHA.111.260026; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Semina EV, 1998, HUM MOL GENET, V7, P415, DOI 10.1093/hmg/7.3.415; Sheng XY, 2011, CIRC-ARRHYTHMIA ELEC, V4, P936, DOI 10.1161/CIRCEP.111.964056; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Sun C, 2013, GENESIS, V51, P515, DOI 10.1002/dvg.22397; Vedantham V, 2013, DEV BIOL, V373, P149, DOI 10.1016/j.ydbio.2012.10.017; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Wessels A, 1996, CIRC RES, V78, P110, DOI 10.1161/01.RES.78.1.110; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang YM, 2002, CIRCULATION, V106, P1294, DOI 10.1161/01.CIR.0000027585.05868.67; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zipes DP., 2018, CARDIAC ELECTROPHYSI, V7	53	20	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2007	2023		10.1074/jbc.M114.619007	http://dx.doi.org/10.1074/jbc.M114.619007			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488669	hybrid, Green Published			2022-12-28	WOS:000348588000009
J	Yang, JX; Zhang, N; Wang, HW; Gao, P; Yang, QP; Wen, QP				Yang, Jing-Xian; Zhang, Nan; Wang, Han-Wei; Gao, Peng; Yang, Qing-Ping; Wen, Qing-Ping			CXCR4 Receptor Overexpression in Mesenchymal Stem Cells Facilitates Treatment of Acute Lung Injury in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BONE-MARROW; STROMAL CELLS; PROMOTING MIGRATION; KI-67 PROTEIN; THERAPY; EXPRESSION; INFLAMMATION; PATHOGENESIS; LESTR/FUSIN	Novel therapeutic regimens for tissue renewal incorporate mesenchymal stem cells (MSCs) as they differentiate into a variety of cell types and are a stem cell type that is easy to harvest and to expand in vitro. However, surface chemokine receptors, such as CXCR4, which are involved in the mobilization of MSCs, are expressed only on the surface of a small proportion of MSCs, and the lack of CXCR4 expression may underlie the low efficiency of homing of MSCs toward tissue damage, which results in a poor curative effect. Here, a rat CXCR4 expressing lentiviral vector was constructed and introduced into MSCs freshly prepared from rat bone marrow. The influence of CXCR4 expression on migration, proliferation, differentiation, and paracrine effects of MSCs was examined in vitro. The in vivo properties of CXCR4-MSCs were also investigated in a model of acute lung injury in rats induced by lipopolysaccharide. Expression of CXCR4 in MSCs significantly enhanced the chemotactic and paracrine characteristics of the cells in vitro but did not affect self-renewal or differentiation into alveolar and vascular endothelial cells. In vivo, CXCR4 improved MSC homing and colonization of damaged lung tissue, and furthermore, the transplanted CXCR4-MSCs suppressed the development of acute lung injury in part by modulating levels of inflammatory molecules and the neutrophil count. These results indicated that efficient mobilization of MSCs to sites of tissue injury may be due to CXCR4, and therefore, increased expression of CXCR4 may improve their therapeutic potential in the treatment of diseases where tissue damage develops.	[Yang, Jing-Xian; Zhang, Nan; Yang, Qing-Ping] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China; [Zhang, Nan] China Med Univ, Sch Pharm, Shenyang 110013, Peoples R China; [Wang, Han-Wei; Wen, Qing-Ping] Dalian Med Univ, Affiliated Hosp 1, Dalian 116011, Peoples R China; [Gao, Peng] Dalian Med Univ, Dept Anesthesiol, Dalian 116044, Peoples R China	Liaoning University of Traditional Chinese Medicine; China Medical University; Dalian Medical University; Dalian Medical University	Wen, QP (corresponding author), Dalian Med Univ, Dept Anesthesiol, Dalian 116044, Peoples R China.	wenqp050607@gmail.com			Natural Science Fund of China [81273923]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Fund of China (no. 81273923).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bosma KJ, 2010, DRUGS, V70, P1255, DOI 10.2165/10898570-000000000-00000; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Du ZY, 2013, LIVER TRANSPLANT, V19, P215, DOI 10.1002/lt.23577; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hariprashad A, 2013, JAAPA-J AM ACAD PHYS, V26, P23, DOI 10.1097/01.JAA.0000433867.15142.5d; Hayes Mairead, 2012, F1000 Med Rep, V4, P2, DOI 10.3410/M4-2; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Hu Y, 2012, J MOL NEUROSCI, V48, P127, DOI 10.1007/s12031-012-9784-7; Inamdar AC, 2013, EXP LUNG RES, V39, P315, DOI 10.3109/01902148.2013.816803; Ke F, 2014, STEM CELLS, V32, P2799, DOI 10.1002/stem.1763; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Li J, 2012, J ASIA TEFL, V9, P1, DOI 10.1186/1476-9255-9-33; Liang ZX, 2011, CHINESE MED J-PEKING, V124, P2715, DOI 10.3760/cma.j.issn.0366-6999.2011.17.027; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Miller AC, 2014, CRIT CARE MED, V42, P413, DOI 10.1097/CCM.0b013e3182a645e5; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Petty JM, 2007, J IMMUNOL, V178, P8148, DOI 10.4049/jimmunol.178.12.8148; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Rahmanzadeh R, 2007, CELL PROLIFERAT, V40, P422, DOI 10.1111/j.1365-2184.2007.00433.x; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Spieth PM, 2014, CURR OPIN CRIT CARE, V20, P113, DOI 10.1097/MCC.0000000000000056; Sung SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071637; Tai Wen-Lin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P283; Villar J, 2014, CURR OPIN CRIT CARE, V20, P3, DOI 10.1097/MCC.0000000000000057; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yan YP, 2012, MOL THER, V20, P1338, DOI 10.1038/mt.2012.12; Yang JX, 2012, ACTA NEUROPATHOL, V124, P491, DOI 10.1007/s00401-012-0989-1; Yang JX, 2010, AM J PATHOL, V177, P1989, DOI 10.2353/ajpath.2010.091203; Yang JX, 2009, J CLIN INVEST, V119, P3678, DOI 10.1172/JCI37914; Zhang P, 2013, ONCOL REP, V30, P1753, DOI 10.3892/or.2013.2619; Zhao J, 2011, AM J PHYSIOL-LUNG C, V301, pL547, DOI 10.1152/ajplung.00058.2011; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504	52	90	96	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1994	2006		10.1074/jbc.M114.605063	http://dx.doi.org/10.1074/jbc.M114.605063			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25492872	Green Published, hybrid			2022-12-28	WOS:000348588000008
J	Liu, YJ; Sun, B; Xiao, ZC; Wang, RW; Guo, WT; Zhang, JZ; Mi, T; Wang, YD; Jones, PP; Van Petegem, F; Chen, SRW				Liu, Yingjie; Sun, Bo; Xiao, Zhichao; Wang, Ruiwu; Guo, Wenting; Zhang, Joe Z.; Mi, Tao; Wang, Yundi; Jones, Peter P.; Van Petegem, Filip; Chen, S. R. Wayne			Roles of the NH2-terminal Domains of Cardiac Ryanodine Receptor in Ca2+ Release Activation and Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Imaging; Calcium Intracellular Release; Cardiac Muscle; Ryanodine Receptor; Sarcoplasmic Reticulum (SR)	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; POLYMORPHIC VENTRICULAR-TACHYCARDIA; DISEASE MUTATIONS; SUDDEN-DEATH; MOLECULAR-IDENTIFICATION; CRYSTAL-STRUCTURES; BINDING SITE; BETA-STRAND; LIGAND; THRESHOLD	Background: The NH2-terminal region of cardiac ryanodine receptor (RyR2) contains three domains (A, B, and C) that harbor many disease-causing mutations. Results: Domains A, B, and C distinctively regulate the activation and termination of Ca2+ release. Conclusion: Individual NH2-terminal domains play distinct roles in RyR2 channel function. Significance: These data shed new insights into the actions of RyR2 NH2-terminal disease mutations. The NH2-terminal region (residues 1-543) of the cardiac ryanodine receptor (RyR2) harbors a large number of mutations associated with cardiac arrhythmias and cardiomyopathies. Functional studies have revealed that the NH2-terminal region is involved in the activation and termination of Ca2+ release. The three-dimensional structure of the NH2-terminal region has recently been solved. It is composed of three domains (A, B, and C). However, the roles of these individual domains in Ca2+ release activation and termination are largely unknown. To understand the functional significance of each of these NH2-terminal domains, we systematically deleted these domains and assessed their impact on caffeine- or Ca2+-induced Ca2+ release and store overload-induced Ca2+ release (SOICR) in HEK293 cells. We found that all deletion mutants were capable of forming caffeine- and ryanodine-sensitive functional channels, indicating that the NH2-terminal region is not essential for channel gating. Ca2+ release measurements revealed that deleting domain A markedly reduced the threshold for SOICR termination but had no effect on caffeine or Ca2+ activation or the threshold for SOICR activation, whereas deleting domain B substantially enhanced caffeine and Ca2+ activation and lowered the threshold for SOICR activation and termination. Conversely, deleting domain C suppressed caffeine activation, abolished Ca2+ activation and SOICR, and diminished protein expression. These results suggest that domain A is involved in channel termination, domain B is involved in channel suppression, and domain C is critical for channel activation and expression. Our data shed new insights into the structure-function relationship of the NH2-terminal domains of RyR2 and the action of NH2-terminal disease mutations.	[Liu, Yingjie; Sun, Bo; Xiao, Zhichao; Wang, Ruiwu; Guo, Wenting; Mi, Tao; Wang, Yundi; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Liu, Yingjie; Sun, Bo; Xiao, Zhichao; Wang, Ruiwu; Guo, Wenting; Mi, Tao; Wang, Yundi; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Zhang, Joe Z.; Jones, Peter P.] Univ Otago, Dept Physiol, Dunedin 9054, New Zealand; [Zhang, Joe Z.; Jones, Peter P.] Univ Otago, HeartOtago, Dunedin 9054, New Zealand; [Van Petegem, Filip] Univ British Columbia, Inst Life Sci, Cardiovasc Res Grp, Vancouver, BC V6T 1Z3, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Otago; University of Otago; University of British Columbia	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, HRIC G48,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	zhang, joe/AAO-5273-2020; Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537; Jones, Pete/0000-0001-7977-1737	Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta; Northwest Territories; Nunavut; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS); AIHS; Alberta Innovates [201400104, 201500221, 201300501] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Northwest Territories; Nunavut; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS); AIHS; Alberta Innovates	This work was supported in part by research grants from the Canadian Institutes of Health Research; the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; the Canada Foundation for Innovation; and the Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research (to S. R. W. C.).; Recipient of an Alberta Innovates-Health Solutions (AIHS) graduate studentship award.; Recipient of an AIHS fellowship award.	Amador FJ, 2013, J MOL BIOL, V425, P4034, DOI 10.1016/j.jmb.2013.08.015; Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; CHEEK TR, 1993, J BIOL CHEM, V268, P27076; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Du GG, 2001, P NATL ACAD SCI USA, V98, P13625, DOI 10.1073/pnas.241516898; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jiang DW, 2010, CHANNELS, V4, P302, DOI 10.4161/chan.4.4.12666; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kimlicka L, 2013, STRUCTURE, V21, P1440, DOI 10.1016/j.str.2013.06.012; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Liu YJ, 2013, BIOCHEM J, V454, P123, DOI 10.1042/BJ20130594; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; Masumiya H, 2001, J BIOL CHEM, V276, P39727, DOI 10.1074/jbc.M106557200; Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P791, DOI 10.1111/j.1540-8167.2007.00766.x; Muschol M, 1999, BIOPHYS J, V77, P577, DOI 10.1016/S0006-3495(99)76914-6; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Tian XX, 2013, J BIOL CHEM, V288, P4066, DOI 10.1074/jbc.M112.427864; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhong XW, 2013, STRUCTURE, V21, P2051, DOI 10.1016/j.str.2013.09.004	41	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7736	7746		10.1074/jbc.M114.618827	http://dx.doi.org/10.1074/jbc.M114.618827			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25627681	hybrid, Green Published			2022-12-28	WOS:000351613600034
J	Gorski, PA; Trieber, CA; Ashrafi, G; Young, HS				Gorski, Przennek A.; Trieber, Catharine A.; Ashrafi, Ghazaleh; Young, Howard S.			Regulation of the Sarcoplasmic Reticulum Calcium Pump by Divergent Phospholamban Isoforms in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; CA2+ PUMP; DILATED CARDIOMYOPATHY; CYTOPLASMIC DOMAIN; PEPTIDE INHIBITORS; STRUCTURAL BASIS; HYBRID SOLUTION; LIPID-BILAYERS; PROTEIN-KINASE; HEART-FAILURE	The sarcoplasmic reticulum calcium pump (SERCA) is regulated by the small integral membrane proteins phospholamban (PLN) and sarcolipin (SLN). These regulators have homologous transmembrane regions, yet they differ in their cytoplasmic and luminal domains. Although the sequences of PLN and SLN are practically invariant among mammals, they vary in fish. Zebrafish (zf) appear to harbor multiple PLN isoforms, one of which contains 18 sequence variations and a unique luminal extension. Characterization of this isoform (zfPLN) revealed that SERCA inhibition and reversal by phosphorylation were comparable with human PLN. To understand the sequence variations in zfPLN, chimeras were created by transferring the N terminus, linker, and C terminus of zfPLN onto human PLN. A chimera containing the N-terminal domain resulted in a mild loss of function, whereas a chimera containing the linker domain resulted in a gain of function. This latter effect was due to changes in basic residues in the linker region of PLN. Removing the unique luminal domain of zfPLN ((53)SFHGM) resulted in loss of function, whereas adding this domain to human PLN had a minimal effect on SERCA inhibition. We conclude that the luminal extension contributes to SERCA inhibition but only in the context of zfPLN. Although this domain is distinct from the SLN luminal tail, zfPLN appears to use a hybrid PLN-SLN inhibitory mechanism. Importantly, the different zebrafish PLN isoforms raise the interesting possibility that sarcoplasmic reticulum calcium handling and cardiac contractility may be regulated by the differential expression of PLN functional variants.	[Gorski, Przennek A.; Trieber, Catharine A.; Ashrafi, Ghazaleh; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2H7, Canada	University of Alberta; National Research Council Canada; University of Alberta	Young, HS (corresponding author), Univ Alberta, Med Sci Bldg,Rm 327, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca		Young, Howard/0000-0002-5990-8422; Trieber, Catharine/0000-0002-1336-1126	Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported in part by a grant from Heart and Stroke Foundation of Canada.	Afara MR, 2008, BIOCHEMISTRY-US, V47, P9522, DOI 10.1021/bi800880q; Afara MR, 2006, BIOCHEMISTRY-US, V45, P8617, DOI 10.1021/bi0523761; Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Ceholski DK, 2012, J BIOL CHEM, V287, P26596, DOI 10.1074/jbc.M112.382713; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; FUJII J, 1989, J BIOL CHEM, V264, P12950; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gorski PA, 2012, J BIOL CHEM, V287, P19876, DOI 10.1074/jbc.M111.335620; Gramolini AO, 2006, P NATL ACAD SCI USA, V103, P2446, DOI 10.1073/pnas.0510883103; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Hughes E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611668200; INESI G, 1988, METHOD ENZYMOL, V157, P154; Karim CB, 2001, J BIOL CHEM, V276, P38814, DOI 10.1074/jbc.M104006200; Katz A M, 1975, Adv Cyclic Nucleotide Res, V5, P453; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Kirchberber M A, 1975, Recent Adv Stud Cardiac Struct Metab, V5, P103; Lamberth S, 2000, HELV CHIM ACTA, V83, P2141, DOI 10.1002/1522-2675(20000906)83:9<2141::AID-HLCA2141>3.0.CO;2-W; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; MORTISHIRESMITH RJ, 1995, BIOCHEMISTRY-US, V34, P7603, DOI 10.1021/bi00023a006; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Reddy LG, 1996, J BIOL CHEM, V271, P14964, DOI 10.1074/jbc.271.25.14964; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Seidel K, 2008, BIOCHEMISTRY-US, V47, P4369, DOI 10.1021/bi7024194; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; Verardi R, 2011, P NATL ACAD SCI USA, V108, P9101, DOI 10.1073/pnas.1016535108; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; WILL H, 1985, EXPERIENTIA, V41, P1052, DOI 10.1007/BF01952139; WILL H, 1983, FEBS LETT, V155, P326, DOI 10.1016/0014-5793(82)80630-3; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7	56	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6777	6788		10.1074/jbc.M114.585604	http://dx.doi.org/10.1074/jbc.M114.585604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25593315	Green Published, hybrid			2022-12-28	WOS:000350991500014
J	Su, C; Zhang, CY; Tecle, A; Fu, X; He, JY; Song, J; Zhang, W; Sun, XM; Ren, YY; Silvennoinen, O; Yao, Z; Yang, X; Wei, MX; Yang, J				Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; He, Jinyan; Song, Juan; Zhang, Wei; Sun, Xiaoming; Ren, Yuanyuan; Silvennoinen, Olli; Yao, Zhi; Yang, Xi; Wei, Minxin; Yang, Jie			Tudor Staphylococcal Nuclease (Tudor-SN), a Novel Regulator Facilitating G(1)/S Phase Transition, Acting as a Co-activator of E2F-1 in Cell Cycle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN P100; HISTONE DEACETYLASE; DOWN-REGULATION; KINASE; IDENTIFICATION; PROLIFERATION; INTERACTS; TARGET; STAT6; CDK4	Tudor staphylococcal nuclease (Tudor-SN) is a multifunctional protein implicated in a variety of cellular processes. In the present study, we identified Tudor-SN as a novel regulator in cell cycle. Tudor-SN was abundant in proliferating cells whereas barely expressed in terminally differentiated cells. Functional analysis indicated that ectopic overexpression of Tudor-SN promoted the G(1)/S transition, whereas knockdown of Tudor-SN caused G(1) arrest. Moreover, the live-cell time-lapse experiment demonstrated that the cell cycle of MEF-/- (knock-out of Tudor-SN in mouse embryonic fibroblasts) was prolonged compared with wild-type MEF+/+ We noticed that Tudor-SN was constantly expressed in every cell cycle phase, but was highly phosphorylated in the G(1)/S border. Further study revealed that Tudor-SN was a potential substrate of Cdk2/4/6, supportively, we found the physical interaction of endogenous Tudor-SN with Cdk4/6 in G(1) and the G(1)/S border, and with Cdk2 in the G(1)/S border and S phase. In addition, roscovitine (Cdk1/2/5 inhibitor) or CINK4 (Cdk4/6 inhibitor) could inhibit the phosphorylation of Tudor-SN, whereas ectopic overexpression of Cdk2/4/6 increased the Tudor-SN phosphorylation. The underlying molecular mechanisms indicated that Tudor-SN could physically interact with E2F-1 in vivo, and could enhance the physical association of E2F-1 with GCN5 (a cofactor of E2F-1, which possesses histone acetyltransferase activity), and promote the binding ability of E2F-1 to the promoter region of its target genes CYCLIN A and E2F-1, and as a result, facilitate the gene transcriptional activation. Taken together, Tudor-SN is identified as a novel co-activator of E2F-1, which could facilitate E2F-1-mediated gene transcriptional activation of target genes, which play essential roles in G(1)/S transition.	[Su, Chao; Zhang, Chunyan; Fu, Xue; Song, Juan; Zhang, Wei; Sun, Xiaoming; Ren, Yuanyuan; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China; [Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; Song, Juan; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin 300070, Peoples R China; [Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; Song, Juan; Yang, Jie] Tianjin Med Univ, Lab Mol Immunol, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China; [Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; He, Jinyan; Song, Juan; Zhang, Wei; Sun, Xiaoming; Ren, Yuanyuan; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Tianjin Key Lab Cellular & Mol Immunol, Tianjin 300070, Peoples R China; [Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; He, Jinyan; Song, Juan; Zhang, Wei; Sun, Xiaoming; Ren, Yuanyuan; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Key Lab, Key Lab Educ Minist China, Tianjin 300070, Peoples R China; [Yang, Xi] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0T5, Canada; [Silvennoinen, Olli; Yang, Jie] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland; [Wei, Minxin] Tianjin Med Univ, Gen Hosp, Dept Cardiovasc Surg, Tianjin 300070, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of Manitoba; Tampere University; Tampere University Hospital; Tianjin Medical University	Wei, MX (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Cardiovasc Surg, Tianjin 300070, Peoples R China.	minxinw@126.com; yangj@tijmu.edu.cn	Song, Juan/O-5818-2017	Song, Juan/0000-0001-7350-9578; Yang, Xi/0000-0002-8831-7488	National Science Foundation for Distinguished Young Scholars of China [31125012]; National Science Foundation of China [31370749, 31170830, 31100967, 90919032]; Program for Innovative Research team of Ministry of Education [IRT13085]; Natural Science Foundation of Tianjin [13JCYBJC21400]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research team of Ministry of Education; Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by National Science Foundation for Distinguished Young Scholars of China Grant 31125012, National Science Foundation of China Grants 31370749, 31170830, 31100967, and 90919032, Program for Innovative Research team of Ministry of Education Grant IRT13085, and Natural Science Foundation of Tianjin Grant 13JCYBJC21400.	Alberts B, 2008, MOL BIOL CELL; Barriere C, 2007, MOL ONCOL, V1, P72, DOI 10.1016/j.molonc.2007.03.001; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Brooks G, 1997, J MOL CELL CARDIOL, V29, P2261, DOI 10.1006/jmcc.1997.0471; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Choi Jina, 2014, J Cancer Prev, V19, P187, DOI 10.15430/JCP.2014.19.3.187; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; KITAGAWA M, 1995, ONCOGENE, V10, P229; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Navarro Garcia- Jove, 2013, PLOS ONE, V8; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Prives C, 1993, CURR OPIN CELL BIOL, V5, P214, DOI 10.1016/0955-0674(93)90105-Y; Rivard N, 1999, AM J PHYSIOL-CELL PH, V277, pC652, DOI 10.1152/ajpcell.1999.277.4.C652; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; TONG X, 1995, MOL CELL BIOL, V15, P4735; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Yin J, 2013, ANAT REC, V296, P1568, DOI 10.1002/ar.22737; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yu WS, 2011, NUCLEIC ACIDS RES, V39, P2234, DOI 10.1093/nar/gkq1117	34	37	41	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7208	7220		10.1074/jbc.M114.625046	http://dx.doi.org/10.1074/jbc.M114.625046			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627688	Green Published, hybrid			2022-12-28	WOS:000350991500050
J	Verma, R; Marchese, A				Verma, Rita; Marchese, Adriano			The Endosomal Sorting Complex Required for Transport Pathway Mediates Chemokine Receptor CXCR4-promoted Lysosomal Degradation of the Mammalian Target of Rapamycin Antagonist DEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RICTOR-MTOR COMPLEX; E3 UBIQUITIN LIGASE; ENDOCYTIC TRAFFICKING; ESCRT MACHINERY; BETA-TRCP; PHOSPHATIDYLINOSITOL 3-KINASE; MULTIVESICULAR ENDOSOMES; SUBSTRATE-SPECIFICITY; DEPENDENT DEGRADATION	G protein-coupled receptor (GPCR) signaling mediates many cellular functions, including cell survival, proliferation, and cell motility. Many of these processes are mediated by GPCR-promoted activation of Akt signaling by mammalian target of rapamycin complex 2 (mTORC2) and the phosphatidylinositol 3-kinase (PI3K)/phosphoinositide-dependent kinase 1 (PDK1) pathway. However, the molecular mechanisms by which GPCRs govern Akt activation by these kinases remain poorly understood. Here, we show that the endosomal sorting complex required for transport (ESCRT) pathway mediates Akt signaling promoted by the chemokine receptor CXCR4. Pharmacological inhibition of heterotrimeric G protein G alpha(i) or PI3K signaling and siRNA targeting ESCRTs blocks CXCR4-promoted degradation of DEPTOR, an endogenous antagonist of mTORC2 activity. Depletion of ESCRTs by siRNA leads to increased levels of DEPTOR and attenuated CXCR4-promoted Akt activation and signaling, consistent with decreased mTORC2 activity. In addition, ESCRTs likely have a broad role in Akt signaling because ESCRT depletion also attenuates receptor tyrosine kinase-promoted Akt activation and signaling. Our data reveal a novel role for the ESCRT pathway in promoting intracellular signaling, which may begin to identify the signal transduction pathways that are important in the physiological roles of ESCRTs and Akt.	[Verma, Rita; Marchese, Adriano] Loyola Univ Chicago, Biochem & Mol Biol Program, Maywood, IL 60153 USA; [Marchese, Adriano] Loyola Univ Chicago, Div Hlth Sci, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago	Marchese, A (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Dept Mol Pharmacol & Therapeut, 2160 S First Ave, Maywood, IL 60153 USA.	amarchese@luc.edu			National Institutes of Health [R01 GM106727]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM106727 (to A. M.).	Agarwal U, 2010, CIRC RES, V107, P667, DOI 10.1161/CIRCRESAHA.110.223289; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Ciechanover A, 2013, BIOORGAN MED CHEM, V21, P3400, DOI 10.1016/j.bmc.2013.01.056; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Dobrowolski R, 2012, CELL REP, V2, P1316, DOI 10.1016/j.celrep.2012.09.026; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Holleman J, 2014, MOL BIOL CELL, V25, P1892, DOI 10.1091/mbc.E13-10-0612; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lobert VH, 2012, J CELL SCI, V125, P29, DOI 10.1242/jcs.088310; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mageswaran SK, 2014, TRAFFIC, V15, P212, DOI 10.1111/tra.12135; Malerod L, 2011, TRAFFIC, V12, P1211, DOI 10.1111/j.1600-0854.2011.01220.x; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peng SB, 2005, MOL CANCER RES, V3, P227; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Raiborg C, 2001, J CELL SCI, V114, P2255; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Robles-Molina E, 2014, BIOCHEM BIOPH RES CO, V444, P218, DOI 10.1016/j.bbrc.2014.01.044; Rodahl LM, 2009, BIOCHEM SOC T, V37, P137, DOI 10.1042/BST0370137; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tu C, 2010, P NATL ACAD SCI USA, V107, P16107, DOI 10.1073/pnas.1009471107; Valiathan RR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-23; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	82	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6810	6824		10.1074/jbc.M114.606699	http://dx.doi.org/10.1074/jbc.M114.606699			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605718	hybrid, Green Published			2022-12-28	WOS:000350991500017
J	You, LY; Zou, JF; Zhao, H; Bertos, NR; Park, M; Wang, E; Yang, XJ				You, Linya; Zou, Jinfeng; Zhao, Hong; Bertos, Nicholas R.; Park, Morag; Wang, Edwin; Yang, Xiang-Jiao			Deficiency of the Chromatin Regulator Brpf1 Causes Abnormal Brain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUBINSTEIN-TAYBI-SYNDROME; HOX GENE-EXPRESSION; DE-NOVO MUTATIONS; HISTONE ACETYLTRANSFERASE; EPIGENETIC MECHANISMS; TRANSCRIPTION FACTOR; RADIAL GLIA; CEREBRAL-CORTEX; MOZ; ACETYLATION	Epigenetic mechanisms are important in different neurological disorders, and one such mechanism is histone acetylation. The multivalent chromatin regulator BRPF1 (bromodomain- and plant homeodomain-linked (PHD) zinc finger-containing protein 1) recognizes different epigenetic marks and activates three histone acetyltransferases, so it is both a reader and a co-writer of the epigenetic language. The three histone acetyltransferases are MOZ, MORF, and HBO1, which are also known as lysine acetyltransferase 6A (KAT6A), KAT6B, and KAT7, respectively. The MORF gene is mutated in four neurodevelopmental disorders sharing the characteristic of intellectual disability and frequently displaying callosal agenesis. Here, we report that forebrain-specific inactivation of the mouse Brpf1 gene caused early postnatal lethality, neocortical abnormalities, and partial callosal agenesis. With respect to the control, the mutant forebrain contained fewer Tbr2-positive intermediate neuronal progenitors and displayed aberrant neurogenesis. Molecularly, Brpf1 loss led to decreased transcription of multiple genes, such as Robo3 and Otx1, important for neocortical development. Surprisingly, elevated expression of different Hox genes and various other transcription factors, such as Lhx4, Foxa1, Tbx5, and Twist1, was also observed. These results thus identify an important role of Brpf1 in regulating forebrain development and suggest that it acts as both an activator and a silencer of gene expression in vivo.	[You, Linya; Zhao, Hong; Bertos, Nicholas R.; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [You, Linya; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Zou, Jinfeng; Wang, Edwin] Natl Res Council Canada, Montreal, PQ H4P 2R2, Canada; [Park, Morag; Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Park, Morag; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; National Research Council Canada; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca	Wang, Edwin/Y-1553-2019	You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and the Canadian Cancer Society (to X. J. Y.).	Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Butler JS, 2013, BLOOD, V121, P3076, DOI 10.1182/blood-2012-10-451237; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Campeau PM, 2012, HUM MUTAT, V33, P1520, DOI 10.1002/humu.22141; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Choe Y, 2012, NEURON, V73, P698, DOI 10.1016/j.neuron.2011.11.036; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Crump JG, 2006, DEVELOPMENT, V133, P2661, DOI 10.1242/dev.02435; Cubelos B, 2008, CEREB CORTEX, V18, P1758, DOI 10.1093/cercor/bhm199; Das Gitanjali, 2013, Methods Mol Biol, V1018, P313, DOI 10.1007/978-1-62703-444-9_29; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lubula MY, 2014, FEBS LETT, V588, P3844, DOI 10.1016/j.febslet.2014.09.028; Maden M, 1998, CURR BIOL, V8, pR846, DOI 10.1016/S0960-9822(07)00528-3; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marszall MP, 2015, EUR J CANCER PREV, V24, P51, DOI 10.1097/CEJ.0000000000000046; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Moffatt P, 2009, CELL MOL LIFE SCI, V66, P1135, DOI 10.1007/s00018-009-8716-3; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Munroe RJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-27; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Perez-Campo FM, 2014, STEM CELLS, V32, P1591, DOI 10.1002/stem.1606; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sansregret L, 2011, P NATL ACAD SCI USA, V108, P1949, DOI 10.1073/pnas.1008403108; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Thomas T, 2000, DEVELOPMENT, V127, P2537; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Voss AK, 2012, DEV CELL, V23, P652, DOI 10.1016/j.devcel.2012.07.010; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Williams S, 2010, BRIT DENT J, V208, P4, DOI 10.1038/sj.bdj.2010.7; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; You LY, 2014, EPIGENETICS-US, V9, P860, DOI 10.4161/epi.28530; Yu HC, 2014, AM J MED GENET A, V164, P950, DOI 10.1002/ajmg.a.36379	81	34	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7114	7129		10.1074/jbc.M114.635250	http://dx.doi.org/10.1074/jbc.M114.635250			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25568313	Green Published, hybrid			2022-12-28	WOS:000350991500042
J	Benton, DJ; Martin, SR; Wharton, SA; McCauley, JW				Benton, Donald J.; Martin, Stephen R.; Wharton, Stephen A.; McCauley, John W.			Biophysical Measurement of the Balance of Influenza A Hemagglutinin and Neuraminidase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; SUBSTRATE-SPECIFICITY; VIRUS NEURAMINIDASE; HUMAN AIRWAY; IN-VITRO; GENERATION; 4-GUANIDINO-NEU5AC2EN; VARIANTS; MUCUS	The interaction of influenza A viruses with the cell surface is controlled by the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). These two glycoproteins have opposing activities: HA is responsible for binding the host receptor (sialic acid) to allow infection, and NA is responsible for cleaving the receptor to facilitate virus release. Several studies have demonstrated that compatible levels of HA and NA activity are required for a virus to replicate efficiently. This is consequently of great interest for determining virus transmissibility. The concurrent role of these two proteins in receptor binding has never been directly measured. We demonstrate a novel biophysical approach based on bio-layer interferornetry to measure the balance of the activities of these two proteins in real time. This technique measures virus binding to and release from a surface coated with either the human-like receptor analog alpha 2,6-linked sialic acid or the avian-like receptor analog alpha 2,3-linked sialic acid in both the presence and absence of NA inhibitors. Biolayer interferometry measurements were also carried out to determine the effect of altering HA receptor affinity and NA stalk length on receptor binding.	[Benton, Donald J.; Wharton, Stephen A.; McCauley, John W.] Natl Inst Med Res, MRC, Div Virol, London NW7 1AA, England; [Martin, Stephen R.] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	McCauley, JW (corresponding author), Natl Inst Med Res, MRC, Div Virol, Mill Hill, London NW7 1AA, England.	john.mccauley@nimr.mrc.ac.uk			Medical Research Council Programs [U117585868, U117512723, U117570592]; Medical Research Council [1112246] Funding Source: researchfish	Medical Research Council Programs(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Programs U117585868, U117512723, and U117570592.	Baigent SJ, 1999, VIROLOGY, V263, P323, DOI 10.1006/viro.1999.9931; Bantia S, 1998, ANTIMICROB AGENTS CH, V42, P801, DOI 10.1128/AAC.42.4.801; BAUM LG, 1991, VIROLOGY, V180, P10, DOI 10.1016/0042-6822(91)90003-T; Blick TJ, 1998, VIROLOGY, V246, P95, DOI 10.1006/viro.1998.9194; BREG J, 1987, EUR J BIOCHEM, V168, P57, DOI 10.1111/j.1432-1033.1987.tb13387.x; CABEZAS JA, 1980, BIOCHIM BIOPHYS ACTA, V616, P228, DOI 10.1016/0005-2744(80)90141-2; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Kaverin NV, 1998, VIROLOGY, V244, P315, DOI 10.1006/viro.1998.9119; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Li JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014722; Li YH, 2011, VIROLOGY, V415, P12, DOI 10.1016/j.virol.2011.03.024; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; van der Vries E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002914; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144	24	35	35	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6516	6521		10.1074/jbc.M114.622308	http://dx.doi.org/10.1074/jbc.M114.622308			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586179	hybrid, Green Published			2022-12-28	WOS:000350732500054
J	Buchner, DA; Charrier, A; Srinivasan, E; Wang, L; Paulsen, MT; Ljungman, M; Bridges, D; Saltiel, AR				Buchner, David A.; Charrier, Alyssa; Srinivasan, Ethan; Wang, Li; Paulsen, Michelle T.; Ljungman, Mats; Bridges, Dave; Saltiel, Alan R.			Zinc Finger Protein 407 (ZFP407) Regulates Insulin-stimulated Glucose Uptake and Glucose Transporter 4 (Glut4) mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TRANSPORTER GLUT4; TRANSCRIPTIONAL REGULATION; PLASMA-MEMBRANE; TRANSGENIC MICE; GENE; COMPLEX; ADIPOCYTES; EXPRESSION; PROMOTER	The glucose transporter GLUT4 facilitates insulin-stimulated glucose uptake in peripheral tissues including adipose, muscle, and heart. GLUT4 function is impaired in obesity and type 2 diabetes leading to hyperglycemia and an increased risk of cardiovascular disease and neuropathy. To better understand the regulation of GTUT4 function, a targeted siRNA screen was performed and led to the discovery that ZFP407 regulates insulin-stimulated glucose uptake in adipocytes. The decrease in insulin-stimulated glucose uptake due to ZFP407 deficiency was attributed to a reduction in GLUT4 mRNA and protein levels. The decrease in GLUT4 was due to both decreased transcription of Glut4 mRNA and decreased efficiency of Glut4 pre-mRNA splicing. Interestingly, ZFP407 coordinately regulated this decrease in transcription with an increase in the stability of Glut4 mRNA, resulting in opposing effects on steady-state Glut4 mRNA levels. More broadly, transcriptome analysis revealed that ZFP407 regulates many peroxisome proliferator-activated receptor (PPAR) gamma target genes beyond Glut4. ZFP407 was required for the PPAR gamma agonist rosiglitazone to increase Glut4 expression, but was not sufficient to increase expression of a PPAR gamma target gene reporter construct. However, ZFP407 and PPAR gamma co-overexpression synergistically activated a PPAR gamma reporter construct beyond the level of PPAR gamma alone. Thus, ZTP407 may represent a new modulator of the PPAR gamma signaling pathway.	[Buchner, David A.; Charrier, Alyssa; Wang, Li] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Buchner, David A.] Case Western Reserve Univ, Dept Biol Chem, Cleveland, OH 44106 USA; [Srinivasan, Ethan; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Paulsen, Michelle T.; Ljungman, Mats] Univ Michigan, Dept Oncol, Div Radiat & Canc Biol, Ctr Canc, Ann Arbor, MI 48109 USA; [Bridges, Dave] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Bridges, Dave] Univ Tennessee, Ctr Hlth Sci, Childrens Fdn Res Inst, Le Bonheur Childrens Hosp,Dept Pediat, Memphis, TN 38103 USA	Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Buchner, DA (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	dab22@case.edu; saltiel@lsi.umich.edu	Bridges, Dave/A-8825-2010; Saltiel, Alan/L-3632-2019	Bridges, Dave/0000-0002-5334-972X; Buchner, David/0000-0003-3920-4871; Saltiel, Alan/0000-0002-9726-9828; Srinivasan, Ethan/0000-0002-9892-5866	National Institutes of Health [DK084079, DK61618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084079, R01DK061618, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in wholeor in part, by National Institutes of Health Grants DK084079 and DK61618.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Armoni M, 2007, TRENDS ENDOCRIN MET, V18, P100, DOI 10.1016/j.tem.2007.02.001; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Deng T, 2011, J BIOL CHEM, V286, P30723, DOI 10.1074/jbc.M111.251926; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Frische EW, 2010, DEV BIOL, V340, P1, DOI 10.1016/j.ydbio.2009.12.043; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, pE38, DOI 10.1152/ajpendo.90306.2008; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Marin-Juez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080628; Morgan BJ, 2011, RECENT PATENTS ENDOC, V5, P25, DOI 10.2174/187221411794351914; Paulsen MT, 2013, P NATL ACAD SCI USA, V110, P2240, DOI 10.1073/pnas.1219192110; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shewan AM, 2013, J CELL SCI, V126, P1576, DOI 10.1242/jcs.114371; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200	44	26	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6376	6386		10.1074/jbc.M114.623736	http://dx.doi.org/10.1074/jbc.M114.623736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25596527	hybrid, Green Published			2022-12-28	WOS:000350732500042
J	Pignataro, MF; Dodes-Traian, MM; Gonzalez-Flecha, FL; Sica, M; Mangialavori, IC; Rossi, JPFC				Florencia Pignataro, Mara; Dodes-Traian, Martin M.; Luis Gonzalez-Flecha, F.; Sica, Mauricio; Mangialavori, Irene C.; Rossi, Juan Pablo F. C.			Modulation of Plasma Membrane Ca2+-ATPase by Neutral Phospholipids EFFECT OF THE MICELLE-VESICLE TRANSITION AND THE BILAYER THICKNESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CALCIUM-PUMP ISOFORMS; ACYL-CHAIN-LENGTH; BIOLOGICAL-MEMBRANES; OCTYL GLUCOSIDE; LIPID-BILAYERS; TRITON X-100; ATP BINDING; PROTEIN; MECHANISM	The effects of lipids on membrane proteins are likely to be complex and unique for each membrane protein. Here we studied different detergent/phosphatidylcholine reconstitution media and tested their effects on plasma membrane Ca2+ pump (PMCA). We found that Ca2+-ATPase activity shows a biphasic behavior with respect to the detergent/phosphatidylcholine ratio. Moreover, the maximal Ca2+-ATPase activity largely depends on the length and the unsaturation degree of the hydrocarbon chain. Using static light scattering and fluorescence correlation spectroscopy, we monitored the changes in hydrodynamic radius of detergent/phosphatidylcholine particles during the micelle-vesicle transition. We found that, when PMCA is reconstituted in mixed micelles, neutral phospholipids increase the enzyme turnover. The biophysical changes associated with the transition from mixed micelles to bicelles increase the time of residence of the phosphorylated intermediate (EP), decreasing the enzyme turnover. Molecular dynamics simulations analysis of the interactions between PMCA and the phospholipid bilayer in which it is embedded show that in the 1,2-dioleoyl-sn-glycero-3-phosphocholine bilayer, charged residues of the protein are trapped in the hydrophobic core. Conversely, in the 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer, the overall hydrophobic-hydrophilic requirements of the protein surface are fulfilled the best, reducing the thermodynamic cost of exposing charged residues to the hydrophobic core. The apparent mismatch produced by a 1,2-dioleoyl-sn-glycero-3-phosphocholine thicker bilayer could be a structural foundation to explain its functional effect on PMCA.	[Mangialavori, Irene C.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, CONICET, RA-1113 Buenos Aires, DF, Argentina; [Sica, Mauricio] CONICET Ctr Atom Bariloche, IEDS, Lab Bioenergias, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Mangialavori, IC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, CONICET, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	irenem@qb.ffyb.uba.ar	Mangialavori, Irene/GLU-8182-2022; González Flecha, F Luis/J-7060-2014	González Flecha, F Luis/0000-0003-2828-7907; Mangialavori, Irene/0000-0003-3187-3130	Agencia Nacional de Promocion Cientifica y Tecnologica; CONICET; Universidad de Buenos Aires, Ciencia y Tecnica	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Ciencia y Tecnica	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, CONICET, and Universidad de Buenos Aires, Ciencia y Tecnica.	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; ALMOG S, 1990, BIOCHEMISTRY-US, V29, P4582, DOI 10.1021/bi00471a012; Booth PJ, 1997, BIOCHEMISTRY-US, V36, P197, DOI 10.1021/bi962200m; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6; Curran AR, 1999, BIOCHEMISTRY-US, V38, P9328, DOI 10.1021/bi982322+; Traian MMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039255; Durr UHN, 2013, PROG NUCL MAG RES SP, V69, P1, DOI 10.1016/j.pnmrs.2013.01.001; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; Echarte MM, 2001, ANAL BIOCHEM, V289, P267, DOI 10.1006/abio.2000.4950; EDWARDS K, 1989, LANGMUIR, V5, P473, DOI 10.1021/la00086a032; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Herscher CJ, 1996, BIOCHEMISTRY-US, V35, P14917, DOI 10.1021/bi961879r; JACKSON ML, 1982, BIOCHEMISTRY-US, V21, P4576, DOI 10.1021/bi00262a010; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kandasamy SK, 2006, BIOPHYS J, V90, P2326, DOI 10.1529/biophysj.105.073395; KOSKKOSICKA D, 1990, MOL CELL BIOCHEM, V99, P75; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Levi V, 2000, J MEMBRANE BIOL, V173, P215, DOI 10.1007/s002320001021; LEVY D, 1990, BIOCHEMISTRY-US, V29, P9480, DOI 10.1021/bi00492a022; LICHTENBERG D, 1985, BIOCHIM BIOPHYS ACTA, V821, P470, DOI 10.1016/0005-2736(85)90052-5; Lind J, 2008, BBA-BIOMEMBRANES, V1778, P2526, DOI 10.1016/j.bbamem.2008.07.010; LUTERBACHER S, 1983, EXPERIENTIA, V39, P311, DOI 10.1007/BF01955322; Mangialavori I, 2011, J BIOL CHEM, V286, P18397, DOI 10.1074/jbc.M110.210088; Mangialavori I, 2011, FEBS LETT, V585, P1153, DOI 10.1016/j.febslet.2011.03.024; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Mangialavori IC, 2013, J BIOL CHEM, V288, P31030, DOI 10.1074/jbc.M113.494633; Mangialavori IC, 2012, BIOCHEM J, V443, P125, DOI 10.1042/BJ20111035; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; MULLER K, 1981, BIOCHEMISTRY-US, V20, P404, DOI 10.1021/bi00505a028; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; PATERNOSTRE MT, 1988, BIOCHEMISTRY-US, V27, P2668, DOI 10.1021/bi00408a006; Penniston JT, 2014, J CELL SCI, V127, P72, DOI 10.1242/jcs.132548; Pinto FD, 2002, J BIOL CHEM, V277, P12784, DOI 10.1074/jbc.M111055200; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; REED PW, 1972, J BIOL CHEM, V247, P6970; Rega A., 1986, CA2 PUMP PLASMA MEMB, P115; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; Roman EA, 2014, BIOMOLECULES, V4, P354, DOI 10.3390/biom4010354; RONNER P, 1977, ARCH BIOCHEM BIOPHYS, V179, P578, DOI 10.1016/0003-9861(77)90146-1; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; SEIGNEURET M, 1985, FEBS LETT, V188, P101, DOI 10.1016/0014-5793(85)80883-8; SILVIUS JR, 1992, BIOCHEMISTRY-US, V31, P3398, DOI 10.1021/bi00128a014; SINES JJ, 1987, BIOCHEM J, V243, P159, DOI 10.1042/bj2430159; Sonntag Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1307; STARLING AP, 1993, BIOCHEMISTRY-US, V32, P1593, DOI 10.1021/bi00057a025; STARLING AP, 1995, BIOCHEM J, V310, P875, DOI 10.1042/bj3100875; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6; Warisnoicharoen W, 2000, AAPS PHARMSCI, V2	63	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6179	6190		10.1074/jbc.M114.585828	http://dx.doi.org/10.1074/jbc.M114.585828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605721	hybrid, Green Published			2022-12-28	WOS:000350732500026
J	Stadler, T; O'Reilly, AO; Lampert, A				Stadler, Theresa; O'Reilly, Andrias O.; Lampert, Angelika			Erythromelalgia Mutation Q875E Stabilizes the Activated State of Sodium Channel Nav1.7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE SENSOR; CRYSTAL-STRUCTURE; NA(V)1.7 CHANNEL; PRIMARY ERYTHERMALGIA; PORE DOMAIN; K+ CHANNEL; PAIN; SCN9A; DISORDER; FAMILY	The human voltage-gated sodium channel Nav1.7 plays a crucial role in transmission of noxious stimuli. The inherited pain disorder erythromelalgia (IEM) has been linked to Nav1.7 gain-of-function mutations. Here we show that the IEM-associated Q875E mutation located on the pore module of Nav1.7 produces a large hyperpolarizing shift (-18 mV) in the voltage dependence of activation. Three-dimensional homology modeling indicates that the side chains of Gln-875 and the gating charge Arg-214 of the domain I voltage sensor are spatially close in the activated conformation of the channel. We verified this proximity by using an engineered disulfide bridge approach. The Q875E mutation introduces a negative charge that may modify the local electrical field experienced by the voltage sensor and, upon activation, interact directly via a salt bridge with the Arg-214 gating charge residue. Together these processes could promote transition to, and stabilization of, the domain I voltage sensor in the activated conformation and thus produce the observed gain of function. In support of this hypothesis, an increase in the extracellular concentration of Ca2+ or Mg2+ reverted the voltage dependence of activation of the IEM mutant to near WT values, suggesting a cation-mediated electrostatic screening of the proposed interaction between Q875E and Arg-214.	[Stadler, Theresa; O'Reilly, Andrias O.; Lampert, Angelika] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [O'Reilly, Andrias O.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England; [Lampert, Angelika] RWTH Aachen Univ Hosp, Inst Physiol, D-52074 Aachen, Germany	University of Erlangen Nuremberg; Liverpool John Moores University; RWTH Aachen University; RWTH Aachen University Hospital	Lampert, A (corresponding author), RWTH Aachen Univ Hosp, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	alampert@ukaachen.de	Lampert, Angelika/F-7198-2010; O'Reilly, Andrias/AAC-7628-2022	Lampert, Angelika/0000-0001-6319-6272; O'Reilly, Andrias/0000-0003-3449-2368	Deutsche Forschungsgemeinschaft (DFG) [LA2740/2-1]; German Israeli Foundation (GIF) [1091-27.1/2010]; Marie-Curie Fellowship FP7-PEOPLE-IEF [275768]; Studienstiftung des deutschen Volkes	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Marie-Curie Fellowship FP7-PEOPLE-IEF; Studienstiftung des deutschen Volkes	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant LA2740/2-1 (to A. L.), German Israeli Foundation (GIF) Grant 1091-27.1/2010 (to A. L.), Marie-Curie Fellowship FP7-PEOPLE-2010-IEF, Number 275768 (to A. O. R.), and a fellowship from the Studienstiftung des deutschen Volkes (to T. S.).	Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cheng XY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-1; Choi JS, 2006, NEUROLOGY, V67, P1563, DOI 10.1212/01.wnl.0000231514.33603.1e; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cregg R, 2013, NEUROMOL MED, V15, P265, DOI 10.1007/s12017-012-8216-8; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Eberhardt M, 2014, J BIOL CHEM, V289, P1971, DOI 10.1074/jbc.M113.502211; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Fertleman CR, 2007, NEUROLOGY, V69, P586, DOI 10.1212/01.wnl.0000268065.16865.5f; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Han CY, 2009, BRAIN, V132, P1711, DOI 10.1093/brain/awp078; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lampert A, 2008, J BIOL CHEM, V283, P24118, DOI 10.1074/jbc.M802900200; Lampert Angelika, 2014, Handb Exp Pharmacol, V221, P91, DOI 10.1007/978-3-642-41588-3_5; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Lampert A, 2009, BIOCHEM BIOPH RES CO, V390, P319, DOI 10.1016/j.bbrc.2009.09.121; Lewis A, 2008, J GEN PHYSIOL, V131, P549, DOI 10.1085/jgp.200809962; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MILLER JA, 1983, BIOCHEMISTRY-US, V22, P462, DOI 10.1021/bi00271a032; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips LR, 2010, J GEN PHYSIOL, V136, P629, DOI 10.1085/jgp.201010517; Sheets PL, 2007, J PHYSIOL-LONDON, V581, P1019, DOI 10.1113/jphysiol.2006.127027; Skeik N, 2012, VASC MED, V17, P44, DOI 10.1177/1358863X11422584; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Takeshita K, 2014, NAT STRUCT MOL BIOL, V21, P352, DOI 10.1038/nsmb.2783; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024; Waxman SG, 2013, TRENDS MOL MED, V19, P406, DOI 10.1016/j.molmed.2013.04.003; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	39	16	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6316	6325		10.1074/jbc.M114.605899	http://dx.doi.org/10.1074/jbc.M114.605899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25575597	Green Published, hybrid			2022-12-28	WOS:000350732500037
J	Sun, YM; Ren, WY; Cote, JF; Hinds, PW; Hu, XX; Du, KY				Sun, Yingmin; Ren, Wenying; Cote, Jean-Franoiscois; Hinds, Philip W.; Hu, Xiaoxiang; Du, Keyong			ClipR-59 Interacts with Elmo2 and Modulates Myoblast Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; RAC ACTIVATION; EXCHANGE FACTORS; APOPTOTIC CELLS; CLIP-170 FAMILY; PROTEIN; DOMAIN; ASSOCIATION; ENGULFMENT; MEMBRANE	Recent studies using ClipR-59 knock-out mice implicated this protein in the regulation of muscle function. In this report, we have examined the role of ClipR-59 in muscle differentiation and found that ClipR-59 knockdown in C2C12 cells suppressed myoblast fusion. To elucidate the molecular mechanism whereby ClipR-59 regulates myoblast fusion, we carried out a yeast two-hybrid screen using ClipR-59 as the bait and identified Elmo2, a member of the Engulfment and cell motility protein family, as a novel ClipR-59-associated protein. We showed that the interaction between ClipR-59 and Elmo2 was mediated by the atypical PH domain of Elmo2 and the Glu-Pro-rich domain of ClipR-59 and regulated by Rho-GTPase. We have examined the impact of ClipR-59 on Elmo2 downstream signaling and found that interaction of ClipR-59 with Elmo2 enhanced Rac1 activation. Collectively, our studies demonstrate that formation of an Elmo2.ClipR-59 complex plays an important role in myoblast fusion.	[Sun, Yingmin; Hu, Xiaoxiang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 10083, Peoples R China; [Sun, Yingmin; Ren, Wenying; Hinds, Philip W.; Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Cote, Jean-Franoiscois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	China Agricultural University; Tufts Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Du, KY (corresponding author), 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org			National Institutes of Health [RO1 DK084319]; Major Transgenic project [2011ZX08009-003-006]; Fonds de recherche du Quebec-Sante senior investigator salary award; Canadian Institutes of Health Research [77591]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Major Transgenic project; Fonds de recherche du Quebec-Sante senior investigator salary award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK084319 (to K. D.).; Supported in part by Major Transgenic project 2011ZX08009-003-006 (to X. H.).; Recipient of a Fonds de recherche du Quebec-Sante senior investigator salary award and supported by Canadian Institutes of Health Research Grant 77591.	Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Burks DJ, 1998, J BIOL CHEM, V273, P31061, DOI 10.1074/jbc.273.47.31061; Couesnon A, 2013, DEVELOPMENT, V140, P1583, DOI 10.1242/dev.087106; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Duquette P. M., 2014, SMALL GTPASES, V5, P1; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fujikura D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.3; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Ho E, 2012, CELL ADHES MIGR, V6, P168, DOI 10.4161/cam.20399; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Lallemand-Breitenbach V, 2004, J BIOL CHEM, V279, P41168, DOI 10.1074/jbc.M406482200; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Maekawa H, 2004, DEV CELL, V6, P746, DOI 10.1016/j.devcel.2004.05.017; Margaron Y, 2013, J BIOL CHEM, V288, P1184, DOI 10.1074/jbc.M112.431825; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; Mohammadi S, 2009, INFECT IMMUN, V77, P4771, DOI 10.1128/IAI.00850-09; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel Manishha, 2011, Small GTPases, V2, P268; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ren WY, 2013, MOL CELL BIOL, V33, P4255, DOI 10.1128/MCB.00527-13; Ren WY, 2012, J BIOL CHEM, V287, P26890, DOI 10.1074/jbc.M112.357699; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Zhang G, 2014, J BIOL CHEM, V289, P23112, DOI 10.1074/jbc.M114.549550	39	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6130	6140		10.1074/jbc.M114.616680	http://dx.doi.org/10.1074/jbc.M114.616680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25572395	Green Published, hybrid			2022-12-28	WOS:000350732500022
J	Baranovskiy, AG; Zhang, YB; Suwa, Y; Babayeva, ND; Gu, JY; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Zhang, Yinbo; Suwa, Yoshiaki; Babayeva, Nigar D.; Gu, Jianyou; Pavlov, Youri I.; Tahirov, Tahir H.			Crystal Structure of the Human Primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; C-TERMINAL DOMAIN; RNA PRIMER SYNTHESIS; P58 SUBUNIT; EUKARYOTIC REPLISOME; NMR SYSTEM; IN-VIVO; REPLICATION; MECHANISM; COMPLEX	DNA replication in bacteria and eukaryotes requires the activity of DNA primase, a DNA-dependent RNA polymerase that lays short RNA primers for DNA polymerases. Eukaryotic and archaeal primases are heterodimers consisting of small catalytic and large accessory subunits, both of which are necessary for RNA primer synthesis. Understanding of RNA synthesis priming in eukaryotes is currently limited due to the lack of crystal structures of the full-length primase and its complexes with substrates in initiation and elongation states. Here we report the crystal structure of the full-length human primase, revealing the precise overall organization of the enzyme, the relative positions of its functional domains, and the mode of its interaction with modeled DNA and RNA. The structure indicates that the dramatic conformational changes in primase are necessary to accomplish the initiation and then elongation of RNA synthesis. The presence of a long linker between the N- and C-terminal domains of p58 provides the structural basis for the bulk of enzyme's conformational flexibility. Deletion of most of this linker affected the initiation and elongation steps of the primer synthesis.	[Tahirov, Tahir H.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo; Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796; Tahirov, Tahir/0000-0002-1238-0069; Gu, Jianyou/0000-0003-0285-8919	National Institutes of Health (NIH), NIGMS [GM101167, P41 GM103403]; NIH, NCI [CA129925]; NIH Cancer Center [P30CA036727]; United States DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA129925, P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIGMS, Grant GM101167 (to T. H. T.) and NIH, NCI, Grant CA129925 (to Y. I. P.). The Eppley Institute X-ray Crystallography Core Facility is supported by NIH Cancer Center Support Grant P30CA036727. This work is also based upon research conducted at the Advanced Photon Source on the NECAT beamlines, which are supported by NIH, NIGMS, Grant P41 GM103403. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Augustin MA, 2001, NAT STRUCT BIOL, V8, P57, DOI 10.1038/83060; Baranovskiy AG, 2014, ACTA CRYSTALLOGR F, V70, P206, DOI 10.1107/S2053230X13034432; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1995, J BIOL CHEM, V270, P3905, DOI 10.1074/jbc.270.8.3905; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; FOIANI M, 1989, J BIOL CHEM, V264, P2189; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Geibel S, 2009, P NATL ACAD SCI USA, V106, P7810, DOI 10.1073/pnas.0902910106; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito N, 2003, GENES CELLS, V8, P913, DOI 10.1111/j.1365-2443.2003.00693.x; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Lipps G, 2004, NAT STRUCT MOL BIOL, V11, P157, DOI 10.1038/nsmb723; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; Pan H, 2000, STRUCTURE, V8, P231, DOI 10.1016/S0969-2126(00)00101-5; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; PODUST VN, 1992, EUR J BIOCHEM, V206, P7, DOI 10.1111/j.1432-1033.1992.tb16895.x; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; SINGH H, 1986, J BIOL CHEM, V261, P8564; THOMPSON HC, 1995, NUCLEIC ACIDS RES, V23, P4109, DOI 10.1093/nar/23.20.4109; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zakharova OD, 1995, BIOCHIMIE, V77, P699, DOI 10.1016/0300-9084(96)88184-3; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333	51	39	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5635	5646		10.1074/jbc.M114.624742	http://dx.doi.org/10.1074/jbc.M114.624742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25550159	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000350044200033
J	Xu, GL; Liu, GL; Xiong, SD; Liu, HY; Chen, X; Zheng, B				Xu, Guiliang; Liu, Guilin; Xiong, Sidong; Liu, Haiyan; Chen, Xi; Zheng, Biao			The Histone Methyltransferase Smyd2 Is a Negative Regulator of Macrophage Activation by Suppressing Interleukin 6 (IL-6) and Tumor Necrosis Factor alpha (TNF-alpha) Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; ALTERNATIVE ACTIVATION; EPIGENETIC REGULATION; POLARIZATION; P53	SET and MYND domain-containing 2 (Smyd2), a histone 3 lysine 4- and histone 3 lysine 36 (H3K36)-specific methyltransferase, plays critical roles in cardiac development and tumorigenesis. However, the role of Smyd2 in immunity and inflammation remains poorly understood. In this study, we report that Smyd2 is a novel negative regulator for macrophage activation and M1 polarization. Elevated Smyd2 expression suppresses the production of proinflammatory cytokines, including IL-6 and TNF, and inhibits the expression of important cell surface molecules, including major MHC-II and costimulatory molecules. Furthermore, macrophages with high Smyd2 expression inhibit Th-17 cell differentiation but promote regulatory T cell differentiation as a result of increased TGF-beta production and decreased IL-6 secretion. In macrophages, Smyd2 specifically facilitates H3K36 dimethylation at Tnf and Il6 promoters to suppress their transcription and inhibits NF-kappa B and ERK signaling. Therefore, our data demonstrate that epigenetic modification by Smyd2-mediated H3K36 dimethylation at Tnf and Il6 promoters plays an important role in the regulation of macrophage activation during inflammation.	[Xu, Guiliang; Liu, Guilin; Xiong, Sidong; Liu, Haiyan] Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Chen, Xi; Zheng, Biao] E China Normal Univ, Sch Biol Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Chen, Xi; Zheng, Biao] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Soochow University - China; East China Normal University; Baylor College of Medicine	Chen, X (corresponding author), E China Normal Univ, Sch Biol Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.	xichen0919@gmail.com; bzheng@bcm.edu	Liu, Haiyan/ABD-8689-2021	Liu, Haiyan/0000-0002-4652-469X				Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bordon Y, 2013, NAT REV IMMUNOL, V13, P706, DOI 10.1038/nri3533; Bordon Y, 2012, NAT REV IMMUNOL, V12, DOI 10.1038/nri3332; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P359, DOI 10.1038/nri3688; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lin L, 2013, J IMMUNOL, V191, P3896, DOI 10.4049/jimmunol.1203450; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Papatriantafyllou M, 2012, NAT REV IMMUNOL, V12, DOI 10.1038/nri3324; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293	40	67	73	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5414	5423		10.1074/jbc.M114.610345	http://dx.doi.org/10.1074/jbc.M114.610345			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25583990	Green Published, hybrid			2022-12-28	WOS:000350044200015
J	Jay, AG; Chen, AN; Paz, MA; Hung, JP; Hamilton, JA				Jay, Anthony G.; Chen, Alexander N.; Paz, Miguel A.; Hung, Justin P.; Hamilton, James A.			CD36 Binds Oxidized Low Density Lipoprotein (LDL) in a Mechanism Dependent upon Fatty Acid Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; SCAVENGER RECEPTOR CD36; FOAM CELL-FORMATION; MEMBRANE-PROTEINS; SR-BI; LONG; EXPRESSION; DYNAMICS; ATHEROSCLEROSIS; TRAFFICKING	The association of unesterified fatty acid (FA) with the scavenger receptor CD36 has been actively researched, with focuses on FA and oxidized low density lipoprotein (oxLDL) uptake. CD36 has been shown to bind FA, but this interaction has been poorly characterized to date. To gain new insights into the physiological relevance of binding of FA to CD36, we characterized FA binding to the ectodomain of CD36 by the biophysical method surface plasmon resonance. Five structurally distinct FAs (saturated, monounsaturated (cis and trans), polyunsaturated, and oxidized) were pulsed across surface plasmon resonance channels, generating association and dissociation binding curves. Except for the oxidized FA HODE, all FAs bound to CD36, with rapid association and dissociation kinetics similar to HSA. Next, to elucidate the role that each FA might play in CD36-mediated oxLDL uptake, we used a fluorescent oxLDL (Dii-oxLDL) live cell assay with confocal microscopy imaging. CD36-mediated uptake in serum-free medium was very low but greatly increased when serum was present. The addition of exogenous FA in serum-free medium increased oxLDL binding and uptake to levels found with serum and affected CD36 plasma membrane distribution. Binding/uptake of oxLDL was dependent upon the FA dose, except for docosahexaenoic acid, which exhibited binding to CD36 but did not activate the uptake of oxLDL. HODEalso did not affect oxLDL uptake. High affinity FA binding to CD36 and the effects of each FA on oxLDL uptake have important implications for protein conformation, binding of other ligands, functional properties of CD36, and high plasma FA levels in obesity and type 2 diabetes.	[Jay, Anthony G.] Boston Univ, Dept Biochem, Boston, MA 02118 USA; [Jay, Anthony G.; Chen, Alexander N.; Paz, Miguel A.; Hung, Justin P.; Hamilton, James A.] Boston Univ, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University; Boston University	Hamilton, JA (corresponding author), Boston Univ, Dept Physiol & Biophys, 700 Albany St,W302, Boston, MA 02118 USA.	jhamilt@gmail.com		Jay, Anthony G./0000-0003-0346-9480; Hamilton, James/0000-0002-4747-7071	American Diabetes Association [1-11-BS-R62]	American Diabetes Association(American Diabetes Association)	This work was supported by the American Diabetes Association Grant 1-11-BS-R62 (to J. A. H.).	Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7; Amezaga N, 2014, J LEUKOCYTE BIOL, V95, P509, DOI 10.1189/jlb.1212660; Avraham-Davidi I, 2013, EXP CELL RES, V319, P1298, DOI 10.1016/j.yexcr.2013.01.009; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Baranova IN, 2012, J IMMUNOL, V188, P1371, DOI 10.4049/jimmunol.1100350; Bassett CMC, 2010, J NUTR, V140, P18, DOI 10.3945/jn.109.105163; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; Byun JY, 2006, MOL VIS, V12, P949; Cai J, 2012, BIOPHYS J, V102, P2585, DOI 10.1016/j.bpj.2012.04.039; CROUSE JR, 1985, J LIPID RES, V26, P566; de Villiers WJS, 2001, J LIPID RES, V42, P1231; Degrace-Passilly P, 2012, CURR OPIN CLIN NUTR, V15, P107, DOI 10.1097/MCO.0b013e32834ff19c; Dushkin MI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P327, DOI 10.1134/S0006297912040025; Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498; FOLCIK VA, 1994, J LIPID RES, V35, P1570; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Gaubatz JW, 2007, J LIPID RES, V48, P348, DOI 10.1194/jlr.M600249-JLR200; GERICH JE, 1974, J CLIN INVEST, V53, P1284, DOI 10.1172/JCI107675; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Gruarin P, 2001, J IMMUNOL, V167, P6510, DOI 10.4049/jimmunol.167.11.6510; Hamilton JA, 2013, BBA-GEN SUBJECTS, V1830, P5418, DOI 10.1016/j.bbagen.2013.08.002; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; HARMON CM, 1992, BIOCHEM SOC T, V20, P811, DOI 10.1042/bst0200811; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; Hofnagel O, 2007, BBA-MOL CELL BIOL L, V1771, P1117, DOI 10.1016/j.bbalip.2007.06.003; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; KASHIWAGI H, 1995, J CLIN INVEST, V95, P1040, DOI 10.1172/JCI117749; Kashyap SR, 2009, OBESITY, V17, P2142, DOI 10.1038/oby.2009.179; Khan-Merchant N, 2002, J NUTR, V132, P3256, DOI 10.1093/jn/132.11.3256; Kozai Y, 2014, BIOSCI BIOTECH BIOCH, V78, P839, DOI 10.1080/09168451.2014.891934; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Krenzel ES, 2013, BIOCHEMISTRY-US, V52, P1559, DOI 10.1021/bi301458b; KU G, 1992, J BIOL CHEM, V267, P14183; Kuda O, 2013, J BIOL CHEM, V288, P15547, DOI 10.1074/jbc.M113.473298; Le Foll C, 2013, DIABETES, V62, P2709, DOI 10.2337/db12-1689; Madonna R, 2011, THROMB HAEMOSTASIS, V106, P500, DOI 10.1160/TH10-09-0574; Maiolino G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/714653; Martin CA, 2007, PROTEIN SCI, V16, P2531, DOI 10.1110/ps.073007207; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Navazo MDP, 1996, ARTERIOSCL THROM VAS, V16, P1033, DOI 10.1161/01.ATV.16.8.1033; Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Pillai BK, 2009, J BIOL CHEM, V284, P33296, DOI 10.1074/jbc.M109.043737; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Pownall H, 2014, ARTERIOSCL THROM VAS, V34, pE8, DOI 10.1161/ATVBAHA.114.303380; Ramos-Arellano LE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-54; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Saez-Cirion A, 2002, BBA-BIOMEMBRANES, V1564, P57, DOI 10.1016/S0005-2736(02)00400-5; Silverstein RL, 2009, CLEVE CLIN J MED S2, V76, pS27, DOI DOI 10.3949/CCJM.76.S2.06; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Simard JR, 2010, J LIPID RES, V51, P914, DOI 10.1194/jlr.M900251; SPECTOR AA, 1975, J LIPID RES, V16, P165; Stachowska E, 2004, EUR J NUTR, V43, P313, DOI 10.1007/s00394-004-0479-x; STOLL LL, 1984, IN VITRO CELL DEV B, V20, P732; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Sun B, 2006, J LIPID RES, V47, P1700, DOI 10.1194/jlr.M500450-JLR200; Takai M, 2014, BIOSCI BIOTECH BIOCH, V78, P238, DOI 10.1080/09168451.2014.882750; Tarhda Z, 2013, BIOINFORM BIOL INSIG, V7, P369, DOI 10.4137/BBI.S12276; Xu S, 2013, BIOCHEMISTRY-US, V52, P7254, DOI 10.1021/bi400914c; Yaney GC, 2001, DIABETES, V50, P56, DOI 10.2337/diabetes.50.1.56; Zhang FL, 1997, J BIOMOL NMR, V9, P213, DOI 10.1023/A:1018666522787; Zhang FL, 1996, BIOCHEMISTRY-US, V35, P16055, DOI 10.1021/bi961685b	70	49	52	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4590	4603		10.1074/jbc.M114.627026	http://dx.doi.org/10.1074/jbc.M114.627026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555908	hybrid, Green Published			2022-12-28	WOS:000350042000006
J	Jendresen, CB; Cui, H; Zhang, X; Vlodavsky, I; Nilsson, LNG; Li, JP				Jendresen, Charlotte B.; Cui, Hao; Zhang, Xiao; Vlodavsky, Israel; Nilsson, Lars N. G.; Li, Jin-Ping			Overexpression of Heparanase Lowers the Amyloid Burden in Amyloid-beta Precursor Protein Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; SULFATE PROTEOGLYCANS; GLYCOSAMINOGLYCANS; ACCUMULATION; AGGREGATION; INHIBITION; REGULATORS; PEPTIDES; DEPOSITS	Heparan sulfate (HS) and HS proteoglycans (HSPGs) colocalize with amyloid-beta (A beta) deposits in Alzheimer disease brain and in A beta precursor protein (A beta PP) transgenic mouse models. Heparanase is an endoglycosidase that specifically degrades the unbranched glycosaminoglycan side chains of HSPGs. The aim of this study was to test the hypothesis that HS and HSPGs are active participators of A beta pathogenesis in vivo. We therefore generated a double-transgenic mouse model overexpressing both human heparanase and human A beta PP harboring the Swedish mutation (tgHpa*Swe). Overexpression of heparanase did not affect A beta PP processing because the steady-state levels of A beta(1-40), A beta(1-42), and soluble A beta PP beta were the same in 2- to 3-month-old double-transgenic tgHpa*Swe and single-transgenic tgSwe mice. In contrast, the Congo red-positive amyloid burden was significantly lower in 15-month-old tgHpa*Swe brain than in tgSwe brain. Likewise, the A beta burden, measured by A beta(x-40) and A beta(x-42) immunohistochemistry, was reduced significantly in tgHpa*Swe brain. The intensity of HS-stained plaques correlated with the A beta(x-42) burden and was reduced in tgHpa*Swe mice. Moreover, the HS-like molecule heparin facilitated A beta(1-42)-aggregation in an in vitro Thioflavin T assay. The findings suggest that HSPGs contribute to amyloid deposition in tgSwe mice by increasing A beta fibril formation because heparanase-induced fragmentation of HS led to a reduced amyloid burden. Therefore, drugs interfering with A beta-HSPG interactions might be a potential strategy for Alzheimer disease treatment.	[Jendresen, Charlotte B.; Nilsson, Lars N. G.] Univ Oslo, Dept Pharmacol, N-0316 Oslo, Norway; [Jendresen, Charlotte B.; Nilsson, Lars N. G.] Oslo Univ Hosp, N-0316 Oslo, Norway; [Cui, Hao; Li, Jin-Ping] Uppsala Univ, Biomed Ctr, SciLifeLab Uppsala, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Zhang, Xiao] Uppsala Univ, Dept Neurosci & Pharmacol, S-75124 Uppsala, Sweden; [Vlodavsky, Israel] Technion Israel Inst Technol, Fac Med, Canc & Vasc Biol Res Ctr Rappaport, IL-31096 Haifa, Israel	University of Oslo; University of Oslo; SciLifeLab; Uppsala University; Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Nilsson, LNG (corresponding author), Univ Oslo, Dept Pharmacol, Postboks 1057 Blindern, N-0316 Oslo, Norway.	lars.nilsson@medisin.uio.no; jin-ping.li@imbim.uu.se		nilsson, lars/0000-0002-8362-1042	University of Oslo; Anders Jahres Stiftelse; Helse Sor-Ost; Civitan Foundation; Joint Programme Neurodegenerative Disease Research grant; Swedish Heart and Lung Foundation [20110131]; Swedish Research Council [K2012-67X-21128-01-4]; Polysackaridforskning Foundation (Uppsala)	University of Oslo; Anders Jahres Stiftelse; Helse Sor-Ost; Civitan Foundation; Joint Programme Neurodegenerative Disease Research grant; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Polysackaridforskning Foundation (Uppsala)	This work was supported by funding from the University of Oslo, by Anders Jahres Stiftelse, by Helse Sor-Ost, by the Civitan Foundation, by a Joint Programme Neurodegenerative Disease Research grant (to L. N. G. N.), by Swedish Heart and Lung Foundation Grant 20110131, by Swedish Research Council Grant K2012-67X-21128-01-4, and by the Polysackaridforskning Foundation (Uppsala) (to J. P. L.).	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; Cui P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023219; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; Leveugle B, 1997, NEUROCHEM INT, V30, P543, DOI 10.1016/S0197-0186(96)00103-9; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2011, AM J PATHOL, V178, P2286, DOI 10.1016/j.ajpath.2011.01.052; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Potter H, 2001, NEUROBIOL AGING, V22, P923, DOI 10.1016/S0197-4580(01)00308-6; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; SNOW AD, 1987, LAB INVEST, V56, P120; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; van Horssen J, 2002, NEUROBIOL AGING, V23, P537, DOI 10.1016/S0197-4580(02)00010-6; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang X, 2012, ACTA NEUROPATHOL, V124, P465, DOI 10.1007/s00401-012-0997-1	35	35	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5053	5064		10.1074/jbc.M114.600569	http://dx.doi.org/10.1074/jbc.M114.600569			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25548284	hybrid, Green Published			2022-12-28	WOS:000350042000046
J	Mizushina, Y; Shirasuna, K; Usui, F; Karasawa, T; Kawashima, A; Kimura, H; Kobayashi, M; Komada, T; Inoue, Y; Mato, N; Yamasawa, H; Latz, E; Iwakura, Y; Kasahara, T; Bando, M; Sugiyama, Y; Takahashi, M				Mizushina, Yoshiko; Shirasuna, Koumei; Usui, Fumitake; Karasawa, Tadayoshi; Kawashima, Akira; Kimura, Hiroaki; Kobayashi, Motoi; Komada, Takanori; Inoue, Yoshiyuki; Mato, Naoko; Yamasawa, Hideaki; Latz, Eicke; Iwakura, Yoichiro; Kasahara, Tadashi; Bando, Masashi; Sugiyama, Yukihiko; Takahashi, Masafumi			NLRP3 Protein Deficiency Exacerbates Hyperoxia-induced Lethality through Stat3 Protein Signaling Independent of Interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; ISCHEMIA-REPERFUSION INJURY; INFLAMMASOME; MICE; CANCER; TRANSCRIPTION-3; CONTRIBUTES; TRANSDUCER; ACTIVATION; MECHANISMS	Supplemental oxygen inhalation is frequently used to treat severe respiratory failure; however, prolonged exposure to hyperoxia causes hyperoxic acute lung injury (HALI), which induces acute respiratory distress syndrome and leads to high mortality rates. Recent investigations suggest the possible role of NLRP3 inflammasomes, which regulate IL-1 beta production and lead to inflammatory responses, in the pathophysiology of HALI; however, their role is not fully understood. In this study, we investigated the role of NLRP3 inflammasomes in mice with HALI. Under hyperoxic conditions, NLRP3(-/-) mice died at a higher rate compared with wild-type and IL-1 beta(-/-) mice, and there was no difference in IL-1 beta production in their lungs. Under hyperoxic conditions, the lungs of NLRP3(-/-) mice exhibited reduced inflammatory responses, such as inflammatory cell infiltration and cytokine expression, as well as increased and decreased expression of MMP-9 and Bcl-2, respectively. NLRP3(-/-) mice exhibited diminished expression and activation of Stat3, which regulatesMMP-9 and Bcl-2, in addition to increased numbers of apoptotic alveolar epithelial cells. In vitro experiments revealed that alveolar macrophages and neutrophils promoted Stat3 activation in alveolar epithelial cells. Furthermore, NLRP3 deficiency impaired the migration of neutrophils and chemokine expression by macrophages. These findings demonstrate that NLRP3 regulates Stat3 signaling in alveolar epithelial cells by affecting macrophage and neutrophil function independent of IL-1 beta production and contributes to the pathophysiology of HALI.	[Mizushina, Yoshiko; Shirasuna, Koumei; Usui, Fumitake; Karasawa, Tadayoshi; Kawashima, Akira; Kimura, Hiroaki; Kobayashi, Motoi; Komada, Takanori; Inoue, Yoshiyuki; Kasahara, Tadashi; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi 3290498, Japan; [Mizushina, Yoshiko; Mato, Naoko; Yamasawa, Hideaki; Bando, Masashi; Sugiyama, Yukihiko] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi 3290498, Japan; [Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, D-53113 Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba 2780022, Japan; [Iwakura, Yoichiro] Chiba Univ, Med Mycol Ctr, Chiba 2608673, Japan	Jichi Medical University; Jichi Medical University; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Tokyo University of Science; Chiba University	Takahashi, M (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	masafumi2@jichi.ac.jp	Kimura, Hiroaki/E-3224-2010; Iwakura, Yoichiro/E-5457-2011; Latz, Eicke/H-3951-2014	Kimura, Hiroaki/0000-0002-7441-0382; Iwakura, Yoichiro/0000-0002-9934-5775; Latz, Eicke/0000-0003-1488-5666; Karasawa, Tadayoshi/0000-0002-6738-2360	Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP); Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Jichi Medical University	Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jichi Medical University	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (CSTP) (to M. T.); the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported program for the Strategic Foundation at Private Universities (to M. T.); and a grant-in-aid for research activity start-up from the Jichi Medical University (to Y. M.).	Alas S, 2001, CANCER RES, V61, P5137; Bhandari V, 2008, FRONT BIOSCI-LANDMRK, V13, P6653, DOI 10.2741/3179; Bhandari V, 2007, J IMMUNOL, V178, P4993, DOI 10.4049/jimmunol.178.8.4993; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; DOBBS LG, 2002, CULTURE EPITHELIAL C, P277; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Gonzalez Robert F, 2013, Methods Mol Biol, V945, P145, DOI 10.1007/978-1-62703-125-7_10; Hokuto I, 2004, J CLIN INVEST, V113, P28, DOI 10.1172/JCI200419491; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Inoue Y, 2014, J IMMUNOL, V192, P4342, DOI 10.4049/jimmunol.1302039; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kolliputi N, 2012, J CELL PHYSIOL, V227, P3310, DOI 10.1002/jcp.24026; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lian XM, 2005, J IMMUNOL, V174, P7250, DOI 10.4049/jimmunol.174.11.7250; Lingappan K, 2013, TOXICOL APPL PHARM, V272, P281, DOI 10.1016/j.taap.2013.06.007; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; Quinton LJ, 2012, J IMMUNOL, V188, P6300, DOI 10.4049/jimmunol.1200256; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Yang L, 2004, MOL ENDOCRINOL, V18, P1520, DOI 10.1210/me.2003-0458; You S, 2014, MOL CANCER THER, V13, P606, DOI 10.1158/1535-7163.MCT-13-0608; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653; Zuurbier CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040643	35	44	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5065	5077		10.1074/jbc.M114.603217	http://dx.doi.org/10.1074/jbc.M114.603217			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25548278	Green Published, hybrid			2022-12-28	WOS:000350042000047
J	Noor, SI; Dietz, S; Heidtmann, H; Boone, CD; McKenna, R; Deitmer, JW; Becker, HM				Noor, Sina Ibne; Dietz, Steffen; Heidtmann, Hella; Boone, Christopher D.; McKenna, Robert; Deitmer, Joachim W.; Becker, Holger M.			Analysis of the Binding Moiety Mediating the Interaction between Monocarboxylate Transporters and Carbonic Anhydrase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; SLC16 GENE FAMILY; LACTATE TRANSPORT; RETINAL-PIGMENT; MCT2; EXPRESSION; CELLS; SITE; COTRANSPORTER; MEMBRANE	Proton-coupled monocarboxylate transporters (MCTs) mediate the exchange of high energy metabolites like lactate between different cells and tissues. We have reported previously that carbonic anhydrase II augments transport activity of MCT1 and MCT4 by a noncatalytic mechanism, while leaving transport activity of MCT2 unaltered. In the present study, we combined electrophysiological measurements in Xenopus oocytes and pulldown experiments to analyze the direct interaction between carbonic anhydrase II (CAII) and MCT1, MCT2, and MCT4, respectively. Transport activity of MCT2-WT, which lacks a putative CAII-binding site, is not augmented by CAII. However, introduction of a CAII-binding site into the C terminus of MCT2 resulted in CAII-mediated facilitation of MCT2 transport activity. Interestingly, introduction of three glutamic acid residues alone was not sufficient to establish a direct interaction between MCT2 and CAII, but the cluster had to be arranged in a fashion that allowed access to the binding moiety in CAII. We further demonstrate that functional interaction between MCT4 and CAII requires direct binding of the enzyme to the acidic cluster (EEE)-E-431 in the C terminus of MCT4 in a similar fashion as previously shown for binding of CAII to the cluster (EEE)-E-489 in the C terminus of MCT1. In CAII, binding to MCT1 and MCT4 is mediated by a histidine residue at position 64. Taken together, our results suggest that facilitation of MCT transport activity by CAII requires direct binding between histidine 64 in CAII and a cluster of glutamic acid residues in the C terminus of the transporter that has to be positioned in surroundings that allow access to CAII.	[Noor, Sina Ibne; Dietz, Steffen; Heidtmann, Hella; Becker, Holger M.] Univ Kaiserslautern, Div Zool Membrane Transport, Dept Biol, D-67653 Kaiserslautern, Germany; [Heidtmann, Hella; Deitmer, Joachim W.] Univ Kaiserslautern, Dept Biol, Div Gen Zool, D-67653 Kaiserslautern, Germany; [Boone, Christopher D.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of Kaiserslautern; University of Kaiserslautern; State University System of Florida; University of Florida	Becker, HM (corresponding author), Univ Kaiserslautern, Div Zool Membrane Transport, Dept Biol, POB 3049, D-67653 Kaiserslautern, Germany.	h.becker@biologie.uni-kl.de	Becker, Holger/AAB-4322-2020	Dietz, Steffen/0000-0003-1478-3969	Stiftung Rheinland-Pfalz fur Innovation Grant [961-386261/957]; Landesschwerpunkt Membrantransport	Stiftung Rheinland-Pfalz fur Innovation Grant; Landesschwerpunkt Membrantransport	This work was supported by Stiftung Rheinland-Pfalz fur Innovation Grant 961-386261/957 (to H. M. B.) and by the Landesschwerpunkt Membrantransport (to H. M. B. and J. W. D.).	Almquist J, 2010, J COMPUT SCI SYST BI, V3, P107, DOI DOI 10.4172/JCSB.1000066; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Becker HM, 2014, NEUROMETHODS, V90, P25, DOI 10.1007/978-1-4939-1059-5_2; Becker HM, 2014, SUBCELL BIOCHEM, V75, P105, DOI 10.1007/978-94-007-7359-2_7; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURG M, 1977, AM J PHYSIOL, V233, pF307, DOI 10.1152/ajprenal.1977.233.4.F307; Deitmer JW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00291; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P2930, DOI 10.1021/bi062066y; Frost SC, 2014, SUBCELL BIOCHEM, V75, P9, DOI 10.1007/978-94-007-7359-2_2; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Grollman EF, 2000, BIOCHEMISTRY-US, V39, P9351, DOI 10.1021/bi000464+; Gross E, 2002, J PHYSIOL-LONDON, V544, P679, DOI 10.1113/jphysiol.2002.029777; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; Jackson VN, 1997, BIOCHEM J, V324, P447, DOI 10.1042/bj3240447; Johnson D. E., 2009, DRUG DESIGN ZINC ENZ; KIFOR G, 1993, J MEMBRANE BIOL, V134, P169; Klier M, 2014, J BIOL CHEM, V289, P2765, DOI 10.1074/jbc.M113.537043; Klier M, 2011, J BIOL CHEM, V286, P27781, DOI 10.1074/jbc.M111.255331; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Loiselle FB, 2004, AM J PHYSIOL-CELL PH, V286, pC1423, DOI 10.1152/ajpcell.00382.2003; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; Martinez C, 2010, FRONT NEUROENERGETIC, V2, P27, DOI DOI 10.3389/FNENE.2010.00027; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Philp NJ, 1998, AM J PHYSIOL-REG I, V274, pR1824, DOI 10.1152/ajpregu.1998.274.6.R1824; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; SASAKI S, 1989, AM J PHYSIOL, V257, pF947, DOI 10.1152/ajprenal.1989.257.6.F947; SEKI G, 1992, PFLUG ARCH EUR J PHY, V422, P60, DOI 10.1007/BF00381514; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Wilson MC, 2009, J BIOL CHEM, V284, P20011, DOI 10.1074/jbc.M109.014217; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Yoon HY, 1997, BIOCHEM BIOPH RES CO, V234, P90, DOI 10.1006/bbrc.1997.6588	56	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4476	4486		10.1074/jbc.M114.624577	http://dx.doi.org/10.1074/jbc.M114.624577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25561737	Green Published, hybrid			2022-12-28	WOS:000349458400053
J	Lawn, S; Krishna, N; Pisklakova, A; Qu, XT; Fenstermacher, DA; Fournier, M; Vrionis, FD; Tran, N; Chan, JA; Kenchappa, RS; Forsyth, PA				Lawn, Samuel; Krishna, Niveditha; Pisklakova, Alexandra; Qu, Xiaotao; Fenstermacher, David A.; Fournier, Michelle; Vrionis, Frank D.; Nam Tran; Chan, Jennifer A.; Kenchappa, Rajappa S.; Forsyth, Peter A.			Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-LIKE CELLS; TYROSINE KINASES; PHASE-II; GLIOBLASTOMA; PATHWAY; INHIBITION; SURVIVAL; GLIOMA; IDENTIFICATION; PROLIFERATION	Neurotrophins and their receptors are frequently expressed in malignant gliomas, yet their functions are largely unknown. Previously, we have shown that p75 neurotrophin receptor is required for glioma invasion and proliferation. However, the role of Trk receptors has not been examined. In this study, we investigated the importance of TrkB and TrkC in survival of brain tumor-initiating cells (BTICs). Here, we show that human malignant glioma tissues and also tumor-initiating cells isolated from fresh human malignant gliomas express the neurotrophin receptors TrkB and TrkC, not TrkA, and they also express neurotrophins NGF, BDNF, and neurotrophin 3 (NT3). Specific activation of TrkB and TrkC receptors by ligands BDNF and NT3 enhances tumor-initiating cell viability through activation of ERK and Akt pathways. Conversely, TrkB and TrkC knockdown or pharmacologic inhibition of Trk signaling decreases neurotrophin-dependent ERK activation and BTIC growth. Further, pharmacological inhibition of both ERK and Akt pathways blocked BDNF, and NT3 stimulated BTIC survival. Importantly, attenuation of BTIC growth by EGFR inhibitors could be overcome by activation of neurotrophin signaling, and neurotrophin signaling is sufficient for long term BTIC growth as spheres in the absence of EGF and FGF. Our results highlight a novel role for neurotrophin signaling in brain tumor and suggest that Trks could be a target for combinatorial treatment of malignant glioma.	[Lawn, Samuel; Chan, Jennifer A.; Forsyth, Peter A.] Univ Calgary, Southern Alberta Canc Res Inst, Tom Baker Canc Ctr, Calgary, AB T2N 4N2, Canada; [Krishna, Niveditha; Pisklakova, Alexandra; Vrionis, Frank D.; Nam Tran; Kenchappa, Rajappa S.; Forsyth, Peter A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL 33612 USA; [Qu, Xiaotao; Fenstermacher, David A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA; [Fournier, Michelle] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tissue Core, Tampa, FL 33612 USA; [Vrionis, Frank D.; Nam Tran; Kenchappa, Rajappa S.; Forsyth, Peter A.] Univ S Florida, Dept Oncol Sci, Coll Med, Tampa, FL 33612 USA	Tom Baker Cancer Clinic; University of Calgary; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Kenchappa, RS (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Rajappa.Kenchappa@Moffitt.org; Peter.Forsyth@Moffitt.org			Moffitt Foundation; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Moffitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Moffitt Foundation.	Assimakopoulou M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-202; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bertrand T, 2012, J MOL BIOL, V423, P439, DOI 10.1016/j.jmb.2012.08.002; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Forsyth PA, 2014, J BIOL CHEM, V289, P8067, DOI 10.1074/jbc.M113.513762; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Marchetti D, 2003, PATHOL ONCOL RES, V9, P147, DOI 10.1007/BF03033729; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Prados MD, 2009, J CLIN ONCOL, V27, P579, DOI 10.1200/JCO.2008.18.9639; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wadhwa S, 2003, J BIOSCIENCES, V28, P181, DOI 10.1007/BF02706217; Wang Jun, 2008, Curr Chem Genomics, V1, P27, DOI 10.2174/1875397300801010027; Wang LM, 2008, PLOS BIOL, V6, P2496, DOI 10.1371/journal.pbio.0060289; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	39	96	99	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3814	3824		10.1074/jbc.M114.599373	http://dx.doi.org/10.1074/jbc.M114.599373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538243	Green Published, hybrid			2022-12-28	WOS:000349456000052
J	Sumida, GM; Yamada, S				Sumida, Grant M.; Yamada, Soichiro			Rho GTPases and the Downstream Effectors Actin-related Protein 2/3 (Arp2/3) Complex and Myosin II Induce Membrane Fusion at Self-contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL FUSION; MYOBLAST FUSION; FUSOGEN EFF-1; CATENIN; DYNAMICS; POLYMERIZATION; MORPHOGENESIS; PHAGOCYTOSIS; PROTRUSIONS; ENDOCYTOSIS	Actin regulation is required for membrane activities that drive cell adhesion and migration. The Rho GTPase family plays critical roles in actin and membrane dynamics; however, the roles of the Rho GTPase family are not limited to cell adhesion and migration. Using micron-sized obstacles to induce the formation of self-contacts in epithelial cells, we previously showed that self-adhesion is distinct from cell-to-cell adhesion in that self-contacts are eliminated by membrane fusion. In the current study, we identified Rho GTPases, RhoA, Rac1, and Cdc42, as potential upstream regulators of membrane fusion. The RhoA downstream effector myosin II is required for fusion as the expression of mutant myosin light chain reduced membrane fusion. Furthermore, an inhibitor of the Arp2/3 complex, a downstream effector of Rac1 and Cdc42, also reduced self-contact-induced membrane fusion. At self-contacts, while the concentration of E-cadherin diminished, the intensity of GFP-tagged Arp3 rapidly fluctuated then decreased and stabilized after membrane fusion. Taken together, these data suggest that the Arp2/3 complex-mediated actin polymerization brings two opposing membranes into close apposition by possibly excluding E-cadherin from contact sites, thus promoting membrane fusion at self-contacts.	[Sumida, Grant M.; Yamada, Soichiro] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Yamada, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dr,GBSF 2317, Davis, CA 95616 USA.	syamada@ucdavis.edu	Yamada, Soichiro/B-7360-2019	Yamada, Soichiro/0000-0001-6413-0814	National Institutes of Health [EUREKA GM094798]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EUREKA GM094798 (to S. Y.).	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Bjerregaard B, 2014, J ASSIST REPROD GEN, V31, P533, DOI 10.1007/s10815-014-0224-1; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Duan R, 2009, DEV BIOL, V325, P374, DOI 10.1016/j.ydbio.2008.10.035; Gallop JL, 2013, P NATL ACAD SCI USA, V110, P7193, DOI 10.1073/pnas.1305286110; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Lammert E, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006619; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Rasmussen JP, 2008, DEV CELL, V14, P559, DOI 10.1016/j.devcel.2008.01.019; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Rougerie P, 2013, IMMUNOL REV, V256, P222, DOI 10.1111/imr.12118; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Stone CE, 2009, DEV BIOL, V329, P201, DOI 10.1016/j.ydbio.2009.02.030; Sumida GM, 2013, P NATL ACAD SCI USA, V110, P18958, DOI 10.1073/pnas.1311135110; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yao LH, 2013, J NEUROSCI, V33, P15793, DOI 10.1523/JNEUROSCI.2171-13.2013; Zeev-Ben-Mordehai T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4912	39	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3238	3247		10.1074/jbc.M114.612168	http://dx.doi.org/10.1074/jbc.M114.612168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25527498	hybrid, Green Published			2022-12-28	WOS:000349456000005
J	Sato, S; Miyazono, S; Tachibanaki, S; Kawamura, S				Sato, Shinya; Miyazono, Sadaharu; Tachibanaki, Shuji; Kawamura, Satoru			RDH13L, an Enzyme Responsible for the Aldehyde-Alcohol Redox Coupling Reaction (AL-OL Coupling Reaction) to Supply 11-cis Retinal in the Carp Cone Retinoid Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Photoreceptor; Retinal Metabolism; Retinoid; Vision; Vitamin A; NADP; Retinal; Retinol; Visual Cycle	VISUAL PIGMENT KINASE; VITAMIN-A; SUBSTRATE-SPECIFICITY; VERTEBRATE RETINA; PROTEIN; PHOTORECEPTORS; METABOLISM; OXIDATION; RPE65; ISOMEROHYDROLASE	Background: In carp cones, 11-cis retinal is formed with the AL-OL coupling reaction. Results: We identified RDH13L which catalyzes both the AL-OL coupling reaction with tightly-bound NADP(+) and the conventional RDH activity with exogenous NADP(+). Mouse RDH14 showed similar activity. Conclusion: Cones have effective mechanisms to regenerate the pigment. Significance: Molecular bases of effective pigment regeneration in cones are uncovered. Cone photoreceptors require effective pigment regeneration mechanisms to maintain their sensitivity in the light. Our previous studies in carp cones suggested the presence of an unconventional and very effective mechanism to produce 11-cis retinal, the necessary component in pigment regeneration. In this reaction (aldehyde-alcohol redox coupling reaction, AL-OL coupling reaction), formation of 11-cis retinal, i.e. oxidation of 11-cis retinol is coupled to reduction of an aldehyde at a 1:1 molar ratio without exogenous NADP(H) which is usually required in this kind of reaction. Here, we identified carp retinol dehydrogenase 13-like (RDH13L) as an enzyme catalyzing the AL-OL coupling reaction. RDH13L was partially purified from purified carp cones, identified as a candidate protein, and its AL-OL coupling activity was confirmed using recombinant RDH13L. We further examined the substrate specificity, subcellular localization, and expression level of RDH13L. Based on these results, we concluded that RDH13L contributes to a significant part, but not all, of the AL-OL coupling activity in carp cones. RDH13L contained tightly bound NADP(+) which presumably functions as a cofactor in the reaction. Mouse RDH14, a mouse homolog of carp RDH13L, also showed the AL-OL coupling activity. Interestingly, although carp cone membranes, carp RDH13L and mouse RDH14 all showed the coupling activity at 15-37 degrees C, they also showed a conventional NADP(+)-dependent 11-cis retinol oxidation activity above 25 degrees C without addition of aldehydes. This dual mechanism of 11-cis retinal synthesis attained by carp RDH13L and mouse RDH14 probably contribute to effective pigment regeneration in cones that function in the light.	[Sato, Shinya; Miyazono, Sadaharu; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Dept Biol Sci, Grad Sch Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp		Sato, Shinya/0000-0002-5978-0975	Japan Society for the Promotion of Science [23227002, 24570085]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grants 23227002 (to S. K.) and 24570085 (to S. T.).	Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; Arinobu D, 2010, J NEUROCHEM, V115, P259, DOI 10.1111/j.1471-4159.2010.06925.x; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Bisswanger H., 2008, MULTISUBSTRATE REACT, P124; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kanan Y, 2008, EXP EYE RES, V86, P344, DOI 10.1016/j.exer.2007.11.006; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Reinheckel T, 1998, FREE RADICAL RES, V29, P297, DOI 10.1080/10715769800300331; Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748; Sato S, 2013, J BIOL CHEM, V288, P36589, DOI 10.1074/jbc.M113.521153; Schenkels P, 2000, MICROBIOL-SGM, V146, P775, DOI 10.1099/00221287-146-4-775; Scott T., 1988, CONCISE ENCY BIOCH, P397; Shimauchi-Matsukawa Y, 2005, MOL VIS, V11, P1220; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200	29	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2983	2992		10.1074/jbc.M114.629162	http://dx.doi.org/10.1074/jbc.M114.629162			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25533474	Green Published, hybrid			2022-12-28	WOS:000349310700036
J	Yang, HJ; Wahlmuller, FC; Sarg, B; Furtmuller, M; Geiger, M				Yang, Hanjiang; Wahlmueller, Felix Christof; Sarg, Bettina; Furtmueller, Margareta; Geiger, Margarethe			A plus -Helix of Protein C Inhibitor (PCI) Is a Cell-penetrating Peptide That Mediates Cell Membrane Permeation of PCI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Permeabilization; Cell-penetrating Peptide (CPP); Nuclear Translocation; Peptides; Serpin; Protein C Inhibitor; Testisin	TESTICULAR GERM-CELLS; SERINE-PROTEASE; IN-VITRO; EXPRESSION; PLASMA; TESTISIN; BINDING; SERPIN; LOCALIZATION; RECOGNITION	Background: Extracellular protein C inhibitor (PCI) can cross the cellular plasma membrane. Results: Testisin (fluid-phase and cell membrane-anchored) cleaves PCI close to its N terminus. N-terminally truncated PCI can no longer be internalized by cells. Conclusion: Testisin removes helix A+, a cell-penetrating peptide, which mediates cell membrane permeation of PCI. Significance: Testisin or other proteases could regulate PCI internalization by removing its N terminus. Protein C inhibitor (PCI) is a serpin with broad protease reactivity. It binds glycosaminoglycans and certain phospholipids that can modulate its inhibitory activity. PCI can penetrate through cellular membranes via binding to phosphatidylethanolamine. The exact mechanism of PCI internalization and the intracellular role of the serpin are not well understood. Here we showed that testisin, a glycosylphosphatidylinositol-anchored serine protease, cleaved human PCI and mouse PCI (mPCI) at their reactive sites as well as at sites close to their N terminus. This cleavage was observed not only with testisin in solution but also with cell membrane-anchored testisin on U937 cells. The cleavage close to the N terminus released peptides rich in basic amino acids. Synthetic peptides corresponding to the released peptides of human PCI (His(1)-Arg(11)) and mPCI (Arg(1)-Ala(18)) functioned as cell-penetrating peptides. Because intact mPCI but not testisin-cleaved mPCI was internalized by Jurkat T cells, a truncated mPCI mimicking testisin-cleaved mPCI was created. The truncated mPCI lacking 18 amino acids at the N terminus was not taken up by Jurkat T cells. Therefore our model suggests that testisin or other proteases could regulate the internalization of PCI by removing its N terminus. This may represent one of the mechanisms regulating the intracellular functions of PCI.	[Yang, Hanjiang; Wahlmueller, Felix Christof; Furtmueller, Margareta; Geiger, Margarethe] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Sarg, Bettina] Med Univ Innsbruck, Div Clin Biochem, Bioctr, A-6020 Innsbruck, Austria	Medical University of Vienna; Medical University of Innsbruck	Geiger, M (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Schwarzspanierstr 17, A-1090 Vienna, Austria.	margarethe.geiger@meduniwien.ac.at		Furtmuller, Margareta/0000-0002-2572-6401; Geiger, Margarethe/0000-0003-2021-5319	Austria Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung) [P22792-B11]; Austrian Science Fund (FWF) [P 22792] Funding Source: researchfish	Austria Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austria Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung) Grant P22792-B11 (to M. G.).	Asanuma K, 2007, INT J CANCER, V121, P955, DOI 10.1002/ijc.22773; Baumgartner P, 2007, J CELL BIOL, V179, P793, DOI 10.1083/jcb.200707165; Bijsmans ITGW, 2011, MODERN PATHOL, V24, P463, DOI 10.1038/modpathol.2010.214; Brenner AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057243; Cao Y, 2003, PROSTATE, V57, P196, DOI 10.1002/pros.10296; ECKE S, 1992, J BIOL CHEM, V267, P7048; ECKE S, 1992, ANN NY ACAD SCI, V667, P84, DOI 10.1111/j.1749-6632.1992.tb51601.x; Elisen MGLM, 1996, THROMB HAEMOSTASIS, V75, P760; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; Fortenberry YM, 2010, BBA-GEN SUBJECTS, V1800, P580, DOI 10.1016/j.bbagen.2010.03.003; Furtmueller M., 2011, J THROMB HAEMOST SS2, V9; Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74; GEIGER M, 1989, BLOOD, V74, P722; GEIGER M, 1991, J BIOL CHEM, V266, P11851; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Hayashi T, 2007, J THROMB HAEMOST, V5, P1477, DOI 10.1111/j.1538-7836.2007.02594.x; He SP, 1999, MOL HUM REPROD, V5, P513, DOI 10.1093/molehr/5.6.513; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hooper JD, 1999, CANCER RES, V59, P3199; Hooper JD, 2000, BBA-GENE STRUCT EXPR, V1492, P63, DOI 10.1016/S0167-4781(00)00071-3; Inoue M, 1998, BIOCHEM BIOPH RES CO, V252, P307, DOI 10.1006/bbrc.1998.9645; KUHN LA, 1990, P NATL ACAD SCI USA, V87, P8506, DOI 10.1073/pnas.87.21.8506; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li W, 2007, J BIOL CHEM, V282, P13759, DOI 10.1074/jbc.M701074200; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Meijers JCM, 2011, SEMIN THROMB HEMOST, V37, P349, DOI 10.1055/s-0031-1276583; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; PRIGLINGER U, 1994, J BIOL CHEM, V269, P14705; Prohaska TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039262; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; Samani FS, 2014, CYTOTECHNOLOGY, V66, P555, DOI 10.1007/s10616-013-9609-8; Shigemasa K, 2000, J SOC GYNECOL INVEST, V7, P358, DOI 10.1016/S1071-5576(00)00086-1; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Sokolikova B., 2011, J THROMB HAEMOST SS2, V9; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Tang T, 2005, CANCER RES, V65, P868; Uhrin P, 2000, J CLIN INVEST, V106, P1531, DOI 10.1172/JCI10768; Wahlmuller FC, 2014, THROMB HAEMOSTASIS, V111, P41, DOI 10.1160/TH13-06-0478; Wakita T, 2004, INT J CANCER, V108, P516, DOI 10.1002/ijc.11594; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x; ZHENG XL, 1994, AM J PHYSIOL, V267, pC466, DOI 10.1152/ajpcell.1994.267.2.C466	47	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3081	3091		10.1074/jbc.M114.581736	http://dx.doi.org/10.1074/jbc.M114.581736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25488662	Green Published, hybrid			2022-12-28	WOS:000349310700044
J	Kong, LY; Shaw, N; Yan, LM; Lou, ZY; Rao, ZH				Kong, Lingying; Shaw, Neil; Yan, Lingming; Lou, Zhiyong; Rao, Zihe			Structural View and Substrate Specificity of Papain-like Protease from Avian Infectious Bronchitis Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-SYNDROME-CORONAVIRUS; INHIBITOR DESIGN IMPLICATIONS; TERMINAL CLEAVAGE SITE; DEUBIQUITINATING ACTIVITY; CRYSTAL-STRUCTURE; SARS; REPLICATION; PROTEINS; BINDING; DOMAIN	Papain-like protease (PLpro) of coronaviruses (CoVs) carries out proteolytic maturation of non-structural proteins that play a role in replication of the virus and performs deubiquitination of host cell factors to scuttle antiviral responses. Avian infectious bronchitis virus (IBV), the causative agent of bronchitis in chicken that results in huge economic losses every year in the poultry industry globally, encodes a PLpro. The substrate specificities of this PLpro are not clearly understood. Here, we show that IBV PLpro can degrade Lys(48)- and Lys(63)-linked polyubiquitin chains to monoubiquitin but not linear polyubiquitin. To explain the substrate specificities, we have solved the crystal structure of PLpro from IBV at 2.15-angstrom resolution. The overall structure is reminiscent of the structure of severe acute respiratory syndrome CoV PLpro. However, unlike the severe acute respiratory syndrome CoV PLpro that lacks blocking loop (BL) 1 of deubiquitinating enzymes, the IBV PLpro has a short BL1-like loop. Access to a conserved catalytic triad consisting of Cys(101), His(264), and Asp(275) is regulated by the flexible BL2. A model of ubiquitin-bound IBV CoV PLpro brings out key differences in substrate binding sites of PLpros. In particular, P3 and P4 subsites as well as residues interacting with the beta-barrel of ubiquitin are different, suggesting different catalytic efficiencies and substrate specificities. We show that IBV PLpro cleaves peptide substrates KKAG-7-amino-4-methylcoumarin and LRGG-7-amino-4-methylcoumarin with different catalytic efficiencies. These results demonstrate that substrate specificities of IBV PLpro are different from other PLpros and that IBV PLpro might target different ubiquitinated host factors to aid the propagation of the virus.	[Kong, Lingying; Yan, Lingming; Lou, Zhiyong; Rao, Zihe] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Shaw, Neil; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Shaw, Neil; Rao, Zihe] Chinese Acad Sci, Natl Lab Macromol, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Nankai University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Rao, ZH (corresponding author), Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022	Shaw, Neil/0000-0003-2722-9967	National Major Project (973 Program) [2014CB542800, 2013CB911100]; National Natural Science Foundation of China [81330036, 81322023]; Tsinghua University Initiative Scientific Research Program [20141080146]	National Major Project (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	This work is supported by National Major Project (973 Program) Grants 2014CB542800 and 2013CB911100, National Natural Science Foundation of China Grants 81330036 and 81322023, and Tsinghua University Initiative Scientific Research Program Grant 20141080146.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baez-Santos YM, 2014, J VIROL, V88, P12511, DOI 10.1128/JVI.01294-14; Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Casais R, 2005, J VIROL, V79, P8065, DOI 10.1128/JVI.79.13.8065-8078.2005; Cavanagh D, 2007, VACCINE, V25, P5558, DOI 10.1016/j.vaccine.2007.02.046; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chaudhuri R, 2011, J MOL BIOL, V414, P272, DOI 10.1016/j.jmb.2011.09.030; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen XJ, 2014, PROTEIN CELL, V5, P369, DOI 10.1007/s13238-014-0026-3; Chou CY, 2014, ACTA CRYSTALLOGR D, V70, P572, DOI 10.1107/S1399004713031040; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh AK, 2010, J MED CHEM, V53, P4968, DOI 10.1021/jm1004489; Ghosh AK, 2009, J MED CHEM, V52, P5228, DOI 10.1021/jm900611t; Han YS, 2005, BIOCHEMISTRY-US, V44, P10349, DOI 10.1021/bi0504761; Hodgson T, 2006, J VIROL, V80, P296, DOI 10.1128/JVI.80.1.296-305.2006; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lee H, 2013, CHEMMEDCHEM, V8, P1361, DOI 10.1002/cmdc.201300134; Lei J, 2014, ANTIVIR RES, V109, P72, DOI 10.1016/j.antiviral.2014.06.011; Lim KP, 1998, ADV EXP MED BIOL, V440, P173; Lim KP, 1998, VIROLOGY, V245, P303, DOI 10.1006/viro.1998.9164; Lim KP, 2000, J VIROL, V74, P1674, DOI 10.1128/JVI.74.4.1674-1685.2000; Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Ng LFP, 2002, J VIROL, V76, P6257, DOI 10.1128/JVI.76.12.6257-6267.2002; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Ratia K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004113; Shaw N, 2013, PROTEIN CELL, V4, P117, DOI 10.1007/s13238-012-2071-0; Stern D F, 1984, Adv Exp Med Biol, V173, P11; STERN DF, 1984, J VIROL, V50, P22, DOI 10.1128/JVI.50.1.22-29.1984; van Ginkel FW, 2008, AVIAN DIS, V52, P608, DOI 10.1637/8349-050908-Reg.1; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Ziebuhr J, 2001, J BIOL CHEM, V276, P33220, DOI 10.1074/jbc.M104097200	36	23	24	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7160	7168		10.1074/jbc.M114.628636	http://dx.doi.org/10.1074/jbc.M114.628636			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25609249	Green Published, hybrid			2022-12-28	WOS:000350991500046
J	Wujak, L; Didiasova, M; Zakrzewicz, D; Frey, H; Schaefer, L; Wygrecka, M				Wujak, Lukasz; Didiasova, Miroslava; Zakrzewicz, Dariusz; Frey, Helena; Schaefer, Liliana; Wygrecka, Malgorzata			Heparan Sulfate Proteoglycans Mediate Factor XIIa Binding to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-XII; PLASMINOGEN-ACTIVATOR RECEPTOR; VEIN ENDOTHELIAL-CELLS; BRADYKININ FORMATION; PULMONARY-FIBROSIS; SIGNALING PATHWAYS; IN-VIVO; GLYCOSAMINOGLYCANS; INHIBITOR; KININOGEN	Hageman factor (FXIIa) initiates the intrinsic coagulation pathway and triggers the kallikrein-kinin and the complement systems. In addition, it functions as a growth factor by expressing promitogenic activities toward several cell types. FXIIa binds to the cell surface via a number of structurally unrelated surface receptors; however, the underlying mechanisms are not yet fully understood. Here, we demonstrate that FXIIa utilizes cell membrane-bound glycosaminoglycans to interact with the cell surface of human lung fibroblasts (HLF). The combination of enzymatic, inhibitory, and overexpression approaches identified a heparan sulfate (HS) component of proteoglycans as an important determinant of the FXIIa binding capacity of HLF. Moreover, cell-free assays and competition experiments revealed preferential binding of FXIIa to HS and heparin over dextran sulfate, dermatan sulfate, and chondroitin sulfate A and C. Finally, we demonstrate that fibroblasts isolated from the lungs of the patients suffering from idiopathic pulmonary fibrosis (IPF) exhibit enhanced FXIIa binding capacity. Increased sulfation of HS resulting from elevated HS 6-O-sulfotransferase-1 expression in IPF HLF accounted, in part, for this phenomenon. Application of RNA interference technology and inhibitors of intracellular sulfation revealed the cooperative action of cell surface-associated HS and urokinase-type plasminogen activator receptor in the accumulation of FXIIa on the cell surface of IPF HLF. Moreover, FXIIa stimulated IPF HIS migration, which was abrogated by pretreatment of cells with heparinase I. Collectively, our study uncovers a novel role of HS-type glycosaminoglycans in a local accumulation of FXIIa on the cell membrane. The enhanced association of FXIIa with IPF HLF suggests its contribution to fibrogenesis.	[Wujak, Lukasz; Didiasova, Miroslava; Zakrzewicz, Dariusz; Wygrecka, Malgorzata] Univ Giessen, Dept Biochem, Lung Ctr, D-35392 Giessen, Germany; [Frey, Helena; Schaefer, Liliana] Goethe Univ Frankfurt, Univ Hosp, Inst Pharmacol & Toxicol, Sch Med, D-60590 Frankfurt, Germany	Justus Liebig University Giessen; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Wygrecka, M (corresponding author), Univ Giessen, Dept Biochem, Lung Ctr, Friedrichstr 24, D-35392 Giessen, Germany.	malgorzata.wygrecka@innere.med.uni-giessen.de	Wygrecka, Malgorzata/AAZ-3679-2020	Wygrecka, Malgorzata/0000-0002-3656-2932; Zakrzewicz, Dariusz/0000-0003-3292-9706; Schaefer, Liliana/0000-0002-3318-3005	Deutsche Forschungsgemeinschaft [WY119/1-1, SFB 815]; Excellence Cluster "Cardiopulmonary System"; University Medical Center Giessen and Marburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster "Cardiopulmonary System"(German Research Foundation (DFG)); University Medical Center Giessen and Marburg	This study was supported by Deutsche Forschungsgemeinschaft Grant WY119/1-1 (to M. W.) and SFB 815, Project A5 (to L. S.), the Excellence Cluster "Cardiopulmonary System" (to M. W. and L S.), and the University Medical Center Giessen and Marburg (to M. W.).	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Badellino KO, 2001, BIOCHEMISTRY-US, V40, P7569, DOI 10.1021/bi0027433; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Beringer DX, 2013, ACTA CRYSTALLOGR F, V69, P94, DOI 10.1107/S1744309113000286; Bradford HN, 2000, J BIOL CHEM, V275, P22756, DOI 10.1074/jbc.M002591200; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gordon EM, 1996, P NATL ACAD SCI USA, V93, P2174, DOI 10.1073/pnas.93.5.2174; HENDERSON LM, 1994, BLOOD, V84, P474; Ho GY, 1997, J BIOL CHEM, V272, P16838, DOI 10.1074/jbc.272.27.16838; HOJIMA Y, 1984, BLOOD, V63, P1453; Jablonska E, 2010, J BIOL CHEM, V285, P11638, DOI 10.1074/jbc.M109.045963; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; KOJIMA T, 1992, J BIOL CHEM, V267, P4859; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Lu JN, 2014, AM J RESP CELL MOL, V50, P106, DOI 10.1165/rcmb.2013-0204OC; Mahdi F, 2002, BLOOD, V99, P3585, DOI 10.1182/blood.V99.10.3585; Malavaki CJ, 2013, FEBS J, V280, P2477, DOI 10.1111/febs.12163; MALI M, 1993, J BIOL CHEM, V268, P24215; Moreth K, 2014, MATRIX BIOL, V35, P143, DOI 10.1016/j.matbio.2014.01.010; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; PIXLEY RA, 1987, ARCH BIOCHEM BIOPHYS, V256, P490, DOI 10.1016/0003-9861(87)90606-0; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; Pol-Fachin L, 2014, GLYCOBIOLOGY, V24, P97, DOI 10.1093/glycob/cwt095; Pucci M, 2001, J BIOL CHEM, V276, P4756, DOI 10.1074/jbc.M005993200; REDDIGARI SR, 1993, J BIOL CHEM, V268, P11982; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2001, FEBS LETT, V500, P36, DOI 10.1016/S0014-5793(01)02570-4; Renne T, 2012, BLOOD, V120, P4296, DOI 10.1182/blood-2012-07-292094; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; SCHMEIDLERSAPIRO KT, 1991, P NATL ACAD SCI USA, V88, P4382, DOI 10.1073/pnas.88.10.4382; Schousboe I, 2003, EUR J BIOCHEM, V270, P111, DOI 10.1046/j.1432-1033.2003.03367.x; Schousboe I, 2001, EUR J BIOCHEM, V268, P3958, DOI 10.1046/j.1432-1327.2001.02305.x; SHIMADA K, 1985, J CLIN INVEST, V75, P1308, DOI 10.1172/JCI111831; Skandalis SS, 2014, MATRIX BIOL, V35, P182, DOI 10.1016/j.matbio.2013.09.002; Stavrou E, 2010, THROMB RES, V125, P210, DOI 10.1016/j.thromres.2009.11.028; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Thacker BE, 2014, MATRIX BIOL, V35, P60, DOI 10.1016/j.matbio.2013.12.001; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314	48	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7027	7039		10.1074/jbc.M114.606343	http://dx.doi.org/10.1074/jbc.M114.606343			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25589788	Green Published, hybrid			2022-12-28	WOS:000350991500036
J	Du, JT; Aleff, RA; Soragni, E; Kalari, K; Nie, JF; Tang, XJ; Davila, J; Kocher, JP; Patel, SV; Gottesfeld, JM; Baratz, KH; Wieben, ED				Du, Jintang; Aleff, Ross A.; Soragni, Elisabetta; Kalari, Krishna; Nie, Jinfu; Tang, Xiaojia; Davila, Jaime; Kocher, Jean-Pierre; Patel, Sanjay V.; Gottesfeld, Joel M.; Baratz, Keith H.; Wieben, Eric D.			RNA Toxicity and Missplicing in the Common Eye Disease Fuchs Endothelial Corneal Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY; SKELETAL-MUSCLE; REPEAT EXPANSION; OXIDATIVE STRESS; BHLH FACTORS; MOUSE MODEL; STEM-CELLS; PROTEIN; EXPRESSION	Fuchs endothelial corneal dystrophy (FECD) is an inherited degenerative disease that affects the internal endothelial cell monolayer of the cornea and can result in corneal edema and vision loss in severe cases. FECD affects similar to 5% of middle-aged Caucasians in the United States and accounts for >14,000 corneal transplantations annually. Among the several genes and loci associated with FECD, the strongest association is with an intronic (CTG.CAG)(n) trinucleotide repeat expansion in the TCF4 gene, which is found in the majority of affected patients. Corneal endothelial cells from FECD patients harbor a poly(CUG)(n) RNA that can be visualized as RNA foci containing this condensed RNA and associated proteins. Similar to myotonic dystrophy type 1, the poly(CUG)(n) RNA co-localizes with and sequesters the mRNA-splicing factor MBNL1, leading to missplicing of essential MBNL1-regulated mRNAs. Such foci and missplicing are not observed in similar cells from FECD patients who lack the repeat expansion. RNA-Seq splicing data from the corneal endothelia of FECD patients and controls reveal hundreds of differential alternative splicing events. These include events previously characterized in the context of myotonic dystrophy type 1 and epithelial-to-mesenchymal transition, as well as splicing changes in genes related to proposed mechanisms of FECD pathogenesis. We report the first instance of RNA toxicity and missplicing in a common non-neurological/neuromuscular disease associated with a repeat expansion. The FECD patient population with this (CTG.CAG)(n) trinucleotide repeat expansion exceeds that of the combined number of patients in all other microsatellite expansion disorders.	[Du, Jintang; Soragni, Elisabetta; Gottesfeld, Joel M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Aleff, Ross A.; Wieben, Eric D.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Kalari, Krishna; Nie, Jinfu; Tang, Xiaojia; Davila, Jaime; Kocher, Jean-Pierre] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Patel, Sanjay V.; Baratz, Keith H.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA	Scripps Research Institute; Mayo Clinic; Mayo Clinic; Mayo Clinic	Wieben, ED (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	wieben.eric@mayo.edu	Davila, Jaime/AAI-2023-2019	Davila, Jaime/0000-0002-8163-6267; Kalari, Krishna/0000-0001-8944-8378; Tang, Xiaojia/0000-0003-2457-9953; Gottesfeld, Joel/0000-0002-4643-5777; Patel, Sanjay/0000-0001-6694-1530	California Institute for Regenerative Medicine (CIRM) Grant [RB3-05022]; Research to Prevent Blindness grants; Myotonic Dystrophy Foundation; Scripps Research Institute Stem Cell Fellowship; Biomarker Discovery Program of the Mayo Clinic Center for Individualized Medicine	California Institute for Regenerative Medicine (CIRM) Grant; Research to Prevent Blindness grants(Research to Prevent Blindness (RPB)); Myotonic Dystrophy Foundation; Scripps Research Institute Stem Cell Fellowship; Biomarker Discovery Program of the Mayo Clinic Center for Individualized Medicine	This work was supported by California Institute for Regenerative Medicine (CIRM) Grant RB3-05022 (to J. D., E. S., and J. M. G.), Research to Prevent Blindness grants (to S. V. P. and K. H. B.), a postdoctoral fellowship from the Myotonic Dystrophy Foundation (to J. D.), a Scripps Research Institute Stem Cell Fellowship (to J. D.), and a grant from the Biomarker Discovery Program of the Mayo Clinic Center for Individualized Medicine (to R. A. A., S. V. P., K. H. B., and E. D. W.).	Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Chamberlain CM, 2012, HUM MOL GENET, V21, P4645, DOI 10.1093/hmg/dds306; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P1984, DOI 10.1021/cb3001606; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Doors M, 2013, JAMA OPHTHALMOL, V131, P1443, DOI 10.1001/jamaophthalmol.2013.5009; Du JT, 2013, HUM MOL GENET, V22, P5276, DOI 10.1093/hmg/ddt386; Eye Bank Association of America, 2014, 2013 EY BANK STAT RE; Gates DP, 2011, J BIOL CHEM, V286, P34224, DOI 10.1074/jbc.M111.236547; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; Iliff BW, 2012, EXPERT REV OPHTHALMO, V7, P363, DOI 10.1586/EOP.12.39; Jonson I, 2013, STEM CELL RES, V11, P1264, DOI 10.1016/j.scr.2013.08.010; Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kazerounian S, 2003, J BIOL CHEM, V278, P36707, DOI 10.1074/jbc.M303896200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klinck R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107324; Koizumi N, 2013, CORNEA, V32, P1167, DOI 10.1097/ICO.0b013e318285475d; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; LeMasters KE, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-22; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Mohan A, 2014, BRAIN RES, V1584, P3, DOI 10.1016/j.brainres.2014.03.039; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Norrmen C, 2010, BLOOD, V115, P906, DOI 10.1182/blood-2009-03-212274; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rao PV, 2009, INVEST OPHTH VIS SCI, V50, P1769, DOI 10.1167/iovs.08-2909; Repp DJ, 2013, OPHTHALMOLOGY, V120, P687, DOI 10.1016/j.ophtha.2012.09.022; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Rossell D, 2014, ANN APPL STAT, V8, P309, DOI 10.1214/13-AOAS687; Samarelli AV, 2014, J BIOL CHEM, V289, P19466, DOI 10.1074/jbc.M113.530972; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sepp M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022138; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Suenaga K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033218; Tse SW, 2005, GENE, V359, P63, DOI 10.1016/j.gene.2005.06.025; Venables JP, 2013, MOL CELL BIOL, V33, P396, DOI 10.1128/MCB.01174-12; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; Yamashita Y, 2012, J HUM GENET, V57, P368, DOI 10.1038/jhg.2012.37; Yamazoe K, 2011, J CATARACT REFR SURG, V37, P2130, DOI 10.1016/j.jcrs.2011.05.039; Zhu AY, 2014, JAMA OPHTHALMOL, V132, P377, DOI 10.1001/jamaophthalmol.2013.7993	53	84	94	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5979	5990		10.1074/jbc.M114.621607	http://dx.doi.org/10.1074/jbc.M114.621607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593321	hybrid, Green Published			2022-12-28	WOS:000350732500004
J	Kuo, IY; Hu, J; Ha, Y; Ehrlich, BE				Kuo, Ivana Y.; Hu, Jian; Ha, Ya; Ehrlich, Barbara E.			Presenilin-like GxGD Membrane Proteases Have Dual Roles as Proteolytic Enzymes and Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE ACTIVITY; CA2+ LEAK CHANNELS; CALCIUM LEAK; LINKED MUTATIONS; MOUSE MODELS; IN-VIVO; CELLS; HOMEOSTASIS; DIMERIZATION	The GxCiD proteases function to cleave protein substrates within the membrane. As these proteases contain multiple transmembrane domains typical of ion channels, we examined if GxGD proteases also function as ion channels. We tested the putative dual function by examining two archeobacterial GxGD proteases (PSH and FlaK), with known three-dimensional structures. Both are in the same GxGD family as presenilin, a protein mutated in Alzheimer Disease. Here, we demonstrate that PSH and FlaK form cation channels in lipid bilayers. A limitation that affected the enzymatic activity of FlaK rendered the channel catalytically inactive and altered the ion selectivity, indicating that the ion channel and the catalytic activities are linked. We report that the GxGD proteases, PSH and FlaK, are true "chanzymes" with interdependent ion channel and protease activity conferred by a single structural domain embedded in the membrane, supporting the proposal that higher-order proteases, including presenilin, have channel function.	[Kuo, Ivana Y.; Hu, Jian; Ha, Ya; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Ehrlich, Barbara E.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	Barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Kuo, Ivana/0000-0002-9867-2408	National Institutes of Health [DK087844, DK090744]; AHA Postdoctoral Fellowship [R10682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090744, R01DK087844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK087844 and DK090744 (to B.E.E.).; Supported by AHA Postdoctoral Fellowship R10682.	Anyatonwu GI, 2005, J BIOL CHEM, V280, P29488, DOI 10.1074/jbc.M504359200; Bandara S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003649; Bezprozvanny I, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004296; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunello L, 2009, J CELL MOL MED, V13, P3358, DOI 10.1111/j.1582-4934.2009.00755.x; Bruno A. M., 2012, NEUROBIOL AGING, V33; Cai CX, 2006, J BIOL CHEM, V281, P16649, DOI 10.1074/jbc.M512026200; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Cervantes S, 2001, FEBS LETT, V505, P81, DOI 10.1016/S0014-5793(01)02785-5; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Das HK, 2012, J NEUROCHEM, V122, P487, DOI 10.1111/j.1471-4159.2012.07794.x; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hebert SS, 2003, BIOCHEM BIOPH RES CO, V301, P119, DOI 10.1016/S0006-291X(02)02984-4; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Leissring MA, 2000, P NATL ACAD SCI USA, V97, P8590, DOI 10.1073/pnas.97.15.8590; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Mattson M. P., 2010, SCI SIGNAL, V3, ppe10; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nelson O, 2011, J BIOL CHEM, V286, P22339, DOI 10.1074/jbc.M111.243063; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shan J, 2012, CIRC RES, V111, P708, DOI 10.1161/CIRCRESAHA.112.273342; Shilling D, 2012, J BIOL CHEM, V287, P10933, DOI 10.1074/jbc.M111.300491; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Supnet C, 2011, CELL CALCIUM, V50, P303, DOI 10.1016/j.ceca.2011.05.013; Torres-Arancivia C., 2010, PLOS ONE, V5; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wolfe MS, 2013, NATURE, V493, P34, DOI 10.1038/nature11768; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	40	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6419	6427		10.1074/jbc.M114.629584	http://dx.doi.org/10.1074/jbc.M114.629584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25609250	Green Published, hybrid			2022-12-28	WOS:000350732500046
J	Weber, S; Salabei, JK; Moller, G; Kremmer, E; Bhatnagar, A; Adamski, J; Barski, OA				Weber, Susanne; Salabei, Joshua K.; Moeller, Gabriele; Kremmer, Elisabeth; Bhatnagar, Aruni; Adamski, Jerzy; Barski, Oleg A.			Aldo-keto Reductase 1B15 (AKR1B15) A MITOCHONDRIAL HUMAN ALDO-KETO REDUCTASE WITH ACTIVITY TOWARD STEROIDS AND 3-KETO-ACYL-CoA CONJUGATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN L-3-HYDROXYACYL-COA DEHYDROGENASE; GAMMA-HYDROXYBUTYRATE; DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE; 3-HYDROXYACYL-COA DEHYDROGENASE; SUBCELLULAR-LOCALIZATION; DIABETIC COMPLICATIONS; ALDEHYDE REDUCTASE; POTASSIUM CHANNELS; INSULIN-SECRETION; ACTIVE-SITE	Aldo-keto reductases (AKRs) comprise a superfamily of proteins involved in the reduction and oxidation of biogenic and xenobiotic carbonyls. In humans, at least 15 AKR superfamily members have been identified so far. One of these is a newly identified gene locus, AKR1B15, which clusters on chromosome 7 with the other human AKR1B subfamily members (i.e. AKR1B1 and AKR1B10). We show that alternative splicing of the AKR1B15 gene transcript gives rise to two protein isoforms with different N termini: AKR1B15.1 is a 316-amino acid protein with 91% amino acid identity to AKR1B10; AKR1B15.2 has a prolonged N terminus and consists of 344 amino acid residues. The two gene products differ in their expression level, subcellutar localization, and activity. In contrast with other AKR enzymes, which are mostly cytosolic, AKR1B15.1 co-localizes with the mitochondria. Kinetic studies show that AKR1B15.1 is predominantly a reductive enzyme that catalyzes the reduction of androgens and estrogens with high positional selectivity (17 beta-hydroxysteroid dehydrogenase activity) as well as 3-ketoacyl-CoA conjugates and exhibits strong cofactor selectivity toward NADP(H). In accordance with its substrate spectrum, the enzyme is expressed at the highest levels in steroid-sensitive tissues, namely placenta, testis, and adipose tissue. Placental and adipose expression could be reproduced in the Be Wo and SCiBS cell lines, respectively. In contrast, AKR1 B15.2 localizes to the cytosol and displays no enzymatic activity with the substrates tested. Collectively, these results demonstrate the exis- tence of a novel catalytically active AKR, which is associated with mitochondria and expressed mainly in steroid-sensitive tissues.	[Weber, Susanne; Moeller, Gabriele; Adamski, Jerzy] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, D-85764 Neuherberg, Germany; [Salabei, Joshua K.; Bhatnagar, Aruni; Barski, Oleg A.] Univ Louisville, Sch Med, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Kremmer, Elisabeth] Helmholtz Zentrum Muenchen, Inst Mol Immunol, German Res Ctr Environm Hlth, D-81377 Munich, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, D-85356 Freising Weihenstephan, Germany; [Adamski, Jerzy] German Ctr Diabet Res, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Louisville; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Adamski, J (corresponding author), Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	Adamski@helmholtz-muenchen.de; olegbarski@gmail.com		Moller, Gabriele/0000-0002-2730-1351; Adamski, Jerzy/0000-0001-9259-0199	National Institutes of Health [HL55477, HL59378, GM103492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055477, R01HL059378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL55477, HL59378, and GM103492.	Alexiou P, 2009, CURR MED CHEM, V16, P734, DOI 10.2174/092986709787458362; Alias M, 2010, ORG BIOMOL CHEM, V8, P788, DOI 10.1039/b919671d; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barski OA, 2005, AM J PHYSIOL-RENAL, V289, pF200, DOI 10.1152/ajprenal.00411.2004; BARSKI OA, 1995, BIOCHEMISTRY-US, V34, P11264, DOI 10.1021/bi00035a036; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Barski OA, 2013, CHEM-BIOL INTERACT, V202, P153, DOI 10.1016/j.cbi.2012.12.012; Bril V, 2006, DIABETES CARE, V29, P68, DOI 10.2337/diacare.29.1.68; Byrns MC, 2011, J STEROID BIOCHEM, V125, P95, DOI 10.1016/j.jsbmb.2010.11.004; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Clayton PT, 2001, J CLIN INVEST, V108, P457; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; Demonacos CV, 1996, STEROIDS, V61, P226, DOI 10.1016/0039-128X(96)00019-0; DVORNIK D, 1973, SCIENCE, V182, P1146, DOI 10.1126/science.182.4117.1146; Endo S, 2009, ARCH BIOCHEM BIOPHYS, V487, P1, DOI 10.1016/j.abb.2009.05.009; FUJII Y, 1990, J BIOL CHEM, V265, P9914; Gabbay Kenneth H, 2004, Curr Diab Rep, V4, P405, DOI 10.1007/s11892-004-0047-z; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P727, DOI 10.1021/tx010005p; Heslegrave AJ, 2013, J CLIN ENDOCR METAB, V98, P496, DOI 10.1210/jc.2012-3134; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; Hyndman DJ, 1998, BBA-GENE STRUCT EXPR, V1399, P198, DOI 10.1016/S0167-4781(98)00109-2; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; Keenan C, 2006, ENZYMOL MOL BIOL CAR, V12, P388; Keller B, 2009, MOL CELL ENDOCRINOL, V301, P43, DOI 10.1016/j.mce.2008.07.022; Kelly VP, 2002, BIOCHEM J, V366, P847, DOI 10.1042/BJ20020342; KINOSHITA JH, 1990, EXP EYE RES, V50, P567, DOI 10.1016/0014-4835(90)90096-D; KONDO KH, 1994, EUR J BIOCHEM, V219, P357, DOI 10.1111/j.1432-1033.1994.tb19947.x; Lam CW, 2006, CLIN CHIM ACTA, V364, P256, DOI 10.1016/j.cca.2005.07.025; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Liu SQ, 2001, CHEM-BIOL INTERACT, V130, P955, DOI 10.1016/S0009-2797(00)00248-9; Luu-The V, 2006, MOL ENDOCRINOL, V20, P437, DOI 10.1210/me.2005-0058; Lyon RC, 2007, J BIOL CHEM, V282, P25986, DOI 10.1074/jbc.M702465200; Malup T. K., 2000, Molekulyarnaya Biologiya (Moscow), V34, P366; Martin HJO, 2006, DRUG METAB DISPOS, V34, P464, DOI 10.1124/dmd; Maser E, 2004, TRENDS PHARMACOL SCI, V25, P235, DOI 10.1016/j.tips.2004.03.001; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Mindnich R, 2005, J MOL ENDOCRINOL, V35, P305, DOI 10.1677/jme.1.01853; Pan A, 2013, BIOCHEM BIOPH RES CO, V441, P418, DOI 10.1016/j.bbrc.2013.10.072; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Peltoketo H, 1999, J MOL ENDOCRINOL, V23, P1, DOI 10.1677/jme.0.0230001; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Penning TM, 2011, J STEROID BIOCHEM, V125, P46, DOI 10.1016/j.jsbmb.2011.01.009; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; PURANEN TJ, 1994, BIOCHEM J, V304, P289, DOI 10.1042/bj3040289; Ramana Kota V, 2011, Biomol Concepts, V2, P103; Ramana KV, 2002, J BIOL CHEM, V277, P32063, DOI 10.1074/jbc.M202126200; Salabei JK, 2011, CHEM-BIOL INTERACT, V191, P177, DOI 10.1016/j.cbi.2011.01.020; Schmitt S, 2013, ANAL BIOCHEM, V443, P66, DOI 10.1016/j.ab.2013.08.007; Schulte U, 2001, J BIOENERG BIOMEMBR, V33, P205, DOI 10.1023/A:1010730919074; Schulz N, 2011, ENDOCRINOLOGY, V152, P4641, DOI 10.1210/en.2011-1547; Shafqat N, 2003, BIOCHEM J, V376, P49, DOI 10.1042/BJ20030877; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Srivastava S, 2004, J BIOL CHEM, V279, P53395, DOI 10.1074/jbc.M403416200; Srivastava S, 1998, BIOCHEM J, V329, P469, DOI 10.1042/bj3290469; Srivastava S, 2009, CIRC RES, V105, P793, DOI 10.1161/CIRCRESAHA.109.200568; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; Vasconsuelo A, 2013, AGEING RES REV, V12, P907, DOI 10.1016/j.arr.2013.09.001; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Weng J, 2006, J BIOL CHEM, V281, P15194, DOI 10.1074/jbc.M513809200; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yang SY, 2005, FEBS J, V272, P4874, DOI 10.1111/j.1742-4658.2005.04911.x; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x; Zhong LL, 2011, TOXICOL APPL PHARM, V255, P40, DOI 10.1016/j.taap.2011.05.014	72	13	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6531	6545		10.1074/jbc.M114.610121	http://dx.doi.org/10.1074/jbc.M114.610121			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25577493	Green Published, hybrid			2022-12-28	WOS:000350732500056
J	Royall, E; Doyle, N; Abdul-Wahab, A; Emmott, E; Morley, SJ; Goodfellow, I; Roberts, LO; Locker, N				Royall, Elizabeth; Doyle, Nicole; Abdul-Wahab, Azimah; Emmott, Ed; Morley, Simon J.; Goodfellow, Ian; Roberts, Lisa O.; Locker, Nicolas			Murine Norovirus 1 (MNV1) Replication Induces Translational Control of the Host by Regulating eIF4E Activity during Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INITIATION-FACTOR 4E; MESSENGER-RNAS; PHOSPHORYLATED EIF4E; SECONDARY STRUCTURE; NORWALK VIRUS; FACTOR EIF-4E; COMPLEX; VPG; BINDING	Protein synthesis is a tightly controlled process responding to several stimuli, including viral infection. As obligate intracellular parasites, viruses depend on the translation machinery of the host and can manipulate it by affecting the availability and function of specific eukaryotic initiation factors (eIFs). Human norovirus is a member of the Caliciviridae family and is responsible for gastroenteritis outbreaks. Previous studies on feline calicivirus and murine norovirus 1 (MNV1) demonstrated that the viral protein, genome-linked (VPg), acts to direct translation by hijacking the host protein synthesis machinery. Here we report that MNV1 infection modulates the MAPK pathway to activate eIF4E phosphorylation. Our results show that the activation of p38 and Mnk during MNV1 infection is important for MNV1 replication. Furthermore, phosphorylated eIF4E relocates to the polysomes, and this contributes to changes in the translational state of specific host mRNAs. We propose that global translational control of the host by eIF4E phosphorylation is a key component of the host-pathogen interaction.	[Royall, Elizabeth; Doyle, Nicole; Abdul-Wahab, Azimah; Roberts, Lisa O.; Locker, Nicolas] Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford GU2 7HX, Surrey, England; [Emmott, Ed; Goodfellow, Ian] Univ Cambridge, Dept Pathol, Addenbrookes Hosp, Div Virol, Cambridge CB2 2QQ, England; [Morley, Simon J.] Univ Sussex, Dept Biochem & Mol Biol, Sch Life Sci, Brighton BN1 9RH, E Sussex, England	University of Surrey; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sussex	Locker, N (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Sch Biosci & Med, Guildford GU2 7HX, Surrey, England.	n.locker@surrey.ac.uk		Doyle, Nicole/0000-0002-6016-5830; Emmott, Edward/0000-0002-3239-8178; Abdul Wahab, Azimah/0000-0002-7381-5978; Locker, Nicolas/0000-0002-0053-2897; Goodfellow, Ian/0000-0002-9483-510X	Biotechnology and Biological Sciences Research Council [BB/I01232X/1, BB/I012303/1, BB/H009728/1]; Wellcome Trust [WT097997MA]; Majlis Amanah Rakyat (MARA), Government of Malaysia; University of Kuala Lumpur; Biotechnology and Biological Sciences Research Council [BB/H018956/1, BB/L018209/1] Funding Source: researchfish; BBSRC [BB/L018209/1, BB/H018956/1, BB/I012303/1, BB/I01232X/1, BB/H009728/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Majlis Amanah Rakyat (MARA), Government of Malaysia; University of Kuala Lumpur; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Research Grants BB/I01232X/1 (to L. O. R. and N. L.), BB/I012303/1 (to I. G.), and BB/H009728/1 (to S. J. M.) as well as Wellcome Trust Senior Fellowship WT097997MA (to I. G.).; Supported by Majlis Amanah Rakyat (MARA), Government of Malaysia, and the University of Kuala Lumpur.	Arias A, 2012, J GEN VIROL, V93, P1432, DOI 10.1099/vir.0.042176-0; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; BURROUGHS JN, 1978, J GEN VIROL, V40, P161, DOI 10.1099/0022-1317-40-1-161; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Capizzi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-131; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cencic R, 2007, METHOD ENZYMOL, V431, P269, DOI 10.1016/S0076-6879(07)31013-6; Cencic R, 2011, J VIROL, V85, P6381, DOI 10.1128/JVI.00078-11; Cencic R, 2011, P NATL ACAD SCI USA, V108, P1046, DOI 10.1073/pnas.1011477108; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Chuluunbaatar U, 2012, J VIROL, V86, P7771, DOI 10.1128/JVI.00622-12; Chung L, 2014, J BIOL CHEM, V289, P21738, DOI 10.1074/jbc.M114.550657; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; Clemens MJ, 2001, J CELL MOL MED, V5, P221, DOI 10.1111/j.1582-4934.2001.tb00157.x; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Daughenbaugh KF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-33; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gingras AC, 2001, GENE DEV, V15, P2852; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; Halbeisen RE, 2009, METHODS, V48, P306, DOI 10.1016/j.ymeth.2009.04.003; Health Protection Agency, 2013, HOSP OUTBR REP; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Ji WT, 2009, J GEN VIROL, V90, P3002, DOI 10.1099/vir.0.013953-0; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Kawai Taro, 2006, Nihon Rinsho, V64, P1231; Khan RR, 2009, J PEDIATR GASTR NUTR, V48, P328, DOI 10.1097/MPG.0b013e31818255cc; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; MADER S, 1995, MOL CELL BIOL, V15, P4990; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; McMahon R, 2011, J VIROL, V85, P853, DOI 10.1128/JVI.01873-10; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Morley SJ, 1997, FEBS LETT, V418, P327, DOI 10.1016/S0014-5793(97)01405-1; Moser LA, 2008, J VIROL, V82, P7475, DOI 10.1128/JVI.02193-07; Muller D, 2013, TRANSLATION, V1, DOI 10.4161/trla.25819; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Papafragkou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063485; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Proud CG, 2015, BBA-GENE REGUL MECH, V1849, P766, DOI 10.1016/j.bbagrm.2014.10.003; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Pyronnet S, 2000, BIOCHEM PHARMACOL, V60, P1237, DOI 10.1016/S0006-2952(00)00429-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwartz S, 2011, BLOOD, V117, P5850, DOI 10.1182/blood-2010-12-325886; Shi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094011; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Stuart RL, 2010, PEDIATR INFECT DIS J, V29, P644, DOI 10.1097/INF.0b013e3181d824e1; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Tuxworth WJ, 2004, BIOCHEM J, V378, P73, DOI 10.1042/BJ20031027; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Vashist S, 2009, FUTURE VIROL, V4, P353, DOI 10.2217/FVL.09.18; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Willett M, 2006, EXP CELL RES, V312, P2942, DOI 10.1016/j.yexcr.2006.05.020; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592	76	29	31	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4748	4758		10.1074/jbc.M114.602649	http://dx.doi.org/10.1074/jbc.M114.602649			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561727	Green Published, hybrid			2022-12-28	WOS:000350042000018
J	Li, J; Feng, ZK; Wu, JY; Huang, Y; Lu, G; Zhu, M; Wang, B; Mao, X; Tao, XR				Li, Jia; Feng, Zhike; Wu, Jianyan; Huang, Ying; Lu, Gang; Zhu, Min; Wang, Bi; Mao, Xiang; Tao, Xiaorong			Structure and Function Analysis of Nucleocapsid Protein of Tomato Spotted Wilt Virus Interacting with RNA Using Homology Modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROPERTIES; N PROTEIN; I-TASSER; TOSPOVIRUS; ARCHITECTURE; REVEALS; TSWV; IDENTIFICATION; SUPPRESSOR; EXPRESSION	The nucleocapsid (N) protein of tomato spotted wilt virus (TSWV) plays key roles in assembling genomic RNA into ribonucleoprotein (RNP), which serves as a template for both viral gene transcription and genome replication. However, little is known about the molecular mechanism of how TSWV N interacts with genomic RNA. In this study, we demonstrated that TSWVN protein forms a range of higher ordered oligomers. Analysis of the RNA binding behavior of N protein revealed that no specific oligomer binds to RNA preferentially, instead each type of N oligomer is able to bind RNA. To better characterize the structure and function of N protein interacting with RNA, we constructed homology models of TSWV N and N-RNA complexes. Based on these homology models, we demonstrated that the positively charged and polar amino acids in its predicted surface cleft of TSWV N are critical for RNA binding. Moreover, by N-RNA homology modeling, we found that the RNA component is deeply embedded in the predicted protein cleft; consistently, TSWV N-RNA complexes are relatively resistant to digestion by RNase. Collectively, using homology modeling, we determined the RNA binding sites on N and found a new protective feature for N protein. Our findings also provide novel insights into the molecular details of the interaction of TSWV N with RNA components.	[Li, Jia; Feng, Zhike; Wu, Jianyan; Huang, Ying; Lu, Gang; Zhu, Min; Tao, Xiaorong] Nanjing Agr Univ, Dept Plant Pathol, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing 210095, Jiangsu, Peoples R China; [Mao, Xiang] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Bi] Zhejiang Univ, Inst Biotechnol, Hangzhou 310029, Zhejiang, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Zhejiang University	Tao, XR (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing 210095, Jiangsu, Peoples R China.	taoxiaorong@njau.edu.cn			National Natural Science Foundation of China [31471746, 31222045]; Program for New Century Excellent Talents in the University [NCET-12-0888]; Special Fund for Agro-scientific Research in the Public Interest [201303028]; Doctoral Fund of Ministry of Education of China [20130097110004]; Fundamental Research Funds for the Central Universities [KYTZ201403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in the University(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-scientific Research in the Public Interest; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31471746 and 31222045, Program for New Century Excellent Talents in the University Grant NCET-12-0888, Special Fund for Agro-scientific Research in the Public Interest Grant 201303028, Doctoral Fund of Ministry of Education of China Grant 20130097110004, and Fundamental Research Funds for the Central Universities Grant KYTZ201403.	ADKINS S, 1995, VIROLOGY, V207, P308, DOI 10.1006/viro.1995.1083; Ariza A, 2013, NUCLEIC ACIDS RES, V41, P5912, DOI 10.1093/nar/gkt268; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Elliott R.M., 1996, BUNYAVIRIDAE; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feng ZK, 2013, NEW PHYTOL, V200, P1212, DOI 10.1111/nph.12447; Ferron F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002030; GOLDBACH R, 1996, BUNYAVIRIDAE; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Hu ZZ, 2011, ARCH VIROL, V156, P1905, DOI 10.1007/s00705-011-1078-9; Kainz M, 2004, PHYTOPATHOLOGY, V94, P759, DOI 10.1094/PHYTO.2004.94.7.759; Komoda K, 2013, ACTA CRYSTALLOGR F, V69, P700, DOI 10.1107/S174430911301302X; KORMELINK R, 1994, VIROLOGY, V200, P56, DOI 10.1006/viro.1994.1162; KORMELINK R, 1993, J GEN VIROL, V74, P790; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Kormelink R, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P163; Li BB, 2013, P NATL ACAD SCI USA, V110, P9048, DOI 10.1073/pnas.1222552110; Mine A, 2010, J VIROL, V84, P6070, DOI 10.1128/JVI.00054-10; Mohl BP, 2009, RNA, V15, P391, DOI 10.1261/rna.1367209; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Niu FF, 2013, P NATL ACAD SCI USA, V110, P9054, DOI 10.1073/pnas.1300035110; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Plyusnin A., 2012, VIRUS TAXONOMY; Raymond DD, 2012, P NATL ACAD SCI USA, V109, P19208, DOI 10.1073/pnas.1213553109; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Reguera J, 2013, P NATL ACAD SCI USA, V110, P7246, DOI 10.1073/pnas.1302298110; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; Richmond KE, 1998, VIROLOGY, V248, P6, DOI 10.1006/viro.1998.9223; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Soellick TR, 2000, P NATL ACAD SCI USA, V97, P2373, DOI 10.1073/pnas.030548397; Uhrig JF, 1999, P NATL ACAD SCI USA, V96, P55, DOI 10.1073/pnas.96.1.55; van Knippenberg I, 2002, VIROLOGY, V303, P278, DOI 10.1006/viro.2002.1632; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; Wu JY, 2013, J VIROL, V87, P12885, DOI 10.1128/JVI.02264-13; Yu Cui, 2008, Journal of Zhejiang University (Agriculture and Life Sciences), V34, P597; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	41	33	39	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3950	3961		10.1074/jbc.M114.604678	http://dx.doi.org/10.1074/jbc.M114.604678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540203	Green Published, hybrid			2022-12-28	WOS:000349458400006
J	Davydov, DR; Davydova, NY; Sineva, EV; Halpert, JR				Davydov, Dmitri R.; Davydova, Nadezhda Y.; Sineva, Elena V.; Halpert, James R.			Interactions among Cytochromes P450 in Microsomal Membranes OLIGOMERIZATION OF CYTOCHROMES P450 3A4, 3A5, AND 2E1 AND ITS FUNCTIONAL CONSEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; HUMAN LIVER-MICROSOMES; SUBSTRATE-BINDING; CROSS-LINKING; FUNCTIONAL INTERACTIONS; ROTATIONAL DIFFUSION; SPIN EQUILIBRIUM; LIGAND-BINDING; P450-P450 INTERACTIONS; ENDOPLASMIC-RETICULUM	The body of evidence of physiologically relevant P450-P450 interactions in microsomal membranes continues to grow. Here we probe oligomerization of human CYP3A4, CYP3A5, and CYP2E1 in microsomal membranes. Using a technique based on luminescence resonance energy transfer, we demonstrate that all three proteins are subject to a concentration-dependent equilibrium between the monomeric and oligomeric states. We also observed the formation of mixed oligomers in CYP3A4/CYP3A5, CYP3A4/CYP2E1, and CYP3A5/CYP2E1 pairs and demonstrated that the association of either CYP3A4 or CYP3A5 with CYP2E1 causes activation of the latter enzyme. Earlier we hypothesized that the intersubunit interface in CYP3A4 oligomers is similar to that observed in the crystallographic dimers of some microsomal drug-metabolizing cytochromes P450 (Davydov, D. R., Davydova, N. Y., Sineva, E. V., Kufareva, I., and Halpert, J. R. (2013) Pivotal role of P450-P450 interactions in CYP3A4 allostery: the case of alpha-naphthoflavone. Biochem. J. 453, 219-230). Here we report the results of intermolecular cross-linking of CYP3A4 oligomers with thiol-reactive bifunctional reagents as well as the luminescence resonance energy transfer measurements of interprobe distances in the oligomers of labeled CYP3A4 single-cysteine mutants. The results provide compelling support for the physiological relevance of the dimer-specific peripheral ligand-binding site observed in certain CYP3A4 structures. According to our interpretation, these results reveal an important general mechanism that regulates the activity and substrate specificity of the cytochrome P450 ensemble through interactions between multiple P450 species. As a result of P450-P450 cross-talk, the catalytic properties of the cytochrome P450 ensemble cannot be predicted by simple summation of the properties of the individual P450 species.	[Davydov, Dmitri R.; Davydova, Nadezhda Y.; Sineva, Elena V.; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Davydov, Dmitri R.] Russian Acad Med Sci, VN Orekhovich Inst Biomed Chem, Moscow 119832, Russia	University of California System; University of California San Diego; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry	Davydov, DR (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,MC 0202, La Jolla, CA 92093 USA.	dmrdavyd@gmail.com	Davydov, Dmitri R/H-2736-2013; Sineva, Elena/A-5267-2008	Davydov, Dmitri R/0000-0001-8520-0033; Sineva, Elena/0000-0003-2307-0581	National Institutes of Health [GM054995]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054995, R01GM054995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM054995 (to J. R. H.).	ALSTON K, 1991, J BIOL CHEM, V266, P735; Backes WL, 1998, BIOCHEMISTRY-US, V37, P12852, DOI 10.1021/bi980674a; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; BACKES WL, 1985, BIOCHEMISTRY-US, V24, P5130, DOI 10.1021/bi00340a026; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Berka K, 2013, J PHYS CHEM B, V117, P11556, DOI 10.1021/jp4059559; BERNDT P, 1989, Biokhimiya, V54, P338; Brenner S, 2007, J PHYS CHEM B, V111, P7879, DOI 10.1021/jp073036n; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Cawley GF, 2001, DRUG METAB DISPOS, V29, P1529; CAWLEY GF, 1995, BIOCHEMISTRY-US, V34, P1244, DOI 10.1021/bi00004a018; Chen GF, 1999, XENOBIOTICA, V29, P437, DOI 10.1080/004982599238461; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Davydov DR, 2008, ARCH BIOCHEM BIOPHYS, V471, P134, DOI 10.1016/j.abb.2008.01.001; Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; Davydov DR, 2011, EXPERT OPIN DRUG MET, V7, P543, DOI 10.1517/17425255.2011.562194; Davydov DR, 2010, BBA-BIOENERGETICS, V1797, P378, DOI 10.1016/j.bbabio.2009.12.008; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Davydov DR, 2000, BIOCHEM BIOPH RES CO, V276, P1005, DOI 10.1006/bbrc.2000.3596; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; Davydov DR, 2001, ADV EXP MED BIOL, V500, P335; Fernando H, 2008, ARCH BIOCHEM BIOPHYS, V471, P20, DOI 10.1016/j.abb.2007.11.020; Fernando H, 2007, ARCH BIOCHEM BIOPHYS, V460, P129, DOI 10.1016/j.abb.2006.12.025; FISHER MT, 1987, BIOCHEMISTRY-US, V26, P4797, DOI 10.1021/bi00389a029; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; GREINERT R, 1982, XENOBIOTICA, V12, P717, DOI 10.3109/00498258209038946; GREINERT R, 1982, BIOSCIENCE REP, V2, P991, DOI 10.1007/BF01122166; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Hazai E, 2005, DRUG METAB DISPOS, V33, P157, DOI 10.1124/dmd.104.001578; HILDEBRANDT P, 1989, EUR J BIOCHEM, V186, P383, DOI 10.1111/j.1432-1033.1989.tb15220.x; Hu G, 2010, DRUG METAB DISPOS, V38, P1976, DOI 10.1124/dmd.110.034942; Jang HH, 2014, ARCH BIOCHEM BIOPHYS, V545, P100, DOI 10.1016/j.abb.2014.01.008; KAMINSKY LS, 1985, EUR J BIOCHEM, V149, P479, DOI 10.1111/j.1432-1033.1985.tb08950.x; Karyakin A. V., 1988, VESTN AKAD MED NAUK, V1988, P53; KAWATO S, 1982, J BIOL CHEM, V257, P7023; Kelley RW, 2006, BIOCHEMISTRY-US, V45, P15807, DOI 10.1021/bi061803n; Kelley RW, 2005, BIOCHEMISTRY-US, V44, P2632, DOI 10.1021/bi0477900; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081980; MCINTOSH PR, 1980, FEBS LETT, V122, P54, DOI 10.1016/0014-5793(80)80400-5; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; MYASOEDOVA KN, 1990, FEBS LETT, V275, P235, DOI 10.1016/0014-5793(90)81479-8; Myasoedova KN, 2001, BIOSCIENCE REP, V21, P63, DOI 10.1023/A:1010486118448; Nagy JK, 2000, BIOCHEMISTRY-US, V39, P4154, DOI 10.1021/bi991781n; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Paumard P, 2002, BIOCHEMISTRY-US, V41, P10390, DOI 10.1021/bi025923g; Prahlad J, 2014, J NEUROCHEM, V130, P839, DOI 10.1111/jnc.12763; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; Reed JR, 2012, BIOCHEM J, V446, P489, DOI 10.1042/BJ20120636; Reed JR, 2012, PHARMACOL THERAPEUT, V133, P299, DOI 10.1016/j.pharmthera.2011.11.009; Reed JR, 2010, J BIOL CHEM, V285, P8942, DOI 10.1074/jbc.M109.076885; Renaud JP, 1996, BIOCHEM J, V319, P675, DOI 10.1042/bj3190675; SCHWARZ D, 1990, BIOCHEM BIOPH RES CO, V171, P175, DOI 10.1016/0006-291X(90)91373-Z; Sineva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083898; SONO M, 1982, J BIOL CHEM, V257, P8308; Spatzenegger M, 2003, J PHARMACOL EXP THER, V304, P477, DOI 10.1124/jpet.102.043323; Subramanian M, 2010, DRUG METAB DISPOS, V38, P1003, DOI 10.1124/dmd.109.030155; Subramanian M, 2009, DRUG METAB DISPOS, V37, P1682, DOI 10.1124/dmd.109.026500; Tan YZ, 1997, ARCH BIOCHEM BIOPHYS, V342, P82, DOI 10.1006/abbi.1997.9995; Tsalkova TN, 2007, BIOCHEMISTRY-US, V46, P106, DOI 10.1021/bi061944p; TSONG TY, 1978, P NATL ACAD SCI USA, V75, P5955, DOI 10.1073/pnas.75.12.5955; TSUPRUN VL, 1986, FEBS LETT, V205, P35, DOI 10.1016/0014-5793(86)80861-4; WATANABE J, 1992, J HISTOCHEM CYTOCHEM, V40, P353, DOI 10.1177/40.3.1552174; WIBO M, 1971, J CELL BIOL, V51, P52, DOI 10.1083/jcb.51.1.52; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Yamada M, 2001, J INORG BIOCHEM, V83, P261, DOI 10.1016/S0162-0134(00)00169-0; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, BIOCHEM PHARMACOL, V51, P313, DOI 10.1016/0006-2952(95)02178-7; ZIEGLER M, 1982, FEBS LETT, V150, P219, DOI 10.1016/0014-5793(82)81338-0	72	52	53	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3850	3864		10.1074/jbc.M114.615443	http://dx.doi.org/10.1074/jbc.M114.615443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533469	hybrid, Green Published			2022-12-28	WOS:000349456000055
J	Guo, BB; Bellingham, SA; Hill, AF				Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.			The Neutral Sphingomyelinase Pathway Regulates Packaging of the Prion Protein into Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; CELLS; APOPTOSIS; DISEASE; INFECTIVITY; ASSOCIATION; SECRETION; VESICLES; RELEASE; IDENTIFICATION	Prion diseases are a group of transmissible, fatal neurodegenerative disorders associated with the misfolding of the host-encoded prion protein, PrPC, into a disease-associated form, PrPSc. The transmissible prion agent is principally formed of PrPSc itself and is associated with extracellular vesicles known as exosomes. Exosomes are released from cells both in vitro and in vivo, and have been proposed as a mechanism by which prions spread intercellularly. The biogenesis of exosomes occurs within the endosomal system, through formation of intraluminal vesicles (ILVs), which are subsequently released from cells as exosomes. ILV formation is known to be regulated by the endosomal sorting complexes required for transport (ESCRT) machinery, although an alternative neutral sphingomyelinase (nSMase) pathway has been suggested to also regulate this process. Here, we investigate a role for the nSMase pathway in exosome biogenesis and packaging of PrP into these vesicles. Inhibition of the nSMase pathway using GW4869 revealed a role for the nSMase pathway in both exosome formation and PrP packaging. In agreement, targeted knockdown of nSMase1 and nSMase2 in mouse neurons using lentivirus-mediated RNAi also decreases exosome release, demonstrating the nSMase pathway regulates the biogenesis and release of exosomes. We also demonstrate that PrPC packaging is dependent on nSMase2, whereas the packaging of disease-associated PrPSc into exosomes occurs independently of nSMase2. These findings provide further insight into prion transmission and identify a pathway which directly assists exosome-mediated transmission of prions.	[Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Guo, Belinda B.; Bellingham, Shayne A.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Bellingham, SA (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.	shayneb@unimelb.edu.au; a.hill@unimelb.edu.au	Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Guo, Belinda/0000-0003-2146-8561	Australian National Health and Medical Research Council (NHMRC) [628946, 1041413]; Australian Postgraduate Award; Faculty of Medicine, Dentistry and Health Sciences (MDHS); MDHS, The University of Melbourne; Australian Research Council [FT100100560]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Faculty of Medicine, Dentistry and Health Sciences (MDHS); MDHS, The University of Melbourne; Australian Research Council(Australian Research Council)	This study was funded by grants from the Australian National Health and Medical Research Council (NHMRC; Grants 628946 and 1041413). This work was also supported by an Australian Postgraduate Award and Faculty of Medicine, Dentistry and Health Sciences (MDHS) Top-Up Scholarship (to B. B. G.); a Bellberry Indigenous Health Fellowship (MDHS, The University of Melbourne) (to S. A. B.); an Australian Research Council (www.arc.gov.au) Future Fellowship (Grant FT100100560) (to A. F. H.). A. F. H is a shareholder of D-Gen Limited, which supplies an antibody used in the study.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Botte CY, 2013, P NATL ACAD SCI USA, V110, P7506, DOI 10.1073/pnas.1301251110; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Choi HS, 2014, BIOCHEM BIOPH RES CO, V448, P157, DOI 10.1016/j.bbrc.2014.04.069; Choi SI, 1998, ACTA NEUROPATHOL, V96, P279, DOI 10.1007/s004010050895; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Garza-Licudine E, 2010, IEEE ENG MED BIO, P5736, DOI 10.1109/IEMBS.2010.5627861; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Mattei V, 2011, MOL BIOL CELL, V22, P4842, DOI 10.1091/mbc.E11-04-0348; Mattei V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005057; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rabesandratana H, 1998, BLOOD, V91, P2573, DOI 10.1182/blood.V91.7.2573.2573_2573_2580; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schatzl HM, 1997, J VIROL, V71, P8821; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tonnetti L, 1999, J EXP MED, V189, P1581, DOI 10.1084/jem.189.10.1581; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	58	144	146	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3455	3467		10.1074/jbc.M114.605253	http://dx.doi.org/10.1074/jbc.M114.605253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25505180	Green Published, hybrid			2022-12-28	WOS:000349456000021
J	Wong, SG; Grigg, JC; Le Brun, NE; Moore, GR; Murphy, MEP; Mauk, AG				Wong, Steve G.; Grigg, Jason C.; Le Brun, Nick E.; Moore, Geoffrey R.; Murphy, Michael E. P.; Mauk, A. Grant			The B-type Channel Is a Major Route for Iron Entry into the Ferroxidase Center and Central Cavity of Bacterioferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; CORE FORMATION; FERRITIN; BINDING; ELECTROSTATICS; MECHANISM; DIFFUSION; OXIDATION	Bacterioferritin is a bacterial iron storage and detoxification protein that is capable of forming a ferric oxyhydroxide mineral core within its central cavity. To do this, iron must traverse the bacterioferritin protein shell, which is expected to occur through one or more of the channels through the shell identified by structural studies. The size and negative electrostatic potential of the 24 B-type channels suggest that they could provide a route for iron into bacterioferritin. Residues at the B-type channel (Asn-34, Glu-66, Asp-132, and Asp-139) of E. coli bacterioferritin were substituted to determine if they are important for iron core formation. A significant decrease in the rates of initial oxidation of Fe(II) at the ferroxidase center and subsequent iron mineralization was observed for the D132F variant. The crystal structure of this variant shows that substitution of residue 132 with phenylalanine caused a steric blockage of the B-type channel and no other material structural perturbation. We conclude that the B-type channel is a major route for iron entry into both the ferroxidase center and the iron storage cavity of bacterioferritin.	[Wong, Steve G.; Mauk, A. Grant] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Grigg, Jason C.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Le Brun, Nick E.; Moore, Geoffrey R.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	University of British Columbia; University of British Columbia; University of East Anglia	Mauk, AG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	grant.mauk@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Le Brun, Nick/0000-0001-9780-4061	Canadian Foundation for Innovation; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; NIGMS; BBSRC [BB/I021884/1, BB/D001943/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001943/1, BB/I021884/1] Funding Source: researchfish	Canadian Foundation for Innovation(Canada Foundation for Innovation); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The stopped-flow spectrometer and spectroscopic instrumentation were obtained with a grant from the Canadian Foundation for Innovation to the University of British Columbia Laboratory of Molecular Biophysics. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the NIGMS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitken-Rogers H, 2004, J BIOL INORG CHEM, V9, P161, DOI 10.1007/s00775-003-0504-1; Antonyuk SV, 2011, BBA-PROTEINS PROTEOM, V1814, P778, DOI 10.1016/j.bbapap.2010.12.017; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Bou-Abdallah F, 2008, J AM CHEM SOC, V130, P17801, DOI 10.1021/ja8054035; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho KJ, 2009, J MOL BIOL, V390, P83, DOI 10.1016/j.jmb.2009.04.078; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018570; LEBRUN NE, 1993, FEBS LETT, V333, P197, DOI 10.1016/0014-5793(93)80404-I; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; Liu HL, 2004, FEBS LETT, V573, P93, DOI 10.1016/j.febslet.2004.07.054; Lv CY, 2014, BIOCHEMISTRY-US, V53, P2232, DOI 10.1021/bi500066m; Macedo S, 2003, NAT STRUCT BIOL, V10, P285, DOI 10.1038/nsb909; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOORE GR, 1994, BIOCHEM J, V304, P493, DOI 10.1042/bj3040493; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Swartz L, 2006, BIOCHEMISTRY-US, V45, P4421, DOI 10.1021/bi060146w; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; Wahlgren WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046992; Willies SC, 2009, J BIOL INORG CHEM, V14, P201, DOI 10.1007/s00775-008-0438-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong SG, 2012, BIOCHEM J, V444, P553, DOI 10.1042/BJ20112200; Wong SG, 2009, J BIOL CHEM, V284, P18873, DOI 10.1074/jbc.M901747200; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119	41	17	17	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3732	3739		10.1074/jbc.M114.623082	http://dx.doi.org/10.1074/jbc.M114.623082			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25512375	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000349456000044
J	Zhang, CB; Hwarng, G; Cooper, DE; Grevengoed, TJ; Eaton, JM; Natarajan, V; Harris, TE; Coleman, RA				Zhang, Chongben; Hwarng, Gwen; Cooper, Daniel E.; Grevengoed, Trisha J.; Eaton, James M.; Natarajan, Viswanathan; Harris, Thurl E.; Coleman, Rosalind A.			Inhibited Insulin Signaling in Mouse Hepatocytes Is Associated with Increased Phosphatidic Acid but Not Diacylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FATTY LIVER-DISEASE; HEPATIC STEATOSIS; DEPENDENT ACTIVATION; PHOSPHOLIPASE D1; MTOR COMPLEX; RESISTANCE; ACYLTRANSFERASE; CELLS; MICE	Although an elevated triacylglycerol content in non-adipose tissues is often associated with insulin resistance, the mechanistic relationship remains unclear. The data support roles for intermediates in the glycerol-3-phosphate pathway of triacylglycerol synthesis: diacylglycerol (DAG), which may cause insulin resistance in liver by activating PKC epsilon, and phosphatidic acid (PA), which inhibits insulin action in hepatocytes by disrupting the assembly of mTOR and rictor. To determine whether increases in DAG and PA impair insulin signaling when produced by pathways other than that of de novo synthesis, we examined primary mouse hepatocytes after enzymatically manipulating the cellular content of DAG or PA. Overexpressing phospholipase D1 or phospholipase D2 inhibited insulin signaling and was accompanied by an elevated cellular content of total PA, without a change in total DAG. Overexpression of diacylglycerol kinase-theta inhibited insulin signaling and was accompanied by an elevated cellular content of total PA and a decreased cellular content of total DAG. Overexpressing glycerol-3-phosphate acyltransferase-1 or -4 inhibited insulin signaling and increased the cellular content of both PA and DAG. Insulin signaling impairment caused by overexpression of phospholipase D1/D2 or diacylglycerol kinase-theta was always accompanied by disassociation of mTOR/rictor and reduction of mTORC2 kinase activity. However, although the protein ratio of membrane to cytosolic PKC epsilon increased, PKC activity itself was unaltered. These data suggest that PA, but not DAG, is associated with impaired insulin action in mouse hepatocytes.	[Zhang, Chongben; Hwarng, Gwen; Cooper, Daniel E.; Grevengoed, Trisha J.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Eaton, James M.; Harris, Thurl E.] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA 22908 USA; [Natarajan, Viswanathan] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Natarajan, Viswanathan] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, 2301 MHRC,Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Grevengoed, Trisha/AAA-3980-2021	Grevengoed, Trisha/0000-0003-4433-3950	National Institutes of Health [DK56598, P01 HL98050]; American Diabetes Association [7-11-JF-21]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056598, R01DK101946, R01DK056598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK56598 (to R. A. C.) and P01 HL98050 (to V. N.) and American Diabetes Association Grant 7-11-JF-21 (to T. E. H.).	Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; DONNELLY R, 1995, ENDOCRINE, V3, P129, DOI 10.1007/BF02990064; Du GW, 2000, MOL BIOL CELL, V11, P4359, DOI 10.1091/mbc.11.12.4359; Epand RM, 2007, METHOD ENZYMOL, V434, P293, DOI 10.1016/S0076-6879(07)34016-0; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Goto K, 2008, TOHOKU J EXP MED, V214, P199, DOI 10.1620/tjem.214.199; Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu BA, 2010, J LIPID RES, V51, P3207, DOI 10.1194/jlr.M007054; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Monetti M, 2011, P NATL ACAD SCI USA, V108, pE523, DOI 10.1073/pnas.1108505108; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Prasad SS, 2011, J LIPID RES, V52, P451, DOI 10.1194/jlr.M007575; Qu XQ, 1999, CLIN SCI, V97, P355, DOI 10.1042/cs0970355; RANDO RR, 1984, BIOCHEM BIOPH RES CO, V122, P818, DOI 10.1016/S0006-291X(84)80107-2; Rector RS, 2013, HEPATOLOGY, V57, P2213, DOI 10.1002/hep.26285; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Usatyuk PV, 2013, PULM CIRC, V3, P108, DOI 10.4103/2045-8932.109925; WALSH JP, 1992, METHOD ENZYMOL, V209, P153; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zhang CB, 2014, AM J PHYSIOL-ENDOC M, V307, pE305, DOI 10.1152/ajpendo.00034.2014; Zhang CB, 2013, CLIN LIPIDOL, V8, P659, DOI 10.2217/clp.13.67; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	50	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3519	3528		10.1074/jbc.M114.602789	http://dx.doi.org/10.1074/jbc.M114.602789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25512376	hybrid, Green Published			2022-12-28	WOS:000349456000026
J	Zulliger, R; Naash, MI; Rajala, RVS; Molday, RS; Azadi, S				Zulliger, Rahel; Naash, Muna I.; Rajala, Raju V. S.; Molday, Robert S.; Azadi, Seifollah			Impaired Association of Retinal Degeneration-3 with Guanylate Cyclase-1 and Guanylate Cyclase-activating Protein-1 Leads to Leber Congenital Amaurosis-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR CELLS; GENETIC-HETEROGENEITY; RETINITIS-PIGMENTOSA; MUTATION ANALYSIS; TRAFFICKING; ROD; LOCALIZATION; SEGMENTS; BINDING; MODEL	One-fifth of all cases of Leber congenital amaurosis are type 1 (LCA1). LCA1 is a severe form of retinal dystrophy caused by loss-of-function mutations in guanylate cyclase 1 (GC1), a key member of the phototransduction cascade involved in modulating the photocurrents. Although GC1 has been studied for some time, the mechanisms responsible for its regulation and membrane targeting are not fully understood. We reported earlier that retinal degeneration 3 (RD3) protein interacts with GC1 and promotes its targeting to the photoreceptor outer segments (POS). Here, we extend our studies to show a direct association between RD3 and guanylate cyclase activating protein 1 (GCAP1). Furthermore, we demonstrate that this functional interaction is important for GC1 targeting to POS. We also show that most LCA1-causing mutations in GC1 result in lost GC1 interaction with RD3 or GC1 being targeted to the plasma membrane. Our data suggest that GC1, GCAP1, and RD3 form a complex in the endoplasmic reticulum that targets GC1 to POS. Interruption of this assembly is likely the underlying mechanism for a subset of LCA1. This study offers insights for the development of therapeutic strategies to treat this severe form of blindness.	[Zulliger, Rahel; Naash, Muna I.; Rajala, Raju V. S.; Azadi, Seifollah] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.; Azadi, Seifollah] Dean McGee Eye Inst, Oklahoma City, OK 73104 USA; [Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of British Columbia	Azadi, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	sazadi@ouhsc.edu			National Institutes of Health from NEI [EY010609, EY000871]; Knights Templar Eye Foundation [C5067001, C5067002]; NATIONAL EYE INSTITUTE [R56EY010609, R01EY010609, R55EY010609, R01EY002422, R01EY000871] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants EY010609 (to M. I. N.) and EY000871 (to R. R.) from NEI. This work was also supported by was supported by Knights Templar Eye Foundation Grants C5067001 and C5067002 (to S. A.).	Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Chen YB, 2013, INVEST OPHTH VIS SCI, V54, P4351, DOI 10.1167/iovs.13-11606; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Deretic D, 1998, EYE, V12, P526, DOI 10.1038/eye.1998.141; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Duda T, 1999, BIOCHEMISTRY-US, V38, P509, DOI 10.1021/bi9824137; Duda T, 2002, MOL CELL BIOCHEM, V230, P129, DOI 10.1023/A:1014296124514; El-Shanti H, 1999, J MED GENET, V36, P862; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; GARBERS DL, 1988, COLD SPRING HARB SYM, V53, P993, DOI 10.1101/SQB.1988.053.01.114; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; KAPLAN J, 1990, HUM GENET, V85, P635; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Karan S, 2010, MOL CELL BIOCHEM, V334, P141, DOI 10.1007/s11010-009-0322-z; Koch KW, 2002, ADV EXP MED BIOL, V514, P349; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; Lodowski KH, 2013, J NEUROSCI, V33, P13621, DOI 10.1523/JNEUROSCI.1520-13.2013; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Lu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078274; Martin RE, 2005, INVEST OPHTH VIS SCI, V46, P1147, DOI 10.1167/iovs.04-1207; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Milam AH, 2003, OPHTHALMOLOGY, V110, P549, DOI 10.1016/S0161-6420(02)01757-8; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; Perrault Isabelle, 2005, Hum Mutat, V25, P222, DOI 10.1002/humu.9304; Perrault I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051622; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Sokal I, 1999, BIOCHEMISTRY-US, V38, P1387, DOI 10.1021/bi982512k; Stephen R, 2008, PHOTOCHEM PHOTOBIOL, V84, P903, DOI 10.1111/j.1751-1097.2008.00323.x; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tucker CL, 2004, MOL VIS, V10, P297; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhong M, 2009, J BIOL CHEM, V284, P3640, DOI 10.1074/jbc.M806580200	45	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3488	3499		10.1074/jbc.M114.616656	http://dx.doi.org/10.1074/jbc.M114.616656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25477517	hybrid, Green Published			2022-12-28	WOS:000349456000023
J	Miyamoto, J; Mizukure, T; Park, SB; Kishino, S; Kimura, I; Hirano, K; Bergamo, P; Rossi, M; Suzuki, T; Arita, M; Ogawa, J; Tanabe, S				Miyamoto, Junki; Mizukure, Taichi; Park, Si-Bum; Kishino, Shigenobu; Kimura, Ikuo; Hirano, Kanako; Bergamo, Paolo; Rossi, Mauro; Suzuki, Takuya; Arita, Makoto; Ogawa, Jun; Tanabe, Soichi			A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Colitis; Epithelial Cell; Microbiome; Tight Junction; Tumor Necrosis Factor (TNF); Caco-2; G Protein-coupled Receptor; Linoleic Acid; Metabolite	INFLAMMATORY-BOWEL-DISEASE; PROTEIN-COUPLED RECEPTOR; TIGHT JUNCTION BARRIER; PANCREATIC BETA-CELLS; NECROSIS-FACTOR-ALPHA; CHAIN FATTY-ACIDS; INSULIN-SECRETION; MOLECULAR-MECHANISM; SIGNALING PATHWAYS; INDUCED COLITIS	Background: The physiological activity of gut microbial metabolites has recently attracted much attention. Results: A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid (HYA), ameliorates intestinal epithelial barrier impairments by regulating TNFR2 expression via the GPR40-MEK-ERK pathway. Conclusion: HYA-induced GPR40 signaling contributes to the intestinal homeostasis. Significance: Our findings indicate a novel function of GPR40 in the inflamed intestine. Gut microbial metabolites of polyunsaturated fatty acids have attracted much attention because of their various physiological properties. Dysfunction of tight junction (TJ) in the intestine contributes to the pathogenesis of many disorders such as inflammatory bowel disease. We evaluated the effects of five novel gut microbial metabolites on tumor necrosis factor (TNF)--induced barrier impairment in Caco-2 cells and dextran sulfate sodium-induced colitis in mice. 10-Hydroxy-cis-12-octadecenoic acid (HYA), a gut microbial metabolite of linoleic acid, suppressed TNF- and dextran sulfate sodium-induced changes in the expression of TJ-related molecules, occludin, zonula occludens-1, and myosin light chain kinase. HYA also suppressed the expression of TNF receptor 2 (TNFR2) mRNA and protein expression in Caco-2 cells and colonic tissue. In addition, HYA suppressed the protein expression of TNFR2 in murine intestinal epithelial cells. Furthermore, HYA significantly up-regulated G protein-coupled receptor (GPR) 40 expression in Caco-2 cells. It also induced [Ca2+](i) responses in HEK293 cells expressing human GPR40 with higher sensitivity than linoleic acid, its metabolic precursor. The barrier-recovering effects of HYA were abrogated by a GPR40 antagonist and MEK inhibitor in Caco-2 cells. Conversely, 10-hydroxyoctadacanoic acid, which is a gut microbial metabolite of oleic acid and lacks a carbon-carbon double bond at 12 position, did not show these TJ-restoring activities and down-regulated GPR40 expression. Therefore, HYA modulates TNFR2 expression, at least partially, via the GPR40-MEK-ERK pathway and may be useful in the treatment of TJ-related disorders such as inflammatory bowel disease.	[Miyamoto, Junki; Mizukure, Taichi; Suzuki, Takuya; Tanabe, Soichi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Park, Si-Bum; Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Kimura, Ikuo; Hirano, Kanako] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo 1838509, Japan; [Bergamo, Paolo; Rossi, Mauro] CNR, Inst Food Sci, I-83100 Avellino, Italy; [Arita, Makoto] RIKEN, Lab Metabol, Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Hiroshima University; Kyoto University; Kyoto University; Tokyo University of Agriculture & Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); RIKEN	Ogawa, J (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.	ogawa@kais.kyoto-u.ac.jp; stanabe@hiroshima-u.ac.jp	Suzuki, Takuya/H-3750-2019; Tanabe, Soichi/R-6229-2019; 宮本, 潤基/ABG-8169-2020; Rossi, Mauro/AAC-2968-2021; Kimura, Ikuo/B-4193-2015; Rossi, Mauro/B-5930-2012; Bergamo, Paolo/F-7835-2013; Rossi, Mauro/R-1715-2019	Suzuki, Takuya/0000-0003-3709-543X; Rossi, Mauro/0000-0001-8631-1683; Bergamo, Paolo/0000-0002-1726-7911; Kishino, Shigenobu/0000-0002-4587-2422; Rossi, Mauro/0000-0002-0252-4321; Arita, Makoto/0000-0001-9902-0463	Japanese Ministry of Education, Science, Sports and Culture [KAKENHI 22380076, 25292074]; Bio-Oriented Technology Research Advancement Institution of Japan; NEDO Innovation Commercialization Venture Support Project; Agreement of Scientific Cooperation [CNR-JSPS 2010-11]; Grants-in-Aid for Scientific Research [14J06559] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution of Japan; NEDO Innovation Commercialization Venture Support Project; Agreement of Scientific Cooperation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japanese Ministry of Education, Science, Sports and Culture Grants-in-aid KAKENHI 22380076 and 25292074 (to S. T.), the Bio-Oriented Technology Research Advancement Institution of Japan (to J. O.), NEDO Innovation Commercialization Venture Support Project (to collaboration of NITTO PHARMA and J. O.) and by Agreement of Scientific Cooperation Grant CNR-JSPS 2010-11 (to S. T. and M. R.).	Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Ayyadurai S, 2013, LAB INVEST, V93, P888, DOI 10.1038/labinvest.2013.77; Baker OJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1191, DOI 10.1152/ajpcell.00144.2008; Bergamo P, 2011, MOL NUTR FOOD RES, V55, pS248, DOI 10.1002/mnfr.201100295; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Cao ZX, 2013, GASTROENTEROLOGY, V144, P808, DOI 10.1053/j.gastro.2012.12.028; Dai C, 2012, INT J MOL MED, V29, P202, DOI 10.3892/ijmm.2011.839; Del Guerra S, 2010, NUTR METAB CARDIOVAS, V20, P22, DOI 10.1016/j.numecd.2009.02.008; Duca FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039748; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Fischer A, 2013, AM J PHYSIOL-GASTR L, V304, pG970, DOI 10.1152/ajpgi.00183.2012; Fujita T, 2011, J INVEST DERMATOL, V131, P1660, DOI 10.1038/jid.2011.123; Fukui A, 2012, AM J PHYSIOL-GASTR L, V303, pG927, DOI 10.1152/ajpgi.00236.2012; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gerasimenko JV, 2013, P NATL ACAD SCI USA, V110, P13186, DOI 10.1073/pnas.1300910110; Hamada K, 2010, CANCER CHEMOTH PHARM, V66, P1031, DOI 10.1007/s00280-010-1253-9; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hossain Z, 2008, MOL BIOSYST, V4, P1181, DOI 10.1039/b800402a; Inoue D, 2012, FEBS LETT, V586, P1547, DOI 10.1016/j.febslet.2012.04.021; Itoh S, 2003, NATURE, V423, P728, DOI 10.1038/nature01699; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kanai T, 2012, MUCOSAL IMMUNOL, V5, P240, DOI 10.1038/mi.2012.6; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Martinasso G, 2010, CANCER LETT, V287, P62, DOI 10.1016/j.canlet.2009.05.036; Meddings J, 2008, GUT, V57, P438, DOI 10.1136/gut.2007.143172; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Miyauchi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079735; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Ogawa J, 2005, J BIOSCI BIOENG, V100, P355, DOI 10.1263/jbb.100.355; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Petecchia L, 2012, LAB INVEST, V92, P1140, DOI 10.1038/labinvest.2012.67; Petit CSV, 2012, GASTROENTEROLOGY, V143, P122, DOI 10.1053/j.gastro.2012.03.029; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Srinivas SP, 2004, EXP EYE RES, V79, P543, DOI 10.1016/j.exer.2004.06.027; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Tanabe S, 2013, INT REV IMMUNOL, V32, P511, DOI 10.3109/08830185.2013.839665; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vivinus-Nebot M, 2014, GUT, V63, P744, DOI 10.1136/gutjnl-2012-304066; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052924; Wang Y, 2013, LAB INVEST, V93, P1024, DOI 10.1038/labinvest.2013.89; Wauquier F, 2013, J BIOL CHEM, V288, P6542, DOI 10.1074/jbc.M112.429084; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Zamarbide M, 2014, HIPPOCAMPUS, V24, P733, DOI 10.1002/hipo.22263; Zenhom M, 2011, IMMUNOBIOLOGY, V216, P715, DOI 10.1016/j.imbio.2010.10.008	63	133	135	4	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2902	2918		10.1074/jbc.M114.610733	http://dx.doi.org/10.1074/jbc.M114.610733			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505251	Green Published, hybrid			2022-12-28	WOS:000349310700030
J	Abrol, N; de Tombe, PP; Robia, SL				Abrol, Neha; de Tombe, Pieter P.; Robia, Seth L.			Acute Inotropic and Lusitropic Effects of Cardiomyopathic R9C Mutation of Phospholamban	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; CYTOPLASMIC DOMAIN; PROTEIN-STRUCTURE; ENERGY-TRANSFER; HEART-FAILURE; CALCIUM-PUMP; PHOSPHORYLATION; LETHAL; SERCA; REVEALS	A naturally occurring R9C mutation of phospholamban (PLB) triggers cardiomyopathy and premature death by altering regulation of sarco/endoplasmic reticulurn calcitun-ATPase (SERCA). The goal of this study was to investigate the acute physiological consequences of the R9C-PLB mutation on cardioniyocyte calcium kinetics and contractility. We measured the physiological consequences of R9C-PLB mutation on calcium transients and sarcomere shortening in adult cardiomyocytes. In contrast to studies of chronic R9C-PLB expression in transgenic mice, we found that acute expression of R9C-PLB exerts a positively inotropic and lusitropic effect in cardiomyocytes. Importantly, R9C-PLB exhibited blunted sensitivity to frequency potentiation and p-adrenergic stimulation, two major physiological mechanisms for the regulation of cardiac performance. To identify the molecular mechanism of R9C pathology, we quantified the effect of R9C on PLB oligomerization and PLB-SERCA binding. FRET measurements in live cells revealed that R9C-PLB exhibited an increased propensity for oligomerization, and this was further increased by oxidative stress. The R9C also decreased PLB binding to SERCA and altered the structure of the PLB-SERCA regulatory complex. The structural change after oxidative modification of R9C-PLB was similar to that observed after PLB phosphorylation. We conclude that R9C mutation of PLB decreases SERCA inhibition by decreasing the amount of the regulatory complex and altering its conformation. This has an acute inotropic/lusitropic effect but yields negative consequences of impaired frequency potentiation and blunted p-adrenergic responsiveness. We envision a self-reinforcing mechanism beginning with phosphomimetic R9C-PLB oxidation and loss of SERCA inhibition, leading to impaired calcium regulation and heart failure.	[Abrol, Neha; de Tombe, Pieter P.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60163 USA	Loyola University Chicago	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, 2160 South First Ave, Maywood, IL 60153 USA.	srobia@luc.edu			National Institutes of Health [HL-092321, HL-62426, HL-75494]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321, P01HL062426, R01HL075494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-092321 (to S. L. R.) and HL-62426 and HL-75494 (to P. dT.).	Abrol N, 2014, J BIOL CHEM, V289, P25855, DOI 10.1074/jbc.M114.562579; Autry JM, 1998, ANN NY ACAD SCI, V853, P92, DOI 10.1111/j.1749-6632.1998.tb08259.x; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Ceholski DK, 2012, J BIOL CHEM, V287, P26596, DOI 10.1074/jbc.M112.382713; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Choudhary Gaurav, 2002, Congest Heart Fail, V8, P148, DOI 10.1111/j.1527-5299.2002.00716.x; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUJII J, 1989, J BIOL CHEM, V264, P12950; Gadella T. W., 2009, FRET FLIM TECHNIQUES, P193; Gramolini AO, 2008, MOL CELL PROTEOMICS, V7, P519, DOI 10.1074/mcp.M700245-MCP200; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; King C, 2014, BIOPHYS J, V106, P1309, DOI 10.1016/j.bpj.2014.01.039; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Landstrom AP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.08.001; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; Parvari R, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/639250; Paterlini MG, 2005, BIOPHYS J, V88, P3243, DOI 10.1529/biophysj.104.054460; Pattison JS, 2008, TRANSGENIC RES, V17, P157, DOI 10.1007/s11248-007-9139-2; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Posch MG, 2009, HEART RHYTHM, V6, P480, DOI 10.1016/j.hrthm.2009.01.016; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Schmitt JP, 2009, CIRCULATION, V119, P436, DOI 10.1161/CIRCULATIONAHA.108.783506; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schroder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Smeazzetto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052744; van Rijsingen IAW, 2014, CIRC-CARDIOVASC GENE, V7, P455, DOI 10.1161/CIRCGENETICS.113.000374; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Yu XT, 2014, J PHYS CHEM B, V118, P2124, DOI 10.1021/jp500316s; Yu XT, 2013, BBA-BIOMEMBRANES, V1828, P2444, DOI 10.1016/j.bbamem.2013.07.003; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	52	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7130	7140		10.1074/jbc.M114.630319	http://dx.doi.org/10.1074/jbc.M114.630319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25593317	hybrid, Green Published			2022-12-28	WOS:000350991500043
J	Keembiyehetty, C; Love, DC; Harwood, KR; Gavrilova, O; Comly, ME; Hanover, JA				Keembiyehetty, Chithra; Love, Dona C.; Harwood, Katryn R.; Gavrilova, Oksana; Comly, Marcella E.; Hanover, John A.			Conditional Knock-out Reveals a Requirement for O-Linked N-Acetylglucosaminase (O-GlcNAcase) in Metabolic Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCE INSULIN-RESISTANCE; TYPE-2 DIABETES-MELLITUS; CAENORHABDITIS-ELEGANS; GLYCOGEN-SYNTHASE; 3T3-L1 ADIPOCYTES; TRANSGENIC MICE; ADIPOSE-TISSUE; NUCLEOCYTOPLASMIC GLYCOSYLATION; PROTEIN GLYCOSYLATION; DYNAMIC INTERPLAY	O-GlcNAc cycling is maintained by the reciprocal activities of the O-GlcNAc transferase and the O-GlcNAcase (OGA) enzymes. O-GlcNAc transferase is responsible forO-GlcNAc addition to serine and threonine (Ser/Thr) residues and OGA for its removal. Although the Oga gene (MGEA5) is a documented human diabetes susceptibility locus, its role in maintaining insulin-glucose homeostasis is unclear. Here, we report a conditional disruption of the Oga gene in the mouse. The resulting homozygous Oga null (KO) animals lack OGA enzymatic activity and exhibit elevated levels of the O-GlcNAc modification. The Oga KO animals showed nearly complete perinatal lethality associated with low circulating glucose and low liver glycogen stores. Defective insulin-responsive GSK3 beta phosphorylation was observed in both heterozygous (HET) and KO Oga animals. Although Oga HET animals were viable, they exhibited alterations in both transcription and metabolism. Transcriptome analysis using mouse embryonic fibroblasts revealed deregulation in the transcripts of both HET and KO animals specifically in genes associated with metabolism and growth. Additionally, metabolic profiling showed increased fat accumulation in HET and KO animals compared with WT, which was increased by a high fat diet. Reduced insulin sensitivity, glucose tolerance, and hyperleptinemia were also observed in HET and KO female mice. Notably, the respiratory exchange ratio of the HET animals was higher than that observed in WT animals, indicating the preferential utilization of glucose as an energy source. These results suggest that the loss of mouse OGA leads to defects in metabolic homeostasis culminating in obesity and insulin resistance.	[Keembiyehetty, Chithra; Love, Dona C.; Harwood, Katryn R.; Comly, Marcella E.; Hanover, John A.] NIDDK, LCBB, NIH, Bethesda, MD 20892 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hanover, JA (corresponding author), NIDDK, LCBB, NIH, 8 Ctr Dr, Bethesda, MD 20892 USA.	jah@helix.nih.gov			National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002, ZIADK060102, ZIADK060101, ZIADK060103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health Intramural Grant.	Abramowitz Lara K, 2014, J Genomics, V2, P77, DOI 10.7150/jgen.8123; Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Babinet C, 2001, AN ACAD BRAS CIENC, V73, P365, DOI 10.1590/S0001-37652001000300007; Benz V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037794; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Farook VS, 2002, MOL GENET METAB, V77, P189, DOI 10.1016/S1096-7192(02)00127-0; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Fuentes L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/219583; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hanover John A, 2013, Worm, V2, pe27043, DOI 10.4161/worm.27043; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Kim EJ, 2006, J AM CHEM SOC, V128, P4234, DOI 10.1021/ja0582915; Kim EJ, 2007, J AM CHEM SOC, V129, P14854, DOI 10.1021/ja076038u; Kim EJ, 2014, CRIT REV BIOCHEM MOL, V49, P327, DOI 10.3109/10409238.2014.931338; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kudlow JE, 2002, MOL GENET METAB, V77, P1, DOI 10.1016/S1096-7192(02)00128-2; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Marshall Stephen, 2006, Sci STKE, V2006, pre7; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; McClain DA, 2000, ENDOCRINOLOGY, V141, P1999, DOI 10.1210/en.141.6.1999; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mondoux MA, 2011, GENETICS, V188, P369, DOI 10.1534/genetics.111.126490; Muller G, 1997, J BIOL CHEM, V272, P10585, DOI 10.1074/jbc.272.16.10585; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Schultz J, 2002, FEBS LETT, V529, P179, DOI 10.1016/S0014-5793(02)03322-7; Sekine O, 2010, J BIOL CHEM, V285, P38684, DOI 10.1074/jbc.M110.155192; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Stichelen SOV, 2014, BIOCHEM BIOPH RES CO, V453, P201, DOI 10.1016/j.bbrc.2014.06.068; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Teo CF, 2010, MOL CELL ENDOCRINOL, V318, P44, DOI 10.1016/j.mce.2009.09.022; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wan M, 2012, MOL CELL BIOL, V32, P96, DOI 10.1128/MCB.05806-11; Wang P, 2013, AUTOPHAGY, V9, P604, DOI 10.4161/auto.23459; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang YR, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.24; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	84	82	82	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7097	7113		10.1074/jbc.M114.617779	http://dx.doi.org/10.1074/jbc.M114.617779			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25596529	hybrid, Green Published			2022-12-28	WOS:000350991500041
J	Mayer, F; Lim, JK; Langer, JD; Kang, SG; Muller, V				Mayer, Florian; Lim, Jae Kyu; Langer, Julian D.; Kang, Sung Gyun; Mueller, Volker			Na+ Transport by the A(1)A(O)-ATP Synthase Purified from Thermococcus onnurineus and Reconstituted into Liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A(1)A(0) ATP SYNTHASE; METHANOSARCINA-MAZEI GO1; PROPIONIGENIUM-MODESTUM; H+-ATPASE; ION; ARCHAEON; EVOLUTION; PROTEINS; FORMATE; SUBUNIT	The ATP synthase of many archaea has the conserved sodium ion binding motif in its rotor subunit, implying that these A(1)A(O)-ATP synthases use Na+ as coupling ion. However, this has never been experimentally verified with a purified system. To experimentally address the nature of the coupling ion, we have purified the A(1)A(O)-ATP synthase from T. onnurineus. It contains nine subunits that are functionally coupled. The enzyme hydrolyzed ATP, CTP, GTP, UTP, and ITP with nearly identical activities of around 40 units/mg of protein and was active over a wide pH range with maximal activity at pH 7. Noteworthy was the temperature profile. ATP hydrolysis was maximal at 80 degrees C and still retained an activity of 2.5 units/mg of protein at 45 degrees C. The high activity of the enzyme at 45 degrees C opened, for the first time, a way to directly measure ion transport in an A(1)A(O)-ATP synthase. Therefore, the enzyme was reconstituted into liposomes generated from Escherichia coli lipids. These proteoliposomes were still active at 45 degrees C. and coupled ATP hydrolysis to primary and electrogenic Na+ transport. This is the first proof of Na+ transport by an A(1)A(O)-ATP synthase and these findings are discussed in light of the distribution of the sodium ion binding motif in archaea and the role of Na+ in the bioenergetics of archaea.	[Mayer, Florian; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Mol Microbiol & Bioenerget, D-60438 Frankfurt, Germany; [Lim, Jae Kyu; Kang, Sung Gyun] Korea Inst Ocean Sci & Technol, Anson 426744, South Korea; [Lim, Jae Kyu; Kang, Sung Gyun] Univ Sci & Technol, Dept Marine Biotechnol, Taejon 350333, South Korea; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Korea Institute of Ocean Science & Technology (KIOST); Max Planck Society	Muller, V (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Mol Microbiol & Bioenerget, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508; LIM, JAE KYU/0000-0002-9696-9830; Langer, Julian David/0000-0002-5190-577X	Deutsche Forschungsgemeinschaft [SFB807]; ESFRI-Instruct initiative of the European Union; Korea Institute of Ocean Science and Technology [PE99212, PE99263]; Ministry of Oceans and Fisheries	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ESFRI-Instruct initiative of the European Union; Korea Institute of Ocean Science and Technology; Ministry of Oceans and Fisheries	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB807 (to V. M.), a grant from the ESFRI-Instruct initiative of the European Union (to J. D. L.), Korea Institute of Ocean Science and Technology in-house program Grants PE99212 and PE99263 (to S. G. K.), and the program "Development of Biohydrogen Production Technology Using the Hyper-thermophilic Archaea" of the Ministry of Oceans and Fisheries (to S. G. K.).	Bae SS, 2006, J MICROBIOL BIOTECHN, V16, P1826; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braley R, 1997, FEBS LETT, V418, P123, DOI 10.1016/S0014-5793(97)01359-8; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Coskun U, 2004, J BIOENERG BIOMEMBR, V36, P249, DOI 10.1023/B:JOBB.0000031976.44466.6e; Coskun U, 2002, J BIOL CHEM, V277, P17327, DOI 10.1074/jbc.M110407200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Deppenmeier Uwe, 2008, V45, P123, DOI 10.1007/400_2006_026; DIMROTH P, 1992, ACTA PHYSIOL SCAND, V146, P97; FENG Y, 1994, J BIOL CHEM, V269, P13224; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gruber G, 2001, BIOCHEMISTRY-US, V40, P1890, DOI 10.1021/bi002195t; Gruber G, 2014, BBA-BIOENERGETICS, V1837, P940, DOI 10.1016/j.bbabio.2014.03.004; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; Kaim G, 1998, BIOCHEMISTRY-US, V37, P4626, DOI 10.1021/bi973022f; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Koga Y, 2012, ARCHAEA, V2012, DOI 10.1155/2012/789652; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lane N, 2012, CELL, V151, P1406, DOI 10.1016/j.cell.2012.11.050; LAUBINGER W, 1988, BIOCHEMISTRY-US, V27, P7531, DOI 10.1021/bi00419a053; Lemker T, 2003, FEBS LETT, V544, P206, DOI 10.1016/S0014-5793(03)00496-4; Lim JK, 2014, P NATL ACAD SCI USA, V111, P11497, DOI 10.1073/pnas.1407056111; Lim JK, 2012, APPL ENVIRON MICROB, V78, P7393, DOI 10.1128/AEM.01316-12; Lingl A, 2003, EXTREMOPHILES, V7, P249, DOI 10.1007/s00792-003-0318-7; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; Mayer F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411223; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McMillan DGG, 2011, J BIOL CHEM, V286, P39882, DOI 10.1074/jbc.M111.281675; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Muller V, 2005, J MOL MICROB BIOTECH, V10, P167, DOI 10.1159/000091563; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Pisa KY, 2007, FEMS MICROBIOL LETT, V277, P56, DOI 10.1111/j.1574-6968.2007.00939.x; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SPRUTH M, 1995, BBA-BIOENERGETICS, V1229, P96, DOI 10.1016/0005-2728(94)00192-8; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	50	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6994	7002		10.1074/jbc.M114.616862	http://dx.doi.org/10.1074/jbc.M114.616862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25593316	hybrid, Green Published			2022-12-28	WOS:000350991500033
J	Nowak, G; Bakajsova, D				Nowak, Grazyna; Bakajsova, Diana			Protein Kinase C-alpha Interaction with F0F1-ATPase Promotes F0F1-ATPase Activity and Reduces Energy Deficits in Injured Renal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ATP SYNTHASE; OXIDATIVE-PHOSPHORYLATION; FOCUSED PROTEOMICS; NA+ TRANSPORT; DELTA-SUBUNIT; BETA-SUBUNIT; F1F0 ATPASE; ACTIVATION; ACID; METABOLISM	We showed previously that active PKC-alpha maintains F0F1-ATPase activity, whereas inactive PKC-alpha mutant (dnPKC-alpha) blocks recovery of F0F1-ATPase activity after injury in renal proximal tubules (RPTC). This study tested whether mitochondrial PKC-alpha interacts with and phosphorylates F0F1-ATPase. Wild-type PKC-alpha (wtPKC-alpha) and dnPKC-alpha were overexpressed in RPTC to increase their mitochondrial levels, and RPTC were exposed to oxidant or hypoxia. Mitochondrial levels of the gamma-subunit, but not the alpha- and beta-subunits, were decreased by injury, an event associated with 54% inhibition of F0F1-ATPase activity. Overexpressing wtPKC-alpha blocked decreases in gamma-subunit levels, maintained F0F1-ATPase activity, and improved ATP levels after injury. Deletion of PKC-alpha decreased levels of alpha-, beta-, and gamma-subunits, decreased F0F1-ATPase activity, and hindered the recovery of ATP content after RPTC injury. Mitochondrial PKC-alpha co-immunoprecipitated with alpha-, beta-, and gamma-subunits of F0F1-ATPase. The association of PKC-alpha with these subunits decreased in injured RPTC overexpressing dnPKC-alpha. Immunocapture of F0F1-ATPase and immunoblotting with phospho(Ser) PKC substrate antibody identified phosphorylation of serine in the PKC consensus site on the alpha- or beta- and gamma-subunits. Overexpressing wtPKC-alpha increased phosphorylation and protein levels, whereas deletion of PKC-alpha decreased protein levels of alpha-, beta-, and gamma-subunits of F0F1-ATPase in RpTc. Phosphoproteomics revealed phosphorylation of Ser(146) on the gamma subunit in response to wtPKC-alpha overexpression. We concluded that active PKC-alpha 1) prevents injury-induced decreases in levels of gamma subunit of F0F1-ATPase, 2) interacts with alpha-, beta-, and gamma-subunits leading to increases in their phosphorylation, and 3) promotes the recovery of F0F1-ATPase activity and ATP content after injury in RPTC.	[Nowak, Grazyna; Bakajsova, Diana] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Coll Pharm, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Nowak, G (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, 4301 West Markham St, Little Rock, AR 72205 USA.	gnowak@uams.edu			National Institutes of Health [R01 DK059558, UL1 RR029884]; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK059558 (to G. N.) and UL1 RR029884, from the National Center for Research Resources, which provided partial funding for the Proteomic Core Facility at the University of Arkansas for Medical Sciences Translational Research Institute.	Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; Arrell DK, 2006, CIRC RES, V99, P706, DOI 10.1161/01.RES.0000243995.74395.f8; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Boja ES, 2009, J PROTEOME RES, V8, P4665, DOI 10.1021/pr900387b; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Covian R, 2012, AM J PHYSIOL-HEART C, V303, pH940, DOI 10.1152/ajpheart.00077.2012; Di Pancrazio F, 2006, PROTEOMICS, V6, P921, DOI 10.1002/pmic.200500077; Fujisawa Y, 2009, BIOCHEM J, V423, P219, DOI 10.1042/BJ20090594; Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Kane L, 2006, PROTEOMICS, V6, P5683, DOI 10.1002/pmic.200600267; Kane LA, 2010, CIRC RES, V106, P504, DOI 10.1161/CIRCRESAHA.109.214155; Ko YH, 2002, MITOCHONDRION, V1, P339, DOI 10.1016/S1567-7249(01)00036-8; Kowalczyk JE, 2012, MITOCHONDRION, V12, P138, DOI 10.1016/j.mito.2011.06.002; Law RHP, 1995, METHOD ENZYMOL, V260, P133, DOI 10.1016/0076-6879(95)60135-X; Liu XL, 2004, AM J PHYSIOL-RENAL, V287, pF64, DOI 10.1152/ajprenal.00216.2003; Murray J, 2004, BBA-BIOENERGETICS, V1659, P206, DOI 10.1016/j.bbabio.2004.07.005; Murray J, 2004, ELECTROPHORESIS, V25, P2520, DOI 10.1002/elps.200406006; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Nowak G, 2004, TOXICOL LETT, V147, P161, DOI 10.1016/j.toxlet.2003.11.002; Nowak G, 2003, AM J PHYSIOL-RENAL, V285, pF440, DOI 10.1152/ajprenal.00233.2002; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; NOWAK G, 1995, AM J PHYSIOL-CELL PH, V268, pC1053, DOI 10.1152/ajpcell.1995.268.4.C1053; Nowak G, 1996, AM J PHYSIOL-CELL PH, V271, pC2072, DOI 10.1152/ajpcell.1996.271.6.C2072; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; Nowak G, 2013, AM J PHYSIOL-RENAL, V305, pF764, DOI 10.1152/ajprenal.00061.2013; Nowak G, 2012, AM J PHYSIOL-RENAL, V303, pF515, DOI 10.1152/ajprenal.00072.2012; Phillips D, 2011, BIOCHEMISTRY-US, V50, P2515, DOI 10.1021/bi101434x; Porter MJ, 2003, AM J PHYSIOL-CELL PH, V285, pC39, DOI 10.1152/ajpcell.00461.2002; Saraswathy S, 2011, MOL VIS, V17, P1814; Shaik ZP, 2007, AM J PHYSIOL-RENAL, V292, pF292, DOI 10.1152/ajprenal.00082.2006; Signorile A, 2014, BBA-MOL CELL RES, V1843, P675, DOI 10.1016/j.bbamcr.2013.12.017; Sugawara K, 2013, FEBS LETT, V587, P3843, DOI 10.1016/j.febslet.2013.10.012; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Yang LF, 2010, BIOCHEM BIOPH RES CO, V400, P16, DOI 10.1016/j.bbrc.2010.07.126; Yarian CS, 2005, BIOCHEM BIOPH RES CO, V330, P151, DOI 10.1016/j.bbrc.2005.02.135; ZHANG FX, 1995, J NEUROCHEM, V65, P2812	41	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7054	7066		10.1074/jbc.M114.588244	http://dx.doi.org/10.1074/jbc.M114.588244			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627689	Green Published, hybrid			2022-12-28	WOS:000350991500038
J	Williams, AS; Kang, L; Zheng, J; Grueter, C; Bracy, DP; James, FD; Pozzi, A; Wasserman, DH				Williams, Ashley S.; Kang, Li; Zheng, Jenny; Grueter, Carrie; Bracy, Deanna P.; James, Freyja D.; Pozzi, Ambra; Wasserman, David H.			Integrin alpha 1-null Mice Exhibit Improved Fatty Liver When Fed a High Fat Diet Despite Severe Hepatic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ENDOGENOUS GLUCOSE-PRODUCTION; TYROSINE-PHOSPHATASE; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; EXTRACELLULAR-MATRIX; RECEPTOR SUBSTRATE-1; DIABETES-MELLITUS; CROSS-TALK; DISEASE	Hepatic insulin resistance is associated with increased collagen. Integrin alpha 1 beta 1 is a collagen-binding receptor expressed on hepatocytes. Here, we show that expression of the alpha 1 subunit is increased in hepatocytes isolated from high fat (HF)-fed mice. To determine whether the integrin al subunit protects against impairments in hepatic glucose metabolism, we analyzed glucose tolerance and insulin sensitivity in Ft-F.-fed integrin alpha 1-null (itgal(-/-)) and wild-type (itga1(+/+)) littermates. Using the insulin clamp, we found that insulin-stimulated hepatic glucose production was suppressed by similar to 50% in HF-fed itgal(+/+) mice. In contrast, it was not suppressed in HF-fed itga1(-/-) mice, indicating severe hepatic insulin resistance. This was associated with decreased hepatic insulin signaling in FIF-fed itgal(-/-) mice. Interestingly, hepatic triglyceride and diglyceride contents were normalized to chow-fed levels in FIF-fed itgal(-/-) mice. This indicates that hepatic steatosis is dissociated from insulin resistance in FIF-fed itgal(-/-) mice. The decrease in hepatic lipid accumulation in HF-fed itgal-1- mice was associated with altered free fatty acid metabolism. These studies establish a role for integrin signaling in facilitating hepatic insulin action while promoting lipid accumulation in mice challenged with a HF diet.	[Williams, Ashley S.; Kang, Li; Zheng, Jenny; Bracy, Deanna P.; James, Freyja D.; Pozzi, Ambra; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Grueter, Carrie] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37232 USA; [Pozzi, Ambra] Vanderbilt Univ, Div Nephrol, Dept Med, Nashville, TN 37232 USA; [Wasserman, David H.] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA; [Pozzi, Ambra] Dept Vet Affairs, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Williams, AS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	ashley.s.williams@vanderbilt.edu		Kang, Li/0000-0002-6990-1996; Grueter, Carrie/0000-0002-1913-2527	National Institutes of Health [R37 DK050277, R01 DK054902, U24 DK059637, R01 DK095761, DK20593]; Veterans Affairs Merit Review [1I01BX002025-01]; Vanderbilt Molecular Endocrinology Training Program; NATIONAL CANCER INSTITUTE [R01CA162433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095761, P60DK020593, R37DK050277, P30DK020593, U24DK059637, R01DK054902] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Vanderbilt Molecular Endocrinology Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R37 DK050277, R01 DK054902, and U24 DK059637 (to D. H. W.); Grant R01 DK095761 (to A. P.); and Grant DK20593 (to the Vanderbilt Diabetes Research and Training Center). This work was also supported by Veterans Affairs Merit Review 1I01BX002025-01 (to A. P.) and the Vanderbilt Molecular Endocrinology Training Program.	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Bisht B, 2008, J PHYSIOL-LONDON, V586, P3825, DOI 10.1113/jphysiol.2008.157107; Buque X, 2012, AM J PHYSIOL-ENDOC M, V303, pE504, DOI 10.1152/ajpendo.00653.2011; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen XW, 2007, MOL CELL BIOL, V27, P3313, DOI 10.1128/MCB.01476-06; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DeFronzo RA, 1996, J DIABETES COMPLICAT, V10, P243, DOI 10.1016/1056-8727(96)00046-3; Dixon LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056100; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; FINEGOOD DT, 1988, DIABETES, V37, P1025, DOI 10.2337/diabetes.37.8.1025; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Guilherme A, 1998, J BIOL CHEM, V273, P22899, DOI 10.1074/jbc.273.36.22899; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jaskiewicz K, 2008, DIGEST DIS SCI, V53, P785, DOI 10.1007/s10620-007-9942-x; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Lebrun P, 1998, J BIOL CHEM, V273, P32244, DOI 10.1074/jbc.273.48.32244; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loster K, 2001, BIOCHEM J, V356, P233, DOI 10.1042/0264-6021:3560233; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; MORRISON WR, 1964, J LIPID RES, V5, P600; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; MURTHY VK, 1979, DIABETES, V28, P472, DOI 10.2337/diab.28.5.472; Nejjari M, 2001, J PATHOL, V195, P473, DOI 10.1002/path.964; PEHLING G, 1984, J CLIN INVEST, V74, P985, DOI 10.1172/JCI111519; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Shi M, 2012, J BIOL CHEM, V287, P35139, DOI 10.1074/jbc.M112.358648; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Summers S. A., 2000, INT J OBES RELAT MET, V24; Tonelli J, 2005, CURR OPIN CLIN NUTR, V8, P450, DOI 10.1097/01.mco.0000172588.47811.63; VOLPES R, 1991, GASTROENTEROLOGY, V101, P200, DOI 10.1016/0016-5085(91)90478-4; Vulin AI, 2005, ENDOCRINOLOGY, V146, P3535, DOI 10.1210/en.2004-1386; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; Wada T, 2013, AM J PHYSIOL-ENDOC M, V305, pE1415, DOI 10.1152/ajpendo.00419.2013; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Zong HH, 2009, J BIOL CHEM, V284, P4679, DOI 10.1074/jbc.M807408200	55	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6546	6557		10.1074/jbc.M114.615716	http://dx.doi.org/10.1074/jbc.M114.615716			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593319	Green Published, hybrid			2022-12-28	WOS:000350732500057
J	Hayer, SN; Bading, H				Hayer, Stefanie N.; Bading, Hilmar			Nuclear Calcium Signaling Induces Expression of the Synaptic Organizers Lrrtm1 and Lrrtm2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT TRANSMEMBRANE PROTEINS; GENE-EXPRESSION; NMDA RECEPTORS; REVERSIBLE INHIBITION; TRANSCRIPTION FACTORS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; CELL-DEATH; CREB; FAMILY	Calcium transients in the cell nucleus evoked by synaptic activity in hippocampal neurons function as a signaling end point in synapse-to-nucleus communication. As an important regulator of neuronal gene expression, nuclear calcium is involved in the conversion of synaptic stimuli into functional and structural changes of neurons. Here we identify two synaptic organizers, Lrrtm1 and Lrrtm2, as targets of nuclear calcium signaling. Expression of both Lrrtm1 and Lrrtm2 increased in a synaptic NMDA receptor- and nuclear calcium-dependent manner in hippocampal neurons within 2-4 h after the induction of action potential bursting. Induction of Lrrtm1 and Lrrtm2 occurred independently of the need for new protein synthesis and required calcium/calmodulin-dependent protein kinases and the nuclear calcium signaling target CREB-binding protein. Analysis of reporter gene constructs revealed a functional cAMP response element in the proximal promoter of Lrrtm2, indicating that at least Lrrtm2 is regulated by the classical nuclear Ca2+ /calmodulin-dependent protein kinase IV-CREB/CREB-binding protein pathway. These results suggest that one mechanism by which nuclear calcium signaling controls neuronal network function is by regulating the expression of Lrrtm1 and Lrrtm2.	[Hayer, Stefanie N.; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, INF 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de						ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bengtson CP, 2010, BIOPHYS J, V99, P4066, DOI 10.1016/j.bpj.2010.10.044; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Kleffmann W, 2012, MOL SYNDROMOL, V3, P68, DOI 10.1159/000341252; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Ludwig KU, 2009, MOL PSYCHIATR, V14, P743, DOI 10.1038/mp.2009.28; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; McNulty SE, 2012, LEARN MEMORY, V19, P588, DOI 10.1101/lm.026385.112; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; OFIR R, 1991, GENE EXPRESSION, V1, P55; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Sepp M, 2012, HUM MOL GENET, V21, P2873, DOI 10.1093/hmg/dds112; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; SIHRA TS, 1995, NEUROPHARMACOLOGY, V34, P731, DOI 10.1016/0028-3908(95)00051-7; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Soler-Llavina GJ, 2013, NEURON, V79, P439, DOI 10.1016/j.neuron.2013.06.007; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; Weislogel JM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003598; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	71	3	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5523	5532		10.1074/jbc.M113.532010	http://dx.doi.org/10.1074/jbc.M113.532010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25527504	Green Published, hybrid			2022-12-28	WOS:000350044200024
J	Wang, HM; Yan, Q; Yang, T; Cheng, H; Du, J; Yoshioka, K; Kung, SKP; Ding, GH				Wang, Hui-ming; Yan, Qi; Yang, Tao; Cheng, Hui; Du, Juan; Yoshioka, Katsuji; Kung, Sam K. P.; Ding, Guo-hua			Scaffold Protein JLP Is Critical for CD40 Signaling in B Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; ENDOTHELIAL-CELLS; RAB PROTEINS; ACTIVATION; KINESIN; RECEPTOR; KINASE; JNK	CD40 expression on the surface of B lymphocytes is essential for their biological function and fate decision. The engagement of CD40 with its cognate ligand, CD154, leads to a sequence of cellular events in B lymphocytes, including CD40 cytoplasmic translocation, a temporal and spatial organization of effector molecules, and a cascade of CD40-induced signal transduction. The JLP scaffold protein was expressed in murine B lymphocytes. Using B lymphocytes from jlp-deficient mice, we observed that JLP deficiency resulted in defective CD40 internalization upon CD154/CD40 engagement. Examination of interactions and co-localization among CD40, JLP, dynein, and Rab5 in B lymphocytes suggested that CD40 internalization is a process of JLP-mediated vesicle transportation that depends on Rab5 and dynein. JLP deficiency also diminished CD40-dependent activation of MAPK and JNK, but not NF-kappa B. Inhibiting vesicle transportation from the direction of cell periphery to the cell center by a dynein inhibitor (ciliobrevin D) impaired both CD154-induced CD40 internalization and CD40-dependent MAPK activities in B lymphocytes. Collectively, our data demonstrate a novel role of the JLP scaffold protein in the bridging of CD154-triggered CD40 internalization and CD40-dependent signaling in splenic B lymphocytes.	[Wang, Hui-ming; Yan, Qi; Yang, Tao; Cheng, Hui; Du, Juan; Ding, Guo-hua] Wuhan Univ, Renmin Hosp, Dept Nephrol, Wuhan 430060, Peoples R China; [Kung, Sam K. P.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3T 2N2, Canada; [Yoshioka, Katsuji] Kanazawa Univ, Canc Res Inst, Dept Mol & Cellular Biol, Div Mol Cell Signaling, Kanazawa, Ishikawa 9200934, Japan	Wuhan University; University of Manitoba; Kanazawa University	Wang, HM (corresponding author), Wuhan Univ, Renmin Hosp, Dept Nephrol, Wuhan 430060, Peoples R China.	wanghuimingwhm@yahoo.com; ghxding@gmail.com	Wang, Huiming/AAU-8981-2021	Wang, Huiming/0000-0002-1706-2342; Wang, Huiming/0000-0002-9344-4609	National Natural Science Foundation of China [81172793, 81370800]; Chongqing Science and Technology Community of Chongqing City [2011BB5028]; Independent Research Project of Wuhan University; National Key Technology R&D Program of China [2011BA110B04]; Canadian Institutes of Health Research/Manitoba Health Research Council Regional Partnership Program Operating Grant [109761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Community of Chongqing City; Independent Research Project of Wuhan University; National Key Technology R&D Program of China(National Key Technology R&D Program); Canadian Institutes of Health Research/Manitoba Health Research Council Regional Partnership Program Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by National Natural Science Foundation of China Grants 81172793 and 81370800, Chongqing Science and Technology Community of Chongqing City Grant 2011BB5028, the Independent Research Project of Wuhan University, and National Key Technology R&D Program of China Grant 2011BA110B04 (to H. W.) and by Canadian Institutes of Health Research/Manitoba Health Research Council Regional Partnership Program Operating Grant 109761 (to S. K. P. K.).	Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chen JJ, 2007, ARTERIOSCL THROM VAS, V27, P2005, DOI 10.1161/ATVBAHA.107.145961; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Clippinger AJ, 2012, GENE DEV, V26, P2015, DOI 10.1101/gad.196147.112; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Iwanaga A, 2008, TRANSGENIC RES, V17, P1045, DOI 10.1007/s11248-008-9191-6; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kashef K, 2005, BIOCHEMISTRY-US, V44, P14090, DOI 10.1021/bi050604l; Kashef K, 2006, J CELL BIOCHEM, V98, P715, DOI 10.1002/jcb.20930; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kikkawa M, 2013, J CELL BIOL, V202, P15, DOI 10.1083/jcb.201304099; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Li YY, 1996, J IMMUNOL, V157, P1440; Manning E, 2002, EUR J IMMUNOL, V32, P39, DOI 10.1002/1521-4141(200201)32:1<39::AID-IMMU39>3.0.CO;2-Y; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; Nadiri A, 2011, EUR J IMMUNOL, V41, P2358, DOI 10.1002/eji.201041143; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Reyes-Moreno C, 2007, J BIOL CHEM, V282, P19473, DOI 10.1074/jbc.M701076200; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Sakata N, 1995, J BIOL CHEM, V270, P30823, DOI 10.1074/jbc.270.51.30823; Schnyder T, 2011, IMMUNITY, V34, P905, DOI 10.1016/j.immuni.2011.06.001; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sutherland CL, 1996, J IMMUNOL, V157, P3381; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wang HM, 2013, IMMUNOBIOLOGY, V218, P835, DOI 10.1016/j.imbio.2012.10.002; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	44	11	16	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5256	5266		10.1074/jbc.M114.618496	http://dx.doi.org/10.1074/jbc.M114.618496			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25586186	Green Published, hybrid			2022-12-28	WOS:000350044200003
J	Jarrett, JT				Jarrett, Joseph T.			The Biosynthesis of Thiol- and Thioether-containing Cofactors and Secondary Metabolites Catalyzed by Radical S-Adenosylmethionine Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COLI BIOTIN SYNTHASE; CLUSTER BINDING-SITES; ESCHERICHIA-COLI; LIPOYL SYNTHASE; TRANSFER-RNA; 4FE-4S CLUSTERS; BOND FORMATION; OCTANOYL SUBSTRATE; SULFUR INSERTION; 2FE-2S CLUSTER	Sulfur atoms are present as thiol and thioether functional groups in amino acids, coenzymes, cofactors, and various products of secondary metabolic pathways. The biosynthetic pathways for several sulfur-containing biomolecules require the substitution of sulfur for hydrogen at unreactive aliphatic or electron-rich aromatic carbon atoms. Examples discussed in this review include biotin, lipoic acid, methylthioether modifications found in some nucleic acids and proteins, and thioether cross-links found in peptide natural products. Radical S-adenosyl-L-methionine (SAM) enzymes use an iron-sulfur cluster to catalyze the reduction of SAM to methionine and a highly reactive 5'-deoxyadenosyl radical; this radical can abstract hydrogen atoms at unreactive positions, facilitating the introduction of a variety of functional groups. Radical SAM enzymes that catalyze sulfur insertion reactions contain a second iron-sulfur cluster that facilitates the chemistry, either by donating the cluster's endogenous sulfide or by binding and activating exogenous sulfide or sulfur-containing substrates. The use of radical chemistry involving iron-sulfur clusters is an efficient anaerobic route to the generation of carbon-sulfur bonds in cofactors, secondary metabolites, and other natural products.	Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Jarrett, JT (corresponding author), Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA.	jtj@hawaii.edu		Jarrett, Joseph/0000-0002-3737-7464	National Science Foundation (NSF) [MCB 09-23829]; Div Of Molecular and Cellular Bioscience [1244632] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) Grant MCB 09-23829. This is the second article in the Thematic Minireview series Radical SAM Enzymes.	Aitken SM, 2005, ARCH BIOCHEM BIOPHYS, V433, P166, DOI 10.1016/j.abb.2004.08.024; Anton BP, 2008, P NATL ACAD SCI USA, V105, P1826, DOI 10.1073/pnas.0708608105; Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Bryant P, 2006, ANAL BIOCHEM, V351, P44, DOI 10.1016/j.ab.2006.01.023; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Cosper MM, 2004, BIOCHEMISTRY-US, V43, P2007, DOI 10.1021/bi0356653; Dey A, 2011, J AM CHEM SOC, V133, P18656, DOI 10.1021/ja203780t; Douglas P, 2006, ANGEW CHEM INT EDIT, V45, P5197, DOI 10.1002/anie.200601910; Emsley J., 1998, ELEMENTS, V3rd; Escalettes F, 1999, J AM CHEM SOC, V121, P3571, DOI 10.1021/ja9811748; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, CURR OPIN CHEM BIOL, V17, P605, DOI 10.1016/j.cbpa.2013.06.031; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Forouhar F, 2013, NAT CHEM BIOL, V9, P333, DOI [10.1038/NCHEMBIO.1229, 10.1038/nchembio.1229]; Fugate CJ, 2012, BBA-PROTEINS PROTEOM, V1824, P1213, DOI 10.1016/j.bbapap.2012.01.010; Fugate CJ, 2012, J AM CHEM SOC, V134, P9042, DOI 10.1021/ja3012963; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Huxtable R.J., 2013, BIOCH SULFUR BIOCH E; Jameson GNL, 2004, BIOCHEMISTRY-US, V43, P2022, DOI 10.1021/bi035666v; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; Landgraf BJ, 2013, J AM CHEM SOC, V135, P15404, DOI 10.1021/ja4048448; Lanz ND, 2014, BIOCHEMISTRY-US, V53, P4557, DOI 10.1021/bi500432r; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Marquet A, 2001, VITAM HORM, V61, P51; Pierrel F, 2003, J BIOL CHEM, V278, P29515, DOI 10.1074/jbc.M301518200; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Reyda MR, 2009, BIOCHEMISTRY-US, V48, P10782, DOI 10.1021/bi901393t; Shaw NM, 1998, BIOCHEM J, V330, P1079; Taylor AM, 2008, BIOCHEMISTRY-US, V47, P9309, DOI 10.1021/bi801035b; Taylor AM, 2011, BIOCHEMISTRY-US, V50, P7953, DOI 10.1021/bi201042r; Ugulava NB, 2002, J AM CHEM SOC, V124, P9050, DOI 10.1021/ja027004j; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8352, DOI 10.1021/bi010463x; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8343, DOI 10.1021/bi0104625; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	41	45	45	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3972	3979		10.1074/jbc.R114.599308	http://dx.doi.org/10.1074/jbc.R114.599308			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25477512	hybrid, Green Published			2022-12-28	WOS:000349458400009
J	Phuyal, S; Skotland, T; Hessvik, NP; Simolin, H; Overbye, A; Brech, A; Parton, RG; Ekroos, K; Sandvig, K; Llorente, A				Phuyal, Santosh; Skotland, Tore; Hessvik, Nina Pettersen; Simolin, Helena; Overbye, Anders; Brech, Andreas; Parton, Robert G.; Ekroos, Kim; Sandvig, Kirsten; Llorente, Alicia			The Ether Lipid Precursor Hexadecylglycerol Stimulates the Release and Changes the Composition of Exosomes Derived from PC-3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT; EXTRACELLULAR VESICLES; ETHANOLAMINE PLASMALOGEN; MULTIVESICULAR BODIES; MOLECULAR LIPIDOMICS; CHOLESTEROL; SECRETION; PLASMENYLETHANOLAMINE; PHOSPHOLIPIDS	Exosomes are vesicles released by cells after fusion of multi-vesicular bodies with the plasma membrane. In this study, we have investigated whether ether lipids affect the release of exosomes in PC-3 cells. To increase the cellular levels of ether lipids, the ether lipid precursor hexadecylglycerol was added to cells. Lipidomic analysis showed that this compound was in fact able to double the cellular levels of ether lipids in these cells. Furthermore, increased levels of ether lipids were also found in exosomes released by cells containing high levels of these lipids. Interestingly, as measured by nanoparticle tracking analysis, cells containing high levels of ether lipids released more exosomes than control cells, and these exosomes were similar in size to control exosomes. Moreover, silver staining and Western blot analyses showed that the protein composition of exosomes released in the presence of hexadecylglycerol was changed; the levels of some proteins were increased, and the levels of others were reduced. In conclusion, this study clearly shows that an increase in cellular ether lipids is associated with changes in the release and composition of exosomes.	[Phuyal, Santosh; Skotland, Tore; Hessvik, Nina Pettersen; Overbye, Anders; Brech, Andreas; Sandvig, Kirsten; Llorente, Alicia] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Biochem, N-0379 Oslo, Norway; [Phuyal, Santosh; Skotland, Tore; Hessvik, Nina Pettersen; Overbye, Anders; Brech, Andreas; Sandvig, Kirsten; Llorente, Alicia] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0379 Oslo, Norway; [Simolin, Helena; Ekroos, Kim] Zora Biosci Oy, Espoo 02150, Finland; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4067, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4067, Australia; [Sandvig, Kirsten] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	University of Oslo; University of Oslo; University of Queensland; University of Queensland; University of Oslo	Llorente, A (corresponding author), Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Biochem, N-0379 Oslo, Norway.	Alicia.Martinez.Llorente@rr-research.no	Llorente, Alicia/AAP-7349-2021; Parton, Robert/C-5673-2009	Llorente, Alicia/0000-0002-0045-071X; Brech, Andreas/0000-0002-9803-1774; Parton, Robert/0000-0002-7494-5248	Norwegian Cancer Society; South-Eastern Norway Regional Health Authority; Research Council of Norway through its Centres of Excellence [179571]; National Health and Medical Research Council of Australia [1045092, 1058565]	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; Research Council of Norway through its Centres of Excellence(Research Council of Norway); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Norwegian Cancer Society, the South-Eastern Norway Regional Health Authority, The Research Council of Norway through its Centres of Excellence funding scheme, Project Number 179571, and by Grant 1045092 and Fellowship 1058565 (to R. G. P.) from the National Health and Medical Research Council of Australia.	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bergan J, 2014, CELL MOL LIFE SCI, V71, P4285, DOI 10.1007/s00018-014-1624-1; Bergan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075904; Biermann J, 1999, IUBMB LIFE, V48, P635, DOI 10.1080/152165499306531; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; Broniec A, 2011, FREE RADICAL BIO MED, V50, P892, DOI 10.1016/j.freeradbiomed.2011.01.002; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Edgar JR, 2014, TRAFFIC, V15, P197, DOI 10.1111/tra.12139; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Farooqui AA, 2010, MOL NEUROBIOL, V41, P267, DOI 10.1007/s12035-009-8091-y; GLASER PE, 1994, BIOCHEMISTRY-US, V33, P5805, DOI 10.1021/bi00185a019; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Hahnel D, 1999, FREE RADICAL BIO MED, V27, P1087, DOI 10.1016/S0891-5849(99)00142-2; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Hossain MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083508; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Huybrechts SJ, 2009, TRAFFIC, V10, P1722, DOI 10.1111/j.1600-0854.2009.00970.x; Jung HR, 2011, BBA-MOL CELL BIOL L, V1811, P925, DOI 10.1016/j.bbalip.2011.06.025; Kuczynski B, 2006, NEUROCHEM RES, V31, P639, DOI 10.1007/s11064-006-9061-7; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; LOHNER K, 1991, BIOCHIM BIOPHYS ACTA, V1061, P132, DOI 10.1016/0005-2736(91)90277-F; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; MORAND OH, 1988, J BIOL CHEM, V263, P11597; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Phuyal S, 2014, FEBS J, V281, P2214, DOI 10.1111/febs.12775; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Sandvig K, 2014, PROG LIPID RES, V54, P1, DOI 10.1016/j.plipres.2014.01.001; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zhan YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077387; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769; Zoeller RA, 2002, AM J PHYSIOL-HEART C, V283, pH671, DOI 10.1152/ajpheart.00524.2001	53	70	70	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4225	4237		10.1074/jbc.M114.593962	http://dx.doi.org/10.1074/jbc.M114.593962			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25519911	Green Published, hybrid			2022-12-28	WOS:000349458400033
J	Saitoh, Y; Fujikake, N; Okamoto, Y; Popiel, HA; Hatanaka, Y; Ueyama, M; Suzuki, M; Gaumer, S; Murata, M; Wada, K; Nagai, Y				Saitoh, Yuji; Fujikake, Nobuhiro; Okamoto, Yuma; Popiel, H. Akiko; Hatanaka, Yusuke; Ueyama, Morio; Suzuki, Mari; Gaumer, Sebastien; Murata, Miho; Wada, Keiji; Nagai, Yoshitaka			p62 Plays a Protective Role in the Autophagic Degradation of Polyglutamine Protein Oligomers in Polyglutamine Disease Model Flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; INCLUSION-BODY FORMATION; MUTANT HUNTINGTIN; IN-VITRO; DROSOPHILA; EXPANSIONS; EXPRESSION; MECHANISM; TAU; NEURODEGENERATION	Oligomer formation and accumulation of pathogenic proteins are key events in the pathomechanisms of many neurodegenerative diseases, such as Alzheimer disease, ALS, and the polyglutamine (polyQ) diseases. The autophagy-lysosome degradation system may have therapeutic potential against these diseases because it can degrade even large oligomers. Although p62/sequestosome 1 plays a physiological role in selective autophagy of ubiquitinated proteins, whether p62 recognizes and degrades pathogenic proteins in neurodegenerative diseases has remained unclear. In this study, to elucidate the role of p62 in such pathogenic conditions in vivo, we used Drosophila models of neurodegenerative diseases. We found that p62 predominantly co-localizes with cytoplasmic polyQ protein aggregates in the MJDtr-Q78 polyQ disease model flies. Loss of p62 function resulted in significant exacerbation of eye degeneration in these flies. Immunohistochemical analyses revealed enhanced accumulation of cytoplasmic aggregates by p62 knockdown in the MJDtr-Q78 flies, similarly to knockdown of autophagy-related genes (Atgs). Knockdown of both p62 and Atgs did not show any additive effects in the MJDtr-Q78 flies, implying that p62 function is mediated by autophagy. Biochemical analyses showed that loss of p62 function delays the degradation of the MJDtr-Q78 protein, especially its oligomeric species. We also found that loss of p62 function exacerbates eye degeneration in another polyQ disease fly model as well as in ALS model flies. We therefore conclude that p62 plays a protective role against polyQ-induced neurodegeneration, by the autophagic degradation of polyQ protein oligomers in vivo, indicating its therapeutic potential for the polyQ diseases and possibly for other neurodegenerative diseases.	[Saitoh, Yuji; Fujikake, Nobuhiro; Okamoto, Yuma; Popiel, H. Akiko; Hatanaka, Yusuke; Ueyama, Morio; Suzuki, Mari; Wada, Keiji; Nagai, Yoshitaka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Saitoh, Yuji; Murata, Miho] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Kodaira, Tokyo 1878551, Japan; [Saitoh, Yuji; Murata, Miho] Chiba Univ, Grad Sch Med & Pharmaceut Sci, Chuo Ku, Chiba 2608670, Japan; [Gaumer, Sebastien] Univ Versailles St Quentin En Yvelines, Lab Genet & Biol Cellulaire, Ecole Prat Hautes Etud, EA4589, F-78035 Versailles, France; [Nagai, Yoshitaka] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Chiba University; UDICE-French Research Universities; Universite Paris Saclay; Japan Science & Technology Agency (JST)	Nagai, Y (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.	nagai@ncnp.go.jp	Saitoh, Yuji/AAC-9090-2020	Saitoh, Yuji/0000-0002-0919-429X; Ueyama, Morio/0000-0002-2950-7361	Japan Society for the Promotion of Science (JSPS), Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Health Labor Sciences Research Grants for Research on Development of New Drugs from the Ministry of Health, Labor, and Welfare, Japan; Research Committee for Ataxic Diseases from the Ministry of Health, Labor, and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25110741] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labor Sciences Research Grants for Research on Development of New Drugs from the Ministry of Health, Labor, and Welfare, Japan; Research Committee for Ataxic Diseases from the Ministry of Health, Labor, and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (to Y. N.) from the Japan Society for the Promotion of Science (JSPS), Japan; by Grants-in-Aid for Scientific Research on Priority Areas (Proteolysis) (to Y. N.) and on Innovative Areas (Synapse and Neurocircuit Pathology) (to Y. N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by Health Labor Sciences Research Grants for Research on Development of New Drugs and the Research Committee for Ataxic Diseases (to Y. N.) from the Ministry of Health, Labor, and Welfare, Japan; and by a grant from Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (to Y. N.).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Doi H, 2013, J NEUROSCI, V33, P7710, DOI 10.1523/JNEUROSCI.3021-12.2013; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuusisto E, 2008, NEUROPATH APPL NEURO, V34, P169, DOI 10.1111/j.1365-2990.2007.00884.x; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lee MJ, 2013, PROG NEUROBIOL, V105, P49, DOI 10.1016/j.pneurobio.2013.03.001; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Menzies FM, 2015, CELL DEATH DIFFER, V22, P433, DOI 10.1038/cdd.2014.151; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Roman G, 2002, GENESIS, V34, P127, DOI 10.1002/gene.10133; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Sontag EM, 2012, J HUNTINGTONS DIS, V1, P119, DOI 10.3233/JHD-2012-129004; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Ueyama M, 2008, J BIOL CHEM, V283, P6076, DOI 10.1074/jbc.M709189200; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; WYERS F, 1995, J VIROL, V69, P4463, DOI 10.1128/JVI.69.7.4463-4470.1995; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113	45	40	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1442	1453		10.1074/jbc.M114.590281	http://dx.doi.org/10.1074/jbc.M114.590281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25480790	hybrid, Green Published			2022-12-28	WOS:000348056400014
J	Ren, AX; Moon, C; Zhang, WQ; Sinha, C; Yarlagadda, S; Arora, K; Wang, XS; Yue, JM; Parthasarathi, K; Heil-Chapdelaine, R; Tigyi, G; Naren, AP				Ren, Aixia; Moon, Changsuk; Zhang, Weiqiang; Sinha, Chandrima; Yarlagadda, Sunitha; Arora, Kavisha; Wang, Xusheng; Yue, Junming; Parthasarathi, Kaushik; Heil-Chapdelaine, Rick; Tigyi, Gabor; Naren, Anjaparavanda P.			Asymmetrical Macromolecular Complex Formation of Lysophosphatidic Acid Receptor 2 (LPA(2)) Mediates Gradient Sensing in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING EVENTS; LIVING CELLS; G-PROTEIN; PHOSPHOLIPASE-C; LEADING-EDGE; CHEMOTAXIS; DICTYOSTELIUM; MOBILITY; MIGRATION; POLARIZATION	Chemotactic migration of fibroblasts toward growth factors relies on their capacity to sense minute extracellular gradients and respond to spatially confined receptor-mediated signals. Currently, mechanisms underlying the gradient sensing of fibroblasts remain poorly understood. Using single-particle tracking methodology, we determined that a lysophosphatidic acid (LPA) gradient induces a spatiotemporally restricted decrease in the mobility of LPA receptor 2 (LPA(2)) on chemotactic fibroblasts. The onset of decreased LPA(2) mobility correlates to the spatial recruitment and coupling to LPA(2)-interacting proteins that anchor the complex to the cytoskeleton. These localized PDZ motif-mediated macromolecular complexes of LPA(2) trigger a Ca2+ puff gradient that governs gradient sensing and directional migration in response to LPA. Disruption of the PDZ motif-mediated assembly of the macromolecular complex of LPA(2) disorganizes the gradient of Ca2+ puffs, disrupts gradient sensing, and reduces the directional migration of fibroblasts toward LPA. Our findings illustrate that the asymmetric macromolecular complex formation of chemoattractant receptors mediates gradient sensing and provides a new mechanistic basis for models to describe gradient sensing of fibroblasts.	[Ren, Aixia; Moon, Changsuk; Zhang, Weiqiang; Sinha, Chandrima; Yarlagadda, Sunitha; Arora, Kavisha; Yue, Junming; Parthasarathi, Kaushik; Tigyi, Gabor; Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Moon, Changsuk; Yarlagadda, Sunitha; Arora, Kavisha; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Dept Pediat, Cincinnati, OH 45229 USA; [Zhang, Weiqiang] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38103 USA; [Wang, Xusheng] St Jude Childrens Res Hosp, Dept Struct Biol & Dev Neurobiol, Memphis, TN 38105 USA; [Heil-Chapdelaine, Rick] Olympus Amer Inc, Center Valley, PA 18034 USA	University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Olympus Corporation	Naren, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Dept Pediat, MLC2120 3333 Burnet Ave, Cincinnati, OH 45229 USA.	anaren@cchmc.org			National Institutes of Health [DK080834, DK093045, CA092160]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080834, R01DK093045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080834 and DK093045 (to A. P. N.) and CA092160 (to G. T.).	Ali GS, 2007, PLANT CELL PHYSIOL, V48, P1601, DOI 10.1093/pcp/pcm132; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cha I, 2010, MOL CELLS, V30, P563, DOI 10.1007/s10059-010-0153-5; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; de Keijzer S, 2008, J CELL SCI, V121, P1750, DOI 10.1242/jcs.030692; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; E SY, 2009, J BIOL CHEM, V284, P14558, DOI 10.1074/jbc.M900185200; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Hasegawa Y, 2008, MOL ONCOL, V2, P54, DOI 10.1016/j.molonc.2008.03.009; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Heringdorf DMZ, 2004, J CELL BIOCHEM, V92, P937, DOI 10.1002/jcb.20107; HILDEBRANDT JP, 1995, J MEMBRANE BIOL, V144, P49; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lee SJ, 2013, MOL CELL BIOL, V33, P2016, DOI 10.1128/MCB.00038-13; Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Lee-Kwon W, 2005, AM J PHYSIOL-CELL PH, V288, pC942, DOI 10.1152/ajpcell.00417.2004; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lin FT, 2008, BBA-MOL CELL BIOL L, V1781, P558, DOI 10.1016/j.bbalip.2008.04.013; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rubin H., 2002, J BIOL CHEM, V277; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Schwarz-Romond T, 2010, EMBO J, V29, P2675, DOI 10.1038/emboj.2010.185; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Sinha C, 2013, J BIOL CHEM, V288, P3786, DOI 10.1074/jbc.M112.435925; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Wei CL, 2010, CAN J PHYSIOL PHARM, V88, P105, DOI 10.1139/Y09-118; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wessels D, 2007, J CELL SCI, V120, P2517, DOI 10.1242/jcs.010876; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Xu XH, 2005, MOL BIOL CELL, V16, P676, DOI 10.1091/mbc.E04-07-0544; Xu XH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000980; Xu XH, 2009, METHODS MOL BIOL, V571, P371, DOI 10.1007/978-1-60761-198-1_25	61	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35757	35769		10.1074/jbc.M114.595512	http://dx.doi.org/10.1074/jbc.M114.595512			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25542932	Green Published, hybrid			2022-12-28	WOS:000346897900008
J	Zhang, FQ; Hao, F; An, D; Zeng, LL; Wang, Y; Xu, XM; Cui, MZ				Zhang, Fuqiang; Hao, Feng; An, Dong; Zeng, Linlin; Wang, Yi; Xu, Xuemin; Cui, Mei-Zhen			The Matricellular Protein Cyr61 Is a Key Mediator of Platelet-derived Growth Factor-induced Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FOCAL ADHESION KINASE; IMMEDIATE-EARLY GENE; PAXILLIN TYROSINE PHOSPHORYLATION; HEPARAN-SULFATE PROTEOGLYCANS; VEIN ENDOTHELIAL-CELLS; HUMAN SKIN FIBROBLASTS; PDGFR-BETA; INTEGRINS ALPHA(V)BETA(3); NEOINTIMAL HYPERPLASIA	Platelet-derived growth factor (PDGF), a potent chemoattractant, induces cell migration via the MAPK and PI3K/Akt pathways. However, the downstream mediators are still elusive. In particular, the role of extracellular mediators is largely unknown. In this study, we identified the matricellular protein Cyr61, which is de novo synthesized in response to PDGF stimulation, as the key downstream mediator of the ERK and JNK pathways, independent of the p38 MAPK and AKT pathways, and, thereby, it mediates PDGF-induced smooth muscle cell migration but not proliferation. Our results revealed that, when Cyr61 was newly synthesized by PDGF, it was promptly translocated to the extracellular matrix and physically interacted with the plasma membrane integrins alpha 6 beta 1 and alpha v beta 3. We further demonstrate that Cyr61 and integrins are integral components of the PDGF signaling pathway via an " outside-in" signaling route to activate intracellular focal adhesion kinase (FAK), leading to cell migration. Therefore, this study provides the first evidence that the PDGF-induced endogenous extracellular matrix component Cyr61 is a key mediator in modulating cell migration by connecting intracellular PDGF-ERK and JNK signals with integrin/FAK signaling. Therefore, extracellular Cyr61 convergencewithgrowthfactorsignalingandintegrin/FAKsignaling is a new concept of growth factor-induced cell migration. The discovered signaling pathway may represent an important therapeutic target in growth factor-mediated cell migration/invasionrelated vascular diseases and tumorigenesis.	[Zhang, Fuqiang; Hao, Feng; An, Dong; Zeng, Linlin; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Zhang, Fuqiang; Wang, Yi] Jilin Univ, Coll Pharm, Dept Regenerat Med, Changchun 130021, Peoples R China; [An, Dong] Jilin Univ, Coll Life Sci, Changchun 130021, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Jilin University; Jilin University	Cui, MZ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu	An, Dong/ABB-6635-2021	An, Dong/0000-0002-7770-2284; Cui, Mei-Zhen/0000-0003-4745-6999; xu, xuemin/0000-0002-7426-272X	National Institutes of Health [HL107466, AG026640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026640, R21AG039596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL107466 (to M.Z.C.) and AG026640 (to X.X.).	ABEDI H, 1995, J BIOL CHEM, V270, P11367, DOI 10.1074/jbc.270.19.11367; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bilato C, 1997, J CLIN INVEST, V100, P693, DOI 10.1172/JCI119582; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BROCK TA, 1985, HYPERTENSION, V7, pI105, DOI 10.1161/01.HYP.7.3_Pt_2.I105; Buetow BS, 2003, AM J PATHOL, V163, P979, DOI 10.1016/S0002-9440(10)63457-8; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Chai YC, 1996, J BIOL CHEM, V271, P17791, DOI 10.1074/jbc.271.30.17791; Changsirikulchai S, 2002, KIDNEY INT, V62, P2043, DOI 10.1046/j.1523-1755.2002.00662.x; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; CHEN HC, 1994, J BIOL CHEM, V269, P31229; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; CHOI ET, 1994, J VASC SURG, V19, P125, DOI 10.1016/S0741-5214(94)70127-X; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; Evanko SP, 1998, AM J PATHOL, V152, P533; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hilfiker A, 2002, CIRCULATION, V106, P254, DOI 10.1161/01.CIR.0000021426.87274.62; JACKSON CL, 1993, ARTERIOSCLER THROMB, V13, P1218, DOI 10.1161/01.ATV.13.8.1218; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Kappert K, 2001, BASIC RES CARDIOL, V96, P42, DOI 10.1007/s003950170076; KIRCHBERG K, 1995, EXP CELL RES, V220, P29, DOI 10.1006/excr.1995.1288; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; KOTITE NJ, 1984, BIOCHEMISTRY-US, V23, P3099, DOI 10.1021/bi00308a038; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Leppanen O, 2000, ARTERIOSCL THROM VAS, V20, pE89, DOI 10.1161/01.ATV.20.11.e89; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Marek I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-102; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Noiseux N, 2000, CIRCULATION, V102, P1330, DOI 10.1161/01.CIR.102.11.1330; O'Kelly J, 2008, INT J ONCOL, V33, P59; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; RANKIN S, 1994, J BIOL CHEM, V269, P704; Sano H, 2001, CIRCULATION, V103, P2955, DOI 10.1161/01.CIR.103.24.2955; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Seki J, 1996, CIRC RES, V78, P596, DOI 10.1161/01.RES.78.4.596; Sirois MG, 1997, CIRCULATION, V95, P669, DOI 10.1161/01.CIR.95.3.669; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Varadarajulu J, 2005, BIOCHEM BIOPH RES CO, V331, P404, DOI 10.1016/j.bbrc.2005.03.175; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Witzenbichler B, 1999, J CLIN INVEST, V104, P1469, DOI 10.1172/JCI7251; Wu DD, 2014, J BIOL CHEM, V289, P5774, DOI 10.1074/jbc.M113.533042; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	56	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8232	8242		10.1074/jbc.M114.623074	http://dx.doi.org/10.1074/jbc.M114.623074			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25623072	Green Published, hybrid			2022-12-28	WOS:000351662600020
J	Abraham, S; Paknikar, R; Bhumbra, S; Luan, D; Garg, R; Dressler, GR; Patel, SR				Abraham, Saji; Paknikar, Raghavendra; Bhumbra, Samina; Luan, Danny; Garg, Rohan; Dressler, Gregory R.; Patel, Sanjeevkumar R.			The Groucho-associated Phosphatase PPM1B Displaces Pax Transactivation Domain Interacting Protein (PTIP) to Switch the Transcription Factor Pax2 from a Transcriptional Activator to a Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRCT-DOMAIN; METHYLTRANSFERASE COMPLEX; H3K4 METHYLATION; GENES; CHROMATIN; 2C; PHOSPHORYLATION; COREPRESSOR; RECOGNITION; EXPRESSION	Pax genes encode developmental regulatory proteins that specify cell lineages and tissues in metazoans. Upon binding to DNA through the conserved paired domain, Pax proteins can recruit both activating and repressing complexes that imprint distinct patterns of histone methylation associated with either gene activation or silencing. How the switch from Pax-mediated activation to repression is regulated remains poorly understood. In this report, we identify the phosphatase PPM1B as an essential component of the Groucho4 repressor complex that is recruited by Pax2 to chromatin. PPM1B can dephosphorylate the Pax2 activation domain and displace the adaptor protein PTIP, thus inhibiting H3K4 methylation and gene activation. Loss of PPM1B prevents Groucho-mediated gene repression. Thus, PPM1B helps switch Pax2 from a transcriptional activator to a repressor protein. This can have profound implications for developmental regulation by Pax proteins and suggests a model for imprinting specific epigenetic marks depending on the availability of co-factors.	[Abraham, Saji; Paknikar, Raghavendra; Bhumbra, Samina; Luan, Danny; Garg, Rohan; Patel, Sanjeevkumar R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Dressler, Gregory R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Patel, SR (corresponding author), Univ Michigan, Dept Internal Med, 1560 W Med Ctr Dr,1560 MSRBII, Ann Arbor, MI 48109 USA.	sanjeevk@umich.edu	Bhumbra, Samina/AAX-8266-2020	Bhumbra, Samina/0000-0002-4036-0479; Abraham, Saji/0000-0001-7035-0610	National Institutes of Health [DK082409, DK073722, DK054740]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062914, R01DK054740, R01DK082409, R01DK073722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK082409 (to S. R. P.) and DK073722 and DK054740 (to G. R. D.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Cai Y, 2002, J BIOL CHEM, V277, P1217, DOI 10.1074/jbc.M109663200; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Kim D, 2009, STEM CELLS, V27, P1516, DOI 10.1002/stem.79; Klumpp S, 1998, FEBS LETT, V437, P229, DOI 10.1016/S0014-5793(98)01237-X; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Lefevre GM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001142; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Liu Y, 2014, BIOCHEM BIOPH RES CO, V444, P634, DOI 10.1016/j.bbrc.2014.01.143; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Patel SR, 2012, MOL CELL, V45, P185, DOI 10.1016/j.molcel.2011.11.007; Patel SR, 2004, DEV BIOL, V267, P505, DOI 10.1016/j.ydbio.2003.11.002; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shimizu K, 2001, MOL CELL BIOL, V21, P3901, DOI 10.1128/MCB.21.12.3901-3912.2001; Soofi A, 2012, DEV BIOL, V365, P241, DOI 10.1016/j.ydbio.2012.02.032; Stein AB, 2011, J CLIN INVEST, V121, P2641, DOI 10.1172/JCI44641; Tasdelen I, 2013, BIOCHEM J, V451, P45, DOI 10.1042/BJ20121113; Torres M, 1995, DEVELOPMENT, V121, P4057; Torres MA, 1996, DEVELOPMENT, V122, P3381; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; Yien YY, 2012, J BIOL CHEM, V287, P15193, DOI 10.1074/jbc.M112.350496	44	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7185	7194		10.1074/jbc.M114.607424	http://dx.doi.org/10.1074/jbc.M114.607424			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631048	Green Published, hybrid			2022-12-28	WOS:000350991500048
J	Aki, S; Yoshioka, K; Okamoto, Y; Takuwa, N; Takuwa, Y				Aki, Sho; Yoshioka, Kazuaki; Okamoto, Yasuo; Takuwa, Noriko; Takuwa, Yoh			Phosphatidylinositol 3-Kinase Class II alpha-Isoform PI3K-C2 alpha Is Required for Transforming Growth Factor beta-induced Smad Signaling in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACTIVATION SARA; YOLK-SAC VASCULATURE; TGF-BETA; PHOSPHOINOSITIDE 3-KINASE; C2 DOMAIN; TUMOR ANGIOGENESIS; COATED VESICLES; EARLY ENDOSOMES; FYVE DOMAIN; MICE	We have recently demonstrated that the PI3K class II-alpha isoform (PI3K-C2 alpha), which generates phosphatidylinositol 3-phosphate and phosphatidylinositol 3,4-bisphosphates, plays crucial roles in angiogenesis, by analyzing PI3K-C2 alpha knock-out mice. The PI3K-C2 alpha actions are mediated at least in part through its participation in the internalization of VEGF receptor-2 and sphingosine-1-phosphate receptor S1P(1) and thereby their signaling on endosomes. TGF beta, which is also an essential angiogenic factor, signals via the serine/threonine kinase receptor complex to induce phosphorylation of Smad2 and Smad3 (Smad2/3). SARA (Smad anchor for receptor activation) protein, which is localized in early endosomes through its FYVE domain, is required for Smad2/3 signaling. In the present study, we showed that PI3K-C2 alpha knockdown nearly completely abolished TGF beta 1-induced phosphorylation and nuclear translocation of Smad2/3 in vascular endothelial cells (ECs). PI3K-C2 alpha was necessary for TGF beta-induced increase in phosphatidylinositol 3,4-bisphosphates in the plasma membrane and TGF beta receptor internalization into the SARA-containing early endosomes, but not for phosphatidylinositol 3-phosphate enrichment or localization of SARA in the early endosomes. PI3K-C2 alpha was also required for TGF beta receptor-mediated formation of SARA-Smad2/3 complex. Inhibition of dynamin, which is required for the clathrin-dependent receptor endocytosis, suppressed both TGF beta receptor internalization and Smad2/3 phosphorylation. TGF beta 1 stimulated Smad-dependent VEGF-A expression, VEGF receptor-mediated EC migration, and capillary-like tube formation, which were all abolished by either PI3K-C2 alpha knockdown or a dynamin inhibitor. Finally, TGF beta 1-induced microvessel formation in Matrigel plugs was greatly attenuated in EC-specific PI3K-C2 alpha-deleted mice. These observations indicate that PI3K-C2 alpha plays the pivotal role in TGF beta receptor endocytosis and thereby Smad2/3 signaling, participating in angiogenic actions of TGF beta.	[Aki, Sho; Yoshioka, Kazuaki; Okamoto, Yasuo; Takuwa, Noriko; Takuwa, Yoh] Kanazawa Univ, Dept Physiol, Sch Med, Kanazawa, Ishikawa 9208640, Japan; [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa 9291210, Japan	Kanazawa University	Takuwa, Y (corresponding author), Kanazawa Univ, Dept Physiol, Sch Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	ytakuwa@med.kanazawa-u.ac.jp	Yoshioka, Kazuaki/G-1038-2013; OKAMOTO, Yasuo/J-8438-2015	Yoshioka, Kazuaki/0000-0002-8631-3846; TAKUWA, Noriko/0000-0002-4278-2704	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Society for the Promotion of Science; Ube foundation; Japan Foundation for Applied Enzymology; Life Science Foundation of Japan; Grants-in-Aid for Scientific Research [15K10970] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ube foundation(UBE Foundation); Japan Foundation for Applied Enzymology; Life Science Foundation of Japan(Life Science Foundation of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, the Japanese Society for the Promotion of Science, the Ube foundation, the Japan Foundation for Applied Enzymology, and the Life Science Foundation of Japan.	Bakkebo M, 2012, FEBS LETT, V586, P3367, DOI 10.1016/j.febslet.2012.07.027; Biswas K, 2013, J PHYSIOL SCI, V63, pS136; Biswas K, 2013, J BIOL CHEM, V288, P2325, DOI 10.1074/jbc.M112.409656; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Breier G, 2002, INT J CANCER, V97, P142, DOI 10.1002/ijc.1599; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; Cui H, 2013, J ALLERGY CLIN IMMUN, V132, P1205, DOI 10.1016/j.jaci.2013.07.026; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Harada K, 2005, MOL CELL BIOL, V25, P11122, DOI 10.1128/MCB.25.24.11122-11130.2005; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Inoki I, 2006, BIOCHEM BIOPH RES CO, V346, P293, DOI 10.1016/j.bbrc.2006.05.119; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Itoh F, 2012, BLOOD, V119, P5320, DOI 10.1182/blood-2011-12-395772; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Mizuide M, 2003, J BIOL CHEM, V278, P531, DOI 10.1074/jbc.C200596200; Molz L, 1996, J BIOL CHEM, V271, P13892, DOI 10.1074/jbc.271.23.13892; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pardali E, 2012, INT J BIOL SCI, V8, P195, DOI [10.7150/ijbs.8.195, 10.7150/ijbs.3805]; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; Simons M., 2012, PHYSL BETHESDA, V27, P213; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Traer Colin J, 2006, Bull Cancer, V93, pE53; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Virbasius JV, 1996, J BIOL CHEM, V271, P13304, DOI 10.1074/jbc.271.23.13304; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928	53	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6086	6105		10.1074/jbc.M114.601484	http://dx.doi.org/10.1074/jbc.M114.601484			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25614622	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000350732500019
J	Chen, ZG; Kang, XJ; Wang, LP; Dong, HL; Wang, CX; Xiong, Z; Zhao, WL; Jia, CH; Lin, J; Zhang, W; Yuan, WP; Zhong, M; Du, HZ; Bai, XC				Chen, Zhenguo; Kang, Xiangjin; Wang, Liping; Dong, Heling; Wang, Caixia; Xiong, Zhi; Zhao, Wanlu; Jia, Chunhong; Lin, Jun; Zhang, Wen; Yuan, Weiping; Zhong, Mei; Du, Hongzi; Bai, Xiaochun			Rictor/mTORC2 Pathway in Oocytes Regulates Folliculogenesis, and Its Inactivation Causes Premature Ovarian Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-VINYLCYCLOHEXENE DIEPOXIDE; MICE REVEALS; ACTIVATION; RICTOR; MTOR; GROWTH; PHOSPHORYLATION; DISRUPTION; MECHANISMS; DELETION	Molecular basis of ovarian folliculogenesis and etiopathogenesis of premature ovarian failure (POF), a common cause of infertility in women, are not fully understood. Mechanistic target of rapamycin complex 2 (mTORC2) is emerging as a central regulator of cell metabolism, proliferation, and survival. However, its role in folliculogenesis and POF has not been reported. Here, we showed that the signaling activity of mTORC2 is inhibited in a 4-vinylcyclohexene diepoxide (VCD)-induced POE mouse model. Notably, mice with oocyte-specific ablation of Rector, a key component of mTORC2, demonstrated POF phenotypes, including massive follicular death, excessive loss of functional ovarian follicles, abnormal gonadal hormone secretion, and consequently, secondary subfertility in conditional knock-out (cKO) mice. Furthermore, reduced levels of Ser-473-phosphorylated Akt and Ser-253-phosphorylated Foxo3a and elevated pro-apoptotic proteins, Bad, Bax, and cleaved poly ADP-ribose polymerase (PARP), were observed in cKO mice, replicating the signaling alterations in 4-VCD-treated ovaries. These results indicate a critical role of the Rictor/mTORC2/Akt/Foxo3a pro-survival signaling axis in folliculogenesis. Interestingly, loss of maternal Rictor did not cause obvious developmental defects in embryos or placentas from cKO mice, suggesting that maternal Rictor is dispensable for preimplantation embryonic development. Our results collectively indicate key roles of Rictor/mTORC2 in folliculogenesis, follicle survival, and female fertility and support the utility of oocyte-specific Rictor knock-out mice as a novel model for POF.	[Chen, Zhenguo; Dong, Heling; Wang, Caixia; Xiong, Zhi; Zhao, Wanlu; Jia, Chunhong; Lin, Jun; Bai, Xiaochun] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China; [Kang, Xiangjin; Zhang, Wen; Du, Hongzi] Guangzhou Med Univ, Affiliated Hosp 3, Ctr Reprod Med, Key Lab Reprod Med Guangdong Prov,Key Lab Major O, Guangzhou 510150, Guangdong, Peoples R China; [Kang, Xiangjin; Zhang, Wen; Du, Hongzi] Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Guangzhou 510150, Guangdong, Peoples R China; [Wang, Liping; Zhong, Mei] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou 510515, Guangdong, Peoples R China; [Yuan, Weiping] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Yuan, Weiping] Peking Union Med Coll, Tianjin 300020, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Du, HZ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Ctr Reprod Med, Key Lab Reprod Med Guangdong Prov,Key Lab Major O, Guangzhou 510150, Guangdong, Peoples R China.	dhz_gz@hotmail.com; baixc15@smu.edu.cn		Chen, Zhenguo/0000-0003-3280-5201; Bai, Xiaochun/0000-0001-9631-4781	State Key Development Program for Basic Research of China [2013CB945203]; National Natural Sciences Foundation of China [81270088, 81301848, U1301222, 31271271, 31401224]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1142]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by The State Key Development Program for Basic Research of China (Grant 2013CB945203), the National Natural Sciences Foundation of China (Grants 81270088, 81301848, U1301222, 31271271, and 31401224), and the Program for Changjiang Scholars and Innovative Research Team in University (Grant IRT1142).	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; Chen ZG, 2010, BIOCHEM CELL BIOL, V88, P737, DOI 10.1139/O10-012; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hoyer PB, 2007, BIRTH DEFECTS RES B, V80, P113, DOI 10.1002/bdrb.20103; Hoyer PB, 2001, TOXICOL PATHOL, V29, P91, DOI 10.1080/019262301301418892; Hu XM, 2001, BIOL REPROD, V65, P87, DOI 10.1095/biolreprod65.1.87; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Keating AF, 2011, BIOL REPROD, V84, P743, DOI 10.1095/biolreprod.110.087650; Kim Jin Yeong, 2012, Clin Exp Reprod Med, V39, P10, DOI 10.5653/cerm.2012.39.1.10; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Latham KE, 1999, INT REV CYTOL, V193, P71; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Rajareddy S, 2007, MOL ENDOCRINOL, V21, P2189, DOI 10.1210/me.2007-0172; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Richards Joanne S, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-02062-9_1; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shelling AN, 2010, REPRODUCTION, V140, P633, DOI 10.1530/REP-09-0567; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sun QY, 2008, BIOL REPROD, V79, P1014, DOI 10.1095/biolreprod.108.070409; Takai Y, 2003, ENDOCRINOLOGY, V144, P69, DOI 10.1210/en.2002-220814; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zheng WJ, 2012, MOL CELL ENDOCRINOL, V356, P24, DOI 10.1016/j.mce.2011.05.027; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	47	53	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6387	6396		10.1074/jbc.M114.605261	http://dx.doi.org/10.1074/jbc.M114.605261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564616	hybrid, Green Published			2022-12-28	WOS:000350732500043
J	Sasazawa, Y; Sato, N; Umezawa, K; Simizu, S				Sasazawa, Yukiko; Sato, Natsumi; Umezawa, Kazuo; Simizu, Siro			Conophylline Protects Cells in Cellular Models of Neurodegenerative Diseases by Inducing Mammalian Target of Rapamycin (mTOR)-independent Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTONS-DISEASE; ALPHA-SYNUCLEIN; MUTANT HUNTINGTIN; SUBSTANTIA-NIGRA; INHIBITION; APOPTOSIS; TOXICITY; POLYGLUTAMINE; AGGREGATION; INVOLVEMENT	Macroautophagy is a cellular response that leads to the bulk, nonspecific degradation of cytosolic components, including-organelles. In recent years, it has been recognized that autophagy is essential for prevention of neurodegenerative diseases, including Parkinson disease (PD) and Huntington disease (HD). Here, we show that conophylline (CNP), a vinca alkaloid, induces autophagy in an mammalian target of rapamycin-independent manner. Using a cellular model of PD, CNP suppressed protein aggregation and protected cells from cell death caused by treatment with 1-methyl-4-phenylpyridinium, a neurotoxin, by inducing autophagy. Moreover, in the HD model, CNP also eliminated mutant huntingtin aggregates. Our findings demonstrate the possible use of CNP as a therapeutic drug for neurodegenerative disorders, including PD and HD.	[Sasazawa, Yukiko; Sato, Natsumi; Simizu, Siro] Keio Univ, Dept Appl Chem, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Umezawa, Kazuo] Aichi Med, Dept Mol Target Med Screening, Sch Med, Aichi 4801195, Japan	Keio University; Aichi Medical University	Simizu, S (corresponding author), Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	simizu@applc.keio.ac.jp		Simizu, Siro/0000-0003-2949-2427	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23310163, 24310167, 26750373]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (B) 23310163 and 24310167 and Grant-in-Aid for Young Scientists (B) 26750373 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Cheng YF, 2009, NEUROSCI RES, V63, P52, DOI 10.1016/j.neures.2008.10.009; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Fujii M, 2009, BIOMED PHARMACOTHER, V63, P710, DOI 10.1016/j.biopha.2009.01.006; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Hyrskyluoto A, 2014, HUM MOL GENET, V23, P5928, DOI 10.1093/hmg/ddu317; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; KAM TS, 1993, J NAT PROD, V56, P1865, DOI 10.1021/np50101a001; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kowall NW, 2000, NEUROREPORT, V11, P211, DOI 10.1097/00001756-200001170-00041; LANGSTON JW, 1984, NEUROSCI LETT, V48, P87, DOI 10.1016/0304-3940(84)90293-3; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Ogata T, 2004, DIABETES, V53, P2596, DOI 10.2337/diabetes.53.10.2596; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sasazawa Y, 2012, ACS CHEM BIOL, V7, P892, DOI 10.1021/cb200492h; Suzuki E, 2009, BIOORGAN MED CHEM, V17, P6188, DOI 10.1016/j.bmc.2009.07.062; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Umezawa K, 2003, BIOMED PHARMACOTHER, V57, P341, DOI 10.1016/S0753-3322(03)00096-9; UMEZAWA K, 1994, ANTICANCER RES, V14, P2413; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	33	40	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6168	6178		10.1074/jbc.M114.606293	http://dx.doi.org/10.1074/jbc.M114.606293			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25596530	Green Published, hybrid			2022-12-28	WOS:000350732500025
J	Schaker, K; Bartsch, S; Patry, C; Stoll, SJ; Hillebrands, JL; Wieland, T; Kroll, J				Schaeker, Kathrin; Bartsch, Susanne; Patry, Christian; Stoll, Sandra J.; Hillebrands, Jan-Luuk; Wieland, Thomas; Kroll, Jens			The Bipartite Rac1 Guanine Nucleotide Exchange Factor Engulfment and Cell Motility 1/Dedicator of Cytokinesis 180 (Elmo1/Dock180) Protects Endothelial Cells from Apoptosis in Blood Vessel Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR MORPHOGENESIS; SIGNAL-TRANSDUCTION; MYOBLAST FUSION; DOCK180; ACTIVATION; RECEPTOR; ANGIOGENESIS; INHIBITION; SURVIVAL; REGRESSION	Engulfment and cell motility 1/dedicator of cytokinesis 180 (Elmol/Dock180) is a bipartite guanine nucleotide exchange factor for the monomeric GTPase Ras-related C3 botulinum toxin substrate 1 (Racl). Elmol/Dock180 regulates Racl activity in a specific spatiotemporal manner in endothelial cells (ECs) during zebrafish development and acts downstream of the Netrin-1/Unc5-homolog B (Unc5B) signaling cascade. However, mechanistic details on the pathways by which Elmol/ Dock 180 regulates endothelial function and vascular development remained elusive. In this study, we aimed to analyze the vascular function of Elmol and Dock180 in human ECs and during vascular development in zebrafish embryos. In vitro overexpression of Elmol and Dock180 in ECs reduced caspase-3/7 activity and annexin V-positive cell number upon induction of apoptosis. This protective effect of Elmol and Dock180 is mediated by activation of Racl, p21-activated kinase (PAK) and AKT/protein kinase B (AKT) signaling. In zebrafish, Elmol and Dock 180 overexpression reduced the total apoptotic cell and apoptotic EC number and promoted the formation of blood vessels during embryogenesis. In conclusion, Elmol and Dock 180 protect ECs from apoptosis by the activation of the Rac 1/ PAK/AKT signaling cascade in vitro and in vivo. Thus, Elmol and Dock180 facilitate blood vessel formation by stabilization of the endothelium during angiogenesis.	[Schaeker, Kathrin; Bartsch, Susanne; Patry, Christian; Kroll, Jens] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany; [Wieland, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Expt & Clin Pharmacol & Toxicol, D-68167 Mannheim, Germany; [Schaeker, Kathrin; Kroll, Jens] German Canc Res Ctr DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, D-69120 Heidelberg, Germany; [Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, NL-9700 RB Groningen, Netherlands	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Groningen	Kroll, J (corresponding author), Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany.	jens.kroll@medma.uni-heidelberg.de	Wieland, Thomas/G-1772-2012; Wieland, Thomas/Q-1506-2019	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Hillebrands, Jan-Luuk/0000-0003-3135-3274	Core Facility Live Cell Imaging [DFG INST 91027/10-1 FUGG]	Core Facility Live Cell Imaging	We thank Stefanie Uhlig, operating the Mannheim Cell Sorting Core Facility and we acknowledge the support of the Core Facility Live Cell Imaging (DFG INST 91027/10-1 FUGG). We thank Dr. Mauro Cozzolino (Rome, Italy) for kindly providing adenoviral constructs for the overexpression of RacN17 and RacV12. We are grateful to Sabine Zapf, Jana Braun and Marlene Hausner for technical assistance with FACS and Western blot experiments.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Bouvree K, 2008, DEV BIOL, V318, P172, DOI 10.1016/j.ydbio.2008.03.023; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374; Claxton S, 2003, EXP EYE RES, V77, P305, DOI 10.1016/S0014-4835(03)00153-2; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Das S, 2011, P NATL ACAD SCI USA, V108, P2136, DOI 10.1073/pnas.1014775108; Del Galdo S, 2013, CELL SIGNAL, V25, P2478, DOI 10.1016/j.cellsig.2013.08.017; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Elliott MR, 2010, ANN NY ACAD SCI, V1209, P30, DOI 10.1111/j.1749-6632.2010.05764.x; Embade N, 2000, MOL BIOL CELL, V11, P4347, DOI 10.1091/mbc.11.12.4347; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Eriksson A, 2003, CIRCULATION, V107, P1532, DOI 10.1161/01.CIR.0000055324.34758.32; Feng HZ, 2012, P NATL ACAD SCI USA, V109, P3018, DOI 10.1073/pnas.1121457109; Franke K, 2012, EMBO J, V31, P2908, DOI 10.1038/emboj.2012.130; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; He XW, 2010, MOL CELL BIOL, V30, P3569, DOI 10.1128/MCB.01366-09; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Im E, 2006, CELL CYCLE, V5, P2057, DOI 10.4161/cc.5.18.3210; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kather JN, 2013, EXP CELL RES, V319, P1289, DOI 10.1016/j.yexcr.2012.12.015; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kochhan E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075060; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lobov IB, 2011, BLOOD, V117, P6728, DOI 10.1182/blood-2010-08-302067; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Makino Y, 2006, J CELL SCI, V119, P923, DOI 10.1242/jcs.02797; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Nacak TG, 2007, CIRC RES, V100, P1155, DOI 10.1161/01.RES.0000265844.56493.ac; Nishida K, 1999, ONCOGENE, V18, P407, DOI 10.1038/sj.onc.1202301; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rao GK, 2008, CIRC RES, V103, P328, DOI 10.1161/CIRCRESAHA.108.182238; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Shen E, 2009, DIABETES, V58, P2386, DOI 10.2337/db08-0617; Soga N, 2001, CELL COMMUN ADHES, V8, P1, DOI 10.3109/15419060109080703; Stoll SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058311; Stoll SJ, 2011, CIRC RES, V108, P1367, DOI 10.1161/CIRCRESAHA.111.244095; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Taniguchi H, 1999, ANN ANAT, V181, P555, DOI 10.1016/S0940-9602(99)80061-2; van Ham TJ, 2012, CURR BIOL, V22, P830, DOI 10.1016/j.cub.2012.03.027; Velaithan R, 2011, BLOOD, V117, P6214, DOI 10.1182/blood-2010-08-301283; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wacker A, 2011, CURR OPIN CELL BIOL, V23, P676, DOI 10.1016/j.ceb.2011.10.002; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yan A, 2013, MED SCI MONIT BASIC, V19, P12, DOI 10.12659/MSMBR.883738; Yoshida T, 2010, MOL CANCER THER, V9, P1657, DOI 10.1158/1535-7163.MCT-09-0906; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044590	76	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6408	6418		10.1074/jbc.M114.633701	http://dx.doi.org/10.1074/jbc.M114.633701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586182	Green Published, hybrid			2022-12-28	WOS:000350732500045
J	Singh, RK; Cho, K; Padi, SKR; Yu, JR; Haldar, M; Mandal, T; Yan, CH; Cook, G; Guo, B; Mallik, S; Srivastava, DK				Singh, Raushan K.; Cho, Kyongshin; Padi, Satish K. R.; Yu, Junru; Haldar, Manas; Mandal, Tanmay; Yan, Changhui; Cook, Gregory; Guo, Bin; Mallik, Sanku; Srivastava, D. K.			Mechanism of N-Acylthiourea-mediated Activation of Human Histone Deacetylase 8 (HDAC8) at Molecular and Cellular Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; BINDING; INHIBITORS; FAMILY; PROTEIN; SIRT1; P53; RESVERATROL; COMPLEXES; CHEMISTRY	We reported previously that an N-acylthiourea derivative (TM-2-51) serves as a potent and isozyme-selective activator for human histone deacetylase 8 (HDAC8). To probe the molecular mechanism of the enzyme activation, we performed a detailed account of the steady-state kinetics, thermodynamics, molecular modeling, and cell biology studies. The steady-state kinetic data revealed that TM-2-51 binds to HDAC8 at two sites in a positive cooperative manner. Isothermal titration calorimetric and molecular modeling data conformed to the two-site binding model of the enzyme-activator complex. We evaluated the efficacy of TM-2-51 on SH-SY5Y and BE(2)-C neuroblastoma cells, wherein the HDAC8 expression has been correlated with cellular malignancy. Whereas TM-2-51 selectively induced cell growth inhibition and apoptosis in SH-SY5Y cells, it showed no such effects in BE(2)-C cells, and this discriminatory feature appears to be encoded in the p53 genotype of the above cells. Our mechanistic and cellular studies on HDAC8 activation have the potential to provide insight into the development of novel anticancer drugs.	[Singh, Raushan K.; Yu, Junru; Mandal, Tanmay; Cook, Gregory; Srivastava, D. K.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Cho, Kyongshin] N Dakota State Univ, Dept Anim Sci, Fargo, ND 58108 USA; [Padi, Satish K. R.; Haldar, Manas; Guo, Bin; Mallik, Sanku] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58108 USA; [Yan, Changhui] N Dakota State Univ, Dept Comp Sci, Fargo, ND 58108 USA	North Dakota State University Fargo; North Dakota State University Fargo; North Dakota State University Fargo; North Dakota State University Fargo	Srivastava, DK (corresponding author), N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA.	dk.srivastava@ndsu.edu	Srivastava, Deo Kumar/P-2435-2017; Guo, Bin/AAA-2445-2019; Padi, Sathish Kumar Reddy/ABG-9521-2021	Srivastava, Deo Kumar/0000-0001-6693-8120; Guo, Bin/0000-0003-3296-9177; Padi, Sathish Kumar Reddy/0000-0002-5526-4287; Singh, Raushan/0000-0002-3636-9112; Mallik, Sanku/0000-0003-4236-2512	National Institutes of Health [CA113746, CA132034, NCRR-P20-RR15566]; NATIONAL CANCER INSTITUTE [R01CA132034, R01CA113746] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1306154] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA113746 and CA132034 (to D. K. S. and S. M.) and NCRR-P20-RR15566 (to G. C.).	Adair GS, 1925, J BIOL CHEM, V63, P529; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Byerly DW, 2002, PROTEIN SCI, V11, P1850, DOI 10.1110/ps.0203402; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dahlquist F W, 1978, Methods Enzymol, V48, P270; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Decroos C, 2014, ACS CHEM BIOL, V9, P2157, DOI 10.1021/cb5003762; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; FRANK HS, 1968, J CHEM PHYS, V48, P4746, DOI 10.1063/1.1668057; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gurard-Levin ZA, 2009, CHEMBIOCHEM, V10, P2159, DOI 10.1002/cbic.200900417; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kasahara K, 2010, BIOINFORMATICS, V26, P1493, DOI 10.1093/bioinformatics/btq232; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KrennHrubec K, 2007, BIOORG MED CHEM LETT, V17, P2874, DOI 10.1016/j.bmcl.2007.02.064; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Lombardi PM, 2011, CURR OPIN STRUC BIOL, V21, P735, DOI 10.1016/j.sbi.2011.08.004; Marmorstein R, 2004, BIOCHEM SOC T, V32, P904, DOI 10.1042/BST0320904; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Schultz BE, 2004, BIOCHEMISTRY-US, V43, P11083, DOI 10.1021/bi0494471; Singh RK, 2014, BIOCHEMISTRY-US, V53, P7445, DOI 10.1021/bi500711x; Singh RK, 2011, BIOORG MED CHEM LETT, V21, P5920, DOI 10.1016/j.bmcl.2011.07.080; Singh RK, 2011, ANAL BIOCHEM, V408, P309, DOI 10.1016/j.ab.2010.08.040; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Tsuzuki S, 2002, J AM CHEM SOC, V124, P104, DOI 10.1021/ja0105212; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	46	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6607	6619		10.1074/jbc.M114.600627	http://dx.doi.org/10.1074/jbc.M114.600627			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605725	Green Published, hybrid			2022-12-28	WOS:000350732500062
J	Wong, KKL; Li, WY; An, YR; Duan, YY; Li, ZH; Kang, YB; Yan, Y				Wong, Kenneth Kin Lam; Li, Wenyang; An, Yanru; Duan, Yangyang; Li, Zhuoheng; Kang, Yibin; Yan, Yan			beta-Spectrin Regulates the Hippo Signaling Pathway and Modulates the Basal Actin Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC FOLLICLE CELLS; ALPHA-SPECTRIN; F-ACTIN; ERYTHROCYTE-MEMBRANE; DROSOPHILA HOMOLOGS; ANTERIOR-POSTERIOR; DISTINCT FUNCTIONS; TUMOR-SUPPRESSOR; PROLIFERATION; PROTEIN	Emerging evidence suggests functional regulation of the Hippo pathway by the actin cytoskeleton, although the detailed molecular mechanism remains incomplete. In a genetic screen, we identified a requirement for beta-Spectrin in the posterior follicle cells for the oocyte repolarization process during Drosophila mid-oogenesis. beta-spectrin mutations lead to loss of Hippo signaling activity in the follicle cells. A similar reduction of Hippo signaling activity was observed after beta-Spectrin knockdown in mammalian cells. We further demonstrated that beta-spectrin mutations disrupt the basal actin network in follicle cells. The abnormal stress fiber-like actin structure on the basal side of follicle cells provides a likely link between the beta-spectrin mutations and the loss of the Hippo signaling activity phenotype.	[Wong, Kenneth Kin Lam; An, Yanru; Duan, Yangyang; Li, Zhuoheng; Yan, Yan] Hong Kong Univ Sci & Technol, Sch Sci, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Wong, Kenneth Kin Lam; An, Yanru; Yan, Yan] Hong Kong Univ Sci & Technol, Sch Sci, Ctr Syst Biol & Human Hlth, Kowloon, Hong Kong, Peoples R China; [Wong, Kenneth Kin Lam; An, Yanru; Yan, Yan] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Li, Wenyang; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Princeton University	Yan, Y (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Ctr Syst Biol & Human Hlth, Hong Kong, Hong Kong, Peoples R China.	yany@ust.hk		, Kin Lam/0000-0002-5597-4051; Kang, Yibin/0000-0002-1626-6730	Research Grants Council of the Hong Kong Special Administrative Region [16103314, AoE/M-09/12, IGN125C01]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This work was supported by Research Grants Council of the Hong Kong Special Administrative Region Grants 16103314, AoE/M-09/12, and IGN125C01.	AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; [Anonymous], DEV CELL, V14, P354; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; BURRIDGE K, 1982, J CELL BIOL, V95, P478, DOI 10.1083/jcb.95.2.478; BYERS TJ, 1989, J CELL BIOL, V109, P1633, DOI 10.1083/jcb.109.4.1633; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; COHEN CM, 1980, CELL, V21, P875, DOI 10.1016/0092-8674(80)90451-1; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Deng WM, 2001, DEVELOPMENT, V128, P4737; DUBREUIL RR, 1990, J CELL BIOL, V111, P1849, DOI 10.1083/jcb.111.5.1849; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Gao YZ, 2011, J NEUROSCI, V31, P16581, DOI 10.1523/JNEUROSCI.3332-11.2011; GLENNEY JR, 1982, CELL, V28, P843, DOI 10.1016/0092-8674(82)90063-0; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; GUTZEIT HO, 1990, EUR J CELL BIOL, V53, P349; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Krieg M, 2014, NAT CELL BIOL, V16, P224, DOI 10.1038/ncb2915; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lee JK, 1997, DEVELOPMENT, V124, P353; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Lucas EP, 2013, J CELL BIOL, V201, P875, DOI 10.1083/jcb.201210073; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; MANGEAT PH, 1984, J CELL BIOL, V98, P1363, DOI 10.1083/jcb.98.4.1363; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McKeown C, 1998, DEVELOPMENT, V125, P2087; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; Oda H, 2001, J CELL SCI, V114, P493; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; PALEK J, 1983, SEMIN HEMATOL, V20, P189; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PESACRETA TC, 1989, J CELL BIOL, V108, P1697, DOI 10.1083/jcb.108.5.1697; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; PINDER JC, 1975, NATURE, V258, P765, DOI 10.1038/258765a0; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Roth S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001891; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Sun JJ, 2005, DEVELOPMENT, V132, P4299, DOI 10.1242/dev.02015; TILNEY LG, 1975, J CELL BIOL, V66, P508, DOI 10.1083/jcb.66.3.508; TSUKITA S, 1980, J CELL BIOL, V85, P567, DOI 10.1083/jcb.85.3.567; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Xi RW, 2003, DEV CELL, V4, P167, DOI 10.1016/S1534-5807(02)00412-4; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yan Y, 2011, DEVELOPMENT, V138, P1697, DOI 10.1242/dev.059279; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001761; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	75	50	51	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6397	6407		10.1074/jbc.M114.629493	http://dx.doi.org/10.1074/jbc.M114.629493			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589787	hybrid, Green Published			2022-12-28	WOS:000350732500044
J	Munns, CH; Chung, MK; Sanchez, YE; Arnzel, LM; Caterina, MJ				Munns, Clare H.; Chung, Man-Kyo; Sanchez, Yuly E.; Arnzel, L. Mario; Caterina, Michael J.			Role of the Outer Pore Domain in Transient Receptor Potential Vanilloid 1 Dynamic Permeability to Large Cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(2) CHANNEL PERMEABILITY; ION-PERMEATION PATHWAY; CAPSAICIN RECEPTOR; POTASSIUM CHANNEL; TRP CHANNEL; MOLECULAR-BASIS; PAIN PATHWAY; ACTIVATION; SELECTIVITY; DILATION	Transient receptor potential vanilloid 1 (TRPV1) has been shown to alter its ionic selectivity profile in a time- and agonist-dependent manner. One hallmark of this dynamic process is an increased permeability to large cations such as N-methyl-D-glucamine (NMDG). In this study, we mutated residues throughout the TRPV1 pore domain to identify loci that contribute to dynamic large cation permeability. Using resiniferatoxin (RTX) as the agonist, we identified multiple gain-of-function substitutions within the TRPV1 pore turret (N628P and S629A), pore helix (F638A), and selectivity filter (M644A) domains. In all of these mutants, maximum NMDG permeability was substantially greater than that recorded in wild type TRPV1, despite similar or even reduced sodium current density. Two additional mutants, located in the pore turret (G618W) and selectivity filter (M644I), resulted in significantly reduced maximum NMDG permeability. M644A and M644I also showed increased and decreased minimum NMDG permeability, respectively. The phenotypes of this panel of mutants were confirmed by imaging the RTX-evoked uptake of the large cationic fluorescent dye YO-PROL Whereas none of the mutations selectively altered capsaicin-induced changes in NMDG permeability, the loss-of-function phenotypes seen with RTX stimulation of G618W and M644I were recapitulated in the capsaicin-evoked YO-PRO1 uptake assay. Curiously, the M644A substitution resulted in a loss, rather than a gain, in capsaicin-evoked YO-PRO1 uptake. Modeling of our mutations onto the recently determined TRPV1 structure revealed several plausible mechanisms for the phenotypes observed. We conclude that side chain interactions at a few specific loci within the TRPV1 pore contribute to the dynamic process of ionic selectivity.	[Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosurg, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Biol Chem, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Munns, Clare H.; Caterina, Michael J.] Johns Hopkins Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Sanchez, Yuly E.; Arnzel, L. Mario] Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Chung, Man-Kyo] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; [Sanchez, Yuly E.] Univ Nacl Colombia, Fac Ciencias, Dept Fis, Bogota 111321, Colombia; [Sanchez, Yuly E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota 110231, Colombia	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Universidad Nacional de Colombia; Pontificia Universidad Javeriana	Caterina, MJ (corresponding author), Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosurg, 725 N Wolfe St, Baltimore, MD 21205 USA.	caterina@jhmi.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148; Amzel, L. Mario/0000-0002-0129-9572	National Institutes of Health from NINDS [NS054902]; National Institutes of Health from NIDCR [DE023846]; Neurosurgery Pain Research Institute; Blaustein Pain Research Fund at Johns Hopkins School of Medicine; John J. Bonica Fellowship from the International Association for the Study of Pain; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054902] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institutes of Health from NIDCR; Neurosurgery Pain Research Institute; Blaustein Pain Research Fund at Johns Hopkins School of Medicine; John J. Bonica Fellowship from the International Association for the Study of Pain; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS054902 from NINDS (to M. J. C.), Grant DE023846 from NIDCR (to M. K. C.) by funding from the Neurosurgery Pain Research Institute and Blaustein Pain Research Fund at Johns Hopkins School of Medicine (to M. J. C.), and a John J. Bonica Fellowship from the International Association for the Study of Pain (to C. H. M.). Dr. Caterina is an inventor on a patent on the use of products related to TRPV1, which is licensed through UCSF and Merck. This conflict is being managed by the Johns Hopkins Office on Policy Coordination.	Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chao CC, 2010, J PHYSIOL SCI, V60, P441, DOI 10.1007/s12576-010-0111-1; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Fujiwara Y, 2004, J PHYSIOL-LONDON, V558, P31, DOI 10.1113/jphysiol.2004.064568; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Jansson ET, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-1; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kim SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059593; Lees-Miller JP, 2009, BIOPHYS J, V96, P3600, DOI 10.1016/j.bpj.2009.01.028; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Meyers JR, 2003, J NEUROSCI, V23, P4054; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Puopolo M, 2013, J NEUROPHYSIOL, V109, P1704, DOI 10.1152/jn.00012.2013; Raisinghani M, 2005, J PHYSIOL-LONDON, V567, P771, DOI 10.1113/jphysiol.2005.087874; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Vriens J, 2014, NAT CHEM BIOL, V10, P188, DOI [10.1038/NCHEMBIO.1428, 10.1038/nchembio.1428]; Wang ZR, 2009, J GEN PHYSIOL, V133, P361, DOI 10.1085/jgp.200810139; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795	49	34	36	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5707	5724		10.1074/jbc.M114.597435	http://dx.doi.org/10.1074/jbc.M114.597435			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568328	Green Published, hybrid			2022-12-28	WOS:000350044200039
J	Subburaj, Y; Ros, U; Hermann, E; Tong, R; Garcia-Saez, AJ				Subburaj, Yamunadevi; Ros, Uris; Hermann, Eduard; Tong, Rudi; Garcia-Saez, Ana J.			Toxicity of an alpha-Pore-forming Toxin Depends on the Assembly Mechanism on the Target Membrane as Revealed by Single Molecule Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMONE STICHODACTYLA-HELIANTHUS; CELL PLASMA-MEMBRANE; EQUINATOXIN-II; SEA-ANEMONE; PARTICLE TRACKING; STICHOLYSIN-I; STRUCTURAL INSIGHTS; TRANSMEMBRANE PORE; LIVING CELLS; PROTEIN	alpha-Pore-forming toxins (alpha-PFTs) are ubiquitous defense tools that kill cells by opening pores in the target cell membrane. Despite their relevance in host/pathogen interactions, very little is known about the pore stoichiometry and assembly pathway leading to membrane permeabilization. Equinatoxin II (EqtII) is a model alpha-PFT from sea anemone that oligomerizes and forms pores in sphingomyelin-containing membranes. Here, we determined the spatiotemporal organization of EqtII in living cells by single molecule imaging. Surprisingly, we found that on the cell surface EqtII did not organize into a unique oligomeric form. Instead, it existed as a mixture of oligomeric species mostly including monomers, dimers, tetramers, and hexamers. Mathematical modeling based on our data supported a new model in which toxin clustering happened in seconds and proceeded via condensation of EqtII dimer units formed upon monomer association. Furthermore, altering the pathway of EqtII assembly strongly affected its toxic activity, which highlights the relevance of the assembly mechanism on toxicity.	[Subburaj, Yamunadevi; Hermann, Eduard; Tong, Rudi; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Subburaj, Yamunadevi; Hermann, Eduard; Garcia-Saez, Ana J.] Bioquant, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Ros, Uris] Fac Biol, Ctr Prot Studies, Havana, Cuba; [Hermann, Eduard; Garcia-Saez, Ana J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen	Garcia-Saez, AJ (corresponding author), Interfac Inst Biochem, D-72076 Tubingen, Germany.	ana.garcia@uni-tuebingen.de	Saez, Ana J. Garcia/U-1611-2019	Subburaj, Yamunadevi/0000-0003-2310-2889	Max Planck Society; German Cancer Research Center; Bundesministerium fur Bildung und Forschung [0312040]; EMBO; DAAD	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Cancer Research Center; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); EMBO(European Molecular Biology Organization (EMBO)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Max Planck Society, the German Cancer Research Center, and Bundesministerium fur Bildung und Forschung Grant 0312040 and grants from the EMBO and DAAD (to U. R.).	Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1998, BIOCHEM BIOPH RES CO, V242, P187, DOI 10.1006/bbrc.1997.7944; Antonini V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110824; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Bayley H, 2009, NATURE, V459, P651, DOI 10.1038/459651a; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bleicken S, 2013, J BIOL CHEM, V288, P33241, DOI 10.1074/jbc.M113.512087; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chappie JS, 2013, J CELL SCI, V126, P2773, DOI 10.1242/jcs.108845; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Fuertes G, 2011, EUR BIOPHYS J BIOPHY, V40, P399, DOI 10.1007/s00249-011-0693-4; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Garcia-Saez AJ, 2011, J BIOL CHEM, V286, P37768, DOI 10.1074/jbc.M111.281592; Groulx N, 2011, J BIOL CHEM, V286, P42274, DOI 10.1074/jbc.M111.296103; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; LEE GM, 1991, P NATL ACAD SCI USA, V88, P6274, DOI 10.1073/pnas.88.14.6274; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JA, 2006, BIOPHYS CHEM, V119, P219, DOI 10.1016/j.bpc.2005.09.021; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Meckel T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600002; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Potrich C, 2005, BIOCONJUGATE CHEM, V16, P369, DOI 10.1021/bc049873z; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Sackmann E, 2014, ADV COLLOID INTERFAC, V208, P153, DOI 10.1016/j.cis.2014.02.006; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Thompson JR, 2011, BIOPHYS J, V101, P2679, DOI 10.1016/j.bpj.2011.09.054; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Valle A, 2011, TOXICON, V58, P8, DOI 10.1016/j.toxicon.2011.04.005; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Xia T, 2013, ANNU REV PHYS CHEM, V64, P459, DOI 10.1146/annurev-physchem-040412-110127	45	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4856	4865		10.1074/jbc.M114.600676	http://dx.doi.org/10.1074/jbc.M114.600676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25525270	Green Published, hybrid			2022-12-28	WOS:000350042000030
J	Bulatov, E; Martin, EM; Chatterjee, S; Knebel, A; Shimamura, S; Konijnenberg, A; Johnson, C; Zinn, N; Grandi, P; Sobott, F; Ciulli, A				Bulatov, Emil; Martin, Esther M.; Chatterjee, Sneha; Knebel, Axel; Shimamura, Satoko; Konijnenberg, Albert; Johnson, Clare; Zinn, Nico; Grandi, Paola; Sobott, Frank; Ciulli, Alessio			Biophysical Studies on Interactions and Assembly of Full-size E3 Ubiquitin Ligase SUPPRESSOR OF CYTOKINE SIGNALING 2 (SOCS2)-ELONGIN BC-CULLIN 5-RING BOX PROTEIN 2 (RBX2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSIBLE SURFACE-AREAS; CULLIN-RING LIGASES; STRUCTURAL BASIS; CUL5-RBX2 MODULES; PROTEINS POP1P; HEAT-CAPACITY; BOX; COMPLEXES; NEDD8; ARCHITECTURE	The multisubunit cullin RINGE3 ubiquitin ligases (CRLs) target post-translationally modified substrates for ubiquitination and proteasomal degradation. The suppressors of cytokine signaling (SOCS) proteins play important roles in inflammatory processes, diabetes, and cancer and therefore represent attractive targets for therapeutic intervention. The SOCS proteins, among their other functions, serve as substrate receptors of CRL5 complexes. A member of the CRL family, SOCS2-EloBC-Cul5-Rbx2 (CRL5(SOCS2)), binds phosphorylated growth hormone receptor as its main substrate. Here, we demonstrate that the components of CRL5(SOCS2) can be specifically pulled from K562 human cell lysates using beads decorated with phosphorylated growth hormone receptor peptides. Subsequently, SOCS2-EloBC and full-length Cul5-Rbx2, recombinantly expressed in Escherichia coli and in Sf21 insect cells, respectively, were used to reconstitute neddylated and unneddylated CRL5(SOCS2) complexes in vitro. Finally, diverse biophysical methods were employed to study the assembly and interactions within the complexes. Unlike other E3 ligases, CRL5(SOCS2) was found to exist in a monomeric state as confirmed by size exclusion chromatography with inline multiangle static light scattering and native MS. Affinities of the protein-protein interactions within the multisubunit complex were measured by isothermal titration calorimetry. A structural model for full-size neddylated and unneddylated CRL5(SOCS2) complexes is supported by traveling wave ion mobility mass spectrometry data.	[Bulatov, Emil; Ciulli, Alessio] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Knebel, Axel; Johnson, Clare] Univ Dundee, Coll Life Sci, Phosphorylat & Ubiquitylat Unit, Med Res Council,Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Bulatov, Emil; Ciulli, Alessio] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Martin, Esther M.; Chatterjee, Sneha; Konijnenberg, Albert; Sobott, Frank] Univ Antwerp, Dept Chem, B-2020 Antwerp, Belgium; [Shimamura, Satoko; Zinn, Nico; Grandi, Paola] Cellzome GmbH, D-69117 Heidelberg, Germany	University of Dundee; University of Dundee; University of Cambridge; University of Antwerp; GlaxoSmithKline; Cellzome GmbH	Ciulli, A (corresponding author), Univ Dundee, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	a.ciulli@dundee.ac.uk	Bulatov, Emil/C-1766-2015	Bulatov, Emil/0000-0003-2961-0032; Knebel, Axel/0000-0002-9197-6054; Sobott, Frank/0000-0001-9029-1865	United Kingdom Biotechnology and Biological Sciences Research Council David Phillips Fellowship [BB/G023123/1]; European Research Council [ERC-2012-StG-311460 DrugE3CRLs]; Government of the Republic of Tatarstan; Wellcome Trust [100476/Z/12/Z]; Hercules Foundation-Flanders; BBSRC [BB/G023123/1, BB/G023123/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023123/2, BB/G023123/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Government of the Republic of Tatarstan; Wellcome Trust(Wellcome TrustEuropean Commission); Hercules Foundation-Flanders; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council David Phillips Fellowship BB/G023123/1 (to A. C.), European Research Council Starting Grant ERC-2012-StG-311460 DrugE3CRLs (to A. C.), and the Government of the Republic of Tatarstan (Ph.D. studentship to E. B.). Molecular biophysics was supported by Wellcome Trust strategic award 100476/Z/12/Z (to the University of Dundee). The Synapt G2 mass spectrometer was funded by a grant from the Hercules Foundation-Flanders.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Anderica-Romero AC, 2013, REDOX BIOL, V1, P366, DOI 10.1016/j.redox.2013.07.003; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hubbard S. J., 1993, NACCESS; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Kershaw NJ, 2014, GROWTH FACTORS, V32, P1, DOI 10.3109/08977194.2013.877005; Kim YK, 2013, ACTA CRYSTALLOGR D, V69, P1587, DOI 10.1107/S0907444913011220; Konijnenberg A, 2013, BBA-PROTEINS PROTEOM, V1834, P1239, DOI 10.1016/j.bbapap.2012.11.013; Lee DW, 2012, ANAL BIOCHEM, V428, P64, DOI 10.1016/j.ab.2012.06.007; Li YF, 2010, J BIOL CHEM, V285, P13896, DOI 10.1074/jbc.M110.111518; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Salter JD, 2012, BIOCHEMISTRY-US, V51, P8702, DOI 10.1021/bi301244z; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Seibert V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-22; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Thomas JC, 2013, BIOCHEMISTRY-US, V52, P5236, DOI 10.1021/bi400758h; van Geersdaele LK, 2013, ACTA CRYSTALLOGR D, V69, P1677, DOI 10.1107/S0907444913012687; Vesterlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025358; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Zhao YC, 2013, CURR PHARM DESIGN, V19, P3215, DOI 10.2174/13816128113199990300; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	55	21	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4178	4191		10.1074/jbc.M114.616664	http://dx.doi.org/10.1074/jbc.M114.616664			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25505247	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000349458400029
J	Byer, AS; Shepard, EM; Peters, JW; Broderick, JB				Byer, Amanda S.; Shepard, Eric M.; Peters, John W.; Broderick, Joan B.			Radical S-Adenosyl-L-methionine Chemistry in the Synthesis of Hydrogenase and Nitrogenase Metal Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CLUSTER-FREE HYDROGENASE; IRON-MOLYBDENUM COFACTOR; H-2-FORMING METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE; METHANOGENIC ARCHAEA; CRYSTAL-STRUCTURE; FEFE HYDROGENASE; ACTIVE-SITE; H-CLUSTER; AZOTOBACTER-VINELANDII; ESCHERICHIA-COLI	Nitrogenase, [FeFe]-hydrogenase, and [Fe]-hydrogenase enzymes perform catalysis at metal cofactors with biologically unusual non-protein ligands. The FeMo cofactor of nitrogenase has a MoFe7S9 cluster with a central carbon, whereas the H-cluster of [FeFe]-hydrogenase contains a 2Fe subcluster coordinated by cyanide and CO ligands as well as dithiomethylamine; the [Fe]hydrogenase cofactor has CO and guanylylpyridinol ligands at a mononuclear iron site. Intriguingly, radical S-adenosyl-L-methionine enzymes are vital for the assembly of all three of these diverse cofactors. This minireview presents and discusses the current state of knowledge of the radical S-adenosylmethionine enzymes required for synthesis of these remarkable metal cofactors.	[Byer, Amanda S.; Shepard, Eric M.; Peters, John W.; Broderick, Joan B.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Broderick, JB (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	jbroderick@chemistry.montana.edu		Peters, John/0000-0001-9117-9568; Broderick, Joan/0000-0001-7057-9124	United States Department of Energy [DE-FG02-10ER16194]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FG02-10ER16194 (to J. B. B., J. W. P., and E. M. S.). This is the fourth article in the Thematic Minireview Series on Radical SAM Enzymes.	Afting C, 2000, ARCH MICROBIOL, V174, P225, DOI 10.1007/s002030000197; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; Boal AK, 2012, SCIENCE, V337, P1617, DOI 10.1126/science.1229088; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Boyd ES, 2011, GEOBIOLOGY, V9, P221, DOI 10.1111/j.1472-4669.2011.00278.x; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Buurman G, 2000, FEBS LETT, V485, P200, DOI 10.1016/S0014-5793(00)02225-0; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; Driesener RC, 2013, BIOCHEMISTRY-US, V52, P8696, DOI 10.1021/bi401143s; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fay AW, 2011, ANGEW CHEM INT EDIT, V50, P7787, DOI 10.1002/anie.201102724; Fay AW, 2010, DALTON T, V39, P3124, DOI 10.1039/c000264j; Fujishiro T, 2014, FEBS LETT, V588, P2789, DOI 10.1016/j.febslet.2014.05.059; Fujishiro T, 2013, ANGEW CHEM INT EDIT, V52, P12555, DOI 10.1002/anie.201306745; George SJ, 2008, J AM CHEM SOC, V130, P5673, DOI 10.1021/ja0755358; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hernandez JA, 2008, P NATL ACAD SCI USA, V105, P11679, DOI 10.1073/pnas.0803576105; Hiromoto T, 2009, FEBS LETT, V583, P585, DOI 10.1016/j.febslet.2009.01.017; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2005, P NATL ACAD SCI USA, V102, P13825, DOI 10.1073/pnas.0506967102; Kaiser JT, 2011, SCIENCE, V331, P91, DOI 10.1126/science.1196954; KIM J, 1994, BIOCHEMISTRY-US, V33, P389, DOI 10.1021/bi00168a001; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Korbas M, 2006, J BIOL CHEM, V281, P30804, DOI 10.1074/jbc.M605306200; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Kuchenreuther JM, 2014, SCIENCE, V343, P424, DOI 10.1126/science.1246572; Kuchenreuther JM, 2013, SCIENCE, V342, P472, DOI 10.1126/science.1241859; Kuchenreuther JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045850; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; Lancaster KM, 2013, J AM CHEM SOC, V135, P610, DOI 10.1021/ja309254g; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Lie TJ, 2013, FEMS MICROBIOL LETT, V343, P156, DOI 10.1111/1574-6968.12141; Lyon EJ, 2004, J AM CHEM SOC, V126, P14239, DOI 10.1021/ja046818s; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Nicolet Y, 2015, CHEMBIOCHEM, V16, P397, DOI 10.1002/cbic.201402661; Nicolet Y, 2013, P NATL ACAD SCI USA, V110, P7188, DOI 10.1073/pnas.1302388110; Nicolet Y, 2012, J BIOL CHEM, V287, P13532, DOI 10.1074/jbc.R111.310797; Nicolet Y, 2010, FEBS LETT, V584, P4197, DOI 10.1016/j.febslet.2010.09.008; Nicolet Y, 2009, P NATL ACAD SCI USA, V106, P14867, DOI 10.1073/pnas.0904385106; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Peters JW, 2012, ANNU REV BIOCHEM, V81, P429, DOI 10.1146/annurev-biochem-052610-094911; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Quitterer F, 2012, ANGEW CHEM INT EDIT, V51, P1339, DOI 10.1002/anie.201106765; Ribbe MW, 2014, CHEM REV, V114, P4063, DOI 10.1021/cr400463x; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Salomone-Stagni M, 2010, DALTON T, V39, P3057, DOI 10.1039/b922557a; Schick M, 2012, J AM CHEM SOC, V134, P3271, DOI 10.1021/ja211594m; Schlogl R, 2003, ANGEW CHEM INT EDIT, V42, P2004, DOI 10.1002/anie.200301553; Shepard EM, 2014, BIOCHEMISTRY-US, V53, P4090, DOI 10.1021/bi500210x; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Shima S, 2004, ANGEW CHEM INT EDIT, V43, P2547, DOI 10.1002/anie.200353763; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Thauer RK, 1996, CHEM REV, V96, P3031, DOI 10.1021/cr9500601; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Tron C, 2011, EUR J INORG CHEM, P1121, DOI 10.1002/ejic.201001101; Vallese F, 2012, J BIOL CHEM, V287, P36544, DOI 10.1074/jbc.M112.388900; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Vogt S, 2008, J BIOL INORG CHEM, V13, P97, DOI 10.1007/s00775-007-0302-2; Wang XF, 2008, CHEM COMMUN, P3555, DOI 10.1039/b805262j; Wiig JA, 2012, SCIENCE, V337, P1672, DOI 10.1126/science.1224603; Wiig JA, 2011, P NATL ACAD SCI USA, V108, P8623, DOI 10.1073/pnas.1102773108; Yoshizawa JM, 2009, J AM CHEM SOC, V131, P9321, DOI 10.1021/ja9035225; Zheng LM, 1997, J BACTERIOL, V179, P5963, DOI 10.1128/jb.179.18.5963-5966.1997	84	17	17	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3987	3994		10.1074/jbc.R114.578161	http://dx.doi.org/10.1074/jbc.R114.578161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25477518	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000349458400011
J	Ohshima, N; Kudo, T; Yamashita, Y; Mariggio, S; Araki, M; Honda, A; Nagano, T; Isaji, C; Kato, N; Corda, D; Izumi, T; Yanaka, N				Ohshima, Noriyasu; Kudo, Takahiro; Yamashita, Yosuke; Mariggio, Stefania; Araki, Mari; Honda, Ayako; Nagano, Tomomi; Isaji, Chiaki; Kato, Norihisa; Corda, Daniela; Izumi, Takashi; Yanaka, Noriyuki			New Members of the Mammalian Glycerophosphodiester Phosphodiesterase Family GDE4 AND GDE7 PRODUCE LYSOPHOSPHATIDIC ACID BY LYSOPHOSPHOLIPASE D ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; LYSOPHOSPHATIDIC ACID; FACTOR ACETYLHYDROLASE; MEMBRANE-PROTEIN; RECEPTOR; ENZYME; LPA; AUTOTAXIN; IDENTIFICATION; TRANSLOCATION	The known mammalian glycerophosphodiester phosphodiesterases (GP-PDEs) hydrolyze glycerophosphodiesters. In this study, two novel members of the mammalian GP-PDE family, GDE4 and GDE7, were isolated, and the molecular basis of mammalian GP-PDEs was further explored. The GDE4 and GDE7 sequences are highly homologous and evolutionarily close. GDE4 is expressed in intestinal epithelial cells, spermatids, and macrophages, whereas GDE7 is particularly expressed in gastro-esophageal epithelial cells. Unlike other mammalian GP-PDEs, GDE4 and GDE7 cannot hydrolyze either glycerophosphoinositol or glycerophosphocholine. Unexpectedly, both GDE4 and GDE7 show a lysophospholipase D activity toward lysophosphatidylcholine (lyso-PC). We purified the recombinant GDE4 and GDE7 proteins and show that these enzymes can hydrolyze lyso-PC to produce lysophosphatidic acid (LPA). Further characterization of purified recombinant GDE4 showed that it can also convert lyso-platelet-activating factor (1-O-alkyl-sn-glycero-3-phosphocholine; lyso-PAF) to alkyl-LPA. These data contribute to our current understanding of mammalian GP-PDEs and of their physiological roles via the control of lyso-PC and lyso-PAF metabolism in gastrointestinal epithelial cells and macrophages.	[Ohshima, Noriyasu; Araki, Mari; Isaji, Chiaki; Izumi, Takashi] Gunma Univ, Dept Biochem, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Kudo, Takahiro; Yamashita, Yosuke; Honda, Ayako; Nagano, Tomomi; Kato, Norihisa; Yanaka, Noriyuki] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Higashi Hiroshima City 7398511, Japan; [Mariggio, Stefania; Corda, Daniela] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Gunma University; Hiroshima University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Yanaka, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Higashi Hiroshima City 7398511, Japan.	yanaka@hiroshima-u.ac.jp	Yanaka, Noriyuki/P-9096-2016; Corda, Daniela/K-6385-2016; Mariggio', Stefania/H-5467-2015	Corda, Daniela/0000-0002-3614-751X; Mariggio', Stefania/0000-0002-6397-3016	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Italian Association for Cancer Research; PRIN Project [2012CK5RPF_05]	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Italian Association for Cancer Research; PRIN Project	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. Y.) and from the Italian Association for Cancer Research (to D. C.) and PRIN Project 2012CK5RPF_05 (to S. M.).	Aaltonen N, 2010, J CHROMATOGR B, V878, P1145, DOI 10.1016/j.jchromb.2010.03.030; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Chang PA, 2008, MOL MEMBR BIOL, V25, P557, DOI 10.1080/09687680802537605; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Corda D, 2014, FEBS J, V281, P998, DOI 10.1111/febs.12699; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Gellett AM, 2012, BIOCHEM BIOPH RES CO, V422, P758, DOI 10.1016/j.bbrc.2012.05.077; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Howard KM, 2000, J BIOL CHEM, V275, P19891, DOI 10.1074/jbc.M001462200; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Jonkers J, 2009, CANCER CELL, V15, P457, DOI 10.1016/j.ccr.2009.05.003; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; Ohshima N, 2002, J BIOL CHEM, V277, P9722, DOI 10.1074/jbc.M112406200; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Okazaki Y, 2010, J BIOL CHEM, V285, P27652, DOI 10.1074/jbc.M110.106708; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Sanada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061931; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; SIMON MF, 1982, BIOCHEM BIOPH RES CO, V108, P1743, DOI 10.1016/S0006-291X(82)80113-7; Tanaka T, 2013, DIGEST DIS SCI, V58, P950, DOI 10.1007/s10620-012-2475-y; Tanaka T, 2009, BIOSCI BIOTECH BIOCH, V73, P1293, DOI 10.1271/bbb.80813; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tokumura A, 2002, BIOCHEM J, V365, P617, DOI 10.1042/BJ20020348; Topanurak S, 2013, P NATL ACAD SCI USA, V110, P7482, DOI 10.1073/pnas.1305220110; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Wu XQ, 2004, J BIOL CHEM, V279, P36158, DOI 10.1074/jbc.M402454200; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999	50	22	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4260	4271		10.1074/jbc.M114.614537	http://dx.doi.org/10.1074/jbc.M114.614537			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25528375	Green Published, hybrid			2022-12-28	WOS:000349458400036
J	Olson, DK; Frohlich, F; Christiano, R; Hannibal-Bach, HK; Ejsing, CS; Walther, TC				Olson, Daniel K.; Froehlich, Florian; Christiano, Romain; Hannibal-Bach, Hans K.; Ejsing, Christer S.; Walther, Tobias C.			Rom2-dependent Phosphorylation of Elo2 Controls the Abundance of Very Long-chain Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GTP-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; SPHINGOLIPID HOMEOSTASIS; EXCHANGE FACTOR; BUDDING YEAST; RHO1 GTPASE; ACTIVATION; LIPIDS; GENE	Sphingolipids are essential components of eukaryotic membranes, where they serve to maintain membrane integrity. They are important components of membrane trafficking and function in signaling as messenger molecules. Sphingolipids are synthesized de novo from very long-chain fatty acids (VLCFA) and sphingoid long-chain bases, which are amide linked to form ceramide and further processed by addition of various headgroups. Little is known concerning the regulation of VLCFA levels and how cells coordinate their synthesis with the availability of long-chain bases for sphingolipid synthesis. Here we show that Elo2, a key enzyme of VLCFA synthesis, is controlled by signaling of the guanine nucleotide exchange factor Rom2, initiating at the plasma membrane. This pathway controls Elo2 phosphorylation state and VLCFA synthesis. Our data identify a regulatory mechanism for coordinating VLCFA synthesis with sphingolipid metabolism and link signal transduction pathways from the plasma membrane to the regulation of lipids for membrane homeostasis.	[Olson, Daniel K.; Froehlich, Florian; Christiano, Romain; Walther, Tobias C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Olson, Daniel K.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06150 USA; [Hannibal-Bach, Hans K.; Ejsing, Christer S.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-0230 Odense, Denmark; [Walther, Tobias C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walther, Tobias C.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Yale University; University of Southern Denmark; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Walther, TC (corresponding author), 665 Huntington Ave,Bldg 1,Room 207, Boston, MA 02115 USA.	twalther@hsph.harvard.edu	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276; Walther, Tobias/0000-0003-1442-1327; Frohlich, Florian/0000-0001-8307-2189	National Institutes of Health [R01GM095982]; Yale Top scholar award; Lundbeckfonden [R44-A4342]; Danish Council for Independent Research Natural Sciences [09-072484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095982, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Top scholar award; Lundbeckfonden(Lundbeckfonden); Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM095982 (to T. C. W.), a Yale Top scholar award (to T. C. W.), Lundbeckfonden Grant R44-A4342 (to C. S. E.), and Danish Council for Independent Research Natural Sciences Grant 09-072484 (to C. S. E.).	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Breslow DK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013326; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Di Gregorio E, 2014, AM J HUM GENET, V95, P209, DOI 10.1016/j.ajhg.2014.07.001; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Frohlich F, 2013, MOL CELL PROTEOMICS, V12, P1995, DOI 10.1074/mcp.M112.025742; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Kobayashi T, 2005, J BIOL CHEM, V280, P18087, DOI 10.1074/jbc.M414138200; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Lyons NA, 2013, NAT STRUCT MOL BIOL, V20, P194, DOI 10.1038/nsmb.2478; Mizunuma M, 2001, EMBO J, V20, P1074, DOI 10.1093/emboj/20.5.1074; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Niles BJ, 2012, CELL CYCLE, V11, P3745, DOI 10.4161/cc.21752; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; REVARDEL E, 1995, BBA-GENE STRUCT EXPR, V1263, P261, DOI 10.1016/0167-4781(95)00124-Y; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; SIKORSKI RS, 1989, GENETICS, V122, P19; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; THEWALT J, 1992, BIOCHEM BIOPH RES CO, V188, P1247, DOI 10.1016/0006-291X(92)91365-W; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yan GH, 2012, MOL CELL, V45, P743, DOI 10.1016/j.molcel.2012.01.028; Zimmermann C, 2013, CELL REP, V5, P1036, DOI 10.1016/j.celrep.2013.10.024	57	17	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4238	4247		10.1074/jbc.M114.629279	http://dx.doi.org/10.1074/jbc.M114.629279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25519905	Green Published, hybrid			2022-12-28	WOS:000349458400034
J	Seifert, W; Kuhnisch, J; Maritzen, T; Lommatzsch, S; Hennies, HC; Bachmann, S; Horn, D; Haucke, V				Seifert, Wenke; Kuehnisch, Jirko; Maritzen, Tanja; Lommatzsch, Stefanie; Hennies, Hans Christian; Bachmann, Sebastian; Horn, Denise; Haucke, Volker			Cohen Syndrome-associated Protein COH1 Physically and Functionally Interacts with the Small GTPase RAB6 at the Golgi Complex and Directs Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBRAL-CORTEX; MEMBRANE TRAFFICKING; MUTATIONAL SPECTRUM; GENE; TRANSPORT; NEURONS; HETEROGENEITY; GLYCOSYLATION; LOCALIZATION; HOMEOSTASIS	Postnatal microcephaly, intellectual disability, and progressive retinal dystrophy are major features of autosomal recessive Cohen syndrome, which is caused by mutations in the gene COH1 (VPS13B). We have recently identified COH1 as a Golgi-enriched scaffold protein that contributes to the structural maintenance and function of the Golgi complex. Here, we show that association of COH1 with the Golgi complex depends on the small GTPase RAB6. RNAi-mediated knockdown of RAB6A/A' prevents the localization of COH1 to the Golgi complex. Expression of the constitutively inactive RAB6_T27N mutant led to an increased solubilization of COH1 from lipid membrane preparations. Co-IP experiments confirmed the physical interaction of COH1 with RAB6 that preferentially occurred with the constitutively active RAB6_Q72L mutants. Depletion of COH1 in primary neurons negatively interfered with neurite outgrowth, indicating a causal link between the integrity of the Golgi complex and axonal outgrowth. We conclude that COH1 is a RAB6 effector protein and that reduced brain size in Cohen syndrome patients likely results from impaired COH1 function at the Golgi complex, causing decreased neuritogenesis.	[Seifert, Wenke; Lommatzsch, Stefanie; Bachmann, Sebastian] Charite, Inst Vegetat Anat, D-10115 Berlin, Germany; [Kuehnisch, Jirko; Horn, Denise] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Kuehnisch, Jirko] Max Planck Inst Mol Genet FG Dev & Dis, D-14195 Berlin, Germany; [Maritzen, Tanja; Haucke, Volker] Leibniz Inst Mol Pharmacol, Dept Mol Pharmacol & Cell Biol, D-13125 Berlin, Germany; [Hennies, Hans Christian] Univ Cologne, CCG, D-50931 Cologne, Germany; [Hennies, Hans Christian] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Hennies, Hans Christian] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Cologne; University of Cologne; Medical University of Innsbruck	Seifert, W (corresponding author), Charite, Inst Vegetat Anat, Charitepl 1, D-10117 Berlin, Germany.	wenke.seifert@charite.de	Seifert, Wenke/B-8772-2011; Kühnisch, Jirko/L-7761-2013; Kühnisch, Jirko/M-3744-2019; Hennies, Hans C/G-9424-2014	Kühnisch, Jirko/0000-0003-4744-5421; Hennies, Hans C/0000-0001-7210-2389; Haucke, Volker/0000-0003-3119-6993; Maritzen, Tanja/0000-0003-4993-0340; Seifert, Wenke/0000-0003-1432-9862	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to T. M., V. H., and W. S.).	Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; COHEN MM, 1973, J PEDIATR-US, V83, P280; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Hennies HC, 2004, AM J HUM GENET, V75, P138, DOI 10.1086/422219; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kivitie-Kallio S, 1998, NEUROPEDIATRICS, V29, P298, DOI 10.1055/s-2007-973581; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubbehusen J, 2010, HUM MOL GENET, V19, P3623, DOI 10.1093/hmg/ddq278; Majeed W, 2014, TRAFFIC, V15, P630, DOI 10.1111/tra.12167; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Miller VJ, 2012, TRAFFIC, V13, P891, DOI 10.1111/j.1600-0854.2012.01338.x; Mochida GH, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014779; Park J. S., J CELL SCI, V125, P3004; Park J. S., EUKARYOT CELL, V12, P1530; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Redding K, 1996, MOL CELL BIOL, V16, P6208; Rosnoblet C, 2013, GLYCOCONJUGATE J, V30, P23, DOI 10.1007/s10719-012-9389-y; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Seifert W, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039867; Seifert W, 2011, J BIOL CHEM, V286, P37665, DOI 10.1074/jbc.M111.267971; Seifert W, 2009, HUM MUTAT, V30, pE404, DOI 10.1002/humu.20886; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	38	55	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3349	3358		10.1074/jbc.M114.608174	http://dx.doi.org/10.1074/jbc.M114.608174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25492866	hybrid, Green Published			2022-12-28	WOS:000349456000013
J	Wegener, KM; Nagarajan, A; Pakrasi, HB				Wegener, Kimberly M.; Nagarajan, Aparna; Pakrasi, Himadri B.			An Atypical psbA Gene Encodes a Sentinel D1 Protein to Form a Physiologically Relevant Inactive Photosystem II Complex in Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; GENOME; FIXATION; LIGHT; PHOTOACTIVATION; PHOTOSYNTHESIS; RECOMBINATION; RESOLUTION; ADAPTATION; EVOLUTION	Photosystem II, a large membrane-bound enzyme complex in cyanobacteria and chloroplasts, mediates light-induced oxidation of water to molecular oxygen. The D1 protein of PSII, encoded by the psbA gene, provides multiple ligands for cofactors crucial to this enzymatic reaction. Cyanobacteria contain multiple psbA genes that respond to various physiological cues and environmental factors. Certain unicellular cyanobacterial cells, such as Cyanothece sp. ATCC 51142, are capable of nitrogen fixation, a highly oxygen-sensitive process, by separating oxygen evolution from nitrogen fixation using a day-night cycle. We have shown that c-psbA4, one of the five psbA orthologs in this cyanobacterium, is exclusively expressed during nighttime. Remarkably, the corresponding D1 isoform has replacements of a number of amino acids that are essential ligands for the catalytic Mn4CaO5 metal center for water oxidation by PSII. At least 30 cyanobacterial strains, most of which are known to have nitrogen fixing abilities, have similar psbA orthologs. We expressed the c-psbA4 gene from Cyanothece 51142 in a 4E-3 mutant strain of the model non-nitrogen-fixing cyanobacterium Synechocystis sp. PCC 6803, which lacks any psbA gene. The resultant strain could not grow photoautotrophically. Moreover, these Synechocystis 6803 cells were incapable of PSII-mediated oxygen evolution. Based on our findings, we have named this physiologically relevant, unusual D1 isoform sentinel D1. Sentinel D1 represents a new class of D1 protein that, when incorporated in a PSII complex, ensures that PSII cannot mediate water oxidation, thus allowing oxygen-sensitive processes such as nitrogen fixation to occur in cyanobacterial cells.	[Wegener, Kimberly M.; Nagarajan, Aparna; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, CB1137,1 Brookings Dr, St Louis, MO 63130 USA.	pakrasi@wustl.edu		Nagarajan, Aparna/0000-0003-4434-5601	National Science Foundation [MCB 0745611, MCB 1331194]; Div Of Molecular and Cellular Bioscience [1331194] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB 0745611 and MCB 1331194 (to H. B. P.).	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Bandyopadhyay A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1139; Bench SR, 2013, J PHYCOL, V49, P786, DOI 10.1111/jpy.12090; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; Burnap RL, 1996, BIOCHEMISTRY-US, V35, P874, DOI 10.1021/bi951964j; Campbell D, 1999, PHYSIOL PLANTARUM, V105, P746, DOI 10.1034/j.1399-3054.1999.105420.x; Cardona T, 2009, BBA-BIOENERGETICS, V1787, P252, DOI 10.1016/j.bbabio.2009.01.015; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Debus R. J., 1990, CURRENT RES PHOTOSYN, V1, P829; DINER BA, 1988, J BIOL CHEM, V263, P8972; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GALLON JR, 1992, NEW PHYTOL, V122, P571; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; Gorbunov MY, 2002, LIMNOL OCEANOGR, V47, P309, DOI 10.4319/lo.2002.47.1.0309; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Komenda J, 2012, CURR OPIN PLANT BIOL, V15, P245, DOI 10.1016/j.pbi.2012.01.017; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; KULKARNI RD, 1994, J BACTERIOL, V176, P959, DOI 10.1128/JB.176.4.959-965.1994; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MANNAN RM, 1993, PLANT PHYSIOL, V103, P971, DOI 10.1104/pp.103.3.971; Mate Z, 1998, J BIOL CHEM, V273, P17439, DOI 10.1074/jbc.273.28.17439; Meeks JC, 2001, PHOTOSYNTH RES, V70, P85, DOI 10.1023/A:1013840025518; Meunier PC, 1998, PLANT PHYSIOL, V116, P1551, DOI 10.1104/pp.116.4.1551; MOHAMED A, 1993, MOL GEN GENET, V238, P161, DOI 10.1007/BF00279543; Mohr R, 2010, ISME J, V4, P1456, DOI 10.1038/ismej.2010.67; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; Murray JW, 2012, PHOTOSYNTH RES, V110, P177, DOI 10.1007/s11120-011-9714-5; Nagarajan A, 2014, BBA-BIOENERGETICS, V1837, P1417, DOI 10.1016/j.bbabio.2014.02.022; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Overmann J., 2013, PROKARYOTES, P203, DOI DOI 10.1007/978-3-642-30123-0_51; Pfreundt U, 2012, ISME J, V6, P1367, DOI 10.1038/ismej.2011.199; Postgate J., 1998, NITROGEN FIXATION; Rakhimberdieva MG, 2007, BBA-BIOENERGETICS, V1767, P757, DOI 10.1016/j.bbabio.2006.12.007; Raven JA, 2006, ASTROBIOLOGY, V6, P668, DOI 10.1089/ast.2006.6.668; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Salih GF, 1997, PLANT CELL, V9, P869, DOI 10.1105/tpc.9.6.869; Satoh K, 2007, PHOTOSYNTH RES, V94, P203, DOI 10.1007/s11120-007-9191-z; Sherman LA, 1998, PHOTOSYNTH RES, V58, P25, DOI 10.1023/A:1006137605802; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Sicora C, 2004, PHYS CHEM CHEM PHYS, V6, P4832, DOI 10.1039/b406695b; Sicora CI, 2008, BBA-BIOENERGETICS, V1777, P130, DOI 10.1016/j.bbabio.2007.09.001; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Stockel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016680; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; TAKAHASHI M, 1988, FEBS LETT, V240, P6, DOI 10.1016/0014-5793(88)80330-2; TAKAHASHI Y, 1990, PLANT CELL PHYSIOL, V31, P273; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiel T., 1990, CURRENT RES PHOTOSYN, V1, P291; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Williams R. J. P., 1997, NATURAL SELECTION CH; Zhang XH, 2012, PHOTOSYNTH RES, V114, P133, DOI 10.1007/s11120-012-9783-0	60	19	20	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3764	3774		10.1074/jbc.M114.604124	http://dx.doi.org/10.1074/jbc.M114.604124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525275	hybrid, Green Published			2022-12-28	WOS:000349456000047
J	Welbourn, S; Kao, S; Du Pont, KE; Andrew, AJ; Berndsen, CE; Strebel, K				Welbourn, Sarah; Kao, Sandra; Du Pont, Kelly E.; Andrew, Amy J.; Berndsen, Christopher E.; Strebel, Klaus			Positioning of Cysteine Residues within the N-terminal Portion of the BST-2/Tetherin Ectodomain Is Important for Functional Dimerization of BST-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 VIRUS RELEASE; CELL-SURFACE; MOLECULAR-CLONING; TETHERIN; VPU; PROTEIN; LOCALIZATION; RESTRICTION; INHIBITION; ANTAGONISM	BST-2/tetherin is a cellular host factor capable of restricting the release of a variety of enveloped viruses, including HIV-1. Structurally, BST-2 consists of an N-terminal cytoplasmic domain, a transmembrane domain, an ectodomain, and a C-terminal membrane anchor. The BST-2 ectodomain encodes three cysteine residues in its N-terminal half, each of which can contribute to the formation of cysteine-linked dimers. We previously reported that any one of the three cysteine residues is sufficient to produce functional BST-2 dimers. Here we investigated the importance of cysteine positioning on the ectodomain for functional dimerization of BST-2. Starting with a cysteine-free monomeric form of BST-2, individual cysteine residues were reintroduced at various locations throughout the ectodomain. The resulting BST-2 variants were tested for expression, dimerization, surface presentation, and inhibition of HIV-1 virus release. We found significant flexibility in the positioning of cysteine residues, although the propensity to form cysteine-linked dimers generally decreased with increasing distance from the N terminus. Interestingly, all BST-2 variants, including the one lacking all three ectodomain cysteines, retained the ability to form non-covalent dimers, and all of the BST-2 variants were efficiently expressed at the cell surface. Importantly, not all BST-2 variants capable of forming cysteine-linked dimers were functional, suggesting that cysteine-linked dimerization of BST-2 is necessary but not sufficient for inhibiting virus release. Our results expose new structural constraints governing the functional dimerization of BST-2, a property essential to its role as a restriction factor tethering viruses to the host cell.	[Welbourn, Sarah; Kao, Sandra; Andrew, Amy J.; Strebel, Klaus] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Du Pont, Kelly E.; Berndsen, Christopher E.] James Madison Univ, Dept Chem & Biochem, Harrisonburg, VA 22807 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); James Madison University	Strebel, K (corresponding author), NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bldg 4,Rm 310,4 Ctr Dr MSC 0460, Bethesda, MD 20892 USA.	kstrebel@nih.gov	Welbourn, Sarah/AAU-5645-2020	Zuccaro, Kelly E/0000-0001-8904-5106; Berndsen, Christopher/0000-0002-4285-4341; Welbourn, Sarah/0000-0002-2932-1436	Intramural Research Program of the NIAID, National Institutes of Health [1 ZO1 AI000669]; Canadian Institutes of Health Research; Research Corporation Development Award [7957]; James Madison University Program of Grants for Faculty Assistance; 4-VA organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000669, ZIAAI000669] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Corporation Development Award; James Madison University Program of Grants for Faculty Assistance; 4-VA organization; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Intramural Research Program of the NIAID, National Institutes of Health Grant 1 ZO1 AI000669.; Supported by a postdoctoral fellowship from the Canadian Institutes of Health Research.; Supported by Research Corporation Development Award 7957, the James Madison University Program of Grants for Faculty Assistance, and the 4-VA organization.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alvarez RA, 2014, J VIROL, V88, P6031, DOI 10.1128/JVI.00449-14; Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108; Andrew A, 2010, MOL ASPECTS MED, V31, P407, DOI 10.1016/j.mam.2010.08.002; Andrew AJ, 2012, J BIOL CHEM, V287, P44278, DOI 10.1074/jbc.M112.418822; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Arias JF, 2014, P NATL ACAD SCI USA, V111, P6425, DOI 10.1073/pnas.1321507111; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hu ZQ, 2010, J COMPUT CHEM, V31, P371, DOI 10.1002/jcc.21330; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; SUTHERLAND R, 1981, P NATL ACAD SCI-BIOL, V78, P4515, DOI 10.1073/pnas.78.7.4515; Swiecki M, 2013, MOL IMMUNOL, V54, P132, DOI 10.1016/j.molimm.2012.11.008; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Venkatesh S., 2013, PLOS PATHOG, DOI [10.1371/journal.ppat.1003483, DOI 10.1371/J0URNAL.PPAT.1003483]; Xu FW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-198; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107	34	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3740	3751		10.1074/jbc.M114.617639	http://dx.doi.org/10.1074/jbc.M114.617639			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525265	Green Published, hybrid			2022-12-28	WOS:000349456000045
J	Asuthkar, S; Elustondo, PA; Demirkhanyan, L; Sun, X; Baskaran, P; Velpula, KK; Thyagarajan, B; Pavlov, EV; Zakharian, E				Asuthkar, Swapna; Elustondo, Pia A.; Demirkhanyan, Lusine; Sun, Xiaohui; Baskaran, Padmamalini; Velpula, Kiran Kumar; Thyagarajan, Baskaran; Pavlov, Evgeny V.; Zakharian, Eleonora			The TRPM8 Protein Is a Testosterone Receptor I. BIOCHEMICAL EVIDENCE FOR DIRECT TRPM8-TESTOSTERONE INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen; Calcium Channel; Ion Channel; Testosterone; Transient Receptor Potential Channels (TRP Channels); Cold and Menthol Receptor TRPM8; Transient Receptor Potential Melastatin 8 Channel	PROSTATE-CANCER; MEDULLOBLASTOMA CELLS; COLD; CHANNEL; EXPRESSION; MENTHOL; TRP-P8; IDENTIFICATION; SURVIVAL; GENE	Background: TRPM8 channels are highly expressed in prostate tissues, where the role of this cold receptor is not well understood. Results: Testosterone directly interacts with the TRPM8 protein. Conclusion: TRPM8 is a testosterone receptor. Significance: TRPM8 channels may be implicated in various physiological processes regulated by androgens. The transient receptor potential ion channel of the melastatin subfamily, TRPM8, is a major cold receptor in the peripheral nervous system. Along with the sensory neurons, the TRPM8 protein is highly expressed in the prostate epithelial cells, and this expression is regulated by androgens. Here we investigated the expression and intracellular localization of the TRPM8 channel in relationship to androgens. We performed experiments using human prostate tissues obtained from healthy individuals and patients with prostate cancer at various stages of the disease as well as in cultured cells. Using an immunohistochemistry approach, we detected an intensive colocalization pattern of the TRPM8 protein with endogenous androgens in all tissues tested, suggesting possible interactions. Co-immunoprecipitation experiments performed using cultured prostate epithelial cells, prostate cancer cells, and HEK-293 cells stably expressing TRPM8 further confirmed direct binding of the steroid hormone, testosterone, to the TRPM8 protein. Applications of picomolar concentrations of testosterone to the primary human prostate cells, endogenously expressing TRPM8, elicited Ca2+ responses and channel currents, and those were inhibited in the presence of TRPM8 antagonist, N-(2-aminoethyl)-N-(4-(benzyloxy)-3-methoxybenzyl)thiophene-2-carboxamide hydrochloride. These results indicate that the TRPM8 channel is physically associated with testosterone and suggest that, in addition to a genomic role, testosterone plays a role in direct regulation of the TRPM8 channel function.	[Asuthkar, Swapna; Demirkhanyan, Lusine; Sun, Xiaohui; Velpula, Kiran Kumar; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Elustondo, Pia A.; Pavlov, Evgeny V.] Dalhousie Univ, Halifax, NS B3H 4R2, Canada; [Baskaran, Padmamalini; Thyagarajan, Baskaran] Univ Wyoming, Sch Pharm, Coll Hlth Sci, Laramie, WY 82071 USA; [Pavlov, Evgeny V.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA	University of Illinois System; University of Illinois Peoria; Dalhousie University; University of Wyoming; New York University	Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	zakharel@uic.edu	Sun, Xiaohui/G-5146-2013	Sun, Xiaohui/0000-0003-0294-6855; Baskaran, Padmamalini/0000-0001-8851-1486	National Institutes of Health [R01GM098052, 8P20GM103432-12]; Heart and Stroke Foundation of Canada [G-13-0003008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098052, P20GM103432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM098052 (to E. Z.). This work was also supported by Heart and Stroke Foundation of Canada Grant G-13-0003008 (to E. P.) and by the pilot project support from the National Institutes of Health Grant 8P20GM103432-12 (to B. T.).	Asuthkar S, 2014, ONCOGENE, V33, P1922, DOI 10.1038/onc.2013.151; Asuthkar S, 2015, J BIOL CHEM, V290, P2670, DOI 10.1074/jbc.M114.610873; Asuthkar S, 2012, J BIOL CHEM, V287, P20576, DOI 10.1074/jbc.M112.348888; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bruck N, 2005, CELL SIGNAL, V17, P1229, DOI 10.1016/j.cellsig.2004.12.006; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Fuessel S, 2003, INT J ONCOL, V23, P221; Henshall SM, 2003, CANCER RES, V63, P4196; Kiessling A, 2003, PROSTATE, V56, P270, DOI 10.1002/pros.10265; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morgentaler A, 2006, EUR UROL, V50, P935, DOI 10.1016/j.eururo.2006.06.034; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Tsavaler L, 2001, CANCER RES, V61, P3760; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Yudin Y, 2011, J PHYSIOL-LONDON, V589, P6007, DOI 10.1113/jphysiol.2011.220228; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	25	65	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2659	2669		10.1074/jbc.M114.610824	http://dx.doi.org/10.1074/jbc.M114.610824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25480783	hybrid, Green Published			2022-12-28	WOS:000349310700011
J	Liu, F; Zhou, Q; Zhou, J; Sun, H; Wang, Y; Zou, XQ; Feng, LL; Hou, ZY; Zhou, AW; Zhou, Y; Li, Y				Liu, Feng; Zhou, Qin; Zhou, Jie; Sun, Hao; Wang, Yan; Zou, Xiuqun; Feng, Lingling; Hou, Zhaoyuan; Zhou, Aiwu; Zhou, Yi; Li, Yong			14-3-3 tau Promotes Surface Expression of Cav2.2 (alpha 1B) Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channel; Electrophysiology; Membrane Trafficking; Protein-Protein Interaction; Trafficking; 14-3-3tau; Cav 2; 2 Channel; Cav Auxiliary Subunits; Endoplasmic Reticulum Retention	BETA-SUBUNIT; CALCIUM-CHANNELS; ENDOPLASMIC-RETICULUM; CHARGE MOVEMENT; IONIC CURRENT; MODULATION; PROTEINS; RETENTION; TRANSPORT; BINDING	Background: The mechanism and dynamics of Cav channels trafficking remains mysterious. Results: 14-3-3 promotes Cav2.2 trafficking independent of Cav auxiliary subunits. Conclusion: 14-3-3 enhances Cav2.2 trafficking by masking the ER retention signal at its proximal C-terminal region. Significance: Uncovering the regulation of Cav2.2 trafficking may contribute to understanding the Cav2.2 surface expression and functional control under physiological and pathophysiological conditions. Surface expression of voltage-gated Ca2+ (Cav) channels is important for their function in calcium homeostasis in the physiology of excitable cells, but whether or not and how the 1 pore-forming subunits of Cav channels are trafficked to plasma membrane in the absence of the known Cav auxiliary subunits, and 2, remains mysterious. Here we showed that 14-3-3 proteins promoted functional surface expression of the Cav2.2 1B channel in transfected tsA-201 cells in the absence of any known Cav auxiliary subunit. Both the surface to total ratio of the expressed 1B protein and the current density of voltage step-evoked Ba2+ current were markedly suppressed by the coexpression of a 14-3-3 antagonist construct, pSCM138, but not its inactive control, pSCM174, as determined by immunofluorescence assay and whole cell voltage clamp recording, respectively. By contrast, coexpression with 14-3-3 significantly enhanced the surface expression and current density of the Cav2.2 1B channel. Importantly, we found that between the two previously identified 14-3-3 binding regions at the 1B C terminus, only the proximal region (amino acids 1706-1940), closer to the end of the last transmembrane domain, was retained by the endoplasmic reticulum and facilitated by 14-3-3 to traffic to plasma membrane. Additionally, we showed that the 14-3-3/Cav subunit coregulated the surface expression of Cav2.2 channels in transfected tsA-201 cells and neurons. Altogether, our findings reveal a previously unidentified regulatory function of 14-3-3 proteins in promoting the surface expression of Cav2.2 1B channels.	[Liu, Feng; Zhou, Qin; Zhou, Jie; Sun, Hao; Wang, Yan; Zou, Xiuqun; Feng, Lingling; Hou, Zhaoyuan; Zhou, Aiwu; Li, Yong] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem & Mol Cell Biol,Shanghai Key Lab Tum, Shanghai 200025, Peoples R China; [Zhou, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Shanghai Jiao Tong University; State University System of Florida; Florida State University	Li, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem & Mol Cell Biol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	liyong68@shsmu.edu.cn	Li, Yong/ABB-5588-2021	ZHOU, Aiwu/0000-0002-2555-5091	National Basic Research Program of China [2010CB912001, 2014CB910303]; National Natural Science Foundation of China [81171230, 31371064, 30970937]; Major Research Plan of the National Natural Science Foundation of China [91132303]; Shanghai Pujiang Program Grant [11PJ1406100]; Shanghai Committee of Science and Technology [11DZ2260200]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program Grant; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Basic Research Program of China Grants 2010CB912001 and 2014CB910303 (to Y. L.), National Natural Science Foundation of China Grants 81171230, 31371064, and 30970937 (to Y. L.), Major Research Plan of the National Natural Science Foundation of China Grant 91132303 (to Tianle Xu and Y. L.), Shanghai Pujiang Program Grant 11PJ1406100 (to Y. L.), and Shanghai Committee of Science and Technology Grant 11DZ2260200.	Allouis M, 2006, CIRC RES, V98, P1538, DOI 10.1161/01.RES.0000229244.97497.2c; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Josephson IR, 1996, BIOPHYS J, V70, P1285, DOI 10.1016/S0006-3495(96)79685-6; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Li Y, 2007, CHANNELS, V1; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Matsuyama Z, 1999, J Neurosci, V19, pRC14; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Sun CC, 2013, J BIOL CHEM, V288, P24676, DOI 10.1074/jbc.M113.462069; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Waithe D, 2011, J BIOL CHEM, V286, P9598, DOI 10.1074/jbc.M110.195909; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zhang ZN, 2008, J CELL SCI, V121, P3243, DOI 10.1242/jcs.026856	41	8	8	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2689	2698		10.1074/jbc.M114.567800	http://dx.doi.org/10.1074/jbc.M114.567800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25516596	Green Published, hybrid			2022-12-28	WOS:000349310700013
J	Allan, CM; Awad, AM; Johnson, JS; Shirasaki, DI; Wang, C; Blaby-Haas, CE; Merchant, SS; Loo, JA; Clarke, CF				Allan, Christopher M.; Awad, Agape M.; Johnson, Jarrett S.; Shirasaki, Dyna I.; Wang, Charles; Blaby-Haas, Crysten E.; Merchant, Sabeeha S.; Loo, Joseph A.; Clarke, Catherine F.			Identification of Coq11, a New Coenzyme Q Biosynthetic Protein in the CoQ-Synthome in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mass Spectrometry (MS); Mitochondrial Metabolism; Protein Complex; Proteomics; Saccharomyces cerevisiae; Ubiquinone; Yeast; Q Biosynthetic Intermediates; Coenzyme Q; Immunoprecipitation	PARA-AMINOBENZOIC ACID; MITOCHONDRIAL FERREDOXIN; C-METHYLTRANSFERASE; YEAST MITOCHONDRIA; ACETOHYDROXYACID SYNTHASE; REGULATORY SUBUNIT; BINDING-PROTEIN; ESSENTIAL GENE; POLYPEPTIDE; KINASE	Background: Yeast synthesizes coenzyme Q via a macromolecular protein complex. Results: The Q biosynthetic complex includes Coq8 and the uncharacterized protein YLR290C; the ylr290c mutant exhibits impaired Q synthesis. Conclusion: YLR290C (Coq11) is a novel protein required for efficient yeast Q biosynthesis. Significance: Discovery and characterization of yeast Coq biosynthetic proteins leads to an improved understanding of coenzyme Q biosynthesis and regulation. Coenzyme Q (Q or ubiquinone) is a redox active lipid composed of a fully substituted benzoquinone ring and a polyisoprenoid tail and is required for mitochondrial electron transport. In the yeast Saccharomyces cerevisiae, Q is synthesized by the products of 11 known genes, COQ1-COQ9, YAH1, and ARH1. The function of some of the Coq proteins remains unknown, and several steps in the Q biosynthetic pathway are not fully characterized. Several of the Coq proteins are associated in a macromolecular complex on the matrix face of the inner mitochondrial membrane, and this complex is required for efficient Q synthesis. Here, we further characterize this complex via immunoblotting and proteomic analysis of tandem affinity-purified tagged Coq proteins. We show that Coq8, a putative kinase required for the stability of the Q biosynthetic complex, is associated with a Coq6-containing complex. Additionally Q(6) and late stage Q biosynthetic intermediates were also found to co-purify with the complex. A mitochondrial protein of unknown function, encoded by the YLR290C open reading frame, is also identified as a constituent of the complex and is shown to be required for efficient de novo Q biosynthesis. Given its effect on Q synthesis and its association with the biosynthetic complex, we propose that the open reading frame YLR290C be designated COQ11.	[Allan, Christopher M.; Awad, Agape M.; Johnson, Jarrett S.; Shirasaki, Dyna I.; Wang, Charles; Blaby-Haas, Crysten E.; Merchant, Sabeeha S.; Loo, Joseph A.; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Allan, Christopher M.; Awad, Agape M.; Johnson, Jarrett S.; Shirasaki, Dyna I.; Wang, Charles; Blaby-Haas, Crysten E.; Merchant, Sabeeha S.; Loo, Joseph A.; Clarke, Catherine F.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.; Loo, Joseph A.] Univ Calif Los Angeles, US DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 156905, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu		Blaby, Crysten/0000-0002-1583-1291	National Institutes of Health [S10RR024605, R01GM103479]; National Science Foundation [MCB-1330803]; Kirschstein National Research Service Award NIH [GM100753]; Office of Science (Biological and Environmental Research), U.S. Department of Energy [DE-FC02-02ER63421]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055052, R01GM103479, F32GM100753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Kirschstein National Research Service Award NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science (Biological and Environmental Research), U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants S10RR024605 and R01GM103479 (to J. A. L.). This work was also supported by National Science Foundation Grant MCB-1330803 (to C. F. C.), Kirschstein National Research Service Award NIH GM100753 (to C. E. B.-H.), and Grant DE-FC02-02ER63421 from the Office of Science (Biological and Environmental Research), U.S. Department of Energy.	Allan CM, 2013, BBA-MOL CELL BIOL L, V1831, P776, DOI 10.1016/j.bbalip.2012.12.007; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Baba SW, 2004, J BIOL CHEM, V279, P10052, DOI 10.1074/jbc.M313712200; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Barros MH, 1999, GENE, V233, P197, DOI 10.1016/S0378-1119(99)00137-7; Belogrudov GI, 2001, ARCH BIOCHEM BIOPHYS, V392, P48, DOI 10.1006/abbi.2001.2448; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Brachmann CB, 1998, YEAST, V14, P115; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Burke D., 2000, METHODS YEAST GENETI, P177; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crane F. L., 1965, BIOCH QUINONES, P183; Cui TZ, 2009, FEBS J, V276, P748, DOI 10.1111/j.1742-4658.2008.06821.x; Cullin C, 1996, YEAST, V12, P1511, DOI 10.1002/(SICI)1097-0061(199612)12:15<1511::AID-YEA41>3.0.CO;2-B; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gin P, 2005, J BIOL CHEM, V280, P2676, DOI 10.1074/jbc.M411527200; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Gulmezian M., 2006, THESIS UCLA LOS ANGE; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; He CWH, 2014, BBA-MOL CELL BIOL L, V1841, P630, DOI 10.1016/j.bbalip.2013.12.017; Hershey HP, 1999, PLANT MOL BIOL, V40, P795, DOI 10.1023/A:1006273224977; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Hsieh EJ, 2004, BIOCHEM BIOPH RES CO, V317, P648, DOI 10.1016/j.bbrc.2004.03.096; Huang MS, 2013, J PROTEOME RES, V12, P491, DOI 10.1021/pr300952g; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Laredj LN, 2014, BIOCHIMIE, V100, P78, DOI 10.1016/j.biochi.2013.12.006; Lee YT, 2001, BIOCHEMISTRY-US, V40, P6836, DOI 10.1021/bi002775q; Lenaz G., 1985, COENZYME Q, P165; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lohman DC, 2014, P NATL ACAD SCI USA, V111, pE4697, DOI 10.1073/pnas.1413128111; Lundquist PK, 2012, TRENDS PLANT SCI, V17, P546, DOI 10.1016/j.tplants.2012.05.010; Lundquist PK, 2012, PLANT PHYSIOL, V158, P1172, DOI 10.1104/pp.111.193144; Manzella L, 1998, YEAST, V14, P839, DOI 10.1002/(SICI)1097-0061(19980630)14:9<839::AID-YEA283>3.0.CO;2-A; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mukai N, 2010, J BIOSCI BIOENG, V109, P564, DOI 10.1016/j.jbiosc.2009.11.011; Murai M, 2014, BIOCHEMISTRY-US, V53, P3995, DOI 10.1021/bi500347s; Nguyen TPT, 2014, BBA-MOL CELL BIOL L, V1841, P1628, DOI 10.1016/j.bbalip.2014.08.007; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Pang SS, 2001, BIOCHEM J, V357, P749, DOI 10.1042/0264-6021:3570749; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Piller LE, 2012, J EXP BOT, V63, P1609, DOI 10.1093/jxb/ers016; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Rea SL, 2010, DEV DISABIL RES REV, V16, P200, DOI 10.1002/ddrr.114; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Tay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055041; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1994, J BIOL CHEM, V269, P26144; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Wheeler B, 2015, PROTEIN EXPRES PURIF, V108, P13, DOI 10.1016/j.pep.2014.12.008; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	90	52	54	1	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7517	7534		10.1074/jbc.M114.633131	http://dx.doi.org/10.1074/jbc.M114.633131			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25631044	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000351613600019
J	Barbato, S; Sgarbi, G; Gorini, G; Baracca, A; Solaini, G				Barbato, Simona; Sgarbi, Gianluca; Gorini, Giulia; Baracca, Alessandra; Solaini, Giancarlo			The Inhibitor Protein (IF1) of the F1F0-ATPase Modulates Human Osteosarcoma Cell Bioenergetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION ENZYMES; ATP SYNTHASE; ADENOSINE-TRIPHOSPHATASE; MITOCHONDRIAL ATPASE; RAT-LIVER; COMPLEX; DYSFUNCTION; MUSCLE; HEART; DIMERIZATION	The bioenergetics of IF1 transiently silenced cancer cells has been extensively investigated, but the role of IF1 (the natural inhibitor protein of F1F0-ATPase) in cancer cell metabolism is still uncertain. To shed light on this issue, we established a method to prepare stably IF1-silenced human osteosarcoma clones and explored the bioenergetics of IF1 null cancer cells. We showed that IF1-silenced cells proliferate normally, consume glucose, and release lactate as controls do, and contain a normal steady-state ATP level. However, IF1-silenced cells displayed an enhanced steady-state mitochondrial membrane potential and consistently showed a reduced ADP-stimulated respiration rate. In the parental cells (i.e. control cells containing IF1) the inhibitor protein was found to be associated with the dimeric form of the ATP synthase complex, therefore we propose that the interaction of IF1 with the complex either directly, by increasing the catalytic activity of the enzyme, or indirectly, by improving the structure of mitochondrial cristae, can increase the oxidative phosphorylation rate in osteosarcoma cells grown under normoxic conditions.	[Barbato, Simona; Sgarbi, Gianluca; Gorini, Giulia; Baracca, Alessandra; Solaini, Giancarlo] Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, I-40126 Bologna, Italy	University of Bologna	Baracca, A (corresponding author), Univ Bologna, Dept Biomed & NeuroMotor Sci DIBINEM, Via Irnerio 48, I-40126 Bologna, Italy.	alessandra.baracca@unibo.it; giancarlo.solaini@unibo.it	Sgarbi, Gianluca/AAG-9727-2021; Sgarbi, Gianluca/AAD-8061-2021	Barbato, Simona/0000-0002-7828-8230; SOLAINI, GIANCARLO/0000-0001-7825-0446; Gorini, Giulia/0000-0002-5127-0049	Ministero dell'Istruzione, dell'Universita e della Ricerca, MIUR, Italy [PRIN2010-11 20107Z8XBW]	Ministero dell'Istruzione, dell'Universita e della Ricerca, MIUR, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca, MIUR, Italy Grant PRIN2010-11 20107Z8XBW.	BARACCA A, 1992, COMP BIOCHEM PHYS B, V101, P421, DOI 10.1016/0305-0491(92)90022-J; Baracca A, 2013, INT J BIOCHEM CELL B, V45, P1356, DOI 10.1016/j.biocel.2013.03.013; Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; Barogi S, 1995, MECH AGEING DEV, V84, P139, DOI 10.1016/0047-6374(95)01640-6; Bason JV, 2014, P NATL ACAD SCI USA, V111, P11305, DOI 10.1073/pnas.1411560111; Bisetto E, 2013, BBA-BIOENERGETICS, V1827, P807, DOI 10.1016/j.bbabio.2013.04.002; Borsi E, 2014, ONCOTARGET, V5, P1779, DOI 10.18632/oncotarget.1736; Bosetti F, 2000, MOL CELL BIOCHEM, V215, P31, DOI 10.1023/A:1026558922596; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bravo C, 2004, J BIOENERG BIOMEMBR, V36, P257, DOI 10.1023/B:JOBB.0000031977.99479.ea; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023; Capuano F, 1997, J BIOENERG BIOMEMBR, V29, P379, DOI 10.1023/A:1022402915431; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; Di Lisa F, 1998, MOL CELL BIOCHEM, V184, P379, DOI 10.1023/A:1006810523586; Faccenda D, 2013, CELL CYCLE, V12, P2530, DOI 10.4161/cc.25840; Formentini L, 2014, EMBO J, V33, P762, DOI 10.1002/embj.201386392; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Fujikawa M, 2012, J BIOL CHEM, V287, P18781, DOI 10.1074/jbc.M112.345793; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; HORSTMAN LL, 1970, J BIOL CHEM, V245, P1336; HUSAIN I, 1985, BIOCHIM BIOPHYS ACTA, V806, P64, DOI 10.1016/0005-2728(85)90082-9; Ichikawa N, 1999, BIOSCI BIOTECH BIOCH, V63, P2225, DOI 10.1271/bbb.63.2225; JENNINGS RB, 1991, J MOL CELL CARDIOL, V23, P1383, DOI 10.1016/0022-2828(91)90185-O; Kun E, 1979, Methods Enzymol, V55, P115; LIPPE G, 1988, BIOCHIM BIOPHYS ACTA, V933, P1, DOI 10.1016/0005-2728(88)90050-3; LOPEZMEDIAVILLA C, 1993, EUR J BIOCHEM, V215, P487, DOI 10.1111/j.1432-1033.1993.tb18058.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCIAKOVA K, 1984, FEBS LETT, V177, P85, DOI 10.1016/0014-5793(84)80986-2; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Porcelli AM, 2009, J BIOL CHEM, V284, P2045, DOI 10.1074/jbc.M807321200; ROUSLIN W, 1991, J BIOENERG BIOMEMBR, V23, P873, DOI 10.1007/BF00786006; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; SCHWERZMANN K, 1981, BIOCHEMISTRY-US, V20, P6305, DOI 10.1021/bi00525a004; Sgarbi G, 2011, J BIOENERG BIOMEMBR, V43, P673, DOI 10.1007/s10863-011-9390-3; Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Solaini G, 1997, BIOCHEM J, V327, P443, DOI 10.1042/bj3270443; SOLAINI G, 1993, EUR J BIOCHEM, V214, P729, DOI 10.1111/j.1432-1033.1993.tb17974.x; Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034; Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	49	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6338	6348		10.1074/jbc.M114.631788	http://dx.doi.org/10.1074/jbc.M114.631788			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605724	hybrid, Green Published			2022-12-28	WOS:000350732500039
J	Ruiz-Perez, MV; Medina, MA; Urdiales, JL; Keinanen, TA; Sanchez-Jimenez, F				Victoria Ruiz-Perez, M.; Angel Medina, Miguel; Luis Urdiales, Jose; Keinanen, Tuomo A.; Sanchez-Jimenez, Francisca			Polyamine Metabolism Is Sensitive to Glycolysis Inhibition in Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; N-MYC; C-MYC; CANCER; CHEMOPREVENTION; EXPRESSION; TARGET; GROWTH; GENE; 2-DEOXYGLUCOSE	Polyamines are essential for cell proliferation, and their levels are elevated in many human tumors. The oncogene n-myc is known to potentiate polyamine metabolism. Neuroblastoma, the most frequent extracranial solid tumor in children, harbors the amplification of n-myc oncogene in 25% of the cases, and it is associated with treatment failure and poor prognosis. We evaluated several metabolic features of the human neuroblastoma cell lines Kelly, IMR-32, and SK-N-SH. We further investigated the effects of glycolysis impairment in polyamine metabolism in these cell lines. A previously unknown linkage between glycolysis impairment and polyamine reduction is unveiled. We show that glycolysis inhibition is able to trigger signaling events leading to the reduction of N-Myc protein levels and a subsequent decrease of both ornithine decarboxylase expression and polyamine levels, accompanied by cell cycle blockade preceding cell death. New anti-tumor strategies could take advantage of the direct relationship between glucose deprivation and polyamine metabolism impairment, leading to cell death, and its apparent dependence on n-myc. Combined therapies targeting glucose metabolism and polyamine synthesis could be effective in the treatment of n-myc-expressing tumors.	[Victoria Ruiz-Perez, M.; Angel Medina, Miguel; Luis Urdiales, Jose; Sanchez-Jimenez, Francisca] Univ Malaga, Andalucia Tech, Dept Biol Mol & Bioquim, Fac Ciencias, E-29071 Malaga, Spain; [Victoria Ruiz-Perez, M.; Angel Medina, Miguel; Luis Urdiales, Jose; Sanchez-Jimenez, Francisca] Univ Malaga, IBIMA Biomed Res Inst Malaga, E-29071 Malaga, Spain; [Angel Medina, Miguel; Luis Urdiales, Jose; Sanchez-Jimenez, Francisca] CIBER Enfermedades Raras CIBERER, Unidad 741, Malaga, Spain; [Keinanen, Tuomo A.] Univ Eastern Finland, Sch Pharm, FIN-70211 Kuopio, Finland	Universidad de Malaga; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Eastern Finland	Ruiz-Perez, MV (corresponding author), Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, Campus Teatinos, E-29071 Malaga, Spain.	mariaviruiz@uma.es	Medina, Miguel Ángel/K-1763-2014; Ruiz-Pérez, María Victoria/F-8639-2014; Urdiales, José Luis/K-1125-2014; Keinänen, Tuomo/AAC-5630-2019; Jiménez, Francisca María Sánchez/H-2513-2015	Medina, Miguel Ángel/0000-0001-7275-6462; Urdiales, José Luis/0000-0002-2519-9293; Jiménez, Francisca María Sánchez/0000-0002-4958-6060; Keinanen, Tuomo/0000-0002-0659-5573	Ministerio de Economia y Competitividad, Spain [SAF2011-26518]; Junta de Andalucia, Spain [CTS-1507, CVI-06585]; fondos PAIDI, Junta de Andalucia, Spain [BIO-267]; University of Eastern Finland	Ministerio de Economia y Competitividad, Spain; Junta de Andalucia, Spain(Junta de Andalucia); fondos PAIDI, Junta de Andalucia, Spain; University of Eastern Finland	Supported by Grants SAF2011-26518 (Ministerio de Economia y Competitividad, Spain), Excellence Grants CTS-1507 and CVI-06585 (Junta de Andalucia, Spain), and BIO-267 (fondos PAIDI, Junta de Andalucia, Spain).; Supported by strategic funding of the University of Eastern Finland.	Agostinelli E, 2010, AMINO ACIDS, V38, P393, DOI 10.1007/s00726-009-0396-7; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bailey HH, 2010, CANCER PREV RES, V3, P35, DOI 10.1158/1940-6207.CAPR-09-0096; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cascante M, 2010, BIOCHEM SOC T, V38, P1302, DOI 10.1042/BST0381302; CELANO P, 1989, J BIOL CHEM, V264, P8922; Coleman CS, 2004, BIOCHEM J, V379, P849, DOI 10.1042/BJ20040035; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dasso M., 2004, SHORT PROTOCOLS CELL; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fajardo I, 2001, EUR J BIOCHEM, V268, P768, DOI 10.1046/j.1432-1327.2001.01930.x; FELL D, 1996, UNDERSTANDING CONTRO; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Forshell TP, 2010, CANCER PREV RES, V3, P140, DOI 10.1158/1940-6207.CAPR-09-0166; Geerts D, 2010, INT J CANCER, V126, P2012, DOI 10.1002/ijc.25074; Gerner EW, 2010, CANCER PREV RES, V3, P125, DOI 10.1158/1940-6207.CAPR-09-0252; Gerner EW, 2003, RECENT RES CANCER, V163, P58; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gnaiger E., 2012, MITOCHONDRIAL PATHWA, P44; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Koomoa DLT, 2009, MOL CANCER THER, V8, P2067, DOI 10.1158/1535-7163.MCT-08-1217; Kunst A., 1984, METHOD ENZYMAT AN, P178; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Ledford H, 2014, NATURE, V508, P158, DOI 10.1038/508158a; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lutz W, 1996, ONCOGENE, V13, P803; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9; MEDINA MA, 1992, FEBS LETT, V311, P99, DOI 10.1016/0014-5793(92)81376-W; Meyskens Frank L Jr, 2014, Recent Results Cancer Res, V202, P115, DOI 10.1007/978-3-642-45195-9_14; Noll F., 1984, METHOD ENZYMAT AN, VIV, P582; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; PASSONNEAU JV, 1976, J BIOL CHEM, V251, P2015; Pegg AE, 2014, IUBMB LIFE, V66, P8, DOI 10.1002/iub.1237; Perez-Leal O, 2012, AMINO ACIDS, V42, P611, DOI 10.1007/s00726-011-1036-6; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Ray RM, 2012, J BIOL CHEM, V287, P3674, DOI 10.1074/jbc.M111.232561; Rodriguez-Caso C, 2006, J BIOL CHEM, V281, P21799, DOI 10.1074/jbc.M602756200; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; SCHULZELOHOFF E, 1994, BIOCHEM J, V298, P647, DOI 10.1042/bj2980647; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Sun Y, 2014, ONCOGENE, V33, P2987, DOI 10.1038/onc.2013.253; Tabib A, 1999, INT J BIOCHEM CELL B, V31, P1289, DOI 10.1016/S1357-2725(99)00098-9; URDIALES JL, 1992, FEBS LETT, V305, P260, DOI 10.1016/0014-5793(92)80682-7; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Wolff EC, 1999, YEAST, V15, P43; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280	55	25	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6106	6119		10.1074/jbc.M114.619197	http://dx.doi.org/10.1074/jbc.M114.619197			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593318	Green Published, hybrid			2022-12-28	WOS:000350732500020
J	Zhong, YM; Dong, S; Strattan, E; Ren, L; Butchar, JP; Thornton, K; Mishra, A; Porcu, P; Bradshaw, JM; Bisconte, A; Owens, TD; Verner, E; Brameld, KA; Funk, JO; Hill, RJ; Johnson, AJ; Dubovsky, JA				Zhong, Yiming; Dong, Shuai; Strattan, Ethan; Ren, Li; Butchar, Jonathan P.; Thornton, Kelsey; Mishra, Anjali; Porcu, Pierluigi; Bradshaw, J. Michael; Bisconte, Angelina; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Funk, Jens Oliver; Hill, Ronald J.; Johnson, Amy J.; Dubovsky, Jason A.			Targeting Interleukin-2-inducible T-cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELL; TEC FAMILY KINASES; TYROSINE KINASE; TH17 CELLS; MICE LACKING; IRREVERSIBLE INHIBITORS; ALLERGIC-ASTHMA; DISCOVERY; RECEPTOR; EXPRESSION	Interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK or TXK) are essential mediators of intracellular signaling in both normal and neoplastic T-cells and natural killer (NK) cells. Thus, ITK and RLK inhibitors have therapeutic potential in a number of human autoimmune, inflammatory, and malignant diseases. Here we describe a novel ITK/RLK inhibitor, PRN694, which covalently binds to cysteine residues 442 of ITK and 350 of RLK and blocks kinase activity. Molecular modeling was utilized to design molecules that interact with cysteine while binding to the ATP binding site in the kinase domain. PRN694 exhibits extended target residence time on ITK and RLK and is highly selective for a subset of the TEC kinase family. In vitro cellular assays confirm that PRN694 prevents T-cell receptor-and Fc receptor-induced cellular and molecular activation, inhibits T-cell receptor-induced T-cell proliferation, and blocks proinflammatory cytokine release as well as activation of Th17 cells. Ex vivo assays demonstrate inhibitory activity against T-cell prolymphocytic leukemia cells, and in vivo assays demonstrate durable pharmacodynamic effects on ITK, which reduces an oxazolone-induced delayed type hypersensitivity reaction. These data indicate that PRN694 is a highly selective and potent covalent inhibitor of ITK and RLK, and its extended target residence time enables durable attenuation of effector cells in vitro and in vivo. The results from this study highlight potential applications of this dual inhibitor for the treatment of T-cell-or NK cell-mediated inflammatory, autoimmune, and malignant diseases.	[Zhong, Yiming; Strattan, Ethan; Ren, Li; Butchar, Jonathan P.; Thornton, Kelsey; Mishra, Anjali; Porcu, Pierluigi; Johnson, Amy J.; Dubovsky, Jason A.] Ohio State Univ, Coll Med, Div Hematol, Columbus, OH 43210 USA; [Dong, Shuai] Ohio State Univ, Div Pharmaceut & Pharmaceut Chem, Coll Pharm, Columbus, OH 43210 USA; [Bradshaw, J. Michael; Bisconte, Angelina; Owens, Timothy D.; Verner, Erik; Brameld, Ken A.; Funk, Jens Oliver; Hill, Ronald J.] Principia Biopharma, San Francisco, CA 94080 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hill, RJ (corresponding author), Principia Biopharma, 400 E Jamie Ct,Suite 302, San Francisco, CA 94080 USA.	ron.hill@principiabio.com; jason.dubovsky@nationwidechildrens.org	Strattan, Ethan/AAK-3373-2021; Butchar, Jonathan/E-2825-2011	Strattan, Ethan/0000-0001-6905-0813; Brameld, Ken/0000-0001-8643-3218; Dong, Shuai/0000-0002-2434-2430	NATIONAL CANCER INSTITUTE [P01CA095426, P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA095426, P30 CA016058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alder CM, 2013, ACS MED CHEM LETT, V4, P948, DOI 10.1021/ml400206q; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Bedoya SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/986789; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Brameld K. A., 2014, International Patent, Patent No. [WO 2014/036016 A1, 2014036016]; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Carpenter RL, 2012, J THORAC DIS, V4, P639, DOI 10.3978/j.issn.2072-1439.2012.10.09; Charrier JD, 2011, J MED CHEM, V54, P2341, DOI 10.1021/jm101499u; Cohnen A, 2013, BLOOD, V122, P1411, DOI 10.1182/blood-2012-07-441832; Das J, 2006, BIOORG MED CHEM LETT, V16, P3706, DOI 10.1016/j.bmcl.2006.04.060; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Dubovsky JA, 2009, CLIN CANCER RES, V15, P3406, DOI 10.1158/1078-0432.CCR-08-2099; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; Finkelstein LD, 2005, J IMMUNOL, V175, P5923, DOI 10.4049/jimmunol.175.9.5923; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Guo WC, 2012, MOL PHARMACOL, V82, P938, DOI 10.1124/mol.112.079889; Han S, 2014, BIOCHEM J, V460, P211, DOI 10.1042/BJ20131139; Harling JD, 2013, J BIOL CHEM, V288, P28195, DOI 10.1074/jbc.M113.474114; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Horwood NJ, 2012, INT REV IMMUNOL, V31, P87, DOI 10.3109/08830185.2012.670334; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Iyer AS, 2011, J BIOL CHEM, V286, P9503, DOI 10.1074/jbc.M110.165613; Kannan Yashaswini, 2012, J Clin Cell Immunol, VSuppl 12, P11; Kaukonen J, 1999, LEUKEMIA LYMPHOMA, V32, P513, DOI 10.3109/10428199909058409; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; Khurana D, 2007, J IMMUNOL, V178, P3575, DOI 10.4049/jimmunol.178.6.3575; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Koprulu AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060476; Kosaka Y, 2006, TRENDS IMMUNOL, V27, P453, DOI 10.1016/j.it.2006.08.006; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; McLean LR, 2012, BIOORG MED CHEM LETT, V22, P3296, DOI 10.1016/j.bmcl.2012.03.016; Melton AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058966; Moriarty KJ, 2008, BIOORG MED CHEM LETT, V18, P5545, DOI 10.1016/j.bmcl.2008.09.015; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pastor RM, 2014, BIOORG MED CHEM LETT, V24, P2448, DOI 10.1016/j.bmcl.2014.04.023; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Sahu N, 2009, CURR TOP MED CHEM, V9, P690, DOI 10.2174/156802609789044443; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Serafimova IM, 2012, NAT CHEM BIOL, V8, P471, DOI [10.1038/NCHEMBIO.925, 10.1038/nchembio.925]; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Shin J, 2007, BLOOD, V110, P3015, DOI 10.1182/blood-2006-12-061507; Snow RJ, 2007, BIOORG MED CHEM LETT, V17, P3660, DOI 10.1016/j.bmcl.2007.04.045; Susaki K, 2010, IMMUNOL LETT, V127, P135, DOI 10.1016/j.imlet.2009.10.009; UYEMURA K, 1993, J INVEST DERMATOL, V101, P701, DOI 10.1111/1523-1747.ep12371679; Vargas L, 2013, SCAND J IMMUNOL, V78, P130, DOI 10.1111/sji.12069; Velankar AD, 2010, BIOORGAN MED CHEM, V18, P4547, DOI 10.1016/j.bmc.2010.04.056; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Warner K, 2013, CRIT REV ONCOL HEMAT, V88, P680, DOI 10.1016/j.critrevonc.2013.07.014; Warner K, 2013, CURR HEMATOL MALIG R, V8, P163, DOI 10.1007/s11899-013-0165-2; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zhao WL, 2010, LEUKEMIA, V24, P13, DOI 10.1038/leu.2009.223; Zhong YM, 2010, BIOCHEM BIOPH RES CO, V398, P377, DOI 10.1016/j.bbrc.2010.06.075	68	28	33	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5960	5978		10.1074/jbc.M114.614891	http://dx.doi.org/10.1074/jbc.M114.614891			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25593320	hybrid, Green Published			2022-12-28	WOS:000350732500003
J	Clifton, MC; Simon, MJ; Erramilli, SK; Zhang, HD; Zaitseva, J; Hermodson, MA; Stauffacher, CV				Clifton, Matthew C.; Simon, Michael J.; Erramilli, Satchal K.; Zhang, Huide; Zaitseva, Jelena; Hermodson, Mark A.; Stauffacher, Cynthia V.			In Vitro Reassembly of the Ribose ATP-binding Cassette Transporter Reveals a Distinct Set of Transport Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG ABC TRANSPORTER; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; INWARD-FACING CONFORMATION; COLI MALTOSE TRANSPORTER; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BTUCD-F; AMP-PNP; ALTERNATING ACCESS	Bacterial ATP-binding cassette (ABC) importers are primary active transporters that are critical for nutrient uptake. Based on structural and functional studies, ABC importers can be divided into two distinct classes, type I and type II. Type I importers follow a strict alternating access mechanism that is driven by the presence of the substrate. Type II importers accept substrates in a nucleotide-free state, with hydrolysis driving an inward facing conformation. The ribose transporter in Escherichia coli is a tripartite complex consisting of a cytoplasmic ATP-binding cassette protein, RbsA, with fused nucleotide binding domains; a transmembrane domain homodimer, RbsC,; and a periplasmic substrate binding protein, RbsB. To investigate the transport mechanism of the complex RbsABC(2) we probed intersubunit interactions by varying the presence of the substrate ribose and the hydrolysis cofactors, ATP/ADP and Mg2+ We were able to purify a full complex, RbsABC(2), in the presence of stable, transition state mimics (ATP, Mg2+, and VO4); a RbsAC complex in the presence of ADP and Mg2+; and a heretofore unobserved RbsBC complex in the absence of cofactors. The presence of excess ribose also destabilized complex formation between RbsB and RbsC. These observations suggest that RbsABC(2), shares functional traits with both type land type II importers, as well as possessing unique features, and employs a distinct mechanism relative to other ABC transporters.	[Clifton, Matthew C.; Simon, Michael J.; Erramilli, Satchal K.; Stauffacher, Cynthia V.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Clifton, Matthew C.; Simon, Michael J.; Erramilli, Satchal K.; Stauffacher, Cynthia V.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Zhang, Huide; Zaitseva, Jelena; Hermodson, Mark A.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stauffacher, CV (corresponding author), Purdue Univ, Dept Biol Sci, Hockmeyer Hall,240 S Martin Jischke Dr, W Lafayette, IN 47907 USA.	cstauffa@purdue.edu		Erramilli, Satchal/0000-0001-8694-7681	National Institutes of Health Cancer Center Core Grant [CA23168]; National Institutes of Health Biophysics Training Grant [T32-GM008296]; National Institutes of Health Public Health Service Grants [GM54993, GM64676]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008296, P01GM064676, R01GM054993] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Public Health Service Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Cancer Center Core Grant CA23168, Biophysics Training Grant T32-GM008296, and Public Health Service Grants GM54993 and GM64676.	Ames GFL, 2001, J BIOENERG BIOMEMBR, V33, P79, DOI 10.1023/A:1010797029183; [Anonymous], 1996, CIRCULAR DICHROISM C; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; Barroga CF, 1996, PROTEIN SCI, V5, P1093; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; BINNIE RA, 1992, PROTEIN SCI, V1, P1642, DOI 10.1002/pro.5560011212; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; BUCKEL SD, 1986, J BIOL CHEM, V261, P7659; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dietrich D, 2009, MOL BIOL CELL, V20, P530, DOI 10.1091/mbc.E08-07-0745; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Findley J. B. C., 1987, BIOL MEMBRANES PRACT, P219; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Greller G, 2001, EUR J BIOCHEM, V268, P4011, DOI 10.1046/j.1432-1327.2001.02313.x; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland I. B., 2003, ABC PROTEINS BACTERI, P147; HOPE JN, 1986, J BIOL CHEM, V261, P7663; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Korkhov VM, 2014, NAT STRUCT MOL BIOL, V21, P1097, DOI 10.1038/nsmb.2918; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Liu PQ, 1998, P NATL ACAD SCI USA, V95, P3495, DOI 10.1073/pnas.95.7.3495; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; Narayanan A, 2011, PROTEIN SCI, V20, P51, DOI 10.1002/pro.535; Newstead S, 2009, STRUCTURE, V17, P1213, DOI 10.1016/j.str.2009.07.009; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Park Y, 1999, J BACTERIOL, V181, P1039, DOI 10.1128/JB.181.3.1039-1042.1999; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rice AJ, 2014, CRIT REV BIOCHEM MOL, V49, P426, DOI 10.3109/10409238.2014.953626; Rice AJ, 2013, J BIOL CHEM, V288, P21228, DOI 10.1074/jbc.M113.483495; Scheffel F, 2004, BBA-BIOENERGETICS, V1656, P57, DOI 10.1016/j.bbabio.2004.01.005; Sharma S, 2005, J BACTERIOL, V187, P2908, DOI 10.1128/JB.187.8.2908-2911.2005; Slotboom DJ, 2014, NAT REV MICROBIOL, V12, P79, DOI 10.1038/nrmicro3175; Stewart JB, 2003, J BACTERIOL, V185, P5234, DOI 10.1128/JB.185.17.5234-5239.2003; TEETERS CL, 1987, BIOPHYS J, V51, P527, DOI 10.1016/S0006-3495(87)83378-7; Tirado-Lee L, 2011, STRUCTURE, V19, P1701, DOI 10.1016/j.str.2011.10.004; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110; WALLACE BA, 1987, BIOCHEMISTRY-US, V26, P65, DOI 10.1021/bi00375a010; WALLACE BA, 1984, ANAL BIOCHEM, V142, P317, DOI 10.1016/0003-2697(84)90471-8; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; WILLIS RC, 1974, J BIOL CHEM, V249, P6926; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Zaitseva J, 1996, PROTEIN SCI, V5, P1100; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	77	8	12	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5555	5565		10.1074/jbc.M114.621573	http://dx.doi.org/10.1074/jbc.M114.621573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25533465	Green Published, hybrid			2022-12-28	WOS:000350044200027
J	Nakao, LS; Everley, RA; Marino, SM; Lo, SM; de Souza, LE; Gygi, SP; Gladyshev, VN				Nakao, Lia S.; Everley, Robert A.; Marino, Stefano M.; Lo, Sze M.; de Souza, Luiz E.; Gygi, Steven P.; Gladyshev, Vadinn N.			Mechanism-based Proteomic Screening Identifies Targets of Thioredoxin-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; INTERMEMBRANE SPACE; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISMS; CYSTEINE RESIDUES; REDOX SWITCHES; NUCLEOREDOXIN; MITOCHONDRIA; REDUCTASE; MOUSE	Thioredoxin (Trx)-fold protein. protagonists of numerous cellular pathways that are subject to thiol-based redox control, The best characterized regulator of thiols in proteins is Trx1 itself, which together with thioredoxin reductase 1 (TR1) and peroxiredoxins (Prxs) comprises a key redox regulatory system in mammalian cells. However, there are numerous other Trx-like proteins, whose functions and redox interactors are unknown. It is also unclear if the principles of Trx1-based redox control apply to these proteins. Here, we employed a proteomic strategy to four Trx-like proteins containing CXXC motifs, namely Trxl, Rdx12, Trx-like protein 1 (Txnl1) and nucleoredoxin 1 (Nrx1), whose cellular targets were trapped in vivo using mutant Trx-like proteins, under conditions of low endogenous expression of these proteins. Prxs were detected as key redox targets of Trxl, but this approach also supported the detection of TR1, which is the Trxl reductant, as well as rnitochondrial intermembrane proteins AIF and Mia40. In addition, glutathione peroxidase 4 was found to be a Rdx12 redox target. In contrast, no redox targets of Txnl1 and Nrx1 could be detected, suggesting that their CXXC motifs do not engage in mixed disulfides with cellular proteins. For some Trx-like proteins, the method allowed distinguishing redox and non-redox interactions. Parallel, comparative analyses of multiple thiol oxidoreductases revealed differences in the functions of their CXXC motifs, providing important insights into thiol-based redox control of cellular processes.	[Nakao, Lia S.; Marino, Stefano M.; Gladyshev, Vadinn N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Nakao, Lia S.; Marino, Stefano M.; Gladyshev, Vadinn N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nakao, Lia S.; Lo, Sze M.; de Souza, Luiz E.] Univ Fed Parana, Dept Patol Basica, BR-81531980 Curitiba, Parana, Brazil; [Everley, Robert A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade Federal do Parana; Harvard University; Harvard Medical School	Gladyshev, VN (corresponding author), 77 Ave Louis Pasteur,Rm 435, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Nakao, Lia S/M-1507-2018	Nakao, Lia S/0000-0001-9647-6350; Gladyshev, Vadim/0000-0002-0372-7016; de Souza, Luiz Eduardo Rizzo/0000-0001-8794-7720	National Institutes of Health [GM065204]; Brazil Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship [3737/10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazil Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065204 (to V. N. G.).; Recipient of Brazil Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship 3737/10.	Andersen KM, 2011, ANTIOXID REDOX SIGN, V14, P1601, DOI 10.1089/ars.2010.3329; Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Banci L, 2013, CHEM BIOL, V20, P747, DOI 10.1016/j.chembiol.2013.05.007; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Dasgupta S, 2011, J BIOL CHEM, V286, P25935, DOI 10.1074/jbc.M111.254599; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Engelhard J, 2011, FREE RADICAL BIO MED, V50, P1234, DOI 10.1016/j.freeradbiomed.2011.01.035; Felberbaum-Corti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001144; Fomenko DE, 2012, ANTIOXID REDOX SIGN, V16, P193, DOI 10.1089/ars.2011.3980; Fu CX, 2009, MOL CELL PROTEOMICS, V8, P1674, DOI 10.1074/mcp.M800580-MCP200; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2013, BIOCHEM BIOPH RES CO, V440, P737, DOI 10.1016/j.bbrc.2013.09.138; Hagglund P, 2008, J PROTEOME RES, V7, P5270, DOI 10.1021/pr800633y; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hayashi T, 2010, J BIOL CHEM, V285, P18586, DOI 10.1074/jbc.M110.106468; Hirasaka K, 2011, ANTIOXID REDOX SIGN, V15, P2645, DOI 10.1089/ars.2011.3888; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Inarrea P, 2007, BIOCHEM J, V405, P173, DOI 10.1042/BJ20061809; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Joza N, 2008, CELL DEATH DIFFER, V15, P1009, DOI 10.1038/cdd.2008.24; Kim Y, 2009, ANTIOXID REDOX SIGN, V11, P907, DOI 10.1089/ars.2008.2316; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Lechward K, 2006, FEBS LETT, V580, P3631, DOI 10.1016/j.febslet.2006.04.101; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Liu J, 2013, EUKARYOT CELL, V12, P1588, DOI 10.1128/EC.00082-13; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Marino SM, 2010, BIOCHEMISTRY-US, V49, P7709, DOI 10.1021/bi100677a; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Muller L, 2011, FEBS LETT, V585, P596, DOI 10.1016/j.febslet.2011.01.024; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; Schwertassek U., 2007, SCI STKE, V2007, pl8; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Turanov AA, 2010, BIOCHEM J, V430, P285, DOI 10.1042/BJ20091378; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Wu CG, 2011, ANTIOXID REDOX SIGN, V15, P2565, DOI 10.1089/ars.2010.3831; Wu RH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009654; Xu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.27; Yamazaki D, 2004, PLANT CELL PHYSIOL, V45, P18, DOI 10.1093/pcp/pch019; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	58	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5685	5695		10.1074/jbc.M114.597245	http://dx.doi.org/10.1074/jbc.M114.597245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561728	Green Published, hybrid			2022-12-28	WOS:000350044200037
J	Simard, JC; Vallieres, F; de Liz, R; Lavastre, V; Girard, D				Simard, Jean-Christophe; Vallieres, Francis; de Liz, Rafael; Lavastre, Valerie; Girard, Denis			Silver Nanoparticles Induce Degradation of the Endoplasmic Reticulum Stress Sensor Activating Transcription Factor-6 Leading to Activation of the NLRP-3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH; ER STRESS; IL-1-BETA RELEASE; CASPASE-4; PYROPTOSIS; IRE1; NANOSILVER; INHIBITION; RECEPTORS	In the past decade, the increasing amount of nanoparticles (NP) and nanomaterials used in multiple applications led the scientific community to investigate the potential toxicity of NP. Many studies highlighted the cytotoxic effects of various NP, including titanium dioxide, zinc oxide, and silver nanoparticles (AgNP). In a few studies, endoplasmic reticulum (ER) stress was found to be associated with NP cytotoxicity leading to apoptosis in different cell types. In this study, we report for the first time that silver nanoparticles of 15 nm (AgNP15), depending on the concentration, induced different signature ER stress markers in human THP-1 monocytes leading to a rapid ER stress response with degradation of the ATF-6 sensor. Also, AgNP15 induced pyroptosis and activation of the NLRP-3 inflammasome as demonstrated by the processing and increased activity of caspase-1 and secretion of IL-1 beta and ASC (apoptosis-associated speck-like protein containing a CARD domain) pyroptosome formation. Transfection of THP-1 cells with siRNA targeting NLRP-3 decreased the AgNP15-induced IL-1 beta production. The absence of caspase-4 expression resulted in a significant reduction of pro-IL-1 beta. However, caspase-1 activity was significantly higher in caspase-4-deficient cells when compared with WT cells. Inhibition of AgNP15-induced ATF-6 degradation with Site-2 protease inhibitors completely blocked the effect of AgNP15 on pyroptosis and secretion of IL-1 beta, indicating that ATF-6 is crucial for the induction of this type of cell death. We conclude that AgNP15 induce degradation of the ER stress sensor ATF-6, leading to activation of the NLRP-3 inflammasome regulated by caspase-4 in human monocytes.	[Simard, Jean-Christophe; Vallieres, Francis; de Liz, Rafael; Lavastre, Valerie; Girard, Denis] Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Lab Rech Inflammat & Physiol Granulocytes, Laval, PQ H7V 1B7, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Simard, JC (corresponding author), Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.	J-Christophe.Simard@iaf.inrs.ca; Denis.girard@iaf.inrs.ca		Girard, Denis/0000-0002-3342-5027				Akhtar MJ, 2014, CLIN CHIM ACTA, V436, P78, DOI 10.1016/j.cca.2014.05.004; Bartlomiejczyk T, 2013, ANN AGR ENV MED, V20, P48; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Binet F, 2010, INT IMMUNOPHARMACOL, V10, P508, DOI 10.1016/j.intimp.2010.01.013; Binet F, 2010, BIOCHEM BIOPH RES CO, V391, P18, DOI 10.1016/j.bbrc.2009.10.141; Chen R, 2014, ACS NANO, V8, P2562, DOI 10.1021/nn406184r; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Christen V, 2013, TOXICOL APPL PHARM, V272, P519, DOI 10.1016/j.taap.2013.06.011; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Edamatsu T, 1997, BRIT J PHARMACOL, V121, P1651, DOI 10.1038/sj.bjp.0701322; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Guan M, 2012, FEBS J, V279, P2399, DOI 10.1111/j.1742-4658.2012.08619.x; Guan M, 2011, CLIN CANCER RES, V17, P1796, DOI 10.1158/1078-0432.CCR-10-3216; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kajiwara Y, 2014, J IMMUNOL, V193, P335, DOI 10.4049/jimmunol.1303424; Kanapathipillai M, 2014, ADV DRUG DELIVER REV, V79-80, P107, DOI 10.1016/j.addr.2014.05.005; Kim HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01142; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim S, 2014, INNATE IMMUN-LONDON, V20, P799, DOI 10.1177/1753425913508593; Kulthong K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-8; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lohcharoenkal W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/180549; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Meunier E, 2012, NANOMED-NANOTECHNOL, V8, P987, DOI 10.1016/j.nano.2011.11.004; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Nowack B, 2011, ENVIRON SCI TECHNOL, V45, P1177, DOI 10.1021/es103316q; Obeng EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/jbc.M502685200; Poirier M, 2014, J APPL TOXICOL, V34, P404, DOI 10.1002/jat.2956; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; SLAWSON RM, 1992, ARCH MICROBIOL, V158, P398; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stebounova LV, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-5; Vallieres F, 2013, J IMMUNOL, V190, P2904, DOI 10.4049/jimmunol.1201941; Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022; Yang EJ, 2012, BIOMATERIALS, V33, P6858, DOI 10.1016/j.biomaterials.2012.06.016; Yang M, 2013, SMALL, V9, P4194, DOI 10.1002/smll.201300481; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang R, 2012, INT J BIOCHEM CELL B, V44, P224, DOI 10.1016/j.biocel.2011.10.019	55	76	81	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5926	5939		10.1074/jbc.M114.610899	http://dx.doi.org/10.1074/jbc.M114.610899			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25593314	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000350044200055
J	Chauhan, AK; Chen, C; Moore, TL; DiPaolo, RJ				Chauhan, Anil K.; Chen, Chen; Moore, Terry L.; DiPaolo, Richard J.			Induced Expression of Fc gamma RIIIa (CD16a) on CD4(+) T Cells Triggers Generation of IFN-gamma(high) Subset	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CIRCULATING IMMUNE-COMPLEXES; NATURAL-KILLER-CELLS; SYK TYROSINE KINASE; EPSILON RI GAMMA; INTERFERON-GAMMA; RECEPTOR-III; ZETA-CHAIN; IGG; IMMUNOGLOBULIN	Whether or not CD4(+) T-cells express low affinity receptor Fc gamma RIIIa (CD16a) in disease pathology has not been examined in great detail. In this study, we show that a subset of activated CD4(+) T-cells in humans express Fc gamma RIIIa. The ligation of Fc gamma RIIIa by immune complexes (ICs) in human CD4(+) T-cells produced co-stimulatory signal like CD28 that triggered IFN-gamma production. The induced expression of Fc gamma RIIIa on CD4(+) helper T-cells is an important finding since these receptors via ITAM contribute to intracellular signaling. The induced expression of Fc gamma RIIIa on CD4(+) T helper cells and their ability to co-stimulate T-cell activation are important and novel findings that may reveal new pathways to regulate adaptive immune responses during inflammation and in autoimmunity.	[Chauhan, Anil K.; Chen, Chen; Moore, Terry L.] St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, St Louis, MO 63104 USA; [Chauhan, Anil K.; DiPaolo, Richard J.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	Saint Louis University; Saint Louis University	Chauhan, AK (corresponding author), St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, St Louis, MO 63104 USA.	chauhana@slu.edu			National Institutes of Health [A1098114]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by National Institutes of Health R01 Grant A1098114 (to A. K. C.).	BIESECKER G, 1981, J EXP MED, V154, P1779, DOI 10.1084/jem.154.6.1779; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Chauhan AK, 2006, CLIN EXP IMMUNOL, V145, P398, DOI 10.1111/j.1365-2249.2006.03135.x; Chauhan AK, 2012, CLIN EXP IMMUNOL, V167, P235, DOI 10.1111/j.1365-2249.2011.04505.x; Chauhan AK, 2011, J BIOL CHEM, V286, P38627, DOI 10.1074/jbc.M111.266809; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; Clynes R, 2007, IMMUNITY, V26, P4, DOI 10.1016/j.immuni.2007.01.006; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; EDBERG JC, 1989, J IMMUNOL, V143, P1642; ENGELHARDT W, 1995, IMMUNOBIOLOGY, V192, P297, DOI 10.1016/S0171-2985(11)80172-5; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; GREAVES M, 1974, J EXP MED, V140, P1, DOI 10.1084/jem.140.1.1; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; HUIZINGA TWJ, 1990, BLOOD, V75, P213; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; LANIER LL, 1985, J EXP MED, V162, P2089, DOI 10.1084/jem.162.6.2089; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Liu CP, 1997, P NATL ACAD SCI USA, V94, P616, DOI 10.1073/pnas.94.2.616; Low JM, 2009, PROTEOM CLIN APPL, V3, P829, DOI 10.1002/prca.200800073; McHugh RS, 2001, EUR J IMMUNOL, V31, P2094, DOI 10.1002/1521-4141(200107)31:7<2094::AID-IMMU2094>3.0.CO;2-S; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Monach Paul, 2007, V136, P269; Monach PA, 2009, P NATL ACAD SCI USA, V106, P15867, DOI 10.1073/pnas.0908032106; MORETTA L, 1982, SEMIN HEMATOL, V19, P273; MORETTA L, 1977, J EXP MED, V146, P184, DOI 10.1084/jem.146.1.184; MORETTA L, 1976, J IMMUNOL, V117, P2171; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nimmerjahn F, 2006, SPRINGER SEMIN IMMUN, V28, P305, DOI 10.1007/s00281-006-0052-1; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; ORY PA, 1989, J CLIN INVEST, V83, P1676, DOI 10.1172/JCI114067; Pollard KM, 2013, DISCOV MED, V16, P123; Ptak W, 1998, SCAND J IMMUNOL, V47, P136; QIAN DP, 1993, P NATL ACAD SCI USA, V90, P11875, DOI 10.1073/pnas.90.24.11875; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Ravindran R, 2005, J IMMUNOL, V175, P4603, DOI 10.4049/jimmunol.175.7.4603; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; SANDOR M, 1990, J EXP MED, V171, P2171, DOI 10.1084/jem.171.6.2171; SANDOR M, 1993, IMMUNOL TODAY, V14, P227, DOI 10.1016/0167-5699(93)90168-K; SANDOR M, 1994, P NATL ACAD SCI USA, V91, P12857, DOI 10.1073/pnas.91.26.12857; SANTANA V, 1975, IMMUNOLOGY, V28, P1173; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Shores E, 1997, J IMMUNOL, V159, P222; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Srivastava S, 2013, CANCER IMMUNOL IMMUN, V62, P1073, DOI 10.1007/s00262-013-1403-0; STRONCEK DF, 1991, BLOOD, V77, P1572; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413	59	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5127	5140		10.1074/jbc.M114.599266	http://dx.doi.org/10.1074/jbc.M114.599266			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25556651	hybrid, Green Published			2022-12-28	WOS:000350042000052
J	Zhang, DY; Liang, YG; Xie, QP; Gao, GX; Wei, JL; Huang, HS; Li, JX; Gao, JM; Huang, CS				Zhang, Dongyun; Liang, Yuguang; Xie, Qipeng; Gao, Guangxun; Wei, Jinlong; Huang, Haishan; Li, Jingxia; Gao, Jimin; Huang, Chuanshu			A Novel Post-translational Modification of Nucleolin, SUMOylation at Lys-294, Mediates Arsenite-induced Cell Death by Regulating gadd45 alpha mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE MODIFIER; OXIDATIVE STRESS; PROTEIN SUMOYLATION; SUMO; APOPTOSIS; CANCER; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; INDUCTION	Nucleolin is a ubiquitously expressed protein and participates in many important biological processes, such as cell cycle regulation and ribosomal biogenesis. The activity of nucleolin is regulated by intracellular localization and post-translational modifications, including phosphorylation, methylation, and ADP-ribosylation. Small ubiquitin-like modifier (SUMO) is a category of recently verified forms of post-translational modifications and exerts various effects on the target proteins. In the studies reported here, we discovered SUMOylational modification of human nucleolin protein at Lys-294, which facilitated the mRNA binding property of nucleolin by maintaining its nuclear localization. In response to arsenic exposure, nucleolin-SUMO was induced and promoted its binding with gadd45 alpha mRNA, which increased gadd45 alpha mRNA stability and protein expression, subsequently causing GADD45 alpha-mediated cell death. On the other hand, ectopic expression of Mn-SOD attenuated the arsenite-generated superoxide radical level, abrogated nucleolin-SUMO, and in turn inhibited arsenite-induced apoptosis by reducing GADD45 alpha expression. Collectively, our results for the first time demonstrate that nucleolin-SUMO at K294R plays a critical role in its nucleus sequestration and gadd45 alpha mRNA binding activity. This novel biological function of nucleolin is distinct from its conventional role as a proto-oncogene. Therefore, our findings here not only reveal a new modification of nucleolin protein and its novel functional paradigm in mRNA metabolism but also expand our understanding of the dichotomous roles of nucleolin in terms of cancer development, which are dependent on multiple intracellular conditions and consequently the appropriate regulations of its modifications, including SUMOylation.	[Zhang, Dongyun; Liang, Yuguang; Gao, Guangxun; Li, Jingxia; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Zhang, Dongyun; Xie, Qipeng; Wei, Jinlong; Huang, Haishan; Gao, Jimin] Wenzhou Med Univ, Zhejiang Prov Key Lab Technol & Applicat Model Or, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China	New York University; Wenzhou Medical University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org		Huang, Chuanshu/0000-0003-4133-5096	National Institutes of Health (NIH), NCI [CA112557, CA177665, CA165980]; NIH, NIEHS [ES000260]; National Science Foundation of China [C81472945]; NATIONAL CANCER INSTITUTE [R01CA112557, R01CA177665, P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grants CA112557, CA177665, and CA165980 and by NIH, NIEHS, Grant ES000260. This work was also supported by National Science Foundation of China Grant C81472945.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Abe JI, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/953463; Aguirre RS, 2013, MOL PHARMACOL, V84, P218, DOI 10.1124/mol.113.085555; Anderson DB, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P233, DOI 10.1007/978-90-481-2649-1_14; Baczyk D, 2013, PLACENTA, V34, P606, DOI 10.1016/j.placenta.2013.03.012; Blomster HA, 2010, J BIOL CHEM, V285, P19324, DOI 10.1074/jbc.M110.106955; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bower JJ, 2006, FREE RADICAL BIO MED, V41, P285, DOI 10.1016/j.freeradbiomed.2006.04.007; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Caudle WM, 2009, NEUROSCI LETT, V459, P11, DOI 10.1016/j.neulet.2009.04.060; Chang QS, 2007, CANCER RES, V67, P6146, DOI 10.1158/0008-5472.CAN-07-0867; Chen CY, 2000, GENE DEV, V14, P1236; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Chiou HYC, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-53; Cong R, 2011, PROTEIN REV, V15, P185, DOI 10.1007/978-1-4614-0514-6_9; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; CREANCIER L, 1993, MOL BIOL CELL, V4, P1239, DOI 10.1091/mbc.4.12.1239; Da Silva-Ferrada E, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875148; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Deyrieux AF, 2007, J CELL SCI, V120, P125, DOI 10.1242/jcs.03317; Ding M, 2002, MOL CELL BIOCHEM, V234, P81, DOI 10.1023/A:1015901232124; Dranovsky A, 2001, NEUROBIOL AGING, V22, P517, DOI 10.1016/S0197-4580(00)00248-7; Fang Y, 2012, J BIOL CHEM, V287, P35234, DOI 10.1074/jbc.M112.389494; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Ginisty H, 1999, J CELL SCI, V112, P761; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Han YH, 2008, MOL CELLS, V26, P18; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Jentsch S., 2009, UBIQUITIN SYSTEM HLT, P1; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim SK, 2003, DNA CELL BIOL, V22, P171, DOI 10.1089/104454903321655792; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Liu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035682; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Maiti S, 2000, ENVIRON TOXICOL PHAR, V8, P227, DOI 10.1016/S1382-6689(00)00046-6; Manza LL, 2004, CHEM RES TOXICOL, V17, P1706, DOI 10.1021/tx049767l; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; NORDENSON I, 1991, HUM HERED, V41, P71, DOI 10.1159/000153979; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pal S, 2010, J VIROL METHODS, V163, P498, DOI 10.1016/j.jviromet.2009.11.010; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Ruse CI, 2008, J PROTEOME RES, V7, P2140, DOI 10.1021/pr800147u; Sakurai T, 1998, CHEM RES TOXICOL, V11, P273, DOI 10.1021/tx9701384; SALNIKOW K, 1994, CANCER RES, V54, P6407; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Sinha M, 2008, J BIOCHEM MOL TOXIC, V22, P15, DOI 10.1002/jbt.20209; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; WARRENER P, 1991, BIOCHEM BIOPH RES CO, V180, P716, DOI 10.1016/S0006-291X(05)81124-6; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yang P, 2007, J TOXICOL ENV HEAL A, V70, P976, DOI 10.1080/15287390701290832; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2012, J BIOL CHEM, V287, P34361, DOI 10.1074/jbc.M112.365882; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927	80	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4784	4800		10.1074/jbc.M114.598219	http://dx.doi.org/10.1074/jbc.M114.598219			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561743	Green Published, hybrid			2022-12-28	WOS:000350042000021
J	Jepsen, MR; Kloverpris, S; Mikkelsen, JH; Pedersen, JH; Fuchtbauer, EM; Laursen, LS; Oxvig, C				Jepsen, Malene R.; Kloverpris, Soren; Mikkelsen, Jakob H.; Pedersen, Josefine H.; Fuchtbauer, Ernst-Martin; Laursen, Lisbeth S.; Oxvig, Claus			Stanniocalcin-2 Inhibits Mammalian Growth by Proteolytic Inhibition of the Insulin-like Growth Factor Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-PROTEIN-A; IGF BINDING PROTEIN-4; PAPP-A; SUBSTRATE-SPECIFICITY; NEGATIVE REGULATOR; MICE DEFICIENT; EXPRESSION; GENE; OVEREXPRESSION; IDENTIFICATION	Mammalian stanniocalcin-2 (STC2) is a secreted polypeptide widely expressed in developing and adult tissues. However, although transgenic expression in mice is known to cause severe dwarfism, and targeted deletion of STC2 causes increased postnatal growth, its precise biological role is still unknown. We found that STC2 potently inhibits the proteolytic activity of the growth-promoting metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A). Proteolytic inhibition requires covalent binding of STC2 to PAPP-A and is mediated by a disulfide bond, which involves Cys-120 of STC2. Binding of STC2 prevents PAPP-A cleavage of insulin-like growth factor-binding protein (IGFBP)-4 and hence release within tissues of bioactive IGF, required for normal growth. Concordantly, we show that STC2 efficiently inhibits PAPP-A-mediated IGF receptor signaling in vitro and that transgenic mice expressing a mutated variant of STC2, STC2(C120A), which is unable to inhibit PAPP-A, grow like wild-type mice. Our work identifies STC2 as a novel proteinase inhibitor and a previously unrecognized extracellular component of the IGF system.	[Jepsen, Malene R.; Kloverpris, Soren; Mikkelsen, Jakob H.; Pedersen, Josefine H.; Fuchtbauer, Ernst-Martin; Laursen, Lisbeth S.; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Aarhus University	Oxvig, C (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark.	co@mbg.au.dk		Laursen, Lisbeth Schmidt/0000-0002-8676-5869; Mikkelsen, Jakob Hauge/0000-0002-2914-3297; Jepsen, Malene/0000-0003-1959-5019; Oxvig, Claus/0000-0002-4715-9719	Lundbeck Foundation; Novo Nordisk Foundation; Danish Council for Independent Research (Medical Sciences); Danish Genetically Modified Animal Resource	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Genetically Modified Animal Resource	This work was supported by grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Council for Independent Research (Medical Sciences), and the Danish Genetically Modified Animal Resource.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bale LK, 2005, J ENDOCRINOL, V186, P325, DOI 10.1677/joe.1.06259; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Boldt HB, 2004, J BIOL CHEM, V279, P38525, DOI 10.1074/jbc.M405222200; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Chang ACM, 2005, MOL CELL BIOL, V25, P10604, DOI 10.1128/MCB.25.23.10604-10610.2005; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; Chang ACM, 1998, MOL CELL ENDOCRINOL, V141, P95, DOI 10.1016/S0303-7207(98)00097-5; Chang ACM, 2008, ENDOCRINOLOGY, V149, P2403, DOI 10.1210/en.2007-1219; Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997; Conover CA, 2011, ENDOCRINOLOGY, V152, P2837, DOI 10.1210/en.2011-0036; Conover CA, 2010, J GERONTOL A-BIOL, V65, P590, DOI 10.1093/gerona/glq032; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Gagliardi AD, 2005, AM J PHYSIOL-ENDOC M, V288, pE92, DOI 10.1152/ajpendo.00268.2004; Gerard N, 2004, J ENDOCRINOL, V182, P457, DOI 10.1677/joe.0.1820457; Gerritsen ME, 2005, VITAM HORM, V70, P105, DOI 10.1016/S0083-6729(05)70004-2; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gyrup C, 2007, BIOCHEMISTRY-US, V46, P1972, DOI 10.1021/bi062229i; Harrington SC, 2007, CIRC RES, V100, P1696, DOI 10.1161/CIRCRESAHA.106.146183; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Laursen LS, 2007, MOL ENDOCRINOL, V21, P1246, DOI 10.1210/me.2006-0522; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; Mader JR, 2013, J ENDOCRINOL, V219, P51, DOI 10.1530/JOE-13-0167; Mikkelsen JH, 2014, ONCOTARGET, V5, P1014, DOI 10.18632/oncotarget.1629; Mikkelsen JH, 2014, J IMMUNOL METHODS, V404, P33, DOI 10.1016/j.jim.2013.12.002; Ning Y, 2008, MOL ENDOCRINOL, V22, P1213, DOI 10.1210/me.2007-0536; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Olsen HS, 1996, P NATL ACAD SCI USA, V93, P1792, DOI 10.1073/pnas.93.5.1792; Overgaard MT, 2000, J BIOL CHEM, V275, P31128, DOI 10.1074/jbc.M001384200; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qin XZ, 2006, ENDOCRINOLOGY, V147, P5653, DOI 10.1210/en.2006-1055; Rehage M, 2007, ENDOCRINOLOGY, V148, P6176, DOI 10.1210/en.2007-0274; Rimbault M, 2013, GENOME RES, V23, P1985, DOI 10.1101/gr.157339.113; Schoenebeck JJ, 2014, ANNU REV CELL DEV BI, V30, P535, DOI 10.1146/annurev-cellbio-100913-012927; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Smith GCS, 2002, NATURE, V417, P916, DOI 10.1038/417916a; Soe R, 2002, EUR J BIOCHEM, V269, P2247, DOI 10.1046/j.1432-1033.2002.02883.x; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Trindade DM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-57; Varghese R, 2002, ENDOCRINOLOGY, V143, P868, DOI 10.1210/en.143.3.868; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; Weyer K, 2007, J BIOL CHEM, V282, P10988, DOI 10.1074/jbc.M607903200; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007	55	85	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3430	3439		10.1074/jbc.M114.611665	http://dx.doi.org/10.1074/jbc.M114.611665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533459	Green Published, hybrid			2022-12-28	WOS:000349456000019
J	Sanyal, N; Arentson, BW; Luo, M; Tanner, JJ; Becker, DF				Sanyal, Nikhilesh; Arentson, Benjamin W.; Luo, Min; Tanner, John J.; Becker, Donald F.			First Evidence for Substrate Channeling between Proline Catabolic Enzymes A VALIDATION OF DOMAIN FUSION ANALYSIS FOR PREDICTING PROTEIN-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE GAMMA-SEMIALDEHYDE; PYRROLINE-5-CARBOXYLIC ACID; STRUCTURAL-CHARACTERIZATION; SALMONELLA-TYPHIMURIUM; DEHYDROGENASE DOMAIN; CRYSTAL-STRUCTURE; METABOLISM; INTERMEDIATE; DEGRADATION; FLAVOENZYME	Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate (P5C) dehydrogenase (P5CDH) catalyze the four-electron oxidation of proline to glutamate via the intermediates P5C and L-glutamate-gamma-semialdehyde (GSA). In Gram-negative bacteria, PRODH and P5CDH are fused together in the bifunctional enzyme proline utilizationA(PutA) whereas in other organisms PRODH and P5CDH are expressed as separate monofunctional enzymes. Substrate channeling has previously been shown for bifunctional PutAs, but whether the monofunctional enzymes utilize an analogous channeling mechanism has not been examined. Here, we report the first evidence of substrate channeling in a PRODH-P5CDH two-enzyme pair. Kinetic data for the coupled reaction of PRODH and P5CDH from Thermus thermophilus are consistent with a substrate channeling mechanism, as the approach to steady-state formation of NADH does not fit a nonchanneling two-enzyme model. Furthermore, inactive P5CDH and PRODH mutants inhibit NADH production and increase trapping of the P5C intermediate in coupled assays of wild-type PRODH-P5CDH enzyme pairs, indicating that the mutants disrupt PRODH-P5CDH channeling interactions. A dissociation constant of 3 mu M was estimated for a putative PRODH-P5CDH complex by surface plasmon resonance (SPR). Interestingly, P5CDH binding to PRODH was only observed when PRODH was immobilized with the top face of its (beta alpha)(8) barrel exposed. Using the known x-ray crystal structures of PRODH and P5CDH from T. thermophilus, a model was built for a proposed PRODH-P5CDH enzyme channeling complex. The structural model predicts that the core channeling pathway of bifunctional PutA enzymes is conserved in monofunctional PRODH-P5CDH enzyme pairs.	[Sanyal, Nikhilesh; Arentson, Benjamin W.; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Luo, Min; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of Nebraska System; University of Nebraska Lincoln; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Becker, DF (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	dbecker3@unl.edu		Tanner, John/0000-0001-8314-113X	National Institutes of Health [GM065546, P30GM103335]; Hatch Act; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, R01GM065546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Act(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065546 and P30GM103335 and is a contribution of the University of Nebraska Agricultural Research Division, supported in part by funds provided through the Hatch Act.	Arentson BW, 2014, BIOCHEMISTRY-US, V53, P5150, DOI 10.1021/bi5007404; Baker P, 2012, BIOCHEMISTRY-US, V51, P4558, DOI 10.1021/bi300407y; Bearne SL, 2001, BIOCHEM J, V356, P223, DOI 10.1042/0264-6021:3560223; BEARNE SL, 1995, BIOCHEMISTRY-US, V34, P11515, DOI 10.1021/bi00036a026; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Curtis J, 2004, PLANT PHYSIOL, V136, P3313, DOI 10.1104/pp.104.044024; EKENA K, 1990, MOL GEN GENET, V220, P492, DOI 10.1007/BF00391761; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Farrant RD, 2001, J BIOL CHEM, V276, P15107, DOI 10.1074/jbc.M010860200; Geck MK, 1999, BIOCHEMISTRY-US, V38, P8032, DOI 10.1021/bi983029c; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; Monteoliva MI, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-21; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; James CL, 2002, BIOCHEMISTRY-US, V41, P3726, DOI 10.1021/bi0159074; Johnson K. A., 1913, BIOCHEMISTRY-US, V50, P8264; KOHL DH, 1988, P NATL ACAD SCI USA, V85, P2036, DOI 10.1073/pnas.85.7.2036; Krishnan N, 2008, INFECT IMMUN, V76, P3037, DOI 10.1128/IAI.01737-07; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Liu W, 2012, BIOFACTORS, V38, P398, DOI 10.1002/biof.1036; Luo M, 2013, J MOL BIOL, V425, P3106, DOI 10.1016/j.jmb.2013.05.027; Luo M, 2012, BIOCHEMISTRY-US, V51, P10099, DOI 10.1021/bi301312f; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Michaelis L, 1913, BIOCHEM Z, V49, P333; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; Moses S, 2012, J BACTERIOL, V194, P745, DOI 10.1128/JB.06380-11; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; Nishimura A, 2012, FEBS LETT, V586, P2411, DOI 10.1016/j.febslet.2012.05.056; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Pang SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6048; Pang SS, 2014, CELL METAB, V19, P221, DOI 10.1016/j.cmet.2013.12.005; Pemberton TA, 2014, BIOCHEMISTRY-US, V53, P1350, DOI 10.1021/bi500048b; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SRERE PA, 1990, FEBS LETT, V268, P360, DOI 10.1016/0014-5793(90)81286-W; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; Surber MW, 1998, ARCH BIOCHEM BIOPHYS, V354, P281, DOI 10.1006/abbi.1998.0697; Takagi H, 2008, APPL MICROBIOL BIOT, V81, P211, DOI 10.1007/s00253-008-1698-5; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P16158, DOI 10.1021/bi991741j; White TA, 2007, J BIOL CHEM, V282, P14316, DOI 10.1074/jbc.M700912200; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; Yadid I, 2013, P NATL ACAD SCI USA, V110, pE2182, DOI 10.1073/pnas.1214052110; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhao H, 2013, CHEM COMMUN, V49, P4444, DOI 10.1039/c3cc41437j	58	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2225	2234		10.1074/jbc.M114.625483	http://dx.doi.org/10.1074/jbc.M114.625483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25492892	Green Published, hybrid			2022-12-28	WOS:000348588000026
J	Somoza, JR; Koditek, D; Villasenor, AG; Novikov, N; Wong, MH; Liclican, A; Xing, WM; Lagpacan, L; Wang, R; Schultz, BE; Papalia, GA; Samuel, D; Lad, L; McGrath, ME				Somoza, John R.; Koditek, David; Villasenor, Armando G.; Novikov, Nikolai; Wong, Melanie H.; Liclican, Albert; Xing, Weimei; Lagpacan, Leanna; Wang, Ruth; Schultz, Brian E.; Papalia, Giuseppe A.; Samuel, Dharmaraj; Lad, Latesh; McGrath, Mary E.			Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PI3K-DELTA INHIBITOR; P110-DELTA; CAL-101; PI3K; WORTMANNIN; MECHANISMS; NETWORKS; BIACORE; ANTIGEN; MAP	Idelalisib (also known as GS-1101, CAL-101, IC489666, and Zydelig) is a PI3K delta inhibitor that has recently been approved for the treatment of several hematological malignancies. Given its use in human diseases, we needed a clear picture of how idelalisib binds to and inhibits PI3K delta. Our data show that idelalisib is a potent and selective inhibitor of the kinase activity of PI3K delta. A kinetic characterization clearly demonstrated ATP-competitive inhibition, and several additional biochemical and biophysical assays showed that the compound binds reversibly and noncovalently to the kinase. A crystal structure of idelalisib bound to the p110 delta subunit of PI3K delta furthers our understanding of the binding interactions that confer the potency and selectivity of idelalisib.	[Somoza, John R.; Villasenor, Armando G.; McGrath, Mary E.] Gilead Sci Inc, Dept Struct Chem, Foster City, CA 94404 USA; [Koditek, David; Novikov, Nikolai; Wong, Melanie H.; Liclican, Albert; Xing, Weimei; Lagpacan, Leanna; Wang, Ruth; Schultz, Brian E.; Papalia, Giuseppe A.; Samuel, Dharmaraj; Lad, Latesh] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA	Gilead Sciences; Gilead Sciences	Somoza, JR (corresponding author), Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA.	john.somoza@gilead.com			National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy [DE-AC02-05CH11231]	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported in part by funds from National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute (to the Berkeley Center for Structural Biology) and by Contract DE-AC02-05CH11231 from the Director of the Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (to the Advanced Light Source).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Bartok B, 2012, AM J PATHOL, V180, P1906, DOI 10.1016/j.ajpath.2012.01.030; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/nchembio.293, 10.1038/NCHEMBIO.293]; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Copeland RA., 2000, ENZYME PRACTICAL INT, P266, DOI 10.1002/0471220639.ch8; Cushing TD, 2015, J MED CHEM, V58, P480, DOI 10.1021/jm501624r; EMA, 2014, ZYD SUMM OP IN AUTH; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; FDA, 2014, FDA APPR ZYD 3 TYP B; Firestein GS, 2004, J CLIN INVEST, V114, P471, DOI 10.1172/JCI200422651; Flinn IW, 2014, BLOOD, V123, P3406, DOI 10.1182/blood-2013-11-538546; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Kahl BS, 2014, BLOOD, V123, P3398, DOI 10.1182/blood-2013-11-537555; Karlsson R, 1999, J MOL RECOGNIT, V12, P285, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<285::AID-JMR469>3.0.CO;2-Y; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Meadows SA, 2012, BLOOD, V119, P1897, DOI 10.1182/blood-2011-10-386763; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Park SJ, 2010, EUR RESPIR J, V36, P1448, DOI 10.1183/09031936.00106609; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wymann MP, 1996, MOL CELL BIOL, V16, P1722	37	102	107	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8439	8446		10.1074/jbc.M114.634683	http://dx.doi.org/10.1074/jbc.M114.634683			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25631052	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000351662600036
J	Gudi, R; Haycraft, CJ; Bell, PD; Li, ZH; Vasu, C				Gudi, Radhika; Haycraft, Courtney J.; Bell, P. Darwin; Li, Zihai; Vasu, Chenthamarakshan			Centrobin-mediated Regulation of the Centrosomal Protein 4.1-associated Protein (CPAP) Level Limits Centriole Length during Elongation Stage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO KINASE; DUPLICATION; CYCLE; BIOGENESIS; TUBULIN; CILIA; REQUIREMENT; COOPERATE; SUBSTRATE; INTERACTS	Microtubule-based centrioles in the centrosome mediate accurate bipolar cell division, spindle orientation, and primary cilia formation. Cellular checkpoints ensure that the centrioles duplicate only once in every cell cycle and achieve precise dimensions, dysregulation of which results in genetic instability and neuro- and ciliopathies. The normal cellular level of centrosomal protein 4.1-associated protein (CPAP), achieved by its degradation at mitosis, is considered as one of the major mechanisms that limits centriole growth at a predetermined length. Here we show that CPAP levels and centriole elongation are regulated by centrobin. Exogenous expression of centrobin causes abnormal elongation of centrioles due to massive accumulation of CPAP in the cell. Conversely, CPAP was undetectable in centrobin-depleted cells, suggesting that it undergoes degradation in the absence of centrobin. Only the reintroduction of full-length centrobin, but not its mutant form that lacks the CPAP binding site, could restore cellular CPAP levels in centrobin-depleted cells, indicating that persistence of CPAP requires its interaction with centrobin. Interestingly, inhibition of the proteasome in centrobin-depleted cells restored the cellular and centriolar CPAP expression, suggesting its ubiquitination and proteasome-mediated degradation when centrobin is absent. Intriguingly, however, centrobin-overexpressing cells also showed proteasome-independent accumulation of ubiquitinated CPAP and abnormal, ubiquitin-positive, elongated centrioles. Overall, our results show that centrobin interacts with ubiquitinated CPAP and prevents its degradation for normal centriole elongation function. Therefore, it appears that loss of centrobin expression destabilizes CPAP and triggers its degradation to restrict the centriole length during biogenesis.	[Gudi, Radhika; Li, Zihai; Vasu, Chenthamarakshan] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Haycraft, Courtney J.] Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Bell, P. Darwin] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Vasu, Chenthamarakshan] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Gudi, R (corresponding author), Med Univ S Carolina, HO602,86 Jonathan Lucas St, Charleston, SC 29425 USA.	gudi@musc.edu		vasu, chenthamarakshan/0000-0002-1772-6508	Department of Surgery, MUSC; Department of Microbiology, MUSC; Department of Immunology, MUSC; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002007] Funding Source: NIH RePORTER	Department of Surgery, MUSC; Department of Microbiology, MUSC; Department of Immunology, MUSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by internal funds from the Departments of Surgery and Microbiology and Immunology, MUSC (to C. V.).	Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Gudi R, 2014, J BIOL CHEM, V289, P15166, DOI 10.1074/jbc.M113.531152; Gudi R, 2011, J CELL BIOL, V193, P711, DOI 10.1083/jcb.201006135; Gul A, 2006, J HUM GENET, V51, P760, DOI 10.1007/s10038-006-0017-1; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; Januschke J, 2013, NAT CELL BIOL, V15, P241, DOI 10.1038/ncb2671; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Kim MK, 2012, EMBO REP, V13, P724, DOI 10.1038/embor.2012.86; Kitagawa D, 2011, J CELL SCI, V124, P3884, DOI 10.1242/jcs.089888; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Korzeniewski N, 2010, MOL BIOL CELL, V21, P3942, DOI 10.1091/mbc.E09-12-1049; Lee J, 2010, J BIOL CHEM, V285, P25476, DOI 10.1074/jbc.M109.099127; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Lin YN, 2013, J CELL BIOL, V202, P211, DOI 10.1083/jcb.201212060; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; ROBBINS E, 1968, J CELL BIOL, V36, P329, DOI 10.1083/jcb.36.2.329; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Schmukle AC, 2012, J CELL SCI, V125, P549, DOI 10.1242/jcs.091793; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Stinchcombe JC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-45; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; VOROBJEV IA, 1980, CELL BIOL INT REP, V4, P1037, DOI 10.1016/0309-1651(80)90177-0; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wu KS, 2012, BIOL OPEN, V1, P559, DOI 10.1242/bio.20121388; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	64	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6890	6902		10.1074/jbc.M114.603423	http://dx.doi.org/10.1074/jbc.M114.603423			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25616662	Green Published, hybrid			2022-12-28	WOS:000350991500024
J	Lorenz, M; Vollmer, B; Unsay, JD; Klupp, BG; Garcia-Saez, AJ; Mettenleiter, TC; Antonin, W				Lorenz, Michael; Vollmer, Benjamin; Unsay, Joseph D.; Klupp, Barbara G.; Garcia-Saez, Ana J.; Mettenleiter, Thomas C.; Antonin, Wolfram			A Single Herpesvirus Protein Can Mediate Vesicle Formation in the Nuclear Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGRESS COMPLEX; PORE COMPLEX; PSEUDORABIES VIRUS; CELLULAR MEMBRANES; LIPID-COMPOSITION; ESCRT MACHINERY; INFECTED-CELLS; GENE-PRODUCTS; CURVATURE; COEXPRESSION	Herpesviruses assemble capsids in the nucleus and egress by unconventional vesicle-mediated trafficking through the nuclear envelope. Capsids bud at the inner nuclear membrane into the nuclear envelope lumen. The resulting intralumenal vesicles fuse with the outer nuclear membrane, delivering the capsids to the cytoplasm. Two viral proteins are required for vesicle formation, the tail-anchored pUL34 and its soluble interactor, pUL31. Whether cellular proteins are involved is unclear. Using giant unilamellar vesicles, we show that pUL31 and pUL34 are sufficient for membrane budding and scission. pUL34 function can be bypassed by membrane tethering of pUL31, demonstrating that pUL34 is required for pUL31 membrane recruitment but not for membrane remodeling. pUL31 can inwardly deform membranes by oligomerizing on their inner surface to form buds that constrict to vesicles. Therefore, a single viral protein can mediate all events necessary for membrane budding and abscission.	[Lorenz, Michael; Vollmer, Benjamin; Antonin, Wolfram] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Unsay, Joseph D.; Garcia-Saez, Ana J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Klupp, Barbara G.; Mettenleiter, Thomas C.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, D-17493 Greifswald, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Friedrich Loeffler Institute	Antonin, W (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Spemannstr 79, D-72076 Tubingen, Germany.	wolfram.antonin@tuebingen.mpg.de	Mettenleiter, h. c. Thomas C./U-1016-2019; Saez, Ana J. Garcia/U-1611-2019; Unsay, Joseph/H-7739-2019; Antonin, Wolfram/A-8656-2014; Vollmer, Benjamin/AAJ-7327-2021; Antonin, Wolfram/P-3648-2019	Unsay, Joseph/0000-0003-0569-7962; Antonin, Wolfram/0000-0003-4669-379X; Vollmer, Benjamin/0000-0002-7526-0582; Antonin, Wolfram/0000-0003-4669-379X	Max Planck Society; German Research Foundation [DFG Me 854/12-1]	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG))	This work was supported by funding from the Max Planck Society (to W. A.) and by German Research Foundation Grant DFG Me 854/12-1.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bigalke JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5131; Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Chang YE, 1997, J VIROL, V71, P8307, DOI 10.1128/JVI.71.11.8307-8315.1997; Cohen S, 2011, BBA-MOL CELL RES, V1813, P1634, DOI 10.1016/j.bbamcr.2010.12.009; Desai PJ, 2012, J VIROL, V86, P594, DOI 10.1128/JVI.05988-11; Eisenhardt N, 2014, J CELL SCI, V127, P908, DOI 10.1242/jcs.141739; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fuchs W, 2002, J VIROL, V76, P364, DOI 10.1128/JVI.76.1.364-378.2002; GAROFF H, 1974, P NATL ACAD SCI USA, V71, P3988, DOI 10.1073/pnas.71.10.3988; Granato M, 2008, J VIROL, V82, P4042, DOI 10.1128/JVI.02436-07; Haugo AC, 2011, J VIROL, V85, P7203, DOI 10.1128/JVI.00262-11; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; KLEINIG H, 1970, J CELL BIOL, V46, P396, DOI 10.1083/jcb.46.2.396; Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104; Klupp BG, 2011, J VIROL, V85, P8285, DOI 10.1128/JVI.00741-11; Kobiler O, 2012, NUCLEUS-PHILA, V3, P526, DOI 10.4161/nucl.21979; Lake CM, 2004, VIROLOGY, V320, P99, DOI 10.1016/j.virol.2003.11.018; Ledesma MD, 2003, INT REV CYTOL, V227, P183, DOI 10.1016/S0074-7696(03)01010-6; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luitweiler EM, 2013, J VIROL, V87, P3915, DOI 10.1128/JVI.03418-12; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Mettenleiter TC, 2013, CELL MICROBIOL, V15, P170, DOI 10.1111/cmi.12044; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mou F, 2007, J VIROL, V81, P6459, DOI 10.1128/JVI.00380-07; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; Reynolds AE, 2004, J VIROL, V78, P5564, DOI 10.1128/JVI.78.11.5564-5575.2004; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Roller RJ, 2011, J VIROL, V85, P11615, DOI 10.1128/JVI.05730-11; Roller RJ, 2010, J VIROL, V84, P3921, DOI 10.1128/JVI.01638-09; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sam MD, 2009, J VIROL, V83, P2996, DOI 10.1128/JVI.02441-08; Schnee M, 2006, J VIROL, V80, P11658, DOI 10.1128/JVI.01662-06; Schooley A, 2012, CHROMOSOMA, V121, P539, DOI 10.1007/s00412-012-0388-3; Schuster F, 2012, J VIROL, V86, P2079, DOI 10.1128/JVI.05484-11; Shnyrova AV, 2007, J CELL BIOL, V179, P627, DOI 10.1083/jcb.200705062; Skepper JN, 2001, J VIROL, V75, P5697, DOI 10.1128/JVI.75.12.5697-5702.2001; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Unsay JD, 2013, LANGMUIR, V29, P15878, DOI 10.1021/la402669z; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vollmer B, 2012, EMBO J, V31, P4072, DOI 10.1038/emboj.2012.256; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	71	57	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6962	6974		10.1074/jbc.M114.627521	http://dx.doi.org/10.1074/jbc.M114.627521			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605719	Green Published, hybrid			2022-12-28	WOS:000350991500030
J	Izumikawa, T; Sato, B; Mikami, T; Tamura, J; Igarashi, M; Kitagawa, H				Izumikawa, Tomomi; Sato, Ban; Mikami, Tadahisa; Tamura, Jun-ichi; Igarashi, Michihiro; Kitagawa, Hiroshi			GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl(2-O-phosphate) Is the Preferred Substrate for Chondroitin N-Acetylgalactosaminyltransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-LINKAGE REGION; SWARM MOUSE-TUMOR; MOLECULAR-CLONING; SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE-1; N-ACETYLGALACTOSAMINYLTRANSFERASE; GLYCOSAMINOGLYCAN BIOSYNTHESIS; POLYMERIZING FACTOR; EXPRESSION; PROTEOGLYCANS; FAMILY	A deficiency in chondroitin N-acetylgalactosaminyltransferase- 1 (ChGn-1) was previously shown to reduce the number of chondroitin sulfate (CS) chains, leading to skeletal dysplasias in mice, suggesting that ChGn-1 regulates the number of CS chains for normal cartilage development. Recently, we demonstrated that 2-phosphoxylose phosphatase (XYLP) regulates the number of CS chains by dephosphorylating the Xyl residue in the glycosaminoglycan-protein linkage region of proteoglycans. However, the relationship between ChGn-1 and XYLP in controlling the number of CS chains is not clear. In this study, we for the first time detected a phosphorylated tetrasaccharide linkage structure, GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl(2-O-phosphate), in ChGn-1(-/-) growth plate cartilage but not in ChGn-2(-/-) or wild-type growth plate cartilage. In contrast, the truncated linkage tetrasaccharide GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl was detected in wild-type, ChGn-1(-/-), and ChGn-2(-/-) growth plate cartilage. Consistent with the findings, ChGn-1 preferentially transferred N-acetylgalactosamine to the phosphorylated tetrasaccharide linkage in vitro. Moreover, ChGn-1 and XYLP interacted with each other, and ChGn-1-mediated addition of N-acetylgalactosamine was accompanied by rapid XYLP-dependent dephosphorylation during formation of the CS linkage region. Taken together, we conclude that the phosphorylated tetrasaccharide linkage is the preferred substrate for ChGn-1 and that ChGn-1 and XYLP cooperatively regulate the number of CS chains in growth plate cartilage.	[Izumikawa, Tomomi; Sato, Ban; Mikami, Tadahisa; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Tamura, Jun-ichi] Tottori Univ, Dept Reg Environm, Tottori 6808557, Japan; [Igarashi, Michihiro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Neurochem & Mol Cell Biol, Chuo Ku, Niigata 9518510, Japan; [Igarashi, Michihiro] Niigata Univ, Trans Disciplinary Program, Chuo Ku, Niigata 9518510, Japan	Kobe Pharmaceutical University; Tottori University; Niigata University; Niigata University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science and Technology, Japan [25293014, 24590132, 23110003]; Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [15K01823, 24590132] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (B) 25293014 (to H. K.), for Scientific Research (C) 24590132 (to T. M.), and for Scientific Research on Innovative Areas 23110003 (to H. K.) and by the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Izumikawa T, 2012, BIOCHEM J, V441, P697, DOI 10.1042/BJ20111472; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kitagawa H, 2014, BIOL PHARM BULL, V37, P1705, DOI 10.1248/bpb.b14-00613; Koike T, 2014, J BIOL CHEM, V289, P6695, DOI 10.1074/jbc.M113.520536; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyata S, 2015, J BIOCHEM, V157, P13, DOI 10.1093/jb/mvu067; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 2014, MATRIX BIOL, V35, P18, DOI 10.1016/j.matbio.2013.10.010; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Saigoh K, 2011, J HUM GENET, V56, P143, DOI 10.1038/jhg.2010.148; Sakaguchi H, 2001, J BIOCHEM-TOKYO, V129, P107, DOI 10.1093/oxfordjournals.jbchem.a002820; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; SUGAHARA K, 1992, EUR J BIOCHEM, V204, P401, DOI 10.1111/j.1432-1033.1992.tb16649.x; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; Takeuchi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3740; Tamura J, 2002, BIOORG MED CHEM LETT, V12, P1901, DOI 10.1016/S0960-894X(02)00327-X; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; WATANABE H, 1995, BIOCHEM J, V308, P433, DOI 10.1042/bj3080433; Watanabe Y, 2010, BIOCHEM J, V432, P47, DOI 10.1042/BJ20100847; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Zeng-Brouwers J, 2014, MATRIX BIOL, V35, P132, DOI 10.1016/j.matbio.2013.12.003	36	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5438	5448		10.1074/jbc.M114.603266	http://dx.doi.org/10.1074/jbc.M114.603266			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568321	Green Published, hybrid			2022-12-28	WOS:000350044200017
J	Zhu, QS; Kao, LY; Azimov, R; Abuladze, N; Newman, D; Kurtz, I				Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Newman, Debra; Kurtz, Ira			Interplay between Disulfide Bonding and N-Glycosylation Defines SLC4 Na+-coupled Transporter Extracellular Topography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-HCO3-COTRANSPORTER NBC1; ANION-EXCHANGER; PLASMA-MEMBRANE; IDENTIFICATION; TOPOLOGY; NBCE1-A; MUTAGENESIS; VARIANTS; MUTATION; ROLES	The extracellular loop 3 (EL-3) of SLC4 Na+-coupled transporters contains 4 highly conserved cysteines and multiple N-glycosylation consensus sites. In the electrogenic Na+-HCO3- cotransporter NBCe1-A, EL-3 is the largest extracellular loop and is predicted to consist of 82 amino acids. To determine the structural-functional importance of the conserved cysteines and the N-glycosylation sites in NBCe1-A EL-3, we analyzed the potential interplay between EL-3 disulfide bonding and N-glycosylation and their roles in EL-3 topological folding. Our results demonstrate that the 4 highly conserved cysteines form two intramolecular disulfide bonds, Cys(583)-Cys(585) and Cys(617)-Cys(642), respectively, that constrain EL-3 in a folded conformation. The formation of the second disulfide bond is spontaneous and unaffected by the N-glycosylation state of EL-3 or the first disulfide bond, whereas formation of the first disulfide bond relies on the presence of the second disulfide bond and is affected by N-glycosylation. Importantly, EL-3 from each monomer is adjacently located at the NBCe1-A dimeric interface. When the two disulfide bonds are missing, EL-3 adopts an extended conformation highly accessible to protease digestion. This unique adjacent parallel location of two symmetrically folded EL-3 loops from each monomer resembles a domain-like structure that is potentially important for NBCe1-A function in vivo. Moreover, the formation of this unique structure is critically dependent on the finely tuned interplay between disulfide bonding and N-glycosylation in the membrane processed NBCe1-A dimer.	[Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Newman, Debra; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, QS (corresponding author), Univ Calif Los Angeles, Dept Med, 7-155 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	quzhu@mednet.ucla.edu			National Institutes of Health [DK077162]; Norman S. Coplon Grant from Satellite Healthcare; Factor Family Foundation; Allan Smidt Charitable Fund; Arvey Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman S. Coplon Grant from Satellite Healthcare; Factor Family Foundation; Allan Smidt Charitable Fund; Arvey Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK077162 (to I. K.). This work was also supported by a Norman S. Coplon Grant from Satellite Healthcare (to Q. Z.) and by the Factor Family Foundation, the Allan Smidt Charitable Fund, and the Arvey Foundation (to I. K.).	Abuladze N, 2000, GENE, V251, P109, DOI 10.1016/S0378-1119(00)00204-3; Blum AP, 2011, J BIOL CHEM, V286, P32251, DOI 10.1074/jbc.M111.254235; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Brast S, 2012, FASEB J, V26, P976, DOI 10.1096/fj.11-180679; Choi I, 2003, AM J PHYSIOL-RENAL, V284, pF1199, DOI 10.1152/ajprenal.00131.2002; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Kurtz I, 2013, SELDIN GIEBISCHS KID, P1837, DOI DOI 10.1016/B978-0-12-381462-3.00053-7; Kurtz I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00350; Li HC, 2004, J BIOL CHEM, V279, P43190, DOI 10.1074/jbc.M405780200; Li HC, 2007, AM J PHYSIOL-RENAL, V292, pF1245, DOI 10.1152/ajprenal.00410.2006; Liu Y, 2011, GENOMICS, V98, P112, DOI 10.1016/j.ygeno.2011.04.010; Lu J, 2007, AM J PHYSIOL-CELL PH, V292, pC1787, DOI 10.1152/ajpcell.00267.2006; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Patterson ST, 2010, J BIOL CHEM, V285, P33423, DOI 10.1074/jbc.M110.144261; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Seki G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00270; Suzuki M, 2010, P NATL ACAD SCI USA, V107, P15963, DOI 10.1073/pnas.1008705107; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Yang HS, 2009, J BIOL CHEM, V284, P15970, DOI 10.1074/jbc.M109.001438; Zhu Q., 2010, J AM SOC NEPHROL, V21, p251A; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2013, AM J PHYSIOL-CELL PH, V305, pC392, DOI 10.1152/ajpcell.00044.2013; Zhu QS, 2013, J BIOL CHEM, V288, P7894, DOI 10.1074/jbc.M112.404533; Zhu QS, 2010, J BIOL CHEM, V285, P37178, DOI 10.1074/jbc.M110.169201; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	30	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5391	5404		10.1074/jbc.M114.619320	http://dx.doi.org/10.1074/jbc.M114.619320			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568315	Green Published, hybrid			2022-12-28	WOS:000350044200013
J	Huang, R; Zhang, M; Rwere, F; Waskell, L; Ramamoorthy, A				Huang, Rui; Zhang, Meng; Rwere, Freeborn; Waskell, Lucy; Ramamoorthy, Ayyalusamy			Kinetic and Structural Characterization of the Interaction between the FMN Binding Domain of Cytochrome P450 Reductase and Cytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ELECTRON-TRANSFER; COENZYME BINDING; P450 REDUCTASE; NMR-SPECTROSCOPY; LIVER MICROSOMES; PARAMAGNETIC NMR; P-450 REDUCTASE; COMPLEX; MECHANISM	Cytochrome P450 reductase (CPR) is a diflavin enzyme that transfers electrons to many protein partners. Electron transfer from CPR to cyt c has been extensively used as a model reaction to assess the redox activity of CPR. CPR is composed of multiple domains, among which the FMN binding domain (FBD) is the direct electron donor to cyt c. Here, electron transfer and complex formation between FBD and cyt c are investigated. Electron transfer from FBD to cyt c occurs at distinct rates that are dependent on the redox states of FBD. When compared with full-length CPR, FBD reduces cyt c at a higher rate in both the semiquinone and hydroquinone states. The NMR titration experiments reveal the formation of dynamic complexes between FBD and cyt c on a fast exchange time scale. Chemical shift mapping identified residues of FBD involved in the binding interface with cyt c, most of which are located in proximity to the solvent-exposed edge of the FMN cofactor along with other residues distributed around the surface of FBD. The structural model of the FBD-cyt c complex indicates two possible orientations of complex formation. The major complex structure shows a salt bridge formation between Glu-213/Glu-214 of FBD and Lys-87 of cyt c, which may be essential for the formation of the complex, and a predicted electron transfer pathway mediated by Lys-13 of cyt c. The findings provide insights into the function of CPR and CPR-cyt c interaction on a structural basis.	[Huang, Rui; Zhang, Meng; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Rwere, Freeborn; Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Rwere, Freeborn; Waskell, Lucy] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu	Huang, Rui/N-4022-2017; Rwere, Freeborn/ABF-3335-2021; Zhang, Meng/P-6278-2017	Huang, Rui/0000-0002-4064-6397; Rwere, Freeborn/0000-0002-7037-6850; Zhang, Meng/0000-0003-4497-3253; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900	National Institutes of Health [GM084018, GM095640, GM094209]; merit review grant from Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095640, R01GM084018, R01GM094209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); merit review grant from Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084018 and GM095640 (to A. R.) and GM094209. This work was also supported by a merit review grant from Veterans Affairs (to L. W.).	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Das A, 2009, BIOCHEMISTRY-US, V48, P12104, DOI 10.1021/bi9011435; Davydov DR, 1996, BIOCHIMIE, V78, P734, DOI 10.1016/S0300-9084(97)82531-X; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deep S, 2005, BIOCHEMISTRY-US, V44, P10654, DOI 10.1021/bi050482x; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Goddard T. D., 2006, SPARKY 3; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Gutierrez A, 2003, EUR J BIOCHEM, V270, P2612, DOI 10.1046/j.1432-1033.2003.03633.x; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Gutierrez A, 2000, BIOCHEMISTRY-US, V39, P15990, DOI 10.1021/bi002135n; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; Hervas M, 2013, FEBS J, V280, P1830, DOI 10.1111/febs.12207; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; HORECKER BL, 1950, J BIOL CHEM, V183, P593; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Hubbard SJ., 1993, COMPUTER PROGRAM; Jang HH, 2010, BBA-PROTEINS PROTEOM, V1804, P1285, DOI 10.1016/j.bbapap.2010.02.003; Kurnikov IV., 2000, HARLEM MOL MODELING; LU AYH, 1968, J BIOL CHEM, V243, P1331; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; NADLER SG, 1988, ARCH BIOCHEM BIOPHYS, V261, P418, DOI 10.1016/0003-9861(88)90358-X; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; Ortiz de Montellano P. R, 2005, CYTOCHROME P450 STRU, P115; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222; RODKEY FL, 1947, FED PROC, V6, P286; Sakamoto K, 2011, P NATL ACAD SCI USA, V108, P12271, DOI 10.1073/pnas.1108320108; Scanu S, 2012, CHEMBIOCHEM, V13, P1312, DOI 10.1002/cbic.201200073; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SEM DS, 1994, BIOCHEMISTRY-US, V33, P12012, DOI 10.1021/bi00206a002; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Shao WP, 2003, BIOCHEMISTRY-US, V42, P14774, DOI 10.1021/bi030145t; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; SHEN SJ, 1994, BIOCHEMISTRY-US, V33, P8807, DOI 10.1021/bi00195a024; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Ubbink M, 2012, BIOCHEM SOC T, V40, P415, DOI 10.1042/BST20110698; Vincent B, 2012, J MOL BIOL, V420, P296, DOI 10.1016/j.jmb.2012.03.022; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; VORKINK WP, 1974, PHOTOCHEM PHOTOBIOL, V19, P205, DOI 10.1111/j.1751-1097.1974.tb06500.x; Wadsater M, 2012, J BIOL CHEM, V287, P34596, DOI 10.1074/jbc.M112.400085; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Worrall JAR, 2003, BIOCHEMISTRY-US, V42, P7068, DOI 10.1021/bi0342968; Worrall JAR, 2002, BIOCHEMISTRY-US, V41, P11721, DOI 10.1021/bi026296y; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Yousafzai FK, 2002, J BIOL CHEM, V277, P34067, DOI 10.1074/jbc.M204305200; ZABINSKI-SNOPKO R M, 1981, Journal of Biological Physics, V9, P155, DOI 10.1007/BF01988248; Zhao Q, 1999, PROTEIN SCI, V8, P298	61	17	19	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4843	4855		10.1074/jbc.M114.582700	http://dx.doi.org/10.1074/jbc.M114.582700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25512382	hybrid, Green Published			2022-12-28	WOS:000350042000029
J	Kim, IK; Stegeman, RA; Brosey, CA; Ellenberger, T				Kim, In-Kwon; Stegeman, Roderick A.; Brosey, Chris A.; Ellenberger, Tom			A Quantitative Assay Reveals Ligand Specificity of the DNA Scaffold Repair Protein XRCC1 and Efficient Disassembly of Complexes of XRCC1 and the Poly(ADP-ribose) Polymerase 1 by Poly(ADP-ribose) Glycohydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; BINDING-PROTEINS; DAMAGE; DOMAINS; UBIQUITINATION; METABOLISM; INHIBITORS; STABILITY; LENGTH; SITES	The posttranslational modification of proteins with poly(ADP-ribose) (PAR) regulates protein-protein interactions in DNA repair, gene expression, chromatin structure, and cell fate determination. The PAR polymerase PARP1 binds to damaged chromatin and synthesizes PAR chains to signal DNA damage and recruit the DNA repair scaffold, XRCC1. Pharmacological blockade of PARP1 enzymatic activity impairs XRCC1-dependent repair of DNA damage and selectively kills cancer cells lacking other DNA repair functions. As such, PARP inhibitors are promising new therapies for repair-deficient tumors such as BRCA mutated breast cancers. Although the XRCC1-PARP1 complex is relevant to the proposed therapeutic mechanism of PARP inhibitors, the physical makeup and dynamics of this complex are not well characterized at the molecular level. Here we describe a fluorescence-based, real-time assay that quantitatively monitors interactions between PARylated PARP1 and XRCC1. Using this assay, we show that the PAR posttranslational modification by itself is a high affinity ligand for XRCC1, requiring a minimum chain length of 7 ADP-ribose units in the oligo(ADP-ribose) ligand for a stable interaction with XRCC1. This discrete binding interface enables the PAR glycohydrolase (PARG) to completely disassemble the PARP1-XRCC1 complex without assistance from a mono(ADP-ribose) glycohydrolase. Our quantitative, real-time assay of PAR-dependent protein-protein interactions and PAR turnover by PARG is an excellent tool for high-throughput screening to identify pharmacological modulators of PAR metabolism that may be useful therapeutic alternatives to PARP inhibitors.	[Kim, In-Kwon; Stegeman, Roderick A.; Brosey, Chris A.; Ellenberger, Tom] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Kim, IK (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	inkwon@biochem.wustl.edu; tome@biochem.wustl.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R01GM052504]; Structural Cell Biology of DNA Repair Program [P01 CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Cell Biology of DNA Repair Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM052504 (to T. E.) and by the Structural Cell Biology of DNA Repair Program (Grant P01 CA92584 to John Tainer, The Scripps Research Institute).	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P443, DOI 10.1038/nrm3601; Gagne JP, 2012, NUCLEIC ACIDS RES, V40, P7788, DOI 10.1093/nar/gks486; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; HATAKEYAMA K, 1986, J BIOL CHEM, V261, P4902; He JX, 2010, ACTA PHARMACOL SIN, V31, P1172, DOI 10.1038/aps.2010.103; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Lakowicz J. R., 2007, PRINCIPLES FLUORESCE, P86; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Liu C, 2013, NUCLEIC ACIDS RES, V41, P1698, DOI 10.1093/nar/gks1278; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Parsons JL, 2010, DNA REPAIR, V9, P835, DOI 10.1016/j.dnarep.2010.04.008; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Tan ES, 2012, ANAL BIOCHEM, V428, P126, DOI 10.1016/j.ab.2012.06.015; Telli Melinda L, 2010, Clin Adv Hematol Oncol, V8, P629; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P1; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Wei LZ, 2013, J CELL SCI, V126, P4414, DOI 10.1242/jcs.128272; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Zaja R, 2013, BIOMOLECULES, V3, P1, DOI 10.3390/biom3010001	36	39	43	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3775	3783		10.1074/jbc.M114.624718	http://dx.doi.org/10.1074/jbc.M114.624718			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25477519	hybrid, Green Published			2022-12-28	WOS:000349456000048
J	Lin, PH; Duann, P; Komazaki, S; Park, KH; Li, HC; Sun, MZ; Sermersheim, M; Gumpper, K; Parrington, J; Galione, A; Evans, AM; Zhu, MX; Ma, JJ				Lin, Pei-Hui; Duann, Pu; Komazaki, Shinji; Park, Ki Ho; Li, Haichang; Sun, Mingzhai; Sermersheim, Mathew; Gumpper, Kristyn; Parrington, John; Galione, Antony; Evans, A. Mark; Zhu, Michael X.; Ma, Jianjie			Lysosomal Two-pore Channel Subtype 2 (TPC2) Regulates Skeletal Muscle Autophagic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR; CALCIUM; NAADP; DEGRADATION; MECHANISMS; PROTEASES; PATHWAYS; DISEASE; FUSION; FLUX	Postnatal skeletal muscle mass is regulated by the balance between anabolic protein synthesis and catabolic protein degradation, and muscle atrophy occurs when protein homeostasis is disrupted. Autophagy has emerged as critical in clearing dysfunctional organelles and thus in regulating protein turnover. Here we show that endolysosomal two-pore channel subtype 2 (TPC2) contributes to autophagy signaling and protein homeostasis in skeletal muscle. Muscles derived from Tpcn2(-/-) mice exhibit an atrophic phenotype with exacerbated autophagy under starvation. Compared with wild types, animals lacking TPC2 demonstrated an enhanced autophagy flux characterized by increased accumulation of autophagosomes upon combined stress induction by starvation and colchicine treatment. In addition, deletion of TPC2 in muscle caused aberrant lysosomal pH homeostasis and reduced lysosomal protease activity. Association between mammalian target of rapamycin and TPC2 was detected in skeletal muscle, allowing for appropriate adjustments to cellular metabolic states and subsequent execution of autophagy. TPC2 therefore impacts mammalian target of rapamycin reactivation during the process of autophagy and contributes to maintenance of muscle homeostasis.	[Lin, Pei-Hui; Duann, Pu; Park, Ki Ho; Li, Haichang; Sun, Mingzhai; Sermersheim, Mathew; Gumpper, Kristyn; Ma, Jianjie] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama 3500495, Japan; [Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University System of Ohio; Ohio State University; Saitama Medical University; University of Oxford; University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston	Lin, PH (corresponding author), Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA.	pei-hui.lin@osumc.edu; jianjie.ma@osumc.edu	Li, Haichang/AAL-6132-2020; Sun, Mingzhai/B-4945-2012; Park, Ki Ho/N-8153-2017; Gumpper, Kristyn/AAD-7637-2019	Li, Haichang/0000-0001-9784-6480; Park, Ki Ho/0000-0002-6193-9826; Gumpper, Kristyn/0000-0003-2704-1868; Galione, Antony/0000-0002-4132-7646	National Institutes of Health [R01AR61385, R01AG028856, R01GM081658]; British Heart Foundation [RG/12/14/29885]; Ohio State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614, R01AG028856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Ohio State University(Ohio State University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR61385 and R01AG028856 (to J. M.) and R01GM081658 (to M. X. Z.). This work was also supported by British Heart Foundation Program Grant RG/12/14/29885 (to A. M. E.) and an Ohio State University intramural Lockwood Early Career Development Award (to P. H. L.).	Amoasii L, 2012, CURR TOP MICROBIOL, V362, P209, DOI 10.1007/978-94-007-5025-8_10; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Chen Y, 2013, EXP CELL RES, V319, P142, DOI 10.1016/j.yexcr.2012.09.004; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; DiCiccio JE, 2011, J GEN PHYSIOL, V137, P385, DOI 10.1085/jgp.201110596; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Fetalvero KM, 2013, MOL CELL BIOL, V33, P98, DOI 10.1128/MCB.01075-12; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hamasaki M, 2013, CURR OPIN CELL BIOL, V25, P455, DOI 10.1016/j.ceb.2013.03.004; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kayala KMN, 2012, BRAIN RES, V1489, P8, DOI 10.1016/j.brainres.2012.10.036; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lu YY, 2013, J BIOL CHEM, V288, P24247, DOI 10.1074/jbc.M113.484253; Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Nascimbeni AC, 2012, CELL DEATH DIFFER, V19, P1698, DOI 10.1038/cdd.2012.52; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; PAVLATH GK, 1994, J CELL BIOL, V127, P1923, DOI 10.1083/jcb.127.6.1923; Penna F, 2013, AM J PATHOL, V182, P1367, DOI 10.1016/j.ajpath.2012.12.023; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Pyo JO, 2013, DIABETES METAB J, V37, P333, DOI 10.4093/dmj.2013.37.5.333; Rennie MJ, 2004, ANNU REV PHYSIOL, V66, P799, DOI 10.1146/annurev.physiol.66.052102.134444; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Tjondrokoesoemo A, 2013, J BIOL CHEM, V288, P2103, DOI 10.1074/jbc.M112.425975; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zois CE, 2011, AUTOPHAGY, V7, P1371, DOI 10.4161/auto.7.11.16664; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	53	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3377	3389		10.1074/jbc.M114.608471	http://dx.doi.org/10.1074/jbc.M114.608471			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25480788	Green Published, hybrid			2022-12-28	WOS:000349456000015
J	Toyjanova, J; Flores-Cortez, E; Reichner, JS; Franck, C				Toyjanova, Jennet; Flores-Cortez, Estefany; Reichner, Jonathan S.; Franck, Christian			Matrix Confinement Plays a Pivotal Role in Regulating Neutrophil-generated Tractions, Speed, and Integrin Utilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPATIOTEMPORAL ORGANIZATION; MIGRATION; FORCES; MICROSCOPY; LOCOMOTION; MECHANISMS; STRESSES; VOLUME	Neutrophils are capable of switching from integrin-dependent motility on two-dimensional substrata to integrin-independent motion following entry into the confined three-dimensional matrix of an afflicted tissue. However, whether integrins still maintain a regulatory role for cell traction generation and cell locomotion under the physical confinement of the three-dimensional matrix is unknown, and this is challenging to deduce from motility studies alone. Using three-dimensional traction force microscopy and a double hydrogel sandwich system, we determined the three-dimensional spatiotemporal traction forces of motile neutrophils at unprecedented resolution and show, for the first time, that entry into a highly confined space (2.5D) is a sufficient trigger to convert to integrin-independent migration. We find that integrins exert a significant regulatory role in determining the magnitude and spatial distribution of tractions and cell speed on confined cells. We also find that 90% of neutrophil tractions are in the out-of-plane axis, and this may be a fundamental element of neutrophil traction force generation.	[Toyjanova, Jennet; Franck, Christian] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Flores-Cortez, Estefany; Reichner, Jonathan S.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Surg, Providence, RI 02903 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Franck, C (corresponding author), Brown Univ, Sch Engn, 182 Hope St,Box D, Providence, RI 02912 USA.	franck@brown.edu		Reichner, Jonathan/0000-0002-7349-6321	National Institutes of Health [GM066194, AI101469]; Brown University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066194, R56GM066194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM066194 (to J. S. R.) and AI101469 (to J. S. R. and C. F.). This work was also supported by a Brown University seed grant (to J. S. R. and C. F.).	Aubry D, 2015, BIOMECH MODEL MECHAN, V14, P143, DOI 10.1007/s10237-014-0595-3; Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Bower A. F., 2010, APPL MECH SOLIDS, P100; BROWN AF, 1982, J CELL SCI, V58, P455; Butler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011921; Byrd AS, 2013, J IMMUNOL, V190, P4136, DOI 10.4049/jimmunol.1202671; Carey SP, 2012, BIOMATERIALS, V33, P4157, DOI 10.1016/j.biomaterials.2012.02.029; D'Errico J., 2020, MATLAB CENTRAL FILE; Delanoe-Ayari H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248103; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Farid H, 2004, IEEE T IMAGE PROCESS, V13, P496, DOI 10.1109/TIP.2004.823819; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2014, SEMIN IMMUNOPATHOL, V36, P227, DOI 10.1007/s00281-014-0418-8; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lin Y, 2010, J MECH PHYS SOLIDS, V58, P502, DOI 10.1016/j.jmps.2010.01.010; Long R, 2011, BIOPHYS J, V101, P643, DOI 10.1016/j.bpj.2011.06.049; Lopez-Fagundo C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0247; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; Pospieszalska MK, 2011, BIOPHYS J, V100, P1697, DOI 10.1016/j.bpj.2011.02.038; Qian J, 2009, BIOPHYS J, V97, P2438, DOI 10.1016/j.bpj.2009.08.027; Renkawitz J, 2010, EMBO REP, V11, P744, DOI 10.1038/embor.2010.147; Shin ME, 2010, BLOOD, V116, P3297, DOI 10.1182/blood-2009-12-260851; Smith LA, 2007, BIOPHYS J, V92, pL58, DOI 10.1529/biophysj.106.102822; Stroka KM, 2009, CELL MOTIL CYTOSKEL, V66, P328, DOI 10.1002/cm.20363; Sundd P, 2010, NAT METHODS, V7, P821, DOI [10.1038/NMETH.1508, 10.1038/nmeth.1508]; TINGBEALL HP, 1993, BLOOD, V81, P2774; Toyjanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090976; WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5	39	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3752	3763		10.1074/jbc.M114.619643	http://dx.doi.org/10.1074/jbc.M114.619643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525264	Green Published, hybrid			2022-12-28	WOS:000349456000046
J	Kang, HJ; Wilkins, AD; Lichtarge, O; Wensel, TG				Kang, Hye Jin; Wilkins, Angela D.; Lichtarge, Olivier; Wensel, Theodore G.			Determinants of Endogenous Ligand Specificity Divergence among Metabotropic Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computational Biology; G Protein; Metabotropic Glutamate Receptor (mGluR); Molecular Evolution; Signal Transduction; G Protein-coupled Receptors	POSITIVE ALLOSTERIC MODULATORS; EVOLUTIONARY TRACE; BINDING-SITE; ACTIVATION; RESIDUES	Background: l-Glutamate and l-serine-O-phosphate (l-SOP) differentially regulate subtypes of metabotropic glutamate receptor (mGluR). Results: Evolutionary trace identified residues whose swapping between mGluR1 or mGluR7 and mGluR4 altered responses as predicted. Conclusion: Determinants for early and later functional divergence of mGluRs were identified. Significance: The structural and evolutionary origins of divergent mGluR specificities may aid in design of new therapeutics. To determine the structural origins of diverse ligand response specificities among metabotropic glutamate receptors (mGluRs), we combined computational approaches with mutagenesis and ligand response assays to identify specificity-determining residues in the group I receptor, mGluR1, and the group III receptors, mGluR4 and mGluR7. Among these, mGluR1 responds to l-glutamate effectively, whereas it binds weakly to another endogenous ligand, l-serine-O-phosphate (l-SOP), which antagonizes the effects of l-glutamate. In contrast, mGluR4 has in common with other group III mGluR that it is activated with higher potency and efficacy by l-SOP. mGluR7 differs from mGluR4 and other group III mGluR in that l-glutamate and l-SOP activate it with low potency and efficacy. Enhanced versions of the evolutionary trace (ET) algorithm were used to identify residues that when swapped between mGluR1 and mGluR4 increased the potency of l-SOP inhibition relative to the potency of l-glutamate activation in mGluR1 mutants and others that diminished the potency/efficacy of l-SOP for mGluR4 mutants. In addition, combining ET identified swaps from mGluR4 with one identified by computational docking produced mGluR7 mutants that respond with dramatically enhanced potency/efficacy to l-SOP. These results reveal that an early functional divergence between group I/II and group III involved variation at positions primarily at allosteric sites located outside of binding pockets, whereas a later divergence within group III occurred through sequence variation both at the ligand-binding pocket and at loops near the dimerization interface and interlobe hinge region. They also demonstrate the power of ET for identifying allosteric determinants of evolutionary importance.	[Kang, Hye Jin; Lichtarge, Olivier; Wensel, Theodore G.] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Wilkins, Angela D.; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lichtarge, Olivier; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wensel, TG (corresponding author), Baylor Coll Med, BCM 125, Houston, TX 77030 USA.	twensel@bcm.edu		Kang, Hye Jin/0000-0001-9067-9050; Wensel, Theodore/0000-0003-3518-9352	National Institutes of Health [R01-GM066099, R01-EY011900, R01-EY007981, R01-GM079656, T90-DK070109]; National Science Foundation [MCB-0818353, CCF-0905536, DBI-1062455]; Welch Foundation [Q-0035]; Direct For Biological Sciences [1356569] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [R01EY011900, R01EY007981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, R01GM066099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM066099, R01-EY011900, R01-EY007981, R01-GM079656, and T90-DK070109. This work was also supported by National Science Foundation Grants MCB-0818353, CCF-0905536, and DBI-1062455 and by the Welch Foundation Grant Q-0035.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Kammermeier PJ, 2012, MOL PHARMACOL, V82, P438, DOI 10.1124/mol.112.078501; Kang HJ, 2014, J BIOL CHEM, V289, P29961, DOI 10.1074/jbc.M114.574483; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Mathiesen JM, 2003, BRIT J PHARMACOL, V138, P1026, DOI 10.1038/sj.bjp.0705159; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Sato T, 2003, J BIOL CHEM, V278, P4314, DOI 10.1074/jbc.M210278200; Sheffler DJ, 2008, NEUROPHARMACOLOGY, V55, P419, DOI 10.1016/j.neuropharm.2008.06.047; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Wilkins AD, 2013, BIOINFORMATICS, V29, P2714, DOI 10.1093/bioinformatics/btt489; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	28	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2870	2878		10.1074/jbc.M114.622233	http://dx.doi.org/10.1074/jbc.M114.622233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25519912	Green Published, hybrid			2022-12-28	WOS:000349310700027
J	Chayka, O; D'Acunto, CW; Middleton, O; Arab, M; Sala, A				Chayka, Olesya; D'Acunto, Cosimo Walter; Middleton, Odette; Arab, Maryann; Sala, Arturo			Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; C-MYC; RECQ HELICASES; N-MYC; DRIVEN TUMORIGENESIS; FUNCTIONAL GENOMICS; PROLIFERATION; KINASE; CANCER; BIOINFORMATICS	The MYC family of transcription factors consists of three well characterized members, c-MYC, L-MYC, and MYCN, deregulated in the majority of human cancers. In neuronal tumors such as neuroblastoma, MYCN is frequently activated by gene amplification, and reducing its expression by RNA interference has been shown to promote growth arrest and apoptosis of tumor cells. From a clinical perspective, RNA interference is not yet a viable option, and small molecule inhibitors of transcription factors are difficult to develop. We therefore planned to identify, at the global level, the genes interacting functionally with MYCN required to promote fitness of tumor cells facing oncogenic stress. To find genes whose inactivation is synthetically lethal to MYCN, we implemented a genome-wide approach in which we carried out a drop-out shRNA screen using a whole genome library that was delivered into isogenic neuroblastoma cell lines expressing or not expressing MYCN. After the screen, we selected for in-depth analysis four shRNAs targeting AHCY, BLM, PKMYT1, and CKS1B. These genes were chosen because they are directly regulated by MYC proteins, associated with poor prognosis of neuroblastoma patients, and inhibited by small molecule compounds. Mechanistically, we found that BLM and PKMYT1 are required to limit oncogenic stress and promote stabilization of the MYCN protein. Cocktails of small molecule inhibitors of CKS1B, AHCY, BLM, and PKMYT1 profoundly affected the growth of all neuroblastoma cell lines but selectively caused death of MYCN-amplified cells. Our findings suggest that drugging the MYCN network is a promising avenue for the treatment of high risk, neuroblastic cancers.	[Chayka, Olesya; Arab, Maryann; Sala, Arturo] Brunel Univ, Brunel Inst Canc Genet & Pharmacogen, Uxbridge UB8 3PH, Middx, England; [Chayka, Olesya; D'Acunto, Cosimo Walter; Middleton, Odette; Sala, Arturo] UCL, Inst Child Hlth, London WC1N 1EH, England	Brunel University; University of London; University College London	Sala, A (corresponding author), Brunel Univ, Brunel Inst Canc Genet & Pharmacogen, Uxbridge UB8 3PH, Middx, England.	arturo.sala@brunel.ac.uk		Sala, Arturo/0000-0002-2841-7866	SPARKS; Neuroblastoma Society	SPARKS; Neuroblastoma Society	This work was supported by grants from SPARKS and the Neuroblastoma Society (to A. S.).	Aubry S, 2000, DNA CELL BIOL, V19, P353, DOI 10.1089/10445490050043326; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bahmanyar M, 2013, LEUKEMIA RES, V37, P1726, DOI 10.1016/j.leukres.2013.09.025; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burkhart CA, 2003, J NATL CANCER I, V95, P1394, DOI 10.1093/jnci/djg045; Campaner S, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-6; Cermelli S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014209; Chanthery Y.H., 2012, SCI TRANSL MED, V4, pra3; Chayka O, 2009, JNCI-J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Corvetta D, 2013, J BIOL CHEM, V288, P8332, DOI 10.1074/jbc.M113.454280; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez-Sanchez ME, 2009, MOL CELL BIOL, V29, P6182, DOI 10.1128/MCB.00973-09; FLEXNER CW, 1992, LANCET, V339, P438, DOI 10.1016/0140-6736(92)90133-N; Fowler T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087003; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Nguyen GH, 2013, CHEM BIOL, V20, P55, DOI 10.1016/j.chembiol.2012.10.016; Gualdrini F, 2010, ONCOTARGET, V1, P278; He S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00001; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Horowitz DP, 2008, CANCER BIOL THER, V7, P1783, DOI 10.4161/cbt.7.11.6779; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang R, 2011, FASEB J, V25, P4138, DOI 10.1096/fj.11-185033; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Komarova NL, 2013, NATURE, V499, P291, DOI 10.1038/499291a; Lan YS, 2008, INT J CANCER, V123, P543, DOI 10.1002/ijc.23548; Lee SW, 2014, APMIS, V122, P206, DOI 10.1111/apm.12136; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mao FJ, 2010, CANCER RES, V70, P6548, DOI 10.1158/0008-5472.CAN-10-0475; Martinsson-Ahlzen HS, 2008, MOL CELL BIOL, V28, P5698, DOI 10.1128/MCB.01833-07; MAYERS DL, 1995, P NATL ACAD SCI USA, V92, P215, DOI 10.1073/pnas.92.1.215; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Moser R, 2012, MOL CANCER RES, V10, P535, DOI 10.1158/1541-7786.MCR-11-0508; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Perier RC, 1999, NUCLEIC ACIDS RES, V27, P307, DOI 10.1093/nar/27.1.307; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Rohe A, 2012, BIOORG MED CHEM LETT, V22, P1219, DOI 10.1016/j.bmcl.2011.11.064; Sankar N, 2009, J BIOL CHEM, V284, P15193, DOI 10.1074/jbc.M900776200; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Seki M, 2008, CELL CYCLE, V7, P2472, DOI 10.4161/cc.7.16.6462; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soucek L, 2002, CANCER RES, V62, P3507; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Wang CX, 2012, CANCER RES, V72, P315, DOI 10.1158/0008-5472.CAN-11-0961; Wang L, 2014, HEPATOLOGY, V59, P1850, DOI 10.1002/hep.26720; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhao X, 2013, LEUKEMIA, V27, P2341, DOI 10.1038/leu.2013.94	66	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2198	2212		10.1074/jbc.M114.624056	http://dx.doi.org/10.1074/jbc.M114.624056			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477524	Green Published, hybrid			2022-12-28	WOS:000348588000024
J	Matevossian, A; Resh, MD				Matevossian, Arnnine; Resh, Marilyn D.			Membrane Topology of Hedgehog Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TOPOLOGY; PREDICTION; PALMITOYLATION; GHRELIN; ACCURACY; REGIONS; RANGE	Hedgehog acyltransferase (Hhat) is a multipass transmembrane enzyme that mediates the covalent attachment of the 16-carbon fatty acid palmitate to the N-terminal cysteine of Sonic Hedgehog (Shh). Palmitoylation of Shh by Hhat is critical for short and long range signaling. Knowledge of the topological organization of Hhat transmembrane helices would enhance our understanding of Hhat-mediated Shh palmitoylation. Bioinformatics analysis of transmembrane domains within human Hhat using 10 different algorithms resulted in highly consistent predictions in the C-terminal, but not in the N-terminal, region of Hhat. To empirically determine the topology of Hhat, we designed and exploited Hhat constructs containing either terminal or 12 different internal epitope tags. We used selective permeabilization coupled with immunofluorescence as well as a protease protection assay to demonstrate that Hhat contains 10 transmembrane domains and 2 re-entrant loops. The invariant His and highly conserved Asp residues within the membrane-bound O-acyltransferase (MBOAT) homology domain are segregated on opposite sides of the endoplasmic reticulum membrane. The localization of His-379 on the lumenal membrane surface is consistent with a role for this invariant residue in catalysis. Analysis of the activity and stability of the Hhat constructs revealed that the C-terminal MBOAT domain is especially sensitive to manipulation. Moreover, there was remarkable similarity in the overall topological organization of Hhat and ghrelin O-acyltransferase, another MBOAT family member. Knowledge of the topological organization of Hhat could serve as an important tool for further design of selective Hhat inhibitors.	[Matevossian, Arnnine; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	reshm@mskcc.org		Resh, Marilyn/0000-0001-6118-9466	National Institutes of Health [GM57966, CA186957]; Cycle for Survival, Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [R21CA186957, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cycle for Survival, Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57966 and CA186957. This work was also supported by Cycle for Survival, Memorial Sloan Kettering Cancer Center.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Konitsiotis AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089899; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Petrova E, 2015, ONCOGENE, V34, P263, DOI 10.1038/onc.2013.575; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Rodriguez-Blanco J, 2013, ONCOGENE, V32, P2335, DOI 10.1038/onc.2012.243; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	30	36	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2235	2243		10.1074/jbc.M114.625764	http://dx.doi.org/10.1074/jbc.M114.625764			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488661	Green Published, hybrid			2022-12-28	WOS:000348588000027
J	Oberhettinger, P; Leo, JC; Linke, D; Autenrieth, IB; Schutz, MS				Oberhettinger, Philipp; Leo, Jack C.; Linke, Dirk; Autenrieth, Ingo B.; Schuetz, Monika S.			The Inverse Autotransporter Intimin Exports Its Passenger Domain via a Hairpin Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; BACTERIAL OUTER-MEMBRANE; YERSINIA-ENTEROCOLITICA; 2-PARTNER SECRETION; BETA-DOMAIN; PROTEINS; BAMA; TRANSLOCATION; BIOGENESIS; TRANSPORT	Autotransporter proteins comprise a large family of virulence factors that consist of a beta-barrel translocation unit and an extracellular effector or passenger domain. The beta-barrel anchors the protein to the outer membrane of Gram-negative bacteria and facilitates the transport of the passenger domain onto the cell surface. By inserting an epitope tag into the N terminus of the passenger domain of the inverse autotransporter intimin, we generated a mutant defective in autotransport. Using this stalled mutant, we could show that (i) at the time point of stalling, the beta-barrel appears folded; (ii) the stalled autotransporter is associated with BamA and SurA; (iii) the stalled intimin is decorated with large amounts of SurA; (iv) the stalled autotransporter is not degraded by periplasmic proteases; and (v) inverse autotransporter passenger domains are translocated by a hairpin mechanism. Our results suggest a function for the BAM complex not only in insertion and folding of the beta-barrel but also for passenger translocation.	[Oberhettinger, Philipp; Autenrieth, Ingo B.; Schuetz, Monika S.] Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, D-72076 Tubingen, Germany; [Leo, Jack C.; Linke, Dirk] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Oslo	Schutz, MS (corresponding author), Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, Elfriede Aulhorn Str 6, D-72076 Tubingen, Germany.	monika.schuetz@med.uni-tuebingen.de	Linke, Dirk/F-9147-2010; Leo, Jack/HHS-7710-2022; Leo, Jack C./F-2177-2011	Linke, Dirk/0000-0003-3150-6752; Leo, Jack C./0000-0002-7066-7527	German Research Council (DFG) [SFB 766]; FEMS; Fortune program [F1433253]; TUFF of the University Clinics Tubingen [E05003231]; German Center for Infection Research (DZIF)	German Research Council (DFG)(German Research Foundation (DFG)); FEMS; Fortune program; TUFF of the University Clinics Tubingen; German Center for Infection Research (DZIF)	This work was supported by grants from the German Research Council (DFG) within the SFB 766 (to M. S., I. B. A., and D. L.), a FEMS Advanced Fellowship (to J. C. L.), the Fortune program F1433253 (to P. O.), the TUFF program E05003231 of the University Clinics Tubingen (to M. S.), and the German Center for Infection Research (DZIF) (to M. S. and I. B. A.).	Adams TM, 2005, J BACTERIOL, V187, P522, DOI 10.1128/JB.187.2.522-533.2005; Adu-Bobie J, 1998, INFECT IMMUN, V66, P5643, DOI 10.1128/IAI.66.12.5643-5649.1998; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Batchelor M, 2000, EMBO J, V19, P2452, DOI 10.1093/emboj/19.11.2452; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; Grosskinsky U, 2007, J BACTERIOL, V189, P9011, DOI 10.1128/JB.00985-07; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jacob-Dubuisson F, 2013, RES MICROBIOL, V164, P583, DOI 10.1016/j.resmic.2013.03.009; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kang'ethe W, 2013, J BIOL CHEM, V288, P35028, DOI 10.1074/jbc.M113.515635; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; Kleinschmidt JH, 2003, CELL MOL LIFE SCI, V60, P1547, DOI 10.1007/s00018-003-3170-0; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Kuhnel K, 2011, J BACTERIOL, V193, P2042, DOI 10.1128/JB.00790-10; Lehr U, 2010, MOL MICROBIOL, V78, P932, DOI 10.1111/j.1365-2958.2010.07377.x; Leo JC, 2015, MOL MICROBIOL, V95, P80, DOI 10.1111/mmi.12840; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Maurer J, 1999, J BACTERIOL, V181, P7014, DOI 10.1128/JB.181.22.7014-7020.1999; Mikula KM, 2012, J BACTERIOL, V194, P827, DOI 10.1128/JB.05322-11; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Oberhettinger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047069; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Paramasivam N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-510; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Schutz M, 2010, INFECT IMMUN, V78, P2677, DOI 10.1128/IAI.01350-09; Shahid SA, 2012, NAT METHODS, V9, P1212, DOI [10.1038/NMETH.2248, 10.1038/nmeth.2248]; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; Touze T, 2004, MOL MICROBIOL, V51, P73, DOI 10.1046/j.1365-2958.2003.03830.x; Tsai JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014403; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x	51	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1837	1849		10.1074/jbc.M114.604769	http://dx.doi.org/10.1074/jbc.M114.604769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25488660	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000348056400048
J	Wu, HW; Gong, WB; Yao, XZ; Wang, JF; Perrett, S; Feng, YG				Wu, Huiwen; Gong, Weibin; Yao, Xingzhe; Wang, Jinfeng; Perrett, Sarah; Feng, Yingang			Evolutionarily Conserved Binding of Translationally Controlled Tumor Protein to Eukaryotic Elongation Factor 1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTAMINE-RELEASING FACTOR; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; IDENTIFICATION; TCTP; EXPRESSION; SITE; ASSIGNMENT; STABILITY; REVEALS	Translationally controlled tumor protein (TCTP) is an abundant protein that is highly conserved in eukaryotes. However, its primary function is still not clear. Human TCTP interacts with the metazoan-specific eukaryotic elongation factor 1B delta (eEF1B delta) and inhibits its guanine nucleotide exchange factor (GEF) activity, but the structural mechanism remains unknown. The interaction between TCTP and eEF1B delta was investigated by NMR titration, structure determination, paramagnetic relaxation enhancement, site-directed mutagenesis, isothermal titration calorimetry, and HADDOCK docking. We first demonstrated that the catalytic GEF domain of eEF1B delta is not responsible for binding to TCTP but rather a previously unnoticed central acidic region (CAR) domain in eEF1B delta. The mutagenesis data and the structural model of the TCTP-eEF1B delta CAR domain complex revealed the key binding residues. These residues are highly conserved in eukaryotic TCTPs and in eEF1B GEFs, including the eukaryotically conserved eEF1B delta, implying the interaction may be conserved in all eukaryotes. Interactions were confirmed between TCTP and the eEF1B delta CAR domain for human, fission yeast, and unicellular photosynthetic microalgal proteins, suggesting that involvement in protein translation through the conserved interaction with eEF1B represents a primary function of TCTP.	[Wu, Huiwen; Gong, Weibin; Wang, Jinfeng; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Yao, Xingzhe; Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao Engn Lab Single Cell Oil, Qingdao 266101, Shandong, Peoples R China; [Yao, Xingzhe; Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Qingdao 266101, Shandong, Peoples R China; [Wu, Huiwen; Yao, Xingzhe] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	sarah.perrett@cantab.net; fengyg@qibebt.ac.cn	Perrett, Sarah/AAS-9483-2020; Feng, Yingang/B-6304-2008	Perrett, Sarah/0000-0003-0137-0997; Feng, Yingang/0000-0002-0879-1316	National Basic Research Program, Ministry of Science and Technology of China (973 Program) [2012CB911000, 2013CB910700]; National High-tech R&D Program, Ministry of Science and Technology of China (863 Program) [2012AA02A707]; National Natural Science Foundation of China [30800179, 31170701, 31200578, 31470747, 31110103914]; Beijing Natural Science Foundation [5092018]	National Basic Research Program, Ministry of Science and Technology of China (973 Program); National High-tech R&D Program, Ministry of Science and Technology of China (863 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Basic Research Program, Ministry of Science and Technology of China (973 Program) Grants 2012CB911000 and 2013CB910700 (to S. P.), National High-tech R&D Program, Ministry of Science and Technology of China (863 Program) Grant 2012AA02A707 (to Y. F.), National Natural Science Foundation of China Grants 30800179 and 31170701 (to Y. F.), 31200578 and 31470747 (to W. G.), and 31110103914 (to S. P.), and Beijing Natural Science Foundation Grant 5092018 (to Y. F.).	Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Atkinson GC, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-35; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baxter NJ, 2000, J BIOMOL NMR, V16, P83, DOI 10.1023/A:1008355030833; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Bommer UA, 2012, OPEN ALLERGY J, V5, P19, DOI DOI 10.2174/1874838401205010019; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chen YJ, 2011, J BIOL CHEM, V286, P32575, DOI 10.1074/jbc.M110.217836; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XC, 2009, J BIOL CHEM, V284, P23754, DOI 10.1074/jbc.M109.012823; Eichhorn T, 2013, BIOCHEM PHARMACOL, V85, P38, DOI 10.1016/j.bcp.2012.10.006; Feng YG, 2007, ARCH BIOCHEM BIOPHYS, V467, P48, DOI 10.1016/j.abb.2007.08.021; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Funston G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042642; Gachet Y, 1999, J CELL SCI, V112, P1257; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hong ST, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3986; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kawakami T., 2012, OPEN ALLERGY J, V5, P41; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Langdon JM, 2004, BBA-MOL BASIS DIS, V1688, P232, DOI 10.1016/j.bbadis.2003.12.007; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Norbeck J, 1997, YEAST, V13, P1519, DOI 10.1002/(SICI)1097-0061(199712)13:16<1519::AID-YEA211>3.0.CO;2-U; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Perez JMJ, 1999, STRUCTURE, V7, P217, DOI 10.1016/S0969-2126(99)80027-6; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Rid R, 2010, J STEROID BIOCHEM, V118, P29, DOI 10.1016/j.jsbmb.2009.09.015; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thiele H, 2000, EUR J BIOCHEM, V267, P5473, DOI 10.1046/j.1432-1327.2000.01609.x; Thompson HGR, 2002, GENOME RES, V12, P1517, DOI 10.1101/gr.418402; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang F, 2013, MOL CANCER RES, V11, P1508, DOI 10.1158/1541-7786.MCR-13-0389	50	20	21	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8694	8710		10.1074/jbc.M114.628594	http://dx.doi.org/10.1074/jbc.M114.628594			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25635048	hybrid, Green Published			2022-12-28	WOS:000352207100002
J	Clister, T; Mehta, S; Zhang, J				Clister, Terri; Mehta, Sohum; Zhang, Jin			Single-cell Analysis of G-protein Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HETEROTRIMERIC G-PROTEINS; COUPLED RECEPTOR ACTIVATION; BETA(2)-ADRENERGIC RECEPTOR; BETA-ARRESTIN; ENERGY-TRANSFER; DYNAMICS; BIOSENSORS; AGONISTS; BINDING; CONFORMATIONS	The growing use of fluorescent biosensors to directly probe the spatiotemporal dynamics of biochemical processes in living cells has revolutionized the study of intracellular signaling. In this review, we summarize recent developments in the use of biosensors to illuminate the molecular details of G-protein-coupled receptor (GPCR) signaling pathways, which have long served as the model for our understanding of signal transduction, while also offering our perspectives on the future of this exciting field. Specifically, we highlight several ways in which biosensor-based single-cell analyses are being used to unravel many of the enduring mysteries that surround these diverse signaling pathways.	[Clister, Terri; Mehta, Sohum; Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Zhang, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 725 N Wolfe St, Baltimore, MD 21205 USA.	jzhang32@jhmi.edu			National Institutes of Health [R01 DK073368, DP1CA174423]; NATIONAL CANCER INSTITUTE [DP1CA174423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK073368 and DP1CA174423 (to J.Z.). This is the first article in the Thematic Minireview series "Cell Biology of G Protein Signaling."	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Campbell RE, 2009, ANAL CHEM, V81, P5972, DOI 10.1021/ac802613w; Chakir K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001909; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Ghanouni P., 2001, P NATL ACAD SCI US, V98; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1565, DOI 10.1073/pnas.1220697110; Kataria R, 2013, P NATL ACAD SCI USA, V110, P6424, DOI 10.1073/pnas.1301851110; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Masseck OA, 2014, METHOD PHARMACOL TOX, P149, DOI 10.1007/978-1-62703-779-2_8; Milde M, 2013, BIOCHEM J, V454, P515, DOI 10.1042/BJ20130554; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Putyrski M, 2011, CHEM BIOL, V18, P1126, DOI 10.1016/j.chembiol.2011.07.013; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sadana R, 2009, MOL PHARMACOL, V76, P1256, DOI 10.1124/mol.109.058370; Seifert R, 2001, J PHARMACOL EXP THER, V297, P1218; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Tall GG, 2013, J RECEPT SIG TRANSD, V33, P139, DOI 10.3109/10799893.2013.763828; Verma V, 2010, J BIOL CHEM, V285, P35092, DOI 10.1074/jbc.M109.088625; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110	44	27	27	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6681	6688		10.1074/jbc.R114.616391	http://dx.doi.org/10.1074/jbc.R114.616391			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605723	Green Published, hybrid			2022-12-28	WOS:000350991500002
J	Hu, YF; Wu, YJ; Li, QW; Zhang, WB; Jin, CW				Hu, Yunfei; Wu, Yujie; Li, Qianwen; Zhang, Wenbo; Jin, Changwen			Solution Structure of Yeast Rpn9 INSIGHTS INTO PROTEASOME LID ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-15 RESONANCE ASSIGNMENTS; TORSION ANGLE DYNAMICS; 26S PROTEASOME; CRYSTAL-STRUCTURE; 20S PROTEASOME; REGULATORY SUBUNIT; ATP BINDING; DEGRADATION; PROTEINS; DEUBIQUITINATION	The regulatory particle (RP) of the 26 S proteasome functions in preparing polyubiquitinated substrates for degradation. The lid complex of the RP contains an Rpn8-Rpn11 heterodimer surrounded by a horseshoe-shaped scaffold formed by six proteasome-COP9/CSN-initiation factor (PCI)-containing subunits. The PCI domains are essential for lid assembly, whereas the detailed molecular mechanisms remain elusive. Recent cryo-EM studies at near-atomic resolution provided invaluable information on the RP architecture in different functional states. Nevertheless, atomic resolution structural information on the RP is still limited, and deeper understanding of RP assembly mechanism requires further studies on the structures and interactions of individual subunits or subcomplexes. Herein we report the high-resolution NMR structures of the PCI-containing subunit Rpn9 from Saccharomyces cerevisiae. The 45-kDa protein contains an all-helical N-terminal domain and a (-terminal PCI domain linked via a semiflexible hinge. The N-terminal domain mediates interaction with the ubiquitin receptor Rpn10, whereas the PCI domain mediates interaction with the neighboring PCI subunit Rpn5. The Rpn9-Rpn5 interface highlights two structural motifs on the winged helix module forming a hydrophobic center surrounded by ionic pairs, which is a common pattern for all PCI-PCI interactions in the lid. The results suggest that divergence in surface composition among different PCI pairs may contribute to the modulation of lid assembly.	[Hu, Yunfei; Wu, Yujie; Li, Qianwen; Zhang, Wenbo; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Wu, Yujie; Li, Qianwen; Zhang, Wenbo; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Being Natl Lab Mol Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Jin, CW (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	changwen@pku.edu.cn		Wu, Yujie/0000-0002-9530-7413	Ministry of Science and Technology of China [2006AA02A323]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Ministry of Science and Technology of China Grant 2006AA02A323 (to C. J.).	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Boehringer J, 2012, BIOCHEM J, V448, P55, DOI 10.1042/BJ20120542; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; FISCHER M, 1994, FEBS LETT, V355, P69, DOI 10.1016/0014-5793(94)01177-X; Fischer MWF, 1999, BIOCHEMISTRY-US, V38, P9013, DOI 10.1021/bi9905213; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Foerster F, 2010, MOL CELL PROTEOMICS, V9, P1666, DOI 10.1074/mcp.R000002-MCP201; Fukunaga K, 2010, BIOCHEM BIOPH RES CO, V396, P1048, DOI 10.1016/j.bbrc.2010.05.061; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Javadi Y, 2013, CURR OPIN STRUC BIOL, V23, P622, DOI 10.1016/j.sbi.2013.06.011; Jin HL, 2006, PLANT PHYSIOL, V142, P651, DOI 10.1104/pp.106.083519; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Lorieau J, 2008, J AM CHEM SOC, V130, P7536, DOI 10.1021/ja801729f; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; PETERS JM, 1993, J MOL BIOL, V234, P932, DOI 10.1006/jmbi.1993.1646; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Serino G, 2013, PLANT SCI, V203, P89, DOI 10.1016/j.plantsci.2012.12.018; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Takeuchi J, 1999, MOL CELL BIOL, V19, P6575; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Wu YJ, 2014, BIOMOL NMR ASSIGN, V8, P391, DOI 10.1007/s12104-013-9525-z; Wu YJ, 2014, BIOMOL NMR ASSIGN, V8, P307, DOI 10.1007/s12104-013-9506-2; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	55	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6878	6889		10.1074/jbc.M114.626762	http://dx.doi.org/10.1074/jbc.M114.626762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631053	hybrid, Green Published			2022-12-28	WOS:000350991500023
J	Hung, HA; Sun, GN; Keles, S; Svaren, J				Hung, Holly A.; Sun, Guannan; Keles, Sunduz; Svaren, John			Dynamic Regulation of Schwann Cell Enhancers after Peripheral Nerve Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN PROTEIN ZERO; ERK-SIGNALING PATHWAY; MARIE-TOOTH-DISEASE; LARGE GENE LISTS; TRANSCRIPTION FACTORS; C-JUN; HUMAN-GENOME; CHIP-SEQ; IN-VIVO; AXONAL REGENERATION	Myelination of the peripheral nervous system is required for axonal function and long term stability. After peripheral nerve injury, Schwann cells transition from axon myelination to a demyelinated state that supports neuronal survival and ultimately remyelination of axons. Reprogramming of gene expression patterns during development and injury responses is shaped by the actions of distal regulatory elements that integrate the actions of multiple transcription factors. We used ChIP-seq to measure changes in histone H3K27 acetylation, a mark of active enhancers, to identify enhancers in myelinating rat peripheral nerve and their dynamics after demyelinating nerve injury. Analysis of injury-induced enhancers identified enriched motifs for c-Jun, a transcription factor required for Schwann cells to support nerve regeneration. We identify a c-Jun-bound enhancer in the gene for Runx2, a transcription factor induced after nerve injury, and we show that Runx2 is required for activation of other induced genes. In contrast, enhancers that lose H3K27ac after nerve injury are enriched for binding sites of the Sox10 and early growth response 2 (Egr2/Krox20) transcription factors, which are critical determinants of Schwann cell differentiation. Egr2 expression is lost after nerve injury, and many Egr2-binding sites lose H3K27ac after nerve injury. However, the majority of Egr2-bound enhancers retain H3K27ac, indicating that other transcription factors maintain active enhancer status after nerve injury. The global epigenomic changes in H3K27ac deposition pinpoint dynamic changes in enhancers that mediate the effects of transcription factors that control Schwann cell myelination and peripheral nervous system responses to nerve injury.	[Hung, Holly A.; Svaren, John] Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA; [Hung, Holly A.] Univ Wisconsin, Cellular & Mol Pathol Grad Program, Madison, WI 53705 USA; [Sun, Guannan; Keles, Sunduz] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Svaren, J (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	jpsvaren@wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921	National Institutes of Health [NS075269, HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS075269 (to J. S.) and Core Grant HD03352.	[Anonymous], CELL STEM CELL; Arthur-Farraj P, 2011, GLIA, V59, P720, DOI 10.1002/glia.21144; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; Barutcu AR, 2014, NUCLEIC ACIDS RES, V42, P10360, DOI 10.1093/nar/gku712; Berti C, 2011, DEVELOPMENT, V138, P4025, DOI 10.1242/dev.065490; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Brewer MH, 2014, HUM MOL GENET, V23, P5171, DOI 10.1093/hmg/ddu240; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen LM, 2010, PROTEIN CELL, V1, P1073, DOI 10.1007/s13238-010-0138-3; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Court FA, 2009, J NEUROSCI, V29, P3908, DOI 10.1523/JNEUROSCI.5672-08.2009; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Denarier E, 2005, J NEUROSCI, V25, P11210, DOI 10.1523/JNEUROSCI.2596-05.2005; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Fischer S, 2008, GLIA, V56, P836, DOI 10.1002/glia.20657; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Fulton DL, 2011, NUCLEIC ACIDS RES, V39, P7974, DOI 10.1093/nar/gkr326; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Ghislain J, 2002, DEVELOPMENT, V129, P155; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heller BA, 2014, J CELL BIOL, V204, P1219, DOI 10.1083/jcb.201307057; Houlden H, 2004, ANN NEUROL, V56, P730, DOI 10.1002/ana.20267; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; Jagalur NB, 2011, J NEUROSCI, V31, P8585, DOI 10.1523/JNEUROSCI.0659-11.2011; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; Jiang N, 2014, NEURAL REGEN RES, V9, P1186, DOI 10.4103/1673-5374.135325; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; Jones EA, 2012, HUM MOL GENET, V21, P1581, DOI 10.1093/hmg/ddr595; Jones EA, 2011, J NEUROSCI, V31, P4242, DOI 10.1523/JNEUROSCI.5893-10.2011; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kim HA, 2013, STEM CELL TRANSL MED, V2, P553, DOI 10.5966/sctm.2013-0011; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mckee KK, 2012, J CELL SCI, V125, P4609, DOI 10.1242/jcs.107995; Meijer D., 2013, PATTERNING CELL TYPE, P759; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Nodari A, 2008, J NEUROSCI, V28, P6714, DOI 10.1523/JNEUROSCI.0326-08.2008; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Painter MW, 2014, NEURON, V83, P331, DOI 10.1016/j.neuron.2014.06.016; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Patodia S, 2012, CELL TISSUE RES, V349, P15, DOI 10.1007/s00441-012-1416-6; Patodia S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00008; Pellegatta M, 2013, J NEUROSCI, V33, P17995, DOI 10.1523/JNEUROSCI.3179-13.2013; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Ramesh V, 2004, NAT REV NEUROSCI, V5, P462, DOI 10.1038/nrn1407; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Salzer James L, 2012, J Peripher Nerv Syst, V17 Suppl 3, P14, DOI 10.1111/j.1529-8027.2012.00425.x; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Sherman DL, 2012, J NEUROSCI, V32, P9419, DOI 10.1523/JNEUROSCI.1220-12.2012; Shin YK, 2013, GLIA, V61, P892, DOI 10.1002/glia.22482; Srinivasan R, 2012, NUCLEIC ACIDS RES, V40, P6449, DOI 10.1093/nar/gks313; STEWART HJS, 1995, EUR J NEUROSCI, V7, P1366, DOI 10.1111/j.1460-9568.1995.tb01128.x; Sun GN, 2013, METHODS MOL BIOL, V1038, P193, DOI 10.1007/978-1-62703-514-9_12; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158; Yu WM, 2009, J CELL SCI, V122, P929, DOI 10.1242/jcs.033928; Yu WM, 2005, J NEUROSCI, V25, P4463, DOI 10.1523/JNEUROSCI.5032-04.2005; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	94	78	81	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6937	6950		10.1074/jbc.M114.622878	http://dx.doi.org/10.1074/jbc.M114.622878			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25614629	Green Published, hybrid			2022-12-28	WOS:000350991500028
J	Chen, CJ; Shih, CH; Chang, YJ; Hong, SJ; Li, TN; Wang, LHC; Chen, LY				Chen, Chien-Jen; Shih, Chien-Hung; Chang, Yu-Jung; Hong, Shao-Jing; Li, Tian-Neng; Wang, Lily Hui-Ching; Chen, Linyi			SH2B1 and IRSp53 Proteins Promote the Formation of Dendrites and Dendritic Branches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL DIFFERENTIATION; ACTIN CYTOSKELETON; SH2-B-BETA; MEMBRANE; IDENTIFICATION; EXPRESSION; FILOPODIA; DYNAMICS; RECEPTOR; DOMAIN	SH2B1 is an adaptor protein known to enhance neurite outgrowth. In this study, we provide evidence suggesting that the SH2B1 level is increased during in vitro culture of hippocampal neurons, and the beta isoform (SH2B1 beta) is the predominant isoform. The fact that formation of filopodia is prerequisite for neurite initiation suggests that SH2B1 may regulate filopodium formation and thus neurite initiation. To investigate whether SH2B1 may regulate filopodium formation, the effect of SH2B1 and a membrane and actin regulator, IRSp53 (insulin receptor tyrosine kinase substrate p53), is investigated. Overexpressing both SH2B1 beta and IRSp53 significantly enhances filopodium formation, neurite outgrowth, and branching. Both in vivo and in vitro data show that SH2B1 interacts with IRSp53 in hippocampal neurons. This interaction depends on the N-terminal proline-rich domains of SH2B1. In addition, SH2B1 and IRSp53 co-localize at the plasma membrane, and their levels increase in the Triton X-100-insoluble fraction of developing neurons. These findings suggest that SH2B1-IRSp53 complexes promote the formation of filopodia, neurite initiation, and neuronal branching.	[Chen, Chien-Jen; Shih, Chien-Hung; Chang, Yu-Jung; Hong, Shao-Jing; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 30013, Taiwan; [Li, Tian-Neng; Wang, Lily Hui-Ching] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Wang, Lily Hui-Ching; Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Chen, LY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	lchen@life.nthu.edu.tw	Chen, Linyi/AAV-2632-2020; Wang, Lily Hui-Ching/D-1967-2011	Chen, Linyi/0000-0001-7258-8817; Wang, Lily Hui-Ching/0000-0003-0659-0139; Chang, Yu-Jung/0000-0002-4781-0946	National Science Council of Taiwan [NSC101-2311-B-007-012-MY3]; National Health Research Institutes [NHRI-EX104-10206NI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by National Science Council of Taiwan Grant NSC101-2311-B-007-012-MY3 and National Health Research Institutes Grant NHRI-EX104-10206NI.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Bisi S, 2013, CURR OPIN CELL BIOL, V25, P565, DOI 10.1016/j.ceb.2013.04.001; Chang YJ, 2014, MOL CELL BIOL, V34, P1003, DOI 10.1128/MCB.00940-13; Chen L, 2008, MOL ENDOCRINOL, V22, P454, DOI 10.1210/me.2007-0384; Chen LY, 2004, MOL CELL BIOL, V24, P3633, DOI 10.1128/MCB.24.9.3633-3647.2004; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Diakonova M, 2007, INFECT IMMUN, V75, P3581, DOI 10.1128/IAI.00214-07; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Futo K, 2013, BBA-MOL CELL BIOL L, V1831, P1651, DOI 10.1016/j.bbalip.2013.07.006; Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230; HUANG XM, 1995, P NATL ACAD SCI USA, V92, P11618, DOI 10.1073/pnas.92.25.11618; Iseki M, 2000, BIOCHEM BIOPH RES CO, V272, P45, DOI 10.1006/bbrc.2000.2736; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Maures TJ, 2011, J CELL SCI, V124, P1542, DOI 10.1242/jcs.078949; Maures TJ, 2009, MOL ENDOCRINOL, V23, P1077, DOI 10.1210/me.2009-0011; Nelms K, 1999, MAMM GENOME, V10, P1160, DOI 10.1007/s003359901183; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Rider L, 2009, MOL ENDOCRINOL, V23, P1065, DOI 10.1210/me.2008-0428; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Schirenbeck A, 2005, BIOCHEM SOC T, V33, P1256, DOI 10.1042/BST0331256; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shih CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079619; Vaggi F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002088; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Volckmar AL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-65; Wang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026433; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; Yousaf N, 2001, J BIOL CHEM, V276, P40940, DOI 10.1074/jbc.M104191200; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005	35	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6010	6021		10.1074/jbc.M114.603795	http://dx.doi.org/10.1074/jbc.M114.603795			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586189	hybrid, Green Published			2022-12-28	WOS:000350732500013
J	Jacobo, SMP; Kazlauskas, A				Jacobo, Sarah Melissa P.; Kazlauskas, Andrius			Insulin-like Growth Factor 1 (IGF-1) Stabilizes Nascent Blood Vessels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; LYSOPHOSPHATIDIC ACID; ENDOTHELIAL-CELLS; RETINAL NEOVASCULARIZATION; VASCULAR MORPHOGENESIS; DIABETIC-RETINOPATHY; ANGIOGENESIS; ACTIVATION; REGRESSION; MIGRATION	Here we report that VEGF-A and IGF-1 differ in their ability to stabilize newly formed blood vessels and endothelial cell tubes. Although VEGF-A failed to support an enduring vascular response, IGF-1 stabilized neovessels generated from primary endothelial cells derived from various vascular beds and mouse retinal explants. In these experimental systems, destabilization/regression was driven by lysophosphatidic acid (LPA). Because previous studies have established that Erk antagonizes LPA-mediated regression, we considered whether Erk was an essential component of IGF-dependent stabilization. Indeed, IGF-1 lost its ability to stabilize neovessels when the Erk pathway was inhibited pharmacologically. Furthermore, stabilization was associated with prolonged Erk activity. In the presence of IGF-1, Erk activity persisted longer than in the presence of VEGF or LPA alone. These studies reveal that VEGF and IGF-1 can have distinct inputs in the angiogenic process. In contrast to VEGF, IGF-1 stabilizes neovessels, which is dependent on Erk activity and associated with prolonged activation.	[Kazlauskas, Andrius] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA; Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Massachusetts Eye & Ear Infirmary	Kazlauskas, A (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA.	andrius_kazlauskas@meei.harvard.edu		Jacobo, Sarah Melissa/0000-0002-1341-7222	Knights Templar Eye Foundation Early Career Award	Knights Templar Eye Foundation Early Career Award	This work was supported by a Knights Templar Eye Foundation Early Career Award (to S. M. P. J.).	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Aranda J, 2013, DIABETOLOGIA, V56, P1444, DOI 10.1007/s00125-013-2884-2; Aranda J, 2012, DIABETES, V61, P1225, DOI 10.2337/db11-1189; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cheng HY, 2012, ARTERIOSCL THROM VAS, V32, P24, DOI 10.1161/ATVBAHA.111.234708; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Goede V, 1998, LAB INVEST, V78, P1385; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hellstrom A, 2002, J CLIN ENDOCR METAB, V87, P3413, DOI 10.1210/jc.87.7.3413; Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016; Hoang MV, 2011, BLOOD, V117, P1751, DOI 10.1182/blood-2010-05-286831; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Im E, 2007, J BIOL CHEM, V282, P29122, DOI 10.1074/jbc.M702637200; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Im E, 2006, CELL CYCLE, V5, P2057, DOI 10.4161/cc.5.18.3210; Im E, 2010, MOL CELL BIOL, V30, P2401, DOI 10.1128/MCB.01275-09; Jacobo SMP, 2013, MOL CELL BIOL, V33, P1976, DOI 10.1128/MCB.01283-12; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; Kwon H, 2011, J CELL MOL MED, V15, P888, DOI 10.1111/j.1582-4934.2010.01079.x; Lin SC, 2011, J CLIN INVEST, V121, P1905, DOI 10.1172/JCI44362; Lofqvist C, 2006, PEDIATRICS, V117, P1930, DOI 10.1542/peds.2005-1926; Lofqvist C, 2006, ARCH OPHTHALMOL-CHIC, V124, P1711, DOI 10.1001/archopht.124.12.1711; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Motiejunaite R, 2014, MICROVASC RES, V93, P62, DOI 10.1016/j.mvr.2014.03.003; Panetti TS, 2000, ARTERIOSCL THROM VAS, V20, P1013, DOI 10.1161/01.ATV.20.4.1013; Park EY, 2012, BIOSCIENCE REP, V32, P393, DOI 10.1042/BSR20120033; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Pukac L, 1998, EXP CELL RES, V242, P548, DOI 10.1006/excr.1998.4138; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Roberts DD, 2011, BLOOD, V117, P1444, DOI 10.1182/blood-2010-11-317198; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; SEELY BL, 1995, J BIOL CHEM, V270, P19151, DOI 10.1074/jbc.270.32.19151; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Stortelers C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-387; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Teo ST, 2009, IUBMB LIFE, V61, P791, DOI 10.1002/iub.220; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458	53	40	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6349	6360		10.1074/jbc.M114.634154	http://dx.doi.org/10.1074/jbc.M114.634154			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564613	Green Published, hybrid			2022-12-28	WOS:000350732500040
J	Moayeri, M; Leysath, CE; Tremblay, JM; Vrentas, C; Crown, D; Leppla, SH; Shoemaker, CB				Moayeri, Mahtab; Leysath, Clinton E.; Tremblay, Jacqueline M.; Vrentas, Catherine; Crown, Devorah; Leppla, Stephen H.; Shoemaker, Charles B.			A Heterodimer of a VHH (Variable Domains of Camelid Heavy Chain-only) Antibody That Inhibits Anthrax Toxin Cell Binding Linked to a VHH Antibody That Blocks Oligomer Formation Is Highly Protective in an Anthrax Spore Challenge Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL FACTOR; MONOCLONAL-ANTIBODIES; ANTIGEN; MICE; NANOBODIES; CLEARANCE; LIBRARIES; AFFINITY; RECEPTOR; AGENTS	Anthrax disease is caused by a toxin consisting of protective antigen (PA), lethal factor, and edema factor. Antibodies against PA have been shown to be protective against the disease. Variable domains of camelid heavy chain-only antibodies (VHHs) with affinity for PA were obtained from immunized alpacas and screened for anthrax neutralizing activity in macrophage toxicity assays. Two classes of neutralizing VHHs were identified recognizing distinct, non-overlapping epitopes. One class recognizes domain 4 of PA at a well characterized neutralizing site through which PA binds to its cellular receptor. A second neutralizing VHH (JKH-C7) recognizes a novel epitope. This antibody inhibits conversion of the PA oligomer from "pre-pore" to its SDS and heat-resistant "pore" conformation while not preventing cleavage of full-length 83-kDa PA (PA83) by cell surface proteases to its oligomer-competent 63-kDa form (PA63). The antibody prevents endocytosis of the cell surface-generated PA63 subunit but not preformed PA63 oligomers formed in solution. JKH-C7 and the receptor-blocking VHH class (JIK-B8) were expressed as a heterodimeric VHH-based neutralizing agent (VNA2-PA). This VNA displayed improved neutralizing potency in cell assays and protected mice from anthrax toxin challenge with much better efficacy than the separate component VHHs. The VNA protected virtually all mice when separately administered at a 1:1 ratio to toxin and protected mice against Bacillus anthracis spore infection. Thus, our studies show the potential of VNAs as anthrax therapeutics. Due to their simple and stable nature, VNAs should be amenable to genetic delivery or administration via respiratory routes.	[Moayeri, Mahtab; Leysath, Clinton E.; Vrentas, Catherine; Crown, Devorah; Leppla, Stephen H.] Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, North Grafton, MA 01536 USA; [Tremblay, Jacqueline M.; Shoemaker, Charles B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Tufts University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shoemaker, CB (corresponding author), Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, 200 Westboro Rd, North Grafton, MA 01536 USA.	charles.shoemaker@tufts.edu		Moayeri, Mahtab/0000-0002-4448-8883	National Institutes of Health [U54 AI057159]; Intramural Research Program of the National Institutes of Health (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032, U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057159 (NIAID) and by the Intramural Research Program of the National Institutes of Health (NIAID).	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Alberti MO, 2013, GENE THER, V20, P733, DOI 10.1038/gt.2012.91; Bakherad H, 2013, MOL BIOTECHNOL, V55, P159, DOI 10.1007/s12033-013-9669-1; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chen ZC, 2011, TOXINS, V3, P1004, DOI 10.3390/toxins3081004; Chen ZC, 2009, INFECT IMMUN, V77, P3902, DOI 10.1128/IAI.00200-09; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Kaur M, 2013, EXPERT REV VACCINES, V12, P955, DOI 10.1586/14760584.2013.814860; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; LITTLE SF, 1988, INFECT IMMUN, V56, P1807, DOI 10.1128/IAI.56.7.1807-1813.1988; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Moayeri M, 2006, INFECT IMMUN, V74, P3707, DOI 10.1128/IAI.00051-06; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Richard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069495; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Sheoran AS, 2015, INFECT IMMUN, V83, P286, DOI 10.1128/IAI.02360-14; SINGH Y, 1994, J BIOL CHEM, V269, P29039; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wang Fei, 2004, Human Antibodies, V13, P105; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196	42	25	27	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6584	6595		10.1074/jbc.M114.627943	http://dx.doi.org/10.1074/jbc.M114.627943			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25564615	hybrid, Green Published			2022-12-28	WOS:000350732500060
J	Bae, C; Sachs, F; Gottlieb, PA				Bae, Chilman; Sachs, Frederick; Gottlieb, Philip A.			Protonation of the Human PIEZO1 Ion Channel Stabilizes Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANOSENSITIVE CHANNELS; MUTATIONS; PATCH; CELL	PIEZO1 is a recently cloned eukaryotic cation-selective channel that opens with mechanical force. We found that extracellular protonation inhibits channel activation by approximate to 90% by increased occupancy in the closed or the inactivated state. Titration between pH 6.3 and 8.3 exhibited a pK of approximate to 6.9. The steepness of the titration data suggests positive cooperativity, implying the involvement of at least two protonation sites. Whole-cell recordings yielded results similar to patches, and pH 6.5 reduced whole-cell currents by >80%. The effects were reversible. To assess whether pH acts on the open or the inactivated state, we tested a double-mutant PIEZO1 that does not inactivate. Cell-attached patches and whole-cell currents from this mutant channel were pH-insensitive. Thus, protonation appears to be associated with domain(s) of the channel involved with inactivation. pH also did not affect mutant channels with point mutations at position 2456 that are known to exhibit slow inactivation. To determine whether the physical properties of the membrane are altered by pH and thereby affect channel gating, we measured patch capacitance during mechanical stimuli at pH 6.5 and 7.3. The rate constants for changes in patch capacitance were independent of pH, suggesting that bilayer mechanics are not involved. In summary, low pH stabilizes the inactivated state. This effect may be important when channels are activated under pathological conditions in which the pH is reduced, such as during ischemia.	[Bae, Chilman; Sachs, Frederick; Gottlieb, Philip A.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gottlieb, PA (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 302 Cary Hall, Buffalo, NY 14214 USA.	philgott@buffalo.edu	Gottlieb, Philip/C-3113-2019	Gottlieb, Philip/0000-0003-3764-9885	National Institutes of Health through the NHLBI [5R01HL054887-19]; United States Army Research Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887] Funding Source: NIH RePORTER	National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Army Research Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL054887-19 (to F. S.) through the NHLBI. This work was also supported by the United States Army Research Office (to F. S.).	Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489; Bae C, 2013, BIOPHYS J, V105, P880, DOI 10.1016/j.bpj.2013.07.019; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; CHAZAN JA, 1968, NEW ENGL J MED, V278, P360, DOI 10.1056/NEJM196802152780703; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Ducret T, 2006, J PHYSIOL-LONDON, V575, P913, DOI 10.1113/jphysiol.2006.115154; Faucherre A, 2014, HAEMATOLOGICA, V99, P70, DOI 10.3324/haematol.2013.086090; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; Gailly P, 2007, J PHYSIOL-LONDON, V582, P1261, DOI 10.1113/jphysiol.2007.132191; Gottlieb PA, 2012, CHANNELS, V6, P214, DOI 10.4161/chan.21050; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Li J., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089893; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Suchyna TM, 2007, J PHYSIOL-LONDON, V581, P369, DOI 10.1113/jphysiol.2006.125021; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2004, PHYS BIOL, V1, P1, DOI 10.1088/1478-3967/1/1/001; Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	26	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5167	5173		10.1074/jbc.M114.604033	http://dx.doi.org/10.1074/jbc.M114.604033			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561736	hybrid, Green Published			2022-12-28	WOS:000350042000055
J	Fernandez, J; Portilho, DM; Danckaert, A; Munier, S; Becker, A; Roux, P; Zambo, A; Shorte, S; Jacob, Y; Vidalain, PO; Charneau, P; Clavel, F; Arhel, NJ				Fernandez, Juliette; Portilho, Debora M.; Danckaert, Anne; Munier, Sandie; Becker, Andreas; Roux, Pascal; Zambo, Anaba; Shorte, Spencer; Jacob, Yves; Vidalain, Pierre-Olivier; Charneau, Pierre; Clavel, Francois; Arhel, Nathalie J.			Microtubule-associated Proteins 1 (MAP1) Promote Human Immunodeficiency Virus Type I (HIV-1) Intracytoplasmic Routing to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIM5-ALPHA RESTRICTION FACTOR; REVERSE TRANSCRIPTION; DNA FLAP; PREINTEGRATION COMPLEX; DYNEIN LIGHT-CHAIN-8; NONDIVIDING CELLS; INFECTION; CYTOSKELETON; REPLICATION; IMPORT	After cell entry, HIV undergoes rapid transport toward the nucleus using microtubules and microfilaments. Neither the cellular cytoplasmic components nor the viral proteins that interact to mediate transport have yet been identified. Using a yeast two-hybrid screen, we identified four cytoskeletal components as putative interaction partners for HIV-1 p24 capsid protein: MAP1A, MAP1S, CKAP1, and WIRE. Depletion of MAP1A/MAP1S in indicator cell lines and primary human macrophages led to a profound reduction in HIV-1 infectivity as a result of impaired retrograde trafficking, demonstrated by a characteristic accumulation of capsids away from the nuclear membrane, and an overall defect in nuclear import. MAP1A/MAP1S did not impact microtubule network integrity or cell morphology but contributed to microtubule stabilization, which was shown previously to facilitate infection. In addition, we found that MAP1 proteins interact with HIV-1 cores both in vitro and in infected cells and that interaction involves MAP1 light chain LC2. Depletion of MAP1 proteins reduced the association of HIV-1 capsids with both dynamic and stable microtubules, suggesting that MAP1 proteins help tether incoming viral capsids to the microtubular network, thus promoting cytoplasmic trafficking. This work shows for the first time that following entry into target cells, HIV-1 interacts with the cytoskeleton via its p24 capsid protein. Moreover, our results support a role for MAP1 proteins in promoting efficient retrograde trafficking of HIV-1 by stimulating the formation of stable microtubules and mediating the association of HIV-1 cores with microtubules.	[Fernandez, Juliette; Portilho, Debora M.; Becker, Andreas; Zambo, Anaba; Clavel, Francois; Arhel, Nathalie J.] Hop St Louis, INSERM, U941, IUH, F-75010 Paris, France; [Danckaert, Anne; Roux, Pascal; Shorte, Spencer] Inst Pasteur, F-75015 Paris, France; [Munier, Sandie; Jacob, Yves] Univ Paris Diderot, Dept Virol, Unite Genet Mol Virus ARN, CNRS,UMR3569, F-75015 Paris, France; [Vidalain, Pierre-Olivier] Inst Pasteur, CNRS, UMR3569, Unite Genom Virale & Vaccinat, F-75015 Paris, France; [Charneau, Pierre] Inst Pasteur, Unite Virol Mol & Vaccinol, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Arhel, NJ (corresponding author), Hop St Louis, INSERM, U941, IUH, 1 Ave Claude Vellefaux, F-75010 Paris, France.	nathalie.arhel@inserm.fr	Vidalain, Pierre-Olivier/F-9778-2019; CHARNEAU, Pierre/M-1565-2017; fernandez, juliette/D-4600-2016; Munier, Sandie/F-6826-2016	Vidalain, Pierre-Olivier/0000-0003-3082-7407; CHARNEAU, Pierre/0000-0003-1184-5773; fernandez, juliette/0000-0003-2969-8150; Munier, Sandie/0000-0001-7819-128X; Arhel, Nathalie/0000-0001-5309-1725; Jacob, Yves/0000-0001-9125-2374; Shorte, Spencer/0000-0002-2125-8663				Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Atherton J, 2013, BIOL CELL, V105, P465, DOI 10.1111/boc.201300012; BARBOSA P, 1994, AIDS RES HUM RETROV, V10, P53, DOI 10.1089/aid.1994.10.53; Black LR, 2010, J VIROL, V84, P6564, DOI 10.1128/JVI.00210-10; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brun S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-57; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gallo DE, 2012, VIROLOGY, V422, P13, DOI 10.1016/j.virol.2011.09.015; Gaudin R, 2013, TRENDS CELL BIOL, V23, P652, DOI 10.1016/j.tcb.2013.09.004; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Grynberg M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-46; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Iglesias C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-92; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Perron MJ, 2007, J VIROL, V81, P2138, DOI 10.1128/JVI.02318-06; Petit C, 2003, J CELL SCI, V116, P3433, DOI 10.1242/jcs.00613; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Roa A, 2012, J VIROL, V86, P1717, DOI 10.1128/JVI.05811-11; Sabo Y, 2013, CELL HOST MICROBE, V14, P535, DOI 10.1016/j.chom.2013.10.012; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Shah VB, 2011, JOVE-J VIS EXP, DOI 10.3791/3384; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tan GS, 2007, P NATL ACAD SCI USA, V104, P7229, DOI 10.1073/pnas.0701397104; Warrilow D, 2009, REV MED VIROL, V19, P324, DOI 10.1002/rmv.627; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Yoder A, 2011, J VIROL, V85, P3020, DOI 10.1128/JVI.02462-10; Zamborlini A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-63; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	51	54	56	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4631	4646		10.1074/jbc.M114.613133	http://dx.doi.org/10.1074/jbc.M114.613133			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25505242	hybrid, Green Published			2022-12-28	WOS:000350042000009
J	La Montanara, P; Rusconi, L; Locarno, A; Forti, L; Barbiero, I; Tramarin, M; Chandola, C; Kilstrup-Nielsen, C; Landsberger, N				La Montanara, Paolo; Rusconi, Laura; Locarno, Albina; Forti, Lia; Barbiero, Isabella; Tramarin, Marco; Chandola, Chetan; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta			Synaptic Synthesis, Dephosphorylation, and Degradation A NOVEL PARADIGM FOR AN ACTIVITY-DEPENDENT NEURONAL CONTROL OF CDKL5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BDNF TRANSCRIPTION; PROTEIN-SYNTHESIS; RETT-SYNDROME; CDKL5; KINASE; MECHANISMS; PHOSPHORYLATION; EXPRESSION; PLASTICITY; RECEPTORS	Mutations in the X-linked CDKL5 (cyclin-dependent kinase-like 5) gene have been associated with several forms of neurodevelopmental disorders, including atypical Rett syndrome, autism spectrum disorders, and early infantile epileptic encephalopathy. Accordingly, loss of CDKL5 in mice results in autistic-like features and impaired neuronal communication. Although the biological functions of CDKL5 remain largely unknown, recent pieces of evidence suggest that CDKL5 is involved in neuronal plasticity. Herein, we show that, at all stages of development, neuronal depolarization induces a rapid increase in CDKL5 levels, mostly mediated by extrasomatic synthesis. In young neurons, this induction is prolonged, whereas in more mature neurons, NMDA receptor stimulation induces a protein phosphatase 1-dependent dephosphorylation of CDKL5 that is mandatory for its proteasome-dependent degradation. As a corollary, neuronal activity leads to a prolonged induction of CDKL5 levels in immature neurons but to a short lasting increase of the kinase in mature neurons. Recent results demonstrate that many genes associated with autism spectrum disorders are crucial components of the activity-dependent signaling networks regulating the composition, shape, and strength of the synapse. Thus, we speculate that CDKL5 deficiency disrupts activity-dependent signaling and the consequent synapse development, maturation, and refinement.	[La Montanara, Paolo; Rusconi, Laura; Locarno, Albina; Forti, Lia; Barbiero, Isabella; Tramarin, Marco; Chandola, Chetan; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta] Univ Insubria, Sect Biomed Res, Dept Theoret & Appl Sci, I-21052 Busto Arsizio, Italy; [Landsberger, Nicoletta] Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy	University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Sect Biomed Res, Dept Theoret & Appl Sci, Via Manara 7, I-21052 Busto Arsizio, Italy.	landsben@uninsubria.it	Forti, Lia/AAU-8156-2020; Forti, Lia/E-9957-2018	Forti, Lia/0000-0003-3979-0284; Forti, Lia/0000-0003-3979-0284; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; La Montanara, Paolo/0000-0002-5146-9269; Landsberger, Nicoletta/0000-0003-0820-3155	Italian parents' association L'Albero di Greta; Italian parents' association ProRett Ricerca	Italian parents' association L'Albero di Greta; Italian parents' association ProRett Ricerca	We are indebted to Dr. R. Fesce for valuable suggestions and thank Desiree Zambroni from the ALEMBIC facility for expertise in the microscopy analysis. We thank the Italian parents' associations L'Albero di Greta and ProRett Ricerca for supporting our research.	Amendola E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091613; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Carouge D, 2010, NEUROBIOL DIS, V38, P414, DOI 10.1016/j.nbd.2010.02.014; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gkogkas C, 2010, J BIOL CHEM, V285, P31913, DOI 10.1074/jbc.R110.154476; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Kilstrup-Nielsen C, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/728267; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lombardi G, 1996, BRIT J PHARMACOL, V117, P189, DOI 10.1111/j.1476-5381.1996.tb15173.x; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Rusconi L, 2011, J BIOL CHEM, V286, P36550, DOI 10.1074/jbc.M111.235630; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sekiguchi M, 2013, ARCH BIOCHEM BIOPHYS, V535, P257, DOI 10.1016/j.abb.2013.04.012; Szafranski P, 2015, EUR J HUM GENET, V23, P915, DOI 10.1038/ejhg.2014.217; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Williamson SL, 2012, HUM GENET, V131, P187, DOI 10.1007/s00439-011-1058-x; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zhu YC, 2013, P NATL ACAD SCI USA, V110, P9118, DOI 10.1073/pnas.1300003110	31	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4512	4527		10.1074/jbc.M114.589762	http://dx.doi.org/10.1074/jbc.M114.589762			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25555910	Green Published, hybrid			2022-12-28	WOS:000349458400056
J	Quan, XL; Nguyen, TT; Choi, SK; Xu, SH; Das, R; Cha, SK; Kim, N; Han, J; Wiederkehr, A; Wollheim, CB; Park, KS				Quan, Xianglan; Tuyet Thi Nguyen; Choi, Seong-Kyung; Xu, Shanhua; Das, Ranjan; Cha, Seung-Kuy; Kim, Nari; Han, Jin; Wiederkehr, Andreas; Wollheim, Claes B.; Park, Kyu-Sang			Essential Role of Mitochondrial Ca2+ Uniporter in the Generation of Mitochondrial pH Gradient and Metabolism-Secretion Coupling in Insulin-releasing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL COMPONENT; BETA-CELL; OXIDATIVE-PHOSPHORYLATION; CALCIUM UNIPORTER; MCU; MICU1; ACTIVATION; EXCHANGER; MEMBRANE; DEFECTS	In pancreatic beta-cells, ATP acts as a signaling molecule initiating plasma membrane electrical activity linked to Ca2+ influx, which triggers insulin exocytosis. The mitochondrial Ca2+ uniporter (MCU) mediates Ca2+ uptake into the organelle, where energy metabolism is further stimulated for sustained second phase insulin secretion. Here, we have studied the contribution of the MCUto the regulation of oxidative phosphorylation and metabolism-secretion coupling in intact and permeabilized clonal beta-cells as well as rat pancreatic islets. Knockdown of MCU with siRNA transfection blunted matrix Ca2+ rises, decreased nutrient-stimulated ATP production as well as insulin secretion. Furthermore, MCUknockdown lowered the expression of respiratory chain complexes, mitochondrial metabolic activity, and oxygen consumption. The pH gradient formed across the inner mitochondrial membrane following nutrient stimulation was markedly lowered in MCU-silenced cells. In contrast, nutrient- induced hyperpolarization of the electrical gradient was not altered. In permeabilized cells, knockdown of MCU ablated matrix acidification in response to extramitochondrial Ca2+. Suppression of the putative Ca2+/H+ antiporter leucine zipper-EF hand-containing transmembrane protein 1 (LETM1) also abolished Ca2+-induced matrix acidification. These results demonstrate that MCU-mediated Ca2+ uptake is essential to establish a nutrient-induced mitochondrial pH gradient which is critical for sustained ATP synthesis and metabolism-secretion coupling in insulin-releasing cells.	[Quan, Xianglan; Tuyet Thi Nguyen; Choi, Seong-Kyung; Xu, Shanhua; Das, Ranjan; Cha, Seung-Kuy; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju 220701, Gangwon Do, South Korea; [Kim, Nari; Han, Jin] Inje Univ, Coll Med, Dept Physiol, Pusan 614735, South Korea; [Wiederkehr, Andreas] Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	Yonsei University; Inje University; Nestle SA; University of Geneva	Park, KS (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Physiol, Inst Lifestyle Med, Wonju 220701, Gangwon Do, South Korea.	qsang@yonsei.ac.kr	DAS, RANJAN/ABE-4002-2021; Das, Ranjan/AFQ-6329-2022	Das, Ranjan/0000-0002-7951-4121; Park, Kyu-Sang/0000-0003-0322-9807; T. Nguyen, Tuyet/0000-0002-2686-6895	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0020224]; Swiss National Foundation [310000-116750/1]; EuroDia a European-Community project [LSHM-CT-2006-518153]	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Swiss National Foundation(Swiss National Science Foundation (SNSF)); EuroDia a European-Community project	This work was supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0020224) (to J. H.) and grants from the Swiss National Foundation (310000-116750/1) and EuroDia (LSHM-CT-2006-518153) a European-Community funded project under framework program 6 (to C. B. W.).	Akhmedov D, 2010, FASEB J, V24, P4613, DOI 10.1096/fj.10-162222; Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; de la Fuente S, 2014, BIOCHEM J, V458, P33, DOI 10.1042/BJ20131025; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Hart L, 2014, DIS MODEL MECH, V7, P535, DOI 10.1242/dmm.014464; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kuum M, 2012, J CELL SCI, V125, P625, DOI 10.1242/jcs.090126; Lee B, 2003, DIABETES, V52, P965, DOI 10.2337/diabetes.52.4.965; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; NICHOLLS DG, 1980, FEBS LETT, V111, P261, DOI 10.1016/0014-5793(80)80806-4; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pendin D, 2014, CELL CALCIUM, V55, P139, DOI 10.1016/j.ceca.2014.02.008; Pitter JG, 2002, CELL CALCIUM, V31, P97, DOI 10.1054/ceca.2001.0264; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Quan X, 2013, MOL CELL ENDOCRINOL, V381, P198, DOI 10.1016/j.mce.2013.08.003; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Tsai MF, 2014, J GEN PHYSIOL, V143, P67, DOI 10.1085/jgp.201311096; Waldeck-Weiermair M, 2013, J BIOL CHEM, V288, P15367, DOI 10.1074/jbc.M113.462259; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Wollheim CB, 2000, DIABETOLOGIA, V43, P265, DOI 10.1007/s001250050044	46	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4086	4096		10.1074/jbc.M114.632547	http://dx.doi.org/10.1074/jbc.M114.632547			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25548283	Green Published, hybrid			2022-12-28	WOS:000349458400020
J	Mahmmoud, YA; Kopec, W; Khandelia, H				Mahmmoud, Yasser A.; Kopec, Wojciech; Khandelia, Himanshu			K+ Congeners That Do Not Compromise Na+ Activation of the Na+, K+-ATPase HYDRATION OF THE ION BINDING CAVITY LIKELY CONTROLS ION SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; OSMOTIC-STRESS; ALPHA-SUBUNIT; FORCE-FIELD; SITES; WATER; NA,K-ATPASE; MECHANISM	The Na+, K+-ATPase is essential for ionic homeostasis in animal cells. The dephosphoenzyme contains Na+ selective inward facing sites, whereas the phosphoenzyme contains K+ selective outward facing sites. Under normal physiological conditions, K+ inhibits cytoplasmic Na+ activation of the enzyme. Acetamidinium (Acet(+)) and formamidinium (Form(+)) have been shown to permeate the pump through the outward facing sites. Here, we show that these cations, unlike K+, are unable to enter the inward facing sites in the dephosphorylated enzyme. Consistently, the organic cations exhibited little to no antagonism to cytoplasmic Na+ activation. Na+, K+-ATPase structures revealed a previously undescribed rotamer transition of the hydroxymethyl side chain of the absolutely conserved Thr(772) of the alpha-subunit. The side chain contributes its hydroxyl to Na+ in site I in the E-1 form and rotates to contribute its methyl group toward K+ in the E-2 form. Molecular dynamics simulations to the E-1 center dot AlF4-center dot ADP center dot 3Na(+) structure indicated that 1) bound organic cations differentially distorted the ion binding sites, 2) the hydroxymethyl of Thr(772) rotates to stabilize bound Form(+) through water molecules, and 3) the rotamer transition is mediated by water traffic into the ion binding cavity. Accordingly, dehydration induced by osmotic stress enhanced the interaction of the congeners with the outward facing sites and profoundly modified the organization of membrane domains of the alpha-subunit. These results assign a catalytic role for water in pump function, and shed light on a backbone-independent but a conformation-dependent switch between H-bond and dispersion contact as part of the catalytic mechanism of the Na+, K+-ATPase.	[Mahmmoud, Yasser A.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kopec, Wojciech; Khandelia, Himanshu] Univ Southern Denmark, Ctr Biomembrane Phys, MEMPHYS, DK-5230 Odense M, Denmark	Aarhus University; University of Southern Denmark	Mahmmoud, YA (corresponding author), Univ Aarhus, Ole Worms 6,Bld 1180, DK-8000 Aarhus C, Denmark.	yasser@privat.dk		Khandelia, Himanshu/0000-0001-9913-6394	Novo Nordic Foundation; Lundbeck Foundation; Lundbeck Foundation [R82-2011-7280] Funding Source: researchfish	Novo Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a grant from the Novo Nordic Foundation (to Y. A. M.) and the Lundbeck Foundation (to H. K. and W. K.).	BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Damjanovic A, 2009, PROTEINS, V76, P1007, DOI 10.1002/prot.22439; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DRAPEAU P, 1980, J BIOL CHEM, V255, P7827; Dudev T, 2010, J AM CHEM SOC, V132, P2321, DOI 10.1021/ja909280g; Dudev T, 2009, J AM CHEM SOC, V131, P8092, DOI 10.1021/ja900168k; Esmann M, 2008, BIOPHYS J, V94, P2767, DOI 10.1529/biophysj.106.101774; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FORBUSH B, 1988, J BIOL CHEM, V263, P7979; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; Gatto C, 2007, J MEMBRANE BIOL, V216, P49, DOI 10.1007/s00232-007-9028-x; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gonzalez-Lebrero RM, 2002, J BIOL CHEM, V277, P5910, DOI 10.1074/jbc.M105886200; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1971, P NATL ACAD SCI USA, V68, P280, DOI 10.1073/pnas.68.2.280; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; Kirschner KN, 2001, P NATL ACAD SCI USA, V98, P10541, DOI 10.1073/pnas.191362798; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Kopec W, 2014, BIOCHEMISTRY-US, V53, P746, DOI 10.1021/bi401425g; KROONBATENBURG LMJ, 1990, BIOPOLYMERS, V29, P1243, DOI 10.1002/bip.360290813; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Mahmmoud YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096909; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Noskov SY, 2007, J GEN PHYSIOL, V129, P135, DOI 10.1085/jgp.200609633; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Ostmeyer J, 2013, NATURE, V501, DOI 10.1038/nature12395; Panman MR, 2013, NAT CHEM, V5, P929, DOI [10.1038/NCHEM.1744, 10.1038/nchem.1744]; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PARSEGIAN VA, 1986, METHOD ENZYMOL, V127, P400; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; Peluffo RD, 2009, BIOCHEMISTRY-US, V48, P8105, DOI 10.1021/bi900687u; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Ratheal IM, 2010, P NATL ACAD SCI USA, V107, P18718, DOI 10.1073/pnas.1004214107; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sugita Y, 2010, P NATL ACAD SCI USA, V107, P21465, DOI 10.1073/pnas.1015819107; Therien AG, 1999, AM J PHYSIOL-CELL PH, V277, pC891, DOI 10.1152/ajpcell.1999.277.5.C891; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y	61	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3720	3731		10.1074/jbc.M114.577486	http://dx.doi.org/10.1074/jbc.M114.577486			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25533461	Green Published, hybrid			2022-12-28	WOS:000349456000043
J	Vadlamani, G; Thomas, MD; Patel, TR; Donald, LJ; Reeve, TM; Stetefeld, J; Standing, KG; Vocadlo, DJ; Mark, BL				Vadlamani, Grishma; Thomas, Misty D.; Patel, Trushar R.; Donald, Lynda J.; Reeve, Thomas M.; Stetefeld, Joerg; Standing, Kenneth G.; Vocadlo, David J.; Mark, Brian L.			The beta-Lactamase Gene Regulator AmpR Is a Tetramer That Recognizes and Binds the D-Ala-D-Ala Motif of Its Repressor UDP-N-acetylmuramic Acid (MurNAc)-pentapeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Mass Spectrometry (MS); Peptidoglycan; Small Angle X-ray Scattering (SAXS); Transcription; AmpC beta-Lactamase; AmpR; LysR-type Transcriptional Regulator	LYSR-TYPE REGULATOR; PSEUDOMONAS-AERUGINOSA; TRANSCRIPTIONAL REGULATOR; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENTEROBACTER-CLOACAE; MASS-SPECTROMETER; STRUCTURAL BASIS; ACTIVATION; INDUCTION	Background: Peptidoglycan metabolites regulate AmpR-mediated control of ampC -lactamase expression. Results: AmpR binds DNA as a tetramer and interacts with up to four copies of its repressor UDP-MurNAc-pentapeptide via its d-Ala-d-Ala motif. Conclusion: d-Ala-d-Ala recognition supports 1,6-anhydroMurNAc-pentapeptide as an AmpR activator, probably through competitive binding with UDP-MurNAc-pentapeptide. Significance: Understanding how peptidoglycan metabolites modulate AmpR provides insight into how -lactam classes differentially induce ampC expression. Inducible expression of chromosomal AmpC -lactamase is a major cause of -lactam antibiotic resistance in the Gram-negative bacteria Pseudomonas aeruginosa and Enterobacteriaceae. AmpC expression is induced by the LysR-type transcriptional regulator (LTTR) AmpR, which activates ampC expression in response to changes in peptidoglycan (PG) metabolite levels that occur during exposure to -lactams. Under normal conditions, AmpR represses ampC transcription by binding the PG precursor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide. When exposed to -lactams, however, PG catabolites (1,6-anhydroMurNAc-peptides) accumulate in the cytosol, which have been proposed to competitively displace UDP-MurNAc-pentapeptide from AmpR and convert it into an activator of ampC transcription. Here we describe the molecular interactions between AmpR (from Citrobacter freundii), its DNA operator, and repressor UDP-MurNAc-pentapeptide. Non-denaturing mass spectrometry revealed AmpR to be a homotetramer that is stabilized by DNA containing the T-N-11-A LTTR binding motif and revealed that it can bind four repressor molecules in an apparently stepwise manner. A crystal structure of the AmpR effector-binding domain bound to UDP-MurNAc-pentapeptide revealed that the terminal d-Ala-d-Ala motif of the repressor forms the primary contacts with the protein. This observation suggests that 1,6-anhydroMurNAc-pentapeptide may convert AmpR into an activator of ampC transcription more effectively than 1,6-anhydroMurNAc-tripeptide (which lacks the d-Ala-d-Ala motif). Finally, small angle x-ray scattering demonstrates that the AmpRDNA complex adopts a flat conformation similar to the LTTR protein AphB and undergoes only a slight conformational change when binding UDP-MurNAc-pentapeptide. Modeling the AmpRDNA tetramer bound to UDP-MurNAc-pentapeptide predicts that the UDP-MurNAc moiety of the repressor participates in modulating AmpR function.	[Vadlamani, Grishma; Thomas, Misty D.; Reeve, Thomas M.; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Patel, Trushar R.; Donald, Lynda J.; Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Standing, Kenneth G.] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB R3T 2N2, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Simon Fraser University	Mark, BL (corresponding author), Univ Manitoba, Winnipeg, MB R3T 2N2, Canada.	brian.mark@umanitoba.ca	Stetefeld, Joerg/H-7630-2017; Patel, Trushar R/F-2776-2011; Vocadlo, David J/E-5508-2014; Patel, Trushar R./AAB-6250-2020	Stetefeld, Joerg/0000-0003-1478-3248; Patel, Trushar R/0000-0003-0627-2923; Vocadlo, David J/0000-0001-6897-5558; Patel, Trushar R./0000-0003-0627-2923; Vadlamani, Grishma/0000-0002-4198-6967; Mark, Brian/0000-0002-7344-1355	Canadian Institutes of Health Research (CIHR) [MOP-97818]; Cystic Fibrosis Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council; CIHR; University of Saskatchewan; Manitoba Research Chair award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; CIHR(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; Manitoba Research Chair award	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-97818 and Cystic Fibrosis Canada grants (to B. L. M. and D. J. V.). The Canadian Light Source is supported by Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council, the CIHR, and the University of Saskatchewan.Recipient of a Manitoba Research Chair award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akakura R, 2002, J BIOL CHEM, V277, P5866, DOI 10.1074/jbc.M110555200; Alanazi AM, 2013, ACTA CRYSTALLOGR D, V69, P1995, DOI 10.1107/S0907444913017320; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Balasubramanian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034067; Balcewich MD, 2010, J MOL BIOL, V400, P998, DOI 10.1016/j.jmb.2010.05.040; BISHOP RE, 1993, EUR J BIOCHEM, V213, P405, DOI 10.1111/j.1432-1033.1993.tb17775.x; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Cheng QM, 2000, J BACTERIOL, V182, P4836, DOI 10.1128/JB.182.17.4836-4840.2000; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Devesse L, 2011, MOL MICROBIOL, V81, P354, DOI 10.1111/j.1365-2958.2011.07673.x; Dietz H, 1997, ANTIMICROB AGENTS CH, V41, P2113, DOI 10.1128/AAC.41.10.2113; DONALD LJ, 2006, CELL BIOL LAB HDB, P457; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ezezika OC, 2007, ACTA CRYSTALLOGR F, V63, P361, DOI 10.1107/S1744309107019185; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; HOLTJE JV, 1994, FEMS MICROBIOL LETT, V122, P159, DOI 10.1111/j.1574-6968.1994.tb07159.x; HONORE N, 1986, EMBO J, V5, P3709, DOI 10.1002/j.1460-2075.1986.tb04704.x; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1995, MOL MICROBIOL, V15, P553, DOI 10.1111/j.1365-2958.1995.tb02268.x; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Juan C, 2006, ANTIMICROB AGENTS CH, V50, P1780, DOI 10.1128/AAC.50.5.1780-1787.2006; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; Kaneko K, 2005, J CLIN MICROBIOL, V43, P2955, DOI 10.1128/JCM.43.6.2955-2958.2005; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kong KF, 2005, ANTIMICROB AGENTS CH, V49, P4567, DOI 10.1128/AAC.49.11.4567-4575.2005; KORAT B, 1991, MOL MICROBIOL, V5, P675, DOI 10.1111/j.1365-2958.1991.tb00739.x; Kozlovski VI, 2011, INT J MASS SPECTROM, V308, P118, DOI 10.1016/j.ijms.2011.08.009; Kuga A, 2000, ANTIMICROB AGENTS CH, V44, P561, DOI 10.1128/AAC.44.3.561-567.2000; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LINDBERG F, 1987, J BACTERIOL, V169, P1923, DOI 10.1128/jb.169.5.1923-1928.1987; LINDQUIST S, 1989, J BACTERIOL, V171, P3746, DOI 10.1128/jb.171.7.3746-3753.1989; Loboda AV, 2000, RAPID COMMUN MASS SP, V14, P1047, DOI 10.1002/1097-0231(20000630)14:12<1047::AID-RCM990>3.0.CO;2-E; Lossl P, 2014, J AM SOC MASS SPECTR, V25, P906, DOI 10.1007/s13361-014-0874-3; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mark BL, 2011, FUTURE MICROBIOL, V6, P1415, DOI [10.2217/FMB.11.128, 10.2217/fmb.11.128]; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Momany C, 2012, MOL MICROBIOL, V83, P453, DOI 10.1111/j.1365-2958.2011.07960.x; Monferrer D, 2010, MOL MICROBIOL, V75, P1199, DOI 10.1111/j.1365-2958.2010.07043.x; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; ORR A, 1995, BIOTECHNIQUES, V19, P204; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PARSEK MR, 1994, J BIOL CHEM, V269, P11279; Patel TR, 2014, MATRIX BIOL, V33, P60, DOI 10.1016/j.matbio.2013.07.009; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Porrua O, 2007, MOL MICROBIOL, V66, P410, DOI 10.1111/j.1365-2958.2007.05927.x; Ruangprasert A, 2010, J MOL BIOL, V404, P568, DOI 10.1016/j.jmb.2010.09.053; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Serdyuk I. N., 2007, METHODS MOL BIOPHYSI, P21; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor JL, 2012, MOL MICROBIOL, V83, P457, DOI 10.1111/j.1365-2958.2011.07919.x; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2002, J BACTERIOL, V184, P4233, DOI 10.1128/JB.184.15.4233-4239.2002; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; Zhou XH, 2010, J MOL BIOL, V396, P1012, DOI 10.1016/j.jmb.2009.12.033	67	46	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2630	2643		10.1074/jbc.M114.618199	http://dx.doi.org/10.1074/jbc.M114.618199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25480792	Green Published, hybrid			2022-12-28	WOS:000349310700009
J	Shah, N; Colbert, KN; Enos, MD; Herschlag, D; Weis, WI				Shah, Niket; Colbert, Karen N.; Enos, Michael D.; Herschlag, Daniel; Weis, William I.			Three alpha SNAP and 10 ATP Molecules Are Used in SNARE Complex Disassembly by N-ethylmaleimide-sensitive Factor (NSF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEIN NSF; VESICULAR TRANSPORT; BACTERIOPHAGE-T4 FIBRITIN; ATTACHMENT PROTEINS; MEMBRANE-FUSION; DOMAIN; PARTICLES; STIMULATION	The fusion of intracellular membranes is driven by the formation of a highly stable four-helix bundle of SNARE proteins embedded in the vesicle and target membranes. N-Ethylmaleimide sensitive factor recycles SNAREs after fusion by binding to the SNARE complex through an adaptor protein, alpha SNAP, and using the energy of ATP hydrolysis to disassemble the complex. Although only a single molecule of alpha SNAP binds to a soluble form of the SNARE complex, we find that three molecules of alpha SNAP are used for SNARE complex disassembly. We describe an engineered alpha SNAP trimer that supports more efficient SNARE complex disassembly than monomeric alpha SNAP. Using the trimerized alpha SNAP, we find that N-ethylmaleimide-sensitive factor hydrolyzes 10 ATP molecules on average to disassemble a single SNARE complex.	[Shah, Niket; Colbert, Karen N.; Enos, Michael D.; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Shah, Niket; Colbert, Karen N.; Enos, Michael D.; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Enos, Michael/0000-0003-3208-7043	National Institutes of Health [R01 GM64798, R01 MH58570, T32 GM007276]; Canadian Institutes of Health Research Postdoctoral Fellowship; Stanford University Dean's Postdoctoral Fellowship; United States National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064798, T32GM007276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Stanford University Dean's Postdoctoral Fellowship; United States National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM64798 (to D. H.) and R01 MH58570 (to W. I. W.).; Supported by a Canadian Institutes of Health Research Postdoctoral Fellowship and a Stanford University Dean's Postdoctoral Fellowship.; Supported by a graduate fellowship from the United States National Science Foundation.; Supported by National Institutes of Health Training Grant T32 GM007276.	Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Buxbaum E, 1999, EUR J BIOCHEM, V265, P54, DOI 10.1046/j.1432-1327.1999.00643.x; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Cipriano DJ, 2013, J BIOL CHEM, V288, P23436, DOI 10.1074/jbc.M113.476705; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Matveeva E, 1998, FEBS LETT, V435, P211, DOI 10.1016/S0014-5793(98)01071-0; Matveeva EA, 2002, BIOCHEMISTRY-US, V41, P530, DOI 10.1021/bi015632s; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; MORGAN A, 1994, J BIOL CHEM, V269, P29347; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Papanikolopoulou K, 2004, J BIOL CHEM, V279, P8991, DOI 10.1074/jbc.M311791200; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steel GJ, 1998, FEBS LETT, V423, P113, DOI 10.1016/S0014-5793(98)00072-6; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Vivona S, 2013, J BIOL CHEM, V288, P24984, DOI 10.1074/jbc.M113.489807; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286	33	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2175	2188		10.1074/jbc.M114.620849	http://dx.doi.org/10.1074/jbc.M114.620849			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25492864	Green Published, hybrid			2022-12-28	WOS:000348588000022
J	Karlberg, T; Klepsch, M; Thorsell, AG; Andersson, CD; Linusson, A; Schuler, H				Karlberg, Tobias; Klepsch, Mirjam; Thorsell, Ann-Gerd; Andersson, C. David; Linusson, Anna; Schuler, Herwig			Structural Basis for Lack of ADP-ribosyltransferase Activity in Poly(ADP-ribose) Polymerase-13/Zinc Finger Antiviral Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; Molecular Dynamics; Post-translational Modification (PTM); Virus; X-ray Crystallography	CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; RNA HELICASE; FAMILY; PARP; ZAP; INHIBITION; SELECTION; COMPLEX; BINDING	Background: PARP13 contains a divergent PARP homology ADP-ribosyltransferase domain of unknown function. Results: The consensus NAD(+) pocket of PARP13 is occluded by interacting protein side chains. Conclusion: PARP13 lacks the structural requirements for NAD(+) binding. Significance: Evolutionary conservation of enzymatic inactivity suggests a need for a rigid domain structure. The mammalian poly(ADP-ribose) polymerase (PARP) family includes ADP-ribosyltransferases with diphtheria toxin homology (ARTD). Most members have mono-ADP-ribosyltransferase activity. PARP13/ARTD13, also called zinc finger antiviral protein, has roles in viral immunity and microRNA-mediated stress responses. PARP13 features a divergent PARP homology domain missing a PARP consensus sequence motif; the domain has enigmatic functions and apparently lacks catalytic activity. We used x-ray crystallography, molecular dynamics simulations, and biochemical analyses to investigate the structural requirements for ADP-ribosyltransferase activity in human PARP13 and two of its functional partners in stress granules: PARP12/ARTD12, and PARP15/BAL3/ARTD7. The crystal structure of the PARP homology domain of PARP13 shows obstruction of the canonical active site, precluding NAD(+) binding. Molecular dynamics simulations indicate that this closed cleft conformation is maintained in solution. Introducing consensus side chains in PARP13 did not result in 3-aminobenzamide binding, but in further closure of the site. Three-dimensional alignment of the PARP homology domains of PARP13, PARP12, and PARP15 illustrates placement of PARP13 residues that deviate from the PARP family consensus. Introducing either one of two of these side chains into the corresponding positions in PARP15 abolished PARP15 ADP-ribosyltransferase activity. Taken together, our results show that PARP13 lacks the structural requirements for ADP-ribosyltransferase activity.	[Karlberg, Tobias; Thorsell, Ann-Gerd; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden; [Karlberg, Tobias; Klepsch, Mirjam; Thorsell, Ann-Gerd; Schuler, Herwig] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Andersson, C. David; Linusson, Anna] Umea Univ, Dept Chem, S-90187 Umea, Sweden	Karolinska Institutet; Karolinska Institutet; Umea University	Schuler, H (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501	Structural Genomics Consortium from Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Swedish Society for Medical Research; Swedish Research Council; Umea University; Swedish Cancer Society; IngaBritt & Arne Lundbergs research foundation	Structural Genomics Consortium from Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Society for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University; Swedish Cancer Society(Swedish Cancer Society); IngaBritt & Arne Lundbergs research foundation	This work was supported by the Structural Genomics Consortium, a registered charity (Number 1097737) that received funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; Supported by a stipend from the Swedish Society for Medical Research.; Supported by the Swedish Research Council and Umea University.; Supported by the Swedish Foundation for Strategic Research, the Swedish Research Council, the Swedish Cancer Society, and IngaBritt & Arne Lundbergs research foundation. To whom correspondence should be addressed: Dept.of Medical Biochemistry and Biophysics, Karolinska lnstitutet, 17177 Stockholm, Sweden. Tel.: 46-8-52486840; Fax: 46-8-52486868; E-mail: herwig.schuler@ki.se.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Aguiar RCT, 2000, BLOOD, V96, P4328, DOI 10.1182/blood.V96.13.4328.h8004328_4328_4334; Andersson CD, 2012, J MED CHEM, V55, P7706, DOI 10.1021/jm300746d; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Blanc E., 2011, BUSTER VERSION 2 11; BLANKE SR, 1994, BIOCHEMISTRY-US, V33, P5155, DOI 10.1021/bi00183a019; Cagliani R, 2012, MOL BIOL EVOL, V29, P1599, DOI 10.1093/molbev/mss002; Case A.D., 2012, AMBER 12; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Chen SD, 2012, NAT STRUCT MOL BIOL, V19, P430, DOI 10.1038/nsmb.2243; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jeong MS, 2010, BIOCHEM BIOPH RES CO, V396, P696, DOI 10.1016/j.bbrc.2010.04.164; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlberg T, 2012, J BIOL CHEM, V287, P24077, DOI 10.1074/jbc.M112.379289; Karlberg T, 2010, J MED CHEM, V53, P5352, DOI 10.1021/jm100249w; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Leung AKL, 2012, RNA BIOL, V9, P542, DOI 10.4161/rna.19899; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Molecular Operating Environment (MOE), 2019, MOL OP ENV MOE; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Todorova T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6362; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044	53	45	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7336	7344		10.1074/jbc.M114.630160	http://dx.doi.org/10.1074/jbc.M114.630160			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635049	Green Published, hybrid			2022-12-28	WOS:000351613600002
J	Dohlman, HG				Dohlman, Henrik G.			Thematic Minireview Series: Cell Biology of G Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								This thematic series is on the topic of cell signaling from a cell biology perspective, with a particular focus on G proteins. G protein-coupled receptors (GPCRs, also known as seven-transmembrane receptors) are typically found at the cell surface. Upon agonist binding, these receptors will activate a GTP-binding G protein at the cytoplasmic face of the plasma membrane. Additionally, there is growing evidence that G proteins can also be activated by non-receptor binding partners, and they can signal from non-plasma membrane compartments. The production of second messengers at multiple, spatially distinct locations represents a type of signal encoding that has been largely neglected. The first minireview in the series describes biosensors that are being used to monitorGprotein signaling events in live cells. The second describes the implementation of antibody-based biosensors to dissect endosome signaling by G proteins and their receptors. The third describes the function of a nonreceptor, cytoplasmic activator of G protein signaling, called GIV (Girdin). Collectively, the advances described in these articles provide a deeper understanding and emerging opportunities for new pharmacology.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729				Clister T, 2015, J BIOL CHEM, V290, P6681, DOI 10.1074/jbc.R114.616391; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951	3	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6679	6680		10.1074/jbc.R114.631093	http://dx.doi.org/10.1074/jbc.R114.631093			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605716	hybrid, Green Published			2022-12-28	WOS:000350991500001
J	Larabee, JL; Krumholz, A; Hunt, JJ; Lanis, JM; Ballard, JD				Larabee, Jason L.; Krumholz, Aleze; Hunt, Jonathan J.; Lanis, Jordi M.; Ballard, Jimmy D.			Exposure of Neutralizing Epitopes in the Carboxyl-terminal Domain of TcdB Is Altered by a Proximal Hypervariable Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; TRANSLOCATION; INFECTION; CELLS; ANTIBODIES; FRAGMENTS; MECHANISM; CLEAVAGE; DISEASE; CYTOSOL	The sequence, activity, and antigenicity of TcdB varies between different strains of Clostridium difficile. As a result, ribotype-specific forms of TcdB exhibit different toxicities and are not strongly cross-neutralized. Using a combination of biochemical and immunological approaches, we compared two important variants of TcdB (TcdB(012) and TcdB(027)) to identify the mechanisms through which sequence differences alter epitopes and activity of the toxin. These analyses led to the discovery of a critical variation in the 1753-1851 (B2') region of Taal, which affects the exposure of neutralizing epitopes in the toxin, Sequence comparisons found that the B2' region exhibits only 77% identity and is the most variable sequence between the two forms of TcdB. A combination of biochemical, analytical, and rnutagenesis experiments revealed that the B2' region promotes protein-protein interactions. These interactions appear to shield neutralizing epitopes that would otherwise be exposed in the toxin, an event found to be less prominent in TcdB012 due to sequence differences in the 1773-1780 and 1791-1798 regions of the B2' domain. When the carboxyl-terminal domains of TcdB(027) and TcdB, are swapped, neutralization experiments suggest that the amino terminus of TcdB interacts with the B2' region and impacts the exposure of neutralizing epitopes in the carboxyl terminus. Collectively, these data suggest that variations in the B2' region affect protein-protein interactions within TcdB and that these interactions influence the exposure of neutralizing epitopes.	[Larabee, Jason L.; Krumholz, Aleze; Hunt, Jonathan J.; Lanis, Jordi M.; Ballard, Jimmy D.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ballard, JD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB 1053,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	jimmy-ballard@ouhsc.edu		Larabee, Jason/0000-0001-5757-7247	National Institutes of Health [R01HL084489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL084489 (to J. D. B.).	Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; Farrow MA, 2013, P NATL ACAD SCI USA, V110, P18674, DOI 10.1073/pnas.1313658110; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Hernandez L. D., 2014, ANTIMICROB AGENTS CH, DOI [101128/AAC.04433-04414, DOI 10.1128/AAC.04433-04414]; Humphreys DP, 2014, CLIN VACCINE IMMUNOL, V21, P913, DOI 10.1128/CVI.00116-14; Lanis JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003523; Lanis JM, 2012, MOL MICROBIOL, V84, P66, DOI 10.1111/j.1365-2958.2012.08009.x; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Leuzzi R, 2013, INFECT IMMUN, V81, P2851, DOI 10.1128/IAI.01341-12; Li S, 2013, PATHOG DIS, V67, P11, DOI 10.1111/2049-632X.12016; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Marsh JW, 2012, J CLIN MICROBIOL, V50, P4078, DOI 10.1128/JCM.02291-12; Musher DM, 2006, NEW ENGL J MED, V354, P1199; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 1997, FEMS MICROBIOL LETT, V148, P197, DOI 10.1016/S0378-1097(97)00033-5; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Sun XM, 2010, TOXINS, V2, P1848, DOI 10.3390/toxins2071848; Valiente E, 2014, CLIN MICROBIOL INFEC, V20, P396, DOI 10.1111/1469-0691.12619; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wohlan K, 2014, CELL MICROBIOL, V16, P1678, DOI 10.1111/cmi.12317; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zhang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058634; Zhang ZF, 2014, P NATL ACAD SCI USA, V111, P3721, DOI 10.1073/pnas.1400680111	34	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6975	6985		10.1074/jbc.M114.612184	http://dx.doi.org/10.1074/jbc.M114.612184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25614625	Green Published, hybrid			2022-12-28	WOS:000350991500031
J	Comeaux, EQ; Cuya, SM; Kojima, K; Jafari, N; Wanzeck, KC; Mobley, JA; Bjornsti, MA; van Waardenburg, RCAM				Comeaux, Evan Q.; Cuya, Selma M.; Kojima, Kyoko; Jafari, Nauzanene; Wanzeck, Keith C.; Mobley, James A.; Bjornsti, Mary-Ann; van Waardenburg, Robert C. A. M.			Tyrosyl-DNA Phosphodiesterase I Catalytic Mutants Reveal an Alternative Nucleophile That Can Catalyze Substrate Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; PHOSPHOLIPASE-D SUPERFAMILY; TOPOISOMERASE-I; ACTIVE-SITE; SPINOCEREBELLAR ATAXIA; SACCHAROMYCES-CEREVISIAE; COVALENT COMPLEXES; CRYSTAL-STRUCTURE; VERTEBRATE CELLS; TDP1	Tyrosyl-DNA phosphodiesterase I (Tdp1) catalyzes the repair of 3'-DNA adducts, such as the 3'-phosphotyrosyl linkage of DNA topoisomerase I to DNA. Tdp1 contains two conserved catalytic histidines: a nucleophilic His (His(nuc)) that attacks DNA adducts to form a covalent 3'-phosphohistidyl intermediate and a general acid/base His (His(gab)), which resolves the Tdp1-DNA linkage. A His(nuc) to Ala mutant protein is reportedly inactive, whereas the autosomal recessive neurodegenerative disease SCAN1 has been attributed to the enhanced stability of the Tdp1-DNA intermediate induced by mutation of His(gab) to Arg. However, here we report that expression of the yeast His(nuc)Ala (H182A) mutant actually induced topoisomerase I-dependent cytotoxicity and further enhanced the cytotoxicity of Tdp1 His(gab) mutants, including H432N and the SCAN1-related H432R. Moreover, the His(nuc)Ala mutant was catalytically active in vitro, albeit at levels 85-fold less than that observed with wild type Tdp1. In contrast, the His(nuc)Phe mutant was catalytically inactive and suppressed His(gab) mutant-induced toxicity. These data suggest that the activity of another nucleophile when His(nuc) is replaced with residues containing a small side chain (Ala, Asn, and Gln), but not with a bulky side chain. Indeed, genetic, biochemical, and mass spectrometry analyses show that a highly conserved His, immediately N-terminal to His(nuc), can act as a nucleophile to catalyze the formation of a covalent Tdp1-DNA intermediate. These findings suggest that the flexibility of Tdp1 active site residues may impair the resolution of mutant Tdp1 covalent phosphohistidyl intermediates and provide the ration-ale for developing chemotherapeutics that stabilize the covalent Tdp1-DNA intermediate.	[Comeaux, Evan Q.; Cuya, Selma M.; Wanzeck, Keith C.; Bjornsti, Mary-Ann; van Waardenburg, Robert C. A. M.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Kojima, Kyoko] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Jafari, Nauzanene] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital; University of Alabama System; University of Alabama Birmingham	van Waardenburg, RCAM (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, VH 155,1720 2nd Ave S, Birmingham, AL 35294 USA.	rvanwaar@uab.edu		Cuya, Selma/0000-0002-5842-0679; mobley, james/0000-0002-3229-7975	National Institutes of Health [CA58755]; NCI [5P30CA013148]; Alabama Drug Discovery Alliance; Comprehensive Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA058755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alabama Drug Discovery Alliance; Comprehensive Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA58755 (to M. A. B.) and NCI Grant 5P30CA013148. This work was also supported in part by funds from the Alabama Drug Discovery Alliance (to R. C. A. M. v. W.) and a Comprehensive Cancer Center Core Support Grant (to A. M. and K. K.).	Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; CHEN GL, 1984, J BIOL CHEM, V259, P3560; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Davies DR, 2003, CHEM BIOL, V10, P139, DOI 10.1016/S1074-5521(03)00021-8; Davies DR, 2002, J MOL BIOL, V324, P917, DOI 10.1016/S0022-2836(02)01154-3; Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; Gajewski S, 2012, J MOL BIOL, V415, P741, DOI 10.1016/j.jmb.2011.11.044; He XP, 2007, J MOL BIOL, V372, P1070, DOI 10.1016/j.jmb.2007.07.055; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Huang SYN, 2013, NUCLEIC ACIDS RES, V41, P7793, DOI 10.1093/nar/gkt483; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; Lebedeva NA, 2011, FEBS LETT, V585, P683, DOI 10.1016/j.febslet.2011.01.032; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Liu CY, 2004, DNA REPAIR, V3, P593, DOI 10.1016/j.dnarep.2004.03.030; LYNN RM, 1989, P NATL ACAD SCI USA, V86, P3559, DOI 10.1073/pnas.86.10.3559; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Murai J, 2012, J BIOL CHEM, V287, P12848, DOI 10.1074/jbc.M111.333963; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Raymond AC, 2004, J MOL BIOL, V338, P895, DOI 10.1016/j.jmb.2004.03.013; SAUER B, 1990, New Biologist, V2, P441; Schellenberg MJ, 2012, NAT STRUCT MOL BIOL, V19, P1363, DOI 10.1038/nsmb.2418; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Shi K, 2012, NAT STRUCT MOL BIOL, V19, P1372, DOI 10.1038/nsmb.2423; SIOUD M, 1989, BIOCHEMISTRY-US, V28, P3638, DOI 10.1021/bi00435a002; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Tumbale P, 2011, NAT STRUCT MOL BIOL, V18, P1189, DOI 10.1038/nsmb.2146; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Yang W, 2010, CRIT REV BIOCHEM MOL, V45, P520, DOI 10.3109/10409238.2010.513375; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170	47	10	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6203	6214		10.1074/jbc.M114.635284	http://dx.doi.org/10.1074/jbc.M114.635284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25609251	hybrid, Green Published			2022-12-28	WOS:000350732500028
J	Kondo, N; Marin, M; Kim, JH; Desai, TM; Melikyan, GB				Kondo, Naoyuki; Marin, Mariana; Kim, Jeong Hwa; Desai, Tanay M.; Melikyan, Gregory B.			Distinct Requirements for HIV-Cell Fusion and HIV-mediated Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIN CYTOSKELETON; MEMBRANE-FUSION; T-CELLS; CONFORMATIONAL-CHANGES; ENDOCYTIC PATHWAY; CYTOPLASMIC TAIL; PLASMA-MEMBRANE; DENDRITIC CELLS; PORE EXPANSION	Whether HIV-1 enters cells by fusing with the plasma membrane or with endosomes is a subject of active debate. The ability of HIV-1 to mediate fusion between adjacent cells, a process referred to as "fusion-from-without" (FFNX10), shows that this virus can fuse with the plasma membrane. To compare FTWO occurring at the cell surface with HIV-cell fusion through a conventional entry route, we designed an experimental approach that enabled the measurements of both processes in the same sample. The following key differences were observed. First, a very small fraction of viruses fusing with target cells participated in MVO. Second, whereas HIV-1 fusion with adherent cells was insensitive to actin inhibitors, post-C1)4/coreceptor binding steps during FTWO were abrogated. A partial dependence of HINT-cell fusion on actin remodeling was observed in CD4(+) T cells, but this effect appeared to be due to the actin dependence of virus uptake. Third, deletion of the cytoplasmic tail of HIV-1 gp41 dramatically enhanced the ability of the virus to promote FFWO, while having a modest effect on virus-cell fusion. Distinct efficiencies and actin dependences of ITWO versus HIVcell fusion are consistent with the notion that, except for a minor fraction of particles that mediate fusion between the plasma membranes of adjacent cells, HIV-1 enters through an endocytic pathway. We surmise, however, that cell-cell contacts enabling HIV-1 fusion with the plasma membrane could be favored at the sites of high density of target cells, such as lymph nodes.	[Kondo, Naoyuki; Marin, Mariana; Kim, Jeong Hwa; Desai, Tanay M.; Melikyan, Gregory B.] Emory Univ, Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA 30322 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat Infect Dis, Sch Med, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Kondo, Naoyuki/W-5845-2019	Kondo, Naoyuki/0000-0002-6624-5989	National Institutes of Health [R01 GM054787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM054787 (to G. B. M.).	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Anand AR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-2; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen A, 2008, J CELL SCI, V121, P3619, DOI 10.1242/jcs.032169; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Clotet-Codina I, 2009, ANTIVIR RES, V83, P94, DOI 10.1016/j.antiviral.2009.03.009; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Cureton DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001127; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Earl LA, 2013, TRENDS MICROBIOL, V21, P397, DOI 10.1016/j.tim.2013.06.004; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Forster MJ, 2000, J MOL BIOL, V298, P841, DOI 10.1006/jmbi.2000.3715; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Gobeil LA, 2013, J VIROL, V87, P735, DOI 10.1128/JVI.01802-12; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Harmon B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000956; Herold N, 2014, J VIROL, V88, P13956, DOI 10.1128/JVI.01543-14; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Janas AM, 2008, VIROLOGY, V375, P442, DOI 10.1016/j.virol.2008.01.044; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Matsuda Z., 2011, CURR PROTOC CELL BIO, V50, DOI [10.1002/0471143030.cb2609s50, DOI 10.1002/0471143030.CB2609S50]; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PELCHENMATTHEWS A, 1995, J VIROL, V69, P8164, DOI 10.1128/JVI.69.12.8164-8168.1995; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Platt EJ, 2014, J VIROL, V88, P4304, DOI 10.1128/JVI.03447-13; Pontow SE, 2004, J VIROL, V78, P7138, DOI 10.1128/JVI.78.13.7138-7147.2004; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; Richard JP, 2009, BBA-BIOMEMBRANES, V1788, P450, DOI 10.1016/j.bbamem.2008.09.014; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Sloan RD, 2013, J VIROL, V87, P8110, DOI 10.1128/JVI.00815-13; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Steffens CM, 2003, J VIROL, V77, P4985, DOI 10.1128/JVI.77.8.4985-4991.2003; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Tardif MR, 2005, J IMMUNOL, V175, P926, DOI 10.4049/jimmunol.175.2.926; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Teeranaipong P, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18723; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; van Wilgenburg B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086071; Vidricaire G, 2007, J MOL BIOL, V368, P1267, DOI 10.1016/j.jmb.2007.03.003; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; WEISS CD, 1993, J VIROL, V67, P7060, DOI 10.1128/JVI.67.12.7060-7066.1993; Weng J, 2009, J VIROL, V83, P7467, DOI 10.1128/JVI.00163-09; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Wurth MA, 2010, VIROLOGY, V404, P117, DOI 10.1016/j.virol.2010.04.024; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yoder A, 2011, J VIROL, V85, P3020, DOI 10.1128/JVI.02462-10; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	94	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6558	6573		10.1074/jbc.M114.623181	http://dx.doi.org/10.1074/jbc.M114.623181			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589785	Green Published, hybrid			2022-12-28	WOS:000350732500058
J	Yang, CH; Pfeffer, SR; Sims, M; Yue, JM; Wang, YN; Linga, VG; Paulus, E; Davidoff, AM; Pfeffer, LM				Yang, Chuan He; Pfeffer, Susan R.; Sims, Michelle; Yue, Junming; Wang, Yinan; Linga, Vijay G.; Paulus, Elena; Davidoff, Andrew M.; Pfeffer, Lawrence M.			The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; TARGETS; MIR-21; CANCER; MECHANISMS; EXPRESSION; LYMPHOMA; SURVIVAL; ONCOMIR; GROWTH	The microRNA miR-21 is overexpressed in most human cancers and accumulating evidence indicates that it functions as an oncogene. Since miRNAs suppress the expression of their target genes, we hypothesized that some miR-21 targets may act as tumor suppressors, and thus their expression would be anticipated to be reduced by the high miR-21 levels observed in various human cancers. By microarray analysis and quantitative PCR we identified and validated FBXO11 (a member of the F-box subfamily lacking a distinct unifying domain) as a miR-21 target gene. FBXO11 is a component of the SKP1-CUL1-F-box ubiquitin ligase complex that targets proteins for ubiquitination and proteosomal degradation. By loss of function and gain of function studies, we show that FBXO11 acts as a tumor suppressor, promotes apoptosis and mediates the degradation of the oncogenic protein BCL6. The critical role that FBXO11 plays in miR-21-mediated tumorigenesis was demonstrated by a rescue experiment, in which silencing FBXO11 in miR-21KD cancer cells restored their high tumorigenicity. Expression of miR-21 and FBXO11 are inversely correlated in tumor tissue, and their expression correlates with patient survival and tumor grade. High FBXO11 expression correlates with better patient survival and lower tumor grade consistent with its tumor suppressor activity. In contrast high miR-21 expression, which correlates with poor patient survival and higher tumor grade, is consistent with its oncogenic activity. Our results identify FBXO11 as a novel miR-21 target gene, and demonstrate that the oncogenic miRNA miR-21 decreases the expression of FBXO11, which normally acts as a tumor suppressor, and thereby promotes tumorigenesis.	[Yang, Chuan He; Pfeffer, Susan R.; Sims, Michelle; Yue, Junming; Wang, Yinan; Linga, Vijay G.; Davidoff, Andrew M.; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Paulus, Elena] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Yang, Chuan He; Pfeffer, Susan R.; Sims, Michelle; Yue, Junming; Wang, Yinan; Linga, Vijay G.; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Pfeffer, LM (corresponding author), Canc Res Bldg,19 South Manassas St Rm 154, Memphis, TN 38163 USA.	lpfeffer@uthsc.edu	Linga, Vijay G/M-5487-2015; Linga, Vijay Gandhi/AAC-6947-2019	Linga, Vijay G/0000-0001-8540-7296; Linga, Vijay Gandhi/0000-0001-8540-7296; Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322]; Department of Defense [W81XWH-11-1-0533]; Cancer Center Support Grant from the National Cancer Institute [21766]; Assisi Foundation of Memphis; Muirhead Chair Endowment of the UTHSC; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA133322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cancer Center Support Grant from the National Cancer Institute; Assisi Foundation of Memphis; Muirhead Chair Endowment of the UTHSC; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Institutes of Health CA133322 (to L. M. P. and A. M. D.), the Department of Defense W81XWH-11-1-0533 (to L. M. P.), the Cancer Center Support Grant 21766 from the National Cancer Institute and the Assisi Foundation of Memphis (to A. M. D.), by the Muirhead Chair Endowment (to L. M. P.) of the UTHSC and by the American Lebanese Syrian Associated Charities (to A. M. D.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hideshima T, 2010, BLOOD, V115, P3772, DOI 10.1182/blood-2010-02-270082; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Yang CH, 2014, J BIOL CHEM, V289, P25079, DOI 10.1074/jbc.M114.593863; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071130; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	27	81	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6037	6046		10.1074/jbc.M114.632125	http://dx.doi.org/10.1074/jbc.M114.632125			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589783	Green Published, hybrid			2022-12-28	WOS:000350732500015
J	Bai, XT; Nicot, C				Bai, Xue Tao; Nicot, Christophe			miR-28-3p Is a Cellular Restriction Factor That Inhibits Human T Cell Leukemia Virus, Type 1 (HTLV-1) Replication and Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAK-STAT PATHWAY; HIV-1 LATENCY; MICRORNAS; TAX; PROTEIN; DNA; PROLIFERATION; TRANSMISSION; LYMPHOCYTES; MECHANISMS	Human T cell leukemia virus, type 1 (HTLV-1) replication and spread are controlled by different viral and cellular factors. Although several anti-HIV cellular microRNAs have been described, such a regulation for HTLV-1 has not been reported. In this study, we found that miR-28-3p inhibits HTLV-1 virus expression and its replication by targeting a specific site within the genomic gag/pol viral mRNA. Because miR-28-3p is highly expressed in resting T cells, which are resistant to HTLV-1 infection, we investigated a potential protective role of miR-28-3p against de novo HTLV-1 infection. To this end, we developed a new sensitive and quantitative assay on the basis of the detection of products of reverse transcription. We demonstrate that miR-28-3p does not prevent virus receptor interaction or virus entry but, instead, induces a post-entry block at the reverse transcription level. In addition, we found that HTLV-1, subtype 1A isolates corresponding to the Japanese strain ATK-1 present a natural, single-nucleotide polymorphism within the miR-28-3p target site. As a result of this polymorphism, the ATK-1 virus sequence was not inhibited by miR-28. Interestingly, genetic studies on the transmission of the virus has shown that the ATK-1 strain, which carries a Thr-to-Cys transition mutation, is transmitted efficiently between spouses, suggesting that miR-28 may play an important role in HTLV-1 transmission.	[Nicot, Christophe] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; Ctr Viral Oncol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Nicot, C (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA.	cnicot@kumc.edu			NIAID/National Institutes of Health [AI058944]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER	NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIAID/National Institutes of Health Grant AI058944 (to C. N.).	Andresen V, 2011, BLOOD, V118, P1549, DOI 10.1182/blood-2010-06-293340; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; ASTIERGIN T, 1995, J VIROL METHODS, V51, P19, DOI 10.1016/0166-0934(94)00097-Z; Bangham CRM, 2009, FRONT BIOSCI-LANDMRK, V14, P2889, DOI 10.2741/3420; Baydoun HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042226; Baydoun HH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-302; Bazarbachi A, 2011, BLOOD, V118, P1736, DOI 10.1182/blood-2011-03-345702; Chaib-Mezrag H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-205; Chiang KR, 2012, VIRUSES-BASEL, V4, P1390, DOI 10.3390/v4091390; Clarke C. J. P., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P117, DOI 10.2174/1568008013341361; Detsika MG, 2012, AIDS REV, V14, P188; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; GESSAIN A, 1985, LANCET, V2, P407; Girardot M., 2014, ONCOGENE, DOI [10.1038/onc.2014.60, DOI 10.1038/0NC.2014.60]; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Gottwein E, 2013, CURR TOP MICROBIOL, V371, P201, DOI 10.1007/978-3-642-37765-5_8; Haller O, 2007, CURR TOP MICROBIOL, V316, P315; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hussenet T, 2006, CANCER GENET CYTOGEN, V169, P102, DOI 10.1016/j.cancergencyto.2006.03.009; Iga M, 2002, J INFECT DIS, V185, P691, DOI 10.1086/339002; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Jopling CL, 2006, COLD SPRING HARB SYM, V71, P369, DOI 10.1101/sqb.2006.71.022; Kirken RA, 2000, J IMMUNOL, V165, P5097, DOI 10.4049/jimmunol.165.9.5097; KITAMURA K, 1993, AIDS RES HUM RETROV, V9, P1167, DOI 10.1089/aid.1993.9.1167; Ko NL, 2013, BLOOD, V121, P791, DOI 10.1182/blood-2012-03-420414; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lei XF, 2010, CELL CYCLE, V9, P1225, DOI 10.4161/cc.9.7.11387; Malbec M, 2011, VIRUSES-BASEL, V3, P254, DOI 10.3390/v3030254; Matsuoka M, 2013, CURR OPIN VIROL, V3, P684, DOI 10.1016/j.coviro.2013.08.010; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Nicot C, 2000, MOL CELL BIOL, V20, P8580, DOI 10.1128/MCB.20.22.8580-8589.2000; Nicot C, 2004, NAT MED, V10, P197, DOI 10.1038/nm984; Pancewicz J, 2010, P NATL ACAD SCI USA, V107, P16619, DOI 10.1073/pnas.1010722107; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093374; PIQUE C, 1992, J VIROL, V66, P906, DOI 10.1128/JVI.66.2.906-913.1992; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rowan Aileen G, 2012, Leuk Res Treatment, V2012, P391953, DOI 10.1155/2012/391953; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Sampey Gavin C., 2012, Frontiers in Genetics, V3, P295, DOI 10.3389/fgene.2012.00295; Satou Y, 2010, J CLIN EXP HEMATOP, V50, P1, DOI 10.3960/jslrt.50.1; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Sun Le, 2012, Virologica Sinica, V27, P333, DOI 10.1007/s12250-012-3266-5; Swaminathan S, 2008, J CELL PHYSIOL, V216, P321, DOI 10.1002/jcp.21480; Tabakin-Fix Y, 2006, CARCINOGENESIS, V27, P673, DOI 10.1093/carcin/bgi274; Takemoto S, 2000, BLOOD, V95, P3939; Tomita M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-22; Watanabe T, 1997, INT J HEMATOL, V66, P257; Zhang H, 2009, INT J BIOCHEM CELL B, V41, P451, DOI 10.1016/j.biocel.2008.07.016	51	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5381	5390		10.1074/jbc.M114.626325	http://dx.doi.org/10.1074/jbc.M114.626325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568327	Green Published, hybrid			2022-12-28	WOS:000350044200012
J	Garenaux, E; Kanagawa, M; Tsuchiyama, T; Hori, K; Kanazawa, T; Goshima, A; Chiba, M; Yasue, H; Ikeda, A; Yamaguchi, Y; Sato, C; Kitajima, K				Garenaux, Estelle; Kanagawa, Mayumi; Tsuchiyama, Tomoyuki; Hori, Kazuki; Kanazawa, Takeru; Goshima, Ami; Chiba, Mitsuru; Yasue, Hiroshi; Ikeda, Akemi; Yamaguchi, Yoshiki; Sato, Chihiro; Kitajima, Ken			Discovery, Primary, and Crystal Structures and Capacitation-related Properties of a Prostate-derived Heparin-binding Protein WGA16 from Boar Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA; MEMBRANE MICRODOMAINS; LIPID RAFTS; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; ACROSOME REACTION; MAMMALIAN SPERM; LECTIN REVEALS; CELL-ADHESION; X-RAY	Mammalian sperm acquire fertility through a functional maturation process called capacitation, where sperm membrane molecules are drastically remodeled. In this study, we found that a wheat germ agglutinin (WGA)-reactive protein on lipid rafts, named WGA16, is removed from the sperm surface on capacitation. WGA16 is a prostate-derived seminal plasma protein that has never been reported and is deposited on the sperm surface in the male reproductive tract. Based on protein and cDNA sequences for purified WGA16, it is a homologue of human zymogen granule protein 16(ZG16) belonging to the Jacalin-relatedlectin(JRL) family in crystal and primary structures. A glycan array shows that WGA16 binds heparin through a basic patch containing Lys-53/Lys-73 residues but not the conventional lectin domain of the JRL family. WGA16 is glycosylated, contrary to other ZG16 members, and comparative mass spectrometry clearly shows its unique N-glycosylation profile among seminal plasma proteins. It has exposed GlcNAc and GalNAc residues without additional Gal residues. The GlcNAc/GalNAc residues can work as binding ligands for a sperm surface galactosyltransferase, which actuallygalactosylates WGA16 in situ in the presence of UDP-Gal. Interestingly, surface removal of WGA16 is experimentally induced by either UDP-Gal or heparin. In the crystal structure, N-glycosylated sites and a potential heparin-binding site face opposite sides. This geography of two functional sites suggest that WGA16 is deposited on the sperm surface through interaction between its N-glycans and the surface galactosyltransferase, whereas its heparin-binding domain may be involved in binding to sulfated glycosaminoglycans in the female tract, enabling removal of WGA16 from the sperm surface.	[Garenaux, Estelle; Tsuchiyama, Tomoyuki; Hori, Kazuki; Kanazawa, Takeru; Goshima, Ami; Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Kanagawa, Mayumi; Ikeda, Akemi; Yamaguchi, Yoshiki] RIKEN Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Tsuchiyama, Tomoyuki; Hori, Kazuki; Kanazawa, Takeru; Goshima, Ami; Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Chiba, Mitsuru] Hirosaki Univ, Grad Sch Hlth Sci, Hirosaki, Aomori 0368564, Japan; [Yasue, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Nagoya University; RIKEN; Nagoya University; Hirosaki University; National Institute of Agrobiological Sciences - Japan	Kitajima, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	kitajima@agr.nagoya-u.ac.jp	SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012; Chiba, Mitsuru/F-4882-2013; Yamaguchi, Yoshiki/N-5246-2015	Naganawa, Shinji/0000-0002-0214-613X; Chiba, Mitsuru/0000-0002-4514-7124; Yamaguchi, Yoshiki/0000-0003-0100-5439	Ministry of Education, Science, and Sports [22380187, 25292216, 21-09722, 23570133]; JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation Ministry of Education, Science, and Sports; CNRS; Japan Science and Technology Agency (JST) Strategic Japanese-French Cooperative Program on Marine Genome and Marine Biotechnology; Naito Foundation Subsidy for Promotion of Specific Research Projects; Grants-in-Aid for Scientific Research [25292216] Funding Source: KAKEN	Ministry of Education, Science, and Sports; JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation Ministry of Education, Science, and Sports; CNRS(Centre National de la Recherche Scientifique (CNRS)); Japan Science and Technology Agency (JST) Strategic Japanese-French Cooperative Program on Marine Genome and Marine Biotechnology; Naito Foundation Subsidy for Promotion of Specific Research Projects; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grants-in-Aid for Scientific Research (B) 22380187 and 25292216; Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows relating to JSPS Postdoctoral Fellowship for Foreign Researchers 21-09722 (to K. K. and E. G.); Grant-in-Aid for Scientific Research (C) 23570133 (to C. S.); the JSPS Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (to K. K.) from the Ministry of Education, Science, and Sports; the CNRS and Japan Science and Technology Agency (JST) Strategic Japanese-French Cooperative Program on Marine Genome and Marine Biotechnology (to K. K.); and a grant from the Naito Foundation Subsidy for Promotion of Specific Research Projects in 2012 (to E. G. and K. K.).	Adachi T, 2007, BIOCHEM BIOPH RES CO, V358, P848, DOI 10.1016/j.bbrc.2007.04.197; Adachi T, 2009, GLYCOCONJUGATE J, V26, P285, DOI 10.1007/s10719-008-9184-y; Ambatipudi KS, 2010, J PROTEOME RES, V9, P6605, DOI 10.1021/pr100786y; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Bourne Y, 1999, STRUCTURE, V7, P1473, DOI 10.1016/S0969-2126(00)88338-0; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Caballero I, 2009, INT J ANDROL, V32, P505, DOI 10.1111/j.1365-2605.2008.00887.x; CALVETE JJ, 1993, EUR J BIOCHEM, V218, P719, DOI 10.1111/j.1432-1033.1993.tb18426.x; Calvete JJ, 1996, FEBS LETT, V379, P207, DOI 10.1016/0014-5793(95)01513-2; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; Dapino DG, 2006, BIOL RES, V39, P631, DOI 10.4067/S0716-97602006000500006; De Jonge C, 2005, HUM REPROD UPDATE, V11, P205, DOI 10.1093/humupd/dmi010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flesch FM, 1999, BIOCHEM BIOPH RES CO, V262, P787, DOI 10.1006/bbrc.1999.1300; Flesch FM, 2001, J CELL SCI, V114, P3543; GADELLA BM, 1995, J CELL SCI, V108, P935; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; HARRIS JD, 1994, DNA SEQUENCE, V4, P361, DOI 10.3109/10425179409010186; HARRISON RAP, 1993, MOL REPROD DEV, V35, P197, DOI 10.1002/mrd.1080350214; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Kanagawa M, 2011, BIOCHEM BIOPH RES CO, V404, P201, DOI 10.1016/j.bbrc.2010.11.093; Kasekarn W, 2012, BIOCHEM BIOPH RES CO, V426, P356, DOI 10.1016/j.bbrc.2012.08.090; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; Kim SA, 2009, CANCER SCI, V100, P828, DOI 10.1111/j.1349-7006.2009.01106.x; Kleene R, 1999, EUR J CELL BIOL, V78, P79, DOI 10.1016/S0171-9335(99)80009-0; Kumazawa-Inoue K, 2012, GLYCOBIOLOGY, V22, P258, DOI 10.1093/glycob/cwr145; Larson JL, 1997, BIOL REPROD, V57, P442, DOI 10.1095/biolreprod57.2.442; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee Y, 2011, EXP MOL MED, V43, P291, DOI 10.3858/emm.2011.43.5.030; Lu QX, 1997, DEVELOPMENT, V124, P4121; Maehashi E, 2003, J BIOL CHEM, V278, P42050, DOI 10.1074/jbc.M307493200; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; MELENDREZ CS, 1994, MOL REPROD DEV, V39, P433, DOI 10.1002/mrd.1080390412; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakata D, 2000, BIOCHEM BIOPH RES CO, V273, P642, DOI 10.1006/bbrc.2000.2983; Nimtz M, 1999, EUR J BIOCHEM, V265, P703, DOI 10.1046/j.1432-1327.1999.00766.x; NOMOTO H, 1982, ARCH BIOCHEM BIOPHYS, V218, P335, DOI 10.1016/0003-9861(82)90352-6; Ohta K, 2000, ZYGOTE, V8, pS63; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Ohtsuki T, 1998, CALCIFIED TISSUE INT, V63, P167, DOI 10.1007/s002239900509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Rebeiz M, 1999, MOL REPROD DEV, V54, P379, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;379::AID-MRD8&gt;3.0.CO;2-8; Rodriguez-Martinez H, 2011, AM J REPROD IMMUNOL, V66, P11, DOI 10.1111/j.1600-0897.2011.01033.x; Sharma A, 2011, GLYCOBIOLOGY, V21, P23, DOI 10.1093/glycob/cwq128; Shur BD, 1993, CURR OPIN CELL BIOL, V5, P854, DOI 10.1016/0955-0674(93)90035-O; SHUR BD, 1982, J CELL BIOL, V95, P567, DOI 10.1083/jcb.95.2.567; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Snell WJ, 1996, CELL, V85, P629, DOI 10.1016/S0092-8674(00)81230-1; Suarez SS, 1996, J ANDROL, V17, P331; Subedi GP, 2012, PROTEIN EXPRES PURIF, V82, P197, DOI 10.1016/j.pep.2011.12.010; Tateno H, 2012, GLYCOBIOLOGY, V22, P210, DOI 10.1093/glycob/cwr130; THERIEN I, 1995, BIOL REPROD, V52, P1372, DOI 10.1095/biolreprod52.6.1372; Tienthai P, 2000, REPROD FERT DEVELOP, V12, P173, DOI 10.1071/RD00034; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Yamamura S, 1997, BIOCHEM BIOPH RES CO, V236, P218, DOI 10.1006/bbrc.1997.6933; Yanagimachi R., 1994, Zygote, V2, P371; Zhou YB, 2007, BIOCHEM BIOPH RES CO, V355, P679, DOI 10.1016/j.bbrc.2007.02.020	68	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5484	5501		10.1074/jbc.M114.635268	http://dx.doi.org/10.1074/jbc.M114.635268			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568322	Green Published, hybrid			2022-12-28	WOS:000350044200021
J	Bauer, C; Gobel, K; Nagaraj, N; Colantuoni, C; Wang, MX; Muller, U; Kremmer, E; Rottach, A; Leonhardt, H				Bauer, Christina; Goebel, Klaus; Nagaraj, Nagarjuna; Colantuoni, Christian; Wang, Mengxi; Mueller, Udo; Kremmer, Elisabeth; Rottach, Andrea; Leonhardt, Heinrich			Phosphorylation of TET Proteins Is Regulated via O-GlcNAcylation by the O-Linked N-Acetylglucosamine Transferase (OGT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; GLCNAC TRANSFERASE; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; COMPLEX; DIFFERENTIATION; DIOXYGENASE; 5-FORMYLCYTOSINE; HYDROXYLATION	TET proteins oxidize 5-methylcytosine to 5-hydroxymethyl-cytosine, 5-formylcytosine, and 5-carboxylcytosine and thus provide a possible means for active DNA demethylation in mammals. Although their catalytic mechanism is well characterized and the catalytic dioxygenase domain is highly conserved, the function of the regulatory regions (the N terminus and the low-complexity insert between the two parts of the dioxygenase domains) is only poorly understood. Here, we demonstrate that TET proteins are subject to a variety of post-translational modifications that mostly occur at these regulatory regions. We mapped TET modification sites at amino acid resolution and show for the first time that TET1, TET2, and TET3 are highly phosphorylated. The O-linked GlcNAc transferase, which we identified as a strong interactor with all three TET proteins, catalyzes the addition of a GlcNAc group to serine and threonine residues of TET proteins and thereby decreases both the number of phosphorylation sites and site occupancy. Interestingly, the different TET proteins display unique post-translational modification patterns, and some modifications occur in distinct combinations. In summary, our results provide a novel potential mechanism for TET protein regulation based on a dynamic interplay of phosphorylation and O-GlcNAcylation at the N terminus and the low-complexity insert region. Our data suggest strong cross-talk between the modification sites that could allow rapid adaption of TET protein localization, activity, or targeting due to changing environmental conditions as well as in response to external stimuli.	[Bauer, Christina; Goebel, Klaus; Colantuoni, Christian; Wang, Mengxi; Mueller, Udo; Rottach, Andrea; Leonhardt, Heinrich] Univ Munich, Bioctr, D-82152 Planegg Martinsried, Germany; [Nagaraj, Nagarjuna] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany; [Leonhardt, Heinrich] CIPSM, D-81377 Munich, Germany	University of Munich; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Rottach, A (corresponding author), Univ Munich, Bioctr, D-82152 Planegg Martinsried, Germany.	a.rottach@lmu.de	Leonhardt, Heinrich/B-2791-2014	Bauer, Christina/0000-0001-9511-2491	Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center [SFB 646/B10, SFB 1064/A17]; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS)	Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center(German Research Foundation (DFG)); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS)	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Collaborative Research Center Grants SFB 646/B10 and SFB 1064/A17.; Supported by the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cartron Pierre-Francois, 2013, Genes Cancer, V4, P235, DOI 10.1177/1947601913489020; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016627; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Huang Y, 2014, P NATL ACAD SCI USA, V111, P1361, DOI 10.1073/pnas.1322921111; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Jost KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026499; Kim M, 2014, HUM MOL GENET, V23, P657, DOI 10.1093/hmg/ddt453; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Konstandin N, 2011, LEUKEMIA, V25, P1649, DOI 10.1038/leu.2011.134; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langlois T, 2014, STEM CELLS, V32, P2084, DOI 10.1002/stem.1718; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062755; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Muller U, 2014, NUCLEIC ACIDS RES, V42, P8592, DOI 10.1093/nar/gku552; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Olivier-Van Stichelen S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00256; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140	59	83	85	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4801	4812		10.1074/jbc.M114.605881	http://dx.doi.org/10.1074/jbc.M114.605881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25568311	Green Published, hybrid			2022-12-28	WOS:000350042000022
J	Nolan, K; Kattamuri, C; Luedeke, DM; Angerman, EB; Rankin, SA; Stevens, ML; Zorn, AM; Thompson, TB				Nolan, Kristof; Kattamuri, Chandramohan; Luedeke, David M.; Angerman, Elizabeth B.; Rankin, Scott A.; Stevens, Mariana L.; Zorn, Aaron M.; Thompson, Thomas B.			Structure of Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1) INSIGHTS FOR THE FUNCTIONAL VARIABILITY ACROSS BONE MORPHOGENETIC PROTEIN (BMP) ANTAGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAN GENE-PRODUCT; RECEPTOR-BINDING; GENOMIC ANALYSIS; FAMILY; WNT; GREMLIN; MEMBER; DIFFERENTIATION; FIBROBLASTS; FOLLISTATIN	Bone morphogenetic proteins (BMPs) are antagonized through the action of numerous extracellular protein antagonists, including members from the differential screening-selected gene aberrative in neuroblastoma (DAN) family. In vivo, misregulation of the balance between BMP signaling and DAN inhibition can lead to numerous disease states, including cancer, kidney nephropathy, and pulmonary arterial hypertension. Despite this importance, very little information is available describing how DAN family proteins effectively inhibit BMP ligands. Furthermore, our understanding for how differences in individual DAN family members arise, including affinity and specificity, remains underdeveloped. Here, we present the structure of the founding member of the DAN family, neuroblastoma suppressor of tumorigenicity 1 (NBL1). Comparing NBL1 to the structure of protein related to Dan and Cerberus (PRDC), a more potent BMP antagonist within the DAN family, a number of differences were identified. Through a mutagenesis-based approach, we were able to correlate the BMP binding epitope in NBL1 with that in PRDC, where introduction of specific PRDC amino acids in NBL1 (A58F and S67Y) correlated with a gain-of-function inhibition toward BMP2 and BMP7, but not GDF5. Although NBL1(S67Y) was able to antagonize BMP7 as effectively as PRDC, NBL1(S67Y) was still 32-fold weaker than PRDC against BMP2. Taken together, this data suggests that alterations in the BMP binding epitope can partially account for differences in the potency of BMP inhibition within the DAN family.	[Nolan, Kristof; Kattamuri, Chandramohan; Luedeke, David M.; Angerman, Elizabeth B.; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Rankin, Scott A.; Stevens, Mariana L.; Zorn, Aaron M.] Univ Cincinnati, Perinatal Inst, Cincinnati Childrens Res Fdn, Cincinnati, OH 45229 USA; [Rankin, Scott A.; Stevens, Mariana L.; Zorn, Aaron M.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Thompson, TB (corresponding author), 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	tom.thompson@uc.edu		Thompson, Thomas/0000-0002-7041-5047	National Institutes of Health from the NIGMS [R01 GM084186]; National Institutes of Health from the NIDDK [R01 DK070858]; American Heart Association [14PRE20480142]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084186, R01GM114640] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health from the NIDDK; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084186 from the NIGMS (to T. B. T.) and Grant R01 DK070858 from the NIDDK, and American Heart Association Grant 14PRE20480142 (to K. N.).	Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Eimon PM, 2001, MECH DEVELOP, V107, P187, DOI 10.1016/S0925-4773(01)00462-2; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hung WT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096172; Kattamuri C, 2012, J MOL BIOL, V424, P313, DOI 10.1016/j.jmb.2012.10.003; Kattamuri C, 2012, PROTEIN EXPRES PURIF, V82, P389, DOI 10.1016/j.pep.2012.02.010; Kim AS, 2003, DEV BRAIN RES, V145, P159, DOI 10.1016/S0165-3806(03)00213-X; KONDO K, 1995, BIOCHEM BIOPH RES CO, V216, P209, DOI 10.1006/bbrc.1995.2612; Lintern KB, 2009, J BIOL CHEM, V284, P23159, DOI 10.1074/jbc.M109.025478; Nolan K, 2014, PROTEIN SCI, V23, P999, DOI 10.1002/pro.2485; Nolan K, 2013, STRUCTURE, V21, P1417, DOI 10.1016/j.str.2013.06.005; Ohtori S, 2002, NEUROSCIENCE, V110, P579, DOI 10.1016/S0306-4522(01)00590-5; OZAKI T, 1995, CANCER RES, V55, P895; Ozaki T, 1997, DNA CELL BIOL, V16, P1031, DOI 10.1089/dna.1997.16.1031; OZAKI T, 1994, CANCER RES, V54, P646; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sidis Y, 2005, ENDOCRINOLOGY, V146, P130, DOI 10.1210/en.2004-1041; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Tamminen JA, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.29; Tanwar V, 2014, STEM CELLS, V32, P1774, DOI 10.1002/stem.1703; Tardif G, 2009, OSTEOARTHR CARTILAGE, V17, P263, DOI 10.1016/j.joca.2008.06.022; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang YL, 2009, BIOCHEM BIOPH RES CO, V383, P1, DOI 10.1016/j.bbrc.2009.03.086	41	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4759	4771		10.1074/jbc.M114.628412	http://dx.doi.org/10.1074/jbc.M114.628412			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561725	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000350042000019
J	Shibata, H; Kanadome, T; Sugiura, H; Yokoyama, T; Yamamuro, M; Moss, SE; Maki, M				Shibata, Hideki; Kanadome, Takashi; Sugiura, Hirofumi; Yokoyama, Takeru; Yamamuro, Minami; Moss, Stephen E.; Maki, Masatoshi			A New Role for Annexin A11 in the Early Secretory Pathway via Stabilizing Sec31A Protein at the Endoplasmic Reticulum Exit Sites (ERES)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED ISOFORM; ALG-2; CALCIUM; COPII; TRANSPORT; LOCALIZATION; ORGANIZATION; EXPORT; ALIX; BINDING	Exit of cargo molecules from the endoplasmic reticulum (ER) for transport to the Golgi is the initial step in intracellular vesicular trafficking. The coat protein complex II (COPII) machinery is recruited to specialized regions of the ER, called ER exit sites (ERES), where it plays a central role in the early secretory pathway. It has been known for more than two decades that calcium is an essential factor in vesicle trafficking from the ER to Golgi apparatus. However, the role of calcium in the early secretory pathway is complicated and poorly understood. We and others previously identified Sec31A, an outer cage component of COPII, as an interacting protein for the penta-EF-hand calcium-binding protein ALG-2. In this study, we show that another calcium-binding protein, annexin A11 (AnxA11), physically associates with Sec31A by the adaptor function of ALG-2. Depletion of AnxA11 or ALG-2 decreases the population of Sec31A that is stably associated with the ERES and causes scattering of juxta-nuclear ERES to the cell periphery. The synchronous ER-to-Golgi transport of transmembrane cargoes is accelerated in AnxA11- or ALG-2-knockdown cells. These findings suggest that AnxA11 maintains architectural and functional features of the ERES by coordinating with ALG-2 to stabilize Sec31A at the ERES.	[Shibata, Hideki; Kanadome, Takashi; Sugiura, Hirofumi; Yokoyama, Takeru; Yamamuro, Minami; Maki, Masatoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Moss, Stephen E.] UCL, Dept Cell Biol, UCL Inst Ophthalmol, London EC1V 9EL, England	Nagoya University; University of London; University College London	Shibata, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	shibabou@agr.nagoya-u.ac.jp	Maki, Masatoshi/AAM-6839-2021	Maki, Masatoshi/0000-0001-9144-5491; Kanadome, Takashi/0000-0002-8851-4780	Uehara Memorial Foundation; Toyoaki Scholarship Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24580138, 23380056]; Japan Society for the Promotion of Science	Uehara Memorial Foundation(Uehara Memorial Foundation); Toyoaki Scholarship Foundation(Toyoaki Scholarship Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Uehara Memorial Foundation (to H. S.), the Toyoaki Scholarship Foundation (to H. S.), Grant-in-aid for Scientific Research (C) 24580138 (to H. S.), and Grant-in aid for Scientific Research (B) 23380056 (to M. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Recipient of Japan Society for the Promotion of Science Research Fellowship for Young Scientists (DC1).	ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arasaki K, 2006, MOL BIOL CELL, V17, P2780, DOI 10.1091/mbc.E05-10-0973; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BECKERS CJM, 1990, J BIOL CHEM, V265, P18298; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhattacharyya D, 2007, MOL BIOL CELL, V18, P839, DOI 10.1091/mbc.E06-08-0707; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200; Inuzuka T, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-25; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; OSBORN M, 2006, CELL BIOL LAB HDB, P549; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; PIND SN, 1994, J CELL BIOL, V125, P239, DOI 10.1083/jcb.125.2.239; Satoh H, 2002, BIOCHEM BIOPH RES CO, V291, P1166, DOI 10.1006/bbrc.2002.6600; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Tomas A, 2004, J CELL BIOL, V165, P813, DOI 10.1083/jcb.200311054; Tomas A, 2003, J BIOL CHEM, V278, P20210, DOI 10.1074/jbc.M212669200; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	54	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4981	4993		10.1074/jbc.M114.592089	http://dx.doi.org/10.1074/jbc.M114.592089			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540196	Green Published, hybrid			2022-12-28	WOS:000350042000040
J	Bhat, KP; Betous, R; Cortez, D				Bhat, Kamakoti P.; Betous, Remy; Cortez, David			High-affinity DNA-binding Domains of Replication Protein A (RPA) Direct SMARCAL1-dependent Replication Fork Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNO-OSSEOUS DYSPLASIA; SINGLE-STRANDED-DNA; HELICASE ACTIVITY; GENOME STABILITY; REPAIR; SMARCAL1; MECHANISM; SUBSTRATE; RECG; STIMULATION	SMARCAL1 catalyzes replication fork remodeling to maintain genome stability. It is recruited to replication forks via an interaction with replication protein A (RPA), the major ssDNA-binding protein in eukaryotic cells. In addition to directing its localization, RPA also activates SMARCAL1 on some fork substrates but inhibits it on others, thereby conferring substrate specificity to SMARCAL1 fork-remodeling reactions. We investigated the mechanism by which RPA regulates SMARCAL1. Our results indicate that although an interaction between SMARCAL1 and RPA is essential for SMARCAL1 activation, the location of the interacting surface on RPA is not. Counter-intuitively, high-affinity DNA binding of RPA DNA-binding domain (DBD) A and DBD-B near the fork junction makes it easier for SMARCAL1 to remodel the fork, which requires removing RPA. We also found that RPA DBD-C and DBD-D are not required for SMARCAL1 regulation. Thus, the orientation of the high-affinity RPA DBDs at forks dictates SMARCAL1 substrate specificity.	[Bhat, Kamakoti P.; Betous, Remy; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Bétous, Rémy/P-2355-2014; Bétous, Rémy/ABF-4789-2020; Classen, Scott/AAY-8176-2020; Bhat, Kamakoti/L-3613-2019	Bétous, Rémy/0000-0003-0518-1763; Bhat, Kamakoti/0000-0001-7425-8336	Structural Biology of DNA Repair Machines Grant from the National Institutes of Health [P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA136933] Funding Source: NIH RePORTER	Structural Biology of DNA Repair Machines Grant from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Miaw-Sheue Tsai for the production of baculovirus to purify SMARCAL1 proteins (supported by Structural Biology of DNA Repair Machines Grant P01CA092584 from the National Institutes of Health). We also thank Dr. Marc S. Wold (University of Iowa) for all of the purified RPA proteins used in this study.	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 2000, J BIOL CHEM, V275, P27332; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Borgstahl GEO, 2014, DNA REPAIR, V21, P12, DOI 10.1016/j.dnarep.2014.05.005; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Carroll C, 2013, PEDIATR BLOOD CANCER, V60, pE88, DOI 10.1002/pbc.24542; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Delagoutte E, 2011, BIOCHEMISTRY-US, V50, P932, DOI 10.1021/bi101583e; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Elizondo LI, 2009, J MED GENET, V46, P49, DOI 10.1136/jmg.2008.060095; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; Hass CS, 2012, J BIOL CHEM, V287, P3908, DOI 10.1074/jbc.M111.287441; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Kolpashchikov DM, 2001, NUCLEIC ACIDS RES, V29, P373, DOI 10.1093/nar/29.2.373; Lavrik OI, 1999, NUCLEIC ACIDS RES, V27, P4235, DOI 10.1093/nar/27.21.4235; Machwe A, 2011, J BIOL CHEM, V286, P3497, DOI 10.1074/jbc.M110.105411; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Ranalli TA, 2002, J BIOL CHEM, V277, P1719, DOI 10.1074/jbc.M109053200; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Sommers JA, 2014, J BIOL CHEM, V289, P19928, DOI 10.1074/jbc.M113.542456; Suhasini AN, 2009, J BIOL CHEM, V284, P18458, DOI 10.1074/jbc.M109.012229; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	45	39	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4110	4117		10.1074/jbc.M114.627083	http://dx.doi.org/10.1074/jbc.M114.627083			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25552480	hybrid, Green Published			2022-12-28	WOS:000349458400022
J	Wang, XY; Li, M; Wang, ZQ; Han, SC; Tang, XH; Ge, YX; Zhou, LQ; Zhou, CC; Yuan, QP; Yang, M				Wang, Xinyu; Li, Meng; Wang, Zhiqiong; Han, Sichong; Tang, Xiaohu; Ge, Yunxia; Zhou, Liqing; Zhou, Changchun; Yuan, Qipeng; Yang, Ming			Silencing of Long Noncoding RNA MALAT1 by miR-101 and miR-217 Inhibits Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; RISK-FACTORS; LUNG-CANCER; ADENOCARCINOMA; MICRORNA-101; TARGET; METASTASIS	MALAT1, a highly conserved long noncoding RNA, is deregulated in several types of cancers. However, its role in esophageal squamous cell carcinoma (ESCC) and its posttranscriptional regulation remain poorly understood. In this study we provide first evidences that a posttranscriptional regulation mechanism of MALAT1 by miR-101 and miR-217 exists in ESCC cells. This posttranscriptional silencing of MALAT1 could significantly suppress the proliferation of ESCC cells through the arrest of G(2)/M cell cycle, which may be due to MALAT1-mediated up-regulation of p21 and p27 expression and the inhibition of B-MYB expression. Moreover, we also found the abilities of migration and invasion of ESCC cells were inhibited after overexpression of miR-101, miR-217, or MALAT1 siRNA. This might be attributed to the deregulation of downstream genes of MALAT1, such as MIA2, HNF4G, ROBO1, CCT4, and CTHRC1. A significant negative correlation exists between miR-101 or miR-217 and MALAT1 in 42 pairs of ESCC tissue samples and adjacent normal tissues. Mice xenograft data also support the tumor suppressor role of both miRNAs in ESCCs.	[Wang, Xinyu; Li, Meng; Wang, Zhiqiong; Han, Sichong; Tang, Xiaohu; Ge, Yunxia; Yuan, Qipeng; Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Lab Biomed Mat, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China; [Zhou, Liqing] Huaian 2 Hosp, Dept Radiat Oncol, Huaian 223002, Jiangsu, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Shandong Canc Hosp, Clin Lab, Jinan 250117, Shandong, Peoples R China	Beijing University of Chemical Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Yang, M (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, POB 53, Beijing 100029, Peoples R China.	yangm@mail.buct.edu.cn	Yang, Ming/G-4705-2012; , CC. Zhou/AGI-1229-2022	Yang, Ming/0000-0002-7722-7487; 	National Natural Science Foundation of China [31271382, 91229126, 81201586]; National High-Tech Research and Development Program of China [SS2015AA020950]; Beijing Higher Education Young Elite Teacher Project [YETP0521]; Fundamental Research Funds for the Central Universities [YS1407]; open project of State Key Laboratory of Molecular Oncology [SKL-KF-2013-03]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Higher Education Young Elite Teacher Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); open project of State Key Laboratory of Molecular Oncology; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Natural Science Foundation of China Grants 31271382, 91229126, and 81201586, National High-Tech Research and Development Program of China Grant SS2015AA020950, Beijing Higher Education Young Elite Teacher Project YETP0521, the Fundamental Research Funds for the Central Universities (YS1407), the open project of State Key Laboratory of Molecular Oncology (SKL-KF-2013-03, and the Program for Changjiang Scholars and Innovative Research Team in University (IRT13045).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han YH, 2013, FEBS LETT, V587, P3875, DOI 10.1016/j.febslet.2013.10.023; HU JF, 1994, INT J CANCER, V57, P38, DOI 10.1002/ijc.2910570108; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Leucci E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02535; Li H, 2013, NEOPLASMA, V60, P511, DOI 10.4149/neo_2013_066; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ren SC, 2013, J UROLOGY, V190, P2278, DOI 10.1016/j.juro.2013.07.001; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang HJ, 2010, EUR J CANCER, V46, P2295, DOI 10.1016/j.ejca.2010.05.012; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhou CC, 2011, FEBS LETT, V585, P1828, DOI 10.1016/j.febslet.2011.04.040; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331	42	253	269	1	78	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3925	3935		10.1074/jbc.M114.596866	http://dx.doi.org/10.1074/jbc.M114.596866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538231	hybrid, Green Published			2022-12-28	WOS:000349458400004
J	Ednie, AR; Bennett, ES				Ednie, Andrew R.; Bennett, Eric S.			Reduced Sialylation Impacts Ventricular Repolarization by Modulating Specific K+ Channel Isoforms Distinctly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiomyocyte; Glycosylation; Patch Clamp; Potassium Channel; Sialic Acid; Sialyltransferase; Action Potential; Arrhythmia; Ion Channel Gating	POLYUNSATURATED FATTY-ACIDS; ADULT-MOUSE VENTRICLES; CARDIAC ION CHANNELS; SIALIC-ACID; LINKED GLYCOSYLATION; MOLECULAR PHYSIOLOGY; CONGENITAL DISORDERS; SURFACE EXPRESSION; TARGETED DELETION; MAMMALIAN BRAIN	Background: Glycosylation results from the coordinated activities of glycogene products that can modulate ion channel function. Results: Gene ablation of the sialyltransferase ST3Gal4 impacts sialylation and gating of specific cardiac voltage-gated K+ channel isoforms and thereby ventricular repolarization. Conclusion: Individual glycogene products serve unique roles in affecting cardiac voltage-gated K+ channel activity. Significance: Protein glycosylation significantly contributes to ventricular electrical signaling. Voltage-gated K+ channels (K-v) are responsible for repolarizing excitable cells and can be heavily glycosylated. Cardiac K-v activity is indispensable where even minimal reductions in function can extend action potential duration, prolong QT intervals, and ultimately contribute to life-threatening arrhythmias. Diseases such as congenital disorders of glycosylation often cause significant cardiac phenotypes that can include arrhythmias. Here we investigated the impact of reduced sialylation on ventricular repolarization through gene deletion of the sialyltransferase ST3Gal4. ST3Gal4-deficient mice (ST3Gal4(-/-)) had prolonged QT intervals with a concomitant increase in ventricular action potential duration. Ventricular apex myocytes isolated from ST3Gal4(-/-) mice demonstrated depolarizing shifts in activation gating of the transient outward (I-to) and delayed rectifier (I-Kslow) components of K+ current with no change in maximum current densities. Consistently, similar protein expression levels of the three K-v isoforms responsible for I-to and I-Kslow were measured for ST3Gal4(-/-)versus controls. However, novel non-enzymatic sialic acid labeling indicated a reduction in sialylation of ST3Gal4(-/-) ventricular K(v)4.2 and K(v)1.5, which contribute to I-to and I-Kslow, respectively. Thus, we describe here a novel form of regulating cardiac function through the activities of a specific glycogene product. Namely, reduced ST3Gal4 activity leads to a loss of isoform-specific K-v sialylation and function, thereby limiting K-v activity during the action potential and decreasing repolarization rate, which likely contributes to prolonged ventricular repolarization. These studies elucidate a novel role for individual glycogene products in contributing to a complex network of cardiac regulation under normal and pathologic conditions.	[Ednie, Andrew R.; Bennett, Eric S.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Bennett, ES (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, MDC 8,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	esbennet@health.usf.edu			National Institutes of Health from NHLBI [1R01HL102171]; National Science Foundation [IOS-1146882, CMMI-1266331]; James and Esther King Florida Biomedical Research Program [09KW-04]; American Heart Association, Greater Southeast Affiliate [14GRNT20450148]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102171] Funding Source: NIH RePORTER; Directorate For Engineering [1266331] Funding Source: National Science Foundation	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); James and Esther King Florida Biomedical Research Program; American Heart Association, Greater Southeast Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by National Institutes of Health Grant 1R01HL102171 from NHLBI. This work was also supported in part by Research Grants IOS-1146882 and CMMI-1266331 from the National Science Foundation; Challenge Grant 09KW-04 from the James and Esther King Florida Biomedical Research Program; and Grant 14GRNT20450148 from the American Heart Association, Greater Southeast Affiliate.	Abbott GW, 2006, CURR PHARM DESIGN, V12, P3631, DOI 10.2174/138161206778522065; Aimond F, 2005, CIRC RES, V96, P451, DOI 10.1161/01.RES.0000156890.25876.63; Antzelevitch C, 2003, J CARDIOVASC ELECTR, V14, P1259, DOI 10.1046/j.1540-8167.2003.03316.x; Belanger MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024874; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Bustamante JM, 2005, INT J CARDIOL, V102, P211, DOI 10.1016/j.ijcard.2004.05.014; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Carchon HA, 2004, CLIN CHEM, V50, P101, DOI 10.1373/clinchem.2003.021568; Chandrasekhar KD, 2011, J PHYSIOL-LONDON, V589, P3721, DOI 10.1113/jphysiol.2011.211284; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Clancy CE, 2002, J CLIN INVEST, V110, P1075, DOI 10.1172/JCI200216945; Ednie AR, 2013, J MOL CELL CARDIOL, V59, P117, DOI 10.1016/j.yjmcc.2013.02.013; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; FERMINI B, 1991, AM J PHYSIOL, V260, pH735, DOI 10.1152/ajpheart.1991.260.3.H735; Freeman LC, 2000, J MEMBRANE BIOL, V177, P65, DOI 10.1007/s002320001100; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Hall MK, 2011, FEBS LETT, V585, P3322, DOI 10.1016/j.febslet.2011.09.021; HRYSHKO LV, 1993, BIOCHIM BIOPHYS ACTA, V1151, P35, DOI 10.1016/0005-2736(93)90068-B; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Johnson D, 2006, J BIOL CHEM, V281, P25875, DOI 10.1074/jbc.M605060200; Jones DK, 2008, CHANNELS, V2, P70, DOI 10.4161/chan.2.2.6000; JOZIASSE DH, 1985, J BIOL CHEM, V260, P4941; Key JA, 2012, BIOCONJUGATE CHEM, V23, P363, DOI 10.1021/bc200276k; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Kodirov SA, 2004, AM J PHYSIOL-HEART C, V286, pH368, DOI 10.1152/ajpheart.00303.2003; Kohler JJ, 2009, CHEMBIOCHEM, V10, P2147, DOI 10.1002/cbic.200900401; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Kratz EM, 2014, ALCOHOL ALCOHOLISM, V49, P23, DOI 10.1093/alcalc/agt152; Laedermann CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00137; LANGER GA, 1976, SCIENCE, V193, P1013, DOI 10.1126/science.948758; Li HL, 2004, AM J PHYSIOL-HEART C, V286, pH319, DOI 10.1152/ajpheart.00665.2003; Marengo FD, 1998, J MOL CELL CARDIOL, V30, P127, DOI 10.1006/jmcc.1997.0579; Martin PT, 2003, GLYCOBIOLOGY, V13, p67R, DOI 10.1093/glycob/cwg077; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Nacher J, 2010, NEUROSCIENCE, V167, P825, DOI 10.1016/j.neuroscience.2010.02.067; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Niwa N, 2008, J MOL CELL CARDIOL, V44, P95, DOI 10.1016/j.yjmcc.2007.10.007; Norring SA, 2013, FASEB J, V27, P622, DOI 10.1096/fj.12-214387; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Oudit GY, 2001, J MOL CELL CARDIOL, V33, P851, DOI 10.1006/jmcc.2001.1376; Pearl PL, 2001, J CHILD NEUROL, V16, P409, DOI 10.1177/088307380101600604; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Schwalbe RA, 2008, BIOCHEM CELL BIOL, V86, P21, DOI 10.1139/o07-152; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Schwetz TA, 2010, BBA-BIOMEMBRANES, V1798, P367, DOI 10.1016/j.bbamem.2009.11.018; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; Stocker PJ, 2006, J GEN PHYSIOL, V127, P253, DOI 10.1085/jgp.200509423; Taha AY, 2010, EPILEPSIA, V51, P1348, DOI 10.1111/j.1528-1167.2010.02654.x; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Todorovic SM, 2014, PFLUG ARCH EUR J PHY, V466, P701, DOI 10.1007/s00424-014-1452-z; Tristani-Firouzi M, 2001, AM J MED, V110, P50, DOI 10.1016/S0002-9343(00)00623-9; Tyrrell L, 2001, J NEUROSCI, V21, P9629, DOI 10.1523/JNEUROSCI.21-24-09629.2001; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Ufret-Vincenty CA, 2001, AM J PHYSIOL-CELL PH, V281, pC464, DOI 10.1152/ajpcell.2001.281.2.C464; VanWagoner DR, 1997, CIRC RES, V80, P772; Vijay IK, 1998, J MAMMARY GLAND BIOL, V3, P325, DOI 10.1023/A:1018771628925; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Xiao YF, 2005, J MEMBRANE BIOL, V206, P141, DOI 10.1007/S00232-005-0786-Z; Xu HD, 1996, J GEN PHYSIOL, V108, P405, DOI 10.1085/jgp.108.5.405; Yacoub S, 2008, HEART, V94, P244, DOI 10.1136/hrt.2007.132316; Yang KC, 2010, J PHYSIOL-LONDON, V588, P5015, DOI 10.1113/jphysiol.2010.197418; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]; Zhang L, 2007, AM J PHYSIOL-CELL PH, V293, pC152, DOI 10.1152/ajpcell.00480.2006	76	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2769	2783		10.1074/jbc.M114.605139	http://dx.doi.org/10.1074/jbc.M114.605139			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525262	hybrid, Green Published			2022-12-28	WOS:000349310700019
J	Kurano, M; Tsukamoto, K; Hara, M; Ohkawa, R; Ikeda, H; Yatomi, Y				Kurano, Makoto; Tsukamoto, Kazuhisa; Hara, Masumi; Ohkawa, Ryunosuke; Ikeda, Hitoshi; Yatomi, Yutaka			LDL Receptor and ApoE Are Involved in the Clearance of ApoM-associated Sphingosine 1-Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; RESIDUAL CARDIOVASCULAR RISK; APOLIPOPROTEIN-M; ENDOTHELIAL-CELLS; HDL; PLASMA; CHOLESTEROL; S1P; OVEREXPRESSION; METABOLISM	Sphingosine 1-phosphate (S1P) is a vasoactive lipid mediator that is speculated to be involved in various aspects of atherosclerosis. About 70% of circulating plasma S1P is carried on HDL, and several pleiotropic properties of HDL have been ascribed to S1P. In the previous study with human subjects, however, LDL, cholesterol or apoB, but not HDL cholesterol or apoA-I, had a significant positive correlation with the plasma SIP level, suggesting that the metabolic pathway for LDL might have some roles in the metabolism of SIP. In this study, we analyzed the association between LDL, receptor, an important protein in the clearance of LDL, and circulating SIP. We observed that in LDL, receptor-overexpressing mice, the plasma SIP levels as well as apolipoprotein M (apoM), a carrier of SIP, were decreased and that exogenously administered C(17)S1P bound to apoM-containing lipoproteins was cleared more rapidly. Unlike the situation in wild-type mice, LDL, receptor overexpression in apoE-deficient mice did not reduce the plasma SIP or apoM levels, suggesting that apoE might be a ligand for the LDL. receptor during the clearance of these factors. The present findings clarify the novel roles of the LDL receptor and apoL in the clearance of S1P, a multifunctional bioactive phospholipid.	[Kurano, Makoto; Ikeda, Hitoshi; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, Tokyo 1138655, Japan; [Tsukamoto, Kazuhisa] Fukushima Med Univ, Aizu Med Ctr, Dept Metab Diabet & Nephrol, Aizu Wakamatsu, Fukushima 9693482, Japan; [Ohkawa, Ryunosuke; Ikeda, Hitoshi; Yatomi, Yutaka] Tokyo Univ Hosp, Dept Clin Lab, Bunkyo Ku, Tokyo 1138655, Japan; [Hara, Masumi] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Med 4,Takatsu Ku, Kawasaki, Kanagawa 2130001, Japan	University of Tokyo; University of Tokyo; Teikyo University	Yatomi, Y (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	yatoyuta-tky@umin.ac.jp	Ohkawa, Ryunosuke/C-5402-2017	Ohkawa, Ryunosuke/0000-0002-8584-133X; Yatomi, Yutaka/0000-0003-1719-4297	Japan Society for the Promotion of Science KAKENHI [22249017, 25253040, 25860740]; CREST from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 22249017 and 25253040 (to Y. Y.) and 25860740 (to M. K.) and CREST from the Japan Science and Technology Agency.	Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Argraves KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-70; Axler O, 2007, J LIPID RES, V48, P1772, DOI 10.1194/jlr.M700113-JLR200; Brewer HB, 2011, J CLIN ENDOCR METAB, V96, P1246, DOI 10.1210/jc.2010-0163; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Christoffersen C, 2012, J LIPID RES, V53, P2198, DOI 10.1194/jlr.P023697; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Christoffersen C, 2010, CIRC RES, V106, P1624, DOI 10.1161/CIRCRESAHA.109.211086; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Goetzl EJ, 2001, PROSTAG OTH LIPID M, V64, P11, DOI 10.1016/S0090-6980(01)00104-6; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Iacob AO, 2012, CURR OPIN LIPIDOL, V23, P172, DOI 10.1097/MOL.0b013e32835135bd; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013; Kappelle PJWH, 2010, ATHEROSCLEROSIS, V213, P247, DOI 10.1016/j.atherosclerosis.2010.07.048; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kowalski GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072449; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Kurano M, 2012, J LIPID RES, V53, P2275, DOI 10.1194/jlr.M026575; Kurano M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-134; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Ohkawa R, 2008, ANN CLIN BIOCHEM, V45, P356, DOI 10.1258/acb.2007.007189; Okajima F, 2002, BBA-MOL CELL BIOL L, V1582, P132, DOI 10.1016/S1388-1981(02)00147-6; Rodriguez C, 2009, THROMB HAEMOSTASIS, V101, P665, DOI 10.1160/TH08-10-0675; Rosales C, 2011, ARTERIOSCL THROM VAS, V31, P1834, DOI 10.1161/ATVBAHA.111.224360; Sampson UK, 2012, CURR ATHEROSCLER REP, V14, P1, DOI 10.1007/s11883-011-0219-7; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5; Schofield JD, 2013, CURR OPIN CARDIOL, V28, P464, DOI 10.1097/HCO.0b013e328362210d; Stewart JE, 1998, INT J BIOCHEM CELL B, V30, P407, DOI 10.1016/S1357-2725(97)00151-9; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006	35	33	34	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2477	2488		10.1074/jbc.M114.596445	http://dx.doi.org/10.1074/jbc.M114.596445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505264	hybrid, Green Published			2022-12-28	WOS:000348588000049
J	Chavan, H; Li, F; Tessman, R; Mickey, K; Dorko, K; Schmitt, T; Kumer, S; Gunewardena, S; Gaikwad, N; Krishnamurthy, P				Chavan, Hemantkumar; Li, Feng; Tessman, Robert; Mickey, Kristen; Dorko, Kenneth; Schmitt, Timothy; Kumer, Sean; Gunewardena, Sumedha; Gaikwad, Nilesh; Krishnamurthy, Partha			Functional Coupling of ATP-binding Cassette Transporter Abcb6 to Cytochrome P450 Expression and Activity in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Cytochrome P450; Gene Regulation; Membrane Transport; Metabolic Regulation	TRANSCRIPTIONAL SUPPRESSION; DRUG-METABOLISM; GENE-EXPRESSION; EVOLUTION; HEME; P450; ACTIVATION; MUTATIONS; ENZYMES; MICE	Background: Physiological signals that negatively regulate CYP450s are not well understood. Results: Loss of Abcb6 in mice results in suppression of CYP450 activity. Conclusion: Suppression of P450 activity in Abcb6 deficiency may result from altered endogenous metabolites involved in maintaining homeostasis. Significance: Understanding metabolite alterations in Abcb6 deficiency should help understand the physiological signals and the mechanisms involved in negative regulation of P450s. Although endogenous mechanisms that negatively regulate cytochrome P450 (P450) monooxygenases in response to physiological and pathophysiological signals are not well understood, they are thought to result from alterations in the level of endogenous metabolites, involved in maintaining homeostasis. Here we show that homeostatic changes in hepatic metabolite profile in Abcb6 (mitochondrial ATP-binding cassette transporter B6) deficiency results in suppression of a specific subset of hepatic P450 activity. Abcb6 null mice are more susceptible to pentobarbital-induced sleep and zoxazolamine-induced paralysis, secondary to decreased expression and activity of Cyp3a11 and Cyp2b10. The knock-out mice also show decrease in both basal and xeno-inducible expression and activity of a subset of hepatic P450s that appear to be related to changes in hepatic metabolite profile. These data, together with the observation that liver extracts from Abcb6-deficient mice suppress P450 expression in human primary hepatocytes, suggest that this mouse model may provide an opportunity to understand the physiological signals and the mechanisms involved in negative regulation of P450s.	[Chavan, Hemantkumar; Li, Feng; Tessman, Robert; Mickey, Kristen; Dorko, Kenneth; Krishnamurthy, Partha] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Schmitt, Timothy; Kumer, Sean] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA; [Gunewardena, Sumedha] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Gunewardena, Sumedha] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA; [Dorko, Kenneth] Univ Kansas, Med Ctr, Cell Isolat Core, Kansas City, KS 66160 USA; [Gaikwad, Nilesh] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Gaikwad, Nilesh] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Gaikwad, Nilesh] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Krishnamurthy, P (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	pkasturi@kumc.edu	Chavan, Hemant/ABA-4925-2021; Chavan, Hemantkumar/AAN-6756-2020; Li, Feng/M-5334-2016	Chavan, Hemantkumar/0000-0002-9963-6230; Li, Feng/0000-0002-9680-4614	National Institutes of Health [U01HG004085, U01HG004080]; Children's Hospital Oakland Research Institute [U42RR024244]; National Center for Research Resources [5P20RR021940-07]; National Institute of General Medical Sciences [8P20GM103549-07]; Biomedical Research Training Grant for the University of Kansas Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244, P20RR021940] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004085, U01HG004080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Oakland Research Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biomedical Research Training Grant for the University of Kansas Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01HG004085 (to Velocigene at Regeneron Inc.) and U01HG004080 (to the CSD Consortium). This work was also supported by Grant U42RR024244 from Children's Hospital Oakland Research Institute, Grant 5P20RR021940-07 from the National Center for Research Resources, Grant 8P20GM103549-07 from the National Institute of General Medical Sciences, and the Biomedical Research Training Grant for the University of Kansas Medical Center (to H. C.).	Abraham A, 2014, ANN HEMATOL, V93, P509, DOI 10.1007/s00277-013-1821-2; Alsaad AMS, 2013, DRUG METAB REV, V45, P173, DOI 10.3109/03602532.2012.754460; Andolfo I, 2013, AM J HEMATOL, V88, P66, DOI 10.1002/ajh.23357; Chavan H, 2013, J BIOL CHEM, V288, P22658, DOI 10.1074/jbc.M113.485284; Chavan H, 2012, J BIOL CHEM, V287, P32054, DOI 10.1074/jbc.M112.371476; Cheng PY, 2003, J PHARMACOL EXP THER, V307, P1205, DOI 10.1124/jpet.103.057174; Cui YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079808; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Easterbrook J, 2001, CHEM-BIOL INTERACT, V134, P243, DOI 10.1016/S0009-2797(01)00159-4; Facciola G, 2001, EUR J CLIN PHARMACOL, V56, P881, DOI 10.1007/s002280000245; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Gaikwad NW, 2013, ANAL CHEM, V85, P4951, DOI 10.1021/ac400016e; Gonzalez FJ, 1996, FASEB J, V10, P1112, DOI 10.1096/fasebj.10.10.8751713; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Hartter S, 2001, CLIN PHARMACOL THER, V70, P10, DOI 10.1067/mcp.2001.116512; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; Jover R, 1996, MOL PHARMACOL, V50, P474; Jover R, 2000, EUR J BIOCHEM, V267, P7128, DOI 10.1046/j.1432-1327.2000.01815.x; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Li F, 2011, CHEM RES TOXICOL, V24, P744, DOI 10.1021/tx200033v; Lin WW, 2008, J BIOL CHEM, V283, P30650, DOI 10.1074/jbc.M806132200; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; Manzardo AM, 2014, ALCOHOL CLIN EXP RES, V38, P1594, DOI 10.1111/acer.12429; Miller MS, 1996, FUND APPL TOXICOL, V34, P165, DOI 10.1006/faat.1996.0187; Moitra K, 2011, BIOL CHEM, V392, P29, DOI 10.1515/BC.2011.006; Mookherjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045077; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Nebert D W, 1994, Prog Liver Dis, V12, P63; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Polireddy K, 2011, MOL ONCOL, V5, P410, DOI 10.1016/j.molonc.2011.07.005; Prough RA, 1996, FASEB J, V10, P1369, DOI 10.1096/fasebj.10.12.8903507; Ramana Kota V., 1998, Indian Journal of Experimental Biology, V36, P437; Riddick DS, 2004, DRUG METAB DISPOS, V32, P367, DOI 10.1124/dmd.32.4.367; ROTH LJ, 1949, J BIOL CHEM, V178, P963; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SRIVASTAVA G, 1989, EUR J BIOCHEM, V178, P689, DOI 10.1111/j.1432-1033.1989.tb14499.x; Tralau T, 2013, EXPERT OPIN DRUG MET, V9, P1541, DOI 10.1517/17425255.2013.828692; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wang LJ, 2012, AM J HUM GENET, V90, P40, DOI 10.1016/j.ajhg.2011.11.026; Watanabe M, 1998, LIFE SCI, V63, P1685, DOI 10.1016/S0024-3205(98)00440-8; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Xie YC, 2014, TOXICOL APPL PHARM, V279, P266, DOI 10.1016/j.taap.2014.05.010; Xu MJ, 2013, DRUG METAB REV, V45, P311, DOI 10.3109/03602532.2013.806537; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Zhang CE, 2013, J INVEST DERMATOL, V133, P2221, DOI 10.1038/jid.2013.145	53	8	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7871	7886		10.1074/jbc.M114.605386	http://dx.doi.org/10.1074/jbc.M114.605386			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623066	Green Published, hybrid			2022-12-28	WOS:000351613600045
J	Liu, Z; Leng, EC; Gunasekaran, K; Pentony, M; Shen, M; Howard, M; Stoops, J; Manchulenko, K; Razinkov, V; Liu, H; Fanslow, W; Hu, ZH; Sun, N; Hasegawa, H; Clark, R; Foltz, IN; Yan, W				Liu, Zhi; Leng, Esther C.; Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Howard, Monique; Stoops, Janelle; Manchulenko, Kathy; Razinkov, Vladimir; Liu, Hua; Fanslow, William; Hu, Zhonghua; Sun, Nancy; Hasegawa, Haruki; Clark, Rutilio; Foltz, Ian N.; Yan, Wei			A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Antibody Engineering; Cancer Therapy; Fc- Receptor; Pancreatic Cancer	GROWTH-FACTOR RECEPTOR; CELLULAR CYTOTOXICITY ADCC; MONOCLONAL-ANTIBODY; DOMAIN; CANCER; EXPRESSION; GENERATION; THERAPY; HUMANIZATION; HERCEPTIN	Background: Bispecific heterodimeric antibody consisting of two different heavy chains and two different light chains requires heterodimerization of heavy chains and cognate light-heavy chain pairings. Results: Cognate light-heavy chain pairing can be achieved by an antibody engineering approach. Conclusion: Bispecific hetero-IgG antibodies can be made in mammalian cells. Significance: The technology could be used in the production of bispecific antibodies for many biotechnological applications. Producing pure and well behaved bispecific antibodies (bsAbs) on a large scale for preclinical and clinical testing is a challenging task. Here, we describe a new strategy for making monovalent bispecific heterodimeric IgG antibodies in mammalian cells. We applied an electrostatic steering mechanism to engineer antibody light chain-heavy chain (LC-HC) interface residues in such a way that each LC strongly favors its cognate HC when two different HCs and two different LCs are co-expressed in the same cell to assemble a functional bispecific antibody. We produced heterodimeric IgGs from transiently and stably transfected mammalian cells. The engineered heterodimeric IgG molecules maintain the overall IgG structure with correct LC-HC pairings, bind to two different antigens with comparable affinity when compared with their parental antibodies, and retain the functionality of parental antibodies in biological assays. In addition, the bispecific heterodimeric IgG derived from anti-HER2 and anti-EGF receptor (EGFR) antibody was shown to induce a higher level of receptor internalization than the combination of two parental antibodies. Mouse xenograft BxPC-3, Panc-1, and Calu-3 human tumor models showed that the heterodimeric IgGs strongly inhibited tumor growth. The described approach can be used to generate tools from two pre-existent antibodies and explore the potential of bispecific antibodies. The asymmetrically engineered Fc variants for antibody-dependent cellular cytotoxicity enhancement could be embedded in monovalent bispecific heterodimeric IgG to make best-in-class therapeutic antibodies.	[Liu, Zhi; Leng, Esther C.; Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Howard, Monique; Stoops, Janelle; Manchulenko, Kathy; Hu, Zhonghua; Sun, Nancy; Hasegawa, Haruki; Clark, Rutilio; Foltz, Ian N.; Yan, Wei] Amgen Inc, Dept Therapeut Discovery, Seattle, WA 98119 USA; [Razinkov, Vladimir] Amgen Inc, Dept Proc & Prod Dev, Seattle, WA 98119 USA; [Liu, Hua; Fanslow, William] Amgen Inc, Therapeut Innovat Unit, Seattle, WA 98119 USA; [Liu, Zhi; Pentony, Martin; Shen, Min; Howard, Monique; Stoops, Janelle; Razinkov, Vladimir; Liu, Hua; Fanslow, William; Hu, Zhonghua; Sun, Nancy; Hasegawa, Haruki; Clark, Rutilio; Yan, Wei] Amgen Inc, Seattle, WA 98119 USA; [Gunasekaran, Kannan] Amgen Inc, Thousand Oaks, CA 91320 USA; [Leng, Esther C.; Manchulenko, Kathy; Foltz, Ian N.] Amgen Inc, Burnaby, BC V5A 1V7, Canada	Amgen; Amgen; Amgen; Amgen; Amgen	Liu, Z (corresponding author), Amgen Inc, Dept Therapeut Discovery, 1201 Amgen Court West, Seattle, WA 98119 USA.	phillipzhiliu@hotmail.com; fondofgo@yahoo.com		Hasegawa, Haruki/0000-0002-3464-4715				Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chames P, 2009, MABS-AUSTIN, V1, P539, DOI 10.4161/mabs.1.6.10015; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P667, DOI 10.1093/protein/gzq034; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; KNARR G, 1995, J BIOL CHEM, V270, P27589, DOI 10.1074/jbc.270.46.27589; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Larbouret C, 2007, CLIN CANCER RES, V13, P3356, DOI 10.1158/1078-0432.CCR-06-2302; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Liu Z, 2014, J BIOL CHEM, V289, P3571, DOI 10.1074/jbc.M113.513366; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; Maron R, 2013, P NATL ACAD SCI USA, V110, P15389, DOI 10.1073/pnas.1313857110; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; MILSTEIN C, 1983, NATURE, V305, P537, DOI 10.1038/305537a0; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Potapov V, 2004, J MOL BIOL, V342, P665, DOI 10.1016/j.jmb.2004.06.072; Reiter Y, 1996, NAT BIOTECHNOL, V14, P1239, DOI 10.1038/nbt1096-1239; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Schlaeth M, 2010, CANCER SCI, V101, P1080, DOI 10.1111/j.1349-7006.2010.01505.x; Seimetz D, 2010, CANCER TREAT REV, V36, P458, DOI 10.1016/j.ctrv.2010.03.001; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tanner M, 2004, MOL CANCER THER, V3, P1585; van Schouwenburg PA, 2014, J BIOL CHEM, V289, P34482, DOI 10.1074/jbc.M114.615500; Vlacich G, 2011, CANCER CELL, V20, P423, DOI 10.1016/j.ccr.2011.10.006; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565; Yamashita-Kashima Y, 2011, CLIN CANCER RES, V17, P5060, DOI 10.1158/1078-0432.CCR-10-2927; Yang XD, 1999, CANCER RES, V59, P1236; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang JB, 2009, PROTEIN EXPRES PURIF, V65, P77, DOI 10.1016/j.pep.2008.10.011	48	50	75	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7535	7562		10.1074/jbc.M114.620260	http://dx.doi.org/10.1074/jbc.M114.620260			28	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25583986	Green Published, hybrid			2022-12-28	WOS:000351613600020
J	Nighot, PK; Hu, CAA; Ma, TY				Nighot, Prashant K.; Hu, Chien-An Andy; Ma, Thomas Y.			Autophagy Enhances Intestinal Epithelial Tight Junction Barrier Function by Targeting Claudin-2 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROHNS-DISEASE; PERMEABILITY; EXPRESSION; CELLS; CONTRIBUTE; COLITIS; RELAPSE; FUSION; FLUX	Autophagy is an intracellular degradation pathway and is considered to be an essential cell survival mechanism. Defects in autophagy are implicated in many pathological processes, including inflammatory bowel disease. Among the innate defense mechanisms of intestinal mucosa, a defective tight junction (TJ) barrier has been postulated as a key pathogenic factor in the causation and progression of inflammatory bowel disease by allowing increased antigenic permeation. The cross-talk between autophagy and the TJ barrier has not yet been described. In this study, we present the novel finding that autophagy enhances TJ barrier function in Caco-2 intestinal epithelial cells. Nutrient starvation-induced autophagy significantly increased transepithelial electrical resistance and reduced the ratio of sodium/chloride paracellular permeability. Nutrient starvation reduced the paracellular permeability of small-sized urea but not larger molecules. The role of autophagy in the modulation of paracellular permeability was confirmed by pharmacological induction as well as pharmacological and genetic inhibition of autophagy. Consistent with the autophagy-induced reduction in paracellular permeability, a marked decrease in the level of the cation-selective, pore-forming TJ protein claudin-2 was observed after cell starvation. Starvation reduced the membrane presence of claudin-2 and increased its cytoplasmic, lysosomal localization. Therefore, our data show that autophagy selectively reduces epithelial TJ permeability of ions and small molecules by lysosomal degradation of the TJ protein claudin-2.	[Nighot, Prashant K.; Ma, Thomas Y.] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Hu, Chien-An Andy] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Ma, Thomas Y.] Vet Affairs Med Ctr, Albuquerque, NM 87108 USA	University of New Mexico; University of New Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ma, TY (corresponding author), 1 Univ New Mexico, Div Gastroenterol & Hepatol, Hlth Sci Ctr, Univ New Mexico, MSC10-5550, Albuquerque, NM 87131 USA.	TMa@salud.unm.edu			NIDDK/National Institutes of Health [R01-DK-64165-01, KO1DK100562-01]; Veterans Affairs merit review grant from VA Research Service; University of New Mexico School of Medicine Research Allocation Committee; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064165, K01DK100562] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs merit review grant from VA Research Service(US Department of Veterans Affairs); University of New Mexico School of Medicine Research Allocation Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK/National Institutes of Health Grants R01-DK-64165-01 (to T. M.) and KO1DK100562-01 (to P. N.). This work was also supported by a Veterans Affairs merit review grant from the VA Research Service (to T. M.) and by the University of New Mexico School of Medicine Research Allocation Committee (to P.N.).	Al-Sadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085345; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Arnott IDR, 2000, SCAND J GASTROENTERO, V35, P1163; Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; BARKER G, 1981, Q J EXP PHYSIOL CMS, V66, P61, DOI 10.1113/expphysiol.1981.sp002529; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Groulx JF, 2012, AUTOPHAGY, V8, P893, DOI 10.4161/auto.19738; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lu RF, 2014, MOL BIOL CELL, V25, P1744, DOI 10.1091/mbc.E13-12-0724; Ma TY, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1559; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Strisciuglio C, 2013, J CROHNS COLITIS, V7, P534, DOI 10.1016/j.crohns.2012.08.009; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Van Itallie CM, 2009, ANN NY ACAD SCI, V1165, P82, DOI 10.1111/j.1749-6632.2009.04052.x; Walczak M, 2013, AUTOPHAGY, V9, P424, DOI 10.4161/auto.22931; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Wildenberg ME, 2012, GASTROENTEROLOGY, V142, P1493, DOI 10.1053/j.gastro.2012.02.034; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	47	121	125	4	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7234	7246		10.1074/jbc.M114.597492	http://dx.doi.org/10.1074/jbc.M114.597492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25616664	Green Published, hybrid			2022-12-28	WOS:000350991500052
J	Zehrmann, A; Hartel, B; Glass, F; Bayer-Csaszar, E; Obata, T; Meyer, E; Brennicke, A; Takenaka, M				Zehrmann, Anja; Haertel, Barbara; Glass, Franziska; Bayer-Csaszar, Eszter; Obata, Toshihiro; Meyer, Etienne; Brennicke, Axel; Takenaka, Mizuki			Selective Homo- and Heteromer Interactions between the Multiple Organellar RNA Editing Factor (MORF) Proteins in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; PLANT ORGANELLES; STRUCTURAL BASIS; MESSENGER-RNAS; PPR PROTEINS; MITOCHONDRIA; RECOGNITION; COMPLEX; COMPLEMENTATION; EXPRESSION	RNA editing in plastids and mitochondria of flowering plants requires pentatricopeptide repeat proteins (PPR proteins) for site recognition and proteins of the multiple organellar RNA editing factor (MORE) family as cofactors. Two MORE proteins, MORES and MOM, are dual-targeted to plastids and mitochondria; two are targeted to plastids, and five are targeted to mitochondria. Pulldown assays from Arabidopsis thaliana tissue culture extracts with the mitochondrial MORE1 and the plastid M()RE2 proteins, respectively, both identify the dualtargeted MORE8 protein, showing that these complexes can assemble in the organelles. We have now determined the scope of potential interactions between the various MORE proteins by yeast two-hybrid, in vitro pulldown, and bimolecular fluorescence complementation assays. The resulting MORE-MORE interactorne identifies specific heterorneric MORE protein interactions in plastids and in mitochondria. Heteromers are observed for MORE protein combinations affecting a common site, suggesting their functional relevance. Most MORE proteins also undergo homomeric interactions. Submolecular analysis of the MOM protein reveals that the MORE-MORE protein connections require the C-terminal region of the central conserved MORE box. This domain has no similarity to known protein modules and may form a novel surface for protein-protein interactions.	[Zehrmann, Anja; Haertel, Barbara; Glass, Franziska; Bayer-Csaszar, Eszter; Brennicke, Axel; Takenaka, Mizuki] Univ Ulm, Mol Bot, D-89069 Ulm, Germany; [Obata, Toshihiro; Meyer, Etienne] Max Planck Inst Pflanzenphysiol, D-14476 Potsdam, Germany	Ulm University; Max Planck Society	Takenaka, M (corresponding author), Univ Ulm, Mol Bot, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/AAK-9884-2020; Obata, Toshihiro/AAX-4353-2020; Meyer, Etienne H/C-1952-2008	Takenaka, Mizuki/0000-0002-3242-5092; Obata, Toshihiro/0000-0001-8931-7722; Meyer, Etienne H/0000-0003-4712-9824	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to M.T. and A.B.).	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bisanz C, 2003, PLANT MOL BIOL, V51, P651, DOI 10.1023/A:1022557825768; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Braun P, 2013, ANNU REV PLANT BIOL, V64, P161, DOI 10.1146/annurev-arplant-050312-120140; Braun P, 2012, PROTEOMICS, V12, P1499, DOI 10.1002/pmic.201100598; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Horstman A, 2014, INT J MOL SCI, V15, P9628, DOI 10.3390/ijms15069628; James P, 1996, GENETICS, V144, P1425; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Obata T, 2011, PHYTOCHEMISTRY, V72, P1081, DOI 10.1016/j.phytochem.2010.11.003; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schutze K., 2009, BIMOLECULAR FLUORESC; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2014, MOL PLANT, V7, P582, DOI 10.1093/mp/sst170; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2011, METHODS MOL BIOL, V718, P163, DOI 10.1007/978-1-61779-018-8_10; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Tanz SK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00214; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Van Leene J, 2011, METHODS MOL BIOL, V754, P195, DOI 10.1007/978-1-61779-154-3_11; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	40	42	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6445	6456		10.1074/jbc.M114.602086	http://dx.doi.org/10.1074/jbc.M114.602086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25583991	hybrid, Green Published			2022-12-28	WOS:000350732500048
J	Kuster, DWD; Govindan, S; Springer, TI; Martin, JL; Finley, NL; Sadayappan, S				Kuster, Diederik W. D.; Govindan, Suresh; Springer, Tzvia I.; Martin, Jody L.; Finley, Natosha L.; Sadayappan, Sakthivel			A Hypertrophic Cardiomyopathy-associated MYBPC3 Mutation Common in Populations of South Asian Descent Causes Contractile Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-C; PROTEASOME SYSTEM; CROSS-LINKING; SITE MUTATION; CMYBP-C; MYOSIN; PHOSPHORYLATION; GENE; ACTIVATION; DOMAIN	Hypertrophic cardiomyopathy (HCM) results from mutations in genes encoding sarcomeric proteins, most often MYBPC3, which encodes cardiac myosin binding protein-C (cMyBP-C). A recently discovered HCM-associated 25-base pair deletion in MYBPC3 is inherited in millions worldwide. Although this mutation causes changes in the C10 domain of cMyBP-C (cMyBP-C-C10mut), which binds to the light meromyosin (LMM) region of the myosin heavy chain, the underlying molecular mechanism causing HCM is unknown. In this study, adenoviral expression of cMyBP-C-C10mut in cultured adult rat cardiomyocytes was used to investigate protein localization and evaluate contractile function and Ca2+ transients, compared with wildtype cMyBP-C expression (cMyBP-C-WT) and controls. Forty-eight hours after infection, 44% of cMyBP-C-WT and 36% of cMyBP-C-C10mut protein levels were determined in total lysates, confirming equal expression. Immunofluorescence experiments showed little or no localization of cMyBP-C-C10mut to the C-zone, whereas cMyBP-C-WT mostly showed C-zone staining, suggesting that cMyBP-C-C10mut could not properly integrate in the C-zone of the sarcomere. Subcellular fractionation confirmed that most cMyBP-C-C10mut resided in the soluble fraction, with reduced presence in the myofilament fraction. Also, cMyBP-C-C10mut displayed significantly reduced fractional shortening, sarcomere shortening, and relaxation velocities, apparently caused by defects in sarcomere function, because Ca2+ transients were unaffected. Co-sedimentation and protein cross-linking assays confirmed that C10(mut) causes the loss of C10 domain interaction with myosin LMM. Protein homology modeling studies showed significant structural perturbation in cMyBP-C-C10mut, providing a potential structural basis for the alteration in its mode of interaction with myosin LMM. Therefore, expression of cMyBP-C-C10mut protein is sufficient to cause contractile dysfunction in vitro.	[Kuster, Diederik W. D.; Govindan, Suresh; Martin, Jody L.; Sadayappan, Sakthivel] Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL 60153 USA; [Springer, Tzvia I.; Finley, Natosha L.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Finley, Natosha L.] Miami Univ, Cell Mol & Struct Biol Program, Oxford, OH 45056 USA	Loyola University Chicago; University System of Ohio; Miami University; University System of Ohio; Miami University	Sadayappan, S (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, 2160 S First Ave, Maywood, IL 60153 USA.	ssadayappan@luc.edu	Kuster, Diederik/AAD-9272-2019	Kuster, Diederik/0000-0003-1498-6862; Springer, Tzvia/0000-0002-2811-5147; Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health [R01HL105826, K02HL114749]; American Heart Association [14GRNT20490025, 13POST17220009, 13POST14720024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL114749, R01HL105826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL105826 and K02HL114749 (to S. S.). This work was also supported by American Heart Association Midwest Affiliate Research Programs Grant-in-Aid 14GRNT20490025 and Postdoctoral Fellowships 13POST17220009 (to D. W. D. K.) and 13POST14720024 (to S. G.),	Adalsteinsdottir B, 2014, CIRCULATION, V130, P1158, DOI 10.1161/CIRCULATIONAHA.114.011207; Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Alders M, 2003, EUR HEART J, V24, P1848, DOI 10.1016/S0195-668X(03)00466-4; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bahrudin U, 2008, J MOL BIOL, V384, P896, DOI 10.1016/j.jmb.2008.09.070; Bardswell SC, 2012, J MUSCLE RES CELL M, V33, P53, DOI 10.1007/s10974-011-9276-3; Barefield D, 2014, AM J PHYSIOL-HEART C, V306, pH807, DOI 10.1152/ajpheart.00913.2013; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Dihazi GH, 2003, RAPID COMMUN MASS SP, V17, P2005, DOI 10.1002/rcm.1144; Flashman E, 2007, BIOCHEM J, V401, P97, DOI 10.1042/BJ20060500; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; FURST DO, 1992, J CELL SCI, V102, P769; Gilbert R, 1996, J CELL SCI, V109, P101; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kuster DWD, 2014, PFLUG ARCH EUR J PHY, V466, P207, DOI 10.1007/s00424-013-1417-7; Kuster DWD, 2013, CIRC RES, V112, P633, DOI 10.1161/CIRCRESAHA.112.275602; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Miyamoto CA, 1999, J MUSCLE RES CELL M, V20, P703, DOI 10.1023/A:1005513312939; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; Predmore JM, 2010, CIRCULATION, V121, P997, DOI 10.1161/CIRCULATIONAHA.109.904557; Razzaque MA, 2013, CIRC RES, V113, P553, DOI 10.1161/CIRCRESAHA.113.301225; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rottbauer W, 1997, J CLIN INVEST, V100, P475, DOI 10.1172/JCI119555; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sarikas A, 2005, CARDIOVASC RES, V66, P33, DOI 10.1016/j.cardiores.2005.01.004; Sarkey JP, 2011, J MOL CELL CARDIOL, V50, P1044, DOI 10.1016/j.yjmcc.2011.03.004; Schlossarek S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0235-3; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Simonson TS, 2010, ANN HUM GENET, V74, P184, DOI 10.1111/j.1469-1809.2010.00561.x; STARR R, 1978, BIOCHEM J, V171, P813, DOI 10.1042/bj1710813; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, CIRC RES, V98, P1212, DOI 10.1161/01.RES.0000219863.94390.ce; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Waldmuller S, 2003, J MOL CELL CARDIOL, V35, P623, DOI 10.1016/S0022-2828(03)00050-6; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Welikson RE, 2002, J CELL SCI, V115, P3517; Wilkins MR, 1999, METH MOL B, V112, P531; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Zahka K, 2008, HEART, V94, P1326, DOI 10.1136/hrt.2007.127241	51	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5855	5867		10.1074/jbc.M114.607911	http://dx.doi.org/10.1074/jbc.M114.607911			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25583989	hybrid, Green Published			2022-12-28	WOS:000350044200050
J	Scazzari, M; Amm, I; Wolf, DH				Scazzari, Mario; Amm, Ingo; Wolf, Dieter H.			Quality Control of a Cytoplasmic Protein Complex CHAPERONE MOTORS AND THE UBIQUITIN-PROTEASOME SYSTEM GOVERN THE FATE OF ORPHAN FATTY ACID SYNTHASE SUBUNIT Fas2 OF YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; ER-ASSOCIATED DEGRADATION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CYTOSOLIC PROTEINS; LUMINAL PROTEIN; ACID SYNTHASE; BUDDING YEAST; LIGASE UBR1; METHIONINE	For the assembly of protein complexes in the cell, the presence of stoichiometric amounts of the respective protein subunits is of utmost importance. A surplus of any of the subunits may trigger unspecific and harmful protein interactions and has to be avoided. A stoichiometric amount of subunits must finally be reached via transcriptional, translational, and/or post-translational regulation. Synthesis of saturated 16 and 18 carbon fatty acids is carried out by fatty acid synthase: in yeast Saccharomyces cerevisiae, a 2.6-MDa molecular mass assembly containing six protomers each of two different subunits, Fas1 (beta) and Fas2 (alpha). The (alpha)(6)(beta)(6) complex carries six copies of all eight enzymatic activities required for fatty acid synthesis. The FAS1 and FAS2 genes in yeast are unlinked and map on two different chromosomes. Here we study the fate of the alpha-subunit of the complex, Fas2, when its partner, the beta-subunit Fas1, is absent. Individual subunits of fatty acid synthase are proteolytically degraded when the respective partner is missing. Elimination of Fas2 is achieved by the proteasome. Here we show that a ubiquitin transfer machinery is required for Fas2 elimination. The major ubiquitin ligase targeting the superfluous Fas2 subunit to the proteasome is Ubr1. The ubiquitin-conjugating enzymes Ubc2 and Ubc4 assist the degradation process. The AAA-ATPase Cdc48 and the Hsp70 chaperone Ssa1 are crucially involved in the elimination of Fas2.	[Scazzari, Mario; Amm, Ingo; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	University of Stuttgart	Wolf, DH (corresponding author), Univ Stuttgart, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	dieter.wolf@ibc.uni-stuttgart.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; ARFIN SM, 1988, BIOCHEMISTRY-US, V27, P7979, DOI 10.1021/bi00421a001; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Ausubel FM, 1992, CURRENT PROTOCOLS MO; Barbin L, 2010, BIOCHEM BIOPH RES CO, V394, P335, DOI 10.1016/j.bbrc.2010.03.005; Becker J, 1996, MOL CELL BIOL, V16, P4378; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; BURKL G, 1972, MOL GEN GENET, V119, P315, DOI 10.1007/BF00272089; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; EGNER R, 1993, J BIOL CHEM, V268, P27269; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Franke J, 2013, NAT PROD REP, V30, P1299, DOI 10.1039/c3np70012g; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Li X, 1995, P NATL ACAD SCI USA, V92, P12357, DOI 10.1073/pnas.92.26.12357; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHULLER HJ, 1992, EUR J BIOCHEM, V203, P607, DOI 10.1111/j.1432-1033.1992.tb16590.x; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; SIEBENLIST U, 1990, YEAST, V6, P411, DOI 10.1002/yea.320060506; Stolz A, 2013, P NATL ACAD SCI USA, V110, P15271, DOI 10.1073/pnas.1304928110; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wolf DH, 2011, FEBS LETT, V585, P2769, DOI 10.1016/j.febslet.2011.08.020; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832	55	19	19	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4677	4687		10.1074/jbc.M114.596064	http://dx.doi.org/10.1074/jbc.M114.596064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564609	Green Published, hybrid			2022-12-28	WOS:000350042000012
J	Stolting, G; de Oliveira, RC; Guzman, RE; Miranda-Laferte, E; Conrad, R; Jordan, N; Schmidt, S; Hendriks, J; Gensch, T; Hidalgo, P				Stoelting, Gabriel; de Oliveira, Regina Campos; Guzman, Raul E.; Miranda-Laferte, Erick; Conrad, Rachel; Jordan, Nadine; Schmidt, Silke; Hendriks, Johnny; Gensch, Thomas; Hidalgo, Patricia			Direct Interaction of Ca-V beta with Actin Up-regulates L-type Calcium Currents in HL-1 Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL SUBUNITS; HUMAN HEART; EXPRESSION; MODULATION; COMPLEX; DOMAIN; CELLS; MECHANISM; CANINE	Expression of the beta-subunit (Ca-V beta) is required for normal function of cardiac L-type calcium channels, and its up-regulation is associated with heart failure. Ca-V beta binds to the alpha(1) poreforming subunit of L-type channels and augments calcium current density by facilitating channel opening and increasing the number of channels in the plasma membrane, by a poorly understood mechanism. Actin, a key component of the intracellular trafficking machinery, interacts with Src homology 3 domains in different proteins. Although Ca-V beta encompasses a highly conserved Src homology 3 domain, association with actin has not yet been explored. Here, using co-sedimentation assays and FRET experiments, we uncover a direct interaction between Ca-V beta and actin filaments. Consistently, single-molecule localization analysis reveals streaklike structures composed by Ca-V beta(2) that distribute over several micrometers along actin filaments in HL-1 cardiomyocytes. Overexpression of Ca-V beta(2)-N3 in HL-1 cells induces an increase in L-type current without altering voltage-dependent activation, thus reflecting an increased number of channels in the plasma membrane. Ca-V beta mediated L-type up-regulation, and Ca-V beta-actin association is prevented by disruption of the actin cytoskeleton with cytochalasin D. Our study reveals for the first time an interacting partner of Ca-V beta that is directly involved in vesicular trafficking. We propose a model in which Ca-V beta promotes anterograde trafficking of the L-type channels by anchoring them to actin filaments in their itinerary to the plasma membrane.	[Stoelting, Gabriel; Guzman, Raul E.; Miranda-Laferte, Erick; Conrad, Rachel; Jordan, Nadine; Hendriks, Johnny; Gensch, Thomas; Hidalgo, Patricia] Forschungszentrum Julich, Inst Complex Syst 4, D-52425 Julich, Germany; [de Oliveira, Regina Campos; Schmidt, Silke] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany	Helmholtz Association; Research Center Julich; Hannover Medical School	Hidalgo, P (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS4, D-52425 Julich, Germany.	pa.hidalgo@fz-juelich.de	Hidalgo, Patricia/I-7506-2013; Stolting, Gabriel/G-3704-2014	Hidalgo, Patricia/0000-0002-4162-6590; Stolting, Gabriel/0000-0002-2339-0545	Deutsche Forschungsgemeinschaft [Hi 800/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Hi 800/3-1 (to P. H.).	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Barde I, 2010, CURR PROTOC NEUROSCI, V53, P4211; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Cribbs LL, 2001, CIRC RES, V88, P403; Dzhura I, 2003, BIOPHYS J, V85, P274, DOI 10.1016/S0006-3495(03)74473-7; Fang K, 2011, J PHYSIOL-LONDON, V589, P4437, DOI 10.1113/jphysiol.2011.214247; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gilbert D, 2007, INT J DEV NEUROSCI, V25, P479, DOI 10.1016/j.ijdevneu.2007.08.001; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Haase H, 1996, J MOL MED-JMM, V74, P99; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Hullin R, 2003, J BIOL CHEM, V278, P21623, DOI 10.1074/jbc.M211164200; Hullin R, 1999, CIRCULATION, V100, P155, DOI 10.1161/01.CIR.100.2.155; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Larsen JK, 2002, J MOL CELL CARDIOL, V34, P519, DOI 10.1006/jmcc.2001.1534; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Luvisetto S, 2004, J GEN PHYSIOL, V124, P445, DOI 10.1085/jgp.200409034; Meissner M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227819; Miranda-Laferte E, 2011, J BIOL CHEM, V286, P22203, DOI 10.1074/jbc.M110.201871; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x; Xia M, 2004, J MOL CELL CARDIOL, V36, P111, DOI 10.1016/j.yjmcc.2003.10.007	49	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4561	4572		10.1074/jbc.M114.573956	http://dx.doi.org/10.1074/jbc.M114.573956			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533460	Green Published, hybrid			2022-12-28	WOS:000350042000004
J	Courtemanche, N; Gifford, SM; Simpson, MA; Pollard, TD; Koleske, AJ				Courtemanche, Naomi; Gifford, Stacey M.; Simpson, Mark A.; Pollard, Thomas D.; Koleske, Anthony J.			Abl2/Abl-related Gene Stabilizes Actin Filaments, Stimulates Actin Branching by Actin-related Protein 2/3 Complex, and Promotes Actin Filament Severing by Cofilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL EDGE PROTRUSION; ABL-FAMILY KINASES; F-ACTIN; TYROSINE KINASE; ARP2/3 COMPLEX; N-WASP; CORTACTIN PHOSPHORYLATION; DENDRITIC SPINE; FH1 DOMAIN; ARG	Both Arp2/3 complex and the Abl2/Arg nonreceptor tyrosine kinase are essential to form and maintain diverse actin-based structures in cells, including cell edge protrusions in fibroblasts and cancer cells and dendritic spines in neurons. The ability of Arg to promote cell edge protrusions in fibroblasts does not absolutely require kinase activity, raising the question of how Arg might modulate actin assembly and turnover in the absence of kinase function. Arg has two distinct actin-binding domains and interacts physically and functionally with cortactin, an activator of the Arp2/3 complex. However, it was not known whether and how Arg influences actin filament stability, actin branch formation, or cofilin-mediated actin severing or how cortactin influences these reactions of Arg with actin. Arg or cortactin bound to actin filaments stabilizes them from depolymerization. Low concentrations of Arg and cortactin cooperate to stabilize filaments by slowing depolymerization. Arg stimulates formation of actin filament branches by Arp2/3 complex and cortactin. An Arg mutant lacking the C-terminal calponin homology actin-binding domain stimulates actin branch formation by the Arp2/3 complex, indicative of autoinhibition. Arg Delta CH can stimulate the Arp2/3 complex even in the absence of cortactin. Arg greatly potentiates cofilin severing of actin filaments, and cortactin attenuates this enhanced severing. The ability of Arg to stabilize filaments, promote branching, and increase severing requires the internal (I/L) WEQ actin-binding domain. These activities likely underlie important roles that Arg plays in the formation, dynamics, and stability of actin-based cellular structures.	[Courtemanche, Naomi; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06511 USA; [Gifford, Stacey M.; Simpson, Mark A.; Pollard, Thomas D.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 219 Prospect St, New Haven, CT 06511 USA.	thomas.pollard@yale.edu; anthony.koleske@yale.edu			National Institutes of Health [CA-133346, GM-100411, GM-026338, NS-089439]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA133346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338, T32GM007223, R01GM100411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS089439, R01NS089662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-133346 and GM-100411 (to A. J. K.), GM-026338 (to T. D. P.), and NS-089439 (to A. J. K. and T. D. P.).; Supported by a postdoctoral fellowship from the Leukemia and Lymphoma Society.	BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Galkin VE, 2005, J MOL BIOL, V346, P565, DOI 10.1016/j.jmb.2004.11.078; Gifford SM, 2014, J BIOL CHEM, V289, P19704, DOI 10.1074/jbc.M114.556480; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Kempiak SJ, 2005, J BIOL CHEM, V280, P5836, DOI 10.1074/jbc.M410713200; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lin YC, 2013, J NEUROSCI, V33, P1846, DOI 10.1523/JNEUROSCI.4284-12.2013; Liu WZ, 2012, ACTA CRYSTALLOGR F, V68, P154, DOI 10.1107/S1744309111056132; MacGrath SM, 2012, BIOCHEMISTRY-US, V51, P6644, DOI 10.1021/bi300722t; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Miller MM, 2010, BIOCHEMISTRY-US, V49, P2227, DOI 10.1021/bi901721u; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pant K, 2006, J MOL BIOL, V359, P840, DOI 10.1016/j.jmb.2006.03.065; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Peacock JG, 2010, CYTOSKELETON, V67, P666, DOI 10.1002/cm.20479; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; van Rossum AGSH, 2003, J BIOL CHEM, V278, P45672, DOI 10.1074/jbc.M306688200; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417	45	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4038	4046		10.1074/jbc.M114.608117	http://dx.doi.org/10.1074/jbc.M114.608117			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540195	Green Published, hybrid			2022-12-28	WOS:000349458400016
J	Vazquez-Victorio, G; Caligaris, C; Del Valle-Espinosa, E; Sosa-Garrocho, M; Gonzalez-Arenas, NR; Reyes-Cruz, G; Briones-Orta, MA; Macias-Silva, M				Vazquez-Victorio, Genaro; Caligaris, Cassandre; Del Valle-Espinosa, Eugenio; Sosa-Garrocho, Marcela; Gonzalez-Arenas, Nelly R.; Reyes-Cruz, Guadalupe; Briones-Orta, Marco A.; Macias-Silva, Marina			Novel Regulation of Ski Protein Stability and Endosomal Sorting by Actin Cytoskeleton Dynamics in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; TGF-BETA RECEPTOR; LIVER-REGENERATION; SMAD PROTEINS; C-SKI; CELL-PROLIFERATION; ONCOPROTEIN; PATHWAY; SNON; GENE	TGF-beta-induced antimitotic signals are highly regulated during cell proliferation under normal and pathological conditions, such as liver regeneration and cancer. Up-regulation of the transcriptional cofactors Ski and SnoN during liver regeneration may favor hepatocyte proliferation by inhibiting TGF-beta signals. In this study, we found a novel mechanism that regulates Ski protein stability through TGF-beta and G protein-coupled receptor (GPCR) signaling. Ski protein is distributed between the nucleus and cytoplasm of normal hepatocytes, and the molecular mechanisms controlling Ski protein stability involve the participation of actin cytoskeleton dynamics. Cytoplasmic Ski is partially associated with actin and localized in cholesterol-rich vesicles. Ski protein stability is decreased by TGF-beta/Smads, GPCR/Rho signals, and actin polymerization, whereas GPCR/cAMP signals and actin depolymerization promote Ski protein stability. In conclusion, TGF-beta and GPCR signals differentially regulate Ski protein stability and sorting in hepatocytes, and this cross-talk may occur during liver regeneration.	[Vazquez-Victorio, Genaro; Caligaris, Cassandre; Del Valle-Espinosa, Eugenio; Sosa-Garrocho, Marcela; Gonzalez-Arenas, Nelly R.; Briones-Orta, Marco A.; Macias-Silva, Marina] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico; [Reyes-Cruz, Guadalupe] CINVESTAV IPN, Dept Biol Celular, Mexico City 07000, DF, Mexico	Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Macias-Silva, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico.	mmacias@ifc.unam.mx	Briones-Orta, Marco A/ABE-4747-2021	Briones-Orta, Marco A/0000-0001-6627-1901; Briones-Orta, Marco Antonio/0000-0003-0808-0570; Vazquez-Victorio, Genaro/0000-0002-2319-8772; Macias-Silva, Marina/0000-0002-3972-0983	PAPIIT/DGAPA/UNAM [IN222909, IN206012]; CONACyT [101826]; CONACyT	PAPIIT/DGAPA/UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by PAPIIT/DGAPA/UNAM Grants IN222909 and IN206012) and CONACyT Grant 101826 (to M. M. S.).; Student of the Ph.D. Program in Ciencias Biomedicas, UNAM and recipient of a fellowship from CONACyT.	Atanasoski S, 2004, NEURON, V43, P499, DOI 10.1016/j.neuron.2004.08.001; Awasthi-Kalia M, 2001, BIOCHEM BIOPH RES CO, V287, P77, DOI 10.1006/bbrc.2001.5536; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bonnon C, 2012, CELL TISSUE RES, V347, P51, DOI 10.1007/s00441-011-1180-z; Briones-Orta MA, 2013, CANCER RES, V73, P1800, DOI 10.1158/0008-5472.CAN-12-1916; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Delgado-Coello B, 2011, LIVER INT, V31, P1271, DOI 10.1111/j.1478-3231.2011.02542.x; Delgado-Coello B, 2010, MOL CELL BIOCHEM, V344, P117, DOI 10.1007/s11010-010-0535-1; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Ferrand N, 2010, CANCER RES, V70, P8457, DOI 10.1158/0008-5472.CAN-09-4088; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Herrera B, 2004, J CELL PHYSIOL, V201, P385, DOI 10.1002/jcp.20078; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Jacob C, 2008, J CELL BIOL, V182, P519, DOI 10.1083/jcb.200710161; Kokura K, 2003, J BIOL CHEM, V278, P20133, DOI 10.1074/jbc.M210855200; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Liu X, 2008, BIOCHEM J, V409, P289, DOI 10.1042/BJ20070545; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Macias-Silva M, 2002, J BIOL CHEM, V277, P28483, DOI 10.1074/jbc.M202403200; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Marcelain K, 2005, ONCOGENE, V24, P4321, DOI 10.1038/sj.onc.1208631; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Mu XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063436; Nagata M, 2006, GENES CELLS, V11, P1267, DOI 10.1111/j.1365-2443.2006.01018.x; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Prunier C, 2003, J BIOL CHEM, V278, P26249, DOI 10.1074/jbc.M304459200; Reed JA, 2005, CANCER METAST REV, V24, P265, DOI 10.1007/s10555-005-1576-x; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; Soeta C, 2001, DEV GROWTH DIFFER, V43, P155; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tecalco-Cruz AC, 2012, J BIOL CHEM, V287, P26764, DOI 10.1074/jbc.M112.386599; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Ye F, 2011, J BIOL CHEM, V286, P40013, DOI 10.1074/jbc.M111.292029; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037	48	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4487	4499		10.1074/jbc.M114.579532	http://dx.doi.org/10.1074/jbc.M114.579532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25561741	Green Published, hybrid			2022-12-28	WOS:000349458400054
J	Wagoner, JA; Sun, T; Lin, L; Hanson, MR				Wagoner, Jessica A.; Sun, Tao; Lin, Lin; Hanson, Maureen R.			Cytidine Deaminase Motifs within the DYW Domain of Two Pentatricopeptide Repeat-containing Proteins Are Required for Site-specific Chloroplast RNA Editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Chloroplast; Cytidine Deaminase; RNA Editing; Site-directed Mutagenesis; Yeast Two-hybrid Assay; PPR Motif; Pentatricopeptide Protein	ARABIDOPSIS MESOPHYLL PROTOPLASTS; PPR PROTEINS; SUBCELLULAR-LOCALIZATION; STRUCTURAL BASIS; GENE-EXPRESSION; MESSENGER-RNAS; RECOGNITION; IDENTIFICATION; MITOCHONDRIA; TRANSCRIPT	Background: Pentatricopeptide repeat (PPR) proteins are site-specific RNA editing factors; many have C-terminal motifs of unknown function. Results: Site-directed mutagenesis of two PPR-DYW domains significantly reduces editing efficiency. Conclusion: Residues conserved in cytidine deaminases in the DYW domains are important for editing activity. Significance: This study strengthens the evidence that the DYW domains of PPR proteins carry the deaminase activity necessary for C-to-U modification. In angiosperm organelles, cytidines are converted to uridines by a deamination reaction in the process termed RNA editing. The C targets of editing are recognized by members of the pentatricopeptide repeat (PPR) protein family. Although other members of the editosome have begun to be identified, the enzyme that catalyzes the C-U conversion is still unknown. The DYW motif at the C terminus of many PPR editing factors contains residues conserved with known cytidine deaminase active sites; however, some PPR editing factors lack a DYW motif. Furthermore, in many PPR-DYW editing factors, the truncation of the DYW motif does not affect editing efficiency, so the role of the DYW motif in RNA editing is unclear. Here, a chloroplast PPR-DYW editing factor, quintuple editing factor 1 (QED1), was shown to affect five different plastid editing sites, the greatest number of chloroplast C targets known to be affected by a single PPR protein. Loss of editing at the five sites resulted in stunted growth and accumulation of apparent photodamage. Adding a C-terminal protein tag to QED1 was found to severely inhibit editing function. QED1 and RARE1, another plastid PPR-DYW editing factor, were discovered to require their DYW motifs for efficient editing. To identify specific residues critical for editing, conserved deaminase residues in each PPR protein were mutagenized. The mutant PPR proteins, when expressed in qed1 or rare1 mutant protoplasts, could not complement the editing defect. Therefore, the DYW motif, and specifically, the deaminase residues, of QED1 and RARE1 are required for editing efficiency.	[Wagoner, Jessica A.; Sun, Tao; Lin, Lin; Hanson, Maureen R.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Hanson, MR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Biotechnol Bldg, Ithaca, NY 14853 USA.	mrh5@cornell.edu	Hanson, Maureen R/D-3879-2009	Hanson, Maureen R/0000-0001-8141-3058	National Science Foundation (NSF) [MCB-0929423, MCB-1330294]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER; Direct For Biological Sciences [1330294] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) Grants MCB-0929423 and MCB-1330294 (to M. R. H.).	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bock R, 1996, EMBO J, V15, P5052, DOI 10.1002/j.1460-2075.1996.tb00885.x; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Brehme N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00127; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2013, J BIOL CHEM, V288, P36519, DOI 10.1074/jbc.M113.485755; HILDEBRAND M, 1988, P NATL ACAD SCI USA, V85, P372, DOI 10.1073/pnas.85.2.372; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Jakoby MJ, 2006, PLANT PHYSIOL, V141, P1293, DOI 10.1104/pp.106.081406; JEFFERSON RA, 1987, EMBO J, V6, P3901; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; KOLLER B, 1987, CELL, V48, P111, DOI 10.1016/0092-8674(87)90361-8; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Tsugeki R, 1996, PLANT J, V10, P479, DOI 10.1046/j.1365-313X.1996.10030479.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zehrmann A, 2010, FEBS LETT, V584, P4181, DOI 10.1016/j.febslet.2010.08.049; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	46	69	73	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2957	2968		10.1074/jbc.M114.622084	http://dx.doi.org/10.1074/jbc.M114.622084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512379	hybrid, Green Published			2022-12-28	WOS:000349310700034
J	Sanyal, A; Chen, AJ; Nakayasu, ES; Lazar, CS; Zbornik, EA; Worby, CA; Koller, A; Mattoo, S				Sanyal, Anwesha; Chen, Andy J.; Nakayasu, Ernesto S.; Lazar, Cheri S.; Zbornik, Erica A.; Worby, Carolyn A.; Koller, Antonius; Mattoo, Seema			A Novel Link between Fic (Filamentation Induced by cAMP)-mediated Adenylylation/AMPylation and the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; KINASE; TRANSFERASE; AMPYLATION; SUBSTRATE; TOPOLOGY; ENZYMES; FAMILY; IBPA; TU	The maintenance of endoplasmic reticulum (ER) homeostasis is a critical aspect of determining cell fate and requires a properly functioning unfolded protein response (UPR). Wehave discovered a previously unknown role of a post-translational modification termed adenylylation/AMPylation in regulating signal transduction events during UPR induction. A family of enzymes, defined by the presence of a Fic (filamentation induced by cAMP) domain, catalyzesthisadenylylationreaction. Thehumangenome encodes a single Fic protein, called HYPE (Huntingtin yeast interacting protein E), with adenylyltransferase activity but unknown physiological target(s). Here, we demonstrate that HYPE localizes to the lumen of the endoplasmic reticulum via its hydrophobic N terminus and adenylylates the ER molecular chaperone, BiP, at Ser-365 and Thr-366. BiP functions as a sentinel for protein misfolding and maintains ER homeostasis. We found that adenylylation enhances BiP's ATPase activity, which is required for refolding misfolded proteins while coping with ER stress. Accordingly, HYPE expression levels increase upon stress. Furthermore, siRNA-mediated knockdown of HYPE prevents the induction of an unfolded protein response. Thus, we identify HYPE as a new UPR regulator and provide the first functional data for Fic-mediated adenylylation in mammalian signaling.	[Sanyal, Anwesha; Chen, Andy J.; Zbornik, Erica A.; Mattoo, Seema] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Nakayasu, Ernesto S.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Lazar, Cheri S.; Worby, Carolyn A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Koller, Antonius] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mattoo, S (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St,LILY G-227, W Lafayette, IN 47907 USA.	smattoo@purdue.edu	Mattoo, Seema/ABD-5624-2021; Nakayasu, Ernesto S./AAJ-8374-2020	Mattoo, Seema/0000-0003-3260-0046; Nakayasu, Ernesto S./0000-0002-4056-2695	American Cancer Society [ACS IRG 58-006-53]; Indiana Clinical and Translational Research Grant [CTSI 106564]; Purdue Research Foundation; Showalter Research Trust [207655]; Yeunkyung Woo Achieve Excellence Travel Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100092] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Indiana Clinical and Translational Research Grant; Purdue Research Foundation; Showalter Research Trust; Yeunkyung Woo Achieve Excellence Travel Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Cancer Society Institutional Research Grant ACS IRG 58-006-53, Indiana Clinical and Translational Research Grant CTSI 106564, a Purdue Research Foundation Summer Faculty Grant, Showalter Research Trust Award 207655 (to S. M.), and a Yeunkyung Woo Achieve Excellence Travel Grant (to A. S.).	Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruz JW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004349; Cruz JW, 2014, J BIOL CHEM, V289, P7788, DOI 10.1074/jbc.M113.544429; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hohfeld J., 1995, CELL, V83, P589; Jwa M, 2012, NAT CELL BIOL, V14, P1223, DOI 10.1038/ncb2593; Lewallen DM, 2014, ACS CHEM BIOL, V9, P433, DOI 10.1021/cb4006886; Lorenz Holger, 2008, V440, P227, DOI 10.1007/978-1-59745-178-9_17; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429; Wiley SE, 2009, METHOD ENZYMOL, V456, P233, DOI 10.1016/S0076-6879(08)04413-3; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zekarias B, 2010, INFECT IMMUN, V78, P1850, DOI 10.1128/IAI.01277-09; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	33	67	70	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8482	8499		10.1074/jbc.M114.618348	http://dx.doi.org/10.1074/jbc.M114.618348			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25601083	Green Published, hybrid			2022-12-28	WOS:000351662600040
J	Maretzky, T; Evers, A; Le Gall, S; Alabi, RO; Speck, N; Reiss, K; Blobel, CP				Maretzky, Thorsten; Evers, Astrid; Le Gall, Sylvain; Alabi, Rolake O.; Speck, Nancy; Reiss, Karina; Blobel, Carl P.			The Cytoplasmic Domain of A Disintegrin and Metalloproteinase 10 (ADAM10) Regulates Its Constitutive Activity but Is Dispensable for Stimulated ADAM10-dependent Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; Cell Surface Enzyme; Metalloprotease; Proprotein Convertase Subtilisin; Kexin Type 9 (PCSK9); Shedding; Cytoplasmic Domain; Protein Ectodomain Shedding	NECROSIS-FACTOR-ALPHA; AMYLOID PRECURSOR PROTEIN; GROWTH-FACTOR-RECEPTOR; SUBSTRATE SELECTIVITY; CONVERTING-ENZYME; SECRETASE ADAM10; NOTCH ACTIVATION; CALCIUM INFLUX; MOUSE MODEL; TACE	Background: Release of membrane proteins from the cell surface by the metalloproteinase ADAM10 is post-translationally regulated. Results: The cytoplasmic domain of ADAM10 negatively controls its constitutive activity but is dispensable for its stimulation. Conclusion: Post-translational stimulation of ADAM10 requires its transmembrane and/or extracellular domain. Significance: Elucidating the regulation of ADAM10 is crucial for understanding the control of ADAM10-dependent cell surface proteolysis. The membrane-anchored metalloproteinase a disintegrin and metalloprotease 10 (ADAM10) is required for shedding of membrane proteins such as EGF, betacellulin, the amyloid precursor protein, and CD23 from cells. ADAM10 is constitutively active and can be rapidly and post-translationally enhanced by several stimuli, yet little is known about the underlying mechanism. Here, we use ADAM10-deficient cells transfected with wild type or mutant ADAM10 to address the role of its cytoplasmic and transmembrane domain in regulating ADAM10-dependent protein ectodomain shedding. We report that the cytoplasmic domain of ADAM10 negatively regulates its constitutive activity through an ER retention motif but is dispensable for its stimulated activity. However, chimeras with the extracellular domain of ADAM10 and the transmembrane domain of ADAM17 with or without the cytoplasmic domain of ADAM17 show reduced stimulated shedding of the ADAM10 substrate betacellulin, whereas the ionomycin-stimulated shedding of the ADAM17 substrates CD62-L and TGF is not affected. Moreover, we show that influx of extracellular calcium activates ADAM10 but is not essential for its activation by APMA and BzATP. Finally, the rapid stimulation of ADAM10 is not significantly affected by incubation with proprotein convertase inhibitors for up to 8 h, arguing against a major role of increased prodomain removal in the rapid stimulation of ADAM10. Thus, the cytoplasmic domain of ADAM10 negatively influences constitutive shedding through an ER retention motif, whereas the cytoplasmic domain and prodomain processing are not required for the rapid activation of ADAM10-dependent shedding events.	[Maretzky, Thorsten; Evers, Astrid; Le Gall, Sylvain; Alabi, Rolake O.; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Blobel, Carl P.] Weill Cornell Med Coll, Dept Physiol Biophys & Syst Biol, New York, NY 10021 USA; [Evers, Astrid; Speck, Nancy; Reiss, Karina] Univ Hosp Schleswig Holstein, Dept Dermatol Venerol & Allergol, D-24105 Kiel, Germany; [Alabi, Rolake O.] Rockefeller Univ, Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, Triinst MD PhD Program, New York, NY 10021 USA	Cornell University; Cornell University; University of Kiel; Schleswig Holstein University Hospital; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University	Blobel, CP (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, Caspary Res Bldg,Rm 426,535 East 70th St, New York, NY 10021 USA.	blobelc@hss.edu	Maretzky, Thorsten/AEN-1915-2022; Maretzky, Thorsten/GSN-2981-2022	Maretzky, Thorsten/0000-0003-1282-6080; ALABI, ROLAKE/0000-0001-7650-297X; Le Gall, Sylvie/0000-0003-0385-926X	National Institutes of Health [R01-GM64750, T32-GM007739, T32-EY713820]; Deutsche Forschungsgemeinschaft [DFG-CRC877, A4, DFG-EV 206/1-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM64750 (to C. P. B.), T32-GM007739 (to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional M.D.-Ph.D. Program), and T32-EY713820 (to R. O. A. and the Tri-Institutional Training Program in Vision Research). This work was also supported by Deutsche Forschungsgemeinschaft Grants DFG-CRC877, A4 (to K. R.) and DFG-EV 206/1-1 (to A. E.).	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; BEELER TJ, 1979, J BIOL CHEM, V254, P6229; BLOBEL CP, 1990, J CELL BIOL, V111, P69, DOI 10.1083/jcb.111.1.69; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; ElEtri M, 1996, AM J PHYSIOL-LUNG C, V270, pL386, DOI 10.1152/ajplung.1996.270.3.L386; Endres K, 2014, NEUROLOGY, V83, P1930, DOI 10.1212/WNL.0000000000001017; Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Hall RJ, 2003, DEV BIOL, V256, P146, DOI 10.1016/S0012-1606(02)00133-1; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Marcello E, 2010, J BIOL CHEM, V285, P10376, DOI 10.1074/jbc.M109.055947; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schmitt U, 2006, BEHAV BRAIN RES, V175, P278, DOI 10.1016/j.bbr.2006.08.030; Schroeder A, 2009, J ALZHEIMERS DIS, V16, P309, DOI 10.3233/JAD-2009-0952; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Wild-Bode C, 2006, J BIOL CHEM, V281, P23824, DOI 10.1074/jbc.M601542200; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084617; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	40	25	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7416	7425		10.1074/jbc.M114.603753	http://dx.doi.org/10.1074/jbc.M114.603753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605720	Green Published, hybrid			2022-12-28	WOS:000351613600010
J	Yang, YK; Mishra, V; Crasto, CJ; Chen, M; Dimmitt, R; Harmon, CM				Yang, Yingkui; Mishra, Vinod; Crasto, Chiquito J.; Chen, Min; Dimmitt, Reed; Harmon, Carroll M.			Third Transmembrane Domain of the Adrenocorticotropic Receptor Is Critical for Ligand Selectivity and Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Cyclic AMP (cAMP); G Protein-coupled Receptor (GPCR); Membrane Protein; Peptide Hormone	FAMILIAL GLUCOCORTICOID DEFICIENCY; MOUSE MELANOCORTIN RECEPTORS; ALPHA-MELANOTROPIN; TETRAPEPTIDE AC-HIS-DPHE-ARG-TRP-NH2; MOLECULAR DETERMINANTS; STIMULATING HORMONE; BIOLOGICAL-ACTIVITY; GENE; ACTH; MUTATIONS	Background: The ACTH receptor regulates adrenocortical function. Results: Substitution of Phe(7) in ACTH with d-Phe or d-Nal(2) and mutation of MC2R TM3 resulted in decreased ACTH binding and signaling. Conclusion: Phe(7) in the ligand ACTH and TM3 of the ACTH receptor are crucial for ligand binding and signaling. Significance: Elucidating the ACTH receptor is crucial for development of MC2R drugs. The ACTH receptor, known as the melanocortin-2 receptor (MC2R), plays an important role in regulating and maintaining adrenocortical function. MC2R is a subtype of the melanocortin receptor (MCR) family and has unique characteristics among MCRs. Endogenous ACTH is the only endogenous agonist for MC2R, whereas the melanocortin peptides -, -, and -melanocyte-stimulating hormone and ACTH are full agonists for all other MCRs. In this study, we examined the molecular basis of MC2R responsible for ligand selectivity using ACTH analogs and MC2R mutagenesis. Our results indicate that substitution of Phe(7) with d-Phe or d-naphthylalanine (d-Nal(2)) in ACTH(1-24) caused a significant decrease in ligand binding affinity and potency. Substitution of Phe(7) with d-Nal(2) in ACTH(1-24) did not switch the ligand from agonist to antagonist at MC2R, which was observed in MC3R and MC4R. Substitution of Phe(7) with d-Phe(7) in ACTH(1-17) resulted in the loss of ligand binding and activity. Molecular analysis of MC2R indicated that only mutation of the third transmembrane domain of MC2R resulted in a decrease in d-Phe ACTH binding affinity and potency. Our results suggest that Phe(7) in ACTH plays an important role in ligand selectivity and that the third transmembrane domain of MC2R is crucial for ACTH selectivity and potency.	[Yang, Yingkui; Chen, Min; Harmon, Carroll M.] SUNY Buffalo, Dept Surg, Buffalo, NY 14203 USA; [Mishra, Vinod] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA; [Crasto, Chiquito J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA; [Dimmitt, Reed] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yang, YK (corresponding author), SUNY Buffalo, Div Pediat Surg, 875 Ellicott St,Rm 8030C, Buffalo, NY 14260 USA.	yingkuiy@buffalo.edu	Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512				BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Chen M, 2007, BIOCHEMISTRY-US, V46, P11389, DOI 10.1021/bi700125e; Clark AJL, 2005, TRENDS ENDOCRIN MET, V16, P451, DOI 10.1016/j.tem.2005.10.006; Clark AJL, 1998, ENDOCR REV, V19, P828, DOI 10.1210/er.19.6.828; CLARK AJL, 1993, LANCET, V341, P461, DOI 10.1016/0140-6736(93)90208-X; Conrad DM, 2004, J CELL BIOCHEM, V92, P387, DOI 10.1002/jcb.20064; Fluck CE, 2002, J CLIN ENDOCR METAB, V87, P4318, DOI 10.1210/jc.2002-020501; GOLDMAN JM, 1970, BRIT J PHARMACOL, V39, P160, DOI 10.1111/j.1476-5381.1970.tb09565.x; HaskellLuevano C, 1997, J MED CHEM, V40, P2133, DOI 10.1021/jm960840h; Holder JR, 2003, PEPTIDES, V24, P73, DOI 10.1016/S0196-9781(02)00278-4; Holder JR, 2003, EUR J PHARMACOL, V462, P41, DOI 10.1016/S0014-2999(03)01322-0; Holder JR, 2002, J MED CHEM, V45, P2801, DOI 10.1021/jm0104872; Holder JR, 2002, J MED CHEM, V45, P3073, DOI 10.1021/jm010524p; HRUBY VJ, 1995, J MED CHEM, V38, P3454, DOI 10.1021/jm00018a005; Imamine H, 2005, TOHOKU J EXP MED, V205, P123, DOI 10.1620/tjem.205.123; Matsuura H, 2006, J PEDIATR ENDOCR MET, V19, P1167; MIGEON CJ, 1968, PEDIATR RES, V2, P501, DOI 10.1203/00006450-196811000-00008; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Naville D, 1996, J CLIN ENDOCR METAB, V81, P1442, DOI 10.1210/jc.81.4.1442; SAWYER TK, 1982, P NATL ACAD SCI-BIOL, V79, P1751, DOI 10.1073/pnas.79.6.1751; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; SAWYER TK, 1982, J MED CHEM, V25, P1022, DOI 10.1021/jm00351a004; Schioth HB, 1999, NEUROPEPTIDES, V33, P191, DOI 10.1054/npep.1999.0760; Selva KA, 2004, J PEDIATR ENDOCR MET, V17, P85; SHEPARD TH, 1959, AMA J DIS CHILD, V97, P154, DOI 10.1001/archpedi.1959.02070010156002; SHIZUME K, 1954, ENDOCRINOLOGY, V54, P553, DOI 10.1210/endo-54-5-553; Slavotinek AM, 1998, CLIN GENET, V53, P57, DOI 10.1034/j.1399-0004.1998.531530112.x; Todorovic A, 2005, J MED CHEM, V48, P3328, DOI 10.1021/jm0490843; TSIGOS C, 1993, J CLIN INVEST, V92, P2458, DOI 10.1172/JCI116853; WEBER A, 1994, HUM MOL GENET, V3, P585, DOI 10.1093/hmg/3.4.585; WEBER A, 1995, J CLIN ENDOCR METAB, V80, P65, DOI 10.1210/jc.80.1.65; Yang Y, 2000, BIOCHEMISTRY-US, V39, P14900, DOI 10.1021/bi001684q; Yang YK, 1997, J BIOL CHEM, V272, P23000, DOI 10.1074/jbc.272.37.23000; Yang YK, 1999, J BIOL CHEM, V274, P14100, DOI 10.1074/jbc.274.20.14100; Yang YK, 2002, J BIOL CHEM, V277, P20328, DOI 10.1074/jbc.M201343200	35	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7685	7692		10.1074/jbc.M114.596122	http://dx.doi.org/10.1074/jbc.M114.596122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25605722	hybrid, Green Published			2022-12-28	WOS:000351613600030
J	Bakhrebah, M; Zhang, T; Mann, JR; Kalitsis, P; Hudson, DF				Bakhrebah, Muhammed; Zhang, Tao; Mann, Jeff R.; Kalitsis, Paul; Hudson, Damien F.			Disruption of a Conserved CAP-D3 Threonine Alters Condensin Loading on Mitotic Chromosomes Leading to Chromosome Hypercondensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL MAINTENANCE; VERTEBRATE CELLS; TOPOISOMERASE-II; EGG EXTRACTS; AURORA-B; CENP-C; MITOSIS; ARCHITECTURE; CHROMATIN; PROTEIN	The condensin complex plays a key role in organizing mitotic chromosomes. In vertebrates, there are two condensin complexes that have independent and cooperative roles in folding mitotic chromosomes. In this study, we dissect the role of a putative Cdk1 site on the condensin II subunit CAP-D3 in chicken DT40 cells. This conserved site has been shown to activate condensin II during prophase in human cells, and facilitate further phosphorylation by polo-like kinase I. We examined the functional significance of this phosphorylation mark by mutating the orthologous site of CAP-D3 (CAP-D3T1403A) in chicken DT40 cells. We show that this mutation is a gain of function mutant in chicken cells; it disrupts prophase, results in a dramatic shortening of the mitotic chromosome axis, and leads to abnormal INCENP localization. Our results imply phosphorylation of CAP-D3 acts to limit condensin II binding onto mitotic chromosomes. We present the first in vivo example that alters the ratio of condensin I: II on mitotic chromosomes. Our results demonstrate this ratio is a critical determinant in shaping mitotic chromosomes.	[Bakhrebah, Muhammed; Zhang, Tao; Mann, Jeff R.; Kalitsis, Paul; Hudson, Damien F.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Bakhrebah, Muhammed; Zhang, Tao; Mann, Jeff R.; Kalitsis, Paul; Hudson, Damien F.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Hudson, DF (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	damien.hudson@mcri.edu.au	Zhang, Tao/ABA-8667-2020; Kalitsis, Paul/C-1916-2015; Bakhrbh, Mohamed/O-2382-2019	Kalitsis, Paul/0000-0001-5569-0609; Zhang, Tao/0000-0003-1155-1492; Mann, Jeff/0000-0003-0028-8692	National Health and Medical Research Council (NHMRC) [GNT1030358, GNT1047009]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council (NHMRC) Project Grants GNT1030358 and GNT1047009 and the Victorian Government's Operational Infrastructure Support Program.	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; Aragon L, 2013, CURR OPIN GENET DEV, V23, P204, DOI 10.1016/j.gde.2012.11.004; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; BAKSA K, 1993, GENETICS, V135, P117; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Farr CJ, 2014, NUCLEIC ACIDS RES, V42, P4414, DOI 10.1093/nar/gku076; Flemming W, 1878, SCHRIFTEN NATURWISSE, V3, P23; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Green LC, 2012, J CELL SCI, V125, P1591, DOI 10.1242/jcs.097790; GURDON JB, 1968, J EMBRYOL EXP MORPH, V20, P401; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Hudson DF, 2002, TRENDS CELL BIOL, V12, P281, DOI 10.1016/S0962-8924(02)02281-X; Kim JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3537; Kim JH, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-50; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kranz AL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r112; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Moser SC, 2011, CHROMOSOME RES, V19, P307, DOI 10.1007/s10577-011-9198-3; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Oliveira RA, 2007, CHROMOSOMA, V116, P259, DOI 10.1007/s00412-007-0097-5; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Piazza I, 2013, CHROMOSOMA, V122, P175, DOI 10.1007/s00412-013-0405-1; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2012, EXP CELL RES, V318, P1435, DOI 10.1016/j.yexcr.2012.03.017; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Wilkins BJ, 2014, SCIENCE, V343, P77, DOI 10.1126/science.1244508	54	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6156	6167		10.1074/jbc.M114.627109	http://dx.doi.org/10.1074/jbc.M114.627109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25605712	Green Published, hybrid			2022-12-28	WOS:000350732500024
J	Piejko, M; Dec, R; Babenko, V; Hoang, A; Szewczyk, M; Mak, P; Dzwolak, W				Piejko, Marcin; Dec, Robert; Babenko, Viktoria; Hoang, Agnieszka; Szewczyk, Monika; Mak, Pawel; Dzwolak, Wojciech			Highly Amyloidogenic Two-chain Peptide Fragments Are Released upon Partial Digestion of Insulin with Pepsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; FIBRIL FORMATION; LIMITED PROTEOLYSIS; ALPHA-LACTALBUMIN; DEGRADING ENZYME; CORE STRUCTURE; AGGREGATION; MICROSCOPY; LYSOZYME; FEATURES	Proteases play a well recognized role in the emergence of highly aggregation-prone protein fragments in vivo, whereas in vitro limited proteolysis is often employed to probe different phases of amyloidogenic pathways. Here, we show that addition of moderate amounts of pepsin to acidified bovine insulin at close to physiological temperature results in an abrupt self-assembly of amyloid-like fibrils from partially digested insulin fragments. Biochemical analysis of the pepsin-induced fibrils implicates peptide fragments (named H) consisting of the 13 or 15 N-terminal residues of the A-chain and 11 or 13 N-terminal residues of the B-chain linked by the disulfide bond between Cys-7A-Cys-7B as the main constituents. There are up to eight pepsin-cleavage sites remaining within the double chain peptide, which become protected upon fast fibrillation unless concentration of the enzyme is increased resulting in complete digestion of insulin. Controlled re-association of H-peptides leads to "explosive" fibrillation only under nonreducing conditions implying the key role of the disulfide bond in their amyloidogenicity. Such re-assembled amyloid is similar in terms of morphology and infrared features to typical bovine insulin fibrils, although it lacks the ability to seed the intact protein.	[Piejko, Marcin; Babenko, Viktoria; Hoang, Agnieszka; Dzwolak, Wojciech] Polish Acad Sci, Inst High Pressure Phys, Prot Biophys Grp, PL-01142 Warsaw, Poland; [Piejko, Marcin; Mak, Pawel] Jagiellonian Univ, Dept Analyt Biochem, PL-30387 Krakow, Poland; [Hoang, Agnieszka] Jagiellonian Univ, Div Cell Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Mak, Pawel] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Dec, Robert; Babenko, Viktoria; Szewczyk, Monika; Dzwolak, Wojciech] Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of High Pressure Physics of the Polish Academy of Sciences; Jagiellonian University; Jagiellonian University; Jagiellonian University; University of Warsaw	Dzwolak, W (corresponding author), Univ Warsaw, Dept Chem, Biol & Chem Res Ctr, Pasteura 1, PL-02093 Warsaw, Poland.	wdzwolak@chem.uw.edu.pl	Piejko, Marcin/U-4183-2018	Piejko, Marcin/0000-0003-3251-5984; Dzwolak, Wojciech/0000-0002-1407-1497; Mak, Pawel/0000-0002-5222-3922	National Science Centre of Poland [DEC-2012/07/B/NZ1/02642]; European Union [POIG.02.01.00-12-064/08, POIG.02.01.00-12-167/08]	National Science Centre of Poland(National Science Centre, Poland); European Union(European Commission)	This work was supported by National Science Centre of Poland Grant DEC-2012/07/B/NZ1/02642 (to W. D.). Biochemical analysis of products of insulin degradation products was partially carried out using equipment obtained with the support of European Union structural funds (grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08).	Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Babenko V, 2013, LANGMUIR, V29, P5271, DOI 10.1021/la400612w; Babenko V, 2011, CHEM COMMUN, V47, P10686, DOI 10.1039/c1cc14230e; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; de Laureto PP, 2005, FEBS J, V272, P2176, DOI 10.1111/j.1742-4658.2005.04638.x; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dzwolak W, 2004, PROTEIN SCI, V13, P1927, DOI 10.1110/ps.03607204; Dzwolak W, 2003, BIOCHEMISTRY-US, V42, P11347, DOI 10.1021/bi034879h; EMESON EE, 1966, J CELL BIOL, V28, P570, DOI 10.1083/jcb.28.3.570; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fodera V, 2010, SOFT MATTER, V6, P4413, DOI 10.1039/c0sm00169d; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; Graveland-Bikker JF, 2006, NANO LETT, V6, P616, DOI 10.1021/nl052205h; Harel M, 2008, J AM CHEM SOC, V130, P7856, DOI 10.1021/ja7109822; Hartman K, 2013, PEERJ, V1, DOI 10.7717/peerj.5; Hooper NM, 2005, BIOCHEM SOC T, V33, P335, DOI 10.1042/BST0330335; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Ipsen R, 2007, BIOTECHNOL ADV, V25, P602, DOI 10.1016/j.biotechadv.2007.07.006; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Kubler E, 2003, BRIT MED BULL, V66, P267, DOI 10.1093/bmb/66.1.267; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Loksztejn A, 2008, J MOL BIOL, V379, P9, DOI 10.1016/j.jmb.2008.03.057; Malisauskas M, 2010, J MOL BIOL, V396, P60, DOI 10.1016/j.jmb.2009.11.012; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Podesta A, 2006, BIOPHYS J, V90, P589, DOI 10.1529/biophysj.105.068833; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Steiner DF, 2009, DIABETES OBES METAB, V11, P189, DOI 10.1111/j.1463-1326.2009.01106.x; STEINER DF, 1967, P NATL ACAD SCI USA, V57, P473, DOI 10.1073/pnas.57.2.473; Stix B, 2001, AM J PATHOL, V159, P561, DOI 10.1016/S0002-9440(10)61727-0; Surmacz-Chwedoruk W, 2012, BIOCHEMISTRY-US, V51, P9460, DOI 10.1021/bi301144d; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weksler ME, 2005, IMMUNOL REV, V205, P244, DOI 10.1111/j.0105-2896.2005.00264.x; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Wolfe MS, 2007, J CELL SCI, V120, P3157, DOI 10.1242/jcs.03481; YAMADA T, 1995, SCAND J IMMUNOL, V41, P94, DOI 10.1111/j.1365-3083.1995.tb03538.x; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	52	22	23	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					5947	5958		10.1074/jbc.M114.608844	http://dx.doi.org/10.1074/jbc.M114.608844			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586185	Green Published, hybrid			2022-12-28	WOS:000350732500002
J	Gregory, JC; Buffa, JA; Org, E; Wang, ZN; Levison, BS; Zhu, WF; Wagner, MA; Bennett, BJ; Li, L; DiDonato, JA; Lusis, AJ; Hazen, SL				Gregory, Jill C.; Buffa, Jennifer A.; Org, Elin; Wang, Zeneng; Levison, Bruce S.; Zhu, Weifei; Wagner, Matthew A.; Bennett, Brian J.; Li, Lin; DiDonato, Joseph A.; Lusis, Aldons J.; Hazen, Stanley L.			Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIMETHYLAMINE-N-OXIDE; INTESTINAL MICROBIOTA; PROGNOSTIC VALUE; METABOLISM; PHOSPHATIDYLCHOLINE; NUTRIENT; DEPENDS; MICE	Recent studies indicate both clinical and mechanistic links between atherosclerotic heart disease and intestinal microbial metabolism of certain dietary nutrients producing trimethylamine N-oxide (TMAO). Here we test the hypothesis that gut microbial transplantation can transmit choline diet-induced TMAO production and atherosclerosis susceptibility. First, a strong association was noted between atherosclerotic plaque and plasma TMAO levels in a mouse diversity panel (n = 22 strains, r = 0.38;p = 0.0001). An atherosclerosis-prone and high TMAO-producing strain, C57BL/6J, and an atherosclerosis-resistant and low TMAO-producing strain, NZW/LacJ, were selected as donors for cecal microbial transplantation into apolipoprotein e null mice in which resident intestinal microbes were first suppressed with antibiotics. Trimethylamine (TMA) and TmAo levels were initially higher in recipients on choline diet that received cecal microbes from C57B1/6J inbred mice; however, durability of choline diet-dependent differences in TMA/TMAO levels was not maintained to the end of the study. Mice receiving C57BL/6J cecal microbes demonstrated choline diet-dependent enhancement in atherosclerotic plaque burden as compared with recipients of NZW/LacJ microbes. Microbial DNA analyses in feces and cecum revealed transplantation of donor microbial community features into recipients with differences in taxa proportions between donor strains that were transmissible to recipients and that tended to show coincident proportions with TMA() levels. Proportions of specific taxa were also identified that correlated with plasma TmAo levels in donors and recipients and with atherosclerotic lesion area in recipients. Atherosclerosis susceptibility may be transmitted via transplantation of gut microbiota. Gut microbes may thus represent a novel therapeutic target for modulating atherosclerosis susceptibility.	[Gregory, Jill C.; Buffa, Jennifer A.; Wang, Zeneng; Levison, Bruce S.; Zhu, Weifei; Wagner, Matthew A.; Li, Lin; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Gregory, Jill C.; Buffa, Jennifer A.; Wang, Zeneng; Levison, Bruce S.; Zhu, Weifei; Wagner, Matthew A.; Li, Lin; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Org, Elin; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Org, Elin; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Bennett, Brian J.] Univ N Carolina, Inst Nutr Res, Dept Genet, Chapel Hill, NC 28081 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, 9500 Euclid Ave,NC 10, Cleveland, OH 44195 USA.	hazens@ccf.org	Wang, Zeneng/AAK-6119-2021; Hazen, Stanley L/ABD-5845-2021; Org, Elin/AAJ-9631-2021	Org, Elin/0000-0003-1451-9375; Org, Elin/0000-0001-8688-9717; bennett, brian/0000-0002-0766-3195; Levison, Bruce/0000-0002-1816-368X	National Institutes of Health from the Office of Dietary Supplements [R01 HL103866, P20 HL113452, HL28481, HL30568]; Cleveland Heart Lab, Inc.; Esperion; Liposciences Inc.; Merck Co., Inc.; Pfizer Inc.; Proctor Gamble; Abbott; Cleveland HeartLab; Liposciences, Inc.; Takeda; National Institutes of Health [T32 GM088088]; MOBILITAS [MJD252]; FP7-People-IOF from the European Union [330381]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103866, P01HL028481, P01HL030568, P20HL113452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088] Funding Source: NIH RePORTER	National Institutes of Health from the Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Heart Lab, Inc.; Esperion; Liposciences Inc.; Merck Co., Inc.(Merck & Company); Pfizer Inc.(Pfizer); Proctor Gamble(Procter & Gamble); Abbott(Abbott Laboratories); Cleveland HeartLab; Liposciences, Inc.; Takeda(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MOBILITAS; FP7-People-IOF from the European Union; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL103866 (to S. L. H.), P20 HL113452 to S. L. H.), and HL28481 and HL30568 (to A. J. L.) from the Office of Dietary Supplements. Drs. Hazen, Wang, and Levison are named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. Dr. Hazen reports he has been paid as a consultant or speaker by the following companies: Cleveland Heart Lab, Inc., Esperion, Liposciences Inc., Merck & Co., Inc., Pfizer Inc., and Proctor & Gamble. Dr. Hazen reports he has received research funds from Abbott, Cleveland HeartLab, Liposciences, Inc., Proctor & Gamble, and Takeda. Drs. Hazen, Wang, and Levison have the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland HeartLab, Inc., Esperion, and/or Frantz Biomarkers.; Supported in part by National Institutes of Health Training Grant T32 GM088088.; Supported in part by Postdoctoral Grants MJD252 (from MOBILITAS) and FP7-People-IOF (330381) (from the European Union).	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Bennett BJ, 2012, ARTERIOSCL THROM VAS, V32, P1790, DOI 10.1161/ATVBAHA.112.253864; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Brown JM, 2014, CURR OPIN LIPIDOL, V25, P48, DOI 10.1097/MOL.0000000000000036; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dolman C. E., 1973, DICT SCI BIOGRAPHY, P420; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EISEMAN B, 1958, SURGERY, V44, P854; Ellekilde M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05922; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koch R., 1880, INVESTIGATIONS ETIOL; Koch R, 1882, BERLINER KLIN WOCHEN, V19, P221, DOI DOI 10.25646/5088; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Pirrung M, 2011, BIOINFORMATICS, V27, P3067, DOI 10.1093/bioinformatics/btr517; Rehg JE, 2012, TOXICOL PATHOL, V40, P345, DOI 10.1177/0192623311430695; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang ZN, 2014, ANAL BIOCHEM, V455, P35, DOI 10.1016/j.ab.2014.03.016; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	37	307	329	4	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5647	5660		10.1074/jbc.M114.618249	http://dx.doi.org/10.1074/jbc.M114.618249			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25550161	hybrid, Green Published			2022-12-28	WOS:000350044200034
J	Katoch, P; Mitra, S; Ray, A; Kelsey, L; Roberts, BJ; Wahl, JK; Johnson, KR; Mehta, PP				Katoch, Parul; Mitra, Shalini; Ray, Anuttoma; Kelsey, Linda; Roberts, Brett J.; Wahl, James K., III; Johnson, Keith R.; Mehta, Parmender P.			The Carboxyl Tail of Connexin32 Regulates Gap Junction Assembly in Human Prostate and Pancreatic Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; LIVING CELLS; CYCLIC-AMP; ZONULA OCCLUDENS-1; EPITHELIAL-CELLS; RAT HEPATOCYTES; TIGHT JUNCTIONS; RAFT DOMAINS; E-CADHERIN; CHANNELS	Connexins, the constituent proteins of gap junctions, are transmembrane proteins. A connexin (Cx) traverses the membrane four times and has one intracellular and two extracellular loops with the amino and carboxyl termini facing the cytoplasm. The transmembrane and the extracellular loop domains are highly conserved among different Cxs, whereas the carboxyl termini, often called the cytoplasmic tails, are highly divergent. We have explored the role of the cytoplasmic tail of Cx32, a Cx expressed in polarized and differentiated cells, in regulating gap junction assembly. Our results demonstrate that compared with the full-length Cx32, the cytoplasmic tail-deleted Cx32 is assembled into small gap junctions in human pancreatic and prostatic cancer cells. Our results further document that the expression of the full-length Cx32 in cells, which express the tail-deleted Cx32, increases the size of gap junctions, whereas the expression of the tail-deleted Cx32 in cells, which express the full-length Cx32, has the opposite effect. Moreover, we show that the tail is required for the clustering of cell-cell channels and that in cells expressing the tail-deleted Cx32, the expression of cell surface-targeted cytoplasmic tail alone is sufficient to enhance the size of gap junctions. Our live-cell imaging data further demonstrate that gap junctions formed of the tail-deleted Cx32 are highly mobile compared with those formed of full-length Cx32. Our results suggest that the cytoplasmic tail of Cx32 is not required to initiate the assembly of gap junctions but for their subsequent growth and stability. Our findings suggest that the cytoplasmic tail of Cx32 may be involved in regulating the permeability of gap junctions by regulating their size.	[Katoch, Parul; Mitra, Shalini; Ray, Anuttoma; Kelsey, Linda; Roberts, Brett J.; Wahl, James K., III; Johnson, Keith R.; Mehta, Parmender P.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Dept Oral Biol, Eppley Inst Res Canc & Allied Dis,Fred & Pamela B, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Mehta, PP (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	pmehta@unmc.edu			National Institutes of Health Phase III CoBRE [5P30GM106397]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health Phase III CoBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Souvik Chakraborty for helpful discussion and suggestions. We thank Tom Dao for help with the live-cell imaging and Robert Svoboda for constructed membrane-targeted form of the cytoplasmic tail of connexin32. We also thank Drs. Steve Caplan and Naava Naslavsky for helpful suggestions regarding endocytosis throughout the course of this study. The live cell imaging studies were supported by the National Institutes of Health Phase III CoBRE Grant 5P30GM106397 (to K. R. J.).	ATKINSON MM, 1995, J CELL SCI, V108, P3079; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Chai ZF, 2011, MOL BIOL CELL, V22, P4503, DOI 10.1091/mbc.E11-05-0438; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; Dobrowolski R, 2009, ANTIOXID REDOX SIGN, V11, P283, DOI 10.1089/ars.2008.2128; Duffy HS, 2007, J BIOL CHEM, V282, P9789, DOI 10.1074/jbc.M605261200; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gemel J, 2004, J CELL SCI, V117, P2469, DOI 10.1242/jcs.01084; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; GOURDIE RG, 1991, J CELL SCI, V99, P41; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Govindarajan R, 2010, MOL BIOL CELL, V21, P4089, DOI 10.1091/mbc.E10-05-0403; GUERRIER A, 1995, J CELL SCI, V108, P2609; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Holm I, 1999, EUR J CELL BIOL, V78, P856, DOI 10.1016/S0171-9335(99)80087-9; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Johnson KE, 2013, MOL BIOL CELL, V24, P715, DOI 10.1091/mbc.E12-07-0537; Kelsey L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032846; Kojima T, 1999, BIOCHEM BIOPH RES CO, V266, P222, DOI 10.1006/bbrc.1999.1778; Kojima T, 2001, EXP CELL RES, V263, P193, DOI 10.1006/excr.2000.5103; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Maass K, 2004, MOL BIOL CELL, V15, P4597, DOI 10.1091/mbc.E04-04-0324; Martin PEM, 2000, BIOCHEM J, V349, P281, DOI 10.1042/0264-6021:3490281; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; MEHTA PP, 1992, MOL BIOL CELL, V3, P839, DOI 10.1091/mbc.3.8.839; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Mitra S, 2006, MOL BIOL CELL, V17, P5400, DOI 10.1091/mbc.E06-04-0280; Nielsen PA, 2003, MOL BIOL CELL, V14, P2470, DOI 10.1091/mbc.E02-10-0637; Paulson AF, 2000, J CELL SCI, V113, P3037; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Roberts BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077012; SAEZ JC, 1990, EUR J BIOCHEM, V192, P263, DOI 10.1111/j.1432-1033.1990.tb19223.x; SAEZ JC, 1989, AM J PHYSIOL, V257, pC1, DOI 10.1152/ajpcell.1989.257.1.C1; Schubert AL, 2002, BIOCHEMISTRY-US, V41, P5754, DOI 10.1021/bi0121656; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Simek J, 2009, J CELL SCI, V122, P554, DOI 10.1242/jcs.036970; Solan Joell L., 2009, P263, DOI 10.1007/978-1-59745-489-6_11; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Sosinsky Gina E., 2009, P241, DOI 10.1007/978-1-59745-489-6_10; STAGG RB, 1990, ENDOCR REV, V11, P302, DOI 10.1210/edrv-11-2-302; Stauch K, 2012, J BIOL CHEM, V287, P27771, DOI 10.1074/jbc.M112.382572; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Tomishige M, 1998, J CELL BIOL, V142, P989, DOI 10.1083/jcb.142.4.989; Torok K, 1997, BIOCHEM J, V326, P479; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; WANG YJ, 1995, EUR J CELL BIOL, V67, P285; WANG YJ, 1995, J BIOL CHEM, V270, P26581, DOI 10.1074/jbc.270.44.26581; WANG YJ, 1995, J CELL SCI, V108, P3501; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033	65	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4647	4662		10.1074/jbc.M114.586057	http://dx.doi.org/10.1074/jbc.M114.586057			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25548281	hybrid, Green Published			2022-12-28	WOS:000350042000010
J	Wei, YC; Yang, CR; Wei, YP; Ge, ZJ; Zhao, ZA; Zhang, B; Hou, Y; Schatten, H; Sun, QY				Wei, Yanchang; Yang, Cai-Rong; Wei, Yan-Ping; Ge, Zhao-Jia; Zhao, Zhen-Ao; Zhang, Bing; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			Enriched Environment-induced Maternal Weight Loss Reprograms Metabolic Gene Expression in Mouse Offspring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER DNA METHYLATION; BODY-MASS INDEX; INSULIN-RESISTANCE; DIABETES-MELLITUS; OBESITY; CHILDHOOD; MICE; INHERITANCE; OOCYTES; OVERNUTRITION	The global prevalence of weight loss is increasing, especially in young women. However, the extent and mechanisms by which maternal weight loss affects the offspring is still poorly understood. Here, using an enriched environment (EE)-induced weight loss model, we show that maternal weight loss improves general health and reprograms metabolic gene expression in mouse offspring, and the epigenetic alterations can be inherited for at least two generations. EE in mothers induced weight loss and its associated physiological and metabolic changes such as decreased adiposity and improved glucose tolerance and insulin sensitivity. Relative to controls, their offspring exhibited improved general health such as reduced fat accumulation, decreased plasma and hepatic lipid levels, and improved glucose tolerance and insulin sensitivity. Maternal weight loss altered gene expression patterns in the liver of offspring with coherent down-regulation of genes involved in lipid and cholesterol biosynthesis. Epigenomic profiling of offspring livers revealed numerous changes in cytosine methylation depending on maternal weight loss, including reproducible changes in promoter methylation over several key lipid biosynthesis genes, correlated with their expression patterns. Embryo transfer studies indicated that oocyte alteration in response to maternal metabolic conditions is a strong factor in determining metabolic and epigenetic changes in offspring. Several important lipid metabolism-related genes have been identified to partially inherit methylated alleles from oocytes. Our study reveals a molecular and mechanistic basis of how maternal lifestyle modification affects metabolic changes in the offspring.	[Wei, Yanchang; Yang, Cai-Rong; Ge, Zhao-Jia; Zhao, Zhen-Ao; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Wei, Yan-Ping] Changyi Peoples Hosp, Dept Obstet & Gynecol, Weifang 261300, Peoples R China; [Zhang, Bing] Chinese Acad Sci, Chinese Acad Sci Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing 100029, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Missouri System; University of Missouri Columbia	Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	sunqy@ioz.ac.cn		Wei, Yanchang/0000-0003-4810-9761; Sun, Qing-Yuan/0000-0002-0148-2414; Yang, Cairong/0000-0001-9594-0529	National Natural Science Foundation of China [3147055]; National Basic Research Program of China [2012CB944404, 2011CB944501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 3147055 and National Basic Research Program of China Grants 2012CB944404 and 2011CB944501.	Acevedo N, 2007, BIOL REPROD, V77, P872, DOI 10.1095/biolreprod.107.060152; Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Anckaert E, 2010, BIOL REPROD, V83, P377, DOI 10.1095/biolreprod.109.082164; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Batsis JA, 2007, CLIN PHARMACOL THER, V82, P509, DOI 10.1038/sj.clpt.6100355; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bouchard C, 2009, AM J CLIN NUTR, V89, pS1494, DOI 10.3945/ajcn.2009.27113C; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Cioffi JA, 1997, MOL HUM REPROD, V3, P467, DOI 10.1093/molehr/3.6.467; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Griffioen KJ, 2011, CELL METAB, V14, P287, DOI 10.1016/j.cmet.2011.08.002; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hypponen E, 2003, DIABETES CARE, V26, P2512, DOI 10.2337/diacare.26.9.2512; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lane M, 2014, SCIENCE, V345, P756, DOI 10.1126/science.1254400; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhlhausler BS, 2007, J NEUROENDOCRINOL, V19, P67, DOI 10.1111/j.1365-2826.2006.01505.x; Ooi EMM, 2013, CURR OPIN LIPIDOL, V24, P192, DOI 10.1097/MOL.0b013e3283613ba2; Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Ratchford AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1198, DOI 10.1152/ajpendo.00097.2007; Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; Tomizawa SI, 2012, INT J DEV BIOL, V56, P867, DOI 10.1387/ijdb.120152gk; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Wei YC, 2010, CELL REPROGRAM, V12, P213, DOI 10.1089/cell.2009.0090; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Xu J, 2006, DIABETES, V55, P3429, DOI 10.2337/db06-0260; Yates T, 2012, AM J PREV MED, V42, P1, DOI 10.1016/j.amepre.2011.09.022	64	18	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4604	4619		10.1074/jbc.M114.605642	http://dx.doi.org/10.1074/jbc.M114.605642			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555918	Green Published, hybrid			2022-12-28	WOS:000350042000007
J	Dong, B; Li, H; Singh, AB; Cao, AQ; Liu, JW				Dong, Bin; Li, Hai; Singh, Amar Bahadur; Cao, Aiqin; Liu, Jingwen			Inhibition of PCSK9 Transcription by Berberine Involves Down-regulation of Hepatic HNF1 alpha Protein Expression through the Ubiquitin-Proteasome Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; LDL RECEPTOR; PLASMA PCSK9; LIVER; CHOLESTEROL; ATORVASTATIN; FENOFIBRATE; MECHANISM; BINDING; TARGET	Our previous in vitro studies have identified hepatocyte nuclear factor 1 alpha (HNF1 alpha) as an obligated trans-activator for PCSK9 gene expression and demonstrated its functional involvement in the suppression of PCSK9 expression by berberine (BBR), a natural cholesterol-lowering compound. In this study, we investigated the mechanism underlying the inhibitory effect of BBR on HNF1 alpha-mediated PCSK9 transcription. Administration of BBR to hyperlipidemic mice and hamsters lowered circulating PCSK9 concentrations and hepatic PCSK9 mRNA levels without affecting the gene expression of HNF1 alpha. However, hepatic HNF1 alpha protein levels were markedly reduced in BBR-treated animals as compared with the control. Using HepG2 cells as a model system, we obtained evidence that BBR treatment let to accelerated degradation of HNF1 alpha protein. By applying inhibitors to selectively block the ubiquitin proteasome system (UPS) and autophagy-lysosomal pathway, we show that HNF1 alpha protein content in HepG2 cells was not affected by bafilomycin A1 treatment, but it was dose-dependently increased by UPS inhibitors bortezomib and MG132. Bortezomib treatment elevated HNF1 alpha and PCSK9 cellular levels with concomitant reductions of LDL receptor protein. More-over, HNF1 alpha protein displayed a multiubiquitination ladder pattern in cells treated withBBRor overexpressing ubiquitin. By expressing GFP-HNF1 alpha fusion protein in cells, we observed that blocking UPS resulted in accumulation of GFP-HNF1 alpha in cytoplasm. Importantly, we show that the BBR reducing effects on HNF1 alpha protein and PCSK9 gene transcription can be eradicated by proteasome inhibitors. Altogether, our studies using BBR as a probe uncovered a new aspect of PCSK9 regulation by ubiquitin- induced proteasomal degradation of HNF1 alpha.	[Dong, Bin; Li, Hai; Singh, Amar Bahadur; Cao, Aiqin; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Liu, JW (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Jingwen.Liu@va.gov	Singh, Amar B/I-2253-2014	Singh, Amar B/0000-0002-7677-2424	National Institutes of Health, NCCIH [1R01 AT002543-01A1, 1R01AT006336-01A1]; Department of Veterans Affairs (Office of Research and Development, Medical Research Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002543] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006336] Funding Source: NIH RePORTER	National Institutes of Health, NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health, NCCIH, Grants 1R01 AT002543-01A1 and 1R01AT006336-01A1. This work was also supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service).	Armendariz AD, 2009, CURR OPIN LIPIDOL, V20, P106, DOI 10.1097/MOL.0b013e3283295ee9; Astudillo AM, 2011, J BIOL CHEM, V286, P35299, DOI 10.1074/jbc.M111.277137; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Costet P, 2010, ATHEROSCLEROSIS, V212, P246, DOI 10.1016/j.atherosclerosis.2010.05.027; Dong B, 2014, ATHEROSCLEROSIS, V235, P449, DOI 10.1016/j.atherosclerosis.2014.05.931; Dong B, 2013, J LIPID RES, V54, P1241, DOI 10.1194/jlr.M032599; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 2005, ANGEW CHEM INT EDIT, V44, P5932, DOI 10.1002/anie.200501724; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lambert G, 2008, CLIN CHEM, V54, P1038, DOI 10.1373/clinchem.2007.099747; Li H, 2012, BIOCHEM J, V443, P757, DOI 10.1042/BJ20111645; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Ling H, 2014, CARDIOVASC THER, V32, P82, DOI 10.1111/1755-5922.12056; Matsui C, 2012, J VIROL, V86, P12903, DOI 10.1128/JVI.01418-12; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; MENDEL DB, 1991, J BIOL CHEM, V266, P677; Park IN, 2004, MOL PHARMACOL, V65, P1475, DOI 10.1124/mol.65.6.1475; Peterson AS, 2008, J LIPID RES, V49, P1595, DOI 10.1194/jlr.CX00001-JLR200; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 2001, J EXP MED, V194, P1683, DOI 10.1084/jem.194.11.1683; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Raal F, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000028; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Singh AB, 2014, J LIPID RES, V55, P1397, DOI 10.1194/jlr.M049429; Thompson JL, 2013, ANN PHARMACOTHER, V47, P56, DOI 10.1345/aph.1R561; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Wu MH, 2012, ATHEROSCLEROSIS, V224, P401, DOI 10.1016/j.atherosclerosis.2012.08.012; Yoshizawa K, 2014, CANCER SCI, V105, P195, DOI 10.1111/cas.12335; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	42	99	105	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4047	4058		10.1074/jbc.M114.597229	http://dx.doi.org/10.1074/jbc.M114.597229			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25540198	Green Published, hybrid			2022-12-28	WOS:000349458400017
J	Laursen, KB; Kashyap, V; Scandura, J; Gudas, LJ				Laursen, Kristian B.; Kashyap, Vasundhra; Scandura, Joseph; Gudas, Lorraine J.			An Alternative Retinoic Acid-responsive Stra6 Promoter Regulated in Response to Retinol Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN RECEPTOR; VITAMIN-A HOMEOSTASIS; MATTHEW-WOOD-SYNDROME; EMBRYONIC STEM-CELLS; MEMBRANE-RECEPTOR; F9 CELLS; DOWN-REGULATION; CELLULAR UPTAKE; MICE LACKING; RAR-ALPHA	Cellular uptake of vitamin A (retinol) is essential for many biological functions. The Stra6 protein binds the serum retinolbinding protein, RBP4, and acts in conjunction with the enzyme lecithin: retinol acyltransferase to facilitate retinol uptake in some cell types. We show that in embryonic stem (ES) cells and in some tissues, the Stra6 gene encodes two distinct mRNAs transcribed from two different promoters. Whereas both are all-trans-retinoic acid (RA)-responsive in ES cells, the downstream promoter contains a half-site RA response element (RARE) and drives an similar to 13-fold, RA-associated increase in luciferase reporter activity. We employed CRISPR-Cas9 genome editing to show that the endogenous RARE is required for RA-induced transcription of both Stra6 isoforms. We further demonstrate that in ES cells, 1) both RAR gamma and RXR alpha are present at the Stra6 RARE; 2) RA increases co-activator p300 (KAT3B) binding and histone H3 Lys-27 acetylation at both promoters; 3) RA decreases Suz12 levels and histone H3 Lys-27 trimethylation epigenetic marks at both promoters; and 4) these epigenetic changes are diminished in the absence of RAR gamma. In the brains of WT mice, both the longer and the shorter Stra6 transcript (Stra6(L) and Stra6(S), respectively) are highly expressed, whereas these transcripts are found only at low levels in RAR gamma(-/-) mice. In the brains of vitamin A-deficient mice, both Stra6(L) and Stra6(S) levels are decreased. In contrast, in the vitamin A-deficient kidneys, the Stra6(L) levels are greatly increased, whereas Stra6(S) levels are decreased. Our data show that kidneys respond to retinol deficiency by differential Stra6 promoter usage, which may play a role in the retention of retinol when vitamin A is low.	[Laursen, Kristian B.; Kashyap, Vasundhra; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Scandura, Joseph; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.	ljgudas@med.cornell.edu	Kashyap, Vasundhra/H-8970-2019	Scandura, Joseph/0000-0002-9525-143X	National Institutes of Health, NCI [R01 CA043796]; Weill Cornell funds; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Weill Cornell funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01 CA043796 (to L.J.G.). This work was also supported by Weill Cornell funds.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Amengual J, 2014, HUM MOL GENET, V23, P5402, DOI 10.1093/hmg/ddu258; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Carrera S, 2013, CELL DEATH DIFFER, V20, P910, DOI 10.1038/cdd.2013.14; Chassaing N, 2013, CLIN GENET, V83, P244, DOI 10.1111/j.1399-0004.2012.01904.x; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Chen CH, 2012, J BIOL CHEM, V287, P9694, DOI 10.1074/jbc.M111.301721; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kashyap V, 2010, J BIOL CHEM, V285, P14534, DOI 10.1074/jbc.M110.115345; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2013, J MEMBRANE BIOL, V246, P647, DOI 10.1007/s00232-013-9578-z; Kim YK, 2008, J BIOL CHEM, V283, P5611, DOI 10.1074/jbc.M708885200; Laursen KB, 2013, NUCLEIC ACIDS RES, V41, P6430, DOI 10.1093/nar/gkt367; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Muenzner M, 2013, MOL CELL BIOL, V33, P4068, DOI 10.1128/MCB.00221-13; NAPOLI JL, 1995, J STEROID BIOCHEM, V53, P497, DOI 10.1016/0960-0760(95)00096-I; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Skazik C, 2014, J INVEST DERMATOL, V134, P1579, DOI 10.1038/jid.2013.507; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Urvalek A, 2014, SUBCELL BIOCHEM, V70, P129, DOI 10.1007/978-94-017-9050-5_7; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Wu LL, 2010, J LIPID RES, V51, P378, DOI 10.1194/jlr.M001222; Zemany L, 2014, MOL CELL BIOL, V34, P1170, DOI 10.1128/MCB.01106-13; Zhong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073838	50	22	23	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4356	4366		10.1074/jbc.M114.613968	http://dx.doi.org/10.1074/jbc.M114.613968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25544292	Green Published, hybrid			2022-12-28	WOS:000349458400044
J	Langlois, C; Ramboarina, S; Cukkemane, A; Auzat, I; Chagot, B; Gilquin, B; Ignatiou, A; Petitpas, I; Kasotakis, E; Paternostre, M; White, HE; Orlova, EV; Baldus, M; Tavares, P; Zinn-Justin, S				Langlois, Chantal; Ramboarina, Stephanie; Cukkemane, Abhishek; Auzat, Isabelle; Chagot, Benjamin; Gilquin, Bernard; Ignatiou, Athanasios; Petitpas, Isabelle; Kasotakis, Emmanouil; Paternostre, Maite; White, Helen E.; Orlova, Elena V.; Baldus, Marc; Tavares, Paulo; Zinn-Justin, Sophie			Bacteriophage SPP1 Tail Tube Protein Self-assembles into beta-Structure-rich Tubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERVER; IDENTIFICATION; REVEALS; ORIGIN; PHAGES; C-13; DNA	The majority of known bacteriophages have long tails that serve for bacterial target recognition and viral DNA delivery into the host. These structures form a tube from the viral capsid to the bacterial cell. The tube is formed primarily by a helical array of tail tube protein (TTP) subunits. In phages with a contractile tail, the TTP tube is surrounded by a sheath structure. Here, we report the first evidence that a phage TTP, gp17.1 of siphophage SPP1, self-assembles into long tubes in the absence of other viral proteins. gp17.1 does not exhibit a stable globular structure when monomeric in solution, even if it was confidently predicted to adopt the beta-sandwich fold of phage lambda TTP. However, Fourier transform infrared and nuclear magnetic resonance spectroscopy analyses showed that its beta-sheet content increases significantly during tube assembly, suggesting that gp17.1 acquires a stable beta-sandwich fold only after self-assembly. EM analyses revealed that the tube is formed by hexameric rings stacked helicoidally with the same organization and helical parameters found for the tail of SPP1 virions. These parameters were used to build a pseudo-atomic model of the TTP tube. The large loop spanning residues 40-56 is located on the inner surface of the tube, at the interface between adjacent monomers and hexamers. In line with our structural predictions, deletion of this loop hinders gp17.1 tube assembly in vitro and interferes with SPP1 tail assembly during phage particle morphogenesis in bacteria.	[Langlois, Chantal; Ramboarina, Stephanie; Chagot, Benjamin; Gilquin, Bernard; Kasotakis, Emmanouil; Paternostre, Maite; Zinn-Justin, Sophie] CEA, UMR CNRS 8221, Lab Biol Struct & Radiobiol, F-91191 Gif Sur Yvette, France; [Langlois, Chantal; Ramboarina, Stephanie; Chagot, Benjamin; Gilquin, Bernard; Kasotakis, Emmanouil; Paternostre, Maite; Zinn-Justin, Sophie] CEA, CEA IBITECS, F-91191 Gif Sur Yvette, France; [Cukkemane, Abhishek; Baldus, Marc] Univ Utrecht, Dept Chem, NMR Spect Grp, Bijvoet Ctr Biomol Res,Fac Med, NL-3584 CH Utrecht, Netherlands; [Cukkemane, Abhishek] Tuljaram Chaturchand Coll, Dept Microbiol, Baramati 413102, India; [Auzat, Isabelle; Petitpas, Isabelle; Tavares, Paulo] CNRS, Ctr Rech Gif, CNRS UPR3296, Unite Virol Mol & Struct, F-91198 Gif Sur Yvette, France; [Ignatiou, Athanasios; White, Helen E.; Orlova, Elena V.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; Birkbeck University London	Zinn-Justin, S (corresponding author), CEA, UMR CNRS 8221, Lab Biol Struct & Radiobiol, Saclay Bat 144, F-91191 Gif Sur Yvette, France.	sophie.zinn@cea.fr	Baldus, Marc/C-2737-2009; Chagot, Benjamin/AAC-6495-2019; Orlova, Elena/CAF-8290-2022; Kasotakis, Emmanouil/M-4980-2016	Baldus, Marc/0000-0001-7068-5613; Chagot, Benjamin/0000-0002-9153-0060; Kasotakis, Emmanouil/0000-0002-7263-1384; Tavares, Paulo/0000-0002-2566-4546; Orlova, Elena/0000-0003-3371-415X; cukkemane, abhishek/0000-0002-1532-6869; Paternostre, Maite/0000-0002-3303-8959	French Agence Nationale de la Recherche Program [ANR-09-BLAN-0149-01]; French National Infrastructure FRISBI Program; European Community's Seventh Framework Program, BioNMR Project [211800]; Commissariat a l'Energie Atomique-Eurotalents grant; Netherlands Organization for Scientific Research [700.26.121, 700.10.443]; BBSRC [BB/F012705/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012705/1, B17360, 1350992] Funding Source: researchfish	French Agence Nationale de la Recherche Program(French National Research Agency (ANR)); French National Infrastructure FRISBI Program; European Community's Seventh Framework Program, BioNMR Project; Commissariat a l'Energie Atomique-Eurotalents grant; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by French Agence Nationale de la Recherche Program Grant ANR-09-BLAN-0149-01 (to P. T. and S. Z. J.), French National Infrastructure FRISBI Program, and European Community's Seventh Framework Program, BioNMR Project Contract 211800.; Supported by a Commissariat a l'Energie Atomique-Eurotalents grant.; Supported by the Netherlands Organization for Scientific Research Grants 700.26.121 and 700.10.443.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Auzat I, 2008, MOL MICROBIOL, V70, P557, DOI 10.1111/j.1365-2958.2008.06435.x; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; BEHRENS B, 1979, MOL GEN GENET, V175, P351, DOI 10.1007/BF00397235; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; Davidson AR, 2012, ADV EXP MED BIOL, V726, P115, DOI 10.1007/978-1-4614-0980-9_6; Douzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086918; Droge A, 2000, J MOL BIOL, V296, P103, DOI 10.1006/jmbi.1999.3449; Effantin G, 2013, STRUCTURE, V21, P298, DOI 10.1016/j.str.2012.12.017; Fokine A, 2013, J MOL BIOL, V425, P1731, DOI 10.1016/j.jmb.2013.02.012; Fraser JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/j.mib.2007.05.018; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gradmann S, 2012, J BIOMOL NMR, V54, P377, DOI 10.1007/s10858-012-9681-y; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Isidro A, 2004, MOL MICROBIOL, V51, P949, DOI 10.1046/j.1365-2958.2003.03880.x; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Katsura I, 1990, Adv Biophys, V26, P1, DOI 10.1016/0065-227X(90)90004-D; KING J, 1971, J MOL BIOL, V58, P693, DOI 10.1016/0022-2836(71)90034-9; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; LEGRICE SFJ, 1990, METHOD ENZYMOL, V185, P201; Lopes A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1027; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MORAN CP, 1982, MOL GEN GENET, V186, P339, DOI 10.1007/BF00729452; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sassi M, 2013, J VIROL, V87, P8099, DOI 10.1128/JVI.01209-13; Seidel K, 2004, PHYS CHEM CHEM PHYS, V6, P5090, DOI 10.1039/b411689e; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STEWART M, 1988, J ELECTRON MICR TECH, V9, P325, DOI 10.1002/jemt.1060090404; van Heel M, 2001, COLD SPRING HARB SYM, V66, P77, DOI 10.1101/sqb.2001.66.77; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	42	19	20	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3836	3849		10.1074/jbc.M114.613166	http://dx.doi.org/10.1074/jbc.M114.613166			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525268	Green Published, hybrid			2022-12-28	WOS:000349456000054
J	Carswell, CL; Sun, JY; Baenziger, JE				Carswell, Casey L.; Sun, Jiayin; Baenziger, John E.			Intramembrane Aromatic Interactions Influence the Lipid Sensitivities of Pentameric Ligand-gated Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; TRANSMEMBRANE DOMAIN; CYS-LOOP; STRUCTURAL-CHARACTERIZATION; PROTEIN INTERACTIONS; MOLECULAR-DYNAMICS; PHOSPHATIDIC-ACID; GATING KINETICS; ANIONIC LIPIDS	Although the Torpedo nicotinic acetylcholine receptor (nAChR) reconstituted into phosphatidylcholine (PC) membranes lacking cholesterol and anionic lipids adopts a conformation where agonist binding is uncoupled from channel gating, the underlying mechanism remains to be defined. Here, we examine the mechanism behind lipid-dependent uncoupling by comparing the propensities of two prokaryotic homologs, Gloebacter and Erwinia ligand-gated ion channel (GLIC and ELIC, respectively), to adopt a similar uncoupled conformation. Membrane-reconstituted GLIC and ELIC both exhibit folded structures in the minimal PC membranes that stabilize an uncoupled nAChR. GLIC, with a large number of aromatic interactions at the interface between the outermost transmembrane a-helix, M4, and the adjacent transmembrane a-helices, M1 and M3, retains the ability to flux cations in this uncoupling PC membrane environment. In contrast, ELIC, with a level of aromatic interactions intermediate between that of the nAChR and GLIC, does not undergo agonist-induced channel gating, although it does not exhibit the expected biophysical characteristics of the uncoupled state. Engineering new aromatic interactions at the M4-M1/M3 interface to promote effective M4 interactions with M1/M3, however, increases the stability of the transmembrane domain to restore channel function. Our data provide direct evidence that M4 interactions with M1/M3 are modulated during lipid sensing. Aromatic residues strengthen M4 interactions with M1/M3 to reduce the sensitivities of pentameric ligand-gated ion channels to their surrounding membrane environment.	[Carswell, Casey L.; Sun, Jiayin; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research (CIHR) [111243]; Natural Sciences and Engineering Research Council of Canada [113312]; CIHR Training Program in Neurodegenerative Lipidomics Grant [TGF-96121]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR Training Program in Neurodegenerative Lipidomics Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant 111243 and Natural Sciences and Engineering Research Council of Canada Grant 113312, as well as CIHR Training Program in Neurodegenerative Lipidomics Grant TGF-96121.	Antollini SS, 2005, MOL MEMBR BIOL, V22, P471, DOI 10.1080/09687860500367915; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; BAENZIGER JE, 1995, J BIOL CHEM, V270, P29129, DOI 10.1074/jbc.270.49.29129; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Barrantes FJ, 2002, MOL MEMBR BIOL, V19, P277, DOI 10.1080/09687680210166226; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Carswell CL, 2008, J BACTERIOL, V190, P5650, DOI 10.1128/JB.00298-08; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; daCosta CJB, 2011, BIOCHEM BIOPH RES CO, V407, P456, DOI 10.1016/j.bbrc.2011.03.026; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Labriola JM, 2013, J BIOL CHEM, V288, P11294, DOI 10.1074/jbc.M113.458133; Lasalde JA, 1996, BIOCHEMISTRY-US, V35, P14139, DOI 10.1021/bi961583l; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LI L, 1990, BIOCHEMISTRY-US, V29, P5428, DOI 10.1021/bi00475a003; Li P, 2010, BRIT J PHARMACOL, V160, P1906, DOI 10.1111/j.1476-5381.2010.00761.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MARSH D, 1981, BIOCHIM BIOPHYS ACTA, V645, P97, DOI 10.1016/0005-2736(81)90516-2; Methot N, 2001, J BIOL CHEM, V276, P23726, DOI 10.1074/jbc.M102101200; MORALES A, 1995, P NATL ACAD SCI USA, V92, P8468, DOI 10.1073/pnas.92.18.8468; Pandhare A, 2012, BIOCHEMISTRY-US, V51, P2425, DOI 10.1021/bi300101r; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Ryan SE, 1996, J BIOL CHEM, V271, P24590, DOI 10.1074/jbc.271.40.24590; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sturgeon RM, 2010, BIOPHYS J, V98, P989, DOI 10.1016/j.bpj.2009.11.030; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; Tol MB, 2013, J BIOL CHEM, V288, P5756, DOI 10.1074/jbc.M112.422287; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Velisetty P, 2012, J BIOL CHEM, V287, P36864, DOI 10.1074/jbc.M112.401067; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang HL, 2012, J BIOL CHEM, V287, P6482, DOI 10.1074/jbc.M111.305839; Williamson PTF, 2005, MOL MEMBR BIOL, V22, P485, DOI 10.1080/09687860500370653; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i	58	25	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2496	2507		10.1074/jbc.M114.624395	http://dx.doi.org/10.1074/jbc.M114.624395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25519904	Green Published, hybrid			2022-12-28	WOS:000348588000051
J	Saidak, Z; Henaff, C; Azzi, S; Marty, C; Da Nascimento, S; Sonnet, P; Marie, PJ				Saidak, Zuzana; Le Henaff, Carole; Azzi, Sofia; Marty, Caroline; Da Nascimento, Sophie; Sonnet, Pascal; Marie, Pierre J.			Wnt/beta-Catenin Signaling Mediates Osteoblast Differentiation Triggered by Peptide-induced alpha 5 beta 1 Integrin Priming in Mesenchymal Skeletal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED KINASE ILK; BETA-CATENIN; BONE-FORMATION; TRANSCRIPTION FACTORS; LIGAND-BINDING; WNT; EXPRESSION; PROMOTES; ADHESION; ACTIVATION	The alpha 5 beta 1 integrin is a key fibronectin (EN) receptor that binds to RGD-containing peptides to mediate cell adhesion. We previously reported that alpha 5 beta 1 integrin promotes osteogenic differentiation in mesenchymal skeletal cells (MSCs), but the underlying mechanisms are not fully understood. In this study, we determined the signaling mechanisms induced by alpha 5 beta 1 integrin interaction with its high-affinity ligand CRRETAWAC in murine and human MSCs and in vivo. We show that cyclized CRRETAWAC fully displaced MSC adhesion to FN, whereas related peptides lacking the full RRET sequence produced a partial displacement, indicating that RRET acts as an RGD-like sequence that is required to antagonize EN-mediated cell adhesion. However, all peptides increased focal adhesion kinase phosphorylation, OSE2 transcriptional activity, osteoblast gene expression, and matrix mineralization in MSCs, indicating that peptide-induced alpha 5 beta 1 integrin priming can promote osteogenic differentiation independently of the RRET sequence. Biochemical analyses showed that peptide-induced alpha 5 beta 1 integrin priming transiently increased PI3K/Akt phosphorylation and promoted Wnt/beta-catenin transcriptional activity independently of RRET. Consistently, pharmacological inhibition of PI3K activity reduced osteoblast differentiation and abolished Wnt regulatory gene expression induced by alpha 5 beta 1 integrin priming. In vivo, systemic delivery of cyclized GACRETAWACGA linked to (DSS)(6) to allow delivery to bone-forming sites for 6 weeks increased serum osteocalcin levels and improved long bone mass and microarchitecture in SAMP-6 senescent osteopenic mice. The results support a mechanism whereby alpha 5 beta 1 integrin priming by high-affinity ligands integrates Wnt/beta-catenin signaling to promote osteoblast differentiation independently of cell adhesion, which could be used to improve bone mass and microarchitecture in the aging skeleton.	[Saidak, Zuzana; Le Henaff, Carole; Azzi, Sofia; Marty, Caroline; Marie, Pierre J.] INSERM, UMR 1132, F-75475 Paris 10, France; [Saidak, Zuzana; Le Henaff, Carole; Azzi, Sofia; Marty, Caroline; Marie, Pierre J.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Da Nascimento, Sophie; Sonnet, Pascal] Univ Picardie Jules Verne, UFR Pharm, Equipe Thera,FRE,CNRS 3517, Lab Glycochim Antimicrobiens & Agroressources LG2, F-80037 Amiens 1, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, UMR 1132, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	sonnet, pascal/AAM-3308-2021	sonnet, pascal/0000-0003-0118-9151	Agence Nationale de la Recherche (Integros) [ANR-2010-BLAN-1505-01]; Association Prevention et Traitement des Decalcifications (Paris, France)	Agence Nationale de la Recherche (Integros)(French National Research Agency (ANR)); Association Prevention et Traitement des Decalcifications (Paris, France)	This work was supported by grants from the Agence Nationale de la Recherche (Integros, ANR-2010-BLAN-1505-01) and the Association Prevention et Traitement des Decalcifications (Paris, France) (to P.J. M.).	Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Brunner M, 2013, INT REV CEL MOL BIO, V305, P1, DOI 10.1016/B978-0-12-407695-2.00001-9; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; El-Hoss J, 2014, GENE, V533, P246, DOI 10.1016/j.gene.2013.09.074; Fonar Y, 2011, ANTI-CANCER AGENT ME, V11, P600, DOI 10.2174/187152011796817673; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Fromigue O, 2012, J CELL BIOCHEM, V113, P3029, DOI 10.1002/jcb.24181; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hay E, 2014, J CELL PHYSIOL, V229, P1765, DOI 10.1002/jcp.24629; Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Khosla S, 2011, J BONE MINER RES, V26, P2565, DOI 10.1002/jbmr.488; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Marie PJ, 2014, J BONE MINER RES, V29, P1311, DOI 10.1002/jbmr.2190; Marie PJ, 2013, NAT REV ENDOCRINOL, V9, P288, DOI 10.1038/nrendo.2013.4; Marie PJ, 2011, EUR J ENDOCRINOL, V165, P1, DOI 10.1530/EJE-11-0132; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Mould AP, 1998, J BIOL CHEM, V273, P25664, DOI 10.1074/jbc.273.40.25664; Moursi AM, 1997, J CELL SCI, V110, P2187; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Saidak Z, 2012, AGING CELL, V11, P467, DOI 10.1111/j.1474-9726.2012.00804.x; Srouji S, 2012, HUM GENE THER, V23, P167, DOI 10.1089/hum.2011.059; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xu JK, 2012, J BIOL CHEM, V287, P26200, DOI 10.1074/jbc.M112.349811; Yao GQ, 2011, J BONE MINER METAB, V29, P141, DOI 10.1007/s00774-010-0202-3; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617	64	77	84	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6903	6912		10.1074/jbc.M114.621219	http://dx.doi.org/10.1074/jbc.M114.621219			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631051	Green Published, hybrid			2022-12-28	WOS:000350991500025
J	Arous, C; Ferreira, PG; Dermitzakis, ET; Halban, PA				Arous, Caroline; Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Halban, Philippe A.			Short Term Exposure of Beta Cells to Low Concentrations of Interleukin-1 beta Improves Insulin Secretion through Focal Adhesion and Actin Remodeling and Regulation of Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN PANCREATIC-ISLETS; ISOLATED RAT ISLETS; EXTRACELLULAR-MATRIX; DIABETES-MELLITUS; ACTIVATION; GLUCOSE; RELEASE; PROTEIN; KINASE	Type 2 diabetes involves defective insulin secretion with islet inflammation governed in part by IL-1 beta. Prolonged exposure of islets to high concentrations of IL-1 beta (>24 h, 20 ng/ml) impairs beta cell function and survival. Conversely, exposure to lower concentrations of IL-1 beta for >24 h improves these same parameters. The impact on insulin secretion of shorter exposure times to IL-1 beta and the underlying molecular mechanisms are poorly understood and were the focus of this study. Treatment of rat primary beta cells, as well as rat or human whole islets, with 0.1 ng/ml IL-1 beta for 2 h increased glucose-stimulated (but not basal) insulin secretion, whereas 20 ng/ml was without effect. Similar differential effects of IL-1 beta depending on concentration were observed after 15 min of KCl stimulation but were prevented by diazoxide. Studies on sorted rat beta cells indicated that the enhancement of stimulated secretion by 0.1 ng/ml IL-1 beta was mediated by the NE-KB pathway and c-JUN/JNK pathway acting in parallel to elicit focal adhesion remodeling and the phosphorylation of paxillin independently of upstream regulation by focal adhesion kinase. Because the beneficial effect of IL-1 beta Ivas dependent in part upon transcription, gene expression was analyzed by RNAseq. There were 18 genes regulated uniquely by 0.1 but not 20 ng/ml IL-1 beta, which are mostly involved in transcription and apoptosis. These results indicate that 2 h of exposure of beta cells to a low but not a high concentration of IL-1 beta enhances glucose-stimulated insulin secretion through focal adhesion and actin remodeling, as well as modulation of gene expression.	[Arous, Caroline; Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Halban, Philippe A.] Univ Geneva, Dept Genet Med & Dev, Univ Med Ctr, CH-1211 Geneva 4, Switzerland	University of Geneva	Arous, C (corresponding author), Univ Med Ctr, Dept Genet Med & Dev, 1 Michel Servet, CH-1211 Geneva 4, Switzerland.	Caroline.Arous@unige.ch	Ferreira, Pedro/HDO-1346-2022; Ferreira, Pedro G/J-6379-2013	Ferreira, Pedro G/0000-0003-3838-8664	JDRF Award [31-2008-416]	JDRF Award	We thank Melanie Cor-nut and Stephane Dupuis for expert technical assistance. We also thank Dr. Samuel W. Lukowski (University Medical Centre, Geneva) for generous help for the transcriptional analysis. Human islets were generously provided through the JDRF Award 31-2008-416 (ECIT Islet for Basic Research Program).	Arous C, 2013, DIABETOLOGIA, V56, P792, DOI 10.1007/s00125-012-2800-1; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; BORG LAH, 1990, IMMUNOL LETT, V26, P253, DOI 10.1016/0165-2478(90)90155-J; Bosco D, 2001, DIABETES, V50, P1039, DOI 10.2337/diabetes.50.5.1039; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; EIZIRIK DL, 1995, MOL CELL ENDOCRINOL, V111, P159, DOI 10.1016/0303-7207(95)03561-K; EIZIRIK DL, 1993, J CLIN ENDOCR METAB, V76, P399, DOI 10.1210/jc.76.2.399; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1989, DIABETOLOGIA, V32, P769; Eswarappa SM, 2008, INNATE IMMUN-LONDON, V14, P309, DOI 10.1177/1753425908096856; Franco-Barraza J, 2010, ARCH MED RES, V41, P170, DOI 10.1016/j.arcmed.2010.04.010; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Guo WK, 2011, MED SCI MONITOR, V17, pBR242, DOI 10.12659/MSM.881927; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; Henquin JC, 2004, DIABETES, V53, pS48, DOI 10.2337/diabetes.53.suppl_3.S48; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Jiao XM, 2008, MOL BIOL CELL, V19, P1378, DOI 10.1091/mbc.E07-08-0753; JOHNSON RC, 1994, ENDOCRINOLOGY, V135, P1178, DOI 10.1210/en.135.3.1178; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lifshitz Y, 2002, SCIENCE, V297, P1531, DOI 10.1126/science.1074551; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Mariot P, 1998, DIABETES, V47, P365, DOI 10.2337/diabetes.47.3.365; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; MCDANIEL ML, 1988, DIABETES, V37, P1311, DOI 10.2337/diabetes.37.10.1311; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Papaccio G, 2005, J CELL PHYSIOL, V204, P124, DOI 10.1002/jcp.20276; Rajshankar D, 2012, FASEB J, V26, P4429, DOI 10.1096/fj.12-207381; Ribaux P, 2007, ENDOCRINOLOGY, V148, P5582, DOI 10.1210/en.2007-0325; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Sachdev S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-12; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; SPINAS GA, 1986, ACTA ENDOCRINOL-COP, V113, P551, DOI 10.1530/acta.0.1130551; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Wang Q, 2011, FASEB J, V25, P3448, DOI 10.1096/fj.11-183459; Weber A., 2010, SCI SIGNAL, V3; WELSH N, 1989, ACTA ENDOCRINOL-COP, V121, P698, DOI 10.1530/acta.0.1210698; ZAWALICH WS, 1989, AM J PHYSIOL, V256, pE19, DOI 10.1152/ajpendo.1989.256.1.E19	66	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6653	6669		10.1074/jbc.M114.611111	http://dx.doi.org/10.1074/jbc.M114.611111			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586177	Green Published, hybrid			2022-12-28	WOS:000350732500066
J	Bialkowska, K; Byzova, TV; Plow, EF				Bialkowska, Katarzyna; Byzova, Tatiana V.; Plow, Edward F.			Site-specific Phosphorylation of Kindlin-3 Protein Regulates Its Capacity to Control Cellular Responses Mediated by Integrin alpha(IIb)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN IIB/IIA COMPLEX; FOCAL ADHESION SITES; TALIN HEAD DOMAIN; KINASE-C; LEUKOCYTE ADHESION; MATRIX ADHESION; IIB-IIIA; ACTIVATION; BINDING; RECEPTOR	The contributions of integrins to cellular responses depend upon their activation, which is regulated by binding of proteins to their cytoplasmic tails. Kindlins are integrin cytoplasmic tail binding partners and are essential for optimal integrin activation, and kindlin-3 fulfills this role in hematopoietic cells. Here, we used human platelets and human erythroleukemia (HEL) cells, which express integrin alpha(IIb)beta 3, to investigate whether phosphorylation of kindlin-3 regulates integrin activation. When HEL cells were stimulated with thrombopoietin or phorbol 12-myristate 13-acetate (PMA), alpha(IIb)beta 3 became activated as evidenced by binding of an activation-specific monoclonal antibody and soluble fibrinogen, adherence and spreading on fibrinogen, colocalization of beta(3) integrin and kindlin-3 in focal adhesions, and enhanced beta(3) integrin-kindlin-3 association in immunoprecipitates. Kindlin-3 knockdown impaired adhesion and spreading on fibrinogen. Stimulation of HEL cells with agonists significantly increased kindlin-3 phosphorylation as detected by mass spectrometric sequencing. Thr482 or Ser484 was identified as a phosphorylation site, which resides in a sequence not conserved in kindlin-1 or kindlin-2. These same residues were phosphorylated in kindlin-3 when platelets were stimulated with thrombin. When expressed in HEL cells, T482A/S484A kindlin-3 decreased soluble ligand binding and cell spreading on fibrinogen compared with wild-type kindlin-3. A membrane-permeable peptide containing residues 476-485 of kindlin-3 was introduced into HEL cells and platelets; adhesion and spreading of both cell types were blunted compared with a scrambled control peptide. These data identify a role of kindlin-3 phosphorylation in integrin beta(3) activation and provide a basis for functional differences between kindlin-3 and the two other kindlin paralogs.	[Bialkowska, Katarzyna; Byzova, Tatiana V.; Plow, Edward F.] Cleveland Clin, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Plow, EF (corresponding author), Dept Mol Cardiol, NB5-50,9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org		Byzova, Tatiana/0000-0002-2615-875X	National Institutes of Health from the NHLBI [P01HL073311, R01 HL096062]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096062, P01HL073311] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL073311 and R01 HL096062 from the NHLBI.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; BoudignonProudhon C, 1996, BLOOD, V87, P968, DOI 10.1182/blood.V87.3.968.bloodjournal873968; BRASS LF, 1991, J BIOL CHEM, V266, P958; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; David T, 2006, J THROMB HAEMOST, V4, P2645, DOI 10.1111/j.1538-7836.2006.02198.x; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Ehlers R, 2003, J EXP MED, V198, P1077, DOI 10.1084/jem.20022181; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; JARVINEN M, 1987, EUR J CELL BIOL, V44, P238; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Kasirer-Friede A, 2014, BLOOD, V123, P3156, DOI 10.1182/blood-2013-08-520627; Kliche S, 2012, BLOOD, V119, P777, DOI 10.1182/blood-2011-06-362269; KOUNS WC, 1991, J BIOL CHEM, V266, P13891; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Meller J, 2012, J THROMB HAEMOST, V10, P1397, DOI 10.1111/j.1538-7836.2012.04768.x; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Nakazawa T, 2013, EXP HEMATOL, V41, P79, DOI 10.1016/j.exphem.2012.09.011; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; PHILLIPS DR, 1980, J CELL BIOL, V86, P77, DOI 10.1083/jcb.86.1.77; PLOW EF, 1981, J BIOL CHEM, V256, P9477; PONCZ M, 1987, J BIOL CHEM, V262, P8476; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Rich S, 1996, J IMMUNOL, V157, P2916; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Ruperez P, 2012, MOL CELL PROTEOMICS, V11, P171, DOI 10.1074/mcp.M112.017863; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Sossey-Alaoui K, 2014, FASEB J, V28, P2260, DOI 10.1096/fj.13-244004; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wagner CL, 1996, BLOOD, V88, P907; WARD NE, 1993, BIOCHEMISTRY-US, V32, P11903, DOI 10.1021/bi00095a020; WILLIAMS AG, 1990, BLOOD, V76, P721; WOODS VL, 1984, BLOOD, V63, P368; Xu Z, 2014, ARTERIOSCL THROM VAS, V34, P1961, DOI 10.1161/ATVBAHA.114.303851; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200; Yates LA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415208; YLANNE J, 1990, BLOOD, V76, P570; YLANNE J, 1988, BLOOD, V72, P1478; Zauli G, 1997, BLOOD, V89, P883, DOI 10.1182/blood.V89.3.883; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469; Zimman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084488; ZIMRIN AB, 1988, J CLIN INVEST, V81, P1470, DOI 10.1172/JCI113478	65	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6226	6242		10.1074/jbc.M114.634436	http://dx.doi.org/10.1074/jbc.M114.634436			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25609252	Green Published, hybrid			2022-12-28	WOS:000350732500030
J	Ousingsawat, J; Wanitchakool, P; Schreiber, R; Wuelling, M; Vortkamp, A; Kunzelmann, K				Ousingsawat, Jiraporn; Wanitchakool, Podchanart; Schreiber, Rainer; Wuelling, Manuela; Vortkamp, Andrea; Kunzelmann, Karl			Anoctamin-6 Controls Bone Mineralization by Activating the Calcium Transporter NCX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/CA2+ EXCHANGER ISOFORMS; MEMBRANE CA2+ ATPASE; CHANNEL; PHOSPHATE; TMEM16F; OSTEOCLASTS; INHIBITION; EXPRESSION; DEPOSITION; REGULATOR	Anoctamin-6 (Ano6, TMEM16F) belongs to a family of putative Ca2+-activated Cl- channels and operates as membrane phospholipid scramblase. Deletion of Ano6 leads to reduced skeleton size, skeletal deformities, and mineralization defects in mice. However, it remains entirely unclear how a lack of Ano6 leads to a delay in bone mineralization by osteoblasts. The Na+/Ca2+ exchanger NCX1 was found to interact with Ano6 in a two-hybrid split-ubiquitin screen. Using human osteoblasts and osteoblasts from Ano6(-/-) and WT mice, we demonstrate that NCX1 requires Ano6 to efficiently translocate Ca2+ out of osteoblasts into the calcifying bone matrix. Ca2+-activated anion currents are missing in primary osteoblasts isolated from Ano6 null mice. Our findings demonstrate the importance of NCX1 for bone mineralization and explain why deletion of an ion channel leads to the observed mineralization defect: Ano6 Cl- currents are probably required to operate as a Cl- bypass channel, thereby compensating net Na+ charge movement by NCX1.	[Ousingsawat, Jiraporn; Wanitchakool, Podchanart; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Wuelling, Manuela; Vortkamp, Andrea] Univ Duisburg Essen, Fak Biol, Dept Entwicklungsbiol, D-45141 Essen, Germany	University of Regensburg; University of Duisburg Essen	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@ur.de		Wuelling, Manuela/0000-0003-4534-3528	Deutsche Forschungsgemeinschaft [DFG SFB699, DFG KU756/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG SFB699 (Project A7/A12) and DFG KU756/12-1.	ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Bonucci E, 2009, J BONE MINER METAB, V27, P255, DOI 10.1007/s00774-009-0061-y; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Faria D, 2014, KIDNEY INT, V85, P1369, DOI 10.1038/ki.2013.535; Francis MJO, 2002, INT J BIOCHEM CELL B, V34, P459, DOI 10.1016/S1357-2725(01)00142-X; GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041; Go W, 2013, BONE, V54, P48, DOI 10.1016/j.bone.2013.01.026; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Harper MT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.495; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Kornak U, 2011, JOINT BONE SPINE, V78, P561, DOI 10.1016/j.jbspin.2011.03.020; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Ladilov Y, 1999, AM J PHYSIOL-HEART C, V276, pH1868, DOI 10.1152/ajpheart.1999.276.6.H1868; Le Henaff C, 2012, AM J PATHOL, V180, P2068, DOI 10.1016/j.ajpath.2012.01.039; Li JP, 2007, ENDOCRINOLOGY, V148, P2116, DOI 10.1210/en.2006-1321; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Lundquist P, 2000, CALCIFIED TISSUE INT, V67, P60, DOI 10.1007/s00223001098; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Rosenberg N, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10080; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Sosnoski DA, 2008, J CELL BIOCHEM, V103, P1101, DOI 10.1002/jcb.21483; Stains JP, 2002, J CELL BIOCHEM, V84, P625, DOI 10.1002/jcb.10050; Stains JP, 2001, J BONE MINER RES, V16, P1434, DOI 10.1359/jbmr.2001.16.8.1434; Stalvey MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080098; Stalvey MS, 2013, CURR OPIN ENDOCRINOL, V20, P547, DOI 10.1097/01.med.0000436191.87727.ec; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Van der Eerden BCJ, 2012, J CELL PHYSIOL, V227, P1951, DOI 10.1002/jcp.22923; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	41	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6270	6280		10.1074/jbc.M114.602979	http://dx.doi.org/10.1074/jbc.M114.602979			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589784	hybrid, Green Published			2022-12-28	WOS:000350732500033
J	Smith, AM; Brown, WC; Harms, E; Smith, JL				Smith, Amber Marie; Brown, William Clay; Harms, Etti; Smith, Janet L.			Crystal Structures Capture Three States in the Catalytic Cycle of a Pyridoxal Phosphate (PLP) Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5'-PHOSPHATE SYNTHASE; CHROMOPHORIC INTERMEDIATE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BIOSYNTHESIS; COMPLEX; ENZYMES; REFINEMENT; MECHANISM; INSIGHTS	PLP synthase (PLPS) is a remarkable single-enzyme biosynthetic pathway that produces pyridoxal 5'-phosphate (PLP) from glutamine, ribose 5-phosphate, and glyceraldehyde 3-phosphate. The intact enzyme includes 12 synthase and 12 glutaminase subunits. PLP synthesis occurs in the synthase active site by a complicated mechanism involving at least two covalent intermediates at a catalytic lysine. The first intermediate forms with ribose 5-phosphate. The glutaminase subunit is a glutamine amidotransferase that hydrolyzes glutamine and channels ammonia to the synthase active site. Ammonia attack on the first covalent intermediate forms the second intermediate. Glyceraldehyde 3-phosphate reacts with the second intermediate to form PLP. To investigate the mechanism of the synthase subunit, crystal structures were obtained for three intermediate states of the Geobacillus stearothermophilus intact PLPS or its synthase subunit. The structures capture the synthase active site at three distinct steps in its complicated catalytic cycle, provide insights into the elusive mechanism, and illustrate the coordinated motions within the synthase subunit that separate the catalytic states. In the intact PLPS with a Michaelis-like intermediate in the glutaminase active site, the first covalent intermediate of the synthase is fully sequestered within the enzyme by the ordering of a generally disordered 20-residue C-terminal tail. Following addition of ammonia, the synthase active site opens and admits the Lys-149 side chain, which participates in formation of the second intermediate and PLP. Roles are identified for conserved Asp-24 in the formation of the first intermediate and for conserved Arg-147 in the conversion of the first to the second intermediate.	[Smith, Amber Marie; Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Smith, Amber Marie; Brown, William Clay; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Brown, William Clay; Smith, Janet L.] Univ Michigan, Struct Biol Ctr, Ann Arbor, MI 48109 USA; [Harms, Etti] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Smith, JL (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu			National Institutes of Health from NIGMS [GM Y1-GM-1104]; National Institutes of Health from NCI, Advanced Photon Source [CA Y1-CO-1020]; United States Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM093461] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health from NCI, Advanced Photon Source(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Boris Belitsky at Tufts University for a plasmid encoding PdxT. We thank the staff at the GM/CA beamlines (supported by National Institutes of Health Grants GM Y1-GM-1104 from NIGMS and CA Y1-CO-1020 from NCI, Advanced Photon Source (supported by the United States Department of Energy), Argonne National Laboratory).	Bauer JA, 2004, J BIOL CHEM, V279, P2704, DOI 10.1074/jbc.M310311200; Belitsky BR, 2004, J BACTERIOL, V186, P1191, DOI 10.1128/JB.186.4.1191-1196.2004; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; BROSIUS J, 1985, J BIOL CHEM, V260, P3539; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; Douangamath A, 2002, STRUCTURE, V10, P185, DOI 10.1016/S0969-2126(02)00702-5; Ehrenshaft M, 1998, MOL CELL, V1, P603, DOI 10.1016/S1097-2765(00)80060-X; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Guedez G, 2012, STRUCTURE, V20, P172, DOI 10.1016/j.str.2011.11.015; Hanes JW, 2008, NAT CHEM BIOL, V4, P425, DOI 10.1038/nchembio.93; Hanes JW, 2008, J AM CHEM SOC, V130, P3043, DOI 10.1021/ja076604l; Hanes JW, 2008, ANGEW CHEM INT EDIT, V47, P2102, DOI 10.1002/anie.200704390; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Jain SK, 2001, FREE RADICAL BIO MED, V30, P232, DOI 10.1016/S0891-5849(00)00462-7; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Matsuura A, 2012, MOL CELLS, V34, P407, DOI 10.1007/s10059-012-0198-8; MCCARTHY JEG, 1985, EMBO J, V4, P519, DOI 10.1002/j.1460-2075.1985.tb03659.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moccand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016042; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Raschle T, 2009, J BIOL CHEM, V284, P7706, DOI 10.1074/jbc.M804728200; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Smart OS, 2011, GRADE WEB SERVER VER; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhang XA, 2010, BIOCHEM J, V432, P445, DOI 10.1042/BJ20101241; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	45	16	15	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5226	5239		10.1074/jbc.M114.626382	http://dx.doi.org/10.1074/jbc.M114.626382			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25568319	hybrid, Green Published			2022-12-28	WOS:000350044200001
J	Guo, MH; Hundseth, K; Ding, H; Vidhyasagar, V; Inoue, A; Nguyen, CH; Zain, R; Lee, JS; Wu, YL				Guo, Manhong; Hundseth, Kristian; Ding, Hao; Vidhyasagar, Venkatasubramanian; Inoue, Akira; Chi-Hung Nguyen; Zain, Rula; Lee, Jeremy S.; Wu, Yuliang			A Distinct Triplex DNA Unwinding Activity of ChlR1 Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; REPLICATION PROTEIN-A; ATAXIA (GAA)(N) REPEATS; G-QUADRUPLEX DNA; MONOCLONAL-ANTIBODY; STRANDED DNA; BIOCHEMICAL-CHARACTERIZATION; H-DNA; FANCJ; HELIX	Mutations in the human ChlR1 (DDX11) gene are associated with a unique genetic disorder known as Warsaw breakage syndrome characterized by cellular defects in genome maintenance. The DNA triplex helix structures that form by Hoogsteen or reverse Hoogsteen hydrogen bonding are examples of alternate DNA structures that can be a source of genomic instability. In this study, we have examined the ability of human ChlR1 helicase to destabilize DNA triplexes. Biochemical studies demonstrated that ChlR1 efficiently melted both intermolecular and intramolecular DNA triplex substrates in an ATP-dependent manner. Compared with other substrates such as replication fork and G-quadruplex DNA, triplex DNA was a preferred substrate for ChlR1. Also, compared with FANCJ, a helicase of the same family, the triplex resolving activity of ChlR1 is unique. On the other hand, the mutant protein from a Warsaw breakage syndrome patient failed to unwind these triplexes. A previously characterized triplex DNA-specific antibody (Jel 466) bound triplex DNA structures and inhibited ChlR1 unwinding activity. Moreover, cellular assays demonstrated that there were increased triplex DNA content and double-stranded breaks in ChlR1-depleted cells, but not in FANCJ(-/-) cells, when cells were treated with a triplex stabilizing compound benzoquinoquinoxaline, suggesting that ChlR1 melting of triple-helix structures is distinctive and physiologically important to defend genome integrity. On the basis of our results, we conclude that the abundance of ChlR1 known to exist in vivo is likely to be a strong deterrent to the stability of triplexes that can potentially form in the human genome.	[Lee, Jeremy S.; Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Inoue, Akira] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Chi-Hung Nguyen] CNRS, Inst Curie, Lab Pharmacochim, Ctr Univ,UMR176, F-91405 Orsay, France; [Zain, Rula] Karolinska Inst, Clin Res Ctr, Dept Lab Med, S-14186 Stockholm, Sweden	University of Saskatchewan; St Jude Children's Research Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Karolinska Institutet	Wu, YL (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada.	yuliang.wu@usask.ca	Nguyen, Chi/GWR-1592-2022; Nguyen, Chi/GZG-5146-2022; Vidhyasagar, Venkatasubramanian/M-9442-2013	Vidhyasagar, Venkatasubramanian/0000-0001-8679-4021; Zain, Rula/0000-0001-8327-846X	Natural Sciences and Engineering Research Council of Canada; Canadian Breast Cancer Foundation; Leukemia & Lymphoma Society of Canada; American Cancer Society Research Scholar Grant [RSG CDD-120969]; Knut och Alice Wallenbergs Stiftelse; Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Swedish Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Leukemia & Lymphoma Society of Canada; American Cancer Society Research Scholar Grant(American Cancer Society); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada, the Canadian Breast Cancer Foundation, and the Leukemia & Lymphoma Society of Canada (to Y. W.); the American Cancer Society Research Scholar Grant RSG CDD-120969 (to A. I.); and the Knut och Alice Wallenbergs Stiftelse, Magnus Bergvalls Stiftelse, Carl Tryggers Stiftelse for Vetenskaplig Forskning, and the Swedish Research Council (to R. Z.).	AGAZIE YM, 1994, J BIOL CHEM, V269, P7019; Amiri H, 2005, J MOL BIOL, V351, P776, DOI 10.1016/j.jmb.2005.03.044; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Benet A, 1999, J MOL BIOL, V294, P851, DOI 10.1006/jmbi.1999.3295; Bergquist H, 2009, CHEMBIOCHEM, V10, P2629, DOI 10.1002/cbic.200900263; Bharti SK, 2014, CELL MOL LIFE SCI, V71, P2625, DOI 10.1007/s00018-014-1569-4; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Boyer AS, 2013, J MOL BIOL, V425, P4767, DOI 10.1016/j.jmb.2013.09.022; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; BURKHOLDER GD, 1988, CHROMOSOMA, V97, P185, DOI 10.1007/BF00292959; BURKHOLDER GD, 1991, CHROMOSOMA, V101, P11, DOI 10.1007/BF00360681; Capo-Chichi JM, 2013, HUM MUTAT, V34, P103, DOI 10.1002/humu.22226; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Duca M, 2008, NUCLEIC ACIDS RES, V36, P5123, DOI 10.1093/nar/gkn493; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Goni JR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-63; Guo MH, 2014, J BIOL CHEM, V289, P10551, DOI 10.1074/jbc.M113.538892; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Jain A, 2013, NUCLEIC ACIDS RES, V41, P10345, DOI 10.1093/nar/gkt804; Khan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113293; Kitao H, 2011, GENES CELLS, V16, P714, DOI 10.1111/j.1365-2443.2011.01523.x; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; LEE JS, 1987, NUCLEIC ACIDS RES, V15, P1047, DOI 10.1093/nar/15.3.1047; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Lin FLM, 2000, J BIOL CHEM, V275, P39117, DOI 10.1074/jbc.M005404200; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Piergentili R, 2008, J CELL SCI, V121, P1605, DOI 10.1242/jcs.025320; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Rajeswari MR, 2012, J BIOSCIENCES, V37, P519, DOI 10.1007/s12038-012-9219-1; Rogers Faye A., 2013, Yale Journal of Biology and Medicine, V86, P471; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; SAGLIO G, 1993, GENE CHROMOSOME CANC, V8, P1, DOI 10.1002/gcc.2870080102; Sakasai R, 2012, GENES CELLS, V17, P962, DOI 10.1111/gtc.12011; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; SCHROTH GP, 1995, NUCLEIC ACIDS RES, V23, P1977, DOI 10.1093/nar/23.11.1977; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Shah N, 2013, EXP CELL RES, V319, P2244, DOI 10.1016/j.yexcr.2013.06.005; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Tiwari MK, 2013, NUCLEIC ACIDS RES, V41, P8979, DOI 10.1093/nar/gkt670; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Vannier JB, 2014, TRENDS CELL BIOL, V24, P416, DOI 10.1016/j.tcb.2014.01.004; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Vasquez KM, 2002, Q REV BIOPHYS, V35, P89, DOI 10.1017/S0033583502003773; Wang GL, 2008, JNCI-J NATL CANCER I, V100, P1815, DOI 10.1093/jnci/djn385; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu Y, 2008, BIOCHEMISTRY-US, V47, P5068, DOI 10.1021/bi702102d; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Xie J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002786; Zaid A, 2004, CHEMBIOCHEM, V5, P1550, DOI 10.1002/cbic.200400074; Zain R, 2003, CHEMBIOCHEM, V4, P856, DOI 10.1002/cbic.200300621; Zain R, 2003, CELL MOL LIFE SCI, V60, P862, DOI 10.1007/s00018-003-3046-3	70	35	35	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5174	5189		10.1074/jbc.M114.634923	http://dx.doi.org/10.1074/jbc.M114.634923			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25561740	hybrid, Green Published			2022-12-28	WOS:000350042000056
J	Kluth, M; Stindt, J; Droge, C; Linnemann, D; Kubitz, R; Schmitt, L				Kluth, Marianne; Stindt, Jan; Droege, Carola; Linnemann, Doris; Kubitz, Ralf; Schmitt, Lutz			A Mutation within the Extended X Loop Abolished Substrate-induced ATPase Activity of the Human Liver ATP-binding Cassette (ABC) Transporter MDR3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; FAMILIAL INTRAHEPATIC CHOLESTASIS; PICHIA-PASTORIS CELLS; SALT EXPORT PUMP; MULTIDRUG-RESISTANCE; FUNCTIONAL-CHARACTERIZATION; CANALICULAR MEMBRANE; DRUG-BINDING; EXPRESSION; PURIFICATION	The human multidrug resistance protein 3 (MDR3/ABCB4) belongs to the ubiquitous family of ATP-binding cassette (ABC) transporters and is located in the canalicular membrane of hepatocytes. There it flops the phospholipids of the phosphatidylcholine (PC) family from the inner to the outer leaflet. Here, we report the characterization of wild type MDR3 and the Q1174E mutant, which was identified previously in a patient with progressive familial intrahepatic cholestasis type 3 (PFIC-3). We expressed different variants of MDR3 in the yeast Pichia pastoris, purified the proteins via tandem affinity chromatography, and determined MDR3-specific ATPase activity in the presence or absence of phospholipids. The ATPase activity of wild type MDR3 was stimulated 2-fold by liver PC or 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine lipids. Furthermore, the cross-linking of MDR3 with a thiol-reactive fluorophore blocked ATP hydrolysis and exhibited no PC stimulation. Similarly, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin lipids did not induce an increase of wild type MDR3 ATPase activity. The phosphate analogues beryllium fluoride and aluminum fluoride led to complete inhibition of ATPase activity, whereas orthovanadate inhibited exclusively the PC-stimulated ATPase activity of MDR3. The Q1174E mutation is located in the nucleotide-binding domain in direct proximity of the leucine of the ABC signature motif and extended the X loop, which is found in ABC exporters. Our data on the Q1174E mutant demonstrated basal ATPase activity, but PC lipids were incapable of stimulating ATPase activity highlighting the role of the extended X loop in the cross-talk of the nucleotide-binding domain and the transmembrane domain.	[Kluth, Marianne; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Stindt, Jan; Droege, Carola; Linnemann, Doris; Kubitz, Ralf] Univ Hosp, Dept Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany; [Schmitt, Lutz] Univ Dusseldorf, Cluster Excellence Plant Sci, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@hhu.de		Stindt, Jan/0000-0002-8760-1989	Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 3; Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 1; Deutsche Forschungsgemeinschaft through the Collaborative Research Center [974 TP B3]	Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 3(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 1(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft through the Collaborative Research Center(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through the Clinical Research Group 217 TP 3 (to L. S.) and TP 1 (to R. K.) and the Collaborative Research Center 974 TP B3 (to R. K. and L. S.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BUSCHMAN E, 1994, CANCER RES, V54, P4892; BUSCHMAN E, 1991, MOL CELL BIOL, V11, P595, DOI 10.1128/MCB.11.2.595; Chang SY, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4832740; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2; Dzagania T, 2012, GENE, V506, P141, DOI 10.1016/j.gene.2012.06.029; Elferink RPJO, 2007, PFLUG ARCH EUR J PHY, V453, P601, DOI 10.1007/s00424-006-0062-9; Elferink RPJO, 2000, SEMIN LIVER DIS, V20, P293, DOI 10.1055/s-2000-9385; Ellinger P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060620; Gabriel MP, 2003, BIOCHEMISTRY-US, V42, P7780, DOI 10.1021/bi0341049; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Groen A, 2011, GASTROENTEROLOGY, V141, P1927, DOI 10.1053/j.gastro.2011.07.042; Gros P, 1993, Int Rev Cytol, V137C, P169; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Infed N, 2011, BBA-BIOMEMBRANES, V1808, P2313, DOI 10.1016/j.bbamem.2011.05.016; Ishigami M, 2013, BBA-MOL CELL BIOL L, V1831, P683, DOI 10.1016/j.bbalip.2012.12.016; Januchowski R, 2014, BIOMED PHARMACOTHER, V68, P111, DOI 10.1016/j.biopha.2013.09.004; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; Keitel V, 2005, HEPATOLOGY, V41, P1160, DOI 10.1002/hep.20682; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Kubitz R, 2004, GASTROENTEROLOGY, V126, P541, DOI 10.1053/j.gastro.2003.11.003; Kubitz R, 2011, Z GASTROENTEROL, V49, P728, DOI 10.1055/s-0031-1273427; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Loo TW, 1999, BBA-BIOMEMBRANES, V1461, P315, DOI 10.1016/S0005-2736(99)00165-0; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; McDevitt CA, 2009, ADV DRUG DELIVER REV, V61, P57, DOI 10.1016/j.addr.2008.07.004; Morita S, 2007, HEPATOLOGY, V46, P188, DOI 10.1002/hep.21591; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Pohl A, 2005, BBA-MOL CELL BIOL L, V1733, P29, DOI 10.1016/j.bbalip.2004.12.007; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Scholz C, 2011, J BIOL CHEM, V286, P13346, DOI 10.1074/jbc.M110.216416; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; SMITH AJ, 1994, FEBS LETT, V354, P263, DOI 10.1016/0014-5793(94)01135-4; Smith AJ, 2000, J BIOL CHEM, V275, P23530, DOI 10.1074/jbc.M909002199; Smith AJ, 1998, HEPATOLOGY, V28, P530, DOI 10.1002/hep.510280234; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Urbatsch IL, 2001, ARCH BIOCHEM BIOPHYS, V388, P171, DOI 10.1006/abbi.2001.2299; VANDERBLIEK AM, 1988, GENE, V71, P401, DOI 10.1016/0378-1119(88)90057-1; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, BIOCHEM SOC T, V33, P990, DOI 10.1042/BST0330990; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122	60	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4896	4907		10.1074/jbc.M114.588566	http://dx.doi.org/10.1074/jbc.M114.588566			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25533467	hybrid, Green Published			2022-12-28	WOS:000350042000034
J	Han, HJ; Kursula, P				Han, Huijong; Kursula, Petri			The Olfactomedin Domain from Gliomedin Is a beta-Propeller with Unique Structural Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNELS; CRYSTAL-STRUCTURE; SODIUM-CHANNELS; MYOCILIN; PROTEIN; GLAUCOMA; NODES; EXPRESSION; BINDING; SYSTEM	All members of the olfactomedin (OLF) family have a conserved extracellular OLF domain, for which a structure has not been available. We present here the crystal structure of the OLF domain from gliomedin. Gliomedin is a protein expressed by Schwann cells in peripheral nerves, important for the formation of the nodes of Ranvier. Gliomedin interacts with neuronal cell adhesion molecules, such as neurofascin, but the structural details of the interaction are not known. The structure of the OLF domain presents a five-bladed beta-propeller fold with unusual geometric properties. The symmetry of the structure is not 5-fold, but rather reveals a twisted arrangement. The conserved top face of the gliomedin OLF domain is likely to be important for binding to neuronal ligands. Our results provide a structural basis for the functions of gliomedin in Schwann cells, enable the understanding of the role of the gliomedin OLF domain in autoimmune neuropathies, and unravel the locations of human disease-causing mutations in other OLF family members, including myocilin.	[Han, Huijong; Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland; [Han, Huijong; Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Han, Huijong; Kursula, Petri] German Electron Synchrotron DESY, D-22607 Hamburg, Germany; [Kursula, Petri] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway	University of Oulu; University of Oulu; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Bergen	Kursula, P (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5020 Bergen, Norway.	petri.kursula@biomed.uib.no	Kursula, Petri/AAF-4563-2020	Kursula, Petri/0000-0001-8529-3751; Han, Huijong/0000-0002-1197-3014	European Community [283570]; Academy of Finland; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Research and Science Foundation of the City of Hamburg	European Community(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Research and Science Foundation of the City of Hamburg	This work was supported by European Community Seventh Framework Programme FP7/2007-2013 under BioStruct-X Grant 283570 and by grants from the Academy of Finland, the Sigrid Juselius Foundation, the Emil Aaltonen Foundation, and the Research and Science Foundation of the City of Hamburg.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amor V, 2014, J NEUROSCI, V34, P5089, DOI 10.1523/JNEUROSCI.4752-13.2014; Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2008, MOL VIS, V14, P2097; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Desmazieres A, 2014, J NEUROSCI, V34, P5083, DOI 10.1523/JNEUROSCI.4662-13.2014; Devaux JJ, 2012, AM J PATHOL, V181, P1402, DOI 10.1016/j.ajpath.2012.06.034; Devaux JJ, 2012, J PERIPHER NERV SYST, V17, P62, DOI 10.1111/j.1529-8027.2012.00372.x; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Donegan RK, 2012, J BIOL CHEM, V287, P43370, DOI 10.1074/jbc.M112.408906; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Han HJ, 2014, ACTA CRYSTALLOGR F, V70, P1536, DOI 10.1107/S2053230X14020305; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Hill SE, 2014, J MOL BIOL, V426, P921, DOI 10.1016/j.jmb.2013.12.002; Hillier BJ, 2003, J CELL BIOL, V160, P597, DOI 10.1083/jcb.200210053; Hillier BJ, 2007, BIOCHEM CELL BIOL, V85, P552, DOI 10.1139/O07-055; Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52; Huang WL, 2010, J MOL BIOL, V401, P374, DOI 10.1016/j.jmb.2010.06.012; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kwon HS, 2014, J NEUROSCI, V34, P5539, DOI 10.1523/JNEUROSCI.4731-13.2014; Kwon HS, 2013, J BIOL CHEM, V288, P26357, DOI 10.1074/jbc.M112.446138; Labasque M, 2011, J BIOL CHEM, V286, P42426, DOI 10.1074/jbc.M111.266353; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Margraf T, 2009, NUCLEIC ACIDS RES, V37, pW480, DOI 10.1093/nar/gkp431; McDowell CM, 2012, EXP EYE RES, V100, P65, DOI 10.1016/j.exer.2012.04.016; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy I, 2003, BIOCHEM BIOPH RES CO, V302, P554, DOI 10.1016/S0006-291X(03)00198-0; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Notturno F, 2014, J NEUROIMMUNOL, V276, P207, DOI 10.1016/j.jneuroim.2014.09.001; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Ohlmann A, 2003, GLIA, V43, P128, DOI 10.1002/glia.10233; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Ricard CS, 2001, EXP EYE RES, V73, P433, DOI 10.1006/exer.2001.1063; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Vabnick I, 1996, J NEUROSCI, V16, P4914; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	72	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3612	3621		10.1074/jbc.M114.627547	http://dx.doi.org/10.1074/jbc.M114.627547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25525261	Green Published, hybrid			2022-12-28	WOS:000349456000034
J	Li, XL; Li, J; Wilson, A; Sipple, J; Schick, J; Pang, QS				Li, Xiaoli; Li, Jie; Wilson, Andrew; Sipple, Jared; Schick, Jonathan; Pang, Qishen			Fancd2 Is Required for Nuclear Retention of Foxo3a in Hematopoietic Stem Cell Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Repair; FOXO; Hematopoietic Stem Cells; Oxidative Stress; Fancd2	CROSS-LINK REPAIR; FANCONI ANEMIA/BRCA PATHWAY; SELF-RENEWAL; OXIDATIVE STRESS; DNA-DAMAGE; TRANSCRIPTION FACTOR; CANCER; MICE; ACTIVATION; INSIGHTS	Background: Maintenance of HSCs is challenged by DNA damage and oxidative stress. Results:Fancd2 deficiency promoted cytoplasmic localization of Foxo3a in HSCs. Re-expression of Fancd2 restored nuclear Foxo3a localization and prevented HSC exhaustion. Conclusion: Fancd2 is required for nuclear retention of Foxo3a and maintaining hematopoietic repopulation of HSCs. Significance: Our results implicate an interaction between FA DNA repair and FOXO3a pathways in HSC maintenance. Functional maintenance of hematopoietic stem cells (HSCs) is constantly challenged by stresses like DNA damage and oxidative stress. Here we show that the Fanconi anemia protein Fancd2 and stress transcriptional factor Foxo3a cooperate to prevent HSC exhaustion in mice. Deletion of both Fancd2 and Foxo3a led to an initial expansion followed by a progressive decline of bone marrow stem and progenitor cells. Limiting dilution transplantation and competitive repopulating experiments demonstrated a dramatic reduction of competitive repopulating units and progressive decline in hematopoietic repopulating ability of double-knockout (dKO) HSCs. Analysis of the transcriptome of dKO HSCs revealed perturbation of multiple pathways implicated in HSC exhaustion. Fancd2 deficiency strongly promoted cytoplasmic localization of Foxo3a in HSCs, and re-expression of Fancd2 completely restored nuclear Foxo3a localization. By co-expressing a constitutively active CA-FOXO3a and WT or a nonubiquitinated Fancd2 in dKO bone marrow stem/progenitor cells, we demonstrated that Fancd2 was required for nuclear retention of CA-FOXO3a and for maintaining hematopoietic repopulation of the HSCs. Collectively, these results implicate a functional interaction between the Fanconi anemia DNA repair and FOXO3a pathways in HSC maintenance.	[Li, Xiaoli; Wilson, Andrew; Sipple, Jared; Schick, Jonathan; Pang, Qishen] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Li, Jie] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA	Cincinnati Children's Hospital Medical Center; University of California System; University of California San Diego	Pang, QS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	qishen.pang@cchmc.org	Li, Xiaoli/GYQ-7384-2022; Li, Jie/L-1737-2015	Li, Jie/0000-0002-0590-9817	National Institutes of Health [R01 HL076712, R01 CA157537, T32 HL091805]; Leukemia and Lymphoma Scholar award; NATIONAL CANCER INSTITUTE [R01CA157537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076712, T32HL091805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Scholar award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL076712, R01 CA157537, and T32 HL091805.; Supported by a Leukemia and Lymphoma Scholar award.	Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011; Briot D, 2008, BLOOD, V111, P1913, DOI 10.1182/blood-2007-07-099218; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; de Haan Gerald, 2002, Methods Mol Med, V63, P143, DOI 10.1385/1-59259-140-X:143; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Li J, 2010, BLOOD, V115, P1545, DOI 10.1182/blood-2009-07-234385; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Prieto-Remon I, 2013, HAEMATOLOGICA, V98, P705, DOI 10.3324/haematol.2012.074187; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schambach A, 2006, EXP HEMATOL, V34, P588, DOI 10.1016/j.exphem.2006.02.005; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tischkowitz M, 2004, BRIT J HAEMATOL, V126, P176, DOI 10.1111/j.1365-2141.2004.05023.x; Unno J, 2014, CELL REP, V7, P1039, DOI 10.1016/j.celrep.2014.04.005; Walden H, 2014, ANNU REV BIOPHYS, V43, P257, DOI 10.1146/annurev-biophys-051013-022737; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson DB, 2014, ANN MED, V46, P353, DOI 10.3109/07853890.2014.915579; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676	39	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2715	2727		10.1074/jbc.M114.619536	http://dx.doi.org/10.1074/jbc.M114.619536			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505262	Green Published, hybrid			2022-12-28	WOS:000349310700015
J	Raval, KK; Tao, R; White, BE; De Lange, WJ; Koonce, CH; Yu, JY; Kishnani, PS; Thomson, JA; Mosher, DF; Ralphe, JC; Kamp, TJ				Raval, Kunil K.; Tao, Ran; White, Brent E.; De lange, Willem J.; Koonce, Chad H.; Yu, Junying; Kishnani, Priya S.; Thomson, James A.; Mosher, Deane F.; Ralphe, John C.; Kamp, Timothy J.			Pompe Disease Results in a Golgi-based Glycosylation Deficit in Human Induced Pluripotent Stem Cell-derived Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cardiomyopathy; Golgi; Induced Pluripotent Stem Cell (iPSC); Lysosomal Glycoprotein; N-linked Glycosylation; Tissue Engineering; Pompe Disease	LYSOSOMAL MEMBRANE-GLYCOPROTEINS; ENZYME REPLACEMENT THERAPY; ACID ALPHA-GLUCOSIDASE; CONGENITAL DISORDERS; CHANNEL ACTIVITY; MANNOSIDASE-II; MOUSE MODEL; DYSTROGLYCAN; COMPLEX; CARDIOMYOPATHY	Background: How the absence of lysosomal enzyme acid -glucosidase causes hypertrophic cardiomyopathy in Pompe disease is unknown. Results: Pompe patient-induced pluripotent stem cell-derived cardiomyocytes have normal autophagic and contractile function but exhibit a deficit of Golgi-based protein glycosylation. Conclusion: Loss of the lysosomal glycogen hydrolyzing ability results in protein glycosylation deficits. Significance: Malfunctioning proteins due to misglycosylation may contribute to the pathophysiology of Pompe cardiomyopathy. Infantile-onset Pompe disease is an autosomal recessive disorder caused by the complete loss of lysosomal glycogen-hydrolyzing enzyme acid -glucosidase (GAA) activity, which results in lysosomal glycogen accumulation and prominent cardiac and skeletal muscle pathology. The mechanism by which loss of GAA activity causes cardiomyopathy is poorly understood. We reprogrammed fibroblasts from patients with infantile-onset Pompe disease to generate induced pluripotent stem (iPS) cells that were differentiated to cardiomyocytes (iPSC-CM). Pompe iPSC-CMs had undetectable GAA activity and pathognomonic glycogen-filled lysosomes. Nonetheless, Pompe and control iPSC-CMs exhibited comparable contractile properties in engineered cardiac tissue. Impaired autophagy has been implicated in Pompe skeletal muscle; however, control and Pompe iPSC-CMs had comparable clearance rates of LC3-II-detected autophagosomes. Unexpectedly, the lysosome-associated membrane proteins, LAMP1 and LAMP2, from Pompe iPSC-CMs demonstrated higher electrophoretic mobility compared with control iPSC-CMs. Brefeldin A induced disruption of the Golgi in control iPSC-CMs reproduced the higher mobility forms of the LAMPs, suggesting that Pompe iPSC-CMs produce LAMPs lacking appropriate glycosylation. Isoelectric focusing studies revealed that LAMP2 has a more alkaline pI in Pompe compared with control iPSC-CMs due largely to hyposialylation. MALDI-TOF-MS analysis of N-linked glycans demonstrated reduced diversity of multiantennary structures and the major presence of a trimannose complex glycan precursor in Pompe iPSC-CMs. These data suggest that Pompe cardiomyopathy has a glycan processing abnormality and thus shares features with hypertrophic cardiomyopathies observed in the congenital disorders of glycosylation.	[Raval, Kunil K.; Tao, Ran; White, Brent E.; Koonce, Chad H.; Mosher, Deane F.; Kamp, Timothy J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53705 USA; [Raval, Kunil K.; Kamp, Timothy J.] WiCell Inst, Madison, WI 53719 USA; [De lange, Willem J.; Ralphe, John C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA; [Yu, Junying] Cellular Dynam Int, Madison, WI 53711 USA; [Thomson, James A.; Kamp, Timothy J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; [Thomson, James A.] Morgridge Inst Res, Madison, WI 53715 USA; [Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Kishnani, Priya S.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; Duke University	Kamp, TJ (corresponding author), Univ Wisconsin, Dept Med, 8459 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	tjk@medicine.wisc.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876; De Lange, Willem/0000-0001-7296-8924	National Institutes of Health [U01 HL099773, P41GM10349010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773, R01HL107367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 HL099773 (to T. J. K. and J. A. T.) and by National Institutes of Health-funded Research Resource for Biomedical Glycomics (National Institutes of Health Grant P41GM10349010 to Parastoo Azadi at the Complex Carbohydrate Research Center).	Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Alberts B., 2008, MOL BIOL CEL, V5th ed.; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Ausems MGEM, 1996, CLIN GENET, V49, P325; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; Carchon HA, 2004, CLIN CHEM, V50, P101, DOI 10.1373/clinchem.2003.021568; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488; Chen CA, 2011, J CARD FAIL, V17, P930, DOI 10.1016/j.cardfail.2011.07.011; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1; Chen LR, 2009, J PEDIATR-US, V155, P271, DOI 10.1016/j.jpeds.2009.03.015; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Cohen MW, 1997, J CELL BIOL, V136, P1047, DOI 10.1083/jcb.136.5.1047; de Lange WJ, 2011, CIRC RES, V109, P8, DOI 10.1161/CIRCRESAHA.111.242354; De Lange WJ, 2013, J GEN PHYSIOL, V142, P241, DOI 10.1085/jgp.201311018; Duplomb L, 2014, HUM MOL GENET, V23, P2391, DOI 10.1093/hmg/ddt630; Ednie AR, 2013, J MOL CELL CARDIOL, V59, P117, DOI 10.1016/j.yjmcc.2013.02.013; ELICES MJ, 1990, CARBOHYD RES, V203, P109, DOI 10.1016/0008-6215(90)80050-D; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FERMINI B, 1991, AM J PHYSIOL, V260, pH735, DOI 10.1152/ajpheart.1991.260.3.H735; Footitt EJ, 2009, J INHERIT METAB DIS, V32, pS313, DOI 10.1007/s10545-009-1262-1; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Freeze H. H., 2009, ESSENTIALS GLYCOBIOL; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Freeze HH, 2014, AM J HUM GENET, V94, P161, DOI 10.1016/j.ajhg.2013.10.024; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gehrmann J, 2003, CARDIOL YOUNG, V13, P345, DOI 10.1017/S1047951103000702; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Hayee B, 2011, GLYCOBIOLOGY, V21, P914, DOI 10.1093/glycob/cwr023; Ikeda Y, 2000, J BIOCHEM, V128, P609, DOI 10.1093/oxfordjournals.jbchem.a022793; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Isaac EL, 2000, EXP CELL RES, V254, P204, DOI 10.1006/excr.1999.4755; Kabaeva Z, 2011, HUM MOL GENET, V20, P3346, DOI 10.1093/hmg/ddr240; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kapusta L, 2013, HEART FAIL REV, V18, P187, DOI 10.1007/s10741-012-9302-6; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knaapen MWM, 1997, ANAT RECORD, V248, P233; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; Marengo FD, 1998, J MOL CELL CARDIOL, V30, P127, DOI 10.1006/jmcc.1997.0579; Maron BJ, 2009, JAMA-J AM MED ASSOC, V301, P1253, DOI 10.1001/jama.2009.371; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; McDowell R, 2008, GENET MED, V10, P758, DOI 10.1097/GIM.0b013e318183722f; Meikle PJ, 1997, CLIN CHEM, V43, P1325; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Nabi IR, 1998, GLYCOBIOLOGY, V8, P947, DOI 10.1093/glycob/8.9.947; Nascimbeni AC, 2012, CELL DEATH DIFFER, V19, P1698, DOI 10.1038/cdd.2012.52; Norring SA, 2013, FASEB J, V27, P622, DOI 10.1096/fj.12-214387; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; POST JA, 1992, AM J PHYSIOL, V263, pH147, DOI 10.1152/ajpheart.1992.263.1.H147; POUS C, 1994, EUR J BIOCHEM, V219, P1073, DOI 10.1111/j.1432-1033.1994.tb18590.x; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2012, AM J MED GENET C, V160C, P13, DOI 10.1002/ajmg.c.31317; Raben N, 2010, MOL GENET METAB, V101, P324, DOI 10.1016/j.ymgme.2010.08.001; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rahman SA, 2014, J PROTEOME RES, V13, P1167, DOI 10.1021/pr401043r; REUSER AJJ, 1978, AM J HUM GENET, V30, P132; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Sparks S., 1993, CONGENITAL MUSCULAR; Sparks S. E., 2005, CONGENITAL DISORDERS; SZUMILO T, 1987, BIOCHEMISTRY-US, V26, P5498, DOI 10.1021/bi00391a043; Takikita S, 2009, MOL GENET METAB, V96, P208, DOI 10.1016/j.ymgme.2008.12.012; Taylor KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056181; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wopereis S, 2003, CLIN CHEM, V49, P1839, DOI 10.1373/clinchem.2003.022541; Xu S, 2010, J APPL PHYSIOL, V108, P1383, DOI 10.1152/japplphysiol.01253.2009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	88	59	59	0	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3121	3136		10.1074/jbc.M114.628628	http://dx.doi.org/10.1074/jbc.M114.628628			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25488666	Green Published, hybrid			2022-12-28	WOS:000349310700047
J	Bertero, T; Cottrill, K; Krauszman, A; Lu, Y; Annis, S; Hale, A; Bhat, B; Waxman, AB; Chau, BN; Kuebler, WM; Chan, SY				Bertero, Thomas; Cottrill, Katherine; Krauszman, Adrienn; Lu, Yu; Annis, Sofia; Hale, Andrew; Bhat, Balkrishen; Waxman, Aaron B.; Chau, B. Nelson; Kuebler, Wolfgang M.; Chan, Stephen Y.			The MicroRNA-130/301 Family Controls Vasoconstriction in Pulmonary Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ACTIVATED RECEPTOR-GAMMA; MOLECULAR PATHOGENESIS; NITRIC-OXIDE; PPAR-GAMMA; ENDOTHELIN-1; EXPRESSION; NETWORKS; HYPOXIA; IMPAIRS	Pulmonary hypertension (PH) is a complex disorder, spanning several known vascular cell types. Recently, we identified the microRNA-130/301 (miR-130/301) family as a regulator of multiple pro-proliferative pathways in PH, but the true breadth of influence of the miR-130/301 family across cell types in PH may be even more extensive. Here, we employed targeted network theory to identify additional pathogenic pathways regulated by miR-130/301, including those involving vasomotor tone. Guided by these predictions, we demonstrated, via gain- and loss-of-function experimentation in vitro and in vivo, that miR-130/301-specific control of the peroxisome proliferator-activated receptor gamma regulates a panel of vasoactive factors communicating between diseased pulmonary vascular endothelial and smooth muscle cells. Of these, the vasoconstrictive factor endothelin-1 serves as an integral point of communication between the miR-130/301-peroxisome proliferator-activated receptor gamma axis in endothelial cells and contractile function in smooth muscle cells. Thus, resulting from an in silico analysis of the architecture of the PH disease gene network coupled with molecular experimentation in vivo, these findings clarify the expanded role of the miR-130/301 family in the global regulation of PH. They further emphasize the importance of molecular cross-talk among the diverse cellular populations involved in PH.	[Bertero, Thomas; Cottrill, Katherine; Lu, Yu; Annis, Sofia; Hale, Andrew; Chan, Stephen Y.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc & Network Med Dept Med, Boston, MA 02115 USA; [Waxman, Aaron B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med,Dept Med, Boston, MA 02115 USA; [Krauszman, Adrienn; Kuebler, Wolfgang M.] Univ Toronto, Keenan Res Ctr Biomed Sci St Michaels, Toronto, ON M5R 0A3, Canada; [Bhat, Balkrishen; Chau, B. Nelson] Regulus Therapeut, San Diego, CA 92127 USA; [Kuebler, Wolfgang M.] Charite, Dept Physiol, D-10717 Berlin, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; Isis Pharmaceuticals Inc; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chan, SY (corresponding author), Brigham & Womens Hosp, New Res Bldg,Rm 630N,77 Ave Louis Pasteur, Boston, MA 02115 USA.	sychan@partners.org	Waxman, Aaron/L-7450-2019; Waxman, Aaron/I-8659-2019	Waxman, Aaron/0000-0001-7797-0361; Kuebler, Wolfgang/0000-0003-4100-2961; BERTERO, Thomas/0000-0002-4801-9902; Annis, Sofia/0000-0003-3264-5260	National Institutes of Health [K08HL096834]; McArthur-Radovsky Fund; Lerner Fund; Harris Fund; Watkins Fund; Pulmonary Hypertension Association; Canadian Institutes for Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL096834, R01HL124021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McArthur-Radovsky Fund; Lerner Fund(March of Dimes); Harris Fund; Watkins Fund; Pulmonary Hypertension Association; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant K08HL096834 (to S. Y. C.). This work was also supported by the McArthur-Radovsky, Lerner, Harris, and Watkins Funds and the Pulmonary Hypertension Association (to S. Y. C.) and by the Canadian Institutes for Health Research (to W. M. K.).	Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bando K, 1997, CIRCULATION, V96, P346; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bertero T, 2014, J CLIN INVEST, V124, P3514, DOI 10.1172/JCI74773; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Din S, 2009, VASC PHARMACOL, V51, P344, DOI 10.1016/j.vph.2009.09.001; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Gou DM, 2012, AM J PHYSIOL-LUNG C, V303, pL682, DOI 10.1152/ajplung.00344.2011; Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, pL1082, DOI 10.1152/ajplung.00199.2009; Hakim TS, 2013, RESP PHYSIOL NEUROBI, V189, P93, DOI 10.1016/j.resp.2013.06.028; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hansmann G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000267; Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079503; Kang BY, 2011, AM J PHYSIOL-LUNG C, V301, pL881, DOI 10.1152/ajplung.00195.2011; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; Liu YH, 2012, HYPERTENSION, V60, P1471, DOI 10.1161/HYPERTENSIONAHA.112.198887; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; Markewitz BA, 2001, CARDIOVASC RES, V49, P200, DOI 10.1016/S0008-6363(00)00221-2; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Meng S, 2012, J MOL CELL CARDIOL, V53, P64, DOI 10.1016/j.yjmcc.2012.04.003; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Nagendran J, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300448; Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Paulin R, 2011, CIRCULATION, V123, P1205, DOI 10.1161/CIRCULATIONAHA.110.963314; Pozeg ZI, 2003, CIRCULATION, V107, P2037, DOI 10.1161/01.CIR.0000062688.76508.B3; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Rabinovitch M, 2010, ADV EXP MED BIOL, V661, P447, DOI 10.1007/978-1-60761-500-2_29; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Shimoda LA, 2000, PHYSIOL RES, V49, P549; Shimoda LA, 2002, RESP PHYSIOL NEUROBI, V132, P93, DOI 10.1016/S1569-9048(02)00052-6; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang LM, 2012, J CLIN INVEST, V122, P4218, DOI 10.1172/JCI59176; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu WH, 2011, AM J HYPERTENS, V24, P1087, DOI 10.1038/ajh.2011.116	50	73	79	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2069	2085		10.1074/jbc.M114.617845	http://dx.doi.org/10.1074/jbc.M114.617845			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505270	Green Published, hybrid			2022-12-28	WOS:000348588000014
J	Chen, T; Kocinsky, HS; Cha, BY; Murtazina, R; Yang, JB; Tse, CM; Singh, V; Cole, R; Aronson, PS; de Jonge, H; Sarker, R; Donowitz, M				Chen, Tiane; Kocinsky, Hetal S.; Cha, Boyoung; Murtazina, Rakhilya; Yang, Jianbo; Tse, C. Ming; Singh, Varsha; Cole, Robert; Aronson, Peter S.; de Jonge, Hugo; Sarker, Rafiquel; Donowitz, Mark			Cyclic GMP Kinase II (cGKII) Inhibits NHE3 by Altering Its Trafficking and Phosphorylating NHE3 at Three Required Sites IDENTIFICATION OF A MULTIFUNCTIONAL PHOSPHORYLATION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER NHE3; ACUTE ACTIVATION; BASAL ACTIVITY; PROTEIN; CAMP; NHERF2; BINDS; STIMULATION; ISOFORM; MULTIPLE	The epithelial brush-border Na+/H+ exchanger NHE3 is acutely inhibited by cGKII/cGMP, but how cGKII inhibits NHE3 is unknown. This study tested the hypothesis that cGMP inhibits NHE3 by phosphorylating it and altering its membrane trafficking. Studies were carried out in PS120/NHERF2 and in Caco-2/Bbe cells overexpressing HA-NHE3 and cGKII, and in mouse ileum. NHE3 activity was measured with 2',7'-bis(carboxyethyl)-S-(and 6) carboxyfluorescein acetoxy methylester/fluorometry. Surface NHE3 was determined by cell surface biotinylation. Identification of NHE3 phosphorylation sites was by iTRAQ/LC-MS/MS with TiO2 enrichment and immunoblotting with specific anti-phospho-NHE3 antibodies. cGMP/cGKII rapidly inhibited NHE3, which was associated with reduced surface NHE3. cGMP/cGKII increased NHE3 phosphorylation at three sites (rabbit Ser(554), Ser(607), and Ser(663), equivalent to mouse Ser(552), Ser(605), and Ser(659)), all of which had to be present at the same time for cGMP to inhibit NHE3. NHE3-Ser(663) phosphorylation was not necessary for cAMP inhibition of NHE3. Dexamethasone (4 h) stimulated wild type NHE3 activity and increased surface expression but failed to stimulate NHE3 activity or increase surface expression when NHE3 was mutated to either S663A or S663D. We conclude that 1) cGMP inhibition of NHE3 is associated with phosphorylation of NHE3 at Ser(554), Ser(607), and Ser(663), all of which are necessary for cGMP/cGKII to inhibitNHE3.2) Dexamethasone stimulates NHE3 by phosphorylation of a single site, Ser(663). The requirement for three phosphorylation sites in NHE3 for cGKII inhibition, and for phos-phorylation of one of these sites for dexamethasone stimulation of NHE3, is a unique example of regulation by phosphorylation.	[Chen, Tiane; Cha, Boyoung; Murtazina, Rakhilya; Yang, Jianbo; Tse, C. Ming; Singh, Varsha; Sarker, Rafiquel; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA; [Chen, Tiane; Cha, Boyoung; Murtazina, Rakhilya; Yang, Jianbo; Tse, C. Ming; Singh, Varsha; Sarker, Rafiquel; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Cole, Robert] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Kocinsky, Hetal S.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Aronson, Peter S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [de Jonge, Hugo] Erasmus MC, GI Div, NL-3015 CN Rotterdam, Netherlands	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Yale University; Yale University; Erasmus University Rotterdam; Erasmus MC	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA.	rndonowit@jhmi.edu	yang, jian/HIK-0188-2022		National Institutes of Health NIDDK [R01-DK26523, R01-DK61765, P01-DK072084, P30-DK89502]; Hopkins Digestive Diseases Basic and Translational Research Core Center; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, R01DK061765, R01DK026523, P01DK072084, P01DK017433] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hopkins Digestive Diseases Basic and Translational Research Core Center; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grants R01-DK26523, R01-DK61765, P01-DK072084, and P30-DK89502, The Hopkins Digestive Diseases Basic and Translational Research Core Center, and the Hopkins Center for Epithelial Disorders.	ANDERSON JM, 1989, J CELL BIOL, V109, P1047, DOI 10.1083/jcb.109.3.1047; AZARANI A, 1995, J BIOL CHEM, V270, P23166, DOI 10.1074/jbc.270.39.23166; Bacic D, 2003, KIDNEY INT, V64, P2133, DOI 10.1046/j.1523-1755.2003.00308.x; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Harada K, 2010, J BIOL CHEM, V285, P24044, DOI 10.1074/jbc.M109.072553; Hayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055623; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Kocinsky HS, 2007, AM J PHYSIOL-RENAL, V293, pF212, DOI 10.1152/ajprenal.00042.2007; Kocinsky HS, 2005, AM J PHYSIOL-RENAL, V289, pF249, DOI 10.1152/ajprenal.00082.2004; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Moe OW, 1999, J AM SOC NEPHROL, V10, P2412; Muller U, 2002, J NEUROSCI, V22, P8739; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; Vaandrager AB, 2000, GASTROENTEROLOGY, V118, P108, DOI 10.1016/S0016-5085(00)70419-7; Vaandrager AB, 1997, GASTROENTEROLOGY, V112, P437, DOI 10.1053/gast.1997.v112.pm9024297; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; Vaandrager AB, 1997, J BIOL CHEM, V272, P4195, DOI 10.1074/jbc.272.7.4195; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wang DS, 2007, AM J PHYSIOL-CELL PH, V292, pC396, DOI 10.1152/ajpcell.00345.2006; WIEPRECHT M, 1994, BIOCHEM J, V297, P241, DOI 10.1042/bj2970241; XU RF, 1995, J CELL PHYSIOL, V165, P30, DOI 10.1002/jcp.1041650105; Yip JW, 1997, J BIOL CHEM, V272, P18473, DOI 10.1074/jbc.272.29.18473; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753; Zizak M, 2012, J BIOL CHEM, V287, P13442, DOI 10.1074/jbc.M111.307256	43	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1952	1965		10.1074/jbc.M114.590174	http://dx.doi.org/10.1074/jbc.M114.590174			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480791	hybrid, Green Published			2022-12-28	WOS:000348588000005
J	Kamath, VG; Hsiung, CH; Lizenby, ZJ; McKee, EE				Kamath, Vasudeva G.; Hsiung, Chia-Heng; Lizenby, Zachary J.; McKee, Edward E.			Heart Mitochondrial TTP Synthesis and the Compartmentalization of TMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HUMAN-CELLS; THYMIDINE KINASE; DEOXYNUCLEOTIDE POOLS; LIVER-MITOCHONDRIA; DNA MAINTENANCE; MONOPHOSPHATE; METABOLISM; PHOSPHORYLATION; IDENTIFICATION; DEFICIENCY	The primary pathway of TTP synthesis in the heart requires thymidine salvage by mitochondrial thymidine kinase 2 (TK2). However, the compartmentalization of this pathway and the transport of thymidine nucleotides are not well understood. We investigated the metabolism of [H-3] thymidine or [H-3]TMP as precursors of [H-3] TTP in isolated intact or broken mitochondria from the rat heart. The results demonstrated that [H-3] thymidine was readily metabolized by the mitochondrial salvage enzymes to TTP in intact mitochondria. The equivalent addition of [H-3] TMP produced far less [H-3] TTP than the amount observed with [H-3] thymidine as the precursor. Using zidovudine to inhibit TK2, the synthesis of [H-3] TTP from [H-3] TMP was effectively blocked, demonstrating that synthesis of [H-3] TTP from [H-3] TMP arose solely from the dephosphory-synthase pathway that includes deoxyuridine triphosphatelation of [H-3] TMP to [H-3] thymidine. To determine the role of the membrane in TMP metabolism, mitochondrial membranes were disrupted by freezing and thawing. In broken mitochondria, [H-3] thymidine was readily converted to [H-3] TMP, but further phosphorylation was prevented even though the energy charge was well maintained by addition of oligomycin A, phosphocreatine, and creatine phosphokinase. The failure to synthesize TTP in broken mitochondria was not related to a loss of membrane potential or inhibition of the electron transport chain, as confirmed by addition of carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone and potassium cyanide, respectively, in intact mitochondria. In summary, these data, taken together, suggest that the thymidine salvage pathway is compartmentalized so that TMP kinase prefers TMP synthesized by TK2 over medium TMP and that this is disrupted in broken mitochondria.	[Kamath, Vasudeva G.; Hsiung, Chia-Heng; Lizenby, Zachary J.; McKee, Edward E.] Cent Michigan Univ, Dept Foundat Sci, Coll Med, Mt Pleasant, MI 48859 USA	Central Michigan University	McKee, EE (corresponding author), Cent Michigan Univ, Dept Foundat Sci, Coll Med, CMU Res Bldg,Rm 119,2630 Denison Dr, Mt Pleasant, MI 48859 USA.	mckee1ee@cmich.edu	Kamath, Vasudeva/AAE-4707-2020	Hsiung, Chia-Heng/0000-0003-3542-587X; McKee, Edward/0000-0002-4467-7668	National Institute of Health [R01/HL096480]; Central Michigan University Office of Research Sponsored Programs summer fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096480] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Michigan University Office of Research Sponsored Programs summer fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grant R01/HL096480. This work was also supported by the Central Michigan University Office of Research Sponsored Programs summer fellowship (to Z. J. L.).	Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; Chen YL, 2008, GENES CELLS, V13, P679, DOI 10.1111/j.1365-2443.2008.01197.x; Chimploy K, 2013, J BIOL CHEM, V288, P13145, DOI 10.1074/jbc.M113.461111; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028; Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200; Lynx MD, 2006, BIOCHEM PHARMACOL, V71, P1342, DOI 10.1016/j.bcp.2006.01.003; Mathews CK, 2014, FASEB J, V28, P3832, DOI 10.1096/fj.14-251249; McCann KA, 2012, J NEUROCHEM, V122, P126, DOI 10.1111/j.1471-4159.2012.07765.x; McKee Edward E, 2004, Cardiovasc Toxicol, V4, P155, DOI 10.1385/CT:4:2:155; MCKEE EE, 1990, AM J PHYSIOL, V258, pE492, DOI 10.1152/ajpendo.1990.258.3.E492; Morris GW, 2010, ANTIVIR THER, V15, P587, DOI 10.3851/IMP1567; Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Schlattner U, 2015, N-S ARCH PHARMACOL, V388, P271, DOI 10.1007/s00210-014-1047-4; Steeg PS, 2011, N-S ARCH PHARMACOL, V384, P331, DOI 10.1007/s00210-011-0651-9; Van Rompay AR, 2000, PHARMACOL THERAPEUT, V87, P189, DOI 10.1016/S0163-7258(00)00048-6	27	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2034	2041		10.1074/jbc.M114.624213	http://dx.doi.org/10.1074/jbc.M114.624213			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505243	hybrid, Green Published			2022-12-28	WOS:000348588000011
J	Mizugishi, K; Inoue, T; Hatayama, H; Bielawski, J; Pierce, JS; Sato, Y; Takaori-Kondo, A; Konishi, I; Yamashita, K				Mizugishi, Kiyomi; Inoue, Takuya; Hatayama, Hiroshi; Bielawski, Jacek; Pierce, Jason S.; Sato, Yukiyasu; Takaori-Kondo, Akifunni; Konishi, Ikuo; Yamashita, Kouhei			Sphingolipid Pathway Regulates Innate Immune Responses at the Fetomaternal Interface during Pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE KINASE TYPE-2; KILLER-CELL ACTIVITY; FUNCTIONAL-CHARACTERIZATION; INTRAVENOUS IMMUNOGLOBULIN; NEUTROPHIL ACTIVATION; TRYPTOPHAN CATABOLISM; RECURRENT MISCARRIAGE; MOLECULAR-CLONING; TISSUE FACTOR; FETAL INJURY	For a successful pregnancy, the mother's immune system has to tolerate the semiallogeneic fetus. A deleterious immune attack is avoided by orchestration of cellular, hormonal, and enzymatic factors. However, the precise mechanisms underlying fetomaternal tolerance are not yet completely understood. In this study, we demonstrate that sphingolipid metabolism constitutes a novel signaling pathway that is indispensable for fetomaternal tolerance by regulating innate immune responses at the fetomaternal interface. Perturbation of the sphingolipid pathway by disruption of the sphingosine kinase gene (Sphk) during pregnancy caused unusually high expression of neutrophil chemoattractants, CXCL1 and CXCL2, in the decidua, leading to a massive infiltration of neutrophils into the fetomaternal interface with enhanced oxidative damage, resulting in early fetal death. Sphk-deficient mice also exhibited neutrophilia in the peripheral blood, enhanced generation of granulocytes in the bone marrow, and a decrease in the number of decidual natural killer cells. The blockage of neutrophil influx protected Sphk-deficient mice against pregnancy loss. Notably, a similar result was obtained in human decidual cells, in which Sphk deficiency dramatically increased the secretion of CXCL1 and IL-8. In conclusion, our findings suggest that the sphingolipid metabolic pathway plays a critical role in fetomaternal tolerance by regulating innate immunity at the fetomaternal interface both in mice and humans, and it could provide novel insight into the development of therapeutic strategies to treat idiopathic pregnancy loss in humans.	[Mizugishi, Kiyomi; Takaori-Kondo, Akifunni; Yamashita, Kouhei] Kyoto Univ Hosp, Dept Hematol & Oncol, Kyoto 6068507, Japan; [Mizugishi, Kiyomi] Musashino Univ, Pharmaceut Sci Res Inst, Dept Pharmacotherapy, Tokyo 2028585, Japan; [Inoue, Takuya; Hatayama, Hiroshi] Adachi Hosp, Dept Gynecol & Obstet, Kyoto 6040837, Japan; [Bielawski, Jacek; Pierce, Jason S.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Sato, Yukiyasu; Konishi, Ikuo] Kyoto Univ, Dept Gynecol & Obstet, Grad Sch Med, Kyoto 6068507, Japan	Kyoto University; Medical University of South Carolina; Kyoto University	Mizugishi, K (corresponding author), Kyoto Univ Hosp, Dept Hematol & Oncol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kiyomim@kuhp.kyoto-u.ac.jp		Sato, Yukiyasu/0000-0003-4033-1229	Japan Society for the Promotion of Science [21591414, 24591600]; Naito Foundation; Japan Foundation for Pediatric Research; Cell Science Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Japan Foundation for Pediatric Research; Cell Science Research Foundation(Cell Science Research Foundation, Japan)	This work was supported by Grants-in-aid for Scientific Research 21591414 and 24591600 from the Japan Society for the Promotion of Science, the Naito Foundation, the Japan Foundation for Pediatric Research, and the Cell Science Research Foundation (to K. M.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; AOKI K, 1995, LANCET, V345, P1340, DOI 10.1016/S0140-6736(95)92539-2; Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Argraves Kelley M, 2010, World J Biol Chem, V1, P291, DOI 10.4331/wjbc.v1.i10.291; Bansal AS, 2012, J REPROD IMMUNOL, V93, P41, DOI 10.1016/j.jri.2011.10.002; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Girardi G, 2011, THROMB RES, V127, pS43, DOI 10.1016/S0049-3848(11)70012-3; HAIMOVICI F, 1991, BIOL REPROD, V44, P69, DOI 10.1095/biolreprod44.1.69; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jaslow CR, 2010, FERTIL STERIL, V93, P1234, DOI 10.1016/j.fertnstert.2009.01.166; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kotlan B, 2006, AM J REPROD IMMUNOL, V55, P331, DOI 10.1111/j.1600-0897.2006.00368.x; Krieg SA, 2012, MOL HUM REPROD, V18, P442, DOI 10.1093/molehr/gas017; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; MUELLERECKHARDT G, 1994, J REPROD IMMUNOL, V27, P95, DOI 10.1016/0165-0378(94)90026-4; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nava VE, 2000, CANCER RES, V60, P4468; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paffaro VA, 2003, PLACENTA, V24, P479, DOI 10.1053/plac.2002.0919; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Saini V, 2011, CLIN CHIM ACTA, V412, P702, DOI 10.1016/j.cca.2011.01.002; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; SUFFYS P, 1989, ANTICANCER RES, V9, P167; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; van den Heuvel MJ, 2007, AM J REPROD IMMUNOL, V58, P447, DOI 10.1111/j.1600-0897.2007.00529.x; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Williams PJ, 2009, REPRODUCTION, V138, P177, DOI 10.1530/REP-09-0007; Winger EE, 2011, AM J REPROD IMMUNOL, V66, P394, DOI 10.1111/j.1600-0897.2011.01018.x; Yamada H, 2003, AM J REPROD IMMUNOL, V50, P351, DOI 10.1034/j.1600-0897.2003.00095.x; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang JH, 2013, HUM REPROD, V28, P3026, DOI 10.1093/humrep/det339	53	24	26	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2053	2068		10.1074/jbc.M114.628867	http://dx.doi.org/10.1074/jbc.M114.628867			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25505239	Green Published, hybrid			2022-12-28	WOS:000348588000013
J	Ogawa, M; Sawaguchi, S; Kawai, T; Nadano, D; Matsuda, T; Yagi, H; Kato, K; Furukawa, K; Okajima, T				Ogawa, Mitsutaka; Sawaguchi, Shogo; Kawai, Takami; Nadano, Daita; Matsuda, Tsukasa; Yagi, Hirokazu; Kato, Koichi; Furukawa, Koichi; Okajima, Tetsuya			Impaired O-Linked N-Acetylglucosaminylation in the Endoplasmic Reticulum by Mutated Epidermal Growth Factor (EGF) Domain-specific O-Linked N-Acetylglucosamine Transferase Found in Adams-Oliver Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SUGAR TRANSPORTER; EXTRACELLULAR DOMAIN; GLCNAC MODIFICATION; MOLECULAR-CLONING; NOTCH RECEPTORS; UDP-GLCNAC; ALPHA-DYSTROGLYCAN; INSULIN-RESISTANCE; MANIC FRINGE; MUTATIONS	Epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine (EOGT) is an endoplasmic reticulum (ER)-resident O-linkedN-acetylglucosamine (O-GlcNAc) transferase that acts on EGF domain-containing proteins such as Notch receptors. Recently, mutations in EOGT have been reported in patients with Adams-Oliver syndrome (AOS). Here, we have characterized enzymatic properties of mouse EOGT and EOGT mutants associated with AOS. Simultaneous expression of EOGT with Notch1 EGF repeats in human embryonic kidney 293T (HEK293T) cells led to immunoreactivity with the CTD110.6 antibody in the ER. Consistent with the GlcNAc modification in the ER, the enzymatic properties of EOGT are distinct from those of Golgi-resident GlcNAc transferases; the pH optimum of EOGT ranges from 7.0 to 7.5, and the K-m value for UDP N-acetylglucosamine (UDP-GlcNAc) is 25 mu M. Despite the relatively low K-m value for UDP-GlcNAc, EOGT-catalyzed GlcNAcylation depends on the hexosamine pathway, as revealed by the increased O-GlcNAcylation of Notch1 EGF repeats upon supplementation with hexosamine, suggesting differential regulation of the luminal UDP-GlcNAc concentration in the ER and Golgi. As compared with wild-type EOGT, O-GlcNAcylation in the ER is nearly abolished in HEK293T cells exogenously expressing EOGT variants associated with AOS. Introduction of the W207S mutation resulted in degradation of the protein via the ubiquitin-proteasome pathway, although the stability and ER localization of EOGTR377Q were not affected. Importantly, the interaction between UDPGlcNAc and EOGTR377Q was impaired without adversely affecting the acceptor substrate interaction. These results suggest that impaired glycosyltransferase activity in mutant EOGT proteins and the consequent defective O-GlcNAcylation in the ER constitute the molecular basis for AOS.	[Ogawa, Mitsutaka; Sawaguchi, Shogo; Kawai, Takami; Furukawa, Koichi; Okajima, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan; [Ogawa, Mitsutaka] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama, Shiga 5260829, Japan; [Nadano, Daita; Matsuda, Tsukasa] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Nagoya University; Nagoya University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Okajima, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	tokajima@med.nagoya-u.ac.jp	Yagi, Hirokazu/ABH-6151-2020; Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X; Kato, Koichi/0000-0001-7187-9612; Yagi, Hirokazu/0000-0001-9296-0225	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Takeda Foundation; Astellas Foundation; Grants-in-Aid for Scientific Research [25670140] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Foundation(Takeda Science Foundation (TSF)); Astellas Foundation(Astellas Pharmaceuticals); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Challenging Exploratory Research (to T.O.) from the Japan Society for the Promotion of Science, a Grant-in-aid for Scientific Research on Innovative Areas (to T.O., H. Y., and K. K.) from the Ministry of Education, Culture, Sports, Science and Technology, and a Grant-in-aid from the Takeda Foundation and the Astellas Foundation (T.O.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Cohen I, 2014, EUR J HUM GENET, V22, P374, DOI 10.1038/ejhg.2013.159; Csala M, 2007, BBA-BIOMEMBRANES, V1768, P1325, DOI 10.1016/j.bbamem.2007.03.009; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Hoffmann BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032762; Hou XH, 2012, J BIOL CHEM, V287, P474, DOI 10.1074/jbc.M111.317578; Ishida N, 2005, GENOMICS, V85, P106, DOI 10.1016/j.ygeno.2004.09.010; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kizuka Y, 2014, J BIOL CHEM, V289, P11253, DOI 10.1074/jbc.M114.554311; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Ma XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063452; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Maszczak-Seneczko D, 2011, ACTA BIOCHIM POL, V58, P413; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Miura Y, 2012, BBA-GEN SUBJECTS, V1820, P1678, DOI 10.1016/j.bbagen.2012.06.013; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062835; Ogawa Mitsutaka, 2014, World J Biol Chem, V5, P224, DOI 10.4331/wjbc.v5.i2.224; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Ogawa M, 2012, BBA-GEN SUBJECTS, V1820, P24, DOI 10.1016/j.bbagen.2011.10.011; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sakaidani Y, 2010, METHOD ENZYMOL, V480, P355, DOI 10.1016/S0076-6879(10)80016-3; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Song ZW, 2013, MOL ASPECTS MED, V34, P590, DOI 10.1016/j.mam.2012.12.004; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stittrich AB, 2014, AM J HUM GENET, V95, P275, DOI 10.1016/j.ajhg.2014.07.011; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Tashima Y, 2014, J BIOL CHEM, V289, P11132, DOI 10.1074/jbc.M113.492512; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Trembath R. C, 2011, AM J HUM GENET, V88, P574; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; Yagi H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03288; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	54	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2137	2149		10.1074/jbc.M114.598821	http://dx.doi.org/10.1074/jbc.M114.598821			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488668	hybrid, Green Published			2022-12-28	WOS:000348588000019
J	Goetze, JP; Johnsen, AH; Kistorp, C; Gustafsson, F; Johnbeck, CB; Rehfeld, JF				Goetze, Jens P.; Johnsen, Anders H.; Kistorp, Caroline; Gustafsson, Finn; Johnbeck, Camilla B.; Rehfeld, Jens F.			Cardiomyocyte Expression and Cell-specific Processing of Procholecystokinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE; CHOLECYSTOKININ; PLASMA; GENE; ACCUMULATION; PRECURSORS; HYPOXIA; PROTEIN; GASTRIN	Heart muscle cells produce peptide hormones such as natriuretic peptides. Developing hearts also express the gene for the classic intestinal hormone cholecystokinin (CCK) in amounts similar to those in the intestine and brain. However, cardiac expression of peptides other than natriuretic peptides has only been suggested using transcriptional measures or methods, with the post-translational phase of gene expression unaddressed. In this study, we examined the cardiac expression of the CCK gene in adult mammals and its expression at the protein level. Using quantitative PCR, a library of sequence-specific pro-CCK assays, peptide purification, and mass spectrometry, we demonstrate that the mammalian heart expresses pro-CCK in amounts comparable to natriuretic prohormones and processes it to a unique, triple-sulfated, and N-terminally truncated product distinct from intestinal and cerebral CCK peptides. Isoprenaline rapidly stimulated cardiac CCK gene expression in vitro and in vivo, which suggests that the cardiac-specific truncated pro-CCK may have pathophysiological relevance as a new marker of heart failure. The suggestion is confirmed by measurement of plasma from heart failure patients.	[Goetze, Jens P.; Johnsen, Anders H.; Kistorp, Caroline; Gustafsson, Finn; Johnbeck, Camilla B.; Rehfeld, Jens F.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Goetze, Jens P.; Johnsen, Anders H.; Kistorp, Caroline; Gustafsson, Finn; Johnbeck, Camilla B.; Rehfeld, Jens F.] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Goetze, Jens P.; Johnsen, Anders H.; Kistorp, Caroline; Gustafsson, Finn; Johnbeck, Camilla B.; Rehfeld, Jens F.] Univ Copenhagen, Herlev Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark; [Goetze, Jens P.] Aarhus Univ, Dept Clin Med, DK-8000 Aarhus C, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University	Goetze, JP (corresponding author), Rigshosp, Dept Clin Biochem KB3014, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark.	jpg@dadlnet.dk; jens.f.rehfeld@regionh.dk		Kistorp, Caroline/0000-0002-3019-6775; Gustafsson, Finn/0000-0003-2144-341X	Novo Nordisk Foundation; Lundbeck Foundation; Danish Biotechnology Center for Cellular Communication; Novo Nordisk Fonden [NNF12OC1016060] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Biotechnology Center for Cellular Communication; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Novo Nordisk Foundation, the Lundbeck Foundation, and The Danish Biotechnology Center for Cellular Communication.	BARDRAM L, 1989, ACTA ENDOCRINOL-COP, V120, P479, DOI 10.1530/acta.0.1200479; CANTOR P, 1989, AM J PHYSIOL, V256, pG53, DOI 10.1152/ajpgi.1989.256.1.G53; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Christoffersen C, 2002, HYPERTENSION, V40, P54, DOI 10.1161/01.HYP.0000021780.21830.DD; DEFTOS LJ, 1993, J CLIN INVEST, V92, P727, DOI 10.1172/JCI116643; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; GEIJER T, 1990, FEBS LETT, V270, P30, DOI 10.1016/0014-5793(90)81227-F; Goetze JP, 2012, CLIN CHEM, V58, P83, DOI 10.1373/clinchem.2011.165696; Goetze JP, 2004, FASEB J, V18, P1928, DOI 10.1096/fj.03-1336fje; HILSTED L, 1986, ANAL BIOCHEM, V152, P119, DOI 10.1016/0003-2697(86)90129-6; ITO H, 1993, J CLIN INVEST, V92, P398, DOI 10.1172/JCI116579; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; LARSSON LI, 1979, BRAIN RES, V165, P201, DOI 10.1016/0006-8993(79)90554-7; Lay JM, 1999, DEV DYNAM, V216, P190, DOI 10.1002/(SICI)1097-0177(199910)216:2<190::AID-DVDY9>3.3.CO;2-B; Rehfeld JF, 2007, CURR TOP MED CHEM, V7, P1154; REHFELD JF, 1978, J BIOL CHEM, V253, P4016; REHFELD JF, 1987, P NATL ACAD SCI USA, V84, P3019, DOI 10.1073/pnas.84.9.3019; Rehfeld JF, 1998, CLIN CHEM, V44, P991; REHFELD JF, 1986, J BIOL CHEM, V261, P5841; Rehfeld JF, 2001, J CLIN ENDOCR METAB, V86, P251, DOI 10.1210/jc.86.1.251; Smith J, 2013, ENDOCRINOLOGY, V154, P1864, DOI 10.1210/en.2012-2186; Weidemann A, 2008, BIOCHEM J, V409, P233, DOI 10.1042/BJ20070629; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yasuoka C, 2004, J BIOL CHEM, V279, P51182, DOI 10.1074/jbc.M407225200; Zimmer HG, 1997, J MOL MED-JMM, V75, P849, DOI 10.1007/s001090050176	25	22	22	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6837	6843		10.1074/jbc.M114.622670	http://dx.doi.org/10.1074/jbc.M114.622670			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627687	Green Published, hybrid			2022-12-28	WOS:000350991500019
J	Zou, J; Li, WJ; Misra, A; Yue, F; Song, K; Chen, Q; Guo, GH; Yi, JL; Kimata, JT; Liu, LY				Zou, Jing; Li, Wenjiao; Misra, Anisha; Yue, Fei; Song, Kun; Chen, Qi; Guo, Guanghua; Yi, Jinglin; Kimata, Jason T.; Liu, Leyuan			The Viral Restriction Factor Tetherin Prevents Leucine-rich Pentatricopeptide Repeat-containing Protein (LRPPRC) from Association with Beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and Enhances Autophagy and Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; HIV-1 RELEASE; BETA-TRCP; T-CELLS; IN-VIVO; MITOCHONDRIA; INSTABILITY; SUPPRESSES; P62/SQSTM1; INFECTION	Tetherin has been characterized as a key factor that restricts viral particles such as HIV and hepatitis C virus on plasma membranes, acts as a ligand of the immunoglobulin-like transcript 7 (ILT7) receptor in tumor cells, and suppresses antiviral innate immune responses mediated by human plasmacytoid dendritic cells. However, the normal cellular function of Tetherin without viral infection is unknown. Here we show that Tetherin not only serves as a substrate of autophagy but itself regulates the initiation of autophagy. Tetherin interacts with the autophagy/mitophagy suppressor LRPPRC and prevents LRPPRC from forming a ternary complex with Beclin 1 and Bcl-2 so that Beclin 1 is released to bind with PI3KCIII (class III PI3K) to activate the initiation of autophagy. Suppression of Tetherin leads to impairment of autophagy, whereas overexpression of Tetherin causes activation of autophagy. Under mitophagic stress, Tetherin is concentrated on mitochondria engulfed in autophagosomes. Tetherin plays a general role in the degradation of autophagosomes containing not only the symbiotic mitochondria but also, possibly, the infected virus. Therefore, Tetherin may enhance autophagy and mitophagy to suppress tumorigenesis, enhance innate immune responses, or prevent T cell apoptosis or pyroptosis,	[Zou, Jing; Li, Wenjiao; Yue, Fei; Song, Kun; Chen, Qi; Liu, Leyuan] Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Zou, Jing; Guo, Guanghua; Yi, Jinglin] Nanchang Univ, Jiangxi Res Inst Ophthalmol & Visual Sci, Affiliated Eye Hosp, Nanchang 330006, Peoples R China; [Misra, Anisha; Kimata, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Liu, Leyuan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Nanchang University; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Liu, LY (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	lliu@ibt.tamhsc.edu	Li, Wenjiao/J-2198-2019; Yue, Fei/N-1891-2018	Li, Wenjiao/0000-0003-1308-8489; Song, Kun/0000-0003-3822-2891; Zou, Jing/0000-0002-0976-7078; Kimata, Jason/0000-0002-0504-0090	NCI/National Institutes of Health [CA142862]; NIAID/National Institutes of Health [AI099007]; Department of Defense [W81XWH]; Baylor College of Medicine-University of Texas Houston Medical School Center for AIDS Research [AI036211]; NATIONAL CANCER INSTITUTE [R01CA142862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R21AI099007] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Baylor College of Medicine-University of Texas Houston Medical School Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grant CA142862 (to L. L.) and NIAID/National Institutes of Health Grant AI099007 (to J. T. K.) This work was also supported by Department of Defense New Investigator Award W81XWH (to L. L.) and by Baylor College of Medicine-University of Texas Houston Medical School Center for AIDS Research Grant AI036211 (to J. T. K.).	Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blanchet FP, 2012, CURR HIV RES, V10, P307, DOI 10.2174/157016212800792441; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; D'Angiolella V, 2007, CELL CYCLE, V6, P576, DOI 10.4161/cc.6.5.3934; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; Fogel AI, 2013, MOL CELL BIOL, V33, P3675, DOI 10.1128/MCB.00079-13; GOTO T, 1994, BLOOD, V84, P1922; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Janvier K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001265; Jiang XH, 2015, MOL CARCINOGEN, V54, P1194, DOI 10.1002/mc.22193; Jiang XH, 2014, CANCER-AM CANCER SOC, V120, P1228, DOI 10.1002/cncr.28551; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Killian MS, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-16; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Margulis L., 1975, S SOC EXP BIOL, V1975, P21; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Mishra PK, 2009, FREE RADICAL RES, V43, P718, DOI 10.1080/10715760903037699; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Ryter Stefan W, 2014, Int J Cell Biol, V2014, P502676, DOI 10.1155/2014/502676; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Schweitzer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040537; Suen YK, 2000, APOPTOSIS, V5, P369, DOI 10.1023/A:1009691727077; Tervo HM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-9; Thippeshappa R, 2013, J VIROL, V87, P6678, DOI 10.1128/JVI.00338-13; Thomas WD, 2000, J IMMUNOL, V165, P5612, DOI 10.4049/jimmunol.165.10.5612; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094903; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306	54	17	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7269	7279		10.1074/jbc.M114.627679	http://dx.doi.org/10.1074/jbc.M114.627679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631043	Green Published, hybrid			2022-12-28	WOS:000350991500055
J	Byrd, AK; Raney, KD				Byrd, Alicia K.; Raney, Kevin D.			A Parallel Quadruplex DNA Is Bound Tightly but Unfolded Slowly by Pif1 Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE PIF1; SINGLE-STRANDED-DNA; C-MYC PROMOTER; TELOMERIC G-QUADRUPLEX; GENOMIC STABILITY; CRYSTAL-STRUCTURE; FAMILY HELICASES; MAMMALIAN-CELLS; NUCLEIC-ACIDS; BINDING	DNA sequences that can form intramolecular quadruplex structures are found in promoters of proto-oncogenes. Many of these sequences readily fold into parallel quadruplexes. Here we characterize the ability of yeast Pill to bind and unfold a parallel quadruplex DNA substrate. We found that Pif1 binds more tightly to the parallel quadruplex DNA than single-stranded DNA or tailed duplexes. However, Pif1 unwinding of duplexes occurs at a much faster rate than unfolding of a parallel intramolecular quadruplex. Pill readily unfolds a parallel quadruplex DNA substrate in a multiturnover reaction and also generates some product under single cycle conditions. The rate of ATP hydrolysis by Pill is reduced when bound to a parallel quadruplex compared with single-stranded DNA. ATP hydrolysis occurs at a faster rate than quadruplex unfolding, indicating that some ATP hydrolysis events are non-productive during unfolding of intramolecular parallel quadruplex DNA. However, product eventually accumulates at a slow rate.	[Byrd, Alicia K.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham, Little Rock, AR 72205 USA.	raneykevind@uams.edu		Byrd, Alicia/0000-0001-5484-0759	National Institutes of Health [R01 GM098922]; Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM098922 (to K. D. R.). This work was also supported by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000.	Adrian M, 2014, J AM CHEM SOC, V136, P6297, DOI 10.1021/ja4125274; Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bhattacharyya B, 2014, PROTEIN SCI, V23, P1498, DOI 10.1002/pro.2533; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Carroll SS, 1996, METHOD ENZYMOL, V275, P365; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Eddy S, 2014, NUCLEIC ACIDS RES, V42, P3272, DOI 10.1093/nar/gkt1314; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Galletto R, 2013, NUCLEIC ACIDS RES, V41, P4613, DOI 10.1093/nar/gkt117; Gavathiotis E, 2003, ORG BIOMOL CHEM, V1, P1650, DOI 10.1039/b300845m; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Halder K, 2005, NUCLEIC ACIDS RES, V33, P4466, DOI 10.1093/nar/gki750; Hatzakis E, 2010, BIOCHEMISTRY-US, V49, P9152, DOI 10.1021/bi100946g; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Inagaki H, 2009, GENOME RES, V19, P191, DOI 10.1101/gr.079244.108; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Long X, 2013, NUCLEIC ACIDS RES, V41, P2746, DOI 10.1093/nar/gks1341; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Narayana N, 2009, J MOL BIOL, V385, P469, DOI 10.1016/j.jmb.2008.10.041; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Piazza A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003033; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Ramanagoudr-Bhojappa R, 2014, BIOCHEMISTRY-US, V53, P7659, DOI 10.1021/bi500746v; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; Raney KD, 2013, ADV EXP MED BIOL, V973, P17, DOI 10.1007/978-1-4614-5037-5_2; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Toseland CP, 2009, J MOL BIOL, V392, P1020, DOI 10.1016/j.jmb.2009.07.071; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Xiao S, 2013, NUCLEIC ACIDS RES, V41, P10379, DOI 10.1093/nar/gkt781; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100; Zhang AYQ, 2012, J AM CHEM SOC, V134, P19297, DOI 10.1021/ja309851t; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	68	47	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6482	6494		10.1074/jbc.M114.630749	http://dx.doi.org/10.1074/jbc.M114.630749			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25589786	hybrid, Green Published			2022-12-28	WOS:000350732500051
J	Ando, Y; Shinozawa, Y; Iijima, Y; Yu, BC; Sone, M; Ooi, Y; Watanaka, Y; Chida, K; Hakuno, F; Takahashi, SI				Ando, Yasutoshi; Shinozawa, Yusuke; Iijima, Yumi; Yu, Bu-Chin; Sone, Meri; Ooi, Yuko; Watanaka, Yusuke; Chida, Kazuhiro; Hakuno, Fumihiko; Takahashi, Shin-Ichiro			Tumor Necrosis Factor (TNF)-alpha-induced Repression of GKAP42 Protein Levels through cGMP-dependent Kinase (cGK)-I alpha Causes Insulin Resistance in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; RECEPTOR SUBSTRATE-1; FACTOR-ALPHA; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; GLUT4 TRANSLOCATION; SIGNALING PATHWAYS; PHOSPHORYLATION; OBESITY; DOMAIN	Insulin receptor substrates (IRSs) have been shown to be major mediators of insulin signaling. Recently, we found that IRSs form high-molecular weight complexes, and here, we identify by yeast two-hybrid screening a novel IRS-1-associated protein: a 42-kDa cGMP-dependent protein kinase-anchoring protein (GKAP42). GKAP42 knockdown in 3T3-L1 adipocytes suppressed insulin-dependent IRS-1 tyrosine phosphorylation and downstream signaling, resulting in suppression of GLUT4 translocation to plasma membrane induced by insulin. In addition, GLUT4 translocation was also suppressed in cells overexpressing GKAP42-N (the IRS-1 binding region of GKAP42), which competed with GKAP42 for IRS-1, indicating that GKAP42 binding to IRS-1 is required for insulin-induced GLUT4 translocation. Long term treatment of 3T3-L1 adipocytes with TNF-alpha, which induced insulin resistance, significantly decreased the GKAP42 protein level. We then investigated the roles of cGMP-dependent kinase (cGK)-I alpha, which bound to GKAP42, in these changes. cGK-I alpha knockdown partially rescued TNF-alpha-induced decrease in GKAP42 and impairment of insulin signals. These data indicated that TNF-alpha-induced repression of GKAP42 via cGK-I alpha caused reduction of insulin-induced IRS-1 tyrosine phosphorylation at least in part. The present study describes analysis of the novel TNF-alpha-induced pathway, cGK-I alpha-GKAP42, which regulates insulin-dependent signals and GLUT4 translocation.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Hakuno, F (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Lab Cell Regulat,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahakuno@mail.ecc.u-tokyo.ac.jp		Hakuno, Fumihiko/0000-0002-4447-6225; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Ando, Yukio/0000-0001-7115-9105	Japan Society for the Promotion of Science [24380152, 16208028, 22248030, 25221204]; Program for Promotion of Basic Research Activities for Innovative Biosciences; Program for Basic and Applied Research for Innovations in Bio-oriented Industry	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences; Program for Basic and Applied Research for Innovations in Bio-oriented Industry	This work was supported in part by Grant-in-aid for Scientific Research (B) 24380152 (to F. H.) and Grants-in-aid for Scientific Research (A) (2) 16208028, (A) (2) 22248030, and (S) 25221204 (to S.-I. T.); a Grant-in-aid for International Joint Research (to S.-I. T.); and the Core-to-Core Program (to S.-I. T.) from the Japan Society for the Promotion of Science. This work was also supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (to F. H.) as well as the Program for Basic and Applied Research for Innovations in Bio-oriented Industry (to S.-I. T.).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Ducluzeau PH, 2002, DIABETES METAB, V28, P85; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Engelman JA, 2000, MOL ENDOCRINOL, V14, P1557, DOI 10.1210/me.14.10.1557; Farhang-Fallah J, 2002, MOL CELL BIOL, V22, P7325, DOI 10.1128/MCB.22.20.7325-7336.2002; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; Fukushima T, 2011, MOL CELL ENDOCRINOL, V344, P81, DOI 10.1016/j.mce.2011.06.029; Fukushima T, 2011, BIOCHEM BIOPH RES CO, V404, P767, DOI 10.1016/j.bbrc.2010.12.045; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Grigsby RJ, 2001, BIOCHEM BIOPH RES CO, V287, P1121, DOI 10.1006/bbrc.2001.5694; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kanatani Y, 2007, DIABETES, V56, P795, DOI 10.2337/db06-1039; Kapur S, 1999, AM J PHYSIOL-ENDOC M, V276, pE635, DOI 10.1152/ajpendo.1999.276.4.E635; Lee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055634; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Ribiere C, 1996, BIOCHEM BIOPH RES CO, V222, P706, DOI 10.1006/bbrc.1996.0824; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; TANTI JF, 1994, J BIOL CHEM, V269, P6051; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Yoneyama Y, 2013, MOL CELL BIOL, V33, P1991, DOI 10.1128/MCB.01394-12; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	54	19	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5881	5892		10.1074/jbc.M114.624759	http://dx.doi.org/10.1074/jbc.M114.624759			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25586176	Green Published, hybrid			2022-12-28	WOS:000350044200052
J	Ji, HL; Zhao, RZ; Komissarov, AA; Chang, YC; Liu, YF; Matthay, MA				Ji, Hong-Long; Zhao, Runzhen; Komissarov, Andrey A.; Chang, Yongchang; Liu, Yongfeng; Matthay, Michael A.			Proteolytic Regulation of Epithelial Sodium Channels by Urokinase Plasminogen Activator CUTTING EDGE AND CLEAVAGE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALVEOLAR FLUID CLEARANCE; SINGLE-CHAIN UROKINASE; INDUCED PLEURAL INJURY; FIBRIN TURNOVER; NA+ CHANNELS; LUNG INJURY; ALPHA-MACROGLOBULIN; GAMMA-SUBUNIT; ENAC; EXPRESSION	Plasminogen activator inhibitor 1 (PAI-1) level is extremely elevated in the edematous fluid of acutely injured lungs and pleurae. Elevated PAI-1 specifically inactivates pulmonary urokinase-type (uPA) and tissue-type plasminogen activators (tPA). We hypothesized that plasminogen activation and fibrinolysis may alter epithelial sodium channel (ENaC) activity, a key player in clearing edematous fluid. Two-chain urokinase (tcuPA) has been found to strongly stimulate heterologous human alpha beta gamma ENaC activity in a dose-and time-dependent manner. This activity of tcuPA was completely ablated by PAI-1. Furthermore, a mutation (S195A) of the active site of the enzyme also prevented ENaC activation. By comparison, three truncation mutants of the amino-terminal fragment of tcuPA still activated ENaC. uPA enzymatic activity was positively correlated with ENaC current amplitude prior to reaching the maximal level. In sharp contrast to uPA, neither single-chain tPA nor derivatives, including two-chain tPA and tenecteplase, affected ENaC activity. Furthermore, gamma but not alpha subunit of ENaC was proteolytically cleaved at ((177)GR down arrow KR180) by tcuPA. In summary, the underlying mechanisms of urokinase-mediated activation of ENaC include release of self-inhibition, proteolysis of gamma ENaC, incremental increase in opening rate, and activation of closed (electrically "silent") channels. This study for the first time demonstrates multifaceted mechanisms for uPA-mediated up-regulation of ENaC, which form the cellular and molecular rationale for the beneficial effects of urokinase in mitigating mortal pulmonary edema and pleural effusions.	[Ji, Hong-Long; Zhao, Runzhen; Komissarov, Andrey A.] Univ Texas Hlth Sci Ctr, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Ji, Hong-Long] Univ Texas Hlth Sci Ctr, Texas Lung Injury Inst, Tyler, TX 75708 USA; [Chang, Yongchang] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Liu, Yongfeng] Xinxiang Med Univ, Coll Publ Hlth, Xinxiang 453100, Henan, Peoples R China; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Anesthesia, San Francisco, CA 94143 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Xinxiang Medical University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ji, HL (corresponding author), 11937 US Hwy 271,604 BMR, Tyler, TX 75708 USA.	james.ji@uthct.edu		Komissarov, Andrey/0000-0003-4346-8888	National Institutes of Health [HL87017, HL095435]; American Heart Association [14GRNT20130034]; University of Texas Health Science Center at Tyler Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095435, R37HL051856, R01HL087017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Texas Health Science Center at Tyler Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL87017 and HL095435. This work was also supported by American Heart Association Grant 14GRNT20130034 and an institutional fund from the University of Texas Health Science Center at Tyler Research Council.	BERTOZZI P, 1990, NEW ENGL J MED, V322, P890, DOI 10.1056/NEJM199003293221304; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Bouros D, 1996, EUR RESPIR J, V9, P1656, DOI 10.1183/09031936.96.09081656; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CHAPMAN HA, 1986, AM REV RESPIR DIS, V133, P437; Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004; Chen ZX, 2014, AM J PHYSIOL-LUNG C, V307, pL609, DOI 10.1152/ajplung.00126.2014; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Coombs GS, 1998, J BIOL CHEM, V273, P4323, DOI 10.1074/jbc.273.8.4323; Crippa MP, 2007, INT J BIOCHEM CELL B, V39, P690, DOI 10.1016/j.biocel.2006.10.008; Dagenais A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-2; Davis IC, 2007, ADV EXP MED BIOL, V618, P127; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Fuller CM, 1996, J BIOL CHEM, V271, P26602, DOI 10.1074/jbc.271.43.26602; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Glas GJ, 2013, J THROMB HAEMOST, V11, P17, DOI 10.1111/jth.12047; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; GROSS TJ, 1990, AM J RESP CELL MOL, V3, P449, DOI 10.1165/ajrcmb/3.5.449; Gunther A, 2003, AM J RESP CRIT CARE, V168, P1358, DOI 10.1164/rccm.2201082; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; Hochberg I, 2008, INT J CARDIOL, V130, P125, DOI 10.1016/j.ijcard.2008.03.015; Huang LT, 2012, ACTA PHARMACOL SIN, V33, P991, DOI 10.1038/aps.2012.66; Hummler E, 2010, CELL PHYSIOL BIOCHEM, V25, P63, DOI 10.1159/000272051; IDELL S, 1992, AM J RESP CELL MOL, V7, P414, DOI 10.1165/ajrcmb/7.4.414; IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240; IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217; IDELL S, 1992, CRIT CARE MED, V20, P1431, DOI 10.1097/00003246-199210000-00012; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; Idell S, 2008, CURR OPIN PULM MED, V14, P310, DOI 10.1097/MCP.0b013e3282fd0d9b; Idell S, 2007, EXP LUNG RES, V33, P419, DOI 10.1080/01902140701703333; Idell S, 2007, AM J PHYSIOL-LUNG C, V292, pL25, DOI 10.1152/ajplung.00118.2006; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Ji HL, 2001, AM J PHYSIOL-CELL PH, V281, pC64, DOI 10.1152/ajpcell.2001.281.1.C64; Ji HL, 1999, J BIOL CHEM, V274, P37693, DOI 10.1074/jbc.274.53.37693; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Ke SH, 1997, J BIOL CHEM, V272, P20456, DOI 10.1074/jbc.272.33.20456; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Komissarov AA, 2013, AM J PHYSIOL-LUNG C, V305, pL682, DOI 10.1152/ajplung.00102.2013; Komissarov AA, 2009, AM J PHYSIOL-LUNG C, V297, pL568, DOI 10.1152/ajplung.00066.2009; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Kuramoto E, 2009, AM J PHYSIOL-LUNG C, V296, pL337, DOI 10.1152/ajplung.90434.2008; KVASSMAN JO, 1995, J BIOL CHEM, V270, P27942, DOI 10.1074/jbc.270.46.27942; LEE KS, 1991, RADIOLOGY, V179, P771, DOI 10.1148/radiology.179.3.2027990; MacLaren R, 2002, PHARMACOTHERAPY, V22, P1140, DOI 10.1592/phco.22.13.1140.33519; MADISON EL, 1995, J BIOL CHEM, V270, P7558, DOI 10.1074/jbc.270.13.7558; Maron MB, 2009, AM J PHYSIOL-LUNG C, V297, pL487, DOI 10.1152/ajplung.90629.2008; MARSHALL BC, 1990, J BIOL CHEM, V265, P8198; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Matthay MA, 2014, AM J RESP CRIT CARE, V189, P1301, DOI 10.1164/rccm.201403-0535OE; Miyake H, 1999, PROSTATE, V39, P123, DOI 10.1002/(SICI)1097-0045(19990501)39:2<123::AID-PROS7>3.0.CO;2-2; Molina R, 2011, BBA-BIOMEMBRANES, V1808, P1818, DOI 10.1016/j.bbamem.2011.03.004; Munster AMB, 2000, J AEROSOL MED, V13, P325; Neitzel J.J., 2010, NAT ED, V3, P21; Nishiuma T, 2004, AM J RESP CELL MOL, V31, P552, DOI 10.1165/rcmb.2004-0162OC; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Pechlaner C, 2002, ACTA MED AUST, V29, P80, DOI 10.1046/j.1563-2571.2002.02011.x; Planes C, 2007, CURR TOP DEV BIOL, V78, P23, DOI 10.1016/S0070-2153(06)78002-4; Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002; Renckens R, 2008, J THROMB HAEMOST, V6, P660, DOI 10.1111/j.1538-7836.2008.02892.x; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sapru A, 2010, INTENS CARE MED, V36, P157, DOI 10.1007/s00134-009-1690-2; Schermuly RT, 2001, AM J PHYSIOL-LUNG C, V280, pL792, DOI 10.1152/ajplung.2001.280.4.L792; Schuliga M, 2013, CURR OPIN PHARMACOL, V13, P386, DOI 10.1016/j.coph.2013.05.014; Sedy J, 2008, PHYSIOL RES, V57, P499, DOI 10.33549/physiolres.931432; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Shetty S, 2008, AM J PHYSIOL-LUNG C, V295, pL967, DOI 10.1152/ajplung.90349.2008; Sisson TH, 2007, CURR DRUG TARGETS, V8, P1016, DOI 10.2174/138945007781662319; Sisson TH, 2002, AM J PHYSIOL-LUNG C, V283, pL1023, DOI 10.1152/ajplung.00049.2002; Stewart RJ, 2000, J BIOL CHEM, V275, P10112, DOI 10.1074/jbc.275.14.10112; STRANGE C, 1995, AM J RESP CRIT CARE, V151, P508, DOI 10.1164/ajrccm.151.2.7842213; Stringer KA, 2004, CLIN EXP PHARMACOL P, V31, P327, DOI 10.1111/j.1440-1681.2004.03999.x; Stringer KA, 1998, FREE RADICAL BIO MED, V25, P184, DOI 10.1016/S0891-5849(98)00047-1; TAKAHASHI K, 1992, AM J RESP CELL MOL, V7, P90, DOI 10.1165/ajrcmb/7.1.90; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; VISCARDI RM, 1992, AM REV RESPIR DIS, V146, P492, DOI 10.1164/ajrccm/146.2.492; Ware LB, 2005, NEW ENGL J MED, V353, P2788, DOI 10.1056/NEJMcp052699; Ware LB, 2006, AM J PHYSIOL-LUNG C, V291, pL307, DOI 10.1152/ajplung.00157.2006; Zeslawska E, 2003, J MOL BIOL, V328, P109, DOI 10.1016/S0022-2836(03)00267-5	91	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5241	5255		10.1074/jbc.M114.623496	http://dx.doi.org/10.1074/jbc.M114.623496			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25555911	Green Published, hybrid			2022-12-28	WOS:000350044200002
J	Li, L; He, MA; Zhou, L; Miao, XP; Wu, FQ; Huang, SL; Dai, XY; Wang, T; Wu, TC				Li, Lu; He, Meian; Zhou, Li; Miao, Xiaoping; Wu, Fangqing; Huang, Suli; Dai, Xiayun; Wang, Tian; Wu, Tangchun			Solute Carrier Family 22 Member 3 Variant rs3088442 G -> A Associated with Coronary Heart Disease Inhibits Lipopolysaccharide-induced Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; ARTERY-DISEASE; ATHEROSCLEROSIS; RISK; POLYMORPHISM; EXPRESSION; MIGRATION; MICRORNA; ADHESION; SLC22A3	Recent genome-wide association studies have identified single-nucleotide polymorphism (SNPs) within the SLC22A3 (solute carrier family 22 member 3) gene associated with coronary heart disease (CHD) in the Caucasian population. We performed molecular analysis to investigate the potential role of SLC22A3 variants in CHD. Our study showed that the common polymorphism rs3088442 G -> A, which is localized in the 3' UTR of the SLC22A3 gene, was associated with a decreased risk of CHD in the Chinese population by a case control study. In silico analysis indicated that G -> A substitution of SNP rs3088442 created a putative binding site for miR-147 in the SLC22A3 mRNA. By overexpressing miR-147 or inhibiting endogenous miR-147, we demonstrated that SNP rs3088442 G -> A recruited miR-147 to inhibit SLC22A3 expression. Moreover, SLC22A3 deficiency significantly decreased LPS-induced monocytic inflammatory response by interrupting NF-kappa B and MAPK signaling cascades in a histamine-dependent manner. Notably, the expression of SLC22A3(A) was also suppressed by LPS stimulus. Our findings might indicate a negative feedback mechanism against inflammatory response by which SLC22A3 polymorphisms decreased the risk of CHD.	[Li, Lu; He, Meian; Zhou, Li; Miao, Xiaoping; Huang, Suli; Dai, Xiayun; Wang, Tian; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Hubei, Peoples R China; [Li, Lu; He, Meian; Zhou, Li; Miao, Xiaoping; Huang, Suli; Dai, Xiayun; Wang, Tian; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, State Key Lab Environm Hlth Incubating, Minist Environm Protect,Sch Publ Hlth, Wuhan 430030, Hubei, Peoples R China; [Wu, Fangqing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol,Inst Cardiovasc Dis, Wuhan 430022, Hubei, Peoples R China; [Huang, Suli] Shenzhen Ctr Dis Control & Prevent, Key Lab Mol Biol Shenzhen, Shenzhen 518055, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Shenzhen Center for Disease Control & Prevention (SZCDC)	Wu, TC (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430030, Hubei, Peoples R China.	wut@mails.tjmu.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722	National Basic Research Program Grant [2011CB503806]; Natural National Scientific Foundation of China [81230069]	National Basic Research Program Grant(National Basic Research Program of China); Natural National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program Grant 2011CB503806 and Natural National Scientific Foundation of China Grant 81230069.	Brown TP, 2013, THROMB RES, V131, P150, DOI 10.1016/j.thromres.2012.11.034; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; DELNESTE Y, 1994, CLIN EXP IMMUNOL, V98, P344; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Guo H, 2010, J CLIN ONCOL, V28, P1928, DOI 10.1200/JCO.2009.24.4954; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Kondo T, 2003, HEART, V89, P931, DOI 10.1136/heart.89.8.931; Lavergne E, 2005, ARTERIOSCL THROM VAS, V25, P847, DOI 10.1161/01.ATV.0000157150.23641.36; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Qi QB, 2012, EUR HEART J, V33, P325, DOI 10.1093/eurheartj/ehr350; Ramirez CM, 2013, CIRC RES, V112, P1592, DOI 10.1161/CIRCRESAHA.112.300626; Schneider E, 2005, J EXP MED, V202, P387, DOI 10.1084/jem.20050195; Schneider E, 2011, J ALLERGY CLIN IMMUN, V128, P864, DOI 10.1016/j.jaci.2011.04.043; Shaw SY, 2011, CIRC-CARDIOVASC GENE, V4, P296, DOI 10.1161/CIRCGENETICS.110.958470; Su EN, 2005, CURR EYE RES, V30, P205, DOI 10.1080/02713680590927524; Tan X, 2007, J IMMUNOL, V179, P7899, DOI 10.4049/jimmunol.179.11.7899; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279; Wu C, 2013, NUTR METAB CARDIOVAS, V23, P693, DOI 10.1016/j.numecd.2012.02.009; Yan TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030110; Yu L, 2013, ONCOL LETT, V6, P1338, DOI 10.3892/ol.2013.1572	30	28	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5328	5340		10.1074/jbc.M114.584953	http://dx.doi.org/10.1074/jbc.M114.584953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25561729	Green Published, hybrid			2022-12-28	WOS:000350044200008
J	Song, KK; Awata, J; Tritschler, D; Bower, R; Witmann, GB; Porter, ME; Nicastro, D				Song, Kangkang; Awata, Junya; Tritschler, Douglas; Bower, Raqual; Witmann, George B.; Porter, Mary E.; Nicastro, Daniela			In Situ Localization of N and C Termini of Subunits of the Flagellar Nexin-Dynein Regulatory Complex (N-DRC) Using SNAP Tag and Cryo-electron Tomography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSCOPE TOMOGRAPHY; RADIAL SPOKES; CHLAMYDOMONAS; PROTEINS; CILIARY; VISUALIZATION; RESISTANCE; LABEL; CELLS	Cryo-electron tomography (cryo-ET) has reached nanoscale resolution for in situ three-dimensional imaging of macromolecular complexes and organelles. Yet its current resolution is not sufficient to precisely localize or identify most proteins in situ; for example, the location and arrangement of components of the nexin-dynein regulatory complex (N-DRC), a key regulator of ciliary/flagellar motility that is conserved from algae to humans, have remained elusive despite many cryo-ET studies of cilia and flagella. Here, we developed an in situ localization method that combines cryo-ET/subtomogram averaging with the clonable SNAP tag, a widely used cell biological probe to visualize fusion proteins by fluorescence microscopy. Using this hybrid approach, we precisely determined the locations of the N and C termini of DRC3 and the C terminus of DRC4 within the three-dimensional structure of the N-DRC in Chlamydomonas flagella. Our data demonstrate that fusion of SNAP with target proteins allowed for protein localization with high efficiency and fidelity using SNAP-linked gold nanoparticles, without disrupting the native assembly, structure, or function of the flagella. After cryo-ET and subtomogram averaging, we localized DRC3 to the L1 projection of the nexin linker, which interacts directly with a dynein motor, whereas DRC4 was observed to stretch along the N-DRC base plate to the nexin linker. Application of the technique developed here to the N-DRC revealed new insights into the organization and regulatory mechanism of this complex, and provides a valuable tool for the structural dissection of macromolecular complexes in situ.	[Song, Kangkang; Nicastro, Daniela] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Awata, Junya; Witmann, George B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Tritschler, Douglas; Bower, Raqual; Porter, Mary E.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Brandeis University; University of Massachusetts System; University of Massachusetts Worcester; University of Minnesota System; University of Minnesota Twin Cities	Nicastro, D (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Ctr, MS029,415 South St, Waltham, MA 02454 USA.	nicastro@brandeis.edu		Nicastro, Daniela/0000-0002-0122-7173; Witman, George/0000-0002-9497-9218	National Institutes of Health [R01 GM083122, R01 GM055667, R37 GM030626]; Robert W. Booth Endowment at University of Massachusetts Medical School; March of Dimes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030626, R01GM055667, R01GM083122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert W. Booth Endowment at University of Massachusetts Medical School; March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM083122 (to D. N.), R01 GM055667 (to M. E. P.), and R37 GM030626 (to G. B. W.). This work was also supported by Robert W. Booth Endowment at University of Massachusetts Medical School (to G. B. W.) and by the March of Dimes Foundation (to D. N.).	Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Awata J, 2014, J CELL SCI, V127, P4714, DOI 10.1242/jcs.155275; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Bosch PJ, 2014, BIOPHYS J, V107, P803, DOI 10.1016/j.bpj.2014.06.040; Bower R, 2013, MOL BIOL CELL, V24, P1134, DOI 10.1091/mbc.E12-11-0801; Bui KH, 2012, J CELL BIOL, V198, P913, DOI 10.1083/jcb.201201120; Correa IR, 2014, CURR OPIN CHEM BIOL, V20, P36, DOI 10.1016/j.cbpa.2014.04.007; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Gan L, 2012, Q REV BIOPHYS, V45, P27, DOI 10.1017/S0033583511000102; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gregori L, 1997, J BIOL CHEM, V272, P58; HARAUZ G, 1986, OPTIK, V73, P146; Heumann JM, 2011, J STRUCT BIOL, V175, P288, DOI 10.1016/j.jsb.2011.05.011; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hoenger A, 2007, METHOD CELL BIOL, V79, P437, DOI 10.1016/S0091-679X(06)79017-3; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Iomini C, 2009, METHOD CELL BIOL, V93, P121, DOI 10.1016/S0091-679X(08)93007-7; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Linck R, 2014, J BIOL CHEM, V289, P17427, DOI 10.1074/jbc.M114.568949; Liu TK, 2014, ACS CHEM BIOL, V9, P2359, DOI 10.1021/cb500502n; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mercogliano CP, 2007, J STRUCT BIOL, V160, P70, DOI 10.1016/j.jsb.2007.06.010; Mizuno N, 2012, J MOL BIOL, V422, P163, DOI 10.1016/j.jmb.2012.05.040; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nicastro D, 2009, METHOD CELL BIOL, V91, P1, DOI 10.1016/S0091-679X(08)91001-3; Oda T., 2014, MOL BIOL CELL; Oda T, 2014, SCIENCE, V346, P857, DOI 10.1126/science.1260214; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Oda T, 2013, J STRUCT BIOL, V183, P305, DOI 10.1016/j.jsb.2013.07.003; Onelli E, 2008, J EXP BOT, V59, P3051, DOI 10.1093/jxb/ern154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; SHAH N, 1995, ENDOCRINOLOGY, V136, P2825, DOI 10.1210/en.136.7.2825; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Yang C, 2005, MOL BIOL CELL, V16, P637, DOI 10.1091/mbc.E04-09-0787	45	27	28	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5341	5353		10.1074/jbc.M114.626556	http://dx.doi.org/10.1074/jbc.M114.626556			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25564608	hybrid, Green Published			2022-12-28	WOS:000350044200009
J	Turco, E; Gallego, LD; Schneider, M; Kohler, A				Turco, Eleonora; Gallego, Laura D.; Schneider, Maren; Koehler, Alwin			Monoubiquitination of Histone H2B Is Intrinsic to the Bre1 RING Domain-Rad6 Interaction and Augmented by a Second Rad6-binding Site on Bre1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; CRYSTAL-STRUCTURE; H3K4 METHYLATION; LIGASE COMPLEX; DNA-BINDING; E3 LIGASE; NUCLEOSOME; UBIQUITYLATION; FINGER; RAD6	Ubiquitin signaling on chromatin is linked to diverse aspects of genome regulation, including gene expression and DNA repair. The yeast RING E3 ligase Bre1 combines with the E2 Rad6 to monoubiquitinate histone H2B during transcription. Little is known about how Bre1 directs Rad6 toward transferring only a single ubiquitin to a specific lysine residue. Using a defined in vitro system, we show that the Bre1 RING domain interaction with Rad6 is minimally sufficient to monoubiquitinate nucleosomes at histoneH2BLys-123. In addition, we reveal a cluster of charged residues on the Bre1 RING domain that is critical for recognizing the nucleosome surface. Notably, a second Rad6 binding domain of Bre1 interacts with the E2 backside and potentiates ubiquitin transfer to the substrate. Taken together, our study establishes a molecular framework for how distinct RING and non-RING E3 elements cooperate to regulate E2 reactivity and substrate selection during gene expression.	[Turco, Eleonora; Gallego, Laura D.; Schneider, Maren; Koehler, Alwin] Med Univ Vienna, Max F Perutz Labs, Vienna Bioctr VBC, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Kohler, A (corresponding author), Med Univ Vienna, Max F Perutz Labs, Vienna Bioctr VBC, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	alwin.koehler@mfpl.ac.at		Gallego, Laura D./0000-0001-8481-8747; Turco, Eleonora/0000-0002-5266-4592	ERC [281354]; NPC GENEXPRESS; START Grant from the Austrian Science Fund [Y557-B11]; Austrian Science Fund (FWF) [Y 557] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); NPC GENEXPRESS; START Grant from the Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by ERC Grant 281354, NPC GENEXPRESS (to the Kohler laboratory), and START Grant Y557-B11 from the Austrian Science Fund.	Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Braun S, 2012, EMBO REP, V13, P619, DOI 10.1038/embor.2012.78; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	39	30	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5298	5310		10.1074/jbc.M114.626788	http://dx.doi.org/10.1074/jbc.M114.626788			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25548288	hybrid, Green Published			2022-12-28	WOS:000350044200006
J	Lecerf, M; Scheel, T; Pashov, AD; Jarossay, A; Ohayon, D; Planchais, C; Mesnage, S; Berek, C; Kaveri, SV; Lacroix-Desmazes, S; Dimitrov, JD				Lecerf, Maxime; Scheel, Tobias; Pashov, Anastas D.; Jarossay, Annaelle; Ohayon, Delphine; Planchais, Cyril; Mesnage, Stephane; Berek, Claudia; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Dimitrov, Jordan D.			Prevalence and Gene Characteristics of Antibodies with Cofactor-induced HIV-1 Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMODYNAMIC STABILITY; ENVELOPE GLYCOPROTEIN; BINDING-SITE; V3 LOOP; HEME; AUTOANTIBODIES; AFFINITY; IMMUNOGLOBULINS; ACTIVATION; INHIBITION	The healthy immune repertoire contains a fraction of antibodies that bind to various biologically relevant cofactors, including heme. Interaction of heme with some antibodies results in induction of new antigen binding specificities and acquisition of binding polyreactivity. In vivo, extracellular heme is released as a result of hemolysis or tissue damage; hence the post-translational acquisition of novel antigen specificities might play an important role in the diversification of the immunoglobulin repertoire and host defense. Here, we demonstrate that seronegative immune repertoires contain antibodies that gain reactivity to HIV-1 gp120 upon exposure to heme. Furthermore, a panel of human recombinant antibodies was cloned from different B cell subpopulations, and the prevalence of antibodies with cofactor-induced specificity for gp120 was determined. Our data reveal that upon exposure to heme, similar to 24% of antibodies acquired binding specificity for divergent strains of HIV-1 gp120. Sequence analyses reveal that heme-sensitive antibodies do not differ in their repertoire of variable region genes and in most of the molecular features of their antigen-binding sites from antibodies that do not change their antigen binding specificity. However, antibodies with cofactor-induced gp120 specificity possess significantly lower numbers of somatic mutations in their variable region genes. This study contributes to the understanding of the significance of cofactor-binding antibodies in immunoglobulin repertoires and of the influence that the tissue microenvironment might have in shaping adaptive immune responses.	[Lecerf, Maxime; Jarossay, Annaelle; Ohayon, Delphine; Planchais, Cyril; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Dimitrov, Jordan D.] Univ Paris 06, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France; [Lecerf, Maxime; Jarossay, Annaelle; Ohayon, Delphine; Planchais, Cyril; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Dimitrov, Jordan D.] Univ Paris 05, UMR S 1138, F-75006 Paris, France; [Lecerf, Maxime; Jarossay, Annaelle; Ohayon, Delphine; Planchais, Cyril; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien; Dimitrov, Jordan D.] INSERM, U1138, F-75006 Paris, France; [Scheel, Tobias; Berek, Claudia] Deutsch Rheuma Forschungszentrum, Inst Leibniz Gemeinschaft, D-10117 Berlin, Germany; [Pashov, Anastas D.] Bulgarian Acad Sci, Inst Microbiol, BU-1113 Sofia, Bulgaria; [Mesnage, Stephane] Univ Sheffield, Krebs Inst, Sheffield S10 2TN, S Yorkshire, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Deutsches Rheuma-Forschungszentrum (DRFZ); Bulgarian Academy of Sciences; Medical University Sofia; University of Sheffield	Dimitrov, JD (corresponding author), Ctr Rech Cordeliers, INSERM, UMR 1138, Equipe 16, F-75006 Paris, France.	jordan.dimitrov@crc.jussieu.fr	Pashov, Anastas/AAE-7997-2019; MESNAGE, Stephane/H-7156-2019; Dimitrov, Jordan/N-2141-2014	Lecerf, Maxime/0000-0002-1477-2162; MESNAGE, Stephane/0000-0003-1648-4890; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; Pashov, Anastas/0000-0002-6033-3566; Kaveri, Srini/0000-0002-0837-4053; Dimitrov, Jordan/0000-0001-8536-8995	INSERM; CNRS; UPMC-Paris 6; Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs); Agence Nationale de la Recherche [ANR-13-JCV1-006-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC-Paris 6; Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from INSERM, CNRS, and UPMC-Paris 6 and by grants from the Centre de Recherche des Cordeliers (Prix Jeunes Chercheurs 2008) and Agence Nationale de la Recherche (Grant ANR-13-JCV1-006-01).	Argyris EG, 1999, J BIOL CHEM, V274, P1549, DOI 10.1074/jbc.274.3.1549; BAKER H, 1967, NATURE, V215, P84, DOI 10.1038/215084a0; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Brancaleon L, 2002, BIOPHYS CHEM, V96, P77, DOI 10.1016/S0301-4622(02)00035-2; Dairou J, 2004, ANTIVIR RES, V61, P37, DOI 10.1016/S0166-3542(03)00176-1; DEBNATH AK, 1994, J MED CHEM, V37, P1099, DOI 10.1021/jm00034a007; Devadas K, 2006, J IMMUNOL, V176, P4252, DOI 10.4049/jimmunol.176.7.4252; Dimitrov JD, 2006, J BIOL CHEM, V281, P439, DOI 10.1074/jbc.M509190200; Dimitrov JD, 2007, J BIOL CHEM, V282, P26696, DOI 10.1074/jbc.M702751200; Dimitrov JD, 2014, J BIOL CHEM, V289, P17767, DOI 10.1074/jbc.M114.556266; Dimitrov JD, 2014, TRENDS BIOCHEM SCI, V39, P221, DOI 10.1016/j.tibs.2014.02.010; Dimitrov JD, 2009, NAT BIOTECHNOL, V27, P892, DOI 10.1038/nbt1009-892a; Ditzel HJ, 1996, J IMMUNOL, V157, P739; FARAH FS, 1973, IMMUNOLOGY, V25, P217; Frimat M, 2013, BLOOD, V122, P282, DOI 10.1182/blood-2013-03-489245; Gladwin MT, 2012, J CLIN INVEST, V122, P1205, DOI 10.1172/JCI62972; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jimenez R, 2004, P NATL ACAD SCI USA, V101, P3803, DOI 10.1073/pnas.0305745101; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; KARJALAINEN K, 1976, EUR J IMMUNOL, V6, P88, DOI 10.1002/eji.1830060204; Krol M, 2006, J BIOMOL STRUCT DYN, V23, P407, DOI 10.1080/07391102.2006.10531235; Kuhl T, 2014, CHEMBIOCHEM, V15, P2024, DOI 10.1002/cbic.201402218; Kuhl T, 2011, CHEMBIOCHEM, V12, P2846, DOI 10.1002/cbic.201100556; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; LEVERE RD, 1991, P NATL ACAD SCI USA, V88, P1756, DOI 10.1073/pnas.88.5.1756; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; McEnaney PJ, 2012, ACS CHEM BIOL, V7, P1139, DOI 10.1021/cb300119g; McIntyre JA, 2004, THROMB RES, V114, P579, DOI 10.1016/j.thromres.2004.08.008; McIntyre JA, 2005, J AUTOIMMUN, V24, P311, DOI 10.1016/j.jaut.2005.03.005; McIntyre JA, 2010, INT J CANCER, V127, P491, DOI 10.1002/ijc.25038; McIntyre JA, 2009, CLIN REV ALLERG IMMU, V37, P49, DOI 10.1007/s12016-008-8093-y; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Munro Andrew W., 2009, P160, DOI 10.1007/978-0-387-78518-9_10; Murelli RP, 2009, J AM CHEM SOC, V131, P17090, DOI 10.1021/ja906844e; Neurath AR, 1995, J MOL RECOGNIT, V8, P345, DOI 10.1002/jmr.300080604; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Nouraie M, 2012, SEX TRANSM INFECT, V88, P528, DOI 10.1136/sextrans-2011-050459; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Parker CG, 2009, J AM CHEM SOC, V131, P16392, DOI 10.1021/ja9057647; Pavlovic S, 2011, CLIN IMMUNOL, V138, P162, DOI 10.1016/j.clim.2010.10.010; Planchais C, 2013, M S-MED SCI, V29, P937, DOI 10.1051/medsci/20132911002; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rajagopalan K, 1996, P NATL ACAD SCI USA, V93, P6019, DOI 10.1073/pnas.93.12.6019; Roumenina LT, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206136; Sahoo N, 2013, P NATL ACAD SCI USA, V110, pE4036, DOI 10.1073/pnas.1313247110; Scheel T., 2009, THESIS HUMBOLDT U BE; Scheel T, 2011, ARTHRITIS RHEUM-US, V63, P63, DOI 10.1002/art.27767; Smith Ann, 2009, P184, DOI 10.1007/978-0-387-78518-9_11; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Staudinger R, 1996, P ASSOC AM PHYSICIAN, V108, P47; Stopa B, 1997, BIOCHIMIE, V79, P23, DOI 10.1016/S0300-9084(97)87621-3; Sun SB, 2013, J AM CHEM SOC, V135, P9980, DOI 10.1021/ja402927u; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; TERNYNCK T, 1986, IMMUNOL REV, V94, P99; Vzorov AN, 2002, ANTIMICROB AGENTS CH, V46, P3917, DOI 10.1128/AAC.46.12.3917-3925.2002; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wang F, 2013, P NATL ACAD SCI USA, V110, P4261, DOI 10.1073/pnas.1301810110; WATSON CD, 1988, BIOCHEM INT, V16, P1067; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Xu Y, 2007, P NATL ACAD SCI USA, V104, P3681, DOI 10.1073/pnas.0611094104; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhang AX, 2010, J AM CHEM SOC, V132, P12711, DOI 10.1021/ja104591m; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhou TQ, 2005, P NATL ACAD SCI USA, V102, P14575, DOI 10.1073/pnas.0507267102; Zhu XY, 2006, P NATL ACAD SCI USA, V103, P3581, DOI 10.1073/pnas.0600251103; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11	72	21	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5203	5213		10.1074/jbc.M114.618124	http://dx.doi.org/10.1074/jbc.M114.618124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564611	Green Published, hybrid			2022-12-28	WOS:000350042000058
J	Nakayama, M; Inoue, T; Naito, M; Nakayama, K; Ohara, N				Nakayama, Masaaki; Inoue, Tetsuyoshi; Naito, Mariko; Nakayama, Koji; Ohara, Naoya			Attenuation of the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway by Porphyromonas gingivalis Gingipains RgpA, RgpB, and Kgp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B/AKT; EPITHELIAL-CELLS; PERIODONTAL PATHOGEN; MEDIATED INTERNALIZATION; MEMBRANE VESICLES; MAMMALIAN TARGET; IMMUNE-RESPONSES; PLASMA-MEMBRANE; POTENTIAL ROLE; LIPID RAFTS	Porphyromonas gingivalis is a major pathogen of periodontal diseases, including periodontitis. We have investigated the effect of P. gingivalis infection on the PI3K/Akt (protein kinase B) signaling pathway in gingival epithelial cells. Here, we found that live P. gingivalis, but not heat-killed P. gingivalis, reduced Akt phosphorylation at both Thr-308 and Ser-473, which implies a decrease in Akt activity. Actually, PI3K, which is upstream of Akt, was also inactivated by P. gingivalis. Furthermore, glycogen synthase kinase 3 alpha/beta, mammalian target of rapamycin, and Bad, which are downstream proteins in the PI3K/Akt cascade, were also dephosphorylated, a phenomenon consistent with Akt inactivation by P. gingivalis. However, these events did not require direct interaction between bacteria and host cells and were independent of P. gingivalis invasion into the cells. The use of gingipain-specific inhibitors and a gingipain-deficient P. gingivalis mutant KDP136 revealed that the gingipains and their protease activities were essential for the inactivation of PI3K and Akt. The associations between the PI3K regulatory subunit p85 alpha and membrane proteins were disrupted by wild-type P. gingivalis. Moreover, PDK1 translocation to the plasma membrane was reduced by wild-type P. gingivalis, but not KDP136, indicating little production of phosphatidylinositol 3,4,5-triphosphate by PI3K. Therefore, it is likely that PI3K failed to transmit homeostatic extracellular stimuli to intracellular signaling pathways by gingipains. Taken together, our findings indicate that P. gingivalis attenuates the PI3K/Akt signaling pathway via the proteolytic effects of gingipains, resulting in the dysregulation of PI3K/Akt-dependent cellular functions and the destruction of epithelial barriers.	[Nakayama, Masaaki; Inoue, Tetsuyoshi; Ohara, Naoya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Okayama 7008558, Japan; [Nakayama, Masaaki; Inoue, Tetsuyoshi; Ohara, Naoya] Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008558, Japan; [Naito, Mariko; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 8528588, Japan	Okayama University; Okayama University; Nagasaki University	Ohara, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	oharan@md.okayama-u.ac.jp	OHARA, Naoya/B-2481-2011	NAITO, Mariko/0000-0003-0769-7747	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ryobi Teien Memory Foundation; Takeda Science Foundation; Institute for Fermentation, Osaka	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Ryobi Teien Memory Foundation, by the Takeda Science Foundation, and by the Institute for Fermentation, Osaka.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Allen LAH, 2005, J LEUKOCYTE BIOL, V78, P220, DOI 10.1189/jlb.0205091; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Bansal M, 2013, J Med Life, V6, P244; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Blair P, 2009, CIRC RES, V104, P346, DOI 10.1161/CIRCRESAHA.108.185785; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chang LC, 2013, CELL MICROBIOL, V15, P1722, DOI 10.1111/cmi.12146; Cho TJ, 2014, ARCH ORAL BIOL, V59, P370, DOI 10.1016/j.archoralbio.2014.01.001; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Forsberg M, 2003, J LEUKOCYTE BIOL, V74, P620, DOI 10.1189/jlb.1202586; Frazer LT, 2006, VACCINE, V24, P6542, DOI 10.1016/j.vaccine.2006.06.013; Fujita Y, 2014, INFECT IMMUN, V82, P202, DOI 10.1128/IAI.01140-12; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Gutierrez-Venegas G, 2013, MOL BIOL REP, V40, P477, DOI 10.1007/s11033-012-2083-0; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Iacopino AM, 2000, J PERIODONTOL, V71, P1375, DOI 10.1902/jop.2000.71.8.1375; Inaba H, 2012, INFECT IMMUN, V80, P2847, DOI 10.1128/IAI.00258-12; Ishikawa M, 2013, BBA-MOL BASIS DIS, V1832, P2035, DOI 10.1016/j.bbadis.2013.07.012; Kadowaki T, 2007, FRONT BIOSCI-LANDMRK, V12, P4800, DOI 10.2741/2428; Kinane JA, 2012, CELL MICROBIOL, V14, P1085, DOI 10.1111/j.1462-5822.2012.01780.x; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee CH, 2014, GENE THER, V21, P309, DOI 10.1038/gt.2013.86; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Naito M, 2006, MOL MICROBIOL, V59, P152, DOI 10.1111/j.1365-2958.2005.04942.x; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nakayama M, 2009, J BIOL CHEM, V284, P1612, DOI 10.1074/jbc.M806981200; Park CH, 2008, BRAIN RES, V1234, P148, DOI 10.1016/j.brainres.2008.07.082; Park SY, 2011, INT IMMUNOPHARMACOL, V11, P1907, DOI 10.1016/j.intimp.2011.07.023; Park YD, 2012, CYTOKINE, V60, P284, DOI 10.1016/j.cyto.2012.05.021; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949; Saito A, 2012, MICROB PATHOGENESIS, V53, P234, DOI 10.1016/j.micpath.2012.08.005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Slomiany BL, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/807279; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stafford P, 2013, MOL ORAL MICROBIOL, V28, P366, DOI 10.1111/omi.12030; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takii R, 2005, INFECT IMMUN, V73, P883, DOI 10.1128/IAI.73.2.883-893.2005; Tsuda K, 2008, CELL STRUCT FUNCT, V33, P123, DOI 10.1247/csf.08012; Urnowey S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-26; Wang JH, 2013, J MICROBIOL, V51, P644, DOI 10.1007/s12275-013-3040-x; Wiles TJ, 2008, MOL BIOL CELL, V19, P1427, DOI 10.1091/mbc.E07-07-0638; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yao L, 2010, MOL ORAL MICROBIOL, V25, P89, DOI 10.1111/j.2041-1014.2010.00569.x; Yilmaz O, 2004, INFECT IMMUN, V72, P3743, DOI 10.1128/IAI.72.7.3743-3751.2004; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	62	41	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5190	5202		10.1074/jbc.M114.591610	http://dx.doi.org/10.1074/jbc.M114.591610			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25564612	hybrid, Green Published			2022-12-28	WOS:000350042000057
J	Sanz, R; Ferraro, GB; Fournier, AE				Sanz, Ricardo; Ferraro, Gino B.; Fournier, Alyson E.			IgLON Cell Adhesion Molecules Are Shed from the Cell Surface of Cortical Neurons to Promote Neuronal Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; MEMBRANE-PROTEIN; MIGRATION; METALLOPROTEINASES; INHIBITORS; CLEAVAGE; SYSTEM; FAMILY; ADAM; L1	Matrix metalloproteinases and a disintegrin and metalloproteinases are members of the zinc endopeptidases, which cleave components of the extracellular matrix as well as cell surface proteins resulting in degradation or release of biologically active fragments. Surface ectodomain shedding affects numerous biological processes, including survival, axon outgrowth, axon guidance, and synaptogenesis. In this study, we evaluated the role of metalloproteinases in regulating cortical neurite growth. We found that treatment of mature cortical neurons with panmetalloproteinase inhibitors or with tissue inhibitors of metal-loproteinase-3 reduced neurite outgrowth. Through mass spectrometry, we characterized the metalloproteinase-sensitive cell surface proteome of mature cortical neurons. Members of the IgLON family of glycosylphosphatidylinositol-anchored neural cell adhesion molecules were identified and validated as proteins that were shed from the surface of mature cortical neurons in a metalloproteinase-dependent manner. Introduction of two members of the IgLON family, neurotrimin and NEGR1, in early embryonic neurons was sufficient to confer sensitivity to metalloproteinase inhibitors in neurite outgrowth assays. Outgrowth experiments on immobilized IgLON proteins revealed a role for all IgLON family members in promoting neurite extension from cortical neurons. Together, our findings support a role for metalloproteinase-dependent shedding of IgLON family members in regulating neurite outgrowth from mature cortical neurons.	[Sanz, Ricardo; Ferraro, Gino B.; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Fournier, AE (corresponding author), McGill Univ, Montreal Neurol Inst, BT-109,3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca			Canadian Institutes of Health Research; McGill Program in Neuroengineering; Canada Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill Program in Neuroengineering; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from the Canadian Institutes of Health Research and the McGill Program in Neuroengineering and by a Canada Research Chair (to A.E.F.).	Akeel M, 2011, BRAIN RES, V1374, P27, DOI 10.1016/j.brainres.2010.12.028; Bajor M, 2013, NEUROCHEM RES, V38, P1113, DOI 10.1007/s11064-012-0919-6; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Brennaman LH, 2008, MOL CELL NEUROSCI, V37, P781, DOI 10.1016/j.mcn.2008.01.006; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chen S, 2001, J NEUROCYTOL, V30, P927, DOI 10.1023/A:1020673318536; DAVIES B, 1993, CANCER RES, V53, P2087; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Diestel S, 2005, J NEUROCHEM, V95, P1777, DOI 10.1111/j.1471-4159.2005.03475.x; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Ferraro GB, 2011, J BIOL CHEM, V286, P31418, DOI 10.1074/jbc.M111.249169; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; Gil OD, 1998, J NEUROSCI, V18, P9312; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Hashimoto T, 2009, CELL BIOCHEM FUNCT, V27, P496, DOI 10.1002/cbf.1600; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; HORTON HL, 1988, J NEUROSCI, V8, P4653; Houri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073296; Huang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071553; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Itoh S, 2008, BIOCHEMISTRY-US, V47, P10132, DOI 10.1021/bi8009778; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kajiwara Y, 2009, BIOL PSYCHIAT, V66, P918, DOI 10.1016/j.biopsych.2009.05.033; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kimura Y, 2001, DEV GROWTH DIFFER, V43, P257; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Lee H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0158; Lodge AP, 2000, MOL BRAIN RES, V82, P84, DOI 10.1016/S0169-328X(00)00184-4; Malinverno M, 2010, J NEUROSCI, V30, P16343, DOI 10.1523/JNEUROSCI.1984-10.2010; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; McNamee CJ, 2011, CELL BIOCHEM FUNCT, V29, P114, DOI 10.1002/cbf.1730; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Minhas HM, 2013, AM J MED GENET A, V161A, P787, DOI 10.1002/ajmg.a.35841; Miyata S, 2003, NEUROSCIENCE, V117, P645, DOI 10.1016/S0306-4522(02)00873-4; Nash M, 2009, MOL NEUROBIOL, V40, P224, DOI 10.1007/s12035-009-8083-y; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Park MJ, 2000, NEUROSCI LETT, V290, P201, DOI 10.1016/S0304-3940(00)01358-6; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pischedda F, 2014, MOL CELL PROTEOMICS, V13, P733, DOI 10.1074/mcp.M113.031716; Prasad A, 2012, G3-GENES GENOM GENET, V2, P1665, DOI 10.1534/g3.112.004689; Reed J, 2004, J CELL SCI, V117, P3961, DOI 10.1242/jcs.01261; Romi E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5058; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Saura CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019430; Schmidt ERE, 2014, NEURON, V83, P372, DOI 10.1016/j.neuron.2014.05.036; Shichi K, 2011, J PHARMACOL EXP THER, V338, P701, DOI 10.1124/jpet.110.178079; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; Tanaka M, 2007, J CELL SCI, V120, P2179, DOI 10.1242/jcs.008607; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Webber CA, 2002, J NEUROSCI, V22, P8091; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Yamada M, 2007, BRAIN RES, V1165, P5, DOI 10.1016/j.brainres.2007.04.062; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; ZACCO A, 1990, J NEUROSCI, V10, P73; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	64	58	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4330	4342		10.1074/jbc.M114.628438	http://dx.doi.org/10.1074/jbc.M114.628438			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538237	hybrid, Green Published			2022-12-28	WOS:000349458400042
J	Dennis, MD; Kimball, SR; Fort, PE; Jefferson, LS				Dennis, Michael D.; Kimball, Scot R.; Fort, Patrice E.; Jefferson, Leonard S.			Regulated in Development and DNA Damage 1 Is Necessary for Hyperglycemia-induced Vascular Endothelial Growth Factor Expression in the Retina of Diabetic Rodents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-INDEPENDENT TRANSLATION; PROTEIN-SYNTHESIS; MULLER CELLS; HIGH GLUCOSE; VEGF EXPRESSION; SKELETAL-MUSCLE; GENE-EXPRESSION; RETINOPATHY; INITIATION; HYPOXIA	Vascular endothelial growth factor (VEGF) is considered a major role player in the pathogenesis of diabetic retinopathy, yet the mechanisms regulating its expression are not fully understood. Our laboratory previously demonstrated that diabetes-induced VEGF expression in the retina was dependent on the repressor of mRNA translation 4E-BP1. Interaction of 4E-BP1 with the cap-binding protein eIF4E regulates protein expression by controlling the selection of mRNAs for translation. The process is regulated by the master kinase mTOR in complex 1 (mTORC1), which phosphorylates 4E-BP1, thus promoting its disassociation from eIF4E. In the present study, we investigated the role of the Akt/mTORC1 repressor REDD1 (regulated in development and DNA damage) in diabetes-induced VEGF expression. REDD1 expression was induced by hyperglycemia in the retina of diabetic rodents and by hyperglycemic conditions in Muller cells concomitant with increased VEGF expression. In Muller cells, hyperglycemic conditions attenuated global rates of protein synthesis and cap-dependent mRNA translation concomitant with up-regulated cap-independent VEGF mRNA translation, as assessed by a bicistronic luciferase reporter assay. Hyperglycemic conditions also attenuated mTORC1 signaling and enhanced 4E-BP1 binding to eIF4E. Furthermore, ectopic expression of REDD1 in Muller cells was sufficient to promote both increased 4E-BP1 binding to eIF4E and VEGF expression. Whereas the retina of wild-type mice exhibited increased expression of VEGF and tumor necrosis factor alpha (TNF-alpha) 4 weeks after streptozotocin administration, the retina of REDD1 knock-out mice failed to do so. Overall, the results demonstrate that REDD1 contributes to the pathogenesis of diabetes in the retina by mediating the pathogenic effects of hyperglycemia.	[Dennis, Michael D.; Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Fort, Patrice E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Michigan System; University of Michigan	Dennis, MD (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	mdennis@psu.edu		Fort, Patrice/0000-0003-3956-1908; Dennis, Michael/0000-0002-0645-6864	American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-04]; National Institutes of Health [EY023612, DK15658, DK13499, EY020895]; NATIONAL EYE INSTITUTE [R01EY020895, R00EY023612, K99EY023612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R01DK015658, P30DK020572, R37DK013499] Funding Source: NIH RePORTER	American Diabetes Association Pathway to Stop Diabetes Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-04 (to M. D. D.), and National Institutes of Health Grants EY023612 (to M. D. D.), DK15658 and DK13499 (to L. S. J.), and EY020895 (to P. E. F.).	Aas V, 2011, BBA-MOL BASIS DIS, V1812, P94, DOI 10.1016/j.bbadis.2010.09.014; Aghdam SY, 2013, BIOCHEM BIOPH RES CO, V432, P339, DOI 10.1016/j.bbrc.2013.01.101; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Bornes S, 2007, CIRC RES, V100, P305, DOI 10.1161/01.RES.0000258873.08041.c9; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; D'Amore PA, 2007, AM J PATHOL, V171, P14, DOI 10.2353/ajpath.2007.070385; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; Dennis MD, 2013, DIABETES, V62, P2204, DOI 10.2337/db12-1453; Dennis MD, 2012, J BIOL CHEM, V287, P42890, DOI 10.1074/jbc.M112.404822; Dennis MD, 2011, J BIOL CHEM, V286, P34286, DOI 10.1074/jbc.M111.259457; Donovan K, 2014, INVEST OPHTH VIS SCI, V55, P7862, DOI 10.1167/iovs.14-14048; Fort PE, 2014, DIABETES, V63, P3077, DOI 10.2337/db14-0235; Fort PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026498; Gologorsky D, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/629452; Gordon BS, 2014, AM J PHYSIOL-ENDOC M, V307, pE703, DOI 10.1152/ajpendo.00250.2014; Hu JY, 2013, EXP EYE RES, V109, P31, DOI 10.1016/j.exer.2013.01.011; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Kim MY, 2012, EXP DIABETES RES, DOI 10.1155/2012/716425; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Li J, 2012, ACTA PHARMACOL SIN, V33, P1030, DOI 10.1038/aps.2012.61; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; MILLER JW, 1994, AM J PATHOL, V145, P574; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Morris MJ, 2010, J AM CHEM SOC, V132, P17831, DOI 10.1021/ja106287x; Okamoto N, 1997, AM J PATHOL, V151, P281; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Rittenhouse KD, 2014, INVEST OPHTH VIS SCI, V55, P1232, DOI 10.1167/iovs.13-13449; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Salam A, 2011, ACTA OPHTHALMOL, V89, P405, DOI 10.1111/j.1755-3768.2010.02079.x; Schoenberger SD, 2012, INVEST OPHTH VIS SCI, V53, P5906, DOI 10.1167/iovs.12-10410; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Thoreen CC, 2013, BIOCHEM SOC T, V41, P913, DOI 10.1042/BST20130082; Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315; Zhou JZ, 2012, CURR EYE RES, V37, P416, DOI 10.3109/02713683.2012.661114	51	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3865	3874		10.1074/jbc.M114.623058	http://dx.doi.org/10.1074/jbc.M114.623058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25548280	Green Published, hybrid			2022-12-28	WOS:000349456000056
J	Qian, Y; van Meel, E; Flanagan-Steet, H; Yox, A; Steet, R; Kornfeld, S				Qian, Yi; van Meel, Eline; Flanagan-Steet, Heather; Yox, Alex; Steet, Richard; Kornfeld, Stuart			Analysis of Mucolipidosis II/III GNPTAB Missense Mutations Identifies Domains of UDP-GlcNAc: lysosomal Enzyme GlcNAc-1-phosphotransferase Involved in Catalytic Function and Lysosomal Enzyme Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme; Genetic Disease; Golgi; Lysosomal Storage Disease; Zebrafish; GlcNAc-1-phosphotransferase; Notch Domains; Mannose 6-phosphate; Mucolipidosis II; Mucolipidosis III	PSEUDO-HURLER POLYDYSTROPHY; III ALPHA/BETA; N-ACETYLGLUCOSAMINE; MOLECULAR ANALYSIS; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE; SUBUNIT; GENE; SEROGROUP; PHENOTYPE	Background: Mutations in GNPTAB cause the lysosomal disorders mucolipidosis II and III . Results: All reported missense mutations were studied and showed various consequences on its gene product, GlcNAc-1-phosphotransferase. Conclusion: Domains responsible for catalytic activity and lysosomal hydrolase recognition were identified. Significance: Analysis of patient mutations provided new insight into the functional domains of GlcNAc-1-phosphotransferase. UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase tags newly synthesized lysosomal enzymes with mannose 6-phosphate recognition markers, which are required for their targeting to the endolysosomal system. GNPTAB encodes the and subunits of GlcNAc-1-phosphotransferase, and mutations in this gene cause the lysosomal storage disorders mucolipidosis II and III . Prior investigation of missense mutations in GNPTAB uncovered amino acids in the N-terminal region and within the DMAP domain involved in Golgi retention of GlcNAc-1-phosphotransferase and its ability to specifically recognize lysosomal hydrolases, respectively. Here, we undertook a comprehensive analysis of the remaining missense mutations in GNPTAB reported in mucolipidosis II and III patients using cell- and zebrafish-based approaches. We show that the Stealth domain harbors the catalytic site, as some mutations in these regions greatly impaired the activity of the enzyme without affecting its Golgi localization and proteolytic processing. We also demonstrate a role for the Notch repeat 1 in lysosomal hydrolase recognition, as missense mutations in conserved cysteine residues in this domain do not affect the catalytic activity but impair mannose phosphorylation of certain lysosomal hydrolases. Rescue experiments using mRNA bearing Notch repeat 1 mutations in GNPTAB-deficient zebrafish revealed selective effects on hydrolase recognition that differ from the DMAP mutation. Finally, the mutant R587P, located in the spacer between Notch 2 and DMAP, was partially rescued by overexpression of the subunit, suggesting a role for this region in subunit binding. These studies provide new insight into the functions of the different domains of the and subunits.	[Qian, Yi; van Meel, Eline; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Flanagan-Steet, Heather; Yox, Alex; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Washington University (WUSTL); University System of Georgia; University of Georgia	Steet, R (corresponding author), Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu			National Institutes of Health [CA-008759, GM-086524-7]; Yash Gandhi Foundation; National Mucopolysaccharidosis Society/International Society for Mannosidosis and Related Disorders; NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yash Gandhi Foundation; National Mucopolysaccharidosis Society/International Society for Mannosidosis and Related Disorders; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-008759 (to S. K.) and GM-086524-7 (to R. S.). This work was also supported by grants from the Yash Gandhi Foundation (to S. K. and R. S.) and the National Mucopolysaccharidosis Society/International Society for Mannosidosis and Related Disorders (to H. F.-S.).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Bargal R, 2006, MOL GENET METAB, V88, P359, DOI 10.1016/j.ymgme.2006.03.003; Braulke T., 2013, I CELL DIS PSEUDO HU; Cathey SS, 2010, J MED GENET, V47, P38, DOI 10.1136/jmg.2009.067736; Cobos PN, 2015, JIMD REP, V15, P123, DOI 10.1007/8904_2014_308; Coutinho MF, 2012, AM J MED GENET A, V158A, P1225, DOI 10.1002/ajmg.a.35295; Cury GK, 2013, GENE, V524, P59, DOI 10.1016/j.gene.2013.03.105; De Pace R, 2014, HUM MUTAT, V35, P368, DOI 10.1002/humu.22502; Encarnacao M, 2009, CLIN GENET, V76, P76, DOI 10.1111/j.1399-0004.2009.01185.x; Fernandez-Marmiesse A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-59; Fiebig T, 2014, J BIOL CHEM, V289, P19395, DOI 10.1074/jbc.M114.575142; Flanagan-Steet H, 2009, AM J PATHOL, V175, P2063, DOI 10.2353/ajpath.2009.090210; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Lam CW, 2007, CLIN CHIM ACTA, V376, P250, DOI 10.1016/j.cca.2006.09.004; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Muindi KM, 2014, GLYCOBIOLOGY, V24, P139, DOI 10.1093/glycob/cwt091; Otomo T, 2009, J HUM GENET, V54, P145, DOI 10.1038/jhg.2009.3; Petrey AC, 2012, DIS MODEL MECH, V5, P177, DOI 10.1242/dmm.008219; Qian Y, 2013, P NATL ACAD SCI USA, V110, P10246, DOI 10.1073/pnas.1308453110; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Reilly MC, 2009, J BIOL CHEM, V284, P36118, DOI 10.1074/jbc.M109.056226; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Tappino B, 2009, HUM MUTAT, V30, pE956, DOI 10.1002/humu.21099; Tiede S, 2005, AM J MED GENET A, V137A, P235, DOI 10.1002/ajmg.a.30868; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; van Meel E, 2014, P NATL ACAD SCI USA, V111, P3532, DOI 10.1073/pnas.1401417111; Vardar D, 2003, BIOCHEMISTRY-US, V42, P7061, DOI 10.1021/bi034156y; Zarghooni M, 2009, AM J MED GENET A, V149A, P2753, DOI 10.1002/ajmg.a.33134	35	37	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3045	3056		10.1074/jbc.M114.612507	http://dx.doi.org/10.1074/jbc.M114.612507			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25505245	Green Published, hybrid			2022-12-28	WOS:000349310700041
J	Guo, YR; Scheuermann, TH; Partch, CL; Tomchick, DR; Gardner, KH				Guo, Yirui; Scheuermann, Thomas H.; Partch, Carrie L.; Tomchick, Diana R.; Gardner, Kevin H.			Coiled-coil Coactivators Play a Structural Role Mediating Interactions in Hypoxia-inducible Factor Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Hypoxia-inducible Factor (HIF); Nuclear Magnetic Resonance (NMR); Transcription Coactivator; Transcription Regulation; ARNT; TACC3; Coiled-coil Coactivator Recruitment	RECEPTOR NUCLEAR TRANSLOCATOR; PAS-B DOMAIN; TRANSCRIPTION FACTOR; SMALL MOLECULES; X-RAY; RECRUITMENT; ARNT; SOFTWARE; BINDING; FAMILY	Background: Coiled-coil coactivators can enhance HIF-dependent gene transcription via direct interaction with the HIF/ARNT heterodimer. Results: ARNT uses the -sheet of the PAS-B domain to recruit coiled-coil coactivators. Conclusion: Coiled-coil coactivators bridge HIF and ARNT via the PAS-B domain -sheet contacts to both proteins to form a ternary structure. Significance: This work reveals the mechanism for assembling a coiled-coil coactivator complex with the HIF-2 transcription factor heterodimer. The hypoxia-inducible factor complex (HIF-alpha.aryl hydrocarbon receptor nuclear translocator (ARNT)) requires association with several transcription coactivators for a successful cellular response to hypoxic stress. In addition to the conventional global transcription coactivator CREB-binding protein/p300 (CBP/p300) that binds to the HIF-alpha transactivation domain, a new group of transcription coactivators called the coiled-coil coactivators (CCCs) interact directly with the second PER-ARNT-SIM (PAS) domain of ARNT (ARNT PAS-B). These less studied transcription coactivators play essential roles in the HIF-dependent hypoxia response, and CCC misregulation is associated with several forms of cancer. To better understand CCC protein recruitment by the heterodimeric HIF transcription factor, we used x-ray crystallography, NMR spectroscopy, and biochemical methods to investigate the structure of the ARNT PAS-B domain in complex with the C-terminal fragment of a coiled-coil coactivator protein, transforming acidic coiled-coil coactivator 3 (TACC3). We found that the HIF-2 alpha PAS-B domain also directly interacts with TACC3, motivating an NMR data-derived model suggesting a means by which TACC3 could form a ternary complex with HIF-2 alpha PAS-B and ARNT PAS-B via beta-sheet/coiled-coil interactions. These findings suggest that TACC3 could be recruited as a bridge to cooperatively mediate between the HIF-2 PAS-B.ARNT PAS-B complex, thereby participating more directly in HIF-dependent gene transcription than previously anticipated.	[Guo, Yirui; Scheuermann, Thomas H.; Partch, Carrie L.; Tomchick, Diana R.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Guo, Yirui; Scheuermann, Thomas H.; Partch, Carrie L.; Tomchick, Diana R.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Gardner, Kevin H.] CUNY, Struct Biol Initiat, Adv Sci Res Ctr, New York, NY 10031 USA; [Gardner, Kevin H.] CUNY City Coll, Dept Chem, New York, NY 10031 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY)	Gardner, KH (corresponding author), CUNY, Struct Biol Initiat, Adv Sci Res Ctr, 85 St Nicholas Terrace, New York, NY 10031 USA.	Kevin.Gardner@asrc.cuny.edu	Gardner, Kevin H./K-7802-2012; Tomchick, Diana/HGV-2018-2022; Gardner, Kevin/K-5493-2019	Gardner, Kevin H./0000-0002-8671-2556; Partch, Carrie/0000-0002-4677-2861; Tomchick, Diana/0000-0002-7529-4643	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [F32CA130441, P01CA095471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081875] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Richard Bruick for discussions about this work and HIF signaling in general, Drs. Arati Ramesh and Dominika Borek for their kind help with x-ray crystallography data analysis, Dr. Fernando Correa for assistance with PRE data analysis, and Dr. Chad Brautigam for assistance with MST assay. Portions of this work were performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. The Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Greenfield NJ, 1998, BIOCHEMISTRY-US, V37, P7834, DOI 10.1021/bi973167m; Guo YR, 2013, ACS CHEM BIOL, V8, P626, DOI 10.1021/cb300604u; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JH, 2004, J BIOL CHEM, V279, P49842, DOI 10.1074/jbc.M408535200; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Sadek CM, 2000, MECH DEVELOP, V97, P13, DOI 10.1016/S0925-4773(00)00415-9; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/NCHEMBIO.1185, 10.1038/nchembio.1185]; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834	35	19	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7707	7721		10.1074/jbc.M114.632786	http://dx.doi.org/10.1074/jbc.M114.632786			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25627682	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000351613600032
J	Rodionova, IA; Zuccola, HJ; Sorci, L; Aleshin, AE; Kazanov, MD; Ma, CT; Sergienko, E; Rubin, EJ; Locher, CP; Osterman, AL				Rodionova, Irina A.; Zuccola, Harmon J.; Sorci, Leonardo; Aleshin, Alexander E.; Kazanov, Marat D.; Ma, Chen-Ting; Sergienko, Eduard; Rubin, Eric J.; Locher, Christopher P.; Osterman, Andrei L.			Mycobacterial Nicotinate Mononucleotide Adenylyltransferase STRUCTURE, MECHANISM, AND IMPLICATIONS FOR DRUG DISCOVERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Enzyme Structure; NAD Biosynthesis; Protein Engineering; Protein Targeting	TARGETING NAD BIOSYNTHESIS; CRYSTAL-STRUCTURE; TUBERCULOSIS; IDENTIFICATION; INHIBITORS; SUBSTRATE; RECONSTRUCTION; DEAMIDASE; INSIGHTS; REVEALS	Background: NAD biosynthesis was implicated as an antibacterial target pathway. Results: Structure-functional analysis of Mycobacterium tuberculosis NadD revealed an over-closed conformation and a sequential kinetic mechanism. Conclusion:M. tuberculosis NadD is a potentially druggable target suitable for the development of selective inhibitors. Significance: This study describes a novel regulatory mechanism and points to a specific strategy for targeting mycobacterial NadD. Nicotinate mononucleotide adenylyltransferase NadD is an essential enzyme in the biosynthesis of the NAD cofactor, which has been implicated as a target for developing new antimycobacterial therapies. Here we report the crystal structure of Mycobacterium tuberculosis NadD (MtNadD) at a resolution of 2.4 angstrom. A remarkable new feature of the MtNadD structure, compared with other members of this enzyme family, is a 3(10) helix that locks the active site in an over-closed conformation. As a result, MtNadD is rendered inactive as it is topologically incompatible with substrate binding and catalysis. Directed mutagenesis was also used to further dissect the structural elements that contribute to the interactions of the two MtNadD substrates, i.e. ATP and nicotinic acid mononucleotide (NaMN). For inhibitory profiling of partially active mutants and wild type MtNadD, we used a small molecule inhibitor of MtNadD with moderate affinity (K-i approximate to 25 m) and antimycobacterial activity (MIC80) approximate to 40-80 m). This analysis revealed interferences with some of the residues in the NaMN binding subsite consistent with the competitive inhibition observed for the NaMN substrate (but not ATP). A detailed steady-state kinetic analysis of MtNadD suggests that ATP must first bind to allow efficient NaMN binding and catalysis. This sequential mechanism is consistent with the requirement of transition to catalytically competent (open) conformation hypothesized from structural modeling. A possible physiological significance of this mechanism is to enable the down-regulation of NAD synthesis under ATP-limiting dormancy conditions. These findings point to a possible new strategy for designing inhibitors that lock the enzyme in the inactive over-closed conformation.	[Rodionova, Irina A.; Aleshin, Alexander E.; Ma, Chen-Ting; Sergienko, Eduard; Osterman, Andrei L.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Zuccola, Harmon J.; Locher, Christopher P.] Vertex Pharmaceut Inc, Boston, MA 02210 USA; [Sorci, Leonardo] Polytech Univ Marche, Biochem Sect, Dept Clin Sci, I-60131 Ancona, Italy; [Kazanov, Marat D.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow 127051, Russia; [Rubin, Eric J.] Harvard Univ, Dept Immunol & Infect Dis, Sch Publ Hlth, Boston, MA 02115 USA	Sanford Burnham Prebys Medical Discovery Institute; Vertex Pharmaceuticals; Marche Polytechnic University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Osterman, AL (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	osterman@sanfordburnham.org	Kazanov, Marat D/D-6381-2013; SORCI, LEONARDO/AAD-7395-2019	Kazanov, Marat D/0000-0002-2314-5507; SORCI, LEONARDO/0000-0002-4356-8873; Zuccola, Harmon/0000-0002-2454-784X	NIH [R03 MH095597-02]; NIGMS, National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH095597] Funding Source: NIH RePORTER; Russian Science Foundation [14-24-00155] Funding Source: Russian Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Russian Science Foundation(Russian Science Foundation (RSF))	Identification of S. aureus NadD inhibitors from National Institutes of Health (NIH) Molecular Libraries Screening Centers Network (MLSCN) collection used in this study was supported by NIH Grant R03 MH095597-02 (to A. O.). We are grateful to Dr. A. Pinkerton and other colleagues at Conrad Prebys Center for Chemical Genomics (Sanford-Burnham Medical Research Institute (SBMRI)) for invaluable contributions to this effort. We thank Dr. Dongyang Li, Yuzhou Xu, and Yannan Wang of Shanghai ChemPartner for protein expression, protein purification, and crystallography support and Dr. John A. Thomson of Vertex Pharmaceuticals for support of the project. We thank Brian Schuster for help on mycobacterial genetics and physiology during his graduate work at Harvard Medical School. The Berkeley Center for Structural Biology is supported in part by the NIGMS, National Institutes of Health and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fattorini L, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.072; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Haagsma AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023575; Han S, 2006, J MOL BIOL, V360, P814, DOI 10.1016/j.jmb.2006.05.055; Hegymegi-Barakonyi B, 2008, CURR MED CHEM, V15, P2760, DOI 10.2174/092986708786242886; Huang NA, 2010, J MED CHEM, V53, P5229, DOI 10.1021/jm100377f; Kim JH, 2013, P NATL ACAD SCI USA, V110, P19095, DOI 10.1073/pnas.1315860110; Koul A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4369; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olland AM, 2002, J BIOL CHEM, V277, P3698, DOI 10.1074/jbc.M109670200; Organization W. H., 2014, GLOB TUB REP 2014, P1; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Rodionova IA, 2014, MBIO, V5, DOI 10.1128/mBio.00747-13; Segel I. H., 1975, ENZYME KINETICS, P819; Sershon VC, 2009, J MOL BIOL, V385, P867, DOI 10.1016/j.jmb.2008.10.037; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Sorci L, 2014, FEBS LETT, V588, P1016, DOI 10.1016/j.febslet.2014.01.063; Sorci L, 2013, J BACTERIOL, V195, P726, DOI 10.1128/JB.02002-12; Sorci L, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P213; Sorci L, 2010, J BIOL CHEM, V285, P39490, DOI 10.1074/jbc.M110.185629; Sorci L, 2009, CHEM BIOL, V16, P849, DOI 10.1016/j.chembiol.2009.07.006; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang C, 2008, J BACTERIOL, V190, P1773, DOI 10.1128/JB.01469-07; Yoon HJ, 2005, J MOL BIOL, V351, P258, DOI 10.1016/j.jmb.2005.06.001; Zhang H, 2002, STRUCTURE, V10, P69, DOI 10.1016/S0969-2126(01)00693-1; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	41	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7693	7706		10.1074/jbc.M114.628016	http://dx.doi.org/10.1074/jbc.M114.628016			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25631047	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000351613600031
J	Choi, SJ; Panhelainen, A; Schmitz, Y; Larsen, KE; Kanter, E; Wu, M; Sulzer, D; Mosharov, EV				Choi, Se Joon; Panhelainen, Anne; Schmitz, Yvonne; Larsen, Kristin E.; Kanter, Ellen; Wu, Min; Sulzer, David; Mosharov, Eugene V.			Changes in Neuronal Dopamine Homeostasis following 1-Methyl-4-phenylpyridinium (MPP+) Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR MONOAMINE TRANSPORTER; PARKINSONISM-INDUCING NEUROTOXIN; MESENCEPHALIC CELL-CULTURES; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; SYNAPTIC VESICLES; CYTOSOLIC DOPAMINE; REVERSE TRANSPORT; MIDBRAIN NEURONS; OXIDATIVE STRESS; QUANTAL SIZE	1-Methyl-4-phenylpyridinium (MPP+), the active metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, selectively kills dopaminergic neurons in vivo and in vitro via a variety of toxic mechanisms, including mitochondrial dysfunction, generation of peroxynitrite, induction of apoptosis, and oxidative stress due to disruption of vesicular dopamine (DA) storage. To investigate the effects of acute MPP+ exposure on neuronal DA homeostasis, we measured stimulation-dependent DA release and non-exocytotic DA efflux from mouse striatal slices and extracellular, intracellular, and cytosolic DA (DAcyt) levels in cultured mouse ventral midbrain neurons. In acute striatal slices, MPP+ exposure gradually decreased stimulation- dependent DA release, followed by massive DA efflux that was dependent on MPP+ concentration, temperature, and DA uptake transporter activity. Similarly, in mouse midbrain neuronal cultures, MPP+ depleted vesicular DA storage accompanied by an elevation of cytosolic and extracellular DA levels. In neuronal cell bodies, increased DAcyt was not due to transmitter leakage from synaptic vesicles but rather to competitive MPP+-dependent inhibition of monoamine oxidase activity. Accordingly, monoamine oxidase blockers pargyline and L-deprenyl had no effect on DAcyt levels in MPP+-treated cells and produced only a moderate effect on the survival of dopaminergic neurons treated with the toxin. In contrast, depletion of intracellular DA by blocking neurotransmitter synthesis resulted in similar to 30% reduction of MPP+-mediated toxicity, whereas overexpression of VMAT2 completely rescued dopaminergic neurons. These results demonstrate the utility of comprehensive analysis of DA metabolism using various electrochemical methods and reveal the complexity of the effects of MPP+ on neuronal DA homeostasis and neurotoxicity.	[Choi, Se Joon; Schmitz, Yvonne; Larsen, Kristin E.; Kanter, Ellen; Wu, Min; Sulzer, David; Mosharov, Eugene V.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA; [Sulzer, David] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY 10032 USA; [Sulzer, David] Columbia Univ, Dept Pharmacol, Med Ctr, New York, NY 10032 USA; [Panhelainen, Anne] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	Columbia University; Columbia University; Columbia University; University of Helsinki	Mosharov, EV (corresponding author), Columbia Univ, Dept Neurol, Black Bldg,Rm 308,650 West 168th St, New York, NY 10032 USA.	em706@columbia.edu		Panhelainen, Anne/0000-0001-5082-4006	National Institutes of Health from NINDS [R01NS075222]; NINDS Morris K. Udall Center of Excellence Research Grant; Parkinson's Disease Foundation; JPB Foundation; Finnish Cultural Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075222] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NINDS Morris K. Udall Center of Excellence Research Grant; Parkinson's Disease Foundation; JPB Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS075222 from NINDS (to E. V. M.) and the NINDS Morris K. Udall Center of Excellence Research Grant (to D. S.). This work was also supported by the Parkinson's Disease and JPB Foundations (to D. S.) and by a fellowship from the Finnish Cultural Foundation (to A. P.).	Barc S, 2001, NEUROCHEM INT, V38, P243, DOI 10.1016/S0197-0186(00)00083-8; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; BROOKS WJ, 1989, J NEURAL TRANSM, V76, P1, DOI 10.1007/BF01244987; Burke RE, 1998, J NEUROCHEM, V71, P517; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Cappelletti G, 1999, J NEUROSCI RES, V56, P28, DOI 10.1002/(SICI)1097-4547(19990401)56:1<28::AID-JNR4>3.0.CO;2-2; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; CHIEN JB, 1990, J NEUROCHEM, V54, P633, DOI 10.1111/j.1471-4159.1990.tb01918.x; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4; EDWARDS RH, 1993, ANN NEUROL, V34, P638, DOI 10.1002/ana.410340504; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Gainetdinov RR, 1998, J NEUROCHEM, V70, P1973; GERLACH M, 1992, EUR J PHARM-MOLEC PH, V226, P97, DOI 10.1016/0922-4106(92)90170-Z; Hasbani DM, 2005, J NEUROSCI, V25, P9428, DOI 10.1523/JNEUROSCI.0130-05.2005; Hastings T. G., 1999, ROLE CATECHOL QUINON, P69; Huguet F, 1997, TOXICOLOGY, V122, P93, DOI 10.1016/S0300-483X(97)00084-X; Inazu M, 2003, J NEUROCHEM, V84, P43, DOI 10.1046/j.1471-4159.2003.01566.x; Jackson-Lewis V, 2005, NEUROTOX RES, V7, P193, DOI 10.1007/BF03036449; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jenner P, 2011, MOVEMENT DISORD, V26, P2316, DOI 10.1002/mds.23926; Jones SR, 1998, J NEUROSCI, V18, P1979; Karunakaran S, 2008, J NEUROSCI, V28, P12500, DOI 10.1523/JNEUROSCI.4511-08.2008; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Krantz DE, 1997, J BIOL CHEM, V272, P6752, DOI 10.1074/jbc.272.10.6752; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Larsen KE, 2002, J NEUROSCI, V22, P8951; LAU YS, 1991, NEUROTOXICOLOGY, V12, P189; Le WD, 1997, NEUROSCI LETT, V224, P197, DOI 10.1016/S0304-3940(97)00170-5; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Lohr KM, 2014, P NATL ACAD SCI USA, V111, P9977, DOI 10.1073/pnas.1402134111; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Michael DJ, 1999, J PHARMACEUT BIOMED, V19, P33, DOI 10.1016/S0731-7085(98)00145-9; MONTINE TJ, 1995, J NEUROPATH EXP NEUR, V54, P311, DOI 10.1097/00005072-199505000-00004; MORIYAMA Y, 1993, ARCH BIOCHEM BIOPHYS, V305, P271, DOI 10.1006/abbi.1993.1422; Mosharov E.V., 2014, HDB NEUROTOXICITY, P973, DOI [10.1007/978-1-4614-5836-4_2, DOI 10.1007/978-1-4614-5836-4_2]; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Mosharov EV, 2003, J NEUROSCI, V23, P5835; Moszczynska A, 2004, BRAIN, V127, P363, DOI 10.1093/brain/awh046; MYTILINEOU C, 1993, J NEUROCHEM, V61, P1470, DOI 10.1111/j.1471-4159.1993.tb13642.x; Naoi M, 2009, EXPERT REV NEUROTHER, V9, P1233, DOI [10.1586/ern.09.68, 10.1586/ERN.09.68]; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; PARDO B, 1995, BRAIN RES, V682, P133, DOI 10.1016/0006-8993(95)00341-M; Pifl C, 2014, J NEUROSCI, V34, P8210, DOI 10.1523/JNEUROSCI.5456-13.2014; Pothos EN, 2000, J NEUROSCI, V20, P7297; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; RANSOM BR, 1987, NEUROSCI LETT, V75, P323, DOI 10.1016/0304-3940(87)90543-X; RAYPORT S, 1992, J NEUROSCI, V12, P4264; ROSSETTI ZL, 1988, BIOCHEM PHARMACOL, V37, P4573, DOI 10.1016/0006-2952(88)90674-0; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; SCHAPIRA AHV, 1994, MOVEMENT DISORD, V9, P125, DOI 10.1002/mds.870090202; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Serra Pier Andrea, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS189, DOI 10.1016/j.parkreldis.2008.04.029; Sharma SK, 2003, J NEUROCYTOL, V32, P329, DOI 10.1023/B:NEUR.0000011327.23739.1b; SIRINATHSINGHJI DJS, 1988, BRAIN RES, V443, P101, DOI 10.1016/0006-8993(88)91603-4; Speciale SG, 1998, NEUROSCIENCE, V84, P1177, DOI 10.1016/S0306-4522(97)00570-8; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; SULZER D, 1995, J NEUROSCI, V15, P4102; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; Sulzer D, 1999, NEUROTOX RES, V1, P181, DOI 10.1007/BF03033289; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Uhl GR, 1998, ANN NEUROL, V43, P555, DOI 10.1002/ana.410430503; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Volz TJ, 2006, J NEUROSCI METH, V155, P109, DOI 10.1016/j.jneumeth.2006.01.002; Wang XL, 2011, AGING CELL, V10, P807, DOI 10.1111/j.1474-9726.2011.00721.x; Whitehead RE, 2001, J NEUROCHEM, V76, P1242, DOI 10.1046/j.1471-4159.2001.00125.x; WILLIAMS JT, 1984, NEUROSCIENCE, V13, P137, DOI 10.1016/0306-4522(84)90265-3; Xie T, 2000, J NEUROSCI, V20, P7838; Yi H, 2006, J NEURAL TRANSM, V113, P21, DOI 10.1007/s00702-005-0299-z; Youdim MBH, 2001, BRIT J PHARMACOL, V132, P500, DOI 10.1038/sj.bjp.0703826	84	37	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6799	6809		10.1074/jbc.M114.631556	http://dx.doi.org/10.1074/jbc.M114.631556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25596531	Green Published, hybrid			2022-12-28	WOS:000350991500016
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.			Evaluating the Role of Retinal Membrane Guanylyl Cyclase 1 (RetGC1) Domains in Binding Guanylyl Cyclase-activating Proteins (GCAPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; CAUSES PHOTORECEPTOR DEGENERATION; LEBER CONGENITAL AMAUROSIS; CALCIUM; GENE; MUTATION; IDENTIFICATION; CA2+; SENSITIVITY; CLONING	Retinal membrane guanylyl cyclase 1 (RetGC1) regulated by guanylyl cyclase-activating proteins (GCAPs) controls photoreceptor recovery and when mutated causes blinding disorders. We evaluated the principal models of how GCAP1 and GCAP2 bind RetGC1: through a shared docking interface versus independent binding sites formed by distant portions of the cydase intracellular domain. At near-saturating concentrations, GCAP1 and GCAP2 activated RetGC1 from HEK293 cells and RetGC2(-/-) GCAPs1,2(-/-) mouse retinas in a non-additive fashion. The M26R GCAP1, which binds but does not activate RetGC1, suppressed activation of recombinant and native RetGC1 by competing with both GCAP1 and GCAP2. Untagged GCAP1 displaced both GCAP1-GFP and GCAP2-GFP from the complex with RetGC1 in HEK293 cells. The intracellular segment of a natriuretic peptide receptor A guanylyl cyclase failed to bind GCAPs, but replacing its kinase homology and dimerization domains with those from RetGC1 restored GCAP1 and GCAP2 binding by the hybrid cyclase and its GCAP-dependent regulation. Deletion of the Tyr(1016)-Ser(1103) fragment in RetGC1 did not block GCAP2 binding to the cyclase. In contrast, substitutions in the kinase homology domain, W708R and 17341, linked to Leber congenital amaurosis prevented binding of both GCAP1-GFP and GCAP2-GFP. Our results demonstrate that GCAPs cannot regulate RetGC1 using independent primary binding sites. Instead, GCAP1 and GCAP2 bind with the cyclase molecule in a mutually exclusive manner using a common or overlapping binding site(s) in the Arg(488)-Arg(851) Arel portion of RetGC1, and mutations in that region causing Leber congenital amaurosis blindness disrupt activation of the cyclase by both GCAP1 and GCAP2.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Res, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416,8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522]; Commonwealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; Commonwealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY11522 from the NEI. This work was also supported by a Commonwealth Universal Research Enhancement formula grant from the Pennsylvania Department of Health.	[Anonymous], 2012, NEUROSCIENCE; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; Duda T, 2012, BIOCHEMISTRY-US, V51, P4650, DOI 10.1021/bi300572w; Duda T, 2011, BIOCHEM BIOPH RES CO, V408, P236, DOI 10.1016/j.bbrc.2011.03.134; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sharma RK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00056; Sokal I, 1999, BIOCHEMISTRY-US, V38, P1387, DOI 10.1021/bi982512k; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Wen XH, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00045; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zinchuk V., 2008, CURR PROTOC CELL BIO, V39, P4191	60	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6913	6924		10.1074/jbc.M114.629642	http://dx.doi.org/10.1074/jbc.M114.629642			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25616661	Green Published, hybrid			2022-12-28	WOS:000350991500026
J	Seviour, T; Hansen, SH; Yang, L; Yau, YH; Wang, VB; Stenvang, MR; Christiansen, G; Marsili, E; Givskov, M; Chen, YC; Otzen, DE; Nielsen, PH; Geifman-Shochat, S; Kjelleberg, S; Dueholm, MS				Seviour, Thomas; Hansen, Susan Hove; Yang, Liang; Yau, Yin Hoe; Wang, Victor Bochuan; Stenvang, Marcel R.; Christiansen, Gunna; Marsili, Enrico; Givskov, Michael; Chen, Yicai; Otzen, Daniel E.; Nielsen, Per Halkjaer; Geifman-Shochat, Susana; Kjelleberg, Staffan; Dueholm, Morten S.			Functional Amyloids Keep Quorum-sensing Molecules in Check	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA VIRULENCE; BIOFILM FORMATION; BACTERIAL BIOFILMS; ALPHA-SYNUCLEIN; PYOCYANIN; SIGNAL; EXOPOLYSACCHARIDE; AGGREGATION; EXPRESSION; PROTEIN	The mechanism by which extracellular metabolites, including redox mediators and quorum-sensing signaling molecules, traffic through the extracellular matrix of biofilms is poorly explored. We hypothesize that functional amyloids, abundant in natural biofilms and possessing hydrophobic domains, retain these metabolites. Using surface plasmon resonance, we demonstrate that the quorum-sensing (QS) molecules, 2-heptyl-3-hydroxy-4(1H)quinolone and N-(3-oxododecanoyl)-L-homoserine lactone, and the redox mediator pyocyaruin bind with transient affinity to functional amyloids from Pseudomonas (Fap). Their high hydrophobicity predisposes them to signal-amyloid interactions, but specific interactions also play a role. Transient interactions allow for rapid association and dissociation kinetics, which make the QS molecules bioavailable and at the same time secure within the extracellular matrix as a consequence of serial bindings. Retention of the QS molecules was confirmed using Pseudomonas aeruginosa P A()1based 2-heptyl-3-hydroxy-4(1H)-quinolone and N-(3-oxododecanoyl)-L-homoserine lactone reporter assays, showing that Fap fibrils pretreated with the QS molecules activate the reporters even after sequential washes. Pyocyanin retention was validated by electrochemical analysis of pyocyanin-pretreated Fap fibrils subjected to the same washing process. Results suggest that QS molecule-amyloid interactions are probably important in the turbulent environments commonly encountered in natural habitats.	[Seviour, Thomas; Yang, Liang; Wang, Victor Bochuan; Marsili, Enrico; Givskov, Michael; Chen, Yicai; Nielsen, Per Halkjaer; Kjelleberg, Staffan] Nanyang Technol Univ, SCELSE, Singapore 637551, Singapore; [Yau, Yin Hoe; Geifman-Shochat, Susana] Nanyang Technol Univ, SBS, Singapore 637551, Singapore; [Hansen, Susan Hove; Nielsen, Per Halkjaer; Dueholm, Morten S.] Aalborg Univ, Ctr Microbial Communities, DK-9220 Aalborg, Denmark; [Wang, Victor Bochuan] Nanyang Technol Univ, Sch Mat Sci & Engn MSE, Singapore 639798, Singapore; [Stenvang, Marcel R.; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Givskov, Michael] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, DK-1165 Copenhagen, Denmark; [Kjelleberg, Staffan] Univ New S Wales, Ctr Marine Bioinnovat, Mosman, NSW 2088, Australia; [Kjelleberg, Staffan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Mosman, NSW 2088, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Aalborg University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Aarhus University; Aarhus University; University of Copenhagen; University of New South Wales Sydney; University of New South Wales Sydney	Seviour, T (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, SBS-B2n-27,50 Nanyang Ave, Singapore 639798, Singapore.	twseviour@ntu.edu.sg	Kjelleberg, Staffan/C-9229-2015; Nielsen, Per Halkjær/T-6796-2018; Marsili, Enrico/A-8652-2008; Hoe, YAU Yin/A-2817-2011; Kjelleberg, Staffan/AAB-4641-2020; Yang, Liang/C-8487-2011; Dueholm, Morten Simonsen/T-6718-2018	Kjelleberg, Staffan/0000-0003-4271-6413; Nielsen, Per Halkjær/0000-0002-6402-1877; Marsili, Enrico/0000-0003-3150-1564; Hoe, YAU Yin/0000-0001-8136-2393; Kjelleberg, Staffan/0000-0003-4271-6413; Yang, Liang/0000-0002-2362-0128; Dueholm, Morten Simonsen/0000-0003-4135-2670; Givskov, Michael/0000-0001-5004-8609; Christiansen, Gunna/0000-0003-0540-1367	Singapore's National Research Foundation; Ministry of Education; Nanyang Technological University (NTU); National University of Singapore (NUS); Sino-Danish Centre for Education and Research	Singapore's National Research Foundation(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University (NTU)(Nanyang Technological University); National University of Singapore (NUS)(National University of Singapore); Sino-Danish Centre for Education and Research	The Singapore Centre on Environmental Life Sciences Engineering is supported by Singapore's National Research Foundation, Ministry of Education, Nanyang Technological University (NTU), and National University of Singapore (NUS), and hosted by NTU in partnership with NUS. Electrical characterization was performed at the Energy Research Institute at NTU.r Supported by the Sino-Danish Centre for Education and Research.	Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; BRITIGAN BE, 1992, J CLIN INVEST, V90, P2187, DOI 10.1172/JCI116104; Britigan BE, 1999, INFECT IMMUN, V67, P1207, DOI 10.1128/IAI.67.3.1207-1212.1999; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Calfee MW, 2001, P NATL ACAD SCI USA, V98, P11633, DOI 10.1073/pnas.201328498; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; del Mercato LL, 2007, P NATL ACAD SCI USA, V104, P18019, DOI 10.1073/pnas.0702843104; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Dueholm M. S., 2013, FUNCTIONAL AMYLOIDS, P411; Dueholm MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076630; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Herbst -A, 2014, J PROTEORNE RES, DOI [110.1021/pr500938x, DOI 10.1021/PR500938X]; Herva ME, 2014, J BIOL CHEM, V289, P11897, DOI 10.1074/jbc.M113.542340; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kawatake S, 2006, BIOL PHARM BULL, V29, P927, DOI 10.1248/bpb.29.927; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren L, 2008, MOL MICROBIOL, V69, P491, DOI 10.1111/j.1365-2958.2008.06302.x; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Myszka DG, 2004, ANAL BIOCHEM, V329, P316, DOI 10.1016/j.ab.2004.03.028; Ohlson S, 2008, DRUG DISCOV TODAY, V13, P433, DOI 10.1016/j.drudis.2008.02.001; Olsen A, 2002, J BIOL CHEM, V277, P34568, DOI 10.1074/jbc.M206353200; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Passador L, 1996, J BACTERIOL, V178, P5995, DOI 10.1128/jb.178.20.5995-6000.1996; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Roden LD, 1996, BIOCHEM BIOPH RES CO, V225, P1073, DOI 10.1006/bbrc.1996.1297; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Seviour T, 2012, WATER RES, V46, P4803, DOI 10.1016/j.watres.2012.06.018; Seviour T, 2012, BIOMACROMOLECULES, V13, P1965, DOI 10.1021/bm3005808; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Wang VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063129; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yang L, 2009, ANTIMICROB AGENTS CH, V53, P2432, DOI 10.1128/AAC.01283-08; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang LB, 2013, MICROBIOL-SGM, V159, P1931, DOI 10.1099/mic.0.066266-0	71	55	55	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2015	290	10					6457	6469		10.1074/jbc.M114.613810	http://dx.doi.org/10.1074/jbc.M114.613810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD0AO	25586180	hybrid, Green Published			2022-12-28	WOS:000350732500049
J	Kwon, MJ; Choi, Y; Yun, JH; Lee, W; Han, IO; Oh, ES				Kwon, Mi-Jung; Choi, Youngsil; Yun, Ji-Hye; Lee, Weontae; Han, Inn-Oc; Oh, Eok-Soo			A Unique Phenylalanine in the Transmembrane Domain Strengthens Homodimerization of the Syndecan-2 Transmembrane Domain and Functionally Regulates Syndecan-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-HELIX INTERACTIONS; GXXXG MOTIFS; ASSOCIATION; MIGRATION; RECEPTOR; DIMERIZATION; RESIDUES; ADHESION	The syndecans are a type of cell surface adhesion receptor that initiates intracellular signaling events through receptor clustering mediated by their highly conserved transmembrane domains (TMDs). However, the exact function of the syndecan TMD is not yet fully understood. Here, we investigated the specific regulatory role of the syndecan-2 TMD. We found that syndecan-2 mutants in which the TMD had been replaced with that of syndecan-4 were defective in syndecan-2-mediated functions, suggesting that the TMD of syndecan-2 plays one or more specific roles. Interestingly, syndecan-2 has a stronger tendency to form sodium dodecyl sulfate (SDS)-resistant homodimers than syndecan-4. Our structural studies showed that a unique phenylalanine residue (Phe(167)) enables an additional molecular interaction between the TMDs of the syndecan-2 homodimer. The presence of Phe(167) was correlated with a higher tendency toward oligomerization, and its replacement with isoleucine significantly reduced the SDS-resistant dimer formation and cellular functions of syndecan-2 (e. g. cell migration). Conversely, replacement of isoleucine with phenylalanine at this position in the syndecan-4 TMD rescued the defects observed in a mutant syndecan-2 harboring the syndecan-4 TMD. Taken together, these data suggest that Phe(167) in the TMD of syndecan-2 endows the protein with specific functions. Our work offers new insights into the signaling mediated by the TMD of syndecan family members.	[Kwon, Mi-Jung; Choi, Youngsil; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Res Ctr Cellular Homeostasis, Seoul 120750, South Korea; [Yun, Ji-Hye; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea	Ewha Womans University; Yonsei University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	OhES@ewha.ac.kr	LEE, WEON TAE/AAQ-9088-2021	Lee, Weontae/0000-0003-2347-1262	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2012R1A5A1048236, 2013R1A2A2A01013565]; Mid-career Researcher Program Grant through an NRF grant - Korean Ministry of Education, Science, and Technology (MEST) [NRF-2013R1A2A2A01068963]; Brain Korea Plus (BK+) grant	National Research Foundation of Korea (NRF) - Korean government (MSIP); Mid-career Researcher Program Grant through an NRF grant - Korean Ministry of Education, Science, and Technology (MEST); Brain Korea Plus (BK+) grant	This work was supported by National Research Foundation of Korea (NRF) Grants 2012R1A5A1048236 and 2013R1A2A2A01013565 (to E. S. O.) funded by the Korean government (MSIP) and Mid-career Researcher Program Grant NRF-2013R1A2A2A01068963 through an NRF grant funded by the Korean Ministry of Education, Science, and Technology (MEST) (to W. T. L.).; Recipient of a Brain Korea Plus (BK+) grant.	CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779; Carey DJ, 1997, BIOCHEM J, V327, P1; Chen LG, 2002, BIOCHEM J, V366, P481, DOI 10.1042/BJ20020711; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Choi Y, 2008, EUR J CELL BIOL, V87, P807, DOI 10.1016/j.ejcb.2008.04.005; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Dawson JP, 2003, J MOL BIOL, V331, P255, DOI 10.1016/S0022-2836(03)00714-9; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Hecker TP, 2002, CANCER RES, V62, P2699; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Johnson RM, 2007, BIOCHEMISTRY-US, V46, P9208, DOI 10.1021/bi7008773; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Melnyk RA, 2004, J BIOL CHEM, V279, P16591, DOI 10.1074/jbc.M313936200; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Schlesinger TK, 1999, BIOCHEM J, V344, P519, DOI 10.1042/0264-6021:3440519; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Unterreitmeier S, 2007, J MOL BIOL, V374, P705, DOI 10.1016/j.jmb.2007.09.056; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9	31	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5772	5782		10.1074/jbc.M114.599845	http://dx.doi.org/10.1074/jbc.M114.599845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25572401	Green Published, hybrid			2022-12-28	WOS:000350044200044
J	Lopez-Pelegrin, M; Ksiazek, M; Karim, AY; Guevara, T; Arolas, JL; Potempa, J; Gomis-Ruth, FX				Lopez-Pelegrin, Mar; Ksiazek, Miroslaw; Karim, Abdulkarim Y.; Guevara, Tibisay; Arolas, Joan L.; Potempa, Jan; Xavier Gomis-Rueth, F.			A Novel Mechanism of Latency in Matrix Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNAKE-VENOM METALLOPROTEINASES; ALPHA-CONVERTING ENZYME; CATALYTIC DOMAIN; CYSTEINE SWITCH; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION MECHANISMS; ACTIVE-SITE; FAMILY; INHIBITORS	The matrix metalloproteinases (MMPs) are a family of secreted soluble or membrane-anchored multimodular peptidases regularly found in several paralogous copies in animals and plants, where they have multiple functions. The minimal consensus domain architecture comprises a signal peptide, a 60-90-residue globular prodomain with a conserved sequence motif including a cysteine engaged in "cysteine-switch" or "Velcro" mediated latency, and a catalytic domain. Karilysin, from the human periodontopathogen Tannerella forsythia, is the only bacterial MMP to have been characterized biochemically to date. It shares with eukaryotic forms the catalytic domain but none of the flanking domains. Instead of the consensus MMP prodomain, it features a 14-residue propeptide, the shortest reported for a metallopeptidase, which lacks cysteines. Here we determined the structure of a prokarilysin fragment encompassing the propeptide and the catalytic domain, and found that the former runs across the cleft in the opposite direction to a bound substrate and inhibits the latter through an "aspartate-switch" mechanism. This finding is reminiscent of latency maintenance in the otherwise unrelated astacin and fragilysin metallopeptidase families. In addition, in vivo and biochemical assays showed that the propeptide contributes to protein folding and stability. Our analysis of prokarilysin reveals a novel mechanism of latency and activation in MMPs. Finally, our findings support the view that the karilysin catalytic domain was co-opted by competent bacteria through horizontal gene transfer from a eukaryotic source, and later evolved in a specific bacterial environment.	[Xavier Gomis-Rueth, F.] CSIC, Proteolysis Lab, Dept Biol Struct, Mol Biol Inst Barcelona, E-08028 Barcelona, Catalonia, Spain; [Ksiazek, Miroslaw; Karim, Abdulkarim Y.; Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Louisville, KY 40202 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Jagiellonian University; University of Louisville		jlacri@ibmb.csic.es; jan.potempa@louisville.edu; fxgr@ibmb.csic.es	Karim, Abdulkarim/M-8690-2019; Potempa, Jan/AAA-6850-2021	Karim, Abdulkarim/0000-0002-8829-9769; Lopez Arolas, Joan/0000-0002-4198-5016; Potempa, Jan/0000-0002-3600-7461; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Guevara Puig, Tibisay/0000-0002-1366-8507	ESRF; European Union [POIG.02.01.00-12-064/08]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761, R01DE022597] Funding Source: NIH RePORTER	ESRF; European Union(European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to the joint IBMB/IRB Automated Crystallography Platform for assistance during crystallization experiments and Robin Rycroft for very helpful contributions to the manuscript. We acknowledge the help provided by local contacts at the ESRF synchrotron. The clone for production of human rhinovirus 3C proteinase was a generous gift from Arie Gerlof (EMBL, Hamburg). Funding for data collection was provided in part by ESRF. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of structural funds from the European Union (POIG.02.01.00-12-064/08).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anderson MT, 2011, MBIO, V2, DOI 10.1128/mBio.00005-11; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Arolas J. L., 2013, ENCY METALLOPROTEINS, P2473, DOI DOI 10.1007/978-1-4614-1533-6_186; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Balaban NP, 2012, BIOCHEMISTRY-MOSCOW+, V77, P119, DOI 10.1134/S0006297912020010; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1979, NATURWISSENSCHAFTEN, V66, P251, DOI 10.1007/BF00571605; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cerda-Costa N, 2014, PROTEIN SCI, V23, P123, DOI 10.1002/pro.2400; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Cha JH, 1996, BIOCHEMISTRY-US, V35, P15831, DOI 10.1021/bi962085f; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOTHIA C, 1977, P NATL ACAD SCI USA, V74, P4130, DOI 10.1073/pnas.74.10.4130; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Das S, 2003, MOL CELL BIOCHEM, V253, P31, DOI 10.1023/A:1026093016148; Debreczeni JE, 2012, ACTA CRYSTALLOGR D, V68, P425, DOI 10.1107/S0907444912000200; Demidyuk IV, 2010, J BIOL CHEM, V285, P2003, DOI 10.1074/jbc.M109.015396; DESOUZA SJ, 1993, J MOL EVOL, V36, P596, DOI 10.1007/BF00556364; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; FOTOUHI N, 1994, J BIOL CHEM, V269, P30227; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Gomis-Ruth FX, 1998, PROTEIN SCI, V7, P283; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Gomis-Ruth FX., 2013, ENCY METALLOPROTEINS, P2345; GOMISRUTH FX, 1993, J MOL BIOL, V229, P945, DOI 10.1006/jmbi.1993.1098; GOMISRUTH FX, 1993, EMBO J, V12, P4151, DOI 10.1002/j.1460-2075.1993.tb06099.x; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Goulas T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112643; Goulas T, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P887, DOI 10.1016/B978-0-12-382219-2.00186-1; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Graef C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043863; GRAMS F, 1995, EUR J BIOCHEM, V228, P830, DOI 10.1111/j.1432-1033.1995.tb20329.x; GRAMS F, 1993, FEBS LETT, V335, P76, DOI 10.1016/0014-5793(93)80443-X; Guevara T, 2013, ACTA CRYSTALLOGR F, V69, P472, DOI 10.1107/S1744309113007392; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Jackson Brian C., 2010, Human Genomics, V4, P345; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karim AY, 2010, BIOL CHEM, V391, P105, DOI 10.1515/BC.2010.009; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Khan AR, 1998, PROTEIN SCI, V7, P815; Klein T, 2011, J PROTEOME RES, V10, P17, DOI 10.1021/pr100556z; Koziel J, 2010, J INNATE IMMUN, V2, P288, DOI 10.1159/000281881; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Marino G, 2012, PHYSIOL PLANTARUM, V145, P196, DOI 10.1111/j.1399-3054.2011.01544.x; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moncrief JS, 1998, INFECT IMMUN, V66, P1735, DOI 10.1128/IAI.66.4.1735-1739.1998; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MURPHY GJP, 1991, FEBS LETT, V289, P4, DOI 10.1016/0014-5793(91)80895-A; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Nagase H, 1997, BIOL CHEM, V378, P151; Ng N, 2013, ACTA CRYSTALLOGR F, V69, P912, DOI 10.1107/S1744309113018927; Ng NM, 2013, STRUCTURE, V21, P2003, DOI 10.1016/j.str.2013.08.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Potempa J, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P883, DOI 10.1016/B978-0-12-382219-2.00185-X; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; Rosenblum G, 2007, J AM CHEM SOC, V129, P13566, DOI 10.1021/ja073941l; Sang QXA, 1996, J PROTEIN CHEM, V15, P137, DOI 10.1007/BF01887395; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Skottrup PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048537; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; STETLERSTEVENSON WG, 1991, AM J MED SCI, V302, P163, DOI 10.1097/00000441-199109000-00009; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; STOCKER W, 1995, PROTEIN SCI, V4, P823; Stocker W., 2013, PROTEASES STRUCTURE, P235, DOI DOI 10.1007/978-3-7091-0885-7; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Takeda S, 2012, BBA-PROTEINS PROTEOM, V1824, P164, DOI 10.1016/j.bbapap.2011.04.009; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Waltersperger S, 2010, PROTEINS, V78, P2720, DOI 10.1002/prot.22777; Wetmore DR, 1996, BIOCHEMISTRY-US, V35, P6549, DOI 10.1021/bi9530752; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woessner J.F., 2000, PROTEIN PROFILE SER; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Gomis-Ruth FX, 2013, STRUCTURE, V21, P1909, DOI 10.1016/j.str.2013.10.004; Gomis-Ruth FX, 2012, BIOL CHEM, V393, P1027, DOI 10.1515/hsz-2012-0149; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yu ACY, 2012, STRUCTURE, V20, P707, DOI 10.1016/j.str.2012.02.015	109	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4728	4740		10.1074/jbc.M114.605956	http://dx.doi.org/10.1074/jbc.M114.605956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25555916	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000350042000016
J	Zhao, NN; Nizzi, CP; Anderson, SA; Wang, JH; Ueno, A; Tsukamoto, H; Eisenstein, RS; Enns, CA; Zhang, AS				Zhao, Ningning; Nizzi, Christopher P.; Anderson, Sheila A.; Wang, Jiaohong; Ueno, Akiko; Tsukamoto, Hidekazu; Eisenstein, Richard S.; Enns, Caroline A.; Zhang, An-Sheng			Low Intracellular Iron Increases the Stability of Matriptase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE TMPRSS6; HEPCIDIN EXPRESSION; JUVENILE HEMOCHROMATOSIS; REGULATORY PROTEINS; CELL-SURFACE; MITOCHONDRIAL ACONITASE; DOWN-REGULATION; HUMAN LIVER; RAT-LIVER; HEMOJUVELIN	Matriptase-2 (MT2) is a type II transmembrane serine protease that is predominantly expressed in hepatocytes. It suppresses the expression of hepatic hepcidin, an iron regulatory hormone, by cleaving membrane hemojuvelin into an inactive form. Hemojuvelin is a bone morphogenetic protein (BMP) co-receptor. Here, we report that MT2 is up-regulated under iron deprivation. In HepG2 cells stably expressing the coding sequence of the MT2 gene, TMPRSS6, incubation with apotransferrin or the membrane-impermeable iron chelator, deferoxamine mesylate salt, was able to increase MT2 levels. This increase did not result from the inhibition of MT2 shedding from the cells. Rather, studies using a membrane-permeable iron chelator, salicylaldehyde isonicotinoyl hydrazone, revealed that depletion of cellular iron was able to decrease the degradation of MT2 independently of internalization. We found that lack of the putative endocytosis motif in its cytoplasmic domain largely abolished the sensitivity of MT2 to iron depletion. Neither acute nor chronic iron deficiency was able to alter the association of Tmprss6 mRNA with polyribosomes in the liver of rats indicating a lack of translational regulation by low iron levels. Studies in mice showed that Tmprss6 mRNA was not regulated by iron nor the BMP-mediated signaling with no evident correlation with either Bmp6 mRNA or Id1 mRNA, a target of BMP signaling. These results suggest that regulation of MT2 occurs at the level of protein degradation rather than by changes in the rate of internalization and translational or transcriptional mechanisms and that the cytoplasmic domain of MT2 is necessary for its regulation.	[Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Nizzi, Christopher P.; Anderson, Sheila A.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Wang, Jiaohong; Ueno, Akiko; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Tsukamoto, Hidekazu] Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA 90073 USA	Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison; University of Southern California	Zhang, AS (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [DK080765, DK102791, DK054488, K99DK104066, DK066600, P50AA11199, R24AA12885]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066600, R56DK066600, K99DK104066, R01DK102791, R01DK072166, R01DK054488, R01DK080765, R37DK054488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080765 and DK102791 (to A. S. Z.), DK054488 (to C. A. E.), K99DK104066 (to N. Z.), DK066600 (to R. S. E.), P50AA11199 (to H. T.), and R24AA12885 (to H. T.).	Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Anthony TG, 2001, J NUTR, V131, P1171, DOI 10.1093/jn/131.4.1171; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; BAKER E, 1985, AM J PHYSIOL, V248, pG93, DOI 10.1152/ajpgi.1985.248.1.G93; Beliveau F, 2011, J BIOL CHEM, V286, P29035, DOI 10.1074/jbc.M111.223461; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chen OS, 1998, J NUTR, V128, P525, DOI 10.1093/jn/128.3.525; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060534; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Maurer E, 2013, BIOCHEM J, V450, P583, DOI 10.1042/BJ20121518; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2010, BLOOD, V116, P851, DOI 10.1182/blood-2010-04-278655; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Parr C, 2010, ANTI-CANCER AGENT ME, V10, P47, DOI 10.2174/1871520611009010047; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Young SP, 1997, FEBS LETT, V411, P93, DOI 10.1016/S0014-5793(97)00478-X; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	53	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4432	4446		10.1074/jbc.M114.611913	http://dx.doi.org/10.1074/jbc.M114.611913			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25550162	Green Published, hybrid			2022-12-28	WOS:000349458400050
J	Bourdin, B; Shakeri, B; Tetreault, MP; Sauve, R; Lesage, S; Parent, L				Bourdin, Benoite; Shakeri, Behzad; Tetreault, Marie-Philippe; Sauve, Remy; Lesage, Sylvie; Parent, Lucie			Functional Characterization of Ca-V alpha 2 delta Mutations Associated with Sudden Cardiac Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channel; Cardiac Muscle; Cardiovascular Disease; Flow Cytometry; Fluorescence; Patch Clamp	CALCIUM-CHANNEL GENE; SUBUNIT REGULATION; HEART-DISEASE; ION-CHANNEL; EXPRESSION; QT; ARRHYTHMIA; IDENTIFICATION; INACTIVATION; DISRUPTION	Background: Missense mutations in Ca(V)21, an auxiliary subunit of cardiac L-type Ca(V)1.2 channels, are associated with arrhythmias. Results: The reduction in the cell surface density of Ca(V)21 D550Y/Q917H was sufficient to impair Ca(V)1.2 currents. Conclusion: Defects in the cell surface trafficking of Ca(V)21 mutants down-regulate L-type currents. Significance:CACNA2D1 genetic variants may trigger arrhythmias by reducing L-type Ca2+ currents. L-type Ca2+ channels play a critical role in cardiac rhythmicity. These ion channels are oligomeric complexes formed by the pore-forming Ca(V)1 with the auxiliary Ca-V and Ca(V)2 subunits. Ca(V)2 increases the peak current density and improves the voltage-dependent activation gating of Ca(V)1.2 channels without increasing the surface expression of the Ca(V)1 subunit. The functional impact of genetic variants of CACNA2D1 (the gene encoding for Ca(V)2), associated with shorter repolarization QT intervals (the time interval between the Q and the T waves on the cardiac electrocardiogram), was investigated after recombinant expression of the full complement of L-type Ca(V)1.2 subunits in human embryonic kidney 293 cells. By performing side-by-side high resolution flow cytometry assays and whole-cell patch clamp recordings, we revealed that the surface density of the Ca(V)2 wild-type protein correlates with the peak current density. Furthermore, the cell surface density of Ca(V)2 mutants S755T, Q917H, and S956T was not significantly different from the cell surface density of the Ca(V)2 wild-type protein expressed under the same conditions. In contrast, the cell surface expression of Ca(V)2 D550Y, Ca(V)2 S709N, and the double mutant D550Y/Q917H was reduced, respectively, by approximate to 30-33% for the single mutants and by 60% for the latter. The cell surface density of D550Y/Q917H was more significantly impaired than protein stability, suggesting that surface trafficking of Ca(V)2 was disrupted by the double mutation. Co-expression with D550Y/Q917H significantly decreased Ca(V)1.2 currents as compared with results obtained with Ca(V)2 wild type. It is concluded that D550Y/Q917H reduced inward Ca2+ currents through a defect in the cell surface trafficking of Ca(V)2. Altogether, our results provide novel insight in the molecular mechanism underlying the modulation of Ca(V)1.2 currents by Ca(V)2.	[Bourdin, Benoite; Shakeri, Behzad; Tetreault, Marie-Philippe; Sauve, Remy; Parent, Lucie] Univ Montreal, Dept Physiol, Montreal Heart Inst, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Lesage, Sylvie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Ctr Rech, Hop Maisonneuve Rosemont, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Physiol, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca		Lesage, Sylvie/0000-0002-0968-2795	Canadian Institutes of Health Research [130256]; Canadian Heart and Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Operating Grant 130256 from the Canadian Institutes of Health Research and a grant from the Canadian Heart and Stroke Foundation (to L. P.).	Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cerrone M, 2012, CURR OPIN CARDIOL, V27, P242, DOI 10.1097/HCO.0b013e328352429d; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Depil K, 2011, J BIOL CHEM, V286, P31557, DOI 10.1074/jbc.M111.255273; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gaborit N, 2005, CIRCULATION, V112, P471, DOI 10.1161/CIRCULATIONAHA.104.506857; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gillis J, 2012, AM J MED GENET A, V158A, P182, DOI 10.1002/ajmg.a.34355; Gyoerke S, 2007, J CLIN INVEST, V117, P1758, DOI 10.1172/JCI32496; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Platano D, 2000, BIOPHYS J, V78, P2959, DOI 10.1016/S0006-3495(00)76835-4; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosati B, 2011, J PHYSIOL-LONDON, V589, P3275, DOI 10.1113/jphysiol.2011.210237; Rosati B, 2008, PHYSIOL GENOMICS, V35, P262, DOI 10.1152/physiolgenomics.00159.2007; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Sivagangabalan G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082179; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Templin C, 2011, EUR HEART J, V32, P1077, DOI 10.1093/eurheartj/ehr076; Tester David J, 2014, Methodist Debakey Cardiovasc J, V10, P29; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Wilde AAM, 2010, HEART RHYTHM, V7, P1883, DOI 10.1016/j.hrthm.2010.10.008; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	45	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2854	2869		10.1074/jbc.M114.597930	http://dx.doi.org/10.1074/jbc.M114.597930			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527503	Green Published, hybrid			2022-12-28	WOS:000349310700026
J	Lee, SH; Johnson, D; Luong, R; Sun, ZJ				Lee, Suk Hyung; Johnson, Daniel; Luong, Richard; Sun, Zijie			Crosstalking between Androgen and PI3K/AKT Signaling Pathways in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Androgen; Androgen Receptor; Mouse; Phosphatidylinositide 3-Kinase (PI 3-kinase); Prostate Cancer	TUMOR-SUPPRESSOR GENE; MOUSE PROSTATE; EARLY-ONSET; C-MET; PTEN; RECEPTOR; CASTRATION; EXPRESSION; DELETION; PTEN/MMAC1	Background: An interaction between androgen and PI3K/AKT pathways has been implicated in prostate cancer cells. Results: Conditional expression of AR transgene represses PI3K/Akt activation, and Pten loss results in reduced AR expression and transcriptional activity. Conclusion: Both androgen and PI3K/AKT pathways inversely regulate each other in prostate cancer cells. Significance: Interplay between androgen and PI3K/AKT pathways may directly contribute to prostate tumorigenesis. Both androgen action and PI3K medicated signaling pathways have been implicated in prostate tumorigenesis. Our androgen receptor (AR) conditional transgenic mice developed murine prostatic intraepithelial neoplasia (mPIN) and prostatic adenocarcinoma lesions recapitulating human prostate cancer development and progression. Role of transgenic AR contributing to malignancy was demonstrated by high degree of transgenic AR expression in atypical and tumor cells in mPIN as well as prostatic adenocarcinoma lesions of the transgenic mice, but not in adjacent normal tissue. Interestingly, reduced PI3K/Akt activation also appeared in these mouse atypical and tumor cells, suggesting an interaction between androgen and PI3K/AKT pathways. In this study, we further investigated this interaction. We showed that the androgen depletion or knockdown of AR expression results in elevated levels of active phosphorylated AKT in prostate cancer cells. Castration of conditional Pten knock-out mice showed increased Akt, phosphorylated Akt, and pS6 expression in the mouse prostate. Using a series of newly generated Ar reporter and Pten knock-out compound mice, we showed that Pten loss directly represses endogenous Ar expression in prostatic epithelial cells. Moreover, Pten loss and PI3K/Akt activation reduced Ar-mediated transcription in purified Pten-null cells. This study provides novel evidence demonstrating interplay between androgen and PI3K pathways, as well as introduces unique and relevant mouse models for further studies of PI3K and AR pathways in the context of prostate tumorigenesis.	[Lee, Suk Hyung; Johnson, Daniel; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, S287,Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	National Cancer Institute [R01CA070297, R01CA151623, U01CA166894, R21CA190021]; NATIONAL CANCER INSTITUTE [R01CA070297, P30CA124435, R01CA151623, R21CA190021, U01CA166894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grants R01CA070297, R01CA151623, U01CA166894, and R21CA190021 from the National Cancer Institute.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cairns P, 1997, CANCER RES, V57, P4997; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Johnson DT, 2013, J BIOL CHEM, V288, P3727, DOI 10.1074/jbc.M112.417568; Koivisto P, 1997, CANCER RES, V57, P314; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Sullivan W. P., 1992, J STEROID BIOCHEM, V43, P37; Suzuki H, 1998, CANCER RES, V58, P204; THALMANN GN, 1994, CANCER RES, V54, P2577; Tu WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-556; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	44	56	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2759	2768		10.1074/jbc.M114.607846	http://dx.doi.org/10.1074/jbc.M114.607846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25527506	Green Published, hybrid			2022-12-28	WOS:000349310700018
J	Ohara, K; Fukuda, T; Okada, H; Kitao, S; Ishida, Y; Kato, K; Takahashi, C; Katayama, M; Uchida, K; Tominaga, M				Ohara, Kazuaki; Fukuda, Takafumi; Okada, Hiroyuki; Kitao, Sayoko; Ishida, Yuko; Kato, Kyoko; Takahashi, Chika; Katayama, Mikio; Uchida, Kunitoshi; Tominaga, Makoto			Identification of Significant Amino Acids in Multiple Transmembrane Domains of Human Transient Receptor Potential Ankyrin 1 (TRPA1) for Activation by Eudesmol, an Oxygenized Sesquiterpene in Hop Essential Oil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channel; Mutagenesis; Natural Product; Terpenoid; Transient Receptor Potential Channels (TRP Channels)	ODOR-ACTIVE COMPOUNDS; HUMULUS-LUPULUS L.; TYROSINE RESIDUES; COVALENT MODIFICATION; CHANNELS; SENSITIVITY; MENTHOL; BEER; DETERMINANTS; VARIETIES	Background: Transient receptor potential ankyrin 1 (TRPA1) is activated by many spicy compounds by unknown mechanisms. Results: The amino acids critical for the activation of TRPA1 by the hop-derived sesquiterpene -eudesmol were identified. Conclusion: Multiple transmembrane domains are crucial for -eudesmol-derived TRPA1 activation. Significance: New insight for activation mechanism of TRPA1 is revealed by our study. Transient receptor potential ankyrin 1 (TRPA1) is a calcium-permeable non-selective cation channel that is activated by various noxious or irritant substances in nature, including spicy compounds. Many TRPA1 chemical activators have been reported; however, only limited information is available regarding the amino acid residues that contribute to the activation by non-electrophilic activators, whereas activation mechanisms by electrophilic ligands have been well characterized. We used intracellular Ca2+ measurements and whole-cell patch clamp recordings to show that eudesmol, an oxygenated sesquiterpene present at high concentrations in the essential oil of hop cultivar Hallertau Hersbrucker, could activate human TRPA1. Gradual activation of inward currents with outward rectification by eudesmol was observed in human embryonic kidney-derived 293 cells expressing human TRPA1. This activation was completely blocked by a TRPA1-specific inhibitor, HC03-0031. We identified three critical amino acid residues in human TRPA1 in putative transmembrane domains 3, 4, and 5, namely threonine at 813, tyrosine at 840, and serine at 873, for activation by -eudesmol in a systematic mutational study. Our results revealed a new TRPA1 activator in hop essential oil and provide a novel insight into mechanisms of human TRPA1 activation by non-electrophilic chemicals.	[Ohara, Kazuaki; Fukuda, Takafumi; Okada, Hiroyuki; Kitao, Sayoko; Ishida, Yuko; Kato, Kyoko; Takahashi, Chika; Katayama, Mikio] Krin Co Ltd, Res Lab Hlth Sci & Food Technol, Yokohama, Kanagawa 2360004, Japan; [Uchida, Kunitoshi; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Ohara, K (corresponding author), Krin Co Ltd, Res Lab Hlth Sci & Food Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Kazuaki_Ohara@kirin.co.jp						Amin J, 1997, MOL PHARMACOL, V51, P833, DOI 10.1124/mol.51.5.833; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; des Gachons CP, 2011, J NEUROSCI, V31, P999, DOI 10.1523/JNEUROSCI.1374-10.2011; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Eyres GT, 2007, J AGR FOOD CHEM, V55, P6252, DOI 10.1021/jf070739t; Goiris K, 2002, J I BREWING, V108, P86, DOI 10.1002/j.2050-0416.2002.tb00129.x; Gros J, 2012, J AGR FOOD CHEM, V60, P7805, DOI 10.1021/jf301478m; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kishimoto T, 2005, J AGR FOOD CHEM, V53, P4701, DOI 10.1021/jf050072f; Kishimoto T, 2006, J AGR FOOD CHEM, V54, P8855, DOI 10.1021/jf061342c; Komatsu T, 2012, PFLUG ARCH EUR J PHY, V463, P549, DOI 10.1007/s00424-011-1069-4; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Lummis SCR, 2012, ACS CHEM NEUROSCI, V3, P186, DOI 10.1021/cn200103n; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Nagatomo K, 2010, BIOPHYS J, V99, P3609, DOI 10.1016/j.bpj.2010.10.014; Nilius B, 2013, REV PHYSIOL BIOCH P, V164, P1, DOI 10.1007/112_2013_11; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Price KL, 2004, J BIOL CHEM, V279, P23294, DOI 10.1074/jbc.M314075200; Saito S, 2014, MOL BIOL EVOL, V31, P708, DOI 10.1093/molbev/msu001; Steinberg X, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00171; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takaishi M, 2014, J PHYSIOL SCI, V64, P47, DOI 10.1007/s12576-013-0289-0; Takoi K, 2009, J AGR FOOD CHEM, V57, P2493, DOI 10.1021/jf8034622; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692	32	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3161	3171		10.1074/jbc.M114.600932	http://dx.doi.org/10.1074/jbc.M114.600932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25525269	Green Published, hybrid			2022-12-28	WOS:000349310700050
J	Song, GJ; Leslie, KL; Barrick, S; Mamonova, T; Fitzpatrick, JM; Drombosky, KW; Peyser, N; Wang, B; Pellegrini, M; Bauer, PM; Friedman, PA; Mierke, DF; Bisello, A				Song, Gyun Jee; Leslie, Kristen L.; Barrick, Stacey; Mamonova, Tatyana; Fitzpatrick, Jeremy M.; Drombosky, Kenneth W.; Peyser, Noah; Wang, Bin; Pellegrini, Maria; Bauer, Philip M.; Friedman, Peter A.; Mierke, Dale F.; Bisello, Alessandro			Phosphorylation of Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) by Akt Promotes Stability and Mitogenic Function of S-phase Kinase-associated Protein-2 (Skp2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Cell Proliferation; PDZ Domain; Phosphorylation; Vascular Smooth Muscle Cells; EBP50; Skp2; nherf; nherf1	MUSCLE-CELL PROLIFERATION; UBIQUITIN-MEDIATED DEGRADATION; SUBCELLULAR-LOCALIZATION; CYTOPLASMIC LOCALIZATION; DEPENDENT REGULATION; NEOINTIMA FORMATION; LIGASE; RECEPTOR; COMPLEX; CYCLE	Background: The PDZ scaffolding protein EBP50 promotes Akt-dependent cell proliferation through the S-phase kinase associated protein-2 Skp2. Results: Akt phosphorylates threonine 156 of EBP50, allosterically promoting the binding of Skp2 to the first PDZ domain of EBP50. Conclusion: The interaction with EBP50 regulates the localization and stability of Skp2 and promotes cell proliferation. Significance: These studies define a regulatory mechanism contributing to Akt-dependent cell proliferation. The regulation of the cell cycle by the ubiquitin-proteasome system is dependent on the activity of E3 ligases. Skp2 (S-phase kinase associated protein-2) is the substrate recognition subunit of the E3 ligase that ubiquitylates the cell cycle inhibitors p21(cip1) and p27(kip1) thus promoting cell cycle progression. Increased expression of Skp2 is frequently observed in diseases characterized by excessive cell proliferation, such as cancer and neointima hyperplasia. The stability and cellular localization of Skp2 are regulated by Akt, but the molecular mechanisms underlying these effects remain only partly understood. The scaffolding protein Ezrin-Binding Phosphoprotein of 50 kDa (EBP50) contains two PDZ domains and plays a critical role in the development of neointimal hyperplasia. Here we report that EBP50 directly binds Skp2 via its first PDZ domain. Moreover, EBP50 is phosphorylated by Akt on Thr-156 within the second PDZ domain, an event that allosterically promotes binding to Skp2. The interaction with EBP50 causes cytoplasmic localization of Skp2, increases Skp2 stability and promotes proliferation of primary vascular smooth muscle cells. Collectively, these studies define a novel regulatory mechanism contributing to aberrant cell growth and highlight the importance of scaffolding function of EBP50 in Akt-dependent cell proliferation.	[Song, Gyun Jee; Leslie, Kristen L.; Barrick, Stacey; Mamonova, Tatyana; Drombosky, Kenneth W.; Peyser, Noah; Wang, Bin; Friedman, Peter A.; Bisello, Alessandro] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Song, Gyun Jee] Kungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol, Taegu 702701, South Korea; [Pellegrini, Maria; Mierke, Dale F.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College	Bisello, A (corresponding author), Univ Pittsburgh, Sch Med, E1358 BST,200 Lothrop St, Pittsburgh, PA 15260 USA.	alb138@pitt.edu	Barrick, Stacey/J-1595-2015; Pellegrini, Maria/W-6005-2019	Pellegrini, Maria/0000-0003-3817-4412; Wang, Bin/0000-0002-5396-6111; Peyser, Noah/0000-0003-4529-8325; Barrick, Stacey/0000-0002-4837-3741	National Institutes of Health [S10 RR-025085, R01-DK069998, UL1 RR024153, UL1TR000005]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2061607]; Pilot Project Program in Hemostasis and Vascular Biology; Institute for Transfusion Medicine; Hemophilia Society of Western Pennsylvania; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Pilot Project Program in Hemostasis and Vascular Biology; Institute for Transfusion Medicine; Hemophilia Society of Western Pennsylvania; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants S10 RR-025085 (to D. F. M.) and R01-DK069998 (to P. A. F.), and by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education [2013R1A1A2061607]. This work was also supported by a Pilot Project Program in Hemostasis and Vascular Biology (to A. B.) supported by grants from the Institute for Transfusion Medicine and the Hemophilia Society of Western Pennsylvania and the National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005.	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Bond M, 2006, CARDIOVASC RES, V69, P198, DOI 10.1016/j.cardiores.2005.08.020; Bond M, 2004, J BIOL CHEM, V279, P37304, DOI 10.1074/jbc.M404307200; Bond M, 2011, FRONT BIOSCI-LANDMRK, V16, P1517, DOI 10.2741/3802; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hershko A, 2005, ANGEW CHEM INT EDIT, V44, P5932, DOI 10.1002/anie.200501724; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Leslie KL, 2013, J BIOL CHEM, V288, P36426, DOI 10.1074/jbc.M113.483339; Li JQ, 2004, INT J ONCOL, V25, P87; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Shigemasa K, 2003, CLIN CANCER RES, V9, P1756; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Song GJ, 2012, J MOL CELL CARDIOL, V53, P809, DOI 10.1016/j.yjmcc.2012.08.022; Song GJ, 2012, ARTERIOSCL THROM VAS, V32, P33, DOI 10.1161/ATVBAHA.111.235200; Song GJ, 2010, J MOL CELL CARDIOL, V49, P1012, DOI 10.1016/j.yjmcc.2010.08.025; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang HB, 2010, CELL CYCLE, V9, P1021, DOI 10.4161/cc.9.5.10916; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Wu YJ, 2006, CIRC RES, V98, P1141, DOI 10.1161/01.RES.0000219905.16312.28; Wu YJ, 2009, J VASC SURG, V50, P1135, DOI 10.1016/j.jvs.2009.07.066; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200; Zhu CQ, 2004, CLIN CANCER RES, V10, P1984, DOI 10.1158/1078-0432.CCR-03-0470	38	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2879	2887		10.1074/jbc.M114.609768	http://dx.doi.org/10.1074/jbc.M114.609768			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25492869	Green Published, hybrid			2022-12-28	WOS:000349310700028
J	Zhong, WB; Qin, SY; Zhu, BY; Pu, MS; Liu, FP; Wang, L; Ye, GL; Yi, Q; Yan, DG				Zhong, Wenbin; Qin, Shengying; Zhu, Biying; Pu, Miaoshui; Liu, Fupei; Wang, Lin; Ye, Guilin; Yi, Qing; Yan, Daoguang			Oxysterol-binding Protein-related Protein 8 (ORP8) Increases Sensitivity of Hepatocellular Carcinoma Cells to Fas-Mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN HEPATOMA-CELLS; ENDOPLASMIC-RETICULUM; LIGAND EXPRESSION; ACTIVATION; LIVER; CHOLESTEROL; MECHANISM; CANCER; INITIATION-FACTOR-2	Human hepatoma (HCC) has been reported to be strongly resistant to Fas-mediated apoptosis. However, the underlying mechanisms are poorly understood. In this study the function of oxysterol-binding protein-related protein 8 (ORP8) in human hepatoma cells apoptosis was assessed. We found that ORP8 is down-regulated, whereas miR-143, which controls ORP8 expression, is up-regulated in clinical HCC tissues as compared with liver tissue from healthy subjects. ORP8 overexpression triggered apoptosis in primary HCC cells and cell lines, which coincided with a relocation of cytoplasmic Fas to the cell plasma membrane and FasL up-regulation. Co-culture of HepG2 cells or primary HCC cells with Jurkat T-cells or T-cells, respectively, provided further evidence that ORP8 increases HCC cell sensitivity to Fas-mediated apoptosis. ORP8-induced Fas translocation is p53-dependent, and FasL was induced upon ORP8 overexpression via the endoplasmic reticulum stress response. Moreover, ORP8 overexpression and miR-143 inhibition markedly inhibited tumor growth in a HepG2 cell xenograft model. These results indicate that ORP8 induces HCC cell apoptosis through the Fas/FasL pathway. The role of ORP8 in Fas translocation to the plasma membrane and its down-regulation by miR-143 offer a putative mechanistic explanation for HCC resistance to apoptosis. ORP8 may be a potential target for HCC therapy.	[Zhong, Wenbin; Qin, Shengying; Zhu, Biying; Liu, Fupei; Wang, Lin; Ye, Guilin; Yan, Daoguang] Jinan Univ, Guangdong Higher Educ Inst, Key Lab Funct Prot Res, Guangzhou 510632, Guangdong, Peoples R China; [Zhong, Wenbin; Qin, Shengying; Zhu, Biying; Liu, Fupei; Wang, Lin; Ye, Guilin; Yan, Daoguang] Jinan Univ, Dept Biotechnol, Guangzhou 510632, Guangdong, Peoples R China; [Pu, Miaoshui] Guangzhou Gen Hosp, Dept Hepatobiliary Surg, Guangzhou 510010, Guangdong, Peoples R China; [Yi, Qing] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Jinan University; Jinan University; Cleveland Clinic Foundation	Yan, DG (corresponding author), Guangdong Higher Educ Inst, Key Lab Funct Prot Res, Guangzhou 510632, Guangdong, Peoples R China.	tydg@jnu.edu.cn		Zhu, Biying/0000-0003-2358-2739	NSFC (National Natural Science Foundation of China), China [91439122, 30971104]; National Basic Research Program of China [2012CB517502]; Fundamental Research Funds for the Central Universities, China [21610609]	NSFC (National Natural Science Foundation of China), China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the NSFC (National Natural Science Foundation of China), China (91439122 and 30971104 (to D. Y.)), the National Basic Research Program of China (2012CB517502 (to D. Y.), and Fundamental Research Funds for the Central Universities, China (21610609 (to D. Y.)).	Beaslas O, 2012, EXP CELL RES, V318, P1933, DOI 10.1016/j.yexcr.2012.05.026; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DESSI S, 1994, CANCER, V73, P253, DOI 10.1002/1097-0142(19940115)73:2<253::AID-CNCR2820730204>3.0.CO;2-F; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; ELKHATIB M, 1995, CELL IMMUNOL, V163, P237, DOI 10.1006/cimm.1995.1122; Faubion WA, 1999, HEPATOLOGY, V29, P1, DOI 10.1002/hep.510290101; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Higaki K, 1996, AM J PATHOL, V149, P429; Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0; Ito Y, 2000, BRIT J CANCER, V82, P1211; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lowin B, 1996, INT IMMUNOL, V8, P57, DOI 10.1093/intimm/8.1.57; NATOLI G, 1995, ONCOGENE, V11, P1157; Ogawa K, 2004, J HEPATOL, V40, P278, DOI 10.1016/j.jhep.2003.09.021; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Trakooljul N, 2010, ANIM GENET, V41, P357, DOI 10.1111/j.1365-2052.2009.02015.x; Wang XD, 2005, HEPATOLOGY, V42, P400, DOI 10.1002/hep.20792; Wang XD, 2007, FREE RADICAL BIO MED, V42, P971, DOI 10.1016/j.freeradbiomed.2006.12.023; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yano H, 1996, J HEPATOL, V25, P454, DOI 10.1016/S0168-8278(96)80204-2; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhao X, 2012, SCI CHINA LIFE SCI, V55, P906, DOI 10.1007/s11427-012-4384-x; Zhong WB, 2014, EXP CELL RES, V322, P227, DOI 10.1016/j.yexcr.2014.01.002; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078	33	31	34	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8876	8887		10.1074/jbc.M114.610188	http://dx.doi.org/10.1074/jbc.M114.610188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25596532	Green Published, hybrid			2022-12-28	WOS:000352207100016
J	Almeida, MT; Mesquita, FS; Cruz, R; Osorio, H; Custodio, R; Brito, C; Vingadassalom, D; Martins, M; Leong, JM; Holden, DW; Cabanes, D; Sousa, S				Almeida, Maria Teresa; Mesquita, Francisco S.; Cruz, Rui; Osorio, Hugo; Custodio, Rafael; Brito, Claudia; Vingadassalom, Didier; Martins, Mariana; Leong, John M.; Holden, David W.; Cabanes, Didier; Sousa, Sandra			Src-dependent Tyrosine Phosphorylation of Non-muscle Myosin Heavy Chain-IIA Restricts Listeria monocytogenes Cellular Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; PHOSPHOINOSITIDE 3-KINASE; MEDIATED INTERNALIZATION; MAMMALIAN-CELLS; MET RECEPTOR; C-SRC; ACTIN; ADHESION; KINASE; VIRULENCE	Bacterial pathogens often interfere with host tyrosine phosphorylation cascades to control host responses and cause infection. Given the role of tyrosine phosphorylation events in different human infections and our previous results showing the activation of the tyrosine kinase Src upon incubation of cells with Listeria monocytogenes, we searched for novel host proteins undergoing tyrosine phosphorylation upon L. monocytogenes infection. We identify the heavy chain of the non-muscle myosin IIA (NMHC-IIA) as being phosphorylated in a specific tyrosine residue in response to L. monocytogenes infection. We characterize this novel post-translational modification event and show that, upon L. monocytogenes infection, Src phosphor-ylates NMHC-IIA in a previously uncharacterized tyrosine residue (Tyr-158) located in its motor domain near the ATP-binding site. In addition, we found that other intracellular and extracellular bacterial pathogens trigger NMHC-IIA tyrosine phosphorylation. Wedemonstrate that NMHC-IIA limits intracellular levels of L. monocytogenes, and this is dependent on the phosphorylation of Tyr-158. Our data suggest a novel mechanism of regulation of NMHC-IIA activity relying on the phosphorylation of Tyr-158 by Src.	[Almeida, Maria Teresa; Mesquita, Francisco S.; Cruz, Rui; Osorio, Hugo; Custodio, Rafael; Brito, Claudia; Martins, Mariana; Cabanes, Didier; Sousa, Sandra] Univ Porto, Inst Invest & Inovacao Saude, P-4200 Oporto, Portugal; [Almeida, Maria Teresa; Mesquita, Francisco S.; Cruz, Rui; Custodio, Rafael; Brito, Claudia; Martins, Mariana; Cabanes, Didier; Sousa, Sandra] Univ Porto, Inst Biol Mol & Celular, Grp Mol Microbiol, P-4150180 Oporto, Portugal; [Almeida, Maria Teresa; Cruz, Rui; Brito, Claudia] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal; [Mesquita, Francisco S.; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Bacteriol & Infect, MRC, London SW7 2AZ, England; [Osorio, Hugo] Univ Porto, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; [Vingadassalom, Didier; Leong, John M.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Imperial College London; Universidade do Porto; University of Massachusetts System; University of Massachusetts Worcester	Cabanes, D (corresponding author), Inst Biol Mol & Celular, Grp Mol Microbiol, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	didier@ibmc.up.pt; srsousa@ibmc.up.pt	Brito, Cláudia/Y-3145-2019; Mesquita, Francisco/AAF-7557-2019; Sousa, Sandra/K-3934-2013; Sousa, Sandra/P-2133-2019; Cabanes, Didier/P-3052-2019; da Silva e Cruz, Rui Filipe/W-1359-2017; Brito, Cláudia/A-3347-2016; Osorio, Hugo/A-7847-2012; Cabanes, Didier/K-3917-2013; Martins, M. Cristina/J-8284-2013	Brito, Cláudia/0000-0002-2320-7747; Mesquita, Francisco/0000-0002-3777-825X; Sousa, Sandra/0000-0001-8578-0461; Sousa, Sandra/0000-0001-8578-0461; Cabanes, Didier/0000-0002-4001-1332; da Silva e Cruz, Rui Filipe/0000-0001-7453-3756; Brito, Cláudia/0000-0002-2320-7747; Osorio, Hugo/0000-0002-6362-8255; Cabanes, Didier/0000-0002-4001-1332; Martins, M. Cristina/0000-0002-6574-4794; Holden, David/0000-0002-8369-5105; Martins, Mariana/0000-0002-5677-7068	Fundo Europeu de Desenvolvimento Regional (FEDER) through the Operational Competitiveness Programme (COMPETE); National Funds through Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BCM/100088/2008FCOMP-01-0124-FEDER-008860, ERANet-Pathogenomics LISTRESS ERA-PTG/0003/2010, NORTE-07-0124-FEDER-000002-Host-Pathogen Interactions]; Programa Operacional Regional do Norte (ON.2-O Novo Norte) under the Quadro de Referencia Estrategico Nacional, through FEDER; FCT; European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Boehringer Ingelheim Fonds; Fundacao para a Ciencia e Tecnologia [BD/43352/2008, BD/90607/2012]; EMBO Long Term Post-doctoral Fellowship [EMBO ALTF 864-2012]; Ciencia; MRC [MR/J006874/1] Funding Source: UKRI; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/100088/2008, ERA-PTG/0003/2010] Funding Source: FCT	Fundo Europeu de Desenvolvimento Regional (FEDER) through the Operational Competitiveness Programme (COMPETE); National Funds through Fundacao para a Ciencia e Tecnologia (FCT); Programa Operacional Regional do Norte (ON.2-O Novo Norte) under the Quadro de Referencia Estrategico Nacional, through FEDER; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO Long Term Post-doctoral Fellowship(European Molecular Biology Organization (EMBO)); Ciencia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundação para a Ciência e a Tecnologia	This work was supported by the Fundo Europeu de Desenvolvimento Regional (FEDER) through the Operational Competitiveness Programme (COMPETE), by National Funds through Fundacao para a Ciencia e Tecnologia (FCT) under Project PTDC/BIA-BCM/100088/2008FCOMP-01-0124-FEDER-008860 and ERANet-Pathogenomics LISTRESS ERA-PTG/0003/2010, Project NORTE-07-0124-FEDER-000002-Host-Pathogen Interactions, co-funded by Programa Operacional Regional do Norte (ON.2-O Novo Norte), under the Quadro de Referencia Estrategico Nacional, through FEDER, by FCT, and by a Research Grant 2014 by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (to S. S.). M. T. A. received a Travel Grant from Boehringer Ingelheim Fonds.; Recipients of Fundacao para a Ciencia e Tecnologia Doctoral Fellowships BD/43352/2008 and BD/90607/2012.; Recipient of EMBO Long Term Post-doctoral Fellowship EMBO ALTF 864-2012.; Supported by Ciencia 2008 and FCT Investigator Programs COMPETE, POPH, and FCT. To whom correspondence may be addressed: Group of Molecular Microbiology, Instituto de Biologia Molecular e Celular, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. Tel.: 351226074907; Fax: 351226099157; E-mail: srsousa@ibmc.up.pt.	Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Barfod ET, 2011, MOL BIOL CELL, V22, P634, DOI 10.1091/mbc.E10-06-0514; Barfod ET, 2005, J BIOL CHEM, V280, P25548, DOI 10.1074/jbc.M411717200; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Bonazzi M, 2008, CELL MICROBIOL, V10, P2208, DOI 10.1111/j.1462-5822.2008.01200.x; Bonazzi M, 2011, J CELL BIOL, V195, P525, DOI 10.1083/jcb.201105152; Bruce-Staskal PJ, 2002, J CELL SCI, V115, P2689; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; Campellone KG, 2007, MOL MICROBIOL, V63, P1468, DOI 10.1111/j.1365-2958.2007.05602.x; Chakraborty S, 2012, P NATL ACAD SCI USA, V109, pE1163, DOI 10.1073/pnas.1119592109; Chandran B, 2010, J VIROL, V84, P2188, DOI 10.1128/JVI.01334-09; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hanisch J, 2011, CELL HOST MICROBE, V9, P273, DOI 10.1016/j.chom.2011.03.009; Harney DF, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-12; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0; Kirchner M, 2008, MOL MICROBIOL, V68, P749, DOI 10.1111/j.1365-2958.2008.06188.x; Kuhbacher A, 2012, J BIOL CHEM, V287, P13128, DOI 10.1074/jbc.M111.315788; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Odendall C, 2012, CELL HOST MICROBE, V12, P657, DOI 10.1016/j.chom.2012.09.011; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Osorio Hugo, 2013, Methods Mol Biol, V1007, P301, DOI 10.1007/978-1-62703-392-3_13; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Rajabian T, 2009, NAT CELL BIOL, V11, P1212, DOI 10.1038/ncb1964; Reis O, 2010, J INFECT DIS, V202, P551, DOI 10.1086/654880; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosado LAR, 2011, J CELL SCI, V124, P483, DOI 10.1242/jcs.074211; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Veettil MV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001238; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wasylnka JA, 2008, INFECT IMMUN, V76, P2722, DOI 10.1128/IAI.00152-08; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; WILSON LK, 1989, MOL CELL BIOL, V9, P1536, DOI 10.1128/MCB.9.4.1536	56	10	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8383	8395		10.1074/jbc.M114.591313	http://dx.doi.org/10.1074/jbc.M114.591313			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25635050	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000351662600032
J	King, SM; Patel-King, RS				King, Stephen M.; Patel-King, Ramila S.			The Oligomeric Outer Dynein Arm Assembly Factor CCDC103 Is Tightly Integrated within the Ciliary Axoneme and Exhibits Periodic Binding to Microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Motility; Chlamydomonas; Cilia; Dynein; Microtubule; Flagella	DOCKING COMPLEX; MUTATIONAL ANALYSIS; INTERMEDIATE CHAIN; PROTEIN; SUBUNIT; MECHANISMS; DYSKINESIA; INTERACTS; DEFECTS; DISEASE	Background: CCDC103 is necessary for the assembly of outer dynein arms on ciliary microtubules. Results: CCDC103 is arrayed along the axoneme, self-assembles, and binds microtubules with a 12-nm periodicity. Conclusion: CCDC103 is an integral component of the axoneme that underlies dynein assembly. Significance: Defining how dynein arms are incorporated is necessary to understand the complex patterning of motile cilia. CCDC103 is an approximate to 29-kDa protein consisting of a central RPAP3_C domain flanked by N- and C-terminal coiled coils. Defects in CCDC103 lead to primary ciliary dyskinesia caused by the loss of outer dynein arms. This protein is present along the entire length of the ciliary axoneme and does not require other dynein or docking complex components for its integration. Unlike other known dynein assembly factors within the axoneme, CCDC103 is not solubilized by 0.6 m NaCl and requires more chaotropic conditions, such as 0.5 m KI. Alternatively, it can be extracted using 0.3% sarkosyl. CCDC103 forms stable dimers and other oligomers in solution through interactions involving the central domain. The smallest particle observed by dynamic light scattering has a hydrodynamic diameter of approximate to 25 nm. Furthermore, CCDC103 binds microtubules directly, forming approximate to 9-nm diameter particles that exhibit a 12-nm spacing on the microtubule lattice, suggesting that there may be two CCDC103 units per outer arm dynein repeat. Although the outer dynein arm docking complex is necessary to form arrays of dyneins along microtubules, it is not sufficient to set up a single array in a precise location on each axonemal doublet. We propose that CCDC103 helps generate a high-affinity site on the doublets for outer arm assembly, either through direct interactions or indirectly, perhaps by modifying the underlying microtubule lattice.	[King, Stephen M.; Patel-King, Ramila S.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [King, Stephen M.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Patel-King, RS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, 263 Farmington Ave, Farmington, CT 06030 USA.	king@uchc.edu			National Institutes of Health [GM051293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant GM051293.	Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Casey DM, 2003, MOL BIOL CELL, V14, P3650, DOI 10.1091/mbc.E03-01-0057; Dean AB, 2013, MOL BIOL CELL, V24, P3689, DOI 10.1091/mbc.E13-06-0310; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; HAIMO LT, 1988, CELL MOTIL CYTOSKEL, V9, P129, DOI 10.1002/cm.970090205; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; HOOPS HJ, 1983, J CELL BIOL, V97, P902, DOI 10.1083/jcb.97.3.902; Inoue M, 2010, BIOCHEM BIOPH RES CO, V403, P340, DOI 10.1016/j.bbrc.2010.11.031; Itsuki Y, 2008, FEBS LETT, V582, P2365, DOI 10.1016/j.febslet.2008.05.041; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; KING SM, 1995, METHOD CELL BIOL, V47, P9, DOI 10.1016/S0091-679X(08)60783-9; KING SM, 1986, METHOD ENZYMOL, V134, P291; KING SM, 1991, J BIOL CHEM, V266, P8401; King SM, 2012, DYNEINS: STRUCTURE, BIOLOGY AND DISEASE, P209, DOI 10.1016/B978-0-12-382004-4.10007-X; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Owa M, 2014, P NATL ACAD SCI USA, V111, P9461, DOI 10.1073/pnas.1403101111; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rompolas P, 2012, MOL BIOL CELL, V23, P3554, DOI 10.1091/mbc.E12-04-0287; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; TAILLON BE, 1992, J CELL BIOL, V119, P1613, DOI 10.1083/jcb.119.6.1613; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Zhao L, 2013, P NATL ACAD SCI USA, V110, P12697, DOI 10.1073/pnas.1300968110	35	25	26	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7388	7401		10.1074/jbc.M114.616425	http://dx.doi.org/10.1074/jbc.M114.616425			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25572396	hybrid, Green Published			2022-12-28	WOS:000351613600008
J	Tapryal, N; Vivek, GV; Mukhopadhyay, CK				Tapryal, Nisha; Vivek, Vishnu G.; Mukhopadhyay, Chinmay K.			Catecholamine Stress Hormones Regulate Cellular Iron Homeostasis by a Posttranscriptional Mechanism Mediated by Iron Regulatory Protein IMPLICATION IN ENERGY HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Catecholamine; Ferritin; Gene Regulation; Iron Metabolism; Mitochondria; Reactive Oxygen Species (ROS); Transferrin Receptor	FERRITIN MESSENGER-RNA; HUMAN SKELETAL-MUSCLE; CITRIC-ACID CYCLE; RESPONSIVE ELEMENT; NITRIC-OXIDE; OXIDATIVE STRESS; NOREPINEPHRINE TRANSPORTERS; TRANSLATIONAL REGULATION; 5-UNTRANSLATED REGION; GENE-EXPRESSION	Background: The role of catecholamines in cellular iron homeostasis is not understood. Results: Epinephrine and norepinephrine up-regulate transferrin receptor-1, inhibit ferritin expression, and increase mitochondrial iron content in hepatic and skeletal muscle cells. Conclusion: Catecholamine stress hormones are novel regulators of cellular iron homeostasis. Significance: Catecholamines may act to increase cellular iron content to meet an increased demand during stress. Adequate availability of iron is important for cellular energy metabolism. Catecholamines such as epinephrine and norepinephrine promote energy expenditure to adapt to conditions that arose due to stress. To restore the energy balance, epinephrine/norepinephrine-exposed cells may face higher iron demand. So far, no direct role of epinephrine/norepinephrine in cellular iron homeostasis has been reported. Here we show that epinephrine/norepinephrine regulates iron homeostasis components such as transferrin receptor-1 and ferritin-H in hepatic and skeletal muscle cells by promoting the binding of iron regulatory proteins to iron-responsive elements present in the UTRs of transferrin receptor-1 and ferritin-H transcripts. Increased transferrin receptor-1, decreased ferritin-H, and increased iron-responsive element-iron regulatory protein interaction are also observed in liver and muscle tissues of epinephrine/norepinephrine-injected mice. We demonstrate the role of epinephrine/norepinephrine-induced generation of reactive oxygen species in converting cytosolic aconitase (ACO1) into iron regulatory protein-1 to bind iron-responsive elements present in UTRs of transferrin receptor-1 and ferritin-H. Our study further reveals that mitochondrial iron content and mitochondrial aconitase (ACO2) activity are elevated by epinephrine/norepinephrine that are blocked by the antioxidant N-acetyl cysteine and iron regulatory protein-1 siRNA, suggesting involvement of reactive oxygen species and iron regulatory protein-1 in this mechanism. This study reveals epinephrine and norepinephrine as novel regulators of cellular iron homeostasis.	[Tapryal, Nisha; Vivek, Vishnu G.; Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Mukhopadhyay, CK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	ckm2300@mail.jnu.ac.in			Council of Scientific and Industrial Research (CSIR) of India; CSIR	Council of Scientific and Industrial Research (CSIR) of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research (CSIR) of India.; Recipient of a fellowship from the CSIR.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Biswas S, 2013, BBA-MOL BASIS DIS, V1832, P293, DOI 10.1016/j.bbadis.2012.11.003; BLAAK EE, 1993, INT J OBESITY, V17, pS78; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; Das NK, 2009, CELL MICROBIOL, V11, P83, DOI 10.1111/j.1462-5822.2008.01241.x; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P1117, DOI 10.1016/0031-9384(90)90361-7; Deugnier Y, 2007, WORLD J GASTROENTERO, V13, P4755, DOI 10.3748/wjg.v13.i35.4755; DIX DJ, 1992, BIOCHEMISTRY-US, V31, P2818, DOI 10.1021/bi00125a024; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Eisenstein RS, 2003, J NUTR, V133, p1510S, DOI 10.1093/jn/133.5.1510S; ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Ganz T, 2006, BBA-MOL CELL RES, V1763, P690, DOI 10.1016/j.bbamcr.2006.03.014; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; Gupta MK, 2006, ANTIOXID REDOX SIGN, V8, P1081, DOI 10.1089/ars.2006.8.1081; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Little R A, 1985, Arch Emerg Med, V2, P46; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Lymboussaki A, 2003, J HEPATOL, V39, P710, DOI 10.1016/S0168-8278(03)00408-2; Muralidharan B, 2007, FEBS LETT, V581, P4103, DOI 10.1016/j.febslet.2007.07.050; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; Oben JA, 2004, ANAT REC PART A, V280A, P874, DOI 10.1002/ar.a.20081; Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Philippe MA, 2007, WORLD J GASTROENTERO, V13, P4746, DOI 10.3748/wjg.v13.i35.4746; Remondino A, 2003, CIRC RES, V92, P136, DOI 10.1161/01.RES.0000054624.03539.B4; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rouault T A, 1996, EXS, V77, P183; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sancho-Bru P, 2006, AM J PHYSIOL-GASTR L, V291, pG877, DOI 10.1152/ajpgi.00537.2005; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; SPENCER MK, 1991, AM J PHYSIOL, V260, pE436, DOI 10.1152/ajpendo.1991.260.3.E436; SYLVIA AL, 1985, BRAIN RES, V338, P281, DOI 10.1016/0006-8993(85)90158-1; TAETLE R, 1987, BLOOD, V70, P852; Tapryal N, 2009, J BIOL CHEM, V284, P1873, DOI 10.1074/jbc.M804079200; Viguerie N, 2004, J CLIN ENDOCR METAB, V89, P2000, DOI 10.1210/jc.2003-031733	47	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7634	7646		10.1074/jbc.M114.592519	http://dx.doi.org/10.1074/jbc.M114.592519			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25572399	Green Published, hybrid			2022-12-28	WOS:000351613600026
J	Garcia-Marcos, M; Ghosh, P; Farquhar, MG				Garcia-Marcos, Mikel; Ghosh, Pradipta; Farquhar, Marilyn G.			GIV/Girdin Transmits Signals from Multiple Receptors by Triggering Trimeric G Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GUANINE-NUCLEOTIDE EXCHANGE; GROWTH-FACTOR RECEPTOR; ACTIN-BINDING PROTEIN; CONTROLS AUTOPHAGIC SEQUESTRATION; RAS-RELATED PROTEIN; G-ALPHA-I; REGULATORY MOTIF; GIRDIN; GIV; EXPRESSION	Activation of trimeric G proteins has been traditionally viewed as the exclusive job of G protein-coupled receptors (GPCRs). This view has been challenged by the discovery of non-receptor activators of trimericGproteins. Among them, GIV (a.k.a. Girdin) is the first for which a guanine nucleotide exchange factor (GEF) activity has been unequivocally associated with a well defined motif. Here we discuss how GIV assembles alternative signaling pathways by sensing cues from various classes of surface receptors and relaying them via G protein activation. We also describe the dysregulation of this mechanism in disease and how its targeting holds promise for novel therapeutics.	[Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Boston University; University of California System; University of California San Diego; University of California System; University of California San Diego	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	mgm1@bu.edu; prghosh@ucsd.edu; mfarguhar@ucsd.edu			National Institutes of Health [R01GM108733, R01CA160911, R01099226, R01CA100768, R37DK17724]; American Cancer Society [RSG-13-362-01-TBE]; Burroughs Wellcome Foundation; NATIONAL CANCER INSTITUTE [R01CA100768, R01CA160911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099226, R01DK017724, R37DK017724, T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM108733 (to M.G.-M), R01CA160911 and R01099226 (to P. G.), and R01CA100768 and R37DK17724 (to M.G.F.) This work was also supported by the American Cancer Society Grant RSG-13-362-01-TBE (to M.G.-M.) and the Burroughs Wellcome Foundation (to P. G.). This is the third article in the Thematic Minireview series "Cell Biology of G Protein Signaling."	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Austin C. P., 2008, COMB CHEM HIGH T SCR, V11, P396; Beas AO, 2012, MOL BIOL CELL, V23, P4623, DOI 10.1091/mbc.E12-02-0133; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Chan P, 2013, P NATL ACAD SCI USA, V110, P3794, DOI 10.1073/pnas.1220943110; Chan P, 2011, J BIOL CHEM, V286, P19932, DOI 10.1074/jbc.M110.163675; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Dunkel Y, 2012, J BIOL CHEM, V287, P41667, DOI 10.1074/jbc.M112.390781; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2006, ANN NY ACAD SCI, V1086, P169, DOI 10.1196/annals.1377.016; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Gabay M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002223; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2011, CELL ADHES MIGR, V5, P237, DOI 10.4161/cam.5.3.15909; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Ito T, 2013, AM J PATHOL, V182, P586, DOI 10.1016/j.ajpath.2012.10.012; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Jun BY, 2013, DIS COLON RECTUM, V56, P51, DOI 10.1097/DCR.0b013e31826b9b7e; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Liu C, 2012, MOL BIOL REP, V39, P8717, DOI 10.1007/s11033-012-1731-8; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Papasergi MM, 2015, MOL PHARMACOL, V87, P52, DOI 10.1124/mol.114.094664; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Simpson F, 2005, TRAFFIC, V6, P442, DOI 10.1111/j.1600-0854.2005.00289.x; Solis-Herruzo JA, 1998, CELL SIGNAL, V10, P173, DOI 10.1016/S0898-6568(97)00036-3; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2013, P NATL ACAD SCI USA, V110, pE3148, DOI 10.1073/pnas.1307476110; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; Tonissoo T, 2010, DEV DYNAM, V239, P3404, DOI 10.1002/dvdy.22480; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; Wang HH, 2015, J AM SOC NEPHROL, V26, P314, DOI 10.1681/ASN.2013090985; Wang LM, 2011, J BIOL CHEM, V286, P31055, DOI 10.1074/jbc.M111.253427; Wang Y, 2011, J NEUROSCI, V31, P8109, DOI 10.1523/JNEUROSCI.1130-11.2011; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Xing BW, 2013, J BIOL CHEM, V288, P32827, DOI 10.1074/jbc.M113.489427	74	54	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6697	6704		10.1074/jbc.R114.613414	http://dx.doi.org/10.1074/jbc.R114.613414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25605737	Green Published, hybrid			2022-12-28	WOS:000350991500004
J	Li, J; Yuan, W; Jiang, S; Ye, W; Yang, H; Shapiro, IM; Risbud, MV				Li, Jun; Yuan, Wen; Jiang, Shuai; Ye, Wei; Yang, Hao; Shapiro, Irving M.; Risbud, Makarand V.			Prolyl-4-hydroxylase Domain Protein 2 Controls NF-kappa B/p65 Transactivation and Enhances the Catabolic Effects of Inflammatory Cytokines on Cells of the Nucleus Pulposus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERVERTEBRAL DISC; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; HYPOXIA-INDUCIBLE FACTOR; PROLYL HYDROXYLASE INHIBITION; TNF-ALPHA; EXPRESSION; DEGENERATION; OXYGEN; DEGRADATION	Prolyl-4-hydroxylase (PHD) proteins are key in sensing tissue hypoxia. In nucleus pulposus (NP) cells, our previous work demonstrated that PHD isoforms have a differential contribution in controlling hypoxia-inducible factor (HIF)-alpha degradation and activity. Recently we have shown that a regulatory relationship exists between PHD3 and inflammatory cytokines in NP cells. With respect to PHD2, the most abundant PHD isoform in NP cells, very little is known concerning its function and regulation under inflammatory conditions that characterize intervertebral disc degeneration. Here, we show that PHD2 is a potent regulator of the catabolic activities of TNF-alpha; silencing of PHD2 significantly decreased TNF-alpha-induced expression of catabolic markers including SDC4, MMP-3, MMP-13, and ADAMTS5, as well as several inflammatory cytokines and chemokines, while partially restoring aggrecan and collagen II expression. Use of NF-kappa B reporters with ShPHD2, SiHIF-1 alpha, as well as p65(-/-), PHD2(-/-), and PHD3(-/-) cells, shows that PHD2 serves as a co-activator of NF-kappa B/p65 signaling in HIF-1-independent fashion. Immunoprecipitation of endogenous and exogenously expressed tagged proteins, as well as fluorescence microscopy, indicates that following TNF-alpha treatment, PHD2 interacts and co-localizes with p65. Conversely, loss of function experiments using lentivirally delivered Sh-p65, Sh-IKK beta, and NF-kappa B inhibitor confirmed that cytokine-dependent PHD2 expression in NP cells requires NF-kappa B signaling. These findings clearly demonstrate that PHD2 forms a regulatory circuit with TNF-alpha via NF-kappa B and thereby plays an important role in enhancing activity of this cytokine. We pro-pose that during disc degeneration PHD2 may offer a therapeutic target to mitigate the deleterious actions of TNF-alpha, a key proinflammatory cytokine.	[Li, Jun; Ye, Wei; Yang, Hao; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Li, Jun; Yuan, Wen; Jiang, Shuai] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai 200003, Peoples R China; [Ye, Wei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthopaed Surg, Guangzhou 510120, Guangdong, Peoples R China; [Yang, Hao] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed, Guangzhou 510080, Guangdong, Peoples R China	Jefferson University; Jefferson University; Naval Medical University; Sun Yat Sen University; Sun Yat Sen University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Suite 511,Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [AR055655, AR064733, AR050087]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055655, R01AR064733, R01AR050087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055655, AR064733, and AR050087.	Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; Haro H, 1997, J ORTHOPAED RES, V15, P734, DOI 10.1002/jor.1100150516; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Mern DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096870; Mern DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081467; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Natarajan R, 2007, AM J PHYSIOL-HEART C, V293, pH1571, DOI 10.1152/ajpheart.00291.2007; Pientka FK, 2012, J CELL SCI, V125, P5168, DOI 10.1242/jcs.109041; Podichetty VK, 2007, CELL MOL BIOL, V53, P4, DOI 10.1170/T814; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Smith MF, 2006, GLYCOBIOLOGY, V16, P221, DOI 10.1093/glycob/cwj061; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2009, ARTERIOSCL THROM VAS, V29, P2132, DOI 10.1161/ATVBAHA.109.196071; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang X, 2014, AM J PATHOL, V184, P2560, DOI 10.1016/j.ajpath.2014.06.006; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Yeramian A, 2011, LAB INVEST, V91, P859, DOI 10.1038/labinvest.2011.58; Yoshida M, 2005, SPINE, V30, P55, DOI 10.1097/01.brs.0000149194.17891.bf; Yu ZG, 2009, CHINESE MED J-PEKING, V122, P2483, DOI 10.3760/cma.j.issn.0366-6999.2009.20.016; Zhao CQ, 2011, J ORTHOP RES, V29, P718, DOI 10.1002/jor.21285	45	43	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7195	7207		10.1074/jbc.M114.611483	http://dx.doi.org/10.1074/jbc.M114.611483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25635047	Green Published, hybrid			2022-12-28	WOS:000350991500049
J	Marinangeli, C; Tasiaux, B; Opsomer, R; Hage, S; Sodero, AO; Dewachter, I; Octave, JN; Smith, SO; Constantinescu, SN; Kienlen-Campard, P				Marinangeli, Claudia; Tasiaux, Bernadette; Opsomer, Remi; Hage, Salim; Sodero, Alejandro O.; Dewachter, Ilse; Octave, Jean Noel; Smith, Steven O.; Constantinescu, Stefan N.; Kienlen-Campard, Pascal			Presenilin Transmembrane Domain 8 Conserved AXXXAXXXG Motifs Are Required for the Activity of the gamma-Secretase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; C-TERMINAL FRAGMENT; ALZHEIMERS-DISEASE; BETA-PROTEIN; GLYCOPHORIN-A; INTRAMEMBRANE CLEAVAGE; MEMBRANE-PROTEINS; SITE CONFORMATION; TRAFFICKING; MUTATIONS	Understanding the molecular mechanisms controlling the physiological and pathological activity of gamma-secretase represents a challenging task in Alzheimer disease research. The assembly and proteolytic activity of this enzyme require the correct interaction of the 19 transmembrane domains (TMDs) present in its four subunits, including presenilin (PS1 or PS2), the gamma-secretase catalytic core. GXXXG and GXXXG-like motifs are critical for TMDs interactions as well as for protein folding and assembly. The GXXXG motifs on gamma-secretase subunits (e. g. APH-1) or on gamma-secretase substrates (e. g. APP) are known to be involved in gamma-secretase assembly and in A beta peptide production, respectively. We identified on PS1 and PS2 TMD8 two highly conserved AXXXAXXXG motifs. The presence of a mutation causing an inherited form of Alzheimer disease (familial Alzheimer disease) in the PS1 motif suggested their involvement in the physiopathological configuration of the gamma-secretase complex. In this study, we targeted the role of these motifs on TMD8 of PSs, focusing on their role in PS assembly and catalytic activity. Each motif was mutated, and the impact on complex assembly, activity, and substrate docking was monitored. Different amino acid substitutions on the same motif resulted in opposite effects on gamma-secretase activity, without affecting the assembly or significantly impairing the maturation of the complex. Our data suggest that AXXXAXXXG motifs in PS TMD8 are key determinants for the conformation of the mature gamma-secretase complex, participating in the switch between the physiological and pathological functional conformations of the gamma-secretase.	[Marinangeli, Claudia; Tasiaux, Bernadette; Opsomer, Remi; Sodero, Alejandro O.; Dewachter, Ilse; Octave, Jean Noel; Kienlen-Campard, Pascal] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Hage, Salim] Catholic Univ Louvain, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Constantinescu, Stefan N.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Constantinescu, Stefan N.] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kienlen-Campard, P (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, Ave Mounier 53 Box B1-53-02, B-1200 Brussels, Belgium.	pascal.kienlen-campard@uclouvain.be	Dewachter, Ilse/AAZ-5661-2020; Smith, Steven/HDM-9496-2022	Dewachter, Ilse/0000-0001-7202-515X; Kienlen-Campard, Pascal/0000-0003-1086-2942; Constantinescu, Stefan N./0000-0002-8599-2699	National Institutes of Health [AG27317]; Fondation Recherche Alzheimer; Foundation for Research on Alzheimer's Disease; Commission du Patrimoine of Universite Catholique de Louvain; Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy (Belgian Medical Genetics Initiative) [P7/16]; Salus Sanguinis Foundation; Action de Recherche Concertee ARC of the University Catholique de Louvain [10/15-027]; Special Fund for Research (FSR, UCL); NATIONAL INSTITUTE ON AGING [R01AG027317, RF1AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Recherche Alzheimer; Foundation for Research on Alzheimer's Disease; Commission du Patrimoine of Universite Catholique de Louvain; Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy (Belgian Medical Genetics Initiative); Salus Sanguinis Foundation; Action de Recherche Concertee ARC of the University Catholique de Louvain; Special Fund for Research (FSR, UCL); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG27317 (to S. O. S.). This work was also supported by grants from the Fondation Recherche Alzheimer, the Foundation for Research on Alzheimer's Disease (to C. M. and P. K. C.), the Commission du Patrimoine of Universite Catholique de Louvain (to C. M.), and the Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy (P7/16-Belgian Medical Genetics Initiative) (to J. N. O., P. K. C., and S. N. C.). This work was also supported by the Salus Sanguinis Foundation, the Action de Recherche Concertee ARC 10/15-027 of the University Catholique de Louvain, and the Special Fund for Research (FSR, UCL) (to S. N. C.).	Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Aldudo J, 1999, HUM MUTAT, V14, P433, DOI 10.1002/(SICI)1098-1004(199911)14:5<433::AID-HUMU10>3.0.CO;2-K; Araki W, 2006, J MOL NEUROSCI, V29, P35, DOI 10.1385/JMN:29:1:35; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berechid BE, 2002, J BIOL CHEM, V277, P8154, DOI 10.1074/jbc.M108238200; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chau DM, 2012, J BIOL CHEM, V287, P17288, DOI 10.1074/jbc.M111.300483; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Eilers M, 2002, BIOPHYS J, V82, P2720, DOI 10.1016/S0006-3495(02)75613-0; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hage S, 2014, NEURODEGENER DIS, V14, P39, DOI 10.1159/000355557; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Huysseune S, 2007, BIOCHEM BIOPH RES CO, V361, P317, DOI 10.1016/j.bbrc.2007.06.186; Jozwiak K, 2008, CHEMMEDCHEM, V3, P627, DOI 10.1002/cmdc.200700189; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011213; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyabi O, 2002, NAT CELL BIOL, V4, pE164, DOI 10.1038/ncb0702-e164a; Octave JN, 2000, J BIOL CHEM, V275, P1525, DOI 10.1074/jbc.275.3.1525; Oh YS, 2005, BIOCHEMISTRY-US, V44, P11821, DOI 10.1021/bi0509494; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shiraishi H, 2006, GENES CELLS, V11, P83, DOI 10.1111/j.1365-2443.2005.00914.x; Smith SO, 2002, BIOPHYS J, V82, P2476, DOI 10.1016/S0006-3495(02)75590-2; Smith SO, 2001, BIOCHEMISTRY-US, V40, P6553, DOI 10.1021/bi010357v; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wang LF, 2009, MOLECULES, V14, P3589, DOI 10.3390/molecules14093589; Wanngren J, 2014, FEBS OPEN BIO, V4, P393, DOI 10.1016/j.fob.2014.04.006; Watanabe N, 2010, J BIOL CHEM, V285, P19738, DOI 10.1074/jbc.M110.101287; Weggen S, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt107; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2014, CELL, V158, P247, DOI 10.1016/j.cell.2014.06.043; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208	82	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7169	7184		10.1074/jbc.M114.601286	http://dx.doi.org/10.1074/jbc.M114.601286			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25614624	Green Published, hybrid			2022-12-28	WOS:000350991500047
J	Ramezani-Moghadam, M; Wang, JH; Ho, V; Iseli, TJ; Alzahrani, B; Xu, AM; Van der Poorten, D; Qiao, L; George, J; Hebbard, L				Ramezani-Moghadam, Mehdi; Wang, Jianhua; Ho, Vikki; Iseli, Tristan J.; Alzahrani, Badr; Xu, Aimin; Van der Poorten, David; Qiao, Liang; George, Jacob; Hebbard, Lionel			Adiponectin Reduces Hepatic Stellate Cell Migration by Promoting Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; RNA EXPRESSION; FIBROSIS; PROLIFERATION; MECHANISMS; RESOLUTION; APOPTOSIS; CD63; RAT	Hepatic stellate cells (HSC) are central players in liver fibrosis that when activated, proliferate, migrate to sites of liver injury, and secrete extracellular matrix, Obesity, a known risk factor for liver fibrosis is associated with reduced levels of adiponectin, a protein that inhibits liver fibrosis in vivo and limits HSC proliferation and migration in vitro. Adiponectin-mediated activation of adenosine monophosphate-activated kinase (AMPK) inhibits HSC proliferation, but the mechanism by which it limits HSC migration to sites of injury is unknown. Here we sought to elucidate how adiponectin regulates HSC motility. Primary rat HSCs were isolated and treated with adiponectin in migration assays. The in vivo actions of adiponectin were examined by treating mice with carbon tetrachloride for 12 weeks and then injecting them with adiponectin. Cell and tissue samples were collected and analyzed for gene expression, signaling, and histology. Serum from patients with liver fibrosis was examined for adiponectin and tissue inhibitor of metalloproteinase-1 (TIMP-1) protein. Adiponectin administration into mice increased TIMP-1 gene and protein expression. In cultured HSCs, adiponectin promoted TIMP-1 expression and through binding of TIMP-1 to the CD63/beta 1-integrin complex reduced phosphorylation of focal adhesion kinase to limit HS( migration. In mice with liver fibrosis, adiponectin had similar effects and limited focal adhesion kinase phosphorylation. Finally, in patients with advanced fibrosis, there was a positive correlation between serum adiponectin and TIMP-1 levels. In sum, these data show that adiponectin stimulates TIMP-1 secretion by HSCs to retard their migration and contributes to the anti-fibrotic effects of adiponectin.	[Ramezani-Moghadam, Mehdi; Wang, Jianhua; Ho, Vikki; Iseli, Tristan J.; Alzahrani, Badr; Van der Poorten, David; Qiao, Liang; George, Jacob; Hebbard, Lionel] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Storr Liver Ctr, Westmead, NSW 2145, Australia; [Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Sydney; Westmead Institute for Medical Research; University of Hong Kong	Hebbard, L (corresponding author), Storr Liver Ctr, Westmead Millennium Inst, POB 412, Westmead, NSW 2145, Australia.	lionel.hebbard@sydney.edu.au	Hebbard, Lionel/W-4057-2019; George, jacob/P-1496-2014; Hebbard, Lionel/O-1489-2017	Hebbard, Lionel/0000-0002-7094-9065	University of Sydney; National Health and Medical Research Council of Australia (NHMRC) Program [1053206]; NHMRC [632630]; Cancer Council NSW Project [1069733]	University of Sydney(University of Sydney); National Health and Medical Research Council of Australia (NHMRC) Program(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW Project(Cancer Council New South Wales)	This project was supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney, National Health and Medical Research Council of Australia (NHMRC) Program Grant 1053206, NHMRC Project Grant 632630 (to L. H. and J. G.), and Cancer Council NSW Project Grant 1069733 (to L. H.).	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; Akahane T, 2004, EXP CELL RES, V301, P158, DOI 10.1016/j.yexcr.2004.08.002; Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Ding XK, 2005, AM J PATHOL, V166, P1655, DOI 10.1016/S0002-9440(10)62476-5; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Herbst H, 1997, AM J PATHOL, V150, P1647; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Mannion BA, 1996, J IMMUNOL, V157, P2039; Marra F, 2005, Eur Rev Med Pharmacol Sci, V9, P279; Mazzocca A, 2002, J HEPATOL, V37, P322, DOI 10.1016/S0168-8278(02)00175-7; Murawaki Y, 1997, J HEPATOL, V26, P1213, DOI 10.1016/S0168-8278(97)80454-0; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/hep.20425; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Safadi Rifaat, 2002, MedGenMed, V4, P27; Salman TA, 2010, HEPATOL INT, V4, P767, DOI 10.1007/s12072-010-9216-0; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stearns ME, 1997, INVAS METAST, V17, P62; Stearns ME, 2003, MOL CANCER RES, V1, P631; Tacke F, 2005, J HEPATOL, V42, P666, DOI 10.1016/j.jhep.2004.12.024; Tietge UJF, 2004, AM J PHYSIOL-ENDOC M, V287, pE82, DOI 10.1152/ajpendo.00494.2003; van der Poorten D, 2013, HEPATOLOGY, V57, P2180, DOI 10.1002/hep.26072; Wang H, 2011, PROTECTING PRIVACY IN CHINA: A RESEARCH ON CHINAS PRIVACY STANDARDS AND THE POSSIBILITY OF ESTABLISHING THE RIGHT TO PRIVACY AND THE INFORMATION PRIVACY PROTECTION LEGISLATION IN MODERN CHINA, P1, DOI 10.1007/978-3-642-21750-0_1; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; Younossi ZM, 2011, OBES SURG, V21, P431, DOI 10.1007/s11695-010-0204-1; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; Zhou XY, 2004, LIVER INT, V24, P492, DOI 10.1111/j.1478-3231.2004.0946.x; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200	43	40	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5533	5542		10.1074/jbc.M114.598011	http://dx.doi.org/10.1074/jbc.M114.598011			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25575598	Green Published, hybrid			2022-12-28	WOS:000350044200025
J	Tsukuda, S; Watashi, K; Iwamoto, M; Suzuki, R; Aizaki, H; Okada, M; Sugiyama, M; Kojima, S; Tanaka, Y; Mizokami, M; Li, JS; Tong, SP; Wakita, T				Tsukuda, Senko; Watashi, Koichi; Iwamoto, Masashi; Suzuki, Ryosuke; Aizaki, Hideki; Okada, Maiko; Sugiyama, Masaya; Kojima, Soichi; Tanaka, Yasuhito; Mizokami, Masashi; Li, Jisu; Tong, Shuping; Wakita, Takaji			Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED TRANSCRIPTION FACTORS; MEMBRANE TRANSPORTER; NUCLEAR RECEPTORS; HEPG2 CELLS; IN-VIVO; ENTRY; MOUSE; INHIBITORS; INTERFERON; PROTEIN	Sodium taurocholate cotransporting polypeptide (NTCP) is an entry receptor for hepatitis B virus (HBV) and is regarded as one of the determinants that confer HBV permissiveness to host cells. However, how host factors regulate the ability of NTCP to support HBV infection is largely unknown. We aimed to identify the host signaling that regulated NTCP expression and thereby permissiveness to HBV. Here, a cell-based chemical screening method identified that Ro41-5253 decreased host susceptibility to HBV infection. Pretreatment with Ro41-5253 inhibited the viral entry process without affecting HBV replication. Intriguingly, Ro41-5253 reduced expression of both NTCP mRNA and protein. We found that retinoic acid receptor (RAR) regulated the promoter activity of the human NTCP (hNTCP) gene and that Ro41-5253 repressed the hNTCP promoter by antagonizing RAR. RAR recruited to the hNTCP promoter region, and nucleotides 112 to 96 of the liNTCP was suggested to be critical for RAR-mediated transcriptional activation. HBV susceptibility was decreased in pharmacologically RAR-inactivated cells. CD2665 showed a stronger anti-HBV potential and disrupted the spread of HBV infection that was achieved by continuous reproduction of the whole HBV life cycle. In addition, this mechanism was significant for drug development, as antagonization of RAR blocked infection of multiple HBV genotypes and also a clinically relevant HBV mutant that was resistant to nucleoside analogs. Thus, RAR is crucial for regulating NTCP expression that determines permissiveness to HBV infection. This is the first demonstration showing host regulation of NTCP to support HBV infection.	[Tsukuda, Senko; Watashi, Koichi; Iwamoto, Masashi; Suzuki, Ryosuke; Aizaki, Hideki; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Tsukuda, Senko; Kojima, Soichi] RIKEN Ctr Life Sci Technol, Microsignaling Regulat Technol Unit, Wako, Saitama 3510198, Japan; [Okada, Maiko] St Marianna Univ, Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa 2168511, Japan; [Sugiyama, Masaya; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa 2728516, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi 4678601, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi 4678601, Japan; [Li, Jisu; Tong, Shuping] Brown Univ, Rhode Isl Hosp, Liver Res Ctr, Warren Alpert Sch Med, Providence, RI 02912 USA	National Institute of Infectious Diseases (NIID); RIKEN; Saint Marianna University; National Center for Global Health & Medicine - Japan; Nagoya City University; Nagoya City University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Watashi, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	kwatashi@nih.go.jp	Kojima, Soichi/N-7104-2015	Kojima, Soichi/0000-0002-5252-1612; Iwamoto, Masashi/0000-0002-0419-4485; Tanaka, Yasuhito/0000-0002-2473-6966	Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science; Liver Forum in Kyoto	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Liver Forum in Kyoto	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare, Japan, from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and from Japan Society for the Promotion of Science, and by the incentive support from Liver Forum in Kyoto.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Arbuthnot P, 2001, INT J EXP PATHOL, V82, P77, DOI 10.1111/j.1365-2613.2001.iep178.x; Bai JR, 2000, MOL THER, V1, P244, DOI 10.1006/mthe.2000.0038; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; CATTANEO R, 1984, EMBO J, V3, P2191, DOI 10.1002/j.1460-2075.1984.tb02113.x; Chen Li-Ping, 2012, World J Virol, V1, P174, DOI 10.5501/wjv.v1.i6.174; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Deuffic-Burban S, 2011, J CLIN VIROL, V52, P4, DOI 10.1016/j.jcv.2011.05.016; Dusheiko G, 2013, LIVER INT, V33, P137, DOI 10.1111/liv.12078; Geier A, 2008, AM J PHYSIOL-GASTR L, V295, pG226, DOI 10.1152/ajpgi.00012.2008; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; HIRSCH RC, 1990, NATURE, V344, P552, DOI 10.1038/344552a0; Ho RH, 2004, J BIOL CHEM, V279, P7213, DOI 10.1074/jbc.M305782200; HUAN BF, 1993, J HEPATOL, V17, pS20, DOI 10.1016/S0168-8278(05)80419-2; HUAN BF, 1992, P NATL ACAD SCI USA, V89, P9059, DOI 10.1073/pnas.89.19.9059; Ishida Y., 2013, INT M MOL BIOL HEP B, VP13; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Jung D, 2004, AM J PHYSIOL-GASTR L, V286, pG752, DOI 10.1152/ajpgi.00456.2003; Kao JH, 2010, ADV CANCER RES, V108, P21, DOI 10.1016/S0065.230X(10)08003.6; Kotani N, 2012, MOL PHARMACEUT, V9, P3434, DOI 10.1021/mp300171p; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liu F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-59; Lok ASF, 2002, NEW ENGL J MED, V346, P1682, DOI 10.1056/NEJM200205303462202; Marusawa H, 2001, MICROBIOL IMMUNOL, V45, P483, DOI 10.1111/j.1348-0421.2001.tb02648.x; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Ohishi W, 2012, HEPATOL RES, V42, P219, DOI 10.1111/j.1872-034X.2011.00921.x; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Pan W, 2011, XENOBIOTICA, V41, P501, DOI 10.3109/00498254.2011.555567; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Rippin SJ, 2001, HEPATOLOGY, V33, P776, DOI 10.1053/jhep.2001.23433; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; SELLS MA, 1988, J VIROL, V62, P2836, DOI 10.1128/JVI.62.8.2836-2844.1988; Shiao T, 2000, GENOMICS, V69, P203, DOI 10.1006/geno.2000.6329; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Watashi Koichi, 2013, J Biol Chem, V288, P31715, DOI 10.1074/jbc.M113.501122; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; YEH CT, 1991, J VIROL, V65, P2327, DOI 10.1128/JVI.65.5.2327-2331.1991; Zollner G, 2005, AM J PHYSIOL-GASTR L, V289, pG798, DOI 10.1152/ajpgi.00319.2004; Zoulim F, 2013, LIVER INT, V33, P116, DOI 10.1111/liv.12069	53	47	49	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5673	5684		10.1074/jbc.M114.602540	http://dx.doi.org/10.1074/jbc.M114.602540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25550158	hybrid, Green Published			2022-12-28	WOS:000350044200036
J	Goedken, ER; Argiriadi, MA; Banach, DL; Fiamengo, BA; Foley, SE; Frank, KE; George, JS; Harris, CM; Hobson, AD; Ihle, DC; Marcotte, D; Merta, PJ; Michalak, ME; Murdock, SE; Tomlinson, MJ; Voss, JW				Goedken, Eric R.; Argiriadi, Maria A.; Banach, David L.; Fiamengo, Bryan A.; Foley, Sage E.; Frank, Kristine E.; George, Jonathan S.; Harris, Christopher M.; Hobson, Adrian D.; Ihle, David C.; Marcotte, Douglas; Merta, Philip J.; Michalak, Mark E.; Murdock, Sara E.; Tomlinson, Medha J.; Voss, Jeffrey W.			Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINIMUM SIGNIFICANT RATIO; JANUS KINASES; IRREVERSIBLE INHIBITORS; TOFACITINIB CP-690,550; RHEUMATOID-ARTHRITIS; INADEQUATE RESPONSE; ERBB FAMILY; ACTIVATION; DESIGN; POTENT	The action of Janus kinases (JAKs) is required for multiple cytokine signaling pathways, and as such, JAK inhibitors hold promise for treatment of autoimmune disorders, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis. However, due to high similarity in the active sites of the four members (Jak1, Jak2, Jak3, and Tyk2), developing selective inhibitors within this family is challenging. We have designed and characterized substituted, tricyclic Jak3 inhibitors that selectively avoid inhibition of the other JAKs. This is accomplished through a covalent interaction between an inhibitor containing a terminal electrophile and an active site cysteine (Cys-909). We found that these ATP competitive compounds are irreversible inhibitors of Jak3 enzyme activity in vitro. They possess high selectivity against other kinases and can potently (IC50 < 100 nM) inhibit Jak3 activity in cell-based assays. These results suggest irreversible inhibitors of this class may be useful selective agents, both as tools to probe Jak3 biology and potentially as therapies for autoimmune diseases.	[Goedken, Eric R.; Argiriadi, Maria A.; Banach, David L.; Fiamengo, Bryan A.; Foley, Sage E.; Frank, Kristine E.; George, Jonathan S.; Harris, Christopher M.; Hobson, Adrian D.; Ihle, David C.; Marcotte, Douglas; Merta, Philip J.; Michalak, Mark E.; Murdock, Sara E.; Tomlinson, Medha J.; Voss, Jeffrey W.] AbbVie Biores Ctr, Worcester, MA 01605 USA	AbbVie	Goedken, ER (corresponding author), AbbVie Biores Ctr, 100 Res Dr, Worcester, MA 01605 USA.	eric.goedken@abbvie.com	Hobson, Adrian D/N-2308-2017	Hobson, Adrian D/0000-0003-3948-0577	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; AbbVie	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); AbbVie(AbbVie)	Use of the Industrial Macromolecular Crystallography Association-Collaborative Access Team beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. The authors are/were employees of AbbVie (or Abbott Laboratories prior to separation) and may own AbbVie/Abbott stocks or stock options. Financial support for this work was provided by AbbVie, who participated in the interpretation of data, review, and approval of the manuscript.	[Anonymous], 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x; Argiriadi MA, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-22; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Bricogne G., 2011, BUSTER VERSION 2 9 7; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen JJ, 2006, BIOORG MED CHEM LETT, V16, P5633, DOI 10.1016/j.bmcl.2006.08.022; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Clark MP, 2007, BIOORG MED CHEM LETT, V17, P1250, DOI 10.1016/j.bmcl.2006.12.018; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Denny WA, 2002, PHARMACOL THERAPEUT, V93, P253, DOI 10.1016/S0163-7258(02)00194-8; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans EK, 2013, J PHARMACOL EXP THER, V346, P219, DOI 10.1124/jpet.113.203489; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gehringer M, 2014, CHEMMEDCHEM, V9, P277, DOI 10.1002/cmdc.201300520; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Goedken ER, 2012, J BIOMOL SCREEN, V17, P857, DOI 10.1177/1087057112447108; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; HARPUR AG, 1992, ONCOGENE, V7, P1347; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Hur W, 2008, BIOORG MED CHEM LETT, V18, P5916, DOI 10.1016/j.bmcl.2008.07.062; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Kulagowski JJ, 2012, J MED CHEM, V55, P5901, DOI 10.1021/jm300438j; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Liang J, 2013, EUR J MED CHEM, V67, P175, DOI 10.1016/j.ejmech.2013.03.070; Liu KD, 1997, CURR BIOL, V7, P817, DOI 10.1016/S0960-9822(06)00369-1; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Rankin AL, 2013, J IMMUNOL, V191, P4540, DOI 10.4049/jimmunol.1301553; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Scott LJ, 2013, DRUGS, V73, P857, DOI 10.1007/s40265-013-0065-8; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; Simmons DL, 2013, CURR OPIN PHARMACOL, V13, P426, DOI 10.1016/j.coph.2013.02.008; Singh J, 2010, CURR OPIN CHEM BIOL, V14, P475, DOI 10.1016/j.cbpa.2010.06.168; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Sonbol MB, 2013, THER ADV HEMATOL, V4, P15, DOI 10.1177/2040620712461047; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Styles M. L., 2005, International Patent, Patent No. [WO 2005066156 A1, 2005066156, WO2005066156 (A1)]; Thompson JE, 2005, DRUG NEWS PERSPECT, V18, P305, DOI 10.1358/dnp.2005.18.5.904198; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Van Epps S, 2013, BIOORG MED CHEM LETT, V23, P693, DOI 10.1016/j.bmcl.2012.11.108; Verma A, 2003, CANCER METAST REV, V22, P423, DOI 10.1023/A:1023805715476; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; Williams NK, 2009, J MOL BIOL, V387, P219, DOI 10.1016/j.jmb.2009.01.041; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhu K, 2014, J CHEM INF MODEL, V54, P1932, DOI 10.1021/ci500118s	64	71	77	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4573	4589		10.1074/jbc.M114.595181	http://dx.doi.org/10.1074/jbc.M114.595181			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25552479	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000350042000005
J	Johnson, JL; Jones, MB; Cobb, BA				Johnson, Jenny L.; Jones, Mark B.; Cobb, Brian A.			Polysaccharide A from the Capsule of Bacteroides fragilis Induces Clonal CD4(+) T Cell Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCESS FORMATION; NITRIC-OXIDE; ANTIGEN; PROTECTION; GLYCOSYLATION; MODULATION	For 3 decades, the view of MHCII-dependent antigen presentation has been completely dominated by peptide antigens despite our 2004 discovery in which MHCII was shown to present processed fragments of zwitterionic capsular polysaccharides to T cells. Published findings further demonstrate that polysaccharide A (PSA) from the capsule of Bacteroides fragilis is a potent activator of CD4(+) T cells and that these T cells have important biological functions, especially in the maintenance of immunological homeostasis. However, little is known about the nature of T cell recognition of the polysaccharide-MHCII complex or the phenotype of the resulting activated cells. Here, we use next-generation sequencing of the alpha beta T cell receptor of CD4(+) T cells from mice stimulated with PSA in comparison with protein antigen simulation and non-immunized controls and found that PSA immunization induced clonal expansion of a small subset of suppressive CD4(+) CD45RB(low) effector/memory T cells. Moreover, the sequences of the complementarity-determining region 3 (CDR3) loop from top clones indicate a lack of specific variable beta and joining region use and average CDR3loop length. There was also a preference for a zwitterionic motif within the CDR3 loop sequences, aligning well with the known requirement for a similar motif within PSA to enable T cell activation. These data support a model in which PSA, and possibly other T cell-dependent polysaccharide antigens, elicits a clonal and therefore specific CD4(+) T cell response often characterized by pairing dual-charged CDR3 loop sequences with dual-charged PSA.	[Johnson, Jenny L.; Jones, Mark B.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Cobb, BA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	brian.cobb@case.edu		Johnson, Jenny/0000-0002-5939-4521	National Institutes of Health [GM082916, OD004225]; American Asthma Foundation [10-0187]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082916] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants GM082916 and OD004225 (to B. A. C.). This work was also supported by American Asthma Foundation Grant 10-0187 (to B. A. C.).	Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Brubaker JO, 1999, J IMMUNOL, V162, P2235; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Cobb BA, 2008, GLYCOBIOLOGY, V18, P707, DOI 10.1093/glycob/cwn050; Kreisman LSC, 2007, GLYCOBIOLOGY, V17, P46, DOI 10.1093/glycob/cwl056; Kreisman LSC, 2011, J BIOL CHEM, V286, P8810, DOI 10.1074/jbc.M110.206011; Lewis CJ, 2011, EUR J IMMUNOL, V41, P2562, DOI 10.1002/eji.201141396; Marrero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076546; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ruiz-Perez B, 2005, P NATL ACAD SCI USA, V102, P16753, DOI 10.1073/pnas.0505688102; Ryan SO, 2014, GLYCOBIOLOGY, V24, P262, DOI 10.1093/glycob/cwt107; Ryan SO, 2012, SEMIN IMMUNOPATHOL, V34, P425, DOI 10.1007/s00281-012-0309-9; Ryan SO, 2011, J EXP MED, V208, P1041, DOI 10.1084/jem.20100508; Stingele F, 2004, J IMMUNOL, V172, P1483, DOI 10.4049/jimmunol.172.3.1483; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; Tzianabos AO, 1995, J CLIN INVEST, V96, P2727, DOI 10.1172/JCI118340; TZIANABOS AO, 1994, INFECT IMMUN, V62, P4881, DOI 10.1128/IAI.62.11.4881-4886.1994; Tzianabos AO, 1998, J INFECT DIS, V178, P200, DOI 10.1086/515594; Tzianabos AO, 2001, P NATL ACAD SCI USA, V98, P9365, DOI 10.1073/pnas.161175598; Velez CD, 2009, IMMUNOLOGY, V127, P73, DOI 10.1111/j.1365-2567.2008.02924.x; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Young NM, 2011, GLYCOBIOLOGY, V21, P1266, DOI 10.1093/glycob/cwr018	27	49	55	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					5007	5014		10.1074/jbc.M114.621771	http://dx.doi.org/10.1074/jbc.M114.621771			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25540199	Green Published, hybrid			2022-12-28	WOS:000350042000042
J	Law, AL; Parinot, C; Chatagnon, J; Gravez, B; Sahel, JA; Bhattacharya, SS; Nandrot, EF				Law, Ah-Lai; Parinot, Celia; Chatagnon, Jonathan; Gravez, Basile; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Nandrot, Emeline F.			Cleavage of Mer Tyrosine Kinase (MerTK) from the Cell Surface Contributes to the Regulation of Retinal Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER SEGMENT PHAGOCYTOSIS; ARREST-SPECIFIC GENE; APOPTOTIC CELLS; PIGMENT-EPITHELIUM; ALPHA-V-BETA-5 INTEGRIN; MEDIATED PHAGOCYTOSIS; DYSTROPHY PHENOTYPE; SOLUBLE FORM; MICE LACKING; PROTEIN-S	Phagocytosis of apoptotic cells by macrophages and spent photoreceptor outer segments (POS) by retinal pigment epithelial (RPE) cells requires several proteins, including MerTK receptors and associated Gas6 and protein S ligands. In the retina, POS phagocytosis is rhythmic, and MerTK is activated promptly after light onset via the alpha v beta 5 integrin receptor and its ligand MFG-E8, thus generating a phagocytic peak. The phagocytic burst is limited in time, suggesting a down-regulation mechanism that limits its duration. Our previous data showed that MerTK helps control POS binding of integrin receptors at the RPE cell surface as a negative feedback loop. Our present results show that a soluble form of MerTK (sMerTK) is released in the conditioned media of RPE-J cells during phagocytosis and in the interphotoreceptor matrix of the mouse retina during the morning phagocytic peak. In contrast to macrophages, the two cognate MerTK ligands have an opposite effect on phagocytosis and sMerTK release, whereas the integrin ligand MFG-E8 markedly increases both phagocytosis and sMerTK levels. sMerTK acts as a decoy receptor blocking the effect of both MerTK ligands. Interestingly, stimulation of sMerTK release decreases POS binding. Conversely, blocking MerTK cleavage increased mostly POS binding by RPE cells. Therefore, our data suggest that MerTK cleavage contributes to the acute regulation of RPE phagocytosis by limiting POS binding to the cell surface.	[Law, Ah-Lai; Parinot, Celia; Chatagnon, Jonathan; Gravez, Basile; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Nandrot, Emeline F.] Univ Paris 06, INSERM, U968, UMR S968,Inst Vis, F-75012 Paris, France; [Law, Ah-Lai; Parinot, Celia; Chatagnon, Jonathan; Gravez, Basile; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Nandrot, Emeline F.] Univ Paris 06, Sorbonne Univ, UMR S968, Inst Vis, F-75012 Paris, France; [Law, Ah-Lai; Parinot, Celia; Chatagnon, Jonathan; Gravez, Basile; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Nandrot, Emeline F.] CNRS, UMR 7210, F-75012 Paris, France; [Sahel, Jose-Alain] INSERM, Ctr Hosp Natl Ophtalmol Quinze Vingts, Direct Hosp & Offre Soins, Ctr Invest Clin 1423, F-75012 Paris, France; [Bhattacharya, Shomi S.] UCL, Inst Ophthalmol, London WC1E 6BT, England; [Nandrot, Emeline F.] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville 41092, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Nandrot, EF (corresponding author), Inst Vis, 17 Rue Moreau, F-75012 Paris, France.	emeline.nandrot@inserm.fr	Sahel, Jose-Alain/F-3172-2017; Nandrot, Emeline F./AAN-3925-2020; Bhattacharya, Shom/N-2926-2016	Sahel, Jose-Alain/0000-0002-4831-1153; Bhattacharya, Shom/0000-0002-1601-6344; Nandrot, Emeline/0000-0003-3087-078X	INSERM; Universite Pierre et Marie Curie-Paris6; CNRS; Department de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie-Paris6; CNRS(Centre National de la Recherche Scientifique (CNRS)); Department de Paris	We thank Stephane Fouquet (Imaging Facility, Institut de la Vision) and Quentin Rieu for help with confocal microscopy. The Institut de la Vision is funded by INSERM, Universite Pierre et Marie Curie-Paris6, CNRS, and Department de Paris.	BOESZEBATTAGLIA K, 1992, EXP EYE RES, V54, P821, DOI 10.1016/0014-4835(92)90040-Y; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; Cheong HS, 2007, RHEUMATOLOGY, V46, P209, DOI 10.1093/rheumatology/kel182; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U; Cummings CT, 2013, CLIN CANCER RES, V19, P5275, DOI 10.1158/1078-0432.CCR-12-1451; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dickhout JG, 2008, ARTERIOSCL THROM VAS, V28, P1413, DOI 10.1161/ATVBAHA.108.169144; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; HALL MO, 1987, EXP EYE RES, V45, P907, DOI 10.1016/S0014-4835(87)80105-7; Hall MO, 2001, EXP EYE RES, V73, P509, DOI 10.1006/exer.2001.1062; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; McHenry CL, 2004, INVEST OPHTH VIS SCI, V45, P1456, DOI 10.1167/iovs.03-0909; Nandrot E, 2000, NEUROBIOL DIS, V7, P586, DOI 10.1006/nbdi.2000.0328; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Nandrot EF, 2012, BIOL CELL, V104, P326, DOI 10.1111/boc.201100076; Parinot C, 2014, JOVE-J VIS EXP, DOI 10.3791/52100; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Ryeom SW, 1996, J BIOL CHEM, V271, P20536, DOI 10.1074/jbc.271.34.20536; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Tschernutter M, 2006, BRIT J OPHTHALMOL, V90, P718, DOI 10.1136/bjo.2005.084897; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wavre-Shapton ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057769; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1977, J ULTRA MOL STRUCT R, V61, P172, DOI 10.1016/S0022-5320(77)80084-1	50	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4941	4952		10.1074/jbc.M114.628297	http://dx.doi.org/10.1074/jbc.M114.628297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25538233	Green Published, hybrid			2022-12-28	WOS:000350042000037
J	Li, XJ; Goodwin, CB; Nabinger, SC; Richine, BM; Yang, ZY; Hanenberg, H; Ohnishi, H; Matozaki, T; Feng, GS; Chan, RJ				Li, Xing Jun; Goodwin, Charles B.; Nabinger, Sarah C.; Richine, Briana M.; Yang, Zhenyun; Hanenberg, Helmut; Ohnishi, Hiroshi; Matozaki, Takashi; Feng, Gen-Sheng; Chan, Rebecca J.			Protein-tyrosine Phosphatase Shp2 Positively Regulates Macrophage Oxidative Burst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; NADPH OXIDASE ACTIVITY; ENCODING GP91(PHOX); FC-RECEPTOR; ACTIVATION; PTPN11; MUTATIONS; PATHWAY; KINASE; DOMAIN	Macrophages are vital to innate immunity and express pattern recognition receptors and integrins for the rapid detection of invading pathogens. Stimulation of Dectin-1 and complement receptor 3 (CR3) activates Erk- and Akt-dependent production of reactive oxygen species (ROS). Shp2, a protein-tyrosine phosphatase encoded by Ptpn11, promotes activation of Ras-Erk and PI3K-Akt and is crucial for hematopoietic cell function; however, no studies have examined Shp2 function in particulate-stimulated ROS production. Maximal Dectin-1-stimulated ROS production corresponded kinetically to maximal Shp2 and Erk phosphorylation. Bone marrow-derived macrophages (BMMs) from mice with a conditionally deleted allele of Ptpn11 (Shp2(flox/flox); Mx1Cre+) produced significantly lower ROS levels compared with control BMMs. Although YFP-tagged phosphatase dead Shp2-C463A was strongly recruited to the early phagosome, its expression inhibited Dectin-1- and CR3-stimulated phospho-Erk and ROS levels, placing Shp2 phosphatase function and Erk activation upstream of ROS production. Further, BMMs expressing gain of function Shp2-D61Y or Shp2-E76K and peritoneal exudate macrophages from Shp2D61Y/+; Mx1Cre + mice produced significantly elevated levels of Dectin-1- and CR3-stimulated ROS, which was reduced by pharmacologic inhibition of Erk. SIRP alpha (signal regulatory protein alpha) is a myeloid inhibitory immunoreceptor that requires tyrosine phosphorylation to exert its inhibitory effect. YFP-Shp2C463A-expressing cells have elevated phospho-SIRP alpha levels and an increased Shp2-SIRP alpha interaction compared with YFP-WT Shp2-expressing cells. Collectively, these findings indicate that Shp2 phosphatase function positively regulates Dectin-1-and CR3-stimulated ROS production in macrophages by dephosphorylating and thus mitigating the inhibitory function of SIRP alpha and by promoting Erk activation.	[Li, Xing Jun; Hanenberg, Helmut; Chan, Rebecca J.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Li, Xing Jun; Goodwin, Charles B.; Richine, Briana M.; Hanenberg, Helmut; Chan, Rebecca J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Goodwin, Charles B.; Nabinger, Sarah C.; Richine, Briana M.; Hanenberg, Helmut; Chan, Rebecca J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Yang, Zhenyun] West Coast Univ, Los Angeles, CA 91606 USA; [Hanenberg, Helmut] Univ Dusseldorf, Dept Otorhinolaryngol & Head Neck Surg, D-40225 Dusseldorf, Germany; [Ohnishi, Hiroshi] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma 3718514, Japan; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Heinrich Heine University Dusseldorf; Gunma University; Kobe University; University of California System; University of California San Diego	Li, XJ (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	xl9@iu.edu; rchan@iu.edu			National Institutes of Health [RO1 CA134777]; Showalter Research Trust; Riley Children's Foundation; Indiana University-Purdue University Indianapolis Office of the Vice Chancellor for Research; NATIONAL CANCER INSTITUTE [R01CA134777, P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910, R01HL129763] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26291022] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Research Trust; Riley Children's Foundation; Indiana University-Purdue University Indianapolis Office of the Vice Chancellor for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA134777 (to R. J. C.). This work was also supported by funds from the Showalter Research Trust (to X. J. L.), the Riley Children's Foundation, and the Indiana University-Purdue University Indianapolis Office of the Vice Chancellor for Research.	Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chan G, 2009, BLOOD, V113, P4414, DOI 10.1182/blood-2008-10-182626; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Goodwin CB, 2012, HAEMATOL-HEMATOL J, V97, P1042, DOI 10.3324/haematol.2011.046896; GREENBERG S, 1990, J EXP MED, V172, P1853, DOI 10.1084/jem.172.6.1853; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Gu HH, 2003, J CELL BIOL, V161, P1151, DOI 10.1083/jcb.200212158; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Huang H, 2012, GENE DEV, V26, P1587, DOI 10.1101/gad.192054.112; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Laplante MA, 2003, J HYPERTENS, V21, P927, DOI 10.1097/00004872-200305000-00017; Li XJ, 2010, J BIOL CHEM, V285, P35169, DOI 10.1074/jbc.M110.164475; Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; Liu Dong-Sheng, 2011, SENSORS, V11, P6494, DOI DOI 10.1109/W; Lorenzana A, 2002, J PEDIAT HEMATOL ONC, V24, P136, DOI 10.1097/00043426-200202000-00016; Mackey-Lawrence NM, 2012, MUCOSAL IMMUNOL, V5, P472, DOI 10.1038/mi.2012.40; Makni-Maalej K, 2013, BIOCHEM PHARMACOL, V85, P92, DOI 10.1016/j.bcp.2012.10.010; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Minakami R, 2006, INT J HEMATOL, V84, P193, DOI 10.1532/IJH97.06133; Miyake A, 2008, GENES CELLS, V13, P209, DOI 10.1111/j.1365-2443.2007.01161.x; Moritake H, 2009, PEDIATR BLOOD CANCER, V53, P1324, DOI 10.1002/pbc.22253; Nabinger SC, 2013, LEUKEMIA, V27, P398, DOI 10.1038/leu.2012.308; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Noguchi T, 1996, J BIOL CHEM, V271, P27652, DOI 10.1074/jbc.271.44.27652; Pinkel D, 1998, BLOOD, V91, P365, DOI 10.1182/blood.V91.1.365.365_365_367; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Torres M, 1999, ARCH BIOCHEM BIOPHYS, V366, P231, DOI 10.1006/abbi.1999.1225; van Beek EM, 2012, CELL REP, V2, P748, DOI 10.1016/j.celrep.2012.08.027; Yang ZY, 2009, MOL CELL BIOL, V29, P4376, DOI 10.1128/MCB.01330-08; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Zeng MY, 2013, BLOOD, V121, P3473, DOI 10.1182/blood-2012-10-461913; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhu C, 2008, J LEUKOCYTE BIOL, V83, P680, DOI 10.1189/jlb.0807514; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476	55	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3894	3909		10.1074/jbc.M114.614057	http://dx.doi.org/10.1074/jbc.M114.614057			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25538234	Green Published, hybrid			2022-12-28	WOS:000349458400002
J	Bergo, A; Strollo, M; Gai, M; Barbiero, I; Stefanelli, G; Sertic, S; Gigli, CC; Di Cunto, F; Kilstrup-Nielsen, C; Landsberger, N				Bergo, Anna; Strollo, Marta; Gai, Marta; Barbiero, Isabella; Stefanelli, Gilda; Sertic, Sarah; Gigli, Clementina Cobolli; Di Cunto, Ferdinando; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta			Methyl-CpG Binding Protein 2 (MeCP2) Localizes at the Centrosome and Is Required for Proper Mitotic Spindle Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL GENE-EXPRESSION; RETT-SYNDROME; MOUSE MODEL; HISTONE DEACETYLASE; LINKED MECP2; CHROMATIN; PHOSPHORYLATION; TRANSCRIPTION; MUTATIONS; CELLS	Mutations in MECP2 cause a broad spectrum of neuropsychiatric disorders of which Rett syndrome represents the best defined condition. Both neuronal and non-neuronal functions of the methyl-binding protein underlie the related pathologies. Nowadays MeCP2 is recognized as a multifunctional protein that modulates its activity depending on its protein partners and posttranslational modifications. However, we are still missing a comprehensive understanding of all MeCP2 functions and their involvement in the related pathologies. The study of human mutations often offers the possibility of clarifying the functions of a protein. Therefore, we decided to characterize a novel MeCP2 phospho-isoform (Tyr-120) whose relevance was suggested by a Rett syndrome patient carrying a Y120D substitution possibly mimicking a constitutively phosphorylated state. Unexpectedly, we found MeCP2 and its Tyr-120 phospho-isoform enriched at the centrosome both in dividing and postmitotic cells. The molecular and functional connection of MeCP2 to the centrosome was further reinforced through cellular and biochemical approaches. We show that, similar to many centrosomal proteins, MeCP2 deficiency causes aberrant spindle geometry, prolonged mitosis, and defects in microtubule nucleation. Collectively, our data indicate a novel function of MeCP2 that might reconcile previous data regarding the role of MeCP2 in cell growth and cytoskeleton stability and that might be relevant to understand some aspects of MeCP2-related conditions. Furthermore, they link the Tyr-120 residue and its phosphorylation to cell division, prompting future studies on the relevance of Tyr-120 for cortical development.	[Bergo, Anna; Strollo, Marta; Barbiero, Isabella; Stefanelli, Gilda; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta] Univ Insubria, Dept Theoret & Appl Sci, Sect Biomed Res, I-21052 Busto Arsizio, Italy; [Gai, Marta; Di Cunto, Ferdinando] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy; [Sertic, Sarah] Univ Milan, Dept Life Sci, I-20133 Milan, Italy; [Gigli, Clementina Cobolli; Landsberger, Nicoletta] Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy	University of Insubria; University of Turin; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Via Manara 7, I-21052 Busto Arsizio, Italy.	landsben@uninsubria.it	Sertic, Sarah/AAD-8972-2021; Di Cunto, Ferdinando/K-5575-2016	SERTIC, SARAH/0000-0003-1458-410X; stefanelli, gilda/0000-0001-7034-8174; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; Landsberger, Nicoletta/0000-0003-0820-3155; di cunto, ferdinando/0000-0001-9367-6357	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-10319]; Telethon [GGP10032, GGP12094]; Ministero della Salute; Fondation Jerome Lejeune; Italian Association proRETT Ricerca; ProRETT Ricerca, an Italian association of parents	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); Ministero della Salute(Ministry of Health, Italy); Fondation Jerome Lejeune; Italian Association proRETT Ricerca; ProRETT Ricerca, an Italian association of parents	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant IG-10319 (to N. L.), by Telethon Grants GGP10032 (to N. L.) and GGP12094 (to F. D. C.), by Ministero della Salute (Ricerca finalizzata 2008-Bando Malattie Rare) (to N. L.), by a Fondation Jerome Lejeune grant (to F. D. C.), by the Italian Association proRETT Ricerca, and by ProRETT Ricerca, an Italian association of parents.	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Ausio J, 2014, TRENDS MOL MED, V20, P487, DOI 10.1016/j.molmed.2014.03.004; Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082; Babbio F, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-19; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Balmer D, 2002, HUM GENET, V110, P545, DOI 10.1007/s00439-002-0724-4; Bedogni F, 2014, NEUROSCI BIOBEHAV R, V46, P187, DOI 10.1016/j.neubiorev.2014.01.011; Bellini E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00236; Bracaglia G, 2009, EMBO REP, V10, P1327, DOI 10.1038/embor.2009.217; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Cheval H, 2012, HUM MOL GENET, V21, P3806, DOI 10.1093/hmg/dds208; Damen D, 2013, BIOL CHEM, V394, P1595, DOI 10.1515/hsz-2013-0193; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Delepine C, 2013, FEBS LETT, V587, P245, DOI 10.1016/j.febslet.2012.11.033; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Inui K, 2001, BRAIN DEV-JPN, V23, P212, DOI 10.1016/S0387-7604(01)00197-8; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; Li HD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6601; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Marschik PB, 2013, RES DEV DISABIL, V34, P1236, DOI 10.1016/j.ridd.2013.01.014; Mazzorana M, 2011, CURR CANCER DRUG TAR, V11, P600, DOI 10.2174/156800911795655949; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Minh VCN, 2012, J NEUROSCI, V32, P10021, DOI 10.1523/JNEUROSCI.1316-12.2012; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Nagai K, 2005, DEV BRAIN RES, V157, P103, DOI 10.1016/j.devbrainres.2005.03.011; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Reber S, 2011, METHODS MOL BIOL, V777, P107, DOI 10.1007/978-1-61779-252-6_8; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Roux JC, 2012, NEUROBIOL DIS, V45, P786, DOI 10.1016/j.nbd.2011.11.002; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Thambirajah AA, 2009, BIOESSAYS, V31, P561, DOI 10.1002/bies.200800220; Webb R, 2009, ARTHRITIS RHEUM-US, V60, P1076, DOI 10.1002/art.24360; Yaqinuddin A, 2008, BIOSCIENCE REP, V28, P319, DOI 10.1042/BSR20080032; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	52	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3223	3237		10.1074/jbc.M114.608125	http://dx.doi.org/10.1074/jbc.M114.608125			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25527496	Green Published, hybrid			2022-12-28	WOS:000349456000004
J	Hamm, DC; Bondra, ER; Harrison, MM				Hamm, Danielle C.; Bondra, Eliana R.; Harrison, Melissa M.			Transcriptional Activation Is a Conserved Feature of the Early Embryonic Factor Zelda That Requires a Cluster of Four Zinc Fingers for DNA Binding and a Low-complexity Activation Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-ZYGOTIC TRANSITION; CELL-FREE FORMATION; DROSOPHILA-MELANOGASTER; GENE; REGIONS; REPRESSION; BLASTODERM; PHYLOGENY; SEQUENCES; THOUSANDS	Delayed transcriptional activation of the zygotic genome is a nearly universal phenomenon in metazoans. Immediately following fertilization, development is controlled by maternally deposited products, and it is not until later stages that widespread activation of the zygotic genome occurs. Although the mechanisms driving this genome activation are currently unknown, the transcriptional activator Zelda (ZLD) has been shown to be instrumental in driving this process in Drosophila melanogaster. Here we define functional domains of ZLD required for both DNA binding and transcriptional activation. We show that the C-terminal cluster of four zinc fingers mediates binding to TAG team DNA elements in the promoters of early expressed genes. All four zinc fingers are required for this activity, and splice isoforms lacking three of the four zinc fingers fail to activate transcription. These truncated splice isoforms dominantly suppress activation by the full-length, embryonically expressed isoform. We map the transcriptional activation domain of ZLD to a central region characterized by low complexity. Despite relatively little sequence conservation within this domain, ZLD orthologs from Drosophila virilis, Anopheles gambiae, and Nasonia vitripennis activate transcription in D. melanogaster cells. Transcriptional activation by these ZLD orthologs suggests that ZLD functions through conserved interactions with a protein cofactor(s). We have identified distinct DNA-binding and activation domains within the critical transcription factor ZLD that controls the initial activation of the zygotic genome.	[Hamm, Danielle C.; Bondra, Eliana R.; Harrison, Melissa M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Harrison, MM (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall 1135, Madison, WI 53706 USA.	mharrison3@wisc.edu		Hamm, Danielle/0000-0003-2966-7389	March of Dimes; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111694] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Basil O'Connor Starter Scholar Research Award from the March of Dimes (to M. M. H.) and by a National Science Foundation predoctoral fellowship (to D. C. H.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Biedler JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033933; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Foo SM, 2014, CURR BIOL, V24, P1341, DOI 10.1016/j.cub.2014.04.032; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Giannios P, 2013, BIOCHEM BIOPH RES CO, V438, P329, DOI 10.1016/j.bbrc.2013.07.071; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Paris M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003748; Pearson JC, 2012, DEV BIOL, V366, P420, DOI 10.1016/j.ydbio.2012.04.001; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Staudt N, 2006, MOL BIOL CELL, V17, P2356, DOI 10.1091/mbc.E05-11-1056; Struffi P, 2011, DEVELOPMENT, V138, P4291, DOI 10.1242/dev.065987; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wrischnik LA, 2003, GENETICS, V165, P2007	40	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3508	3518		10.1074/jbc.M114.602292	http://dx.doi.org/10.1074/jbc.M114.602292			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538246	Green Published, hybrid			2022-12-28	WOS:000349456000025
J	Itou, H; Yagura, M; Shirakihara, Y; Itoh, T				Itou, Hiroshi; Yagura, Masaru; Shirakihara, Yasuo; Itoh, Tateo			Structural Basis for Replication Origin Unwinding by an Initiator Primase of Plasmid ColE2-P9 DUPLEX DNA UNWINDING BY A SINGLE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REP PROTEIN; SPECIFICITY DETERMINANTS; CRYSTAL-STRUCTURE; COLE3 PLASMIDS; STRANDED-DNA; REFINEMENT; MECHANISM; INSIGHTS; COMPLEX	Duplex DNA is generally unwound by protein oligomers prior to replication. The Rep protein of plasmid ColE2-P9 (34 kDa) is an essential initiator for plasmid DNA replication. This protein binds the replication origin (Ori) in a sequence-specific manner as a monomer and unwinds DNA. Here we present the crystal structure of the DNA-binding domain of Rep (E2Rep-DBD) in complex with Ori DNA. The structure unveils the basis for Ori-specific recognition by the E2Rep-DBD and also reveals that it unwinds DNA by the concerted actions of its three contiguous structural modules. The structure also shows that the functionally unknown PriCT domain, which forms a compact module, plays a central role in DNA unwinding. The conservation of the PriCT domain in the C termini of some archaeo-eukaryotic primases indicates that it probably plays a similar role in these proteins. Thus, this is the first report providing the structural basis for the functional importance of the conserved PriCT domain and also reveals a novel mechanism for DNA unwinding by a single protein.	[Itou, Hiroshi; Shirakihara, Yasuo] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan; [Yagura, Masaru] Natl Inst Genet, Dept Cell Genet, Mishima, Shizuoka 4118540, Japan; [Itoh, Tateo] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Shinshu University	Itou, H (corresponding author), Natl Inst Genet, Struct Biol Ctr, Yata 1111, Mishima, Shizuoka 4118540, Japan.	hitou@nig.ac.jp			Japan Society for the Promotion of Science KAKENHI [25840027]; Grants-in-Aid for Scientific Research [25840027] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 25840027 (to H. I.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki K, 2007, J BACTERIOL, V189, P2392, DOI 10.1128/JB.01695-06; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boulikas T, 1996, J CELL BIOCHEM, V60, P297, DOI 10.1002/(SICI)1097-4644(19960301)60:3<297::AID-JCB2>3.0.CO;2-R; CARRERA P, 1994, NUCLEIC ACIDS RES, V22, P3671, DOI 10.1093/nar/22.18.3671; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Duderstadt KE, 2013, CURR OPIN STRUC BIOL, V23, P144, DOI 10.1016/j.sbi.2012.11.012; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giraldo R, 2004, PLASMID, V52, P69, DOI 10.1016/j.plasmid.2004.06.002; Giraldo R, 2003, NAT STRUCT BIOL, V10, P565, DOI 10.1038/nsb937; Han M, 2007, J BACTERIOL, V189, P1061, DOI 10.1128/JB.01455-06; Han M., 2007, THESIS SHINSHU U MAT; Han M, 2007, BIOCHEM BIOPH RES CO, V353, P306, DOI 10.1016/j.bbrc.2006.12.015; HORII T, 1988, MOL GEN GENET, V212, P225, DOI 10.1007/BF00334689; ITOH T, 1989, MOL GEN GENET, V219, P249, DOI 10.1007/BF00261184; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; KIDO M, 1991, NUCLEIC ACIDS RES, V19, P2875, DOI 10.1093/nar/19.11.2875; KINGSBURY D T, 1970, Biochemical and Biophysical Research Communications, V41, P1538, DOI 10.1016/0006-291X(70)90562-0; Komori H, 1999, EMBO J, V18, P4597, DOI 10.1093/emboj/18.17.4597; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Le Chatelier E, 2001, J BIOL CHEM, V276, P10234, DOI 10.1074/jbc.M010118200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura A, 2007, P NATL ACAD SCI USA, V104, P18484, DOI 10.1073/pnas.0705623104; Neuwald AF, 1999, GENOME RES, V9, P27; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Schumacher MA, 2014, P NATL ACAD SCI USA, V111, P9121, DOI 10.1073/pnas.1406065111; Shinohara M, 1996, J MOL BIOL, V257, P290, DOI 10.1006/jmbi.1996.0163; Swan MK, 2006, P NATL ACAD SCI USA, V103, P18481, DOI 10.1073/pnas.0609046103; TAKECHI S, 1995, NUCLEIC ACIDS RES, V23, P4196, DOI 10.1093/nar/23.20.4196; TAKECHI S, 1995, EMBO J, V14, P5141, DOI 10.1002/j.1460-2075.1995.tb00196.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Yagura M, 2006, J BACTERIOL, V188, P999, DOI 10.1128/JB.188.3.999-1010.2006; Yagura M, 2006, BIOCHEM BIOPH RES CO, V345, P872, DOI 10.1016/j.bbrc.2006.04.168; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; YASUEDA H, 1989, MOL GEN GENET, V215, P209, DOI 10.1007/BF00339719; Zannis-Hadjopoulos M, 1999, J CELL BIOCHEM, P1	46	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3601	3611		10.1074/jbc.M114.595645	http://dx.doi.org/10.1074/jbc.M114.595645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25538245	hybrid, Green Published			2022-12-28	WOS:000349456000033
J	Nishihara, T; Remacle, AG; Angert, M; Shubayev, I; Shiryaev, SA; Liu, HQ; Dolkas, J; Chernov, AV; Strongin, AY; Shubayev, VI				Nishihara, Tasuku; Remacle, Albert G.; Angert, Mila; Shubayev, Igor; Shiryaev, Sergey A.; Liu, Huaqing; Dolkas, Jennifer; Chernov, Andrei V.; Strongin, Alex Y.; Shubayev, Veronica I.			Matrix Metalloproteinase-14 Both Sheds Cell Surface Neuronal Glial Antigen 2 (NG2) Proteoglycan on Macrophages and Governs the Response to Peripheral Nerve Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; AXONAL REGENERATION; SENSORY AXONS; EXPRESSION; GROWTH; INHIBITION; CLEAVAGE; PROTEIN; PROTEOLYSIS; ACTIVATION	Neuronal glial antigen 2 (NG2) is an integral membrane chondroitin sulfate proteoglycan expressed by vascular pericytes, macrophages (NG2-M phi), and progenitor glia of the nervous system. Herein, we revealed that NG2 shedding and axonal growth, either independently or jointly, depended on the pericellular remodeling events executed by membrane-type 1 matrix metalloproteinase (MT1-MMP/MMP-14). Using purified NG2 ectodomain constructs, individual MMPs, and primary NG2-M phi cultures, we demonstrated for the first time that MMP-14 performed as an efficient and unconventional NG2 sheddase and that NG2-M phi infiltrated into the damaged peripheral nervous system. We then characterized the spatiotemporal relationships among MMP-14, MMP-2, and tissue inhibitor of metalloproteinases-2 in sciatic nerve. Tissue inhibitor of metalloproteinases-2-free MMP-14 was observed in the primary Schwann cell cultures using the inhibitory hydroxamate warhead-based MP-3653 fluorescent reporter. In teased nerve fibers, MMP-14 translocated postinjury toward the nodes of Ranvier and its substrates, laminin and NG2. Inhibition of MMP-14 activity using the selective, function-blocking DX2400 human monoclonal antibody increased the levels of regeneration-associated factors, including laminin, growth-associated protein 43, and cAMP-dependent transcription factor 3, thereby promoting sensory axon regeneration after nerve crush. Concomitantly, DX2400 therapy attenuated mechanical hypersensitivity associated with nerve crush in rats. Together, our findings describe a new model in which MMP-14 proteolysis regulates the extracellular milieu and presents a novel therapeutic target in the damaged peripheral nervous system and neuropathic pain.	[Nishihara, Tasuku; Angert, Mila; Liu, Huaqing; Dolkas, Jennifer; Shubayev, Veronica I.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Nishihara, Tasuku; Angert, Mila; Shubayev, Igor; Liu, Huaqing; Dolkas, Jennifer; Shubayev, Veronica I.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92037 USA; [Remacle, Albert G.; Shiryaev, Sergey A.; Chernov, Andrei V.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Nishihara, Tasuku] Ehime Univ, Dept Anesthesiol & Resuscitol, Toon, Ehime 7910295, Japan	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Sanford Burnham Prebys Medical Discovery Institute; Ehime University	Shubayev, VI (corresponding author), Univ Calif San Diego, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	vshubayev@ucsd.edu	Strongin, Alex/R-6609-2019; Chernov, Andrei/I-1623-2019	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418	National Institutes of Health [RO1DE022757, UL1 RR031980]; Department of Veterans Affairs [5IO1BX000638]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DE022757 (to V. I. S. and A. Y. S.) and UL1 RR031980 (to University of California, San Diego and A. G. R.). This work was also supported by Department of Veterans Affairs Grant 5IO1BX000638 (to V. I. S.).	Asher RA, 2005, MOL CELL NEUROSCI, V29, P82, DOI 10.1016/j.mcn.2005.02.001; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851; Chen EI, 2003, J BIOL CHEM, V278, P17158, DOI 10.1074/jbc.M210324200; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Court FA, 2011, J NEUROSCI, V31, P12208, DOI 10.1523/JNEUROSCI.0141-11.2011; de Castro R, 2005, EXP NEUROL, V192, P299, DOI 10.1016/j.expneurol.2004.11.027; Devy L, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/191670; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Hossain-Ibrahim MK, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-80; Hughes PM, 2002, NEUROSCIENCE, V113, P273, DOI 10.1016/S0306-4522(02)00183-5; Hunanyan AS, 2010, J NEUROSCI, V30, P7761, DOI 10.1523/JNEUROSCI.4659-09.2010; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P85; Kobayashi H, 2008, MOL CELL NEUROSCI, V39, P619, DOI 10.1016/j.mcn.2008.08.008; Krekoski CA, 2002, J NEUROSCI, V22, P10408; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Lehmann HC, 2009, GLIA, V57, P479, DOI 10.1002/glia.20774; Liu HQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-119; Liu HQ, 2010, J NEUROPATH EXP NEUR, V69, P386, DOI 10.1097/NEN.0b013e3181d68d12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; Martin S, 2001, J NEUROSCI, V21, P8119, DOI 10.1523/JNEUROSCI.21-20-08119.2001; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; MCQUARRIE IG, 1977, BRAIN RES, V132, P443, DOI 10.1016/0006-8993(77)90193-7; Milward E, 2008, J NEUROIMMUNOL, V193, P140, DOI 10.1016/j.jneuroim.2007.11.001; Morgenstern DA, 2003, MOL CELL NEUROSCI, V24, P787, DOI 10.1016/S1044-7431(03)00245-8; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nishihara T, 2011, EXP NEUROL, V229, P507, DOI 10.1016/j.expneurol.2011.04.006; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Onda A, 2001, SPINE, V26, P2186, DOI 10.1097/00007632-200110150-00005; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Remacle AG, 2013, J BIOL CHEM, V288, P20568, DOI 10.1074/jbc.M113.471508; Rezajooi K, 2004, MOL CELL NEUROSCI, V25, P572, DOI 10.1016/j.mcn.2003.10.009; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Schneider S, 2001, J NEUROSCI, V21, P920, DOI 10.1523/JNEUROSCI.21-03-00920.2001; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Shiryaev SA, 2011, FEBS J, V278, P3277, DOI 10.1111/j.1742-4658.2011.08244.x; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Tan AM, 2006, J NEUROSCI, V26, P4729, DOI 10.1523/JNEUROSCI.3900-05.2006; Tanaka J, 1998, GLIA, V24, P198, DOI 10.1002/(SICI)1098-1136(199810)24:2<198::AID-GLIA5>3.3.CO;2-S; Tillet E, 1997, J BIOL CHEM, V272, P10769; Ughrin YM, 2003, J NEUROSCI, V23, P175; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	65	38	40	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3693	3707		10.1074/jbc.M114.603431	http://dx.doi.org/10.1074/jbc.M114.603431			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25488667	Green Published, hybrid			2022-12-28	WOS:000349456000041
J	Wigington, CP; Jung, J; Rye, EA; Belauret, SL; Philpot, AM; Feng, Y; Santangelo, PJ; Corbett, AH				Wigington, Callie P.; Jung, Jeenah; Rye, Emily A.; Belauret, Sara L.; Philpot, Akahne M.; Feng, Yue; Santangelo, Philip J.; Corbett, Anita H.			Post-transcriptional Regulation of Programmed Cell Death 4 (PDCD4) mRNA by the RNA-binding Proteins Human Antigen R (HuR) and T-cell Intracellular Antigen 1 (TIA1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PDCD4; INITIATION-FACTOR 4A; BREAST-CANCER CELLS; AU-RICH ELEMENT; GENE-EXPRESSION; TRANSFORMATION SUPPRESSOR; TRANSLATIONAL SILENCER; ARGININE METHYLATION; SPLICING REGULATOR; PROXIMITY LIGATION	Post-transcriptional processing of mRNA transcripts plays a critical role in establishing the gene expression profile of a cell. Such processing events are mediated by a host of factors, including RNA-binding proteins and microRNAs. A number of critical cellular pathways are subject to regulation at multiple levels that allow fine-tuning of key biological responses. Programmed cell death 4 (PDCD4) is a tumor suppressor and an important modulator of mRNA translation that is regulated by a number of mechanisms, most notably as a target of the on comiR, miR-21. Here, we provide evidence for post-transcriptional regulation of PDCD4 by the RNA-binding proteins, HuR and TIA1. Complementary approaches reveal binding of both HuR and TIA1 to the PDCD4 transcript. Consistent with a model where RNA-binding proteins modulate the PDCD4 transcript, knockdown of HuR and/or TIA1 results in a significant decrease in steady-state PDCD4 mRNA and protein levels. However, fractionation experiments suggest that the mode of regulation of the PDCD4 transcript likely differs in the cytoplasm and the nucleus as the pool of PDCD4 mRNA present in the cytoplasm is more stable than the nuclear pool of PDCD4 transcript. We observe a competitive mode of binding between HuR and TIA1 on the PDCD4 transcript in the cytoplasm, suggesting that these two factors dynamically interact with one another as well as the PDCD4 transcript to maintain tight control of PDCD4 levels. Overall, this study reveals an additional set of regulatory interactions that modulate the expression of PDCD4, a key pro-apoptotic factor, and also reveals new insights into how HuR and TIA1 functions are integrated to achieve such regulation.	[Wigington, Callie P.; Rye, Emily A.; Philpot, Akahne M.; Corbett, Anita H.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Wigington, Callie P.; Rye, Emily A.] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA; [Jung, Jeenah; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Jung, Jeenah; Santangelo, Philip J.] Emory Univ, Atlanta, GA 30332 USA; [Belauret, Sara L.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30322 USA; [Philpot, Akahne M.] Winship Canc Inst, Summer Scholars Res Program, Atlanta, GA 30332 USA; [Feng, Yue] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021	Corbett, Anita/0000-0002-0461-6895; Feng, Yue/0000-0002-7905-2182	National Institutes of Health [R01 GM058728, R01 GM094198, R21 CA147922, F31 CA168321, T32 GM008367]; NATIONAL CANCER INSTITUTE [F31CA168321, R21CA147922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728, T32GM008169, T32GM008367, R01GM094198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM058728 (to A. H. C.), R01 GM094198 and R21 CA147922 (to P. J. S.), and F31 CA168321 and T32 GM008367 (to C. P. W.).	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Abdelmohsen K, 2014, NUCLEIC ACIDS RES, V42, P10099, DOI 10.1093/nar/gku686; Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Abe R, 1996, NUCLEIC ACIDS RES, V24, P4895, DOI 10.1093/nar/24.24.4895; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blackinton JG, 2014, SEMIN CELL DEV BIOL, V34, P44, DOI 10.1016/j.semcdb.2014.05.014; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chan YA, 2014, TRENDS GENET, V30, P245, DOI 10.1016/j.tig.2014.03.005; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Fan H, 2007, EUR J GASTROEN HEPAT, V19, P952, DOI 10.1097/MEG.0b013e3282c3a89e; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fay MM, 2014, J BIOL CHEM, V289, P17541, DOI 10.1074/jbc.M113.541300; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guo X, 2006, CANCER RES, V66, P7948, DOI 10.1158/0008-5472.CAN-05-4362; HURWITZ J, 1962, P NATL ACAD SCI USA, V48, P1222, DOI 10.1073/pnas.48.7.1222; Irier HA, 2009, J NEUROCHEM, V109, P584, DOI 10.1111/j.1471-4159.2009.05992.x; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Jung J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks837; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim J, 2014, CELL DEATH DIFFER, V21, P481, DOI 10.1038/cdd.2013.171; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kulikov AV, 2012, CELL MOL LIFE SCI, V69, P1787, DOI 10.1007/s00018-011-0895-z; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leupold JH, 2012, BIOSCIENCE REP, V32, P281, DOI 10.1042/BSR20110045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loreni F, 2000, EUR J BIOCHEM, V267, P6594, DOI 10.1046/j.1432-1327.2000.01753.x; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Powers MA, 2011, CANCER RES, V71, P5579, DOI 10.1158/0008-5472.CAN-11-0458; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Santangelo PJ, 2012, METHOD ENZYMOL, V505, P383, DOI 10.1016/B978-0-12-388448-0.00028-0; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Srikantan S, 2011, MOL CELL BIOL, V31, P3790, DOI 10.1128/MCB.05639-11; Subramaniam K, 2010, CANCER LETT, V297, P259, DOI 10.1016/j.canlet.2010.05.019; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tominaga K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; Vikhreva PN, 2014, BBA-GENE REGUL MECH, V1839, P43, DOI 10.1016/j.bbagrm.2013.12.001; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; Wang H, 2011, ACTA CRYSTALLOGR F, V67, P546, DOI 10.1107/S1744309110052930; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07; Zhu H, 2006, MOL BIOL CELL, V17, P5105, DOI 10.1091/mbc.E06-02-0099; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	94	39	40	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3468	3487		10.1074/jbc.M114.631937	http://dx.doi.org/10.1074/jbc.M114.631937			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25519906	Green Published, hybrid			2022-12-28	WOS:000349456000022
J	Losick, R				Losick, Richard			A Love Affair with Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; Biofilm; Differentiation; RNA Polymerase; Sporulation	DEVELOPMENTAL TRANSCRIPTION FACTOR; POLYMERASE SIGMA-FACTOR; CELL-SPECIFIC TRANSCRIPTION; GREEN FLUORESCENT PROTEIN; RNA-POLYMERASE; GENE-EXPRESSION; BIOFILM FORMATION; REGULATORY PROTEIN; MOTHER-CELL; SPORE COAT	My career in science was launched when I was an undergraduate at Princeton University and reinforced by graduate training at the Massachusetts Institute of Technology. However, it was only after I moved to Harvard University as a junior fellow that my affections were captured by a seemingly mundane soil bacterium. What Bacillus subtilis offered was endless fascinating biological problems (alternative sigma factors, sporulation, swarming, biofilm formation, stochastic cell fate switching) embedded in a uniquely powerful genetic system. Along the way, my career in science became inseparably interwoven with teaching and mentoring, which proved to be as rewarding as the thrill of discovery.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 01238 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 01238 USA.	losick@mcb.harvard.edu						ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Alper S, 1996, J MOL BIOL, V260, P165, DOI 10.1006/jmbi.1996.0390; Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; BINNIE C, 1986, P NATL ACAD SCI USA, V83, P5943, DOI 10.1073/pnas.83.16.5943; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Camp AH, 2008, MOL MICROBIOL, V69, P402, DOI 10.1111/j.1365-2958.2008.06289.x; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; Carniol K, 2005, J BACTERIOL, V187, P3511, DOI 10.1128/JB.187.10.3511-3520.2005; Carniol K, 2004, J BIOL CHEM, V279, P14860, DOI 10.1074/jbc.M314274200; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chai YR, 2009, J BACTERIOL, V191, P2423, DOI 10.1128/JB.01464-08; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; CLARK S, 1974, NATURE, V252, P21, DOI 10.1038/252021a0; CUTTING S, 1989, J MOL BIOL, V207, P393, DOI 10.1016/0022-2836(89)90262-3; CUTTING S, 1991, GENE DEV, V5, P456, DOI 10.1101/gad.5.3.456; CUTTING S, 1990, CELL, V62, P239, DOI 10.1016/0092-8674(90)90362-I; DONOVAN W, 1987, J MOL BIOL, V196, P1, DOI 10.1016/0022-2836(87)90506-7; DRIKS A, 1991, P NATL ACAD SCI USA, V88, P9934, DOI 10.1073/pnas.88.22.9934; DUBNAU E, 1988, J BACTERIOL, V170, P1054, DOI 10.1128/jb.170.3.1054-1062.1988; DUNCAN L, 1993, P NATL ACAD SCI USA, V90, P2325, DOI 10.1073/pnas.90.6.2325; Duncan L, 1996, J MOL BIOL, V260, P147, DOI 10.1006/jmbi.1996.0389; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; DUNCAN ML, 1987, J BACTERIOL, V169, P771, DOI 10.1128/jb.169.2.771-778.1987; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Eichenberger P, 2003, J MOL BIOL, V327, P945, DOI 10.1016/S0022-2836(03)00205-5; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FOX TD, 1976, J MOL BIOL, V101, P427, DOI 10.1016/0022-2836(76)90157-1; FUJITA DJ, 1971, J MOL BIOL, V57, P301, DOI 10.1016/0022-2836(71)90348-2; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; GROSSMAN AD, 1988, P NATL ACAD SCI USA, V85, P4369, DOI 10.1073/pnas.85.12.4369; HALDENWANG WG, 1981, CELL, V23, P615, DOI 10.1016/0092-8674(81)90157-4; HALDENWANG WG, 1980, P NATL ACAD SCI-BIOL, V77, P7000, DOI 10.1073/pnas.77.12.7000; HALDENWANG WG, 1979, NATURE, V282, P256, DOI 10.1038/282256a0; HARRY EJ, 1995, J BACTERIOL, V177, P3386, DOI 10.1128/jb.177.12.3386-3393.1995; HOFMEISTER AEM, 1995, CELL, V83, P219, DOI 10.1016/0092-8674(95)90163-9; IGO M, 1987, J BACTERIOL, V169, P3464, DOI 10.1128/jb.169.8.3464-3469.1987; IGO MM, 1986, J MOL BIOL, V191, P615, DOI 10.1016/0022-2836(86)90449-3; KARMAZYNCAMPELLI C, 1989, GENE DEV, V3, P150, DOI 10.1101/gad.3.2.150; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; KUNKEL B, 1989, GENE DEV, V3, P1735, DOI 10.1101/gad.3.11.1735; LABELL TL, 1987, P NATL ACAD SCI USA, V84, P1784, DOI 10.1073/pnas.84.7.1784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LINN T, 1976, CELL, V8, P103, DOI 10.1016/0092-8674(76)90191-4; LINN TG, 1973, P NATL ACAD SCI USA, V70, P1865, DOI 10.1073/pnas.70.6.1865; LOSICK R, 1966, J BIOL CHEM, V241, P2340; LOSICK R, 1981, CELL, V25, P582, DOI 10.1016/0092-8674(81)90164-1; LOSICK R, 1969, SCI AM, V221, P120, DOI 10.1038/scientificamerican1169-120; LOSICK R, 1969, NATURE, V224, P35, DOI 10.1038/224035a0; LOSICK R, 1992, NATURE, V355, P601, DOI 10.1038/355601a0; LOSICK R, 1967, J MOL BIOL, V30, P445, DOI 10.1016/0022-2836(67)90361-0; MARGOLIS P, 1991, SCIENCE, V254, P562, DOI 10.1126/science.1948031; McLoon AL, 2011, J BACTERIOL, V193, P2027, DOI 10.1128/JB.01542-10; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; MORAN CP, 1981, CELL, V25, P783, DOI 10.1016/0092-8674(81)90186-0; Norman TM, 2013, NATURE, V503, P481, DOI 10.1038/nature12804; OKE V, 1993, J BACTERIOL, V175, P7341, DOI 10.1128/JB.175.22.7341-7347.1993; Okubo S., 1972, BIKEN J, V2, P81; OLLINGTON JF, 1981, J BACTERIOL, V147, P443, DOI 10.1128/JB.147.2.443-451.1981; OLLINGTON JF, 1981, J BACTERIOL, V147, P432, DOI 10.1128/JB.147.2.432-442.1981; PERO J, 1975, NATURE, V257, P248, DOI 10.1038/257248a0; Ramamurthi KS, 2008, MOL CELL, V31, P406, DOI 10.1016/j.molcel.2008.05.030; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; RICCA E, 1992, J BACTERIOL, V174, P3177, DOI 10.1128/jb.174.10.3177-3184.1992; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; SANDMAN K, 1988, J MOL BIOL, V200, P461, DOI 10.1016/0022-2836(88)90536-0; SANDMAN K, 1987, GENETICS, V117, P603; SCHMIDT R, 1990, P NATL ACAD SCI USA, V87, P9221, DOI 10.1073/pnas.87.23.9221; SEGALL J, 1977, CELL, V11, P751, DOI 10.1016/0092-8674(77)90289-6; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shapiro L., 1984, MICROBIAL DEV; SHORENSTEIN RG, 1973, J BIOL CHEM, V248, P6163; STEPHENS MA, 1984, J MOL BIOL, V176, P333, DOI 10.1016/0022-2836(84)90493-5; STRAGIER P, 1989, SCIENCE, V243, P507, DOI 10.1126/science.2536191; SUN DX, 1989, GENE DEV, V3, P141, DOI 10.1101/gad.3.2.141; TJIAN R, 1974, P NATL ACAD SCI USA, V71, P2872, DOI 10.1073/pnas.71.7.2872; TREMPY JE, 1985, P NATL ACAD SCI USA, V82, P4189, DOI 10.1073/pnas.82.12.4189; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; WEBB CD, 1995, J BACTERIOL, V177, P5906, DOI 10.1128/jb.177.20.5906-5911.1995; YOUNGMAN P, 1985, SCIENCE, V228, P285, DOI 10.1126/science.228.4697.285; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305; ZHENG LB, 1988, GENE DEV, V2, P1047, DOI 10.1101/gad.2.8.1047; ZHENG LB, 1990, J MOL BIOL, V212, P645, DOI 10.1016/0022-2836(90)90227-D; ZHENG LB, 1992, J MOL BIOL, V226, P1037, DOI 10.1016/0022-2836(92)91051-P; ZUBER P, 1983, CELL, V35, P275, DOI 10.1016/0092-8674(83)90230-1	104	5	5	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2529	2538		10.1074/jbc.X114.634808	http://dx.doi.org/10.1074/jbc.X114.634808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25533458	Green Published, hybrid			2022-12-28	WOS:000349310700001
J	Wang, RR; You, JX				Wang, Ranran; You, Jianxin			Mechanistic Analysis of the Role of Bromodomain-containing Protein 4 (BRD4) in BRD4-NUT Oncoprotein-induced Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyltransferase; Bromodomain-containing Protein 4 (BRD4); E1A Binding Protein p300 (P300); Transcription Elongation Factor; Transcription Factor; BRD4-NUT; NUT Midline Carcinoma; Transcriptional Activation	NUT MIDLINE CARCINOMA; PAPILLOMAVIRUS E2 PROTEIN; ACETYLATED CHROMATIN; SELECTIVE-INHIBITION; BET BROMODOMAINS; GENE-EXPRESSION; S-PHASE; DIFFERENTIATION; PROGRESSION; TARGET	Background: NUT midline carcinoma is an aggressive cancer typically caused by the formation of the BRD4-NUT fusion oncoprotein. Results: BRD4-NUT-stimulated histone hyperacetylation recruits BRD4 and associated transcription factors to activate gene expression. Conclusion:BRD4-NUT perturbs normal gene expression to trigger oncogenic events in NMC. Significance: Breaking BRD4-NUT interaction with histone acetyltransferases is an excellent strategy to abrogate the BRD4-NUT oncogenic activities. NUT midline carcinoma (NMC) is a rare but highly aggressive cancer typically caused by the translocation t(15;19), which results in the formation of the BRD4-NUT fusion oncoprotein. Previous studies have demonstrated that fusion of the NUT protein with the double bromodomains of BRD4 may significantly alter the cellular gene expression profile to contribute to NMC tumorigenesis. However, the mechanistic details of this BRD4-NUT function remain poorly understood. In this study, we examined the NUT function in transcriptional regulation by targeting it to a LacO transgene array integrated in U2OS 2-6-3 cells, which allow us to visualize how NUT alters the in situ gene transcription dynamic. Using this system, we demonstrated that the NUT protein tethered to the LacO locus recruits p300/CREB-binding protein (CBP), induces histone hyperacetylation, and enriches BRD4 to the transgene array chromatin foci. We also discovered that, in BRD4-NUT expressed in NMC cells, the NUT moiety of the fusion protein anchored to chromatin by the double bromodomains also stimulates histone hyperacetylation, which causes BRD4 to bind tighter to chromatin. Consequently, multiple BRD4-interacting factors are recruited to the NUT-associated chromatin locus to activate in situ transgene expression. This gene transcription function was repressed by either expression of a dominant negative inhibitor of the p300-NUT interaction or treatment with (+)-JQ1, which dissociates BRD4 from the LacO chromatin locus. Our data support a model in which BRD4-NUT-stimulated histone hyperacetylation recruits additional BRD4 and interacting partners to support transcriptional activation, which underlies the BRD4-NUT oncogenic mechanism in NMC.	[Wang, Ranran; You, Jianxin] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	You, JX (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu		Wang, Ranran/0000-0002-7920-0704	National Institutes of Health [R01CA148768, R01CA142723]; NATIONAL CANCER INSTITUTE [R01CA148768, R01CA142723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA148768 and R01CA142723.	Bauer DE, 2012, CLIN CANCER RES, V18, P5773, DOI 10.1158/1078-0432.CCR-12-1153; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2003, CANCER RES, V63, P304; French CA, 2014, CANCER DISCOV, V4, P928, DOI 10.1158/2159-8290.CD-14-0014; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Grayson AR, 2014, ONCOGENE, V33, P1736, DOI 10.1038/onc.2013.126; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Li J, 2014, VIRUSES-BASEL, V6, P319, DOI 10.3390/v6010319; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Rafalska-Metcalf IU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010272; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Rodriguez RM, 2012, J MOL MED, V90, P587, DOI 10.1007/s00109-011-0837-0; Wang RR, 2014, CANCER RES, V74, P3332, DOI 10.1158/0008-5472.CAN-13-2658; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yan JP, 2011, J BIOL CHEM, V286, P27663, DOI 10.1074/jbc.M111.246975; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	34	42	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2744	2758		10.1074/jbc.M114.600759	http://dx.doi.org/10.1074/jbc.M114.600759			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25512383	Green Published, hybrid			2022-12-28	WOS:000349310700017
